Citrus Sinensis ID: 041921

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810----
Protein Sequence
MTSARLYFIFLLFQLPYFSHLAIAQNNGTVPVGATLTAGTSSSPWLSPSGDFAFGFHQLDEENNTNDLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLTADQGLVLNDPQGKQVWSSKIDIGTVAVGHMNDTGNFVLASSSSGRLWDSFSNPTDTLLLGQMMETEQGLFSRKSENNFSRGRFQFRLLEDGNLVLNIANLATGFAYDAYYTSGTYDPANSSNSGYRVMFNESGYMYILRRNGGRFDLTTERVVPAADFYYRATLNFDGVFAQYFYPKNGNGNWSVAWSEPENICVDIGGGLGSGACGYNSICTLDSDRRPRCACPKGYSLLDENDRYGSCRPDFELSCWGGGQGYNKELFDFHELKNINWPQSDYERFKPYNEVQCKNTCLSDCFCAAVIFNDGSCWFKKLPLSNGMTDSRIAGKAFIKYKNKGDDPPSVPRPPDPEDKKKSKMMNATGSVLLGSSVFVNFALVCAFVLGFSFIYKKKWIRNSPDDGTIETNLRCFSYKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVPPNPYPFSSSMGLY
Secondary Structure (PSIPRED)
cccccHHHHHHHHHHHHHHHHHHHccccccccccccccccccccEEcccccEEEEEEccccccccccEEEEEEEEcccccccEEEEEcccccccccccccEEEEEEccEEEEEcccccEEEEccccccccEEEEEEccccEEEEccccccccccccccccccccccccccccEEEEcccccccccEEEEEEEEEcccEEEEEEcccccccccccccccccccccccccccEEEEEcccEEEEEEccccEEEEEEEccccccccEEEEEEcccccEEEEEEcccccccEEEEEEccccccccccccccccccccccccccccccccccccccccEEccccccccccccccccccccccccccccEEEEEEEcccccccccccccccccHHHHHHHHHccccEEEEEEccccEEEcccccccccccccccccEEEEEEccccccccccccccccccccccccccEEEEHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccEEEHHHHHHHHcccccccccccccEEEEEEEcccccccEEEEEEcccccHHHHHHHHHHHHHHHHHcccccccEEEcccccccEEEEEEccccccccccccccccccHHHHHHHHHHHHHHHHHHcccccccEEEEcccccccccccccccccccccccccccccccccccccEEEcccccccHHHccccccEEcEEEEEEEEEEEEEEEcccccccccccHHcHHHHHHHHHHcccccccccccccccccHHHHHHHHHHHHHcccccccccccHHHHHHHHcccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccHHHHHHHHHHHHHHHHcHHHHHccccccccccccccccccEEEccccEEEEEEEcccccccccccEEEEEEEEcccccEEEEEEEcccccccccccEEEEEccccEEEEEEccccEEEEEccccccccEEEEEccccEEEEEccccEEEEEccccccccccccccccccEEEEcccccccccccEEEEEccccccEEEEEEccccccccEEEEcccccccEEcccccccccccccEEEEEEEEccccEEEEEEEEEcccEEEEEEEccccEEEEEEEEccccccEEEEEEcccccccccccccHHcccccccEEccccccccccccccccccccccccccccEEccEcEccccccccccccccEEEEcccccccccHHHHHcccHHHHHHHHHHcccEEEEEEEccccccccEEEccccccEEEEccccEHHHHHccccccEEEEEcHHHccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccEcHHHHHHHHHcHHHHccccccccEEEEEccccccccEEEEEEccccccccHHHHHHHHHHHHHHHHHHHHHHHccccccccEEEEEEEcccccHHHHHcccccccHHHHHHHHHHHHHHHHHHHHccccEEEcccccHHHEEEcccccccccHHcHHHHcccccccccccEEEEEcccccHHHHHcccEEEcccHEHHHEEEEEEEccccccccccccccccHHHHHHHHHHccccHHHHcHHHcccccHHHHHHHHHHHHHHHcccccccccHHHHEHEccccccccccccccccccccccc
Coil and Loop (DISEMBL)
MTSARLYFIFLLFqlpyfshlaiaqnngtvpvgatltagtssspwlspsgdfafgfhqldeenntndLFLLSIFYNKIPEKTVVWYtdnkdqnpavprgsqvkltadqglvlndpqgkqvwsskidiGTVAVGHMNDTGNFVLAssssgrlwdsfsnptdtLLLGQMMEteqglfsrksennfsrgrfQFRLLEDGNLVLNIANLATgfaydayytsgtydpanssnsgyrvmfNESGYMYILRrnggrfdlttervvpaadfYYRATLnfdgvfaqyfypkngngnwsvawsepenicvdiggglgsgacgynsictldsdrrprcacpkgyslldendrygscrpdfelscwgggqgynkelfdfhelkninwpqsdyerfkpynevqckntclsdcfcAAVIfndgscwfkklplsngmtdsriAGKAFIKYknkgddppsvprppdpedkkkskmmnaTGSVLLGSSVFVNFALVCAFVLGFSfiykkkwirnspddgtietnlrcfsykelegatnnfkeevgrgsfGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNngtlasflfgnlkpnwnlrTNIAFQIARGLLYLHEDCRAQIihcdikpqnillddyytaRISDFGLAKLLTLNQSKTIKTAIrgtkgyvapewfrnskitakvdVYSFGVLLLEIISCRKsfdiemgeEYAILTDWAFdcyrngklnvlvgedkeamnDIECLGKLVMVSIWCiqedpslrpTMKKVLQMLEGVvevsvppnpypfsssmgly
Flexible Loop (DISEMBL)
MTSARLYFIFLLFQLPYFSHLAIAQNNGTVPVGATLTAGTSSSPWLSPSGDFAFGFHQLDEENNTNDLFLLSIFYNKIPEKTVVWYTDNkdqnpavprgsqVKLTADQGlvlndpqgkqvwSSKIDIGTVAVGHMNDTGNFVLASSSSGRLWDSFSNPTDTLLLGQMMETEQGLfsrksennfSRGRFQFRLLEDGNLVLNIANLATGFAYDAYYTSGTydpanssnsgYRVMFNESGYMYILRRNGGRFDLTTERVVPAADFYYRATLNFDGVFAQYFYPKNGNGNWSVAWSEPENICVDIGGGLGSGACGYNSIctldsdrrprCACPKGYSLLDENDRYGSCRPDFELSCWGGGQGYNKELFDFHELKNINWPQSDYERFKPYNEVQCKNTCLSDCFCAAVIFNDGSCWFKKLPLSNGMTDSRIAGKAFIkyknkgddppsvprppdpedKKKSKMMNATGSVLLGSSVFVNFALVCAFVLGFSFIYKKkwirnspddgtiETNLRCFSYKELEGAtnnfkeevgrgSFGIVYKGViqtrtsttavavKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKlltlnqsktiktairgtkgyvapewfrnskitakvdVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVvevsvppnpypfsssmgly
Low Complexity Region (SEG)
MTSARLYFIFLLFQLPYFSHLAIAQNNGTVPVGATLTAGTSSSPWLSPSGDFAFGFHQLDEENNTNDLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLTADQGLVLNDPQGKQVWSSKIDIGTVAVGHMNDTGNFVLASSSSGRLWDSFSNPTDTLLLGQMMETEQGLFSRKSENNFSRGRFQFRLLEDGNLVLNIANLATGFAYDAYYTSGTYDPANSSNSGYRVMFNESGYMYILRRNGGRFDLTTERVVPAADFYYRATLNFDGVFAQYFYPKNGNGNWSVAWSEPENICVDIGGGLGSGACGYNSICTLDSDRRPRCACPKGYSLLDENDRYGSCRPDFELSCWGGGQGYNKELFDFHELKNINWPQSDYERFKPYNEVQCKNTCLSDCFCAAVIFNDGSCWFKKLPLSNGMTDSRIAGKAFIKYKNKGddppsvprppdpedKKKSKMMNATGSVLLGSSVFVNFALVCAFVLGFSFIYKKKWIRNSPDDGTIETNLRCFSYKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVPPNPYPFSSSMGLY
Disordered region (IsUnstruct)
****RLYFIFLLFQLPYFSHLAIAQNNGTVPVGATLTAGTSSSPWLSPSGDFAFGFHQLDEENNTNDLFLLSIFYNKIPEKTVVWYT*****************************GKQVWSSKIDIGTVAVGHMNDTGNFVLASSSSGRLWDSFSNPTDTLLLG*****************FSRGRFQFRLLEDGNLVLNIANLATGFAYDAYYTSGTYDPANSSNSGYRVMFNESGYMYILRRNGGRFDLTTERVVPAADFYYRATLNFDGVFAQYFYPKNGNGNWSVAWSEPENICVDIGGGLGSGACGYNSICTLDSDRRPRCACPKGYSLLDENDRYGSCRPDFELSCWGGGQGYNKELFDFHELKNINWPQSDYERFKPYNEVQCKNTCLSDCFCAAVIFNDGSCWFKKLPLSNGMTDSRIAGKAFIKY*****************************SVLLGSSVFVNFALVCAFVLGFSFIYKKKWIRNSPDDGTIETNLRCFSYKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV****************
Disordered Region (DISOPRED)
***ARLYFIFLLFQLPYFSHLAIAQNNGTVPVGATLTAGTS**PWLSPSGDFAFGFHQLDEENNTNDLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLTADQGLVLNDPQGKQVWSSKID*GTVAVGHMNDTGNFVLASSSSGRLWDSFSNPTDTLLLGQMMETEQGLFSRKSENNFSRGRFQFRLLEDGNLVLNIANLATGFAYDAYYTSGTYDPANSSNSGYRVMFNESGYMYILRRNGGRFDLTTERVVPAADFYYRATLNFDGVFAQYFYPKNGNGNWSVAWSEPENICVDIGGGLGSGACGYNSICTLDSDRRPRCACPKGYSLLDEN*R**SCR**F************KELFDFHELKNINWPQSDYERFKPYNEVQCKNTCLSDCFCAAVIFNDGSCWFKKLPLSNGMTDSRIAGKAFIKYKNKG**********************ATGSVLLGSSVFVNFALVCAFVLGFSFIY******************RCFSYKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSF****GEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVPPNPYPF**SMGL*
Disordered Region (DISEMBL)
MTSARLYFIFLLFQLPYFSHLAIAQNNGTVPVGATLTAGTSSSPWLSPSGDFAFGFHQLDEENNTNDLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLTADQGLVLNDPQGKQVWSSKIDIGTVAVGHMNDTGNFVLASSSSGRLWDSFSNPTDTLLLGQMMETEQGLFSRKSENNFSRGRFQFRLLEDGNLVLNIANLATGFAYDAYYTSGTYDPANSSNSGYRVMFNESGYMYILRRNGGRFDLTTERVVPAADFYYRATLNFDGVFAQYFYPKNGNGNWSVAWSEPENICVDIGGGLGSGACGYNSICTLDSDRRPRCACPKGYSLLDENDRYGSCRPDFELSCWGGGQGYNKELFDFHELKNINWPQSDYERFKPYNEVQCKNTCLSDCFCAAVIFNDGSCWFKKLPLSNGMTDSRIAGKAFIKYKNK*********************MNATGSVLLGSSVFVNFALVCAFVLGFSFIYKKKWIRNSPDDGTIETNLRCFSYKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVPPNPYPFSSSMGLY
Disordered Region (DISPRO)
*TSARLYFIFLLFQLPYFSHLAIAQNNGTVPVGATLTAGTSSSPWLSPSGDFAFGFHQLDEENNTNDLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLTADQGLVLNDPQGKQVWSSKIDIGTVAVGHMNDTGNFVLASSSSGRLWDSFSNPTDTLLLGQMMETEQGLFSRKSENNFSRGRFQFRLLEDGNLVLNIANLATGFAYDAYYTSGTYDPANSSNSGYRVMFNESGYMYILRRNGGRFDLTTERVVPAADFYYRATLNFDGVFAQYFYPKNGNGNWSVAWSEPENICVDIGGGLGSGACGYNSICTLDSDRRPRCACPKGYSLLDENDRYGSCRPDFELSCWGGGQGYNKELFDFHELKNINWPQSDYERFKPYNEVQCKNTCLSDCFCAAVIFNDGSCWFKKLPLSNGMTDSRIAGKAFIKYKNKGDDPPSVPRPPDPEDKKKSKMMNATGSVLLGSSVFVNFALVCAFVLGFSFIYKKKWIR********ETNLRCFSYKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVPPNPYPFSSSMGLY
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
iiiiiHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MTSARLYFIFLLFQLPYFSHLAIAQNNGTVPVGATLTAGTSSSPWLSPSGDFAFGFHQLDEENNTNDLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLTADQGLVLNDPQGKQVWSSKIDIGTVAVGHMNDTGNFVLASSSSGRLWDSFSNPTDTLLLGQMMETEQGLFSRKSENNFSRGRFQFRLLEDGNLVLNIANLATGFAYDAYYTSGTYDPANSSNSGYRVMFNESGYMYILRRNGGRFDLTTERVVPAADFYYRATLNFDGVFAQYFYPKNGNGNWSVAWSEPENICVDIGGGLGSGACGYNSICTLDSDRRPRCACPKGYSLLDENDRYGSCRPDFELSCWGGGQGYNKELFDFHELKNINWPQSDYERFKPYNEVQCKNTCLSDCFCAAVIFNDGSCWFKKLPLSNGMTDSRIAGKAFIKYKNKGDDPPSVPRPPDPEDKKKSKMMNATGSVLLGSSVFVNFALVCAFVLGFSFIYKKKWIRNSPDDGTIETNLRCFSYKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVPPNPYPFSSSMGLY
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	814	2.2.26 [Sep-21-2011]
Q39202	832	G-type lectin S-receptor-	yes	no	0.955	0.935	0.479	0.0
Q9XID3	829	G-type lectin S-receptor-	no	no	0.878	0.862	0.336	1e-105
Q9FLV4	872	G-type lectin S-receptor-	no	no	0.931	0.869	0.313	2e-98
P17801	817	Putative receptor protein	N/A	no	0.889	0.886	0.322	5e-89
O64477	828	G-type lectin S-receptor-	no	no	0.864	0.850	0.323	2e-85
Q8RWZ5	821	G-type lectin S-receptor-	no	no	0.391	0.388	0.460	1e-76
Q39203	797	G-type lectin S-receptor-	no	no	0.825	0.843	0.306	1e-75
O81905	850	Receptor-like serine/thre	no	no	0.875	0.838	0.295	3e-73
O65238	872	G-type lectin S-receptor-	no	no	0.821	0.767	0.298	7e-73
Q9ZR08	852	G-type lectin S-receptor-	no	no	0.936	0.894	0.273	1e-71

>sp|Q39202|RLK1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 OS=Arabidopsis thaliana GN=RLK1 PE=2 SV=2

 Score =  716 bits (1847), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 403/841 (47%), Positives = 529/841 (62%), Gaps = 63/841 (7%)

Query: 3   SARLYFIFLLFQLPYFSHLAIAQNNGTVPVGATLTAGTS---SSPWLSPSGDFAFGFHQL 59
           S  +  + L+ QL  F   +    NG+VPVG +LTA  S   SS W SPSGDFAFGF ++
Sbjct: 5   SCSIIHLVLILQLQTFFVFSQNIRNGSVPVGESLTASESQQISSSWRSPSGDFAFGFRKI 64

Query: 60  DEENNTNDLFLLSIFYNKIPEKTVVWYTDNKDQNPA-VPRGSQVKLTADQGLVLNDPQGK 118
                 ND F LSI+++KI +KT+VW+    +     VP GS+V LTAD GLV+ DP+G+
Sbjct: 65  ----QPNDGFTLSIWFDKISDKTIVWHAQAVNTTTGLVPNGSKVTLTADGGLVIADPRGQ 120

Query: 119 QVWSSKIDIGTVAVGHMNDTGNFVL----ASSSSGRLWDSFSNPTDTLLLGQMMETEQGL 174
           ++W + +  G+V+ G   D GNFVL    +  S   LW SF NPTDTLL  Q +E  + L
Sbjct: 121 ELWRA-LSGGSVSRGRFTDDGNFVLFRDGSEDSDEVLWSSFENPTDTLLPNQNIEVGRNL 179

Query: 175 FSRKSENNFSRGRFQFRLLEDGNLVLNIANLATGFA---YDAYYTSGTYDPANSSNSGYR 231
            SR++E +F +GRF  RL +DGNL L+  N  T      Y  YY S T DP   +N G +
Sbjct: 180 SSRRTETSFKKGRFSLRLEDDGNLQLHSLNAETASESDIYSQYYESNTNDP---NNPGIQ 236

Query: 232 VMFNESGYMYILRRNGGRFDLTTER---VVPAADFYYRATLNFDGVFAQYFYPKNGN--- 285
           ++FN+SG +Y+L+RN  RF +  +R      AA FY        G       PK      
Sbjct: 237 LVFNQSGEIYVLQRNNSRF-VVKDRDPDFSIAAPFYIST-----GFLLSTIIPKEARRIV 290

Query: 286 GNWSVAWSEPENICVDIGGGLGSGACGYNSICTLDSDRRPRCACPKGYSLLDENDRYGSC 345
           G   +     +N+C      LG+ ACGYN+IC+L +++RP+C CP+ + L D ++ YG C
Sbjct: 291 GGCLLGLCR-DNMC-SPDDALGNMACGYNNICSLGNNKRPKCECPERFVLKDPSNEYGDC 348

Query: 346 RPDFEL-SCWGGGQGYNKE--LFDFHELKNINWPQSDYERFKPYNEVQCKNTCLSDCFCA 402
            PDFE+ +C    Q  N +  L++F  L+  NWP  DYE +  Y+E +CK +CLSDC CA
Sbjct: 349 LPDFEMQTCRPENQTANSDVNLYEFITLEKTNWPFGDYESYANYDEERCKASCLSDCLCA 408

Query: 403 AVIF---NDGSCWFKKLPLSNGMTDSRIAGKAFIKYKNK--GDDPPSVPRPPDPEDKKKS 457
           AVIF    D  CW KK PLS+G    R     FIK +N+   D P +  R       KK 
Sbjct: 409 AVIFGTNRDLKCWKKKFPLSHGERSPRGDSDTFIKVRNRSIADVPVTGNR------AKKL 462

Query: 458 KMMNATGSVLLGSSVFVNFALVCAFVLGFSFIYKKKWIRNSPDD--------GTIETNLR 509
             +    SVLLG+S FV F   C++         K  ++N   D           E NLR
Sbjct: 463 DWLIIACSVLLGTSAFVIFDTSCSYR---KTKKSKNMMKNQARDIGRTTATTTANELNLR 519

Query: 510 CFSYKELEGATNNFKEEVGRGSFGIVYKGVIQTRT-STTAVAVKKLDRVFQDGEREFKNE 568
            F+Y EL  AT +F EE+GRG+FGIVYKG ++    S   VAVKKLDR+  D E+EFKNE
Sbjct: 520 VFTYGELAEATRDFTEELGRGAFGIVYKGYLEVAGGSEVTVAVKKLDRLDLDNEKEFKNE 579

Query: 569 VFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIA 628
           V VIGQ HHKNLVRL+GFC+EGQ++++VYEFL  GTLA+FLF   +P+W  R NIA  IA
Sbjct: 580 VKVIGQIHHKNLVRLIGFCNEGQSQMIVYEFLPQGTLANFLFRRPRPSWEDRKNIAVAIA 639

Query: 629 RGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKG 688
           RG+LYLHE+C  QIIHCDIKPQNILLD+YYT RISDFGLAKLL +NQ+ T+ T IRGTKG
Sbjct: 640 RGILYLHEECSEQIIHCDIKPQNILLDEYYTPRISDFGLAKLLLMNQTYTL-TNIRGTKG 698

Query: 689 YVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLN 748
           YVAPEWFRNS IT+KVDVYS+GV+LLEI+ C+K+ D+   E+  IL +WA+DC+R G+L 
Sbjct: 699 YVAPEWFRNSPITSKVDVYSYGVMLLEIVCCKKAVDL---EDNVILINWAYDCFRQGRLE 755

Query: 749 VLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVPPNPYPFS 808
            L  +D EAMND+E + + V ++IWCIQE+  +RP M+ V QMLEGV++V  PPNP P+S
Sbjct: 756 DLTEDDSEAMNDMETVERYVKIAIWCIQEEHGMRPNMRNVTQMLEGVIQVFDPPNPSPYS 815

Query: 809 S 809
           +
Sbjct: 816 T 816

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1

 Score =  384 bits (986), Expect = e-105,   Method: Compositional matrix adjust.
 Identities = 273/812 (33%), Positives = 400/812 (49%), Gaps = 97/812 (11%)

Query: 29  TVPVGATLTAGTSSSPWLSPSGDFAFGFHQLDEENNTNDLFLLSI-FYNKIPEKTVVWYT 87
           T+P+G+ + A  S+  W SP+  F+  F      N+    FL ++ F   +P    +W  
Sbjct: 26  TIPLGSVIYASGSNQNWPSPNSTFSVSFVPSPSPNS----FLAAVSFAGSVP----IWSA 77

Query: 88  DNKDQNPAVPRGSQVKLTADQGLVLNDPQGKQVWSSKIDIGTVAVGHMNDTGNFVLASSS 147
              D      RGS ++L     L L +  G  VW SK D   V  G + DTG F+L ++ 
Sbjct: 78  GTVDS-----RGS-LRLHTSGSLRLTNGSGTTVWDSKTDRLGVTSGSIEDTGEFILLNNR 131

Query: 148 SGRLWDSFSNPTDTLLLGQMMETEQGLFSRKSENNFSRGRFQFRLLEDGNLVLNIANLAT 207
           S  +W SF NPTDT++  Q     + L S         G + F+L   GNL L     A 
Sbjct: 132 SVPVWSSFDNPTDTIVQSQNFTAGKILRS---------GLYSFQLERSGNLTLRWNTSAI 182

Query: 208 GFAYDAYYTSGTYDPANSSNSGYRVMFNESGYMYILRRNGGRFDLTTERVVPAADFYYRA 267
                 Y+  G     +S+ S  R+    +G + I   N     L    +V + D+    
Sbjct: 183 ------YWNHGLNSSFSSNLSSPRLSLQTNGVVSIFESN----LLGGAEIVYSGDYGDSN 232

Query: 268 TLNF-----DGVFAQYFYPKNGNGNWSVAWSEPENICVDIGGGLGSGACGYNSICTLDSD 322
           T  F     DG    Y      +G  +  WS  +   V        G CG   IC+ + D
Sbjct: 233 TFRFLKLDDDGNLRIYSSASRNSGPVNAHWSAVDQCLV-------YGYCGNFGICSYN-D 284

Query: 323 RRPRCACP-KGYSLLDENDRYGSCRPDFELSCWGGGQGYNKELFDFHELKNINWPQSDYE 381
             P C+CP + +  +D NDR   C+   ELS   G    N  + D    +   +      
Sbjct: 285 TNPICSCPSRNFDFVDVNDRRKGCKRKVELSDCSG----NTTMLDLVHTRLFTYEDDPNS 340

Query: 382 RFKPYNEVQCKNTCLSDCFC-AAVIFNDGS--CWFKKLPLS--NGMTDSRIAGKAFIKYK 436
                    C+  CLS   C A+V  +DGS  CW +K P S   G     +   +++K  
Sbjct: 341 ESFFAGSSPCRANCLSSVLCLASVSMSDGSGNCW-QKHPGSFFTGYQWPSVPSTSYVKVC 399

Query: 437 NKGDDPPSVPRPPDPEDKKKSKMMNATGSVLLGSSVFVNFALVCAFVLGFSFIYKKKW-- 494
             G    +        D   SK+            +++    V A +LG   +    W  
Sbjct: 400 --GPVVANTLERATKGDDNNSKVH-----------LWIVAVAVIAGLLGLVAVEIGLWWC 446

Query: 495 -IRNSPDDGTIETNLRC----------FSYKELEGATNNFKEEVGRGSFGIVYKGVIQTR 543
             R +P  GT+ ++             F+YKEL+  T +FKE++G G FG VY+GV+  R
Sbjct: 447 CCRKNPRFGTLSSHYTLLEYASGAPVQFTYKELQRCTKSFKEKLGAGGFGTVYRGVLTNR 506

Query: 544 TSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNG 603
           T    VAVK+L+ + Q GE++F+ EV  I  THH NLVRL+GFC +G++RLLVYEF+ NG
Sbjct: 507 T---VVAVKQLEGIEQ-GEKQFRMEVATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNG 562

Query: 604 TLASFLFGNLKP---NWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTA 660
           +L +FLF         W  R NIA   A+G+ YLHE+CR  I+HCDIKP+NIL+DD + A
Sbjct: 563 SLDNFLFTTDSAKFLTWEYRFNIALGTAKGITYLHEECRDCIVHCDIKPENILVDDNFAA 622

Query: 661 RISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCR 720
           ++SDFGLAKLL    ++   +++RGT+GY+APEW  N  IT+K DVYS+G++LLE++S +
Sbjct: 623 KVSDFGLAKLLNPKDNRYNMSSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLELVSGK 682

Query: 721 KSFDIEMGEEYAILTDWAFDCYRNGK----LNVLVGEDKEAMNDIECLGKLVMVSIWCIQ 776
           ++FD+     +   + WA++ +  G     L+  + ED+    D+E + ++V  S WCIQ
Sbjct: 683 RNFDVSEKTNHKKFSIWAYEEFEKGNTKAILDTRLSEDQTV--DMEQVMRMVKTSFWCIQ 740

Query: 777 EDPSLRPTMKKVLQMLEGVVEVSVPPNPYPFS 808
           E P  RPTM KV+QMLEG+ E+  P  P   S
Sbjct: 741 EQPLQRPTMGKVVQMLEGITEIKNPLCPKTIS 772

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1

 Score =  360 bits (924), Expect = 2e-98,   Method: Compositional matrix adjust.
 Identities = 263/839 (31%), Positives = 406/839 (48%), Gaps = 81/839 (9%)

Query: 7   YFIFLLFQLPYFSHLAIAQNNGTVPVGATLTAGTSSSPWLSPSGDFAFGFHQLDEENNTN 66
           +F F L  L    H+ +         G+ L A   +  W+S +G FA GF +        
Sbjct: 16  FFCFFLVSLATEPHIGL---------GSKLKASEPNRAWVSANGTFAIGFTRFKP----T 62

Query: 67  DLFLLSIFYNKIP-EKTVVWYTDNKDQNPAVPRGSQVKLTADQGLVLNDPQGKQVWSSKI 125
           D FLLSI++ ++P + T+VW   + ++N  V + + ++L A   LVL+D Q   VW+S  
Sbjct: 63  DRFLLSIWFAQLPGDPTIVW---SPNRNSPVTKEAVLELEATGNLVLSD-QNTVVWTSNT 118

Query: 126 DIGTVAVGHMNDTGNFVLASS---SSGRLWDSFSNPTDTLLLGQMMETEQGLFSRKSENN 182
               V    M+++GNF+L  +   +   +W SFS P+DTLL  Q +     L S  S + 
Sbjct: 119 SNHGVESAVMSESGNFLLLGTEVTAGPTIWQSFSQPSDTLLPNQPLTVSLELTSNPSPSR 178

Query: 183 FSRGRFQFRLLEDGN-----LVLNI-----ANLATGFAYDAYYTSGTYDPANSSNSGYRV 232
              G +  ++L+        L  NI     AN +     D    +G           +++
Sbjct: 179 --HGHYSLKMLQQHTSLSLGLTYNINLDPHANYSYWSGPDISNVTGDVTAVLDDTGSFKI 236

Query: 233 MFNES--GYMYILRR---------NGGRFDLTTERVVPAADFYYRATLNFDGVFAQYFYP 281
           ++ ES  G +Y+ +          N     LT   V+       R  L  +G    Y + 
Sbjct: 237 VYGESSIGAVYVYKNPVDDNRNYNNSSNLGLTKNPVL------RRLVLENNGNLRLYRWD 290

Query: 282 K--NGNGNWSVAWSEPENICVDIGGGLGSGACGYNSICTLDSDRR-PRCACPKGYSLLDE 338
              NG+  W   W+   N C DI     +G CG N +C LD  ++   C C  G   L +
Sbjct: 291 NDMNGSSQWVPEWAAVSNPC-DI-----AGICG-NGVCNLDRTKKNADCLCLPGSVKLPD 343

Query: 339 NDRYGSCRPDFELSCWGGGQGYNKELFDFHELKNINWPQSDYERFKPYNEV----QCKNT 394
            +    C  +  L             F    ++  N+  S+    +  +++    +C   
Sbjct: 344 QENAKLCSDNSSLVQECESNINRNGSFKISTVQETNYYFSERSVIENISDISNVRKCGEM 403

Query: 395 CLSDCFCAAVIF----NDGSCWFKKLPLSNGMTDSRIAGKAFIKYKNKGDDPPSVPRPPD 450
           CLSDC C A ++        CW  K     G  D       F+K +   +  PS     D
Sbjct: 404 CLSDCKCVASVYGLDDEKPYCWILKSLNFGGFRDP--GSTLFVKTR-ANESYPSNSNNND 460

Query: 451 PEDKKKSKMMNATGSVLLGSSVFVNFALVCAFVLGFSFIYKKKWIRNSPDDGTIETNLRC 510
            + +K   +      + +   + V  AL+   +L ++   K+   R + +   +  +   
Sbjct: 461 SKSRKSHGLRQKVLVIPIVVGMLVLVALL-GMLLYYNLDRKRTLKRAAKNSLILCDSPVS 519

Query: 511 FSYKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVF 570
           F+Y++L+  TNNF + +G G FG VYKG +      T VAVK+LDR    GEREF  EV 
Sbjct: 520 FTYRDLQNCTNNFSQLLGSGGFGTVYKGTV---AGETLVAVKRLDRALSHGEREFITEVN 576

Query: 571 VIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP----NWNLRTNIAFQ 626
            IG  HH NLVRL G+C E  +RLLVYE++ NG+L  ++F + +     +W  R  IA  
Sbjct: 577 TIGSMHHMNLVRLCGYCSEDSHRLLVYEYMINGSLDKWIFSSEQTANLLDWRTRFEIAVA 636

Query: 627 IARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGT 686
            A+G+ Y HE CR +IIHCDIKP+NILLDD +  ++SDFGLAK++    S  + T IRGT
Sbjct: 637 TAQGIAYFHEQCRNRIIHCDIKPENILLDDNFCPKVSDFGLAKMMGREHSHVV-TMIRGT 695

Query: 687 KGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 746
           +GY+APEW  N  IT K DVYS+G+LLLEI+  R++ D+    E      WA+    NG 
Sbjct: 696 RGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSYDAEDFFYPGWAYKELTNGT 755

Query: 747 LNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV-EVSVPPNP 804
               V +  + + + E + K + V+ WCIQ++ S+RP+M +V+++LEG   E+++PP P
Sbjct: 756 SLKAVDKRLQGVAEEEEVVKALKVAFWCIQDEVSMRPSMGEVVKLLEGTSDEINLPPMP 814

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P17801|KPRO_MAIZE Putative receptor protein kinase ZmPK1 OS=Zea mays GN=PK1 PE=2 SV=2

 Score =  329 bits (844), Expect = 5e-89,   Method: Compositional matrix adjust.
 Identities = 268/832 (32%), Positives = 398/832 (47%), Gaps = 108/832 (12%)

Query: 24  AQNNGTVPVGATLTAGT-SSSPWLSPSGDFAFGFHQLDEENNTNDLFLLSIFYNKIPE-- 80
           A +   +P+G++L   +  SS   S  G F+ GF+++         F  S++Y+K     
Sbjct: 26  ASSRDILPLGSSLVVESYESSTLQSSDGTFSSGFYEV-----YTHAFTFSVWYSKTEAAA 80

Query: 81  ---KTVVWYTDNKDQNPAVPRGSQVKLTADQGLVLNDPQGKQVWSSKIDIGT-VAVGHMN 136
              KT+VW + N D+ P   R S + L  D  +VL D  G  VW +  +  T V    + 
Sbjct: 81  ANNKTIVW-SANPDR-PVHARRSALTLQKDGNMVLTDYDGAAVWRADGNNFTGVQRARLL 138

Query: 137 DTGNFVLASSSSGRLWDSFSNPTDTLLLGQMMETEQGLFSRKSENNFSRGRFQFRLLEDG 196
           DTGN V+  S    +W SF +PTDT L  Q++     L       +     F+F  L   
Sbjct: 139 DTGNLVIEDSGGNTVWQSFDSPTDTFLPTQLITAATRLVPTTQSRSPGNYIFRFSDLSVL 198

Query: 197 NLVLNIANLATGFAYDAYYTSGTY----DPANSSNSGYRVMFNESGYMYILRRNGGRFDL 252
           +L+ ++  ++     D Y+         D  N  NS    M  +SG +       G+  L
Sbjct: 199 SLIYHVPQVS-----DIYWPDPDQNLYQDGRNQYNSTRLGMLTDSGVLASSDFADGQ-AL 252

Query: 253 TTERVVPAADFYYRATLNFDGVFAQYFYPKNGNGNWSV---AWSEPENICVDIGGGLGSG 309
               V P      R TL+ DG    Y    + +G+WSV   A ++P NI          G
Sbjct: 253 VASDVGPGVK--RRLTLDPDGNLRLYSM-NDSDGSWSVSMVAMTQPCNI---------HG 300

Query: 310 ACGYNSICTLDSDRRPRCACPKGYSLLDENDRYGSCRPDFELSCWGGGQGYNKELFDFHE 369
            CG N IC       P C+CP GY+  +  +    C      +C      Y+K    F  
Sbjct: 301 LCGPNGICHYSPT--PTCSCPPGYATRNPGNWTEGCMAIVNTTC----DRYDKRSMRFVR 354

Query: 370 LKNINWPQSDYERFKPYNEVQCKNTCLSDCFCAAVIFNDG--SCWFKKLPLSNGMTDSRI 427
           L N ++  SD +     +   C++ C+SDC C    + +G  SC+ K    S     +  
Sbjct: 355 LPNTDFWGSDQQHLLSVSLRTCRDICISDCTCKGFQYQEGTGSCYPKAYLFSGRTYPTSD 414

Query: 428 AGKAFIKYKN----------KGDDPPSVPRPPDPEDKKKSKM-----MNATGSVLLGSSV 472
               ++K             + D   SVPR  D +   KS       ++ TG     S  
Sbjct: 415 VRTIYLKLPTGVSVSNALIPRSDVFDSVPRRLDCDRMNKSIREPFPDVHKTGGG--ESKW 472

Query: 473 FVNFALVCAF-VLGFSFI------YKKKWIRNS----PDDG--TIETNLRCFSYKELEGA 519
           F  +  + AF V+  SFI        K+ +R S     + G   + +N R +SY+EL  A
Sbjct: 473 FYFYGFIAAFFVVEVSFISFAWFFVLKRELRPSELWASEKGYKAMTSNFRRYSYRELVKA 532

Query: 520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKN 579
           T  FK E+GRG  G VYKGV++       VAVKKL+ V Q G+  F+ E+ VIG+ +H N
Sbjct: 533 TRKFKVELGRGESGTVYKGVLE---DDRHVAVKKLENVRQ-GKEVFQAELSVIGRINHMN 588

Query: 580 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPNWNLRTNIAFQIARGLLYLHE 636
           LVR+ GFC EG +RLLV E++ NG+LA+ LF   GN+  +W  R NIA  +A+GL YLH 
Sbjct: 589 LVRIWGFCSEGSHRLLVSEYVENGSLANILFSEGGNILLDWEGRFNIALGVAKGLAYLHH 648

Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR 696
           +C   +IHCD+KP+NILLD  +  +I+DFGL KLL    S    + +RGT GY+APEW  
Sbjct: 649 ECLEWVIHCDVKPENILLDQAFEPKITDFGLVKLLNRGGSTQNVSHVRGTLGYIAPEWVS 708

Query: 697 NSKITAKVDVYSFGVLLLEIISCRKSFDIEMG--EEYAILTDWA--------------FD 740
           +  ITAKVDVYS+GV+LLE+++  +  ++  G  E +++L                   D
Sbjct: 709 SLPITAKVDVYSYGVVLLELLTGTRVSELVGGTDEVHSMLRKLVRMLSAKLEGEEQSWID 768

Query: 741 CYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQML 792
            Y + KLN         +N ++    L+ +++ C++ED S RPTM+  +Q L
Sbjct: 769 GYLDSKLN-------RPVNYVQAR-TLIKLAVSCLEEDRSKRPTMEHAVQTL 812

Probable receptor. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain.

Zea mays (taxid: 4577)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1

 Score =  317 bits (812), Expect = 2e-85,   Method: Compositional matrix adjust.
 Identities = 257/795 (32%), Positives = 389/795 (48%), Gaps = 91/795 (11%)

Query: 46  LSPSGDFAFGFHQLDEENNTNDLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLT 105
           +S  G +  GF +    +N    F + ++Y ++ + T++W   N+D+  +    S  K++
Sbjct: 39  VSSDGTYEMGFFKPGSSSN----FYIGMWYKQLSQ-TILWVA-NRDKAVSDKNSSVFKIS 92

Query: 106 ADQGLVLNDPQGKQVWSSKIDIGTVAVGHM----NDTGNFVL----ASSSSGRLWDSFSN 157
               ++L+      VWS+ ++  T +V  +     D GN VL    +S S+  LW SF +
Sbjct: 93  NGNLILLDGNYQTPVWSTGLN-STSSVSALEAVLQDDGNLVLRTGGSSLSANVLWQSFDH 151

Query: 158 PTDTLLLGQMMETE------QGLFSRKSENNFSRGRFQFRLLEDG--NLVLNIANLATGF 209
           P DT L G  +  +      Q L S KS  + S G F   L E     ++ N +N     
Sbjct: 152 PGDTWLPGVKIRLDKRTGKSQRLTSWKSLEDPSPGLFSLELDESTAYKILWNGSN----- 206

Query: 210 AYDAYYTSGTYDPANSSNSGYRVMFNESGYMYILRRNGGRFDLTTERVVPAADF----YY 265
               Y++SG ++P +        M     Y+Y    N   F  TT+     + +      
Sbjct: 207 ---EYWSSGPWNPQSRIFDSVPEM--RLNYIY----NFSFFSNTTDSYFTYSIYNQLNVS 257

Query: 266 RATLNFDGVFAQYFYPKNGNGNWSVAWSEPENICVDIGGGLGSGACGYNSICTLDSDRRP 325
           R  ++  G   Q+ + + GN  W++ WS+P   C           CG   IC+  S+  P
Sbjct: 258 RFVMDVSGQIKQFTWLE-GNKAWNLFWSQPRQQCQVYR------YCGSFGICSDKSE--P 308

Query: 326 RCACPKGYSLL-----DENDRYGSCRPDFELSCWGGGQGYNKELFDFHELKNINWPQSDY 380
            C CP+G+  +     D  D    C    EL C  G      ++  F  L N+    +  
Sbjct: 309 FCRCPQGFRPMSQKDWDLKDYSAGCVRKTELQCSRG------DINQFFRLPNMKLADNS- 361

Query: 381 ERFKPYNEVQCKNTCLSDCFCAAVIFNDGS----CWFKKLPLSNGMTDSRIAGKAFIKYK 436
           E     +   C + C  DC C A  +++GS     W K +     + D    G  F   +
Sbjct: 362 EVLTRTSLSICASACQGDCSCKAYAYDEGSSKCLVWSKDVLNLQQLEDENSEGNIFY-LR 420

Query: 437 NKGDDPPSVPRPPDPEDKKKSKMMNATGSVLLGSSVFVNFALVCAFVLGFSFIYKKKWIR 496
               D P+V          KS         +LGS       LV   V+      ++K +R
Sbjct: 421 LAASDVPNVGA------SGKSNNKGLIFGAVLGS--LGVIVLVLLVVILILRYRRRKRMR 472

Query: 497 NSPDDGTIETNLRCFSYKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDR 556
               DGT    L  FSY+EL+ AT NF +++G G FG V+KG +     ++ +AVK+L+ 
Sbjct: 473 GEKGDGT----LSAFSYRELQNATKNFSDKLGGGGFGSVFKGAL---PDSSDIAVKRLEG 525

Query: 557 VFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN---- 612
           + Q GE++F+ EV  IG   H NLVRL GFC EG  +LLVY+++ NG+L S LF N    
Sbjct: 526 ISQ-GEKQFRTEVVTIGTIQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEE 584

Query: 613 -LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLL 671
            +   W LR  IA   ARGL YLH++CR  IIHCDIKP+NILLD  +  +++DFGLAKL+
Sbjct: 585 KIVLGWKLRFQIALGTARGLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLV 644

Query: 672 TLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY 731
             + S+ + T +RGT+GY+APEW     ITAK DVYS+G++L E++S R++ +    E+ 
Sbjct: 645 GRDFSRVL-TTMRGTRGYLAPEWISGVAITAKADVYSYGMMLFELVSGRRNTEQSENEKV 703

Query: 732 AILTDWAFDCY-RNGKLNVLVGEDKEA-MNDIECLGKLVMVSIWCIQEDPSLRPTMKKVL 789
                WA     ++G +  LV    E    DIE + +   V+ WCIQ++ S RP M +V+
Sbjct: 704 RFFPSWAATILTKDGDIRSLVDPRLEGDAVDIEEVTRACKVACWCIQDEESHRPAMSQVV 763

Query: 790 QMLEGVVEVSVPPNP 804
           Q+LEGV+EV+ PP P
Sbjct: 764 QILEGVLEVNPPPFP 778

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1

 Score =  288 bits (737), Expect = 1e-76,   Method: Compositional matrix adjust.
 Identities = 158/343 (46%), Positives = 221/343 (64%), Gaps = 24/343 (6%)

Query: 484 LGFSFIYKKKWIRNSPDDGTIETN---------LRCFSYKELEGATNNFKEEVGRGSFGI 534
           + F    +KK I  +P + + E N         +R F+YK+L+ ATNNF  ++G+G FG 
Sbjct: 448 VAFRIHKRKKMILEAPQESSEEDNFLENLSGMPIR-FAYKDLQSATNNFSVKLGQGGFGS 506

Query: 535 VYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRL 594
           VY+G   T    + +AVKKL+ + Q G++EF+ EV +IG  HH +LVRL GFC EG +RL
Sbjct: 507 VYEG---TLPDGSRLAVKKLEGIGQ-GKKEFRAEVSIIGSIHHLHLVRLRGFCAEGAHRL 562

Query: 595 LVYEFLNNGTLASFLF----GNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQ 650
           L YEFL+ G+L  ++F    G++  +W+ R NIA   A+GL YLHEDC A+I+HCDIKP+
Sbjct: 563 LAYEFLSKGSLERWIFRKKDGDVLLDWDTRFNIALGTAKGLAYLHEDCDARIVHCDIKPE 622

Query: 651 NILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFG 710
           NILLDD + A++SDFGLAKL+T  QS    T +RGT+GY+APEW  N  I+ K DVYS+G
Sbjct: 623 NILLDDNFNAKVSDFGLAKLMTREQSHVF-TTMRGTRGYLAPEWITNYAISEKSDVYSYG 681

Query: 711 VLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL-NVLVGEDKEAMNDIECLGKLVM 769
           ++LLE+I  RK++D     E      +AF     GKL +++ G+ K      E + + + 
Sbjct: 682 MVLLELIGGRKNYDPSETSEKCHFPSFAFKKMEEGKLMDIVDGKMKNVDVTDERVQRAMK 741

Query: 770 VSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVPPNPYPFSSSMG 812
            ++WCIQED   RP+M KV+QMLEGV  V  PP+    SS+MG
Sbjct: 742 TALWCIQEDMQTRPSMSKVVQMLEGVFPVVQPPS----SSTMG 780

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q39203|SD22_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-2 OS=Arabidopsis thaliana GN=SD22 PE=1 SV=1

 Score =  285 bits (728), Expect = 1e-75,   Method: Compositional matrix adjust.
 Identities = 240/784 (30%), Positives = 355/784 (45%), Gaps = 112/784 (14%)

Query: 46  LSPSGDFAFGFHQLDEENNTNDLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLT 105
           LS    F  GF       N +  + L I Y  +P  T VW   N+ +  + P  S ++LT
Sbjct: 34  LSFKAIFRLGFFS---TTNGSSNWYLGISYASMPTPTHVWVA-NRIRPVSDPDSSTLELT 89

Query: 106 ADQGLVLNDPQGKQVWSSKIDIGTVAVGHMNDTGNFVLASSSSGRLWDSFSNPTDTLLLG 165
           +   L++++ +   VW +            ++TGN +L +     +W SF NPTDT L G
Sbjct: 90  STGYLIVSNLRDGVVWQTDNKQPGTDF-RFSETGNLILINDDGSPVWQSFDNPTDTWLPG 148

Query: 166 QMMETEQGLFSRKSENNFSRGRFQFRLLEDGNLVLNIANLATGFAYDAYYTSGTYDPANS 225
             +     + S +S  + S G +  RL    N    +    T +     +T   +     
Sbjct: 149 MNVTGLTAMTSWRSLFDPSPGFYSLRLSPSFNEFQLVYKGTTPYWSTGNWTGEAF----- 203

Query: 226 SNSGYRVMFNESGYMYILRRNGGRFDLTTERVVPAADFYY--------------RATLNF 271
                 V   E    YI R     F        P A F+Y              R  +  
Sbjct: 204 ------VGVPEMTIPYIYR-----FHFVNP-YTPTASFWYIVPPLDSVSEPRLTRFMVGA 251

Query: 272 DGVFAQYFYPKNGNGNWSVAWSEPENICVDIGGGLGSGACGYNSICTLDSDRRPRCACPK 331
           +G   QY +      +W++ W +PE+ C           CG    C+  S+    CAC +
Sbjct: 252 NGQLKQYTWDPQTQ-SWNMFWLQPEDPCRVYN------LCGQLGFCS--SELLKPCACIR 302

Query: 332 GYSLLDE-----NDRYGSCRPDFELSCWGGGQGYNKELFDFHELKNINWPQSDYERFKPY 386
           G+   ++     +D    CR +       G  G   + F+   + ++ +           
Sbjct: 303 GFRPRNDAAWRSDDYSDGCRRE------NGDSGEKSDTFE--AVGDLRYDGDVKMSRLQV 354

Query: 387 NEVQCKNTCLSDCFCAAVIFNDGSCWFKKLPLSNGMTDSRIAGKAFIKYKNKGDDPPSVP 446
           ++  C  TCL +  C      + S   K L  S                           
Sbjct: 355 SKSSCAKTCLGNSSCVGFYHKEKSNLCKILLES--------------------------- 387

Query: 447 RPPDPEDKKKSKMMNATGSVLL-----GSSVFVNFALVCAFVLGFSFIYKKKWIRNSPDD 501
               P + K SK  N + S+++     GS   + F L+   +L      K+K  R   +D
Sbjct: 388 ----PNNLKNSKG-NISKSIIILCSVVGSISVLGFTLLVPLIL-LKRSRKRKKTRKQDED 441

Query: 502 GTIETNLRCFSYKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG 561
           G    NL+ FS+KEL+ ATN F ++VG G FG V+KG +    S+T VAVK+L+R    G
Sbjct: 442 GFAVLNLKVFSFKELQSATNGFSDKVGHGGFGAVFKGTLPG--SSTFVAVKRLERP-GSG 498

Query: 562 EREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP---NWN 618
           E EF+ EV  IG   H NLVRL GFC E  +RLLVY+++  G+L+S+L     P   +W 
Sbjct: 499 ESEFRAEVCTIGNIQHVNLVRLRGFCSENLHRLLVYDYMPQGSLSSYL-SRTSPKLLSWE 557

Query: 619 LRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT 678
            R  IA   A+G+ YLHE CR  IIHCDIKP+NILLD  Y A++SDFGLAKLL  + S+ 
Sbjct: 558 TRFRIALGTAKGIAYLHEGCRDCIIHCDIKPENILLDSDYNAKVSDFGLAKLLGRDFSRV 617

Query: 679 IKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIE---MGEEYAILT 735
           + T +RGT GYVAPEW     IT K DVYSFG+ LLE+I  R++  +    +GE+     
Sbjct: 618 LAT-MRGTWGYVAPEWISGLPITTKADVYSFGMTLLELIGGRRNVIVNSDTLGEKETEPE 676

Query: 736 DWAFDCYR-----NGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
            W F  +       G ++ +V        + E + ++  V+IWCIQ++  +RP M  V++
Sbjct: 677 KWFFPPWAAREIIQGNVDSVVDSRLNGEYNTEEVTRMATVAIWCIQDNEEIRPAMGTVVK 736

Query: 791 MLEG 794
           MLEG
Sbjct: 737 MLEG 740

Serine/threonine-protein kinase.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1

 Score =  277 bits (708), Expect = 3e-73,   Method: Compositional matrix adjust.
 Identities = 251/848 (29%), Positives = 386/848 (45%), Gaps = 135/848 (15%)

Query: 29  TVPVGATLTAGTSSSPWLSPSGDFAFGFHQ--LDEENNTNDLFLLSIFYNKIPEKTVVWY 86
           T+    +LT  +S++  +SP   F  GF +  LD        + L I+Y  I ++T VW 
Sbjct: 31  TLSASESLTI-SSNNTIVSPGNVFELGFFKPGLDSR------WYLGIWYKAISKRTYVWV 83

Query: 87  TDNKDQNPAVPRGSQVKLTADQGLVLNDPQGKQVWSSKI---DIGTVAVGHMNDTGNFVL 143
             N+D  P       +K+ +D  LV+ D     VWS+ +   D+ +  V  + D GNFVL
Sbjct: 84  A-NRD-TPLSSSIGTLKI-SDSNLVVLDQSDTPVWSTNLTGGDVRSPLVAELLDNGNFVL 140

Query: 144 A----SSSSGRLWDSFSNPTDTLL----LGQMMETEQGLFSR--KSENNFSRGRFQFRLL 193
                S+  G LW SF  PTDTLL    LG   +T    F R  KS ++ S G F F+L 
Sbjct: 141 RDSKNSAPDGVLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPSSGDFSFKLE 200

Query: 194 EDGNLVLNIANLATGFAYDAYYTSGTYDPANSSNSGYRVMFNESGYMYILRRNGGRFDLT 253
            +G   + + N  +       Y SG ++    S       F    YM +      + ++T
Sbjct: 201 TEGFPEIFLWNRESRM-----YRSGPWNGIRFSGVPEMQPFE---YM-VFNFTTSKEEVT 251

Query: 254 TERVVPAADFYYRATLNFDGVFAQYFYPKNGNGNWSVAWSEPENICVDIGGGLGSGACGY 313
               +  +D Y R +++  G+  ++ + +    NW+  W  P++ C +         CG 
Sbjct: 252 YSFRITKSDVYSRLSISSSGLLQRFTWIETAQ-NWNQFWYAPKDQCDEYK------ECGV 304

Query: 314 NSICTLDSDRRPRCACPKGY-----SLLDENDRYGSCRPDFELSCWGGGQGYNKELFDFH 368
              C  DS+  P C C KG+      +    D    C     LSC GGG G       F 
Sbjct: 305 YGYC--DSNTSPVCNCIKGFKPRNPQVWGLRDGSDGCVRKTLLSC-GGGDG-------FV 354

Query: 369 ELKNINWPQSDYERF-KPYNEVQCKNTCLSDCFCAAVIFNDGSCWFKKLPLSNGMTDSRI 427
            LK +  P +      +     +C+  CL DC C A                   TD R 
Sbjct: 355 RLKKMKLPDTTTASVDRGIGVKECEQKCLRDCNCTAF----------------ANTDIRG 398

Query: 428 AGKAFI----------KYKNKGDDPPSVPRPPDPEDKKKSKMMNATGSVLLGSSVFVNFA 477
           +G   +           Y   G D        D EDK+         + ++GSS+ V+  
Sbjct: 399 SGSGCVTWTGELFDIRNYAKGGQDLYVRLAATDLEDKRNR------SAKIIGSSIGVSVL 452

Query: 478 LVCAFVLGFSFIYKKKWIRN------------------------------SPDDGTIETN 507
           L+ +F++   F++K+K  R+                              S ++ T +  
Sbjct: 453 LLLSFII--FFLWKRKQKRSILIETPIVDHQLRSRDLLMNEVVISSRRHISRENNTDDLE 510

Query: 508 LRCFSYKELEGATNNFKE--EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREF 565
           L    ++E+  ATNNF    ++G+G FGIVYKG +        +AVK+L +    G  EF
Sbjct: 511 LPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKL---LDGQEMAVKRLSKTSVQGTDEF 567

Query: 566 KNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFG---NLKPNWNLRTN 622
           KNEV +I +  H NLVRLL  C +   ++L+YE+L N +L S LF    N K NW +R +
Sbjct: 568 KNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRNSKLNWQMRFD 627

Query: 623 IAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTA 682
           I   IARGLLYLH+D R +IIH D+K  NILLD Y T +ISDFG+A++   ++++     
Sbjct: 628 IINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGRDETEANTRK 687

Query: 683 IRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 742
           + GT GY++PE+  +   + K DV+SFGVLLLEIIS +++      +    L    +  +
Sbjct: 688 VVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDRDLNLLGCVWRNW 747

Query: 743 RNGK----LNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV 798
           + GK    ++ ++ +        E L + + + + C+QE    RPTM  V+ ML G    
Sbjct: 748 KEGKGLEIIDPIITDSSSTFRQHEIL-RCIQIGLLCVQERAEDRPTMSLVILML-GSEST 805

Query: 799 SVPPNPYP 806
           ++P    P
Sbjct: 806 TIPQPKAP 813

Involved in the regulation of cellular expansion and differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O65238|Y5537_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g35370 OS=Arabidopsis thaliana GN=At5g35370 PE=2 SV=2

 Score =  276 bits (705), Expect = 7e-73,   Method: Compositional matrix adjust.
 Identities = 233/780 (29%), Positives = 357/780 (45%), Gaps = 111/780 (14%)

Query: 82  TVVWYTDNKDQNPAVPRGSQVKLTADQGLVLNDPQGK-QVWSSKIDIGTVAVGHMNDTGN 140
           + +W + N+D +P    G+ + LT     V+ D + +  VWS+ +    V    + D GN
Sbjct: 84  STIW-SSNRD-SPVSSSGT-MNLTPQGISVIEDGKSQIPVWSTPVLASPVKSLRLTDAGN 140

Query: 141 FVLASSSSGRLWDSFSNPTDTLLLGQMMETEQGLFSRKSENNFSRGRFQFRLLEDGNLVL 200
            +L    +  LW+SF  PTD+++LGQ ++    L    S ++FS G ++F + E   L+ 
Sbjct: 141 LLLLDHLNVSLWESFDFPTDSIVLGQRLKLGMFLSGSVSRSDFSTGDYKFLVGESDGLM- 199

Query: 201 NIANLATGFAYDAYYTSGTYDPAN-SSNSGYRVMFNESGYMYILRRNGGRFDLTTERVV- 258
                   +    Y+    +  AN  SN     +   +  + ++ RNG    +   RV  
Sbjct: 200 -------QWRGQNYWKLRMHIRANVDSNFPVEYLTVTTSGLALMARNG---TVVVVRVAL 249

Query: 259 -PAADFYYRATLNFDGVFAQYFYPKNGNGNWSVAWSEPENICVDIGGGLGSGACGYNSIC 317
            P++DF   A ++  G   ++   +    N    +S P + C           CG   +C
Sbjct: 250 PPSSDFRV-AKMDSSG---KFIVSRFSGKNLVTEFSGPMDSCQI------PFVCGKLGLC 299

Query: 318 TLD-SDRRPRCACPKGYSLLDENDRYGSCRP-----DFELSCWGGGQGYNK-----ELFD 366
            LD +     C+CP    +   +   G C P        +SC      Y +       F 
Sbjct: 300 NLDNASENQSCSCPDEMRM---DAGKGVCVPVSQSLSLPVSCEARNISYLELGLGVSYFS 356

Query: 367 FHELKNINWPQSDYERFKPYNEVQCKNTCLSDCFCAAVIFNDGS--CW-----FKKLPL- 418
            H    +       E   P   + C + C  +C C  V + + S  C+     F  L L 
Sbjct: 357 THFTDPV-------EHGLPL--LACHDICSKNCSCLGVFYENTSRSCYLVKDSFGSLSLV 407

Query: 419 SNGMTDSRIAGKAFIKYKNKGDDPPSVPRPPDPEDKKKSKMMNATGSVLLGSSVFVNFAL 478
            N   +  + G   +  +     PP         + +          VLL  S F  F L
Sbjct: 408 KNSPENHDLIGYVKLSIRKTNAQPPG-------NNNRGGSSFPVIALVLLPCSGF--FLL 458

Query: 479 V---------CAFVLGFSFIYKKKWIR----NSPDDGT--IETNLRCFSYKELEGATNNF 523
           +         CA V+ +S I +K+  R     S D G+  I    + F ++ELE AT NF
Sbjct: 459 IALGLLWWRRCA-VMRYSSIREKQVTRPGSFESGDLGSFHIPGLPQKFEFEELEQATENF 517

Query: 524 KEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           K ++G G FG VYKG   T    T +AVKK+      G +EF  E+ +IG   H NLV+L
Sbjct: 518 KMQIGSGGFGSVYKG---TLPDETLIAVKKITNHGLHGRQEFCTEIAIIGNIRHTNLVKL 574

Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP--NWNLRTNIAFQIARGLLYLHEDCRAQ 641
            GFC  G+  LLVYE++N+G+L   LF    P   W  R +IA   ARGL YLH  C  +
Sbjct: 575 RGFCARGRQLLLVYEYMNHGSLEKTLFSGNGPVLEWQERFDIALGTARGLAYLHSGCDQK 634

Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKIT 701
           IIHCD+KP+NILL D++  +ISDFGL+KLL   +S ++ T +RGT+GY+APEW  N+ I+
Sbjct: 635 IIHCDVKPENILLHDHFQPKISDFGLSKLLNQEES-SLFTTMRGTRGYLAPEWITNAAIS 693

Query: 702 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD--------------------WAFDC 741
            K DVYS+G++LLE++S RK+         ++  D                    +A D 
Sbjct: 694 EKADVYSYGMVLLELVSGRKNCSFR-SRSNSVTEDNNQNHSSTTTTSTGLVYFPLYALDM 752

Query: 742 YRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVP 801
           +  G+   L     E     +   KLV +++ C+ E+P+LRPTM  V+ M EG + +  P
Sbjct: 753 HEQGRYMELADPRLEGRVTSQEAEKLVRIALCCVHEEPALRPTMAAVVGMFEGSIPLGNP 812

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZR08|Y4230_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g03230 OS=Arabidopsis thaliana GN=At4g03230 PE=3 SV=3

 Score =  271 bits (694), Expect = 1e-71,   Method: Compositional matrix adjust.
 Identities = 232/847 (27%), Positives = 385/847 (45%), Gaps = 85/847 (10%)

Query: 6   LYFIFLLFQLPYFSHLAIAQNNGTVPVGATLTAGTSSSPWLSPSGDFAFGFHQLDEENNT 65
           ++F   L  +         Q++ T+  G+TL   +     +S    F  GF       ++
Sbjct: 5   VFFYMFLLHIRRLDCFVAVQDSKTLFKGSTLINDSHGETLVSAGQRFELGF--FTPNGSS 62

Query: 66  NDLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLTADQGLVLNDPQGKQVWSSKI 125
           ++   L I++  +   TVVW  +   ++P + R     ++ D  L + D +G+  W + +
Sbjct: 63  DERRYLGIWFYNLHPLTVVWVANR--ESPVLDRSCIFTISKDGNLEVIDSKGRVYWDTGV 120

Query: 126 DIGTVAVGHM---NDTGNFVLAS--SSSGRLWDSFSNPTDTLLLGQMMETEQGLFSRKSE 180
              +V+   M    D GN VL S  + +  +W SF NPTDT L G  M+    L S +S 
Sbjct: 121 KPSSVSAERMVKLMDNGNLVLISDGNEANVVWQSFQNPTDTFLPGMRMDENMTLSSWRSF 180

Query: 181 NNFSRGRFQFRLLEDGNLVLNIANLATGFAYDAYYTSGTYDPANSSNSGYRVMFNESGYM 240
           N+ S G F F++ ++ +    I   +       Y+ SG         SG  +  +E  Y 
Sbjct: 181 NDPSHGNFTFQMDQEEDKQFIIWKRSM-----RYWKSGI--------SGKFIGSDEMPYA 227

Query: 241 --YILRRNGGRFDLTTERVVPAADFYY---RATLNFDGVFAQYFYPKNGNGNWSVAWSEP 295
             Y L        +    V P     Y   R T++  G  AQYF   +G   W+  W+EP
Sbjct: 228 ISYFLSNFTETVTVHNASVPPLFTSLYTNTRFTMSSSGQ-AQYFR-LDGERFWAQIWAEP 285

Query: 296 ENICVDIGGGLGSGACGYNSICTLDSDRRPRCACPKGY--SLLDE---NDRYGSCRPDFE 350
            + C          ACG    C  +S     C C  G+  + L++    D  G C  +  
Sbjct: 286 RDECSVYN------ACGNFGSC--NSKNEEMCKCLPGFRPNFLEKWVKGDFSGGCSRESR 337

Query: 351 LSCWGGGQGYNKELFDFHELKNINWPQSDYERFKPYNEVQCKNTCLSDCFCAA------- 403
           +   G       ++F    +  +  P S   +F  +NE +C+  CL++C C A       
Sbjct: 338 IC--GKDGVVVGDMFLNLSVVEVGSPDS---QFDAHNEKECRAECLNNCQCQAYSYEEVD 392

Query: 404 VIFNDGSCWFKKLPLSNGMTDSRIAGKAFIKYKNKGDDPPSVPRPPDPEDKKKSKMMNAT 463
           ++ ++  CW     L+N       +   FI+     D    V R      + K+ ++   
Sbjct: 393 ILQSNTKCWIWLEDLNNLKEGYLGSRNVFIRVAVP-DIGSHVERGRGRYGEAKTPVVLII 451

Query: 464 GSVLLGSSVFVNFALVCAFVL---------------GFSFIYKKKWIRNSPDDGTIE--- 505
                 +++ V  +   ++V                G      ++ I+   + G  +   
Sbjct: 452 VVTFTSAAILVVLSSTASYVFLQRRKVNKELGSIPRGVHLCDSERHIKELIESGRFKQDD 511

Query: 506 ---TNLRCFSYKELEGATNNFKE--EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD 560
               ++  F  + +  AT+NF    ++G+G FG VYKG+         +AVK+L R    
Sbjct: 512 SQGIDVPSFELETILYATSNFSNANKLGQGGFGPVYKGMF---PGDQEIAVKRLSRCSGQ 568

Query: 561 GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN---LKPNW 617
           G  EFKNEV +I +  H+NLVRLLG+C  G+ +LL+YE++ + +L  F+F      + +W
Sbjct: 569 GLEEFKNEVVLIAKLQHRNLVRLLGYCVAGEEKLLLYEYMPHKSLDFFIFDRKLCQRLDW 628

Query: 618 NLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSK 677
            +R NI   IARGLLYLH+D R +IIH D+K  NILLD+    +ISDFGLA++   +++ 
Sbjct: 629 KMRCNIILGIARGLLYLHQDSRLRIIHRDLKTSNILLDEEMNPKISDFGLARIFGGSETS 688

Query: 678 TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW 737
                + GT GY++PE+      + K DV+SFGV+++E IS +++      E+   L   
Sbjct: 689 ANTNRVVGTYGYMSPEYALEGLFSFKSDVFSFGVVVIETISGKRNTGFHEPEKSLSLLGH 748

Query: 738 AFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 797
           A+D ++  +   L+ +  +   + E   K + V + C+QEDP+ RPTM  V+ ML G  E
Sbjct: 749 AWDLWKAERGIELLDQALQESCETEGFLKCLNVGLLCVQEDPNDRPTMSNVVFML-GSSE 807

Query: 798 VSVPPNP 804
            +  P P
Sbjct: 808 AATLPTP 814

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	814
109676362	2037	CCHC-type integrase [Populus trichocarpa	0.917	0.366	0.641	0.0
224099309	801	predicted protein [Populus trichocarpa]	0.944	0.960	0.577	0.0
224143661	691	predicted protein [Populus trichocarpa]	0.845	0.995	0.598	0.0
224103119	799	predicted protein [Populus trichocarpa]	0.963	0.981	0.567	0.0
356575025	800	PREDICTED: G-type lectin S-receptor-like	0.953	0.97	0.561	0.0
255544746	800	ATP binding protein, putative [Ricinus c	0.936	0.952	0.573	0.0
224057535	775	predicted protein [Populus trichocarpa]	0.936	0.983	0.565	0.0
224053032	752	predicted protein [Populus trichocarpa]	0.916	0.992	0.566	0.0
356555196	869	PREDICTED: G-type lectin S-receptor-like	0.917	0.859	0.535	0.0
356555135	815	PREDICTED: G-type lectin S-receptor-like	0.976	0.975	0.531	0.0

>gi|109676362|gb|ABG37663.1| CCHC-type integrase [Populus trichocarpa]

 Score =  977 bits (2525), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 492/767 (64%), Positives = 587/767 (76%), Gaps = 20/767 (2%)

Query: 8   FIFLLFQLPYFSHLAIAQNNGTVPVGATLTAGTSSSPWLSPSGDFAFGFHQLDEENNTND 67
              +L QL     +A+AQ NG VP GA++TA   S  W S SG+FAFGF QL+ +    D
Sbjct: 43  LTMVLLQL-----MAVAQTNGRVPTGASITATDDSPSWPSASGEFAFGFRQLENK----D 93

Query: 68  LFLLSIFYNKIPEKTVVWYTDNKD--QNPAVPRGSQVKLTADQGLVLNDPQGKQVWSSKI 125
            FLLSI+Y KIPEKTVVWY   +D   +PAVPRGS+++LT D+GL+L DPQG Q+WSS I
Sbjct: 94  YFLLSIWYEKIPEKTVVWYAIGEDPTDDPAVPRGSKLELTDDRGLLLADPQGNQIWSSGI 153

Query: 126 DIGT-VAVGHMNDTGNFVLASSSSGRLWDSFSNPTDTLLLGQMMETEQGLFSRKSENNFS 184
             G  V+ G MNDTGNFVL + +S RLW+SF+NPTDTLL  Q+ME    + SR++E NFS
Sbjct: 154 PPGAAVSSGVMNDTGNFVLQNRNSFRLWESFNNPTDTLLPTQIMEVGGVVSSRRTETNFS 213

Query: 185 RGRFQFRLLEDGNLVLNIANLATGFAYDAYYTSGTYDPANSSNSGYRVMFNESGYMYILR 244
            GRFQ RLL++GNLVLN  NL T F YD YY+S T D +NSSNSGYR++FNESGYMYILR
Sbjct: 214 LGRFQLRLLDNGNLVLNYMNLPTKFVYDDYYSSETSDASNSSNSGYRLIFNESGYMYILR 273

Query: 245 RNGGRFDLTTERVVPAADFYYRATLNFDGVFAQYFYPK--NGNGNWSVAWSEPENICVDI 302
           RNG   DLT +  +P  DFY+RATLNFDGVF QYFYPK  +GN +WS  WS+P++ICV++
Sbjct: 274 RNGLIEDLT-KTALPTIDFYHRATLNFDGVFTQYFYPKASSGNRSWSSVWSKPDDICVNM 332

Query: 303 GGGLGSGACGYNSICTLDSDRRPRCACPKGYSLLDENDRYGSCRPDFELSCWGGGQGYNK 362
           G  LGSGACGYNSIC L +D+RP C CP+G+SLLD+ND+YGSC PDFELSC   G    +
Sbjct: 333 GADLGSGACGYNSICNLKADKRPECKCPQGFSLLDQNDKYGSCIPDFELSCRDDGLNSTE 392

Query: 363 ELFDFHELKNINWPQSDYERFKPYNEVQCKNTCLSDCFCAAVIFNDGSCWFKKLPLSNGM 422
           + +DF EL N++WP SDYER+KP NE +C+ +CL+DC C+  IF DG CW KKLPLSNG 
Sbjct: 393 DQYDFVELINVDWPTSDYERYKPINEDECRKSCLNDCLCSVAIFRDG-CWKKKLPLSNGR 451

Query: 423 TDSRIAGKAFIKYKNKGDDPPSVPRPPDPEDKKKSKMMNATGSVLLGSSVFVNFALVCAF 482
            D  + GKAF+K+  KG  P   P P  P +KKK  +   TGSV+LG+SVFVNF LV AF
Sbjct: 452 FDIGMNGKAFLKFP-KGYVPLDRPPPQLPGEKKKPDIKFITGSVVLGTSVFVNFVLVGAF 510

Query: 483 VLGFSFIYKKKWIRNSPDDGTIETNLRCFSYKELEGATNNFKEEVGRGSFGIVYKGVIQT 542
            L  SFIY+KK  +       +ETNLR F+YKEL  ATN+FK+EVGRG FG+VYKG IQ 
Sbjct: 511 CLTSSFIYRKKTEKVKEGGSGLETNLRYFTYKELAEATNDFKDEVGRGGFGVVYKGTIQA 570

Query: 543 RTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN 602
             ST  VAVKKLD+V QDGE+EFK EV VIGQTHHKNLVRLLGFCDEGQNRLLVYEFL+N
Sbjct: 571 -GSTRVVAVKKLDKVVQDGEKEFKTEVQVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLSN 629

Query: 603 GTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARI 662
           GTLA+FLFG  KPNW  RT IAF IARGLLYLHE+C  QIIHCDIKPQNILLD+YY ARI
Sbjct: 630 GTLANFLFGCSKPNWKQRTQIAFGIARGLLYLHEECGTQIIHCDIKPQNILLDNYYNARI 689

Query: 663 SDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKS 722
           SDFGLAKLL ++QSKT +TAIRGTKGYVAPEWFRN  IT KVDVYSFGV+LLEII CR++
Sbjct: 690 SDFGLAKLLVMDQSKT-QTAIRGTKGYVAPEWFRNRPITVKVDVYSFGVMLLEIICCRRN 748

Query: 723 FDIEMGE-EYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLV 768
            D+E+GE E  +LTDWA+DCY +G L+VL+G+D EA NDI  L +L+
Sbjct: 749 VDLEIGEVENPVLTDWAYDCYMDGSLDVLIGDDTEAKNDISTLERLL 795

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224099309|ref|XP_002334494.1| predicted protein [Populus trichocarpa] gi|222872794|gb|EEF09925.1| predicted protein [Populus trichocarpa]

 Score =  899 bits (2322), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 455/788 (57%), Positives = 561/788 (71%), Gaps = 19/788 (2%)

Query: 11  LLFQLPYFSHLAIAQNNGTVPVGATLTAGTSSSPWLSPSGDFAFGFHQLDEENNTNDLFL 70
           LL  LP F   A++Q  G + VGA+L+   ++S WLSPSGDFAFGFH L        LFL
Sbjct: 12  LLIMLPPF---AVSQTGGNITVGASLSTSENTS-WLSPSGDFAFGFHPL---YGNKYLFL 64

Query: 71  LSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLTADQGLVLNDPQGKQVWSSKIDIGTV 130
           L+I+Y+KIPEKT+VWY  N D+ PA P GS+  LTA++G+ L DPQG+++W S+  IG V
Sbjct: 65  LAIWYDKIPEKTIVWYA-NGDK-PA-PTGSKAVLTANRGISLTDPQGRELWRSETIIGVV 121

Query: 131 AVGHMNDTGNFVLASSSSGRLWDSFSNPTDTLLLGQMMETEQGLFSRKSENNFSRGRFQF 190
           A G M D GNFVL    S +LW+SF NP DTLL  Q+++    L SR+SENNFS GRFQ 
Sbjct: 122 AYGAMTDKGNFVLQDRVSDKLWESFKNPADTLLPSQVLDRGMTLSSRQSENNFSMGRFQL 181

Query: 191 RLLEDGNLVLNIANLATGFAYDAYYTSGTYDPANSSNSGYRVMFNESGYMYILRRNGGRF 250
           +L +DGNL L   NL + +  + YY SGT    +SS+ GY+V+FNESGY+YILR N   F
Sbjct: 182 KLTDDGNLELATINLPSDYTNEPYYKSGTDGGLDSSSPGYQVVFNESGYLYILRENDQIF 241

Query: 251 DLTTERVVPAADFYYRATLNFDGVFAQYFYPKNGNGN--WSVAWSEPENICVDIGGGLGS 308
            LT        DFY RATLNFDG+F QY++PK   GN  W+  WS+P+NIC       GS
Sbjct: 242 SLTQRVTASTGDFYRRATLNFDGLFTQYYHPKASTGNERWTPIWSQPDNICQASFVSSGS 301

Query: 309 GACGYNSICTLDSDRRPRCACPKGYSLLDENDRYGSCRPDFELSCWGGGQGYNKELFDFH 368
           G CG+NS+C L+SDRRP C CP GYSLLD +D+YGSCRP++  SC        ++L+DF 
Sbjct: 302 GTCGFNSVCRLNSDRRPICECPGGYSLLDPSDQYGSCRPNYTQSCEEDEVAPVEDLYDFE 361

Query: 369 ELKNINWPQSDYERFKPYNEVQCKNTCLSDCFCAAVIFNDGS-CWFKKLPLSNGMTDSRI 427
           EL N +WP SDY   KP+ E +C+ +CL+DC CA  IF  G  CW KKLPLSNG   + +
Sbjct: 362 ELTNTDWPTSDYALLKPFTEEKCRQSCLNDCMCAVAIFRSGDMCWKKKLPLSNGRVQTNL 421

Query: 428 AGKAFIKYKNKGDDPPSVPRPPDPEDKKKSKMMNATGSVLLGSSVFVNFALVCAFVLGFS 487
            GKA +K +    +P S   P  P +KK    +   GSV LG SVFVNF LVCA  + F 
Sbjct: 422 DGKALLKVRRSNVNPRS---PYFPNNKKDRDGLILVGSVFLGCSVFVNFLLVCAIFMCFF 478

Query: 488 FIYKKKWIRNSPDDGTIETNLRCFSYKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTT 547
           FIY+++  R    DG +ETNLRCF+Y+EL  AT  FKEE+GRG+FG+VYKGV+    S+ 
Sbjct: 479 FIYRRRTKRIPQKDGAVETNLRCFTYQELAEATEGFKEELGRGAFGVVYKGVVHI-GSSI 537

Query: 548 AVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLAS 607
            VAVKKL+ V +D  REFK EV VIGQTHHKNLVRLLGFC+EG  RLLVYEF++NG+L+S
Sbjct: 538 VVAVKKLNNVAEDRVREFKTEVNVIGQTHHKNLVRLLGFCEEGDQRLLVYEFMSNGSLSS 597

Query: 608 FLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGL 667
           F+F + KP W +R  IAF +ARGLLYLHE+C  QIIHCDIKPQNILLD+YY ARISDFGL
Sbjct: 598 FIFQDAKPGWKIRIQIAFGVARGLLYLHEECSNQIIHCDIKPQNILLDEYYNARISDFGL 657

Query: 668 AKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEM 727
           AKLL L+QS+T  TAIRGTKGYVAPEWFRN  +T KVDVYS+GVLLLEII CR++ D + 
Sbjct: 658 AKLLLLDQSQT-HTAIRGTKGYVAPEWFRNLPVTVKVDVYSYGVLLLEIICCRRNVDSKA 716

Query: 728 G-EEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMK 786
             EE AILTDWA+DCYR G L+ LVG D  A++DIE L + +M++ WCIQEDPSLRPTM+
Sbjct: 717 TIEEQAILTDWAYDCYREGTLDALVGSDTGALDDIEKLERFLMIAFWCIQEDPSLRPTMR 776

Query: 787 KVLQMLEG 794
           KV QMLEG
Sbjct: 777 KVTQMLEG 784

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224143661|ref|XP_002336066.1| predicted protein [Populus trichocarpa] gi|222869874|gb|EEF07005.1| predicted protein [Populus trichocarpa]

 Score =  893 bits (2308), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 469/784 (59%), Positives = 552/784 (70%), Gaps = 96/784 (12%)

Query: 27  NGTVPVGATLTAGTSSSPWLSPSGDFAFGFHQLDEENNTNDLFLLSIFYNKIPEKTVVWY 86
           NG++PVGA +TA   +  WLS SG+FAFGF  L+ +    D FLLSI+Y KIPEKT+VWY
Sbjct: 1   NGSMPVGAFITATDDAPSWLSSSGEFAFGFQPLEYK----DHFLLSIWYAKIPEKTIVWY 56

Query: 87  TDNKDQNPAVPRGSQVKLTADQGLVLNDPQGKQVWSSKIDIGTVAVGHMNDTGNFVLASS 146
            +    NPA PR S+V+L  D GLVL DPQG  +WSS   +GTV+ G MNDTGNFVL +S
Sbjct: 57  ANG--DNPA-PRESKVELRGDSGLVLTDPQGNLIWSSGSLLGTVSSGVMNDTGNFVLQNS 113

Query: 147 SSGRLWDSFSNPTDTLLLGQMMETEQGLFSRKSENNFSRGRFQFRLLEDGNLVLNIANLA 206
           +S RLW+SFSNPTDTLL  Q+ME    + SR++E NFS GRFQ RLL++GNLVLN  NL 
Sbjct: 114 NSFRLWESFSNPTDTLLPTQIMEVGGVVSSRRTETNFSLGRFQLRLLDNGNLVLNYMNLP 173

Query: 207 TGFAYDAYYTSGTYDPANSSNSGYRVMFNESGYMYILRRNGGRFDLTTERVVPAADFYYR 266
           T F YD YY+S T D +NSSNSGYR++FNESGYMYILRRNG   DLT +  +P  DFY+R
Sbjct: 174 TKFVYDDYYSSETSDASNSSNSGYRLIFNESGYMYILRRNGLIEDLT-KTALPTIDFYHR 232

Query: 267 ATLNFDGVFAQYFYPKNGNGNWSVAWSEPENICVDIGGGLGSGACGYNSICTLDSDRRPR 326
           ATLNFD                                 LGSGACGYNSIC L +D+RP 
Sbjct: 233 ATLNFDA-------------------------------DLGSGACGYNSICNLKADKRPE 261

Query: 327 CACPKGYSLLDENDRYGSCRPDFELSCWGGGQGYNKELFDFHELKNINWPQSDYERFKPY 386
           C CP+G+SLLD+ND+YGSC PDFELSC   G    ++ +DF EL N++WP SDYER+KP 
Sbjct: 262 CKCPQGFSLLDQNDKYGSCIPDFELSCRDDGLNSTEDQYDFVELINVDWPTSDYERYKPI 321

Query: 387 NEVQCKNTCLSDCFCAAVIFNDGSCWFKKLPLSNGMTDSRIAGKAFIKYKNKGDDPPSVP 446
           NE +C+ +CL+DC C+  IF DG CW KKLPLSNG  D  + GKAF+K+           
Sbjct: 322 NEDECRKSCLNDCLCSVAIFRDG-CWKKKLPLSNGRFDIGMNGKAFLKF----------- 369

Query: 447 RPPDPEDKKKSKMMNATGSVLLGSSVFVNFALVCAFVLGFSFIYKKKWIRNSPDDGTIET 506
               P+  K  K+         GS                                 +ET
Sbjct: 370 ----PKGYKTEKVKEG------GSG--------------------------------LET 387

Query: 507 NLRCFSYKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFK 566
           NLR F+YKEL  ATN+FK+EVGRG FG+VYKG IQ   ST  VAVKKLD+V QDGE+EFK
Sbjct: 388 NLRYFTYKELAEATNDFKDEVGRGGFGVVYKGTIQA-GSTRVVAVKKLDKVVQDGEKEFK 446

Query: 567 NEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQ 626
            EV VIGQTHHKNLVRLLGFCDEGQNRLLVYEFL+NGTLA+FLFG  KPNW  RT IAF 
Sbjct: 447 TEVQVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLSNGTLANFLFGCSKPNWKQRTQIAFG 506

Query: 627 IARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGT 686
           IARGLLYLHE+C  QIIHCDIKPQNILLD+YY ARISDFGLAKLL ++QSKT +TAIRGT
Sbjct: 507 IARGLLYLHEECGTQIIHCDIKPQNILLDNYYNARISDFGLAKLLVMDQSKT-QTAIRGT 565

Query: 687 KGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGE-EYAILTDWAFDCYRNG 745
           KGYVAPEWFRN  IT KVDVYSFGV+LLEII CR++ D+E+GE E  +LTDWA+DCY +G
Sbjct: 566 KGYVAPEWFRNRPITVKVDVYSFGVMLLEIICCRRNVDLEIGEVENPVLTDWAYDCYMDG 625

Query: 746 KLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVPPNPY 805
            L+VL+G+D EA NDI  L +L+ V IWCIQEDPSLRPTM+KV QMLEGVVEV   PNP+
Sbjct: 626 SLDVLIGDDTEAKNDISTLERLLKVGIWCIQEDPSLRPTMRKVTQMLEGVVEVPAAPNPF 685

Query: 806 PFSS 809
           P+SS
Sbjct: 686 PYSS 689

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224103119|ref|XP_002334088.1| predicted protein [Populus trichocarpa] gi|222839594|gb|EEE77931.1| predicted protein [Populus trichocarpa]

 Score =  889 bits (2298), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 457/805 (56%), Positives = 575/805 (71%), Gaps = 21/805 (2%)

Query: 11  LLFQLPYFSHLAIAQNNGTVPVGATLTAGTSSSPWLSPSGDFAFGFHQLDEENNTNDLFL 70
           LL  LP F   A++Q  G + VGA+L+   ++S WLSPSGDFAFGF+QL       DLFL
Sbjct: 12  LLIMLPPF---AVSQTGGNITVGASLSTSDNTS-WLSPSGDFAFGFYQL---YGNKDLFL 64

Query: 71  LSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLTADQGLVLNDPQGKQVWSSKIDIGTV 130
           L+I+Y+KIP+KT+VWY  N D+ PA P GS+  LTA++G+ L DPQG+++W S+  IG V
Sbjct: 65  LAIWYDKIPDKTIVWYA-NGDK-PA-PTGSKAVLTANRGISLTDPQGRELWRSETIIGDV 121

Query: 131 AVGHMNDTGNFVLASSSSGRLWDSFSNPTDTLLLGQMMETEQGLFSRKSENNFSRGRFQF 190
           A G M DTGNFVL    S +LW+SF NP DTLL  Q+++    L SR+SE NFS GRFQ 
Sbjct: 122 AYGAMTDTGNFVLRDRVSDKLWESFKNPADTLLPSQVLDRGMTLSSRQSETNFSMGRFQL 181

Query: 191 RLLEDGNLVLNIANLATGFAYDAYYTSGTYDPANSSNSGYRVMFNESGYMYILRRNGGRF 250
           +L +DGNLVL   NL + +  + YY SGT    +SS+ GY+V+FNESGY+YILR+N   F
Sbjct: 182 KLRDDGNLVLATINLPSDYTNEPYYKSGTDGGLDSSSPGYQVVFNESGYLYILRKNDQIF 241

Query: 251 DLTTERVVPAADFYYRATLNFDGVFAQYFYPKNGNGN--WSVAWSEPENICVDIGGGLGS 308
            LT        DFY+RATLNFDGVF QY++PK   GN  W+  WS+P+NIC       GS
Sbjct: 242 SLTQRVTASTGDFYHRATLNFDGVFTQYYHPKASTGNERWTPIWSQPDNICQASSVSAGS 301

Query: 309 GACGYNSICTLDSDRRPRCACPKGYSLLDENDRYGSCRPDFELSCWGGGQGYNKELFDFH 368
           G CG+NS+C L+SD RP C CP GYSLLD +D+YGSCRP++  SC        ++L+DF 
Sbjct: 302 GTCGFNSVCRLNSDGRPICECPGGYSLLDPSDQYGSCRPNYTQSCEEDEVAPVEDLYDFE 361

Query: 369 ELKNINWPQSDYERFKPYNEVQCKNTCLSDCFCAAVIFNDGS-CWFKKLPLSNGMTDSRI 427
           EL N +WP SDY   +P+ E +C+ +CL+DC CA  IF  G  CW KKLPLSNG   + +
Sbjct: 362 ELTNTDWPTSDYALLQPFTEEKCRQSCLNDCMCAVAIFRSGDMCWKKKLPLSNGRVQTIV 421

Query: 428 AGKAFIKYKNKGDDPPSVPRPPDPEDKKKSKMMNATGSVLLGSSVFVNFALVCAFVLGFS 487
             KA +K +    +P S   P  P +KK    +   GSV LG SVFVNF LVCA  +GF 
Sbjct: 422 DAKALLKVRRSNVNPRS---PYFPNNKKDRDGLILVGSVFLGCSVFVNFLLVCAICMGFF 478

Query: 488 FIYKKKWIRNSPDDGTIETNLRCFSYKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTT 547
           FIY+++  R    DG +ETNLRCF+Y+EL  AT  FKEE+GRG+FG+VY+GV+    S+ 
Sbjct: 479 FIYRRRTKRIPQKDGAVETNLRCFTYQELAEATEGFKEELGRGAFGVVYRGVVHI-GSSI 537

Query: 548 AVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLAS 607
            VAVKKL+ V +D  REFK EV VIGQTHHKNLVRLLGFC+EG  RLLVYEF++NG+L+S
Sbjct: 538 VVAVKKLNNVAEDRVREFKTEVNVIGQTHHKNLVRLLGFCEEGDQRLLVYEFMSNGSLSS 597

Query: 608 FLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGL 667
           F+F + KP W +R  IAF +ARGLLYLHED  +QIIHCDIKPQNILLD+   ARISDFGL
Sbjct: 598 FIFQDAKPGWKIRIQIAFGVARGLLYLHED--SQIIHCDIKPQNILLDESLNARISDFGL 655

Query: 668 AKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIE- 726
           AKLL  +Q+KT  TAIRGTKGYVAPEWF+N  +T KVD YSFG+LLLE++ CRK+F+I  
Sbjct: 656 AKLLKTDQTKT-TTAIRGTKGYVAPEWFKNLPVTTKVDTYSFGILLLELVCCRKNFEINA 714

Query: 727 MGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMK 786
           M E   +L DWA DC + GKLN+LV ED+EAM D++ + + VMV+IWCIQEDPSLRP MK
Sbjct: 715 MQEHQIVLADWACDCLKEGKLNLLVEEDEEAMEDMKRVERFVMVAIWCIQEDPSLRPGMK 774

Query: 787 KVLQMLEGVVEVSVPPNPYPFSSSM 811
           KV+QMLEG V+VSVPP+P  F S++
Sbjct: 775 KVVQMLEGGVQVSVPPDPSSFISTI 799

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356575025|ref|XP_003555643.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Glycine max]

 Score =  882 bits (2279), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 454/808 (56%), Positives = 572/808 (70%), Gaps = 32/808 (3%)

Query: 8   FIFLLFQLPYFSHLAIAQNNGTVPVGATLTAGTSSSPWLSPSGDFAFGFHQLDEENNTND 67
            +  L QLPY S    A N   V +G TL AG     WLSPS DFAFGFHQLD     ND
Sbjct: 13  ILLPLLQLPYVS----ATN---VSIGETLVAGNGGKRWLSPSEDFAFGFHQLD-----ND 60

Query: 68  LFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLTADQGLVLNDPQGKQVWSSKIDI 127
           L+LL+I Y  IP  + +WY +    NPA P+GS+++L    GLVL  PQG ++W+S++  
Sbjct: 61  LYLLAISYQNIPRDSFIWYANG--DNPA-PKGSKLELNQYTGLVLKSPQGVELWTSQLIS 117

Query: 128 GTVAVGHMNDTGNFVLASSSSGRLWDSFSNPTDTLLLGQMMETEQGLFSRKSENNFSRGR 187
           GT++ G MNDTGNF L   +S  LWDSFSNPTDTL+  Q+ME +  L SR+ E NFSRGR
Sbjct: 118 GTISYGLMNDTGNFQLLDENSQVLWDSFSNPTDTLVPTQIMEVKGTLSSRQKEANFSRGR 177

Query: 188 FQFRLLEDGNLVLNIANLATGFAYDAYYTSGTYDPANSSNSGYRVMFNESGYMYILRRNG 247
           FQFRLL DGN VLN  NL T + YDA+Y S TYD  N++NSG++V+F+ SG +YIL+R+G
Sbjct: 178 FQFRLLPDGNAVLNPINLPTNYTYDAHYISATYDSTNTTNSGFQVIFDNSG-LYILKRSG 236

Query: 248 GRFDLTTERVVPAAD-FYYRATLNFDGVFAQYFYPKN--GNGNWSVAWSEPENICVDIGG 304
            +  +T  +   + D +YYRAT+NFDG F    YPKN   N +W+V  + P+NIC+++ G
Sbjct: 237 EKVYITNPKDALSTDSYYYRATINFDGTFTISNYPKNPASNPSWTVMKTLPDNICMNLLG 296

Query: 305 GLG-SGACGYNSICTLDSDRRPRCACPKGYSLLDENDRYGSCRPDFELSCWGGGQGYNKE 363
             G SG CG+NSICTL +D+RP+C+CP+GYS LD  D YGSC+P+ EL C   GQ    +
Sbjct: 297 NTGGSGVCGFNSICTLKADQRPKCSCPEGYSPLDSRDEYGSCKPNLELGCGSSGQSLQGD 356

Query: 364 LFDFHELKNINWPQSDYERFKPYNEVQCKNTCLSDCFCAAVIFNDGSCWFKKLPLSNGMT 423
           L+   E+ N +WP SDYE +KPYN   CK +CL DC CA  IF D SC+ KKLPLSNG  
Sbjct: 357 LYFMKEMANTDWPVSDYELYKPYNSEDCKTSCLQDCLCAVSIFRDDSCYKKKLPLSNGRR 416

Query: 424 DSRIAGKAFIK-YKNKGDDPPSVPRPPDPEDKKKSKMMNATGSVLLGSSVFVNFALVCAF 482
           D  +   AFIK  KN     P  P   + + KK    +    SVLLG SVF  F LV A 
Sbjct: 417 DRAVGASAFIKLMKNGVSLSPPNPFIEEKKYKKDQDTLITVISVLLGGSVF--FNLVSAV 474

Query: 483 VLGFSFIYKKKWIRNSPDDGTIETNLRCFSYKELEGATNNFKEEVGRGSFGIVYKGVIQT 542
            +GF F Y KK   +S +    E+NL  F++ EL  AT+NFKEE+GRGS GIVYKG    
Sbjct: 475 WVGFYFYYNKK---SSTNKTATESNLCSFTFAELVQATDNFKEELGRGSCGIVYKGT--- 528

Query: 543 RTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN 602
            T+   +AVKKLD+V +D ++EFK EV VIGQTHHK+LVRLLG+CDE Q+R+LVYEFL+N
Sbjct: 529 -TNLATIAVKKLDKVLKDCDKEFKTEVNVIGQTHHKSLVRLLGYCDEEQHRILVYEFLSN 587

Query: 603 GTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARI 662
           GTLA+FLFG+ KPNWN R  IAF IARGL+YLHE+C  QIIHCDIKPQNILLD+ Y ARI
Sbjct: 588 GTLANFLFGDFKPNWNQRVQIAFGIARGLVYLHEECCTQIIHCDIKPQNILLDEQYNARI 647

Query: 663 SDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKS 722
           SDFGL+KLL +N+S T +T IRGTKGYVAP+WFR++ IT KVDVYSFGVLLLEII CR++
Sbjct: 648 SDFGLSKLLKINESHT-ETGIRGTKGYVAPDWFRSAPITTKVDVYSFGVLLLEIICCRRN 706

Query: 723 FDIEMG-EEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSL 781
            D E+G EE AILTDWA+DCYR G++++L+  D EA++D   L + VMV+IWC+QEDPSL
Sbjct: 707 VDGEVGNEEKAILTDWAYDCYRAGRIDILLENDDEAIDDTNRLERFVMVAIWCLQEDPSL 766

Query: 782 RPTMKKVLQMLEGVVEVSVPPNPYPFSS 809
           RP MKKV+ MLEG+  V++PP+P P++S
Sbjct: 767 RPPMKKVMLMLEGIAPVTIPPSPSPYTS 794

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255544746|ref|XP_002513434.1| ATP binding protein, putative [Ricinus communis] gi|223547342|gb|EEF48837.1| ATP binding protein, putative [Ricinus communis]

 Score =  872 bits (2254), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 447/780 (57%), Positives = 554/780 (71%), Gaps = 18/780 (2%)

Query: 24  AQNNGTVPVGATLTAGTSSSPWLSPSGDFAFGFHQLDEENNTNDLFLLSIFYNKIPEKTV 83
           AQN  T+ VG  L A   +  WLSPSGDFAFGF QL+ +N    L+LL+I YNKI +KT+
Sbjct: 23  AQNGDTIIVGDFLAAADPAESWLSPSGDFAFGFRQLENKN----LYLLAICYNKISDKTI 78

Query: 84  VWYTDNKDQNPAVPRGSQVKLTADQGLVLNDPQGKQVWSSKIDIGTVAVGHMNDTGNFVL 143
           VWY +  D  PA P GS+V+LTAD+GLVL  PQGK++W S I+IG  A G MNDTGNF +
Sbjct: 79  VWYANGDD--PA-PTGSKVELTADRGLVLTSPQGKEIWKSGINIGDAARGMMNDTGNFRI 135

Query: 144 ASSSSGRLWDSFSNPTDTLLLGQMMETE-QGLFSRKSENNFSRGRFQFRLLEDGNLVLNI 202
            ++   +LW +F +P DTLL GQ +E   + L SR  E NFSRGRFQFRL+ DGN VLN 
Sbjct: 136 VNTGGEKLWQTFDDPKDTLLPGQALERGGKILSSRLRETNFSRGRFQFRLIPDGNGVLNA 195

Query: 203 ANLATGFAYDAYYTSGTYDPANSSNSGYRVMFNESGYMYILRRNGGRFDLTTERVVPAAD 262
            NL TG AYDAYY + T D AN SN+G R++FNESGY+Y LR +  R  +T ERVVP  +
Sbjct: 196 NNLRTGDAYDAYYWTNTVD-ANLSNAGLRIVFNESGYLYTLRASNKRELITPERVVPTTE 254

Query: 263 FYYRATLNFDGVFAQYFYPKNG--NGNWSVAWSEPENICVDIGGGLGSGACGYNSICTLD 320
           +Y+R TLNFDGV  QY +PKN   NGNWS+ +S PENIC  I   +G+G CG+NS+C L+
Sbjct: 255 YYHRVTLNFDGVLTQYSHPKNSTDNGNWSIIFSAPENICFLITD-IGTGPCGFNSVCQLN 313

Query: 321 SDRRPRCACPKGYSLLDENDRYGSCRPDFELSCWGGGQGYNKELFDFHELKNINWPQSDY 380
           +D+R  C CP  +S +D  D Y  C+PDF           + E +DF EL N +WP SDY
Sbjct: 314 ADQRAICRCPPRFSSVDPGDDYAGCKPDFSTQFCEDAPSTSPEDYDFLELTNTDWPTSDY 373

Query: 381 ERFKPYNEVQCKNTCLSDCFCAAVIFNDGSCWFKKLPLSNGMTDSRIAGKAFIKYKNKGD 440
           ER+  YN  +C+  C+ DCFC  V+F  GSCW KKLPLSNG    ++ G+AFIK +    
Sbjct: 374 ERYDSYNIEECQKACIQDCFCNVVVFR-GSCWKKKLPLSNGRQSEKVNGRAFIKVRKDDY 432

Query: 441 DPPSVPRPPDPEDKKKSKMMNATGSVLLGSSVFVNFALVCAFVLGFSFIYKKKWIRNSPD 500
               +P  P P  K+    +    SVLLGSSVF+NF L+      F F Y KK       
Sbjct: 433 MGRGLPPRPFPNAKEDQDSLVLVISVLLGSSVFINFILIGLVTFCFLFFYHKKSTGIPQG 492

Query: 501 DGTIETNLRCFSYKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD 560
           +   ++NLRCFSYKEL  AT  FKEE+GRGSFGIVYKG+I+  T T  VAVKKLDRV + 
Sbjct: 493 E---KSNLRCFSYKELVEATKGFKEELGRGSFGIVYKGLIEMGT-TVPVAVKKLDRVVEY 548

Query: 561 GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR 620
           GE+E+K EV  IGQTHHKNLV+LLGFCDEGQ +LLVYE L+NGTLA+FLFG+ K +W  R
Sbjct: 549 GEKEYKAEVKAIGQTHHKNLVQLLGFCDEGQQKLLVYELLSNGTLANFLFGDTKLSWKQR 608

Query: 621 TNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIK 680
           T IAF IARGL+YLHE+C  QIIHCDIKPQNIL+D+YY A+ISDFGLAKLL L+QS+T  
Sbjct: 609 TQIAFGIARGLVYLHEECNTQIIHCDIKPQNILVDEYYDAKISDFGLAKLLLLDQSQTF- 667

Query: 681 TAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD 740
           T IRGTKGYVAPEWFRN  IT KVD YSFGVLLLEII  R+S D E+  E AILTDWA+D
Sbjct: 668 TTIRGTKGYVAPEWFRNVPITVKVDAYSFGVLLLEIICSRRSVDTEISGERAILTDWAYD 727

Query: 741 CYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSV 800
           CY  G+++ LV  D+EA++D++ + + +MV+IWCIQEDP+LRPTMK V+ MLEG+++V+V
Sbjct: 728 CYMEGRIDDLVENDEEALSDLKKVERFLMVAIWCIQEDPTLRPTMKTVILMLEGIIQVAV 787

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224057535|ref|XP_002299255.1| predicted protein [Populus trichocarpa] gi|222846513|gb|EEE84060.1| predicted protein [Populus trichocarpa]

 Score =  867 bits (2240), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 455/805 (56%), Positives = 567/805 (70%), Gaps = 43/805 (5%)

Query: 6   LYFIFLLFQLPYFSHLAIAQNNGTVPVGATLTAGTSSSPWLSPSGDFAFGFHQLDEENNT 65
           LYF FLLF     S L +AQ NG   VG +LTAG  ++ WLSP+ DFAFGF QLD++   
Sbjct: 9   LYFFFLLFP----SSL-VAQRNGNATVGDSLTAGDEATLWLSPAEDFAFGFRQLDKK--- 60

Query: 66  NDLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLTADQGLVLNDPQGKQVWSSKI 125
            DL+LL+I+YNKIP+KT+VWY  N D+ PA P+ S VKLTA+ G+VLN+PQG ++W S  
Sbjct: 61  -DLYLLAIWYNKIPDKTIVWYA-NGDR-PA-PKKSTVKLTAELGVVLNNPQGGEIWKSGP 116

Query: 126 DIGTVAVGHMNDTGNFVLASSSSGRLWDSFSNPTDTLLLGQMMETEQGLFSRKSENNFSR 185
             G  A G MNDTGNF++A+++  +LW SF   TDTLL  Q+ME    L SR SE NFS+
Sbjct: 117 GNGEAAYGFMNDTGNFLVANANGEKLWQSFELLTDTLLPTQIMEKGGILSSRLSETNFSQ 176

Query: 186 GRFQFRLLEDGNLVLNIANLATGFAYDAYYTSGTYDPANSSNSGYRVMFNESGYMYILRR 245
           GRFQFRL+ DGN VLN  NL TGF Y+AY+ S T D +NSSN+GY+V+FNESGY+Y+LR 
Sbjct: 177 GRFQFRLIPDGNAVLNTINLPTGFPYEAYFWSKTVD-SNSSNAGYQVVFNESGYLYVLRA 235

Query: 246 NGGRFDLTTERVVPAADFYYRATLNFDGVFAQYFYPKN--GNGNWSVAWSEPENICVDIG 303
           N  R  LT  RVVPA + Y+RATL+FDGVF  Y +PKN  GN NWSV  + PENIC  + 
Sbjct: 236 NNTREALTLGRVVPATENYHRATLHFDGVFVLYSHPKNSPGNENWSVVRTMPENICTVVR 295

Query: 304 GGLGSGACGYNSICTLDSDRRPRCACPKGYSLLDENDRYGSCRPDFELSCWGGGQGYNKE 363
           G  GSG CGYN +CT+ +D+R  C CP+ +SLLD +D YG C+PDF             E
Sbjct: 296 GLKGSGPCGYNGVCTISTDKRAICRCPQRFSLLDPDDPYGGCKPDFPTQVCAEEVPNAPE 355

Query: 364 LFDFHELKNINWPQSDYERFKPYNEVQCKNTCLSDCFCAAVIFNDGSCWFKKLPLSNGMT 423
            ++   L NI+WP+SDYE + PYN   CK  CL D FC  ++F +G+CW K+LPLSNG  
Sbjct: 356 DYELVPLTNIDWPESDYEMYTPYNIEDCKKACLQDFFCNVIVFGEGTCWKKRLPLSNGRQ 415

Query: 424 DSRIAGKAFIKYKNKGDDPPSVPRPPDPEDKKKSKMMNATGSVLLGSSVFVNFALVCAFV 483
              + G +F+K + KG+   ++P PP P  KK   ++    SVLLG SVF NF LV    
Sbjct: 416 GESVNGASFMKVR-KGNY--TLPGPP-PIPKKNLLVV----SVLLGGSVFFNFVLVGVVS 467

Query: 484 LGFSFIYKKKWIRNSPDDGTIETNLRCFSYKELEGATNNFKEEVGRGSFGIVYKGVIQTR 543
             F FIY  K+ R    +  +++NLRCFSYKEL  ATN FKEE+GRG+FGIVYKG+ Q  
Sbjct: 468 FAFFFIYHNKFTRTPQVERAVQSNLRCFSYKELMEATNGFKEELGRGAFGIVYKGLTQI- 526

Query: 544 TSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNG 603
            S   VA+KK+DR  ++ ++EFK EV VIG            FCDEGQ+R+LVYEFL+NG
Sbjct: 527 GSGVPVAIKKVDRFVKESDKEFKTEVDVIG------------FCDEGQHRMLVYEFLSNG 574

Query: 604 TLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARIS 663
            LASFLFG++K +WN RT IAF IARGLLYLH++C  QIIHCDIKPQNILLD++Y ARI+
Sbjct: 575 ALASFLFGDVKLSWNQRTQIAFGIARGLLYLHDECSTQIIHCDIKPQNILLDEHYDARIA 634

Query: 664 DFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSF 723
           DFGLAKL    Q K       GTKGYVAPEWFRN  IT KVDVY+FGVLLLEII CR+S 
Sbjct: 635 DFGLAKLFRNPQHK-------GTKGYVAPEWFRNMLITVKVDVYNFGVLLLEIICCRRSV 687

Query: 724 DIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRP 783
           D E+GEE AILTDWA+DCY+ G ++ LV  D+EA+ND++ L + VMV+IWCIQEDP+LRP
Sbjct: 688 DTEVGEERAILTDWAYDCYQEGMMHALVESDEEALNDMKKLERFVMVAIWCIQEDPNLRP 747

Query: 784 TMKKVLQMLEGVVEVSVPPNPYPFS 808
           TMK V+ MLEG+++V VPP P PFS
Sbjct: 748 TMKMVMLMLEGIIQVPVPPCPSPFS 772

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224053032|ref|XP_002297673.1| predicted protein [Populus trichocarpa] gi|222844931|gb|EEE82478.1| predicted protein [Populus trichocarpa]

 Score =  855 bits (2208), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 444/784 (56%), Positives = 555/784 (70%), Gaps = 38/784 (4%)

Query: 27  NGTVPVGATLTAGTSSSPWLSPSGDFAFGFHQLDEENNTNDLFLLSIFYNKIPEKTVVWY 86
           NG   VG +LTAG  ++ WLSP+ DFAFGF QLD++    DL+LL+I+YNKIP+KT+VWY
Sbjct: 2   NGNATVGDSLTAGDEATLWLSPAEDFAFGFRQLDKK----DLYLLAIWYNKIPDKTIVWY 57

Query: 87  TDNKDQNPAVPRGSQVKLTADQGLVLNDPQGKQVWSSKIDIGTVAVGHMNDTGNFVLASS 146
             N D+ PA P+ S VKLTA+ G+VLN+PQG ++W S    G  A G MNDTGNF++A++
Sbjct: 58  A-NGDR-PA-PKKSTVKLTAELGVVLNNPQGGEIWKSGPGNGEAAYGFMNDTGNFLVANA 114

Query: 147 SSGRLWDSFSNPTDTLLLGQMMETEQGLFSRKSENNFSRGRFQFRLLEDGNLVLNIANLA 206
           +  +LW SF   TDTLL  Q+ME    L SR SE NFS+GRFQFRL+ DGN VLN  NL 
Sbjct: 115 NGEKLWQSFELLTDTLLPTQIMEKGGILSSRLSETNFSQGRFQFRLIPDGNAVLNTINLP 174

Query: 207 TGFAYDAYYTSGTYDPANSSNSGYRVMFNESGYMYILRRNGGRFDLTTERVVPAADFYYR 266
           TGF Y+AY+ S T D +NSSN+GY+V+FNESGY+Y+LR N  R  LT  RVVPA + Y+R
Sbjct: 175 TGFPYEAYFWSKTVD-SNSSNAGYQVVFNESGYLYVLRANNTREALTLGRVVPATENYHR 233

Query: 267 ATLNFDGVFAQYFYPKN--GNGNWSVAWSEPENICVDIGGGLGSGACGYNSICTLDSDRR 324
           ATL+FDGVF  Y +PKN  GN NWSV  + PENIC  + G  GSG CGYN +CT+ +D+R
Sbjct: 234 ATLHFDGVFVLYSHPKNSPGNENWSVVRTMPENICTVVRGLKGSGPCGYNGVCTISTDKR 293

Query: 325 PRCACPKGYSLLDENDRYGSCRPDFELSCWGGGQGYNKELFDFHELKNINWPQSDYERFK 384
             C CP+ +SLLD +D YG C+PDF             E ++   L NI+WP+SDYE + 
Sbjct: 294 AICRCPQRFSLLDPDDPYGGCKPDFPTQVCAEEVPNAPEDYELVPLTNIDWPESDYEMYT 353

Query: 385 PYNEVQCKNTCLSDCFCAAVIFNDGSCWFKKLPLSNGMTDSRIAGKAFIKYKNKGDDPPS 444
           PYN   CK  CL D FC  ++F +G+CW K+LPLSNG     + G +F+K + KG+   +
Sbjct: 354 PYNIEDCKKACLQDFFCNVIVFGEGTCWKKRLPLSNGRQGESVNGASFMKVR-KGNY--T 410

Query: 445 VPRPPDPEDKKKSKMMNATGSVLLGSSVFVNFALVCAFVLGFSFIYKKKWIRNSPDDGTI 504
           +P PP P  KK   ++    SVLLG SVF NF LV      F FIY  K+ R    +  +
Sbjct: 411 LPGPP-PIPKKNLLVV----SVLLGGSVFFNFVLVGVVSFAFFFIYHNKFTRTPQVERAV 465

Query: 505 ETNLRCFSYKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE 564
           ++NLRCFSYKEL  ATN FKEE+GRG+FGIVYKG+ Q   S   VA+KK+DR  ++ ++E
Sbjct: 466 QSNLRCFSYKELMEATNGFKEELGRGAFGIVYKGLTQI-GSGVPVAIKKVDRFVKESDKE 524

Query: 565 FKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA 624
           FK EV VIG            FCDEGQ+R+LVYEFL+NG LASFLFG++K +WN RT IA
Sbjct: 525 FKTEVDVIG------------FCDEGQHRMLVYEFLSNGALASFLFGDVKLSWNQRTQIA 572

Query: 625 FQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIR 684
           F IARGLLYLH++C  QIIHCDIKPQNILLD++Y ARI+DFGLAKL    Q K       
Sbjct: 573 FGIARGLLYLHDECSTQIIHCDIKPQNILLDEHYDARIADFGLAKLFRNPQHK------- 625

Query: 685 GTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 744
           GTKGYVAPEWFRN  IT KVDVY+FGVLLLEII CR+S D E+GEE AILTDWA+DCY+ 
Sbjct: 626 GTKGYVAPEWFRNMLITVKVDVYNFGVLLLEIICCRRSVDTEVGEERAILTDWAYDCYQE 685

Query: 745 GKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVPPNP 804
           G ++ LV  D+EA+ND++ L + VMV+IWCIQEDP+LRPTMK V+ MLEG+++V VPP P
Sbjct: 686 GMMHALVESDEEALNDMKKLERFVMVAIWCIQEDPNLRPTMKMVMLMLEGIIQVPVPPCP 745

Query: 805 YPFS 808
            PFS
Sbjct: 746 SPFS 749

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356555196|ref|XP_003545921.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Glycine max]

 Score =  808 bits (2088), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 413/771 (53%), Positives = 540/771 (70%), Gaps = 24/771 (3%)

Query: 38  AGTSSSPWLSPSGDFAFGFHQLDEENNTNDLFLLSIFYNKIPEKTVVWYTDNKDQNPAVP 97
           AG  +S WLSPSGDFAFGF+QL      N+ FLL+++Y+K+P KT++W+ +    NPA P
Sbjct: 2   AGNGTSRWLSPSGDFAFGFYQL-----PNEFFLLAVWYDKMPNKTIIWFANG--DNPA-P 53

Query: 98  RGSQVKLTADQGLVLNDPQGKQVWSSKIDIGTVAVGHMNDTGNFVLASSSSGRLWDSFSN 157
            GS+++L  D GLVLN+PQG ++W S    GT+  G MND GNF L   ++  LW++F++
Sbjct: 54  IGSRLELN-DSGLVLNNPQGLELWRSNFASGTIFNGLMNDDGNFQLLDQNAVSLWETFTH 112

Query: 158 PTDTLLLGQMMETEQGLFSRKSENNFSRGRFQFRLLEDGNLVLNIANLATGFAYDAYYTS 217
           PTDTL+  Q+ME    LFSR+ E NFS GRF+  L ED NLVL++ NL + ++Y+ YY +
Sbjct: 113 PTDTLVPNQVMELNGKLFSRRGEFNFSHGRFKLHLQEDVNLVLSLINLPSNYSYEPYYDT 172

Query: 218 GTYDPANSSNSGYRVMFNESGYMYILRRNGGRFDLTT-ERVVPAADFYYRATLNFDGVFA 276
           GT D  N +N G +++F++SG++YIL+++G +F +T     +   DFYY+AT+N+DGVF 
Sbjct: 173 GTADANNQTNIGMKLIFDKSGFLYILKKSGEKFYITKPNETISTNDFYYKATINYDGVFT 232

Query: 277 QYFYPKN---GNGNWSVAWSEPENICVDIGGGLGSGACGYNSICTLDSDRRPRCACPKGY 333
             +YPK+   G G W    + PENIC+      G G CG+NSIC L +D+RP C CP+ Y
Sbjct: 233 VSYYPKDLRKGQG-WVTTKTIPENICLSSTFTDGEGVCGFNSICNLKADQRPICNCPERY 291

Query: 334 SLLDENDRYGSCRPDFELSCWGGGQGYNKELFDFHELKNINWPQSDYERFKPYNEVQCKN 393
           SL+D N+ YG C P+F++ C GGG   +++ +   EL+N +WP SDYE   PY+  +C  
Sbjct: 292 SLIDSNNMYGGCVPNFQVVCQGGGYMVSQDDYIMKELRNTDWPTSDYETLSPYSLKECTK 351

Query: 394 TCLSDCFCAAVIFNDGSCWFKKLPLSNGMTDSRIAGKAFIKYKNKGDDPPSVPRPPDPED 453
           +CL DC C  V F+  SCW KKLPL+NG  D  +   + IK         S P   +P  
Sbjct: 352 SCLQDCLCVLVTFSGSSCWKKKLPLTNGRRDKGVNATSVIKLMKNDYLLTSFP---NPNG 408

Query: 454 KKKSKMMNATGSVLLGSSVFVNFALVCAFVLGFSFIYKKKWIRNSPDDGTIETNLRCFSY 513
           KK   ++    SVLL  SV +   LV A   GFS   +KK   +  +    + NL  F++
Sbjct: 409 KKDHDVLIVVLSVLLAGSVLIILMLVGALYFGFS-CNRKKIESSRTNKSVAKKNLHDFTF 467

Query: 514 KELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIG 573
           KEL  ATNNF+EE+GRGSF IVYKG I+     T+VAVKKLD++FQD +REF+ EV VIG
Sbjct: 468 KELVEATNNFREELGRGSFSIVYKGTIEM----TSVAVKKLDKLFQDNDREFQTEVNVIG 523

Query: 574 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLY 633
           QTHH+NLVRLLG+C+EGQ+R+LVYEF++NGTLASFLF +LK NW  R +IA  IARGL+Y
Sbjct: 524 QTHHRNLVRLLGYCNEGQHRILVYEFMSNGTLASFLFSSLKSNWGQRFDIALGIARGLVY 583

Query: 634 LHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE 693
           LHE+C  QIIHCDIKPQNILLDD Y ARISDFGLAKLL +NQS+T +T IRGTKGYVAP+
Sbjct: 584 LHEECCTQIIHCDIKPQNILLDDQYNARISDFGLAKLLLINQSRT-ETGIRGTKGYVAPD 642

Query: 694 WFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEM-GEEYAILTDWAFDCYRNGKLNVLVG 752
           WFR++ ITAKVD YSFGVLLLEII CRK+ + E+  EE  ILTDWA+DCY+  +L +L+ 
Sbjct: 643 WFRSAPITAKVDTYSFGVLLLEIICCRKNVEKELVNEEKGILTDWAYDCYKTRRLEILLE 702

Query: 753 EDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVPPN 803
            D EA+NDI+   KLVM++IWCIQE PSLRPTMKKVL MLEG VEV  PP+
Sbjct: 703 NDDEAINDIKSFEKLVMIAIWCIQEHPSLRPTMKKVLLMLEGNVEVLTPPS 753

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356555135|ref|XP_003545892.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Glycine max]

 Score =  807 bits (2085), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 438/824 (53%), Positives = 562/824 (68%), Gaps = 29/824 (3%)

Query: 1   MTSARLYFIFLLFQLPYFSHL-AIAQNNGTVPVGATLTAGTSSSPWL--SPSGDFAFGFH 57
           M S  L F+FL   L  F H+  +AQ    + +G + TAG S+SPWL  SPSGDFAFGF 
Sbjct: 1   MASPLLPFLFLSMVLLPFQHINVMAQTKSNIAIGDSHTAGASTSPWLVSSPSGDFAFGFL 60

Query: 58  QLDEENNTNDLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLTADQGLVL-NDPQ 116
            L++   T D F+L I+Y KI +KT+VW+  N+D+ PA P+GS+V LTAD GLVL   P 
Sbjct: 61  PLED---TPDHFMLCIWYAKIQDKTIVWFA-NRDK-PA-PKGSKVVLTADDGLVLITAPN 114

Query: 117 GKQVWSSKIDIGTVAVGHMNDTGNFVLASSSSGRLWDSFSNPTDTLLLGQMMETEQGLFS 176
           G Q+W +      V+ G +N+TGNFVL    S  +W+SF +  DTLL  Q ME  Q L S
Sbjct: 115 GNQLWKTGGLTVRVSSGVLNNTGNFVLQDGDSNTVWESFKDYRDTLLPYQTMERGQKLSS 174

Query: 177 RKSENNFSRGRFQFRLLEDGNLVLNIANLATGFAYDAYYTSGTYDPANSSNSGYRVMFNE 236
           +   N F++GRF      DGNLV++  NL +G+A + YY SGT + +N S++G +++F+ 
Sbjct: 175 KLRRNYFNKGRFVLFFQNDGNLVMHSINLPSGYANEHYYESGTVE-SNISSAGTQLVFDG 233

Query: 237 SGYMYILRRNGGRFDLTTERVVPAAD---FYYRATLNFDGVFAQYFYPK--NGNGNWSVA 291
           SG MY+LR N  +++L+      ++    FY RATL+FDGVF  Y +PK  +G G W+  
Sbjct: 234 SGDMYVLRENNEKYNLSRGGSGASSTTQFFYLRATLDFDGVFTLYQHPKGSSGTGGWTPV 293

Query: 292 WSEPENICVDIGGGLGSGACGYNSICTLDSDRRPRCACPKGYSLLDENDRYGSCRPDFEL 351
           WS P+NIC D     GSG CGYNSIC+L  D+RP C CPK YSL+D ND  GSC+PDF  
Sbjct: 294 WSHPDNICKDYVASAGSGVCGYNSICSLRDDKRPNCKCPKWYSLVDPNDPNGSCKPDFVQ 353

Query: 352 SCWGGGQGYNKELFDFHELKNINWPQSDYERFKPYNEVQCKNTCLSDCFCAAVIFNDG-S 410
           +C        K+L+DF  L + +WPQSDY   +P+NE QC+ +C+ DC C+  IF  G S
Sbjct: 354 ACAVDELSNRKDLYDFEVLIDTDWPQSDYVLQRPFNEEQCRQSCMEDCMCSVAIFRLGDS 413

Query: 411 CWFKKLPLSNGMTDSRIAG-KAFIKYKNKGDDPPSVPRPPDPEDKKKSKMMNATGSVLLG 469
           CW KKLPLSNG  D+ + G KAF+K +    D  S+  P    +K ++  +   GSVLLG
Sbjct: 414 CWKKKLPLSNGRVDATLNGAKAFMKVRK---DNSSLIVPTIIVNKNRNTSI-LVGSVLLG 469

Query: 470 SSVFVNFALVCAFVLGFSFI--YKKKWIRNSPDDGTIETNLRCFSYKELEGATNNFKEEV 527
           SS F+N  L+ A  L  S++  YKKK       D  +ETNLRCF+YKELE AT+ F + +
Sbjct: 470 SSAFLNLILLGAICLSTSYVFRYKKKLRSIGRSDTIVETNLRCFTYKELEKATDGFDKVL 529

Query: 528 GRGSFGIVYKGVIQTRTSTTAVAVKKLDR-VFQDGEREFKNEVFVIGQTHHKNLVRLLGF 586
           G+G+FGIVY+GVI    S T VAVK+L+  + +D  +EFKNE+  IG THHKNLVR+LGF
Sbjct: 530 GKGAFGIVYEGVINM-GSDTRVAVKRLNTFLLEDVHKEFKNELNAIGLTHHKNLVRILGF 588

Query: 587 CDEGQNRLLVYEFLNNGTLASFLFGNL-KPNWNLRTNIAFQIARGLLYLHEDCRAQIIHC 645
           C+  + RLLVYE+++NGTLAS LF  L KP+W LR  IA  +ARGLLYLHE+C  QIIHC
Sbjct: 589 CETEEKRLLVYEYMSNGTLASLLFNILEKPSWELRLQIAIGVARGLLYLHEECSTQIIHC 648

Query: 646 DIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVD 705
           DIKPQNILLDDYY ARISDFGLAKLL +NQS+T  TAIRGTKGYVA EWF+N  ITAKVD
Sbjct: 649 DIKPQNILLDDYYNARISDFGLAKLLNMNQSRT-NTAIRGTKGYVALEWFKNMPITAKVD 707

Query: 706 VYSFGVLLLEIISCRKSFDIEM-GEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECL 764
           VYS+GVLLLEI+SCRKS + E   +E AIL +WA+DCY    L+ LV  DKEA++D++ L
Sbjct: 708 VYSYGVLLLEIVSCRKSVEFETEDKEKAILAEWAYDCYTERTLHALVEGDKEALDDMKNL 767

Query: 765 GKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVPPNPYPFS 808
            KLVM+++WC+QEDP LRPTM+ V QMLEGVVEV VPP P   S
Sbjct: 768 EKLVMIALWCVQEDPDLRPTMRNVTQMLEGVVEVKVPPCPSQIS 811

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	814
TAIR|locus:2116525	821	SD2-5 "S-domain-2 5" [Arabidop	0.493	0.489	0.401	2.7e-86
TAIR|locus:2026155	829	AT1G34300 [Arabidopsis thalian	0.726	0.712	0.346	6.2e-85
TAIR|locus:2059103	828	AT2G19130 [Arabidopsis thalian	0.573	0.564	0.370	1.4e-78
TAIR|locus:2182603	872	AT5G35370 [Arabidopsis thalian	0.781	0.729	0.310	4.1e-73
TAIR|locus:2141181	850	RK3 "receptor kinase 3" [Arabi	0.373	0.357	0.377	5.6e-72
TAIR|locus:2141176	849	B120 [Arabidopsis thaliana (ta	0.368	0.353	0.408	6.5e-70
TAIR|locus:2200923	802	AT1G61550 [Arabidopsis thalian	0.362	0.367	0.4	7.9e-67
TAIR|locus:2200908	842	AT1G61610 [Arabidopsis thalian	0.371	0.358	0.384	1.2e-66
TAIR|locus:2197714	792	AT1G61440 [Arabidopsis thalian	0.574	0.590	0.334	6.8e-65
TAIR|locus:2018546	843	RK1 "receptor kinase 1" [Arabi	0.346	0.334	0.38	9.6e-65

TAIR|locus:2116525 SD2-5 "S-domain-2 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 750 (269.1 bits), Expect = 2.7e-86, Sum P(2) = 2.7e-86
 Identities = 176/438 (40%), Positives = 253/438 (57%)

Query:   391 CKNTCLSDCFCAAVIFND--GSCWFKKLPLSNGMTDSRIAGKAFIKYKNKGXXXXXXXXX 448
             CK  C ++C C  + F +  G+C+            S   G  F+ Y             
Sbjct:   363 CKEFCHNNCSCLGLFFQNSSGNCFL--FDYIGSFKTSGNGGSGFVSYIKIASTGSGGGDN 420

Query:   449 XXXXXKKKSKMMNATGSVLLGSSVFVNFALVCAFVLGFSFIYKKKWIRNSPDDGTIETN- 507
                  K    ++     +++  +VF+   L+  FV  F    +KK I  +P + + E N 
Sbjct:   421 GEDDGKHFPYVV-----IIVVVTVFIIAVLI--FV-AFRIHKRKKMILEAPQESSEEDNF 472

Query:   508 --------LRCFSYKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ 559
                     +R F+YK+L+ ATNNF  ++G+G FG VY+G   T    + +AVKKL+ + Q
Sbjct:   473 LENLSGMPIR-FAYKDLQSATNNFSVKLGQGGFGSVYEG---TLPDGSRLAVKKLEGIGQ 528

Query:   560 DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF----GNLKP 615
              G++EF+ EV +IG  HH +LVRL GFC EG +RLL YEFL+ G+L  ++F    G++  
Sbjct:   529 -GKKEFRAEVSIIGSIHHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERWIFRKKDGDVLL 587

Query:   616 NWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ 675
             +W+ R NIA   A+GL YLHEDC A+I+HCDIKP+NILLDD + A++SDFGLAKL+T  Q
Sbjct:   588 DWDTRFNIALGTAKGLAYLHEDCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMTREQ 647

Query:   676 SKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILT 735
             S    T +RGT+GY+APEW  N  I+ K DVYS+G++LLE+I  RK++D     E     
Sbjct:   648 SHVF-TTMRGTRGYLAPEWITNYAISEKSDVYSYGMVLLELIGGRKNYDPSETSEKCHFP 706

Query:   736 DWAFDCYRNGKL-NVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEG 794
              +AF     GKL +++ G+ K      E + + +  ++WCIQED   RP+M KV+QMLEG
Sbjct:   707 SFAFKKMEEGKLMDIVDGKMKNVDVTDERVQRAMKTALWCIQEDMQTRPSMSKVVQMLEG 766

Query:   795 VVEVSVPPNPYPFSSSMG 812
             V  V  PP+    SS+MG
Sbjct:   767 VFPVVQPPS----SSTMG 780

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0046777 "protein autophosphorylation" evidence=RCA;IDA

TAIR|locus:2026155 AT1G34300 [Arabidopsis thaliana (taxid:3702)]

 Score = 850 (304.3 bits), Expect = 6.2e-85, P = 6.2e-85
 Identities = 223/644 (34%), Positives = 329/644 (51%)

Query:   186 GRFQFRLLEDGNLVLNIANLATGFAYDAYYTSGTYDPANSSNSGYRVMFNESGYMYILRR 245
             G + F+L   GNL L     A       Y+  G     +S+ S  R+    +G + I   
Sbjct:   161 GLYSFQLERSGNLTLRWNTSAI------YWNHGLNSSFSSNLSSPRLSLQTNGVVSIFES 214

Query:   246 N--GGRFDLTTERVVPAADFYYRATLNFDGVFAQYFYPKNGNGNWSVAWSEPENICVDIG 303
             N  GG   + +     +  F +   L+ DG    Y      +G  +  WS  +  C    
Sbjct:   215 NLLGGAEIVYSGDYGDSNTFRF-LKLDDDGNLRIYSSASRNSGPVNAHWSAVDQ-C---- 268

Query:   304 GGLGSGACGYNSICTLDSDRRPRCACP-KGYSLLDENDRYGSCRPDFELSCWGGGQGYNK 362
               L  G CG   IC+ + D  P C+CP + +  +D NDR   C+   ELS   G    N 
Sbjct:   269 --LVYGYCGNFGICSYN-DTNPICSCPSRNFDFVDVNDRRKGCKRKVELSDCSG----NT 321

Query:   363 ELFDFHELKNINWPQS-DYERFKPYNEVQCKNTCLSDCFC-AAVIFNDGS--CWFKKLPL 418
              + D    +   +    + E F   +   C+  CLS   C A+V  +DGS  CW +K P 
Sbjct:   322 TMLDLVHTRLFTYEDDPNSESFFAGSS-PCRANCLSSVLCLASVSMSDGSGNCW-QKHPG 379

Query:   419 S--NGMTDSRIAGKAFIKYKNKGXXXXXXXXXXXXXXKKKSKMMNATGSVLLG--SSVFV 474
             S   G     +   +++K                     K  +     +V+ G    V V
Sbjct:   380 SFFTGYQWPSVPSTSYVKVCGPVVANTLERATKGDDNNSKVHLWIVAVAVIAGLLGLVAV 439

Query:   475 NFAL---VCAFVLGFSFIYKKKWIRNSPDDGTIETNLRCFSYKELEGATNNFKEEVGRGS 531
                L    C     F  +     +        ++     F+YKEL+  T +FKE++G G 
Sbjct:   440 EIGLWWCCCRKNPRFGTLSSHYTLLEYASGAPVQ-----FTYKELQRCTKSFKEKLGAGG 494

Query:   532 FGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ 591
             FG VY+GV+   T+ T VAVK+L+ + Q GE++F+ EV  I  THH NLVRL+GFC +G+
Sbjct:   495 FGTVYRGVL---TNRTVVAVKQLEGIEQ-GEKQFRMEVATISSTHHLNLVRLIGFCSQGR 550

Query:   592 NRLLVYEFLNNGTLASFLF--GNLK-PNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIK 648
             +RLLVYEF+ NG+L +FLF   + K   W  R NIA   A+G+ YLHE+CR  I+HCDIK
Sbjct:   551 HRLLVYEFMRNGSLDNFLFTTDSAKFLTWEYRFNIALGTAKGITYLHEECRDCIVHCDIK 610

Query:   649 PQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYS 708
             P+NIL+DD + A++SDFGLAKLL    ++   +++RGT+GY+APEW  N  IT+K DVYS
Sbjct:   611 PENILVDDNFAAKVSDFGLAKLLNPKDNRYNMSSVRGTRGYLAPEWLANLPITSKSDVYS 670

Query:   709 FGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK----LNVLVGEDKEAMNDIECL 764
             +G++LLE++S +++FD+     +   + WA++ +  G     L+  + ED+    D+E +
Sbjct:   671 YGMVLLELVSGKRNFDVSEKTNHKKFSIWAYEEFEKGNTKAILDTRLSEDQTV--DMEQV 728

Query:   765 GKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVPPNPYPFS 808
              ++V  S WCIQE P  RPTM KV+QMLEG+ E+  P  P   S
Sbjct:   729 MRMVKTSFWCIQEQPLQRPTMGKVVQMLEGITEIKNPLCPKTIS 772

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0006487 "protein N-linked glycosylation" evidence=RCA

TAIR|locus:2059103 AT2G19130 [Arabidopsis thaliana (taxid:3702)]

 Score = 767 (275.1 bits), Expect = 1.4e-78, Sum P(2) = 1.4e-78
 Identities = 189/510 (37%), Positives = 274/510 (53%)

Query:   311 CGYNSICTLDSDRRPRCACPKGYSLLDEND----RYGS-CRPDFELSCWGGGQGYNKELF 365
             CG   IC+  S+  P C CP+G+  + + D     Y + C    EL C  G      ++ 
Sbjct:   296 CGSFGICSDKSE--PFCRCPQGFRPMSQKDWDLKDYSAGCVRKTELQCSRG------DIN 347

Query:   366 DFHELKNINWPQSDYERFKPYNEVQCKNTCLSDCFCAAVIFNDGS--C--WFKKLPLSNG 421
              F  L N+    +     +    + C + C  DC C A  +++GS  C  W K +     
Sbjct:   348 QFFRLPNMKLADNSEVLTRTSLSI-CASACQGDCSCKAYAYDEGSSKCLVWSKDVLNLQQ 406

Query:   422 MTDSRIAGKAFIKYKNKGXXXXXXXXXXXXXXKKKSKMMNATGSVLLGSSVFVNFALVCA 481
             + D    G  F  Y                  K  +K +   G+VL    V V   LV  
Sbjct:   407 LEDENSEGNIF--YLR---LAASDVPNVGASGKSNNKGL-IFGAVLGSLGVIVLVLLVVI 460

Query:   482 FVLGFSFIYKKKWIRNSPDDGTIETNLRCFSYKELEGATNNFKEEVGRGSFGIVYKGVIQ 541
              +L +    ++K +R    DGT    L  FSY+EL+ AT NF +++G G FG V+KG + 
Sbjct:   461 LILRYR---RRKRMRGEKGDGT----LSAFSYRELQNATKNFSDKLGGGGFGSVFKGALP 513

Query:   542 TRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLN 601
                 ++ +AVK+L+ + Q GE++F+ EV  IG   H NLVRL GFC EG  +LLVY+++ 
Sbjct:   514 ---DSSDIAVKRLEGISQ-GEKQFRTEVVTIGTIQHVNLVRLRGFCSEGSKKLLVYDYMP 569

Query:   602 NGTLASFLFGN-----LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDD 656
             NG+L S LF N     +   W LR  IA   ARGL YLH++CR  IIHCDIKP+NILLD 
Sbjct:   570 NGSLDSHLFLNQVEEKIVLGWKLRFQIALGTARGLAYLHDECRDCIIHCDIKPENILLDS 629

Query:   657 YYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEI 716
              +  +++DFGLAKL+  + S+ + T +RGT+GY+APEW     ITAK DVYS+G++L E+
Sbjct:   630 QFCPKVADFGLAKLVGRDFSRVL-TTMRGTRGYLAPEWISGVAITAKADVYSYGMMLFEL 688

Query:   717 ISCRKSFDIEMGEEYAILTDWAFDCY-RNGKLNVLVGEDKEA-MNDIECLGKLVMVSIWC 774
             +S R++ +    E+      WA     ++G +  LV    E    DIE + +   V+ WC
Sbjct:   689 VSGRRNTEQSENEKVRFFPSWAATILTKDGDIRSLVDPRLEGDAVDIEEVTRACKVACWC 748

Query:   775 IQEDPSLRPTMKKVLQMLEGVVEVSVPPNP 804
             IQ++ S RP M +V+Q+LEGV+EV+ PP P
Sbjct:   749 IQDEESHRPAMSQVVQILEGVLEVNPPPFP 778

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

TAIR|locus:2182603 AT5G35370 [Arabidopsis thaliana (taxid:3702)]

 Score = 659 (237.0 bits), Expect = 4.1e-73, Sum P(2) = 4.1e-73
 Identities = 219/705 (31%), Positives = 337/705 (47%)

Query:    46 LSPSGDFAFG-FHQLDEENNTNDLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKL 104
             LS +  F  G F    ++++T   F  S+ +  +   + +W + N+D +P    G+ + L
Sbjct:    51 LSRNSIFKAGLFSPGGDDSSTG--FYFSVVH--VDSGSTIW-SSNRD-SPVSSSGT-MNL 103

Query:   105 TADQGL-VLNDPQGK-QVWSSKIDIGTVAVGHMNDTGNFVLASSSSGRLWDSFSNPTDTL 162
             T  QG+ V+ D + +  VWS+ +    V    + D GN +L    +  LW+SF  PTD++
Sbjct:   104 TP-QGISVIEDGKSQIPVWSTPVLASPVKSLRLTDAGNLLLLDHLNVSLWESFDFPTDSI 162

Query:   163 LLGQMMETEQGLFSRKSENNFSRGRFQFRLLEDGNLVLNIANLATGFAYDAYYTSGTYDP 222
             +LGQ ++    L    S ++FS G ++F + E   L+         +    Y+    +  
Sbjct:   163 VLGQRLKLGMFLSGSVSRSDFSTGDYKFLVGESDGLMQ--------WRGQNYWKLRMHIR 214

Query:   223 AN-SSNSGYRVMFNESGYMYILRRNGGRFDLTTERVV--PAADFYYRATLNFDGVFAQYF 279
             AN  SN     +   +  + ++ RNG    +   RV   P++DF   A ++  G F    
Sbjct:   215 ANVDSNFPVEYLTVTTSGLALMARNG---TVVVVRVALPPSSDFRV-AKMDSSGKFIVSR 270

Query:   280 YPKNGNGNWSVAWSEPENICVDIGGGLGSGACGYNSICTLDS-DRRPRCACPKGYSLLDE 338
             +  +G  N    +S P + C  I        CG   +C LD+      C+CP    + D 
Sbjct:   271 F--SGK-NLVTEFSGPMDSC-QI-----PFVCGKLGLCNLDNASENQSCSCPDEMRM-DA 320

Query:   339 NDRYGSCRPDFE-LSCWGGGQGYNKELFDFH-ELKNINWPQSD-YERFKPYNEVQCKNTC 395
                 G C P  + LS     +  N    +    +   +   +D  E   P   + C + C
Sbjct:   321 GK--GVCVPVSQSLSLPVSCEARNISYLELGLGVSYFSTHFTDPVEHGLPL--LACHDIC 376

Query:   396 LSDCFCAAVIFNDGS--CWFKKLPLSN-GMTDSRIAGKAFIKYKNKGXXXXXXXXXXXXX 452
               +C C  V + + S  C+  K    +  +  +       I Y                 
Sbjct:   377 SKNCSCLGVFYENTSRSCYLVKDSFGSLSLVKNSPENHDLIGYVK--LSIRKTNAQPPGN 434

Query:   453 XKKKSKMMNATGSVLLGSSVF---VNFALV----CAFVLGFSFIYKKKWIR----NSPDD 501
               +          VLL  S F   +   L+    CA V+ +S I +K+  R     S D 
Sbjct:   435 NNRGGSSFPVIALVLLPCSGFFLLIALGLLWWRRCA-VMRYSSIREKQVTRPGSFESGDL 493

Query:   502 GTIET-NL-RCFSYKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ 559
             G+     L + F ++ELE AT NFK ++G G FG VYKG   T    T +AVKK+     
Sbjct:   494 GSFHIPGLPQKFEFEELEQATENFKMQIGSGGFGSVYKG---TLPDETLIAVKKITNHGL 550

Query:   560 DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP--NW 617
              G +EF  E+ +IG   H NLV+L GFC  G+  LLVYE++N+G+L   LF    P   W
Sbjct:   551 HGRQEFCTEIAIIGNIRHTNLVKLRGFCARGRQLLLVYEYMNHGSLEKTLFSGNGPVLEW 610

Query:   618 NLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSK 677
               R +IA   ARGL YLH  C  +IIHCD+KP+NILL D++  +ISDFGL+KLL   +S 
Sbjct:   611 QERFDIALGTARGLAYLHSGCDQKIIHCDVKPENILLHDHFQPKISDFGLSKLLNQEES- 669

Query:   678 TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKS 722
             ++ T +RGT+GY+APEW  N+ I+ K DVYS+G++LLE++S RK+
Sbjct:   670 SLFTTMRGTRGYLAPEWITNAAISEKADVYSYGMVLLELVSGRKN 714

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 512 (185.3 bits), Expect = 5.6e-72, Sum P(2) = 5.6e-72
 Identities = 120/318 (37%), Positives = 181/318 (56%)

Query:   498 SPDDGTIETNLRCFSYKELEGATNNFKE--EVGRGSFGIVYKGVIQTRTSTTAVAVKKLD 555
             S ++ T +  L    ++E+  ATNNF    ++G+G FGIVYKG +        +AVK+L 
Sbjct:   501 SRENNTDDLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKL---LDGQEMAVKRLS 557

Query:   556 RVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFG---N 612
             +    G  EFKNEV +I +  H NLVRLL  C +   ++L+YE+L N +L S LF    N
Sbjct:   558 KTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRN 617

Query:   613 LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLT 672
              K NW +R +I   IARGLLYLH+D R +IIH D+K  NILLD Y T +ISDFG+A++  
Sbjct:   618 SKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFG 677

Query:   673 LNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA 732
              ++++     + GT GY++PE+  +   + K DV+SFGVLLLEIIS +++      +   
Sbjct:   678 RDETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDRDL 737

Query:   733 ILTDWAFDCYRNGK----LNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKV 788
              L    +  ++ GK    ++ ++ +        E L + + + + C+QE    RPTM  V
Sbjct:   738 NLLGCVWRNWKEGKGLEIIDPIITDSSSTFRQHEIL-RCIQIGLLCVQERAEDRPTMSLV 796

Query:   789 LQMLEGVVEVSVPPNPYP 806
             + ML G    ++P    P
Sbjct:   797 ILML-GSESTTIPQPKAP 813

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0005773 "vacuole" evidence=IDA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0009506 "plasmodesma" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=RCA

TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)]

 Score = 542 (195.9 bits), Expect = 6.5e-70, Sum P(2) = 6.5e-70
 Identities = 127/311 (40%), Positives = 182/311 (58%)

Query:   506 TNLRCFSYKELEGATNNF-KE-EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGER 563
             + L  FS   +  ATN+F KE E+GRG FG VYKGV++       +AVK+L      G  
Sbjct:   512 SELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGRE---IAVKRLSGKSGQGVD 568

Query:   564 EFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP---NWNLR 620
             EFKNE+ +I +  H+NLVRLLG C EG+ ++LVYE++ N +L  FLF   K    +W LR
Sbjct:   569 EFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLR 628

Query:   621 TNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIK 680
              +I   IARGLLYLH D R +IIH D+K  N+LLD     +ISDFG+A++   NQ++   
Sbjct:   629 FSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANT 688

Query:   681 TAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD 740
               + GT GY++PE+      + K DVYSFGVLLLEI+S +++  +    E+  L  +A+ 
Sbjct:   689 VRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLR-SSEHGSLIGYAWY 747

Query:   741 CYRNGKLNVLVGED-KEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 799
              Y +G+   LV    +   +  E L + + V++ C+Q+  + RP M  VL MLE      
Sbjct:   748 LYTHGRSEELVDPKIRVTCSKREAL-RCIHVAMLCVQDSAAERPNMASVLLMLESDTATL 806

Query:   800 VPPNPYPFSSS 810
               P    F+S+
Sbjct:   807 AAPRQPTFTST 817

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0006979 "response to oxidative stress" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2200923 AT1G61550 [Arabidopsis thaliana (taxid:3702)]

 Score = 522 (188.8 bits), Expect = 7.9e-67, Sum P(3) = 7.9e-67
 Identities = 122/305 (40%), Positives = 176/305 (57%)

Query:   506 TNLRCFSYKELEGATNNFK--EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGER 563
             + L  F  K +E ATNNF    ++G+G FG VYKG +Q       +AVK+L      G+ 
Sbjct:   472 SGLYFFEMKTIEIATNNFSLVNKLGQGGFGPVYKGKLQDGKE---IAVKRLSSSSGQGKE 528

Query:   564 EFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP---NWNLR 620
             EF NE+ +I +  H NLVR+LG C EG+ RLLVYEF+ N +L +F+F + K    +W  R
Sbjct:   529 EFMNEILLISKLQHINLVRILGCCIEGEERLLVYEFMVNKSLDTFIFDSRKRVEIDWPKR 588

Query:   621 TNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIK 680
              +I   IARGLLYLH D R +IIH D+K  NILLDD    +ISDFGLA++    + +   
Sbjct:   589 FSIIQGIARGLLYLHRDSRLRIIHRDVKVSNILLDDKMNPKISDFGLARMYEGTKYQDNT 648

Query:   681 TAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD 740
               I GT GY++PE+      + K D YSFGVLLLE+IS  K       +E   L  +A++
Sbjct:   649 RRIVGTLGYMSPEYAWTGVFSEKSDTYSFGVLLLEVISGEKISRFSYDKERKNLLAYAWE 708

Query:   741 CY-RNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 799
              +  NG +  L  +  ++ +  E +G+ V + + C+Q  P+ RP   ++L ML    ++ 
Sbjct:   709 SWCENGGVGFLDKDATDSCHPSE-VGRCVQIGLLCVQHQPADRPNTLELLSMLTTTSDLP 767

Query:   800 VPPNP 804
             +P  P
Sbjct:   768 LPKEP 772

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)]

 Score = 518 (187.4 bits), Expect = 1.2e-66, Sum P(2) = 1.2e-66
 Identities = 120/312 (38%), Positives = 170/312 (54%)

Query:   504 IET-NLRCFSYKELEGATNNFKEE--VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD 560
             ++T +L  FS+  +  AT +F EE  +G+G FG VYKG     +    +AVK+L    + 
Sbjct:   505 VDTPDLPIFSFDSVASATGDFAEENKLGQGGFGTVYKGNF---SEGREIAVKRLSGKSKQ 561

Query:   561 GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP---NW 617
             G  EFKNE+ +I +  H+NLVRLLG C E   ++L+YE++ N +L  FLF   K    +W
Sbjct:   562 GLEEFKNEILLIAKLQHRNLVRLLGCCIEDNEKMLLYEYMPNKSLDRFLFDESKQGSLDW 621

Query:   618 NLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSK 677
               R  +   IARGLLYLH D R +IIH D+K  NILLD     +ISDFG+A++    Q  
Sbjct:   622 RKRWEVIGGIARGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKISDFGMARIFNYRQDH 681

Query:   678 TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW 737
                  + GT GY+APE+      + K DVYSFGVL+LEI+S RK+     G ++  L  +
Sbjct:   682 ANTIRVVGTYGYMAPEYAMEGIFSEKSDVYSFGVLILEIVSGRKNVSFR-GTDHGSLIGY 740

Query:   738 AFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 797
             A+  +  GK   ++    +   D+    + + V + C Q+    RP M  VL MLE    
Sbjct:   741 AWHLWSQGKTKEMIDPIVKDTRDVTEAMRCIHVGMLCTQDSVIHRPNMGSVLLMLESQTS 800

Query:   798 VSVPPNPYPFSS 809
                PP    F S
Sbjct:   801 QLPPPRQPTFHS 812

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0009693 "ethylene biosynthetic process" evidence=RCA

TAIR|locus:2197714 AT1G61440 [Arabidopsis thaliana (taxid:3702)]

 Score = 614 (221.2 bits), Expect = 6.8e-65, Sum P(2) = 6.8e-65
 Identities = 171/511 (33%), Positives = 255/511 (49%)

Query:   309 GACGYNSICTLDSDRRPRCACPKGY--SLLDENDR---YGSCRPDFELSCWGGGQGYNKE 363
             G CG    C + SD  P+C C KG+    ++E  R      C    EL C G   G  K+
Sbjct:   279 GVCGPFGFCVI-SDP-PKCKCFKGFVPKSIEEWKRGNWTSGCARRTELHCQGNSTG--KD 334

Query:   364 LFDFHELKNINWPQSDYERFKPYNEVQCKNTCLSDCFCAAVIFNDG-SCWFKKLPLSNGM 422
                FH + NI  P   YE     +   C  +CL +C C A  +  G  C      L + M
Sbjct:   335 ANVFHTVPNIK-PPDFYEYANSVDAEGCYQSCLHNCSCLAFAYIPGIGCLMWSKDLMDTM 393

Query:   423 TDSRIAGKAFIKYKNKGXXXXXXXXXXXXXXKKKSKMMNATGSVLLGSSVFVNFALVCAF 482
               S  AG   +  +                 K+K  ++ +T S+ L   V + FA     
Sbjct:   394 QFS--AGGEILSIR--------LAHSELDVHKRKMTIVASTVSLTL--FVILGFA----- 436

Query:   483 VLGF---SFIYKKKWIRNSPDDGTIETNLRCFSYKELEGATNNFK--EEVGRGSFGIVYK 537
               GF      +   W RN      +   L  F    ++ AT+NF    ++G G FG VYK
Sbjct:   437 TFGFWRNRVKHHDAW-RNDLQSQDVP-GLEFFEMNTIQTATSNFSLSNKLGHGGFGSVYK 494

Query:   538 GVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 597
             G +Q       +AVK+L    + G++EF NE+ +I +  H+NLVR+LG C EG+ +LL+Y
Sbjct:   495 GKLQDGRE---IAVKRLSSSSEQGKQEFMNEIVLISKLQHRNLVRVLGCCVEGKEKLLIY 551

Query:   598 EFLNNGTLASFLFGN---LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILL 654
             EF+ N +L +F+FG+   L+ +W  R +I   I RGLLYLH D R ++IH D+K  NILL
Sbjct:   552 EFMKNKSLDTFVFGSRKRLELDWPKRFDIIQGIVRGLLYLHRDSRLRVIHRDLKVSNILL 611

Query:   655 DDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLL 714
             D+    +ISDFGLA+L   +Q +     + GT GY++PE+      + K D+YSFGVLLL
Sbjct:   612 DEKMNPKISDFGLARLFQGSQYQDKTRRVVGTLGYMSPEYAWTGVFSEKSDIYSFGVLLL 671

Query:   715 EIISCRKSFDIEMGEEYAILTDWAFDCYRNGK-LNVLVGEDKEAMNDIECLGKLVMVSIW 773
             EIIS  K      GEE   L  + ++C+   + +N+L     ++ +  E +G+ V + + 
Sbjct:   672 EIISGEKISRFSYGEEGKALLAYVWECWCETRGVNLLDQALDDSSHPAE-VGRCVQIGLL 730

Query:   774 CIQEDPSLRPTMKKVLQMLEGVVEVSVPPNP 804
             C+Q  P+ RP   ++L ML    ++ +P  P
Sbjct:   731 CVQHQPADRPNTLELLSMLTTTSDLPLPKQP 761

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 464 (168.4 bits), Expect = 9.6e-65, Sum P(2) = 9.6e-65
 Identities = 114/300 (38%), Positives = 173/300 (57%)

Query:   516 LEGATNNFKEE--VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIG 573
             L  ATNNF  +  +G+G FGIVYKG +        +AVK+L ++   G  EF NEV +I 
Sbjct:   512 LATATNNFSNDNKLGQGGFGIVYKGRL---LDGKEIAVKRLSKMSSQGTDEFMNEVRLIA 568

Query:   574 QTHHKNLVRLLGFC-DEGQNRLLVYEFLNNGTLASFLFGNLKP---NWNLRTNIAFQIAR 629
             +  H NLVRLLG C D+G+ ++L+YE+L N +L S LF   +    NW  R +I   IAR
Sbjct:   569 KLQHINLVRLLGCCVDKGE-KMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDIINGIAR 627

Query:   630 GLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGY 689
             GLLYLH+D R +IIH D+K  N+LLD   T +ISDFG+A++    +++     + GT GY
Sbjct:   628 GLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVVGTYGY 687

Query:   690 VAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG-KLN 748
             ++PE+  +   + K DV+SFGVLLLEIIS +++           L  + +  ++ G +L 
Sbjct:   688 MSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWKEGNELE 747

Query:   749 VLVGEDKEAMNDI----ECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVPPNP 804
             ++   + ++++      E L + + + + C+QE    RP M  V+ ML    E +  P P
Sbjct:   748 IVDPINIDSLSSKFPTHEIL-RCIQIGLLCVQERAEDRPVMSSVMVMLGS--ETTAIPQP 804

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0009875 "pollen-pistil interaction" evidence=TAS

GO:0016020 "membrane" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0019199 "transmembrane receptor protein kinase activity" evidence=ISS

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q39202	RLK1_ARATH	2, ., 7, ., 1, 1, ., 1	0.4791	0.9557	0.9350	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.914
3rd Layer	2.7.11	0.921

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: fgenesh4_pg.C_scaffold_1505000001 hypothetical protein (801 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	814
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	9e-50
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-49
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-48
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	4e-46
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-45
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-44
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	4e-43
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-40
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	8e-33
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	5e-31
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-30
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	8e-30
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-29
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-27
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-27
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-27
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-26
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-26
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-26
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-26
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	8e-26
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-25
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-25
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-25
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	4e-25
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-24
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-24
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-24
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-24
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	3e-24
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	5e-24
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	3e-23
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	4e-23
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	4e-23
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	9e-23
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-22
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-22
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-22
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-22
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-22
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	4e-22
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	7e-22
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	7e-22
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-21
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-21
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-21
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-21
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-21
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-21
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-21
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	4e-21
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	7e-21
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	9e-21
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	9e-21
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-20
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-20
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-20
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-20
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-20
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	3e-20
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	4e-20
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	5e-20
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	5e-20
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	5e-20
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	9e-20
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	9e-20
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-19
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-19
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-19
pfam01453	109	pfam01453, B_lectin, D-mannose binding lectin	2e-19
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-19
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-19
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	3e-19
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-19
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-19
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	6e-19
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-18
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-18
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-18
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-18
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-18
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-18
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-18
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-18
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	3e-18
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	4e-18
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	4e-18
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	4e-18
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	5e-18
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	5e-18
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	7e-18
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	7e-18
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	7e-18
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	8e-18
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	9e-18
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-17
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-17
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-17
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-17
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-17
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-17
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-17
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-17
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-17
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-17
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	4e-17
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	5e-17
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	5e-17
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	6e-17
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	6e-17
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	8e-17
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	9e-17
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	9e-17
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-16
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-16
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-16
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-16
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-16
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-16
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-16
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-16
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-16
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-16
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-16
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-16
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	3e-16
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	4e-16
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	4e-16
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	4e-16
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	4e-16
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	5e-16
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	8e-16
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	8e-16
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	8e-16
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	8e-16
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	9e-16
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	9e-16
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-15
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-15
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-15
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-15
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-15
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-15
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-15
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	4e-15
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	6e-15
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	6e-15
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	7e-15
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	7e-15
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	8e-15
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	9e-15
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-14
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-14
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-14
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-14
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-14
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-14
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-14
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-14
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-14
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-14
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-14
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	3e-14
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-14
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	4e-14
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	4e-14
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-14
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	4e-14
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	5e-14
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	7e-14
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	9e-14
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	9e-14
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-13
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-13
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-13
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-13
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-13
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-13
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-13
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-13
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-13
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-13
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-13
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-13
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	4e-13
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	4e-13
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	7e-13
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	7e-13
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	9e-13
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-12
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-12
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-12
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-12
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-12
smart00108	114	smart00108, B_lectin, Bulb-type mannose-specific l	2e-12
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-12
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-12
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-12
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-12
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	4e-12
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	4e-12
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	4e-12
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	4e-12
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	4e-12
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	6e-12
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	6e-12
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	7e-12
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	7e-12
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-11
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-11
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-11
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-11
cd00028	116	cd00028, B_lectin, Bulb-type mannose-specific lect	1e-11
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-11
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	2e-11
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-11
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-11
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-11
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	3e-11
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	3e-11
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	4e-11
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	4e-11
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	5e-11
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	6e-11
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	7e-11
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	8e-11
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	8e-11
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	9e-11
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-10
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-10
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-10
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-10
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-10
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-10
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-10
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-10
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	3e-10
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	4e-10
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	4e-10
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	5e-10
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	5e-10
cd01098	84	cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain	6e-10
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	6e-10
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	7e-10
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	9e-10
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	9e-10
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-09
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-09
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-09
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-09
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-09
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-09
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	3e-09
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-09
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	5e-09
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	5e-09
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	5e-09
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	6e-09
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	6e-09
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	6e-09
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-08
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-08
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-08
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-08
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-08
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-08
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	3e-08
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-08
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	3e-08
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	4e-08
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	4e-08
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	5e-08
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	6e-08
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	6e-08
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	7e-08
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	9e-08
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-07
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-07
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-07
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-07
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-07
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	3e-07
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	4e-07
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	6e-07
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	6e-07
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-06
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-06
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-06
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	3e-06
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	3e-06
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	5e-06
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	5e-06
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	6e-06
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	7e-06
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-05
pfam00954	110	pfam00954, S_locus_glycop, S-locus glycoprotein fa	1e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-05
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-05
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	2e-05
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	4e-05
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	7e-05
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	9e-05
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	1e-04
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-04
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	3e-04
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	8e-04
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	8e-04
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	0.002
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	0.003
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	0.003
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	0.004
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	0.004

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  175 bits (446), Expect = 9e-50
 Identities = 76/274 (27%), Positives = 121/274 (44%), Gaps = 30/274 (10%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE-FKNEVFVIGQTHHKNLV 581
             E++G GSFG VY      +T    VA+K + +     +RE    E+ ++ +  H N+V
Sbjct: 3   ILEKLGEGSFGKVYL-ARDKKTGKL-VAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLHEDCR 639
           RL    ++     LV E+   G L   L   G L  +         QI   L YLH    
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDE--ARFYLRQILSALEYLHS--- 115

Query: 640 AQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSK 699
             I+H D+KP+NILLD+    +++DFGLA+   L+  + + T + GT  Y+APE      
Sbjct: 116 KGIVHRDLKPENILLDEDGHVKLADFGLARQ--LDPGEKLTTFV-GTPEYMAPEVLLGKG 172

Query: 700 ITAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEA 757
               VD++S GV+L E+++ +  F  D ++ E +  +                     EA
Sbjct: 173 YGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDI-----SPEA 227

Query: 758 MNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM 791
            + I             + +DP  R T ++ LQ 
Sbjct: 228 KDLIRK----------LLVKDPEKRLTAEEALQH 251

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  173 bits (441), Expect = 1e-49
 Identities = 66/199 (33%), Positives = 101/199 (50%), Gaps = 11/199 (5%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE-FKNEVFVIGQTHHKNLVRLLG 585
           +G G FG VY      + +   VA+K + +       E    E+ ++ + +H N+V+L G
Sbjct: 1   LGEGGFGTVYLARD--KKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYG 58

Query: 586 FCDEGQNRLLVYEFLNNGTLASFLFGNLKP-NWNLRTNIAFQIARGLLYLHEDCRAQIIH 644
             ++  +  LV E+   G+L   L  N    + +    I  QI  GL YLH      IIH
Sbjct: 59  VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHS---NGIIH 115

Query: 645 CDIKPQNILLD-DYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE-WFRNSKITA 702
            D+KP+NILLD D    +++DFGL+KLLT    K++   I GT  Y+APE        + 
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLT--SDKSLLKTIVGTPAYMAPEVLLGKGYYSE 173

Query: 703 KVDVYSFGVLLLEIISCRK 721
           K D++S GV+L E+   + 
Sbjct: 174 KSDIWSLGVILYELPELKD 192

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  171 bits (435), Expect = 3e-48
 Identities = 87/273 (31%), Positives = 134/273 (49%), Gaps = 24/273 (8%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD--GEREFKNEVFVIGQTHHKNL 580
              ++G GSFG VYK     + +   VAVK L +  +    ++  + E+ ++ +  H N+
Sbjct: 3   LLRKLGSGSFGTVYKAK--HKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           VRL+   ++  +  LV E+   G L  +L      + +    IA QI RGL YLH     
Sbjct: 61  VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHS---N 117

Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW-FRNSK 699
            IIH D+KP+NILLD+    +I+DFGLAK L  + S    T   GT  Y+APE     + 
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSL--TTFVGTPWYMAPEVLLGGNG 175

Query: 700 ITAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEA 757
              KVDV+S GV+L E+++ +  F  +  + +   I         R     +   E K +
Sbjct: 176 YGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLI--------RRILGPPLEFDEPKWS 227

Query: 758 MNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
               E    L+     C+ +DPS RPT +++LQ
Sbjct: 228 SGSEEAK-DLI---KKCLNKDPSKRPTAEEILQ 256

Length = 260

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  165 bits (419), Expect = 4e-46
 Identities = 84/289 (29%), Positives = 139/289 (48%), Gaps = 53/289 (18%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTT--AVAVKKLDRVFQDGER-EFKNEVFVIGQTHHKN 579
             +++G G+FG VYKG ++ +       VAVK L     + +  EF  E  ++ +  H N
Sbjct: 3   LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62

Query: 580 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHED 637
           +V+LLG C E +   +V E++  G L S+L    +P  +L    + A QIARG+ YL   
Sbjct: 63  VVKLLGVCTEEEPLYIVMEYMEGGDLLSYL-RKNRPKLSLSDLLSFALQIARGMEYLE-- 119

Query: 638 CRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTA---IRGTKGYVAPEW 694
                IH D+  +N L+ +    +ISDFGL++ L  +     +     IR    ++APE 
Sbjct: 120 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIR----WMAPES 174

Query: 695 FRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLNVLVGE 753
            +  K T+K DV+SFGVLL EI +        +GE+ Y  ++                  
Sbjct: 175 LKEGKFTSKSDVWSFGVLLWEIFT--------LGEQPYPGMS------------------ 208

Query: 754 DKEAMNDIE----------CLGKLVMVSIWCIQEDPSLRPTMKKVLQML 792
           ++E +  ++          C  +L  + + C  EDP  RPT  +++++L
Sbjct: 209 NEEVLEYLKNGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  163 bits (415), Expect = 2e-45
 Identities = 85/289 (29%), Positives = 137/289 (47%), Gaps = 52/289 (17%)

Query: 523 FKEEVGRGSFGIVYKGVI--QTRTSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQTHHKN 579
             +++G G+FG VYKG +  +       VAVK L +   +    EF  E  ++ +  H N
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62

Query: 580 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHED 637
           +V+LLG C E +  ++V E++  G L  +L  N     +L    + A QIARG+ YL   
Sbjct: 63  IVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE-- 120

Query: 638 CRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTA---IRGTKGYVAPEW 694
                IH D+  +N L+ +    +ISDFGL++ L  +    +K     IR    ++APE 
Sbjct: 121 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIR----WMAPES 175

Query: 695 FRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLNVLVGE 753
            +  K T+K DV+SFGVLL EI +        +GEE Y  ++                  
Sbjct: 176 LKEGKFTSKSDVWSFGVLLWEIFT--------LGEEPYPGMS------------------ 209

Query: 754 DKEAMNDIE----------CLGKLVMVSIWCIQEDPSLRPTMKKVLQML 792
           + E +  ++          C  +L  + + C  EDP  RPT  +++++L
Sbjct: 210 NAEVLEYLKKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  160 bits (408), Expect = 1e-44
 Identities = 84/280 (30%), Positives = 134/280 (47%), Gaps = 34/280 (12%)

Query: 523 FKEEVGRGSFGIVYKGV--IQTRTSTTAVAVKKLDRVFQDGER-EFKNEVFVIGQTHHKN 579
             +++G G+FG VYKG        + T VAVK L     + ER EF  E  ++ +  H N
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62

Query: 580 LVRLLGFCDEGQNRLLVYEFLNNGTLASFL---FGNLKPNWNLRTNIAFQIARGLLYLHE 636
           +VRLLG C +G+   +V E++  G L  FL      L         +A QIA+G+ YL  
Sbjct: 63  IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKD--LLQMALQIAKGMEYLES 120

Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKG---YVAPE 693
                 +H D+  +N L+ +    +ISDFGL++ +  +     +    G K    ++APE
Sbjct: 121 ---KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRG---GGKLPIKWMAPE 174

Query: 694 WFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVG 752
             ++ K T+K DV+SFGVLL EI +   + +     EE   + +   D YR  +      
Sbjct: 175 SLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE---VLELLEDGYRLPRP----- 226

Query: 753 EDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQML 792
             +   +++  L    M+   C   DP  RPT  ++++ L
Sbjct: 227 --ENCPDELYEL----MLQ--CWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  156 bits (398), Expect = 4e-43
 Identities = 90/288 (31%), Positives = 141/288 (48%), Gaps = 45/288 (15%)

Query: 525 EEVGRGSFGIVYKGVIQTR-TSTTAVAVKKLDRVFQDGER-EFKNEVFVIGQTHHKNLVR 582
           +++G G+FG VYKG ++ +   TT VAVK L     + ER +F  E  V+ +  H N+VR
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPN---WNLRTNIAFQIARGLLY 633
           LLG C E +   LV E++  G L  +L      F + + +        + A QIA+G+ Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 634 LHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTA----IRGTKGY 689
           L      + +H D+  +N L+ +    +ISDFGL++ +  +     KT     IR    +
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR----W 173

Query: 690 VAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILTDWAFDCYRNGKL 747
           +APE  ++   T+K DV+SFGVLL EI +        +G      +  +   +  R G  
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFT--------LGATPYPGLSNEEVLEYLRKG-- 223

Query: 748 NVLVGEDKEAMNDIECLGKL--VMVSIWCIQEDPSLRPTMKKVLQMLE 793
             L     E      C  +L  +M+S W  Q DP  RPT  ++++ LE
Sbjct: 224 YRL--PKPE-----YCPDELYELMLSCW--QLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  148 bits (376), Expect = 3e-40
 Identities = 81/276 (29%), Positives = 130/276 (47%), Gaps = 35/276 (12%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKK--LDRVFQDGEREFKNEVFVIGQTHHKNLVR 582
           E +GRGSFG VY      + +   +AVK   L    ++     + E+ ++    H N+VR
Sbjct: 6   ELLGRGSFGSVYLA--LDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVR 63

Query: 583 LLGFC-DEGQNRLLVY-EFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLHEDC 638
             G   DE +N L ++ E+++ G+L+S L  FG L     +R     QI  GL YLH   
Sbjct: 64  YYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEP-VIR-KYTRQILEGLAYLH--- 118

Query: 639 RAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNS 698
              I+H DIK  NIL+D     +++DFG AK L   ++     ++RGT  ++APE  R  
Sbjct: 119 SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE 178

Query: 699 KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVL----VGED 754
           +     D++S G  ++E+ + +  +  E+G   A L       Y+ G             
Sbjct: 179 EYGRAADIWSLGCTVIEMATGKPPWS-ELGNPMAAL-------YKIGSSGEPPEIPEHLS 230

Query: 755 KEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
           +EA + +            C++ DP  RPT  ++LQ
Sbjct: 231 EEAKDFLRK----------CLRRDPKKRPTADELLQ 256

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  127 bits (320), Expect = 8e-33
 Identities = 64/198 (32%), Positives = 96/198 (48%), Gaps = 15/198 (7%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVR 582
               +G+G FG V  G  + +     VAVK L        + F  E  V+    H NLV+
Sbjct: 10  LGATIGKGEFGDVMLGDYRGQK----VAVKCLKDD-STAAQAFLAEASVMTTLRHPNLVQ 64

Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNI--AFQIARGLLYLHEDCRA 640
           LLG   +G    +V E++  G+L  +L    +    L   +  A  +  G+ YL E    
Sbjct: 65  LLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK--- 121

Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
             +H D+  +N+L+ +   A++SDFGLAK  +  Q  + K  ++ T    APE  R  K 
Sbjct: 122 NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-SGKLPVKWT----APEALREKKF 176

Query: 701 TAKVDVYSFGVLLLEIIS 718
           + K DV+SFG+LL EI S
Sbjct: 177 STKSDVWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  121 bits (307), Expect = 5e-31
 Identities = 60/197 (30%), Positives = 96/197 (48%), Gaps = 17/197 (8%)

Query: 524 KEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
            E++G+G FG VYK     RT    VA+K +    ++ + +  NE+ ++ +  H N+V+ 
Sbjct: 5   LEKIGKGGFGEVYK-ARHKRTGKE-VAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKY 62

Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNL-RTNIAFQIARGLL----YLHEDC 638
            G   +     +V EF + G+L   L    +    L  + IA+ + + LL    YLH   
Sbjct: 63  YGSYLKKDELWIVMEFCSGGSLKDLLKSTNQT---LTESQIAY-VCKELLKGLEYLHS-- 116

Query: 639 RAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNS 698
              IIH DIK  NILL      ++ DFGL+    L+ +K   T + GT  ++APE     
Sbjct: 117 -NGIIHRDIKAANILLTSDGEVKLIDFGLSA--QLSDTKARNTMV-GTPYWMAPEVINGK 172

Query: 699 KITAKVDVYSFGVLLLE 715
               K D++S G+  +E
Sbjct: 173 PYDYKADIWSLGITAIE 189

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  123 bits (308), Expect = 3e-30
 Identities = 78/288 (27%), Positives = 117/288 (40%), Gaps = 35/288 (12%)

Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE---FKNEVFVIGQ-THH 577
               ++G GSFG VY            VA+K L +  +   +E   F  E+ ++    H 
Sbjct: 3   RILRKLGEGSFGEVYLAR-----DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 578 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL-----FGNLKPNWNLRTNIAFQIARGLL 632
            N+V+L  F  +  +  LV E+++ G+L   L      G L  +  L   I  QI   L 
Sbjct: 58  PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALF--ILAQILSALE 115

Query: 633 YLHEDCRAQIIHCDIKPQNILLD-DYYTARISDFGLAKLLTLNQSKTI----KTAIRGTK 687
           YLH      IIH DIKP+NILLD D    ++ DFGLAKLL    S +      +   GT 
Sbjct: 116 YLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP 172

Query: 688 GYVAPEWFR---NSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 744
           GY+APE       +  ++  D++S G+ L E+++    F+ E        T         
Sbjct: 173 GYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILE 229

Query: 745 GKLNVLVGE--DKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
                L             +    L+      + +DP  R +    L 
Sbjct: 230 LPTPSLASPLSPSNPELISKAASDLLKK---LLAKDPKNRLSSSSDLS 274

Length = 384

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  118 bits (298), Expect = 8e-30
 Identities = 74/276 (26%), Positives = 132/276 (47%), Gaps = 37/276 (13%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLD--RVFQDGEREFKNEVFVIGQTHHKNL 580
             + +GRG+FG+VYKG +   T    VA+K++   ++ ++  +    E+ ++    H N+
Sbjct: 4   LGDLIGRGAFGVVYKG-LNLETGDF-VAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNI 61

Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLHEDC 638
           V+ +G  +   +  ++ E+  NG+L   +  FG      +L     +Q+ +GL YLHE  
Sbjct: 62  VKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPF--PESLVAVYVYQVLQGLAYLHEQ- 118

Query: 639 RAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNS 698
              +IH DIK  NIL       +++DFG+A    LN       ++ GT  ++APE    S
Sbjct: 119 --GVIHRDIKAANILTTKDGVVKLADFGVA--TKLNDVSKDDASVVGTPYWMAPEVIEMS 174

Query: 699 KITAKVDVYSFGVLLLEIISCRKS-FDIE-MGEEYAILTDWAFDCYRNGKLNVLVGEDKE 756
             +   D++S G  ++E+++     +D+  M   + I+ D   D     +          
Sbjct: 175 GASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQD---DHPPLPE---------- 221

Query: 757 AMNDI--ECLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
               I  E    L    + C Q+DP+LRPT K++L+
Sbjct: 222 ---GISPELKDFL----MQCFQKDPNLRPTAKQLLK 250

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  117 bits (296), Expect = 2e-29
 Identities = 74/277 (26%), Positives = 128/277 (46%), Gaps = 35/277 (12%)

Query: 524 KEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFK---NEVFVIGQTHHKNL 580
            +++G+GSFG VY  V +         +K++D +    E+E +   NEV ++ + +H N+
Sbjct: 5   IKQIGKGSFGKVYL-VRRKSDGKL-YVLKEID-LSNMSEKEREDALNEVKILKKLNHPNI 61

Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT----NIAFQIARGLLYLHE 636
           ++     +E     +V E+ + G L+  +    K           +   Q+   L YLH 
Sbjct: 62  IKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS 121

Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR 696
               +I+H DIKPQNI L      ++ DFG++K+L+       KT + GT  Y++PE  +
Sbjct: 122 R---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA-KTVV-GTPYYLSPELCQ 176

Query: 697 NSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKE 756
           N     K D++S G +L E+ + +  F+   GE    L            L +L G+   
Sbjct: 177 NKPYNYKSDIWSLGCVLYELCTLKHPFE---GENLLELA-----------LKILKGQ-YP 221

Query: 757 AMNDI--ECLGKLVMVSIWCIQEDPSLRPTMKKVLQM 791
            +       L  LV      +Q+DP  RP++ ++LQ 
Sbjct: 222 PIPSQYSSELRNLVS---SLLQKDPEERPSIAQILQS 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  113 bits (284), Expect = 1e-27
 Identities = 79/287 (27%), Positives = 134/287 (46%), Gaps = 42/287 (14%)

Query: 526 EVGRGSFGIVYKGV---IQTRTSTTAVAVKKLDRVFQDGER-EFKNEVFVIGQTHHKNLV 581
           E+G+GSFG+VY+G+   +      T VA+K ++      ER EF NE  V+ + +  ++V
Sbjct: 13  ELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVV 72

Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFL--------FGNLK--PNWNLRTNIAFQIARGL 631
           RLLG    GQ  L+V E +  G L S+L               P       +A +IA G+
Sbjct: 73  RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132

Query: 632 LYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKG--- 688
            YL      + +H D+  +N ++ +  T +I DFG+ +   + ++   +   +G KG   
Sbjct: 133 AYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRD--IYETDYYR---KGGKGLLP 184

Query: 689 --YVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 746
             ++APE  ++   T K DV+SFGV+L E+               A L +  +    N +
Sbjct: 185 VRWMAPESLKDGVFTTKSDVWSFGVVLWEM---------------ATLAEQPYQGLSNEE 229

Query: 747 LNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
           +   V +         C  KL+ +   C Q +P +RPT  +++  L+
Sbjct: 230 VLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  113 bits (284), Expect = 1e-27
 Identities = 64/209 (30%), Positives = 111/209 (53%), Gaps = 13/209 (6%)

Query: 523 FKEEVGRGSFGIVYKGV--IQTRTSTTAVAVKKLDRVFQDGER-EFKNEVFVIGQTHHKN 579
           F +++G G FG V           +   VAVK L+   ++  R +F+ E+ ++    H+N
Sbjct: 8   FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67

Query: 580 LVRLLGFCDE--GQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNI--AFQIARGLLYLH 635
           +V+  G C++  G++  L+ E+L +G+L  +L  + +   NL+  +  + QI +G+ YL 
Sbjct: 68  IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRH-RDQINLKRLLLFSSQICKGMDYLG 126

Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS-KTIKTAIRGTKGYVAPEW 694
                + IH D+  +NIL++     +ISDFGLAK+L  ++    +K        + APE 
Sbjct: 127 S---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPEC 183

Query: 695 FRNSKITAKVDVYSFGVLLLEIIS-CRKS 722
            R SK ++  DV+SFGV L E+ +    S
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFTYGDPS 212

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  112 bits (282), Expect = 2e-27
 Identities = 73/222 (32%), Positives = 114/222 (51%), Gaps = 35/222 (15%)

Query: 523 FKEEVGRGSFGIVYKGVIQT---RTSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQTHHK 578
           F EE+G G+FG VYKG +     R S T+VA+K L +      ++EF+ E  ++    H 
Sbjct: 9   FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHP 68

Query: 579 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT----------------- 621
           N+V LLG C + Q   +++E+L +G L  FL  N  P+ ++                   
Sbjct: 69  NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRN-SPHSDVGAESGDETVKSSLDCSDFL 127

Query: 622 NIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN-----QS 676
           +IA QIA G+ YL        +H D+  +N L+ +  T +ISDFGL++ +        QS
Sbjct: 128 HIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQS 184

Query: 677 KTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS 718
           K++   +R    ++ PE     K T + D++SFGV+L EI S
Sbjct: 185 KSL-LPVR----WMPPEAILYGKFTTESDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  109 bits (275), Expect = 1e-26
 Identities = 70/198 (35%), Positives = 104/198 (52%), Gaps = 9/198 (4%)

Query: 525 EEVGRGSFGIVYKGVIQTRT-STTAVAVKKL-DRVFQDGEREFKNEVFVIGQTHHKNLVR 582
           +E+G G+FG V KGV   ++     VAVK L       G++EF  E  V+ Q  H  +VR
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK-PNWNLRTNIAFQIARGLLYLHEDCRAQ 641
           L+G C +G+  +LV E    G L  +L    + P  +L   +A Q+A G+ YL E     
Sbjct: 61  LIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDL-KELAHQVAMGMAYL-ESKH-- 115

Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSK-TIKTAIRGTKGYVAPEWFRNSKI 700
            +H D+  +N+LL + + A+ISDFG+++ L          TA R    + APE     K 
Sbjct: 116 FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKF 175

Query: 701 TAKVDVYSFGVLLLEIIS 718
           ++K DV+S+GV L E  S
Sbjct: 176 SSKSDVWSYGVTLWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  109 bits (276), Expect = 1e-26
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 33/227 (14%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQ-THHK 578
           F + +G GSF  V     + + +    A+K LD+     +   +  K E  V+ +   H 
Sbjct: 5   FGKIIGEGSFSTVVLA--KEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62

Query: 579 NLVRLLG-FCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLH 635
            +++L   F DE +N   V E+  NG L  ++  +G+L  +       A +I   L YLH
Sbjct: 63  GIIKLYYTFQDE-ENLYFVLEYAPNGELLQYIRKYGSL--DEKCTRFYAAEILLALEYLH 119

Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS---------KTIKTAIR-- 684
                 IIH D+KP+NILLD     +I+DFG AK+L  N S                +  
Sbjct: 120 ---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176

Query: 685 -------GTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFD 724
                  GT  YV+PE           D+++ G ++ ++++ +  F 
Sbjct: 177 RRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFR 223

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  116 bits (292), Expect = 1e-26
 Identities = 92/352 (26%), Positives = 154/352 (43%), Gaps = 51/352 (14%)

Query: 470 SSVFVNFALVCAFVLGFSFIYKKKWI---RNSPDDGTIETNLRCFSYK-----ELEGATN 521
           +     F ++     GF FI  +  +   R   +DGT E     F  K      +    +
Sbjct: 633 TCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQF--FDSKVSKSITINDILS 690

Query: 522 NFKEE--VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKN 579
           + KEE  + RG  G  YKG  ++  +     VK+++ V      E  +    +G+  H N
Sbjct: 691 SLKEENVISRGKKGASYKG--KSIKNGMQFVVKEINDVNSIPSSEIAD----MGKLQHPN 744

Query: 580 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCR 639
           +V+L+G C   +   L++E++    L+  L      +W  R  IA  IA+ L +LH  C 
Sbjct: 745 IVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCS 801

Query: 640 AQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSK 699
             ++  ++ P+ I++D      +    L  LL  +    I +A      YVAPE      
Sbjct: 802 PAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSA------YVAPETRETKD 854

Query: 700 ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL----------NV 749
           IT K D+Y FG++L+E+++ +   D E G   +I+ +WA  CY +  L          +V
Sbjct: 855 ITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIV-EWARYCYSDCHLDMWIDPSIRGDV 913

Query: 750 LVGEDK--EAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 799
            V +++  E MN          +++ C   DP+ RP    VL+ LE     S
Sbjct: 914 SVNQNEIVEVMN----------LALHCTATDPTARPCANDVLKTLESASRSS 955

Length = 968

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  108 bits (271), Expect = 3e-26
 Identities = 68/200 (34%), Positives = 100/200 (50%), Gaps = 16/200 (8%)

Query: 524 KEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           + ++G G FG V+ G   T   TT VAVK L       E  F  E  ++ +  H  LV+L
Sbjct: 11  ERKLGAGQFGEVWMG---TWNGTTKVAVKTLKPGTMSPE-AFLQEAQIMKKLRHDKLVQL 66

Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHEDCRAQ 641
              C E +   +V E+++ G+L  FL         L    ++A QIA G+ YL       
Sbjct: 67  YAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRN 123

Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVAPEWFRNS 698
            IH D+  +NIL+ +    +I+DFGLA+L+  +      TA  G K    + APE     
Sbjct: 124 YIHRDLAARNILVGENLVCKIADFGLARLIEDD----EYTAREGAKFPIKWTAPEAANYG 179

Query: 699 KITAKVDVYSFGVLLLEIIS 718
           + T K DV+SFG+LL EI++
Sbjct: 180 RFTIKSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  107 bits (269), Expect = 8e-26
 Identities = 77/275 (28%), Positives = 123/275 (44%), Gaps = 33/275 (12%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGER----EFKNEVFVIGQTHHKNLVR 582
           +G G+FG VY  V     +   +AVK++    QD +     E  +E+ V+    H NLV+
Sbjct: 8   IGGGTFGKVYTAV--NLDTGELMAVKEIR--IQDNDPKTIKEIADEMKVLELLKHPNLVK 63

Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFL-FGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ 641
             G     +   +  E+ + GTL   L  G +     +R     Q+  GL YLH      
Sbjct: 64  YYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRV-YTLQLLEGLAYLHS---HG 119

Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAI---RGTKGYVAPEWFRNS 698
           I+H DIKP NI LD     ++ DFG A  L  N + T+   +    GT  Y+APE     
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLK-NNTTTMGEEVQSLAGTPAYMAPEVITGG 178

Query: 699 KITAK---VDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDK 755
           K        D++S G ++LE+ + ++ +  E+  E+ I+       +  G  +     D 
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRPWS-ELDNEFQIM-------FHVGAGHKPPIPDS 230

Query: 756 EAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
             ++     GK  +    C++ DP  RPT  ++LQ
Sbjct: 231 LQLSP---EGKDFLDR--CLESDPKKRPTASELLQ 260

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  106 bits (267), Expect = 2e-25
 Identities = 70/266 (26%), Positives = 120/266 (45%), Gaps = 23/266 (8%)

Query: 528 GRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ-DGEREFKNEVFVIGQTHHKNLVRLLG- 585
           G+GS G+VYK   + + +    A+KK+      +  ++   E+  +       +V+  G 
Sbjct: 10  GQGSSGVVYKV--RHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67

Query: 586 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHC 645
           F  EG+  + V E+++ G+LA  L    K    +   IA QI +GL YLH      IIH 
Sbjct: 68  FYKEGEISI-VLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH--IIHR 124

Query: 646 DIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVD 705
           DIKP N+L++     +I+DFG++K   L  +        GT  Y++PE  +    +   D
Sbjct: 125 DIKPSNLLINSKGEVKIADFGISK--VLENTLDQCNTFVGTVTYMSPERIQGESYSYAAD 182

Query: 706 VYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLG 765
           ++S G+ LLE    +  F       +  L            +  +      ++   E   
Sbjct: 183 IWSLGLTLLECALGKFPFLPPGQPSFFEL------------MQAICDGPPPSLPAEEFSP 230

Query: 766 KLV-MVSIWCIQEDPSLRPTMKKVLQ 790
           +    +S  C+Q+DP  RP+  ++LQ
Sbjct: 231 EFRDFISA-CLQKDPKKRPSAAELLQ 255

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  105 bits (265), Expect = 2e-25
 Identities = 60/202 (29%), Positives = 102/202 (50%), Gaps = 22/202 (10%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLL 584
            ++G G FG V++G+ + R     VA+K L       +++F+ EV  + +  HK+L+ L 
Sbjct: 12  RKLGSGYFGEVWEGLWKNRVR---VAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLF 68

Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT----NIAFQIARGLLYLHEDCRA 640
             C  G+   ++ E +  G+L +FL         L      ++A Q+A G+ YL E    
Sbjct: 69  AVCSVGEPVYIITELMEKGSLLAFL--RSPEGQVLPVASLIDMACQVAEGMAYLEEQ--- 123

Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLT----LNQSKTIKTAIRGTKGYVAPEWFR 696
             IH D+  +NIL+ +    +++DFGLA+L+     L+  K I         + APE   
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYK------WTAPEAAS 177

Query: 697 NSKITAKVDVYSFGVLLLEIIS 718
           +   + K DV+SFG+LL E+ +
Sbjct: 178 HGTFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  105 bits (264), Expect = 3e-25
 Identities = 61/209 (29%), Positives = 106/209 (50%), Gaps = 16/209 (7%)

Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ 574
           E++  +     ++G G FG V++G+     +TT VAVK L     D + +F  E  ++ +
Sbjct: 2   EIDRTSIQLLRKLGAGQFGEVWEGLWN---NTTPVAVKTLKPGTMDPK-DFLAEAQIMKK 57

Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLL 632
             H  L++L   C   +   +V E +  G+L  +L G       L    ++A Q+A G+ 
Sbjct: 58  LRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMA 117

Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK---GY 689
           YL        IH D+  +N+L+ +    +++DFGLA+++  +    I  A  G K    +
Sbjct: 118 YLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKED----IYEAREGAKFPIKW 170

Query: 690 VAPEWFRNSKITAKVDVYSFGVLLLEIIS 718
            APE    ++ + K DV+SFG+LL EI++
Sbjct: 171 TAPEAALYNRFSIKSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  105 bits (263), Expect = 4e-25
 Identities = 83/287 (28%), Positives = 131/287 (45%), Gaps = 36/287 (12%)

Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ 574
           E+E      K ++G G +G VY+GV +  + T AV   K D +  +   EF  E  V+ +
Sbjct: 2   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKE 58

Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLL 632
             H NLV+LLG C       ++ EF+  G L  +L    +   N      +A QI+  + 
Sbjct: 59  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 118

Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK---GY 689
           YL    +   IH D+  +N L+ + +  +++DFGL++L+T        TA  G K    +
Sbjct: 119 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT----GDTYTAHAGAKFPIKW 171

Query: 690 VAPEWFRNSKITAKVDVYSFGVLLLEIIS--CRKSFDIEMGEEYAILTDWAFDCYRNGKL 747
            APE    +K + K DV++FGVLL EI +        I++ + Y +L             
Sbjct: 172 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL------------- 218

Query: 748 NVLVGEDKEAMNDIE-CLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
                E    M   E C  K+  +   C Q +PS RP+  ++ Q  E
Sbjct: 219 -----EKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFE 260

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  103 bits (260), Expect = 2e-24
 Identities = 61/203 (30%), Positives = 103/203 (50%), Gaps = 21/203 (10%)

Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLV 581
              E++G G+ G VYK      T    VA+KK+ R+ +  +    NE+ ++    H N+V
Sbjct: 22  KNLEKIGEGASGEVYKA-TDRATGKE-VAIKKM-RLRKQNKELIINEILIMKDCKHPNIV 78

Query: 582 RLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTN---IAF---QIARGLLYL 634
                     + L +V E+++ G+L   +  N      +R N   IA+   ++ +GL YL
Sbjct: 79  DYYD-SYLVGDELWVVMEYMDGGSLTDIITQN-----FVRMNEPQIAYVCREVLQGLEYL 132

Query: 635 HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 694
           H      +IH DIK  NILL    + +++DFG A  LT  +SK  + ++ GT  ++APE 
Sbjct: 133 H---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK--RNSVVGTPYWMAPEV 187

Query: 695 FRNSKITAKVDVYSFGVLLLEII 717
            +      KVD++S G++ +E+ 
Sbjct: 188 IKRKDYGPKVDIWSLGIMCIEMA 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  102 bits (257), Expect = 2e-24
 Identities = 67/212 (31%), Positives = 110/212 (51%), Gaps = 33/212 (15%)

Query: 523 FKEEVGRGSFGIV----YKGVIQTRTSTTAVAVKKLDRVFQDG---EREFKNEVFVIGQT 575
           F +E+G G FG+V    ++G I        VA+K +    ++G   E +F  E  V+ + 
Sbjct: 8   FLKELGSGQFGVVHLGKWRGKID-------VAIKMI----REGAMSEDDFIEEAKVMMKL 56

Query: 576 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPNWNLRTNIAFQIARGLL 632
            H NLV+L G C + +   +V E++ NG L ++L    G L   W L  ++   +   + 
Sbjct: 57  SHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLL--DMCSDVCEAME 114

Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK---GY 689
           YL  +     IH D+  +N L+ +    ++SDFGLA+ +  +Q     T+ +GTK    +
Sbjct: 115 YLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY----TSSQGTKFPVKW 167

Query: 690 VAPEWFRNSKITAKVDVYSFGVLLLEIISCRK 721
             PE F  S+ ++K DV+SFGVL+ E+ S  K
Sbjct: 168 APPEVFDYSRFSSKSDVWSFGVLMWEVFSEGK 199

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  102 bits (256), Expect = 2e-24
 Identities = 61/201 (30%), Positives = 102/201 (50%), Gaps = 17/201 (8%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVR 582
             +E+G G FG+V+ G    +     VA+K +       E +F  E  V+ +  H  LV+
Sbjct: 8   LVQEIGSGQFGLVWLGYWLEKRK---VAIKTIREGAMS-EEDFIEEAQVMMKLSHPKLVQ 63

Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHEDCRA 640
           L G C E     LV+EF+ +G L+ +L    +  ++  T   +   +  G+ YL      
Sbjct: 64  LYGVCTERSPICLVFEFMEHGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLESSN-- 120

Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVAPEWFRN 697
            +IH D+  +N L+ +    ++SDFG+ + +  +Q     T+  GTK    + +PE F  
Sbjct: 121 -VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY----TSSTGTKFPVKWSSPEVFSF 175

Query: 698 SKITAKVDVYSFGVLLLEIIS 718
           SK ++K DV+SFGVL+ E+ S
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFS 196

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  103 bits (258), Expect = 3e-24
 Identities = 59/196 (30%), Positives = 101/196 (51%), Gaps = 10/196 (5%)

Query: 528 GRGSFGIVYKGV--IQTRTSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQTHHKNLVRLL 584
           G G+FG VYKGV   +       VA+K L +       +E  +E +V+    H ++VRLL
Sbjct: 16  GSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLL 75

Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHEDCRAQI 642
           G C       L+ + +  G L  ++  + K N   +   N   QIA+G+ YL E    ++
Sbjct: 76  GIC-LSSQVQLITQLMPLGCLLDYVRNH-KDNIGSQYLLNWCVQIAKGMSYLEE---KRL 130

Query: 643 IHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITA 702
           +H D+  +N+L+      +I+DFGLAKLL +++ +      +    ++A E   +   T 
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTH 190

Query: 703 KVDVYSFGVLLLEIIS 718
           K DV+S+GV + E+++
Sbjct: 191 KSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  102 bits (256), Expect = 3e-24
 Identities = 78/289 (26%), Positives = 128/289 (44%), Gaps = 57/289 (19%)

Query: 522 NFK--EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLD-RVFQDGEREFK-NEVFVIGQTHH 577
           +FK  +++G+GS+G VYK  ++  +     A+K++D       ERE   NE+ ++   +H
Sbjct: 1   DFKVLKKLGKGSYGSVYK--VKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNH 58

Query: 578 KNLVR-----LLGFCDEGQNRL-LVYEFLNNGTLASFL-----FGNLKPN---WNLRTNI 623
            N++      L G      N+L +V E+   G L+  +        L P    W     I
Sbjct: 59  PNIISYKEAFLDG------NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWR----I 108

Query: 624 AFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAI 683
             Q+ RGL  LHE    +I+H D+K  NILL      +I D G++K+L  N +KT     
Sbjct: 109 FIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI--- 162

Query: 684 RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILTDWAFDC 741
            GT  Y+APE ++    + K D++S G LL E+ +    F+    ++  Y +        
Sbjct: 163 -GTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR------ 215

Query: 742 YRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
              GK   +     + +         +      +Q  P LRP   K+L 
Sbjct: 216 ---GKYPPIPPIYSQDLQ------NFIR---SMLQVKPKLRPNCDKILA 252

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  101 bits (254), Expect = 5e-24
 Identities = 66/203 (32%), Positives = 103/203 (50%), Gaps = 22/203 (10%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           E++G+G+FG VYKGV++  T    VAVK     +  D +R+F  E  ++ Q  H N+V+L
Sbjct: 1   EKIGKGNFGDVYKGVLKGNTE---VAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKL 57

Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQI----ARGLLYLHEDCR 639
           +G C + Q   +V E +  G+L +FL    K    L      Q+    A G+ YL     
Sbjct: 58  IGVCVQKQPIYIVMELVPGGSLLTFL---RKKKNRLTVKKLLQMSLDAAAGMEYLESKN- 113

Query: 640 AQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK----GYVAPEWF 695
              IH D+  +N L+ +    +ISDFG+++     +   I T   G K     + APE  
Sbjct: 114 --CIHRDLAARNCLVGENNVLKISDFGMSR----EEEGGIYTVSDGLKQIPIKWTAPEAL 167

Query: 696 RNSKITAKVDVYSFGVLLLEIIS 718
              + T++ DV+S+G+LL E  S
Sbjct: 168 NYGRYTSESDVWSYGILLWETFS 190

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 99.7 bits (248), Expect = 3e-23
 Identities = 67/198 (33%), Positives = 104/198 (52%), Gaps = 11/198 (5%)

Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVF----VIGQTHHKNLV 581
           E+G G+FG V KG+ + + S   VAVK L     + +   K+E+     V+ Q  +  +V
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKN--DNNDPALKDELLREANVMQQLDNPYIV 59

Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ 641
           R++G C E ++ +LV E    G L  FL  N        T +  Q++ G+ YL E     
Sbjct: 60  RMIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEET---N 115

Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS-KTIKTAIRGTKGYVAPEWFRNSKI 700
            +H D+  +N+LL   + A+ISDFGL+K L  +++    KT  +    + APE     K 
Sbjct: 116 FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKF 175

Query: 701 TAKVDVYSFGVLLLEIIS 718
           ++K DV+SFGVL+ E  S
Sbjct: 176 SSKSDVWSFGVLMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 99.7 bits (249), Expect = 4e-23
 Identities = 77/287 (26%), Positives = 132/287 (45%), Gaps = 51/287 (17%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTT-AVAVKKLDRVFQDGER-EFKNEVFVIGQTHHKNLVR 582
           + +G G FG V +G ++        VA+K L     D +R +F  E  ++GQ  H N++R
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69

Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQ 641
           L G   + +  +++ E++ NG+L  FL  N  K        +   IA G+ YL E     
Sbjct: 70  LEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN--- 126

Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS----KTIKTAIRGTKGYVAPEWFRN 697
            +H D+  +NIL++     ++SDFGL++ L  +++    K  K  IR T    APE    
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT----APEAIAY 182

Query: 698 SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLNVLVGEDKE 756
            K T+  DV+SFG+++ E++S         GE  Y    D +               +++
Sbjct: 183 RKFTSASDVWSFGIVMWEVMS--------YGERPYW---DMS---------------NQD 216

Query: 757 AMNDIE----------CLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
            +  +E          C   L  + + C Q+D + RPT  +++  L+
Sbjct: 217 VIKAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLD 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score =  100 bits (249), Expect = 4e-23
 Identities = 79/291 (27%), Positives = 135/291 (46%), Gaps = 42/291 (14%)

Query: 522 NFKEEVGRGSFGIVYKGV---IQTRTSTTAVAVKKLDRVFQDGER-EFKNEVFVIGQTHH 577
               E+G+GSFG+VY+G    I    + T VAVK ++      ER EF NE  V+     
Sbjct: 9   TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC 68

Query: 578 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF----------GNLKPNWNLRTNIAFQI 627
            ++VRLLG   +GQ  L+V E + +G L S+L           G   P       +A +I
Sbjct: 69  HHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 128

Query: 628 ARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK 687
           A G+ YL+     + +H D+  +N ++   +T +I DFG+ +   + ++   +   +G K
Sbjct: 129 ADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYR---KGGK 180

Query: 688 G-----YVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 742
           G     ++APE  ++   T   D++SFGV+L EI S               L +  +   
Sbjct: 181 GLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGL 225

Query: 743 RNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
            N ++   V +         C  ++  +   C Q +P +RPT  +++ +L+
Sbjct: 226 SNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 98.7 bits (246), Expect = 9e-23
 Identities = 82/290 (28%), Positives = 122/290 (42%), Gaps = 50/290 (17%)

Query: 527 VGRGSFGIVYKGVIQTR---TSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVR 582
           +G G+FG VY+G+ + R        VAVK L     +  E +F  E  ++ + +H+N+VR
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73

Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--------NIAFQIARGLLYL 634
           L+G   E   R ++ E +  G L SFL  N +P     +          A  +A+G  YL
Sbjct: 74  LIGVSFERLPRFILLELMAGGDLKSFLREN-RPRPERPSSLTMKDLLFCARDVAKGCKYL 132

Query: 635 HEDCRAQIIHCDIKPQNILLDDY---YTARISDFGLAKLLTLNQSKTIKTAIRGTKG--- 688
            E      IH DI  +N LL        A+I+DFG+A        + I  A    KG   
Sbjct: 133 EE---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMA--------RDIYRASYYRKGGRA 181

Query: 689 -----YVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR 743
                ++ PE F +   T+K DV+SFGVLL EI S               L    +    
Sbjct: 182 MLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS---------------LGYMPYPGRT 226

Query: 744 NGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
           N ++   V           C G +  +   C Q  P  RP    +L+ ++
Sbjct: 227 NQEVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 98.5 bits (246), Expect = 1e-22
 Identities = 61/199 (30%), Positives = 97/199 (48%), Gaps = 19/199 (9%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE---FKNEVFVIGQTHHKNLV 581
           E +G+GSFG VYK +   + +   VA+K +D   ++ E E    + E+  + Q     + 
Sbjct: 7   ECIGKGSFGEVYKAID--KRTNQVVAIKVID--LEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF---QIARGLLYLHEDC 638
           +  G   +G    ++ E+   G+    L    KP     T IAF   ++  GL YLHE+ 
Sbjct: 63  KYYGSFLKGSKLWIIMEYCGGGSCLDLL----KPGKLDETYIAFILREVLLGLEYLHEE- 117

Query: 639 RAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNS 698
               IH DIK  NILL +    +++DFG++  LT   SK       GT  ++APE  + S
Sbjct: 118 --GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV--GTPFWMAPEVIKQS 173

Query: 699 KITAKVDVYSFGVLLLEII 717
               K D++S G+  +E+ 
Sbjct: 174 GYDEKADIWSLGITAIELA 192

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 98.1 bits (245), Expect = 1e-22
 Identities = 73/282 (25%), Positives = 120/282 (42%), Gaps = 40/282 (14%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLD-RVFQDGERE-FKNEVFVIGQTHHKNLVR 582
           E +G+GSFG V K  ++ ++    +  K++D     + E++   +EV ++ +  H N+VR
Sbjct: 6   ETIGKGSFGTVRK--VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVR 63

Query: 583 LLG-FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPN---------WNLRTNIAFQIARGL 631
                 D     L +V E+   G LA  +    K           W     I  Q+   L
Sbjct: 64  YYDRIIDRSNQTLYIVMEYCEGGDLAQLI-QKCKKERKYIEEEFIWR----ILTQLLLAL 118

Query: 632 LYLH--EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGY 689
              H   D    ++H D+KP NI LD     ++ DFGLAK+L  + S   KT + GT  Y
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFA-KTYV-GTPYY 176

Query: 690 VAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNV 749
           ++PE   +     K D++S G L+ E+ +    F          L        + GK   
Sbjct: 177 MSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFT---ARNQLQLASKI----KEGKFRR 229

Query: 750 LVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM 791
           +       +N        V+ S   +  DP  RP+ +++LQ+
Sbjct: 230 IPYRYSSELN-------EVIKS--MLNVDPDKRPSTEELLQL 262

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 97.3 bits (242), Expect = 2e-22
 Identities = 76/278 (27%), Positives = 124/278 (44%), Gaps = 46/278 (16%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLL 584
           E +G G FG V +G  +      AV   K D   Q     F  E  V+ + HHKNLVRLL
Sbjct: 12  EIIGEGEFGAVLQG--EYTGQKVAVKNIKCDVTAQ----AFLEETAVMTKLHHKNLVRLL 65

Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLF--GNLKPNWNLRTNIAFQIARGLLYLHEDCRAQI 642
           G         +V E ++ G L +FL   G    +       +  +A G+ YL      ++
Sbjct: 66  GVILH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KL 121

Query: 643 IHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITA 702
           +H D+  +NIL+ +   A++SDFGLA++     S  +  +    K + APE  ++ K ++
Sbjct: 122 VHRDLAARNILVSEDGVAKVSDFGLARV----GSMGVDNSKLPVK-WTAPEALKHKKFSS 176

Query: 703 KVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMND-- 760
           K DV+S+GVLL E+ S  ++        Y  ++               + E KE +    
Sbjct: 177 KSDVWSYGVLLWEVFSYGRA-------PYPKMS---------------LKEVKECVEKGY 214

Query: 761 -----IECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
                  C   + ++   C + +P  RP+  K+ + LE
Sbjct: 215 RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 97.2 bits (243), Expect = 2e-22
 Identities = 67/202 (33%), Positives = 96/202 (47%), Gaps = 24/202 (11%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLD--RVFQDGEREF-KNEVFVIGQTHHKNLVRL 583
           +G+GSFG V   V +  T     A+K L   ++ +  E E    E  ++ + +H  +V+L
Sbjct: 1   LGKGSFGKVLL-VRKKDTGKL-YAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL 58

Query: 584 L-GFCDEGQNRL-LVYEFLNNGTLASFL--FGNLKPNWNLRTNIAF---QIARGLLYLHE 636
              F  E   +L LV E+   G L S L   G             F   +I   L YLH 
Sbjct: 59  HYAFQTE--EKLYLVLEYAPGGELFSHLSKEGRFSEER-----ARFYAAEIVLALEYLH- 110

Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR 696
                II+ D+KP+NILLD     +++DFGLAK L+   S+T      GT  Y+APE   
Sbjct: 111 --SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRT--NTFCGTPEYLAPEVLL 166

Query: 697 NSKITAKVDVYSFGVLLLEIIS 718
                  VD +S GVLL E+++
Sbjct: 167 GKGYGKAVDWWSLGVLLYEMLT 188

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 97.0 bits (242), Expect = 2e-22
 Identities = 66/213 (30%), Positives = 96/213 (45%), Gaps = 33/213 (15%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVK---KLDRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G+G+FG V   ++Q R +    A+K   K   V +   R   NE  ++ + +H  LV L
Sbjct: 8   IGKGAFGKVC--IVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65

Query: 584 -LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQ----------IARGLL 632
              F DE +N  LV + L  G L           ++L   + F           I   L 
Sbjct: 66  WYSFQDE-ENMYLVVDLLLGGDL----------RYHLSQKVKFSEEQVKFWICEIVLALE 114

Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 692
           YLH      IIH DIKP NILLD+     I+DF +A  +T   + T  T+  GT GY+AP
Sbjct: 115 YLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVT-PDTLTTSTS--GTPGYMAP 168

Query: 693 EWFRNSKITAKVDVYSFGVLLLEIISCRKSFDI 725
           E       +  VD +S GV   E +  ++ +  
Sbjct: 169 EVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRG 201

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 96.5 bits (240), Expect = 4e-22
 Identities = 77/274 (28%), Positives = 128/274 (46%), Gaps = 30/274 (10%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVR 582
           F +E+G G FG+V+ G  +   +   VA+K +       E +F  E  V+ +  H  LV+
Sbjct: 8   FMKELGSGQFGVVHLGKWR---AQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQ 63

Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFL---FGNLKPNWNLRTNIAFQIARGLLYLHEDCR 639
           L G C + +   +V EF+ NG L ++L    G L  +  L  ++   +  G+ YL    R
Sbjct: 64  LYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLL--SMCQDVCEGMEYLE---R 118

Query: 640 AQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSK 699
              IH D+  +N L+      ++SDFG+ + + L+   T  +  +    +  PE F  SK
Sbjct: 119 NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYV-LDDEYTSSSGAKFPVKWSPPEVFNFSK 177

Query: 700 ITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAM 758
            ++K DV+SFGVL+ E+ +  +  F+ +   E   +    F  YR    ++ V E     
Sbjct: 178 YSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYE----- 232

Query: 759 NDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQML 792
                    VM S W   E P  RPT  ++L+ +
Sbjct: 233 ---------VMYSCW--HEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 96.4 bits (241), Expect = 7e-22
 Identities = 64/205 (31%), Positives = 106/205 (51%), Gaps = 26/205 (12%)

Query: 524 KEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE-------REFKNEVFVIGQTH 576
            E++G G++G+VYK     +T    VA+KK+ R+  + E       RE    + ++ +  
Sbjct: 4   LEKLGEGTYGVVYKA-RDKKTGEI-VALKKI-RLDNEEEGIPSTALRE----ISLLKELK 56

Query: 577 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL---FGNLKPNWNLRTNIAFQIARGLLY 633
           H N+V+LL      +   LV+E+ +   L  +L    G L PN  +++ I +Q+ RGL Y
Sbjct: 57  HPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNL-IKS-IMYQLLRGLAY 113

Query: 634 LHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE 693
            H     +I+H D+KPQNIL++     +++DFGLA+   +         +  T  Y APE
Sbjct: 114 CH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV--TLWYRAPE 168

Query: 694 WFRNSKI-TAKVDVYSFGVLLLEII 717
               SK  +  VD++S G +  E+I
Sbjct: 169 ILLGSKHYSTAVDIWSVGCIFAEMI 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 95.8 bits (238), Expect = 7e-22
 Identities = 74/290 (25%), Positives = 138/290 (47%), Gaps = 54/290 (18%)

Query: 527 VGRGSFGIVYKGVIQTR-TSTTAVAVKKLDRVFQDGER-EFKNEVFVIGQTHHKNLVRLL 584
           +G G FG V++G+++       AVA+K L   + + +R +F +E  ++GQ  H N++RL 
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72

Query: 585 GFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPNWNLRTNIAFQIARGLLYLHEDC 638
           G   + +  +++ E++ NG L  +L      F + +    LR      IA G+ YL +  
Sbjct: 73  GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRG-----IAAGMKYLSD-- 125

Query: 639 RAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTA-----IRGTKGYVAPE 693
               +H D+  +NIL++     ++SDFGL+++L  +   T  T+     IR T    APE
Sbjct: 126 -MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWT----APE 180

Query: 694 WFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGE 753
                K T+  DV+SFG+++ E++S  +    +M                         E
Sbjct: 181 AIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH----------------------E 218

Query: 754 DKEAMND-------IECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 796
             +A+ND       ++C   +  + + C Q+D + RP    ++ +L+ ++
Sbjct: 219 VMKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 95.9 bits (239), Expect = 1e-21
 Identities = 81/298 (27%), Positives = 131/298 (43%), Gaps = 53/298 (17%)

Query: 527 VGRGSFGIVYKGV---IQTRTSTTAVAVKKL--DRVFQDGEREFKN-----EVF-VIGQT 575
           +G G+FG V K     +     T+ VAVK L  D      E++  +     E+  +IG+ 
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT----EKDLSDLVSEMEMMKMIGK- 74

Query: 576 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNI------------ 623
            HKN++ LLG C +     +V E+  +G L  FL     P      +             
Sbjct: 75  -HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKD 133

Query: 624 ----AFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI 679
               A+Q+ARG+ +L      + IH D+  +N+L+ + +  +I+DFGLA+ +        
Sbjct: 134 LVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRK 190

Query: 680 KTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWA 738
            T  R    ++APE   +   T + DV+SFGVLL EI +         G  Y  I  +  
Sbjct: 191 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLG-------GSPYPGIPVEEL 243

Query: 739 FDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 796
           F   + G        +K       C  +L  +   C  E PS RPT K++++ L+ ++
Sbjct: 244 FKLLKEGYR-----MEKPQ----NCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 94.8 bits (236), Expect = 1e-21
 Identities = 77/274 (28%), Positives = 130/274 (47%), Gaps = 33/274 (12%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE---REFKNEVFVIGQTHHKNLV 581
           E +G GSFG VY+G+        AV    L    Q G+   ++ + E+ ++ +  H N+V
Sbjct: 6   ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65

Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLK-PNWNLRTNIAFQIARGLLYLHEDC 638
           + LG   E  N  +  E +  G+LA  L  +G+   P   L T    QI  GL YLH+  
Sbjct: 66  QYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR---QILLGLEYLHDR- 121

Query: 639 RAQIIHCDIKPQNILLDDYYTARISDFGLAK-LLTLNQSKTIKTAIRGTKGYVAPEWF-R 696
               +H DIK  NIL+D     +++DFG+AK ++  + +K+ K    G+  ++APE   +
Sbjct: 122 --NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFK----GSPYWMAPEVIAQ 175

Query: 697 NSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKE 756
                   D++S G  +LE+ + +  +     E  A +       ++ G+      E   
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGKPPWSQL--EGVAAV-------FKIGR----SKELPP 222

Query: 757 AMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
             + +    K  ++   C+Q DPSLRPT  ++L+
Sbjct: 223 IPDHLSDEAKDFILK--CLQRDPSLRPTAAELLE 254

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 94.5 bits (235), Expect = 2e-21
 Identities = 61/205 (29%), Positives = 106/205 (51%), Gaps = 13/205 (6%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKL--DRVFQDGEREFKNEVFVIGQTHHKNLVRLL 584
           VGRG+FGIV+  + + +     V +K++  +++ +D     +NE  V+    H N++   
Sbjct: 8   VGRGAFGIVH--LCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYY 65

Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF--QIARGLLYLHEDCRAQI 642
               E +  ++V E+   GTLA ++        +  T + F  QI   LL LH      I
Sbjct: 66  ENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQI---LLALHHVHTKLI 122

Query: 643 IHCDIKPQNILLDDYYTA-RISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKIT 701
           +H D+K QNILLD +    +I DFG++K+L+   SK+    + GT  Y++PE        
Sbjct: 123 LHRDLKTQNILLDKHKMVVKIGDFGISKILS---SKSKAYTVVGTPCYISPELCEGKPYN 179

Query: 702 AKVDVYSFGVLLLEIISCRKSFDIE 726
            K D+++ G +L E+ S +++F+  
Sbjct: 180 QKSDIWALGCVLYELASLKRAFEAA 204

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 94.5 bits (235), Expect = 2e-21
 Identities = 64/200 (32%), Positives = 109/200 (54%), Gaps = 13/200 (6%)

Query: 527 VGRGSFGIVYKG-VIQTRTSTTAVAVKKLDRVFQDGERE-FKNEVFVIGQTHHKNLVRLL 584
           +G+G FG VY G +I +       AVK L+R+    E E F  E  ++    H N++ LL
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 585 GFC--DEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF--QIARGLLYLHEDCRA 640
           G C   EG   L+V  ++ +G L +F+  +   N  ++  I F  Q+A+G+ YL      
Sbjct: 63  GICLPSEGSP-LVVLPYMKHGDLRNFI-RSETHNPTVKDLIGFGLQVAKGMEYLASK--- 117

Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI--KTAIRGTKGYVAPEWFRNS 698
           + +H D+  +N +LD+ +T +++DFGLA+ +   +  ++   T  +    ++A E  +  
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQ 177

Query: 699 KITAKVDVYSFGVLLLEIIS 718
           K T K DV+SFGVLL E+++
Sbjct: 178 KFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 94.7 bits (235), Expect = 2e-21
 Identities = 75/287 (26%), Positives = 136/287 (47%), Gaps = 42/287 (14%)

Query: 526 EVGRGSFGIVYKGV---IQTRTSTTAVAVKKLDRVFQDGER-EFKNEVFVIGQTHHKNLV 581
           E+G+GSFG+VY+G+   +      T VA+K ++      ER EF NE  V+ + +  ++V
Sbjct: 13  ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72

Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLF----------GNLKPNWNLRTNIAFQIARGL 631
           RLLG   +GQ  L++ E +  G L S+L               P+      +A +IA G+
Sbjct: 73  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132

Query: 632 LYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKG--- 688
            YL+ +   + +H D+  +N ++ + +T +I DFG+ +   + ++   +   +G KG   
Sbjct: 133 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYR---KGGKGLLP 184

Query: 689 --YVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 746
             +++PE  ++   T   DV+SFGV+L EI               A L +  +    N +
Sbjct: 185 VRWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------ATLAEQPYQGMSNEQ 229

Query: 747 LNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
           +   V E         C   L  +   C Q +P +RP+  +++  ++
Sbjct: 230 VLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 94.2 bits (234), Expect = 3e-21
 Identities = 78/285 (27%), Positives = 136/285 (47%), Gaps = 36/285 (12%)

Query: 524 KEEVGRGSFGIVYKGVI-QTRTSTTAVAVKKLDRVFQDGER-EFKNEVFVIGQTHHKNLV 581
           +E +G G FG V +G +         VA+K L   + + +R +F +E  ++GQ  H N++
Sbjct: 9   EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPNWNLRTNIAFQIARGLLYLH 635
            L G   + +  +++ EF+ NG L SFL      F  ++    LR      IA G+ YL 
Sbjct: 69  HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRG-----IAAGMKYLS 123

Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVAP 692
           E      +H D+  +NIL++     ++SDFGL++ L  + S    T+  G K    + AP
Sbjct: 124 E---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180

Query: 693 EWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLNVLV 751
           E     K T+  DV+S+G+++ E++S         GE  Y     W  D      +N  +
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMS--------YGERPY-----W--DMSNQDVINA-I 224

Query: 752 GEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 796
            +D      ++C   L  + + C Q+D + RP   +++  L+ ++
Sbjct: 225 EQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 93.7 bits (233), Expect = 3e-21
 Identities = 69/227 (30%), Positives = 110/227 (48%), Gaps = 18/227 (7%)

Query: 515 ELEGATNNFKEEV--GRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVI 572
           E E   +   E V  G+G++GIVY    +  ++   +A+K++        +    E+ + 
Sbjct: 2   EYEYEYDENGERVVLGKGTYGIVYAA--RDLSTQVRIAIKEIPERDSRYVQPLHEEIALH 59

Query: 573 GQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL---FGNLKPNWNLRTNIAFQIAR 629
               H+N+V+ LG   E     +  E +  G+L++ L   +G LK N         QI  
Sbjct: 60  SYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILE 119

Query: 630 GLLYLHEDCRAQIIHCDIKPQNILLDDYY-TARISDFGLAKLLT-LNQSKTIKTAIRGTK 687
           GL YLH++   QI+H DIK  N+L++ Y    +ISDFG +K L  +N      T   GT 
Sbjct: 120 GLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT---GTL 173

Query: 688 GYVAPEWFRNSK--ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA 732
            Y+APE          A  D++S G  ++E+ + +  F IE+GE  A
Sbjct: 174 QYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF-IELGEPQA 219

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 93.3 bits (232), Expect = 4e-21
 Identities = 60/209 (28%), Positives = 97/209 (46%), Gaps = 15/209 (7%)

Query: 524 KEEVGRGSFGIVYKGVIQTRTSTTA---VAVKKLDRVFQDGEREFKNEVFVIGQTHHKNL 580
             ++G+GSFG+V+K V +      A   + + K++R  ++   E  +E  V+ +     +
Sbjct: 5   LNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRRERE---EAIDEARVLAKLDSSYI 61

Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFL---FGNLKPNWNLRTNIAFQIARGLLYLHED 637
           +R      +     +V E+  NG L   L    G   P  +       QI  GL +LH  
Sbjct: 62  IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPE-DQVWRFFIQILLGLAHLHSK 120

Query: 638 CRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRN 697
              +I+H DIK  N+ LD Y   +I D G+AKL  L+ +      I GT  Y++PE   +
Sbjct: 121 ---KILHRDIKSLNLFLDAYDNVKIGDLGVAKL--LSDNTNFANTIVGTPYYLSPELCED 175

Query: 698 SKITAKVDVYSFGVLLLEIISCRKSFDIE 726
                K DV++ GV+L E  + +  FD  
Sbjct: 176 KPYNEKSDVWALGVVLYECCTGKHPFDAN 204

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 93.4 bits (233), Expect = 7e-21
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 30/212 (14%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE-----REFKNEVFVIGQTHHKN 579
           +++G G+FG VY    + + +   VA+KK+ + F   E     RE K    +     H N
Sbjct: 5   KQLGDGTFGSVYLA--RNKETGELVAIKKMKKKFYSWEECMNLREVK---SLRKLNEHPN 59

Query: 580 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLF-------GNLKPNWNLRTNIAFQIARGLL 632
           +V+L     E      V+E++        L+       G       +R +I +QI +GL 
Sbjct: 60  IVKLKEVFRENDELYFVFEYMEGN-----LYQLMKDRKGKPFSESVIR-SIIYQILQGLA 113

Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 692
           ++H   +    H D+KP+N+L+      +I+DFGLA+ +   +S+   T    T+ Y AP
Sbjct: 114 HIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREI---RSRPPYTDYVSTRWYRAP 167

Query: 693 EWF-RNSKITAKVDVYSFGVLLLEIISCRKSF 723
           E   R++  ++ VD+++ G ++ E+ + R  F
Sbjct: 168 EILLRSTSYSSPVDIWALGCIMAELYTLRPLF 199

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 92.3 bits (229), Expect = 9e-21
 Identities = 63/198 (31%), Positives = 103/198 (52%), Gaps = 11/198 (5%)

Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGER-EFKNEVFVIGQTHHKNLVRLL 584
           E+G G+FG V KGV + R     VA+K L    +   R E   E  ++ Q  +  +VR++
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA---FQIARGLLYLHEDCRAQ 641
           G C E +  +LV E  + G L  FL G  K +    +N+     Q++ G+ YL       
Sbjct: 62  GVC-EAEALMLVMEMASGGPLNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEG---KN 115

Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS-KTIKTAIRGTKGYVAPEWFRNSKI 700
            +H D+  +N+LL + + A+ISDFGL+K L  + S    ++A +    + APE     K 
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKF 175

Query: 701 TAKVDVYSFGVLLLEIIS 718
           +++ DV+S+G+ + E  S
Sbjct: 176 SSRSDVWSYGITMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 92.2 bits (229), Expect = 9e-21
 Identities = 66/199 (33%), Positives = 101/199 (50%), Gaps = 17/199 (8%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLL 584
           +++G G FG V+ G        T VA+K L +     E  F  E  ++ Q  H  LVRL 
Sbjct: 12  KKLGAGQFGEVWMGYYN---GHTKVAIKSLKQGSMSPE-AFLAEANLMKQLQHPRLVRLY 67

Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQI 642
               + +   ++ E++ NG+L  FL     +K   N   ++A QIA G+ ++    R   
Sbjct: 68  AVVTQ-EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNY 123

Query: 643 IHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVAPEWFRNSK 699
           IH D++  NIL+ +    +I+DFGLA+L+  N+     TA  G K    + APE      
Sbjct: 124 IHRDLRAANILVSETLCCKIADFGLARLIEDNEY----TAREGAKFPIKWTAPEAINYGT 179

Query: 700 ITAKVDVYSFGVLLLEIIS 718
            T K DV+SFG+LL EI++
Sbjct: 180 FTIKSDVWSFGILLTEIVT 198

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 92.1 bits (229), Expect = 1e-20
 Identities = 65/273 (23%), Positives = 119/273 (43%), Gaps = 33/273 (12%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKK---LDRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G+G+FG      +  RT   ++ V K   L R+ +   R+  NE+ ++    H N++  
Sbjct: 8   LGKGAFGE---ATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAY 64

Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA--FQIARGLLYLHEDCRAQ 641
                +    L+  E+ N GTL   +       +     +   FQI   + Y+H+   A 
Sbjct: 65  YNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK---AG 121

Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKIT 701
           I+H DIK  NI L      ++ DFG++K+L      ++   + GT  Y++PE  +  K  
Sbjct: 122 ILHRDIKTLNIFLTKAGLIKLGDFGISKIL--GSEYSMAETVVGTPYYMSPELCQGVKYN 179

Query: 702 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVG--EDKEAMN 759
            K D+++ G +L E+++ +++FD                      LN++V   +      
Sbjct: 180 FKSDIWALGCVLYELLTLKRTFD------------------ATNPLNLVVKIVQGNYTPV 221

Query: 760 DIECLGKLVMVSIWCIQEDPSLRPTMKKVLQML 792
                 +L+ +    +Q+DP  RPT  +VL   
Sbjct: 222 VSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 92.2 bits (229), Expect = 1e-20
 Identities = 63/211 (29%), Positives = 110/211 (52%), Gaps = 20/211 (9%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE-------FKNEVFVIGQTHHKN 579
           +G GSFG VY G+  +     AV   +L  V    +            E+ ++ +  H+N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 580 LVRLLGFCDEGQNRLLVY-EFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLHE 636
           +V+ LG      + L ++ E++  G++A+ L  +G  +    L  N   QI +GL YLH 
Sbjct: 68  IVQYLG-SSLDADHLNIFLEYVPGGSVAALLNNYGAFEET--LVRNFVRQILKGLNYLHN 124

Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN----QSKTIKTAIRGTKGYVAP 692
                IIH DIK  NIL+D+    +ISDFG++K L  N    ++   + +++G+  ++AP
Sbjct: 125 ---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181

Query: 693 EWFRNSKITAKVDVYSFGVLLLEIISCRKSF 723
           E  + +  T K D++S G L++E+++ +  F
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGKHPF 212

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 92.8 bits (230), Expect = 1e-20
 Identities = 72/229 (31%), Positives = 113/229 (49%), Gaps = 34/229 (14%)

Query: 513 YKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKL-DRVFQDGEREFKNEVFV 571
           Y  LE     F++ +G G+FG V K  I+        A+K++ +   +D  R+F  E+ V
Sbjct: 1   YPVLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV 60

Query: 572 IGQT-HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIA-- 628
           + +  HH N++ LLG C+      L  E+  +G L  FL    + +  L T+ AF IA  
Sbjct: 61  LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL----RKSRVLETDPAFAIANS 116

Query: 629 ------------------RGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKL 670
                             RG+ YL +    Q IH D+  +NIL+ + Y A+I+DFGL++ 
Sbjct: 117 TASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRG 173

Query: 671 LTLNQSKTI-KTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS 718
             +   KT+ +  +R    ++A E    S  T   DV+S+GVLL EI+S
Sbjct: 174 QEVYVKKTMGRLPVR----WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 91.9 bits (228), Expect = 2e-20
 Identities = 73/268 (27%), Positives = 125/268 (46%), Gaps = 27/268 (10%)

Query: 527 VGRGSFGIVYKGVI--QTRTSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G G FG V+KG+   +  +    VA+K + DR  +   +E  + +  +G   H  +VRL
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74

Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           LG C  G +  LV +    G+L   +     +L P      N   QIA+G+ YL E    
Sbjct: 75  LGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQ--RLLNWCVQIAKGMYYLEEHR-- 129

Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            ++H ++  +NILL      +I+DFG+A LL  +  K   +  +    ++A E     + 
Sbjct: 130 -MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRY 188

Query: 701 TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMND 760
           T + DV+S+GV + E++S          E YA +        R  ++  L+ + +     
Sbjct: 189 THQSDVWSYGVTVWEMMSYG-------AEPYAGM--------RPHEVPDLLEKGERLAQP 233

Query: 761 IECLGKLVMVSIWCIQEDPSLRPTMKKV 788
             C   + MV + C   D ++RPT K++
Sbjct: 234 QICTIDVYMVMVKCWMIDENVRPTFKEL 261

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 91.4 bits (227), Expect = 3e-20
 Identities = 61/219 (27%), Positives = 102/219 (46%), Gaps = 31/219 (14%)

Query: 523 FKEEVGRGSFGIVYKG---VIQTRTSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQTHHK 578
            K E+G G+FG V+ G    ++       VAVK L +    D  ++F+ E  ++    H+
Sbjct: 9   LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68

Query: 579 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN---------------I 623
           N+V+  G C EG   ++V+E++ +G L  FL  +  P+     +               I
Sbjct: 69  NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSH-GPDAAFLKSPDSPMGELTLSQLLQI 127

Query: 624 AFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTA- 682
           A QIA G++YL        +H D+  +N L+      +I DFG+++ +       +    
Sbjct: 128 AVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHT 184

Query: 683 ---IRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS 718
              IR    ++ PE     K T + DV+SFGV+L EI +
Sbjct: 185 MLPIR----WMPPESIMYRKFTTESDVWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 90.8 bits (225), Expect = 3e-20
 Identities = 82/287 (28%), Positives = 129/287 (44%), Gaps = 58/287 (20%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLL 584
           +++G G FG V+ G   T    T VAVK L       E  F  E  ++ +  H  LV+L 
Sbjct: 12  KKLGNGQFGEVWMG---TWNGNTKVAVKTLKPGTMSPE-SFLEEAQIMKKLRHDKLVQLY 67

Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFG----NLK-PNWNLRTNIAFQIARGLLYLHEDCR 639
               E +   +V E+++ G+L  FL       LK PN     ++A Q+A G+ Y+    R
Sbjct: 68  AVVSE-EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNL---VDMAAQVAAGMAYIE---R 120

Query: 640 AQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVAPEWFR 696
              IH D++  NIL+ D    +I+DFGLA+L+  N+     TA +G K    + APE   
Sbjct: 121 MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY----TARQGAKFPIKWTAPEAAL 176

Query: 697 NSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKE 756
             + T K DV+SFG+LL E+++                          G++      ++E
Sbjct: 177 YGRFTIKSDVWSFGILLTELVT-------------------------KGRVPYPGMNNRE 211

Query: 757 AMNDIE----------CLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
            +  +E          C   L  + + C ++DP  RPT + +   LE
Sbjct: 212 VLEQVERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLE 258

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 91.0 bits (226), Expect = 4e-20
 Identities = 79/288 (27%), Positives = 131/288 (45%), Gaps = 31/288 (10%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTA--VAVKKLDRVFQDGEREFKNEVFVIGQTHHKNL 580
           F +++G+G+FG V           T   VAVKKL     +  R+F+ E+ ++    H N+
Sbjct: 8   FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNI 67

Query: 581 VRLLGFC-DEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIAF--QIARGLLYLHE 636
           V+  G C   G+  L LV E+L  G+L  +L  + +   + R  + +  QI +G+ YL  
Sbjct: 68  VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLGS 126

Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS-KTIKTAIRGTKGYVAPEWF 695
               + +H D+  +NIL++     +I DFGL K+L  ++    ++        + APE  
Sbjct: 127 ---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESL 183

Query: 696 RNSKITAKVDVYSFGVLLLEIIS-CRKS------FDIEMGEE---YAILTDWAFDCYRNG 745
             SK +   DV+SFGV+L E+ +   KS      F   MG +     I+         NG
Sbjct: 184 TESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNG 243

Query: 746 KLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
           +L    G          C  ++  +   C   DPS RP+  ++   +E
Sbjct: 244 RLPAPPG----------CPAEIYAIMKECWNNDPSQRPSFSELALQVE 281

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 90.6 bits (225), Expect = 5e-20
 Identities = 83/289 (28%), Positives = 132/289 (45%), Gaps = 47/289 (16%)

Query: 527 VGRGSFGIVYKGVI-QTRTSTTAVAVK--KLDRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G G FG V +G + Q   S   VAVK  KLD        EF +E   +    H N+++L
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66

Query: 584 LGFCDEGQNR------LLVYEFLNNGTLASFLF----GNLKPNWNLRTNIAF--QIARGL 631
           +G C E  +       +++  F+ +G L SFL     G L     L+T + F   IA G+
Sbjct: 67  IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126

Query: 632 LYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLL----TLNQSKTIKTAIRGTK 687
            YL        IH D+  +N +L +  T  ++DFGL+K +       Q +  K  ++   
Sbjct: 127 EYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK--- 180

Query: 688 GYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDCYRNG 745
            ++A E   +   T+K DV++FGV + EI +  ++    +E  E Y  L        R+G
Sbjct: 181 -WIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYL--------RHG 231

Query: 746 -KLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
            +L              +CL +L  +   C + DP  RPT  K+ ++LE
Sbjct: 232 NRLK----------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLE 270

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 90.5 bits (224), Expect = 5e-20
 Identities = 66/198 (33%), Positives = 104/198 (52%), Gaps = 17/198 (8%)

Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLG 585
           ++G+G FG V+ G   T   TT VA+K L       E  F  E  V+ +  H+ LV+L  
Sbjct: 13  KLGQGCFGEVWMG---TWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYA 68

Query: 586 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR--TNIAFQIARGLLYLHEDCRAQII 643
              E +   +V E+++ G+L  FL G +     L    ++A QIA G+ Y+    R   +
Sbjct: 69  VVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 124

Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVAPEWFRNSKI 700
           H D++  NIL+ +    +++DFGLA+L+  N+     TA +G K    + APE     + 
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARLIEDNEY----TARQGAKFPIKWTAPEAALYGRF 180

Query: 701 TAKVDVYSFGVLLLEIIS 718
           T K DV+SFG+LL E+ +
Sbjct: 181 TIKSDVWSFGILLTELTT 198

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 90.9 bits (226), Expect = 5e-20
 Identities = 52/203 (25%), Positives = 100/203 (49%), Gaps = 12/203 (5%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKN--EVFVIGQTHHKNLVR 582
            ++G G++G+VYK   + + +   VA+KK+   F+          E+ ++ + +H N+++
Sbjct: 5   GKIGEGTYGVVYKA--RDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIK 62

Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR-TNIAFQIARGLLYLHEDCRAQ 641
           LL       +  LV+EF++   L   +    +        +  +Q+ +GL + H      
Sbjct: 63  LLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHG 118

Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI- 700
           I+H D+KP+N+L++     +++DFGLA+  +        T    T+ Y APE     K  
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLAR--SFGSPVRPYTHYVVTRWYRAPELLLGDKGY 176

Query: 701 TAKVDVYSFGVLLLEIISCRKSF 723
           +  VD++S G +  E++S R  F
Sbjct: 177 STPVDIWSVGCIFAELLSRRPLF 199

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 90.4 bits (224), Expect = 9e-20
 Identities = 63/220 (28%), Positives = 105/220 (47%), Gaps = 31/220 (14%)

Query: 527 VGRGSFGIVYKGV---IQTRTSTTAVAVKKLDRVFQDGE-REFKNEVFVIGQTHHKNLVR 582
           +G G FG V K     ++ R   T VAVK L       E R+  +E  ++ Q +H ++++
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP------------------------NWN 618
           L G C +    LL+ E+   G+L SFL  + K                            
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127

Query: 619 LRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT 678
              + A+QI+RG+ YL E    +++H D+  +N+L+ +    +ISDFGL++ +    S  
Sbjct: 128 DLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184

Query: 679 IKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS 718
            ++  R    ++A E   +   T + DV+SFGVLL EI++
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 89.3 bits (221), Expect = 9e-20
 Identities = 61/201 (30%), Positives = 98/201 (48%), Gaps = 17/201 (8%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           E +GRG+FG V+ G  + R   T VAVK   + +  D + +F  E  ++ Q  H N+VRL
Sbjct: 1   ERIGRGNFGEVFSG--RLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL 58

Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF--QIARGLLYLHEDCRAQ 641
           +G C + Q   +V E +  G   +FL     P   ++  I      A G+ YL       
Sbjct: 59  IGVCTQKQPIYIVMELVQGGDFLTFL-RTEGPRLKVKELIQMVENAAAGMEYLESKH--- 114

Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK----GYVAPEWFRN 697
            IH D+  +N L+ +    +ISDFG+++     +   +  +  G K     + APE    
Sbjct: 115 CIHRDLAARNCLVTEKNVLKISDFGMSR----EEEDGVYASTGGMKQIPVKWTAPEALNY 170

Query: 698 SKITAKVDVYSFGVLLLEIIS 718
            + +++ DV+SFG+LL E  S
Sbjct: 171 GRYSSESDVWSFGILLWEAFS 191

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 89.2 bits (221), Expect = 1e-19
 Identities = 63/203 (31%), Positives = 106/203 (52%), Gaps = 15/203 (7%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVR 582
           F +E+G G FG+V  G  + +     VA+K + +     E EF  E  V+ +  H+ LV+
Sbjct: 8   FLKELGTGQFGVVKYGKWRGQYD---VAIKMI-KEGSMSEDEFIEEAKVMMKLSHEKLVQ 63

Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK-PNWNLRTNIAFQIARGLLYLHEDCRAQ 641
           L G C + +   +V E+++NG L ++L  + K    +    +   +  G+ YL      Q
Sbjct: 64  LYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---Q 120

Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYV---APEWFRNS 698
            IH D+  +N L+DD    ++SDFGL++ +  ++     T+  G+K  V    PE    S
Sbjct: 121 FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY----TSSVGSKFPVRWSPPEVLLYS 176

Query: 699 KITAKVDVYSFGVLLLEIISCRK 721
           K ++K DV++FGVL+ E+ S  K
Sbjct: 177 KFSSKSDVWAFGVLMWEVYSLGK 199

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 89.0 bits (221), Expect = 1e-19
 Identities = 60/199 (30%), Positives = 91/199 (45%), Gaps = 9/199 (4%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTT-AVAVKKL-DRVFQDGEREFKNEVFVIGQTHHKNLVR 582
           +++G GSFG+V +G   T       VAVK L      D   +F  E  ++    H+NL+R
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60

Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHEDCRA 640
           L G        ++V E    G+L   L  +   ++ + T  + A QIA G+ YL      
Sbjct: 61  LYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES---K 116

Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK-GYVAPEWFRNSK 699
           + IH D+  +NILL      +I DFGL + L  N+   +          + APE  R   
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT 176

Query: 700 ITAKVDVYSFGVLLLEIIS 718
            +   DV+ FGV L E+ +
Sbjct: 177 FSHASDVWMFGVTLWEMFT 195

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 89.5 bits (222), Expect = 1e-19
 Identities = 68/203 (33%), Positives = 104/203 (51%), Gaps = 15/203 (7%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV---FQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G+G FG V     Q + +    A KKLD+     + GE+   NE  ++ +   + +V L
Sbjct: 1   LGKGGFGEVC--ACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL 58

Query: 584 LGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNI--AFQIARGLLYLHEDCRA 640
             +  E ++ L LV   +N G L   ++   +P +     I  A QI  GL +LH+    
Sbjct: 59  -AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR--- 114

Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
           +I++ D+KP+N+LLDD+   RISD GLA  + L   K IK    GT GY+APE  +    
Sbjct: 115 RIVYRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGRA-GTPGYMAPEVLQGEVY 171

Query: 701 TAKVDVYSFGVLLLEIISCRKSF 723
              VD ++ G  L E+I+ R  F
Sbjct: 172 DFSVDWFALGCTLYEMIAGRSPF 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin

 Score = 84.3 bits (209), Expect = 2e-19
 Identities = 45/113 (39%), Positives = 55/113 (48%), Gaps = 12/113 (10%)

Query: 80  EKTVVWYTDNKDQNPAVPRGSQVKLTADQGLVLNDPQGKQVWSSKIDI---GTVAVGHMN 136
            +TVVW   N+  NP       + L +D  LVL D  G+ VWSS       G VAV  + 
Sbjct: 1   NQTVVWVA-NRL-NPLTDSSYTLILQSDGNLVLYDGNGRVVWSSNTSGKGSGCVAV--LQ 56

Query: 137 DTGNFVLASSSSGRLWDSFSNPTDTLLLGQMMET-----EQGLFSRKSENNFS 184
           D GN VL  +S   LW SF +PTDTLL GQ          + L S KS  + S
Sbjct: 57  DDGNLVLYDNSGKVLWQSFDHPTDTLLPGQKDGNVVIGGSRRLTSWKSNTDPS 109

These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 88.1 bits (219), Expect = 2e-19
 Identities = 60/216 (27%), Positives = 93/216 (43%), Gaps = 32/216 (14%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVR 582
             + +G G++G VYK          A+ V KL+    D     + E+ ++ +  H N+V 
Sbjct: 7   LIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP--GDDFEIIQQEISMLKECRHPNIVA 64

Query: 583 LLGFCDEGQNRLLVYEFLNNGTLA---SFLFGNLKPNWNLRTNIAF---QIARGLLYLHE 636
             G         +V E+   G+L        G L         IA+   +  +GL YLHE
Sbjct: 65  YFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLS-----ELQIAYVCRETLKGLAYLHE 119

Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF- 695
                 IH DIK  NILL +    +++DFG++  LT   +K  K+ I GT  ++APE   
Sbjct: 120 ---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKR-KSFI-GTPYWMAPEVAA 174

Query: 696 --RNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGE 729
             R      K D+++ G      I+      IE+ E
Sbjct: 175 VERKGGYDGKCDIWALG------ITA-----IELAE 199

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 88.6 bits (220), Expect = 3e-19
 Identities = 76/284 (26%), Positives = 133/284 (46%), Gaps = 30/284 (10%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKK-LDRVFQDGEREFK-NEVFVIGQTHHKNLVRLL 584
           VG GS+G+V K   + + +   VA+KK L+       ++    E+ ++ Q  H+NLV L+
Sbjct: 9   VGEGSYGMVMK--CKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLI 66

Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPN---WNLRTNIAFQIARGLLYLHEDCRAQ 641
                 +   LV+EF+++  L         PN    +      FQI RG+ + H      
Sbjct: 67  EVFRRKKRLYLVFEFVDHTVLDDL---EKYPNGLDESRVRKYLFQILRGIEFCH---SHN 120

Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF-RNSKI 700
           IIH DIKP+NIL+      ++ DFG A+  TL     + T    T+ Y APE    ++K 
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFAR--TLAAPGEVYTDYVATRWYRAPELLVGDTKY 178

Query: 701 TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAILTDWAFDCYRNGKL----NVLVGED 754
              VD+++ G L+ E+++    F  D ++ + Y I+        R+ ++     +  G  
Sbjct: 179 GRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMR 238

Query: 755 KEAMNDIECLGKL------VMVSIW--CIQEDPSLRPTMKKVLQ 790
              + +IE L K       +++ +   C++ DP  RP+  ++L 
Sbjct: 239 LPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 88.0 bits (218), Expect = 3e-19
 Identities = 72/292 (24%), Positives = 139/292 (47%), Gaps = 36/292 (12%)

Query: 516 LEGATNNFKEEVGRGSFGIVYKGVIQTRTS-TTAVAVKKLDRVFQDGER-EFKNEVFVIG 573
           ++ +    ++ +G G FG V  G ++        VA+K L   + + +R +F +E  ++G
Sbjct: 1   IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMG 60

Query: 574 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPNWNLRTNIAFQI 627
           Q  H N++ L G   + +  ++V E++ NG+L +FL      F  ++    LR      I
Sbjct: 61  QFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRG-----I 115

Query: 628 ARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK 687
           A G+ YL +      +H D+  +NIL++     ++SDFGL+++L  +      T  RG K
Sbjct: 116 ASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTT--RGGK 170

Query: 688 ---GYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 744
               + APE     K T+  DV+S+G+++ E++S  +    EM  +  I           
Sbjct: 171 IPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKA--------- 221

Query: 745 GKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 796
                 + E       ++C   L  + + C Q+D + RP  ++++ +L+ ++
Sbjct: 222 ------IEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 88.3 bits (219), Expect = 3e-19
 Identities = 60/217 (27%), Positives = 111/217 (51%), Gaps = 33/217 (15%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKL----------DRVFQDGEREFKNEVFVIGQ 574
           E +G+G++G VY  +    T+   +AVK++          D   +D  +  ++E+  +  
Sbjct: 7   ELIGKGTYGRVYLAL--NVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKD 64

Query: 575 THHKNLVRLLGFCDEGQNRLLVY-EFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGL 631
             H N+V+ LGF +  +  L ++ E++  G++ S L  +G  +    L      Q+  GL
Sbjct: 65  LDHLNIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQ--LVRFFTEQVLEGL 121

Query: 632 LYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI-----KTAIRGT 686
            YLH      I+H D+K  N+L+D     +ISDFG++K     +S  I       +++G+
Sbjct: 122 AYLHSK---GILHRDLKADNLLVDADGICKISDFGISK-----KSDDIYDNDQNMSMQGS 173

Query: 687 KGYVAPEWFRNSK--ITAKVDVYSFGVLLLEIISCRK 721
             ++APE   +     +AKVD++S G ++LE+ + R+
Sbjct: 174 VFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 88.2 bits (218), Expect = 3e-19
 Identities = 75/270 (27%), Positives = 128/270 (47%), Gaps = 31/270 (11%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKN---EVFVIGQTHHKNLV 581
           E +G+GSFG V+KG I  RT    VA+K +D   ++ E E ++   E+ V+ Q     + 
Sbjct: 10  ERIGKGSFGEVFKG-IDNRTQQV-VAIKIID--LEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ 641
           +  G   +G    ++ E+L  G+    L       + + T +  +I +GL YLH + +  
Sbjct: 66  KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK-EILKGLDYLHSEKK-- 122

Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKIT 701
            IH DIK  N+LL +    +++DFG+A  LT  Q K  +    GT  ++APE  + S   
Sbjct: 123 -IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK--RNTFVGTPFWMAPEVIQQSAYD 179

Query: 702 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMND- 760
           +K D++S G+  +E+       + +M     +      +         L GE  +   + 
Sbjct: 180 SKADIWSLGITAIELAKGEPP-NSDMHPMRVLFLIPKNNP------PTLTGEFSKPFKEF 232

Query: 761 IECLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
           I+           C+ +DPS RPT K++L+
Sbjct: 233 IDA----------CLNKDPSFRPTAKELLK 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 87.4 bits (216), Expect = 6e-19
 Identities = 84/299 (28%), Positives = 133/299 (44%), Gaps = 48/299 (16%)

Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTA--VAVKKLDRVFQDGE-REFKNEVFV 571
           EL  +   F EE+G  +FG +YKG +       A  VA+K L  +    +  EF+ E  +
Sbjct: 1   ELPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASL 60

Query: 572 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF---------------GNLKPN 616
           + + HH N+V LLG   + Q   +++E+LN G L  FL                G +K +
Sbjct: 61  MAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSS 120

Query: 617 WNLRT--NIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN 674
            +     +IA QIA G+ YL        +H D+  +NIL+ +    +ISD GL++ +   
Sbjct: 121 LDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSA 177

Query: 675 -----QSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGE 729
                Q K++   IR    ++ PE     K ++  D++SFGV+L EI      F   +  
Sbjct: 178 DYYRVQPKSL-LPIR----WMPPEAIMYGKFSSDSDIWSFGVVLWEI------FSFGLQP 226

Query: 730 EYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKV 788
            Y        +  R  +L +   ED        C  ++  +   C QE PS RP  K +
Sbjct: 227 YYGFSNQEVIEMVRKRQL-LPCSED--------CPPRMYSLMTECWQEGPSRRPRFKDI 276

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 86.6 bits (214), Expect = 1e-18
 Identities = 61/195 (31%), Positives = 97/195 (49%), Gaps = 13/195 (6%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLL 584
           E +G+GSFG VYKG+        A+ +  L+   +D   + + E+ V+ Q     + R  
Sbjct: 10  ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYY 68

Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF---QIARGLLYLHEDCRAQ 641
           G   +G    ++ E+L  G+    L    KP     T IA    +I +GL YLH + +  
Sbjct: 69  GSYLKGTKLWIIMEYLGGGSALDLL----KPGPLEETYIATILREILKGLDYLHSERK-- 122

Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKIT 701
            IH DIK  N+LL +    +++DFG+A  LT  Q K  +    GT  ++APE  + S   
Sbjct: 123 -IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK--RNTFVGTPFWMAPEVIKQSAYD 179

Query: 702 AKVDVYSFGVLLLEI 716
            K D++S G+  +E+
Sbjct: 180 FKADIWSLGITAIEL 194

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 86.2 bits (213), Expect = 1e-18
 Identities = 64/195 (32%), Positives = 94/195 (48%), Gaps = 17/195 (8%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGF 586
           +G+G FG V  G    R +  AV   K D   Q     F  E  V+ Q  H NLV+LLG 
Sbjct: 14  IGKGEFGDVMLG--DYRGNKVAVKCIKNDATAQ----AFLAEASVMTQLRHSNLVQLLGV 67

Query: 587 CDEGQNRL-LVYEFLNNGTLASFLF--GNLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
             E +  L +V E++  G+L  +L   G      +     +  +   + YL  +     +
Sbjct: 68  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFV 124

Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK 703
           H D+  +N+L+ +   A++SDFGL K  +  Q  T K  ++ T    APE  R  K + K
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-TGKLPVKWT----APEALREKKFSTK 179

Query: 704 VDVYSFGVLLLEIIS 718
            DV+SFG+LL EI S
Sbjct: 180 SDVWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 85.8 bits (212), Expect = 2e-18
 Identities = 63/199 (31%), Positives = 98/199 (49%), Gaps = 16/199 (8%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLL 584
           +++G G FG V+ G      ++T VAVK L       +  F  E  ++    H  LVRL 
Sbjct: 12  KKLGAGQFGEVWMGYYN---NSTKVAVKTLKPGTMSVQ-AFLEEANLMKTLQHDKLVRLY 67

Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF--QIARGLLYLHEDCRAQI 642
               + +   ++ E++  G+L  FL  +      L   I F  QIA G+ Y+    R   
Sbjct: 68  AVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNY 124

Query: 643 IHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVAPEWFRNSK 699
           IH D++  N+L+ +    +I+DFGLA+++  N+     TA  G K    + APE      
Sbjct: 125 IHRDLRAANVLVSESLMCKIADFGLARVIEDNEY----TAREGAKFPIKWTAPEAINFGS 180

Query: 700 ITAKVDVYSFGVLLLEIIS 718
            T K DV+SFG+LL EI++
Sbjct: 181 FTIKSDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 85.9 bits (213), Expect = 2e-18
 Identities = 74/283 (26%), Positives = 122/283 (43%), Gaps = 37/283 (13%)

Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLD----RVFQDGEREFKNEVFVIGQTHH 577
              E +G G+  +VY  +         VA+K++D    +   D   E + EV  + Q +H
Sbjct: 4   ELIEVIGVGATAVVYAAICLPNNEK--VAIKRIDLEKCQTSVD---ELRKEVQAMSQCNH 58

Query: 578 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF---QIARGLLYL 634
            N+V+       G    LV  +L+ G+L   +  +          IA    ++ +GL YL
Sbjct: 59  PNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL 118

Query: 635 HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLL---TLNQSKTIKTAIRGTKGYVA 691
           H       IH DIK  NILL +  + +I+DFG++  L        K  KT + GT  ++A
Sbjct: 119 H---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFV-GTPCWMA 174

Query: 692 PEWFRNSK-ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILT-DWAFDCYRNGKLNV 749
           PE          K D++SFG+  +E+ +    +      +  +LT          G    
Sbjct: 175 PEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGA--- 231

Query: 750 LVGEDKEAMNDIECLGKLV--MVSIWCIQEDPSLRPTMKKVLQ 790
                     D +   K    M+S+ C+Q+DPS RPT +++L+
Sbjct: 232 ----------DYKKYSKSFRKMISL-CLQKDPSKRPTAEELLK 263

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 90.3 bits (224), Expect = 2e-18
 Identities = 55/185 (29%), Positives = 84/185 (45%), Gaps = 25/185 (13%)

Query: 548 AVAVKKLDRVFQDGERE---FKNEVFVIGQTHHKNLVRLLGFCDEGQ---NRLL-VYEFL 600
            VA+K L     + E +   F+ E  +  + +H N+V LL   D G+     L  V+E++
Sbjct: 5   EVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALL---DSGEAPPGLLFAVFEYV 61

Query: 601 NNGTLASFLF--GNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILL---D 655
              TL   L   G L      R  +  Q+   L   H      I+H D+KPQNI++    
Sbjct: 62  PGRTLREVLAADGALPAGETGR--LMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTG 116

Query: 656 DYYTARISDFGLAKLL-----TLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFG 710
               A++ DFG+  LL         + T  T + GT  Y APE  R   +T   D+Y++G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176

Query: 711 VLLLE 715
           ++ LE
Sbjct: 177 LIFLE 181

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 85.4 bits (212), Expect = 2e-18
 Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 22/205 (10%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAV----AVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVR 582
           + +G++G V+   +  + ST  +     +KK D + ++   +   E  ++ Q     +V+
Sbjct: 1   ISKGAYGRVF---LAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVK 57

Query: 583 LL-GFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLHEDCR 639
           L   F  + +N  LV E+L  G LAS L   G+L  +         +I   L YLH    
Sbjct: 58  LYYSFQGK-KNLYLVMEYLPGGDLASLLENVGSLDEDV--ARIYIAEIVLALEYLH---S 111

Query: 640 AQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI------KTAIRGTKGYVAPE 693
             IIH D+KP NIL+D     +++DFGL+K+  + +   +         I GT  Y+APE
Sbjct: 112 NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE 171

Query: 694 WFRNSKITAKVDVYSFGVLLLEIIS 718
                  +  VD +S G +L E + 
Sbjct: 172 VILGQGHSKTVDWWSLGCILYEFLV 196

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 85.8 bits (213), Expect = 2e-18
 Identities = 55/213 (25%), Positives = 94/213 (44%), Gaps = 31/213 (14%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKN----EVFVIGQTHHKNL 580
             VG G++G+V K   + + +   VA+KK      + + + K     EV V+ Q  H+N+
Sbjct: 7   GVVGEGAYGVVLK--CRNKATGEIVAIKKFKES--EDDEDVKKTALREVKVLRQLRHENI 62

Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPN---WNLRTNIAFQIARGLLYLHED 637
           V L           LV+E++   TL   L     P     +   +  +Q+ + + Y H  
Sbjct: 63  VNLKEAFRRKGRLYLVFEYVER-TLLELL--EASPGGLPPDAVRSYIWQLLQAIAYCH-- 117

Query: 638 CRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR- 696
               IIH DIKP+NIL+ +    ++ DFG A+ L    +  +         YVA  W+R 
Sbjct: 118 -SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD-------YVATRWYRA 169

Query: 697 ------NSKITAKVDVYSFGVLLLEIISCRKSF 723
                 ++     VDV++ G ++ E++     F
Sbjct: 170 PELLVGDTNYGKPVDVWAIGCIMAELLDGEPLF 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 86.3 bits (213), Expect = 2e-18
 Identities = 62/197 (31%), Positives = 104/197 (52%), Gaps = 10/197 (5%)

Query: 527 VGRGSFGIVYKG--VIQTRTSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRL 583
           +G G+FG VYKG  V +  T    VA+K L+         EF +E  ++    H +LVRL
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74

Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNW--NLRTNIAFQIARGLLYLHEDCRAQ 641
           LG C     +L V + + +G L  ++  + K N    L  N   QIA+G++YL E    +
Sbjct: 75  LGVCLSPTIQL-VTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEE---RR 129

Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKIT 701
           ++H D+  +N+L+      +I+DFGLA+LL  ++ +      +    ++A E     K T
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFT 189

Query: 702 AKVDVYSFGVLLLEIIS 718
            + DV+S+GV + E+++
Sbjct: 190 HQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 85.4 bits (211), Expect = 3e-18
 Identities = 70/284 (24%), Positives = 117/284 (41%), Gaps = 36/284 (12%)

Query: 523 FKEEVGRGSFGIVYKGV---IQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKN 579
            K E+G G+FG V+      +        VAVK L    +   ++F+ E  ++    H++
Sbjct: 9   LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQH 68

Query: 580 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLF-----------GNLKPNWNLR----TNIA 624
           +VR  G C EG+  L+V+E++ +G L  FL            G       L       IA
Sbjct: 69  IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128

Query: 625 FQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIR 684
            QIA G++YL        +H D+  +N L+      +I DFG+++ +       +     
Sbjct: 129 SQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 185

Query: 685 GTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 744
               ++ PE     K T + D++SFGV+L EI +  K         Y +    A +C   
Sbjct: 186 LPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQ------PWYQLSNTEAIECITQ 239

Query: 745 GKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKV 788
           G         +E      C  ++  +   C Q +P  R  +K +
Sbjct: 240 G---------RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDI 274

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 85.1 bits (211), Expect = 4e-18
 Identities = 73/273 (26%), Positives = 125/273 (45%), Gaps = 30/273 (10%)

Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKN---EVFVIGQTHHKNLVR 582
           E+G G+ G+V K  +  R +   +AVK + R+  + E   K    E+ ++ + +   +V 
Sbjct: 8   ELGAGNSGVVSK--VLHRPTGKIMAVKTI-RLEIN-EAIQKQILRELDILHKCNSPYIVG 63

Query: 583 LLG-FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHEDCR 639
             G F + G   + + E+++ G+L   L          R    IA  + +GL YLHE   
Sbjct: 64  FYGAFYNNGDISICM-EYMDGGSLDKILKEVQGR-IPERILGKIAVAVLKGLTYLHEK-- 119

Query: 640 AQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSK 699
            +IIH D+KP NIL++     ++ DFG++  L  + +KT      GT  Y+APE  + + 
Sbjct: 120 HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV----GTSSYMAPERIQGND 175

Query: 700 ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVL-VGEDKEAM 758
            + K D++S G+ L+E+ + R  +  E      I          N     L  G+     
Sbjct: 176 YSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFE--LLQYIVNEPPPRLPSGKFSPDF 233

Query: 759 NDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM 791
            D   L         C+ +DP  RP+ K++L+ 
Sbjct: 234 QDFVNL---------CLIKDPRERPSYKELLEH 257

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 85.0 bits (210), Expect = 4e-18
 Identities = 61/204 (29%), Positives = 102/204 (50%), Gaps = 20/204 (9%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKK--LDRVFQDG-EREFKN---EVFVIGQTHHK 578
           E +G+G++G VY G+         +AVK+  LD       E+E++    EV ++    H 
Sbjct: 6   EVLGKGAYGTVYCGLTNQ---GQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHV 62

Query: 579 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLHE 636
           N+V+ LG C +     +  EF+  G+++S L  FG L P          QI  G+ YLH 
Sbjct: 63  NIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPL-PEPVFCKYTK-QILDGVAYLHN 120

Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLL---TLNQSKT-IKTAIRGTKGYVAP 692
           +C   ++H DIK  N++L      ++ DFG A+ L    L+ + + +  ++ GT  ++AP
Sbjct: 121 NC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177

Query: 693 EWFRNSKITAKVDVYSFGVLLLEI 716
           E    S    K D++S G  + E+
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEM 201

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 84.3 bits (208), Expect = 4e-18
 Identities = 63/204 (30%), Positives = 105/204 (51%), Gaps = 25/204 (12%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           E +G+G+FG V+KG ++ +T    VAVK   + + Q+ + +F +E  ++ Q  H N+V+L
Sbjct: 1   ELLGKGNFGEVFKGTLKDKTP---VAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKL 57

Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN----IAFQIARGLLYLH-EDC 638
           +G C + Q   +V E +  G   SFL    K    L+T      A   A G+ YL  ++C
Sbjct: 58  IGVCTQRQPIYIVMELVPGGDFLSFL---RKKKDELKTKQLVKFALDAAAGMAYLESKNC 114

Query: 639 RAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK----GYVAPEW 694
               IH D+  +N L+ +    +ISDFG+++     Q      +  G K     + APE 
Sbjct: 115 ----IHRDLAARNCLVGENNVLKISDFGMSR-----QEDDGIYSSSGLKQIPIKWTAPEA 165

Query: 695 FRNSKITAKVDVYSFGVLLLEIIS 718
               + +++ DV+S+G+LL E  S
Sbjct: 166 LNYGRYSSESDVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 84.9 bits (211), Expect = 5e-18
 Identities = 59/199 (29%), Positives = 93/199 (46%), Gaps = 13/199 (6%)

Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDR---VFQDGEREFKNEVFVIGQTHHK 578
            F + +G GSFG V   +++ + S    A+K L +   V         NE  ++    H 
Sbjct: 4   EFIKTLGTGSFGRVM--LVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHP 61

Query: 579 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDC 638
            LV L G   +  N  LV E++  G L S L  + +    +    A Q+   L YLH   
Sbjct: 62  FLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLH--- 118

Query: 639 RAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNS 698
              I++ D+KP+N+LLD     +I+DFG AK +         T + GT  Y+APE   + 
Sbjct: 119 SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRV----KGRTYT-LCGTPEYLAPEIILSK 173

Query: 699 KITAKVDVYSFGVLLLEII 717
                VD ++ G+L+ E++
Sbjct: 174 GYGKAVDWWALGILIYEML 192

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 85.1 bits (210), Expect = 5e-18
 Identities = 68/293 (23%), Positives = 126/293 (43%), Gaps = 34/293 (11%)

Query: 523 FKEEVGRGSFGIVYKGV---IQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKN 579
            K E+G G+FG V+      +        VAVK L     +  ++F  E  ++    H++
Sbjct: 9   LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68

Query: 580 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN-----LKPNWNLRT--------NIAFQ 626
           +V+  G C EG   ++V+E++ +G L  FL  +     L    N           +IA Q
Sbjct: 69  IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128

Query: 627 IARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGT 686
           IA G++YL        +H D+  +N L+ +    +I DFG+++ +       +       
Sbjct: 129 IAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 185

Query: 687 KGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 746
             ++ PE     K T + DV+S GV+L EI +  K         Y +  +   +C   G+
Sbjct: 186 IRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ------PWYQLSNNEVIECITQGR 239

Query: 747 LNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 799
           +               C  ++  + + C Q +P +R  +K++  +L+ + + S
Sbjct: 240 V---------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS 283

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 84.4 bits (208), Expect = 7e-18
 Identities = 57/195 (29%), Positives = 99/195 (50%), Gaps = 13/195 (6%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLL 584
           E++G+GSFG V+KG+        A+ +  L+   +D   + + E+ V+ Q     + +  
Sbjct: 10  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYY 68

Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF---QIARGLLYLHEDCRAQ 641
           G   +     ++ E+L  G+    L    +P     T IA    +I +GL YLH + +  
Sbjct: 69  GSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHSEKK-- 122

Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKIT 701
            IH DIK  N+LL ++   +++DFG+A  LT  Q K  +    GT  ++APE  + S   
Sbjct: 123 -IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK--RNTFVGTPFWMAPEVIKQSAYD 179

Query: 702 AKVDVYSFGVLLLEI 716
           +K D++S G+  +E+
Sbjct: 180 SKADIWSLGITAIEL 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 84.5 bits (209), Expect = 7e-18
 Identities = 78/302 (25%), Positives = 134/302 (44%), Gaps = 60/302 (19%)

Query: 526 EVGRGSFGIVYK----GVIQTRTSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQTHHKNL 580
           ++G+G+FG V++    G++     T  VAVK L +    D + +F+ E  ++ +  H N+
Sbjct: 12  DIGQGAFGRVFQARAPGLLPYEPFTM-VAVKMLKEEASADMQADFQREAALMAEFDHPNI 70

Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWN---------------------- 618
           V+LLG C  G+   L++E++  G L  FL     P                         
Sbjct: 71  VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHR-SPRAQCSLSHSTSSARKCGLNPLPLSC 129

Query: 619 -LRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGL------AKLL 671
             +  IA Q+A G+ YL E    + +H D+  +N L+ +    +I+DFGL      A   
Sbjct: 130 TEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 186

Query: 672 TLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY 731
             +++  I   IR    ++ PE    ++ T + DV+++GV+L EI      F   M   Y
Sbjct: 187 KASENDAI--PIR----WMPPESIFYNRYTTESDVWAYGVVLWEI------FSYGMQPYY 234

Query: 732 AILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM 791
            +  +      R+G  NVL   D        C  +L  +   C  + PS RP+   + ++
Sbjct: 235 GMAHEEVIYYVRDG--NVLSCPDN-------CPLELYNLMRLCWSKLPSDRPSFASINRI 285

Query: 792 LE 793
           L+
Sbjct: 286 LQ 287

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 84.1 bits (208), Expect = 7e-18
 Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 25/209 (11%)

Query: 527 VGRGSFGIVYKGVIQTRTST---TAVAVKKLDRV-FQDGEREFKNEVFVIGQTHHKNLVR 582
           +GRG FG V+    +        T V VK L +   ++ + EF+ E+ +  +  HKN+VR
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72

Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFLFGN------LKP---NWNLRTNIAFQIARGLLY 633
           LLG C E +   ++ E+ + G L  FL         LKP   +   +  +  QIA G+ +
Sbjct: 73  LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132

Query: 634 LHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS----KTIKTAIRGTKGY 689
           L     A+ +H D+  +N L+      ++S   L+K    N      +     +R    +
Sbjct: 133 LS---NARFVHRDLAARNCLVSSQREVKVSLLSLSK-DVYNSEYYKLRNALIPLR----W 184

Query: 690 VAPEWFRNSKITAKVDVYSFGVLLLEIIS 718
           +APE  +    + K DV+SFGVL+ E+ +
Sbjct: 185 LAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 83.6 bits (206), Expect = 8e-18
 Identities = 68/198 (34%), Positives = 100/198 (50%), Gaps = 17/198 (8%)

Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLG 585
           ++G+G FG V+ G   T   TT VA+K L       E  F  E  ++ +  H  LV L  
Sbjct: 13  KLGQGCFGEVWMG---TWNGTTKVAIKTLKPGTMMPE-AFLQEAQIMKKLRHDKLVPLYA 68

Query: 586 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR--TNIAFQIARGLLYLHEDCRAQII 643
              E +   +V EF+  G+L  FL         L    ++A QIA G+ Y+    R   I
Sbjct: 69  VVSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYI 124

Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVAPEWFRNSKI 700
           H D++  NIL+ D    +I+DFGLA+L+  N+     TA +G K    + APE     + 
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLIEDNEY----TARQGAKFPIKWTAPEAALYGRF 180

Query: 701 TAKVDVYSFGVLLLEIIS 718
           T K DV+SFG+LL E+++
Sbjct: 181 TIKSDVWSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 84.2 bits (208), Expect = 9e-18
 Identities = 63/203 (31%), Positives = 99/203 (48%), Gaps = 16/203 (7%)

Query: 526 EVGRGSFGIVYKGVIQTRTSTTA--VAVKKLDRVFQDGER---EFKNEVFVIGQTHHKNL 580
           ++G G FG V           T   VAVK L    + G     + K E+ ++   +H+N+
Sbjct: 11  DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKP--ESGGNHIADLKKEIEILRNLYHENI 68

Query: 581 VRLLGFCDEGQNR--LLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHE 636
           V+  G C E       L+ EFL +G+L  +L  N K   NL+     A QI +G+ YL  
Sbjct: 69  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRN-KNKINLKQQLKYAVQICKGMDYLGS 127

Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS-KTIKTAIRGTKGYVAPEWF 695
               Q +H D+  +N+L++  +  +I DFGL K +  ++   T+K  +     + APE  
Sbjct: 128 ---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL 184

Query: 696 RNSKITAKVDVYSFGVLLLEIIS 718
             SK     DV+SFGV L E+++
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 83.9 bits (207), Expect = 1e-17
 Identities = 66/207 (31%), Positives = 106/207 (51%), Gaps = 23/207 (11%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKNLVRL 583
           +G+G FG V     Q R +    A KKL++     + GE    NE  ++ + + + +V L
Sbjct: 8   LGKGGFGEVC--ACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL 65

Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDC----- 638
             +  E ++ L +   L NG       G+LK +        F+  R + Y  E C     
Sbjct: 66  -AYAYETKDALCLVLTLMNG-------GDLKFHIYHMGEAGFEEGRAVFYAAEICCGLED 117

Query: 639 --RAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR 696
             + +I++ D+KP+NILLDD+   RISD GLA  + + + +TIK  + GT GY+APE  +
Sbjct: 118 LHQERIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRV-GTVGYMAPEVVK 174

Query: 697 NSKITAKVDVYSFGVLLLEIISCRKSF 723
           N + T   D ++ G LL E+I+ +  F
Sbjct: 175 NERYTFSPDWWALGCLLYEMIAGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 83.7 bits (207), Expect = 1e-17
 Identities = 67/203 (33%), Positives = 107/203 (52%), Gaps = 15/203 (7%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKNLVRL 583
           +G+G FG V     Q R +    A KKL++     + GE    NE  ++ + + + +V L
Sbjct: 8   LGKGGFGEVC--ACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 65

Query: 584 LGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNI--AFQIARGLLYLHEDCRA 640
             +  E ++ L LV   +N G L   ++    P ++    +  A +I  GL  LH   R 
Sbjct: 66  -AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RE 121

Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
           +I++ D+KP+NILLDDY   RISD GLA  + + + +TI+  + GT GY+APE  +N + 
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLA--VEIPEGETIRGRV-GTVGYMAPEVVKNERY 178

Query: 701 TAKVDVYSFGVLLLEIISCRKSF 723
           T   D +  G L+ E+I  +  F
Sbjct: 179 TFSPDWWGLGCLIYEMIEGKSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 84.5 bits (210), Expect = 1e-17
 Identities = 61/212 (28%), Positives = 98/212 (46%), Gaps = 39/212 (18%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ---DGEREFKNEVFVIGQTHHKNLVRL 583
           +G G++G+V   V   RT    VA+KK+  VF    D +R  + E+ ++    H+N++ L
Sbjct: 8   IGSGAYGVVCSAV-DKRTGRK-VAIKKISNVFDDLIDAKRILR-EIKLLRHLRHENIIGL 64

Query: 584 LG-FCDEGQNRL----LVYEFLNNGT-LASFLFGNLKPNWNLRTN----IAFQIARGLLY 633
           L               +V E +   T L   +    K    L  +      +QI RGL Y
Sbjct: 65  LDILRPPSPEDFNDVYIVTELM--ETDLHKVI----KSPQPLTDDHIQYFLYQILRGLKY 118

Query: 634 LHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS-KTIKTAIRGTKGYVAP 692
           LH    A +IH D+KP NIL++     +I DFGLA+ +  ++  K   T       YV  
Sbjct: 119 LH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT------EYVVT 169

Query: 693 EWFR-------NSKITAKVDVYSFGVLLLEII 717
            W+R       +S+ T  +D++S G +  E++
Sbjct: 170 RWYRAPELLLSSSRYTKAIDIWSVGCIFAELL 201

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 83.4 bits (206), Expect = 1e-17
 Identities = 79/287 (27%), Positives = 129/287 (44%), Gaps = 41/287 (14%)

Query: 527 VGRGSFGIVYKGVIQT----RTSTTAVAVKKLDRVFQDGER-EFKNEVFVIGQTHHKNLV 581
           +G G+FG VY+G         +    VAVK L +   D E+ EF  E  ++   +H N+V
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK-----PNWNLR--TNIAFQIARGLLYL 634
           +LLG C   + + ++ E +  G L S+L          P   L+   +I   +A+G +YL
Sbjct: 63  KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122

Query: 635 HEDCRAQIIHCDIKPQNILLD--DYYTAR---ISDFGLAKLLTLNQSKTIKTAIRGTKGY 689
               +   IH D+  +N L+    Y   R   I DFGLA+ +  +     +        +
Sbjct: 123 E---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW 179

Query: 690 VAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLN 748
           +APE   + K T + DV+SFGVL+ EI++        +G++ Y  L +            
Sbjct: 180 MAPESLLDGKFTTQSDVWSFGVLMWEILT--------LGQQPYPALNN----------QE 221

Query: 749 VL--VGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
           VL  V           C  K+  +   C  +DPS RPT  ++ ++L+
Sbjct: 222 VLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 83.6 bits (207), Expect = 1e-17
 Identities = 49/157 (31%), Positives = 74/157 (47%), Gaps = 17/157 (10%)

Query: 575 THHKNLVRLLG-FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTN------IAFQ 626
                +V+  G F DE  + + +  E+   G+L S ++  +K     R        IA  
Sbjct: 56  CKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKR-GGRIGEKVLGKIAES 113

Query: 627 IARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGT 686
           + +GL YLH     +IIH DIKP NILL      ++ DFG++  L  + + T      GT
Sbjct: 114 VLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT----GT 166

Query: 687 KGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSF 723
             Y+APE  +    +   DV+S G+ LLE+   R  F
Sbjct: 167 SFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPF 203

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 83.3 bits (206), Expect = 1e-17
 Identities = 76/291 (26%), Positives = 123/291 (42%), Gaps = 52/291 (17%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKL---DRVFQDGERE-------FKNEVFVIG- 573
           E +G G+FG VYK V +       +A+K++   +  F   +RE         +EV +I  
Sbjct: 6   EHLGSGAFGCVYK-VRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKE 64

Query: 574 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPN---------WNLRTNIA 624
           Q  H N+VR      E     +V + +    L    F +LK           WN    I 
Sbjct: 65  QLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGE-HFNSLKEKKQRFTEERIWN----IF 119

Query: 625 FQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIR 684
            Q+   L YLH++   +I+H D+ P NI+L +     I+DFGLAK     Q ++  T++ 
Sbjct: 120 VQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSVV 174

Query: 685 GTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 744
           GT  Y  PE  +N     K DV++FG +L ++ + +  F                  Y  
Sbjct: 175 GTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPF------------------YST 216

Query: 745 GKLNV---LVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQML 792
             L++   +V    E + +      +  V   C+  D   RP + +V  M+
Sbjct: 217 NMLSLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 84.5 bits (210), Expect = 1e-17
 Identities = 65/215 (30%), Positives = 113/215 (52%), Gaps = 28/215 (13%)

Query: 524 KEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ---DGEREFKNEVFVIGQTHHKNL 580
            +++G+G++GIV+K  I  RT    VA+KK+   F+   D +R F+  +F+     H N+
Sbjct: 12  LQKLGKGAYGIVWKA-IDRRTKEV-VALKKIFDAFRNATDAQRTFREIMFLQELGDHPNI 69

Query: 581 VRLLGF--CDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDC 638
           V+LL     +  ++  LV+E++    L + +  N+  + + R  I +Q+ + L Y+H   
Sbjct: 70  VKLLNVIKAENDKDIYLVFEYMET-DLHAVIRANILEDVHKRY-IMYQLLKALKYIHS-- 125

Query: 639 RAQIIHCDIKPQNILLDDYYTARISDFGLAKLLT---LNQSKTIKTAIRGTKGYVAPEWF 695
              +IH D+KP NILL+     +++DFGLA+ L+    N    + T       YVA  W+
Sbjct: 126 -GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTD------YVATRWY 178

Query: 696 RNSKI-------TAKVDVYSFGVLLLEIISCRKSF 723
           R  +I       T  VD++S G +L E++  +  F
Sbjct: 179 RAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLF 213

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 83.5 bits (207), Expect = 2e-17
 Identities = 64/210 (30%), Positives = 100/210 (47%), Gaps = 33/210 (15%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE--------REFKNEVFVIGQT- 575
            E+G G++G VYK   +   +   VA+KK+       E        RE    + ++ Q  
Sbjct: 5   AEIGEGAYGTVYKA--RDLNTGRFVALKKV--RVPLSEEGIPLSTLRE----IALLKQLE 56

Query: 576 --HHKNLVRLLGFC-----DEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQ 626
              H N+VRLL  C     D      LV+E ++   LA++L    KP     T  ++  Q
Sbjct: 57  SFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQ 115

Query: 627 IARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGT 686
           + RG+ +LH      I+H D+KPQNIL+      +I+DFGLA++ +   +    T++  T
Sbjct: 116 LLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA---LTSVVVT 169

Query: 687 KGYVAPEWFRNSKITAKVDVYSFGVLLLEI 716
             Y APE    S     VD++S G +  E+
Sbjct: 170 LWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 83.0 bits (205), Expect = 2e-17
 Identities = 65/204 (31%), Positives = 99/204 (48%), Gaps = 14/204 (6%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKN---EVFVIGQTHHKNLVRL 583
           +G+G FG V     Q R +    A KKL++      + ++    E  ++ + H + +V L
Sbjct: 1   LGKGGFGEVS--ACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL 58

Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF----QIARGLLYLHEDCR 639
                   +  LV   +N G L   ++   + N       A     QI  GL +LH+   
Sbjct: 59  AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR-- 116

Query: 640 AQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSK 699
            +II+ D+KP+N+LLD+    RISD GLA  L   QSKT   A  GT G++APE  +  +
Sbjct: 117 -RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA--GTPGFMAPELLQGEE 173

Query: 700 ITAKVDVYSFGVLLLEIISCRKSF 723
               VD ++ GV L E+I+ R  F
Sbjct: 174 YDFSVDYFALGVTLYEMIAARGPF 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 82.1 bits (203), Expect = 3e-17
 Identities = 55/212 (25%), Positives = 94/212 (44%), Gaps = 19/212 (8%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKN----EVFVIGQTHHKNL 580
           + + +G+FG VY  + + R++    A+K L +     + +  N       ++ Q     +
Sbjct: 2   KPISKGAFGSVY--LAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYV 59

Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLHEDC 638
            +L           LV E+LN G  AS +   G L  +W  +  IA ++  G+  LH+  
Sbjct: 60  AKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDW-AKQYIA-EVVLGVEDLHQR- 116

Query: 639 RAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNS 698
              IIH DIKP+N+L+D     +++DFGL++    N+         GT  Y+APE     
Sbjct: 117 --GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK------FVGTPDYLAPETILGV 168

Query: 699 KITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 730
                 D +S G ++ E +     F  E  + 
Sbjct: 169 GDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 81.5 bits (202), Expect = 4e-17
 Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 40/210 (19%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVR 582
             E++G GS+G VYK  I   T    VA+K +  V +D + E   E+ ++ Q     +V+
Sbjct: 7   ILEKLGEGSYGSVYKA-IHKETGQV-VAIKVV-PVEEDLQ-EIIKEISILKQCDSPYIVK 62

Query: 583 LLGFCDEGQNRLLVYEF----------------LNNGTLASFLFGNLKPNWNLRTNIAFQ 626
             G   +  +  +V E+                L    +A+ L+  LK            
Sbjct: 63  YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLK------------ 110

Query: 627 IARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGT 686
              GL YLH     + IH DIK  NILL++   A+++DFG++  LT   +K   T I GT
Sbjct: 111 ---GLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKR-NTVI-GT 162

Query: 687 KGYVAPEWFRNSKITAKVDVYSFGVLLLEI 716
             ++APE  +      K D++S G+  +E+
Sbjct: 163 PFWMAPEVIQEIGYNNKADIWSLGITAIEM 192

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 81.9 bits (202), Expect = 5e-17
 Identities = 75/295 (25%), Positives = 129/295 (43%), Gaps = 43/295 (14%)

Query: 525 EEVGRGSFG--IVYKGVIQTRTSTTAVAVKKLDR-VFQDGEREFKNEVFVIGQTHHKNLV 581
             +G G FG   +Y        +   VAVK L R   Q     +K E+ ++   +H+N+V
Sbjct: 10  RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69

Query: 582 RLLGFCDE--GQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF--QIARGLLYLHED 637
           +  G C E  G+   L+ E++  G+L  +L    K   NL   + F  QI  G+ YLH  
Sbjct: 70  KYKGCCSEQGGKGLQLIMEYVPLGSLRDYL---PKHKLNLAQLLLFAQQICEGMAYLHSQ 126

Query: 638 CRAQIIHCDIKPQNILLDDYYTARISDFGLAKLL-TLNQSKTIKTAIRGTKGYVAPEWFR 696
                IH D+  +N+LLD+    +I DFGLAK +   ++   ++        + A E  +
Sbjct: 127 ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK 183

Query: 697 NSKITAKVDVYSFGVLLLEII-------SCRKSFDIEMGEEYAILTDWAFDCYRNGKLNV 749
            +K +   DV+SFGV L E++       S  K F  EM               + G++ V
Sbjct: 184 ENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIG------------PKQGQMTV 230

Query: 750 L----VGEDKEAM---NDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 797
           +    + E    +    +      ++M + W  + +   RPT + ++ +L+ +  
Sbjct: 231 VRLIELLERGMRLPCPKNCPQEVYILMKNCW--ETEAKFRPTFRSLIPILKEMHH 283

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 82.0 bits (202), Expect = 5e-17
 Identities = 65/219 (29%), Positives = 108/219 (49%), Gaps = 34/219 (15%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQT-HHKNL 580
           F++ +G G+FG V + +I+        A+K L +   ++  R+F  E+ V+ +  HH N+
Sbjct: 6   FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNI 65

Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF--------------- 625
           + LLG C+      +  E+   G L  FL    + +  L T+ AF               
Sbjct: 66  INLLGACENRGYLYIAIEYAPYGNLLDFL----RKSRVLETDPAFAKEHGTASTLTSQQL 121

Query: 626 -----QIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI- 679
                 +A G+ YL E    Q IH D+  +N+L+ +   ++I+DFGL++   +   KT+ 
Sbjct: 122 LQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMG 178

Query: 680 KTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS 718
           +  +R    ++A E    S  T K DV+SFGVLL EI+S
Sbjct: 179 RLPVR----WMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 81.7 bits (202), Expect = 6e-17
 Identities = 63/199 (31%), Positives = 99/199 (49%), Gaps = 15/199 (7%)

Query: 522 NFKEEVGRGSFGIVYKGVIQTRTST-TAVAVKKLD-RVFQDGEREFKNEVFVIGQTHHKN 579
           NF + +G GS GIV    I T  ST   VAVKK+D R  Q  E  F NEV ++    H N
Sbjct: 23  NFVK-IGEGSTGIV---CIATDKSTGRQVAVKKMDLRKQQRRELLF-NEVVIMRDYQHPN 77

Query: 580 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCR 639
           +V +      G    +V EFL  G L   +  + + N      +   + + L +LH    
Sbjct: 78  IVEMYSSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKALSFLH---- 132

Query: 640 AQ-IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNS 698
           AQ +IH DIK  +ILL      ++SDFG    ++    +  + ++ GT  ++APE     
Sbjct: 133 AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR--RKSLVGTPYWMAPEVISRL 190

Query: 699 KITAKVDVYSFGVLLLEII 717
               +VD++S G++++E++
Sbjct: 191 PYGTEVDIWSLGIMVIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 81.5 bits (201), Expect = 6e-17
 Identities = 61/211 (28%), Positives = 92/211 (43%), Gaps = 28/211 (13%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +E+G G FG V  G      S   V VK+L      D +  F  EV    + +H N+++ 
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60

Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGN-----LKPNWNLRTNIAFQIARGLLYLHEDC 638
           LG C E    LLV EF   G L ++L  N          ++   +A ++A GLL+LH   
Sbjct: 61  LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH--- 117

Query: 639 RAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTA------IRGTKGYVAP 692
           +A  IH D+  +N  L    + +I D+GLA  L         T       +R    ++AP
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLA--LEQYPEDYYITKDCHAVPLR----WLAP 171

Query: 693 EW-------FRNSKITAKVDVYSFGVLLLEI 716
           E              T K +++S GV + E+
Sbjct: 172 ELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 82.3 bits (204), Expect = 8e-17
 Identities = 65/217 (29%), Positives = 103/217 (47%), Gaps = 43/217 (19%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE---REFKNEVFVIGQTHHKNLVRL 583
           VG G++G V      T+T    VA+KKL R FQ      R ++ E+ ++    H+N++ L
Sbjct: 23  VGSGAYGQVCS-AFDTKTGRK-VAIKKLSRPFQSAIHAKRTYR-ELRLLKHMDHENVIGL 79

Query: 584 LG-FC-----DEGQNRLLVYEF----LNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLY 633
           L  F      ++ Q+  LV       LNN      +    K + +    + +QI RGL Y
Sbjct: 80  LDVFTPASSLEDFQDVYLVTHLMGADLNN------IVKCQKLSDDHIQFLVYQILRGLKY 133

Query: 634 LHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE 693
           +H    A IIH D+KP NI +++    +I DFGLA+    +   T         GYVA  
Sbjct: 134 IHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARH--TDDEMT---------GYVATR 179

Query: 694 WFRNSKI-------TAKVDVYSFGVLLLEIISCRKSF 723
           W+R  +I          VD++S G ++ E+++ +  F
Sbjct: 180 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLF 216

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 81.1 bits (200), Expect = 9e-17
 Identities = 61/202 (30%), Positives = 99/202 (49%), Gaps = 13/202 (6%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKNLVRL 583
           +G+G FG V    +Q + +    A KKLD+     + GE+    E  ++ + +   +V L
Sbjct: 1   LGKGGFGEVC--AVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL 58

Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLF--GNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ 641
               +   +  LV   +N G L   ++  G          + + QI  G+L+LH      
Sbjct: 59  AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MD 115

Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKIT 701
           I++ D+KP+N+LLDD    R+SD GLA  + L   KTI T   GT GY+APE  +    +
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTI-TQRAGTNGYMAPEILKEEPYS 172

Query: 702 AKVDVYSFGVLLLEIISCRKSF 723
             VD ++ G  + E+++ R  F
Sbjct: 173 YPVDWFAMGCSIYEMVAGRTPF 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 81.2 bits (200), Expect = 9e-17
 Identities = 69/289 (23%), Positives = 124/289 (42%), Gaps = 37/289 (12%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTT---AVAVKKLDRVFQDGEREFKNEVFVIGQTHHKN 579
            K E+G G+FG V+       + T     VAVK L        ++F+ E  ++    H++
Sbjct: 9   LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68

Query: 580 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN------------LKPNWNL----RTNI 623
           +V+  G C +G   ++V+E++ +G L  FL  +             +    L      +I
Sbjct: 69  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128

Query: 624 AFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAI 683
           A QIA G++YL        +H D+  +N L+      +I DFG+++ +       +    
Sbjct: 129 ASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 185

Query: 684 RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR 743
                ++ PE     K T + DV+SFGV+L EI +  K    ++     I      +C  
Sbjct: 186 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI------ECIT 239

Query: 744 NGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQML 792
            G+    V E         C  ++  + + C Q +P  R  +K++ ++L
Sbjct: 240 QGR----VLERPRV-----CPKEVYDIMLGCWQREPQQRLNIKEIYKIL 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 81.8 bits (202), Expect = 2e-16
 Identities = 71/279 (25%), Positives = 123/279 (44%), Gaps = 48/279 (17%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG-EREFKNEVFVIGQTHHKNLVRLLG 585
           +G G+ G VYK  +  R +    A+K +    +D   R+   E+ ++   +H N+V+   
Sbjct: 82  IGSGAGGTVYK--VIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139

Query: 586 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHC 645
             D      ++ EF++ G+L     G    +     ++A QI  G+ YLH   R  I+H 
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLE----GTHIADEQFLADVARQILSGIAYLH---RRHIVHR 192

Query: 646 DIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKV- 704
           DIKP N+L++     +I+DFG++++  L Q+     +  GT  Y++PE     +I   + 
Sbjct: 193 DIKPSNLLINSAKNVKIADFGVSRI--LAQTMDPCNSSVGTIAYMSPE-----RINTDLN 245

Query: 705 ---------DVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA----FDCYRNGKLNVLV 751
                    D++S GV +LE    R  F   +G +     DWA      C          
Sbjct: 246 HGAYDGYAGDIWSLGVSILEFYLGR--FPFGVGRQ----GDWASLMCAICMSQPP-EAPA 298

Query: 752 GEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
              +E  + I C          C+Q +P+ R +  ++LQ
Sbjct: 299 TASREFRHFISC----------CLQREPAKRWSAMQLLQ 327

Length = 353

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 80.4 bits (199), Expect = 2e-16
 Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 15/208 (7%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKK--LDRVFQDGEREFKNEVFVIGQTHHKNLVRLL 584
           +G G+ GIV+K     R +   VA+KK  L R+      +   E+  +    H  +V+LL
Sbjct: 8   IGEGAHGIVFKAKD--RETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLL 65

Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN-IAFQIARGLLYLHEDCRAQII 643
                G   +LV E++    L+  L    +P    +       + +G+ Y+H      I+
Sbjct: 66  DVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA---NGIM 121

Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNS-KITA 702
           H D+KP N+L+      +I+DFGLA+L +  +   + +    T+ Y APE    + K   
Sbjct: 122 HRDLKPANLLISADGVLKIADFGLARLFS-EEEPRLYSHQVATRWYRAPELLYGARKYDP 180

Query: 703 KVDVYSFGVLLLEIISCRKSF----DIE 726
            VD+++ G +  E+++    F    DIE
Sbjct: 181 GVDLWAVGCIFAELLNGSPLFPGENDIE 208

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 80.5 bits (198), Expect = 2e-16
 Identities = 57/192 (29%), Positives = 93/192 (48%), Gaps = 8/192 (4%)

Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLG 585
           ++G GS GIV   +   + +   VAVKK+D   Q       NEV ++   HH+N+V +  
Sbjct: 29  KIGEGSTGIVC--IATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYN 86

Query: 586 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHC 645
               G    +V EFL  G L   +  + + N      +   + R L YLH      +IH 
Sbjct: 87  SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQ---GVIHR 142

Query: 646 DIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVD 705
           DIK  +ILL      ++SDFG    ++    K  + ++ GT  ++APE         +VD
Sbjct: 143 DIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RKSLVGTPYWMAPEVISRLPYGTEVD 200

Query: 706 VYSFGVLLLEII 717
           ++S G++++E+I
Sbjct: 201 IWSLGIMVIEMI 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 80.2 bits (198), Expect = 2e-16
 Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 18/203 (8%)

Query: 524 KEEVGRGSFGIVYKGVIQTRTS-TTAVAVK--KLDRVFQDGEREFKNEVFVIGQTHHKNL 580
              +G G FG VY+GV  +  +   AVAVK  K        E+ F  E +++ Q  H ++
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREK-FLQEAYIMRQFDHPHI 69

Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNI--AFQIARGLLYLHEDC 638
           V+L+G   E     +V E    G L S+L  N K + +L + I  ++Q++  L YL    
Sbjct: 70  VKLIGVITE-NPVWIVMELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLES-- 125

Query: 639 RAQIIHCDIKPQNILLDDYYTARISDFGLAKLL---TLNQSKTIKTAIRGTKGYVAPEWF 695
             + +H DI  +N+L+      ++ DFGL++ L   +  ++   K  I+    ++APE  
Sbjct: 126 -KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIK----WMAPESI 180

Query: 696 RNSKITAKVDVYSFGVLLLEIIS 718
              + T+  DV+ FGV + EI+ 
Sbjct: 181 NFRRFTSASDVWMFGVCMWEILM 203

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 80.6 bits (199), Expect = 2e-16
 Identities = 65/205 (31%), Positives = 107/205 (52%), Gaps = 14/205 (6%)

Query: 523 FKEEVGRGSFGIVYK----GVIQTRTSTTAVAVKKLDRVFQDGERE-FKNEVFVIGQT-H 576
           F + +G G+FG V +    G+ ++      VAVK L       ERE   +E+ ++    +
Sbjct: 39  FGKTLGAGAFGKVVEATAYGLSKSDAVMK-VAVKMLKPTAHSSEREALMSELKIMSHLGN 97

Query: 577 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF--QIARGLLYL 634
           H+N+V LLG C  G   L++ E+   G L +FL    +    L   ++F  Q+A+G+ +L
Sbjct: 98  HENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL 157

Query: 635 -HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE 693
             ++C    IH D+  +N+LL      +I DFGLA+ +  + +  +K   R    ++APE
Sbjct: 158 ASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPE 213

Query: 694 WFRNSKITAKVDVYSFGVLLLEIIS 718
              N   T + DV+S+G+LL EI S
Sbjct: 214 SIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 79.7 bits (196), Expect = 2e-16
 Identities = 64/210 (30%), Positives = 104/210 (49%), Gaps = 19/210 (9%)

Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ 574
           E+   +   ++++G G FG V+   + T    T VAVK +       E  F  E  V+  
Sbjct: 2   EIPRESLKLEKKLGAGQFGEVW---MATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKT 57

Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPNWNLRTNIAFQIARGL 631
             H  LV+L     + +   ++ EF+  G+L  FL    G+ +P   L  + + QIA G+
Sbjct: 58  LQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKL-IDFSAQIAEGM 115

Query: 632 LYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK---G 688
            ++    +   IH D++  NIL+      +I+DFGLA+++  N+     TA  G K    
Sbjct: 116 AFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY----TAREGAKFPIK 168

Query: 689 YVAPEWFRNSKITAKVDVYSFGVLLLEIIS 718
           + APE       T K DV+SFG+LL+EI++
Sbjct: 169 WTAPEAINFGSFTIKSDVWSFGILLMEIVT 198

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 79.9 bits (197), Expect = 2e-16
 Identities = 59/203 (29%), Positives = 105/203 (51%), Gaps = 18/203 (8%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV-FQDGERE-----FKNEVFVIGQTHHK 578
           +++G G+F   Y+   +   + T +AVK++  V     E+E      + E+ ++ + +H 
Sbjct: 6   QQLGTGAFSSCYQA--RDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHP 63

Query: 579 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLHE 636
           +++R+LG   E  +  L  E++  G+++  L  +G  K    +  N   Q+ RGL YLHE
Sbjct: 64  HIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKE--AVIINYTEQLLRGLSYLHE 121

Query: 637 DCRAQIIHCDIKPQNILLDDY-YTARISDFGLAKLLT--LNQSKTIKTAIRGTKGYVAPE 693
           +   QIIH D+K  N+L+D      RI+DFG A  L      +   +  + GT  ++APE
Sbjct: 122 N---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178

Query: 694 WFRNSKITAKVDVYSFGVLLLEI 716
             R  +     DV+S G +++E+
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEM 201

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 79.9 bits (197), Expect = 2e-16
 Identities = 63/213 (29%), Positives = 112/213 (52%), Gaps = 23/213 (10%)

Query: 522 NFK--EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE-----FKNEVFVIGQ 574
           NF+  E++G G++G+VYK   + + +   VA+KK+ R+  D E E        E+ ++ +
Sbjct: 1   NFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKI-RL--DTETEGVPSTAIREISLLKE 55

Query: 575 THHKNLVRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPN--WNLRTNIAFQIARGL 631
            +H N+V+LL      +N+L LV+EFL+   L  F+  +        L  +  FQ+ +GL
Sbjct: 56  LNHPNIVKLLDVI-HTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGL 113

Query: 632 LYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVA 691
            + H     +++H D+KPQN+L++     +++DFGLA+   +         +  T  Y A
Sbjct: 114 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRA 168

Query: 692 PEWFRNSKI-TAKVDVYSFGVLLLEIISCRKSF 723
           PE     K  +  VD++S G +  E+++ R  F
Sbjct: 169 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 79.8 bits (197), Expect = 2e-16
 Identities = 55/202 (27%), Positives = 95/202 (47%), Gaps = 19/202 (9%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHH---KNLV 581
           E +GRG++G VY+G         A+ +  LD    D   + + EV ++ Q       N+ 
Sbjct: 7   ELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP-DDDVSDIQREVALLSQLRQSQPPNIT 65

Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLL----YLHED 637
           +  G   +G    ++ E+   G++ + +    K        I+  I R +L    Y+H+ 
Sbjct: 66  KYYGSYLKGPRLWIIMEYAEGGSVRTLM----KAGPIAEKYISV-IIREVLVALKYIHKV 120

Query: 638 CRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRN 697
               +IH DIK  NIL+ +    ++ DFG+A LL  N SK  ++   GT  ++APE    
Sbjct: 121 ---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK--RSTFVGTPYWMAPEVITE 175

Query: 698 SKI-TAKVDVYSFGVLLLEIIS 718
            K    K D++S G+ + E+ +
Sbjct: 176 GKYYDTKADIWSLGITIYEMAT 197

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 80.5 bits (199), Expect = 3e-16
 Identities = 67/216 (31%), Positives = 104/216 (48%), Gaps = 13/216 (6%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREF-KNEVFVIGQT-HHKNLVRLL 584
           +G+GSFG V    ++      AV V K D + QD + E    E  V+     H  L +L 
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62

Query: 585 GFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
             C + ++RL  V E++N G L   +  + + +       A +I  GL +LHE     II
Sbjct: 63  S-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHER---GII 118

Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK 703
           + D+K  N+LLD     +I+DFG+ K   L    T  +   GT  Y+APE          
Sbjct: 119 YRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT--STFCGTPDYIAPEILSYQPYGPA 176

Query: 704 VDVYSFGVLLLEIISCRKSFDIEMGEEY---AILTD 736
           VD ++ GVLL E+++ +  F+ +  E+    +IL D
Sbjct: 177 VDWWALGVLLYEMLAGQSPFEGD-DEDELFQSILED 211

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 79.9 bits (197), Expect = 3e-16
 Identities = 63/218 (28%), Positives = 111/218 (50%), Gaps = 18/218 (8%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE---REFKNEVFVIGQTHHKNLV 581
           E++G G++G+VYK   + R +   +A+KK+ R+ Q+ E        E+ ++ +  H N+V
Sbjct: 8   EKIGEGTYGVVYKA--RDRVTNETIALKKI-RLEQEDEGVPSTAIREISLLKEMQHGNIV 64

Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFG--NLKPNWNLRTNIAFQIARGLLYLHEDCR 639
           RL       +   LV+E+L+   L   +    +   N  L     +QI RG+ Y H    
Sbjct: 65  RLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH-- 121

Query: 640 AQIIHCDIKPQNILLDDYYTA-RISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNS 698
            +++H D+KPQN+L+D    A +++DFGLA+   +         +  T  Y APE    S
Sbjct: 122 -RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV--TLWYRAPEILLGS 178

Query: 699 K-ITAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAI 733
           +  +  VD++S G +  E+++ +  F  D E+ E + I
Sbjct: 179 RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKI 216

Length = 294

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 80.4 bits (198), Expect = 3e-16
 Identities = 83/300 (27%), Positives = 133/300 (44%), Gaps = 49/300 (16%)

Query: 527 VGRGSFGIVYK----GVIQTRTST-TAVAVKKL-----DRVFQDGEREFKNEVFVIGQTH 576
           +G G FG V      G+ + + +    VAVK L     D+   D   E +  + +IG+  
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEME-MMKMIGK-- 76

Query: 577 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR---------------- 620
           HKN++ LLG C +     ++ E+ + G L  +L     P  +                  
Sbjct: 77  HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL 136

Query: 621 TNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIK 680
            + A+Q+ARG+ YL      + IH D+  +N+L+ +    +I+DFGLA+ +         
Sbjct: 137 VSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT 193

Query: 681 TAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAF 739
           T  R    ++APE   +   T + DV+SFGVLL EI +         G  Y  I  +  F
Sbjct: 194 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLG-------GSPYPGIPVEELF 246

Query: 740 DCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 799
              + G        DK A     C  +L M+   C    PS RPT K++++ L+ V+ V+
Sbjct: 247 KLLKEGHR-----MDKPA----NCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 79.5 bits (197), Expect = 3e-16
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 33/210 (15%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTA-VAVKKLDRVFQDGERE-----FKNEVFVIGQTHHK 578
            ++G G++G VYK        T   VA+KK+     + E+E        E+ ++ +  H 
Sbjct: 5   AQIGEGTYGQVYKA---RNKKTGELVALKKIR---MENEKEGFPITAIREIKLLQKLRHP 58

Query: 579 NLVRLLGFC-DEGQNRL-LVYEFLN---NGTLAS----FLFGNLKPNWNLRTNIAFQIAR 629
           N+VRL      +G+  + +V+E+++    G L S    F    +K           Q+  
Sbjct: 59  NIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIK-------CYMKQLLE 111

Query: 630 GLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGY 689
           GL YLH      I+H DIK  NIL+++    +++DFGLA+  T  ++    T    T  Y
Sbjct: 112 GLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYT-KRNSADYTNRVITLWY 167

Query: 690 VAPEWFRNSKI-TAKVDVYSFGVLLLEIIS 718
             PE    +     +VD++S G +L E+  
Sbjct: 168 RPPELLLGATRYGPEVDMWSVGCILAELFL 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 79.5 bits (197), Expect = 4e-16
 Identities = 55/215 (25%), Positives = 92/215 (42%), Gaps = 38/215 (17%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKL---------DRVFQDGEREFKNEVFVIGQTHH 577
           +G G++ +VYK      T    VA+KK+         D +     RE K    ++ +  H
Sbjct: 8   LGEGTYAVVYKAR-DKETGRI-VAIKKIKLGERKEAKDGINFTALREIK----LLQELKH 61

Query: 578 KNLVRLLGFCDEGQNRLLVYEFL--------NNGTLASFLFGNLKPNWNLRTNIAFQIAR 629
            N++ LL       N  LV+EF+         + ++      ++K       +      R
Sbjct: 62  PNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSI-VLTPADIK-------SYMLMTLR 113

Query: 630 GLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGY 689
           GL YLH      I+H D+KP N+L+      +++DFGLA+  +        T    T+ Y
Sbjct: 114 GLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLAR--SFGSPNRKMTHQVVTRWY 168

Query: 690 VAPEWFRNSKI-TAKVDVYSFGVLLLEIISCRKSF 723
            APE    ++     VD++S G +  E++  R  F
Sbjct: 169 RAPELLFGARHYGVGVDMWSVGCIFAELLL-RVPF 202

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 79.7 bits (197), Expect = 4e-16
 Identities = 83/314 (26%), Positives = 127/314 (40%), Gaps = 70/314 (22%)

Query: 522 NFKEEVGRGSFGIVY---------KGVIQTRTS-----TTAVAVKKLDRVFQDGER-EFK 566
           NF E++G G FG V+                 +        VAVK L     D  R +F 
Sbjct: 8   NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67

Query: 567 NEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL----------------- 609
            EV ++ +    N+ RLLG C       ++ E++ NG L  FL                 
Sbjct: 68  KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127

Query: 610 -FGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLA 668
            F  L         +A QIA G+ YL        +H D+  +N L+   YT +I+DFG++
Sbjct: 128 SFSTLL-------YMATQIASGMRYLES---LNFVHRDLATRNCLVGKNYTIKIADFGMS 177

Query: 669 KLLTLNQSKTIK----TAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSF 723
           + L  +    ++      IR    ++A E     K T K DV++FGV L EI++ CR+  
Sbjct: 178 RNLYSSDYYRVQGRAPLPIR----WMAWESVLLGKFTTKSDVWAFGVTLWEILTLCRE-- 231

Query: 724 DIEMGEEYAILTDW-----AFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQED 778
                + Y  LTD      A   +R+    + +        DI  L    M+  W  + D
Sbjct: 232 -----QPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYEL----MLECW--RRD 280

Query: 779 PSLRPTMKKVLQML 792
              RPT +++   L
Sbjct: 281 EEDRPTFREIHLFL 294

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 79.3 bits (195), Expect = 4e-16
 Identities = 55/193 (28%), Positives = 94/193 (48%), Gaps = 10/193 (5%)

Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLG 585
           ++G GS GIV    +  ++S   VAVKK+D   Q       NEV ++    H+N+V +  
Sbjct: 27  KIGEGSTGIVCIATV--KSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN 84

Query: 586 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ-IIH 644
               G    +V EFL  G L   +  + + N      +   + + L  LH    AQ +IH
Sbjct: 85  SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLH----AQGVIH 139

Query: 645 CDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKV 704
            DIK  +ILL      ++SDFG      +++    + ++ GT  ++APE         +V
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKSLVGTPYWMAPELISRLPYGPEV 197

Query: 705 DVYSFGVLLLEII 717
           D++S G++++E++
Sbjct: 198 DIWSLGIMVIEMV 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 79.2 bits (195), Expect = 4e-16
 Identities = 64/203 (31%), Positives = 103/203 (50%), Gaps = 15/203 (7%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKNLVRL 583
           +G+G FG V     Q R +    A K+L++     + GE    NE  ++ + + + +V L
Sbjct: 8   LGKGGFGEVC--ACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL 65

Query: 584 LGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNI--AFQIARGLLYLHEDCRA 640
             +  E ++ L LV   +N G L   ++    P +     +  A +I  GL  LH   R 
Sbjct: 66  -AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RE 121

Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
             ++ D+KP+NILLDDY   RISD GLA  + + + ++I+  + GT GY+APE   N + 
Sbjct: 122 NTVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRV-GTVGYMAPEVLNNQRY 178

Query: 701 TAKVDVYSFGVLLLEIISCRKSF 723
           T   D +  G L+ E+I  +  F
Sbjct: 179 TLSPDYWGLGCLIYEMIEGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 79.3 bits (196), Expect = 5e-16
 Identities = 63/200 (31%), Positives = 94/200 (47%), Gaps = 20/200 (10%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE-----FKNEVFVIGQTHHKNLV 581
           +G G++GIVY+   +  TS   VA+KK   V  D ER+        E+ ++    H N+V
Sbjct: 15  IGEGTYGIVYRA--RDTTSGEIVALKK---VRMDNERDGIPISSLREITLLLNLRHPNIV 69

Query: 582 RLLGFC--DEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN-IAFQIARGLLYLHEDC 638
            L          +  LV E+     LAS L     P    +   +  Q+ RGL YLHE+ 
Sbjct: 70  ELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF 128

Query: 639 RAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE-WFRN 697
              IIH D+K  N+LL D    +I+DFGLA+   L         +  T  Y APE     
Sbjct: 129 ---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV--TLWYRAPELLLGC 183

Query: 698 SKITAKVDVYSFGVLLLEII 717
           +  T  +D+++ G +L E++
Sbjct: 184 TTYTTAIDMWAVGCILAELL 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 78.2 bits (193), Expect = 8e-16
 Identities = 76/287 (26%), Positives = 125/287 (43%), Gaps = 43/287 (14%)

Query: 520 TNNFKEE--VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKN----EVFVIG 573
             NFK E  +G+G F +VYK           VA+KK+ ++F+  + + +     E+ ++ 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKA--ICLLDGRVVALKKV-QIFEMMDAKARQDCLKEIDLLK 57

Query: 574 QTHHKNLVRLL-GFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNL---RT--NIAFQ 626
           Q  H N+++ L  F +   N L +V E  + G L S +  + K    L   RT      Q
Sbjct: 58  QLDHPNVIKYLASFIEN--NELNIVLELADAGDL-SRMIKHFKKQKRLIPERTIWKYFVQ 114

Query: 627 IARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKT-AIRG 685
           +   L ++H     +I+H DIKP N+ +      ++ D GL +  +   SKT    ++ G
Sbjct: 115 LCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFS---SKTTAAHSLVG 168

Query: 686 TKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 745
           T  Y++PE    +    K D++S G LL E+ + +  F  +    Y++            
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK---------- 218

Query: 746 KLNVLVGEDKEAMNDI--ECLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
              +   +      D   E L  LV     CI  DP  RP +  VLQ
Sbjct: 219 --KIEKCDYPPLPADHYSEELRDLVSR---CINPDPEKRPDISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 78.5 bits (193), Expect = 8e-16
 Identities = 74/300 (24%), Positives = 127/300 (42%), Gaps = 45/300 (15%)

Query: 523 FKEEVGRGSFGIVY------------KGVIQTRTSTTAVAVKKL-DRVFQDGEREFKNEV 569
            KE++G G FG V+            +G  +       VAVK L   V +    +F  E+
Sbjct: 9   LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68

Query: 570 FVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFG-NLKPNWNLRTNI----- 623
            ++ +  + N++RLLG C       ++ E++ NG L  FL    ++  +    NI     
Sbjct: 69  KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128

Query: 624 ------AFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSK 677
                 A QIA G+ YL        +H D+  +N L+ ++YT +I+DFG+++ L      
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY 185

Query: 678 TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW 737
            I+        ++A E     K T   DV++FGV L E+ +  K       + Y++L+D 
Sbjct: 186 RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKE------QPYSLLSDE 239

Query: 738 AF-----DCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQML 792
                  + +RN    + + +         C   +  + + C   D   RPT  K+   L
Sbjct: 240 QVIENTGEFFRNQGRQIYLSQTP------LCPSPVFKLMMRCWSRDIKDRPTFNKIHHFL 293

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 77.9 bits (192), Expect = 8e-16
 Identities = 53/200 (26%), Positives = 97/200 (48%), Gaps = 15/200 (7%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKL--DRVFQDGERE---FKNEVFVIGQTHHKNLV 581
           +G+G+FG VY  +     +   +AVK++  D    + ++E    + E+ ++    H+ +V
Sbjct: 10  LGQGAFGRVY--LCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67

Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLHEDCR 639
           +  G   + +   +  E++  G++   L  +G L     +      QI  G+ YLH    
Sbjct: 68  QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGAL--TETVTRKYTRQILEGVEYLH---S 122

Query: 640 AQIIHCDIKPQNILLDDYYTARISDFGLAK-LLTLNQSKTIKTAIRGTKGYVAPEWFRNS 698
             I+H DIK  NIL D     ++ DFG +K L T+  S T   ++ GT  +++PE     
Sbjct: 123 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGE 182

Query: 699 KITAKVDVYSFGVLLLEIIS 718
               K DV+S G  ++E+++
Sbjct: 183 GYGRKADVWSVGCTVVEMLT 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 77.7 bits (191), Expect = 8e-16
 Identities = 55/209 (26%), Positives = 96/209 (45%), Gaps = 24/209 (11%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGF 586
           +G GSFG +Y    ++ +    +    L ++    +   K EV ++ +  H N+V     
Sbjct: 8   IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67

Query: 587 CDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF----------QIARGLLYLHE 636
             E     +V E+ + G L   +        N +  + F          QI+ GL ++H+
Sbjct: 68  FQENGRLFIVMEYCDGGDLMKRI--------NRQRGVLFSEDQILSWFVQISLGLKHIHD 119

Query: 637 DCRAQIIHCDIKPQNILLD-DYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
               +I+H DIK QNI L  +   A++ DFG+A+   LN S  +     GT  Y++PE  
Sbjct: 120 ---RKILHRDIKSQNIFLSKNGMVAKLGDFGIAR--QLNDSMELAYTCVGTPYYLSPEIC 174

Query: 696 RNSKITAKVDVYSFGVLLLEIISCRKSFD 724
           +N     K D++S G +L E+ + +  F+
Sbjct: 175 QNRPYNNKTDIWSLGCVLYELCTLKHPFE 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 78.1 bits (193), Expect = 9e-16
 Identities = 65/210 (30%), Positives = 103/210 (49%), Gaps = 28/210 (13%)

Query: 524 KEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ-THHKNLVR 582
            E +G G++G VYK     +T    VA+K +D + +D E E K E  ++ + ++H N+  
Sbjct: 11  VEVIGEGTYGKVYKA-RHKKTGQL-VAIKIMD-IIEDEEEEIKEEYNILRKYSNHPNIAT 67

Query: 583 LLG-------FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTN-IAF---QIARG 630
             G         ++ Q  L LV E    G++   + G  K    L+   IA+   +  RG
Sbjct: 68  FYGAFIKKNPPGNDDQ--LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRG 125

Query: 631 LLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYV 690
           L YLHE+   ++IH DIK QNILL      ++ DFG++  L     +   T I GT  ++
Sbjct: 126 LAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRR-NTFI-GTPYWM 180

Query: 691 APEWF-----RNSKITAKVDVYSFGVLLLE 715
           APE        ++   A+ DV+S G+  +E
Sbjct: 181 APEVIACDEQPDASYDARSDVWSLGITAIE 210

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 78.1 bits (192), Expect = 9e-16
 Identities = 67/208 (32%), Positives = 102/208 (49%), Gaps = 25/208 (12%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKNLVRL 583
           +G+G FG V     Q R +    A KKL++     + GE    NE  ++ + + + +V L
Sbjct: 8   LGKGGFGEVC--ACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL 65

Query: 584 LGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDC---- 638
             +  E ++ L LV   +N G L  F   N+        N  F   R + Y  E C    
Sbjct: 66  -AYAYETKDALCLVLTIMNGGDL-KFHIYNMG-------NPGFDEQRAIFYAAELCCGLE 116

Query: 639 ---RAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
              R +I++ D+KP+NILLDD    RISD GLA  + + + +T++  + GT GY+APE  
Sbjct: 117 DLQRERIVYRDLKPENILLDDRGHIRISDLGLA--VQIPEGETVRGRV-GTVGYMAPEVI 173

Query: 696 RNSKITAKVDVYSFGVLLLEIISCRKSF 723
            N K T   D +  G L+ E+I  +  F
Sbjct: 174 NNEKYTFSPDWWGLGCLIYEMIQGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 78.1 bits (192), Expect = 1e-15
 Identities = 61/225 (27%), Positives = 109/225 (48%), Gaps = 25/225 (11%)

Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRT---STTAVAVKKL-DRVFQDGEREFKNEVF 570
           E+  +T  F EE+G   FG VYKG +        T AVA+K L D+       EFK+E  
Sbjct: 1   EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60

Query: 571 VIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--------FGNLKPNWNLRT- 621
           +  +  H N+V LLG   + Q   +++ + ++  L  FL         G+   +  +++ 
Sbjct: 61  MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120

Query: 622 -------NIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAK-LLTL 673
                  +I  QIA G+ +L       ++H D+  +N+L+ D    +ISD GL + +   
Sbjct: 121 LEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAA 177

Query: 674 NQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS 718
           +  K +  ++   + +++PE     K +   D++S+GV+L E+ S
Sbjct: 178 DYYKLMGNSLLPIR-WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 77.8 bits (192), Expect = 1e-15
 Identities = 77/296 (26%), Positives = 144/296 (48%), Gaps = 52/296 (17%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE---REFKNEVFVIGQTHHKNLV 581
           E++G G++G+VYKG  + + +   VA+KK+ R+  + E        E+ ++ +  H N+V
Sbjct: 6   EKIGEGTYGVVYKG--RNKKTGQIVAMKKI-RLESEEEGVPSTAIREISLLKELQHPNIV 62

Query: 582 RLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIA----FQIARGLLYLHE 636
            L     + ++RL L++EFL+   L  +L  +L     +   +     +QI +G+L+ H 
Sbjct: 63  CLQDVLMQ-ESRLYLIFEFLSM-DLKKYL-DSLPKGQYMDAELVKSYLYQILQGILFCH- 118

Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR 696
               +++H D+KPQN+L+D+    +++DFGLA+   +     + T    T  Y APE   
Sbjct: 119 --SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI--PVRVYTHEVVTLWYRAPEVLL 174

Query: 697 NS-KITAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAI-----------------LTD 736
            S + +  VD++S G +  E+ + +  F  D E+ + + I                 L D
Sbjct: 175 GSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234

Query: 737 W--AFDCYRNGKLNVLV-GEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVL 789
           +   F  ++ G L   V   D++    ++ L K+++        DP+ R + KK L
Sbjct: 235 YKNTFPKWKKGSLRSAVKNLDEDG---LDLLEKMLIY-------DPAKRISAKKAL 280

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 77.0 bits (189), Expect = 2e-15
 Identities = 67/215 (31%), Positives = 107/215 (49%), Gaps = 34/215 (15%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQT-HHKNLVRLL 584
           +G G+FG V K  I+        A+K++ +   +D  R+F  E+ V+ +  HH N++ LL
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF------------------- 625
           G C+      L  E+  +G L  FL    + +  L T+ AF                   
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFL----RKSRVLETDPAFAIANSTASTLSSQQLLHFA 118

Query: 626 -QIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI-KTAI 683
             +ARG+ YL +    Q IH D+  +NIL+ + Y A+I+DFGL++   +   KT+ +  +
Sbjct: 119 ADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV 175

Query: 684 RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS 718
           R    ++A E    S  T   DV+S+GVLL EI+S
Sbjct: 176 R----WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 78.2 bits (193), Expect = 2e-15
 Identities = 64/223 (28%), Positives = 100/223 (44%), Gaps = 31/223 (13%)

Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD------GEREFKNEVFVIGQTHHKN 579
           E+G+G++GIV        +    VA+KK+  VF          RE K      G   HKN
Sbjct: 7   ELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG---HKN 63

Query: 580 LVRL--LGFCDEGQ-NRLLVYEFLNNGTLASFL-FGNLKPNWNLRTNIAFQIARGLLYLH 635
           +  L  +     G  N L +YE L    L   +  G    + + ++ I +QI  GL Y+H
Sbjct: 64  ITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFI-YQILCGLKYIH 122

Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
               A ++H D+KP N+L++     +I DFGLA+  + N  +           YVA  W+
Sbjct: 123 S---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGF----MTEYVATRWY 175

Query: 696 R-------NSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY 731
           R           T  +DV+S G +L E++  +  F    G++Y
Sbjct: 176 RAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVF---KGKDY 215

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 77.6 bits (191), Expect = 2e-15
 Identities = 55/194 (28%), Positives = 97/194 (50%), Gaps = 10/194 (5%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTA-VAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           E++G+G+ G VY        +T   VA+K+++   Q  +    NE+ V+ +  H N+V  
Sbjct: 25  EKIGQGASGTVY---TAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNY 81

Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
           L     G    +V E+L  G+L   +         +   +  +  + L +LH +   Q+I
Sbjct: 82  LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALEFLHSN---QVI 137

Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK 703
           H DIK  NILL    + +++DFG    +T  QSK  ++ + GT  ++APE         K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPK 195

Query: 704 VDVYSFGVLLLEII 717
           VD++S G++ +E++
Sbjct: 196 VDIWSLGIMAIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 77.9 bits (192), Expect = 2e-15
 Identities = 66/223 (29%), Positives = 100/223 (44%), Gaps = 20/223 (8%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE---FKNEVFVIGQTHHKNLVRL 583
           +G+GSFG V    ++      A+   K D V +D + E    +  V  +    H  L  L
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALA-WEHPFLTHL 61

Query: 584 LGFC--DEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ 641
             FC     ++   V E+LN G L   +  + + +       A +I  GL +LH+     
Sbjct: 62  --FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKK---G 116

Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKIT 701
           II+ D+K  N+LLD     +I+DFG+ K     + K   +   GT  Y+APE  +  K  
Sbjct: 117 IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA--STFCGTPDYIAPEILKGQKYN 174

Query: 702 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 744
             VD +SFGVLL E++  +  F  E  +E        FD   N
Sbjct: 175 ESVDWWSFGVLLYEMLIGQSPFHGEDEDEL-------FDSILN 210

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 77.9 bits (192), Expect = 2e-15
 Identities = 67/216 (31%), Positives = 101/216 (46%), Gaps = 17/216 (7%)

Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFK-NEVFVIGQTHHKNL 580
           NF   +G+GSFG V     +      A+ + K D + QD + E    E  V+        
Sbjct: 3   NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPF 62

Query: 581 VRLLGFCDEGQNRL-LVYEFLNNGTLASFL--FGNLKPNWNLRTNIAF---QIARGLLYL 634
           +  L  C +  +RL  V E++N G L   +   G  K       +  F   +IA GL +L
Sbjct: 63  LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFK-----EPHAVFYAAEIAIGLFFL 117

Query: 635 HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 694
           H      II+ D+K  N++LD     +I+DFG+ K   +   KT +T   GT  Y+APE 
Sbjct: 118 H---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKE-NIFGGKTTRTFC-GTPDYIAPEI 172

Query: 695 FRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 730
                    VD ++FGVLL E+++ +  FD E  +E
Sbjct: 173 IAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE 208

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 76.2 bits (188), Expect = 4e-15
 Identities = 63/229 (27%), Positives = 114/229 (49%), Gaps = 41/229 (17%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE-------REFKNEVFVIGQTHH 577
           E++G G++G+VYK   + + +   VA+KK+ R+  + E       RE    + ++ + +H
Sbjct: 5   EKIGEGTYGVVYKA--RDKLTGEIVALKKI-RLETEDEGVPSTAIRE----ISLLKELNH 57

Query: 578 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNI----AFQIARGLLY 633
            N+VRLL          LV+EFL+   L  ++  +  P   L   +     +Q+ +G+ Y
Sbjct: 58  PNIVRLLDVVHSENKLYLVFEFLDL-DLKKYM--DSSPLTGLDPPLIKSYLYQLLQGIAY 114

Query: 634 LHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRG------TK 687
            H     +++H D+KPQN+L+D     +++DFGLA+   +         +R       T 
Sbjct: 115 CHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGV--------PVRTYTHEVVTL 163

Query: 688 GYVAPEWFRNSK-ITAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAI 733
            Y APE    S+  +  VD++S G +  E+++ R  F  D E+ + + I
Sbjct: 164 WYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRI 212

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 75.4 bits (185), Expect = 6e-15
 Identities = 49/153 (32%), Positives = 72/153 (47%), Gaps = 11/153 (7%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKL--DRVFQDGEREFKNEVFVIGQTHHKNLVR 582
           +E+G G FG V  G + +  +   V VK+L      Q+ + +F  E        H NL++
Sbjct: 1   KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQE-QMKFLEEAQPYRSLQHSNLLQ 59

Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFLFG-----NLKPNWNLRTNIAFQIARGLLYLHED 637
            LG C E    LLV EF   G L  +L        + P+      +A +IA GLL+LH  
Sbjct: 60  CLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH-- 117

Query: 638 CRAQIIHCDIKPQNILLDDYYTARISDFGLAKL 670
            +   IH D+  +N LL    T +I D+GL+  
Sbjct: 118 -KNNFIHSDLALRNCLLTADLTVKIGDYGLSHN 149

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 75.9 bits (186), Expect = 6e-15
 Identities = 53/193 (27%), Positives = 97/193 (50%), Gaps = 8/193 (4%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLL 584
           E++G+G+ G VY  +     +   VA+K+++   Q  +    NE+ V+ +  + N+V  L
Sbjct: 25  EKIGQGASGTVYTAI--DIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYL 82

Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIH 644
                G    +V E+L  G+L   +         +   +  +  + L +LH +   Q+IH
Sbjct: 83  DSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALDFLHSN---QVIH 138

Query: 645 CDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKV 704
            DIK  NILL    + +++DFG    +T  QSK  ++ + GT  ++APE         KV
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKV 196

Query: 705 DVYSFGVLLLEII 717
           D++S G++ +E++
Sbjct: 197 DIWSLGIMAIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 76.2 bits (188), Expect = 7e-15
 Identities = 53/210 (25%), Positives = 99/210 (47%), Gaps = 19/210 (9%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTA-VAVKKLDRVF---QDGEREFKNEVFVIGQTHHKNL 580
           E +G G++G+V   +    T +   VA+KK+   F      +R  + E+ ++    H N+
Sbjct: 11  ENIGSGAYGVVCSAI---DTRSGKKVAIKKIPHAFDVPTLAKRTLR-ELKILRHFKHDNI 66

Query: 581 VRLLGFC----DEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHE 636
           + +         + ++  +V + L    L   +  +            +Q+ RGL Y+H 
Sbjct: 67  IAIRDILRPPGADFKDVYVVMD-LMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHS 125

Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS--KTIKTAIRGTKGYVAPE- 693
              A +IH D+KP N+L+++    RI DFG+A+ L+ + +  K   T    T+ Y APE 
Sbjct: 126 ---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPEL 182

Query: 694 WFRNSKITAKVDVYSFGVLLLEIISCRKSF 723
                + T  +D++S G +  E++  R+ F
Sbjct: 183 LLSLPEYTTAIDMWSVGCIFAEMLGRRQLF 212

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 75.0 bits (184), Expect = 7e-15
 Identities = 66/218 (30%), Positives = 100/218 (45%), Gaps = 34/218 (15%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLD-RVFQDGEREF-KNEVFVIGQTHHKNL 580
           F   VG+GS+G V   +++ RT      +KKL+ R     ER+  + E  ++ Q  H N+
Sbjct: 4   FVRVVGKGSYGEV--SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI 61

Query: 581 VR--------------LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQ 626
           V               ++GFC+ G     +Y  L          G L P  N       Q
Sbjct: 62  VAYRESWEGEDGLLYIVMGFCEGGD----LYHKLKEQK------GKLLPE-NQVVEWFVQ 110

Query: 627 IARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGT 686
           IA  L YLHE     I+H D+K QN+ L      ++ D G+A++L  NQ     T I GT
Sbjct: 111 IAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLE-NQCDMASTLI-GT 165

Query: 687 KGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFD 724
             Y++PE F N     K DV++ G  + E+ + + +F+
Sbjct: 166 PYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFN 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 75.5 bits (185), Expect = 8e-15
 Identities = 53/193 (27%), Positives = 97/193 (50%), Gaps = 8/193 (4%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLL 584
           E++G+G+ G VY  +     +   VA+++++   Q  +    NE+ V+ +  + N+V  L
Sbjct: 26  EKIGQGASGTVYTAM--DVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYL 83

Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIH 644
                G    +V E+L  G+L   +         +   +  +  + L +LH +   Q+IH
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALEFLHSN---QVIH 139

Query: 645 CDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKV 704
            DIK  NILL    + +++DFG    +T  QSK  ++ + GT  ++APE         KV
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKV 197

Query: 705 DVYSFGVLLLEII 717
           D++S G++ +E+I
Sbjct: 198 DIWSLGIMAIEMI 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 75.8 bits (186), Expect = 9e-15
 Identities = 79/299 (26%), Positives = 131/299 (43%), Gaps = 47/299 (15%)

Query: 527 VGRGSFGIVYK----GVIQTR-TSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQT-HHKN 579
           +G G FG V      G+ + +      VAVK L D   +    +  +E+ ++     HKN
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 580 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA--------------- 624
           ++ LLG C +     ++ E+ + G L  +L     P      +IA               
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 625 -FQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAI 683
            +Q+ARG+ YL      + IH D+  +N+L+ +    +I+DFGLA+   +N     K   
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DVNNIDYYKKTT 197

Query: 684 RG--TKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAFD 740
            G     ++APE   +   T + DV+SFGVL+ EI +         G  Y  I  +  F 
Sbjct: 198 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG-------GSPYPGIPVEELFK 250

Query: 741 CYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 799
             + G        DK A     C  +L M+   C    PS RPT K++++ L+ ++ ++
Sbjct: 251 LLKEGHR-----MDKPA----NCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 75.4 bits (185), Expect = 1e-14
 Identities = 56/209 (26%), Positives = 111/209 (53%), Gaps = 25/209 (11%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGER-EFKNEVFVIGQTHHKNLVRL 583
           E++G G++  V+KG  +++ +   VA+K++    ++G       EV ++    H N+V L
Sbjct: 12  EKLGEGTYATVFKG--RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTL 69

Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ 641
                  ++  LV+E+L+   L  ++   GN+    N++  + +QI RGL Y H   R +
Sbjct: 70  HDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFL-YQILRGLAYCH---RRK 124

Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR----- 696
           ++H D+KPQN+L+++    +++DFGLA+      +K++ T     +  V   W+R     
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLAR------AKSVPTKTYSNE--VVTLWYRPPDVL 176

Query: 697 --NSKITAKVDVYSFGVLLLEIISCRKSF 723
             +S+ + ++D++  G +  E+ S R  F
Sbjct: 177 LGSSEYSTQIDMWGVGCIFFEMASGRPLF 205

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 75.8 bits (186), Expect = 1e-14
 Identities = 66/224 (29%), Positives = 111/224 (49%), Gaps = 37/224 (16%)

Query: 513 YKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEV 569
           Y++L+        +VG G++G V   +   RT    VA+KKL R FQ     +R ++ E+
Sbjct: 17  YRDLK--------QVGSGAYGTVCSAL-DRRTGAK-VAIKKLYRPFQSELFAKRAYR-EL 65

Query: 570 FVIGQTHHKNLVRLLGF--CDEGQNRL----LVYEFLNNGTLASFLFGNLKPNWNLRTNI 623
            ++    H+N++ LL     D   +R     LV  F+  GT    L  + K + +    +
Sbjct: 66  RLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFL 123

Query: 624 AFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAI 683
            +Q+ +GL Y+H    A IIH D+KP N+ +++    +I DFGLA+     Q+ +  T  
Sbjct: 124 VYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGY 175

Query: 684 RGTKGYVAPE----WFRNSKITAKVDVYSFGVLLLEIISCRKSF 723
             T+ Y APE    W      T  VD++S G ++ E+++ +  F
Sbjct: 176 VVTRWYRAPEVILNWMH---YTQTVDIWSVGCIMAEMLTGKPLF 216

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 75.4 bits (185), Expect = 1e-14
 Identities = 64/200 (32%), Positives = 91/200 (45%), Gaps = 9/200 (4%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE---FKNEVFVIGQTHHKNLVRL 583
           +G+GSFG V+   ++      A+   K D V  D + E    +  V  +    H  L  L
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW-EHPFLTHL 61

Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
                  +N   V E+LN G L   +    K +    T  A +I  GL +LH      I+
Sbjct: 62  YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK---GIV 118

Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK 703
           + D+K  NILLD     +I+DFG+ K   L  +KT      GT  Y+APE     K    
Sbjct: 119 YRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT--CTFCGTPDYIAPEILLGQKYNTS 176

Query: 704 VDVYSFGVLLLEIISCRKSF 723
           VD +SFGVLL E++  +  F
Sbjct: 177 VDWWSFGVLLYEMLIGQSPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 74.7 bits (183), Expect = 2e-14
 Identities = 53/192 (27%), Positives = 94/192 (48%), Gaps = 8/192 (4%)

Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLG 585
           ++G GS GIV   + + + S   VAVK +D   Q       NEV ++    H+N+V +  
Sbjct: 28  KIGEGSTGIVC--IAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYK 85

Query: 586 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHC 645
               G+   ++ EFL  G L   +    + N      +   + + L YLH      +IH 
Sbjct: 86  SYLVGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLHSQ---GVIHR 141

Query: 646 DIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVD 705
           DIK  +ILL      ++SDFG    ++ +  K  + ++ GT  ++APE    +    +VD
Sbjct: 142 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRTPYGTEVD 199

Query: 706 VYSFGVLLLEII 717
           ++S G++++E++
Sbjct: 200 IWSLGIMVIEMV 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 75.0 bits (184), Expect = 2e-14
 Identities = 87/318 (27%), Positives = 139/318 (43%), Gaps = 65/318 (20%)

Query: 527 VGRGSFGIVYK----GVIQTRTSTTA-VAVKKL-----DRVFQD--GEREFKNEVFVIGQ 574
           +G G FG V +    G+ ++R   T  VAVK L     D+   D   E E      +IG+
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMK---LIGK 76

Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNI----------- 623
             HKN++ LLG C +     ++ E+   G L  FL     P  +   +I           
Sbjct: 77  --HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFK 134

Query: 624 -----AFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT 678
                A+Q+ARG+ YL      + IH D+  +N+L+ +    +I+DFGLA+   ++    
Sbjct: 135 DLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVTEDNVMKIADFGLAR--GVHDIDY 189

Query: 679 IKTAIRGTK--GYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILT 735
            K    G     ++APE   +   T + DV+SFG+L+ EI +         G  Y  I  
Sbjct: 190 YKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLG-------GSPYPGIPV 242

Query: 736 DWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV 795
           +  F   R G        DK +     C  +L M+   C    P+ RPT K++++ L+ V
Sbjct: 243 EELFKLLREGHR-----MDKPS----NCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV 293

Query: 796 --------VEVSVPPNPY 805
                   +++S+P   Y
Sbjct: 294 LAAVSEEYLDLSMPFEQY 311

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 73.8 bits (181), Expect = 2e-14
 Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 15/211 (7%)

Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTT-AVAVKKLDRVFQDGERE-FKNEVFVI 572
           EL+  +   +  +G G FG + +G ++  +     VA+  L     D +R  F  E   +
Sbjct: 1   ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTL 60

Query: 573 GQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPNWNLRTNIAFQIAR 629
           GQ  H N+VRL G    G   ++V E+++NG L SFL    G L     +   +   +A 
Sbjct: 61  GQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLM--GMLPGLAS 118

Query: 630 GLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKG- 688
           G+ YL E      +H  +    +L++     +IS F     L  ++S+ I T + G    
Sbjct: 119 GMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSEAIYTTMSGKSPV 172

Query: 689 -YVAPEWFRNSKITAKVDVYSFGVLLLEIIS 718
            + APE  +    ++  DV+SFG+++ E++S
Sbjct: 173 LWAAPEAIQYHHFSSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 74.2 bits (182), Expect = 2e-14
 Identities = 69/239 (28%), Positives = 110/239 (46%), Gaps = 35/239 (14%)

Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFK----NEVFVIG---QTHHK 578
           E+G G++G VYK   +   S   VA+K + RV Q  E         EV ++       H 
Sbjct: 7   EIGVGAYGTVYKA--RDPHSGHFVALKSV-RV-QTNEDGLPLSTVREVALLKRLEAFDHP 62

Query: 579 NLVRLLGFC-----DEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGL 631
           N+VRL+  C     D      LV+E ++   L ++L     P     T  ++  Q  RGL
Sbjct: 63  NIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGL 121

Query: 632 LYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVA 691
            +LH +C   I+H D+KP+NIL+      +++DFGLA++ +   +    T +  T  Y A
Sbjct: 122 DFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA---LTPVVVTLWYRA 175

Query: 692 PEWFRNSKITAKVDVYSFGVLLLEIIS-----CRKSFDIEMGEEYAIL-----TDWAFD 740
           PE    S     VD++S G +  E+       C  S   ++G+ + ++      DW  D
Sbjct: 176 PEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 74.4 bits (182), Expect = 2e-14
 Identities = 52/196 (26%), Positives = 96/196 (48%), Gaps = 14/196 (7%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTT---AVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLV 581
           E++G+G+ G V+     T         VA+K+++   Q  +    NE+ V+ +  + N+V
Sbjct: 25  EKIGQGASGTVF-----TAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIV 79

Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ 641
             L     G    +V E+L  G+L   +         +   +  +  + L +LH +   Q
Sbjct: 80  NFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAA-VCRECLQALEFLHAN---Q 135

Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKIT 701
           +IH DIK  N+LL    + +++DFG    +T  QSK  ++ + GT  ++APE        
Sbjct: 136 VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYG 193

Query: 702 AKVDVYSFGVLLLEII 717
            KVD++S G++ +E++
Sbjct: 194 PKVDIWSLGIMAIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 75.6 bits (186), Expect = 2e-14
 Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 15/205 (7%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           +G G+FG+V+  V   R     VA+KK+  VFQ+    +R F+ E+ ++    H N++  
Sbjct: 8   IGYGAFGVVW-SVTDPR-DGKRVALKKMPNVFQNLVSCKRVFR-ELKMLCFFKHDNVLSA 64

Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN----IAFQIARGLLYLHEDCR 639
           L              ++    + S L   +     L ++      +QI RGL YLH    
Sbjct: 65  LDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHS--- 121

Query: 640 AQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSK 699
           A I+H DIKP N+L++     +I DFGLA++   ++SK + T    T+ Y APE    S+
Sbjct: 122 AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHM-TQEVVTQYYRAPEILMGSR 180

Query: 700 -ITAKVDVYSFGVLLLEIISCRKSF 723
             T+ VD++S G +  E++  R  F
Sbjct: 181 HYTSAVDIWSVGCIFAELLGRRILF 205

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 74.6 bits (183), Expect = 2e-14
 Identities = 55/198 (27%), Positives = 102/198 (51%), Gaps = 12/198 (6%)

Query: 527 VGRGSFGIVYKG--VIQTRTSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G G+FG VYKG  + +       VA+K+L +       +E  +E +V+    + ++ RL
Sbjct: 15  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74

Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           LG C     +L + + +  G L  ++     N+   + L  N   QIA+G+ YL E    
Sbjct: 75  LGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLEE---R 128

Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
           +++H D+  +N+L+      +I+DFGLAKLL  ++ +      +    ++A E   +   
Sbjct: 129 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIY 188

Query: 701 TAKVDVYSFGVLLLEIIS 718
           T + DV+S+GV + E+++
Sbjct: 189 THQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 74.3 bits (182), Expect = 2e-14
 Identities = 59/216 (27%), Positives = 110/216 (50%), Gaps = 25/216 (11%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGER-EFKNEVFVIGQTHHKNLVRL 583
           +++G G++  VYKG  +++ +   VA+K++    ++G       EV ++    H N+V L
Sbjct: 12  DKLGEGTYATVYKG--RSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTL 69

Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ 641
                  ++  LV+E+L+   L  +L   GN     N++  + FQ+ RGL Y H   R +
Sbjct: 70  HDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFL-FQLLRGLNYCH---RRK 124

Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI- 700
           ++H D+KPQN+L+++    +++DFGLA+      +K+I T     +  V   W+R   I 
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLAR------AKSIPTKTYSNE--VVTLWYRPPDIL 176

Query: 701 ------TAKVDVYSFGVLLLEIISCRKSFDIEMGEE 730
                 + ++D++  G +  E+ + R  F     EE
Sbjct: 177 LGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE 212

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 73.6 bits (181), Expect = 3e-14
 Identities = 74/289 (25%), Positives = 127/289 (43%), Gaps = 58/289 (20%)

Query: 530 GSFGIVYKGVI--QTRTSTTAVAVKKLDRVFQDGERE-----FKNEVFVIGQTHHKNLVR 582
           G+FG ++ G++  +       V VK +    +D   E        E  ++    H+N++ 
Sbjct: 17  GTFGRIFYGILIDEKPGKEEEVFVKTV----KDHASEIQVTLLLQESCLLYGLSHQNILP 72

Query: 583 LLGFCDEGQNRLLV-YEFLNNGTLASFL-FGNLKPNWNLRT-------NIAFQIARGLLY 633
           +L  C E      V Y ++N G L  FL    L    N +        ++A QIA G+ Y
Sbjct: 73  ILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSY 132

Query: 634 LHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAK--------LLTLNQSKTIKTAIRG 685
           LH   +  +IH DI  +N ++D+    +I+D  L++         L  N+++ +K     
Sbjct: 133 LH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK----- 184

Query: 686 TKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDCYR 743
              ++A E   N + ++  DV+SFGVLL E+++  ++   +I+  E  A L D     YR
Sbjct: 185 ---WMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG----YR 237

Query: 744 NGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQML 792
             +              I C  +L  V   C   DP  RP+  +++Q L
Sbjct: 238 LAQ-------------PINCPDELFAVMACCWALDPEERPSFSQLVQCL 273

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 73.7 bits (181), Expect = 3e-14
 Identities = 58/211 (27%), Positives = 113/211 (53%), Gaps = 19/211 (9%)

Query: 522 NFK--EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFK-NEVFVIGQTHHK 578
           NFK  E++G G++  VYKG  + RT+   VA+K++    ++G       E+ ++ +  H+
Sbjct: 1   NFKQLEKLGEGTYATVYKG--RNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHE 58

Query: 579 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFL-----FGNLKPNWNLRTNIAFQIARGLLY 633
           N+VRL          +LV+E+++   L  ++      G L PN     +  +Q+ +G+ +
Sbjct: 59  NIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPN--TVKSFTYQLLKGIAF 115

Query: 634 LHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE 693
            HE+   +++H D+KPQN+L++     +++DFGLA+   +  +      +  T  Y AP+
Sbjct: 116 CHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYRAPD 170

Query: 694 WFRNSKI-TAKVDVYSFGVLLLEIISCRKSF 723
               S+  +  +D++S G ++ E+I+ R  F
Sbjct: 171 VLLGSRTYSTSIDIWSVGCIMAEMITGRPLF 201

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 73.5 bits (180), Expect = 4e-14
 Identities = 56/209 (26%), Positives = 110/209 (52%), Gaps = 25/209 (11%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGER-EFKNEVFVIGQTHHKNLVRL 583
           +++G G++  V+KG  +++ +   VA+K++    ++G       EV ++    H N+V L
Sbjct: 11  DKLGEGTYATVFKG--RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTL 68

Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ 641
                  +   LV+E+L++  L  +L   GNL    N++    FQ+ RGL Y H   + +
Sbjct: 69  HDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKI-FMFQLLRGLSYCH---KRK 123

Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR----- 696
           I+H D+KPQN+L+++    +++DFGLA+      +K++ T     +  V   W+R     
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLAR------AKSVPTKTYSNE--VVTLWYRPPDVL 175

Query: 697 --NSKITAKVDVYSFGVLLLEIISCRKSF 723
             +++ +  +D++  G +L E+ + R  F
Sbjct: 176 LGSTEYSTPIDMWGVGCILYEMATGRPMF 204

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 72.9 bits (179), Expect = 4e-14
 Identities = 55/212 (25%), Positives = 102/212 (48%), Gaps = 27/212 (12%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLD-RVFQDGER-EFKNEVFVIGQTHHKNLVR 582
           +++G GSFG     +++++       +K+++       ER E + EV V+    H N+V+
Sbjct: 6   KKIGEGSFGKAI--LVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ 63

Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF----------QIARGLL 632
                +E  N  +V ++   G L   +        N +  + F          QI   L 
Sbjct: 64  YQESFEENGNLYIVMDYCEGGDLYKKI--------NAQRGVLFPEDQILDWFVQICLALK 115

Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 692
           ++H+    +I+H DIK QNI L    T ++ DFG+A++L  +  +  +T I GT  Y++P
Sbjct: 116 HVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLN-STVELARTCI-GTPYYLSP 170

Query: 693 EWFRNSKITAKVDVYSFGVLLLEIISCRKSFD 724
           E   N     K D+++ G +L E+ + + +F+
Sbjct: 171 EICENRPYNNKSDIWALGCVLYEMCTLKHAFE 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 73.2 bits (180), Expect = 4e-14
 Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 21/201 (10%)

Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGER--EFKNEVFVIGQTHHKNLVRL 583
           E+G G+FG VYK   Q + +    A K +    +  E   +F  E+ ++ +  H N+V L
Sbjct: 12  ELGDGAFGKVYK--AQHKETGLFAAAKIIQ--IESEEELEDFMVEIDILSECKHPNIVGL 67

Query: 584 L-GFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-NWNLRTNIAFQIARGLLYLHEDCRAQ 641
              +  E +  +L+ EF + G L S +    +         +  Q+   L +LH     +
Sbjct: 68  YEAYFYENKLWILI-EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---K 123

Query: 642 IIHCDIKPQNILLDDYYTARISDFGL-AKLLTLNQSKTIKTAIRGTKGYVAP-----EWF 695
           +IH D+K  NILL      +++DFG+ AK  +  Q +   T I GT  ++AP     E F
Sbjct: 124 VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRD--TFI-GTPYWMAPEVVACETF 180

Query: 696 RNSKITAKVDVYSFGVLLLEI 716
           +++    K D++S G+ L+E+
Sbjct: 181 KDNPYDYKADIWSLGITLIEL 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 74.3 bits (182), Expect = 4e-14
 Identities = 66/215 (30%), Positives = 103/215 (47%), Gaps = 39/215 (18%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           VG G++G V      T+T    VAVKKL R FQ     +R ++ E+ ++    H+N++ L
Sbjct: 25  VGSGAYGSVCAA-FDTKTGLR-VAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 81

Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTN----IAFQIARGLLYLH 635
           L      ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H
Sbjct: 82  LDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 137

Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
               A IIH D+KP N+ +++    +I DFGLA+           T    T GYVA  W+
Sbjct: 138 S---ADIIHRDLKPSNLAVNEDCELKILDFGLAR----------HTDDEMT-GYVATRWY 183

Query: 696 RNSKI-------TAKVDVYSFGVLLLEIISCRKSF 723
           R  +I          VD++S G ++ E+++ R  F
Sbjct: 184 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 218

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 73.5 bits (180), Expect = 5e-14
 Identities = 64/247 (25%), Positives = 108/247 (43%), Gaps = 40/247 (16%)

Query: 571 VIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN-------- 622
           +IG+  HKN++ LLG C +     ++ E+ + G L  +L     P      N        
Sbjct: 79  MIGK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQ 136

Query: 623 --------IAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN 674
                    A+Q+ARG+ YL      + IH D+  +N+L+ +    +I+DFGLA+ +   
Sbjct: 137 LSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 193

Query: 675 QSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYA 732
                 T  R    ++APE   +   T + DV+SFGVLL EI +   S    + + E + 
Sbjct: 194 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 253

Query: 733 ILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQML 792
           +L                  E         C  +L M+   C    PS RPT K++++ L
Sbjct: 254 LLK-----------------EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 296

Query: 793 EGVVEVS 799
           + ++ ++
Sbjct: 297 DRILALT 303

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 74.5 bits (183), Expect = 7e-14
 Identities = 53/174 (30%), Positives = 80/174 (45%), Gaps = 22/174 (12%)

Query: 631 LLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYV 690
           LL +H      +IH DIK  NILL      ++ DFG +K+     S  +     GT  YV
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212

Query: 691 APEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVL 750
           APE +R    + K D++S GVLL E+++ ++ FD E  EE    T         G+ + L
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKT-------LAGRYDPL 265

Query: 751 VGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM------LEGVVEV 798
                  M +I        V+   +  DP  RP+  K+L M      + G++E+
Sbjct: 266 PPSISPEMQEI--------VTA-LLSSDPKRRPSSSKLLNMPICKLFISGLLEI 310

Length = 496

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 73.0 bits (179), Expect = 9e-14
 Identities = 63/214 (29%), Positives = 101/214 (47%), Gaps = 9/214 (4%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFK-NEVFVIGQTHHKNLVRLLG 585
           +G+GSFG V    ++      AV V K D + QD + E    E  ++    +   +  L 
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 586 FCDEGQNRLL-VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIH 644
            C +  +RL  V EF+N G L   +  + + +       A +I   L++LH+     II+
Sbjct: 63  CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHD---KGIIY 119

Query: 645 CDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKV 704
            D+K  N+LLD     +++DFG+ K    N   T  +   GT  Y+APE  +       V
Sbjct: 120 RDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT--STFCGTPDYIAPEILQEMLYGPSV 177

Query: 705 DVYSFGVLLLEIISCRKSFDIEMGEEY--AILTD 736
           D ++ GVLL E++     F+ E  ++   AIL D
Sbjct: 178 DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND 211

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 72.4 bits (177), Expect = 9e-14
 Identities = 79/291 (27%), Positives = 136/291 (46%), Gaps = 38/291 (13%)

Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFK----NEVFVIGQTH---HK 578
           E+G G++G V+K     +     VA+K++ RV Q GE         EV V+       H 
Sbjct: 8   EIGEGAYGKVFKAR-DLKNGGRFVALKRV-RV-QTGEEGMPLSTIREVAVLRHLETFEHP 64

Query: 579 NLVRLLGFC-----DEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGL 631
           N+VRL   C     D      LV+E ++   L ++L    +P     T  ++ FQ+ RGL
Sbjct: 65  NVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGL 123

Query: 632 LYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVA 691
            +LH     +++H D+KPQNIL+      +++DFGLA++ +    +   T++  T  Y A
Sbjct: 124 DFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWYRA 177

Query: 692 PEWFRNSKITAKVDVYSFGVLLLEIISCRKSF----DI-EMGEEYAIL-----TDWAFDC 741
           PE    S     VD++S G +  E+   +  F    D+ ++G+   ++      DW  D 
Sbjct: 178 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 237

Query: 742 Y--RNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
              R    +      ++ + DI+ LGK +++   C+  +P+ R +    L 
Sbjct: 238 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLK--CLTFNPAKRISAYSALS 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 72.7 bits (179), Expect = 1e-13
 Identities = 40/101 (39%), Positives = 57/101 (56%), Gaps = 5/101 (4%)

Query: 625 FQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIK-TAI 683
           +QI RGL Y+H    A ++H D+KP N+LL+     +I DFGLA++       T   T  
Sbjct: 113 YQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEY 169

Query: 684 RGTKGYVAPEWFRNSK-ITAKVDVYSFGVLLLEIISCRKSF 723
             T+ Y APE   NSK  T  +D++S G +L E++S R  F
Sbjct: 170 VATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLF 210

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 72.1 bits (177), Expect = 1e-13
 Identities = 55/195 (28%), Positives = 101/195 (51%), Gaps = 13/195 (6%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKL---DRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           VG G+FG V+   ++ R S    A+K +   + +    E+   NE  V+ +  H  ++RL
Sbjct: 9   VGTGTFGRVHL--VRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL 66

Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
                + +   ++ E++  G L S+L  + + + +     A +I   L YLH     +I+
Sbjct: 67  FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHS---KEIV 123

Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK 703
           + D+KP+NILLD     +++DFG AK L  +++ T+     GT  Y+APE  ++      
Sbjct: 124 YRDLKPENILLDKEGHIKLTDFGFAKKLR-DRTWTLC----GTPEYLAPEVIQSKGHNKA 178

Query: 704 VDVYSFGVLLLEIIS 718
           VD ++ G+L+ E++ 
Sbjct: 179 VDWWALGILIYEMLV 193

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 71.5 bits (176), Expect = 1e-13
 Identities = 65/215 (30%), Positives = 97/215 (45%), Gaps = 15/215 (6%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAV--AVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLL 584
           +G G FG V   V     + T     VKK   V    +    +E  ++ + +H  +V+L 
Sbjct: 1   LGVGGFGRVEL-VKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY 59

Query: 585 -GFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ 641
             F D+ +   ++ E+   G L + L   G     +  R  IA  +     YLH      
Sbjct: 60  RTFKDK-KYIYMLMEYCLGGELWTILRDRGLF-DEYTARFYIA-CVVLAFEYLH---NRG 113

Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKIT 701
           II+ D+KP+N+LLD     ++ DFG AK L  +  KT  T   GT  YVAPE   N    
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKLK-SGQKT-WTFC-GTPEYVAPEIILNKGYD 170

Query: 702 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD 736
             VD +S G+LL E+++ R  F  +  +   I  D
Sbjct: 171 FSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYND 205

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 72.0 bits (177), Expect = 1e-13
 Identities = 56/213 (26%), Positives = 102/213 (47%), Gaps = 42/213 (19%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE--FKN----EVFVIGQTHHK 578
            ++G GS+G+V+K   + R +   VA+KK    F + E +   K     E+ ++ Q  H 
Sbjct: 7   SKIGEGSYGVVFK--CRNRETGQIVAIKK----FVESEDDPVIKKIALREIRMLKQLKHP 60

Query: 579 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK--PNWNLRTNIAFQIARGLLYLHE 636
           NLV L+      +   LV+E+ ++ T+ + L  N +  P   ++  I +Q  + + + H+
Sbjct: 61  NLVNLIEVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIK-KIIWQTLQAVNFCHK 118

Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKG----YVAP 692
                 IH D+KP+NIL+      ++ DFG A++LT            G       YVA 
Sbjct: 119 H---NCIHRDVKPENILITKQGQIKLCDFGFARILT------------GPGDDYTDYVAT 163

Query: 693 EWFR-------NSKITAKVDVYSFGVLLLEIIS 718
            W+R       +++    VDV++ G +  E+++
Sbjct: 164 RWYRAPELLVGDTQYGPPVDVWAIGCVFAELLT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 71.7 bits (175), Expect = 1e-13
 Identities = 63/207 (30%), Positives = 103/207 (49%), Gaps = 24/207 (11%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ-THHKNLVRL 583
           E VG G++G VYKG       T  +A  K+  V  D E E K E+ ++ + +HH+N+   
Sbjct: 12  ELVGNGTYGQVYKG---RHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATY 68

Query: 584 LG-FCDEGQNRL-----LVYEFLNNGTLASFLFGNLKPNWNLRTNIAF---QIARGLLYL 634
            G F  +    +     LV EF   G++   L  N K N      IA+   +I RGL +L
Sbjct: 69  YGAFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNTLKEEWIAYICREILRGLSHL 127

Query: 635 HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 694
           H+    ++IH DIK QN+LL +    ++ DFG++    L+++   +    GT  ++APE 
Sbjct: 128 HQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMAPEV 182

Query: 695 FR-----NSKITAKVDVYSFGVLLLEI 716
                  ++    K D++S G+  +E+
Sbjct: 183 IACDENPDATYDFKSDLWSLGITAIEM 209

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 71.6 bits (175), Expect = 1e-13
 Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 25/208 (12%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVK--KLDRVFQDGEREFKNEVFVIGQTHHKNLVRLL 584
           +G G FG V +G +    S   VAVK  K+    +    +F +E   + +  H N++RL+
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 585 GFCDEGQNR------LLVYEFLNNGTLASFLF----GNLKPNWNLRTNIAF--QIARGLL 632
           G C +          +++  F+ +G L SFL     G+       +  + F   IA G+ 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLL----TLNQSKTIKTAIRGTKG 688
           YL        IH D+  +N +L++     ++DFGL+K +       Q +  K  ++    
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVK---- 179

Query: 689 YVAPEWFRNSKITAKVDVYSFGVLLLEI 716
           ++A E   +   T K DV+SFGV + EI
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEI 207

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 70.8 bits (173), Expect = 2e-13
 Identities = 63/267 (23%), Positives = 122/267 (45%), Gaps = 23/267 (8%)

Query: 527 VGRGSFGIVYKGVI--QTRTSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G G+FG VYKG+           VA+K L +       +E  +E +V+       + RL
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74

Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNL-KPNWNLRTNIAFQIARGLLYLHEDCRAQI 642
           LG C     +L V + +  G L  ++  N  +       N   QIA+G+ YL E    ++
Sbjct: 75  LGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE---VRL 130

Query: 643 IHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITA 702
           +H D+  +N+L+      +I+DFGLA+LL +++++      +    ++A E   + + T 
Sbjct: 131 VHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTH 190

Query: 703 KVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIE 762
           + DV+S+GV + E++    +F  +            +D     ++  L+ + +       
Sbjct: 191 QSDVWSYGVTVWELM----TFGAK-----------PYDGIPAREIPDLLEKGERLPQPPI 235

Query: 763 CLGKLVMVSIWCIQEDPSLRPTMKKVL 789
           C   + M+ + C   D   RP  ++++
Sbjct: 236 CTIDVYMIMVKCWMIDSECRPRFRELV 262

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 71.6 bits (176), Expect = 2e-13
 Identities = 64/239 (26%), Positives = 96/239 (40%), Gaps = 43/239 (17%)

Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKK-LDRVFQDG-----EREFKNEVFVIGQT 575
               ++G G+FG VYK       +   VA+KK L    +DG      RE K    ++ + 
Sbjct: 11  EILGKLGEGTFGEVYKAR--QIKTGRVVALKKILMHNEKDGFPITALREIK----ILKKL 64

Query: 576 HHKNLVRLLGFC-----DEGQNRLLVY--EFLNNGTLASFLFGNLKPNWNLR----TNIA 624
            H N+V L+           + R  VY      +  L+  L  N  P+  L         
Sbjct: 65  KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLL-EN--PSVKLTESQIKCYM 121

Query: 625 FQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIR 684
            Q+  G+ YLHE     I+H DIK  NIL+D+    +I+DFGLA+               
Sbjct: 122 LQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGG 178

Query: 685 GTKGY---VAPEWFR-------NSKITAKVDVYSFGVLLLEIISCRKSF----DIEMGE 729
           GT+ Y   V   W+R         + T  VD++  G +  E+ + R       DI+   
Sbjct: 179 GTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLH 237

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 70.9 bits (174), Expect = 2e-13
 Identities = 50/202 (24%), Positives = 96/202 (47%), Gaps = 24/202 (11%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKN---EVFVIGQTHHKNLV 581
           E++G G++G V+K     R +   VA+K++ R+  D E    +   E+ ++ +  HKN+V
Sbjct: 6   EKIGEGTYGTVFKAK--NRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKHKNIV 62

Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ 641
           RL       +   LV+E+ +      F   N   +  +  +  FQ+ +GL + H      
Sbjct: 63  RLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH---N 119

Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI- 700
           ++H D+KPQN+L++     +++DFGLA+   +         +R     V   W+R   + 
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLARAFGI--------PVRCYSAEVVTLWYRPPDVL 171

Query: 701 ------TAKVDVYSFGVLLLEI 716
                 +  +D++S G +  E+
Sbjct: 172 FGAKLYSTSIDMWSAGCIFAEL 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 72.0 bits (176), Expect = 2e-13
 Identities = 60/200 (30%), Positives = 97/200 (48%), Gaps = 21/200 (10%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           +G G+ GIV             VAVKKL R FQ+    +R ++ E+ ++   +HKN++ L
Sbjct: 29  IGSGAQGIVCAAF--DTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISL 85

Query: 584 LGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHED 637
           L         +E Q+  LV E ++   L   +   L  +    + + +Q+  G+ +LH  
Sbjct: 86  LNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIHMEL--DHERMSYLLYQMLCGIKHLHS- 141

Query: 638 CRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRN 697
             A IIH D+KP NI++    T +I DFGLA+    N    + T    T+ Y APE    
Sbjct: 142 --AGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN---FMMTPYVVTRYYRAPEVILG 196

Query: 698 SKITAKVDVYSFGVLLLEII 717
                 VD++S G ++ E++
Sbjct: 197 MGYKENVDIWSVGCIMGELV 216

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 71.4 bits (175), Expect = 3e-13
 Identities = 61/201 (30%), Positives = 98/201 (48%), Gaps = 28/201 (13%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           VG G+FG+V     Q       VA+KK+ + F      +R ++ E+ ++    H+N++ L
Sbjct: 18  VGMGAFGLVCSARDQLTG--QNVAIKKIMKPFSTPVLAKRTYR-ELKLLKHLRHENIISL 74

Query: 584 LG-FCDEGQNRLLVYEFLNNGT-LASFL-FGNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
              F    ++   V E L  GT L   L    L+  +       +QI RGL Y+H    A
Sbjct: 75  SDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQF--IQYFLYQILRGLKYVHS---A 127

Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE----WFR 696
            ++H D+KP NIL+++    +I DFGLA++    Q   + T    T+ Y APE    W  
Sbjct: 128 GVVHRDLKPSNILINENCDLKICDFGLARI----QDPQM-TGYVSTRYYRAPEIMLTW-- 180

Query: 697 NSKITAKVDVYSFGVLLLEII 717
             K   +VD++S G +  E++
Sbjct: 181 -QKYDVEVDIWSAGCIFAEML 200

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 71.2 bits (175), Expect = 3e-13
 Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 27/208 (12%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ---DGEREFKNEVFVIGQTHHKNLVRL 583
           +GRG++GIV         +   VA+KK+   F    D +R  + E+ ++    H+N++ +
Sbjct: 13  IGRGAYGIVCSAK--NSETNEKVAIKKIANAFDNRIDAKRTLR-EIKLLRHLDHENVIAI 69

Query: 584 LGFCDEGQNR-----LLVYEFLNNGTLASFLFGNLKPNWNLRTN----IAFQIARGLLYL 634
                           +VYE ++       L   ++ +  L  +      +Q+ RGL Y+
Sbjct: 70  KDIMPPPHREAFNDVYIVYELMDTD-----LHQIIRSSQTLSDDHCQYFLYQLLRGLKYI 124

Query: 635 HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 694
           H    A ++H D+KP N+LL+     +I DFGLA+  T ++     T    T+ Y APE 
Sbjct: 125 HS---ANVLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVVTRWYRAPEL 179

Query: 695 FRN-SKITAKVDVYSFGVLLLEIISCRK 721
             N S+ T  +DV+S G +  E++  RK
Sbjct: 180 LLNCSEYTTAIDVWSVGCIFAELLG-RK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 71.2 bits (174), Expect = 4e-13
 Identities = 68/214 (31%), Positives = 102/214 (47%), Gaps = 13/214 (6%)

Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKN-EVFVIGQTHHKNL 580
           NF   +G+GSFG V     +      A+ + K D V QD + E    E  V+  +     
Sbjct: 3   NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPF 62

Query: 581 VRLLGFCDEGQNRL-LVYEFLNNGTLASFL--FGNLK-PNWNLRTNIAFQIARGLLYLHE 636
           +  L  C +  +RL  V E++N G L   +   G  K P+       A +IA GL +LH 
Sbjct: 63  LTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPH---AVFYAAEIAIGLFFLHS 119

Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR 696
                II+ D+K  N++LD     +I+DFG+ K    +   T KT   GT  Y+APE   
Sbjct: 120 K---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD-GVTTKTFC-GTPDYIAPEIIA 174

Query: 697 NSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 730
                  VD ++FGVLL E+++ +  F+ E  +E
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 208

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 70.4 bits (172), Expect = 4e-13
 Identities = 63/207 (30%), Positives = 104/207 (50%), Gaps = 24/207 (11%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ-THHKNLVRL 583
           E VG G++G VYKG       T  +A  K+  V +D E E K E+ ++ + +HH+N+   
Sbjct: 22  EVVGNGTYGQVYKG---RHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATY 78

Query: 584 LG-FCDE---GQNR--LLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF---QIARGLLYL 634
            G F  +   G +    LV EF   G++   L  N K N      IA+   +I RGL +L
Sbjct: 79  YGAFIKKSPPGHDDQLWLVMEFCGAGSVTD-LVKNTKGNALKEDWIAYICREILRGLAHL 137

Query: 635 HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 694
           H     ++IH DIK QN+LL +    ++ DFG++    L+++   +    GT  ++APE 
Sbjct: 138 HAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMAPEV 192

Query: 695 FR-----NSKITAKVDVYSFGVLLLEI 716
                  ++    + D++S G+  +E+
Sbjct: 193 IACDENPDATYDYRSDIWSLGITAIEM 219

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 69.8 bits (171), Expect = 7e-13
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 36/211 (17%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE-REFKNEVFVIGQTHH-KNLVR 582
           EE+GRG++G+V K  ++   + T +AVK++       E +    ++ +  ++      V 
Sbjct: 7   EELGRGAYGVVDK--MRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVT 64

Query: 583 LLG---------FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNI----AFQIAR 629
             G          C E          + + +L  F          +  +I    A  I +
Sbjct: 65  FYGALFREGDVWICME----------VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVK 114

Query: 630 GLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGY 689
            L YLH   +  +IH D+KP N+L++     ++ DFG++  L  + +KTI     G K Y
Sbjct: 115 ALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDA---GCKPY 169

Query: 690 VAPEWF---RNSK-ITAKVDVYSFGVLLLEI 716
           +APE      N K    K DV+S G+ ++E+
Sbjct: 170 MAPERINPELNQKGYDVKSDVWSLGITMIEL 200

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 70.0 bits (171), Expect = 7e-13
 Identities = 72/305 (23%), Positives = 126/305 (41%), Gaps = 46/305 (15%)

Query: 523 FKEEVGRGSFGIVYKGVIQT--------------RTSTTAVAVKKL-DRVFQDGEREFKN 567
           FKE++G G FG V+   +                +     VAVK L     ++   +F  
Sbjct: 9   FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68

Query: 568 EVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN--------------- 612
           EV ++ +    N++RLLG C +     ++ E++ NG L  FL  +               
Sbjct: 69  EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128

Query: 613 ----LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLA 668
                  +++   ++A QIA G+ YL        +H D+  +N L+ +  T +I+DFG++
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRDLATRNCLVGENLTIKIADFGMS 185

Query: 669 KLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEM 727
           + L       I+        ++A E     K T   DV++FGV L EI+  C++    E+
Sbjct: 186 RNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGEL 245

Query: 728 GEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKK 787
            +E  I  + A + +R+    V +           C   L  + + C   D   RP+   
Sbjct: 246 TDEQVI--ENAGEFFRDQGRQVYLFRPP------PCPQGLYELMLQCWSRDCRERPSFSD 297

Query: 788 VLQML 792
           +   L
Sbjct: 298 IHAFL 302

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 69.6 bits (170), Expect = 9e-13
 Identities = 65/213 (30%), Positives = 99/213 (46%), Gaps = 7/213 (3%)

Query: 520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKN-EVFVIGQTHHK 578
             NF   +G+GSFG V     +      A+ + K D V QD + E    E  V+      
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60

Query: 579 NLVRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHED 637
             +  L  C +  +RL  V E++N G L   +    K         A +I+ GL +LH  
Sbjct: 61  PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLH-- 118

Query: 638 CRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRN 697
            R  II+ D+K  N++LD     +I+DFG+ K   +    T +T   GT  Y+APE    
Sbjct: 119 -RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKE-HMVDGVTTRTFC-GTPDYIAPEIIAY 175

Query: 698 SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 730
                 VD +++GVLL E+++ +  FD E  +E
Sbjct: 176 QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE 208

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 69.1 bits (169), Expect = 1e-12
 Identities = 64/269 (23%), Positives = 121/269 (44%), Gaps = 24/269 (8%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVR 582
           ++E +G G+ G VYK          AV V  LD +  + +++  +E+ ++ +     ++ 
Sbjct: 5   YQEILGHGNGGTVYKAYHLLTRRILAVKVIPLD-ITVELQKQIMSELEILYKCDSPYIIG 63

Query: 583 LLG-FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
             G F  E  NR+ +  EF++ G+L   ++  + P   L   IA  + +GL YL      
Sbjct: 64  FYGAFFVE--NRISICTEFMDGGSLD--VYRKI-PEHVL-GRIAVAVVKGLTYLWS---L 114

Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
           +I+H D+KP N+L++     ++ DFG++  L      +I     GT  Y+APE     + 
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV----NSIAKTYVGTNAYMAPERISGEQY 170

Query: 701 TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMND 760
               DV+S G+  +E+   R  +      + +++      C        +V ED   +  
Sbjct: 171 GIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQC--------IVDEDPPVLPV 222

Query: 761 IECLGKLVMVSIWCIQEDPSLRPTMKKVL 789
            +   K V     C+++ P  RP  + ++
Sbjct: 223 GQFSEKFVHFITQCMRKQPKERPAPENLM 251

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 68.7 bits (168), Expect = 1e-12
 Identities = 55/206 (26%), Positives = 95/206 (46%), Gaps = 21/206 (10%)

Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKN----EVFVIGQTHHKNLV 581
           ++G G+ G V K  ++   + T +A K    V    +   +     E+ ++ +     +V
Sbjct: 12  DLGAGNGGSVSK--VKHIPTGTVMAKKV---VHIGAKSSVRKQILRELQIMHECRSPYIV 66

Query: 582 RLLG-FCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLHEDC 638
              G F +E  N  +  EF++ G+L       G +     +   IA  +  GL YL+   
Sbjct: 67  SFYGAFLNEN-NICMCMEFMDCGSLDRIYKKGGPIPVE--ILGKIAVAVVEGLTYLYNVH 123

Query: 639 RAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNS 698
           R  I+H DIKP NIL++     ++ DFG++  L      +I     GT  Y++PE  +  
Sbjct: 124 R--IMHRDIKPSNILVNSRGQIKLCDFGVSGELI----NSIADTFVGTSTYMSPERIQGG 177

Query: 699 KITAKVDVYSFGVLLLEIISCRKSFD 724
           K T K DV+S G+ ++E+   +  F 
Sbjct: 178 KYTVKSDVWSLGISIIELALGKFPFA 203

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 69.2 bits (170), Expect = 1e-12
 Identities = 50/236 (21%), Positives = 93/236 (39%), Gaps = 64/236 (27%)

Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE-------REFKNEVFVIGQTHHK 578
            +GRG++G VYK   +        A+KK     +          R    E+ ++ +  H+
Sbjct: 7   CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACR----EIALLRELKHE 62

Query: 579 NLVRLLGFCDEGQNRL--LVYEF-------------------LNNGTLASFLFGNLKPNW 617
           N+V L+    E  ++   L++++                   +    + S L        
Sbjct: 63  NVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLL-------- 114

Query: 618 NLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILL----DDYYTARISDFGLAKLLTL 673
                  +QI  G+ YLH +    ++H D+KP NIL+     +    +I D GLA+L   
Sbjct: 115 -------WQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF-- 162

Query: 674 NQSKTIKTAIRG-----TKGYVAPEWFRNSK-ITAKVDVYSFGVLLLEIISCRKSF 723
             +  +K          T  Y APE    ++  T  +D+++ G +  E+++    F
Sbjct: 163 --NAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIF 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 68.9 bits (168), Expect = 1e-12
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 25/208 (12%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ-THHKNLVRL 583
           E +G+G++G VYK  +  +   +  AVK LD +  D + E + E  ++    +H N+V+ 
Sbjct: 28  ETIGKGTYGKVYK--VTNKKDGSLAAVKILDPI-SDVDEEIEAEYNILQSLPNHPNVVKF 84

Query: 584 LGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR----TNIAFQIARGLLY 633
            G          GQ   LV E  N G++   + G L     L     + I +    GL +
Sbjct: 85  YGMFYKADKLVGGQ-LWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQH 143

Query: 634 LHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE 693
           LH +   +IIH D+K  NILL      ++ DFG++  LT   ++  +    GT  ++APE
Sbjct: 144 LHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT--STRLRRNTSVGTPFWMAPE 198

Query: 694 WFR-----NSKITAKVDVYSFGVLLLEI 716
                   +    A+ DV+S G+  +E+
Sbjct: 199 VIACEQQYDYSYDARCDVWSLGITAIEL 226

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 69.4 bits (170), Expect = 2e-12
 Identities = 64/215 (29%), Positives = 99/215 (46%), Gaps = 51/215 (23%)

Query: 527 VGRGSFGIV---YKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNL 580
           +G G+ GIV   Y  V         VA+KKL R FQ+    +R ++ E+ ++   +HKN+
Sbjct: 24  IGSGAQGIVCAAYDTVTGQN-----VAIKKLSRPFQNVTHAKRAYR-ELVLMKLVNHKNI 77

Query: 581 VRLLG-FC-----DEGQNRLLVYEF------------LNNGTLASFLFGNLKPNWNLRTN 622
           + LL  F      +E Q+  LV E             L++  ++  L             
Sbjct: 78  IGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLL------------- 124

Query: 623 IAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTA 682
             +Q+  G+ +LH    A IIH D+KP NI++    T +I DFGLA+  T   S  + T 
Sbjct: 125 --YQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTS-FMMTP 176

Query: 683 IRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEII 717
              T+ Y APE          VD++S G ++ E+I
Sbjct: 177 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 211

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin

 Score = 64.3 bits (157), Expect = 2e-12
 Identities = 40/119 (33%), Positives = 50/119 (42%), Gaps = 10/119 (8%)

Query: 40  TSSSPWLSPSGDFAFGFHQLDEENNTNDLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRG 99
           +S    +S +  F  GF  L      ND     I Y     +TVVW   N+D NP V   
Sbjct: 5   SSGQTLVSGNSLFELGFFTL---IMQNDY--NLILYKSSS-RTVVWVA-NRD-NP-VSDS 55

Query: 100 SQVKLTADQGLVLNDPQGKQVWSSKIDIGT-VAVGHMNDTGNFVLASSSSGRLWDSFSN 157
             + L +D  LVL D  G+ VWSS         V  + D GN V+  S    LW SF  
Sbjct: 56  CTLTLQSDGNLVLYDGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYDSDGNFLWQSFDY 114

Length = 114

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 69.0 bits (169), Expect = 2e-12
 Identities = 64/219 (29%), Positives = 106/219 (48%), Gaps = 36/219 (16%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ---DGEREFKNEVFVIGQTHHKNLV 581
           E +G+GS+G+V    I T T    VA+KK++ VF+   D  R  + E+ ++    H ++V
Sbjct: 6   EVIGKGSYGVVC-SAIDTHTGEK-VAIKKINDVFEHVSDATRILR-EIKLLRLLRHPDIV 62

Query: 582 RLLGFC-----DEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN----IAFQIARGLL 632
            +          E ++  +V+E +      S L   +K N +L         +Q+ R L 
Sbjct: 63  EIKHIMLPPSRREFKDIYVVFELME-----SDLHQVIKANDDLTPEHHQFFLYQLLRALK 117

Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 692
           Y+H    A + H D+KP+NIL +     +I DFGLA++   +      TAI  T  YVA 
Sbjct: 118 YIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP----TAIFWTD-YVAT 169

Query: 693 EWFRN--------SKITAKVDVYSFGVLLLEIISCRKSF 723
            W+R         SK T  +D++S G +  E+++ +  F
Sbjct: 170 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 208

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 68.0 bits (166), Expect = 2e-12
 Identities = 67/286 (23%), Positives = 123/286 (43%), Gaps = 37/286 (12%)

Query: 527 VGRGSFGIVYKGVIQTRTST---TAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G+G FG V +  +++   +    AV + K D        EF  E   + +  H N+++L
Sbjct: 7   LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66

Query: 584 LGFC--DEGQNRL----LVYEFLNNGTLASFLF----GNLKPNWNLRTNIAF--QIARGL 631
           +G       + RL    ++  F+ +G L +FL     G       L+T + F   IA G+
Sbjct: 67  IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126

Query: 632 LYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVA 691
            YL        IH D+  +N +L++  T  ++DFGL+K +          A +    ++A
Sbjct: 127 EYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLA 183

Query: 692 PEWFRNSKITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDCYRNGKLNV 749
            E   ++  T   DV++FGV + EI++  ++    +E  E Y                N 
Sbjct: 184 LESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIY----------------NY 227

Query: 750 LVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV 795
           L+  ++      +CL  +  +   C   +P  RP+ + +   LE +
Sbjct: 228 LIKGNR-LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 68.1 bits (166), Expect = 2e-12
 Identities = 57/211 (27%), Positives = 107/211 (50%), Gaps = 29/211 (13%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFK--NEVFVIGQTHHKNLVR 582
           E++G GS+  VYKG+  +R +   VA+K +    ++G   F    E  ++    H N+V 
Sbjct: 11  EKLGEGSYATVYKGI--SRINGQLVALKVISMKTEEG-VPFTAIREASLLKGLKHANIVL 67

Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPNWNLRTNIAFQIARGLLYLHEDCR 639
           L       +    V+E+++   LA ++    G L P +N+R    FQ+ RGL Y+H    
Sbjct: 68  LHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHP-YNVRL-FMFQLLRGLAYIH---G 121

Query: 640 AQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR--- 696
             I+H D+KPQN+L+      +++DFGLA+      +K+I +    ++  V   W+R   
Sbjct: 122 QHILHRDLKPQNLLISYLGELKLADFGLAR------AKSIPSQTYSSE--VVTLWYRPPD 173

Query: 697 ----NSKITAKVDVYSFGVLLLEIISCRKSF 723
                +  ++ +D++  G + +E++  + +F
Sbjct: 174 VLLGATDYSSALDIWGAGCIFIEMLQGQPAF 204

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 68.4 bits (167), Expect = 3e-12
 Identities = 60/200 (30%), Positives = 92/200 (46%), Gaps = 9/200 (4%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE---FKNEVFVIGQTHHKNLVRL 583
           +G+GSFG V    ++ +    AV   K D V  D + E    +  V  +    +  L  L
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAW-ENPFLTHL 61

Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
                  ++   V EFLN G L   +    + +    T  A +I  GL +LH      II
Sbjct: 62  YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK---GII 118

Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK 703
           + D+K  N++LD     +I+DFG+ K      ++   +   GT  Y+APE  +  K T  
Sbjct: 119 YRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA--STFCGTPDYIAPEILQGLKYTFS 176

Query: 704 VDVYSFGVLLLEIISCRKSF 723
           VD +SFGVLL E++  +  F
Sbjct: 177 VDWWSFGVLLYEMLIGQSPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 67.9 bits (166), Expect = 4e-12
 Identities = 60/216 (27%), Positives = 106/216 (49%), Gaps = 13/216 (6%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE---FKNEVFVIGQTHHKNLVRL 583
           +G+GSFG V    ++      A+ V K D + QD + +    +  +  +   H    +  
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKH--PFLTA 60

Query: 584 LGFCDEGQNRLL-VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQI 642
           L  C + ++RL  V E++N G L   +  + K +       A ++   L++LH   R  +
Sbjct: 61  LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLH---RHGV 117

Query: 643 IHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITA 702
           I+ D+K  NILLD     +++DFG+ K   LN   T  T   GT  Y+APE  +  +   
Sbjct: 118 IYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT--TTFCGTPDYIAPEILQELEYGP 175

Query: 703 KVDVYSFGVLLLEIISCRKSFDIEMGEEY--AILTD 736
            VD ++ GVL+ E+++ +  F+ +  ++   +IL D
Sbjct: 176 SVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD 211

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 67.7 bits (165), Expect = 4e-12
 Identities = 70/220 (31%), Positives = 103/220 (46%), Gaps = 22/220 (10%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKN---EVFVIGQTHHKNLVRL 583
           +G+GSFG V +  ++ R +    A+K + +       E  +   E  V+ Q +   +V L
Sbjct: 1   IGKGSFGKVMQ--VRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL 58

Query: 584 LGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIA-FQIARGLLYLHEDCRAQ 641
             F  +   +L LV  F+N G L    F +L+       + A F  A  L  L    +  
Sbjct: 59  -KFSFQSPEKLYLVLAFINGGEL----FHHLQREGRFDLSRARFYTAELLCALENLHKFN 113

Query: 642 IIHCDIKPQNILLDDYYTARIS--DFGLAKLLTLNQSKTIKT-AIRGTKGYVAPEWFRNS 698
           +I+ D+KP+NILLD  Y   I+  DFGL K   LN     KT    GT  Y+APE     
Sbjct: 114 VIYRDLKPENILLD--YQGHIALCDFGLCK---LNMKDDDKTNTFCGTPEYLAPELLLGH 168

Query: 699 KITAKVDVYSFGVLLLEIISCRKSF-DIEMGEEY-AILTD 736
             T  VD ++ GVLL E+++    F D  + E Y  IL +
Sbjct: 169 GYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE 208

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 68.0 bits (166), Expect = 4e-12
 Identities = 59/221 (26%), Positives = 104/221 (47%), Gaps = 39/221 (17%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           VG G++G V    I  RT    VA+KKL R FQ     +R ++ E+ ++    H+N++ L
Sbjct: 23  VGSGAYGSVCSA-IDKRTGEK-VAIKKLSRPFQSEIFAKRAYR-ELTLLKHMQHENVIGL 79

Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN------IAFQIARGLLYLHED 637
           L   D   + +   EF +   +  ++  +L+       +      + +Q+  GL Y+H  
Sbjct: 80  L---DVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIH-- 134

Query: 638 CRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRN 697
             A IIH D+KP N+ +++    +I DFGLA           + A     GYV   W+R 
Sbjct: 135 -SAGIIHRDLKPGNLAVNEDCELKILDFGLA-----------RHADAEMTGYVVTRWYRA 182

Query: 698 SKI-------TAKVDVYSFGVLLLEIISCRKSFDIEMGEEY 731
            ++          VD++S G ++ E+++ +  F    G++Y
Sbjct: 183 PEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFK---GKDY 220

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 67.4 bits (164), Expect = 4e-12
 Identities = 54/199 (27%), Positives = 96/199 (48%), Gaps = 17/199 (8%)

Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLG 585
           E+G G+FG VYK   Q + +    A K +D   ++   ++  E+ ++    H N+V+LL 
Sbjct: 12  ELGDGAFGKVYKA--QNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLD 69

Query: 586 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF-QIARGLLYLHEDCRAQIIH 644
                 N  ++ EF   G + + +    +P    +  +   Q    L YLHE+   +IIH
Sbjct: 70  AFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIH 126

Query: 645 CDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI--KTAIRGTKGYVAPEWF-----RN 697
            D+K  NIL       +++DFG++       ++TI  + +  GT  ++APE       ++
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSA----KNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 182

Query: 698 SKITAKVDVYSFGVLLLEI 716
                K DV+S G+ L+E+
Sbjct: 183 RPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 67.8 bits (165), Expect = 4e-12
 Identities = 65/214 (30%), Positives = 96/214 (44%), Gaps = 37/214 (17%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD--GEREFKNEVFVIGQTHHKNLVRLL 584
           VG G++G V      TR     VAVKKL R FQ     R    E+ ++    H+N++ LL
Sbjct: 23  VGSGAYGSVCSA-YDTRLRQK-VAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80

Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTN----IAFQIARGLLYLHE 636
                  +     E  N   L + L G    N+     L       + +Q+ RGL Y+H 
Sbjct: 81  DVFTPATS----IENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHS 136

Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR 696
              A IIH D+KP N+ +++    RI DFGLA+     Q+    T      GYVA  W+R
Sbjct: 137 ---AGIIHRDLKPSNVAVNEDCELRILDFGLAR-----QADDEMT------GYVATRWYR 182

Query: 697 NSKI-------TAKVDVYSFGVLLLEIISCRKSF 723
             +I          VD++S G ++ E++  +  F
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLKGKALF 216

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 67.4 bits (164), Expect = 6e-12
 Identities = 63/202 (31%), Positives = 98/202 (48%), Gaps = 9/202 (4%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREF-KNEVFVIGQTHHKNLVRLLG 585
           +GRGS+  V    ++      A+ V K + V  D + ++ + E  V  Q      +  L 
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62

Query: 586 FCDEGQNRL-LVYEFLNNGTLASFLFGNLK-PNWNLRTNIAFQIARGLLYLHEDCRAQII 643
            C +  +RL LV E++N G L   +    K P  + R   A +I   L +LHE     II
Sbjct: 63  SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAA-EICIALNFLHE---RGII 118

Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK 703
           + D+K  N+LLD     +++D+G+ K   L    T  T   GT  Y+APE  R  +    
Sbjct: 119 YRDLKLDNVLLDADGHIKLTDYGMCKE-GLGPGDTTSTFC-GTPNYIAPEILRGEEYGFS 176

Query: 704 VDVYSFGVLLLEIISCRKSFDI 725
           VD ++ GVL+ E+++ R  FDI
Sbjct: 177 VDWWALGVLMFEMMAGRSPFDI 198

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 67.4 bits (164), Expect = 6e-12
 Identities = 50/193 (25%), Positives = 100/193 (51%), Gaps = 11/193 (5%)

Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGER-EFKNEVFVIGQTHHKNLVRLL 584
           E+G G+ G+V K  +Q + S   +A K +    +   R +   E+ V+ + +   +V   
Sbjct: 12  ELGAGNGGVVTK--VQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFY 69

Query: 585 G-FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
           G F  +G+  + + E ++ G+L   L    +    +   ++  + RGL YL E  + QI+
Sbjct: 70  GAFYSDGEISICM-EHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLRE--KHQIM 126

Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK 703
           H D+KP NIL++     ++ DFG++  L      ++  +  GT+ Y++PE  + +  + +
Sbjct: 127 HRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMSPERLQGTHYSVQ 182

Query: 704 VDVYSFGVLLLEI 716
            D++S G+ L+E+
Sbjct: 183 SDIWSMGLSLVEL 195

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 66.9 bits (163), Expect = 7e-12
 Identities = 62/248 (25%), Positives = 108/248 (43%), Gaps = 51/248 (20%)

Query: 523 FKEEVGRGSFGIVY----KGVIQ----------TRTSTTAVAVKKL-DRVFQDGEREFKN 567
           FKE++G G FG V+    +G+ +          +      VAVK L +   ++   +F  
Sbjct: 9   FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68

Query: 568 EVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL------------------ 609
           E+ ++ +    N++RLL  C       ++ E++ NG L  FL                  
Sbjct: 69  EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128

Query: 610 FGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAK 669
           +  L         +A QIA G+ YL        +H D+  +N L+   YT +I+DFG+++
Sbjct: 129 YSTLI-------FMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGMSR 178

Query: 670 LLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMG 728
            L       I+        +++ E     K T   DV++FGV L EI++ C++       
Sbjct: 179 NLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKE------- 231

Query: 729 EEYAILTD 736
           + Y+ L+D
Sbjct: 232 QPYSQLSD 239

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 66.6 bits (162), Expect = 7e-12
 Identities = 55/206 (26%), Positives = 103/206 (50%), Gaps = 31/206 (15%)

Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLG 585
           E+G G+FG VYK   + + +    A K ++   ++   ++  E+ ++   +H  +V+LLG
Sbjct: 19  ELGDGAFGKVYKA--KNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLG 76

Query: 586 -FCDEGQNRLLVYEFLNNGTLASFLF----GNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
            F  +G+  +++ EF   G + + +     G  +P   +   I  Q+   L YLH     
Sbjct: 77  AFYWDGKLWIMI-EFCPGGAVDAIMLELDRGLTEPQIQV---ICRQMLEALQYLHS---M 129

Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIR-----GTKGYVAP--- 692
           +IIH D+K  N+LL      +++DFG++       +K +KT  R     GT  ++AP   
Sbjct: 130 KIIHRDLKAGNVLLTLDGDIKLADFGVS-------AKNVKTLQRRDSFIGTPYWMAPEVV 182

Query: 693 --EWFRNSKITAKVDVYSFGVLLLEI 716
             E  +++    K D++S G+ L+E+
Sbjct: 183 MCETMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 66.3 bits (161), Expect = 1e-11
 Identities = 56/211 (26%), Positives = 109/211 (51%), Gaps = 29/211 (13%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFK--NEVFVIGQTHHKNLVR 582
           E++G GS+  VYKG  +++ +   VA+K + R+ ++    F    E  ++    H N+V 
Sbjct: 11  EKLGEGSYATVYKG--KSKVNGKLVALKVI-RLQEEEGTPFTAIREASLLKGLKHANIVL 67

Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPNWNLRTNIAFQIARGLLYLHEDCR 639
           L       +   LV+E+++   L  ++    G L P  N++  + FQ+ RGL Y+H+   
Sbjct: 68  LHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPE-NVKLFL-FQLLRGLSYIHQ--- 121

Query: 640 AQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR--- 696
             I+H D+KPQN+L+ D    +++DFGLA+      +K++ +     +  V   W+R   
Sbjct: 122 RYILHRDLKPQNLLISDTGELKLADFGLAR------AKSVPSHTYSNE--VVTLWYRPPD 173

Query: 697 ----NSKITAKVDVYSFGVLLLEIISCRKSF 723
               +++ +  +D++  G + +E+I    +F
Sbjct: 174 VLLGSTEYSTCLDMWGVGCIFVEMIQGVAAF 204

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 66.2 bits (162), Expect = 1e-11
 Identities = 60/225 (26%), Positives = 107/225 (47%), Gaps = 28/225 (12%)

Query: 503 TIETNLRCFSYKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE 562
           TI+         +LE        E+G G+ G VYK  ++ + +   +AVK++ R     +
Sbjct: 4   TIDGQKYPADLNDLE-----NLGEIGSGTCGQVYK--MRFKKTGHVMAVKQMRRT--GNK 54

Query: 563 REFKN---EVFVIGQTHH-KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK---P 615
            E K    ++ V+ ++H    +V+  G+     +  +  E +   T    L   ++   P
Sbjct: 55  EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIP 112

Query: 616 NWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ 675
             ++   +   I + L YL E  +  +IH D+KP NILLD     ++ DFG++  L  ++
Sbjct: 113 E-DILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169

Query: 676 SKTIKTAIRGTKGYVAPEWF----RNSKITAKVDVYSFGVLLLEI 716
           +KT ++A  G   Y+APE       N K   + DV+S G+ L+E+
Sbjct: 170 AKT-RSA--GCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVEL 211

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 66.6 bits (162), Expect = 1e-11
 Identities = 62/202 (30%), Positives = 99/202 (49%), Gaps = 9/202 (4%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREF-KNEVFVIGQTHHKNLVRLLG 585
           +GRGS+  V    ++      A+ V K + V  D + ++ + E  V  Q  +   +  L 
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62

Query: 586 FCDEGQNRLL-VYEFLNNGTLASFLFGNLK-PNWNLRTNIAFQIARGLLYLHEDCRAQII 643
            C + ++RL  V E++N G L   +    K P  + R   A +I+  L YLHE     II
Sbjct: 63  SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHE---RGII 118

Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK 703
           + D+K  N+LLD     +++D+G+ K   L    T  +   GT  Y+APE  R       
Sbjct: 119 YRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDT-TSTFCGTPNYIAPEILRGEDYGFS 176

Query: 704 VDVYSFGVLLLEIISCRKSFDI 725
           VD ++ GVL+ E+++ R  FDI
Sbjct: 177 VDWWALGVLMFEMMAGRSPFDI 198

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 66.4 bits (162), Expect = 1e-11
 Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 28/205 (13%)

Query: 527 VGRGSFGIVY-KGVIQTRTSTTAVAVKKL--------DRVFQDGEREFKNEVFVIGQTHH 577
           +G+GSFG V+    I    +    A+K L        DRV    ER+   EV      +H
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV------NH 57

Query: 578 KNLVRL-LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF---QIARGLLY 633
             +V+L   F  EG+   L+ +FL  G L + L    K       ++ F   ++A  L +
Sbjct: 58  PFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLS---KEVMFTEEDVKFYLAELALALDH 113

Query: 634 LHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE 693
           LH      II+ D+KP+NILLD+    +++DFGL+K    ++ K    +  GT  Y+APE
Sbjct: 114 LH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY--SFCGTVEYMAPE 168

Query: 694 WFRNSKITAKVDVYSFGVLLLEIIS 718
                  T   D +SFGVL+ E+++
Sbjct: 169 VVNRRGHTQSADWWSFGVLMFEMLT 193

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin

 Score = 61.6 bits (150), Expect = 1e-11
 Identities = 39/133 (29%), Positives = 48/133 (36%), Gaps = 18/133 (13%)

Query: 27  NGTVPVGATLTAGTSSSPWLSPSGDFAFGFHQLDEENNTNDLFLLSIFYNKIPEKTVVWY 86
           +  +  G TL +  S    L   G F                    I Y     +TVVW 
Sbjct: 1   SNPLSSGQTLVSSGS----LFELGFFKLIM---------QSRDYNLILYKGSS-RTVVWV 46

Query: 87  TDNKDQNPAVPRGSQVKLTADQGLVLNDPQGKQVWSSKIDIGT-VAVGHMNDTGNFVLAS 145
             N+D NP       + L +D  LV+ D  G  VWSS         V  + D GN VL  
Sbjct: 47  A-NRD-NP-SGSSCTLTLQSDGNLVIYDGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYD 103

Query: 146 SSSGRLWDSFSNP 158
           S    LW SF  P
Sbjct: 104 SDGNFLWQSFDYP 116

The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 66.0 bits (161), Expect = 1e-11
 Identities = 62/198 (31%), Positives = 92/198 (46%), Gaps = 19/198 (9%)

Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKN---EVFVIGQTHHKNLVR 582
           E+G GSFG VY      RT+   VA+KK+    +    ++++   EV  + Q  H N + 
Sbjct: 22  EIGHGSFGAVYFAR-DVRTNEV-VAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIE 79

Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR-TNIAFQIARGLLYLHEDCRAQ 641
             G         LV E+   G+ +  L  + KP   +    I     +GL YLH   R  
Sbjct: 80  YKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHER-- 136

Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE---WFRNS 698
            IH DIK  NILL +  T +++DFG A L++   S        GT  ++APE        
Sbjct: 137 -IHRDIKAGNILLTEPGTVKLADFGSASLVSPANS------FVGTPYWMAPEVILAMDEG 189

Query: 699 KITAKVDVYSFGVLLLEI 716
           +   KVDV+S G+  +E+
Sbjct: 190 QYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 65.3 bits (159), Expect = 2e-11
 Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 16/205 (7%)

Query: 525 EEVGRGSFGIVYKGVIQ-----TRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKN 579
           E +G+G+F  ++KG+ +          T V +K LD+  ++    F     ++ Q  HK+
Sbjct: 1   ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60

Query: 580 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN---LKPNWNLRTNIAFQIARGLLYLHE 636
           LV   G C  G   ++V E++  G+L ++L  N   +  +W L   +A Q+A  L +L +
Sbjct: 61  LVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLE--VAKQLAWALHFLED 118

Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI--KTAIRGTKGYVAPEW 694
                + H ++  +N+LL      +  +    KL     S T+  K  +     +V PE 
Sbjct: 119 K---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPEC 175

Query: 695 FRNSK-ITAKVDVYSFGVLLLEIIS 718
             N + ++   D +SFG  L EI S
Sbjct: 176 IENPQNLSLAADKWSFGTTLWEIFS 200

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 65.4 bits (160), Expect = 2e-11
 Identities = 54/203 (26%), Positives = 96/203 (47%), Gaps = 28/203 (13%)

Query: 528 GRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFK-NEVFVIGQ-THHKNLVRLLG 585
           G G+F  V K   Q+R +    A+K + + F+  E+     E+  + + + H N++RL+ 
Sbjct: 8   GEGTFSEVLK--AQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIE 65

Query: 586 FC-DEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRT-NIAFQIARGLLYLHEDCRAQI 642
              D    RL LV+E L +  L   + G  +P    R  +  +Q+ + L ++H   R  I
Sbjct: 66  VLFDRKTGRLALVFE-LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNGI 121

Query: 643 IHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR------ 696
            H DIKP+NIL+ D    +++DFG  + +      T          Y++  W+R      
Sbjct: 122 FHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYTE---------YISTRWYRAPECLL 171

Query: 697 -NSKITAKVDVYSFGVLLLEIIS 718
            +     K+D+++ G +  EI+S
Sbjct: 172 TDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 65.1 bits (159), Expect = 2e-11
 Identities = 60/223 (26%), Positives = 100/223 (44%), Gaps = 37/223 (16%)

Query: 511 FSYKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG--EREFKNE 568
           F+ ++L+        E+GRG+FG V K  +  + S T +AVK++ R   D   ++    +
Sbjct: 1   FTAEDLKD-----LGEIGRGAFGTVNK--MLHKPSGTIMAVKRI-RSTVDEKEQKRLLMD 52

Query: 569 VFVIGQTHH-KNLVRLLG---------FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNW- 617
           + V+ ++     +V+  G          C E     L+   L+      +++  LK    
Sbjct: 53  LDVVMRSSDCPYIVKFYGALFREGDCWICME-----LMDISLDK--FYKYVYEVLKSVIP 105

Query: 618 -NLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS 676
             +   IA    + L YL E+ +  IIH D+KP NILLD     ++ DFG++  L     
Sbjct: 106 EEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQL---VD 160

Query: 677 KTIKTAIRGTKGYVAPEW---FRNSKITAKVDVYSFGVLLLEI 716
              KT   G + Y+APE            + DV+S G+ L E+
Sbjct: 161 SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEV 203

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 65.0 bits (158), Expect = 2e-11
 Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 23/207 (11%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVI-GQTHHKNLVRL 583
           E +G+G++G V+K  +  + + +  AVK LD +  D + E + E  ++   + H N+V+ 
Sbjct: 24  ETIGKGTYGKVFK--VLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKF 80

Query: 584 LGF-----CDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIAR----GLLYL 634
            G         G    LV E  N G++   + G LK    +   I   I      GL +L
Sbjct: 81  YGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHL 140

Query: 635 HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 694
           H +   + IH D+K  NILL      ++ DFG++  LT   ++  +    GT  ++APE 
Sbjct: 141 HVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLT--STRLRRNTSVGTPFWMAPEV 195

Query: 695 FR-----NSKITAKVDVYSFGVLLLEI 716
                  +S   A+ DV+S G+  +E+
Sbjct: 196 IACEQQLDSTYDARCDVWSLGITAIEL 222

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 65.6 bits (160), Expect = 3e-11
 Identities = 51/178 (28%), Positives = 87/178 (48%), Gaps = 21/178 (11%)

Query: 624 AFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAI 683
           +FQ+ARG+ +L      + IH D+  +NILL +    +I DFGLA+ +  +     K   
Sbjct: 179 SFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 235

Query: 684 RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDC 741
           R    ++APE   +   T + DV+SFGVLL EI S   S    +++ EE+         C
Sbjct: 236 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEF---------C 286

Query: 742 YRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 799
            R  K    +   + A  +I      +M+  W    +P  RPT  +++++L  +++ +
Sbjct: 287 -RRLKEGTRMRAPEYATPEIYS----IMLDCW--HNNPEDRPTFSELVEILGDLLQEN 337

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 65.5 bits (159), Expect = 3e-11
 Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 27/203 (13%)

Query: 527 VGRGSFGIV---YKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNL 580
           +G G+ GIV   Y  V+        VA+KKL R FQ+    +R ++ E+ ++   +HKN+
Sbjct: 25  IGSGAQGIVCAAYDAVLDRN-----VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNI 78

Query: 581 VRLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYL 634
           + LL         +E Q+  LV E ++   L   +   ++ +    + + +Q+  G+ +L
Sbjct: 79  ISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVI--QMELDHERMSYLLYQMLCGIKHL 135

Query: 635 HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 694
           H    A IIH D+KP NI++    T +I DFGLA+      +  + T    T+ Y APE 
Sbjct: 136 HS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEV 189

Query: 695 FRNSKITAKVDVYSFGVLLLEII 717
                    VD++S G ++ E++
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 64.3 bits (157), Expect = 4e-11
 Identities = 59/227 (25%), Positives = 113/227 (49%), Gaps = 43/227 (18%)

Query: 512 SYKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFK--NEV 569
           +YK+L+        ++G GS+  VYKG  +++ +   VA+K++ R+  +    F    E 
Sbjct: 6   TYKKLD--------KLGEGSYATVYKG--RSKLTGQLVALKEI-RLEHEEGAPFTAIREA 54

Query: 570 FVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPNWNLRTNIAFQ 626
            ++    H N+V L       +   LV+E+L+   L  ++    G L  + N+R    FQ
Sbjct: 55  SLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMH-NVRL-FLFQ 111

Query: 627 IARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGT 686
           + RGL Y H   + +++H D+KPQN+L+ +    +++DFGLA+      +K++      +
Sbjct: 112 LLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLAR------AKSVP-----S 157

Query: 687 KGY---VAPEWFR-------NSKITAKVDVYSFGVLLLEIISCRKSF 723
           K Y   V   W+R       +++ +  +D++  G +  E+ + R  F
Sbjct: 158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLF 204

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 64.7 bits (158), Expect = 4e-11
 Identities = 52/200 (26%), Positives = 94/200 (47%), Gaps = 19/200 (9%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGE-REFKNEVFVIGQTHHKNLV 581
            +VG+G +G V+  + + + +   VA+K++ +  +F+  E R    E  ++  T  + LV
Sbjct: 7   TQVGQGGYGQVF--LAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLV 64

Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLHEDCR 639
           +LL    + +   L  E++  G   + L   G L  +     +  F +A     +     
Sbjct: 65  KLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSED-----HARFYMAEMFEAVDALHE 119

Query: 640 AQIIHCDIKPQNILLDDYYTARISDFGLAK-LLTLNQSKTIKTAIRGTKGYVAPEWFRNS 698
              IH D+KP+N L+D     +++DFGL+K ++T   S      + G+  Y+APE  R  
Sbjct: 120 LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANS------VVGSPDYMAPEVLRGK 173

Query: 699 KITAKVDVYSFGVLLLEIIS 718
                VD +S G +L E + 
Sbjct: 174 GYDFTVDYWSLGCMLYEFLC 193

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 65.1 bits (158), Expect = 5e-11
 Identities = 59/203 (29%), Positives = 103/203 (50%), Gaps = 27/203 (13%)

Query: 527 VGRGSFGIV---YKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNL 580
           +G G+ GIV   Y  +++       VA+KKL R FQ+    +R ++ E+ ++   +HKN+
Sbjct: 32  IGSGAQGIVCAAYDAILERN-----VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNI 85

Query: 581 VRLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYL 634
           + LL         +E Q+  +V E ++   L   +   ++ +    + + +Q+  G+ +L
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVI--QMELDHERMSYLLYQMLCGIKHL 142

Query: 635 HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 694
           H    A IIH D+KP NI++    T +I DFGLA+  T   S  +   +  T+ Y APE 
Sbjct: 143 HS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVV-TRYYRAPEV 196

Query: 695 FRNSKITAKVDVYSFGVLLLEII 717
                    VD++S G ++ E+I
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMI 219

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 63.9 bits (155), Expect = 6e-11
 Identities = 73/272 (26%), Positives = 111/272 (40%), Gaps = 34/272 (12%)

Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKN---EVFVIGQTHHKNLVR 582
           E+G GSFG VY        +   VAVKK+    +    ++++   EV  + Q  H N + 
Sbjct: 28  EIGHGSFGAVY--FATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIE 85

Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR-TNIAFQIARGLLYLHEDCRAQ 641
             G   +     LV E+   G+ +  L  + KP   +    I     +GL YLH      
Sbjct: 86  YKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--- 141

Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE---WFRNS 698
           +IH DIK  NILL +    +++DFG A   +   S        GT  ++APE        
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS------FVGTPYWMAPEVILAMDEG 195

Query: 699 KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAM 758
           +   KVDV+S G      I+C     IE+ E    L    F+      L  +   D   +
Sbjct: 196 QYDGKVDVWSLG------ITC-----IELAERKPPL----FNMNAMSALYHIAQNDSPTL 240

Query: 759 NDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
              E          +C+Q+ P  RP   ++L+
Sbjct: 241 QSNEWTDSFRGFVDYCLQKIPQERPASAELLR 272

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 63.6 bits (155), Expect = 7e-11
 Identities = 63/227 (27%), Positives = 109/227 (48%), Gaps = 37/227 (16%)

Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE-FK----NEVFVIGQTHHKNL 580
           ++G G++G VYK     + +   VA+KK   V  D E+E F      E+ ++ Q +H+N+
Sbjct: 14  QIGEGTYGQVYKAR--DKDTGELVALKK---VRLDNEKEGFPITAIREIKILRQLNHRNI 68

Query: 581 VRL----------LGFCDEGQNRLLVYEFLNN---GTLASFLFGNLKPNWNLRTNIAF-- 625
           V L          L F  +     LV+E++++   G L S L      +++     +F  
Sbjct: 69  VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLV-----HFSEDHIKSFMK 123

Query: 626 QIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRG 685
           Q+  GL Y H   +   +H DIK  NILL++    +++DFGLA+L    +S+     +  
Sbjct: 124 QLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI- 179

Query: 686 TKGYVAPEWFR-NSKITAKVDVYSFGVLLLEIISCRKSF--DIEMGE 729
           T  Y  PE      +    +DV+S G +L E+ + +  F  + E+ +
Sbjct: 180 TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQ 226

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 64.3 bits (156), Expect = 8e-11
 Identities = 86/336 (25%), Positives = 134/336 (39%), Gaps = 89/336 (26%)

Query: 527 VGRGSFGIVYKGV---IQTRTSTTAVAVKKLDRVFQDGE-REFKNEV-FVIGQTHHKNLV 581
           +G G+FG V +     I  ++S   VAVK L       E +   +E+  +I   +H N+V
Sbjct: 15  LGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVV 74

Query: 582 RLLGFCDEGQNRLLV------YEFLNN--------------------------------- 602
            LLG C +    L+V      Y  L+N                                 
Sbjct: 75  NLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVD 134

Query: 603 ----GTLASFLFGNLKPNWNLRTN--------------------IAFQIARGLLYLHEDC 638
                  AS LF   +P+ +  TN                     +FQ+ARG+ +L    
Sbjct: 135 RRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFL---A 191

Query: 639 RAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNS 698
             + IH D+  +NILL +    +I DFGLA+ +  +     K + R    ++APE   + 
Sbjct: 192 SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDK 251

Query: 699 KITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKE 756
             T + DV+SFGVLL EI S   S    +++ EE+         C R     +  G    
Sbjct: 252 VYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF---------CQR-----LKDGTRMR 297

Query: 757 AMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQML 792
           A  +       +M++ W  Q DP  RPT   ++++L
Sbjct: 298 APENATPEIYRIMLACW--QGDPKERPTFSALVEIL 331

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 64.2 bits (157), Expect = 8e-11
 Identities = 56/224 (25%), Positives = 94/224 (41%), Gaps = 41/224 (18%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKL---DRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +GRG+FG V+  +++ + +    A+K L   D + ++     + E  ++       +V+L
Sbjct: 9   IGRGAFGEVW--LVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKL 66

Query: 584 L-GFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
              F DE ++  LV E++  G L + L                 F IA  +L L    + 
Sbjct: 67  YYSFQDE-EHLYLVMEYMPGGDLMNLLIRKDVFPEET-----ARFYIAELVLALDSVHKL 120

Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLL---------------------------TL 673
             IH DIKP NIL+D     +++DFGL K +                             
Sbjct: 121 GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDH 180

Query: 674 NQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEII 717
            Q +    +  GT  Y+APE  R +    + D +S GV+L E++
Sbjct: 181 KQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 63.3 bits (154), Expect = 9e-11
 Identities = 60/210 (28%), Positives = 106/210 (50%), Gaps = 30/210 (14%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE-REFKNEVFVIGQTHHKNLV 581
             +E+G+G++G VYK V+   T  T +A+K++     + +  +   E+ ++ +     +V
Sbjct: 5   VLDELGKGNYGSVYK-VLHRPTGVT-MAMKEIRLELDESKFNQIIMELDILHKAVSPYIV 62

Query: 582 RLLG-FCDEGQNRLLVY---EFLNNGTLASFLFGNL----KPNWNLRTNIAFQIARGLLY 633
              G F  EG     VY   E+++ G+L     G +     P   LR  I + + +GL +
Sbjct: 63  DFYGAFFIEGA----VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLR-RITYAVVKGLKF 117

Query: 634 LHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT-IKTAIRGTKGYVAP 692
           L E+    IIH D+KP N+L++     ++ DFG++  L  + +KT I     G + Y+AP
Sbjct: 118 LKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI-----GCQSYMAP 170

Query: 693 EWFR------NSKITAKVDVYSFGVLLLEI 716
           E  +      N   T + DV+S G+ +LE+
Sbjct: 171 ERIKSGGPNQNPTYTVQSDVWSLGLSILEM 200

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 57/201 (28%), Positives = 96/201 (47%), Gaps = 15/201 (7%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE---FKNEVFVIGQTHHKNLVRL 583
           +GRG+FG VY           AV     D   Q+  +E    + E+ ++    H  +V+ 
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69

Query: 584 LGFC--DEGQNRLLVY-EFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLHEDC 638
            G C  D  + +L ++ E++  G++   L  +G L  N   R     QI +G+ YLH + 
Sbjct: 70  YG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRR--YTRQILQGVSYLHSN- 125

Query: 639 RAQIIHCDIKPQNILLDDYYTARISDFGLAK-LLTLNQSKTIKTAIRGTKGYVAPEWFRN 697
              I+H DIK  NIL D     ++ DFG +K + T+  S T   ++ GT  +++PE    
Sbjct: 126 --MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISG 183

Query: 698 SKITAKVDVYSFGVLLLEIIS 718
                K DV+S    ++E+++
Sbjct: 184 EGYGRKADVWSVACTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 53/212 (25%), Positives = 98/212 (46%), Gaps = 18/212 (8%)

Query: 522 NFKEE--VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ----DGEREFKNEVFVIGQT 575
           NF+ E  +GRG F  VY+           VA+KK+ ++F+       ++   E+ ++ Q 
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKP--VALKKV-QIFEMMDAKARQDCVKEIDLLKQL 59

Query: 576 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAF--QIARGL 631
           +H N+++ L    E     +V E  + G L+  +  F   K     RT   +  Q+   +
Sbjct: 60  NHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAV 119

Query: 632 LYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVA 691
            ++H     +++H DIKP N+ +      ++ D GL +  +     T   ++ GT  Y++
Sbjct: 120 EHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS--SKTTAAHSLVGTPYYMS 174

Query: 692 PEWFRNSKITAKVDVYSFGVLLLEIISCRKSF 723
           PE    +    K D++S G LL E+ + +  F
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPF 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 63.4 bits (154), Expect = 1e-10
 Identities = 38/114 (33%), Positives = 54/114 (47%), Gaps = 15/114 (13%)

Query: 626 QIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRG 685
           QI  GL YLH     +IIH D+K +NI ++D     I D G A      Q   +  A  G
Sbjct: 165 QILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAA------QFPVVAPAFLG 215

Query: 686 TKGYV---APEWFRNSKITAKVDVYSFGVLLLEIISCRKS-FDIE--MGEEYAI 733
             G V   APE     K  +K D++S G++L E+++   + F+      EEY  
Sbjct: 216 LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVK 269

Length = 357

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 62.4 bits (151), Expect = 2e-10
 Identities = 54/202 (26%), Positives = 93/202 (46%), Gaps = 13/202 (6%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE---FKNEVFVIGQTHHKNLVRL 583
           +G+G+FG VY           AV   + D    +  +E    + E+ ++    H+ +V+ 
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69

Query: 584 LGFCDEGQNRLL--VYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLHEDCR 639
            G   +   R L    E +  G++   L  +G L  N   +     QI  G+ YLH +  
Sbjct: 70  YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRK--YTRQILEGVSYLHSN-- 125

Query: 640 AQIIHCDIKPQNILLDDYYTARISDFGLAK-LLTLNQSKTIKTAIRGTKGYVAPEWFRNS 698
             I+H DIK  NIL D     ++ DFG +K L T+  S T   ++ GT  +++PE     
Sbjct: 126 -MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGE 184

Query: 699 KITAKVDVYSFGVLLLEIISCR 720
               K D++S G  ++E+++ +
Sbjct: 185 GYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 63.0 bits (153), Expect = 2e-10
 Identities = 54/176 (30%), Positives = 85/176 (48%), Gaps = 25/176 (14%)

Query: 622 NIAFQIARGLLYL-HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIK 680
           + ++Q+A+G+ +L  ++C    IH D+  +NILL      +I DFGLA+ +  + +  +K
Sbjct: 218 SFSYQVAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVK 273

Query: 681 TAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAF 739
              R    ++APE   N   T + DV+S+G+LL EI S   S        Y  +  D  F
Sbjct: 274 GNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSS-------PYPGMPVDSKF 326

Query: 740 DCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIW--CIQEDPSLRPTMKKVLQMLE 793
             Y+  K       +   M   EC     M  I   C   DP  RPT K+++Q++E
Sbjct: 327 --YKMIK-------EGYRMLSPEC-APSEMYDIMKSCWDADPLKRPTFKQIVQLIE 372

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 62.9 bits (153), Expect = 2e-10
 Identities = 51/172 (29%), Positives = 87/172 (50%), Gaps = 21/172 (12%)

Query: 624 AFQIARGLLYL-HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTA 682
           + Q+A+G+ +L  ++C    IH D+  +N+LL D   A+I DFGLA+ +  + +  +K  
Sbjct: 218 SSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273

Query: 683 IRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAFDC 741
            R    ++APE   +   T + DV+S+G+LL EI S  KS        Y  IL +  F  
Sbjct: 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS-------PYPGILVNSKF-- 324

Query: 742 YRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
           Y+  K    +     A  +I      +M   W +  +P+ RPT  ++ Q+++
Sbjct: 325 YKMVKRGYQMSRPDFAPPEI----YSIMKMCWNL--EPTERPTFSQISQLIQ 370

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 62.5 bits (152), Expect = 2e-10
 Identities = 63/203 (31%), Positives = 101/203 (49%), Gaps = 11/203 (5%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREF-KNEVFVIGQ-THHKNLVRLL 584
           +GRGS+  V    ++      A+ V K + V  D + ++ + E  V    ++H  LV L 
Sbjct: 3   IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62

Query: 585 GFCDEGQNRL-LVYEFLNNGTLASFLFGNLK-PNWNLRTNIAFQIARGLLYLHEDCRAQI 642
             C + ++RL  V EF++ G L   +    K P  + R   A +I+  L +LHE     I
Sbjct: 63  S-CFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSA-EISLALNFLHE---RGI 117

Query: 643 IHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITA 702
           I+ D+K  N+LLD     +++D+G+ K   +    T  T   GT  Y+APE  R      
Sbjct: 118 IYRDLKLDNVLLDAEGHIKLTDYGMCKE-GIRPGDTTSTFC-GTPNYIAPEILRGEDYGF 175

Query: 703 KVDVYSFGVLLLEIISCRKSFDI 725
            VD ++ GVL+ E+++ R  FDI
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDI 198

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 61.6 bits (149), Expect = 3e-10
 Identities = 54/198 (27%), Positives = 94/198 (47%), Gaps = 16/198 (8%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLL 584
           + VG G++G VYK          AV + KL+    D     + E+F++ +  H N+V   
Sbjct: 15  QRVGSGTYGDVYKARNLHTGELAAVKIIKLEP--GDDFSLIQQEIFMVKECKHCNIVAYF 72

Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF---QIARGLLYLHEDCRAQ 641
           G     +   +  E+   G+L   ++    P   L+  IA+   +  +GL YLH   +  
Sbjct: 73  GSYLSREKLWICMEYCGGGSLQD-IYHVTGPLSELQ--IAYVCRETLQGLAYLHSKGK-- 127

Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF---RNS 698
            +H DIK  NILL D    +++DFG+A  +T   +K  + +  GT  ++APE     +N 
Sbjct: 128 -MHRDIKGANILLTDNGDVKLADFGVAAKITATIAK--RKSFIGTPYWMAPEVAAVEKNG 184

Query: 699 KITAKVDVYSFGVLLLEI 716
                 D+++ G+  +E+
Sbjct: 185 GYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 62.1 bits (151), Expect = 3e-10
 Identities = 62/213 (29%), Positives = 97/213 (45%), Gaps = 45/213 (21%)

Query: 524 KEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKN---- 579
            E +G GSFG V   + + + +    A+K L           K E+  + Q  H      
Sbjct: 23  GETLGTGSFGRVR--IAKHKGTGEYYAIKCLK----------KREILKMKQVQHVAQEKS 70

Query: 580 ---------LVRLL-GFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIA-FQI 627
                    +V ++  F DE  NR+  + EF+  G L    F +L+       ++A F  
Sbjct: 71  ILMELSHPFIVNMMCSFQDE--NRVYFLLEFVVGGEL----FTHLRKAGRFPNDVAKFYH 124

Query: 628 ARGLL---YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIR 684
           A  +L   YLH      II+ D+KP+N+LLD+    +++DFG AK +     +T    + 
Sbjct: 125 AELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP---DRTF--TLC 176

Query: 685 GTKGYVAPEWFRNSKITAKVDVYSFGVLLLEII 717
           GT  Y+APE  ++      VD ++ GVLL E I
Sbjct: 177 GTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFI 209

Length = 329

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 61.7 bits (150), Expect = 4e-10
 Identities = 62/207 (29%), Positives = 89/207 (42%), Gaps = 33/207 (15%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAV-AVKKLDRVFQDGEREFKNEV--------FVIGQTHH 577
           +G+GSFG V    +    +     AVK    V Q      K E          ++    H
Sbjct: 3   IGKGSFGKVL---LAKHKADGKFYAVK----VLQKKAILKKKEQKHIMAERNVLLKNVKH 55

Query: 578 KNLVRLLGFCDEGQNRL-LVYEFLNNGTLASFL-----FGNLKPNWNLRTNIAFQIARGL 631
             LV L  +  +  ++L  V +++N G L   L     F   +  +      A +IA  L
Sbjct: 56  PFLVGL-HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-----YAAEIASAL 109

Query: 632 LYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVA 691
            YLH      II+ D+KP+NILLD      ++DFGL K   +  SKT  T   GT  Y+A
Sbjct: 110 GYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFC-GTPEYLA 164

Query: 692 PEWFRNSKITAKVDVYSFGVLLLEIIS 718
           PE  R       VD +  G +L E++ 
Sbjct: 165 PEVLRKQPYDRTVDWWCLGAVLYEMLY 191

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 61.4 bits (149), Expect = 4e-10
 Identities = 56/212 (26%), Positives = 102/212 (48%), Gaps = 31/212 (14%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE-------REFKNEVFVIGQTHH 577
           E++G G++G VYK   + + +   VA+KK  R+  D E       RE  + + ++ ++ +
Sbjct: 7   EKIGEGTYGKVYKA--RDKNTGKLVALKK-TRLEMDEEGIPPTALREI-SLLQMLSESIY 62

Query: 578 KNLVRLLGF----CDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWN-LRTNIA----FQI 627
             +VRLL         G+  L LV+E+L++  L  F+  N +     L         +Q+
Sbjct: 63  --IVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119

Query: 628 ARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTA-RISDFGLAKLLTLNQSKTIKTAIRGT 686
            +G+ + H   +  ++H D+KPQN+L+D      +I+D GL +  ++         +  T
Sbjct: 120 LKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV--T 174

Query: 687 KGYVAPEWFRNSK-ITAKVDVYSFGVLLLEII 717
             Y APE    S   +  VD++S G +  E+ 
Sbjct: 175 LWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS 206

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 60.8 bits (147), Expect = 5e-10
 Identities = 54/212 (25%), Positives = 96/212 (45%), Gaps = 18/212 (8%)

Query: 522 NFKEE--VGRGSFGIVYKGVIQTRTSTTAVAVKKL---DRVFQDGEREFKNEVFVIGQTH 576
           NF+ E  +GRG F  VY+           VA+KK+   D +      +   E+ ++ Q +
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLL--DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60

Query: 577 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAF--QIARGLL 632
           H N+++      E     +V E  + G L+  +  F   K     +T   +  Q+   L 
Sbjct: 61  HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120

Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKT-AIRGTKGYVA 691
           ++H     +++H DIKP N+ +      ++ D GL +  +   SKT    ++ GT  Y++
Sbjct: 121 HMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS---SKTTAAHSLVGTPYYMS 174

Query: 692 PEWFRNSKITAKVDVYSFGVLLLEIISCRKSF 723
           PE    +    K D++S G LL E+ + +  F
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPF 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 60.8 bits (147), Expect = 5e-10
 Identities = 56/202 (27%), Positives = 90/202 (44%), Gaps = 14/202 (6%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVK--KLDRVFQDGEREFKNEVFVIGQTHHKNLVRLL 584
           VG GSFG     ++Q   S    A+K  +L +     E   K E  ++ +  H N+V   
Sbjct: 8   VGEGSFGRAL--LVQHVNSDQKYAMKEIRLPKSSSAVEDSRK-EAVLLAKMKHPNIVAFK 64

Query: 585 GFCDEGQNRLLVYEFLNNGTLASFL---FGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ 641
              +   +  +V E+ + G L   +    G L P  +       Q+  G+ ++HE    +
Sbjct: 65  ESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPE-DTILQWFVQMCLGVQHIHEK---R 120

Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKIT 701
           ++H DIK +NI L      ++ DFG A+LLT            GT  YV PE + N    
Sbjct: 121 VLHRDIKSKNIFLTQNGKVKLGDFGSARLLT--SPGAYACTYVGTPYYVPPEIWENMPYN 178

Query: 702 AKVDVYSFGVLLLEIISCRKSF 723
            K D++S G +L E+ + +  F
Sbjct: 179 NKSDIWSLGCILYELCTLKHPF 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins

 Score = 56.3 bits (136), Expect = 6e-10
 Identities = 21/88 (23%), Positives = 38/88 (43%), Gaps = 8/88 (9%)

Query: 349 FELSCWGGGQGYNKELFDFHELKNINWPQSDYERFKPYNEVQCKNTCLSDCFCAAVIFND 408
             L+C     G +     F +L ++  P +        +  +C+  CLS+C C A  +N+
Sbjct: 1   TPLNC-----GGDGSTDGFLKLPDVKLPDNAS-AITAISLEECREACLSNCSCTAYAYNN 54

Query: 409 GS--CWFKKLPLSNGMTDSRIAGKAFIK 434
           GS  C      L+N  + S   G  +++
Sbjct: 55  GSGGCLLWNGLLNNLRSLSSGGGTLYLR 82

PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 60.9 bits (148), Expect = 6e-10
 Identities = 55/184 (29%), Positives = 86/184 (46%), Gaps = 27/184 (14%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE-FK----NEVFVIGQTHHKNLV 581
           +G+G+FG V+K   + + +   VA+KK   V  + E+E F      E+ ++    H+N+V
Sbjct: 20  IGQGTFGEVFKA--RHKKTKQIVALKK---VLMENEKEGFPITALREIKILQLLKHENVV 74

Query: 582 RLLGFCD---EGQNR-----LLVYEFLNNGTLASFLFGNLKPNWNLR--TNIAFQIARGL 631
            L+  C       NR      LV+EF  +  LA  L  N    + L     +   +  GL
Sbjct: 75  NLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLL-SNKNVKFTLSEIKKVMKMLLNGL 132

Query: 632 LYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTL--NQSKTIKTAIRGTKGY 689
            Y+H   R +I+H D+K  NIL+      +++DFGLA+  +L  N      T    T  Y
Sbjct: 133 YYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWY 189

Query: 690 VAPE 693
             PE
Sbjct: 190 RPPE 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 60.2 bits (146), Expect = 7e-10
 Identities = 75/297 (25%), Positives = 131/297 (44%), Gaps = 68/297 (22%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF-----QDGER--EFKNEVFVIGQTHH 577
           E +G+G+F  +YKGV++ ++    V   +   V       D      F     ++ Q  H
Sbjct: 1   EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSH 60

Query: 578 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPNWNLRTNIAFQIARGLLYL 634
           K+LV+L G C   +N ++V E++  G L  FL     N+  +W L  ++A Q+A  L YL
Sbjct: 61  KHLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHWKL--DVAKQLASALHYL 117

Query: 635 HEDCRAQIIHCDIKPQNILL-----DDYYT--ARISDFGLAKLLTLNQSKTIKTAIRGTK 687
            +    +++H ++  +NIL+     ++ Y    ++SD G+   + L++ + ++       
Sbjct: 118 EDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITV-LSREERVERI----- 168

Query: 688 GYVAPEWFRN--SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 745
            ++APE  RN  + +T   D +SFG  LLEI                        C    
Sbjct: 169 PWIAPECIRNGQASLTIAADKWSFGTTLLEI------------------------CSNGE 204

Query: 746 K-LNVLVGEDKE---------AMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQML 792
           + L+ L   +KE          M D   L  L+     C   DP+ RP+ + +L+ L
Sbjct: 205 EPLSTLSSSEKERFYQDQHRLPMPDCAELANLINQ---CWTYDPTKRPSFRAILRDL 258

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 61.6 bits (149), Expect = 9e-10
 Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 47/215 (21%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKN-EVFVIGQTHHKNLVRL-- 583
           +G GSFG+VY+ +     ++  VA+KK   V QD   ++KN E+ ++   +H N++ L  
Sbjct: 74  IGNGSFGVVYEAI--CIDTSEKVAIKK---VLQD--PQYKNRELLIMKNLNHINIIFLKD 126

Query: 584 -------------------LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA 624
                              + F  +  ++ + +   NN  L  FL              +
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLV----------KLYS 176

Query: 625 FQIARGLLYLHEDCRAQIIHCDIKPQNILLD-DYYTARISDFGLAKLLTLNQSKTIKTAI 683
           +Q+ R L Y+H      I H D+KPQN+L+D + +T ++ DFG AK L   Q        
Sbjct: 177 YQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICS 233

Query: 684 RGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEII 717
           R    Y APE    +   T  +D++S G ++ E+I
Sbjct: 234 R---FYRAPELMLGATNYTTHIDLWSLGCIIAEMI 265

Length = 440

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 60.5 bits (147), Expect = 9e-10
 Identities = 30/94 (31%), Positives = 56/94 (59%), Gaps = 6/94 (6%)

Query: 623 IAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTA 682
           I+  + RGL YL E  + +I+H D+KP NIL++     ++ DFG++  L      ++  +
Sbjct: 104 ISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANS 157

Query: 683 IRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEI 716
             GT+ Y++PE  + +  T + D++S G+ L+E+
Sbjct: 158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEM 191

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 62.1 bits (151), Expect = 1e-09
 Identities = 55/229 (24%), Positives = 91/229 (39%), Gaps = 39/229 (17%)

Query: 527 VGRGSFGIVYKG--VIQTRTSTTAVAVKKLDRVFQDGER---EFKNEVFVIGQTHHKNLV 581
           +G+G  G VY     + +R     VA+KK+     +       F  E  +     H  +V
Sbjct: 10  IGKGGMGEVYLAYDPVCSRR----VALKKIREDLSENPLLKKRFLREAKIAADLIHPGIV 65

Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFG-----NLKPNWNLRTNI-AF-----QIARG 630
            +   C +G        ++   TL S L       +L      +T++ AF     +I   
Sbjct: 66  PVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICAT 125

Query: 631 LLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ--------------- 675
           + Y+H      ++H D+KP NILL  +    I D+G A    L +               
Sbjct: 126 IEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182

Query: 676 -SKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSF 723
            S TI   I GT  Y+APE       +   D+Y+ GV+L ++++    +
Sbjct: 183 SSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231

Length = 932

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 60.4 bits (146), Expect = 1e-09
 Identities = 47/193 (24%), Positives = 100/193 (51%), Gaps = 11/193 (5%)

Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGER-EFKNEVFVIGQTHHKNLVRLL 584
           E+G G+ G+V+K  +  + S   +A K +    +   R +   E+ V+ + +   +V   
Sbjct: 12  ELGAGNGGVVFK--VSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFY 69

Query: 585 G-FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
           G F  +G+  + + E ++ G+L   L    +    +   ++  + +GL YL E  + +I+
Sbjct: 70  GAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE--KHKIM 126

Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK 703
           H D+KP NIL++     ++ DFG++  L      ++  +  GT+ Y++PE  + +  + +
Sbjct: 127 HRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMSPERLQGTHYSVQ 182

Query: 704 VDVYSFGVLLLEI 716
            D++S G+ L+E+
Sbjct: 183 SDIWSMGLSLVEM 195

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 60.4 bits (146), Expect = 1e-09
 Identities = 60/206 (29%), Positives = 92/206 (44%), Gaps = 26/206 (12%)

Query: 522 NFKEEVGRGSFGIV----YKG------VIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFV 571
           NF   +G GSFG V    YK        I+    +  +  K++D VF   ER+  N +  
Sbjct: 33  NFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFS--ERKILNYI-- 88

Query: 572 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGL 631
               +H   V L G   +     LV EF+  G   +FL  N +   ++    A QI    
Sbjct: 89  ----NHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIF 144

Query: 632 LYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVA 691
            YL       I++ D+KP+N+LLD     +++DFG AK++      T    + GT  Y+A
Sbjct: 145 EYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV-----DTRTYTLCGTPEYIA 196

Query: 692 PEWFRNSKITAKVDVYSFGVLLLEII 717
           PE   N       D ++ G+ + EI+
Sbjct: 197 PEILLNVGHGKAADWWTLGIFIYEIL 222

Length = 340

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 59.3 bits (143), Expect = 1e-09
 Identities = 53/200 (26%), Positives = 94/200 (47%), Gaps = 13/200 (6%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE---FKNEVFVIGQTHHKNLVRL 583
           +G+G+FG VY           A    + D    +  +E    + E+ ++    H+ +V+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69

Query: 584 LG-FCDEGQNRLLVY-EFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLHEDCR 639
            G   D  +  L ++ E++  G++   L  +G L  +  +      QI  G+ YLH +  
Sbjct: 70  YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTES--VTRKYTRQILEGMSYLHSN-- 125

Query: 640 AQIIHCDIKPQNILLDDYYTARISDFGLAK-LLTLNQSKTIKTAIRGTKGYVAPEWFRNS 698
             I+H DIK  NIL D     ++ DFG +K L T+  S T   ++ GT  +++PE     
Sbjct: 126 -MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGE 184

Query: 699 KITAKVDVYSFGVLLLEIIS 718
               K DV+S G  ++E+++
Sbjct: 185 GYGRKADVWSLGCTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 60.0 bits (145), Expect = 2e-09
 Identities = 35/95 (36%), Positives = 53/95 (55%), Gaps = 3/95 (3%)

Query: 624 AFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAI 683
           +FQ+A+G+ +L      + IH D+  +NILL +    +I DFGLA+ +  +     K   
Sbjct: 185 SFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241

Query: 684 RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS 718
           R    ++APE   +   T + DV+SFGVLL EI S
Sbjct: 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 59.7 bits (145), Expect = 2e-09
 Identities = 57/231 (24%), Positives = 99/231 (42%), Gaps = 46/231 (19%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR---VFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +GRG+FG V   ++Q + +    A+KKL +   + ++     + E  ++ +  +  +V+L
Sbjct: 9   IGRGAFGEVR--LVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKL 66

Query: 584 L-GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQI 642
              F DE     L+ E+L  G + + L   +K +        F IA  +L +    +   
Sbjct: 67  YYSFQDE-NYLYLIMEYLPGGDMMTLL---MKKDTFTEEETRFYIAETILAIDSIHKLGY 122

Query: 643 IHCDIKPQNILLDDYYTARISDFGLAKLL--------------------------TLNQS 676
           IH DIKP N+LLD     ++SDFGL   L                           ++  
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182

Query: 677 KTIKTAIR----------GTKGYVAPEWFRNSKITAKVDVYSFGVLLLEII 717
           +  +T  R          GT  Y+APE F  +    + D +S GV++ E++
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 59.0 bits (143), Expect = 3e-09
 Identities = 45/237 (18%), Positives = 99/237 (41%), Gaps = 28/237 (11%)

Query: 563 REFKNEVFVIGQTHHKNLVRLLGF----CDEGQNRLLVYEFLNNGTLASFLFGNLKPNWN 618
              +NE+  + +    N++++ GF     D+     L+ E+   G L   L      ++ 
Sbjct: 63  DITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFK 122

Query: 619 LRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT 678
            + ++A    +GL  L++       + ++   + L+ + Y  +I   GL K+L+    K 
Sbjct: 123 TKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKN 180

Query: 679 IKTAIRGTKGYVAPEWFRN--SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD 736
           +   +     Y + +   +  S+ T K D+YS GV+L EI + +  F+            
Sbjct: 181 VNFMV-----YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFE---NLTTK---- 228

Query: 737 WAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
              + Y     ++++ ++      ++C  ++  +   C   D   RP +K++L  L 
Sbjct: 229 ---EIY-----DLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLS 277

Length = 283

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 58.9 bits (142), Expect = 3e-09
 Identities = 58/198 (29%), Positives = 90/198 (45%), Gaps = 19/198 (9%)

Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKN---EVFVIGQTHHKNLVR 582
           E+G GSFG VY      RT+   VA+KK+    +    ++++   EV  + +  H N + 
Sbjct: 32  EIGHGSFGAVYFAR-DVRTNEV-VAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIE 89

Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR-TNIAFQIARGLLYLHEDCRAQ 641
             G         LV E+   G+ +  L  + KP   +    I     +GL YLH      
Sbjct: 90  YKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---N 145

Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE---WFRNS 698
           +IH DIK  NILL +    +++DFG A + +   S        GT  ++APE        
Sbjct: 146 MIHRDIKAGNILLTEPGQVKLADFGSASIASPANS------FVGTPYWMAPEVILAMDEG 199

Query: 699 KITAKVDVYSFGVLLLEI 716
           +   KVDV+S G+  +E+
Sbjct: 200 QYDGKVDVWSLGITCIEL 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 58.5 bits (141), Expect = 5e-09
 Identities = 62/200 (31%), Positives = 91/200 (45%), Gaps = 21/200 (10%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEV----FVIGQTHHKNLVR 582
           +G+GSFG V   + + +      AVK L +      +E K+ +     ++    H  LV 
Sbjct: 3   IGKGSFGKVL--LAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK-----PNWNLRTNIAFQIARGLLYLHED 637
           L       +    V +F+N G L    F +L+     P    R   A +IA  L YLH  
Sbjct: 61  LHYSFQTTEKLYFVLDFVNGGEL----FFHLQRERSFPEPRARFYAA-EIASALGYLHS- 114

Query: 638 CRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRN 697
               I++ D+KP+NILLD      ++DFGL K   + QS T  T   GT  Y+APE  R 
Sbjct: 115 --INIVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDT-TTTFCGTPEYLAPEVIRK 170

Query: 698 SKITAKVDVYSFGVLLLEII 717
                 VD +  G +L E++
Sbjct: 171 QPYDNTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 58.5 bits (141), Expect = 5e-09
 Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 12/201 (5%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR---VFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G+G+FG V   +++ + S    A+K L +   + +D       E  V+  T H  L  L
Sbjct: 3   LGKGTFGKVI--LVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60

Query: 584 LGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQI 642
             +  + ++RL  V E++N G L   L      + +       +I   L YLH     +I
Sbjct: 61  -KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHS---GKI 116

Query: 643 IHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITA 702
           ++ D+K +N++LD     +I+DFGL K   +  + T+KT   GT  Y+APE   ++    
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCK-EGITDAATMKTFC-GTPEYLAPEVLEDNDYGR 174

Query: 703 KVDVYSFGVLLLEIISCRKSF 723
            VD +  GV++ E++  R  F
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 58.5 bits (141), Expect = 5e-09
 Identities = 63/215 (29%), Positives = 104/215 (48%), Gaps = 27/215 (12%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGE----REFKNEVFVIGQTHHKNL 580
           +GRG+FG V   V++ + +    A+K L++  + +  E    RE +N V V G       
Sbjct: 9   IGRGAFGEV--AVVKMKHTERIYAMKILNKWEMLKRAETACFREERN-VLVNGDCQ---W 62

Query: 581 VRLLGFCDEGQNRL-LVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLHED 637
           +  L +  + +N L LV ++   G L + L  F +  P    R    F IA  +L +H  
Sbjct: 63  ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMAR----FYIAEMVLAIHSI 118

Query: 638 CRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIR-GTKGYVAPEWFR 696
            +   +H DIKP N+LLD     R++DFG    L +NQ  T+++++  GT  Y++PE  +
Sbjct: 119 HQLHYVHRDIKPDNVLLDMNGHIRLADFG--SCLKMNQDGTVQSSVAVGTPDYISPEILQ 176

Query: 697 N-----SKITAKVDVYSFGVLLLEIISCRKSFDIE 726
                  K   + D +S GV + E++     F  E
Sbjct: 177 AMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE 211

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 58.5 bits (141), Expect = 6e-09
 Identities = 61/248 (24%), Positives = 103/248 (41%), Gaps = 42/248 (16%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVK---KLDRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +GRG+FG V   ++Q + +    A+K   K D + ++     + E  ++ +     +V++
Sbjct: 9   IGRGAFGEVR--LVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKM 66

Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
                +  N  L+ EFL  G + + L   +K +        F IA  +L +    +   I
Sbjct: 67  FYSFQDKLNLYLIMEFLPGGDMMTLL---MKKDTLTEEETQFYIAETVLAIDSIHQLGFI 123

Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLL-----------------------TLNQSKTIK 680
           H DIKP N+LLD     ++SDFGL   L                        +N  +  +
Sbjct: 124 HRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAE 183

Query: 681 TAIR----------GTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 730
           T  R          GT  Y+APE F  +      D +S GV++ E++     F  E  +E
Sbjct: 184 TWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQE 243

Query: 731 -YAILTDW 737
            Y  + +W
Sbjct: 244 TYKKVMNW 251

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 58.1 bits (140), Expect = 6e-09
 Identities = 53/198 (26%), Positives = 89/198 (44%), Gaps = 19/198 (9%)

Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKN---EVFVIGQTHHKNLVR 582
           E+G GSFG VY    +   ++  VA+KK+    +    ++++   EV  + +  H N ++
Sbjct: 22  EIGHGSFGAVY--FARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79

Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR-TNIAFQIARGLLYLHEDCRAQ 641
             G         LV E+   G+ +  L  + KP   +    +     +GL YLH      
Sbjct: 80  YRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---N 135

Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE---WFRNS 698
           +IH D+K  NILL +    ++ DFG A ++             GT  ++APE        
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX------FVGTPYWMAPEVILAMDEG 189

Query: 699 KITAKVDVYSFGVLLLEI 716
           +   KVDV+S G+  +E+
Sbjct: 190 QYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 58.2 bits (141), Expect = 6e-09
 Identities = 61/227 (26%), Positives = 99/227 (43%), Gaps = 36/227 (15%)

Query: 528 GRGSFGIVYKGVIQTRTSTTAVAVKKL---DRVFQDGEREFKNE--VF-VIGQTHHKNLV 581
           GRG FG V   + + + +    A+K L   D + +D       E  +F       H  LV
Sbjct: 8   GRGHFGKVL--LAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLV 65

Query: 582 RLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNI---------AFQIARGL 631
            L   C + ++ +  V E+   G L            ++ T++         A  +  GL
Sbjct: 66  NLFA-CFQTEDHVCFVMEYAAGGDLM----------MHIHTDVFSEPRAVFYAACVVLGL 114

Query: 632 LYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVA 691
            YLHE+   +I++ D+K  N+LLD     +I+DFGL K       +T  +   GT  ++A
Sbjct: 115 QYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT--STFCGTPEFLA 169

Query: 692 PEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY--AILTD 736
           PE    +  T  VD +  GVL+ E++     F  +  EE   +I+ D
Sbjct: 170 PEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND 216

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 56.4 bits (137), Expect = 1e-08
 Identities = 40/160 (25%), Positives = 66/160 (41%), Gaps = 18/160 (11%)

Query: 576 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT----NIAFQIARGL 631
            + N ++L       +  +L+ +++ +G L    F  LK    L       I  Q+   L
Sbjct: 67  DNPNFIKLYYSVTTLKGHVLIMDYIKDGDL----FDLLKKEGKLSEAEVKKIIRQLVEAL 122

Query: 632 LYLHEDCRAQIIHCDIKPQNILLDDY-YTARISDFGLAKLLTLNQSKTIKTAIRGTKGYV 690
             LH   +  IIH DIK +N+L D       + D+GL K           +   GT  Y 
Sbjct: 123 NDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK------IIGTPSCYDGTLDYF 173

Query: 691 APEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 730
           +PE  +        D ++ GVL  E+++ +  F  +  EE
Sbjct: 174 SPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE 213

Length = 267

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 56.6 bits (136), Expect = 1e-08
 Identities = 58/204 (28%), Positives = 94/204 (46%), Gaps = 16/204 (7%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV---FQDGEREFKNEVFVIG--QTHHKNLV 581
           +GRG FG VY G  +  T     A+K LD+     + GE    NE  ++    T     +
Sbjct: 2   IGRGGFGEVY-GCRKADTGKM-YAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59

Query: 582 RLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
             + +     ++L  + + +N G L   L  +   +       A +I  GL ++H     
Sbjct: 60  VCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF-- 117

Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF-RNSK 699
            +++ D+KP NILLD++   RISD GLA     + SK    A  GT GY+APE   + + 
Sbjct: 118 -VVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPEVLQKGTA 172

Query: 700 ITAKVDVYSFGVLLLEIISCRKSF 723
             +  D +S G +L +++     F
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSPF 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 57.1 bits (138), Expect = 1e-08
 Identities = 58/212 (27%), Positives = 97/212 (45%), Gaps = 16/212 (7%)

Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDR---VFQDGEREFKNEVFVIGQTHHK 578
           + K  VGRG FG V   V++ + +    A+K + +   + Q+    F+ E  ++  ++  
Sbjct: 4   DVKSLVGRGHFGEVQ--VVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSP 61

Query: 579 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA-FQIARGLLYLHED 637
            + +L     +  N  LV E+   G L S L            ++A F +A  +L +H  
Sbjct: 62  WIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQ---FDEDMAQFYLAELVLAIHSV 118

Query: 638 CRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR- 696
            +   +H DIKP+N+L+D     +++DFG A  LT N+    K  + GT  Y+APE    
Sbjct: 119 HQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPV-GTPDYIAPEVLTT 177

Query: 697 -----NSKITAKVDVYSFGVLLLEIISCRKSF 723
                      + D +S GV+  E+I  R  F
Sbjct: 178 MNGDGKGTYGVECDWWSLGVIAYEMIYGRSPF 209

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 57.1 bits (138), Expect = 2e-08
 Identities = 54/225 (24%), Positives = 102/225 (45%), Gaps = 46/225 (20%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE--REFKNEVFVIGQTHHKNLVRLL 584
           +G GS G+V+  V         VAVKK+  V  D +  +    E+ +I +  H N+V++ 
Sbjct: 13  LGCGSNGLVFSAV--DSDCDKRVAVKKI--VLTDPQSVKHALREIKIIRRLDHDNIVKVY 68

Query: 585 GFCDEGQNRL--------------LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARG 630
                  + L              +V E++    LA+ L        + R    +Q+ RG
Sbjct: 69  EVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARL-FMYQLLRG 126

Query: 631 LLYLHEDCRAQIIHCDIKPQNILLD-DYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGY 689
           L Y+H    A ++H D+KP N+ ++ +    +I DFGLA+++  + S          KGY
Sbjct: 127 LKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSH---------KGY 174

Query: 690 ----VAPEWFRNSKI-------TAKVDVYSFGVLLLEIISCRKSF 723
               +  +W+R+ ++       T  +D+++ G +  E+++ +  F
Sbjct: 175 LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLF 219

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 56.0 bits (135), Expect = 2e-08
 Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 37/220 (16%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGER-EF--KNEVFVIGQTHHKNLV 581
           +E+G G FG V    I T T    V VK+L       E+ EF  + + + I Q  H N++
Sbjct: 1   QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQ--HPNIL 58

Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN-------IAFQIARGLLYL 634
           + LG C E    LLV+E+   G L S+L    +  W+ R +       +A +IA G+ ++
Sbjct: 59  QCLGQCVEAIPYLLVFEYCELGDLKSYL---SQEQWHRRNSQLLLLQRMACEIAAGVTHM 115

Query: 635 HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKT------AIRGTKG 688
           H   +   +H D+  +N  L    T ++ D+G+    +  +   I+T       +R    
Sbjct: 116 H---KHNFLHSDLALRNCFLTSDLTVKVGDYGIG--PSRYKEDYIETEDDKCVPLR---- 166

Query: 689 YVAPEW---FRNSKITAK----VDVYSFGVLLLEIISCRK 721
           ++APE    F    ITA+     +V++ GV L E+     
Sbjct: 167 WLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAA 206

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 56.7 bits (137), Expect = 2e-08
 Identities = 59/213 (27%), Positives = 94/213 (44%), Gaps = 36/213 (16%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTA--VAVKKLDR---VFQDGEREFKNEVFVIGQTHHKNLV 581
           +G+G+FG     VI  R   T    A+K L +   + +D       E  V+  T H  L 
Sbjct: 3   LGKGTFG----KVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLT 58

Query: 582 RLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIAF----------QIARG 630
            L  +  +  +RL  V E+ N G L           ++L     F          +I   
Sbjct: 59  AL-KYSFQTHDRLCFVMEYANGGELF----------FHLSRERVFSEDRARFYGAEIVSA 107

Query: 631 LLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYV 690
           L YLH      +++ D+K +N++LD     +I+DFGL K   ++   T+KT   GT  Y+
Sbjct: 108 LGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFC-GTPEYL 162

Query: 691 APEWFRNSKITAKVDVYSFGVLLLEIISCRKSF 723
           APE   ++     VD +  GV++ E++  R  F
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 56.2 bits (135), Expect = 3e-08
 Identities = 63/248 (25%), Positives = 107/248 (43%), Gaps = 42/248 (16%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVK---KLDRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +GRG+FG V   ++Q + +    A+K   K D + ++     + E  ++ +     +V++
Sbjct: 9   IGRGAFGEVR--LVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKM 66

Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
                + +N  L+ EFL  G + + L   +K +        F IA  +L +    +   I
Sbjct: 67  FYSFQDKRNLYLIMEFLPGGDMMTLL---MKKDTLSEEATQFYIAETVLAIDAIHQLGFI 123

Query: 644 HCDIKPQNILLDDYYTARISDFGLA------------KLLTLN--------------QSK 677
           H DIKP N+LLD     ++SDFGL             + LT N              +++
Sbjct: 124 HRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAE 183

Query: 678 TIKTAIR-------GTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 730
           T K   R       GT  Y+APE F  +      D +S GV++ E++     F  E  +E
Sbjct: 184 TWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQE 243

Query: 731 -YAILTDW 737
            Y  + +W
Sbjct: 244 TYRKVMNW 251

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 55.7 bits (134), Expect = 3e-08
 Identities = 54/197 (27%), Positives = 85/197 (43%), Gaps = 15/197 (7%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE--FKNEVFVIGQTHHKNLVRLL 584
           +G+GSFG V     ++  S  AV V +   + +  E+         ++    H  LV L 
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62

Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN----IAFQIARGLLYLHEDCRA 640
                 +    V +++N G L    F +L+             A ++A  + YLH     
Sbjct: 63  YSFQTAEKLYFVLDYVNGGEL----FFHLQRERCFLEPRARFYAAEVASAIGYLHS---L 115

Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            II+ D+KP+NILLD      ++DFGL K     +  T  +   GT  Y+APE  R    
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT--STFCGTPEYLAPEVLRKEPY 173

Query: 701 TAKVDVYSFGVLLLEII 717
              VD +  G +L E++
Sbjct: 174 DRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 55.7 bits (134), Expect = 3e-08
 Identities = 59/198 (29%), Positives = 97/198 (48%), Gaps = 16/198 (8%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREF-----KNEVFVIGQTHHKNLV 581
           +G+G+FG VY+  ++ + +    A+K L +     ++E      +  + V         +
Sbjct: 1   IGKGTFGQVYQ--VRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFI 58

Query: 582 RLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIA-FQIARGLLYLHEDCR 639
             L F  +  + L LV ++++ G L    F +L+       + A F IA  +L L    +
Sbjct: 59  VGLKFSFQTDSDLYLVTDYMSGGEL----FWHLQKEGRFSEDRAKFYIAELVLALEHLHK 114

Query: 640 AQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSK 699
             I++ D+KP+NILLD      + DFGL+K   L  +KT  T   GT  Y+APE   + K
Sbjct: 115 YDIVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFC-GTTEYLAPEVLLDEK 172

Query: 700 -ITAKVDVYSFGVLLLEI 716
             T  VD +S GVL+ E+
Sbjct: 173 GYTKHVDFWSLGVLVFEM 190

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 55.4 bits (133), Expect = 4e-08
 Identities = 54/197 (27%), Positives = 94/197 (47%), Gaps = 18/197 (9%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE--REFKN----EVFVIGQTHHKNL 580
           VG G++G+V K   + + +   VA+KK    F+D E   E K     E+ ++     +N+
Sbjct: 9   VGEGAYGVVLK--CRHKETKEIVAIKK----FKDSEENEEVKETTLRELKMLRTLKQENI 62

Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFL-FGNLKPNWNLRTNIAFQIARGLLYLHEDCR 639
           V L           LV+E++    L       N  P   +R+ I +Q+ + + + H++  
Sbjct: 63  VELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYI-YQLIKAIHWCHKN-- 119

Query: 640 AQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSK 699
             I+H DIKP+N+L+      ++ DFG A+ L+   S    T    T+ Y +PE    + 
Sbjct: 120 -DIVHRDIKPENLLISHNDVLKLCDFGFARNLS-EGSNANYTEYVATRWYRSPELLLGAP 177

Query: 700 ITAKVDVYSFGVLLLEI 716
               VD++S G +L E+
Sbjct: 178 YGKAVDMWSVGCILGEL 194

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 55.1 bits (132), Expect = 4e-08
 Identities = 71/279 (25%), Positives = 122/279 (43%), Gaps = 42/279 (15%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREF---KNEVFVIGQTHHKNLV 581
           + +G G++G VYK          A+ V KL    + GE +F   + E+ ++    H N+V
Sbjct: 15  QRIGSGTYGDVYKARNVNTGELAAIKVIKL----EPGE-DFAVVQQEIIMMKDCKHSNIV 69

Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASF--LFGNLKPNWNLRTNIAF---QIARGLLYLHE 636
              G         +  EF   G+L     + G L       + IA+   +  +GL YLH 
Sbjct: 70  AYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLS-----ESQIAYVSRETLQGLYYLHS 124

Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF- 695
             +   +H DIK  NILL D    +++DFG++  +T   +K  + +  GT  ++APE   
Sbjct: 125 KGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAK--RKSFIGTPYWMAPEVAA 179

Query: 696 --RNSKITAKVDVYSFGVLLLEIISCRKS-FDIEMGEEYAILTDWAFDCYRNGKLNVLVG 752
             R        D+++ G+  +E+   +   FD+       ++T   F   +  KL     
Sbjct: 180 VERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNF---QPPKL----- 231

Query: 753 EDK-EAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
           +DK +  N      K+ +       ++P  RPT +K+LQ
Sbjct: 232 KDKMKWSNSFHHFVKMALT------KNPKKRPTAEKLLQ 264

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 55.2 bits (133), Expect = 5e-08
 Identities = 52/228 (22%), Positives = 89/228 (39%), Gaps = 51/228 (22%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLD----RVFQDGEREFKNEV---F-------VI 572
           +G G++G V K    T T    VA+KK+           +R+        F       ++
Sbjct: 17  LGEGTYGKVEKA-YDTLTGKI-VAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 573 GQTHHKNLVRLLG-FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN--------I 623
            +  H+N++ L+  + +          F+N   +   +  +LK   + +          I
Sbjct: 75  NEIKHENIMGLVDVYVEGD--------FIN--LVMDIMASDLKKVVDRKIRLTESQVKCI 124

Query: 624 AFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAK-----LLTLNQSKT 678
             QI  GL  LH   +   +H D+ P NI ++     +I+DFGLA+       +   SK 
Sbjct: 125 LLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKD 181

Query: 679 IKTAIRG-------TKGYVAPE-WFRNSKITAKVDVYSFGVLLLEIIS 718
                R        T  Y APE      K    VD++S G +  E+++
Sbjct: 182 ETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT 229

Length = 335

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 55.8 bits (134), Expect = 6e-08
 Identities = 39/162 (24%), Positives = 76/162 (46%), Gaps = 7/162 (4%)

Query: 566 KNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN--- 622
           ++E+  +    H  +V+           LL+ E+ + G L   +   LK +   +     
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172

Query: 623 -IAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKT 681
            + +QI   L  +H      ++H D+K  NI L      ++ DFG +K  + + S  + +
Sbjct: 173 LLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVAS 229

Query: 682 AIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSF 723
           +  GT  Y+APE +   + + K D++S GV+L E+++  + F
Sbjct: 230 SFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPF 271

Length = 478

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 54.6 bits (131), Expect = 6e-08
 Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 32/213 (15%)

Query: 525 EEVGRGSFGIVYKGVIQTRTS------TTAVAVKKLDRVFQDGEREFKNEVF----VIGQ 574
           E +GRG+   +Y G++  +        +    +K + +V     R+     F    ++ Q
Sbjct: 1   EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQ 60

Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN---LKPNWNLRTNIAFQIARGL 631
             HK++V L G C      ++V EF+  G L  F+      L   W     +A Q+A  L
Sbjct: 61  VSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKF--KVAKQLASAL 118

Query: 632 LYLHEDCRAQIIHCDIKPQNILL-----DDYYTA--RISDFGLAKLLTLNQSKTIKTAIR 684
            YL ED    ++H ++  +NILL     D       ++SD G+  +  L++ + ++    
Sbjct: 119 SYL-ED--KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP-ITVLSRQECVERI-- 172

Query: 685 GTKGYVAPEWFRNSK-ITAKVDVYSFGVLLLEI 716
               ++APE   +SK ++   D +SFG  L EI
Sbjct: 173 ---PWIAPECVEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 55.0 bits (132), Expect = 7e-08
 Identities = 51/201 (25%), Positives = 99/201 (49%), Gaps = 20/201 (9%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVK---KLDRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +GRG+FG V   +++ ++S    A+K   K + + +     F  E  ++   +   +V+L
Sbjct: 51  IGRGAFGEVQ--LVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108

Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA-FQIARGLLYLHEDCRAQI 642
                + +   +V E++  G L      NL  N+++    A F  A  +L L       +
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLV-----NLMSNYDVPEKWAKFYTAEVVLALDAIHSMGL 163

Query: 643 IHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIK--TAIRGTKGYVAPEWFR---- 696
           IH D+KP N+LLD +   +++DFG    + ++++  ++  TA+ GT  Y++PE  +    
Sbjct: 164 IHRDVKPDNMLLDKHGHLKLADFGTC--MKMDETGMVRCDTAV-GTPDYISPEVLKSQGG 220

Query: 697 NSKITAKVDVYSFGVLLLEII 717
           +     + D +S GV L E++
Sbjct: 221 DGYYGRECDWWSVGVFLFEML 241

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 54.2 bits (130), Expect = 9e-08
 Identities = 34/95 (35%), Positives = 52/95 (54%), Gaps = 8/95 (8%)

Query: 624 AFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAI 683
           A +I  GL ++H      +++ D+KP NILLD++   RISD GLA     + SK    A 
Sbjct: 103 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHAS 155

Query: 684 RGTKGYVAPEWF-RNSKITAKVDVYSFGVLLLEII 717
            GT GY+APE   +     +  D +S G +L +++
Sbjct: 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 53.9 bits (129), Expect = 1e-07
 Identities = 56/197 (28%), Positives = 86/197 (43%), Gaps = 15/197 (7%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE--FKNEVFVIGQTHHKNLVRLL 584
           +G+GSFG V     +      AV V +   + +  E +        ++    H  LV L 
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL- 61

Query: 585 GFCDEGQNRL-LVYEFLNNGTLASFLFGN---LKPNWNLRTNIAFQIARGLLYLHEDCRA 640
            F  +  ++L  V +++N G L   L      L+P        A +IA  L YLH     
Sbjct: 62  HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF---YAAEIASALGYLHS---L 115

Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            I++ D+KP+NILLD      ++DFGL K    +   T  +   GT  Y+APE       
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTT--STFCGTPEYLAPEVLHKQPY 173

Query: 701 TAKVDVYSFGVLLLEII 717
              VD +  G +L E++
Sbjct: 174 DRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 53.9 bits (129), Expect = 2e-07
 Identities = 55/211 (26%), Positives = 99/211 (46%), Gaps = 19/211 (9%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGERE-FKNEVFVIGQTHHKNLVRL 583
           +GRG+FG V   V++ + +    A+K L++  + +  E   F+ E  V+    ++ +  L
Sbjct: 9   IGRGAFGEV--AVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTL 66

Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ 641
                +  N  LV ++   G L + L  F +  P    R    F +A  ++ +    +  
Sbjct: 67  HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMAR----FYLAEMVIAIDSVHQLH 122

Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIR-GTKGYVAPEWFR---- 696
            +H DIKP NIL+D     R++DFG    L L +  T+++++  GT  Y++PE  +    
Sbjct: 123 YVHRDIKPDNILMDMNGHIRLADFG--SCLKLMEDGTVQSSVAVGTPDYISPEILQAMED 180

Query: 697 -NSKITAKVDVYSFGVLLLEIISCRKSFDIE 726
              K   + D +S GV + E++     F  E
Sbjct: 181 GKGKYGPECDWWSLGVCMYEMLYGETPFYAE 211

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 53.1 bits (127), Expect = 2e-07
 Identities = 56/201 (27%), Positives = 93/201 (46%), Gaps = 12/201 (5%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR---VFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G+G+FG V   +++ + +    A+K L +   + +D       E  V+  T H  L  L
Sbjct: 3   LGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60

Query: 584 LGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQI 642
             +  +  +RL  V E+ N G L   L                +I   L YLH      +
Sbjct: 61  -KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DV 116

Query: 643 IHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITA 702
           ++ DIK +N++LD     +I+DFGL K    + + T+KT   GT  Y+APE   ++    
Sbjct: 117 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKTFC-GTPEYLAPEVLEDNDYGR 174

Query: 703 KVDVYSFGVLLLEIISCRKSF 723
            VD +  GV++ E++  R  F
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 52.9 bits (127), Expect = 3e-07
 Identities = 42/136 (30%), Positives = 69/136 (50%), Gaps = 10/136 (7%)

Query: 595 LVYEFLNNGTLASFLF--GNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNI 652
           L+ +++N G L + L+   +   +  +R  IA +I   L +LH+     II+ DIK +NI
Sbjct: 82  LILDYVNGGELFTHLYQREHFTES-EVRVYIA-EIVLALDHLHQ---LGIIYRDIKLENI 136

Query: 653 LLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR--NSKITAKVDVYSFG 710
           LLD      ++DFGL+K       +    +  GT  Y+APE  R  +      VD +S G
Sbjct: 137 LLDSEGHVVLTDFGLSKEFLAE-EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLG 195

Query: 711 VLLLEIISCRKSFDIE 726
           VL  E+++    F ++
Sbjct: 196 VLTFELLTGASPFTVD 211

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 53.1 bits (127), Expect = 3e-07
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 11/201 (5%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR---VFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G+G+FG V   +++ + +    A+K L +   V +D       E  V+  + H  L  L
Sbjct: 3   LGKGTFGKVI--LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60

Query: 584 LGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQI 642
             +  +  +RL  V E+ N G L   L      + +       +I   L YLH +    +
Sbjct: 61  -KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE--KNV 117

Query: 643 IHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITA 702
           ++ D+K +N++LD     +I+DFGL K   +    T+KT   GT  Y+APE   ++    
Sbjct: 118 VYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFC-GTPEYLAPEVLEDNDYGR 175

Query: 703 KVDVYSFGVLLLEIISCRKSF 723
            VD +  GV++ E++  R  F
Sbjct: 176 AVDWWGLGVVMYEMMCGRLPF 196

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 52.6 bits (126), Expect = 3e-07
 Identities = 38/105 (36%), Positives = 58/105 (55%), Gaps = 6/105 (5%)

Query: 626 QIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRG 685
           +I   L +LH   +  I++ DIK +NILLD      ++DFGL+K   L++ K    +  G
Sbjct: 113 EIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF-LSEEKERTYSFCG 168

Query: 686 TKGYVAPEWFRNSKITAK-VDVYSFGVLLLEIISCRKSFDIEMGE 729
           T  Y+APE  R      K VD +S G+L+ E+++    F +E GE
Sbjct: 169 TIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE-GE 212

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 52.5 bits (126), Expect = 4e-07
 Identities = 56/203 (27%), Positives = 96/203 (47%), Gaps = 21/203 (10%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGERE-FKNEVFVIGQTHHKNLVRL 583
           +GRG+FG V   V++ + +    A+K L++  + +  E   F+ E  V+     + +  L
Sbjct: 9   IGRGAFGEV--AVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNL 66

Query: 584 -LGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
              F DE  N  LV ++   G L + L  F +  P    R    F +A  +L +    + 
Sbjct: 67  HYAFQDE-NNLYLVMDYYVGGDLLTLLSKFEDRLPEDMAR----FYLAEMVLAIDSVHQL 121

Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIR-GTKGYVAPEWFR--- 696
             +H DIKP N+LLD     R++DFG    L L    T+++ +  GT  Y++PE  +   
Sbjct: 122 GYVHRDIKPDNVLLDKNGHIRLADFG--SCLRLLADGTVQSNVAVGTPDYISPEILQAME 179

Query: 697 --NSKITAKVDVYSFGVLLLEII 717
               +   + D +S GV + E++
Sbjct: 180 DGKGRYGPECDWWSLGVCMYEML 202

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 51.5 bits (123), Expect = 6e-07
 Identities = 40/138 (28%), Positives = 70/138 (50%), Gaps = 7/138 (5%)

Query: 595 LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILL 654
           L+ +++N G L + L    +         + +I   L +LH   +  II+ DIK +NILL
Sbjct: 82  LILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILL 138

Query: 655 DDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR--NSKITAKVDVYSFGVL 712
           D      ++DFGL+K    ++ +    +  GT  Y+AP+  R  +      VD +S GVL
Sbjct: 139 DSNGHVVLTDFGLSKEFHEDEVER-AYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVL 197

Query: 713 LLEIISCRKSFDIEMGEE 730
           + E+++    F ++ GE+
Sbjct: 198 MYELLTGASPFTVD-GEK 214

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 51.5 bits (123), Expect = 6e-07
 Identities = 43/165 (26%), Positives = 80/165 (48%), Gaps = 22/165 (13%)

Query: 626 QIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRG 685
           Q+  G+ Y+H+    +I+H D+K +NI L +    +I DFG+++LL    S  + T   G
Sbjct: 114 QLLLGVHYMHQ---RRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLM--GSCDLATTFTG 167

Query: 686 TKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 745
           T  Y++PE  ++    +K D++S G +L E+     +F    G+ +  +           
Sbjct: 168 TPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAF---EGQNFLSVV---------- 214

Query: 746 KLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
            L ++ G               +M S+  + +DPSLRP+  ++L+
Sbjct: 215 -LRIVEGPTPSLPETYSRQLNSIMQSM--LNKDPSLRPSAAEILR 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 51.6 bits (123), Expect = 1e-06
 Identities = 45/177 (25%), Positives = 83/177 (46%), Gaps = 21/177 (11%)

Query: 622 NIAFQIARGLLYL-HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIK 680
           +  +Q+ARG+ +L  ++C    +H D+  +N+LL      +I DFGLA+ +  + +   K
Sbjct: 241 SFTYQVARGMEFLASKNC----VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSK 296

Query: 681 TAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAF 739
            +      ++APE   ++  T   DV+S+G+LL EI S         G  Y  ++ D  F
Sbjct: 297 GSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLG-------GTPYPGMIVDSTF 349

Query: 740 DCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 796
             Y   K    + +   A  ++      +MV  W    +P  RP+   +  ++E ++
Sbjct: 350 --YNKIKSGYRMAKPDHATQEV----YDIMVKCW--NSEPEKRPSFLHLSDIVESLL 398

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 50.6 bits (121), Expect = 2e-06
 Identities = 34/106 (32%), Positives = 46/106 (43%), Gaps = 7/106 (6%)

Query: 622 NIAFQIARGLL----YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSK 677
             A  I R LL    YLH      IIH D+K +NI LD+   A + DFG A  L  +   
Sbjct: 185 EQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241

Query: 678 TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSF 723
                  GT    +PE        AK D++S G++L E+     + 
Sbjct: 242 PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287

Length = 392

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 50.5 bits (121), Expect = 2e-06
 Identities = 56/201 (27%), Positives = 97/201 (48%), Gaps = 20/201 (9%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE----FKNEVFVIGQTHHKNLVR 582
           +GRG+FG V   +++ ++S    A+K L + F+  +R     F  E  ++   + + +V+
Sbjct: 51  IGRGAFGEVQ--LVRHKSSKQVYAMKLLSK-FEMIKRSDSAFFWEERDIMAHANSEWIVQ 107

Query: 583 L-LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA-FQIARGLLYLHEDCRA 640
           L   F D+ +   +V E++  G L      NL  N+++    A F  A  +L L      
Sbjct: 108 LHYAFQDD-KYLYMVMEYMPGGDLV-----NLMSNYDIPEKWARFYTAEVVLALDAIHSM 161

Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
             IH D+KP N+LLD     +++DFG    +  N      TA+ GT  Y++PE  ++   
Sbjct: 162 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISPEVLKSQGG 220

Query: 701 TA----KVDVYSFGVLLLEII 717
                 + D +S GV L E++
Sbjct: 221 DGYYGRECDWWSVGVFLYEML 241

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 50.4 bits (120), Expect = 3e-06
 Identities = 30/96 (31%), Positives = 55/96 (57%), Gaps = 5/96 (5%)

Query: 624 AFQIARGLLYL-HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTA 682
           ++Q+A G+ +L  ++C    +H D+  +N+L+ +    +I DFGLA+ +  + +   K +
Sbjct: 245 SYQVANGMEFLASKNC----VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGS 300

Query: 683 IRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS 718
                 ++APE   N+  T   DV+SFG+LL EI +
Sbjct: 301 TFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 49.8 bits (119), Expect = 3e-06
 Identities = 34/101 (33%), Positives = 52/101 (51%), Gaps = 5/101 (4%)

Query: 626 QIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRG 685
           +I+  L +LH   +  II+ D+KP+NILLD     +++DFGL K      + T      G
Sbjct: 108 EISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVT--HTFCG 162

Query: 686 TKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIE 726
           T  Y+APE    S     VD +S G L+ ++++    F  E
Sbjct: 163 TIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAE 203

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 48.7 bits (116), Expect = 5e-06
 Identities = 53/185 (28%), Positives = 81/185 (43%), Gaps = 34/185 (18%)

Query: 549 VAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASF 608
           V +K LD   +D    F     ++ Q  H +L  + G C  G   ++V EF+ +G L   
Sbjct: 47  VVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVC 106

Query: 609 LF---GNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDF 665
           L    G +   W +   +A Q+A  L YL ED    ++H ++  +NILL     AR+   
Sbjct: 107 LRKEKGRVPVAWKI--TVAQQLASALSYL-ED--KNLVHGNVCAKNILL-----ARL--- 153

Query: 666 GLAKLLTLNQSKTIKTAIRGTK-------------GYVAPEWFRN-SKITAKVDVYSFGV 711
           GLA+      S  IK +  G                ++APE     + ++   D +SFG 
Sbjct: 154 GLAE----GTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGT 209

Query: 712 LLLEI 716
            LLEI
Sbjct: 210 TLLEI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 49.2 bits (117), Expect = 5e-06
 Identities = 34/102 (33%), Positives = 51/102 (50%), Gaps = 6/102 (5%)

Query: 623 IAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKL-LTLNQSKTIKT 681
           I   + R + YLHE+   +IIH DIK +NI ++      + DFG A   + +N +K    
Sbjct: 187 IERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGW 243

Query: 682 AIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSF 723
           A  GT    APE          VD++S G++L E+ +C  S 
Sbjct: 244 A--GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283

Length = 391

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 48.4 bits (116), Expect = 6e-06
 Identities = 50/208 (24%), Positives = 97/208 (46%), Gaps = 40/208 (19%)

Query: 530 GSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE-FK----NEVFVIGQTHHKNLVRL- 583
           G++G+VY+   + + +   VA+KKL     + E+E F      E+ ++ +  H N+V + 
Sbjct: 16  GTYGVVYRA--RDKKTGEIVALKKLK---MEKEKEGFPITSLREINILLKLQHPNIVTVK 70

Query: 584 ---LGFCDEGQNRL-LVYEF--------LNNGTLASFLFGNLKPNWNLRTNIAFQIARGL 631
              +G      +++ +V E+        +       FL   +K        +  Q+  G+
Sbjct: 71  EVVVG---SNLDKIYMVMEYVEHDLKSLMETMK-QPFLQSEVK-------CLMLQLLSGV 119

Query: 632 LYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVA 691
            +LH++    I+H D+K  N+LL++    +I DFGLA+           T +  T  Y A
Sbjct: 120 AHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY--TQLVVTLWYRA 174

Query: 692 PEWFRNSKI-TAKVDVYSFGVLLLEIIS 718
           PE    +K  +  +D++S G +  E+++
Sbjct: 175 PELLLGAKEYSTAIDMWSVGCIFAELLT 202

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 49.4 bits (117), Expect = 7e-06
 Identities = 62/249 (24%), Positives = 108/249 (43%), Gaps = 48/249 (19%)

Query: 513 YKELEGATNNFK--EEVGRGSFGIVYKGVIQTRTST----TAVAVKKLDRVFQDGEREFK 566
           Y + E   N ++  +++G G FG V+  V   RT       A++ + L       ERE  
Sbjct: 5   YDDGESRLNEYEVIKKIGNGRFGEVFL-VKHKRTQEFFCWKAISYRGLK------EREKS 57

Query: 567 N---EVFVIGQTHHKNLVRLLG-FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRT 621
               EV V+ +  HKN+VR +  F ++   +L ++ EF + G L+  +    K    +  
Sbjct: 58  QLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEE 117

Query: 622 NIAFQIARGLLYLHEDCR--------AQIIHCDIKPQNIL-----------------LDD 656
           +    I R LL+    C          +++H D+KPQNI                  L+ 
Sbjct: 118 HAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNG 177

Query: 657 YYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF--RNSKITAKVDVYSFGVLLL 714
              A+I DFGL+K + +   +++  +  GT  Y +PE           K D+++ G ++ 
Sbjct: 178 RPIAKIGDFGLSKNIGI---ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIY 234

Query: 715 EIISCRKSF 723
           E+ S +  F
Sbjct: 235 ELCSGKTPF 243

Length = 1021

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 48.5 bits (115), Expect = 1e-05
 Identities = 51/201 (25%), Positives = 96/201 (47%), Gaps = 20/201 (9%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVK---KLDRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +GRG+FG V   +++ +++    A+K   K + + +     F  E  ++   +   +V+L
Sbjct: 51  IGRGAFGEVQ--LVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108

Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA-FQIARGLLYLHEDCRAQI 642
                + +   +V E++  G L      NL  N+++    A F  A  +L L        
Sbjct: 109 FYAFQDDRYLYMVMEYMPGGDLV-----NLMSNYDVPEKWARFYTAEVVLALDAIHSMGF 163

Query: 643 IHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIK--TAIRGTKGYVAPEWFR---- 696
           IH D+KP N+LLD     +++DFG    + +N+   ++  TA+ GT  Y++PE  +    
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTC--MKMNKEGMVRCDTAV-GTPDYISPEVLKSQGG 220

Query: 697 NSKITAKVDVYSFGVLLLEII 717
           +     + D +S GV L E++
Sbjct: 221 DGYYGRECDWWSVGVFLYEML 241

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family

 Score = 45.0 bits (107), Expect = 1e-05
 Identities = 22/70 (31%), Positives = 35/70 (50%), Gaps = 9/70 (12%)

Query: 263 FYYRATLNFDGVFAQYFYPKNGNGNWSVAWSEPENICVDIGGGLGSGACGYNSICTLDSD 322
            Y R TL+ +G   ++ +  N   +W++ WS P++ C D+      G CG    C  D +
Sbjct: 45  IYSRLTLSSEGSLERFTWIPNSQ-DWNLFWSAPKDQC-DV-----YGRCGPYGYC--DVN 95

Query: 323 RRPRCACPKG 332
             P+C C KG
Sbjct: 96  TSPKCNCIKG 105

In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 48.7 bits (116), Expect = 1e-05
 Identities = 48/152 (31%), Positives = 78/152 (51%), Gaps = 9/152 (5%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAV-KKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLG 585
           + RG+FG VY G  +  +   AV V KK D + ++   + + E   +  +    +V L  
Sbjct: 12  ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71

Query: 586 FCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
                 N  LV E+L  G + S L  +G       ++  I+ ++A  L YLH   R  II
Sbjct: 72  SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKY-IS-EVALALDYLH---RHGII 126

Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQ 675
           H D+KP N+L+ +    +++DFGL+K +TLN+
Sbjct: 127 HRDLKPDNMLISNEGHIKLTDFGLSK-VTLNR 157

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 47.7 bits (114), Expect = 1e-05
 Identities = 54/228 (23%), Positives = 90/228 (39%), Gaps = 43/228 (18%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVF----VIGQTHHKNL 580
           + +G+G  G V+  +++ + +    A+K LD+  +  +R     V     ++    H  L
Sbjct: 7   KLLGKGDVGRVF--LVRLKGTGKLFALKVLDK-KEMIKRNKVKRVLTEQEILATLDHPFL 63

Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA-FQIARGLL---YLHE 636
             L           LV ++   G L   L    +P   L   +A F  A  LL   YLH 
Sbjct: 64  PTLYASFQTETYLCLVMDYCPGGELFRLL--QRQPGKCLSEEVARFYAAEVLLALEYLH- 120

Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIR------------ 684
                I++ D+KP+NILL +     +SDF L+K   +      K   +            
Sbjct: 121 -LLG-IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPS 178

Query: 685 ---------------GTKGYVAPEWFRNSKITAKVDVYSFGVLLLEII 717
                          GT+ Y+APE        + VD ++ G+LL E++
Sbjct: 179 ETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEML 226

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 46.9 bits (111), Expect = 2e-05
 Identities = 51/215 (23%), Positives = 80/215 (37%), Gaps = 35/215 (16%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRL--- 583
           +G G FG VY+    +       AV K++ +          E  V    +  + + L   
Sbjct: 20  IGCGGFGCVYETQCASDHCINNQAVAKIENL---ENETIVMETLVYNNIYDIDKIALWKN 76

Query: 584 ------LGF-----CDEGQNRLLVYEF-------LNNGTLASFLFGNLKPNWNLRTNIAF 625
                 LG      C   +   + Y F        N   +   +    K    L  NI  
Sbjct: 77  IHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKK---LIKNIMK 133

Query: 626 QIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN-----QSKTIK 680
            +   L Y+HE     I H DIKP+NI++D      I D+G+A    ++      SK  K
Sbjct: 134 DMLTTLEYIHE---HGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQK 190

Query: 681 TAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLE 715
              RGT  Y   +    + +T + D+ S G  +L+
Sbjct: 191 DLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225

Length = 294

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 46.3 bits (110), Expect = 4e-05
 Identities = 54/224 (24%), Positives = 97/224 (43%), Gaps = 55/224 (24%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR-----------VFQDGERE---FKNEVFVI 572
           +  G++G VY  +++ + +    A+KK+++           VF   ER+   F    FV+
Sbjct: 9   ISNGAYGAVY--LVRHKETRQRFAMKKINKQNLILRNQIQQVF--VERDILTFAENPFVV 64

Query: 573 GQTHHKNLVRLLGFCD-EGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIA-FQIAR 629
                        FC  E +  L +V E++  G  A+ L  N+     L  ++A    A 
Sbjct: 65  SM-----------FCSFETKRHLCMVMEYVEGGDCAT-LLKNIGA---LPVDMARMYFAE 109

Query: 630 GLL---YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI------- 679
            +L   YLH      I+H D+KP N+L+      +++DFGL+K+  ++ +  +       
Sbjct: 110 TVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEK 166

Query: 680 ------KTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEII 717
                    + GT  Y+APE          VD ++ G++L E +
Sbjct: 167 DTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL 210

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 45.7 bits (108), Expect = 7e-05
 Identities = 30/95 (31%), Positives = 45/95 (47%), Gaps = 3/95 (3%)

Query: 621 TNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIK 680
           T +A Q+   + Y+H      IIH DIK +N+L++      + DFG A     + S    
Sbjct: 263 TAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFH 319

Query: 681 TAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLE 715
             I GT    APE       T  VD++S G+++ E
Sbjct: 320 YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 45.2 bits (107), Expect = 9e-05
 Identities = 59/239 (24%), Positives = 95/239 (39%), Gaps = 57/239 (23%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKL--DRVFQ-DGEREFKNEVFVIGQTHHKNLVRL 583
           +G+G+FG V   ++Q + +    A+K L    +F+ D     K E  V+ ++    +V L
Sbjct: 9   IGKGAFGEVR--LVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66

Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN--IAFQIARGLLYLHEDCRAQ 641
                + Q   L+ EFL  G L + L       ++  +     F +A  +L +    +  
Sbjct: 67  YYSFQDAQYLYLIMEFLPGGDLMTMLI-----KYDTFSEDVTRFYMAECVLAIEAVHKLG 121

Query: 642 IIHCDIKPQNILLDDYYTARISDFGLA-------------KL------------------ 670
            IH DIKP NIL+D     ++SDFGL+             KL                  
Sbjct: 122 FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAV 181

Query: 671 ----LTLNQSKTIKTAIR----------GTKGYVAPEWFRNSKITAKVDVYSFGVLLLE 715
               LT++    I T  +          GT  Y+APE F       + D +S G ++ E
Sbjct: 182 DSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 44.7 bits (105), Expect = 1e-04
 Identities = 51/217 (23%), Positives = 99/217 (45%), Gaps = 27/217 (12%)

Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLD--RVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +VGRG++G VYK   +        A+K+++   +     R    E+ ++ +  H N++ L
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACR----EIALLRELKHPNVIAL 63

Query: 584 LG-FCDEGQNRL-LVYEFLNNGTLASFLF-----GNLKPNWNLRT---NIAFQIARGLLY 633
              F      ++ L++++  +       F      N KP    R+   ++ +QI  G+ Y
Sbjct: 64  QKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHY 123

Query: 634 LHEDCRAQIIHCDIKPQNILL----DDYYTARISDFGLAKLLT--LNQSKTIKTAIRGTK 687
           LH +    ++H D+KP NIL+     +    +I+D G A+L    L     +   +  T 
Sbjct: 124 LHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TF 179

Query: 688 GYVAPEWFRNSK-ITAKVDVYSFGVLLLEIISCRKSF 723
            Y APE    ++  T  +D+++ G +  E+++    F
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 44.7 bits (105), Expect = 1e-04
 Identities = 55/231 (23%), Positives = 104/231 (45%), Gaps = 34/231 (14%)

Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLD--RVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +VGRG++G VYK   +        A+K+++   +     R    E+ ++ +  H N++ L
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACR----EIALLRELKHPNVISL 63

Query: 584 LG-FCDEGQNRL-LVYEFLNNGTLASFLF-----GNLKPNWNLR---TNIAFQIARGLLY 633
              F      ++ L++++  +       F      N KP    R    ++ +QI  G+ Y
Sbjct: 64  QKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 123

Query: 634 LHEDCRAQIIHCDIKPQNILL----DDYYTARISDFGLAKLLT--LNQSKTIKTAIRGTK 687
           LH +    ++H D+KP NIL+     +    +I+D G A+L    L     +   +  T 
Sbjct: 124 LHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TF 179

Query: 688 GYVAPEWFRNSK-ITAKVDVYSFGVLLLEIIS------CRKSFDIEMGEEY 731
            Y APE    ++  T  +D+++ G +  E+++      CR+  DI+    Y
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE-DIKTSNPY 229

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 43.1 bits (102), Expect = 3e-04
 Identities = 40/207 (19%), Positives = 74/207 (35%), Gaps = 23/207 (11%)

Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGER--EFKNEVFVIGQTHHKNLVRL 583
            +G+    ++   + + + + T VAVKK++      E     + E+    Q  H N++  
Sbjct: 5   LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64

Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF---QIARGLLYLHEDCRA 640
           +          +V   +  G+    L     P       IAF    +   L Y+H     
Sbjct: 65  VTSFIVDSELYVVSPLMAYGS-CEDLLKTHFPEGLPELAIAFILKDVLNALDYIH---SK 120

Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKG------YVAPEW 694
             IH  +K  +ILL       +S    +  + +   K  +      K       +++PE 
Sbjct: 121 GFIHRSVKASHILLSGDGKVVLSGLRYSVSM-IKHGKRQRVVHDFPKSSVKNLPWLSPEV 179

Query: 695 FRNS--KITAKVDVYSFGVLLLEIISC 719
            + +      K D+YS G     I +C
Sbjct: 180 LQQNLQGYNEKSDIYSVG-----ITAC 201

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 42.1 bits (99), Expect = 8e-04
 Identities = 30/92 (32%), Positives = 45/92 (48%), Gaps = 5/92 (5%)

Query: 523 FKEEVGRGSFGIVYKGV---IQTRTSTTAVAVKKLDRVFQDGERE-FKNEVFVIGQT-HH 577
           F + +G G+FG V +     +    +   VAVK L       ERE   +E+ ++     H
Sbjct: 42  FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQH 101

Query: 578 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL 609
           KN+V LLG C  G   L++ E+   G L +FL
Sbjct: 102 KNIVNLLGACTHGGPVLVITEYCCYGDLLNFL 133

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 42.3 bits (99), Expect = 8e-04
 Identities = 56/247 (22%), Positives = 96/247 (38%), Gaps = 57/247 (23%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAV----AVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVR 582
           +G G+FG V    +  +  T A+     ++K D + ++     K E  ++ +  ++ +V+
Sbjct: 9   LGIGAFGEV---CLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVK 65

Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCRAQ 641
           L     +  N   V +++  G + S L    + P    R    F IA   L +    +  
Sbjct: 66  LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLAR----FYIAELTLAIESVHKMG 121

Query: 642 IIHCDIKPQNILLDDYYTARISDFGLA--------------------------------- 668
            IH DIKP NIL+D     +++DFGL                                  
Sbjct: 122 FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVS 181

Query: 669 ------KLLTLNQ------SKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEI 716
                 +L TL Q       + +  ++ GT  Y+APE       T   D +S GV+L E+
Sbjct: 182 NCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEM 241

Query: 717 ISCRKSF 723
           +  +  F
Sbjct: 242 LVGQPPF 248

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 41.5 bits (97), Expect = 0.002
 Identities = 35/144 (24%), Positives = 57/144 (39%), Gaps = 32/144 (22%)

Query: 623 IAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTA----------------RISDFG 666
           I FQ    L Y H +    ++H D+KP+NIL++   T                 RI D G
Sbjct: 236 IIFQTGVALDYFHTELH--LMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG 293

Query: 667 LAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIE 726
                     +  +TAI  T+ Y +PE           D++S G ++ E+ + +  +D  
Sbjct: 294 -----GCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH 348

Query: 727 MGEEYAIL---------TDWAFDC 741
              E+  L         ++WA  C
Sbjct: 349 DNLEHLHLMEKTLGRLPSEWAGRC 372

Length = 467

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 40.3 bits (94), Expect = 0.003
 Identities = 32/93 (34%), Positives = 49/93 (52%), Gaps = 7/93 (7%)

Query: 523 FKEEVGRGSFGIVYK----GVIQTRTSTTAVAVKKLDRVFQDGERE-FKNEVFVIGQT-H 576
           F + +G G+FG V +    G+ ++  + T VAVK L       ERE   +E+ V+    +
Sbjct: 39  FGKTLGAGAFGKVVEATAYGLFKSDAAMT-VAVKMLKPSAHLTEREALMSELKVLSYLGN 97

Query: 577 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL 609
           H N+V LLG C  G   L++ E+   G L +FL
Sbjct: 98  HINIVNLLGACTVGGPTLVITEYCCYGDLLNFL 130

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 40.4 bits (94), Expect = 0.003
 Identities = 38/164 (23%), Positives = 73/164 (44%), Gaps = 18/164 (10%)

Query: 564 EFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV---YEFLNNGTLASFLF-GNLKPN--- 616
           + +NE+  +G+ +H+N++++        N  ++   Y+F     L SF++          
Sbjct: 209 QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF----DLYSFMYDEAFDWKDRP 264

Query: 617 --WNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN 674
                R  I  Q+   + Y+H+    ++IH DIK +NI L+      + DFG A      
Sbjct: 265 LLKQTRA-IMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFE-K 319

Query: 675 QSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS 718
           + +       GT    +PE           D++S G++LL+++S
Sbjct: 320 EREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 40.2 bits (94), Expect = 0.004
 Identities = 55/244 (22%), Positives = 97/244 (39%), Gaps = 55/244 (22%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAV-AVKKLDR--VFQDGE-REFKNEVFVIGQTHHKNLVR 582
           +G G+FG V    +  +  T A+ A+K L +  V    +    K E  ++ +  ++ +V+
Sbjct: 9   IGIGAFGEVC---LVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVK 65

Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           L     +  N   V +++  G + S L   G +      R  IA ++   +  +H   + 
Sbjct: 66  LYYSFQDKDNLYFVMDYIPGGDMMSLLIRLG-IFEEDLARFYIA-ELTCAIESVH---KM 120

Query: 641 QIIHCDIKPQNILLDDYYTARISDFGL--------------------------------- 667
             IH DIKP NIL+D     +++DFGL                                 
Sbjct: 121 GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEI 180

Query: 668 --AKLLTL------NQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISC 719
              +L  L         + +  ++ GT  Y+APE    +  T   D +S GV+L E++  
Sbjct: 181 DRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 240

Query: 720 RKSF 723
           +  F
Sbjct: 241 QPPF 244

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 38.2 bits (89), Expect = 0.004
 Identities = 29/134 (21%), Positives = 53/134 (39%), Gaps = 11/134 (8%)

Query: 539 VIQTRTSTTAVAVKKLDRVFQDGEREFKNEVF-VIGQTHHKNLV-RLLGFCDEGQNRLLV 596
           V    T      +K      +  +RE +  +  ++ +      V ++L   +      L+
Sbjct: 14  VYLLGTKDEDYVLKINPSREKGADREREVAILQLLAR--KGLPVPKVLASGESDGWSYLL 71

Query: 597 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDD 656
            E++   TL        + +   + +IA Q+A  L  LH+     + H D+ P NIL+DD
Sbjct: 72  MEWIEGETLD-------EVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDD 124

Query: 657 YYTARISDFGLAKL 670
                I D+  A  
Sbjct: 125 GKILGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	814
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.98
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.98
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.98
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.98
PHA03210	501	serine/threonine kinase US3; Provisional	99.98
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.98
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.98
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.98
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.98
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.98
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.98
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.98
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.98
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.98
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.98
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.98
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.98
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.98
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.98
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.98
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.97
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.97
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.97
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.97
PLN00009	294	cyclin-dependent kinase A; Provisional	99.97
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.97
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.97
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.97
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.97
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.97
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.97
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.97
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.97
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.97
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.97
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.97
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.97
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.97
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.97
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.97
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.97
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.97
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.97
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.97
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.97
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.97
KOG0586	596	consensus Serine/threonine protein kinase [General	99.97
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.97
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.97
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.97
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.97
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.97
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.97
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.97
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.97
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.97
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.97
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.96
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.96
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.96
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.96
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.96
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.96
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.96
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.96
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.96
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.96
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.95
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.95
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.95
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.95
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.95
PF01453	114	B_lectin: D-mannose binding lectin; InterPro: IPR0	99.94
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.94
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.94
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.94
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.94
KOG1152	772	consensus Signal transduction serine/threonine kin	99.93
cd00028	116	B_lectin Bulb-type mannose-specific lectin. The do	99.93
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.93
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.93
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.92
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.92
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.92
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.91
smart00108	114	B_lectin Bulb-type mannose-specific lectin.	99.91
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.9
PLN00181	793	protein SPA1-RELATED; Provisional	99.9
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.89
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.88
PRK09188	365	serine/threonine protein kinase; Provisional	99.86
PF00954	110	S_locus_glycop: S-locus glycoprotein family; Inter	99.85
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.84
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.84
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.82
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.81
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.8
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.8
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.79
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.77
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.77
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.75
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.74
PRK12274	218	serine/threonine protein kinase; Provisional	99.71
PRK10345	210	hypothetical protein; Provisional	99.69
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.69
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.68
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.65
smart00090	237	RIO RIO-like kinase.	99.65
PRK14879	211	serine/threonine protein kinase; Provisional	99.64
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.62
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.61
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.6
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.59
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.5
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.49
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.46
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.45
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.45
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.32
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.26
PF08276	66	PAN_2: PAN-like domain; InterPro: IPR013227 PAN do	99.18
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.14
cd01098	84	PAN_AP_plant Plant PAN/APPLE-like domain; present	99.13
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.12
KOG1243	690	consensus Protein kinase [General function predict	99.08
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.0
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.99
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.93
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.91
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.9
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	98.89
KOG3087	229	consensus Serine/threonine protein kinase [General	98.8
cd00129	80	PAN_APPLE PAN/APPLE-like domain; present in N-term	98.78
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.77
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.7
smart00108	114	B_lectin Bulb-type mannose-specific lectin.	98.64
cd00028	116	B_lectin Bulb-type mannose-specific lectin. The do	98.58
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.53
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.5
PRK09902	216	hypothetical protein; Provisional	98.49
COG4248	637	Uncharacterized protein with protein kinase and he	98.44
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.42
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.31
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.2
PF01453	114	B_lectin: D-mannose binding lectin; InterPro: IPR0	98.05
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.98
smart00473	78	PAN_AP divergent subfamily of APPLE domains. Apple	97.96
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	97.89
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.89
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.85
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	97.81
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.71
PF01636	239	APH: Phosphotransferase enzyme family This family	97.7
KOG0576	829	consensus Mitogen-activated protein kinase kinase	97.66
PLN02876	822	acyl-CoA dehydrogenase	97.57
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.45
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.43
PRK10593	297	hypothetical protein; Provisional	97.34
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.25
cd01100	73	APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d	97.1
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.08
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.04
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	96.97
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	96.96
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	96.96
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	96.77
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.47
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	96.45
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	95.61
PLN02236	344	choline kinase	95.51
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	95.49
KOG2268	465	consensus Serine/threonine protein kinase [Signal	95.37
PRK05231	319	homoserine kinase; Provisional	95.34
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.31
PLN02756	418	S-methyl-5-thioribose kinase	95.29
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	95.15
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	94.97
KOG1236	565	consensus Predicted unusual protein kinase [Genera	94.92
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	94.48
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	94.43

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-53  Score=458.10  Aligned_cols=287  Identities=47%  Similarity=0.765  Sum_probs=253.1

Q ss_pred             cccccCHHHHHHhhhccc--cceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCcccee
Q 041921          507 NLRCFSYKELEGATNNFK--EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLL  584 (814)
Q Consensus       507 ~~~~~~~~~l~~~~~~~~--~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  584 (814)
                      ..+.|++.||..||++|+  +.||+|+||.||+|.+.   ++..||||++.....+..++|.+|++++.+++|||||+|+
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~---~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~Ll  137 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLS---DGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLL  137 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEEC---CCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEE
Confidence            577899999999999998  58999999999999997   4589999998765433156799999999999999999999


Q ss_pred             eeecccc-cceEEEecCCCCCHHHHhcCCC--CCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEE
Q 041921          585 GFCDEGQ-NRLLVYEFLNNGTLASFLFGNL--KPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTAR  661 (814)
Q Consensus       585 ~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~k  661 (814)
                      |||.+.+ +++||||||++|+|.++|+...  .++|..|++||.++|+||+|||+.+.+.|+|||||++|||||+++++|
T Consensus       138 GyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK  217 (361)
T KOG1187|consen  138 GYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK  217 (361)
T ss_pred             EEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence            9999998 5999999999999999999874  899999999999999999999999989999999999999999999999


Q ss_pred             EeecCCcccccc-CCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHH
Q 041921          662 ISDFGLAKLLTL-NQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD  740 (814)
Q Consensus       662 l~DfGla~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  740 (814)
                      |+|||+++.... .....  +...||.+|+|||++..+..+.|+|||||||+|+||+||+.+.+...+.....+.+|++.
T Consensus       218 lsDFGLa~~~~~~~~~~~--~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~  295 (361)
T KOG1187|consen  218 LSDFGLAKLGPEGDTSVS--TTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKP  295 (361)
T ss_pred             ccCccCcccCCcccccee--eecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHH
Confidence            999999976554 22111  111799999999999999999999999999999999999998886654444458899999


Q ss_pred             HhhcCccceeecCccc-ccCcH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 041921          741 CYRNGKLNVLVGEDKE-AMNDI-ECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV  798 (814)
Q Consensus       741 ~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~~  798 (814)
                      .+.++++.+++|+.+. ..... ++..++.+++.+|++.+|.+||+|.+|+++|+.+...
T Consensus       296 ~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~  355 (361)
T KOG1187|consen  296 LLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL  355 (361)
T ss_pred             HHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence            9999999999999976 44443 6889999999999999999999999999999766544

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-45  Score=388.28  Aligned_cols=252  Identities=35%  Similarity=0.538  Sum_probs=209.3

Q ss_pred             cccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccc--hHhHHHHHHhhhccCCCCccceeeeecccc-cceEEEec
Q 041921          523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG--EREFKNEVFVIGQTHHKNLVRLLGFCDEGQ-NRLLVYEF  599 (814)
Q Consensus       523 ~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~  599 (814)
                      +.+.||+|+||+||+|.+.   ....||||++.......  .++|.+|+.+|.+++|||||+++|+|.+.. ..+|||||
T Consensus        45 ~~~~iG~G~~g~V~~~~~~---g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy  121 (362)
T KOG0192|consen   45 IEEVLGSGSFGTVYKGKWR---GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY  121 (362)
T ss_pred             hhhhcccCCceeEEEEEeC---CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence            4456999999999999997   23349999997543222  458999999999999999999999999988 79999999


Q ss_pred             CCCCCHHHHhcC--CCCCChhhHHHHHHHHHHHHHHhhhcCCCC-eeecCCCCCcEEEcCCC-cEEEeecCCccccccCC
Q 041921          600 LNNGTLASFLFG--NLKPNWNLRTNIAFQIARGLLYLHEDCRAQ-IIHCDIKPQNILLDDYY-TARISDFGLAKLLTLNQ  675 (814)
Q Consensus       600 ~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~-i~H~dlkp~NIll~~~~-~~kl~DfGla~~~~~~~  675 (814)
                      |++|+|.++|+.  ...+++..+++++.|||+||.|||++   + ||||||||+||||+.++ ++||+|||+++......
T Consensus       122 ~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~  198 (362)
T KOG0192|consen  122 MPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK  198 (362)
T ss_pred             CCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence            999999999988  58899999999999999999999998   6 99999999999999997 99999999998766432


Q ss_pred             cccccccccCCCCcccccccc--cCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecC
Q 041921          676 SKTIKTAIRGTKGYVAPEWFR--NSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGE  753 (814)
Q Consensus       676 ~~~~~~~~~gt~~y~aPE~~~--~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  753 (814)
                        ...+...||+.|||||+++  ...++.|+||||||+++|||+||+.||........      +......+.       
T Consensus       199 --~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~------~~~v~~~~~-------  263 (362)
T KOG0192|consen  199 --TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQV------ASAVVVGGL-------  263 (362)
T ss_pred             --ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHH------HHHHHhcCC-------
Confidence              2224467999999999999  56999999999999999999999999986554211      111111111       


Q ss_pred             cccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 041921          754 DKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE  797 (814)
Q Consensus       754 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~  797 (814)
                        .-..+..+...+..++.+||+.||+.||++.+++.+|+.+..
T Consensus       264 --Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~  305 (362)
T KOG0192|consen  264 --RPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS  305 (362)
T ss_pred             --CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence              111122367788999999999999999999999999987655

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-44  Score=383.41  Aligned_cols=262  Identities=29%  Similarity=0.451  Sum_probs=221.6

Q ss_pred             HHHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccce
Q 041921          515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRL  594 (814)
Q Consensus       515 ~l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  594 (814)
                      ++......+.++||+|.||.|+.|.++   ....||||.++.. ....++|.+|+.+|++++|+|||+++|+|..++.++
T Consensus       202 ei~r~~l~l~~~LG~G~FG~V~~g~~~---~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piy  277 (468)
T KOG0197|consen  202 EIPREELKLIRELGSGQFGEVWLGKWN---GSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIY  277 (468)
T ss_pred             eecHHHHHHHHHhcCCccceEEEEEEc---CCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceE
Confidence            455566677889999999999999997   3558999999865 455678999999999999999999999999989999


Q ss_pred             EEEecCCCCCHHHHhcC--CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccc
Q 041921          595 LVYEFLNNGTLASFLFG--NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLT  672 (814)
Q Consensus       595 lv~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~  672 (814)
                      ||||||+.|+|.+||..  ...++..+.+.++.|||+|++||+++   ++|||||.++||||+++..+||+|||||+...
T Consensus       278 IVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~  354 (468)
T KOG0197|consen  278 IVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIG  354 (468)
T ss_pred             EEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccC
Confidence            99999999999999986  46788999999999999999999998   99999999999999999999999999999555


Q ss_pred             cCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceee
Q 041921          673 LNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLV  751 (814)
Q Consensus       673 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  751 (814)
                      .+.... .....-+..|.|||.+....++.|+|||||||+||||+| |+.|+....-.+       +.+.+.+       
T Consensus       355 d~~Y~~-~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e-------v~~~le~-------  419 (468)
T KOG0197|consen  355 DDEYTA-SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE-------VLELLER-------  419 (468)
T ss_pred             CCceee-cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH-------HHHHHhc-------
Confidence            443322 233445778999999999999999999999999999999 888886543322       1222222       


Q ss_pred             cCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCCC
Q 041921          752 GEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSV  800 (814)
Q Consensus       752 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~~~~  800 (814)
                        ..+.+.+..++.++.+++..||+.+|++|||++.+...|+.+.....
T Consensus       420 --GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~~  466 (468)
T KOG0197|consen  420 --GYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTSTE  466 (468)
T ss_pred             --cCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhccc
Confidence              33344566688999999999999999999999999999998766543

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=8e-44  Score=361.38  Aligned_cols=249  Identities=25%  Similarity=0.360  Sum_probs=208.1

Q ss_pred             ccceeeeeeeeEEEEEEecCCCceEEEEEEeccc-cccchHhHHHHHHhhhccCCCCccceeeeecccc-cceEEEecCC
Q 041921          524 KEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV-FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ-NRLLVYEFLN  601 (814)
Q Consensus       524 ~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~~  601 (814)
                      .+.||+|..|+|||+.++.  +++.+|+|.+... .....+++.+|++++++.+||+||.++|.|..+. ...|+||||.
T Consensus        84 ~~~lG~G~gG~V~kv~Hk~--t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMD  161 (364)
T KOG0581|consen   84 LGVLGSGNGGTVYKVRHKP--TGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMD  161 (364)
T ss_pred             hhhcccCCCcEEEEEEEcC--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcC
Confidence            4689999999999999874  6789999999533 3445678999999999999999999999999888 4999999999


Q ss_pred             CCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcccccc
Q 041921          602 NGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKT  681 (814)
Q Consensus       602 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  681 (814)
                      +|||++++...+++++...-+|+.+|++||.|||+.  .+|+||||||+||||+..|++||+|||.++.+...    ...
T Consensus       162 gGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----~a~  235 (364)
T KOG0581|consen  162 GGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----IAN  235 (364)
T ss_pred             CCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh----hcc
Confidence            999999999888899999999999999999999974  39999999999999999999999999999877654    235


Q ss_pred             cccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCcH
Q 041921          682 AIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDI  761 (814)
Q Consensus       682 ~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  761 (814)
                      ...||..|||||.+.+..|+.++||||||+.++|+.+|+.|+....+.... ..+. ...+-.+       +.+..+.. 
T Consensus       236 tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~-~~~L-l~~Iv~~-------ppP~lP~~-  305 (364)
T KOG0581|consen  236 TFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLD-IFEL-LCAIVDE-------PPPRLPEG-  305 (364)
T ss_pred             cccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCC-HHHH-HHHHhcC-------CCCCCCcc-
Confidence            678999999999999999999999999999999999999999765221111 1111 1111111       22222212 


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          762 ECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       762 ~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      ....+++.++..||++||.+|||+.++++
T Consensus       306 ~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  306 EFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            57789999999999999999999999975

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.9e-43  Score=393.14  Aligned_cols=268  Identities=29%  Similarity=0.493  Sum_probs=227.2

Q ss_pred             HHHHHHhhhccccceeeeeeeeEEEEEEecC---CCceEEEEEEecccccc-chHhHHHHHHhhhccCCCCccceeeeec
Q 041921          513 YKELEGATNNFKEEVGRGSFGIVYKGVIQTR---TSTTAVAVKKLDRVFQD-GEREFKNEVFVIGQTHHKNLVRLLGFCD  588 (814)
Q Consensus       513 ~~~l~~~~~~~~~~LG~G~~g~Vy~~~~~~~---~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~  588 (814)
                      ..++......+.++||+|+||.||+|.....   +....||||.|+..... ...+|++|++++..++|||||+|+|+|.
T Consensus       480 ~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~  559 (774)
T KOG1026|consen  480 VLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCR  559 (774)
T ss_pred             eeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEc
Confidence            3456666677889999999999999986643   35679999999876655 6778999999999999999999999999


Q ss_pred             ccccceEEEecCCCCCHHHHhcCC----------C----CCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE
Q 041921          589 EGQNRLLVYEFLNNGTLASFLFGN----------L----KPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILL  654 (814)
Q Consensus       589 ~~~~~~lv~e~~~~gsL~~~l~~~----------~----~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll  654 (814)
                      +++..+||+|||..|+|.+||..+          .    +++..+.+.||.|||.|+.||-++   .++||||..+|+||
T Consensus       560 ~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLV  636 (774)
T KOG1026|consen  560 EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLV  636 (774)
T ss_pred             cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhcee
Confidence            999999999999999999999632          2    267888999999999999999998   99999999999999


Q ss_pred             cCCCcEEEeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhh
Q 041921          655 DDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAI  733 (814)
Q Consensus       655 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~  733 (814)
                      .++..|||+||||++.....+.........-.++||+||.+.-+++|.++|||||||||||++| |+.|+.....++   
T Consensus       637 ge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E---  713 (774)
T KOG1026|consen  637 GENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE---  713 (774)
T ss_pred             ccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH---
Confidence            9999999999999998776554433223335789999999999999999999999999999999 999987554433   


Q ss_pred             HHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCC
Q 041921          734 LTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS  799 (814)
Q Consensus       734 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~~~  799 (814)
                          +.+.+++|.+         .+.+..++.+++.|+..||+.+|++||+++||-.+|+......
T Consensus       714 ----VIe~i~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s  766 (774)
T KOG1026|consen  714 ----VIECIRAGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS  766 (774)
T ss_pred             ----HHHHHHcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence                3455666654         2335568899999999999999999999999999998765443

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-42  Score=355.48  Aligned_cols=203  Identities=32%  Similarity=0.518  Sum_probs=182.1

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccc--cccchHhHHHHHHhhhccCCCCccceeeeecccccceEEE
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV--FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY  597 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  597 (814)
                      .|.+.++||+|+|++||+|.+..  .+..||||.+...  ..+..+.+..|+.+|+.++|||||++++++..++..+|||
T Consensus        11 ~y~~~~~iG~GsfavVykg~h~~--~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen   11 DYELSREIGSGSFAVVYKGRHKK--SGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cceehhhccCcceEEEEEeEecc--CCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            34566789999999999999875  4589999999765  3444556899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC------CcEEEeecCCcccc
Q 041921          598 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDY------YTARISDFGLAKLL  671 (814)
Q Consensus       598 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~------~~~kl~DfGla~~~  671 (814)
                      |||.+|+|.+||+..+.+++.....++.|||.||++||++   +|+||||||+||||+..      -.+||+|||+|+.+
T Consensus        89 EyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L  165 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL  165 (429)
T ss_pred             EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence            9999999999999999999999999999999999999999   99999999999999864      46899999999988


Q ss_pred             ccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchh
Q 041921          672 TLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE  730 (814)
Q Consensus       672 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~  730 (814)
                      ....   .....+|++-|||||++..++|+.|+|+||.|+|||++++|+.||......+
T Consensus       166 ~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e  221 (429)
T KOG0595|consen  166 QPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKE  221 (429)
T ss_pred             Cchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHH
Confidence            7443   2356789999999999999999999999999999999999999998665544

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.8e-42  Score=351.68  Aligned_cols=256  Identities=26%  Similarity=0.401  Sum_probs=210.6

Q ss_pred             HHHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccccc-------chHhHHHHHHhhhccCCCCccceeeee
Q 041921          515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD-------GEREFKNEVFVIGQTHHKNLVRLLGFC  587 (814)
Q Consensus       515 ~l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~  587 (814)
                      +.....|.+.+.||+|+||.|-+|.-.  .+++.||||.+.+....       ......+|+++|++++|||||++.+++
T Consensus       168 ks~~d~yii~~~LGsGafg~Vkla~e~--~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f  245 (475)
T KOG0615|consen  168 KSFNDYYIISKTLGSGAFGLVKLAYEK--KTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFF  245 (475)
T ss_pred             chhcceeEeeeeecCCceeEEEEEEEc--ccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeee
Confidence            335667778899999999999999855  47899999999642211       122357999999999999999999999


Q ss_pred             cccccceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC---CcEEEee
Q 041921          588 DEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDY---YTARISD  664 (814)
Q Consensus       588 ~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~---~~~kl~D  664 (814)
                      ...+..|||+||+++|+|.+++..++.+.+..-..++.|++.|+.|||++   ||+||||||+|||+..+   ..+||+|
T Consensus       246 ~~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItD  322 (475)
T KOG0615|consen  246 EVPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITD  322 (475)
T ss_pred             ecCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecc
Confidence            99999999999999999999999998899999999999999999999999   99999999999999866   7899999


Q ss_pred             cCCccccccCCcccccccccCCCCcccccccccCCC--C-cchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHH
Q 041921          665 FGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI--T-AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC  741 (814)
Q Consensus       665 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--s-~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  741 (814)
                      ||+|+..+..   ..+...+||+.|.|||++.++..  . .+.|+||+|||||-+++|..||....++..      ..+.
T Consensus       323 FGlAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s------l~eQ  393 (475)
T KOG0615|consen  323 FGLAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS------LKEQ  393 (475)
T ss_pred             cchhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc------HHHH
Confidence            9999987632   23366899999999999987643  3 478999999999999999999986544321      1233


Q ss_pred             hhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          742 YRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       742 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      +..|+....      .....+..++.++++.+||..||++|||+.|+++
T Consensus       394 I~~G~y~f~------p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  394 ILKGRYAFG------PLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             HhcCccccc------ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            444443221      0123456788999999999999999999999874

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.2e-41  Score=362.74  Aligned_cols=248  Identities=25%  Similarity=0.383  Sum_probs=211.0

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccc---cccchHhHHHHHHhhhccCCCCccceeeeecccccceE
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV---FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL  595 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  595 (814)
                      .+|...+.||+|+|+.+|+++..  ..+..||+|.+.+.   .....+.+.+||++.+.|+|||||+++++|++.+..||
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~--~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYi   95 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDL--DTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYI   95 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEc--CCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEE
Confidence            56777889999999999999864  36789999999763   23344568999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCC
Q 041921          596 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ  675 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~  675 (814)
                      |.|+|++++|..+++.++.+++.+.+.++.||+.||.|||+.   +|+|||||..|+||+++.++||+|||||..+..+.
T Consensus        96 vLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~  172 (592)
T KOG0575|consen   96 VLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG  172 (592)
T ss_pred             EEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCcc
Confidence            999999999999999889999999999999999999999998   99999999999999999999999999999887553


Q ss_pred             cccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcc
Q 041921          676 SKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDK  755 (814)
Q Consensus       676 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  755 (814)
                      ...  ...+||+.|+|||++.....+..+||||+|||||-|+.|++||+...-.+       ..++++.....       
T Consensus       173 Erk--~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke-------ty~~Ik~~~Y~-------  236 (592)
T KOG0575|consen  173 ERK--KTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE-------TYNKIKLNEYS-------  236 (592)
T ss_pred             ccc--ceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH-------HHHHHHhcCcc-------
Confidence            322  55789999999999999999999999999999999999999998543222       11222222111       


Q ss_pred             cccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          756 EAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       756 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                         .+.....+..+||..+|+.+|.+|||+++|+.
T Consensus       237 ---~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  237 ---MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             ---cccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence               11234456778999999999999999999984

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.3e-42  Score=332.11  Aligned_cols=256  Identities=26%  Similarity=0.349  Sum_probs=210.3

Q ss_pred             HhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEec--cccccchHhHHHHHHhhhccCCCCccceee-eeccccc-c
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLD--RVFQDGEREFKNEVFVIGQTHHKNLVRLLG-FCDEGQN-R  593 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~-~  593 (814)
                      .+.+.+.++||+|.||+|||+...  .++..||.|.+.  ..+.+..+.+..|+.+|++++|||||++++ -+.++++ +
T Consensus        18 l~~y~Il~~IG~GsFg~vykv~~~--~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evl   95 (375)
T KOG0591|consen   18 LADYQILKKIGRGSFGEVYKVQCL--LDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVL   95 (375)
T ss_pred             HHHHHHHHHHcCCcchheEEeeec--cCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhh
Confidence            455677889999999999999865  368899999986  334455667999999999999999999999 4555555 8


Q ss_pred             eEEEecCCCCCHHHHhcC----CCCCChhhHHHHHHHHHHHHHHhhhcCC-CCeeecCCCCCcEEEcCCCcEEEeecCCc
Q 041921          594 LLVYEFLNNGTLASFLFG----NLKPNWNLRTNIAFQIARGLLYLHEDCR-AQIIHCDIKPQNILLDDYYTARISDFGLA  668 (814)
Q Consensus       594 ~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~~l~yLH~~~~-~~i~H~dlkp~NIll~~~~~~kl~DfGla  668 (814)
                      .|||||+..|+|...++.    .+.+++..+++++.|++.||.++|.... ..|+||||||.||+++++|.+||+|||++
T Consensus        96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~  175 (375)
T KOG0591|consen   96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLG  175 (375)
T ss_pred             HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhH
Confidence            899999999999998863    4678999999999999999999999432 24999999999999999999999999999


Q ss_pred             cccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccc
Q 041921          669 KLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLN  748 (814)
Q Consensus       669 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  748 (814)
                      +.+.......  ...+||+.||+||.+...+++.|+||||+||++|||..-+.||.+..   ...    ..+++.++...
T Consensus       176 r~l~s~~tfA--~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n---~~~----L~~KI~qgd~~  246 (375)
T KOG0591|consen  176 RFLSSKTTFA--HSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN---LLS----LCKKIEQGDYP  246 (375)
T ss_pred             hHhcchhHHH--HhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc---HHH----HHHHHHcCCCC
Confidence            9887654332  56789999999999999999999999999999999999999997541   111    23455555432


Q ss_pred             eeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 041921          749 VLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQML  792 (814)
Q Consensus       749 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L  792 (814)
                      .+.        +......+..++..|+..||+.||+...+++.+
T Consensus       247 ~~p--------~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di  282 (375)
T KOG0591|consen  247 PLP--------DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI  282 (375)
T ss_pred             CCc--------HHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence            221        245678899999999999999999865555544

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-41  Score=370.30  Aligned_cols=271  Identities=24%  Similarity=0.447  Sum_probs=225.8

Q ss_pred             ccccCHHHHHHhhhc-----------cccceeeeeeeeEEEEEEecCC-CceEEEEEEeccccc-cchHhHHHHHHhhhc
Q 041921          508 LRCFSYKELEGATNN-----------FKEEVGRGSFGIVYKGVIQTRT-STTAVAVKKLDRVFQ-DGEREFKNEVFVIGQ  574 (814)
Q Consensus       508 ~~~~~~~~l~~~~~~-----------~~~~LG~G~~g~Vy~~~~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~  574 (814)
                      ...++|+|-..|..+           +.++||.|.||.|++|.++..+ ....||||.|+.... +..++|+.|..+|.+
T Consensus       607 iDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQ  686 (996)
T KOG0196|consen  607 IDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQ  686 (996)
T ss_pred             cCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhccc
Confidence            345677755444444           4567999999999999987533 467999999986554 345689999999999


Q ss_pred             cCCCCccceeeeecccccceEEEecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEE
Q 041921          575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNIL  653 (814)
Q Consensus       575 l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIl  653 (814)
                      ++||||++|.|+....+..+||.|||+||+|+.||..+ .++.+.+...++++||.|++||.+.   +++||||.++|||
T Consensus       687 FdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNIL  763 (996)
T KOG0196|consen  687 FDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNIL  763 (996)
T ss_pred             CCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhc---Cchhhhhhhhhee
Confidence            99999999999999999999999999999999999875 6789999999999999999999998   9999999999999


Q ss_pred             EcCCCcEEEeecCCccccccCCcccccccc--cCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchh
Q 041921          654 LDDYYTARISDFGLAKLLTLNQSKTIKTAI--RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEE  730 (814)
Q Consensus       654 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~--~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~  730 (814)
                      |+.+..+|++|||+++.+..+..... +..  .-..+|.|||.+...+++.++||||||+||||+++ |.+||-.....+
T Consensus       764 VNsnLvCKVsDFGLSRvledd~~~~y-tt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd  842 (996)
T KOG0196|consen  764 VNSNLVCKVSDFGLSRVLEDDPEAAY-TTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD  842 (996)
T ss_pred             eccceEEEeccccceeecccCCCccc-cccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH
Confidence            99999999999999998765542221 222  23579999999999999999999999999999998 999986433222


Q ss_pred             hhhHHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 041921          731 YAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV  798 (814)
Q Consensus       731 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~~  798 (814)
                                      +-..++.....+.+.+++..|.+|++.|||+|-.+||++.+|+..|+++..-
T Consensus       843 ----------------VIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn  894 (996)
T KOG0196|consen  843 ----------------VIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN  894 (996)
T ss_pred             ----------------HHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence                            1112233455566788999999999999999999999999999999886543

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.4e-39  Score=317.37  Aligned_cols=261  Identities=22%  Similarity=0.299  Sum_probs=206.3

Q ss_pred             cccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEecC
Q 041921          523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL  600 (814)
Q Consensus       523 ~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  600 (814)
                      --.++|+|+||.|||+..+  ..++.||||++.+..  +...+-.++|+++|++++|+|||.|+++|......+||+||+
T Consensus         6 ~LgkvGEGSYGvV~KCrnk--~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~   83 (396)
T KOG0593|consen    6 KLGKVGEGSYGVVMKCRNK--DTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYC   83 (396)
T ss_pred             hhhccccCcceEEEEeccC--CcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeec
Confidence            3457999999999999865  478999999996532  223345789999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccccc
Q 041921          601 NNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIK  680 (814)
Q Consensus       601 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  680 (814)
                      +..-|+++-+....++.....+++.|+++|+.|+|++   +++||||||+||||+.++.+||+|||+|+.+...  ....
T Consensus        84 dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p--gd~Y  158 (396)
T KOG0593|consen   84 DHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAP--GDNY  158 (396)
T ss_pred             chHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCC--cchh
Confidence            9877777666667788999999999999999999999   9999999999999999999999999999988742  2223


Q ss_pred             ccccCCCCccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHH--------HHHh-hcCcccee
Q 041921          681 TAIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA--------FDCY-RNGKLNVL  750 (814)
Q Consensus       681 ~~~~gt~~y~aPE~~~~-~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~--------~~~~-~~~~~~~~  750 (814)
                      +..+.|..|.|||.+.+ .+|....||||.||++.||++|...|.+..+.++-......        .+.+ .+.....+
T Consensus       159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv  238 (396)
T KOG0593|consen  159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGV  238 (396)
T ss_pred             hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeee
Confidence            67789999999999987 68999999999999999999999998766553332221111        0111 11222222


Q ss_pred             ecCcccccCc-----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          751 VGEDKEAMND-----IECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       751 ~~~~~~~~~~-----~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      .-+.+..+.+     .....-+++++..||+.||.+|++-++++.
T Consensus       239 ~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  239 RLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             ecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            2222222222     223457889999999999999999999873

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-39  Score=374.56  Aligned_cols=265  Identities=27%  Similarity=0.464  Sum_probs=218.4

Q ss_pred             HHHHhhhccccceeeeeeeeEEEEEEecCCC---ceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccceeeeeccc
Q 041921          515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTS---TTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEG  590 (814)
Q Consensus       515 ~l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~---~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  590 (814)
                      ++...+..+.+.||+|+||.||.|...+...   ...||||.+++.. .+...+|.+|..+|+.++|||||+++|+|.+.
T Consensus       688 ~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~  767 (1025)
T KOG1095|consen  688 EVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS  767 (1025)
T ss_pred             cCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC
Confidence            3445566677889999999999999876443   4569999997653 45567899999999999999999999999999


Q ss_pred             ccceEEEecCCCCCHHHHhcCC-------CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEe
Q 041921          591 QNRLLVYEFLNNGTLASFLFGN-------LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARIS  663 (814)
Q Consensus       591 ~~~~lv~e~~~~gsL~~~l~~~-------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~  663 (814)
                      ...+|++|||++|+|..||++.       ..+.....+.++.|||+|+.||+++   ++|||||.++|+||+....+||+
T Consensus       768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIa  844 (1025)
T KOG1095|consen  768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIA  844 (1025)
T ss_pred             CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEc
Confidence            9999999999999999999865       4577888999999999999999998   99999999999999999999999


Q ss_pred             ecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHh
Q 041921          664 DFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCY  742 (814)
Q Consensus       664 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  742 (814)
                      |||+|+.+.............-...|||||.+..+.++.|+|||||||+||||+| |..||......+.      .....
T Consensus       845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v------~~~~~  918 (1025)
T KOG1095|consen  845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV------LLDVL  918 (1025)
T ss_pred             ccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH------HHHHH
Confidence            9999995554433222122234578999999999999999999999999999999 8999875433221      11122


Q ss_pred             hcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 041921          743 RNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV  798 (814)
Q Consensus       743 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~~  798 (814)
                      +.|+          .+.+..+++.+++++..||+.+|++||++..|+++++.+...
T Consensus       919 ~ggR----------L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~  964 (1025)
T KOG1095|consen  919 EGGR----------LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA  964 (1025)
T ss_pred             hCCc----------cCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence            2332          233556889999999999999999999999999998876544

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-39  Score=346.20  Aligned_cols=265  Identities=29%  Similarity=0.435  Sum_probs=211.6

Q ss_pred             CHHHHHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeecc
Q 041921          512 SYKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDE  589 (814)
Q Consensus       512 ~~~~l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  589 (814)
                      .+-||......+.+.||+|.||+||+|.+.     ..||||.+....  .+..++|++|+..+++-+|.||+-+.|+|..
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh-----GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~  459 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH-----GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN  459 (678)
T ss_pred             cccccCHHHhhccceeccccccceeecccc-----cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence            344566666677889999999999999985     369999996533  3455789999999999999999999999998


Q ss_pred             cccceEEEecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCc
Q 041921          590 GQNRLLVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLA  668 (814)
Q Consensus       590 ~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla  668 (814)
                      ... .||+.+|++.+|..+|+-. ..++....+.|+.|||+|+.|||.+   +|||||||..||++.+++.|||+||||+
T Consensus       460 p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLa  535 (678)
T KOG0193|consen  460 PPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLA  535 (678)
T ss_pred             Cce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccce
Confidence            887 9999999999999999865 6688889999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCcccccccccCCCCcccccccccC---CCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcC
Q 041921          669 KLLTLNQSKTIKTAIRGTKGYVAPEWFRNS---KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG  745 (814)
Q Consensus       669 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  745 (814)
                      ..-.............|...|||||+++.+   +|+..+||||||+|+|||+||..||.....+..-      + .+..|
T Consensus       536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIi------f-mVGrG  608 (678)
T KOG0193|consen  536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQII------F-MVGRG  608 (678)
T ss_pred             eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheE------E-Eeccc
Confidence            765433222211334478899999999754   6899999999999999999999999833222110      0 11111


Q ss_pred             ccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 041921          746 KLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE  797 (814)
Q Consensus       746 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~  797 (814)
                      -+    .+++ ......+..++.+|+..||..++++||.+.+|+..|+.++.
T Consensus       609 ~l----~pd~-s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  609 YL----MPDL-SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             cc----Cccc-hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence            00    0011 11133567788899999999999999999999998887655

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=8.4e-39  Score=349.15  Aligned_cols=263  Identities=27%  Similarity=0.398  Sum_probs=205.1

Q ss_pred             HHhhhccccceeeeeeeeEEEEEEec---CCCceEEEEEEeccccc-cchHhHHHHHHhhhcc-CCCCccceeeeecccc
Q 041921          517 EGATNNFKEEVGRGSFGIVYKGVIQT---RTSTTAVAVKKLDRVFQ-DGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQ  591 (814)
Q Consensus       517 ~~~~~~~~~~LG~G~~g~Vy~~~~~~---~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  591 (814)
                      ....+.+.++||+|+||.||+|....   ...+..||||++..... ...+.+.+|+.++.++ +||||+++++++...+
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            34567788999999999999998531   22456899999975332 2345689999999999 8999999999887644


Q ss_pred             -cceEEEecCCCCCHHHHhcCC----------------------------------------------------------
Q 041921          592 -NRLLVYEFLNNGTLASFLFGN----------------------------------------------------------  612 (814)
Q Consensus       592 -~~~lv~e~~~~gsL~~~l~~~----------------------------------------------------------  612 (814)
                       ..++||||+++|+|.+++...                                                          
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence             578999999999999998642                                                          


Q ss_pred             ----CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcccccccccCCCC
Q 041921          613 ----LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKG  688 (814)
Q Consensus       613 ----~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~  688 (814)
                          ..+++.....++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++...............++..
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence                2366778889999999999999998   999999999999999999999999999986643322221123346788


Q ss_pred             cccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCcHHHHHHH
Q 041921          689 YVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKL  767 (814)
Q Consensus       689 y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  767 (814)
                      |+|||.+.+..++.++||||||+++|||++ |..||......+.      ....+..+....         .+......+
T Consensus       242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~------~~~~~~~~~~~~---------~~~~~~~~l  306 (338)
T cd05102         242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE------FCQRLKDGTRMR---------APENATPEI  306 (338)
T ss_pred             ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH------HHHHHhcCCCCC---------CCCCCCHHH
Confidence            999999998899999999999999999997 9999875432211      112222221110         111234678


Q ss_pred             HHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 041921          768 VMVSIWCIQEDPSLRPTMKKVLQMLEGVVE  797 (814)
Q Consensus       768 ~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~  797 (814)
                      .+++.+||+.||.+|||+.+++++|+.+.+
T Consensus       307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         307 YRIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            899999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-38  Score=324.52  Aligned_cols=261  Identities=23%  Similarity=0.306  Sum_probs=208.6

Q ss_pred             HhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc-cchHhHHHHHHhhhccCCCCccceeeeecccccceEE
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV  596 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  596 (814)
                      ...|++.++||.|.-++||+|....  .+..||||++.-... ...+++++|+..++.++||||++++..|..++.+++|
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p--~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV  102 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIP--TNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV  102 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecc--cCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence            3457788999999999999998764  458999999964322 2357899999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccC
Q 041921          597 YEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN  674 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~  674 (814)
                      |.||.+||+.++++..  ..+++..+..|.+++++||.|||++   |.||||||+.||||+++|.|||+|||.+.-+...
T Consensus       103 mpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~  179 (516)
T KOG0582|consen  103 MPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS  179 (516)
T ss_pred             ehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence            9999999999999864  5588999999999999999999999   9999999999999999999999999987655433


Q ss_pred             Ccc-ccc-ccccCCCCccccccccc--CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCcccee
Q 041921          675 QSK-TIK-TAIRGTKGYVAPEWFRN--SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVL  750 (814)
Q Consensus       675 ~~~-~~~-~~~~gt~~y~aPE~~~~--~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  750 (814)
                      ... ... ...+||+.|||||++..  ..|+.|+||||||+...||.+|..||....+-+      .....+.+. ...+
T Consensus       180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk------vLl~tLqn~-pp~~  252 (516)
T KOG0582|consen  180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK------VLLLTLQND-PPTL  252 (516)
T ss_pred             CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH------HHHHHhcCC-CCCc
Confidence            221 111 45689999999999643  369999999999999999999999998554322      112222222 2211


Q ss_pred             ecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          751 VGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       751 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      .-..............+.+++..||++||.+|||++++++
T Consensus       253 ~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  253 LTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             ccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            1111222223345568889999999999999999999985

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-38  Score=330.92  Aligned_cols=253  Identities=27%  Similarity=0.402  Sum_probs=201.3

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccc--cceEEEe
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ--NRLLVYE  598 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e  598 (814)
                      ....+.||+|.||+||++....  .+...|||..........+.+.+|+.+|.+++|||||+.+|......  .+++.||
T Consensus        19 ~~~~~~lG~Gs~G~V~l~~~~~--~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   19 WSKGKLLGRGSFGSVYLATNKK--TGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             hhhhccccCccceEEEEEEecC--CCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            4456889999999999999763  37889999986543333567899999999999999999999855444  5889999


Q ss_pred             cCCCCCHHHHhcCCC-CCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC-CCcEEEeecCCccccccCCc
Q 041921          599 FLNNGTLASFLFGNL-KPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDD-YYTARISDFGLAKLLTLNQS  676 (814)
Q Consensus       599 ~~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~-~~~~kl~DfGla~~~~~~~~  676 (814)
                      |+++|+|.+++...+ .+++..+..+..||++||+|||++   +|+||||||+||||+. ++.+||+|||++........
T Consensus        97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~  173 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT  173 (313)
T ss_pred             ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence            999999999998775 799999999999999999999998   9999999999999999 79999999999987764111


Q ss_pred             -ccccccccCCCCcccccccccCC-CCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCc
Q 041921          677 -KTIKTAIRGTKGYVAPEWFRNSK-ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGED  754 (814)
Q Consensus       677 -~~~~~~~~gt~~y~aPE~~~~~~-~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  754 (814)
                       ........||+.|||||++..+. ...++|||||||++.||+||+.||.....     ...+...........      
T Consensus       174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~-----~~~~~~~ig~~~~~P------  242 (313)
T KOG0198|consen  174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFE-----EAEALLLIGREDSLP------  242 (313)
T ss_pred             cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcc-----hHHHHHHHhccCCCC------
Confidence             11223567999999999998643 34599999999999999999999974211     111112222222111      


Q ss_pred             ccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 041921          755 KEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQML  792 (814)
Q Consensus       755 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L  792 (814)
                         ..+...+.+..+++..|++.+|++|||++++++..
T Consensus       243 ---~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp  277 (313)
T KOG0198|consen  243 ---EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP  277 (313)
T ss_pred             ---CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence               11223557788999999999999999999999765

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-38  Score=323.14  Aligned_cols=240  Identities=27%  Similarity=0.342  Sum_probs=201.0

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEE
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY  597 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  597 (814)
                      ..+.+.||+|+||.||+++..  +.++.+|+|.+++..   ....+...+|..+|.+++||.||+++-.|.+.+++|||+
T Consensus        27 F~~lkviGkG~fGkV~~Vrk~--dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl  104 (357)
T KOG0598|consen   27 FEILKVIGKGSFGKVFQVRKK--DTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL  104 (357)
T ss_pred             eeeeeeeeccCCceEEEEEEc--ccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence            345688999999999999876  468899999997532   233456899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcc
Q 041921          598 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSK  677 (814)
Q Consensus       598 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  677 (814)
                      ||+.||.|..+|.+.+.+++....-++..|+.||.|||+.   +|+||||||+|||||.+|.++|+||||++........
T Consensus       105 d~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~  181 (357)
T KOG0598|consen  105 DYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDA  181 (357)
T ss_pred             eccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcccCCCc
Confidence            9999999999999999999999999999999999999999   9999999999999999999999999999865443222


Q ss_pred             cccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccc
Q 041921          678 TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEA  757 (814)
Q Consensus       678 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  757 (814)
                      .  ...+||+.|||||++.+..++..+|.||+|+++|||++|.+||......+       ..+.+..+++..        
T Consensus       182 t--~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~-------~~~~I~~~k~~~--------  244 (357)
T KOG0598|consen  182 T--RTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK-------MYDKILKGKLPL--------  244 (357)
T ss_pred             c--ccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH-------HHHHHhcCcCCC--------
Confidence            2  44789999999999999999999999999999999999999997654322       122233333111        


Q ss_pred             cCcHHHHHHHHHHHHHccccCCCCCC
Q 041921          758 MNDIECLGKLVMVSIWCIQEDPSLRP  783 (814)
Q Consensus       758 ~~~~~~~~~l~~l~~~Cl~~dp~~RP  783 (814)
                       .+.-...+..+++...|++||++|.
T Consensus       245 -~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  245 -PPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             -CCccCCHHHHHHHHHHhccCHHHhc
Confidence             1111345677888899999999995

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8e-39  Score=331.94  Aligned_cols=265  Identities=24%  Similarity=0.327  Sum_probs=207.3

Q ss_pred             HHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchH-hHHHHHHhhhccC-CCCccceeeeecccc-cc
Q 041921          517 EGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGER-EFKNEVFVIGQTH-HKNLVRLLGFCDEGQ-NR  593 (814)
Q Consensus       517 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~-~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~  593 (814)
                      ...+|...++||.|.||+||+|+-..  .+..||||++++.....++ .=.+|+..|++++ |||||+|.+++.+.+ .+
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~--~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L   85 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKE--TGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL   85 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecC--CCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence            34577888999999999999999654  5678999999765443322 2478999999998 999999999999888 89


Q ss_pred             eEEEecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccc
Q 041921          594 LLVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLT  672 (814)
Q Consensus       594 ~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~  672 (814)
                      ++|||||+. +|.++++++ +.+++..+..|+.||++||+|+|.+   |+.|||+||+|||+..+..+||+|||+||.+.
T Consensus        86 ~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~  161 (538)
T KOG0661|consen   86 YFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVR  161 (538)
T ss_pred             eeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccc
Confidence            999999955 899999876 6789999999999999999999999   99999999999999999999999999999876


Q ss_pred             cCCcccccccccCCCCcccccccc-cCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhh-hhHHHHH----HHHhhcC-
Q 041921          673 LNQSKTIKTAIRGTKGYVAPEWFR-NSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWA----FDCYRNG-  745 (814)
Q Consensus       673 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~-~~~~~~~----~~~~~~~-  745 (814)
                      ....   .+..+.|..|.|||++. ...|+.+.|+|++|||++||.+-+..|.+..+-++ .-+.+.+    ++.+.+| 
T Consensus       162 SkpP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~  238 (538)
T KOG0661|consen  162 SKPP---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY  238 (538)
T ss_pred             cCCC---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence            5433   36788999999999875 56799999999999999999999998876544221 1111111    0000110 


Q ss_pred             --------ccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          746 --------KLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       746 --------~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                              ++.......+... -.....+..+++.+|++-||.+|||++++++.
T Consensus       239 ~La~~mnf~~P~~~~~~l~~L-~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  239 NLASAMNFRFPQVKPSPLKDL-LPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHHHHhccCCCcCCCCChHHh-CcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence                    0011111111111 12367888999999999999999999999875

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5e-38  Score=328.44  Aligned_cols=261  Identities=24%  Similarity=0.261  Sum_probs=205.5

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeeccc--ccceEE
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEG--QNRLLV  596 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv  596 (814)
                      ++-.++||+|.||.||||...  ..+..||+|+++-..  .....-..+||.+|++++||||++|.+...+.  ..+|||
T Consensus       119 feki~kIGeGTyg~VYkAr~~--~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  119 FEKIEKIGEGTYGQVYKARDL--ETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHhcCcchhheeEeeec--ccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            344578999999999999865  468899999997533  33445678999999999999999999998776  679999


Q ss_pred             EecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCC
Q 041921          597 YEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ  675 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~  675 (814)
                      +|||++ +|.-++... -.++..++..++.|++.||.|+|+.   +|+|||||.+|||||.+|.+||+|||||+++....
T Consensus       197 FeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~  272 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG  272 (560)
T ss_pred             Eecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence            999987 787877764 6789999999999999999999998   99999999999999999999999999999888766


Q ss_pred             cccccccccCCCCcccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHh--------hcCc
Q 041921          676 SKTIKTAIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY--------RNGK  746 (814)
Q Consensus       676 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~--------~~~~  746 (814)
                      .... +..+-|..|.|||.+.+. .|+.+.|+||.||||.||+.|+..|.+..+.++-..   +.+..        ...+
T Consensus       273 ~~~~-T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~k---IfklcGSP~e~~W~~~k  348 (560)
T KOG0600|consen  273 SAPY-TSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHK---IFKLCGSPTEDYWPVSK  348 (560)
T ss_pred             Cccc-ccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHH---HHHHhCCCChhcccccc
Confidence            5544 667789999999998876 799999999999999999999999987665443221   22211        1111


Q ss_pred             cceeecCcccccC-------cHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          747 LNVLVGEDKEAMN-------DIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       747 ~~~~~~~~~~~~~-------~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                      +...........+       -.......++|+..+|..||.+|.|+.++++-
T Consensus       349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s  400 (560)
T KOG0600|consen  349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS  400 (560)
T ss_pred             CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence            1110000111111       11234567788899999999999999998753

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-39  Score=347.95  Aligned_cols=266  Identities=30%  Similarity=0.401  Sum_probs=215.7

Q ss_pred             HHHHhhhccccceeeeeeeeEEEEEEecCCC--ceEEEEEEecc---ccccchHhHHHHHHhhhccCCCCccceeeeecc
Q 041921          515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTS--TTAVAVKKLDR---VFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDE  589 (814)
Q Consensus       515 ~l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~--~~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  589 (814)
                      +|......+.++||+|+||.||+|.+...+.  ...||||..+.   .......+|.+|.+++++++|||||+++|++..
T Consensus       153 el~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~  232 (474)
T KOG0194|consen  153 ELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL  232 (474)
T ss_pred             EEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC
Confidence            4555556667899999999999999986543  12389999975   334456789999999999999999999999999


Q ss_pred             cccceEEEecCCCCCHHHHhcCCC-CCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCc
Q 041921          590 GQNRLLVYEFLNNGTLASFLFGNL-KPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLA  668 (814)
Q Consensus       590 ~~~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla  668 (814)
                      ...++||||+|.+|+|.++|...+ .++..++..++.++|.||+|||+.   +++||||.++|+|++.++.+||+|||++
T Consensus       233 ~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs  309 (474)
T KOG0194|consen  233 EEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLS  309 (474)
T ss_pred             CCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccc
Confidence            999999999999999999999876 599999999999999999999999   9999999999999999999999999998


Q ss_pred             cccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHh-hcCc
Q 041921          669 KLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCY-RNGK  746 (814)
Q Consensus       669 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~-~~~~  746 (814)
                      +.-.......  ....-+.+|+|||.+....++.++|||||||++||+++ |..||......+       +...+ .++.
T Consensus       310 ~~~~~~~~~~--~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~-------v~~kI~~~~~  380 (474)
T KOG0194|consen  310 RAGSQYVMKK--FLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE-------VKAKIVKNGY  380 (474)
T ss_pred             cCCcceeecc--ccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH-------HHHHHHhcCc
Confidence            7654111111  12235789999999999999999999999999999999 888987554322       12222 2221


Q ss_pred             cceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCCCC
Q 041921          747 LNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVP  801 (814)
Q Consensus       747 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~~~~p  801 (814)
                      -         ...+...+..+..++..|+..+|++||||.++.+.|+.+.....+
T Consensus       381 r---------~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~  426 (474)
T KOG0194|consen  381 R---------MPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA  426 (474)
T ss_pred             c---------CCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence            1         111224556777888899999999999999999999887665544

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-38  Score=330.60  Aligned_cols=270  Identities=28%  Similarity=0.398  Sum_probs=206.7

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhc--cCCCCccceeeeecccc----cce
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ--THHKNLVRLLGFCDEGQ----NRL  594 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~~  594 (814)
                      .++.+.||+|+||.||||.+.    .+.||||++..   +..+.|++|-++.+.  ++|+||+++++.-....    +++
T Consensus       212 l~l~eli~~Grfg~V~KaqL~----~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw  284 (534)
T KOG3653|consen  212 LQLLELIGRGRFGCVWKAQLD----NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW  284 (534)
T ss_pred             hhhHHHhhcCccceeehhhcc----CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence            345688999999999999996    58999999964   355678887777665  48999999999987655    789


Q ss_pred             EEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcC------CCCeeecCCCCCcEEEcCCCcEEEeecCCc
Q 041921          595 LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDC------RAQIIHCDIKPQNILLDDYYTARISDFGLA  668 (814)
Q Consensus       595 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~------~~~i~H~dlkp~NIll~~~~~~kl~DfGla  668 (814)
                      ||+||.+.|+|.+||..+ .++|....+|+..+++||+|||+..      ++.|+|||||.+||||.++++..|+|||+|
T Consensus       285 LVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA  363 (534)
T KOG3653|consen  285 LVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA  363 (534)
T ss_pred             EEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence            999999999999999765 5899999999999999999999753      578999999999999999999999999999


Q ss_pred             cccccCCcccccccccCCCCcccccccccCC-CC-----cchhhHHHHHHHHHHHhCCCCCCcccchhhh-hHH------
Q 041921          669 KLLTLNQSKTIKTAIRGTKGYVAPEWFRNSK-IT-----AKVDVYSFGVLLLEIISCRKSFDIEMGEEYA-ILT------  735 (814)
Q Consensus       669 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-----~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~-~~~------  735 (814)
                      ..+.+..........+||.+|||||++.+.- +.     .+.||||+|.|||||++...-+......++. .+.      
T Consensus       364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~h  443 (534)
T KOG3653|consen  364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNH  443 (534)
T ss_pred             EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCC
Confidence            9998776665545578999999999997652 22     4699999999999999977655321111110 000      


Q ss_pred             ---HHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCCCC
Q 041921          736 ---DWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVP  801 (814)
Q Consensus       736 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~~~~p  801 (814)
                         +-.+..+-.++..-.+....   .....+.-+++.+..||..||+-|.|+.=+.+++.++..+..-
T Consensus       444 Pt~e~mq~~VV~kK~RP~~p~~W---~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~  509 (534)
T KOG3653|consen  444 PTLEEMQELVVRKKQRPKIPDAW---RKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED  509 (534)
T ss_pred             CCHHHHHHHHHhhccCCCChhhh---hcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence               01111111111111110000   1235677889999999999999999999999998877666543

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=2e-38  Score=334.56  Aligned_cols=268  Identities=25%  Similarity=0.400  Sum_probs=220.7

Q ss_pred             HHHHHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccch-HhHHHHHHhhhccCCCCccceeeeecccc
Q 041921          513 YKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE-REFKNEVFVIGQTHHKNLVRLLGFCDEGQ  591 (814)
Q Consensus       513 ~~~l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~  591 (814)
                      .+|+.+....|.|+||+|-||.|.++...   ....||||+++....... ++|.+|+++|.+++||||++|+|+|..++
T Consensus       532 l~EfPRs~L~~~ekiGeGqFGEVhLCeve---g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De  608 (807)
T KOG1094|consen  532 LVEFPRSRLRFKEKIGEGQFGEVHLCEVE---GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDD  608 (807)
T ss_pred             hhhcchhheehhhhhcCcccceeEEEEec---CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC
Confidence            44666666678899999999999999986   468999999988766555 78999999999999999999999999999


Q ss_pred             cceEEEecCCCCCHHHHhcCCC--CCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcc
Q 041921          592 NRLLVYEFLNNGTLASFLFGNL--KPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAK  669 (814)
Q Consensus       592 ~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~  669 (814)
                      .+++|+|||++|+|..||..+.  .+.-....+|+.|||.|++||.+.   +++||||.++|+|++.++++||+|||+++
T Consensus       609 PicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR  685 (807)
T KOG1094|consen  609 PLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSR  685 (807)
T ss_pred             chHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCccccc
Confidence            9999999999999999998773  334556678999999999999998   99999999999999999999999999999


Q ss_pred             ccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh--CCCCCCcccchhhhhHHHHHHHHhhcCcc
Q 041921          670 LLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS--CRKSFDIEMGEEYAILTDWAFDCYRNGKL  747 (814)
Q Consensus       670 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  747 (814)
                      -+............+-.++|||||.+..++++.++|||+||+.+||+++  ..+||.....+...   +.....++.+..
T Consensus       686 ~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vv---en~~~~~~~~~~  762 (807)
T KOG1094|consen  686 NLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVV---ENAGEFFRDQGR  762 (807)
T ss_pred             ccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHH---HhhhhhcCCCCc
Confidence            8777666555455667899999999999999999999999999999876  66787644332211   112222222221


Q ss_pred             ceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 041921          748 NVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV  795 (814)
Q Consensus       748 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~  795 (814)
                      ...      ...+.-++.++++++.+||..+.++||+++++...|.+.
T Consensus       763 ~~~------l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  763 QVV------LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             cee------ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            111      122445778899999999999999999999999988754

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=7.8e-38  Score=327.93  Aligned_cols=251  Identities=33%  Similarity=0.542  Sum_probs=198.4

Q ss_pred             cccceeeeeeeeEEEEEEe--cCCCceEEEEEEeccccc-cchHhHHHHHHhhhccCCCCccceeeeecccccceEEEec
Q 041921          523 FKEEVGRGSFGIVYKGVIQ--TRTSTTAVAVKKLDRVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  599 (814)
Q Consensus       523 ~~~~LG~G~~g~Vy~~~~~--~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  599 (814)
                      +.+.||.|.||.||+|.+.  .......|+||.+..... ...++|.+|++.+++++||||++++|++.+.+..++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            5678999999999999998  444578999999965332 2367899999999999999999999999988889999999


Q ss_pred             CCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcc
Q 041921          600 LNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSK  677 (814)
Q Consensus       600 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  677 (814)
                      +++|+|.++|...  ..+++..+..|+.||++||.|||+.   +++|++|+++||+++.++.+||+|||++.........
T Consensus        83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             cccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence            9999999999876  7789999999999999999999998   9999999999999999999999999999877332222


Q ss_pred             cccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeecCccc
Q 041921          678 TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKE  756 (814)
Q Consensus       678 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  756 (814)
                      ...........|+|||.+....++.++||||||+++|||++ |+.|+......+       +...+.++...        
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~-------~~~~~~~~~~~--------  224 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE-------IIEKLKQGQRL--------  224 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH-------HHHHHHTTEET--------
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccc-------ccccccccccc--------
Confidence            22233446789999999999999999999999999999999 778876442221       11222222211        


Q ss_pred             ccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 041921          757 AMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQML  792 (814)
Q Consensus       757 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L  792 (814)
                       ......+..+.+++..||+.+|.+||||.++++.|
T Consensus       225 -~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  225 -PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             -TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             -eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence             11222456788999999999999999999999987

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.3e-37  Score=330.53  Aligned_cols=260  Identities=20%  Similarity=0.316  Sum_probs=205.8

Q ss_pred             ccccCHHHHHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccc---hHhHHHHHHhhhccCCCCcccee
Q 041921          508 LRCFSYKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG---EREFKNEVFVIGQTHHKNLVRLL  584 (814)
Q Consensus       508 ~~~~~~~~l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~  584 (814)
                      .+..+.+++...+   ...||+|+++.||+|.+.    +..||||+++......   .+.|.+|+.++.+++||||++++
T Consensus        12 ~~~i~~~~i~~~~---~~~i~~g~~~~v~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~   84 (283)
T PHA02988         12 IKCIESDDIDKYT---SVLIKENDQNSIYKGIFN----NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIY   84 (283)
T ss_pred             ceecCHHHcCCCC---CeEEeeCCceEEEEEEEC----CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEe
Confidence            3445555552221   136999999999999973    7799999997643322   35688999999999999999999


Q ss_pred             eeecc----cccceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcE
Q 041921          585 GFCDE----GQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTA  660 (814)
Q Consensus       585 ~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~  660 (814)
                      +++.+    ....++||||+++|+|.+++.....+++....+++.|++.||.|||+.  .+++||||||+||++++++.+
T Consensus        85 g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~  162 (283)
T PHA02988         85 GFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKL  162 (283)
T ss_pred             eeEEecccCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcE
Confidence            99866    346789999999999999999888899999999999999999999973  267899999999999999999


Q ss_pred             EEeecCCccccccCCcccccccccCCCCccccccccc--CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHH
Q 041921          661 RISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRN--SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA  738 (814)
Q Consensus       661 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  738 (814)
                      ||+|||+++.+....     ....++..|+|||++.+  ..++.++|||||||++|||++|+.||......+.       
T Consensus       163 kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~-------  230 (283)
T PHA02988        163 KIICHGLEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI-------  230 (283)
T ss_pred             EEcccchHhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHH-------
Confidence            999999998654322     22357899999999976  6789999999999999999999999975432211       


Q ss_pred             HHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 041921          739 FDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV  796 (814)
Q Consensus       739 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~  796 (814)
                      ...+..+...      .  ..+...+..+.+++.+||+.||++|||++++++.|+.+.
T Consensus       231 ~~~i~~~~~~------~--~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        231 YDLIINKNNS------L--KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             HHHHHhcCCC------C--CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            1111111110      0  112234567899999999999999999999999998754

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-38  Score=329.68  Aligned_cols=249  Identities=25%  Similarity=0.328  Sum_probs=207.0

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEeccc---cccchHhHHHHHHhhhcc-CCCCccceeeeecccccceEE
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV---FQDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRLLV  596 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  596 (814)
                      ..|+++||+|+|++|++|+...  .++.+|||.+.+.   .+...+-...|-++|.+| .||.|++|+-.|.++..+|+|
T Consensus        75 F~Fg~~lGeGSYStV~~A~~~~--t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv  152 (604)
T KOG0592|consen   75 FKFGKILGEGSYSTVVLAREKA--TGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV  152 (604)
T ss_pred             cchhheeccccceeEEEeeecC--CCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence            4578999999999999999764  6789999999652   233334577888899999 899999999999999999999


Q ss_pred             EecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCc
Q 041921          597 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS  676 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  676 (814)
                      +||+++|+|.++|...+.+++...+-++.+|+.||+|||+.   |||||||||+|||||.++++||+|||.|+.+.+...
T Consensus       153 Le~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~  229 (604)
T KOG0592|consen  153 LEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQK  229 (604)
T ss_pred             EEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCChhhc
Confidence            99999999999999999999999999999999999999998   999999999999999999999999999998865432


Q ss_pred             c---------cc--cccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcC
Q 041921          677 K---------TI--KTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG  745 (814)
Q Consensus       677 ~---------~~--~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  745 (814)
                      .         ..  ...++||..|.+||++.....+..+|+|+|||+||.|+.|..||....+  +..     ++.+..-
T Consensus       230 ~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne--yli-----FqkI~~l  302 (604)
T KOG0592|consen  230 SQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE--YLI-----FQKIQAL  302 (604)
T ss_pred             cccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH--HHH-----HHHHHHh
Confidence            2         11  1447899999999999999999999999999999999999999975432  222     2222111


Q ss_pred             ccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          746 KLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       746 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                      .          ...+...++.+.+|+.+.|..||.+|+|.++|.+.
T Consensus       303 ~----------y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  303 D----------YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             c----------ccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence            1          11122233677788999999999999999888754

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-38  Score=332.70  Aligned_cols=246  Identities=27%  Similarity=0.391  Sum_probs=209.2

Q ss_pred             ccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEecCCCC
Q 041921          524 KEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNG  603 (814)
Q Consensus       524 ~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  603 (814)
                      -++||+|+.|.||.+.-.  ..++.||||++........+-+.+|+.+|+..+|+|||+++..+..++++++|||||++|
T Consensus       278 ~~kigqgaSG~vy~A~~~--~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~gg  355 (550)
T KOG0578|consen  278 FKKIGQGATGGVYVARKI--STKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGG  355 (550)
T ss_pred             hhhhccccccceeeeeec--cCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCC
Confidence            368999999999999854  367789999998766666677899999999999999999999999899999999999999


Q ss_pred             CHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcccccccc
Q 041921          604 TLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAI  683 (814)
Q Consensus       604 sL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~  683 (814)
                      +|.+.+... .+++.++..|+..+++||+|||.+   +|+|||||.+|||++.++.+||+|||++..+......  ....
T Consensus       356 sLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K--R~Tm  429 (550)
T KOG0578|consen  356 SLTDVVTKT-RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK--RSTM  429 (550)
T ss_pred             chhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccCc--cccc
Confidence            999988655 488999999999999999999999   9999999999999999999999999999988765543  2567


Q ss_pred             cCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCcHHH
Q 041921          684 RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIEC  763 (814)
Q Consensus       684 ~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  763 (814)
                      +||+.|||||+.....|.+|.||||||++++||+-|..||-.+.+-..-      +....+|        .+........
T Consensus       430 VGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAl------yLIa~ng--------~P~lk~~~kl  495 (550)
T KOG0578|consen  430 VGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------YLIATNG--------TPKLKNPEKL  495 (550)
T ss_pred             cCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHH------HHHhhcC--------CCCcCCcccc
Confidence            8999999999999999999999999999999999999999754332110      1111122        2223334456


Q ss_pred             HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          764 LGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       764 ~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                      ...+.+++.+||+.|+.+||++.|+|+.
T Consensus       496 S~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  496 SPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             CHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence            6789999999999999999999999863

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=3.1e-37  Score=297.95  Aligned_cols=273  Identities=22%  Similarity=0.279  Sum_probs=210.2

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEE
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY  597 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  597 (814)
                      +|.-.++||+|.||.||+|...  ..++.||||+++...  ........+|++.|+.++|+||+.+++++.+.+...||+
T Consensus         3 rY~~~~~lGEG~~gvVyka~d~--~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf   80 (318)
T KOG0659|consen    3 RYEKLEKLGEGTYGVVYKARDT--ETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF   80 (318)
T ss_pred             hhhhhhhhcCcceEEEEEEEec--CCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence            3445678999999999999964  478899999997542  223456899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCc
Q 041921          598 EFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS  676 (814)
Q Consensus       598 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  676 (814)
                      |||+. +|+..|++. ..+....+..++.++++||+|||++   .|+||||||.|+|++++|.+||+|||+++.+.....
T Consensus        81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~  156 (318)
T KOG0659|consen   81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR  156 (318)
T ss_pred             Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence            99965 999999876 6678889999999999999999999   999999999999999999999999999998875443


Q ss_pred             ccccccccCCCCcccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCcc------ce
Q 041921          677 KTIKTAIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL------NV  749 (814)
Q Consensus       677 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------~~  749 (814)
                      ..  +..+-|..|.|||.+.+. .|....|+||.|||+.||+-|.+-|.+..+-++-   ..+++.+..-..      ..
T Consensus       157 ~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL---~~If~~LGTP~~~~WP~~~~  231 (318)
T KOG0659|consen  157 IQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQL---SKIFRALGTPTPDQWPEMTS  231 (318)
T ss_pred             cc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHH---HHHHHHcCCCCcccCccccc
Confidence            32  334679999999988765 6899999999999999999988777655443322   222332221111      11


Q ss_pred             eec-------Cccccc-CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCCCCCCC
Q 041921          750 LVG-------EDKEAM-NDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVPPNP  804 (814)
Q Consensus       750 ~~~-------~~~~~~-~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~~~~p~~p  804 (814)
                      +.+       +..... .-......+++++..++..||.+|+|+.|++++= .+...|.|..|
T Consensus       232 lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~-yf~~~P~pt~~  293 (318)
T KOG0659|consen  232 LPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHP-YFKSLPLPTPP  293 (318)
T ss_pred             cccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcch-hhhcCCCCCCh
Confidence            111       000000 1123455668999999999999999999998753 34444444443

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-38  Score=332.55  Aligned_cols=238  Identities=28%  Similarity=0.441  Sum_probs=201.9

Q ss_pred             cceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEecCCCCC
Q 041921          525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGT  604 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  604 (814)
                      +=||.|+.|.||+|.+.    ...||||+++...       ..+|+-|++++|+||+.+.|+|...--+|||||||+.|-
T Consensus       130 eWlGSGaQGAVF~Grl~----netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq  198 (904)
T KOG4721|consen  130 EWLGSGAQGAVFLGRLH----NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ  198 (904)
T ss_pred             hhhccCcccceeeeecc----CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence            34999999999999996    6789999986432       357888999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccccccccc
Q 041921          605 LASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIR  684 (814)
Q Consensus       605 L~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~  684 (814)
                      |...|+..+.+.......+..+||.|+.|||.+   .|||||||.-||||+.+..+||+|||-++.....   ...-.+.
T Consensus       199 L~~VLka~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSFa  272 (904)
T KOG4721|consen  199 LYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSFA  272 (904)
T ss_pred             HHHHHhccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhhh
Confidence            999999999999999999999999999999999   9999999999999999999999999998865533   2224578


Q ss_pred             CCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCcHHHH
Q 041921          685 GTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECL  764 (814)
Q Consensus       685 gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  764 (814)
                      ||..|||||++++.++++|.||||||||||||+||..||..-....      .+|.         .=...+..+.+..++
T Consensus       273 GTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA------IIwG---------VGsNsL~LpvPstcP  337 (904)
T KOG4721|consen  273 GTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA------IIWG---------VGSNSLHLPVPSTCP  337 (904)
T ss_pred             hhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe------eEEe---------ccCCcccccCcccCc
Confidence            9999999999999999999999999999999999999996321110      0000         001112334455677


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 041921          765 GKLVMVSIWCIQEDPSLRPTMKKVLQMLEG  794 (814)
Q Consensus       765 ~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~  794 (814)
                      +-+.-|++.||+-.|..||++.+++..|+-
T Consensus       338 ~GfklL~Kqcw~sKpRNRPSFrqil~HldI  367 (904)
T KOG4721|consen  338 DGFKLLLKQCWNSKPRNRPSFRQILLHLDI  367 (904)
T ss_pred             hHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence            888889999999999999999999999863

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.6e-37  Score=343.11  Aligned_cols=260  Identities=27%  Similarity=0.404  Sum_probs=204.5

Q ss_pred             HhhhccccceeeeeeeeEEEEEEe---cCCCceEEEEEEecccc-ccchHhHHHHHHhhhcc-CCCCccceeeeeccccc
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQ---TRTSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQN  592 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~---~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  592 (814)
                      ...+.+.+.||+|+||.||+|+..   ....+..||||.++... ....+.+.+|+.++..+ +||||+++++++.+...
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            445677899999999999999753   22346689999996432 23345688999999999 89999999999999999


Q ss_pred             ceEEEecCCCCCHHHHhcCC------------------------------------------------------------
Q 041921          593 RLLVYEFLNNGTLASFLFGN------------------------------------------------------------  612 (814)
Q Consensus       593 ~~lv~e~~~~gsL~~~l~~~------------------------------------------------------------  612 (814)
                      .++||||+++|+|.+++...                                                            
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            99999999999999998642                                                            


Q ss_pred             ---------------CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcc
Q 041921          613 ---------------LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSK  677 (814)
Q Consensus       613 ---------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  677 (814)
                                     ..+++..+.+++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                           1367888899999999999999998   9999999999999999999999999999876543322


Q ss_pred             cccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeecCccc
Q 041921          678 TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKE  756 (814)
Q Consensus       678 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  756 (814)
                      .......++..|+|||.+.+..++.++||||||+++|||++ |..||.......  .    ..+.+..+....       
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~----~~~~~~~~~~~~-------  337 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--K----FYKMIKEGYRML-------  337 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--H----HHHHHHhCccCC-------
Confidence            22122345678999999999999999999999999999998 888886433221  1    111222221000       


Q ss_pred             ccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 041921          757 AMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV  795 (814)
Q Consensus       757 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~  795 (814)
                        .+...+.++.+++.+||+.||++|||+.+|+++|++.
T Consensus       338 --~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         338 --SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             --CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence              0111245788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-37  Score=332.70  Aligned_cols=251  Identities=25%  Similarity=0.374  Sum_probs=207.0

Q ss_pred             HHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccc----cc-cchHhHHHHHHhhhccC-CCCccceeeeecc
Q 041921          516 LEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV----FQ-DGEREFKNEVFVIGQTH-HKNLVRLLGFCDE  589 (814)
Q Consensus       516 l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~  589 (814)
                      .....|.+.+.||+|.||+|+.|....  .+..||||.+...    .. ...+.+.+|+.++++++ ||||++++.++..
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~--t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t   91 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRL--TGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT   91 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeecc--CCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec
Confidence            345567788999999999999998764  4589999976542    11 23456778999999998 9999999999999


Q ss_pred             cccceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC-CcEEEeecCCc
Q 041921          590 GQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDY-YTARISDFGLA  668 (814)
Q Consensus       590 ~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~-~~~kl~DfGla  668 (814)
                      ..+.++||||+.+|+|.+++....++.+....+++.|++.|++|||+.   +|+||||||+|||++.+ +++||+|||++
T Consensus        92 ~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s  168 (370)
T KOG0583|consen   92 PTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLS  168 (370)
T ss_pred             CCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence            999999999999999999999988899999999999999999999998   99999999999999999 99999999999


Q ss_pred             cccccCCcccccccccCCCCcccccccccCC-CC-cchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCc
Q 041921          669 KLLTLNQSKTIKTAIRGTKGYVAPEWFRNSK-IT-AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK  746 (814)
Q Consensus       669 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  746 (814)
                      .....  ........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+......       ....+..+.
T Consensus       169 ~~~~~--~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~-------l~~ki~~~~  239 (370)
T KOG0583|consen  169 AISPG--EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN-------LYRKIRKGE  239 (370)
T ss_pred             cccCC--CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH-------HHHHHhcCC
Confidence            98741  112225678999999999999877 86 67999999999999999999998632111       112233333


Q ss_pred             cceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 041921          747 LNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVL  789 (814)
Q Consensus       747 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl  789 (814)
                      ....        .... ..++..++.+||+.+|.+|+|+.+++
T Consensus       240 ~~~p--------~~~~-S~~~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  240 FKIP--------SYLL-SPEARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             ccCC--------CCcC-CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence            2211        1111 57788999999999999999999998

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=9e-37  Score=328.02  Aligned_cols=265  Identities=26%  Similarity=0.396  Sum_probs=204.1

Q ss_pred             HhhhccccceeeeeeeeEEEEEEecC--------------CCceEEEEEEeccccc-cchHhHHHHHHhhhccCCCCccc
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQTR--------------TSTTAVAVKKLDRVFQ-DGEREFKNEVFVIGQTHHKNLVR  582 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~~--------------~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~  582 (814)
                      ...+.+.++||+|+||.||++.+...              +.+..||+|.+..... ....+|.+|+.++.+++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            34567788999999999999986432              2345799999875432 23457999999999999999999


Q ss_pred             eeeeecccccceEEEecCCCCCHHHHhcCC-------------------CCCChhhHHHHHHHHHHHHHHhhhcCCCCee
Q 041921          583 LLGFCDEGQNRLLVYEFLNNGTLASFLFGN-------------------LKPNWNLRTNIAFQIARGLLYLHEDCRAQII  643 (814)
Q Consensus       583 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-------------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~  643 (814)
                      +++++.+.+..++||||+++++|.+++...                   ..+++..+.+++.||+.||.|||+.   +|+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~iv  160 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFV  160 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence            999999999999999999999999998542                   2357788899999999999999998   999


Q ss_pred             ecCCCCCcEEEcCCCcEEEeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh--CCC
Q 041921          644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS--CRK  721 (814)
Q Consensus       644 H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt--g~~  721 (814)
                      ||||||+|||++.++.+||+|||+++.+.............++..|+|||++....++.++||||||+++|||++  +..
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence            999999999999999999999999986644332222233446789999999988899999999999999999987  556


Q ss_pred             CCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 041921          722 SFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEG  794 (814)
Q Consensus       722 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~  794 (814)
                      ||......+.   ...+...+.........      ..+..++..+.+++.+||+.+|++|||+.+|.+.|++
T Consensus       241 p~~~~~~~~~---~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         241 PYGELTDEQV---IENAGEFFRDQGRQVYL------FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CCCcCCHHHH---HHHHHHHhhhccccccc------cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            6654332221   11121212111111100      0112345678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=3.5e-37  Score=324.44  Aligned_cols=260  Identities=23%  Similarity=0.371  Sum_probs=208.2

Q ss_pred             HHHhhhccccceeeeeeeeEEEEEEecC-CCceEEEEEEeccccc-cchHhHHHHHHhhhccCCCCccceeeeecccccc
Q 041921          516 LEGATNNFKEEVGRGSFGIVYKGVIQTR-TSTTAVAVKKLDRVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNR  593 (814)
Q Consensus       516 l~~~~~~~~~~LG~G~~g~Vy~~~~~~~-~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  593 (814)
                      +....+.+.+.||+|+||.||+|.+... .....||+|.++.... ...+.|.+|+.++.+++||||+++++++..++..
T Consensus         2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   81 (266)
T cd05064           2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM   81 (266)
T ss_pred             CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence            4456778889999999999999986532 2467899999975432 2345689999999999999999999999999999


Q ss_pred             eEEEecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccc
Q 041921          594 LLVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLT  672 (814)
Q Consensus       594 ~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~  672 (814)
                      ++||||+++++|.+++... ..+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+|++|||.+....
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~  158 (266)
T cd05064          82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK  158 (266)
T ss_pred             EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence            9999999999999999764 5789999999999999999999998   99999999999999999999999999876543


Q ss_pred             cCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceee
Q 041921          673 LNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLV  751 (814)
Q Consensus       673 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  751 (814)
                      ...... .....++..|+|||.+.+..++.++||||||++++|+++ |+.||......+       ....+.++..    
T Consensus       159 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~-------~~~~~~~~~~----  226 (266)
T cd05064         159 SEAIYT-TMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD-------VIKAVEDGFR----  226 (266)
T ss_pred             ccchhc-ccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHHCCCC----
Confidence            221111 112235678999999999999999999999999999875 999997543322       1112222211    


Q ss_pred             cCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 041921          752 GEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV  795 (814)
Q Consensus       752 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~  795 (814)
                           .+.+...+..+.+++..||+.+|.+||++++|++.|+++
T Consensus       227 -----~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         227 -----LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             -----CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence                 011223456788999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.5e-37  Score=341.11  Aligned_cols=263  Identities=26%  Similarity=0.405  Sum_probs=205.4

Q ss_pred             HHHhhhccccceeeeeeeeEEEEEEec---CCCceEEEEEEeccccc-cchHhHHHHHHhhhcc-CCCCccceeeeeccc
Q 041921          516 LEGATNNFKEEVGRGSFGIVYKGVIQT---RTSTTAVAVKKLDRVFQ-DGEREFKNEVFVIGQT-HHKNLVRLLGFCDEG  590 (814)
Q Consensus       516 l~~~~~~~~~~LG~G~~g~Vy~~~~~~---~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  590 (814)
                      +....+.+.+.||+|+||.||+|+...   ......||||++..... .....+.+|+.+++.+ +|+||+++++++.+.
T Consensus        35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~  114 (374)
T cd05106          35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG  114 (374)
T ss_pred             ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence            345567788999999999999998542   22345899999975332 2345688999999999 899999999999999


Q ss_pred             ccceEEEecCCCCCHHHHhcCC----------------------------------------------------------
Q 041921          591 QNRLLVYEFLNNGTLASFLFGN----------------------------------------------------------  612 (814)
Q Consensus       591 ~~~~lv~e~~~~gsL~~~l~~~----------------------------------------------------------  612 (814)
                      ...++||||+++|+|.+++...                                                          
T Consensus       115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (374)
T cd05106         115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS  194 (374)
T ss_pred             CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence            9999999999999999988532                                                          


Q ss_pred             ------------CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccccc
Q 041921          613 ------------LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIK  680 (814)
Q Consensus       613 ------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  680 (814)
                                  ..+++....+++.||++||.|||+.   +|+||||||+|||+++++.+||+|||+++...........
T Consensus       195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~  271 (374)
T cd05106         195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK  271 (374)
T ss_pred             ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence                        1356778899999999999999998   9999999999999999999999999999865433222221


Q ss_pred             ccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccC
Q 041921          681 TAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMN  759 (814)
Q Consensus       681 ~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  759 (814)
                      ....++..|+|||++.+..++.++||||||+++|||++ |+.||........      .......+. .    ..    .
T Consensus       272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~------~~~~~~~~~-~----~~----~  336 (374)
T cd05106         272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK------FYKMVKRGY-Q----MS----R  336 (374)
T ss_pred             cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH------HHHHHHccc-C----cc----C
Confidence            22345678999999998899999999999999999997 9999865432211      111111110 0    00    0


Q ss_pred             cHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 041921          760 DIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV  796 (814)
Q Consensus       760 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~  796 (814)
                      +...+.++.+++.+||+.||.+|||+.+|+++|+++.
T Consensus       337 ~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         337 PDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            1112467889999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.4e-37  Score=327.18  Aligned_cols=246  Identities=28%  Similarity=0.415  Sum_probs=208.0

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEE
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY  597 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  597 (814)
                      .|.+.+.||+|.||.||||+-+  .+.+.||+|.+.+..  ++..+.+.+|++++++++|||||.+++.++...+.++|.
T Consensus         3 ~yhv~e~iG~Gsfg~VYKgrrK--~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt   80 (808)
T KOG0597|consen    3 QYHVYEMIGEGSFGRVYKGRRK--YTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT   80 (808)
T ss_pred             chhHHHHhcCCccceeeecccc--cceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence            4556789999999999999865  467899999996532  333456899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcc
Q 041921          598 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSK  677 (814)
Q Consensus       598 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  677 (814)
                      ||+.+ +|..+|.....++++....|+.+++.||.|||+.   +|+|||+||+|||++..+.+|++|||+|+.+....  
T Consensus        81 e~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t--  154 (808)
T KOG0597|consen   81 EYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT--  154 (808)
T ss_pred             hhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccCc--
Confidence            99977 9999999999999999999999999999999999   99999999999999999999999999999887543  


Q ss_pred             cccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccc
Q 041921          678 TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEA  757 (814)
Q Consensus       678 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  757 (814)
                      .+.+.+.||+-|||||..++++|+..+|.||+|||+||+++|++||-..      .+...+. .+..+.+          
T Consensus       155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~------si~~Lv~-~I~~d~v----------  217 (808)
T KOG0597|consen  155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR------SITQLVK-SILKDPV----------  217 (808)
T ss_pred             eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH------HHHHHHH-HHhcCCC----------
Confidence            3346788999999999999999999999999999999999999999532      1111111 1111111          


Q ss_pred             cCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          758 MNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       758 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      ..+......+..++...|++||..|.|-.+++.
T Consensus       218 ~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  218 KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             CCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            112255667788888999999999999999874

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=9.9e-37  Score=324.12  Aligned_cols=257  Identities=31%  Similarity=0.488  Sum_probs=207.4

Q ss_pred             hhccccceeeeeeeeEEEEEEecCC---CceEEEEEEeccccc-cchHhHHHHHHhhhccCCCCccceeeeecccccceE
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRT---STTAVAVKKLDRVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL  595 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~---~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  595 (814)
                      .+.+.+.||+|+||.||+|......   ....|++|.+..... ....+|.+|+.++.+++||||+++++++.+....++
T Consensus         6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   85 (283)
T cd05048           6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM   85 (283)
T ss_pred             HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence            4567789999999999999876432   236899999864322 234568999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhcCC----------------CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCc
Q 041921          596 VYEFLNNGTLASFLFGN----------------LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYT  659 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~  659 (814)
                      +|||+++++|.+++...                ..+++.....++.|++.||.|||+.   +++|+||||+||++++++.
T Consensus        86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~~  162 (283)
T cd05048          86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLT  162 (283)
T ss_pred             EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCCc
Confidence            99999999999999653                3467888899999999999999998   9999999999999999999


Q ss_pred             EEEeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHH
Q 041921          660 ARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWA  738 (814)
Q Consensus       660 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~  738 (814)
                      +||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||......+       .
T Consensus       163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~-------~  235 (283)
T cd05048         163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE-------V  235 (283)
T ss_pred             EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------H
Confidence            99999999986643332222233446788999999998899999999999999999998 999987543322       1


Q ss_pred             HHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 041921          739 FDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV  795 (814)
Q Consensus       739 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~  795 (814)
                      ...+..+....         .+...+.++.+++.+||+.+|.+||++.+|++.|+.+
T Consensus       236 ~~~i~~~~~~~---------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         236 IEMIRSRQLLP---------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             HHHHHcCCcCC---------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence            12222222111         1234567899999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=3.2e-36  Score=373.65  Aligned_cols=270  Identities=26%  Similarity=0.496  Sum_probs=214.1

Q ss_pred             cCHHHHHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeeccc
Q 041921          511 FSYKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEG  590 (814)
Q Consensus       511 ~~~~~l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  590 (814)
                      ++++++..+ ....+.||+|+||.||+|....  ++..||||+++....    ....|++.+++++|||||+++++|.++
T Consensus       683 ~~~~~~~~~-~~~~~~ig~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~  755 (968)
T PLN00113        683 ITINDILSS-LKEENVISRGKKGASYKGKSIK--NGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSE  755 (968)
T ss_pred             hhHHHHHhh-CCcccEEccCCCeeEEEEEECC--CCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcC
Confidence            455555443 2344679999999999998743  578999999865322    223568899999999999999999999


Q ss_pred             ccceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccc
Q 041921          591 QNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKL  670 (814)
Q Consensus       591 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~  670 (814)
                      +..++||||+++|+|.++++   .++|..+.+|+.|+|+||+|||+.+.++|+||||||+||+++.++.+++. |+....
T Consensus       756 ~~~~lv~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~  831 (968)
T PLN00113        756 KGAYLIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGL  831 (968)
T ss_pred             CCCEEEEeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccc
Confidence            99999999999999999996   37899999999999999999997767799999999999999999888876 665543


Q ss_pred             cccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCcccee
Q 041921          671 LTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVL  750 (814)
Q Consensus       671 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  750 (814)
                      ....      ....++..|+|||++.+..++.++|||||||++|||+||+.|+...... ...+.+|+............
T Consensus       832 ~~~~------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~  904 (968)
T PLN00113        832 LCTD------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCYSDCHLDMW  904 (968)
T ss_pred             cccC------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHhcCccchhhe
Confidence            3211      2235789999999999999999999999999999999999999644332 22344555544444445555


Q ss_pred             ecCcccc--cCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 041921          751 VGEDKEA--MNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV  798 (814)
Q Consensus       751 ~~~~~~~--~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~~  798 (814)
                      .++....  ....++..++.+++.+|++.+|++||||+|++++|+++...
T Consensus       905 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  954 (968)
T PLN00113        905 IDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS  954 (968)
T ss_pred             eCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence            5554422  23456777899999999999999999999999999987553

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-37  Score=319.45  Aligned_cols=244  Identities=26%  Similarity=0.396  Sum_probs=207.1

Q ss_pred             ccceeeeeeeeEEEEEEecCCCceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEecCCC
Q 041921          524 KEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN  602 (814)
Q Consensus       524 ~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  602 (814)
                      .+.||+|.||.||||....  .++.||+|.+.-.. ....++++.|+.++.+++|+||.++++.+..+..++++|||+.+
T Consensus        18 ~~~IgrGsfG~Vyk~~d~~--t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~g   95 (467)
T KOG0201|consen   18 LELIGRGSFGEVYKAIDNK--TKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGG   95 (467)
T ss_pred             chhccccccceeeeeeecc--ccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcC
Confidence            4789999999999999763  67889999996432 33446789999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccccccc
Q 041921          603 GTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTA  682 (814)
Q Consensus       603 gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  682 (814)
                      |++.+.|.....+++....-|++++..||.|||.+   +.+|||||+.||||..+|.+||+|||++..+.......  ..
T Consensus        96 Gsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr--~t  170 (467)
T KOG0201|consen   96 GSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR--KT  170 (467)
T ss_pred             cchhhhhccCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhcc--cc
Confidence            99999999888878888889999999999999999   99999999999999999999999999999887654433  55


Q ss_pred             ccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCcHH
Q 041921          683 IRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIE  762 (814)
Q Consensus       683 ~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  762 (814)
                      ++||+-|||||++....|+.|+||||||++.+||.+|.+|+....+..                +..++-....-.....
T Consensus       171 fvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr----------------vlflIpk~~PP~L~~~  234 (467)
T KOG0201|consen  171 FVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR----------------VLFLIPKSAPPRLDGD  234 (467)
T ss_pred             ccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce----------------EEEeccCCCCCccccc
Confidence            789999999999998899999999999999999999999997544322                1111111111111225


Q ss_pred             HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          763 CLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       763 ~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      ....+.+++..||.+||+.||++.++++
T Consensus       235 ~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  235 FSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             cCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            6677999999999999999999999875

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=4e-37  Score=326.31  Aligned_cols=262  Identities=28%  Similarity=0.406  Sum_probs=220.6

Q ss_pred             HHHHhhhccccceeeeeeeeEEEEEEecC--CCceEEEEEEeccc-cccchHhHHHHHHhhhccCCCCccceeeeecccc
Q 041921          515 ELEGATNNFKEEVGRGSFGIVYKGVIQTR--TSTTAVAVKKLDRV-FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ  591 (814)
Q Consensus       515 ~l~~~~~~~~~~LG~G~~g~Vy~~~~~~~--~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  591 (814)
                      +|.++...+.++||.|-||.||+|++.+-  +..-.||||..+.. .....+.|+.|..+|+.++|||||+|+|+|.+ .
T Consensus       385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~  463 (974)
T KOG4257|consen  385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-Q  463 (974)
T ss_pred             eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-c
Confidence            45666667788999999999999987653  34458999999763 34456679999999999999999999999975 5


Q ss_pred             cceEEEecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccc
Q 041921          592 NRLLVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKL  670 (814)
Q Consensus       592 ~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~  670 (814)
                      ..+||||.++-|.|..||..+ ..++......++.||..||+|||+.   .++||||..+||||....-+||+|||+++.
T Consensus       464 P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~  540 (974)
T KOG4257|consen  464 PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRY  540 (974)
T ss_pred             ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhh
Confidence            789999999999999999865 6688888899999999999999998   999999999999999999999999999998


Q ss_pred             cccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccce
Q 041921          671 LTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNV  749 (814)
Q Consensus       671 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  749 (814)
                      +..+..... +...-.+.|||||.+.-.+++.++|||.|||++||+++ |..||.+-.                +.++-.
T Consensus       541 ~ed~~yYka-S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvk----------------NsDVI~  603 (974)
T KOG4257|consen  541 LEDDAYYKA-SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVK----------------NSDVIG  603 (974)
T ss_pred             ccccchhhc-cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccc----------------ccceEE
Confidence            876544332 33456789999999999999999999999999999998 999996432                222333


Q ss_pred             eecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 041921          750 LVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE  797 (814)
Q Consensus       750 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~  797 (814)
                      .++...+.+.+..++..|+.++.+||..+|.+||.+.++...|..+..
T Consensus       604 ~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  604 HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence            334444556677899999999999999999999999999988877655

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.9e-37  Score=329.22  Aligned_cols=256  Identities=24%  Similarity=0.327  Sum_probs=215.4

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEE
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY  597 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  597 (814)
                      +.+++.||.|+-|.|-.|++.  ..|+.+|||.+.+..   ......+.+|+.+|+.+.|||++++++++.+.+++|||.
T Consensus        14 wkLgkTLG~Gstg~vrlakh~--~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   14 WKLGKTLGKGSTGCVRLAKHA--ETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             eeccccccCCCCceehhhhcc--cccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            456788999999999999976  478999999996542   223446889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcc
Q 041921          598 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSK  677 (814)
Q Consensus       598 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  677 (814)
                      ||+++|.|.++|...+.+.+.+..+++.||+.|+.|+|..   +|+|||+||+|+|||...++||+|||+|.+-.++.-.
T Consensus        92 Eyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklL  168 (786)
T KOG0588|consen   92 EYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLL  168 (786)
T ss_pred             EecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCCccc
Confidence            9999999999999999999999999999999999999998   9999999999999999999999999999876554322


Q ss_pred             cccccccCCCCcccccccccCCCC-cchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCccc
Q 041921          678 TIKTAIRGTKGYVAPEWFRNSKIT-AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKE  756 (814)
Q Consensus       678 ~~~~~~~gt~~y~aPE~~~~~~~s-~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  756 (814)
                         ...+|++.|.|||++.+.+|. .++||||.|||||.|+||+.||+...-       .....++..|..+..      
T Consensus       169 ---eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi-------r~LLlKV~~G~f~MP------  232 (786)
T KOG0588|consen  169 ---ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI-------RVLLLKVQRGVFEMP------  232 (786)
T ss_pred             ---cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH-------HHHHHHHHcCcccCC------
Confidence               456899999999999999886 689999999999999999999983321       223445556654432      


Q ss_pred             ccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HhcCcCCCCC
Q 041921          757 AMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM--LEGVVEVSVP  801 (814)
Q Consensus       757 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~--L~~~~~~~~p  801 (814)
                          ...+.+..+|+.+|+..||++|.|++||++.  |.+...++.+
T Consensus       233 ----s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~  275 (786)
T KOG0588|consen  233 ----SNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSS  275 (786)
T ss_pred             ----CcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCChh
Confidence                2344677889999999999999999999974  4554444333

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-36  Score=316.67  Aligned_cols=256  Identities=27%  Similarity=0.442  Sum_probs=207.3

Q ss_pred             HHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceE
Q 041921          516 LEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL  595 (814)
Q Consensus       516 l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  595 (814)
                      +...++.+.++||+|++|.||+|...   .+..||||.++.. ....+++.+|+.++++++|+||+++++++...+..++
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~---~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   78 (261)
T cd05068           3 IDRTSIQLLRKLGAGQFGEVWEGLWN---NTTPVAVKTLKPG-TMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYI   78 (261)
T ss_pred             cchhheeeEEEecccCCccEEEEEec---CCeEEEEEeeCCC-cccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeee
Confidence            44566778899999999999999865   3568999998753 2345679999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcccccc
Q 041921          596 VYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTL  673 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~  673 (814)
                      ||||+++++|.+++...  ..+++..+..++.|++.||.|||+.   +|+|+||||+||++++++.+||+|||++.....
T Consensus        79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05068          79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKE  155 (261)
T ss_pred             eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence            99999999999999765  3689999999999999999999998   999999999999999999999999999987653


Q ss_pred             CCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeec
Q 041921          674 NQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVG  752 (814)
Q Consensus       674 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  752 (814)
                      ...... .....+..|+|||.+.+..++.++||||||++++||++ |+.||.......       ....+.....     
T Consensus       156 ~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~-----  222 (261)
T cd05068         156 DIYEAR-EGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE-------VLQQVDQGYR-----  222 (261)
T ss_pred             Cccccc-CCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCC-----
Confidence            221111 11223468999999998899999999999999999999 999986443221       1111111110     


Q ss_pred             CcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 041921          753 EDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV  795 (814)
Q Consensus       753 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~  795 (814)
                          .......+..+.+++.+|++.+|.+||++.++++.|+++
T Consensus       223 ----~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         223 ----MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             ----CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence                011123456789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2.5e-36  Score=320.41  Aligned_cols=258  Identities=27%  Similarity=0.475  Sum_probs=208.3

Q ss_pred             HhhhccccceeeeeeeeEEEEEEecC---CCceEEEEEEecccccc-chHhHHHHHHhhhccCCCCccceeeeecccccc
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQTR---TSTTAVAVKKLDRVFQD-GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNR  593 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~~---~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  593 (814)
                      ..++.+.+.||+|+||.||+|.....   .....||||.+...... ..+.+.+|++++.+++|+||+++++++......
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            45677788999999999999987543   34578999999764433 356799999999999999999999999999999


Q ss_pred             eEEEecCCCCCHHHHhcCC--------------CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCc
Q 041921          594 LLVYEFLNNGTLASFLFGN--------------LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYT  659 (814)
Q Consensus       594 ~lv~e~~~~gsL~~~l~~~--------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~  659 (814)
                      ++||||+++++|.+++...              ..+++.....++.|++.||.|||+.   +++||||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence            9999999999999999643              3467888899999999999999998   9999999999999999999


Q ss_pred             EEEeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHH
Q 041921          660 ARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWA  738 (814)
Q Consensus       660 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~  738 (814)
                      +||+|||++................++..|+|||.+.+..++.++||||||++++||++ |..||......+.       
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~-------  233 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV-------  233 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH-------
Confidence            99999999976543322221133346788999999999999999999999999999999 9999864433221       


Q ss_pred             HHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 041921          739 FDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEG  794 (814)
Q Consensus       739 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~  794 (814)
                      ...+..+.....         +...+..+.+++.+||+.+|.+||++.|++++|++
T Consensus       234 ~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         234 IECITQGRLLQR---------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             HHHHHcCCcCCC---------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence            112222222111         11245678899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=4.9e-36  Score=320.15  Aligned_cols=260  Identities=25%  Similarity=0.450  Sum_probs=210.0

Q ss_pred             hhhccccceeeeeeeeEEEEEEec---CCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceE
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQT---RTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL  595 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~---~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  595 (814)
                      ..+.+.+.||+|+||.||+|....   ......+++|.+........+.+.+|+.++++++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            345667899999999999998643   12456799999876555555679999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhcCC----------------CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCc
Q 041921          596 VYEFLNNGTLASFLFGN----------------LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYT  659 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~  659 (814)
                      ||||+++++|.+++...                ..+++..++.++.||+.||+|||+.   +|+||||||+||+++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence            99999999999999643                2378899999999999999999998   9999999999999999999


Q ss_pred             EEEeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHH
Q 041921          660 ARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWA  738 (814)
Q Consensus       660 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~  738 (814)
                      +||+|||++................++..|+|||.+.+..++.++||||||++++||++ |+.||......+       .
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~  234 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-------V  234 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------H
Confidence            99999999976544332222233456788999999998899999999999999999999 999986443322       1


Q ss_pred             HHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 041921          739 FDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE  797 (814)
Q Consensus       739 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~  797 (814)
                      .+....+.....         ....+..+.+++.+||+.+|++|||+.+|+++|+.+..
T Consensus       235 ~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         235 IECITQGRVLER---------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             HHHHhCCCCCCC---------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence            122222222111         11234678899999999999999999999999998755

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.9e-36  Score=327.83  Aligned_cols=263  Identities=21%  Similarity=0.302  Sum_probs=204.5

Q ss_pred             HhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccceeeeecccccceEE
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV  596 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  596 (814)
                      ...+.+.++||+|+||.||++....  .+..+|+|.+.... ....+.+.+|++++++++||||+++++++.+++..++|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKP--SGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   81 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECC--CCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            4456677899999999999998753  56789999886432 22345799999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCc
Q 041921          597 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS  676 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  676 (814)
                      |||+++++|.+++.....+++..+..++.|++.||.|||+.  .+|+||||||+|||++.++.+||+|||++....... 
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  158 (331)
T cd06649          82 MEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  158 (331)
T ss_pred             eecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccccccc-
Confidence            99999999999998888889999999999999999999985  269999999999999999999999999987654321 


Q ss_pred             ccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCcc---------
Q 041921          677 KTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL---------  747 (814)
Q Consensus       677 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------  747 (814)
                         .....|+..|+|||.+.+..++.++|||||||++|||++|+.||......+..   .........+..         
T Consensus       159 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  232 (331)
T cd06649         159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELE---AIFGRPVVDGEEGEPHSISPR  232 (331)
T ss_pred             ---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHhcccccccccCCccccCcc
Confidence               13346899999999999989999999999999999999999999654332211   000000000000         


Q ss_pred             -------------------------ceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          748 -------------------------NVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       748 -------------------------~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                                               ..+...............++.+++.+||+.||++|||++++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                                     00000000000011245678999999999999999999999864

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=3.7e-36  Score=316.69  Aligned_cols=258  Identities=26%  Similarity=0.431  Sum_probs=207.4

Q ss_pred             hhhccccceeeeeeeeEEEEEEecC-CCceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccceeeeecccccceEE
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTR-TSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV  596 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  596 (814)
                      ..+.+.+.||+|+||.||+|.+... .....|+||.++... .....+|.+|+.++++++||||+++++++.+.+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            4456788999999999999998643 235689999986543 23345789999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCC
Q 041921          597 YEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ  675 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~  675 (814)
                      |||+++++|.+++... ..+++..+.+++.|++.||+|||+.   +|+|+||||+||++++++.+||+|||+++......
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~  160 (266)
T cd05033          84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE  160 (266)
T ss_pred             EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence            9999999999999764 4689999999999999999999998   99999999999999999999999999998775222


Q ss_pred             cccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeecCc
Q 041921          676 SKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGED  754 (814)
Q Consensus       676 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  754 (814)
                      .........++..|+|||.+....++.++||||||++++||++ |..||......+       ....+..+...      
T Consensus       161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~------  227 (266)
T cd05033         161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD-------VIKAVEDGYRL------  227 (266)
T ss_pred             cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH-------HHHHHHcCCCC------
Confidence            2211122335678999999998899999999999999999998 999986433221       11222221100      


Q ss_pred             ccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 041921          755 KEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV  795 (814)
Q Consensus       755 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~  795 (814)
                         +.....+..+.+++.+|++.+|++||++++++++|+++
T Consensus       228 ---~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         228 ---PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             ---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence               01123456788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.2e-36  Score=334.98  Aligned_cols=262  Identities=23%  Similarity=0.352  Sum_probs=205.4

Q ss_pred             HhhhccccceeeeeeeeEEEEEEecC---CCceEEEEEEeccccc-cchHhHHHHHHhhhccC-CCCccceeeeeccccc
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQTR---TSTTAVAVKKLDRVFQ-DGEREFKNEVFVIGQTH-HKNLVRLLGFCDEGQN  592 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~~---~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~  592 (814)
                      ...+.+.++||+|+||.||+|+....   .....||||+++.... ...+.+.+|+++++++. ||||+++++++.+...
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            44566778999999999999986422   2235799999975332 23456899999999996 9999999999999999


Q ss_pred             ceEEEecCCCCCHHHHhcCC------------------------------------------------------------
Q 041921          593 RLLVYEFLNNGTLASFLFGN------------------------------------------------------------  612 (814)
Q Consensus       593 ~~lv~e~~~~gsL~~~l~~~------------------------------------------------------------  612 (814)
                      .+|||||+++|+|.++|+..                                                            
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (400)
T cd05105         116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK  195 (400)
T ss_pred             eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence            99999999999999988532                                                            


Q ss_pred             ------------------------------------CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC
Q 041921          613 ------------------------------------LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDD  656 (814)
Q Consensus       613 ------------------------------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~  656 (814)
                                                          ..+++..+..++.|+++||+|||+.   +|+||||||+|||++.
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~  272 (400)
T cd05105         196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeC
Confidence                                                1356777889999999999999998   9999999999999999


Q ss_pred             CCcEEEeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHH
Q 041921          657 YYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILT  735 (814)
Q Consensus       657 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~  735 (814)
                      ++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||........    
T Consensus       273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~----  348 (400)
T cd05105         273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST----  348 (400)
T ss_pred             CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH----
Confidence            99999999999986643322222123346788999999998889999999999999999997 8899864322211    


Q ss_pred             HHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 041921          736 DWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE  797 (814)
Q Consensus       736 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~  797 (814)
                        .......+..       .  ......+..+.+++.+||+.+|++|||+.+|.++|+.+.+
T Consensus       349 --~~~~~~~~~~-------~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         349 --FYNKIKSGYR-------M--AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             --HHHHHhcCCC-------C--CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence              1111222210       0  1112345678899999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=3e-36  Score=321.28  Aligned_cols=262  Identities=24%  Similarity=0.456  Sum_probs=210.0

Q ss_pred             HhhhccccceeeeeeeeEEEEEEec---CCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccce
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQT---RTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRL  594 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~---~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  594 (814)
                      ...+.+.+.||+|+||.||++....   ......+|+|.+........+.+.+|++++++++||||+++++++...+..+
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            3445667899999999999998643   2245679999987655555667999999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHhcCCC-------------CCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEE
Q 041921          595 LVYEFLNNGTLASFLFGNL-------------KPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTAR  661 (814)
Q Consensus       595 lv~e~~~~gsL~~~l~~~~-------------~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~k  661 (814)
                      +||||+++++|.+++....             .+++..+..++.|++.||+|||+.   +++||||||+||++++++.+|
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEE
Confidence            9999999999999986432             478999999999999999999998   999999999999999999999


Q ss_pred             EeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHH
Q 041921          662 ISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFD  740 (814)
Q Consensus       662 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~  740 (814)
                      |+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |..||......+       ...
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-------~~~  233 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-------VIE  233 (288)
T ss_pred             eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHH
Confidence            999999986643322222223345778999999998899999999999999999998 888886443221       112


Q ss_pred             HhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 041921          741 CYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV  798 (814)
Q Consensus       741 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~~  798 (814)
                      .+..+.....         ....+..+.+++.+|++.+|.+|||+.++++.|+++...
T Consensus       234 ~i~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         234 CITQGRVLQR---------PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             HHHcCCcCCC---------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence            2223221111         112345689999999999999999999999999887643

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-36  Score=308.19  Aligned_cols=248  Identities=21%  Similarity=0.353  Sum_probs=211.0

Q ss_pred             HhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccch---HhHHHHHHhhhccCCCCccceeeeecccccce
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE---REFKNEVFVIGQTHHKNLVRLLGFCDEGQNRL  594 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~---~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  594 (814)
                      +-+|+|.+.||+|.||.|-+|...  ..++.||||.+++...+.+   -.+.+|+++|..++||||+.++++|++.+.+.
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~--~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIv  129 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEH--KSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIV  129 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhc--cCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEE
Confidence            456788899999999999999853  3688999999976544443   35789999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccC
Q 041921          595 LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN  674 (814)
Q Consensus       595 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~  674 (814)
                      |||||..+|.|.+|+.+.+.+++.+...+++||..|+.|+|.+   +++|||||.+|||+|+++++||+|||++-++...
T Consensus       130 ivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~  206 (668)
T KOG0611|consen  130 IVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYADK  206 (668)
T ss_pred             EEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhccc
Confidence            9999999999999999999999999999999999999999998   9999999999999999999999999999887654


Q ss_pred             CcccccccccCCCCcccccccccCCCC-cchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecC
Q 041921          675 QSKTIKTAIRGTKGYVAPEWFRNSKIT-AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGE  753 (814)
Q Consensus       675 ~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  753 (814)
                      ..   ...++|++-|.+||++.+.+|. +..|.|||||+||-|+.|..||++..-.   .    ..+.+..|...+.   
T Consensus       207 kf---LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk---~----lvrQIs~GaYrEP---  273 (668)
T KOG0611|consen  207 KF---LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK---R----LVRQISRGAYREP---  273 (668)
T ss_pred             cH---HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH---H----HHHHhhcccccCC---
Confidence            32   2568899999999999999885 6799999999999999999999854321   1    2233444433221   


Q ss_pred             cccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          754 DKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       754 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                              +.+....-||.|||-.+|++|.|+++|...
T Consensus       274 --------~~PSdA~gLIRwmLmVNP~RRATieDiAsH  303 (668)
T KOG0611|consen  274 --------ETPSDASGLIRWMLMVNPERRATIEDIASH  303 (668)
T ss_pred             --------CCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence                    223455678999999999999999999764

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-36  Score=322.32  Aligned_cols=245  Identities=24%  Similarity=0.252  Sum_probs=201.5

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhccCCCCccceeeeecccccceEE
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV  596 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  596 (814)
                      .+.+.++||+|+||.||+|....  .++.||+|.+....   ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   79 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLVRDRI--SEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYML   79 (291)
T ss_pred             CceeeeeeecCCCeEEEEEEEcC--CCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEE
Confidence            35667899999999999998753  56789999986422   12345688999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCc
Q 041921          597 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS  676 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  676 (814)
                      |||+++++|.+++.....+++.....++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++...... 
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~-  155 (291)
T cd05612          80 MEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT-  155 (291)
T ss_pred             EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCCc-
Confidence            99999999999998888899999999999999999999998   99999999999999999999999999998654321 


Q ss_pred             ccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCccc
Q 041921          677 KTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKE  756 (814)
Q Consensus       677 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  756 (814)
                          ....|++.|+|||.+.+..++.++|||||||++|||++|+.||......+       ..+.+..+...        
T Consensus       156 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~-------~~~~i~~~~~~--------  216 (291)
T cd05612         156 ----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG-------IYEKILAGKLE--------  216 (291)
T ss_pred             ----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCcC--------
Confidence                23458999999999998889999999999999999999999997543322       11122222211        


Q ss_pred             ccCcHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 041921          757 AMNDIECLGKLVMVSIWCIQEDPSLRPT-----MKKVLQM  791 (814)
Q Consensus       757 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-----~~~vl~~  791 (814)
                        .+......+.+++.+||+.||.+||+     ++++++.
T Consensus       217 --~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         217 --FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             --CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence              01112456789999999999999995     8887754

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=5.6e-36  Score=314.76  Aligned_cols=255  Identities=28%  Similarity=0.422  Sum_probs=206.0

Q ss_pred             HhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEE
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY  597 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  597 (814)
                      ...+.+.++||+|++|.||+|....  .+..|++|.+... .....++.+|++++++++|+||+++++++..+...+++|
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~--~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (263)
T cd05052           5 RTDITMKHKLGGGQYGEVYEGVWKK--YSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   81 (263)
T ss_pred             hHHeEEeeecCCcccceEEEEEEec--CCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEE
Confidence            3445677899999999999999763  5678999988753 334567899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCC
Q 041921          598 EFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ  675 (814)
Q Consensus       598 e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~  675 (814)
                      ||+++++|.+++...  ..+++..++.++.|+++||+|||+.   +++||||||+||++++++.+||+|||++.......
T Consensus        82 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~  158 (263)
T cd05052          82 EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  158 (263)
T ss_pred             EeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence            999999999999753  4578999999999999999999998   99999999999999999999999999998765432


Q ss_pred             cccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeecCc
Q 041921          676 SKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGED  754 (814)
Q Consensus       676 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  754 (814)
                      .... ....++..|+|||.+.+..++.++||||||++++||++ |..|+.....++.       ...+..+..       
T Consensus       159 ~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-------~~~~~~~~~-------  223 (263)
T cd05052         159 YTAH-AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-------YELLEKGYR-------  223 (263)
T ss_pred             eecc-CCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHHHHCCCC-------
Confidence            2111 12234668999999998899999999999999999998 8899865432221       111211110       


Q ss_pred             ccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 041921          755 KEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV  795 (814)
Q Consensus       755 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~  795 (814)
                        ...+...+..+.+++.+|++.+|++|||+.+++++|+.+
T Consensus       224 --~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         224 --MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             --CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence              011122456788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=3.2e-36  Score=326.36  Aligned_cols=242  Identities=23%  Similarity=0.271  Sum_probs=198.1

Q ss_pred             cceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEecCC
Q 041921          525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLN  601 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  601 (814)
                      +.||+|+||.||++....  .+..||||.++...   ......+.+|+.++++++||||+++++++...+..++||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~   78 (323)
T cd05571           1 KLLGKGTFGKVILVREKA--TGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYAN   78 (323)
T ss_pred             CeeeeCCCeEEEEEEECC--CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCC
Confidence            469999999999998753  57889999987532   2233467889999999999999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcccccc
Q 041921          602 NGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKT  681 (814)
Q Consensus       602 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  681 (814)
                      +++|.+++.....+++.....++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......  ...
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~  153 (323)
T cd05571          79 GGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--TMK  153 (323)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC--ccc
Confidence            999999998888899999999999999999999998   999999999999999999999999999875322211  113


Q ss_pred             cccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCcH
Q 041921          682 AIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDI  761 (814)
Q Consensus       682 ~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  761 (814)
                      ...||+.|+|||.+.+..++.++|||||||++|||++|+.||.....+.       ....+..+...          .+.
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-------~~~~~~~~~~~----------~p~  216 (323)
T cd05571         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-------LFELILMEEIR----------FPR  216 (323)
T ss_pred             ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH-------HHHHHHcCCCC----------CCC
Confidence            4569999999999999999999999999999999999999996543221       11111111111          111


Q ss_pred             HHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 041921          762 ECLGKLVMVSIWCIQEDPSLRP-----TMKKVLQ  790 (814)
Q Consensus       762 ~~~~~l~~l~~~Cl~~dp~~RP-----t~~~vl~  790 (814)
                      ....++.+++.+||+.||++||     ++.++++
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            2346788999999999999999     7888874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=4.4e-36  Score=324.44  Aligned_cols=261  Identities=25%  Similarity=0.399  Sum_probs=205.3

Q ss_pred             HHhhhccccceeeeeeeeEEEEEEecCCC--ceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccceeeeecccccc
Q 041921          517 EGATNNFKEEVGRGSFGIVYKGVIQTRTS--TTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNR  593 (814)
Q Consensus       517 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~--~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  593 (814)
                      ....+...+.||+|+||.||+|++...+.  ...||||.++... ....+++.+|+.+++.++||||++++++|... ..
T Consensus         5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~   83 (316)
T cd05108           5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV   83 (316)
T ss_pred             chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence            34456667899999999999998754322  3358999986532 33456799999999999999999999999764 57


Q ss_pred             eEEEecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccc
Q 041921          594 LLVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLT  672 (814)
Q Consensus       594 ~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~  672 (814)
                      ++|+||+++|+|.+++... ..+++...+.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.+.
T Consensus        84 ~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          84 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             eeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccccc
Confidence            8999999999999999875 4678999999999999999999998   99999999999999999999999999998776


Q ss_pred             cCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceee
Q 041921          673 LNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLV  751 (814)
Q Consensus       673 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  751 (814)
                      .............+..|+|||.+.+..++.++||||||+++|||++ |+.||......+.       ......+..  . 
T Consensus       161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~-------~~~~~~~~~--~-  230 (316)
T cd05108         161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-------SSILEKGER--L-  230 (316)
T ss_pred             CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHHHhCCCC--C-
Confidence            4332221122334678999999999999999999999999999998 9999875432221       111111110  0 


Q ss_pred             cCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 041921          752 GEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE  797 (814)
Q Consensus       752 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~  797 (814)
                            .....+...+.+++.+||+.+|.+||++.+++..|..+..
T Consensus       231 ------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~  270 (316)
T cd05108         231 ------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  270 (316)
T ss_pred             ------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence                  1111234567899999999999999999999999886654

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=4.8e-36  Score=317.81  Aligned_cols=259  Identities=26%  Similarity=0.457  Sum_probs=203.4

Q ss_pred             HHhhhccccceeeeeeeeEEEEEEec---CCCceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccceeeeeccccc
Q 041921          517 EGATNNFKEEVGRGSFGIVYKGVIQT---RTSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQN  592 (814)
Q Consensus       517 ~~~~~~~~~~LG~G~~g~Vy~~~~~~---~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  592 (814)
                      ....+.+.++||+|+||.||+|....   ...+..||||++.... .....++.+|+.+++.++|+||+++++++.+...
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            34557778999999999999998652   1235679999986432 2234568999999999999999999999999999


Q ss_pred             ceEEEecCCCCCHHHHhcCC----------CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEE
Q 041921          593 RLLVYEFLNNGTLASFLFGN----------LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARI  662 (814)
Q Consensus       593 ~~lv~e~~~~gsL~~~l~~~----------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl  662 (814)
                      .++|+||+++++|.+++...          ..+++..+..++.|+++||.|||+.   +++|+||||+||++++++.+||
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEE
Confidence            99999999999999998642          2356788899999999999999998   9999999999999999999999


Q ss_pred             eecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHH
Q 041921          663 SDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDC  741 (814)
Q Consensus       663 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~  741 (814)
                      +|||+++...............++..|+|||.+.+..++.++||||||++++||++ |..||.....++       ....
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~-------~~~~  233 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ-------VLRF  233 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHH
Confidence            99999876543322211122345778999999998899999999999999999999 788886443221       1111


Q ss_pred             hhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 041921          742 YRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEG  794 (814)
Q Consensus       742 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~  794 (814)
                      ..++....         .....+..+.+++.+|++.+|++|||+.|+++.|++
T Consensus       234 ~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         234 VMEGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             HHcCCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            11221111         011234678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=7.8e-36  Score=317.53  Aligned_cols=249  Identities=24%  Similarity=0.289  Sum_probs=199.1

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEE
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY  597 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  597 (814)
                      +...+.||+|+||.||++....  ++..||||.+....   ......+.+|+.++.+++|+||+++++++.+++..++|+
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~   79 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRA--TGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVL   79 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEec--CCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEE
Confidence            4556789999999999998763  57899999986432   122345789999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCC
Q 041921          598 EFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ  675 (814)
Q Consensus       598 e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~  675 (814)
                      ||+++|+|.+++...  ..+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+||+|||++.......
T Consensus        80 e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05631          80 TIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE  156 (285)
T ss_pred             EecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence            999999999888643  4678999999999999999999998   99999999999999999999999999998754322


Q ss_pred             cccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcc
Q 041921          676 SKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDK  755 (814)
Q Consensus       676 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  755 (814)
                      ..   ....||..|+|||.+.+..++.++|||||||++|||++|+.||.........   +.+...+.....        
T Consensus       157 ~~---~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~~--------  222 (285)
T cd05631         157 TV---RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR---EEVDRRVKEDQE--------  222 (285)
T ss_pred             ee---cCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH---HHHHHHhhcccc--------
Confidence            11   3346899999999999999999999999999999999999999754332110   111111111111        


Q ss_pred             cccCcHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 041921          756 EAMNDIECLGKLVMVSIWCIQEDPSLRPT-----MKKVLQ  790 (814)
Q Consensus       756 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-----~~~vl~  790 (814)
                        .........+.+++.+||+.||.+||+     ++++++
T Consensus       223 --~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         223 --EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             --cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence              111223467889999999999999997     788876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=5e-36  Score=319.45  Aligned_cols=265  Identities=20%  Similarity=0.243  Sum_probs=202.1

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEE
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY  597 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  597 (814)
                      .|.+.+.||+|+||.||++....  .+..+|||++....  ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKCRHKE--TKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF   79 (287)
T ss_pred             CceEEEEecccCCEEEEEEEECC--CCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence            35677899999999999999753  56789999986432  223456889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcc
Q 041921          598 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSK  677 (814)
Q Consensus       598 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  677 (814)
                      ||++++.|..+......+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++.........
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  156 (287)
T cd07848          80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA  156 (287)
T ss_pred             ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence            9999988876665556788999999999999999999998   9999999999999999999999999999876433221


Q ss_pred             cccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHH---------HHHhhcCccc
Q 041921          678 TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA---------FDCYRNGKLN  748 (814)
Q Consensus       678 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~---------~~~~~~~~~~  748 (814)
                      . .....|+..|+|||.+.+..++.++|||||||++|||++|+.||......+........         ..........
T Consensus       157 ~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07848         157 N-YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH  235 (287)
T ss_pred             c-ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence            1 13346899999999999888999999999999999999999999754332211100000         0000010111


Q ss_pred             eeecCcccccC------cHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          749 VLVGEDKEAMN------DIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       749 ~~~~~~~~~~~------~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      ....+......      .......+.+++.+||+.||++|||++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            11001000000      1123457899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=8.4e-36  Score=312.28  Aligned_cols=250  Identities=30%  Similarity=0.420  Sum_probs=202.1

Q ss_pred             ceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEecCCCC
Q 041921          526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNG  603 (814)
Q Consensus       526 ~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  603 (814)
                      +||+|+||.||+|.+.....+..+|+|.++...  ....+++.+|+.++++++|+||+++++++. .+..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            689999999999987666667899999986432  223457899999999999999999999885 45678999999999


Q ss_pred             CHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcccc-ccc
Q 041921          604 TLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI-KTA  682 (814)
Q Consensus       604 sL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~-~~~  682 (814)
                      +|.+++.....+++.....++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.+........ ...
T Consensus        81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  157 (257)
T cd05116          81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH  157 (257)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence            9999998777889999999999999999999998   999999999999999999999999999987654332111 122


Q ss_pred             ccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCcH
Q 041921          683 IRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDI  761 (814)
Q Consensus       683 ~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  761 (814)
                      ..++..|+|||.+....++.++||||||+++|||++ |+.||......+       ....+..+....         .+.
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~i~~~~~~~---------~~~  221 (257)
T cd05116         158 GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE-------VTQMIESGERME---------CPQ  221 (257)
T ss_pred             CCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHCCCCCC---------CCC
Confidence            234678999999988889999999999999999998 999997543322       112222221110         112


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 041921          762 ECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV  795 (814)
Q Consensus       762 ~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~  795 (814)
                      ..+.++.+++.+|++.||.+||++.+|++.|++.
T Consensus       222 ~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         222 RCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             CCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence            2456788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=5e-36  Score=314.72  Aligned_cols=254  Identities=26%  Similarity=0.424  Sum_probs=205.1

Q ss_pred             HhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEE
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY  597 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  597 (814)
                      ...+.+.++||+|+||.||+|...   ++..|++|.+... ....+.+.+|+.++++++|+||+++++.+.+.+..+++|
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~---~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYN---NSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIIT   80 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEec---CCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEE
Confidence            445667889999999999999865   4567999988643 234567999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCC
Q 041921          598 EFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ  675 (814)
Q Consensus       598 e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~  675 (814)
                      ||+++++|.+++...  ..+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++.......
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05072          81 EYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE  157 (261)
T ss_pred             ecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence            999999999999653  5678889999999999999999998   99999999999999999999999999998765322


Q ss_pred             cccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeecCc
Q 041921          676 SKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGED  754 (814)
Q Consensus       676 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  754 (814)
                      ... .....++..|+|||.+....++.++||||||+++|||++ |+.||......+   .    ...+..+..       
T Consensus       158 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~----~~~~~~~~~-------  222 (261)
T cd05072         158 YTA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---V----MSALQRGYR-------  222 (261)
T ss_pred             eec-cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---H----HHHHHcCCC-------
Confidence            111 123346778999999988889999999999999999998 999986433221   1    111111110       


Q ss_pred             ccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 041921          755 KEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV  795 (814)
Q Consensus       755 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~  795 (814)
                        .+.....+..+.+++.+|++.+|++||+++++++.|+++
T Consensus       223 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         223 --MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             --CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence              011112446788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=7e-36  Score=312.68  Aligned_cols=250  Identities=27%  Similarity=0.443  Sum_probs=201.2

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEec
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  599 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  599 (814)
                      .+.+.++||+|+||.||++...   ++..+|+|.+... ....+++.+|+.++++++||||+++++++.+....++||||
T Consensus         5 ~~~~~~~lg~G~~~~vy~~~~~---~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   80 (256)
T cd05114           5 ELTFMKELGSGQFGVVHLGKWR---AQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF   80 (256)
T ss_pred             HcEEeeEecCCcCceEEEEEec---cCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence            4566788999999999999875   3567999988643 33456789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccc
Q 041921          600 LNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT  678 (814)
Q Consensus       600 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  678 (814)
                      +++++|.+++... ..+++..+..++.|++.||.|||+.   +|+|+||||+||++++++.+||+|||+++.........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05114          81 MENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS  157 (256)
T ss_pred             CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence            9999999999754 4688999999999999999999998   99999999999999999999999999988654322111


Q ss_pred             ccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccc
Q 041921          679 IKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEA  757 (814)
Q Consensus       679 ~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  757 (814)
                       .....++..|+|||.+....++.++||||||++++||++ |+.||......+.       ...+.++..  ...     
T Consensus       158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~-------~~~i~~~~~--~~~-----  222 (256)
T cd05114         158 -SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV-------VEMISRGFR--LYR-----  222 (256)
T ss_pred             -cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHHHHCCCC--CCC-----
Confidence             122335678999999998889999999999999999999 8999865432211       111222211  000     


Q ss_pred             cCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 041921          758 MNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE  793 (814)
Q Consensus       758 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~  793 (814)
                        +......+.+++.+|++.+|.+||+++++++.|.
T Consensus       223 --~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         223 --PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             --CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence              1112357889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-36  Score=324.55  Aligned_cols=240  Identities=25%  Similarity=0.278  Sum_probs=195.1

Q ss_pred             eeeeeeeeEEEEEEecCCCceEEEEEEeccc---cccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEecCCCC
Q 041921          527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV---FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNG  603 (814)
Q Consensus       527 LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  603 (814)
                      ||+|+||.||++....  .+..||+|.+...   .......+..|+.++.+++||||+++++++.+.+..++||||++++
T Consensus         1 lg~G~~g~Vy~~~~~~--~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   78 (312)
T cd05585           1 IGKGSFGKVMQVRKRD--TQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGG   78 (312)
T ss_pred             CCcCCCeEEEEEEECC--CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCC
Confidence            7999999999998753  5678999998643   2233456888999999999999999999999999999999999999


Q ss_pred             CHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcccccccc
Q 041921          604 TLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAI  683 (814)
Q Consensus       604 sL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~  683 (814)
                      +|.+++.....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.......  .....
T Consensus        79 ~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~~  153 (312)
T cd05585          79 ELFHHLQREGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTNTF  153 (312)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--ccccc
Confidence            9999998888899999999999999999999998   999999999999999999999999999886432221  11345


Q ss_pred             cCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCcHHH
Q 041921          684 RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIEC  763 (814)
Q Consensus       684 ~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  763 (814)
                      .||+.|+|||.+.+..++.++|||||||++|||++|+.||......+       ..+.+..+...          .+...
T Consensus       154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~-------~~~~~~~~~~~----------~~~~~  216 (312)
T cd05585         154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE-------MYRKILQEPLR----------FPDGF  216 (312)
T ss_pred             cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH-------HHHHHHcCCCC----------CCCcC
Confidence            69999999999999999999999999999999999999997543221       11111111111          11123


Q ss_pred             HHHHHHHHHHccccCCCCCCC---HHHHHH
Q 041921          764 LGKLVMVSIWCIQEDPSLRPT---MKKVLQ  790 (814)
Q Consensus       764 ~~~l~~l~~~Cl~~dp~~RPt---~~~vl~  790 (814)
                      ...+.+++.+||+.||.+||+   +.++++
T Consensus       217 ~~~~~~li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         217 DRDAKDLLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             CHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence            467789999999999999986   455543

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=5.1e-36  Score=318.71  Aligned_cols=257  Identities=29%  Similarity=0.447  Sum_probs=204.1

Q ss_pred             hhhccccceeeeeeeeEEEEEEec--CCCceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccceeeeecccccceE
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQT--RTSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL  595 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~--~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  595 (814)
                      ..+.+.++||+|+||.||+|....  ...+..|++|.+.... .+...++.+|+.++++++||||+++++++..++..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            456677899999999999998532  2346789999997432 2233578999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhcCC-----------------CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC
Q 041921          596 VYEFLNNGTLASFLFGN-----------------LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYY  658 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~~-----------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~  658 (814)
                      ||||+++++|.+++...                 ..+++.....++.|++.||+|||+.   +|+|+||||+|||+++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence            99999999999998522                 2467888899999999999999998   999999999999999999


Q ss_pred             cEEEeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHH
Q 041921          659 TARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDW  737 (814)
Q Consensus       659 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~  737 (814)
                      .+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |..||.......       
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~-------  234 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE-------  234 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-------
Confidence            999999999987654332222233446778999999988889999999999999999999 888886433211       


Q ss_pred             HHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 041921          738 AFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEG  794 (814)
Q Consensus       738 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~  794 (814)
                      +.+.+..+...         ..+.....++.+++.+|++.+|.+||++.+|+++|..
T Consensus       235 ~~~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         235 VIEMVRKRQLL---------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHHHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            11122222111         0111234678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=4e-36  Score=326.31  Aligned_cols=245  Identities=23%  Similarity=0.291  Sum_probs=202.1

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhccCCCCccceeeeecccccceE
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL  595 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  595 (814)
                      ..+.+.+.||+|+||.||+|....  .++.||||.+....   ....+.+.+|+.++++++||||+++++++.+++..++
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   95 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKG--TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF   95 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECC--CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence            346677899999999999999753  56789999986432   2234568899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCC
Q 041921          596 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ  675 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~  675 (814)
                      ||||+++++|.+++.....+++.....++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        96 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  172 (329)
T PTZ00263         96 LLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT  172 (329)
T ss_pred             EEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence            999999999999998888889999999999999999999998   99999999999999999999999999998664322


Q ss_pred             cccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcc
Q 041921          676 SKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDK  755 (814)
Q Consensus       676 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  755 (814)
                           ....||+.|+|||.+.+..++.++|||||||++|||++|+.||......+       ....+.++.+..      
T Consensus       173 -----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-------~~~~i~~~~~~~------  234 (329)
T PTZ00263        173 -----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR-------IYEKILAGRLKF------  234 (329)
T ss_pred             -----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH-------HHHHHhcCCcCC------
Confidence                 23468999999999999999999999999999999999999996543211       112222332211      


Q ss_pred             cccCcHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 041921          756 EAMNDIECLGKLVMVSIWCIQEDPSLRPT-----MKKVLQ  790 (814)
Q Consensus       756 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-----~~~vl~  790 (814)
                          +.....++.+++.+||+.||.+||+     ++++++
T Consensus       235 ----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        235 ----PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             ----CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence                1112356789999999999999997     677763

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8e-37  Score=323.19  Aligned_cols=262  Identities=27%  Similarity=0.387  Sum_probs=218.5

Q ss_pred             CHHHHHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccc
Q 041921          512 SYKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ  591 (814)
Q Consensus       512 ~~~~l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  591 (814)
                      .--|+++......++||-|.||.||.|+++.  -...||||.|++. ....++|+.|..+|+.++|||+|+|+|+|..+-
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKk--yslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep  336 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKK--YSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP  336 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeec--cceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCC
Confidence            3445666666778899999999999999974  4568999999864 456789999999999999999999999999999


Q ss_pred             cceEEEecCCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcc
Q 041921          592 NRLLVYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAK  669 (814)
Q Consensus       592 ~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~  669 (814)
                      ..|||+|||.+|+|.+||.+.  ..++--..+.++.||+.|+.||...   ++|||||.++|.||.++..+||+||||++
T Consensus       337 PFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsR  413 (1157)
T KOG4278|consen  337 PFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSR  413 (1157)
T ss_pred             CeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhh
Confidence            999999999999999999875  4456667788999999999999998   99999999999999999999999999999


Q ss_pred             ccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccc
Q 041921          670 LLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLN  748 (814)
Q Consensus       670 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  748 (814)
                      ++..+..... ....-.+.|.|||-+.-..++.|+|||+|||+||||.| |..||.+..-.       .+...++.    
T Consensus       414 lMtgDTYTAH-AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS-------qVY~LLEk----  481 (1157)
T KOG4278|consen  414 LMTGDTYTAH-AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-------QVYGLLEK----  481 (1157)
T ss_pred             hhcCCceecc-cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH-------HHHHHHhc----
Confidence            9986654321 33334678999999998899999999999999999999 88888643221       12222222    


Q ss_pred             eeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 041921          749 VLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV  796 (814)
Q Consensus       749 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~  796 (814)
                           ......+..|++++++|++.||+-+|.+||+++|+-+.+|.+.
T Consensus       482 -----gyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf  524 (1157)
T KOG4278|consen  482 -----GYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF  524 (1157)
T ss_pred             -----cccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence                 2223345568899999999999999999999999999888754

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-36  Score=326.71  Aligned_cols=252  Identities=20%  Similarity=0.257  Sum_probs=204.1

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEE
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY  597 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  597 (814)
                      +.+.++||+|+||.||+|....  .+..||||.+....   ....+.+..|+.++..++||||+++++++.+.+..+|||
T Consensus         3 y~~~~~ig~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           3 FQILTQVGQGGYGQVFLAKKKD--TGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             cEEEEEEeecCCeEEEEEEECC--CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            5667899999999999999763  46789999986532   223456889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcc
Q 041921          598 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSK  677 (814)
Q Consensus       598 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  677 (814)
                      ||+++++|.+++.....+++.....++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++.....    
T Consensus        81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----  153 (333)
T cd05600          81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----  153 (333)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc----
Confidence            9999999999998888889999999999999999999998   999999999999999999999999999986543    


Q ss_pred             cccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccc
Q 041921          678 TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEA  757 (814)
Q Consensus       678 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  757 (814)
                       ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+..       ..+....  .........
T Consensus       154 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-------~~i~~~~--~~~~~~~~~  223 (333)
T cd05600         154 -YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETW-------ENLKYWK--ETLQRPVYD  223 (333)
T ss_pred             -ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHH-------HHHHhcc--ccccCCCCC
Confidence             113456899999999999989999999999999999999999999755432211       1111100  000000000


Q ss_pred             cCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          758 MNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       758 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                      ........++.+++.+||+.+|.+||+++++++.
T Consensus       224 ~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         224 DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            0012345678899999999999999999999865

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=4.4e-36  Score=326.74  Aligned_cols=262  Identities=27%  Similarity=0.395  Sum_probs=204.7

Q ss_pred             HhhhccccceeeeeeeeEEEEEEecC---CCceEEEEEEeccccc-cchHhHHHHHHhhhcc-CCCCccceeeeecc-cc
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQTR---TSTTAVAVKKLDRVFQ-DGEREFKNEVFVIGQT-HHKNLVRLLGFCDE-GQ  591 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~~---~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~  591 (814)
                      ...+.+.+.||+|+||.||+|.....   ..++.||+|+++.... ...+.+..|+.++.++ +|+||++++++|.. +.
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            34677889999999999999975422   2346899999875322 2234678899999999 89999999998865 45


Q ss_pred             cceEEEecCCCCCHHHHhcCC-----------------------------------------------------------
Q 041921          592 NRLLVYEFLNNGTLASFLFGN-----------------------------------------------------------  612 (814)
Q Consensus       592 ~~~lv~e~~~~gsL~~~l~~~-----------------------------------------------------------  612 (814)
                      ..++++||+++++|.++|...                                                           
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            678999999999999998532                                                           


Q ss_pred             --CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcccccccccCCCCcc
Q 041921          613 --LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYV  690 (814)
Q Consensus       613 --~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~  690 (814)
                        ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.+.............++..|+
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence              2568889999999999999999998   99999999999999999999999999998764433222223344677899


Q ss_pred             cccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCcHHHHHHHHH
Q 041921          691 APEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVM  769 (814)
Q Consensus       691 aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  769 (814)
                      |||++.+..++.++|||||||+++||++ |..||......+.      ....+..+...         ..+.....++.+
T Consensus       243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~------~~~~~~~~~~~---------~~~~~~~~~~~~  307 (337)
T cd05054         243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE------FCRRLKEGTRM---------RAPEYATPEIYS  307 (337)
T ss_pred             CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH------HHHHHhccCCC---------CCCccCCHHHHH
Confidence            9999999999999999999999999998 9999865332211      11111222110         011223467889


Q ss_pred             HHHHccccCCCCCCCHHHHHHHHhcCcC
Q 041921          770 VSIWCIQEDPSLRPTMKKVLQMLEGVVE  797 (814)
Q Consensus       770 l~~~Cl~~dp~~RPt~~~vl~~L~~~~~  797 (814)
                      ++.+||+.+|++||++.+++++|+.+.+
T Consensus       308 l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         308 IMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            9999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.2e-35  Score=315.19  Aligned_cols=258  Identities=26%  Similarity=0.369  Sum_probs=202.1

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCc--eEEEEEEeccccc-cchHhHHHHHHhhhccCCCCccceeeeecccccceEE
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTST--TAVAVKKLDRVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV  596 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~--~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  596 (814)
                      .+.+.+.||+|+||.||+|.....+..  ..+++|.+..... ....++..|+..+++++||||+++++++.. ...+++
T Consensus         8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i   86 (279)
T cd05111           8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLV   86 (279)
T ss_pred             hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEE
Confidence            345568899999999999997543322  3588888864322 233567888889999999999999999864 457899


Q ss_pred             EecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCC
Q 041921          597 YEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ  675 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~  675 (814)
                      +||+++|+|.+++... ..+++..+..++.||+.||.|||+.   +++||||||+||++++++.+||+|||+++......
T Consensus        87 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~  163 (279)
T cd05111          87 TQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDD  163 (279)
T ss_pred             EEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccCCC
Confidence            9999999999999764 5689999999999999999999998   99999999999999999999999999998765433


Q ss_pred             cccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeecCc
Q 041921          676 SKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGED  754 (814)
Q Consensus       676 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  754 (814)
                      .........++..|+|||.+.+..++.++||||||+++|||++ |+.||........       .+.+..+....  .  
T Consensus       164 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-------~~~~~~~~~~~--~--  232 (279)
T cd05111         164 KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV-------PDLLEKGERLA--Q--  232 (279)
T ss_pred             cccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHHHHCCCcCC--C--
Confidence            2222233457789999999998899999999999999999998 9999875433221       11122221110  0  


Q ss_pred             ccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 041921          755 KEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE  797 (814)
Q Consensus       755 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~  797 (814)
                           ...+...+.+++.+|++.+|.+|||+.|+++.|+.+..
T Consensus       233 -----~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         233 -----PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             -----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence                 11133567889999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.1e-35  Score=321.10  Aligned_cols=203  Identities=23%  Similarity=0.363  Sum_probs=176.0

Q ss_pred             HHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccceeeeecccccce
Q 041921          516 LEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRL  594 (814)
Q Consensus       516 l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  594 (814)
                      +....|.+.++||+|+||.||++...  ..+..+|+|.+.... ......+.+|++++++++|+||+++++++.+++..+
T Consensus         2 l~~~~y~~~~~lg~g~~g~V~~~~~~--~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (333)
T cd06650           2 LKDDDFEKISELGAGNGGVVFKVSHK--PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS   79 (333)
T ss_pred             cchhhhheeccccCCCCEEEEEEEEC--CCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEE
Confidence            44566778899999999999999875  356788999876432 233456899999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccC
Q 041921          595 LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN  674 (814)
Q Consensus       595 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~  674 (814)
                      +||||+++++|.+++.....+++.....++.|++.||.|||+.  .+|+|+||||+|||++.++.+||+|||++......
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~  157 (333)
T cd06650          80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  157 (333)
T ss_pred             EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence            9999999999999998877889999999999999999999974  26999999999999999999999999998765332


Q ss_pred             CcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 041921          675 QSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIE  726 (814)
Q Consensus       675 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~  726 (814)
                      .    .....|+..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus       158 ~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~  205 (333)
T cd06650         158 M----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP  205 (333)
T ss_pred             c----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence            1    13346899999999999888999999999999999999999999754

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-36  Score=287.74  Aligned_cols=263  Identities=24%  Similarity=0.267  Sum_probs=212.7

Q ss_pred             HHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccc-----
Q 041921          517 EGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ-----  591 (814)
Q Consensus       517 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  591 (814)
                      ...+|.+.++||+|||+-||.++.-  ..+..+|+|++.....++.+..++|++..++++||||++++++...+.     
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~--s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~   96 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGL--STGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH   96 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeeccc--CcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence            3456788899999999999999833  467899999998766677788999999999999999999999985433     


Q ss_pred             cceEEEecCCCCCHHHHhcCC----CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCC
Q 041921          592 NRLLVYEFLNNGTLASFLFGN----LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGL  667 (814)
Q Consensus       592 ~~~lv~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGl  667 (814)
                      ..+|+++|...|+|.+.+...    ..+++.+.+.|+.+|++||++||+. .+.++||||||.|||+.+.+.++|.|||.
T Consensus        97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS  175 (302)
T KOG2345|consen   97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGS  175 (302)
T ss_pred             eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccC
Confidence            489999999999999998643    4689999999999999999999997 33599999999999999999999999999


Q ss_pred             ccccccCCcc-------cccccccCCCCccccccccc---CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHH
Q 041921          668 AKLLTLNQSK-------TIKTAIRGTKGYVAPEWFRN---SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW  737 (814)
Q Consensus       668 a~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~---~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~  737 (814)
                      +....-....       .......-|..|.|||.+.-   ...++++|||||||+||+|+.|..||+....         
T Consensus       176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~---------  246 (302)
T KOG2345|consen  176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ---------  246 (302)
T ss_pred             ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh---------
Confidence            8765421110       01122346899999999853   4578999999999999999999999963322         


Q ss_pred             HHHHhhcCccceee-cCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 041921          738 AFDCYRNGKLNVLV-GEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV  796 (814)
Q Consensus       738 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~  796 (814)
                           +.+.+...+ ......+.....++.+.+++.+|++.||.+||++.+++..++.+.
T Consensus       247 -----~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  247 -----QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             -----cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence                 122333222 224444555568899999999999999999999999999998754

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-36  Score=293.13  Aligned_cols=234  Identities=28%  Similarity=0.324  Sum_probs=198.3

Q ss_pred             ccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc---cchHhHHHHHHhhhccCCCCccceeeeecccccceEEEe
Q 041921          522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ---DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE  598 (814)
Q Consensus       522 ~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  598 (814)
                      ++.+.||.|+||.|.+++.+.  .+..+|+|.+++..-   +..+...+|..+|+.+.||.++++.+.+.+.+..+||||
T Consensus        47 e~~~tlGtGSFGrV~LVr~k~--~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvme  124 (355)
T KOG0616|consen   47 ERLKTLGTGSFGRVHLVREKH--SGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVME  124 (355)
T ss_pred             hheeeeccCccceEEEEEEcc--CCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEe
Confidence            345689999999999999774  578999999975332   223457889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccc
Q 041921          599 FLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT  678 (814)
Q Consensus       599 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  678 (814)
                      |.++|.|..+|+..++++....+-++.||+.||+|||+.   +|++|||||+|||+|.+|.+||+|||+|+.+...    
T Consensus       125 yv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r----  197 (355)
T KOG0616|consen  125 YVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR----  197 (355)
T ss_pred             ccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecCc----
Confidence            999999999999999999999999999999999999998   9999999999999999999999999999976533    


Q ss_pred             ccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCccccc
Q 041921          679 IKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAM  758 (814)
Q Consensus       679 ~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  758 (814)
                       .-..+||+.|+|||.++...+..++|.|||||++|||+.|..||....+..       +.+++.++++..         
T Consensus       198 -T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~-------iY~KI~~~~v~f---------  260 (355)
T KOG0616|consen  198 -TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ-------IYEKILEGKVKF---------  260 (355)
T ss_pred             -EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH-------HHHHHHhCcccC---------
Confidence             245789999999999999999999999999999999999999998665422       234444554432         


Q ss_pred             CcHHHHHHHHHHHHHccccCCCCC
Q 041921          759 NDIECLGKLVMVSIWCIQEDPSLR  782 (814)
Q Consensus       759 ~~~~~~~~l~~l~~~Cl~~dp~~R  782 (814)
                       +......+.+|+...|+.|-.+|
T Consensus       261 -P~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  261 -PSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             -CcccCHHHHHHHHHHHhhhhHhh
Confidence             22233456677777788887777

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=8.4e-36  Score=312.94  Aligned_cols=253  Identities=26%  Similarity=0.458  Sum_probs=207.9

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEe
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE  598 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  598 (814)
                      ..+.+.++||+|+||.||+|...   .+..+++|.+.........++..|+.+++.++|+||+++++++.+.+..++|||
T Consensus         6 ~~y~~~~~ig~g~~~~vy~~~~~---~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   82 (261)
T cd05148           6 EEFTLERKLGSGYFGEVWEGLWK---NRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE   82 (261)
T ss_pred             HHHHHhhhhccCCCccEEEeEec---CCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence            44667789999999999999986   367899999976655456789999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCc
Q 041921          599 FLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS  676 (814)
Q Consensus       599 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  676 (814)
                      |+++++|.+++...  ..+++..+..++.|+++||.|||+.   +|+|+||+|+||++++++.+||+|||++........
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~  159 (261)
T cd05148          83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY  159 (261)
T ss_pred             ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence            99999999999753  4678999999999999999999998   999999999999999999999999999987643221


Q ss_pred             ccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcc
Q 041921          677 KTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDK  755 (814)
Q Consensus       677 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  755 (814)
                      ..  ....++..|+|||.+....++.++||||||+++++|++ |+.||......+.       ...+..+.         
T Consensus       160 ~~--~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~-------~~~~~~~~---------  221 (261)
T cd05148         160 LS--SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEV-------YDQITAGY---------  221 (261)
T ss_pred             cc--cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHH-------HHHHHhCC---------
Confidence            11  23346778999999988889999999999999999998 8999865432211       11111110         


Q ss_pred             cccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 041921          756 EAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV  795 (814)
Q Consensus       756 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~  795 (814)
                      ....+...+..+.+++.+|++.+|.+|||++++++.|+.+
T Consensus       222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         222 RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence            0111223456788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=8.4e-36  Score=316.99  Aligned_cols=258  Identities=26%  Similarity=0.381  Sum_probs=205.1

Q ss_pred             HhhhccccceeeeeeeeEEEEEEecC---CCceEEEEEEecccccc-chHhHHHHHHhhhccCCCCccceeeeecccccc
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQTR---TSTTAVAVKKLDRVFQD-GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNR  593 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~~---~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  593 (814)
                      ...+.+.++||+|+||.||+|.....   .....||||+++..... ..+.+.+|+.++.+++||||+++++++.+....
T Consensus         4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~   83 (283)
T cd05091           4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL   83 (283)
T ss_pred             HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence            44567788999999999999987532   23578999999754322 235688999999999999999999999999999


Q ss_pred             eEEEecCCCCCHHHHhcCC----------------CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC
Q 041921          594 LLVYEFLNNGTLASFLFGN----------------LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDY  657 (814)
Q Consensus       594 ~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~  657 (814)
                      ++++||+++++|.+++...                ..+++..+..++.|++.||.|||+.   +|+||||||+||+++++
T Consensus        84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~  160 (283)
T cd05091          84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDK  160 (283)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCC
Confidence            9999999999999998521                2467888899999999999999998   99999999999999999


Q ss_pred             CcEEEeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHH
Q 041921          658 YTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTD  736 (814)
Q Consensus       658 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~  736 (814)
                      +.+||+|||+++...............+++.|+|||.+....++.++||||||++++||++ |..||......+      
T Consensus       161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------  234 (283)
T cd05091         161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD------  234 (283)
T ss_pred             CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH------
Confidence            9999999999886643322221123346789999999988889999999999999999998 888876433221      


Q ss_pred             HHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 041921          737 WAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEG  794 (814)
Q Consensus       737 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~  794 (814)
                       ....+.++....         .+...+..+.+++..|++.+|.+||++.+|++.|+.
T Consensus       235 -~~~~i~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         235 -VIEMIRNRQVLP---------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             -HHHHHHcCCcCC---------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence             112222222111         122355678899999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=8.1e-36  Score=324.71  Aligned_cols=249  Identities=24%  Similarity=0.285  Sum_probs=203.7

Q ss_pred             HHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhccCCCCccceeeeecccccc
Q 041921          517 EGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNR  593 (814)
Q Consensus       517 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  593 (814)
                      ....+.+.+.||+|+||.||+|..... ....||+|++....   ....+.+.+|+.++..++||||+++++++.+....
T Consensus        28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~  106 (340)
T PTZ00426         28 KYEDFNFIRTLGTGSFGRVILATYKNE-DFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYL  106 (340)
T ss_pred             ChhhcEEEEEEeecCCeEEEEEEEECC-CCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEE
Confidence            344577789999999999999987532 34689999986432   22345688999999999999999999999999999


Q ss_pred             eEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcccccc
Q 041921          594 LLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTL  673 (814)
Q Consensus       594 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~  673 (814)
                      ++||||+++|+|.+++.....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus       107 ~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~  183 (340)
T PTZ00426        107 YLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT  183 (340)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence            99999999999999998888899999999999999999999998   999999999999999999999999999986543


Q ss_pred             CCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecC
Q 041921          674 NQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGE  753 (814)
Q Consensus       674 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  753 (814)
                      ..     ....||+.|+|||.+.+..++.++|||||||++|||++|+.||.......       ....+..+....    
T Consensus       184 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-------~~~~i~~~~~~~----  247 (340)
T PTZ00426        184 RT-----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL-------IYQKILEGIIYF----  247 (340)
T ss_pred             Cc-----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH-------HHHHHhcCCCCC----
Confidence            21     23568999999999998889999999999999999999999997543221       112222222110    


Q ss_pred             cccccCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 041921          754 DKEAMNDIECLGKLVMVSIWCIQEDPSLRP-----TMKKVLQM  791 (814)
Q Consensus       754 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~~vl~~  791 (814)
                            +......+.+++.+||+.+|.+|+     +++++++.
T Consensus       248 ------p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        248 ------PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             ------CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence                  111235577899999999999995     89888764

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.4e-35  Score=314.84  Aligned_cols=257  Identities=26%  Similarity=0.438  Sum_probs=205.0

Q ss_pred             hhhccccceeeeeeeeEEEEEEec---CCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceE
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQT---RTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL  595 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~---~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  595 (814)
                      ..+.+.++||+|+||.||++....   ...+..+++|.+..........+.+|++++++++|+||+++++++.+....++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            345567899999999999997542   23466899999876655556789999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhcCC---------------CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcE
Q 041921          596 VYEFLNNGTLASFLFGN---------------LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTA  660 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~~---------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~  660 (814)
                      ++||+++++|.+++...               ..+++..+..++.|++.||+|||+.   +++|+||||+|||+++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCE
Confidence            99999999999998754               2478899999999999999999998   99999999999999999999


Q ss_pred             EEeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHH
Q 041921          661 RISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAF  739 (814)
Q Consensus       661 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~  739 (814)
                      ||+|||++................++..|+|||.+.+..++.++||||||+++|||++ |..||......+.       .
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-------~  234 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA-------I  234 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH-------H
Confidence            9999999976543322211122335778999999998899999999999999999998 8888854332211       1


Q ss_pred             HHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 041921          740 DCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEG  794 (814)
Q Consensus       740 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~  794 (814)
                      .....+...         ..+...+..+.+++.+||+.||.+||++.+|++.|+.
T Consensus       235 ~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         235 ECITQGREL---------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             HHHHcCccC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence            111111100         0111234678899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.1e-35  Score=338.23  Aligned_cols=250  Identities=21%  Similarity=0.283  Sum_probs=201.6

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEecC
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL  600 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  600 (814)
                      |.+.+.||+|++|.||+|..... .+..|++|.+..........+..|+.+++.++||||+++++++..++..+|||||+
T Consensus        69 y~~~~~lg~G~~g~vy~a~~~~~-~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         69 YVLTTLVGRNPTTAAFVATRGSD-PKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             EEEEEEEEeCCCcEEEEEEEcCC-CCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            66788999999999999986532 25678888775444444456888999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcC----CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCc
Q 041921          601 NNGTLASFLFG----NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS  676 (814)
Q Consensus       601 ~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  676 (814)
                      ++|+|.++|..    ...+++.....++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.+.....
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            99999988754    34578888999999999999999998   999999999999999999999999999987654332


Q ss_pred             ccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCccc
Q 041921          677 KTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKE  756 (814)
Q Consensus       677 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  756 (814)
                      ........||+.|+|||.+.+..++.++|||||||++|||++|+.||......+       +...+..+....       
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~-------~~~~~~~~~~~~-------  290 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE-------IMQQVLYGKYDP-------  290 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCCC-------
Confidence            222244569999999999999999999999999999999999999997543211       111111121110       


Q ss_pred             ccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          757 AMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       757 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                        .+......+.+++.+||+.+|++||+++++++
T Consensus       291 --~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        291 --FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             --CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence              11123457889999999999999999998864

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.6e-35  Score=309.12  Aligned_cols=248  Identities=27%  Similarity=0.414  Sum_probs=197.6

Q ss_pred             cceeeeeeeeEEEEEEecCCCceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEecCCCC
Q 041921          525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNG  603 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  603 (814)
                      ++||+|+||.||+|+...  ++..+|+|.+.... ......+.+|++++++++||||+++++++......++|+||++++
T Consensus         1 ~~lg~g~~g~vy~~~~~~--~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRA--DNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG   78 (252)
T ss_pred             CccCcccCccEEEEEEec--CCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence            479999999999999753  56789999876432 233457999999999999999999999999999999999999999


Q ss_pred             CHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccccccc
Q 041921          604 TLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTA  682 (814)
Q Consensus       604 sL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  682 (814)
                      +|.+++... ..+++..+..++.|++.||+|||+.   +|+|+||||+||+++.++.+||+|||++..............
T Consensus        79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  155 (252)
T cd05084          79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM  155 (252)
T ss_pred             cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence            999999754 4578999999999999999999998   999999999999999999999999999876542211111111


Q ss_pred             ccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCcH
Q 041921          683 IRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDI  761 (814)
Q Consensus       683 ~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  761 (814)
                      ...+..|+|||.+.+..++.++||||||++++||++ |..||........       ...+.....         .....
T Consensus       156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~-------~~~~~~~~~---------~~~~~  219 (252)
T cd05084         156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT-------REAIEQGVR---------LPCPE  219 (252)
T ss_pred             CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHH-------HHHHHcCCC---------CCCcc
Confidence            123567999999998889999999999999999998 8888864332211       111111100         01112


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 041921          762 ECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE  793 (814)
Q Consensus       762 ~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~  793 (814)
                      ..+..+.+++.+|++.+|++|||+.+++++|+
T Consensus       220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            33567889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-35  Score=317.17  Aligned_cols=266  Identities=25%  Similarity=0.384  Sum_probs=203.4

Q ss_pred             HHhhhccccceeeeeeeeEEEEEEecC------------CCceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccce
Q 041921          517 EGATNNFKEEVGRGSFGIVYKGVIQTR------------TSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRL  583 (814)
Q Consensus       517 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~------------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l  583 (814)
                      ....+.+.++||+|+||.||++.....            +....||+|.++... ......|.+|++++++++|+||+++
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~   82 (295)
T cd05097           3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL   82 (295)
T ss_pred             chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence            345677889999999999999876431            123468999986532 2234568999999999999999999


Q ss_pred             eeeecccccceEEEecCCCCCHHHHhcCC------------CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCc
Q 041921          584 LGFCDEGQNRLLVYEFLNNGTLASFLFGN------------LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQN  651 (814)
Q Consensus       584 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~N  651 (814)
                      ++++...+..++||||+++++|.+++...            ..+++..++.++.|+++||+|||+.   +++|+||||+|
T Consensus        83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~N  159 (295)
T cd05097          83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRN  159 (295)
T ss_pred             EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhh
Confidence            99999999999999999999999998543            1357888999999999999999998   99999999999


Q ss_pred             EEEcCCCcEEEeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh--CCCCCCcccch
Q 041921          652 ILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS--CRKSFDIEMGE  729 (814)
Q Consensus       652 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt--g~~p~~~~~~~  729 (814)
                      |++++++.+||+|||++................++..|+|||.+....++.++||||||++++||++  +..||.....+
T Consensus       160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~  239 (295)
T cd05097         160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE  239 (295)
T ss_pred             EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence            9999999999999999986543322222123345778999999988889999999999999999998  55676543322


Q ss_pred             hhhhHHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 041921          730 EYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEG  794 (814)
Q Consensus       730 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~  794 (814)
                      +..   ................      ......+..+.+++.+|++.+|.+||||.+|++.|+.
T Consensus       240 ~~~---~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         240 QVI---ENTGEFFRNQGRQIYL------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             HHH---HHHHHhhhhccccccC------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence            211   1111111111100000      0111234689999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.2e-35  Score=322.45  Aligned_cols=243  Identities=24%  Similarity=0.281  Sum_probs=198.1

Q ss_pred             cceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEecCC
Q 041921          525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLN  601 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  601 (814)
                      +.||+|+||.||++...  ..+..||||.+....   ......+.+|+.+++.++||||+++.+++.+.+..++||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~   78 (328)
T cd05593           1 KLLGKGTFGKVILVREK--ASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVN   78 (328)
T ss_pred             CeeeeCCCEEEEEEEEC--CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCC
Confidence            46999999999999865  357899999996532   2234568889999999999999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcccccc
Q 041921          602 NGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKT  681 (814)
Q Consensus       602 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  681 (814)
                      +++|..++.....+++.....++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......  ...
T Consensus        79 ~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~  153 (328)
T cd05593          79 GGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA--TMK  153 (328)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCccc--ccc
Confidence            999999998888899999999999999999999998   999999999999999999999999999875432211  113


Q ss_pred             cccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCcH
Q 041921          682 AIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDI  761 (814)
Q Consensus       682 ~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  761 (814)
                      ...||+.|+|||.+.+..++.++|||||||++|||++|+.||......+.       ...+..+...          .+.
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~-------~~~~~~~~~~----------~p~  216 (328)
T cd05593         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL-------FELILMEDIK----------FPR  216 (328)
T ss_pred             cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHH-------HHHhccCCcc----------CCC
Confidence            45699999999999988999999999999999999999999965432211       1111111110          111


Q ss_pred             HHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 041921          762 ECLGKLVMVSIWCIQEDPSLRP-----TMKKVLQM  791 (814)
Q Consensus       762 ~~~~~l~~l~~~Cl~~dp~~RP-----t~~~vl~~  791 (814)
                      ....++.+++.+||+.||.+||     ++.++++.
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            2345678999999999999997     88888753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.2e-35  Score=321.81  Aligned_cols=242  Identities=24%  Similarity=0.277  Sum_probs=196.9

Q ss_pred             cceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEecCC
Q 041921          525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLN  601 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  601 (814)
                      +.||+|+||.||++...  ..+..||+|.++...   ......+.+|+.++++++||||+++++.+...+..++||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~   78 (323)
T cd05595           1 KLLGKGTFGKVILVREK--ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYAN   78 (323)
T ss_pred             CeeeeCCCEEEEEEEEC--CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCC
Confidence            46999999999999865  357899999996532   2233457889999999999999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcccccc
Q 041921          602 NGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKT  681 (814)
Q Consensus       602 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  681 (814)
                      +++|..++.....+++.....++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++........  ...
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~  153 (323)
T cd05595          79 GGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMK  153 (323)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--ccc
Confidence            999999998888899999999999999999999998   999999999999999999999999999875332211  113


Q ss_pred             cccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCcH
Q 041921          682 AIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDI  761 (814)
Q Consensus       682 ~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  761 (814)
                      ...||+.|+|||.+.+..++.++|||||||++|||++|+.||........       ...+..+...          .+.
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~-------~~~~~~~~~~----------~p~  216 (323)
T cd05595         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-------FELILMEEIR----------FPR  216 (323)
T ss_pred             cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH-------HHHHhcCCCC----------CCC
Confidence            35689999999999998999999999999999999999999965432211       1111111111          111


Q ss_pred             HHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 041921          762 ECLGKLVMVSIWCIQEDPSLRP-----TMKKVLQ  790 (814)
Q Consensus       762 ~~~~~l~~l~~~Cl~~dp~~RP-----t~~~vl~  790 (814)
                      .....+.+++.+||+.||.+||     ++.++++
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            2346778999999999999998     7888764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=2.1e-35  Score=311.88  Aligned_cols=255  Identities=25%  Similarity=0.410  Sum_probs=199.5

Q ss_pred             ccccceeeeeeeeEEEEEEecCCCceEEEEEEeccc--cccchHhHHHHHHhhhccCCCCccceeeeeccc------ccc
Q 041921          522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV--FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEG------QNR  593 (814)
Q Consensus       522 ~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~  593 (814)
                      .+.++||+|+||.||+|.....+....+|+|.++..  .....+.+..|+.++++++|+||+++++++...      ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            356889999999999999875444457999988643  223345789999999999999999999987432      246


Q ss_pred             eEEEecCCCCCHHHHhcC------CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCC
Q 041921          594 LLVYEFLNNGTLASFLFG------NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGL  667 (814)
Q Consensus       594 ~lv~e~~~~gsL~~~l~~------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGl  667 (814)
                      ++++||+++++|.+++..      ...+++.....++.|++.||+|||+.   +|+||||||+|||+++++.+||+|||+
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~  158 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGL  158 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCc
Confidence            899999999999998742      23478999999999999999999998   999999999999999999999999999


Q ss_pred             ccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCc
Q 041921          668 AKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGK  746 (814)
Q Consensus       668 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  746 (814)
                      ++.+.............++..|+|||.+....++.++||||||+++|||++ |+.||......+       ....+..+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------~~~~~~~~~  231 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE-------IYDYLRQGN  231 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHcCC
Confidence            987654322111122345778999999998899999999999999999999 788886432211       112222222


Q ss_pred             cceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 041921          747 LNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV  795 (814)
Q Consensus       747 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~  795 (814)
                      ...         .....+..+.+++.+||+.+|.+|||+.++++.|+++
T Consensus       232 ~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         232 RLK---------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            110         1112345688999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.2e-35  Score=318.14  Aligned_cols=260  Identities=27%  Similarity=0.424  Sum_probs=204.5

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc-ccchHhHHHHHHhhhcc-CCCCccceeeeecccccceEEE
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRLLVY  597 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  597 (814)
                      .+.+.+.||+|+||.||+|.....+....+++|.++... ....+.+..|+.++.++ +||||+++++++.+....++++
T Consensus         3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~   82 (297)
T cd05089           3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAI   82 (297)
T ss_pred             cceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEE
Confidence            356778999999999999998754444568888887432 23345789999999999 7999999999999999999999


Q ss_pred             ecCCCCCHHHHhcCC----------------CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEE
Q 041921          598 EFLNNGTLASFLFGN----------------LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTAR  661 (814)
Q Consensus       598 e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~k  661 (814)
                      ||+++++|.+++...                ..+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+|
T Consensus        83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~k  159 (297)
T cd05089          83 EYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASK  159 (297)
T ss_pred             EecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeEE
Confidence            999999999999643                2467888999999999999999998   999999999999999999999


Q ss_pred             EeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHH
Q 041921          662 ISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFD  740 (814)
Q Consensus       662 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~  740 (814)
                      |+|||++.........   .....+..|+|||.+....++.++||||||++++||++ |..||......+.       ..
T Consensus       160 l~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~-------~~  229 (297)
T cd05089         160 IADFGLSRGEEVYVKK---TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL-------YE  229 (297)
T ss_pred             ECCcCCCccccceecc---CCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-------HH
Confidence            9999998643211111   11223567999999998889999999999999999998 9999965433221       11


Q ss_pred             HhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCCCC
Q 041921          741 CYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVP  801 (814)
Q Consensus       741 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~~~~p  801 (814)
                      .+..+..         ..........+.+++.+|++.+|.+|||++++++.|+++.+...+
T Consensus       230 ~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~  281 (297)
T cd05089         230 KLPQGYR---------MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA  281 (297)
T ss_pred             HHhcCCC---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence            1111110         001112346788999999999999999999999999887765443

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.6e-35  Score=326.13  Aligned_cols=259  Identities=21%  Similarity=0.234  Sum_probs=197.7

Q ss_pred             HhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEE
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY  597 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  597 (814)
                      ...|.+.++||+|+||.||++...  ..++.||+|....      ..+.+|++++++++||||+++++++......++|+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~--~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~  162 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDN--KTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL  162 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEEC--CCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence            345778899999999999999865  3577899997532      35788999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcc
Q 041921          598 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSK  677 (814)
Q Consensus       598 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  677 (814)
                      |++. ++|..++.....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++........
T Consensus       163 e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~  238 (391)
T PHA03212        163 PRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN  238 (391)
T ss_pred             ecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence            9985 68999988777889999999999999999999998   9999999999999999999999999999754322111


Q ss_pred             cccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccch-----hhhhHHHHHHHHhhcC-------
Q 041921          678 TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGE-----EYAILTDWAFDCYRNG-------  745 (814)
Q Consensus       678 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~-----~~~~~~~~~~~~~~~~-------  745 (814)
                       ......||+.|+|||++.+..++.++|||||||++|||++|+.|+......     ....+. .+.......       
T Consensus       239 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~-~i~~~~g~~p~~~~~~  316 (391)
T PHA03212        239 -KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIK-LIIRRSGTHPNEFPID  316 (391)
T ss_pred             -ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHH-HHHHHhcCChhhcCcc
Confidence             113456999999999999889999999999999999999999886432210     000010 010000000       


Q ss_pred             ---cccee---------ecC--cccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          746 ---KLNVL---------VGE--DKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       746 ---~~~~~---------~~~--~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                         .+...         ..+  ..........+..+.+++.+||+.||.+|||++|+++
T Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence               00000         000  0000011234567889999999999999999999985

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.3e-35  Score=318.95  Aligned_cols=268  Identities=26%  Similarity=0.406  Sum_probs=211.2

Q ss_pred             HHHHhhhccccceeeeeeeeEEEEEEec-----CCCceEEEEEEecccc-ccchHhHHHHHHhhhcc-CCCCccceeeee
Q 041921          515 ELEGATNNFKEEVGRGSFGIVYKGVIQT-----RTSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQT-HHKNLVRLLGFC  587 (814)
Q Consensus       515 ~l~~~~~~~~~~LG~G~~g~Vy~~~~~~-----~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  587 (814)
                      ++....+.+.+.||+|+||.||++....     ......||+|.+.... ....+++.+|+.++..+ +||||+++++++
T Consensus        11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   90 (304)
T cd05101          11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC   90 (304)
T ss_pred             cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence            3456667788999999999999997532     1234579999886432 33446789999999999 899999999999


Q ss_pred             cccccceEEEecCCCCCHHHHhcCC----------------CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCc
Q 041921          588 DEGQNRLLVYEFLNNGTLASFLFGN----------------LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQN  651 (814)
Q Consensus       588 ~~~~~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~N  651 (814)
                      ......++||||+++++|.+++...                ..+++..+..++.||++||.|||+.   +|+||||||+|
T Consensus        91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N  167 (304)
T cd05101          91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARN  167 (304)
T ss_pred             ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeecccccce
Confidence            9999999999999999999999753                2467788899999999999999998   99999999999


Q ss_pred             EEEcCCCcEEEeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchh
Q 041921          652 ILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEE  730 (814)
Q Consensus       652 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~  730 (814)
                      |++++++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |..||......+
T Consensus       168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~  247 (304)
T cd05101         168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  247 (304)
T ss_pred             EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence            9999999999999999987654332222123345678999999998889999999999999999998 778875432222


Q ss_pred             hhhHHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCCCC
Q 041921          731 YAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVP  801 (814)
Q Consensus       731 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~~~~p  801 (814)
                             ....+..+...         .........+.+++.+||+.+|.+|||+.++++.|+++..+..+
T Consensus       248 -------~~~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~~  302 (304)
T cd05101         248 -------LFKLLKEGHRM---------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTTN  302 (304)
T ss_pred             -------HHHHHHcCCcC---------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhhc
Confidence                   11222222110         01123456788999999999999999999999999988776543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-36  Score=310.14  Aligned_cols=254  Identities=24%  Similarity=0.316  Sum_probs=200.8

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccccc--------------chHhHHHHHHhhhccCCCCcccee
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD--------------GEREFKNEVFVIGQTHHKNLVRLL  584 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~--------------~~~~~~~E~~~l~~l~h~niv~l~  584 (814)
                      .+|.+.++||+|.||.|-+|...  .+++.||||.+.+....              ..+...+|+.+|++++|||||+|+
T Consensus        97 Nqy~l~~eiG~G~yGkVkLar~~--~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li  174 (576)
T KOG0585|consen   97 NQYELIKEIGSGQYGKVKLARDE--VDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI  174 (576)
T ss_pred             hheehhhhhcCCccceEEEEeec--CCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence            45677889999999999999854  47889999999642111              124688999999999999999999


Q ss_pred             eeecc--cccceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEE
Q 041921          585 GFCDE--GQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARI  662 (814)
Q Consensus       585 ~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl  662 (814)
                      ++..+  .+..|||+|||..|.+...=-....+...+.++++.+++.||.|||.+   +|+||||||+|+||++++.+||
T Consensus       175 EvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~VKI  251 (576)
T KOG0585|consen  175 EVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGTVKI  251 (576)
T ss_pred             EeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCcEEe
Confidence            99876  457899999999888754433334488999999999999999999999   9999999999999999999999


Q ss_pred             eecCCccccccCCc---ccccccccCCCCcccccccccCC----CCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHH
Q 041921          663 SDFGLAKLLTLNQS---KTIKTAIRGTKGYVAPEWFRNSK----ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILT  735 (814)
Q Consensus       663 ~DfGla~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~----~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~  735 (814)
                      +|||.+........   ........||+.|+|||...++.    ...+.||||+||.||-|+.|+.||.....-+     
T Consensus       252 sDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~-----  326 (576)
T KOG0585|consen  252 SDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE-----  326 (576)
T ss_pred             eccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH-----
Confidence            99999986633211   11123467999999999887632    3568999999999999999999997543322     


Q ss_pred             HHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 041921          736 DWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQML  792 (814)
Q Consensus       736 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L  792 (814)
                        ..+++.+        ..+..+...+..+.+.+|++++|++||..|.+..+|....
T Consensus       327 --l~~KIvn--------~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp  373 (576)
T KOG0585|consen  327 --LFDKIVN--------DPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP  373 (576)
T ss_pred             --HHHHHhc--------CcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence              1222222        2333333445678889999999999999999999997665

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.4e-35  Score=328.20  Aligned_cols=264  Identities=23%  Similarity=0.385  Sum_probs=205.5

Q ss_pred             HHHHhhhccccceeeeeeeeEEEEEEec---CCCceEEEEEEecccccc-chHhHHHHHHhhhccC-CCCccceeeeecc
Q 041921          515 ELEGATNNFKEEVGRGSFGIVYKGVIQT---RTSTTAVAVKKLDRVFQD-GEREFKNEVFVIGQTH-HKNLVRLLGFCDE  589 (814)
Q Consensus       515 ~l~~~~~~~~~~LG~G~~g~Vy~~~~~~---~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~-h~niv~l~~~~~~  589 (814)
                      ++....+.+.++||+|+||.||+|++..   ......||||+++..... ..+.+..|+.++.++. ||||+++++++..
T Consensus        33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~  112 (401)
T cd05107          33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK  112 (401)
T ss_pred             eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence            3445556677899999999999998752   224568999999754222 2346889999999997 9999999999999


Q ss_pred             cccceEEEecCCCCCHHHHhcCCC--------------------------------------------------------
Q 041921          590 GQNRLLVYEFLNNGTLASFLFGNL--------------------------------------------------------  613 (814)
Q Consensus       590 ~~~~~lv~e~~~~gsL~~~l~~~~--------------------------------------------------------  613 (814)
                      .+..++|+||+++|+|.++++...                                                        
T Consensus       113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (401)
T cd05107         113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM  192 (401)
T ss_pred             CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence            999999999999999999986421                                                        


Q ss_pred             ------------------------------------------CCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCc
Q 041921          614 ------------------------------------------KPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQN  651 (814)
Q Consensus       614 ------------------------------------------~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~N  651 (814)
                                                                .+++....+++.|++.||.|||+.   +|+||||||+|
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~N  269 (401)
T cd05107         193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARN  269 (401)
T ss_pred             hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcce
Confidence                                                      245667788999999999999987   99999999999


Q ss_pred             EEEcCCCcEEEeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchh
Q 041921          652 ILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEE  730 (814)
Q Consensus       652 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~  730 (814)
                      ||+++++.+||+|||+++...............++..|+|||.+....++.++||||||++++||++ |..||......+
T Consensus       270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~  349 (401)
T cd05107         270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE  349 (401)
T ss_pred             EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence            9999999999999999986543222111122346788999999998889999999999999999998 888886432221


Q ss_pred             hhhHHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 041921          731 YAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV  796 (814)
Q Consensus       731 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~  796 (814)
                      .      ....+..+..       +  ..+.....++.+++..||+.+|.+||++++|++.|+++.
T Consensus       350 ~------~~~~~~~~~~-------~--~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         350 Q------FYNAIKRGYR-------M--AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             H------HHHHHHcCCC-------C--CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            1      1111111110       0  011123567889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-35  Score=311.17  Aligned_cols=255  Identities=27%  Similarity=0.446  Sum_probs=201.2

Q ss_pred             ccccceeeeeeeeEEEEEEecCC-CceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeeccccc------
Q 041921          522 NFKEEVGRGSFGIVYKGVIQTRT-STTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQN------  592 (814)
Q Consensus       522 ~~~~~LG~G~~g~Vy~~~~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------  592 (814)
                      .+.+.||+|+||.||+|.+..+. ....||||+++...  .....++.+|+..++.++|+||+++++++.+...      
T Consensus         2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   81 (273)
T cd05035           2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK   81 (273)
T ss_pred             ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence            45688999999999999986432 35789999987432  2234578999999999999999999998866554      


Q ss_pred             ceEEEecCCCCCHHHHhcCC------CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecC
Q 041921          593 RLLVYEFLNNGTLASFLFGN------LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFG  666 (814)
Q Consensus       593 ~~lv~e~~~~gsL~~~l~~~------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfG  666 (814)
                      .++++||+++++|..++...      ..+++.....++.|++.||.|||+.   +|+||||||+||++++++.+||+|||
T Consensus        82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg  158 (273)
T cd05035          82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFG  158 (273)
T ss_pred             cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCcc
Confidence            78999999999999998532      3578889999999999999999998   99999999999999999999999999


Q ss_pred             CccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcC
Q 041921          667 LAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNG  745 (814)
Q Consensus       667 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  745 (814)
                      +++.+..............+..|+|||.+....++.++||||||++++||++ |..||......+   +    .+....+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~----~~~~~~~  231 (273)
T cd05035         159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---I----YDYLRHG  231 (273)
T ss_pred             ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---H----HHHHHcC
Confidence            9987654332211122335678999999988889999999999999999999 888886433221   1    1111222


Q ss_pred             ccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 041921          746 KLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV  795 (814)
Q Consensus       746 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~  795 (814)
                      ....         .+.....++.+++.+|++.||.+|||+.++++.|+++
T Consensus       232 ~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         232 NRLK---------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             CCCC---------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            1110         1123456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.2e-35  Score=314.50  Aligned_cols=260  Identities=22%  Similarity=0.296  Sum_probs=197.2

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEe
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE  598 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  598 (814)
                      .|.+.++||+|+||.||+|....  .+..||+|.++... ......+.+|+.++++++||||+++++++.+++..++|||
T Consensus         6 ~y~~~~~lg~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (288)
T cd07871           6 TYVKLDKLGEGTYATVFKGRSKL--TENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE   83 (288)
T ss_pred             cceEeeEEecCCCEEEEEEEECC--CCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence            46677899999999999998653  57789999986432 2234567899999999999999999999999889999999


Q ss_pred             cCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcc
Q 041921          599 FLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSK  677 (814)
Q Consensus       599 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  677 (814)
                      |+++ +|.+++... ..+++.....++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++........
T Consensus        84 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~  159 (288)
T cd07871          84 YLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT  159 (288)
T ss_pred             CCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcc
Confidence            9975 899888654 4578889999999999999999998   9999999999999999999999999999765432211


Q ss_pred             cccccccCCCCccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhc------------
Q 041921          678 TIKTAIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN------------  744 (814)
Q Consensus       678 ~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------------  744 (814)
                        .....+++.|+|||.+.+ ..++.++||||+||++|||++|+.||......+....   +.+....            
T Consensus       160 --~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  234 (288)
T cd07871         160 --YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHL---IFRLLGTPTEETWPGITSN  234 (288)
T ss_pred             --ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHhCCCChHHhhccccc
Confidence              133457899999998865 5689999999999999999999999975543221111   1111100            


Q ss_pred             CccceeecCcccc----cCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          745 GKLNVLVGEDKEA----MNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       745 ~~~~~~~~~~~~~----~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      ........+....    ........++.+++.+||+.||.+|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            0000001000000    000112356789999999999999999999975

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-36  Score=329.91  Aligned_cols=254  Identities=29%  Similarity=0.427  Sum_probs=214.8

Q ss_pred             ccceeeeeeeeEEEEEEecCCC--ceEEEEEEeccc-cccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEecC
Q 041921          524 KEEVGRGSFGIVYKGVIQTRTS--TTAVAVKKLDRV-FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL  600 (814)
Q Consensus       524 ~~~LG~G~~g~Vy~~~~~~~~~--~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  600 (814)
                      .++||+|+||+||||.+-.+++  ..+||||.+... ..+...++.+|+.+|.+++||||++|+|+|.... ..||++||
T Consensus       701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m  779 (1177)
T KOG1025|consen  701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM  779 (1177)
T ss_pred             hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence            4689999999999998765432  348999998653 3455678999999999999999999999998876 88999999


Q ss_pred             CCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcccc
Q 041921          601 NNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI  679 (814)
Q Consensus       601 ~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  679 (814)
                      +.|+|.+|++.+ ..+..+..+.+..|||+||.|||++   +++||||..+||||..-..+||.|||+++++..+..+..
T Consensus       780 P~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~  856 (1177)
T KOG1025|consen  780 PLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYS  856 (1177)
T ss_pred             ccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCccccccc
Confidence            999999999865 6688889999999999999999998   999999999999999999999999999999987766554


Q ss_pred             cccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeecCccccc
Q 041921          680 KTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAM  758 (814)
Q Consensus       680 ~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  758 (814)
                      .....-.+.|||-|.+....++.++|||||||.+||++| |..|++....++..++       ++.         ..+..
T Consensus       857 ~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dl-------le~---------geRLs  920 (1177)
T KOG1025|consen  857 APGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDL-------LEK---------GERLS  920 (1177)
T ss_pred             ccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHH-------Hhc---------cccCC
Confidence            444455778999999999999999999999999999999 9999987665553332       222         22233


Q ss_pred             CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 041921          759 NDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE  797 (814)
Q Consensus       759 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~  797 (814)
                      .+.-+...+..++.+||..|+..||+++++...+.++..
T Consensus       921 qPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar  959 (1177)
T KOG1025|consen  921 QPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR  959 (1177)
T ss_pred             CCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence            455677889999999999999999999999988866543

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.4e-35  Score=316.97  Aligned_cols=261  Identities=28%  Similarity=0.406  Sum_probs=206.7

Q ss_pred             HHhhhccccceeeeeeeeEEEEEEecC---CCceEEEEEEecccc-ccchHhHHHHHHhhhcc-CCCCccceeeeecccc
Q 041921          517 EGATNNFKEEVGRGSFGIVYKGVIQTR---TSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQ  591 (814)
Q Consensus       517 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~---~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  591 (814)
                      ....+.+.+.||+|+||.||++.....   .....+|+|.+.... .+...++.+|+.++.++ +|+||+++++++..+.
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   89 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG   89 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence            344556778999999999999987532   234689999887532 23345688999999999 8999999999999999


Q ss_pred             cceEEEecCCCCCHHHHhcC----------------CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc
Q 041921          592 NRLLVYEFLNNGTLASFLFG----------------NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLD  655 (814)
Q Consensus       592 ~~~lv~e~~~~gsL~~~l~~----------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~  655 (814)
                      ..+++|||+++++|.+++..                ...+++..++.++.|++.||.|||+.   +|+||||||+||+++
T Consensus        90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~  166 (293)
T cd05053          90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVT  166 (293)
T ss_pred             CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEc
Confidence            99999999999999999853                24578889999999999999999998   999999999999999


Q ss_pred             CCCcEEEeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhH
Q 041921          656 DYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAIL  734 (814)
Q Consensus       656 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~  734 (814)
                      +++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |..||.....++.   
T Consensus       167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---  243 (293)
T cd05053         167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL---  243 (293)
T ss_pred             CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH---
Confidence            999999999999987654322211122335678999999988899999999999999999998 8888864432221   


Q ss_pred             HHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 041921          735 TDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV  796 (814)
Q Consensus       735 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~  796 (814)
                          .+....+...         ..+......+.+++.+|++.+|.+|||+.++++.|+++.
T Consensus       244 ----~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         244 ----FKLLKEGYRM---------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             ----HHHHHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence                1112121110         112234567889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.9e-35  Score=315.52  Aligned_cols=258  Identities=28%  Similarity=0.418  Sum_probs=203.7

Q ss_pred             hccccceeeeeeeeEEEEEEecC---CCceEEEEEEeccccc-cchHhHHHHHHhhhccCCCCccceeeeecccccceEE
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTR---TSTTAVAVKKLDRVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV  596 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~---~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  596 (814)
                      +.+.+.||+|+||.||+|.....   .....+++|.+..... ...+++.+|+.+++.++||||+++++.+...+..+++
T Consensus         2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (290)
T cd05045           2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLI   81 (290)
T ss_pred             ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEE
Confidence            34568899999999999986532   1335788888864332 2345789999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhcCC------------------------CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcE
Q 041921          597 YEFLNNGTLASFLFGN------------------------LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNI  652 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~~------------------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NI  652 (814)
                      +||+++++|.+++...                        ..+++..++.++.|++.||.|||+.   +|+||||||+||
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~ni  158 (290)
T cd05045          82 VEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNV  158 (290)
T ss_pred             EEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---CeehhhhhhheE
Confidence            9999999999998542                        2467888899999999999999998   999999999999


Q ss_pred             EEcCCCcEEEeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhh
Q 041921          653 LLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEY  731 (814)
Q Consensus       653 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~  731 (814)
                      |+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |+.||.....++ 
T Consensus       159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-  237 (290)
T cd05045         159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER-  237 (290)
T ss_pred             EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH-
Confidence            999999999999999986543322211123345778999999988889999999999999999999 999986543322 


Q ss_pred             hhHHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 041921          732 AILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE  797 (814)
Q Consensus       732 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~  797 (814)
                            .+.....+.     .    ...+.....++.+++.+|++.+|.+||+++++++.|+++..
T Consensus       238 ------~~~~~~~~~-----~----~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         238 ------LFNLLKTGY-----R----MERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             ------HHHHHhCCC-----C----CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence                  112222111     0    01112234678899999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-35  Score=307.66  Aligned_cols=252  Identities=31%  Similarity=0.470  Sum_probs=202.5

Q ss_pred             cceeeeeeeeEEEEEEecCC-CceEEEEEEeccccc-cchHhHHHHHHhhhccCCCCccceeeeecccccceEEEecCCC
Q 041921          525 EEVGRGSFGIVYKGVIQTRT-STTAVAVKKLDRVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN  602 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  602 (814)
                      ++||+|+||.||+|+....+ ....+|+|.+..... ...+++.+|+.++++++|+||+++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            47999999999999876443 347899999875433 24567999999999999999999999876 4568999999999


Q ss_pred             CCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcccc-cc
Q 041921          603 GTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI-KT  681 (814)
Q Consensus       603 gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~-~~  681 (814)
                      ++|.+++.....+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||+++.+........ ..
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~  156 (257)
T cd05060          80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT  156 (257)
T ss_pred             CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccccccc
Confidence            99999998877889999999999999999999998   999999999999999999999999999987654332211 11


Q ss_pred             cccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCc
Q 041921          682 AIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMND  760 (814)
Q Consensus       682 ~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  760 (814)
                      ...++..|+|||.+....++.++||||||++++||++ |..||......+   +.    ..+..+..         ...+
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~---~~----~~~~~~~~---------~~~~  220 (257)
T cd05060         157 AGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE---VI----AMLESGER---------LPRP  220 (257)
T ss_pred             CccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH---HH----HHHHcCCc---------CCCC
Confidence            1224568999999998899999999999999999998 999987543321   11    11112110         0112


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 041921          761 IECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV  796 (814)
Q Consensus       761 ~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~  796 (814)
                      ...+..+.+++.+|++.+|.+||++.++++.|+++.
T Consensus       221 ~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         221 EECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence            234467889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2.2e-35  Score=312.78  Aligned_cols=255  Identities=30%  Similarity=0.449  Sum_probs=201.3

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCC---CceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccceeeeecccccce
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRT---STTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRL  594 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~---~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  594 (814)
                      ..+.+.+.||+|++|.||+|.+....   ....|++|.+.... ......|..|+.++++++|+||+++++++.+....+
T Consensus         6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   85 (277)
T cd05036           6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRF   85 (277)
T ss_pred             HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcE
Confidence            44566789999999999999986422   46789999886443 223456899999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHhcCCC-------CCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC---cEEEee
Q 041921          595 LVYEFLNNGTLASFLFGNL-------KPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYY---TARISD  664 (814)
Q Consensus       595 lv~e~~~~gsL~~~l~~~~-------~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~---~~kl~D  664 (814)
                      +||||+++++|.+++....       .+++..+.+++.||++||+|||+.   +++|+||||+||+++.++   .+||+|
T Consensus        86 lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~d  162 (277)
T cd05036          86 ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIAD  162 (277)
T ss_pred             EEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEecc
Confidence            9999999999999997542       478899999999999999999998   999999999999998654   599999


Q ss_pred             cCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhh
Q 041921          665 FGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYR  743 (814)
Q Consensus       665 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  743 (814)
                      ||+++................+..|+|||.+.+..++.++|||||||+++||++ |+.||......+..       ..+.
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~-------~~~~  235 (277)
T cd05036         163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM-------EFVT  235 (277)
T ss_pred             CccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-------HHHH
Confidence            999987643221111112223568999999998899999999999999999997 99998754332211       1111


Q ss_pred             c-CccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 041921          744 N-GKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE  793 (814)
Q Consensus       744 ~-~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~  793 (814)
                      . ...          ..+...+..+.+++.+|++.+|++|||+.+|++.|+
T Consensus       236 ~~~~~----------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         236 GGGRL----------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             cCCcC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            1 111          111223467889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2.8e-35  Score=315.87  Aligned_cols=260  Identities=26%  Similarity=0.399  Sum_probs=205.6

Q ss_pred             HhhhccccceeeeeeeeEEEEEEec---CCCceEEEEEEeccccc-cchHhHHHHHHhhhcc-CCCCccceeeeeccccc
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQT---RTSTTAVAVKKLDRVFQ-DGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQN  592 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~---~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  592 (814)
                      ...+.+.+.||+|+||.||++....   ......||||.++.... ...+.+.+|+.+++++ +|+||+++++++...+.
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  113 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP  113 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence            3456677899999999999998532   22456899999875432 2345689999999999 79999999999999999


Q ss_pred             ceEEEecCCCCCHHHHhcCCC--CCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccc
Q 041921          593 RLLVYEFLNNGTLASFLFGNL--KPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKL  670 (814)
Q Consensus       593 ~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~  670 (814)
                      .++|+||+++++|.+++....  .+++.++..++.|++.||+|||+.   +|+|+||||+||+++.++.+||+|||+++.
T Consensus       114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~  190 (302)
T cd05055         114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARD  190 (302)
T ss_pred             eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCccccc
Confidence            999999999999999997543  379999999999999999999998   999999999999999999999999999986


Q ss_pred             cccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccce
Q 041921          671 LTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNV  749 (814)
Q Consensus       671 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  749 (814)
                      ..............++..|+|||.+....++.++||||||+++|||++ |..||......+.  +    ......+... 
T Consensus       191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~--~----~~~~~~~~~~-  263 (302)
T cd05055         191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK--F----YKLIKEGYRM-  263 (302)
T ss_pred             ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH--H----HHHHHcCCcC-
Confidence            654322111122346778999999998889999999999999999998 9999864432211  1    1111111100 


Q ss_pred             eecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 041921          750 LVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV  795 (814)
Q Consensus       750 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~  795 (814)
                              ........++.+++.+|++.+|++|||+.++++.|+++
T Consensus       264 --------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         264 --------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             --------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence                    01112246788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.1e-35  Score=319.31  Aligned_cols=258  Identities=29%  Similarity=0.459  Sum_probs=202.7

Q ss_pred             HhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc-ccchHhHHHHHHhhhcc-CCCCccceeeeecccccceE
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRLL  595 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  595 (814)
                      -..+.+.+.||+|+||.||+|.....+....+++|++.... ....+++.+|++++.++ +|+||+++++++.+++..++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            34567788999999999999998654444577888876532 23445788999999999 89999999999999999999


Q ss_pred             EEecCCCCCHHHHhcCC----------------CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCc
Q 041921          596 VYEFLNNGTLASFLFGN----------------LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYT  659 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~  659 (814)
                      |+||+++++|.+++...                ..+++..++.++.|+++||+|||+.   +|+||||||+|||++.++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCc
Confidence            99999999999999643                2467888999999999999999998   9999999999999999999


Q ss_pred             EEEeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHH
Q 041921          660 ARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWA  738 (814)
Q Consensus       660 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~  738 (814)
                      +||+|||++.........   .....+..|+|||.+....++.++||||||++++||+| |..||......+.       
T Consensus       163 ~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-------  232 (303)
T cd05088         163 AKIADFGLSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL-------  232 (303)
T ss_pred             EEeCccccCcccchhhhc---ccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH-------
Confidence            999999998643211111   11234668999999988889999999999999999998 9999864432211       


Q ss_pred             HHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 041921          739 FDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE  797 (814)
Q Consensus       739 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~  797 (814)
                      ......+.       ..  .........+.+++.+|++.+|.+||+++++++.|+.+.+
T Consensus       233 ~~~~~~~~-------~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~  282 (303)
T cd05088         233 YEKLPQGY-------RL--EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  282 (303)
T ss_pred             HHHHhcCC-------cC--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            11111110       00  0111234568899999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=3e-35  Score=314.94  Aligned_cols=265  Identities=26%  Similarity=0.403  Sum_probs=206.2

Q ss_pred             HhhhccccceeeeeeeeEEEEEEecCC--------------CceEEEEEEeccccc-cchHhHHHHHHhhhccCCCCccc
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQTRT--------------STTAVAVKKLDRVFQ-DGEREFKNEVFVIGQTHHKNLVR  582 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~--------------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~  582 (814)
                      ...+.+.++||+|+||.||++.....+              ....||+|.+..... ...+++.+|+.++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            345677899999999999999876422              235689999875432 33557899999999999999999


Q ss_pred             eeeeecccccceEEEecCCCCCHHHHhcCCC-----------CCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCc
Q 041921          583 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNL-----------KPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQN  651 (814)
Q Consensus       583 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~N  651 (814)
                      +++++..+...++++||+++++|.+++....           .+++..++.++.|++.||+|||+.   +|+|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence            9999999999999999999999999997654           688999999999999999999998   99999999999


Q ss_pred             EEEcCCCcEEEeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh--CCCCCCcccch
Q 041921          652 ILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS--CRKSFDIEMGE  729 (814)
Q Consensus       652 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt--g~~p~~~~~~~  729 (814)
                      |+++.++.++|+|||+++...............++..|+|||.+....++.++||||||+++|||++  +..|+......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ  240 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence            9999999999999999986543332222233456789999999988889999999999999999998  66777533221


Q ss_pred             hhhhHHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 041921          730 EYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEG  794 (814)
Q Consensus       730 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~  794 (814)
                      .   ....+............      .......+.++.+++.+|++.+|.+|||+.+|++.|+.
T Consensus       241 ~---~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         241 Q---VIENAGHFFRDDGRQIY------LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             H---HHHHHHhcccccccccc------CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence            1   11111111111111111      11112234678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=2.8e-35  Score=308.13  Aligned_cols=251  Identities=27%  Similarity=0.423  Sum_probs=201.8

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEe
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE  598 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  598 (814)
                      ..+.+.+.||+|+||.||+|...   +...+|||.+... .....++.+|+.++++++||||+++++++.+....++|||
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~---~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWR---GQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTE   79 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEec---CCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEE
Confidence            34567789999999999999865   3456999988743 2345679999999999999999999999999889999999


Q ss_pred             cCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcc
Q 041921          599 FLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSK  677 (814)
Q Consensus       599 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  677 (814)
                      |+++++|.+++... ..+++..+..++.||+.||+|||+.   +++|+||||+||++++++.+||+|||+++........
T Consensus        80 ~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~  156 (256)
T cd05113          80 YMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT  156 (256)
T ss_pred             cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence            99999999999764 4689999999999999999999998   9999999999999999999999999998765433211


Q ss_pred             cccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeecCccc
Q 041921          678 TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKE  756 (814)
Q Consensus       678 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  756 (814)
                      . .....++..|+|||.+....++.++||||||+++|||++ |..||......+       .......+....       
T Consensus       157 ~-~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~~-------  221 (256)
T cd05113         157 S-SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE-------TVEKVSQGLRLY-------  221 (256)
T ss_pred             e-cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHhcCCCCC-------
Confidence            1 122335678999999988889999999999999999999 999986443221       111111221110       


Q ss_pred             ccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 041921          757 AMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE  793 (814)
Q Consensus       757 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~  793 (814)
                        ........+.+++.+||+.+|.+|||+.++++.|+
T Consensus       222 --~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         222 --RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             --CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence              01113478899999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.9e-35  Score=310.19  Aligned_cols=258  Identities=24%  Similarity=0.458  Sum_probs=205.4

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCC-CceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccceeeeecccccceEE
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRT-STTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV  596 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  596 (814)
                      ..+...+.||+|+||.||+|.....+ ....+++|.+.... ....+++..|++++++++|+||+++.+++.+.+..++|
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII   84 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence            34556788999999999999986432 23579999986542 23345789999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCC
Q 041921          597 YEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ  675 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~  675 (814)
                      |||+++++|.+++... ..+++..+..++.|++.||+|||+.   +++|+||||+||++++++.+||+|||++.......
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~  161 (268)
T cd05063          85 TEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP  161 (268)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence            9999999999999764 5789999999999999999999998   99999999999999999999999999998665332


Q ss_pred             ccccc-ccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeecC
Q 041921          676 SKTIK-TAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGE  753 (814)
Q Consensus       676 ~~~~~-~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  753 (814)
                      ..... .....+..|+|||.+....++.++||||||+++|||++ |+.||......+       ....+..+.       
T Consensus       162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~-------~~~~i~~~~-------  227 (268)
T cd05063         162 EGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE-------VMKAINDGF-------  227 (268)
T ss_pred             ccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH-------HHHHHhcCC-------
Confidence            21111 11223457999999988889999999999999999998 999986443221       111122111       


Q ss_pred             cccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 041921          754 DKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV  795 (814)
Q Consensus       754 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~  795 (814)
                        ..+.....+..+.+++.+|++.+|.+||++.+|++.|+++
T Consensus       228 --~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         228 --RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             --CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence              0111223456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.4e-35  Score=315.43  Aligned_cols=264  Identities=26%  Similarity=0.421  Sum_probs=202.2

Q ss_pred             hhccccceeeeeeeeEEEEEEe--cCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecc--cccceE
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQ--TRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDE--GQNRLL  595 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~--~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l  595 (814)
                      .+.+.+.||+|+||+||++...  ....+..|++|++........+.+.+|++++++++||||+++++++..  ....++
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   84 (284)
T cd05081           5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRL   84 (284)
T ss_pred             cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEE
Confidence            4556788999999999999864  234577899999876555556689999999999999999999998754  346789


Q ss_pred             EEecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccC
Q 041921          596 VYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN  674 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~  674 (814)
                      |+||+++++|.+++... ..+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||+++.....
T Consensus        85 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~  161 (284)
T cd05081          85 VMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQD  161 (284)
T ss_pred             EEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccccCC
Confidence            99999999999999764 5689999999999999999999998   9999999999999999999999999999876543


Q ss_pred             Cccc-ccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhh---------hhHHHHHHHHhhc
Q 041921          675 QSKT-IKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY---------AILTDWAFDCYRN  744 (814)
Q Consensus       675 ~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~---------~~~~~~~~~~~~~  744 (814)
                      .... ......++..|+|||.+.+..++.++||||||++++||++|..++........         ........+....
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
T cd05081         162 KEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKN  241 (284)
T ss_pred             CcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhc
Confidence            2211 11112234569999999988899999999999999999998876542211000         0000000011111


Q ss_pred             CccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 041921          745 GKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV  795 (814)
Q Consensus       745 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~  795 (814)
                      +         ...+.....+..+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus       242 ~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         242 N---------GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             C---------CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            1         11111223456789999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=3.3e-35  Score=310.22  Aligned_cols=250  Identities=30%  Similarity=0.462  Sum_probs=197.8

Q ss_pred             cceeeeeeeeEEEEEEecCCCceEEEEEEecccc-ccchHhHHHHHHhhhcc-CCCCccceeeeecccccceEEEecCCC
Q 041921          525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRLLVYEFLNN  602 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  602 (814)
                      +.||+|+||.||+|.+...+....+++|.+.... ....+.+.+|++++.++ +||||+++++++......++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            4689999999999998754444578999887532 33445788999999999 899999999999999999999999999


Q ss_pred             CCHHHHhcCCC----------------CCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecC
Q 041921          603 GTLASFLFGNL----------------KPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFG  666 (814)
Q Consensus       603 gsL~~~l~~~~----------------~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfG  666 (814)
                      ++|.+++....                .+++..+..++.|++.||+|||+.   +++|+||||+||++++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence            99999986432                467889999999999999999998   99999999999999999999999999


Q ss_pred             CccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcC
Q 041921          667 LAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNG  745 (814)
Q Consensus       667 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  745 (814)
                      ++.........   .....+..|+|||++....++.++||||||++++||++ |..||......+       ..+....+
T Consensus       158 l~~~~~~~~~~---~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~-------~~~~~~~~  227 (270)
T cd05047         158 LSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LYEKLPQG  227 (270)
T ss_pred             Cccccchhhhc---cCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH-------HHHHHhCC
Confidence            98632211111   11234567999999988889999999999999999997 999986432211       11111111


Q ss_pred             ccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 041921          746 KLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV  796 (814)
Q Consensus       746 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~  796 (814)
                      ..       .  .........+.+++.+|++.+|.+|||+.++++.|+++.
T Consensus       228 ~~-------~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         228 YR-------L--EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             CC-------C--CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            10       0  011123457889999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.5e-35  Score=321.83  Aligned_cols=273  Identities=23%  Similarity=0.349  Sum_probs=200.5

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeeccc-----ccc
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEG-----QNR  593 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~  593 (814)
                      |.+.++||+|+||.||+|...  ..+..||||++....  ......+.+|+.++++++||||+++++++...     ...
T Consensus         2 y~i~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   79 (338)
T cd07859           2 YKIQEVIGKGSYGVVCSAIDT--HTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI   79 (338)
T ss_pred             eEEEEEEeecCCeEEEEEEEC--CCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence            567789999999999999865  357899999986432  22345688999999999999999999987543     247


Q ss_pred             eEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcccccc
Q 041921          594 LLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTL  673 (814)
Q Consensus       594 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~  673 (814)
                      ++||||+. ++|.+++.....+++..+..++.||++||.|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus        80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~  155 (338)
T cd07859          80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFN  155 (338)
T ss_pred             EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence            99999995 68999998877899999999999999999999998   999999999999999999999999999986543


Q ss_pred             CCcc-cccccccCCCCccccccccc--CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHH-H-------HHHHHh
Q 041921          674 NQSK-TIKTAIRGTKGYVAPEWFRN--SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILT-D-------WAFDCY  742 (814)
Q Consensus       674 ~~~~-~~~~~~~gt~~y~aPE~~~~--~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~-~-------~~~~~~  742 (814)
                      .... .......||..|+|||.+.+  ..++.++|||||||++|||++|+.||............ .       .....+
T Consensus       156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i  235 (338)
T cd07859         156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRV  235 (338)
T ss_pred             ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence            2211 11133568999999999876  57899999999999999999999999654321110000 0       000001


Q ss_pred             hcCccceeec---Ccccc---cCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HhcCcCCC
Q 041921          743 RNGKLNVLVG---EDKEA---MNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM--LEGVVEVS  799 (814)
Q Consensus       743 ~~~~~~~~~~---~~~~~---~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~--L~~~~~~~  799 (814)
                      ..........   .....   .........+.+++.+||+.+|++|||++++++.  ++++....
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~  300 (338)
T cd07859         236 RNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVE  300 (338)
T ss_pred             hhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCccc
Confidence            1110000000   00000   0001123567899999999999999999999853  55544433

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=3.9e-35  Score=312.74  Aligned_cols=265  Identities=27%  Similarity=0.435  Sum_probs=205.8

Q ss_pred             HHhhhccccceeeeeeeeEEEEEEecC---CCceEEEEEEeccccc-cchHhHHHHHHhhhccCCCCccceeeeeccccc
Q 041921          517 EGATNNFKEEVGRGSFGIVYKGVIQTR---TSTTAVAVKKLDRVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQN  592 (814)
Q Consensus       517 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~---~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  592 (814)
                      ...++.+.++||+|+||.||+|...+.   .....||+|.+..... ....++.+|+.++++++|+||+++++++.+...
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            345677789999999999999976531   2356899998864322 223468899999999999999999999999999


Q ss_pred             ceEEEecCCCCCHHHHhcCC----------CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEE
Q 041921          593 RLLVYEFLNNGTLASFLFGN----------LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARI  662 (814)
Q Consensus       593 ~~lv~e~~~~gsL~~~l~~~----------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl  662 (814)
                      .++||||+++|+|.+++...          ..+.+.....++.|++.||.|||+.   +|+||||||+||++++++.+||
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEE
Confidence            99999999999999999642          2345677889999999999999998   9999999999999999999999


Q ss_pred             eecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHH
Q 041921          663 SDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDC  741 (814)
Q Consensus       663 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~  741 (814)
                      +|||+++...............++..|+|||.+.+..++.++||||||++++||++ |..||.....++       ....
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~-------~~~~  233 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ-------VLKF  233 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHH
Confidence            99999986543322111122335678999999998899999999999999999999 788886433222       1111


Q ss_pred             hhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCCC
Q 041921          742 YRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSV  800 (814)
Q Consensus       742 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~~~~  800 (814)
                      +..+....         .....+..+.+++.+|++.+|++|||+.++++.|++......
T Consensus       234 ~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~  283 (288)
T cd05061         234 VMDGGYLD---------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSF  283 (288)
T ss_pred             HHcCCCCC---------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCC
Confidence            11111110         111234688999999999999999999999999988654433

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.8e-35  Score=318.96  Aligned_cols=244  Identities=26%  Similarity=0.305  Sum_probs=197.6

Q ss_pred             cceeeeeeeeEEEEEEec-CCCceEEEEEEecccc----ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEec
Q 041921          525 EEVGRGSFGIVYKGVIQT-RTSTTAVAVKKLDRVF----QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  599 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~-~~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  599 (814)
                      +.||+|+||.||++.... ...+..||||.++...    ......+.+|+.++++++||||+++++++.+++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            579999999999998643 2357789999986432    12234578899999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcccc
Q 041921          600 LNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI  679 (814)
Q Consensus       600 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  679 (814)
                      +++++|.+++.....+.+.....++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++........  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--  156 (323)
T cd05584          82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTV--  156 (323)
T ss_pred             CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCc--
Confidence            99999999998888888888999999999999999998   9999999999999999999999999998754322211  


Q ss_pred             cccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccC
Q 041921          680 KTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMN  759 (814)
Q Consensus       680 ~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  759 (814)
                      .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.......       ....+..+...          .
T Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~-------~~~~~~~~~~~----------~  219 (323)
T cd05584         157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK-------TIDKILKGKLN----------L  219 (323)
T ss_pred             ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCCC----------C
Confidence            133568999999999998889999999999999999999999997543221       11112222211          0


Q ss_pred             cHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 041921          760 DIECLGKLVMVSIWCIQEDPSLRP-----TMKKVLQ  790 (814)
Q Consensus       760 ~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~~vl~  790 (814)
                      +......+.+++.+||+.+|++||     +++++++
T Consensus       220 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         220 PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence            112345678999999999999999     7888765

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=3e-35  Score=312.28  Aligned_cols=263  Identities=24%  Similarity=0.377  Sum_probs=208.3

Q ss_pred             HHHhhhccccceeeeeeeeEEEEEEecCC--CceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccceeeeecc-cc
Q 041921          516 LEGATNNFKEEVGRGSFGIVYKGVIQTRT--STTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDE-GQ  591 (814)
Q Consensus       516 l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~--~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~  591 (814)
                      +...++.+.+.||+|+||.||+|......  ....|++|++.... ....+.+.+|+.++++++|+||+++++++.+ +.
T Consensus         3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   82 (280)
T cd05043           3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE   82 (280)
T ss_pred             cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            34566778899999999999999986422  26789999886532 2334568899999999999999999998866 56


Q ss_pred             cceEEEecCCCCCHHHHhcCC--------CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEe
Q 041921          592 NRLLVYEFLNNGTLASFLFGN--------LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARIS  663 (814)
Q Consensus       592 ~~~lv~e~~~~gsL~~~l~~~--------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~  663 (814)
                      ..++++||+++++|.+++...        ..+++..+..++.|++.||+|||+.   +++|+||||+||++++++.+||+
T Consensus        83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~  159 (280)
T cd05043          83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKIT  159 (280)
T ss_pred             CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEEC
Confidence            789999999999999998653        3578999999999999999999998   99999999999999999999999


Q ss_pred             ecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHh
Q 041921          664 DFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCY  742 (814)
Q Consensus       664 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  742 (814)
                      |||+++.+.............++..|+|||.+.+..++.++||||||+++||+++ |+.||......+   +    ...+
T Consensus       160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~----~~~~  232 (280)
T cd05043         160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---M----AAYL  232 (280)
T ss_pred             CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---H----HHHH
Confidence            9999987654332222123346778999999988889999999999999999999 999986543222   1    1111


Q ss_pred             hcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 041921          743 RNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE  797 (814)
Q Consensus       743 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~  797 (814)
                      ..+.       ..  ......+.++.+++.+|++.+|++|||+.++++.|+.+.+
T Consensus       233 ~~~~-------~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         233 KDGY-------RL--AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             HcCC-------CC--CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            1111       00  0112234678999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.6e-35  Score=313.22  Aligned_cols=270  Identities=25%  Similarity=0.359  Sum_probs=202.6

Q ss_pred             ccccceeeeeeeeEEEEEEe--cCCCceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccceeeeeccc--ccceEE
Q 041921          522 NFKEEVGRGSFGIVYKGVIQ--TRTSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEG--QNRLLV  596 (814)
Q Consensus       522 ~~~~~LG~G~~g~Vy~~~~~--~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv  596 (814)
                      .+.+.||+|+||+||++...  ....+..||+|.+.... ......+.+|++++++++||||+++++++...  ...++|
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI   86 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence            66788999999999887643  22356789999987542 23456788999999999999999999988653  357899


Q ss_pred             EecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCc
Q 041921          597 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS  676 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  676 (814)
                      |||+++++|.+++... .+++..+..++.|+++||.|||+.   +|+|+||||+||++++++.+||+|||+++.......
T Consensus        87 ~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~  162 (283)
T cd05080          87 MEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE  162 (283)
T ss_pred             ecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccCCcch
Confidence            9999999999999764 589999999999999999999998   999999999999999999999999999987654322


Q ss_pred             cc-ccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcc
Q 041921          677 KT-IKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDK  755 (814)
Q Consensus       677 ~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  755 (814)
                      .. ......++..|+|||.+....++.++||||||++++||++|+.|+......... .............+....+...
T Consensus       163 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  241 (283)
T cd05080         163 YYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEE-MIGPKQGQMTVVRLIELLERGM  241 (283)
T ss_pred             hhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhh-hhcccccccchhhhhhhhhcCC
Confidence            11 112223566799999998888999999999999999999999998643221100 0000000000001111111111


Q ss_pred             cccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 041921          756 EAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV  796 (814)
Q Consensus       756 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~  796 (814)
                      ....+...+.++.+++..|++.+|++|||+++++++|+.+.
T Consensus       242 ~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         242 RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            11112234578899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=4.8e-35  Score=310.53  Aligned_cols=262  Identities=25%  Similarity=0.403  Sum_probs=204.6

Q ss_pred             HhhhccccceeeeeeeeEEEEEEecCCC--ceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccceeeeecccccce
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQTRTS--TTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRL  594 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~--~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  594 (814)
                      .....+.++||+|+||+||+|.....+.  ...||+|.++... ....+++.+|+.+++.++|+||+++++++.. ...+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence            3445567899999999999998654332  2358999986532 2335678999999999999999999999975 4578


Q ss_pred             EEEecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcccccc
Q 041921          595 LVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTL  673 (814)
Q Consensus       595 lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~  673 (814)
                      +++||+++|+|.+++... ..+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+||+|||+++....
T Consensus        85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~  161 (279)
T cd05109          85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDI  161 (279)
T ss_pred             EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence            999999999999999764 5689999999999999999999998   999999999999999999999999999987654


Q ss_pred             CCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeec
Q 041921          674 NQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVG  752 (814)
Q Consensus       674 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  752 (814)
                      ...........++..|+|||.+.+..++.++||||||+++|||++ |..||.......   +.    ..+..+...    
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~----~~~~~~~~~----  230 (279)
T cd05109         162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IP----DLLEKGERL----  230 (279)
T ss_pred             ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HH----HHHHCCCcC----
Confidence            322211122235678999999998899999999999999999998 889886433222   11    111221110    


Q ss_pred             CcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCC
Q 041921          753 EDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS  799 (814)
Q Consensus       753 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~~~  799 (814)
                           .........+.+++.+||+.||++||++.++++.|+.+...+
T Consensus       231 -----~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         231 -----PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             -----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence                 011224467889999999999999999999999998765444

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-35  Score=330.80  Aligned_cols=259  Identities=21%  Similarity=0.279  Sum_probs=210.1

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccC-CCCccceeee-ecc------ccc
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTH-HKNLVRLLGF-CDE------GQN  592 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~~------~~~  592 (814)
                      ..+.+.|.+|||+.||.|....  .+..+|+|++-..++...+.+.+|+.+|++|+ |+|||.+++. ...      ..+
T Consensus        39 v~V~~vLAEGGFa~VYla~~~~--~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E  116 (738)
T KOG1989|consen   39 VTVEKVLAEGGFAQVYLAQDVK--GGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE  116 (738)
T ss_pred             EEEEEEEccCCcEEEEEEEecC--CCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence            3456789999999999999763  33899999997777778889999999999996 9999999993 221      246


Q ss_pred             ceEEEecCCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccc
Q 041921          593 RLLVYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKL  670 (814)
Q Consensus       593 ~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~  670 (814)
                      .+|+||||++|+|-+++..+  ..+++.++++|+.|+++|+++||.. .++|||||||-+||||+.++..||||||.+.-
T Consensus       117 vllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt  195 (738)
T KOG1989|consen  117 VLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATT  195 (738)
T ss_pred             EEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccccc
Confidence            78999999999999999854  5599999999999999999999985 67899999999999999999999999999864


Q ss_pred             cccCCcc-cccc------cccCCCCccccccc---ccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHH
Q 041921          671 LTLNQSK-TIKT------AIRGTKGYVAPEWF---RNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD  740 (814)
Q Consensus       671 ~~~~~~~-~~~~------~~~gt~~y~aPE~~---~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  740 (814)
                      ....... ....      ...-|+.|.|||.+   .+..+++|+|||+|||+||-|+....||+...             
T Consensus       196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg-------------  262 (738)
T KOG1989|consen  196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG-------------  262 (738)
T ss_pred             ccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc-------------
Confidence            4332211 0000      11258999999987   57789999999999999999999999997321             


Q ss_pred             HhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCCCC
Q 041921          741 CYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVP  801 (814)
Q Consensus       741 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~~~~p  801 (814)
                           .+ .++......+....+..++.+||..||++||.+||++-+|+..+-.++..+.|
T Consensus       263 -----~l-aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~  317 (738)
T KOG1989|consen  263 -----KL-AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCP  317 (738)
T ss_pred             -----ce-eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCC
Confidence                 11 22333344444567889999999999999999999999999998776665433

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.2e-34  Score=305.61  Aligned_cols=254  Identities=26%  Similarity=0.377  Sum_probs=194.1

Q ss_pred             cceeeeeeeeEEEEEEecCCCceEEEEEEeccccc-cchHhHHHHHHhhhccCCCCccceeeeecccccceEEEecCCCC
Q 041921          525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNG  603 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  603 (814)
                      ++||+|+||.||+|....+.....+++|+++.... .....+.+|+.++++++||||+++++++.+....++||||++++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            36999999999999876555667899999865432 23357889999999999999999999999999999999999999


Q ss_pred             CHHHHhcCC-----CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccc
Q 041921          604 TLASFLFGN-----LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT  678 (814)
Q Consensus       604 sL~~~l~~~-----~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  678 (814)
                      +|.+++...     ..+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            999999643     2456778889999999999999998   99999999999999999999999999987544322211


Q ss_pred             ccccccCCCCcccccccccC-------CCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCcccee
Q 041921          679 IKTAIRGTKGYVAPEWFRNS-------KITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVL  750 (814)
Q Consensus       679 ~~~~~~gt~~y~aPE~~~~~-------~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  750 (814)
                      ......++..|+|||++...       .++.++||||||+++|||++ |+.||......+...      ..+.... ...
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~------~~~~~~~-~~~  230 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLT------YTVREQQ-LKL  230 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHH------HHhhccc-CCC
Confidence            11234577889999998642       35789999999999999996 999996543322110      0111111 111


Q ss_pred             ecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 041921          751 VGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE  793 (814)
Q Consensus       751 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~  793 (814)
                      ..+...    ....+.+.+++..|+ .+|++|||+++|++.|+
T Consensus       231 ~~~~~~----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         231 PKPRLK----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCccC----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            111111    112345677888998 58999999999999985

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.3e-35  Score=308.69  Aligned_cols=260  Identities=28%  Similarity=0.447  Sum_probs=206.4

Q ss_pred             HHHhhhccccceeeeeeeeEEEEEEecC---CCceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccceeeeecccc
Q 041921          516 LEGATNNFKEEVGRGSFGIVYKGVIQTR---TSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ  591 (814)
Q Consensus       516 l~~~~~~~~~~LG~G~~g~Vy~~~~~~~---~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  591 (814)
                      +....+.+.++||+|+||.||+|.....   .....|++|.+.... .....++.+|+.++..++|+||+++++++....
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   82 (277)
T cd05032           3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ   82 (277)
T ss_pred             cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence            3445566778999999999999987632   234789999986442 233456889999999999999999999999999


Q ss_pred             cceEEEecCCCCCHHHHhcCC----------CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEE
Q 041921          592 NRLLVYEFLNNGTLASFLFGN----------LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTAR  661 (814)
Q Consensus       592 ~~~lv~e~~~~gsL~~~l~~~----------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~k  661 (814)
                      ..++||||+++++|.+++...          ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+|
T Consensus        83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~k  159 (277)
T cd05032          83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVK  159 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEE
Confidence            999999999999999999642          2367889999999999999999998   999999999999999999999


Q ss_pred             EeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHH
Q 041921          662 ISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFD  740 (814)
Q Consensus       662 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~  740 (814)
                      |+|||+++.+.............++..|+|||.+.+..++.++||||||++++||++ |..||......+.       .+
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-------~~  232 (277)
T cd05032         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV-------LK  232 (277)
T ss_pred             ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHH-------HH
Confidence            999999986654332211133346789999999988889999999999999999998 8888864433221       11


Q ss_pred             HhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 041921          741 CYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEG  794 (814)
Q Consensus       741 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~  794 (814)
                      ....+....         .+...+.++.+++.+||+.+|++|||+.++++.|++
T Consensus       233 ~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         233 FVIDGGHLD---------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             HHhcCCCCC---------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence            111221111         111235788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=5.6e-35  Score=306.04  Aligned_cols=250  Identities=28%  Similarity=0.424  Sum_probs=199.9

Q ss_pred             ceeeeeeeeEEEEEEecCCCceEEEEEEeccccc-cchHhHHHHHHhhhccCCCCccceeeeecccccceEEEecCCCCC
Q 041921          526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGT  604 (814)
Q Consensus       526 ~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  604 (814)
                      .||+|+||.||+|.+...+.+..||+|.+..... ...+++.+|+.++++++|+||+++++++. ....++|+||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            4899999999999887555567899999875432 22356899999999999999999999885 457899999999999


Q ss_pred             HHHHhcC-CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcccc-ccc
Q 041921          605 LASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI-KTA  682 (814)
Q Consensus       605 L~~~l~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~-~~~  682 (814)
                      |.+++.. ...+++..+++++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++........... ...
T Consensus        81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  157 (257)
T cd05115          81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA  157 (257)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence            9999975 45689999999999999999999998   999999999999999999999999999986544322111 122


Q ss_pred             ccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCcH
Q 041921          683 IRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDI  761 (814)
Q Consensus       683 ~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  761 (814)
                      ..++..|+|||.+....++.++||||||+++||+++ |..||......+       +...+..+...         ..+.
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~---------~~~~  221 (257)
T cd05115         158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE-------VMSFIEQGKRL---------DCPA  221 (257)
T ss_pred             CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHHCCCCC---------CCCC
Confidence            224578999999988889999999999999999996 999987543322       11222222110         1122


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 041921          762 ECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV  795 (814)
Q Consensus       762 ~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~  795 (814)
                      ...+++.+++.+||+.+|++||++.+|.+.|+.+
T Consensus       222 ~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         222 ECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            3457888999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=5.7e-35  Score=306.90  Aligned_cols=254  Identities=28%  Similarity=0.449  Sum_probs=203.3

Q ss_pred             HHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEE
Q 041921          517 EGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV  596 (814)
Q Consensus       517 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  596 (814)
                      ....+.+.++||+|+||.||+|...   +...||+|+++.. ....+++..|+.++++++|+||+++++++.+ ...++|
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~---~~~~valK~~~~~-~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv   78 (262)
T cd05071           4 PRESLRLEVKLGQGCFGEVWMGTWN---GTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV   78 (262)
T ss_pred             ChHHeeEeeecCCCCCCcEEEEEec---CCceEEEEecccC-ccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEE
Confidence            3456788899999999999999875   3356999999753 2345678999999999999999999998754 567999


Q ss_pred             EecCCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccC
Q 041921          597 YEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN  674 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~  674 (814)
                      |||+++++|.+++...  ..+++..+..++.|+++||+|||+.   +|+|+||||+||++++++.+||+|||+++.+...
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~  155 (262)
T cd05071          79 TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN  155 (262)
T ss_pred             EEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence            9999999999999753  4578999999999999999999998   9999999999999999999999999999866533


Q ss_pred             CcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeecC
Q 041921          675 QSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGE  753 (814)
Q Consensus       675 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  753 (814)
                      .... .....++..|+|||.+.+..++.++||||||++++||++ |..||......+       .......+.       
T Consensus       156 ~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~-------~~~~~~~~~-------  220 (262)
T cd05071         156 EYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGY-------  220 (262)
T ss_pred             cccc-ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH-------HHHHHhcCC-------
Confidence            2211 122346678999999988889999999999999999999 888886443221       111111111       


Q ss_pred             cccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 041921          754 DKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV  795 (814)
Q Consensus       754 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~  795 (814)
                        ......+.+..+.+++.+|++++|++||+++++++.|++.
T Consensus       221 --~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         221 --RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             --CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence              0011234557788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=4.1e-35  Score=309.28  Aligned_cols=258  Identities=26%  Similarity=0.452  Sum_probs=205.0

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCC-CceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccceeeeecccccceEE
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRT-STTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV  596 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  596 (814)
                      ..+.+.+.||+|+||.||+|.+...+ ....|+||.+.... .....+|..|+.++++++||||+++++++.++...++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            44677899999999999999986433 23579999987542 33456799999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCC
Q 041921          597 YEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ  675 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~  675 (814)
                      +||+++++|.+++... ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++.......
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~  160 (269)
T cd05065          84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  160 (269)
T ss_pred             EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence            9999999999999764 5678999999999999999999998   99999999999999999999999999987664332


Q ss_pred             ccccccc-cc--CCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceee
Q 041921          676 SKTIKTA-IR--GTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLV  751 (814)
Q Consensus       676 ~~~~~~~-~~--gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  751 (814)
                      ....... ..  .+..|+|||.+....++.++||||||++++|+++ |..||......+   .    ...+....     
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~---~----~~~i~~~~-----  228 (269)
T cd05065         161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---V----INAIEQDY-----  228 (269)
T ss_pred             cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH---H----HHHHHcCC-----
Confidence            2111111 11  2457999999998899999999999999999987 999986443221   1    11111110     


Q ss_pred             cCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 041921          752 GEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV  795 (814)
Q Consensus       752 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~  795 (814)
                          ..+...+.+..+.+++.+|++.+|.+||++.++++.|+.+
T Consensus       229 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         229 ----RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             ----cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                0111223456788999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.5e-36  Score=283.69  Aligned_cols=244  Identities=26%  Similarity=0.375  Sum_probs=204.6

Q ss_pred             ccccceeeeeeeeEEEEEEecCCCceEEEEEEeccc---cccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEe
Q 041921          522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV---FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE  598 (814)
Q Consensus       522 ~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  598 (814)
                      ++++.||+|-||.||.|..+  .....||+|.+.+.   ..+.++++.+|+++-..++||||+++++++.+....||++|
T Consensus        25 eigr~LgkgkFG~vYlarek--ks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilE  102 (281)
T KOG0580|consen   25 EIGRPLGKGKFGNVYLAREK--KSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILE  102 (281)
T ss_pred             cccccccCCccccEeEeeec--cCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEE
Confidence            45789999999999999975  36779999999642   23345689999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhc--CCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCc
Q 041921          599 FLNNGTLASFLF--GNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS  676 (814)
Q Consensus       599 ~~~~gsL~~~l~--~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  676 (814)
                      |.+.|+|...|.  ...+++......++.|+|.||.|+|..   +|+||||||+|+|++..+.+||+|||-+..-.... 
T Consensus       103 ya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~k-  178 (281)
T KOG0580|consen  103 YAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSNK-  178 (281)
T ss_pred             ecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecCCCC-
Confidence            999999999999  457788999999999999999999998   99999999999999999999999999987654221 


Q ss_pred             ccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCccc
Q 041921          677 KTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKE  756 (814)
Q Consensus       677 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  756 (814)
                         ....+||..|++||..++...+...|+|++|++.||++.|..||......+       ..+.+..-++.   .    
T Consensus       179 ---R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e-------tYkrI~k~~~~---~----  241 (281)
T KOG0580|consen  179 ---RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE-------TYKRIRKVDLK---F----  241 (281)
T ss_pred             ---ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH-------HHHHHHHcccc---C----
Confidence               245789999999999999999999999999999999999999997654322       11222222111   1    


Q ss_pred             ccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          757 AMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       757 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                         +........+++..|+..+|.+|.+..|+++.
T Consensus       242 ---p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  242 ---PSTISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             ---CcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence               12334667889999999999999999998753

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=3.2e-35  Score=319.16  Aligned_cols=244  Identities=25%  Similarity=0.322  Sum_probs=193.8

Q ss_pred             cceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhcc-CCCCccceeeeecccccceEEEecC
Q 041921          525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRLLVYEFL  600 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  600 (814)
                      +.||+|+||.||++....  .++.+|+|.++...   ....+.+..|+.++.++ +||||+++++++.+.+..++||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~   78 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKK--TERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYV   78 (329)
T ss_pred             CeeeeCCCeEEEEEEECC--CCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCC
Confidence            469999999999998763  56789999987532   22334577888888776 8999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccccc
Q 041921          601 NNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIK  680 (814)
Q Consensus       601 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  680 (814)
                      ++++|..++.....+++.....++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++.......  ..
T Consensus        79 ~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--~~  153 (329)
T cd05618          79 NGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TT  153 (329)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--cc
Confidence            9999999998888899999999999999999999998   999999999999999999999999999875332211  11


Q ss_pred             ccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccch--hhhhHHHHHHHHhhcCccceeecCccccc
Q 041921          681 TAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGE--EYAILTDWAFDCYRNGKLNVLVGEDKEAM  758 (814)
Q Consensus       681 ~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  758 (814)
                      ....||..|+|||.+.+..++.++||||||+++|||++|+.||......  .......+..+.+..+...          
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~----------  223 (329)
T cd05618         154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR----------  223 (329)
T ss_pred             ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCC----------
Confidence            3456899999999999999999999999999999999999999632211  1111122233333222221          


Q ss_pred             CcHHHHHHHHHHHHHccccCCCCCCCH
Q 041921          759 NDIECLGKLVMVSIWCIQEDPSLRPTM  785 (814)
Q Consensus       759 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~  785 (814)
                      .+......+.+++.+||+.||.+||+.
T Consensus       224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         224 IPRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence            111234567899999999999999983

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-35  Score=300.80  Aligned_cols=261  Identities=25%  Similarity=0.332  Sum_probs=201.0

Q ss_pred             ccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc--cchHhHHHHHHhhhccCCCCccceeeeecc-----cccceEE
Q 041921          524 KEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ--DGEREFKNEVFVIGQTHHKNLVRLLGFCDE-----GQNRLLV  596 (814)
Q Consensus       524 ~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~~~lv  596 (814)
                      .+.||+|+||.|.++....  ++..||||++.....  -..++-.+|+.+|+.++|+||+.+++.+..     -+..|+|
T Consensus        27 ~~~iG~GAyGvVcsA~~~~--t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV  104 (359)
T KOG0660|consen   27 IEPIGRGAYGVVCSAKDKR--TGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLV  104 (359)
T ss_pred             cccccCcceeeEEEEEEcC--CCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEe
Confidence            4679999999999999764  568999999974332  234567899999999999999999998855     3568999


Q ss_pred             EecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCc
Q 041921          597 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS  676 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  676 (814)
                      +|+| ..+|...|+..+.++.....-++.|+++||+|+|+.   +|+||||||+|+|++.+..+||+|||+|+.......
T Consensus       105 ~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~  180 (359)
T KOG0660|consen  105 FELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFE  180 (359)
T ss_pred             hhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeeccccCc
Confidence            9999 669999999888899999999999999999999998   999999999999999999999999999998865433


Q ss_pred             ccccccccCCCCccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHH--------HHHHHHhhcCcc
Q 041921          677 KTIKTAIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILT--------DWAFDCYRNGKL  747 (814)
Q Consensus       677 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~--------~~~~~~~~~~~~  747 (814)
                      ....+..+.|..|.|||.+.. ..|+.+.||||.|||+.||++|+..|.+.....+-.+.        +.....+.....
T Consensus       181 ~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~a  260 (359)
T KOG0660|consen  181 DGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKA  260 (359)
T ss_pred             ccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHH
Confidence            333467788999999998754 57999999999999999999999999755332211110        001111111111


Q ss_pred             ceeecCcccc---c---CcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          748 NVLVGEDKEA---M---NDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       748 ~~~~~~~~~~---~---~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      ...+...+..   +   .-.......++++.+||..||.+|+|++|.++
T Consensus       261 r~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  261 RPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             HHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence            1111100000   0   01123456778999999999999999999985

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.7e-35  Score=307.25  Aligned_cols=250  Identities=27%  Similarity=0.436  Sum_probs=200.4

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEec
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  599 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  599 (814)
                      .+.+.+.||+|+||.||+|...   ....+|+|.+... .....++.+|++++++++|+||+++++++.+.+..++|+||
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~---~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWR---GKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY   80 (256)
T ss_pred             HcchhhhhccCCCceEEEeEec---CCccEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence            3557789999999999999875   3557999988643 23445788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccc
Q 041921          600 LNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT  678 (814)
Q Consensus       600 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  678 (814)
                      +++++|.+++... ..+++..+..++.|+++||+|||+.   +|+||||||+||++++++.+||+|||+++.........
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~  157 (256)
T cd05059          81 MANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS  157 (256)
T ss_pred             CCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence            9999999999754 4678999999999999999999998   99999999999999999999999999987654322111


Q ss_pred             ccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccc
Q 041921          679 IKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEA  757 (814)
Q Consensus       679 ~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  757 (814)
                      . ....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.       ......+..         .
T Consensus       158 ~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-------~~~~~~~~~---------~  220 (256)
T cd05059         158 S-QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV-------VESVSAGYR---------L  220 (256)
T ss_pred             c-CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH-------HHHHHcCCc---------C
Confidence            1 11224567999999998899999999999999999999 8888864432211       111111110         0


Q ss_pred             cCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 041921          758 MNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE  793 (814)
Q Consensus       758 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~  793 (814)
                      ..+...+.++.+++.+|++.+|++|||+.++++.|.
T Consensus       221 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~  256 (256)
T cd05059         221 YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT  256 (256)
T ss_pred             CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence            111224568899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=3.6e-35  Score=318.90  Aligned_cols=249  Identities=24%  Similarity=0.322  Sum_probs=197.9

Q ss_pred             cceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhcc-CCCCccceeeeecccccceEEEecC
Q 041921          525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRLLVYEFL  600 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  600 (814)
                      +.||+|+||.||++....  .+..||||.++...   ....+.+..|..++.++ +||||+++++++.+.+..++||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~--~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~   78 (329)
T cd05588           1 RVIGRGSYAKVLLVELKK--TRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFV   78 (329)
T ss_pred             CeEeeCCCeEEEEEEECC--CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCC
Confidence            469999999999999753  57789999997532   22334578899999888 7999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccccc
Q 041921          601 NNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIK  680 (814)
Q Consensus       601 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  680 (814)
                      ++++|..++.....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.......  ..
T Consensus        79 ~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~--~~  153 (329)
T cd05588          79 SGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--TT  153 (329)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCC--cc
Confidence            9999999998878899999999999999999999998   999999999999999999999999999874321111  11


Q ss_pred             ccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchh--hhhHHHHHHHHhhcCccceeecCccccc
Q 041921          681 TAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILTDWAFDCYRNGKLNVLVGEDKEAM  758 (814)
Q Consensus       681 ~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  758 (814)
                      ....||..|+|||.+.+..++.++|||||||++|||++|+.||......+  ......+..+.+..+....         
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------  224 (329)
T cd05588         154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRI---------  224 (329)
T ss_pred             ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCC---------
Confidence            34568999999999999999999999999999999999999996432111  1111222333333322211         


Q ss_pred             CcHHHHHHHHHHHHHccccCCCCCCC------HHHHHH
Q 041921          759 NDIECLGKLVMVSIWCIQEDPSLRPT------MKKVLQ  790 (814)
Q Consensus       759 ~~~~~~~~l~~l~~~Cl~~dp~~RPt------~~~vl~  790 (814)
                       +.....++.+++.+||+.||.+||+      ++++++
T Consensus       225 -p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         225 -PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             -CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence             1123456789999999999999997      667753

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2.4e-35  Score=317.38  Aligned_cols=264  Identities=28%  Similarity=0.407  Sum_probs=206.8

Q ss_pred             HHHHhhhccccceeeeeeeeEEEEEEecCC-----CceEEEEEEecccc-ccchHhHHHHHHhhhcc-CCCCccceeeee
Q 041921          515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRT-----STTAVAVKKLDRVF-QDGEREFKNEVFVIGQT-HHKNLVRLLGFC  587 (814)
Q Consensus       515 ~l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~-----~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  587 (814)
                      ++....+.+.++||+|+||.||++......     ....+|+|.+.... .....++..|+.++.++ +|+||+++++++
T Consensus        14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (307)
T cd05098          14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC   93 (307)
T ss_pred             eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            344566788899999999999999864321     23579999987532 23345688899999999 799999999999


Q ss_pred             cccccceEEEecCCCCCHHHHhcCC----------------CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCc
Q 041921          588 DEGQNRLLVYEFLNNGTLASFLFGN----------------LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQN  651 (814)
Q Consensus       588 ~~~~~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~N  651 (814)
                      .+.+..++|+||+++++|.+++...                ..+++.++++++.|++.||+|||+.   +++||||||+|
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N  170 (307)
T cd05098          94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARN  170 (307)
T ss_pred             ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHh
Confidence            9999999999999999999999753                2478889999999999999999998   99999999999


Q ss_pred             EEEcCCCcEEEeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchh
Q 041921          652 ILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEE  730 (814)
Q Consensus       652 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~  730 (814)
                      |+++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.....++
T Consensus       171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~  250 (307)
T cd05098         171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE  250 (307)
T ss_pred             eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence            9999999999999999876543221111122234568999999998889999999999999999998 888886433221


Q ss_pred             hhhHHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 041921          731 YAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE  797 (814)
Q Consensus       731 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~  797 (814)
                             ....+..+...         ..+.....++.+++.+|++.+|.+||||.++++.|+.+.+
T Consensus       251 -------~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~  301 (307)
T cd05098         251 -------LFKLLKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA  301 (307)
T ss_pred             -------HHHHHHcCCCC---------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence                   11122222110         1112335678899999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=5.4e-35  Score=306.69  Aligned_cols=255  Identities=29%  Similarity=0.456  Sum_probs=205.0

Q ss_pred             HHHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccce
Q 041921          515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRL  594 (814)
Q Consensus       515 ~l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  594 (814)
                      ++...++++.++||+|+||.||+|...   ++..||+|.+.... ....++.+|+.++++++|+||+++++++. .+..+
T Consensus         2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~---~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~   76 (260)
T cd05067           2 EVPRETLKLVKKLGAGQFGEVWMGYYN---GHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY   76 (260)
T ss_pred             ccchHHceeeeeeccCccceEEeeecC---CCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence            355677888999999999999999865   46789999987542 34567999999999999999999999874 45789


Q ss_pred             EEEecCCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccc
Q 041921          595 LVYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLT  672 (814)
Q Consensus       595 lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~  672 (814)
                      +++||+++++|.+++...  ..+++..+..++.|++.||+|||+.   +++|+||||+||++++++.++|+|||++....
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  153 (260)
T cd05067          77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIE  153 (260)
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecC
Confidence            999999999999998653  4678899999999999999999988   99999999999999999999999999997665


Q ss_pred             cCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceee
Q 041921          673 LNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLV  751 (814)
Q Consensus       673 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  751 (814)
                      ...... .....++..|+|||.+....++.++||||||++++||++ |+.||......+.       ...+..+...   
T Consensus       154 ~~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-------~~~~~~~~~~---  222 (260)
T cd05067         154 DNEYTA-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV-------IQNLERGYRM---  222 (260)
T ss_pred             CCCccc-ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH-------HHHHHcCCCC---
Confidence            322111 123346778999999998889999999999999999999 9999964432211       1111111100   


Q ss_pred             cCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 041921          752 GEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEG  794 (814)
Q Consensus       752 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~  794 (814)
                            ......+.++.+++.+|++.+|++|||++++++.|+.
T Consensus       223 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         223 ------PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             ------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence                  0111234679999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=6.2e-35  Score=306.26  Aligned_cols=252  Identities=28%  Similarity=0.432  Sum_probs=201.8

Q ss_pred             HhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEE
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY  597 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  597 (814)
                      ...+.+.++||+|+||.||+|...   .+..+++|.+.... ...+.+.+|+.++++++|+|++++++++. ....+++|
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~---~~~~~~~k~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~   79 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWN---GNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVT   79 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEec---CCceeEEEEecCCC-CCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEE
Confidence            445677889999999999999875   45679999987532 24567999999999999999999999885 45689999


Q ss_pred             ecCCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCC
Q 041921          598 EFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ  675 (814)
Q Consensus       598 e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~  675 (814)
                      ||+++++|.+++...  ..+++..+..++.|++.||+|||+.   +|+|+||||+||++++++.++|+|||++..+....
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05070          80 EYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence            999999999999753  4578999999999999999999998   99999999999999999999999999998765332


Q ss_pred             cccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeecCc
Q 041921          676 SKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGED  754 (814)
Q Consensus       676 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  754 (814)
                      .... ....++..|+|||.+.+..++.++||||||++++||++ |..||......+   .    ...+..+.        
T Consensus       157 ~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~----~~~~~~~~--------  220 (260)
T cd05070         157 YTAR-QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE---V----LEQVERGY--------  220 (260)
T ss_pred             cccc-cCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---H----HHHHHcCC--------
Confidence            1111 22235678999999988889999999999999999999 888886433221   1    11111110        


Q ss_pred             ccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 041921          755 KEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEG  794 (814)
Q Consensus       755 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~  794 (814)
                       ..+.+...+..+.+++.+|++.+|.+|||+.++.+.|++
T Consensus       221 -~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         221 -RMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             -CCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence             001122345678999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=3.9e-35  Score=317.27  Aligned_cols=237  Identities=25%  Similarity=0.357  Sum_probs=193.0

Q ss_pred             cceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhcc-CCCCccceeeeecccccceEEEecC
Q 041921          525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRLLVYEFL  600 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  600 (814)
                      +.||+|+||.||+|....  ++..||||.+....   ....+.+..|..++..+ +||||+++++++.+.+..++||||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~   78 (320)
T cd05590           1 RVLGKGSFGKVMLARLKE--SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFV   78 (320)
T ss_pred             CeeeeCCCeEEEEEEEcC--CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCC
Confidence            469999999999998653  56789999986431   23345677888888776 7999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccccc
Q 041921          601 NNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIK  680 (814)
Q Consensus       601 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  680 (814)
                      ++++|.+++.....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......  ..
T Consensus        79 ~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~--~~  153 (320)
T cd05590          79 NGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--TT  153 (320)
T ss_pred             CCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC--cc
Confidence            9999999998888899999999999999999999998   999999999999999999999999999875432211  11


Q ss_pred             ccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCc
Q 041921          681 TAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMND  760 (814)
Q Consensus       681 ~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  760 (814)
                      ....||+.|+|||.+.+..++.++|||||||++|||++|+.||......+       ....+..+...          .+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-------~~~~i~~~~~~----------~~  216 (320)
T cd05590         154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD-------LFEAILNDEVV----------YP  216 (320)
T ss_pred             cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH-------HHHHHhcCCCC----------CC
Confidence            34568999999999998899999999999999999999999997543322       11222222111          01


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCH
Q 041921          761 IECLGKLVMVSIWCIQEDPSLRPTM  785 (814)
Q Consensus       761 ~~~~~~l~~l~~~Cl~~dp~~RPt~  785 (814)
                      ......+.+++.+||+.||.+||++
T Consensus       217 ~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         217 TWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             CCCCHHHHHHHHHHcccCHHHCCCC
Confidence            1234577899999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=6.5e-35  Score=305.43  Aligned_cols=250  Identities=28%  Similarity=0.411  Sum_probs=201.8

Q ss_pred             cceeeeeeeeEEEEEEecC-CCceEEEEEEeccccc-cchHhHHHHHHhhhccCCCCccceeeeecccccceEEEecCCC
Q 041921          525 EEVGRGSFGIVYKGVIQTR-TSTTAVAVKKLDRVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN  602 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~-~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  602 (814)
                      ++||+|++|.||+|.+... +....||||.+..... ...+.+..|+.++++++||||+++++++.+ ...++|+||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            4689999999999998652 3345799999976544 455679999999999999999999999988 888999999999


Q ss_pred             CCHHHHhcCCC--CCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcc-cc
Q 041921          603 GTLASFLFGNL--KPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSK-TI  679 (814)
Q Consensus       603 gsL~~~l~~~~--~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~-~~  679 (814)
                      ++|.+++....  .+++.....++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++..+...... ..
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  156 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM  156 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence            99999997653  689999999999999999999998   9999999999999999999999999999876543221 11


Q ss_pred             cccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeecCccccc
Q 041921          680 KTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAM  758 (814)
Q Consensus       680 ~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  758 (814)
                      .....++..|+|||.+....++.++||||||++++||++ |+.||......+.   ....   .....       ..  .
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~~---~~~~~-------~~--~  221 (257)
T cd05040         157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI---LKKI---DKEGE-------RL--E  221 (257)
T ss_pred             ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHH---HhcCC-------cC--C
Confidence            123457789999999998899999999999999999999 9999864433221   1111   00110       00  0


Q ss_pred             CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 041921          759 NDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE  793 (814)
Q Consensus       759 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~  793 (814)
                      .....+..+.+++.+|++.+|++|||+.++++.|.
T Consensus       222 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         222 RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            11234567889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=9.6e-35  Score=306.01  Aligned_cols=256  Identities=21%  Similarity=0.338  Sum_probs=204.6

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhccCCCCccceeeeecccccceEE
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV  596 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  596 (814)
                      .+.+.++||+|+||.||+|+...  ++..||||.+....   ......+.+|+++++.++||||+++++++.+.+..+++
T Consensus         3 ~~~i~~~l~~g~~~~v~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08228           3 NFQIEKKIGRGQFSEVYRATCLL--DRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV   80 (267)
T ss_pred             ceeeeeeeccCCCeeEEEEEEeC--CCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence            45677899999999999999753  56789999875321   22334688999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhcC----CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccc
Q 041921          597 YEFLNNGTLASFLFG----NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLT  672 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~  672 (814)
                      +||+++++|.+++..    ...++......++.|+++||.|||+.   +++|+||||+||+++.++.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~  157 (267)
T cd08228          81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence            999999999988853    34578888999999999999999998   99999999999999999999999999988765


Q ss_pred             cCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeec
Q 041921          673 LNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVG  752 (814)
Q Consensus       673 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  752 (814)
                      .....  .....++..|+|||.+.+..++.++|+||||+++|||++|+.||........    .. ...+.....     
T Consensus       158 ~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~----~~-~~~~~~~~~-----  225 (267)
T cd08228         158 SKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF----SL-CQKIEQCDY-----  225 (267)
T ss_pred             chhHH--HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHH----HH-HHHHhcCCC-----
Confidence            33211  1234588899999999888899999999999999999999999864332211    11 111111110     


Q ss_pred             CcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 041921          753 EDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV  795 (814)
Q Consensus       753 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~  795 (814)
                      +.   .........+.+++.+||+.+|++||+++++++.|+++
T Consensus       226 ~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         226 PP---LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             CC---CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence            00   01123456789999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=7.7e-35  Score=306.77  Aligned_cols=255  Identities=22%  Similarity=0.294  Sum_probs=202.5

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEe
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE  598 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  598 (814)
                      ..+.+.++||+|+||.||+|+...  ++..||+|.+..........+.+|+.++.+++||||+++++++..++..++|+|
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~--~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e   86 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLH--TGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME   86 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECC--CCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence            456777899999999999998653  567899999875444445678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccc
Q 041921          599 FLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT  678 (814)
Q Consensus       599 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  678 (814)
                      |+++++|.+++.....+++..+..++.|+++||.|||+.   +|+||||+|+||+++.++.+||+|||++..+...... 
T Consensus        87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~-  162 (267)
T cd06646          87 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK-  162 (267)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecccccc-
Confidence            999999999998777889999999999999999999998   9999999999999999999999999999866432211 


Q ss_pred             ccccccCCCCcccccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcc
Q 041921          679 IKTAIRGTKGYVAPEWFR---NSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDK  755 (814)
Q Consensus       679 ~~~~~~gt~~y~aPE~~~---~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  755 (814)
                       .....++..|+|||.+.   ...++.++||||||++++||++|+.|+......+...       .......   ..+..
T Consensus       163 -~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~-------~~~~~~~---~~~~~  231 (267)
T cd06646         163 -RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-------LMSKSNF---QPPKL  231 (267)
T ss_pred             -cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe-------eeecCCC---CCCCC
Confidence             12345888999999884   3457889999999999999999999985332211000       0000000   00001


Q ss_pred             cccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 041921          756 EAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQML  792 (814)
Q Consensus       756 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L  792 (814)
                        .........+.+++.+||+.+|++|||++++++.|
T Consensus       232 --~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         232 --KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             --ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence              11123456888999999999999999999998754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2.3e-35  Score=320.01  Aligned_cols=243  Identities=23%  Similarity=0.273  Sum_probs=196.8

Q ss_pred             cceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEecCC
Q 041921          525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLN  601 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  601 (814)
                      +.||+|+||.||++...  ..+..||+|.+....   ......+..|++++..++||||+++.+++.+.+..++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~--~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~   78 (325)
T cd05594           1 KLLGKGTFGKVILVKEK--ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYAN   78 (325)
T ss_pred             CeeeeCCCEEEEEEEEC--CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence            46999999999999865  357899999997532   2233467889999999999999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccccc
Q 041921          602 NGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHE-DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIK  680 (814)
Q Consensus       602 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  680 (814)
                      +++|..++.....+++.....++.||+.||+|||+ .   +|+||||||+|||++.++.+||+|||+++........  .
T Consensus        79 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~--~  153 (325)
T cd05594          79 GGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--M  153 (325)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc--c
Confidence            99999999888889999999999999999999997 5   8999999999999999999999999998754322111  1


Q ss_pred             ccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCc
Q 041921          681 TAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMND  760 (814)
Q Consensus       681 ~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  760 (814)
                      ....||+.|+|||.+.+..++.++|||||||++|||++|+.||.....+..       ...+..+...          .+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~-------~~~i~~~~~~----------~p  216 (325)
T cd05594         154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL-------FELILMEEIR----------FP  216 (325)
T ss_pred             ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH-------HHHHhcCCCC----------CC
Confidence            335699999999999999999999999999999999999999965432221       1111111111          01


Q ss_pred             HHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 041921          761 IECLGKLVMVSIWCIQEDPSLRP-----TMKKVLQM  791 (814)
Q Consensus       761 ~~~~~~l~~l~~~Cl~~dp~~RP-----t~~~vl~~  791 (814)
                      ......+.+++.+||+.||.+|+     ++.++++.
T Consensus       217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         217 RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            12345678899999999999996     89998753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=4.2e-35  Score=317.42  Aligned_cols=243  Identities=23%  Similarity=0.334  Sum_probs=196.4

Q ss_pred             cceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhcc-CCCCccceeeeecccccceEEEecC
Q 041921          525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRLLVYEFL  600 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  600 (814)
                      ++||+|+||.||+|...  ..+..||||.+....   ....+.+..|.+++..+ +||||+++++++.+.+..++||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~   78 (321)
T cd05591           1 KVLGKGSFGKVMLAELK--GTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYV   78 (321)
T ss_pred             CccccCCCeEEEEEEEC--CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCC
Confidence            46999999999999875  356789999986532   22334577888888866 8999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccccc
Q 041921          601 NNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIK  680 (814)
Q Consensus       601 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  680 (814)
                      ++++|..++.....+++.....++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++........  ..
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~  153 (321)
T cd05591          79 NGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TT  153 (321)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCc--cc
Confidence            9999999998888899999999999999999999998   999999999999999999999999999875432221  11


Q ss_pred             ccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCc
Q 041921          681 TAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMND  760 (814)
Q Consensus       681 ~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  760 (814)
                      ....||..|+|||.+.+..++.++||||||+++|||++|+.||......+.       ...+..+...          .+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~-------~~~i~~~~~~----------~p  216 (321)
T cd05591         154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL-------FESILHDDVL----------YP  216 (321)
T ss_pred             cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH-------HHHHHcCCCC----------CC
Confidence            345689999999999998999999999999999999999999975543221       1112222110          01


Q ss_pred             HHHHHHHHHHHHHccccCCCCCC-------CHHHHHHH
Q 041921          761 IECLGKLVMVSIWCIQEDPSLRP-------TMKKVLQM  791 (814)
Q Consensus       761 ~~~~~~l~~l~~~Cl~~dp~~RP-------t~~~vl~~  791 (814)
                      .....++.+++..||+.||++||       +++++++.
T Consensus       217 ~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         217 VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            11345678999999999999999       77777643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.3e-35  Score=324.01  Aligned_cols=268  Identities=19%  Similarity=0.196  Sum_probs=205.2

Q ss_pred             HHHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccce
Q 041921          515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRL  594 (814)
Q Consensus       515 ~l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  594 (814)
                      .+...++.+.+.||+|+||.||++..........|+||.+...     +.+.+|+.++++++||||+++++++......+
T Consensus        88 ~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~  162 (392)
T PHA03207         88 SVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVC  162 (392)
T ss_pred             hhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence            3344567888999999999999998765556788999988642     24578999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccC
Q 041921          595 LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN  674 (814)
Q Consensus       595 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~  674 (814)
                      +|||++. ++|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++......
T Consensus       163 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        163 MVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH  238 (392)
T ss_pred             EEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence            9999985 68888887777899999999999999999999998   9999999999999999999999999999866543


Q ss_pred             CcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCcccee----
Q 041921          675 QSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVL----  750 (814)
Q Consensus       675 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  750 (814)
                      ..........||+.|+|||.+....++.++|||||||++|||++|+.||..............+.+.+........    
T Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~  318 (392)
T PHA03207        239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS  318 (392)
T ss_pred             cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence            3322223456999999999999999999999999999999999999999654332111111111111111100000    


Q ss_pred             -------------ecCccccc---CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          751 -------------VGEDKEAM---NDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       751 -------------~~~~~~~~---~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                                   ..+....+   ........+.+++.+||+.||.+|||+.+++..
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence                         00000000   001123567789999999999999999999875

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-34  Score=298.05  Aligned_cols=267  Identities=24%  Similarity=0.326  Sum_probs=201.6

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhcc--CCCCccceeeeecccc----c
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQT--HHKNLVRLLGFCDEGQ----N  592 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~~----~  592 (814)
                      .+..+.+.||+|.||.||+|.++    |..||||.+..   .+++.+.+|.++.+.+  +|+||+.+++....++    +
T Consensus       211 rqI~L~e~IGkGRyGEVwrG~wr----Ge~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ  283 (513)
T KOG2052|consen  211 RQIVLQEIIGKGRFGEVWRGRWR----GEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ  283 (513)
T ss_pred             heeEEEEEecCccccceeecccc----CCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence            34456788999999999999996    78899999964   3456788888877765  9999999999886654    5


Q ss_pred             ceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhc-----CCCCeeecCCCCCcEEEcCCCcEEEeecCC
Q 041921          593 RLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHED-----CRAQIIHCDIKPQNILLDDYYTARISDFGL  667 (814)
Q Consensus       593 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~-----~~~~i~H~dlkp~NIll~~~~~~kl~DfGl  667 (814)
                      ++||.+|.++|||.|||.. ..++....++++..+|.||+|||-+     .+|.|+|||||+.||||..++.+.|+|+||
T Consensus       284 LwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL  362 (513)
T KOG2052|consen  284 LWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  362 (513)
T ss_pred             EEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence            7899999999999999987 6788899999999999999999964     478899999999999999999999999999


Q ss_pred             ccccccCCcc--cccccccCCCCcccccccccCC----C--CcchhhHHHHHHHHHHHhCC----------CCCCcccch
Q 041921          668 AKLLTLNQSK--TIKTAIRGTKGYVAPEWFRNSK----I--TAKVDVYSFGVLLLEIISCR----------KSFDIEMGE  729 (814)
Q Consensus       668 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~----~--s~~~Dv~s~Gvvl~elltg~----------~p~~~~~~~  729 (814)
                      |.....+...  ...+..+||.+|||||++...-    +  -..+||||||.|+||+....          .||....+.
T Consensus       363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~  442 (513)
T KOG2052|consen  363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS  442 (513)
T ss_pred             eEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC
Confidence            9877655321  1224567999999999996432    2  13599999999999997432          333322221


Q ss_pred             hhhhHHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 041921          730 EYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV  798 (814)
Q Consensus       730 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~~  798 (814)
                      +. .+.+ ..+.+-..++.-.+   +..-...+.+..+.++++.||..+|.-|-|+-.+-+.|.++.+.
T Consensus       443 DP-s~ee-MrkVVCv~~~RP~i---pnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~  506 (513)
T KOG2052|consen  443 DP-SFEE-MRKVVCVQKLRPNI---PNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS  506 (513)
T ss_pred             CC-CHHH-HhcceeecccCCCC---CcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence            11 0000 01111011111111   11122457888999999999999999999999999999887653

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=7.6e-35  Score=314.45  Aligned_cols=241  Identities=27%  Similarity=0.338  Sum_probs=191.9

Q ss_pred             cceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhcc-CCCCccceeeeecccccceEEEecC
Q 041921          525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRLLVYEFL  600 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  600 (814)
                      +.||+|+||.||+|....  .+..||||.++...   ....+.+..|..++... +||||+++++++..++..++||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~   78 (316)
T cd05592           1 KVLGKGSFGKVMLAELKG--TNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYL   78 (316)
T ss_pred             CeeeeCCCeEEEEEEECC--CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCC
Confidence            469999999999999753  56789999986432   22334456666666654 8999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccccc
Q 041921          601 NNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIK  680 (814)
Q Consensus       601 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  680 (814)
                      ++++|..++.....+++.....++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++......  ...
T Consensus        79 ~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~  153 (316)
T cd05592          79 NGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKA  153 (316)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Ccc
Confidence            9999999998877889999999999999999999998   99999999999999999999999999997643322  112


Q ss_pred             ccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCc
Q 041921          681 TAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMND  760 (814)
Q Consensus       681 ~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  760 (814)
                      ....||+.|+|||.+.+..++.++|||||||++|||++|+.||......+       ....+.....        .  .+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~-------~~~~i~~~~~--------~--~~  216 (316)
T cd05592         154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE-------LFDSILNDRP--------H--FP  216 (316)
T ss_pred             ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCCC--------C--CC
Confidence            34568999999999998899999999999999999999999997543321       1111111110        0  11


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 041921          761 IECLGKLVMVSIWCIQEDPSLRPTMK-KVL  789 (814)
Q Consensus       761 ~~~~~~l~~l~~~Cl~~dp~~RPt~~-~vl  789 (814)
                      .....++.+++.+||+.+|.+||++. +++
T Consensus       217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         217 RWISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            12345678899999999999999876 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1e-34  Score=318.67  Aligned_cols=246  Identities=24%  Similarity=0.382  Sum_probs=191.7

Q ss_pred             ccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc-cchHhHHHHHHhhhccCCCCccceeeeecccccceEEEecC
Q 041921          522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL  600 (814)
Q Consensus       522 ~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  600 (814)
                      .+.++||+|+||.||+|....  .++.||||.+..... ...+.+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus        77 ~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  154 (353)
T PLN00034         77 ERVNRIGSGAGGTVYKVIHRP--TGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM  154 (353)
T ss_pred             hhhhhccCCCCeEEEEEEECC--CCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence            355789999999999998753  567999999864322 23457899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccccc
Q 041921          601 NNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIK  680 (814)
Q Consensus       601 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  680 (814)
                      ++++|.+.    ...++.....++.||+.||.|||+.   +|+||||||+|||+++++.+||+|||+++.+......  .
T Consensus       155 ~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~--~  225 (353)
T PLN00034        155 DGGSLEGT----HIADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP--C  225 (353)
T ss_pred             CCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccccc--c
Confidence            99998653    3356677889999999999999998   9999999999999999999999999999876532211  1


Q ss_pred             ccccCCCCccccccccc-----CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcc
Q 041921          681 TAIRGTKGYVAPEWFRN-----SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDK  755 (814)
Q Consensus       681 ~~~~gt~~y~aPE~~~~-----~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  755 (814)
                      ....||..|+|||.+..     ...+.++|||||||++|||++|+.||......+...+   ... .....       . 
T Consensus       226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~---~~~-~~~~~-------~-  293 (353)
T PLN00034        226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASL---MCA-ICMSQ-------P-  293 (353)
T ss_pred             cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHH---HHH-HhccC-------C-
Confidence            33468999999998743     2345689999999999999999999974322221111   100 00000       0 


Q ss_pred             cccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          756 EAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       756 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                       .........++.+++.+||+.||++|||+.|+++.
T Consensus       294 -~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        294 -PEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             -CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             01112345678899999999999999999999875

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-35  Score=324.89  Aligned_cols=253  Identities=23%  Similarity=0.281  Sum_probs=204.0

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhccCCCCccceeeeecccccceEE
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV  596 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  596 (814)
                      .|.+.+.||+|+||+||+|....  .+..||||.+....   ......+..|+.++..++|+||+++++++.+++..++|
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   79 (350)
T cd05573           2 DFEVIKVIGRGAFGEVWLVRDKD--TGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLV   79 (350)
T ss_pred             CceEEEEEEeCCcEEEEEEEECC--CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEE
Confidence            35677899999999999999753  57899999986432   23345688999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCC-
Q 041921          597 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ-  675 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~-  675 (814)
                      |||+++++|.+++.....+++.....++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++....... 
T Consensus        80 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  156 (350)
T cd05573          80 MEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD  156 (350)
T ss_pred             EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence            99999999999998888899999999999999999999998   99999999999999999999999999998665432 


Q ss_pred             --------------------------cccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccch
Q 041921          676 --------------------------SKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGE  729 (814)
Q Consensus       676 --------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~  729 (814)
                                                .........||+.|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~  236 (350)
T cd05573         157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ  236 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence                                      001113346899999999999999999999999999999999999999755432


Q ss_pred             hhhhHHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCC-HHHHHHH
Q 041921          730 EYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPT-MKKVLQM  791 (814)
Q Consensus       730 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-~~~vl~~  791 (814)
                      +.       ...+....      .....+........+.+++.+|++ +|.+||+ ++++++.
T Consensus       237 ~~-------~~~i~~~~------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         237 ET-------YNKIINWK------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             HH-------HHHHhccC------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            11       11111100      000011111145678889999998 9999999 9999874

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.6e-35  Score=304.38  Aligned_cols=249  Identities=29%  Similarity=0.429  Sum_probs=204.7

Q ss_pred             HhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEE
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY  597 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  597 (814)
                      ...+.+.+.||+|+||.||+|...    ++.|+||.+..... ..+++.+|+.++++++|+||+++++++.+....++|+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~----~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   79 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR----GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVT   79 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec----CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEE
Confidence            345667889999999999999864    67899999976533 4667999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhcCCC--CCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCC
Q 041921          598 EFLNNGTLASFLFGNL--KPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ  675 (814)
Q Consensus       598 e~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~  675 (814)
                      ||+++++|.+++....  .+++..+..++.|++.||.|||+.   +++|+||||+||++++++.+||+|||+++......
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~  156 (256)
T cd05039          80 EYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ  156 (256)
T ss_pred             EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccccccc
Confidence            9999999999997654  689999999999999999999998   99999999999999999999999999998763222


Q ss_pred             cccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeecCc
Q 041921          676 SKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGED  754 (814)
Q Consensus       676 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  754 (814)
                      .     ....+..|+|||.+....++.++||||||++++|+++ |+.||......+       ....+..+...      
T Consensus       157 ~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~------  218 (256)
T cd05039         157 D-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPHVEKGYRM------  218 (256)
T ss_pred             c-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHhcCCCC------
Confidence            1     2235678999999988889999999999999999998 999986443221       11111111100      


Q ss_pred             ccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 041921          755 KEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV  795 (814)
Q Consensus       755 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~  795 (814)
                         ..+...+..+.+++.+|++.+|++|||+++++++|+.+
T Consensus       219 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         219 ---EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             ---CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence               01112357788999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=5.7e-35  Score=323.87  Aligned_cols=252  Identities=21%  Similarity=0.269  Sum_probs=196.7

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEE
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY  597 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  597 (814)
                      +.+.++||+|+||+||+|....  .+..+|||.+....   ....+.+..|+.++++++|+||+++++++.+.+..++||
T Consensus         3 f~~~~~LG~G~~g~Vy~~~~~~--~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~   80 (381)
T cd05626           3 FVKIKTLGIGAFGEVCLACKVD--THALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (381)
T ss_pred             ceEEEEEeecCCEEEEEEEECC--CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence            4566889999999999998653  57899999996532   223456889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCc-
Q 041921          598 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS-  676 (814)
Q Consensus       598 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~-  676 (814)
                      ||+++|+|.+++.....+++.....++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++..+..... 
T Consensus        81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~  157 (381)
T cd05626          81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS  157 (381)
T ss_pred             ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence            9999999999998888889999999999999999999998   999999999999999999999999999764321100 


Q ss_pred             --------------------------------------------ccccccccCCCCcccccccccCCCCcchhhHHHHHH
Q 041921          677 --------------------------------------------KTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVL  712 (814)
Q Consensus       677 --------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvv  712 (814)
                                                                  ........||..|+|||.+.+..++.++|||||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i  237 (381)
T cd05626         158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI  237 (381)
T ss_pred             ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence                                                        000123469999999999998889999999999999


Q ss_pred             HHHHHhCCCCCCcccchhhhhHHHHHHHHhh-cCccceeecCcccccCcHHHHHHHHHHHHH--ccccCCCCCCCHHHHH
Q 041921          713 LLEIISCRKSFDIEMGEEYAILTDWAFDCYR-NGKLNVLVGEDKEAMNDIECLGKLVMVSIW--CIQEDPSLRPTMKKVL  789 (814)
Q Consensus       713 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--Cl~~dp~~RPt~~~vl  789 (814)
                      +|||++|+.||......+..      ..... ...+        ..+.......++.+++.+  |+..++..||++++++
T Consensus       238 l~elltG~~Pf~~~~~~~~~------~~i~~~~~~~--------~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l  303 (381)
T cd05626         238 LFEMLVGQPPFLAPTPTETQ------LKVINWENTL--------HIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIK  303 (381)
T ss_pred             HHHHHhCCCCCcCCCHHHHH------HHHHcccccc--------CCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHh
Confidence            99999999999754432211      01010 0011        011111223456667766  6667777899999998


Q ss_pred             HH
Q 041921          790 QM  791 (814)
Q Consensus       790 ~~  791 (814)
                      +.
T Consensus       304 ~h  305 (381)
T cd05626         304 AH  305 (381)
T ss_pred             cC
Confidence            63

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=8e-35  Score=331.26  Aligned_cols=252  Identities=24%  Similarity=0.309  Sum_probs=201.1

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccc--cccchHhHHHHHHhhhccCCCCccceeeeecccc-----
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV--FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ-----  591 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  591 (814)
                      ..|.+.++||+|+||+||+|....  +++.||||.+...  .......+.+|+..+..++|+|++++...+....     
T Consensus        32 ~rY~i~~~LG~G~fG~Vy~a~~~~--~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~  109 (496)
T PTZ00283         32 KKYWISRVLGSGATGTVLCAKRVS--DGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE  109 (496)
T ss_pred             CCEEEEEEEecCCCEEEEEEEEcC--CCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence            467788999999999999998653  5789999998643  2333456889999999999999999988764332     


Q ss_pred             ---cceEEEecCCCCCHHHHhcCC----CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEee
Q 041921          592 ---NRLLVYEFLNNGTLASFLFGN----LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISD  664 (814)
Q Consensus       592 ---~~~lv~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~D  664 (814)
                         ..++||||+++|+|.++|...    ..+++.....++.|++.||.|||+.   +|+||||||+|||++.++.+||+|
T Consensus       110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~D  186 (496)
T PTZ00283        110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGD  186 (496)
T ss_pred             cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEe
Confidence               257999999999999998643    4678889999999999999999998   999999999999999999999999


Q ss_pred             cCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhc
Q 041921          665 FGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN  744 (814)
Q Consensus       665 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  744 (814)
                      ||+++.+.............||+.|+|||.+.+..++.++||||||+++|||++|+.||......+       +......
T Consensus       187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~-------~~~~~~~  259 (496)
T PTZ00283        187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE-------VMHKTLA  259 (496)
T ss_pred             cccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHhc
Confidence            999987654333322244679999999999999999999999999999999999999997543221       1111112


Q ss_pred             CccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          745 GKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       745 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                      +....         .+.....++.+++.+||+.+|.+||++.++++.
T Consensus       260 ~~~~~---------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        260 GRYDP---------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             CCCCC---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            21111         112345678899999999999999999999763

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=7.8e-35  Score=310.43  Aligned_cols=257  Identities=27%  Similarity=0.430  Sum_probs=203.3

Q ss_pred             hhhccccceeeeeeeeEEEEEEec---CCCceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccceeeeecccccce
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQT---RTSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRL  594 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~---~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  594 (814)
                      ..+.+.+.||+|+||.||++....   ......||+|.+.... ....+++.+|+.++++++||||+++++++.++...+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~   84 (288)
T cd05050           5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMC   84 (288)
T ss_pred             HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccE
Confidence            345667889999999999998653   2346789999986532 233467999999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHhcCC----------------------CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcE
Q 041921          595 LVYEFLNNGTLASFLFGN----------------------LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNI  652 (814)
Q Consensus       595 lv~e~~~~gsL~~~l~~~----------------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NI  652 (814)
                      +|+||+++++|.+++...                      ..+++..++.++.|++.||.|||+.   +++||||||+||
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~ni  161 (288)
T cd05050          85 LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNC  161 (288)
T ss_pred             EEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhhe
Confidence            999999999999999632                      2367788899999999999999998   999999999999


Q ss_pred             EEcCCCcEEEeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhh
Q 041921          653 LLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEY  731 (814)
Q Consensus       653 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~  731 (814)
                      ++++++.+||+|||++..+..............+..|+|||.+.+..++.++||||||+++|||++ |..||.....++ 
T Consensus       162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~-  240 (288)
T cd05050         162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE-  240 (288)
T ss_pred             EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-
Confidence            999999999999999876543322111122235678999999998899999999999999999998 888886433222 


Q ss_pred             hhHHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 041921          732 AILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEG  794 (814)
Q Consensus       732 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~  794 (814)
                            ....+..+....         .+...+.++.+++.+|++.+|.+|||+.|+++.|++
T Consensus       241 ------~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         241 ------VIYYVRDGNVLS---------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             ------HHHHHhcCCCCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence                  112222222211         111235678999999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-34  Score=303.65  Aligned_cols=250  Identities=33%  Similarity=0.512  Sum_probs=205.6

Q ss_pred             cceeeeeeeeEEEEEEecC-CCceEEEEEEeccccccc-hHhHHHHHHhhhccCCCCccceeeeecccccceEEEecCCC
Q 041921          525 EEVGRGSFGIVYKGVIQTR-TSTTAVAVKKLDRVFQDG-EREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN  602 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~-~~~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  602 (814)
                      +.||+|+||.||+|..... ..+..+++|.+....... .+++.+|++.+..++|+||+++++++.+....++|+||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            4699999999999998643 237789999997654333 56799999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCC---------CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcccccc
Q 041921          603 GTLASFLFGN---------LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTL  673 (814)
Q Consensus       603 gsL~~~l~~~---------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~  673 (814)
                      ++|.+++...         ..+++..+..++.|+++||+|||+.   +++|+||+|+||+++.++.+||+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999999875         6789999999999999999999998   999999999999999999999999999987765


Q ss_pred             CCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeec
Q 041921          674 NQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVG  752 (814)
Q Consensus       674 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  752 (814)
                      ...........++..|+|||.+....++.++||||||++++||++ |..||......+       ..+....+..     
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~-----  225 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE-------VLEYLRKGYR-----  225 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCC-----
Confidence            432222234457889999999988889999999999999999999 699987553221       1122222110     


Q ss_pred             CcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 041921          753 EDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE  793 (814)
Q Consensus       753 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~  793 (814)
                          .......+.++.+++.+|++.+|.+|||+.++++.|+
T Consensus       226 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         226 ----LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ----CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                0112233578889999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.5e-34  Score=303.30  Aligned_cols=252  Identities=29%  Similarity=0.441  Sum_probs=200.9

Q ss_pred             HhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEE
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY  597 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  597 (814)
                      ...+.+.++||+|++|.||++...   ....+++|.+... ....+.+.+|+.++++++|+|++++++++. .+..+++|
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~---~~~~~~lK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~   79 (260)
T cd05069           5 RESLRLDVKLGQGCFGEVWMGTWN---GTTKVAIKTLKPG-TMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVT   79 (260)
T ss_pred             hHHeeeeeeecCcCCCeEEEEEEc---CCceEEEEEcccC-CccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEE
Confidence            445777889999999999999875   3346999988643 234467899999999999999999999875 45688999


Q ss_pred             ecCCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCC
Q 041921          598 EFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ  675 (814)
Q Consensus       598 e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~  675 (814)
                      ||+++++|.+++...  ..+++..+..++.|++.||.|||+.   +++|+||||+||++++++.++|+|||++.......
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05069          80 EFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             EcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence            999999999999754  3478999999999999999999998   99999999999999999999999999998664322


Q ss_pred             cccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeecCc
Q 041921          676 SKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGED  754 (814)
Q Consensus       676 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  754 (814)
                      ... .....++..|+|||.+....++.++||||||+++|||++ |+.||......+   .    ...+..+..       
T Consensus       157 ~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~----~~~~~~~~~-------  221 (260)
T cd05069         157 YTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---V----LEQVERGYR-------  221 (260)
T ss_pred             ccc-cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---H----HHHHHcCCC-------
Confidence            111 122346778999999988889999999999999999999 899986543221   1    111111100       


Q ss_pred             ccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 041921          755 KEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEG  794 (814)
Q Consensus       755 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~  794 (814)
                        .......+..+.+++.+||+.+|.+||+++++++.|++
T Consensus       222 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         222 --MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             --CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence              01112345678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=9.9e-35  Score=310.89  Aligned_cols=265  Identities=25%  Similarity=0.373  Sum_probs=202.5

Q ss_pred             HhhhccccceeeeeeeeEEEEEEec--------------CCCceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccc
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQT--------------RTSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVR  582 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~--------------~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~  582 (814)
                      ...+.+.++||+|+||.||++....              .+....+|+|.+.... .....++.+|+.++++++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            3456778899999999999986431              1234579999987532 233467999999999999999999


Q ss_pred             eeeeecccccceEEEecCCCCCHHHHhcCCC-----------CCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCc
Q 041921          583 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNL-----------KPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQN  651 (814)
Q Consensus       583 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~N  651 (814)
                      +++++...+..++||||+++++|.+++....           .+++.....++.|++.||+|||+.   +++|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~N  160 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhe
Confidence            9999999999999999999999999986532           356778999999999999999998   99999999999


Q ss_pred             EEEcCCCcEEEeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh--CCCCCCcccch
Q 041921          652 ILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS--CRKSFDIEMGE  729 (814)
Q Consensus       652 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt--g~~p~~~~~~~  729 (814)
                      |+++.++.++|+|||+++.+.............++..|+|||......++.++||||||+++|||++  |..||......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE  240 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence            9999999999999999986643322221122334678999999888889999999999999999998  67787643322


Q ss_pred             hhhhHHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 041921          730 EYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEG  794 (814)
Q Consensus       730 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~  794 (814)
                      +..   ............... .     +....++..+.+++.+||+.||.+||++.+|++.|++
T Consensus       241 ~~~---~~~~~~~~~~~~~~~-~-----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         241 QVI---ENTGEFFRDQGRQVY-L-----PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             HHH---HHHHHHHhhcccccc-C-----CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            211   111111111110000 0     1112244678899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=4.5e-35  Score=309.28  Aligned_cols=246  Identities=21%  Similarity=0.294  Sum_probs=199.7

Q ss_pred             ccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc---cchHhHHHHHHhhhccCCCCccceeeeecccccceEEEecC
Q 041921          524 KEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ---DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL  600 (814)
Q Consensus       524 ~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  600 (814)
                      ...||+|+||.||+++-++  .+..+|+|+|++..-   ...+..+.|-.+|....+|.||+|+-.|.+.+.+||||||+
T Consensus       146 Lk~IgkGAfGeVrLarKk~--Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEyl  223 (550)
T KOG0605|consen  146 LKVIGKGAFGEVRLARKKD--TGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYL  223 (550)
T ss_pred             heeeccccceeEEEEEEcc--CCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEec
Confidence            4679999999999998664  678999999976432   22345788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccC------
Q 041921          601 NNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN------  674 (814)
Q Consensus       601 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~------  674 (814)
                      +||++..+|.....|++.....++.+++-|+.-||+.   |+|||||||+|+|||..|++||+||||+.-+...      
T Consensus       224 PGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~  300 (550)
T KOG0605|consen  224 PGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESY  300 (550)
T ss_pred             CCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhhhhhhhh
Confidence            9999999999999999999999999999999999998   9999999999999999999999999998543210      


Q ss_pred             --------------Ccc-c-----c-------------------cccccCCCCcccccccccCCCCcchhhHHHHHHHHH
Q 041921          675 --------------QSK-T-----I-------------------KTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLE  715 (814)
Q Consensus       675 --------------~~~-~-----~-------------------~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~e  715 (814)
                                    ... .     .                   ....+||+.|||||++.+..+...+|.||+|||+||
T Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyE  380 (550)
T KOG0605|consen  301 RLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYE  380 (550)
T ss_pred             cchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHH
Confidence                          000 0     0                   012369999999999999999999999999999999


Q ss_pred             HHhCCCCCCcccchh-hhhHHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCC---HHHHH
Q 041921          716 IISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPT---MKKVL  789 (814)
Q Consensus       716 lltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt---~~~vl  789 (814)
                      |+.|-+||..+.+.+ ...+..|-.              .+..+.......+..++|.+|+. ||.+|.-   ++||-
T Consensus       381 mLvGyPPF~s~tp~~T~rkI~nwr~--------------~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK  443 (550)
T KOG0605|consen  381 MLVGYPPFCSETPQETYRKIVNWRE--------------TLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIK  443 (550)
T ss_pred             HHhCCCCCCCCCHHHHHHHHHHHhh--------------hccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHh
Confidence            999999998777643 233333211              11112223334788899999999 9999975   44443

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.6e-34  Score=303.50  Aligned_cols=242  Identities=24%  Similarity=0.372  Sum_probs=191.7

Q ss_pred             cceeeeeeeeEEEEEEecCC----------CceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccce
Q 041921          525 EEVGRGSFGIVYKGVIQTRT----------STTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRL  594 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~----------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  594 (814)
                      +.||+|+||.||+|+...+.          ....|++|.+..........|.+|+.++..++||||+++++++..+...+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            46899999999999864321          23468999887654444557889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCc-------EEEeecC
Q 041921          595 LVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYT-------ARISDFG  666 (814)
Q Consensus       595 lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~-------~kl~DfG  666 (814)
                      +||||+++++|..++... ..+++..+.+++.||++||+|||+.   +|+||||||+|||++.++.       +|++|||
T Consensus        81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            999999999999998754 5689999999999999999999998   9999999999999986654       8999999


Q ss_pred             CccccccCCcccccccccCCCCcccccccc-cCCCCcchhhHHHHHHHHHHH-hCCCCCCcccchhhhhHHHHHHHHhhc
Q 041921          667 LAKLLTLNQSKTIKTAIRGTKGYVAPEWFR-NSKITAKVDVYSFGVLLLEII-SCRKSFDIEMGEEYAILTDWAFDCYRN  744 (814)
Q Consensus       667 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~~Dv~s~Gvvl~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~  744 (814)
                      ++......      ....++..|+|||.+. ...++.++||||||+++|||+ +|+.|+......+..        ....
T Consensus       158 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~--------~~~~  223 (262)
T cd05077         158 IPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE--------RFYE  223 (262)
T ss_pred             CCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH--------HHHh
Confidence            98755322      2234788999999887 466889999999999999998 588887643221110        0111


Q ss_pred             CccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 041921          745 GKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE  793 (814)
Q Consensus       745 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~  793 (814)
                      +...          ........+.+++.+||+.||.+||++.+|++.|+
T Consensus       224 ~~~~----------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         224 GQCM----------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             cCcc----------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            1110          01112356789999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.5e-34  Score=301.41  Aligned_cols=246  Identities=26%  Similarity=0.404  Sum_probs=197.9

Q ss_pred             cceeeeeeeeEEEEEEecCCCceEEEEEEecccccc-chHhHHHHHHhhhccCCCCccceeeeecccccceEEEecCCCC
Q 041921          525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD-GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNG  603 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  603 (814)
                      +.||+|+||.||+|.+.   ++..+|+|.+...... ....+.+|++++++++||||+++++++...+..++||||++++
T Consensus         1 ~~ig~g~~g~vy~~~~~---~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   77 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK---DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG   77 (250)
T ss_pred             CccCCCCCceEEEEEec---CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence            46999999999999865   4678999998754322 2346889999999999999999999999999999999999999


Q ss_pred             CHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccccccc
Q 041921          604 TLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTA  682 (814)
Q Consensus       604 sL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  682 (814)
                      +|.+++... ..+++..+..++.|++.+|.|||+.   +++|+||||+||+++.++.+||+|||++.......... ...
T Consensus        78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~~  153 (250)
T cd05085          78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS-SGL  153 (250)
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceecccccccc-CCC
Confidence            999998754 4578999999999999999999998   99999999999999999999999999987544322111 112


Q ss_pred             ccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCcH
Q 041921          683 IRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDI  761 (814)
Q Consensus       683 ~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  761 (814)
                      ..++..|+|||++....++.++||||||++++|+++ |..||.......       ....+..+..       .  ....
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~-------~~~~~~~~~~-------~--~~~~  217 (250)
T cd05085         154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ-------AREQVEKGYR-------M--SCPQ  217 (250)
T ss_pred             CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH-------HHHHHHcCCC-------C--CCCC
Confidence            234678999999998889999999999999999999 999986443221       1111111110       0  1112


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 041921          762 ECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE  793 (814)
Q Consensus       762 ~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~  793 (814)
                      ..+..+.+++.+|++.+|++||++.++++.|.
T Consensus       218 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         218 KCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            24567899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.4e-34  Score=318.84  Aligned_cols=202  Identities=24%  Similarity=0.321  Sum_probs=174.1

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEE
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY  597 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  597 (814)
                      +.+.+.||+|+||+||++....  .++.+|||.+....   ......+..|+.++.+++|+||+++++.+.+....+|||
T Consensus         3 y~~~~~LG~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           3 FESLKVIGRGAFGEVRLVQKKD--TGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             ceEeEEEEeCCCEEEEEEEECC--CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            4567889999999999998653  57799999996532   222346788999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcc
Q 041921          598 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSK  677 (814)
Q Consensus       598 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  677 (814)
                      ||+++|+|.+++.....+++.....++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.+......
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~  157 (363)
T cd05628          81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT  157 (363)
T ss_pred             cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence            9999999999998888899999999999999999999998   9999999999999999999999999998754321100


Q ss_pred             ---------------------------------cccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 041921          678 ---------------------------------TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFD  724 (814)
Q Consensus       678 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~  724 (814)
                                                       .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~  237 (363)
T cd05628         158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC  237 (363)
T ss_pred             cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence                                             00123469999999999999999999999999999999999999997


Q ss_pred             ccc
Q 041921          725 IEM  727 (814)
Q Consensus       725 ~~~  727 (814)
                      ...
T Consensus       238 ~~~  240 (363)
T cd05628         238 SET  240 (363)
T ss_pred             CCC
Confidence            544

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=6e-35  Score=319.05  Aligned_cols=262  Identities=27%  Similarity=0.377  Sum_probs=201.8

Q ss_pred             HhhhccccceeeeeeeeEEEEEEec---CCCceEEEEEEecccc-ccchHhHHHHHHhhhcc-CCCCccceeeeeccc-c
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQT---RTSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEG-Q  591 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~---~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~  591 (814)
                      ...+.+.+.||+|+||.||+|....   ...++.||||+++... ......+.+|+.++.++ +|+||+++++++... .
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            4567888999999999999998532   2346789999997532 22345688999999999 789999999988654 4


Q ss_pred             cceEEEecCCCCCHHHHhcCC-----------------------------------------------------------
Q 041921          592 NRLLVYEFLNNGTLASFLFGN-----------------------------------------------------------  612 (814)
Q Consensus       592 ~~~lv~e~~~~gsL~~~l~~~-----------------------------------------------------------  612 (814)
                      ..++|+||+++|+|.+++...                                                           
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            578999999999999998642                                                           


Q ss_pred             --------CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccccccccc
Q 041921          613 --------LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIR  684 (814)
Q Consensus       613 --------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~  684 (814)
                              ..+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||++................
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                    1256777889999999999999998   99999999999999999999999999998654332211112234


Q ss_pred             CCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCcHHH
Q 041921          685 GTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIEC  763 (814)
Q Consensus       685 gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  763 (814)
                      ++..|+|||.+.+..++.++||||||++++||++ |..||........      ....+.++.....         +...
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~------~~~~~~~~~~~~~---------~~~~  307 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRRLKEGTRMRA---------PDYT  307 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH------HHHHHhccCCCCC---------CCCC
Confidence            5678999999988899999999999999999997 8888864322211      1111222211100         1112


Q ss_pred             HHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 041921          764 LGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE  797 (814)
Q Consensus       764 ~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~  797 (814)
                      ..++.+++..||+.+|.+|||+.+|++.|+.+.+
T Consensus       308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            3568899999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=8.6e-35  Score=316.88  Aligned_cols=266  Identities=28%  Similarity=0.414  Sum_probs=208.7

Q ss_pred             HHHHhhhccccceeeeeeeeEEEEEEecCC-----CceEEEEEEecccc-ccchHhHHHHHHhhhcc-CCCCccceeeee
Q 041921          515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRT-----STTAVAVKKLDRVF-QDGEREFKNEVFVIGQT-HHKNLVRLLGFC  587 (814)
Q Consensus       515 ~l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~-----~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  587 (814)
                      ++...++.+.+.||+|+||.||++......     ....||+|.++... ....+++.+|++++.++ +||||+++++++
T Consensus         8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (334)
T cd05100           8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC   87 (334)
T ss_pred             ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence            455567888999999999999999754211     23478999886432 23346789999999999 899999999999


Q ss_pred             cccccceEEEecCCCCCHHHHhcCC----------------CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCc
Q 041921          588 DEGQNRLLVYEFLNNGTLASFLFGN----------------LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQN  651 (814)
Q Consensus       588 ~~~~~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~N  651 (814)
                      .+....++++||+++++|.+++...                ..+++..+..++.|+++||.|||+.   +|+||||||+|
T Consensus        88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N  164 (334)
T cd05100          88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARN  164 (334)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccce
Confidence            9999999999999999999998642                2467888999999999999999998   99999999999


Q ss_pred             EEEcCCCcEEEeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchh
Q 041921          652 ILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEE  730 (814)
Q Consensus       652 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~  730 (814)
                      |+++.++.+||+|||+++...............++..|+|||.+....++.++||||||+++|||++ |..||.....++
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~  244 (334)
T cd05100         165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE  244 (334)
T ss_pred             EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            9999999999999999986643322111122334568999999998899999999999999999998 888886443222


Q ss_pred             hhhHHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCC
Q 041921          731 YAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS  799 (814)
Q Consensus       731 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~~~  799 (814)
                             ....+..+...         ........++.+++.+|++.+|.+|||+.++++.|+.+....
T Consensus       245 -------~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~  297 (334)
T cd05100         245 -------LFKLLKEGHRM---------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT  297 (334)
T ss_pred             -------HHHHHHcCCCC---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence                   11112221110         011223467889999999999999999999999999887544

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.6e-34  Score=304.37  Aligned_cols=257  Identities=21%  Similarity=0.327  Sum_probs=205.4

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhccCCCCccceeeeecccccceEE
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV  596 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  596 (814)
                      .+.+.+.||+|++|.||++....  ++..++||.+....   .....++.+|+.+++.++|+||+++++++.+++..+++
T Consensus         3 ~y~~~~~ig~g~~g~v~~~~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08229           3 NFRIEKKIGRGQFSEVYRATCLL--DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV   80 (267)
T ss_pred             hhhhhhhhcccCCeEEEEEeecC--CCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence            45667889999999999998653  56789999876422   22335788999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhcC----CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccc
Q 041921          597 YEFLNNGTLASFLFG----NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLT  672 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~  672 (814)
                      |||+++++|.+++..    ...+++.....++.|+++||.|||+.   +++|+||||+||+++.++.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd08229          81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence            999999999998863    35678999999999999999999998   99999999999999999999999999987664


Q ss_pred             cCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeec
Q 041921          673 LNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVG  752 (814)
Q Consensus       673 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  752 (814)
                      .....  .....++..|+|||.+.+..++.++||||||+++|||++|..||.....+... .    ...+....     .
T Consensus       158 ~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~----~~~~~~~~-----~  225 (267)
T cd08229         158 SKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS-L----CKKIEQCD-----Y  225 (267)
T ss_pred             cCCcc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHH-H----hhhhhcCC-----C
Confidence            33221  12345889999999999888999999999999999999999998643221111 1    11111111     0


Q ss_pred             CcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 041921          753 EDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV  796 (814)
Q Consensus       753 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~  796 (814)
                      +..   ........+.+++.+|++.+|.+||||.+|+++++++.
T Consensus       226 ~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         226 PPL---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             CCC---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence            100   11234567889999999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-35  Score=317.31  Aligned_cols=252  Identities=25%  Similarity=0.360  Sum_probs=210.3

Q ss_pred             hccccceeeeeeeeEEEEEEecC-CCceEEEEEEecccccc-chHhHHHHHHhhhccCCCCccceeeeecccccceEEEe
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTR-TSTTAVAVKKLDRVFQD-GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE  598 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~-~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  598 (814)
                      ..+.|+||+|.||.|++|.+..- ++...||||.++..... ...+|+.|+.+|.+|+|+|+|+|+|+..+ ....||+|
T Consensus       112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E  190 (1039)
T KOG0199|consen  112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE  190 (1039)
T ss_pred             HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence            34568999999999999998753 24568999999765443 56789999999999999999999999988 78899999


Q ss_pred             cCCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCc
Q 041921          599 FLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS  676 (814)
Q Consensus       599 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  676 (814)
                      .++.|||.+.|+..  ..+-......++.|||.|+.||.++   ++|||||..+|+||-....+||+||||.+.+.....
T Consensus       191 LaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned  267 (1039)
T KOG0199|consen  191 LAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENED  267 (1039)
T ss_pred             hcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence            99999999999873  4567788889999999999999998   999999999999999999999999999998876554


Q ss_pred             cccc-ccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeecCc
Q 041921          677 KTIK-TAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGED  754 (814)
Q Consensus       677 ~~~~-~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  754 (814)
                      .... ....-.+.|.|||.++...++.++|||+|||.+|||+| |..||-+..+..       +.+         .+|..
T Consensus       268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q-------IL~---------~iD~~  331 (1039)
T KOG0199|consen  268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ-------ILK---------NIDAG  331 (1039)
T ss_pred             ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH-------HHH---------hcccc
Confidence            3322 22345678999999999999999999999999999999 888886543321       112         22333


Q ss_pred             ccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 041921          755 KEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQML  792 (814)
Q Consensus       755 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L  792 (814)
                      .....+..+++.++++++.||..+|.+|||+..|.+.+
T Consensus       332 erLpRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  332 ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence            44455677899999999999999999999999997443

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.3e-34  Score=312.54  Aligned_cols=241  Identities=28%  Similarity=0.352  Sum_probs=193.1

Q ss_pred             cceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhcc-CCCCccceeeeecccccceEEEecC
Q 041921          525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRLLVYEFL  600 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  600 (814)
                      +.||+|+||.||+|....  .+..||||.++...   ....+.+..|..++... +||||+++++++.+.+..++||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~   78 (316)
T cd05619           1 KMLGKGSFGKVFLAELKG--TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYL   78 (316)
T ss_pred             CeeeeCCCEEEEEEEECC--CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCC
Confidence            469999999999998753  56789999987532   22334566777777764 9999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccccc
Q 041921          601 NNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIK  680 (814)
Q Consensus       601 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  680 (814)
                      ++|+|.+++.....+++.....++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.......  ..
T Consensus        79 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~  153 (316)
T cd05619          79 NGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--KT  153 (316)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--ce
Confidence            9999999998877889999999999999999999998   999999999999999999999999999875332211  11


Q ss_pred             ccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCc
Q 041921          681 TAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMND  760 (814)
Q Consensus       681 ~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  760 (814)
                      ....||..|+|||.+.+..++.++|||||||++|||++|+.||......+       ..+.+......          .+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~-------~~~~i~~~~~~----------~~  216 (316)
T cd05619         154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE-------LFQSIRMDNPC----------YP  216 (316)
T ss_pred             eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCC----------CC
Confidence            34568999999999999899999999999999999999999997543221       11111111100          01


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 041921          761 IECLGKLVMVSIWCIQEDPSLRPTMK-KVL  789 (814)
Q Consensus       761 ~~~~~~l~~l~~~Cl~~dp~~RPt~~-~vl  789 (814)
                      ......+.+++.+||+.+|.+||++. ++.
T Consensus       217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         217 RWLTREAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             ccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence            12335678899999999999999997 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=9.2e-35  Score=314.20  Aligned_cols=242  Identities=25%  Similarity=0.323  Sum_probs=196.4

Q ss_pred             cceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhcc-CCCCccceeeeecccccceEEEecC
Q 041921          525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRLLVYEFL  600 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  600 (814)
                      +.||+|+||.||++....  .+..||||.++...   ......+..|..++..+ +||||+++++++.+.+..++||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   78 (318)
T cd05570           1 KVLGKGSFGKVLLAELKG--TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYV   78 (318)
T ss_pred             CeeeeCCCeEEEEEEECC--CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCC
Confidence            469999999999998753  56789999987532   22344577888888877 7999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccccc
Q 041921          601 NNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIK  680 (814)
Q Consensus       601 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  680 (814)
                      ++++|..++.....+++.....++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++........  .
T Consensus        79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~  153 (318)
T cd05570          79 NGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--T  153 (318)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCc--c
Confidence            9999999998888899999999999999999999998   9999999999999999999999999998753222111  1


Q ss_pred             ccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCc
Q 041921          681 TAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMND  760 (814)
Q Consensus       681 ~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  760 (814)
                      ....|+..|+|||.+.+..++.++|||||||++|||++|+.||.......       ....+..+...          .+
T Consensus       154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~-------~~~~i~~~~~~----------~~  216 (318)
T cd05570         154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE-------LFQSILEDEVR----------YP  216 (318)
T ss_pred             cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH-------HHHHHHcCCCC----------CC
Confidence            33468999999999999999999999999999999999999997543221       11112222111          01


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 041921          761 IECLGKLVMVSIWCIQEDPSLRPTM-----KKVLQ  790 (814)
Q Consensus       761 ~~~~~~l~~l~~~Cl~~dp~~RPt~-----~~vl~  790 (814)
                      ......+.+++.+||+.||.+||++     .++++
T Consensus       217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            1234678899999999999999999     77764

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=7.9e-35  Score=315.90  Aligned_cols=244  Identities=25%  Similarity=0.301  Sum_probs=194.8

Q ss_pred             cceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhcc-CCCCccceeeeecccccceEEEecC
Q 041921          525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRLLVYEFL  600 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  600 (814)
                      +.||+|+||.||++....  .++.+|+|.++...   ....+.+..|+.++.++ +||||+++++++.+.+..++||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKK--NDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYV   78 (327)
T ss_pred             CeeeeCCCeEEEEEEECC--CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCC
Confidence            469999999999998753  56789999997532   22334578899998888 6999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccccc
Q 041921          601 NNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIK  680 (814)
Q Consensus       601 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  680 (814)
                      ++++|..++.....+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++........  ..
T Consensus        79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~  153 (327)
T cd05617          79 NGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--TT  153 (327)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--ce
Confidence            9999999998778899999999999999999999998   999999999999999999999999999875322111  11


Q ss_pred             ccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCc
Q 041921          681 TAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMND  760 (814)
Q Consensus       681 ~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  760 (814)
                      ....||+.|+|||.+.+..++.++||||||+++|||++|+.||................+........          .+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~----------~p  223 (327)
T cd05617         154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIR----------IP  223 (327)
T ss_pred             ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCC----------CC
Confidence            34568999999999999999999999999999999999999996433222212222233333222211          11


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCH
Q 041921          761 IECLGKLVMVSIWCIQEDPSLRPTM  785 (814)
Q Consensus       761 ~~~~~~l~~l~~~Cl~~dp~~RPt~  785 (814)
                      ......+.+++.+||+.||.+||++
T Consensus       224 ~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         224 RFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             CCCCHHHHHHHHHHhccCHHHcCCC
Confidence            1233567889999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.3e-34  Score=306.15  Aligned_cols=241  Identities=23%  Similarity=0.371  Sum_probs=190.0

Q ss_pred             ceeeeeeeeEEEEEEecC----------------------CCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccce
Q 041921          526 EVGRGSFGIVYKGVIQTR----------------------TSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRL  583 (814)
Q Consensus       526 ~LG~G~~g~Vy~~~~~~~----------------------~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l  583 (814)
                      .||+|+||.||+|.+...                      .....|++|.+.........+|.+|+.++++++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            699999999999986421                      1234689999875444445678899999999999999999


Q ss_pred             eeeecccccceEEEecCCCCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC----
Q 041921          584 LGFCDEGQNRLLVYEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYY----  658 (814)
Q Consensus       584 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~----  658 (814)
                      ++++.+....++||||+++++|..++.. ...+++..+..++.|+++||+|||+.   +|+||||||+|||++..+    
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCcccC
Confidence            9999999999999999999999999975 46788999999999999999999998   999999999999997543    


Q ss_pred             ---cEEEeecCCccccccCCcccccccccCCCCccccccccc-CCCCcchhhHHHHHHHHHHH-hCCCCCCcccchhhhh
Q 041921          659 ---TARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEII-SCRKSFDIEMGEEYAI  733 (814)
Q Consensus       659 ---~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~s~Gvvl~ell-tg~~p~~~~~~~~~~~  733 (814)
                         .+|++|||++......      ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||......+.. 
T Consensus       159 ~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~-  231 (274)
T cd05076         159 TSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE-  231 (274)
T ss_pred             ccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH-
Confidence               4899999987644321      12346788999998865 56899999999999999995 688888654332211 


Q ss_pred             HHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 041921          734 LTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE  793 (814)
Q Consensus       734 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~  793 (814)
                        ..    +....       ...    ......+.+++.+||+.+|++|||+.++++.|.
T Consensus       232 --~~----~~~~~-------~~~----~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         232 --RF----YEKKH-------RLP----EPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             --HH----HHhcc-------CCC----CCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence              10    11000       000    011246889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.4e-34  Score=308.72  Aligned_cols=260  Identities=23%  Similarity=0.323  Sum_probs=192.6

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhcc---CCCCccceeeeec-----c
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQT---HHKNLVRLLGFCD-----E  589 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~-----~  589 (814)
                      +|.+.++||+|+||.||+|.... ..+..||||.++...  ......+.+|+.+++.+   +||||+++++++.     .
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLK-NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcC-CCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            46677899999999999998642 236789999886432  22234566777776665   6999999999885     2


Q ss_pred             cccceEEEecCCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCC
Q 041921          590 GQNRLLVYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGL  667 (814)
Q Consensus       590 ~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGl  667 (814)
                      ....++|+||++ ++|.+++...  ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL  156 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccc
Confidence            446789999996 6899998653  4578999999999999999999998   999999999999999999999999999


Q ss_pred             ccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhc---
Q 041921          668 AKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN---  744 (814)
Q Consensus       668 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---  744 (814)
                      ++......   ......|+..|+|||.+....++.++|||||||++|||++|+.||......+..   ..+.+....   
T Consensus       157 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~---~~i~~~~~~~~~  230 (290)
T cd07862         157 ARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL---GKILDVIGLPGE  230 (290)
T ss_pred             eEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHH---HHHHHHhCCCCh
Confidence            98654331   113456899999999998888999999999999999999999999765432211   111111000   


Q ss_pred             Ccc-------ceeecCcccc---cCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          745 GKL-------NVLVGEDKEA---MNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       745 ~~~-------~~~~~~~~~~---~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      ...       ..........   .........+.+++.+||+.||++|||+.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         231 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            000       0000000000   000123456789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.2e-34  Score=305.24  Aligned_cols=258  Identities=24%  Similarity=0.445  Sum_probs=205.3

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCC-CceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccceeeeecccccceEE
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRT-STTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV  596 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  596 (814)
                      ..+.+.+.||+|+||.||+|.....+ ....+|+|.++... ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            45667889999999999999875332 35589999986532 22345789999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCC
Q 041921          597 YEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ  675 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~  675 (814)
                      |||+++++|.+++... ..+++.....++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++..+....
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd05066          84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  160 (267)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence            9999999999999764 5678999999999999999999998   99999999999999999999999999998765432


Q ss_pred             cccc-cccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeecC
Q 041921          676 SKTI-KTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGE  753 (814)
Q Consensus       676 ~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  753 (814)
                      .... .....++..|+|||.+.+..++.++||||||++++|+++ |..||......+   .    ...+.++. .     
T Consensus       161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~----~~~~~~~~-~-----  227 (267)
T cd05066         161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---V----IKAIEEGY-R-----  227 (267)
T ss_pred             ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---H----HHHHhCCC-c-----
Confidence            2111 011223568999999998889999999999999999887 999986443221   1    11111211 0     


Q ss_pred             cccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 041921          754 DKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV  795 (814)
Q Consensus       754 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~  795 (814)
                         .+.....+..+.+++.+|++.+|.+||+|.++++.|+++
T Consensus       228 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         228 ---LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             ---CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence               011122356788999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-34  Score=303.63  Aligned_cols=255  Identities=29%  Similarity=0.477  Sum_probs=206.0

Q ss_pred             HHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceE
Q 041921          516 LEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL  595 (814)
Q Consensus       516 l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  595 (814)
                      +....+.+.++||+|+||.||+|..+   +...|+||.+... ....+++.+|+.++++++|+||+++++++......++
T Consensus         3 ~~~~~~~i~~~ig~g~~~~v~~~~~~---~~~~~~vK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   78 (261)
T cd05034           3 IPRESLKLERKLGAGQFGEVWMGTWN---GTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYI   78 (261)
T ss_pred             cchhheeeeeeeccCcceEEEEEEEc---CCceEEEEEecCC-ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEE
Confidence            44556778899999999999999865   3567999998753 2345679999999999999999999999998899999


Q ss_pred             EEecCCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcccccc
Q 041921          596 VYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTL  673 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~  673 (814)
                      ||||+++++|.+++...  ..+++..+..++.|++.||.|||+.   +++|+||||+||++++++.+||+|||++..+..
T Consensus        79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~  155 (261)
T cd05034          79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIED  155 (261)
T ss_pred             EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccc
Confidence            99999999999999764  4688999999999999999999998   999999999999999999999999999987653


Q ss_pred             CCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeec
Q 041921          674 NQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVG  752 (814)
Q Consensus       674 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  752 (814)
                      ...... .....+..|+|||.+.+..++.++||||||++++||++ |+.||.......       ....+..+.      
T Consensus       156 ~~~~~~-~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-------~~~~~~~~~------  221 (261)
T cd05034         156 DEYTAR-EGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE-------VLEQVERGY------  221 (261)
T ss_pred             hhhhhh-hccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCC------
Confidence            221111 22234678999999998889999999999999999999 999986443221       111111110      


Q ss_pred             CcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 041921          753 EDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEG  794 (814)
Q Consensus       753 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~  794 (814)
                         ....+...+.++.+++.+|++.+|.+||+++++++.|+.
T Consensus       222 ---~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         222 ---RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             ---CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence               001111235678999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5.8e-35  Score=310.52  Aligned_cols=265  Identities=26%  Similarity=0.444  Sum_probs=206.9

Q ss_pred             hhhccccceeeeeeeeEEEEEEec--CCCceEEEEEEecccccc-chHhHHHHHHhhhccCCCCccceeeeecc--cccc
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQT--RTSTTAVAVKKLDRVFQD-GEREFKNEVFVIGQTHHKNLVRLLGFCDE--GQNR  593 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~--~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~  593 (814)
                      ..+.+.+.||+|+||.||++.+..  ...+..+|||.+...... ..++|.+|+++++.++|+||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            345567889999999999998753  234678999999754332 45679999999999999999999999877  5578


Q ss_pred             eEEEecCCCCCHHHHhcCCC-CCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccc
Q 041921          594 LLVYEFLNNGTLASFLFGNL-KPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLT  672 (814)
Q Consensus       594 ~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~  672 (814)
                      ++++||+++++|.+++.... .+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++....
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLP  160 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence            99999999999999997653 689999999999999999999998   99999999999999999999999999998775


Q ss_pred             cCCcc-cccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhh--------hHHHHHHHHhh
Q 041921          673 LNQSK-TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA--------ILTDWAFDCYR  743 (814)
Q Consensus       673 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~--------~~~~~~~~~~~  743 (814)
                      ..... .......++..|+|||.+.+..++.++||||||++++||++|+.|+.........        .........+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05038         161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK  240 (284)
T ss_pred             cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence            33221 1111223566799999998888999999999999999999999998643221100        00011111111


Q ss_pred             cCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 041921          744 NGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV  795 (814)
Q Consensus       744 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~  795 (814)
                      .+         .........+.++.+++.+|++.+|.+||||.||+++|+.+
T Consensus       241 ~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         241 EG---------ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             cC---------CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            11         11111223447789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=3.3e-34  Score=307.90  Aligned_cols=262  Identities=22%  Similarity=0.287  Sum_probs=195.2

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc-cchHhHHHHHHhhhccCCCCccceeeeecccccceEEE
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY  597 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  597 (814)
                      ..|.+.++||+|+||.||+|....  .+..||||.+..... .....+.+|+.+++.++||||+++++++.+....++||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   82 (303)
T cd07869           5 DSYEKLEKLGEGSYATVYKGKSKV--NGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF   82 (303)
T ss_pred             ccceEeeeEEecCCEEEEEEEECC--CCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence            346677899999999999998753  567899999864322 22346788999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCc
Q 041921          598 EFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS  676 (814)
Q Consensus       598 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  676 (814)
                      ||++ ++|.+++... ..++...+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++........
T Consensus        83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  158 (303)
T cd07869          83 EYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH  158 (303)
T ss_pred             ECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc
Confidence            9996 5777777654 5678889999999999999999998   999999999999999999999999999875432211


Q ss_pred             ccccccccCCCCccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCc---------
Q 041921          677 KTIKTAIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK---------  746 (814)
Q Consensus       677 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---------  746 (814)
                        ......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||........ .+ ..+........         
T Consensus       159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~  234 (303)
T cd07869         159 --TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD-QL-ERIFLVLGTPNEDTWPGVHS  234 (303)
T ss_pred             --cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH-HH-HHHHHHhCCCChhhccchhh
Confidence              1133458899999998865 4578899999999999999999999975432111 11 11111100000         


Q ss_pred             cceeecCccc--ccCc-------HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          747 LNVLVGEDKE--AMND-------IECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       747 ~~~~~~~~~~--~~~~-------~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      ..........  ....       ......+.+++.+||+.||++|||++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            0000000000  0000       012346778999999999999999999985

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=3.7e-34  Score=301.93  Aligned_cols=254  Identities=28%  Similarity=0.404  Sum_probs=191.3

Q ss_pred             cceeeeeeeeEEEEEEecCCCceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEecCCCC
Q 041921          525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNG  603 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  603 (814)
                      ++||+|+||.||+|..........+++|.+.... .....++.+|+.+++.++|+||+++++.+.+....++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            3699999999999987654456688999876432 223456889999999999999999999999999999999999999


Q ss_pred             CHHHHhcCCC-----CCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccc
Q 041921          604 TLASFLFGNL-----KPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT  678 (814)
Q Consensus       604 sL~~~l~~~~-----~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  678 (814)
                      +|.+++....     ..++.....++.||+.||+|||+.   +|+||||||+|||+++++.+||+|||++..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            9999997542     245777889999999999999998   99999999999999999999999999987543322111


Q ss_pred             ccccccCCCCccccccccc-------CCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCcccee
Q 041921          679 IKTAIRGTKGYVAPEWFRN-------SKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVL  750 (814)
Q Consensus       679 ~~~~~~gt~~y~aPE~~~~-------~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  750 (814)
                      ......++..|+|||++..       ..++.++||||||+++|||++ |..||......+  .    .......+.. .+
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--~----~~~~~~~~~~-~~  230 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ--V----LKQVVREQDI-KL  230 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH--H----HHHHhhccCc-cC
Confidence            1122345678999998743       356789999999999999999 778876432221  1    1111222211 11


Q ss_pred             ecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 041921          751 VGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE  793 (814)
Q Consensus       751 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~  793 (814)
                      ..+..    .......+.+++..|+ .||++|||+++|+++|.
T Consensus       231 ~~~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         231 PKPQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCCcc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            11111    1223455667778888 59999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.2e-34  Score=312.87  Aligned_cols=241  Identities=27%  Similarity=0.331  Sum_probs=193.0

Q ss_pred             cceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhcc-CCCCccceeeeecccccceEEEecC
Q 041921          525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRLLVYEFL  600 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  600 (814)
                      +.||+|+||.||+|....  .+..||+|.++...   ....+.+..|..++... +||||+++++++.+.+..++||||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~   78 (316)
T cd05620           1 KVLGKGSFGKVLLAELKG--KGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFL   78 (316)
T ss_pred             CeeeeCCCeEEEEEEECC--CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCC
Confidence            469999999999999763  56789999986532   22334567777777654 8999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccccc
Q 041921          601 NNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIK  680 (814)
Q Consensus       601 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  680 (814)
                      ++++|..++.....+++.....++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++.......  ..
T Consensus        79 ~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~  153 (316)
T cd05620          79 NGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--RA  153 (316)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC--ce
Confidence            9999999998877889999999999999999999998   999999999999999999999999999874322111  12


Q ss_pred             ccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCc
Q 041921          681 TAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMND  760 (814)
Q Consensus       681 ~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  760 (814)
                      ....||..|+|||.+.+..++.++|||||||++|||++|+.||......+       ..+.+..+..      ..    +
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~-------~~~~~~~~~~------~~----~  216 (316)
T cd05620         154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE-------LFESIRVDTP------HY----P  216 (316)
T ss_pred             eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCC------CC----C
Confidence            34568999999999999999999999999999999999999997543221       1111111111      00    1


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 041921          761 IECLGKLVMVSIWCIQEDPSLRPTMK-KVL  789 (814)
Q Consensus       761 ~~~~~~l~~l~~~Cl~~dp~~RPt~~-~vl  789 (814)
                      .....++.+++.+||+.||++||++. +++
T Consensus       217 ~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         217 RWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            11345678899999999999999985 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.3e-34  Score=312.74  Aligned_cols=261  Identities=27%  Similarity=0.412  Sum_probs=204.1

Q ss_pred             HhhhccccceeeeeeeeEEEEEEec-----CCCceEEEEEEecccc-ccchHhHHHHHHhhhcc-CCCCccceeeeeccc
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQT-----RTSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEG  590 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~-----~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  590 (814)
                      ...+.+.++||+|+||.||++....     ......+|+|.++... .....++..|+.++.++ +||||+++++++.+.
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            3556678899999999999997532     1234578999887432 23345688999999999 699999999999998


Q ss_pred             ccceEEEecCCCCCHHHHhcCC----------------CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE
Q 041921          591 QNRLLVYEFLNNGTLASFLFGN----------------LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILL  654 (814)
Q Consensus       591 ~~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll  654 (814)
                      ...++++||+++++|.+++...                ..+++..+.+++.|++.||.|||+.   +|+||||||+||++
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill  167 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLV  167 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEE
Confidence            8999999999999999999643                3478888999999999999999998   99999999999999


Q ss_pred             cCCCcEEEeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhh
Q 041921          655 DDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAI  733 (814)
Q Consensus       655 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~  733 (814)
                      +.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||......+   
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---  244 (314)
T cd05099         168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE---  244 (314)
T ss_pred             cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH---
Confidence            9999999999999986653222111112234567999999998889999999999999999999 888886433222   


Q ss_pred             HHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 041921          734 LTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE  797 (814)
Q Consensus       734 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~  797 (814)
                          +......+...         ........++.+++.+|++.+|++|||+.++++.|+++..
T Consensus       245 ----~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~  295 (314)
T cd05099         245 ----LFKLLREGHRM---------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA  295 (314)
T ss_pred             ----HHHHHHcCCCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence                11122222110         0112334578899999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.4e-34  Score=315.09  Aligned_cols=253  Identities=21%  Similarity=0.219  Sum_probs=198.7

Q ss_pred             hccccceeeeeeeeEEEEEEec-CCCceEEEEEEecccc----ccchHhHHHHHHhhhcc-CCCCccceeeeecccccce
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQT-RTSTTAVAVKKLDRVF----QDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRL  594 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~-~~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  594 (814)
                      +.+.++||+|+||.||++.... ...+..||+|.+....    ....+.+..|+.++.++ +|+||+++++++.+++..+
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (332)
T cd05614           2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH   81 (332)
T ss_pred             ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence            4567899999999999987642 2357889999986422    12234578899999999 5999999999999999999


Q ss_pred             EEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccC
Q 041921          595 LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN  674 (814)
Q Consensus       595 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~  674 (814)
                      +||||+++|+|.+++.....+++.....++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.+...
T Consensus        82 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~  158 (332)
T cd05614          82 LILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE  158 (332)
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence            9999999999999998888899999999999999999999998   9999999999999999999999999999865433


Q ss_pred             CcccccccccCCCCcccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecC
Q 041921          675 QSKTIKTAIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGE  753 (814)
Q Consensus       675 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  753 (814)
                      .... .....||..|+|||.+.+. .++.++|||||||++|||++|+.||.........   ..+...+....      +
T Consensus       159 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---~~~~~~~~~~~------~  228 (332)
T cd05614         159 EKER-TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ---SEVSRRILKCD------P  228 (332)
T ss_pred             CCCc-cccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH---HHHHHHHhcCC------C
Confidence            2221 1345699999999999865 4788999999999999999999999643321110   11111111111      0


Q ss_pred             cccccCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 041921          754 DKEAMNDIECLGKLVMVSIWCIQEDPSLRP-----TMKKVLQ  790 (814)
Q Consensus       754 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~~vl~  790 (814)
                      .    .+......+.+++.+||+.||++||     +++++++
T Consensus       229 ~----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         229 P----FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             C----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence            0    1112345678899999999999999     6777764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.8e-34  Score=300.33  Aligned_cols=248  Identities=27%  Similarity=0.366  Sum_probs=202.8

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEeccc--cccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEe
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV--FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE  598 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  598 (814)
                      +.+.+.||+|++|.||+|+...  ++..|++|.+...  .....+++.+|++++++++||||+++++++.+.+..++|+|
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08529           2 FEILNKIGKGSFGVVFKVVRKA--DKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME   79 (256)
T ss_pred             ceEeEEecCCCCeEEEEEEEcC--CCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence            4566889999999999999763  5678999988632  23445678999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCc
Q 041921          599 FLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS  676 (814)
Q Consensus       599 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  676 (814)
                      |+++++|.+++...  ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++........
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~  156 (256)
T cd08529          80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN  156 (256)
T ss_pred             eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence            99999999999764  5678899999999999999999998   999999999999999999999999999886654322


Q ss_pred             ccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCccc
Q 041921          677 KTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKE  756 (814)
Q Consensus       677 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  756 (814)
                      .  .....++..|+|||++.+..++.++|+||||++++||++|+.||.......       .......+....+      
T Consensus       157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~~------  221 (256)
T cd08529         157 F--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA-------LILKIIRGVFPPV------  221 (256)
T ss_pred             h--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCCCCCC------
Confidence            1  133458889999999999889999999999999999999999997543211       1111112211111      


Q ss_pred             ccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          757 AMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       757 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                         .......+.+++.+|++.+|++||++.++++.
T Consensus       222 ---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         222 ---SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             ---ccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence               11345678999999999999999999999864

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.1e-35  Score=318.06  Aligned_cols=241  Identities=25%  Similarity=0.264  Sum_probs=195.3

Q ss_pred             cceeeeeeeeEEEEEEec-CCCceEEEEEEeccccc--cchHhHHHHHHhhhccCCCCccceeeeecccccceEEEecCC
Q 041921          525 EEVGRGSFGIVYKGVIQT-RTSTTAVAVKKLDRVFQ--DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLN  601 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~-~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  601 (814)
                      +.||+|+||.||++.... ...+..+|+|.+.....  .....+..|++++++++||||+++++++.++...++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            579999999999987542 23578999999975322  223457789999999999999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcccccc
Q 041921          602 NGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKT  681 (814)
Q Consensus       602 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  681 (814)
                      +++|.+++.....+++.....++.||++||+|||+.   +|+||||||+|||++.++.+||+|||++.........  ..
T Consensus        82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~--~~  156 (318)
T cd05582          82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AY  156 (318)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCc--ee
Confidence            999999998877899999999999999999999998   9999999999999999999999999998765432211  13


Q ss_pred             cccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCcH
Q 041921          682 AIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDI  761 (814)
Q Consensus       682 ~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  761 (814)
                      ...|+..|+|||.+....++.++||||||+++|||++|+.||......+.       ...+......          .+.
T Consensus       157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~-------~~~i~~~~~~----------~p~  219 (318)
T cd05582         157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET-------MTMILKAKLG----------MPQ  219 (318)
T ss_pred             cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHH-------HHHHHcCCCC----------CCC
Confidence            45689999999999988899999999999999999999999975432211       1111111111          011


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHHH
Q 041921          762 ECLGKLVMVSIWCIQEDPSLRPTMKK  787 (814)
Q Consensus       762 ~~~~~l~~l~~~Cl~~dp~~RPt~~~  787 (814)
                      .....+.+++.+||+.||.+||++.+
T Consensus       220 ~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         220 FLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            23456788999999999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.6e-34  Score=313.20  Aligned_cols=244  Identities=25%  Similarity=0.303  Sum_probs=192.7

Q ss_pred             ccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhh---hccCCCCccceeeeecccccceE
Q 041921          522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVI---GQTHHKNLVRLLGFCDEGQNRLL  595 (814)
Q Consensus       522 ~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~l  595 (814)
                      .+.+.||+|+||.||+|....  .++.||||.++...   ....+.+..|+.++   ..++||||+++++++.+.+..++
T Consensus         2 ~i~~~lg~G~~g~Vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~l   79 (324)
T cd05589           2 RCLAVLGRGHFGKVLLAEYKK--TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCF   79 (324)
T ss_pred             eEEEEEeecCCEEEEEEEECC--CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEE
Confidence            456889999999999998753  57889999997432   22234566666554   56789999999999999999999


Q ss_pred             EEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCC
Q 041921          596 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ  675 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~  675 (814)
                      ||||+++++|..++.. ..+++.....++.||+.||.|||+.   +|+||||||+||+++.++.+||+|||+++......
T Consensus        80 v~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05589          80 VMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG  155 (324)
T ss_pred             EEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence            9999999999988865 4689999999999999999999998   99999999999999999999999999987533221


Q ss_pred             cccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcc
Q 041921          676 SKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDK  755 (814)
Q Consensus       676 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  755 (814)
                      .  ......|++.|+|||.+.+..++.++|||||||++|||++|+.||......+.       ...+..+...       
T Consensus       156 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~-------~~~i~~~~~~-------  219 (324)
T cd05589         156 D--RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV-------FDSIVNDEVR-------  219 (324)
T ss_pred             C--cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhCCCC-------
Confidence            1  11345689999999999998999999999999999999999999975433221       1111121111       


Q ss_pred             cccCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 041921          756 EAMNDIECLGKLVMVSIWCIQEDPSLRP-----TMKKVLQ  790 (814)
Q Consensus       756 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~~vl~  790 (814)
                         .+......+.+++.+||+.||.+||     ++.++++
T Consensus       220 ---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         220 ---YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             ---CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence               1112346678999999999999999     4666655

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2e-35  Score=299.45  Aligned_cols=251  Identities=26%  Similarity=0.337  Sum_probs=190.6

Q ss_pred             ccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccc-----cceEEEe
Q 041921          524 KEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ-----NRLLVYE  598 (814)
Q Consensus       524 ~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e  598 (814)
                      .+.+|.|.||.||+|++..  .+..||||+.-...    +.--.|+.+|++++|||||+|+-++....     ...||+|
T Consensus        29 ~~liG~GsFg~Vyq~~~~e--~~~~vAIKKv~~d~----r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVle  102 (364)
T KOG0658|consen   29 VRLIGSGSFGVVYQAKLRE--TEEEVAIKKVLQDK----RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLE  102 (364)
T ss_pred             eEEEeecccceEEEEEEcC--CCceeEEEEecCCC----CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHH
Confidence            4789999999999999875  37899999985432    22356899999999999999999885422     2358999


Q ss_pred             cCCCCCHHHHhcC----CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC-CcEEEeecCCcccccc
Q 041921          599 FLNNGTLASFLFG----NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDY-YTARISDFGLAKLLTL  673 (814)
Q Consensus       599 ~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~-~~~kl~DfGla~~~~~  673 (814)
                      |||. +|..+++.    +..++...+.-+..||.+||+|||+.   +|+||||||.|+|+|.+ +.+||+|||.|+.+..
T Consensus       103 ymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~  178 (364)
T KOG0658|consen  103 YMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK  178 (364)
T ss_pred             hchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeecc
Confidence            9987 88888764    46667777777999999999999997   99999999999999954 9999999999998876


Q ss_pred             CCcccccccccCCCCcccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhh--------c
Q 041921          674 NQSKTIKTAIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR--------N  744 (814)
Q Consensus       674 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------~  744 (814)
                      +...   ....-|.-|.|||.+.+. .|+.+.||||.|||+.||+-|+..|.+..+.++...   +.+.+.        .
T Consensus       179 ~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~e---Iik~lG~Pt~e~I~~  252 (364)
T KOG0658|consen  179 GEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVE---IIKVLGTPTREDIKS  252 (364)
T ss_pred             CCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHH---HHHHhCCCCHHHHhh
Confidence            5543   334568899999998765 799999999999999999999999987655332211   111111        1


Q ss_pred             Cc-------cceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          745 GK-------LNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       745 ~~-------~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      -.       ...+...............+.++++.++|+.+|.+|.++.|++.
T Consensus       253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence            00       01111111111112234567889999999999999999998873

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-34  Score=304.34  Aligned_cols=250  Identities=26%  Similarity=0.330  Sum_probs=199.5

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhccCCCCccceeeeecccccceEE
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV  596 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  596 (814)
                      +++..++||+|+||.||++....  .+..||||.+....   ......+.+|+.++++++||||+++++.+..++..++|
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRA--TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV   78 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcC--CCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEE
Confidence            35567889999999999998653  57799999986432   12234578899999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccC
Q 041921          597 YEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN  674 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~  674 (814)
                      |||+++++|.+++...  ..+++.....++.|++.||.|||+.   +|+||||||+||++++++.++|+|||++......
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05605          79 LTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG  155 (285)
T ss_pred             EeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence            9999999999888643  4688999999999999999999998   9999999999999999999999999999865432


Q ss_pred             CcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCc
Q 041921          675 QSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGED  754 (814)
Q Consensus       675 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  754 (814)
                      ...   ....|+..|+|||.+.+..++.++||||||+++|||++|+.||.........   +.+...+....        
T Consensus       156 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~--------  221 (285)
T cd05605         156 ETI---RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR---EEVERRVKEDQ--------  221 (285)
T ss_pred             Ccc---ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH---HHHHHHhhhcc--------
Confidence            211   2346899999999999888999999999999999999999999754332111   11111111111        


Q ss_pred             ccccCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 041921          755 KEAMNDIECLGKLVMVSIWCIQEDPSLRP-----TMKKVLQ  790 (814)
Q Consensus       755 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~~vl~  790 (814)
                        ..........+.+++..||+.||.+||     +++++++
T Consensus       222 --~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         222 --EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             --cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence              011223456788999999999999999     8888854

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=4.5e-35  Score=318.61  Aligned_cols=251  Identities=22%  Similarity=0.251  Sum_probs=200.0

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhccCCCCccceeeeecccccceEE
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV  596 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  596 (814)
                      .+.+.+.||+|+||.||++....  .+..||||.++...   ....+.+.+|+.+++.++|+||+++++++.+.+..++|
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv   79 (330)
T cd05601           2 DFDVKSLVGRGHFGEVQVVREKA--TGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLV   79 (330)
T ss_pred             CceEEEEEEeccCEEEEEEEECC--CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEE
Confidence            35677899999999999998653  57789999997532   22345688999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCC
Q 041921          597 YEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ  675 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~  675 (814)
                      |||+++++|.+++... ..+++.....++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++..+....
T Consensus        80 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  156 (330)
T cd05601          80 MEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK  156 (330)
T ss_pred             ECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence            9999999999999876 6789999999999999999999998   99999999999999999999999999998765432


Q ss_pred             cccccccccCCCCcccccccc------cCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccce
Q 041921          676 SKTIKTAIRGTKGYVAPEWFR------NSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNV  749 (814)
Q Consensus       676 ~~~~~~~~~gt~~y~aPE~~~------~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  749 (814)
                      .. ......||+.|+|||.+.      ...++.++|||||||++|||++|+.||........       ...+....  .
T Consensus       157 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~-------~~~i~~~~--~  226 (330)
T cd05601         157 MV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT-------YNNIMNFQ--R  226 (330)
T ss_pred             ce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH-------HHHHHcCC--C
Confidence            22 113346899999999986      45678899999999999999999999975433221       11111110  0


Q ss_pred             eecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          750 LVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       750 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      .    ...+........+.+++..|++ +|.+|||++++++
T Consensus       227 ~----~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         227 F----LKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             c----cCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            0    0011112234667888999998 9999999999885

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.7e-34  Score=304.78  Aligned_cols=260  Identities=25%  Similarity=0.389  Sum_probs=206.1

Q ss_pred             HHhhhccccceeeeeeeeEEEEEEecC-CCceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccceeeeecccccce
Q 041921          517 EGATNNFKEEVGRGSFGIVYKGVIQTR-TSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRL  594 (814)
Q Consensus       517 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  594 (814)
                      ...++.+.+.||+|+||.||+|...+. +....|+||...... ....+.+.+|+.++++++||||+++++++.+ ...+
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~   82 (270)
T cd05056           4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW   82 (270)
T ss_pred             chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence            345567788999999999999987643 334579999886543 3345579999999999999999999998875 5678


Q ss_pred             EEEecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcccccc
Q 041921          595 LVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTL  673 (814)
Q Consensus       595 lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~  673 (814)
                      +||||+++++|.+++... ..+++..+..++.|+++||+|||+.   +++|+||||+||+++.++.+||+|||+++....
T Consensus        83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  159 (270)
T cd05056          83 IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED  159 (270)
T ss_pred             EEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeeccc
Confidence            999999999999999764 4579999999999999999999998   999999999999999999999999999986654


Q ss_pred             CCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeec
Q 041921          674 NQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVG  752 (814)
Q Consensus       674 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  752 (814)
                      ..... .....++..|+|||.+....++.++||||||++++|+++ |..||......+..       ..+..+...    
T Consensus       160 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~-------~~~~~~~~~----  227 (270)
T cd05056         160 ESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI-------GRIENGERL----  227 (270)
T ss_pred             cccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH-------HHHHcCCcC----
Confidence            32111 122334568999999988889999999999999999996 99999654332211       111111100    


Q ss_pred             CcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 041921          753 EDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE  797 (814)
Q Consensus       753 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~  797 (814)
                           ......+..+.+++.+|+..+|.+|||+.++++.|+++..
T Consensus       228 -----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~  267 (270)
T cd05056         228 -----PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ  267 (270)
T ss_pred             -----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                 0112335678899999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=7.6e-35  Score=315.64  Aligned_cols=238  Identities=26%  Similarity=0.294  Sum_probs=190.2

Q ss_pred             cceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHH-hhhccCCCCccceeeeecccccceEEEecC
Q 041921          525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVF-VIGQTHHKNLVRLLGFCDEGQNRLLVYEFL  600 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  600 (814)
                      +.||+|+||+||+|....  +++.||||.+....   ....+++..|.. +++.++||||+++++.+.+.+..++||||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~   78 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKA--DGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYV   78 (323)
T ss_pred             CeeeeCCCeEEEEEEECC--CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCC
Confidence            469999999999999753  57899999986432   122234455544 567889999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccccc
Q 041921          601 NNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIK  680 (814)
Q Consensus       601 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  680 (814)
                      ++++|..++.....+++.....++.||++||.|||+.   +|+||||||+|||++.++.+||+|||+++.......  ..
T Consensus        79 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~  153 (323)
T cd05575          79 NGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--TT  153 (323)
T ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC--cc
Confidence            9999999998888889999999999999999999998   999999999999999999999999999875432211  11


Q ss_pred             ccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCc
Q 041921          681 TAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMND  760 (814)
Q Consensus       681 ~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  760 (814)
                      ....||+.|+|||.+.+..++.++|||||||++|||++|+.||......+       ..+.+..+....          .
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-------~~~~i~~~~~~~----------~  216 (323)
T cd05575         154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE-------MYDNILNKPLRL----------K  216 (323)
T ss_pred             ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH-------HHHHHHcCCCCC----------C
Confidence            34568999999999999999999999999999999999999997543221       111111221110          1


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHH
Q 041921          761 IECLGKLVMVSIWCIQEDPSLRPTMK  786 (814)
Q Consensus       761 ~~~~~~l~~l~~~Cl~~dp~~RPt~~  786 (814)
                      ......+.+++.+||+.||.+||++.
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         217 PNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            12246788999999999999999984

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.3e-35  Score=284.87  Aligned_cols=249  Identities=26%  Similarity=0.379  Sum_probs=204.8

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc----cch----HhHHHHHHhhhcc-CCCCccceeeeecccc
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ----DGE----REFKNEVFVIGQT-HHKNLVRLLGFCDEGQ  591 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~----~~~----~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  591 (814)
                      |.-.++||+|..++|-+..++.  .+...|+|++.....    +..    ++-..|+.+|+++ .||+|+.+.+++..+.
T Consensus        19 y~pkeilgrgvss~vrRci~k~--t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s   96 (411)
T KOG0599|consen   19 YEPKEILGRGVSSVVRRCIHKE--TGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA   96 (411)
T ss_pred             cChHHHhcccchhhhhhhhhcc--cccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence            4446789999999999998764  567788888853221    112    2356789999998 6999999999999999


Q ss_pred             cceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcccc
Q 041921          592 NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLL  671 (814)
Q Consensus       592 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~  671 (814)
                      -.++|+|.|+.|.|.++|.+.-.++++...+|+.|+.+|+.|||..   .|+||||||+|||++++.++||+|||++..+
T Consensus        97 F~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGFa~~l  173 (411)
T KOG0599|consen   97 FVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGFACQL  173 (411)
T ss_pred             hhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccceeecc
Confidence            9999999999999999999999999999999999999999999998   9999999999999999999999999999988


Q ss_pred             ccCCcccccccccCCCCcccccccccC------CCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcC
Q 041921          672 TLNQSKTIKTAIRGTKGYVAPEWFRNS------KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG  745 (814)
Q Consensus       672 ~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  745 (814)
                      .++...   ...+||++|+|||.++..      .|+...|.|++||++|.|+.|..||-....       -...+.+.+|
T Consensus       174 ~~GekL---relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ-------mlMLR~ImeG  243 (411)
T KOG0599|consen  174 EPGEKL---RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ-------MLMLRMIMEG  243 (411)
T ss_pred             CCchhH---HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH-------HHHHHHHHhc
Confidence            766543   557899999999998643      578899999999999999999999853211       1123455555


Q ss_pred             ccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          746 KLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       746 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      +.+.-      .+.-.+......+++.+||+.||.+|.|++|+++
T Consensus       244 kyqF~------speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  244 KYQFR------SPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             ccccC------CcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            54321      1222345667889999999999999999999874

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.5e-34  Score=287.41  Aligned_cols=269  Identities=22%  Similarity=0.241  Sum_probs=202.3

Q ss_pred             ccceeeeeeeeEEEEEEecCCCceEEEEEEecccccc--chHhHHHHHHhhhccCCCCccceeeeec--ccccceEEEec
Q 041921          524 KEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD--GEREFKNEVFVIGQTHHKNLVRLLGFCD--EGQNRLLVYEF  599 (814)
Q Consensus       524 ~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~lv~e~  599 (814)
                      .++|++|.||.||+|+..  .+...||+|+++-..+.  -.-.-.+||.+|.+.+|||||.+..+..  +-+..||||||
T Consensus        81 lnrI~EGtyGiVYRakdk--~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~  158 (419)
T KOG0663|consen   81 LNRIEEGTYGVVYRAKDK--KTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEY  158 (419)
T ss_pred             HhhcccCcceeEEEeccC--CcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHH
Confidence            467999999999999865  46789999999743211  1123589999999999999999998774  45679999999


Q ss_pred             CCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccc
Q 041921          600 LNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT  678 (814)
Q Consensus       600 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  678 (814)
                      +++ +|..++... +++...+...++.|+++|++|||.+   .|+|||||++|+|++..|.+||+|||+|+.+.....  
T Consensus       159 ~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k--  232 (419)
T KOG0663|consen  159 VEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLK--  232 (419)
T ss_pred             HHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCCcc--
Confidence            976 899999876 4788999999999999999999998   999999999999999999999999999998875422  


Q ss_pred             ccccccCCCCcccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcC---ccceeecCc
Q 041921          679 IKTAIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG---KLNVLVGED  754 (814)
Q Consensus       679 ~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  754 (814)
                      ..+..+-|..|.|||.+.+. .|+.+.|+||+|||+.||+++++.|.+...-++..   .+++.+...   ....+....
T Consensus       233 ~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~---~If~llGtPte~iwpg~~~lp  309 (419)
T KOG0663|consen  233 PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLD---KIFKLLGTPSEAIWPGYSELP  309 (419)
T ss_pred             cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHH---HHHHHhCCCccccCCCccccc
Confidence            22566789999999998765 69999999999999999999999997665433222   122222111   000000000


Q ss_pred             -------ccccC-----c---HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCCCCCCC
Q 041921          755 -------KEAMN-----D---IECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVPPNP  804 (814)
Q Consensus       755 -------~~~~~-----~---~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~~~~p~~p  804 (814)
                             ...+.     .   ....+.-.+++...|..||.+|.|++|.++. .-..+.|.|..|
T Consensus       310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h-~~F~e~P~p~~P  373 (419)
T KOG0663|consen  310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH-EYFRETPLPIDP  373 (419)
T ss_pred             hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc-cccccCCCCCCh
Confidence                   00000     0   0123566778888899999999999998864 234555555544

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.7e-34  Score=313.09  Aligned_cols=241  Identities=26%  Similarity=0.313  Sum_probs=193.9

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhccCCC-CccceeeeecccccceEE
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHK-NLVRLLGFCDEGQNRLLV  596 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv  596 (814)
                      +.+.+.||+|+||.||+|....  .++.||||.+....   ....+.+..|..++..++|+ +|+++.+++.+.+..++|
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv   79 (324)
T cd05587           2 FNFLMVLGKGSFGKVMLAERKG--TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV   79 (324)
T ss_pred             ceEEEEEeeccCeEEEEEEECC--CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEE
Confidence            4567899999999999998653  56789999986432   23345678899999999765 588899999888999999


Q ss_pred             EecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCc
Q 041921          597 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS  676 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  676 (814)
                      |||+++++|.+++.....+++.....++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++........
T Consensus        80 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~  156 (324)
T cd05587          80 MEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK  156 (324)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC
Confidence            99999999999998888889999999999999999999998   999999999999999999999999999875322111


Q ss_pred             ccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCccc
Q 041921          677 KTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKE  756 (814)
Q Consensus       677 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  756 (814)
                        ......||..|+|||++.+..++.++|||||||++|||++|+.||......+.       ...+......        
T Consensus       157 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~-------~~~i~~~~~~--------  219 (324)
T cd05587         157 --TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL-------FQSIMEHNVS--------  219 (324)
T ss_pred             --ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH-------HHHHHcCCCC--------
Confidence              11345689999999999999999999999999999999999999975433221       1111121111        


Q ss_pred             ccCcHHHHHHHHHHHHHccccCCCCCCCH
Q 041921          757 AMNDIECLGKLVMVSIWCIQEDPSLRPTM  785 (814)
Q Consensus       757 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~  785 (814)
                        .+.....++.+++.+||+.+|.+||+.
T Consensus       220 --~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         220 --YPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             --CCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence              011234567899999999999999976

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.2e-35  Score=321.05  Aligned_cols=251  Identities=21%  Similarity=0.249  Sum_probs=198.5

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEE
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY  597 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  597 (814)
                      +.+.++||+|+||.||++....  .++.||||.+....   ......+.+|+.++..++||||+++++++.+++..++||
T Consensus         3 y~~~~~lG~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           3 FESIKVIGRGAFGEVRLVQKKD--TGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             ceEEEEEEecCCEEEEEEEECC--CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            4567899999999999999753  56789999996432   223345788999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcc
Q 041921          598 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSK  677 (814)
Q Consensus       598 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  677 (814)
                      ||+++|+|.+++.....+++.....++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++..+......
T Consensus        81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  157 (364)
T cd05599          81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT  157 (364)
T ss_pred             CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence            9999999999998888899999999999999999999998   9999999999999999999999999998765322110


Q ss_pred             c------------------------------------ccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCC
Q 041921          678 T------------------------------------IKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRK  721 (814)
Q Consensus       678 ~------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~  721 (814)
                      .                                    ......||+.|+|||++....++.++|||||||++|||++|+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~  237 (364)
T cd05599         158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP  237 (364)
T ss_pred             cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence            0                                    0012358999999999999999999999999999999999999


Q ss_pred             CCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCC---HHHHHH
Q 041921          722 SFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPT---MKKVLQ  790 (814)
Q Consensus       722 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt---~~~vl~  790 (814)
                      ||......+.       ...+.....      ....+......+.+.+++.+|+. +|.+|++   ++++++
T Consensus       238 Pf~~~~~~~~-------~~~i~~~~~------~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         238 PFCSDNPQET-------YRKIINWKE------TLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             CCCCCCHHHH-------HHHHHcCCC------ccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            9975433211       011111110      00011111234567788888886 8999998   888876

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.4e-34  Score=305.21  Aligned_cols=244  Identities=27%  Similarity=0.305  Sum_probs=194.2

Q ss_pred             eeeeeeeeEEEEEEecCCCceEEEEEEeccccc---cchHhHHHHHHhhhccCCCCccceeeeecccccceEEEecCCCC
Q 041921          527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ---DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNG  603 (814)
Q Consensus       527 LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  603 (814)
                      ||+|+||+||++....  .++.+|+|.+.....   ...+.+..|+.++++++|+||+++.+++......++||||+++|
T Consensus         1 lg~G~~g~Vy~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g   78 (280)
T cd05608           1 LGKGGFGEVSACQMRA--TGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGG   78 (280)
T ss_pred             CCCCCceeEEEEEEcc--CCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCC
Confidence            7999999999998653  567999999864321   22346788999999999999999999999999999999999999


Q ss_pred             CHHHHhcC----CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcccc
Q 041921          604 TLASFLFG----NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI  679 (814)
Q Consensus       604 sL~~~l~~----~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  679 (814)
                      +|..++..    ...+++..+..++.||+.||.|||+.   +|+||||||+||+++.++.+||+|||++..+......  
T Consensus        79 ~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--  153 (280)
T cd05608          79 DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--  153 (280)
T ss_pred             CHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--
Confidence            99988743    35688999999999999999999998   9999999999999999999999999999766543221  


Q ss_pred             cccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccC
Q 041921          680 KTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMN  759 (814)
Q Consensus       680 ~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  759 (814)
                      .....||..|+|||.+.+..++.++||||||+++|||++|+.||.........   ...........        .  ..
T Consensus       154 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~--------~--~~  220 (280)
T cd05608         154 TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN---KELKQRILNDS--------V--TY  220 (280)
T ss_pred             ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH---HHHHHhhcccC--------C--CC
Confidence            13356899999999999999999999999999999999999999754321100   00111111111        0  11


Q ss_pred             cHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 041921          760 DIECLGKLVMVSIWCIQEDPSLRP-----TMKKVLQ  790 (814)
Q Consensus       760 ~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~~vl~  790 (814)
                      +...+..+.+++.+||+.||++||     +++++++
T Consensus       221 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         221 PDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             cccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            123456788999999999999999     7778875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=8.6e-35  Score=320.67  Aligned_cols=254  Identities=20%  Similarity=0.248  Sum_probs=199.8

Q ss_pred             HhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhccCCCCccceeeeecccccce
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRL  594 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  594 (814)
                      ...+.+.++||+|+||.||++....  .+..+|+|.+....   ......+.+|+.+++.++||||+++++++.+++..+
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~  119 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKS--SKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY  119 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECC--CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            4456777899999999999998753  57789999986421   223345788999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccC
Q 041921          595 LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN  674 (814)
Q Consensus       595 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~  674 (814)
                      +||||+++|+|.+++... .++......++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++......
T Consensus       120 lv~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~  195 (370)
T cd05596         120 MVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN  195 (370)
T ss_pred             EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence            999999999999998654 477888888999999999999998   9999999999999999999999999999865433


Q ss_pred             CcccccccccCCCCcccccccccC----CCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCcccee
Q 041921          675 QSKTIKTAIRGTKGYVAPEWFRNS----KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVL  750 (814)
Q Consensus       675 ~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  750 (814)
                      .... .....||+.|+|||.+.+.    .++.++|||||||++|||++|+.||.......       ....+......  
T Consensus       196 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-------~~~~i~~~~~~--  265 (370)
T cd05596         196 GMVR-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-------TYSKIMDHKNS--  265 (370)
T ss_pred             Cccc-CCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH-------HHHHHHcCCCc--
Confidence            2111 1345699999999998653    47889999999999999999999997543321       11111111100  


Q ss_pred             ecCcccccCcHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 041921          751 VGEDKEAMNDIECLGKLVMVSIWCIQEDPSL--RPTMKKVLQM  791 (814)
Q Consensus       751 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~--RPt~~~vl~~  791 (814)
                          ...+........+.+++.+||+.+|.+  |||++++++.
T Consensus       266 ----~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         266 ----LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             ----CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence                111112234567889999999999987  9999999753

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2.4e-34  Score=301.78  Aligned_cols=254  Identities=26%  Similarity=0.438  Sum_probs=203.7

Q ss_pred             HHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceE
Q 041921          516 LEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL  595 (814)
Q Consensus       516 l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  595 (814)
                      +....+.+.++||+|+||.||++...   .+..+++|.+... ....+.+.+|+.++++++|+||+++.+++.+ ...++
T Consensus         3 ~~~~~~~~~~~lg~g~~~~vy~~~~~---~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~   77 (260)
T cd05073           3 IPRESLKLEKKLGAGQFGEVWMATYN---KHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYI   77 (260)
T ss_pred             ccccceeEEeEecCccceEEEEEEec---CCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEE
Confidence            45567788899999999999999865   3557999988643 2334678999999999999999999999887 77899


Q ss_pred             EEecCCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcccccc
Q 041921          596 VYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTL  673 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~  673 (814)
                      +|||+++++|.+++...  ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  154 (260)
T cd05073          78 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIED  154 (260)
T ss_pred             EEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence            99999999999999753  4578889999999999999999998   999999999999999999999999999976543


Q ss_pred             CCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeec
Q 041921          674 NQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVG  752 (814)
Q Consensus       674 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  752 (814)
                      .... ......++..|+|||.+....++.++|+||||++++|+++ |+.||.......   +    ...+..+...    
T Consensus       155 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~----~~~~~~~~~~----  222 (260)
T cd05073         155 NEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---V----IRALERGYRM----  222 (260)
T ss_pred             CCcc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH---H----HHHHhCCCCC----
Confidence            2211 1122345678999999998889999999999999999999 899986433211   1    1111121110    


Q ss_pred             CcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 041921          753 EDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEG  794 (814)
Q Consensus       753 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~  794 (814)
                           ......+.++.+++.+|++.+|++||++.++++.|+.
T Consensus       223 -----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         223 -----PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             -----CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                 1112344678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2e-34  Score=302.05  Aligned_cols=253  Identities=28%  Similarity=0.448  Sum_probs=200.9

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchH--hHHHHHHhhhccCCCCccceeeeecccccceEEEe
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGER--EFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE  598 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~--~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  598 (814)
                      |.+.+.||+|+||+||++....  .+..+|+|.+.........  ....|+.++++++||||+++++++.+....++|||
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~--~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~   78 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKK--NGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVME   78 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETT--TTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECC--CCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccc
Confidence            4577899999999999999763  5678999999764332222  34569999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccc
Q 041921          599 FLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT  678 (814)
Q Consensus       599 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  678 (814)
                      |+++++|.+++.....+++..+..++.|+++||.+||+.   +|+|+||||+||+++.++.++|+|||.+......  ..
T Consensus        79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~--~~  153 (260)
T PF00069_consen   79 YCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN--NE  153 (260)
T ss_dssp             EETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTST--TS
T ss_pred             ccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc--cc
Confidence            999999999998777889999999999999999999998   9999999999999999999999999999764211  12


Q ss_pred             ccccccCCCCcccccccc-cCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccc
Q 041921          679 IKTAIRGTKGYVAPEWFR-NSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEA  757 (814)
Q Consensus       679 ~~~~~~gt~~y~aPE~~~-~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  757 (814)
                      ......++..|+|||.+. ....+.++||||+|+++++|++|+.|+.............   +.. ......   ..   
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~---~~~-~~~~~~---~~---  223 (260)
T PF00069_consen  154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIE---KIL-KRPLPS---SS---  223 (260)
T ss_dssp             EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHH---HHH-HTHHHH---HT---
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhh---hcc-cccccc---cc---
Confidence            224456899999999998 8889999999999999999999999998652211111110   000 000000   00   


Q ss_pred             cCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          758 MNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       758 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      .........+.+++..||+.||++|||+.++++
T Consensus       224 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  224 QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000111278899999999999999999999985

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-34  Score=305.16  Aligned_cols=260  Identities=27%  Similarity=0.421  Sum_probs=205.9

Q ss_pred             HhhhccccceeeeeeeeEEEEEEecCCC--ceEEEEEEeccccc-cchHhHHHHHHhhhccCCCCccceeeeecccccce
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQTRTS--TTAVAVKKLDRVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRL  594 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~--~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  594 (814)
                      ...+.+.+.||+|+||.||+|.....+.  ...+++|.+..... ....++.+|+.++++++|+||+++++++.. ...+
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   84 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ   84 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence            3455677899999999999999764332  34689998865432 334578999999999999999999999987 7889


Q ss_pred             EEEecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcccccc
Q 041921          595 LVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTL  673 (814)
Q Consensus       595 lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~  673 (814)
                      +|+||+++++|.+++... ..+++.....++.|++.||+|||+.   +|+|+||||+||++++++.+||+|||+++....
T Consensus        85 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~  161 (279)
T cd05057          85 LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV  161 (279)
T ss_pred             EEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence            999999999999999764 5689999999999999999999997   999999999999999999999999999987654


Q ss_pred             CCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeec
Q 041921          674 NQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVG  752 (814)
Q Consensus       674 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  752 (814)
                      ...........++..|+|||.+....++.++|+||||++++|+++ |+.||.....++.       ...+..+..  .  
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-------~~~~~~~~~--~--  230 (279)
T cd05057         162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEI-------PDLLEKGER--L--  230 (279)
T ss_pred             cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHH-------HHHHhCCCC--C--
Confidence            322211112224568999999988889999999999999999999 9999875433221       111222111  0  


Q ss_pred             CcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 041921          753 EDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE  797 (814)
Q Consensus       753 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~  797 (814)
                           ..+......+.+++.+||..+|.+||++.++++.|+.+..
T Consensus       231 -----~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         231 -----PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             -----CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                 0111133567889999999999999999999999988644

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=2.6e-34  Score=300.78  Aligned_cols=247  Identities=27%  Similarity=0.396  Sum_probs=198.5

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeec-ccccceEEE
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCD-EGQNRLLVY  597 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~  597 (814)
                      ..+.+.+.||+|+||.||++...    +..+++|.++..  ...+.+.+|+.++++++|+|++++++++. ++...++++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~----~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~   79 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR----GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT   79 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc----CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEE
Confidence            45667789999999999999764    567899988643  23457899999999999999999999764 456789999


Q ss_pred             ecCCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCC
Q 041921          598 EFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ  675 (814)
Q Consensus       598 e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~  675 (814)
                      ||+++++|.+++...  ..+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||+++......
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  156 (256)
T cd05082          80 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ  156 (256)
T ss_pred             ECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence            999999999999764  3478999999999999999999998   99999999999999999999999999987554322


Q ss_pred             cccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeecCc
Q 041921          676 SKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGED  754 (814)
Q Consensus       676 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  754 (814)
                           ....++..|+|||.+....++.++||||||+++|||++ |+.||......+   +    ...+..+...      
T Consensus       157 -----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~---~----~~~~~~~~~~------  218 (256)
T cd05082         157 -----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---V----VPRVEKGYKM------  218 (256)
T ss_pred             -----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---H----HHHHhcCCCC------
Confidence                 22235678999999998899999999999999999998 998886432211   1    1111111100      


Q ss_pred             ccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 041921          755 KEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV  795 (814)
Q Consensus       755 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~  795 (814)
                         ......+..+.+++.+|++.+|++|||+.++++.|+.+
T Consensus       219 ---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         219 ---DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             ---CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence               01123456788999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=7.1e-34  Score=299.65  Aligned_cols=254  Identities=24%  Similarity=0.340  Sum_probs=190.5

Q ss_pred             cceeeeeeeeEEEEEEecCCCceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEecCCCC
Q 041921          525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNG  603 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  603 (814)
                      ++||+|+||.||+|..........+++|.+.... ....+.+.+|+.+++.++||||+++++.+.+....++||||++++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            3699999999999987654445567788776433 234567999999999999999999999999999999999999999


Q ss_pred             CHHHHhcCC----CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcccc
Q 041921          604 TLASFLFGN----LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI  679 (814)
Q Consensus       604 sL~~~l~~~----~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  679 (814)
                      +|.+++...    ...++.....++.||++||+|||+.   +++||||||+|||++.++.+||+|||++...........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            999999753    3356667789999999999999998   999999999999999999999999999864322211111


Q ss_pred             cccccCCCCccccccccc-------CCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceee
Q 041921          680 KTAIRGTKGYVAPEWFRN-------SKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLV  751 (814)
Q Consensus       680 ~~~~~gt~~y~aPE~~~~-------~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  751 (814)
                      .....++..|+|||++..       ..++.++||||||+++|||++ |..||......+      .....+.++. ..+.
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~~~~~~~~~-~~~~  230 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE------VLNHVIKDQQ-VKLF  230 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHhhcc-cccC
Confidence            133457889999998753       245789999999999999997 566775332211      1111111211 1222


Q ss_pred             cCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 041921          752 GEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE  793 (814)
Q Consensus       752 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~  793 (814)
                      ++....    ...+.+.+++..|+ .+|.+||++++|++.|.
T Consensus       231 ~~~~~~----~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         231 KPQLEL----PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CCccCC----CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            222211    13356777888899 57999999999999885

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=2.5e-34  Score=317.88  Aligned_cols=262  Identities=25%  Similarity=0.312  Sum_probs=197.8

Q ss_pred             ccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeecccc-----cce
Q 041921          522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ-----NRL  594 (814)
Q Consensus       522 ~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  594 (814)
                      .+.++||+|+||.||++...  ..+..||||++....  ....+.+.+|+.+++.++|+||+++++++...+     ..+
T Consensus         3 ~~~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           3 EPDRPIGYGAFGVVWSVTDP--RDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             cccceeeeCCCEEEEEEEEC--CCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            45678999999999999865  357899999986532  223457889999999999999999999998766     789


Q ss_pred             EEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccC
Q 041921          595 LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN  674 (814)
Q Consensus       595 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~  674 (814)
                      +|+||+. ++|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~  156 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD  156 (372)
T ss_pred             EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence            9999996 58888888778899999999999999999999998   9999999999999999999999999999865433


Q ss_pred             CcccccccccCCCCcccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHH-H---------------H
Q 041921          675 QSKTIKTAIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILT-D---------------W  737 (814)
Q Consensus       675 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~-~---------------~  737 (814)
                      ..... ....++..|+|||.+.+. .++.++|||||||+++||++|+.||............ .               .
T Consensus       157 ~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  235 (372)
T cd07853         157 ESKHM-TQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG  235 (372)
T ss_pred             ccccC-CCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHH
Confidence            22221 334578999999998764 4789999999999999999999999755432211100 0               0


Q ss_pred             HHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          738 AFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       738 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                      ....+........ .............+++.+++.+||+.||.+|||+.++++.
T Consensus       236 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         236 ARAHILRGPHKPP-SLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HHHHHHhCCCCCC-chHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence            0000000000000 0000000011225678899999999999999999999863

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.9e-34  Score=312.46  Aligned_cols=241  Identities=25%  Similarity=0.306  Sum_probs=193.9

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhcc-CCCCccceeeeecccccceEE
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRLLV  596 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  596 (814)
                      +.+.+.||+|+||.||+|...  ..+..||||.+....   ....+.+..|..++..+ +|++|+++.+++.+.+..++|
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv   79 (323)
T cd05616           2 FNFLMVLGKGSFGKVMLAERK--GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFV   79 (323)
T ss_pred             ceEEEEEeeCCCeEEEEEEEC--CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEE
Confidence            456788999999999999875  356789999987532   22234567777887777 689999999999999999999


Q ss_pred             EecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCc
Q 041921          597 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS  676 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  676 (814)
                      |||+++|+|.+++.....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......
T Consensus        80 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~  156 (323)
T cd05616          80 MEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV  156 (323)
T ss_pred             EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC
Confidence            99999999999998878899999999999999999999998   999999999999999999999999999875432211


Q ss_pred             ccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCccc
Q 041921          677 KTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKE  756 (814)
Q Consensus       677 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  756 (814)
                        ......||+.|+|||.+.+..++.++|||||||++|||++|+.||........       ...+......        
T Consensus       157 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~-------~~~i~~~~~~--------  219 (323)
T cd05616         157 --TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL-------FQSIMEHNVA--------  219 (323)
T ss_pred             --ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHH-------HHHHHhCCCC--------
Confidence              11345689999999999999999999999999999999999999975433221       1111122111        


Q ss_pred             ccCcHHHHHHHHHHHHHccccCCCCCCCH
Q 041921          757 AMNDIECLGKLVMVSIWCIQEDPSLRPTM  785 (814)
Q Consensus       757 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~  785 (814)
                        .+.....++.+++.+||+.+|.+|++.
T Consensus       220 --~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         220 --YPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             --CCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence              111234677899999999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.2e-34  Score=308.25  Aligned_cols=266  Identities=27%  Similarity=0.383  Sum_probs=204.6

Q ss_pred             HhhhccccceeeeeeeeEEEEEEec--CCCceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccceeeeeccc--cc
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQT--RTSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEG--QN  592 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~--~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~  592 (814)
                      +.++...++||+|+||.||++....  ...+..||+|.++... ......+.+|+.++++++||||+++.+++.+.  ..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (284)
T cd05079           3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   82 (284)
T ss_pred             hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence            4456667889999999999998642  3357789999987543 23345799999999999999999999998775  56


Q ss_pred             ceEEEecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcccc
Q 041921          593 RLLVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLL  671 (814)
Q Consensus       593 ~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~  671 (814)
                      .++||||+++++|.+++... ..+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||+++..
T Consensus        83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05079          83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAI  159 (284)
T ss_pred             eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccccc
Confidence            78999999999999999654 4679999999999999999999998   9999999999999999999999999999876


Q ss_pred             ccCCcc-cccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchh--------hhhHHHHHHHHh
Q 041921          672 TLNQSK-TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE--------YAILTDWAFDCY  742 (814)
Q Consensus       672 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~--------~~~~~~~~~~~~  742 (814)
                      ...... .......++..|+|||.+.+..++.++||||||++++||++++.|........        ............
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05079         160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL  239 (284)
T ss_pred             ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH
Confidence            533221 11123446778999999988889999999999999999999877643221100        000000111111


Q ss_pred             hcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 041921          743 RNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV  795 (814)
Q Consensus       743 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~  795 (814)
                      ..+..         .+.....+..+.+++.+||+.+|.+|||++++++.|+.+
T Consensus       240 ~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         240 EEGKR---------LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HcCcc---------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            11110         011123457899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=3.6e-34  Score=306.47  Aligned_cols=250  Identities=26%  Similarity=0.370  Sum_probs=202.3

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEec
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  599 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  599 (814)
                      ++.+.++||+|++|.||+|...  ..+..|++|.+........+.+.+|+.+++.++|+||+++++.+..+.+.++||||
T Consensus        21 ~y~~~~~lg~g~~~~v~~~~~~--~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~   98 (296)
T cd06654          21 KYTRFEKIGQGASGTVYTAMDV--ATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (296)
T ss_pred             ceeeEEEecCCCCeEEEEEEEC--CCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence            4566788999999999999854  35678999998765555556789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcccc
Q 041921          600 LNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI  679 (814)
Q Consensus       600 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  679 (814)
                      +++++|.+++... .+++.++..++.|++.||+|||+.   +|+|+||||+||+++.++.+||+|||++.........  
T Consensus        99 ~~~~~L~~~~~~~-~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~--  172 (296)
T cd06654          99 LAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--  172 (296)
T ss_pred             cCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccccc--
Confidence            9999999998643 578899999999999999999998   9999999999999999999999999998865433221  


Q ss_pred             cccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccC
Q 041921          680 KTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMN  759 (814)
Q Consensus       680 ~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  759 (814)
                      .....+++.|+|||.+.+..++.++|||||||+++||++|+.||........  +    ......+.        .....
T Consensus       173 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~--~----~~~~~~~~--------~~~~~  238 (296)
T cd06654         173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--L----YLIATNGT--------PELQN  238 (296)
T ss_pred             cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh--H----HHHhcCCC--------CCCCC
Confidence            1234588999999999988899999999999999999999999975433211  0    01111110        00111


Q ss_pred             cHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          760 DIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       760 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                      .......+.+++.+||+.+|.+|||+.++++.
T Consensus       239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             ccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence            22344678899999999999999999999873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=3.6e-34  Score=300.78  Aligned_cols=253  Identities=27%  Similarity=0.480  Sum_probs=194.9

Q ss_pred             cceeeeeeeeEEEEEEecC-CCceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccceeeeec-ccccceEEEecCC
Q 041921          525 EEVGRGSFGIVYKGVIQTR-TSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCD-EGQNRLLVYEFLN  601 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~~  601 (814)
                      +.||+|+||.||+|...+. .....||+|++.... ....+.+.+|+.+++.++||||+++++++. .+...++|+||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            4689999999999987532 345689999986432 233457889999999999999999999875 4556789999999


Q ss_pred             CCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccc--
Q 041921          602 NGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT--  678 (814)
Q Consensus       602 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~--  678 (814)
                      +++|.+++... ..+.+..+..++.|+++||+|||+.   +++||||||+|||+++++.+||+|||+++.+.......  
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  157 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH  157 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence            99999999764 4567788889999999999999998   99999999999999999999999999998654322111  


Q ss_pred             ccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCC-CCCCcccchhhhhHHHHHHHHhhcCccceeecCcccc
Q 041921          679 IKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCR-KSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEA  757 (814)
Q Consensus       679 ~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  757 (814)
                      ......++..|+|||.+....++.++||||||++++||++|. .||......+   +..    .+..+..       .. 
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~---~~~----~~~~~~~-------~~-  222 (262)
T cd05058         158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD---ITV----YLLQGRR-------LL-  222 (262)
T ss_pred             ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH----HHhcCCC-------CC-
Confidence            112234577899999998889999999999999999999954 4554322111   111    1111110       00 


Q ss_pred             cCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 041921          758 MNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV  796 (814)
Q Consensus       758 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~  796 (814)
                       .+...+..+.+++..||+.+|++||++.++++.|+++.
T Consensus       223 -~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         223 -QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             -CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence             01123457889999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-36  Score=285.76  Aligned_cols=253  Identities=23%  Similarity=0.331  Sum_probs=203.4

Q ss_pred             HHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEec--cccccchHhHHHHHHhhhccCCCCccceeeeecccccce
Q 041921          517 EGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLD--RVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRL  594 (814)
Q Consensus       517 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  594 (814)
                      ....|.+.++||+|.|+.||+.....  .++..|+|.+.  +....+.+++.+|+.+-+.++||||++|.....+..-.+
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~--tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~y   86 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKT--TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY   86 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhcc--chHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeE
Confidence            34567778899999999999988653  56777777664  233446778999999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc---CCCcEEEeecCCcccc
Q 041921          595 LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLD---DYYTARISDFGLAKLL  671 (814)
Q Consensus       595 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~---~~~~~kl~DfGla~~~  671 (814)
                      ||+|+|.+++|..-|-.+...++...-..+.||+++|.|+|.+   +|+|||+||+|+++-   ...-+||+|||++..+
T Consensus        87 lvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l  163 (355)
T KOG0033|consen   87 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  163 (355)
T ss_pred             EEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEe
Confidence            9999999999977665554556777778999999999999999   999999999999995   3456999999999987


Q ss_pred             ccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceee
Q 041921          672 TLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLV  751 (814)
Q Consensus       672 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  751 (814)
                      ..   ........||++|||||+++..+++..+|||+.|||||-|+.|+.||..+....       +.+.+..+....  
T Consensus       164 ~~---g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r-------lye~I~~g~yd~--  231 (355)
T KOG0033|consen  164 ND---GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-------LYEQIKAGAYDY--  231 (355)
T ss_pred             CC---ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH-------HHHHHhccccCC--
Confidence            72   233356789999999999999999999999999999999999999998644332       223333443221  


Q ss_pred             cCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          752 GEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       752 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                          ..+.-....++..+++.+||..||.+|.|+.|.++
T Consensus       232 ----~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  232 ----PSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             ----CCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence                11122234466778999999999999999988764

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2.6e-34  Score=303.12  Aligned_cols=251  Identities=27%  Similarity=0.472  Sum_probs=198.2

Q ss_pred             cceeeeeeeeEEEEEEecC----CCceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEec
Q 041921          525 EEVGRGSFGIVYKGVIQTR----TSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  599 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  599 (814)
                      +.||+|+||.||+|+..+.    ..+..++||.+.... .....++.+|+.+++.++||||+++++++......++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            3689999999999987531    234679999886432 23456789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCC-------CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC-----cEEEeecCC
Q 041921          600 LNNGTLASFLFGN-------LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYY-----TARISDFGL  667 (814)
Q Consensus       600 ~~~gsL~~~l~~~-------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~-----~~kl~DfGl  667 (814)
                      +++++|.+++...       ..+++..++.++.|++.||+|||+.   +++|+||||+||+++.+.     .++|+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            9999999999642       3467899999999999999999988   999999999999999877     899999999


Q ss_pred             ccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCc
Q 041921          668 AKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGK  746 (814)
Q Consensus       668 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  746 (814)
                      ++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||......+   .    ...+..+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~---~----~~~~~~~~  230 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---V----LQHVTAGG  230 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---H----HHHHhcCC
Confidence            976543322111122345678999999999999999999999999999998 999986433221   1    11111111


Q ss_pred             cceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 041921          747 LNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEG  794 (814)
Q Consensus       747 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~  794 (814)
                             ..  ......+..+.+++.+||+.+|.+||++.++++.|++
T Consensus       231 -------~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         231 -------RL--QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             -------cc--CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence                   00  1112345678899999999999999999999999863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.2e-34  Score=303.62  Aligned_cols=242  Identities=24%  Similarity=0.406  Sum_probs=191.2

Q ss_pred             cceeeeeeeeEEEEEEecCC-----CceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEec
Q 041921          525 EEVGRGSFGIVYKGVIQTRT-----STTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  599 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~-----~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  599 (814)
                      +.||+|+||.||+|.....+     ....|++|.+........+++.+|+.+++.++||||+++++++..+...++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            47999999999999875322     1335888888655444556789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCc--------EEEeecCCccc
Q 041921          600 LNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYT--------ARISDFGLAKL  670 (814)
Q Consensus       600 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~--------~kl~DfGla~~  670 (814)
                      +++|+|.+++... ..+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.        ++++|||++..
T Consensus        81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence            9999999999765 4578999999999999999999998   9999999999999987665        69999998865


Q ss_pred             cccCCcccccccccCCCCcccccccccC-CCCcchhhHHHHHHHHHHHhCC-CCCCcccchhhhhHHHHHHHHhhcCccc
Q 041921          671 LTLNQSKTIKTAIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIISCR-KSFDIEMGEEYAILTDWAFDCYRNGKLN  748 (814)
Q Consensus       671 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~s~Gvvl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~  748 (814)
                      ....      ....++..|+|||++.+. .++.++||||||+++|||++|. .|+.........       .... ... 
T Consensus       158 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~-------~~~~-~~~-  222 (258)
T cd05078         158 VLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL-------QFYE-DRH-  222 (258)
T ss_pred             cCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH-------HHHH-ccc-
Confidence            4321      234578899999999864 5789999999999999999985 454432221110       0001 100 


Q ss_pred             eeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 041921          749 VLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE  793 (814)
Q Consensus       749 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~  793 (814)
                             .  .+.....++.+++.+||+.+|++|||++++++.|+
T Consensus       223 -------~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         223 -------Q--LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             -------c--CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                   0  01112356889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=3e-34  Score=308.14  Aligned_cols=257  Identities=28%  Similarity=0.452  Sum_probs=200.2

Q ss_pred             ccccceeeeeeeeEEEEEEecCCCc--eEEEEEEeccccc-cchHhHHHHHHhhhccCCCCccceeeeecccccceEEEe
Q 041921          522 NFKEEVGRGSFGIVYKGVIQTRTST--TAVAVKKLDRVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE  598 (814)
Q Consensus       522 ~~~~~LG~G~~g~Vy~~~~~~~~~~--~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  598 (814)
                      ...+.||+|+||.||+|.....+..  ..||+|.+..... ....++.+|+.++++++||||+++++++... ..++++|
T Consensus        10 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e   88 (303)
T cd05110          10 KRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQ   88 (303)
T ss_pred             eeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeeh
Confidence            4457899999999999987643322  3678998865432 2234688999999999999999999998754 4679999


Q ss_pred             cCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcc
Q 041921          599 FLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSK  677 (814)
Q Consensus       599 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  677 (814)
                      |+++|+|.+++... ..+++..+..++.|++.||+|||+.   +|+|+||||+||+++.++.+||+|||+++........
T Consensus        89 ~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~  165 (303)
T cd05110          89 LMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE  165 (303)
T ss_pred             hcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccCcccc
Confidence            99999999998765 4678999999999999999999998   9999999999999999999999999999876543322


Q ss_pred             cccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeecCccc
Q 041921          678 TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKE  756 (814)
Q Consensus       678 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  756 (814)
                      .......++..|+|||.+.+..++.++||||||+++|||++ |+.||........   .    +.+..+..  .      
T Consensus       166 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~---~----~~~~~~~~--~------  230 (303)
T cd05110         166 YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI---P----DLLEKGER--L------  230 (303)
T ss_pred             cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---H----HHHHCCCC--C------
Confidence            11123345778999999998899999999999999999998 8899864432221   1    11111110  0      


Q ss_pred             ccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 041921          757 AMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV  798 (814)
Q Consensus       757 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~~  798 (814)
                       .........+.+++..|+..+|++||+++++++.|+.+.+-
T Consensus       231 -~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~  271 (303)
T cd05110         231 -PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD  271 (303)
T ss_pred             -CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence             00112345788999999999999999999999999876433

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-34  Score=300.40  Aligned_cols=251  Identities=21%  Similarity=0.264  Sum_probs=200.8

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc-----cchHhHHHHHHhhhccCCCCccceeeeecccccceE
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ-----DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL  595 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  595 (814)
                      +...+.||+|++|.||++....  .+..+++|.+.....     ...+.+.+|++++++++||||+++++++.+++..++
T Consensus         4 ~~~~~~lg~g~~~~vy~~~~~~--~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           4 WRRGKLLGQGAFGRVYLCYDVD--TGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             ccccceecCCCceEEEEEEEcC--CCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            4567899999999999998653  567899998864321     123468899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCC
Q 041921          596 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ  675 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~  675 (814)
                      |+||+++++|.+++.....+++.....++.|++.||.|||+.   +|+|+||+|+||++++++.++|+|||+++......
T Consensus        82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~  158 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC  158 (263)
T ss_pred             EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence            999999999999998877888999999999999999999998   99999999999999999999999999987654322


Q ss_pred             cccc-cccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCc
Q 041921          676 SKTI-KTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGED  754 (814)
Q Consensus       676 ~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  754 (814)
                      .... .....++..|+|||.+.+..++.++||||||+++|||++|+.||........      ..........       
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~~~~-------  225 (263)
T cd06625         159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA------IFKIATQPTN-------  225 (263)
T ss_pred             cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH------HHHHhccCCC-------
Confidence            1111 0234578899999999998899999999999999999999999864422211      0111111000       


Q ss_pred             ccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          755 KEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       755 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                        ...+......+.+++.+||+.+|.+|||+.++++.
T Consensus       226 --~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         226 --PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             --CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence              01122344678899999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=9.7e-35  Score=315.10  Aligned_cols=241  Identities=26%  Similarity=0.284  Sum_probs=191.6

Q ss_pred             cceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHH-hhhccCCCCccceeeeecccccceEEEecC
Q 041921          525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVF-VIGQTHHKNLVRLLGFCDEGQNRLLVYEFL  600 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  600 (814)
                      +.||+|+||.||++...  .++..+|||.+....   .....++..|.. +++.++||||+++++.+..++..++||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~   78 (325)
T cd05604           1 KVIGKGSFGKVLLAKRK--LDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFV   78 (325)
T ss_pred             CceeeCCCeEEEEEEEC--CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCC
Confidence            46999999999999865  357899999986431   222344555554 567789999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccccc
Q 041921          601 NNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIK  680 (814)
Q Consensus       601 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  680 (814)
                      ++++|..++.....+++.....++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......  ..
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~  153 (325)
T cd05604          79 NGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--TT  153 (325)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--Cc
Confidence            9999999998888899999999999999999999998   999999999999999999999999999875332211  11


Q ss_pred             ccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCc
Q 041921          681 TAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMND  760 (814)
Q Consensus       681 ~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  760 (814)
                      ....||..|+|||.+.+..++.++|||||||++|||++|+.||......+       ..+.+..+.+..          .
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~-------~~~~~~~~~~~~----------~  216 (325)
T cd05604         154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE-------MYDNILHKPLVL----------R  216 (325)
T ss_pred             ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH-------HHHHHHcCCccC----------C
Confidence            34568999999999999999999999999999999999999997543221       111122221110          1


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 041921          761 IECLGKLVMVSIWCIQEDPSLRPTMKKVL  789 (814)
Q Consensus       761 ~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl  789 (814)
                      ......+.+++.+|++.+|.+||++.+.+
T Consensus       217 ~~~~~~~~~ll~~ll~~~p~~R~~~~~~~  245 (325)
T cd05604         217 PGASLTAWSILEELLEKDRQRRLGAKEDF  245 (325)
T ss_pred             CCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence            12345677899999999999999886433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=9e-34  Score=298.47  Aligned_cols=257  Identities=22%  Similarity=0.352  Sum_probs=206.0

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccc---cccchHhHHHHHHhhhccCCCCccceeeeecccccceEE
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV---FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV  596 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  596 (814)
                      .+.+.+.||+|++|.||+|....  ++..|++|.++..   .....+.+.+|++++++++|+||+++++++.+++..++|
T Consensus         3 ~y~~~~~lg~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv   80 (267)
T cd08224           3 NFKIEKKIGKGQFSVVYKAICLL--DGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIV   80 (267)
T ss_pred             ceeeeeeeccCCceEEEEEEEcC--CCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            46678899999999999999763  5678999988532   122345789999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhcC----CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccc
Q 041921          597 YEFLNNGTLASFLFG----NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLT  672 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~  672 (814)
                      |||+++++|.+++..    ...+++..+..++.|+++||.|||+.   +|+|+||+|+||+++.++.++|+|||++..+.
T Consensus        81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~  157 (267)
T cd08224          81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeecc
Confidence            999999999998853    34578999999999999999999998   99999999999999999999999999987654


Q ss_pred             cCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeec
Q 041921          673 LNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVG  752 (814)
Q Consensus       673 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  752 (814)
                      .....  .....++..|+|||.+.+..++.++||||||+++|||++|+.||........    . ..+.+..+....   
T Consensus       158 ~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~-~~~~~~~~~~~~---  227 (267)
T cd08224         158 SKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY----S-LCKKIEKCDYPP---  227 (267)
T ss_pred             CCCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHH----H-HHhhhhcCCCCC---
Confidence            32211  1234578899999999988899999999999999999999999864322110    1 111111221110   


Q ss_pred             CcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 041921          753 EDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV  796 (814)
Q Consensus       753 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~  796 (814)
                           .........+.+++.+|++.+|.+|||+.+|+++|+++.
T Consensus       228 -----~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         228 -----LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             -----CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence                 011234567889999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=3.4e-34  Score=308.43  Aligned_cols=260  Identities=22%  Similarity=0.315  Sum_probs=200.1

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEec
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  599 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  599 (814)
                      +.+.++||+|+||.||++....  .+..+++|.+.... .....++.+|++++++++||||+++++++.+++..++|+||
T Consensus         3 ~~~~~~lg~G~~g~v~~~~~~~--~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           3 FEKLGELGAGNGGVVTKVLHRP--SGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             ceEEeeccCCCCeEEEEEEEcC--CCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            4567889999999999998653  46788989886432 22345688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcccc
Q 041921          600 LNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI  679 (814)
Q Consensus       600 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  679 (814)
                      +++++|.+++.....+++.....++.|+++||.|||+.  .+++|+||||+||+++.++.+||+|||++.......    
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~----  154 (308)
T cd06615          81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----  154 (308)
T ss_pred             cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCcccccccc----
Confidence            99999999998888889999999999999999999973  289999999999999999999999999987653221    


Q ss_pred             cccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCcc------------
Q 041921          680 KTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL------------  747 (814)
Q Consensus       680 ~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------------  747 (814)
                      .....++..|+|||.+.+..++.++||||||++++||++|+.||.........   ............            
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  231 (308)
T cd06615         155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELE---AMFGRPVSEGEAKESHRPVSGHPP  231 (308)
T ss_pred             cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHH---HhhcCccccccccCCcccccCCCC
Confidence            13346889999999998888999999999999999999999998643321111   000000000000            


Q ss_pred             ------------ceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          748 ------------NVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       748 ------------~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                                  ..+................+.+++.+||+.+|++|||++++++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                        00000000000001134568899999999999999999999876

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.8e-35  Score=311.50  Aligned_cols=250  Identities=24%  Similarity=0.342  Sum_probs=209.3

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecc--ccccchHhHHHHHHhhhccCCCCccceeeeeccccc-ceE
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQN-RLL  595 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~l  595 (814)
                      ..|...+.+|+|+||.++...++.  +...+++|++.-  ......+...+|+.++++++|||||.+.+.+.+++. .+|
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~--~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I   81 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKS--DDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI   81 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhcc--CCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence            356678899999999999988764  566899998853  333344568999999999999999999999999988 899


Q ss_pred             EEecCCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcccccc
Q 041921          596 VYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTL  673 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~  673 (814)
                      ||+|++||+|.+.|...  ..++++.+.+++.|++.|+.|||++   .|+|||||+.||+++.+..+||.|||+|+.+..
T Consensus        82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~  158 (426)
T KOG0589|consen   82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP  158 (426)
T ss_pred             EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence            99999999999999765  4568888999999999999999988   999999999999999999999999999999886


Q ss_pred             CCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecC
Q 041921          674 NQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGE  753 (814)
Q Consensus       674 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  753 (814)
                      ....  .....||+.||.||.+.+.+|..|+|||||||++|||++-+.+|.......      .+.+ +.++    .   
T Consensus       159 ~~~~--a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~------Li~k-i~~~----~---  222 (426)
T KOG0589|consen  159 EDSL--ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE------LILK-INRG----L---  222 (426)
T ss_pred             chhh--hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH------HHHH-Hhhc----c---
Confidence            6422  255789999999999999999999999999999999999999997553322      1111 1111    1   


Q ss_pred             cccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          754 DKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       754 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                        ..+.+..+..++..++..|++.+|..||++.+++.+
T Consensus       223 --~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  223 --YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             --CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence              122344567888999999999999999999999865

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.7e-34  Score=292.25  Aligned_cols=262  Identities=26%  Similarity=0.328  Sum_probs=200.4

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc--cchHhHHHHHHhhhccCCCC-ccceeeeecccc----
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ--DGEREFKNEVFVIGQTHHKN-LVRLLGFCDEGQ----  591 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~----  591 (814)
                      ..+...++||+|+||+||+|....  .++.||+|+++-...  .......+|+.++++++|+| |++|.+++...+    
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~--~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~   88 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKR--TGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG   88 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEec--CCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence            344456789999999999999764  568999999975433  23455789999999999999 999999998877    


Q ss_pred             --cceEEEecCCCCCHHHHhcCCC----CCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeec
Q 041921          592 --NRLLVYEFLNNGTLASFLFGNL----KPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDF  665 (814)
Q Consensus       592 --~~~lv~e~~~~gsL~~~l~~~~----~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~Df  665 (814)
                        ..+||+||+. -+|..++....    .++...+..++.||++||+|||++   +|+||||||+||||++.|.+||+||
T Consensus        89 ~~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDF  164 (323)
T KOG0594|consen   89 IGKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADF  164 (323)
T ss_pred             cceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeecc
Confidence              7789999984 49999997654    456678899999999999999999   9999999999999999999999999


Q ss_pred             CCccccccCCcccccccccCCCCcccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhc
Q 041921          666 GLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN  744 (814)
Q Consensus       666 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  744 (814)
                      |+|+........  .+..++|..|.|||++.+. .|+...||||+||++.||++++..|.+..+.++   ...+.+.+..
T Consensus       165 GlAra~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~q---l~~If~~lGt  239 (323)
T KOG0594|consen  165 GLARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQ---LFRIFRLLGT  239 (323)
T ss_pred             chHHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHH---HHHHHHHcCC
Confidence            999966532221  2556789999999999876 799999999999999999999988876554222   1223333221


Q ss_pred             C---ccce---eecCcc-----cccCc-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          745 G---KLNV---LVGEDK-----EAMND-----IECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       745 ~---~~~~---~~~~~~-----~~~~~-----~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                      .   ....   +.+...     ....+     ........+++.+||+.+|.+|.|++.+++.
T Consensus       240 P~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  240 PNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            1   1100   001110     00000     0111467789999999999999999999875

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=7.2e-34  Score=301.49  Aligned_cols=250  Identities=21%  Similarity=0.351  Sum_probs=196.2

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEeccc-cccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEec
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV-FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  599 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  599 (814)
                      +.+.+.||+|+||.||+|...  ..+..||+|.+... .....+++.+|++++++++||||+++++++...+..++|+||
T Consensus         3 ~~~~~~lg~g~~~~v~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           3 IQYQEILGHGNGGTVYKAYHL--LTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             chheeeeccCCCeEEEEEEEc--CCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            456688999999999999865  35778999988643 233345789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcccc
Q 041921          600 LNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI  679 (814)
Q Consensus       600 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  679 (814)
                      +++++|..+.    .+++.....++.|++.||.|||+.   +|+|+||||+||+++.++.+||+|||++.......    
T Consensus        81 ~~~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~----  149 (279)
T cd06619          81 MDGGSLDVYR----KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI----  149 (279)
T ss_pred             CCCCChHHhh----cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc----
Confidence            9999997653    467888889999999999999998   99999999999999999999999999997654321    


Q ss_pred             cccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccC
Q 041921          680 KTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMN  759 (814)
Q Consensus       680 ~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  759 (814)
                      .....++..|+|||.+.+..++.++||||||+++|||++|+.||.............-..........        ....
T Consensus       150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~  221 (279)
T cd06619         150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP--------PVLP  221 (279)
T ss_pred             ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCC--------CCCC
Confidence            13356899999999999889999999999999999999999999643221111000001111111110        0001


Q ss_pred             cHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          760 DIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       760 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                      ......++.+++.+|++.+|.+||+++++++.
T Consensus       222 ~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         222 VGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            11234568899999999999999999999864

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.6e-34  Score=320.56  Aligned_cols=251  Identities=21%  Similarity=0.251  Sum_probs=193.4

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEE
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY  597 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  597 (814)
                      +.+.++||+|+||.||+|....  .++.+|||.+....   ....+.+.+|+.++++++|+||+++++.+.+++..++||
T Consensus         3 f~~~~~LG~G~~g~Vy~a~~~~--~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~   80 (382)
T cd05625           3 FVKIKTLGIGAFGEVCLARKVD--TKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM   80 (382)
T ss_pred             cEEEEEEEeCCCEEEEEEEECC--CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence            4566889999999999998653  57789999986532   223356889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCc-
Q 041921          598 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS-  676 (814)
Q Consensus       598 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~-  676 (814)
                      ||+++|+|.+++.....+++.....++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++..+..... 
T Consensus        81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~  157 (382)
T cd05625          81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  157 (382)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence            9999999999998877888899999999999999999998   999999999999999999999999999754321000 


Q ss_pred             --------------------------------------------ccccccccCCCCcccccccccCCCCcchhhHHHHHH
Q 041921          677 --------------------------------------------KTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVL  712 (814)
Q Consensus       677 --------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvv  712 (814)
                                                                  ........||+.|+|||++.+..++.++|||||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi  237 (382)
T cd05625         158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  237 (382)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence                                                        000122468999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCC---HHHHH
Q 041921          713 LLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPT---MKKVL  789 (814)
Q Consensus       713 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt---~~~vl  789 (814)
                      +|||++|+.||......+..      .. +....      .....+.......++.+++.+++ .+|.+|++   +.+++
T Consensus       238 l~elltG~~Pf~~~~~~~~~------~~-i~~~~------~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~  303 (382)
T cd05625         238 LYEMLVGQPPFLAQTPLETQ------MK-VINWQ------TSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIK  303 (382)
T ss_pred             HHHHHhCCCCCCCCCHHHHH------HH-HHccC------CCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHh
Confidence            99999999999754332211      01 11100      00011111122345566666655 49999997   77766


Q ss_pred             H
Q 041921          790 Q  790 (814)
Q Consensus       790 ~  790 (814)
                      +
T Consensus       304 ~  304 (382)
T cd05625         304 A  304 (382)
T ss_pred             c
Confidence            4

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-34  Score=320.13  Aligned_cols=252  Identities=23%  Similarity=0.243  Sum_probs=196.4

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEE
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY  597 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  597 (814)
                      |.+.++||+|+||.||++....  .+..||||.+....   ....+.+.+|++++++++||||+++++++.+.+..+|||
T Consensus         3 y~~~~~lG~G~~g~Vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           3 FHTVKVIGKGAFGEVRLVQKKD--TGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             ceEeEEEeecCCEEEEEEEECC--CCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            4567899999999999998653  57789999986421   223456889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcc
Q 041921          598 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSK  677 (814)
Q Consensus       598 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  677 (814)
                      ||+++|+|.+++.....+++.....++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.+......
T Consensus        81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  157 (377)
T cd05629          81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS  157 (377)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence            9999999999998888889999999999999999999998   9999999999999999999999999999643211000


Q ss_pred             ---------------------------------------------cccccccCCCCcccccccccCCCCcchhhHHHHHH
Q 041921          678 ---------------------------------------------TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVL  712 (814)
Q Consensus       678 ---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvv  712 (814)
                                                                   .......||+.|+|||++.+..++.++|||||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi  237 (377)
T cd05629         158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI  237 (377)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence                                                         00012458999999999998899999999999999


Q ss_pred             HHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCC---CCHHHHH
Q 041921          713 LLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLR---PTMKKVL  789 (814)
Q Consensus       713 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~R---Pt~~~vl  789 (814)
                      +|||++|+.||......+.       ...+.... .     ....+.......++.+++.+||+ +|.+|   +++.+++
T Consensus       238 l~elltG~~Pf~~~~~~~~-------~~~i~~~~-~-----~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l  303 (377)
T cd05629         238 MFECLIGWPPFCSENSHET-------YRKIINWR-E-----TLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIK  303 (377)
T ss_pred             hhhhhcCCCCCCCCCHHHH-------HHHHHccC-C-----ccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHh
Confidence            9999999999975433221       01111100 0     00011111234567788899997 66665   6999988


Q ss_pred             HH
Q 041921          790 QM  791 (814)
Q Consensus       790 ~~  791 (814)
                      +.
T Consensus       304 ~h  305 (377)
T cd05629         304 SH  305 (377)
T ss_pred             cC
Confidence            64

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.9e-34  Score=312.30  Aligned_cols=238  Identities=24%  Similarity=0.269  Sum_probs=189.4

Q ss_pred             cceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHH-HhhhccCCCCccceeeeecccccceEEEecC
Q 041921          525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEV-FVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL  600 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  600 (814)
                      ++||+|+||.||+|....  ++..||+|.+....   .....++..|. .+++.++||||+++++++.+.+..++||||+
T Consensus         1 ~~lg~G~~g~Vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~   78 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKS--DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYV   78 (321)
T ss_pred             CeeeeCCCEEEEEEEECC--CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCC
Confidence            469999999999999753  57789999986432   12233455555 4678889999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccccc
Q 041921          601 NNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIK  680 (814)
Q Consensus       601 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  680 (814)
                      ++++|..++.....++......++.||++||.|||+.   +|+||||||+||+++.++.+||+|||+++.......  ..
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~  153 (321)
T cd05603          79 NGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--TT  153 (321)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC--cc
Confidence            9999999998777788888999999999999999998   999999999999999999999999999875322211  12


Q ss_pred             ccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCc
Q 041921          681 TAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMND  760 (814)
Q Consensus       681 ~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  760 (814)
                      ....||+.|+|||.+.+..++.++|||||||++|||++|+.||.......       ....+..+...          .+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-------~~~~i~~~~~~----------~~  216 (321)
T cd05603         154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ-------MYDNILHKPLQ----------LP  216 (321)
T ss_pred             ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH-------HHHHHhcCCCC----------CC
Confidence            34568999999999998899999999999999999999999997543211       11111111111          11


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHH
Q 041921          761 IECLGKLVMVSIWCIQEDPSLRPTMK  786 (814)
Q Consensus       761 ~~~~~~l~~l~~~Cl~~dp~~RPt~~  786 (814)
                      ......+.+++.+||+.+|.+||++.
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         217 GGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            12345788999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.8e-34  Score=313.05  Aligned_cols=241  Identities=26%  Similarity=0.290  Sum_probs=190.6

Q ss_pred             cceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHH-HhhhccCCCCccceeeeecccccceEEEecC
Q 041921          525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEV-FVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL  600 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  600 (814)
                      +.||+|+||.||++....  ++..+|+|.+....   ......+..|. .+++.++|+||+++++++.+.+..++||||+
T Consensus         1 ~~lg~G~fg~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~   78 (325)
T cd05602           1 KVIGKGSFGKVLLARHKA--EEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYI   78 (325)
T ss_pred             CeeeeCCCeEEEEEEECC--CCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCC
Confidence            469999999999998753  56789999986432   12223444444 4567889999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccccc
Q 041921          601 NNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIK  680 (814)
Q Consensus       601 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  680 (814)
                      ++++|.+++.....+.......++.||++||.|||+.   +|+||||||+|||++.++.+||+|||+++.......  ..
T Consensus        79 ~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--~~  153 (325)
T cd05602          79 NGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TT  153 (325)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--Cc
Confidence            9999999998877788888889999999999999998   999999999999999999999999999875432211  11


Q ss_pred             ccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCc
Q 041921          681 TAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMND  760 (814)
Q Consensus       681 ~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  760 (814)
                      ....||+.|+|||.+.+..++.++|||||||++|||++|+.||......+.       ...+......          ..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-------~~~i~~~~~~----------~~  216 (325)
T cd05602         154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM-------YDNILNKPLQ----------LK  216 (325)
T ss_pred             ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH-------HHHHHhCCcC----------CC
Confidence            345699999999999999999999999999999999999999975432221       1111111111          11


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 041921          761 IECLGKLVMVSIWCIQEDPSLRPTMKKVL  789 (814)
Q Consensus       761 ~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl  789 (814)
                      ......+.+++.+||+.+|.+||++.+.+
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         217 PNITNSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             CCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence            12345678899999999999999887544

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5e-34  Score=303.56  Aligned_cols=260  Identities=23%  Similarity=0.303  Sum_probs=206.7

Q ss_pred             HHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccceeeeecccccce
Q 041921          516 LEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRL  594 (814)
Q Consensus       516 l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  594 (814)
                      |....+.+.++||+|+||+||++....  .+..+|+|.+.... ....+.+.+|+++++.++||||+++++++......+
T Consensus         2 l~~~~~~~~~~ig~g~~g~v~~~~~~~--~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   79 (284)
T cd06620           2 LRNEDLETISDLGAGNGGSVSKVKHIP--TGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNIC   79 (284)
T ss_pred             ccHHHHHHHHHcCCCCCeEEEEEEEcC--CCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEE
Confidence            344566778899999999999998653  56789999876432 334567899999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccC
Q 041921          595 LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN  674 (814)
Q Consensus       595 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~  674 (814)
                      +||||+++++|.+++.....+++.....++.+++.+|.|||+.  .+++|+||+|+||++++++.++|+|||++......
T Consensus        80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~  157 (284)
T cd06620          80 MCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS  157 (284)
T ss_pred             EEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence            9999999999999998877889999999999999999999973  27999999999999999999999999998754322


Q ss_pred             CcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchh-----hhhHHHHHHHHhhcCccce
Q 041921          675 QSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-----YAILTDWAFDCYRNGKLNV  749 (814)
Q Consensus       675 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~  749 (814)
                      ..    ....|+..|+|||.+.+..++.++|||||||+++||++|+.||......+     ...+.+.........    
T Consensus       158 ~~----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  229 (284)
T cd06620         158 IA----DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP----  229 (284)
T ss_pred             cc----CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc----
Confidence            11    23468999999999988889999999999999999999999997543321     111111111111111    


Q ss_pred             eecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 041921          750 LVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQML  792 (814)
Q Consensus       750 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L  792 (814)
                           .........+..+.+++.+|++.||.+|||+.|+++..
T Consensus       230 -----~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         230 -----PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             -----CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence                 00011112456788999999999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.9e-35  Score=314.47  Aligned_cols=246  Identities=26%  Similarity=0.417  Sum_probs=198.3

Q ss_pred             ccccceeeeeeeeEEEEEEecCCCceEEEEE--Eecccc--ccchHhHHHHHHhhhccCCCCccceeeeeccccc--ceE
Q 041921          522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVK--KLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQN--RLL  595 (814)
Q Consensus       522 ~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK--~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~l  595 (814)
                      .|.++||+|+|-+||||....  .+..||=-  +++...  ....+.|..|+.+|+.|+|+||++++.++.+...  ..+
T Consensus        43 k~~evLGrGafKtVYka~De~--~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~  120 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEE--EGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINF  120 (632)
T ss_pred             ehhhhcccccceeeeeccccc--cchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeee
Confidence            466889999999999999753  45555422  222222  2334679999999999999999999999877655  678


Q ss_pred             EEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc-CCCcEEEeecCCccccccC
Q 041921          596 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLD-DYYTARISDFGLAKLLTLN  674 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~-~~~~~kl~DfGla~~~~~~  674 (814)
                      |+|.+..|+|..|+.+.+..+.+....+++||++||.|||++ .|+|+|||||-+||+|+ ..|.|||+|+|||.+++..
T Consensus       121 iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s  199 (632)
T KOG0584|consen  121 ITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS  199 (632)
T ss_pred             eeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence            999999999999999999999999999999999999999997 67999999999999998 5689999999999988765


Q ss_pred             CcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCc
Q 041921          675 QSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGED  754 (814)
Q Consensus       675 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  754 (814)
                      ..    ..+.||+.|||||.+. ..|++..||||||++++||+|+..||..-...      ..+.+++-.|.....+..-
T Consensus       200 ~a----ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~------AQIYKKV~SGiKP~sl~kV  268 (632)
T KOG0584|consen  200 HA----KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP------AQIYKKVTSGIKPAALSKV  268 (632)
T ss_pred             cc----ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCH------HHHHHHHHcCCCHHHhhcc
Confidence            43    3467999999999998 77999999999999999999999999633221      1233444444322211111


Q ss_pred             ccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          755 KEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       755 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                          .    -.++.++|.+||.. .++|||+.|+|+
T Consensus       269 ----~----dPevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  269 ----K----DPEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             ----C----CHHHHHHHHHHhcC-chhccCHHHHhh
Confidence                1    24678899999999 999999999985

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.3e-34  Score=297.41  Aligned_cols=248  Identities=27%  Similarity=0.430  Sum_probs=199.0

Q ss_pred             cceeeeeeeeEEEEEEecCCCceEEEEEEecccccc-chHhHHHHHHhhhccCCCCccceeeeecccccceEEEecCCCC
Q 041921          525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD-GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNG  603 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  603 (814)
                      ++||+|+||.||++...   .++.|++|.+...... ....+.+|++++++++|+||+++++++.+....++|+||++++
T Consensus         1 ~~lg~g~~g~v~~~~~~---~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~   77 (251)
T cd05041           1 EKIGKGNFGDVYKGVLK---GNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG   77 (251)
T ss_pred             CccccCCCceEEEEEEe---CCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence            47999999999999975   3788999988754333 4567999999999999999999999999999999999999999


Q ss_pred             CHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccccccc
Q 041921          604 TLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTA  682 (814)
Q Consensus       604 sL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  682 (814)
                      +|.+++... ..+++..+..++.+++.+|+|||++   +++||||+|+||+++.++.+||+|||++..............
T Consensus        78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  154 (251)
T cd05041          78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL  154 (251)
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence            999999653 5678899999999999999999998   999999999999999999999999999986543221111112


Q ss_pred             ccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCcH
Q 041921          683 IRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDI  761 (814)
Q Consensus       683 ~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  761 (814)
                      ...+..|+|||.+.+..++.++|+||||++++||++ |..||.........       ..+..+.         ....+.
T Consensus       155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~-------~~~~~~~---------~~~~~~  218 (251)
T cd05041         155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTR-------ERIESGY---------RMPAPQ  218 (251)
T ss_pred             CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHH-------HHHhcCC---------CCCCCc
Confidence            234567999999988889999999999999999999 88888644322111       1111110         001112


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 041921          762 ECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEG  794 (814)
Q Consensus       762 ~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~  794 (814)
                      ..+.++.+++.+|++.+|.+|||+.++++.|+.
T Consensus       219 ~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~  251 (251)
T cd05041         219 LCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI  251 (251)
T ss_pred             cCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence            345678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=4.3e-34  Score=309.55  Aligned_cols=241  Identities=26%  Similarity=0.313  Sum_probs=193.6

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhccC-CCCccceeeeecccccceEE
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTH-HKNLVRLLGFCDEGQNRLLV  596 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv  596 (814)
                      +++.+.||+|+||.||++....  ++..||||.+....   ....+.+..|..++..+. |++|+++.+++.+.+..++|
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv   79 (323)
T cd05615           2 FNFLMVLGKGSFGKVMLAERKG--TDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFV   79 (323)
T ss_pred             ceEEEEEEecCCeEEEEEEECC--CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEE
Confidence            4567899999999999998653  57789999986432   223345778888888885 57788899999998999999


Q ss_pred             EecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCc
Q 041921          597 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS  676 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  676 (814)
                      |||+++|+|.+++.....+++.....++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.......
T Consensus        80 ~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~  156 (323)
T cd05615          80 MEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV  156 (323)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCCc
Confidence            99999999999998888899999999999999999999998   999999999999999999999999999875432211


Q ss_pred             ccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCccc
Q 041921          677 KTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKE  756 (814)
Q Consensus       677 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  756 (814)
                      .  .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.......       ..+.+......        
T Consensus       157 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~-------~~~~i~~~~~~--------  219 (323)
T cd05615         157 T--TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE-------LFQSIMEHNVS--------  219 (323)
T ss_pred             c--ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCC--------
Confidence            1  133568999999999998899999999999999999999999997543321       11111111111        


Q ss_pred             ccCcHHHHHHHHHHHHHccccCCCCCCCH
Q 041921          757 AMNDIECLGKLVMVSIWCIQEDPSLRPTM  785 (814)
Q Consensus       757 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~  785 (814)
                        .+......+.+++.+||+.+|.+|++.
T Consensus       220 --~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         220 --YPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             --CCccCCHHHHHHHHHHcccCHhhCCCC
Confidence              011234567889999999999999974

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.8e-34  Score=304.27  Aligned_cols=244  Identities=24%  Similarity=0.329  Sum_probs=192.5

Q ss_pred             eeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEecCCCC
Q 041921          527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNG  603 (814)
Q Consensus       527 LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  603 (814)
                      ||+|+||.||++....  .+..+|+|.+....   ....+.+..|++++++++||||+++.+++.++...++||||++++
T Consensus         1 lg~G~~g~Vy~~~~~~--~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~   78 (277)
T cd05607           1 LGKGGFGEVCAVQVKN--TGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGG   78 (277)
T ss_pred             CCCCCceEEEEEEEcc--CCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCC
Confidence            7999999999998763  57899999986421   112345667999999999999999999999999999999999999


Q ss_pred             CHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcccccc
Q 041921          604 TLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKT  681 (814)
Q Consensus       604 sL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  681 (814)
                      +|.+++...  ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++|+|||++........   ..
T Consensus        79 ~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~  152 (277)
T cd05607          79 DLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---IT  152 (277)
T ss_pred             CHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---ee
Confidence            999888653  4578888999999999999999998   999999999999999999999999999886643221   13


Q ss_pred             cccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCcH
Q 041921          682 AIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDI  761 (814)
Q Consensus       682 ~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  761 (814)
                      ...|+..|+|||++.+..++.++|||||||++|||++|+.||.........  .... .......+..         ...
T Consensus       153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~--~~~~-~~~~~~~~~~---------~~~  220 (277)
T cd05607         153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK--EELK-RRTLEDEVKF---------EHQ  220 (277)
T ss_pred             ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH--HHHH-HHhhcccccc---------ccc
Confidence            345899999999999888999999999999999999999999643321110  1111 1111111110         011


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          762 ECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       762 ~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      ....++.+++..||+.||.+||+++|+++
T Consensus       221 ~~~~~~~~li~~~L~~~P~~R~~~~~~~~  249 (277)
T cd05607         221 NFTEESKDICRLFLAKKPEDRLGSREKND  249 (277)
T ss_pred             cCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence            23456889999999999999999976553

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.8e-34  Score=317.76  Aligned_cols=254  Identities=19%  Similarity=0.248  Sum_probs=197.6

Q ss_pred             HhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhccCCCCccceeeeecccccce
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRL  594 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  594 (814)
                      ...+.+.++||+|+||.||++....  .+..+|+|.+....   ....+.+.+|+.+++.++||||+++++++.+++..+
T Consensus        42 ~~~y~~~~~lG~G~fg~Vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~  119 (370)
T cd05621          42 AEDYDVVKVIGRGAFGEVQLVRHKS--SQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY  119 (370)
T ss_pred             HHHCeEEEEEEecCCeEEEEEEECC--CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence            3556777899999999999999753  56789999986421   223345889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccC
Q 041921          595 LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN  674 (814)
Q Consensus       595 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~  674 (814)
                      +||||+++|+|.+++... .++......++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++......
T Consensus       120 lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~  195 (370)
T cd05621         120 MVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET  195 (370)
T ss_pred             EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence            999999999999999654 578888899999999999999998   9999999999999999999999999999876432


Q ss_pred             CcccccccccCCCCcccccccccC----CCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCcccee
Q 041921          675 QSKTIKTAIRGTKGYVAPEWFRNS----KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVL  750 (814)
Q Consensus       675 ~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  750 (814)
                      .... .....||+.|+|||.+...    .++.++|||||||++|||++|+.||........       ...+.....   
T Consensus       196 ~~~~-~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~-------~~~i~~~~~---  264 (370)
T cd05621         196 GMVR-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT-------YSKIMDHKN---  264 (370)
T ss_pred             Ccee-cccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH-------HHHHHhCCc---
Confidence            2111 1345699999999998754    378899999999999999999999975432211       111111110   


Q ss_pred             ecCcccccCcHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 041921          751 VGEDKEAMNDIECLGKLVMVSIWCIQEDPSL--RPTMKKVLQM  791 (814)
Q Consensus       751 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~--RPt~~~vl~~  791 (814)
                         ....+........+.+++..|++.++.+  ||+++++++.
T Consensus       265 ---~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         265 ---SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             ---ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence               0111112233456778888899755543  8999999875

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.1e-34  Score=317.90  Aligned_cols=261  Identities=21%  Similarity=0.207  Sum_probs=195.1

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEe
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE  598 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  598 (814)
                      ..+.+.+.||+|+||.||++....  .++.||||...      ...+.+|+.++++++|+||+++++++..++..++|||
T Consensus       169 ~gy~i~~~Lg~G~~G~Vy~a~~~~--~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e  240 (461)
T PHA03211        169 LGFAIHRALTPGSEGCVFESSHPD--YPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP  240 (461)
T ss_pred             CCeEEEEEEccCCCeEEEEEEECC--CCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence            345667899999999999999764  46789999642      2346789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcc
Q 041921          599 FLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSK  677 (814)
Q Consensus       599 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  677 (814)
                      ++. ++|.+++... ..+++..++.|+.||++||.|||+.   +|+||||||+|||++.++.+||+|||+++........
T Consensus       241 ~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~  316 (461)
T PHA03211        241 KYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST  316 (461)
T ss_pred             ccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence            985 6888888654 5689999999999999999999998   9999999999999999999999999999876543322


Q ss_pred             cccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCccc-chhhhhHHHHHHHHhhcCccc--eee---
Q 041921          678 TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEM-GEEYAILTDWAFDCYRNGKLN--VLV---  751 (814)
Q Consensus       678 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~--~~~---  751 (814)
                      .......||..|+|||++.+..++.++|||||||++|||++|..++.... ..........+.+.+......  .+.   
T Consensus       317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~  396 (461)
T PHA03211        317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA  396 (461)
T ss_pred             ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence            22234569999999999999999999999999999999999886643221 110000001111111111100  000   


Q ss_pred             ----------------cCccccc---CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          752 ----------------GEDKEAM---NDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       752 ----------------~~~~~~~---~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                                      .+.....   ........+.+|+.+||+.||.+|||+.|+++.
T Consensus       397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence                            0000000   000122367889999999999999999999874

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=8.1e-34  Score=301.60  Aligned_cols=250  Identities=22%  Similarity=0.290  Sum_probs=199.3

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEecC
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL  600 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  600 (814)
                      +++.++||+|+||.||+|....  .+..+++|.+........+.+.+|+++++.++||||+++++++..+...++|+||+
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~   84 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKE--TGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   84 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECC--CCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence            4566789999999999998753  56788999987655555667899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcccc
Q 041921          601 NNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI  679 (814)
Q Consensus       601 ~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  679 (814)
                      ++++|..++.. ...+++..+..++.|+++||.|||+.   +++||||||+||+++.++.+||+|||++........  .
T Consensus        85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~  159 (282)
T cd06643          85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--R  159 (282)
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccc--c
Confidence            99999998865 45689999999999999999999998   999999999999999999999999999876543221  1


Q ss_pred             cccccCCCCcccccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCc
Q 041921          680 KTAIRGTKGYVAPEWFR-----NSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGED  754 (814)
Q Consensus       680 ~~~~~gt~~y~aPE~~~-----~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  754 (814)
                      .....++..|+|||.+.     +..++.++|||||||++|||++|+.||......+.      ..... ......     
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~------~~~~~-~~~~~~-----  227 (282)
T cd06643         160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV------LLKIA-KSEPPT-----  227 (282)
T ss_pred             cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH------HHHHh-hcCCCC-----
Confidence            13345889999999984     34577899999999999999999999865432111      11111 110000     


Q ss_pred             ccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          755 KEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       755 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                      .  ..+.....++.+++.+||+.+|.+||++.++++.
T Consensus       228 ~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         228 L--AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             C--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0  1112234678899999999999999999998754

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=4.9e-34  Score=307.47  Aligned_cols=264  Identities=20%  Similarity=0.288  Sum_probs=196.9

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc-cchHhHHHHHHhhhccCCCCccceeeeecccccceEEE
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY  597 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  597 (814)
                      .+|.+.++||+|+||.||+|....  .+..||+|.++.... .....+.+|+.++++++||||+++++++..++..++||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   83 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKL--TENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF   83 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecC--CCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence            346677899999999999998653  567899999864322 23346788999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCc
Q 041921          598 EFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS  676 (814)
Q Consensus       598 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  676 (814)
                      ||+++ +|.+++... ..+++.....++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.......
T Consensus        84 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  159 (309)
T cd07872          84 EYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK  159 (309)
T ss_pred             eCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence            99975 888877654 4578889999999999999999998   999999999999999999999999999876543221


Q ss_pred             ccccccccCCCCccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHH--------HHHhhcC-c
Q 041921          677 KTIKTAIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA--------FDCYRNG-K  746 (814)
Q Consensus       677 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~~-~  746 (814)
                      .  .....++..|+|||.+.+ ..++.++||||||++++||++|+.||......+........        +..+... .
T Consensus       160 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07872         160 T--YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE  237 (309)
T ss_pred             c--cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence            1  123457899999998865 46889999999999999999999999755432211110000        0000000 0


Q ss_pred             cceeecCccc----ccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          747 LNVLVGEDKE----AMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       747 ~~~~~~~~~~----~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      ......+...    .........++.+++.+||+.||.+|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            0000000000    0001123456789999999999999999999987

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.5e-34  Score=320.25  Aligned_cols=252  Identities=20%  Similarity=0.239  Sum_probs=195.9

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEE
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY  597 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  597 (814)
                      |.+.++||+|+||.||++....  .++.||||.+....   ......+.+|+.++++++|+||+++++.+.+++..++||
T Consensus         3 y~~~~~lG~G~~g~V~~a~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           3 FVKIKTIGIGAFGEVCLVRKVD--TNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             ceEEEEEEeCCCeEEEEEEECC--CCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            5667899999999999998653  57899999986432   123356889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCc-
Q 041921          598 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS-  676 (814)
Q Consensus       598 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~-  676 (814)
                      ||+++|+|.+++.....++......++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++..+..... 
T Consensus        81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~  157 (376)
T cd05598          81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  157 (376)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence            9999999999998888888999999999999999999998   999999999999999999999999999753321000 


Q ss_pred             ----------------------------------------ccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHH
Q 041921          677 ----------------------------------------KTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEI  716 (814)
Q Consensus       677 ----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~el  716 (814)
                                                              ........||+.|+|||++.+..++.++|||||||++|||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel  237 (376)
T cd05598         158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM  237 (376)
T ss_pred             cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence                                                    0001134699999999999999999999999999999999


Q ss_pred             HhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCC---CHHHHHHH
Q 041921          717 ISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRP---TMKKVLQM  791 (814)
Q Consensus       717 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RP---t~~~vl~~  791 (814)
                      ++|+.||......+..       ..+...... +     ..+........+.+++.+|+ .+|.+|+   |+.++++.
T Consensus       238 l~G~~Pf~~~~~~~~~-------~~i~~~~~~-~-----~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         238 LVGQPPFLADTPAETQ-------LKVINWETT-L-----HIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             hhCCCCCCCCCHHHHH-------HHHhccCcc-c-----cCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            9999999755432211       011111000 0     00111122345566777765 4999999   88888754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=6e-34  Score=331.70  Aligned_cols=259  Identities=24%  Similarity=0.358  Sum_probs=200.8

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc---cchHhHHHHHHhhhccCCCCccceeeeecccccceEE
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ---DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV  596 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  596 (814)
                      .+.+.++||+|+||.||+|...  ..++.||||++.....   ...+++.+|++++++++||||+++++++.+++..++|
T Consensus         3 rYeIi~~LGkGgfG~VYlA~d~--~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV   80 (932)
T PRK13184          3 RYDIIRLIGKGGMGEVYLAYDP--VCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT   80 (932)
T ss_pred             CeEEEEEEecCCCEEEEEEEEC--CCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence            4567789999999999999865  3578999999965322   2245689999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhcCC-----------CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeec
Q 041921          597 YEFLNNGTLASFLFGN-----------LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDF  665 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~~-----------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~Df  665 (814)
                      |||+++++|.+++...           ...++....+++.||++||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDF  157 (932)
T PRK13184         81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDW  157 (932)
T ss_pred             EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEec
Confidence            9999999999998631           2345677889999999999999998   9999999999999999999999999


Q ss_pred             CCccccccCCc----------------ccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccch
Q 041921          666 GLAKLLTLNQS----------------KTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGE  729 (814)
Q Consensus       666 Gla~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~  729 (814)
                      |+++.......                ........||+.|+|||.+.+..++.++|||||||+++||+||+.||......
T Consensus       158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~  237 (932)
T PRK13184        158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR  237 (932)
T ss_pred             CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence            99987621110                00012246999999999999999999999999999999999999999753322


Q ss_pred             hhhhHHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHhcCcC
Q 041921          730 EYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRP-TMKKVLQMLEGVVE  797 (814)
Q Consensus       730 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-t~~~vl~~L~~~~~  797 (814)
                      ....      .    ..+   ..+. ......+.+..+.+++.+|++.||++|| +++++++.|+....
T Consensus       238 ki~~------~----~~i---~~P~-~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq  292 (932)
T PRK13184        238 KISY------R----DVI---LSPI-EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ  292 (932)
T ss_pred             hhhh------h----hhc---cChh-hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            1100      0    000   0000 0001123446688899999999999996 67777777766543

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=8.3e-34  Score=297.32  Aligned_cols=240  Identities=28%  Similarity=0.467  Sum_probs=191.7

Q ss_pred             cceeeeeeeeEEEEEEecCCC--------ceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEE
Q 041921          525 EEVGRGSFGIVYKGVIQTRTS--------TTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV  596 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~~--------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  596 (814)
                      +.||+|+||.||+|.+.....        ...|++|.+...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            469999999999999874331        135788877644332 6789999999999999999999999988 778999


Q ss_pred             EecCCCCCHHHHhcCCC-CCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC-------cEEEeecCCc
Q 041921          597 YEFLNNGTLASFLFGNL-KPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYY-------TARISDFGLA  668 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~-------~~kl~DfGla  668 (814)
                      +||+++++|.+++.... .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++       .+||+|||++
T Consensus        79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            99999999999998765 789999999999999999999998   999999999999999887       7999999999


Q ss_pred             cccccCCcccccccccCCCCcccccccccC--CCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcC
Q 041921          669 KLLTLNQSKTIKTAIRGTKGYVAPEWFRNS--KITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNG  745 (814)
Q Consensus       669 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  745 (814)
                      ......      ....++..|+|||.+...  .++.++||||||++++||++ |..|+......+..   .    .+...
T Consensus       156 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~---~----~~~~~  222 (259)
T cd05037         156 ITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE---R----FYQDQ  222 (259)
T ss_pred             cccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHH---H----HHhcC
Confidence            865431      223467789999999876  78999999999999999999 57777544321110   0    01000


Q ss_pred             ccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 041921          746 KLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE  793 (814)
Q Consensus       746 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~  793 (814)
                      .  .     .    .......+.+++.+||..+|.+|||+.++++.|+
T Consensus       223 ~--~-----~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         223 H--R-----L----PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             C--C-----C----CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            0  0     0    0011167889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=9.6e-34  Score=303.28  Aligned_cols=250  Identities=25%  Similarity=0.348  Sum_probs=202.6

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEe
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE  598 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  598 (814)
                      ..+.+.++||+|++|.||++...  ..+..||+|.+........+.+.+|+.+++.++|+||+++++++..++..++|||
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   96 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDI--ATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   96 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEEC--CCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence            45667789999999999999864  3577899999976545555678999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccc
Q 041921          599 FLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT  678 (814)
Q Consensus       599 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  678 (814)
                      |+++++|.+++.+ ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++......... 
T Consensus        97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~-  171 (297)
T cd06656          97 YLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-  171 (297)
T ss_pred             ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCccC-
Confidence            9999999999865 3578889999999999999999998   9999999999999999999999999998765443221 


Q ss_pred             ccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCccccc
Q 041921          679 IKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAM  758 (814)
Q Consensus       679 ~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  758 (814)
                       .....+++.|+|||.+.+..++.++||||||+++++|++|+.||..........              ...........
T Consensus       172 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~--------------~~~~~~~~~~~  236 (297)
T cd06656         172 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY--------------LIATNGTPELQ  236 (297)
T ss_pred             -cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee--------------eeccCCCCCCC
Confidence             133458889999999998889999999999999999999999996543221100              00000011111


Q ss_pred             CcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          759 NDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       759 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      ........+.+++.+||+.+|.+||+++++++
T Consensus       237 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         237 NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            12234466788999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=7.7e-34  Score=307.14  Aligned_cols=197  Identities=22%  Similarity=0.398  Sum_probs=161.4

Q ss_pred             ccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecc--cccceEEEecCC
Q 041921          524 KEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDE--GQNRLLVYEFLN  601 (814)
Q Consensus       524 ~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~  601 (814)
                      .++||+|+||.||+|...+......+|+|.+...  .....+.+|+.++++++||||+++++++..  +...++++||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            4689999999999999765556789999998643  233467889999999999999999998854  456789999986


Q ss_pred             CCCHHHHhcCC---------CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE----cCCCcEEEeecCCc
Q 041921          602 NGTLASFLFGN---------LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILL----DDYYTARISDFGLA  668 (814)
Q Consensus       602 ~gsL~~~l~~~---------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll----~~~~~~kl~DfGla  668 (814)
                      + +|.+++...         ..+++.....++.||+.||.|||+.   +|+||||||+|||+    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            4 787776421         2478888999999999999999998   99999999999999    45678999999999


Q ss_pred             cccccCCcc-cccccccCCCCcccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 041921          669 KLLTLNQSK-TIKTAIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIISCRKSFDIE  726 (814)
Q Consensus       669 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~s~Gvvl~elltg~~p~~~~  726 (814)
                      +........ .......+|+.|+|||++.+. .++.++||||+||+++||++|+.||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            876533211 111345689999999998764 5889999999999999999999999643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=7.3e-34  Score=299.33  Aligned_cols=253  Identities=21%  Similarity=0.306  Sum_probs=201.2

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEe
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE  598 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  598 (814)
                      ..+.+.++||+|+||.||+|....  .+..+|+|.++.........+.+|+.+++.++||||+++++.+...+..++|+|
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e   86 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVN--TGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME   86 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcC--CCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence            356677899999999999998653  567899999875444445568899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccc
Q 041921          599 FLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT  678 (814)
Q Consensus       599 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  678 (814)
                      |+++++|.+++.....+++.....++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++......... 
T Consensus        87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~-  162 (267)
T cd06645          87 FCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAK-  162 (267)
T ss_pred             ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcccc-
Confidence            999999999998888899999999999999999999998   9999999999999999999999999998765432211 


Q ss_pred             ccccccCCCCcccccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcc
Q 041921          679 IKTAIRGTKGYVAPEWFR---NSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDK  755 (814)
Q Consensus       679 ~~~~~~gt~~y~aPE~~~---~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  755 (814)
                       .....|+..|+|||.+.   ...++.++|||||||++|||++|..||.........      .. .......   .+..
T Consensus       163 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~------~~-~~~~~~~---~~~~  231 (267)
T cd06645         163 -RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL------FL-MTKSNFQ---PPKL  231 (267)
T ss_pred             -cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH------Hh-hhccCCC---CCcc
Confidence             13346899999999974   456889999999999999999999998543321110      00 0011100   0000


Q ss_pred             cccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          756 EAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       756 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                        .........+.+++.+|++.+|++|||++++++
T Consensus       232 --~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         232 --KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             --cccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence              011123456889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=7.9e-34  Score=297.07  Aligned_cols=250  Identities=27%  Similarity=0.467  Sum_probs=200.5

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEec
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  599 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  599 (814)
                      .+.+.+.||+|+||.||++...   .+..+++|.+... .....+|.+|++++++++|||++++++++......++|+||
T Consensus         5 ~~~~~~~ig~g~~g~v~~~~~~---~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd05112           5 ELTLVQEIGSGQFGLVWLGYWL---EKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF   80 (256)
T ss_pred             HeEEEeeecCcccceEEEEEEe---CCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence            4566789999999999999875   3567999988643 23456799999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccc
Q 041921          600 LNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT  678 (814)
Q Consensus       600 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  678 (814)
                      +++++|.+++... ..+++..+..++.|++.+|+|||+.   +++|+||||+||+++.++.+||+|||++..........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~  157 (256)
T cd05112          81 MEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS  157 (256)
T ss_pred             CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence            9999999999764 4578999999999999999999998   99999999999999999999999999987654322111


Q ss_pred             ccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccc
Q 041921          679 IKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEA  757 (814)
Q Consensus       679 ~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  757 (814)
                       .....++.+|+|||.+.+..++.++||||||+++|||++ |+.||......+       ..+.+..+.  ....+    
T Consensus       158 -~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~--~~~~~----  223 (256)
T cd05112         158 -STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE-------VVETINAGF--RLYKP----  223 (256)
T ss_pred             -cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH-------HHHHHhCCC--CCCCC----
Confidence             112235678999999998889999999999999999998 999986433221       111111110  00011    


Q ss_pred             cCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 041921          758 MNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE  793 (814)
Q Consensus       758 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~  793 (814)
                         ......+.+++.+||+.+|++|||+.+++++|.
T Consensus       224 ---~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         224 ---RLASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             ---CCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence               113467899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=6.3e-34  Score=301.24  Aligned_cols=256  Identities=26%  Similarity=0.392  Sum_probs=203.0

Q ss_pred             hhccccceeeeeeeeEEEEEEecC---CCceEEEEEEecccccc-chHhHHHHHHhhhccCCCCccceeeeecccccceE
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTR---TSTTAVAVKKLDRVFQD-GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL  595 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~---~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  595 (814)
                      .+...+.||+|+||.||+|+....   .....|++|.+...... ..+++.+|++++++++|+||+++++++.+....++
T Consensus         6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   85 (275)
T cd05046           6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYM   85 (275)
T ss_pred             hceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceE
Confidence            344567899999999999997532   23567999988654333 34679999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhcCCC---------CCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecC
Q 041921          596 VYEFLNNGTLASFLFGNL---------KPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFG  666 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~~~---------~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfG  666 (814)
                      ||||+++++|.+++....         .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++|+|||
T Consensus        86 v~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~~  162 (275)
T cd05046          86 ILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLS  162 (275)
T ss_pred             EEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEcccc
Confidence            999999999999997654         689999999999999999999998   99999999999999999999999999


Q ss_pred             CccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcC
Q 041921          667 LAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNG  745 (814)
Q Consensus       667 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  745 (814)
                      ++.......... .....++..|+|||.+.+...+.++||||||++++||++ |..||.......       .......+
T Consensus       163 ~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~-------~~~~~~~~  234 (275)
T cd05046         163 LSKDVYNSEYYK-LRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE-------VLNRLQAG  234 (275)
T ss_pred             cccccCcccccc-cCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH-------HHHHHHcC
Confidence            987543222111 122346778999999988888999999999999999999 778885432211       11122222


Q ss_pred             ccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 041921          746 KLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEG  794 (814)
Q Consensus       746 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~  794 (814)
                      .....        .....+..+.+++.+||+.+|.+|||+.++++.|.+
T Consensus       235 ~~~~~--------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         235 KLELP--------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             CcCCC--------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence            22111        111244678899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.1e-33  Score=298.18  Aligned_cols=253  Identities=25%  Similarity=0.337  Sum_probs=197.7

Q ss_pred             HHhhhccc--cceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccce
Q 041921          517 EGATNNFK--EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRL  594 (814)
Q Consensus       517 ~~~~~~~~--~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  594 (814)
                      +.++.++.  ..||+|+||.||+|....  ++..|++|.+........+.+.+|+.++++++|+||+++++++..++..+
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~--~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLS--TQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK   81 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecC--CCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence            34444443  479999999999998653  56789999987655555678999999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHhcCC-CCC--ChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC-CCcEEEeecCCccc
Q 041921          595 LVYEFLNNGTLASFLFGN-LKP--NWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDD-YYTARISDFGLAKL  670 (814)
Q Consensus       595 lv~e~~~~gsL~~~l~~~-~~l--~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~-~~~~kl~DfGla~~  670 (814)
                      +|+||+++++|.+++... ..+  ++..+..++.||++||+|||+.   +|+||||||+||+++. ++.+||+|||++..
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~  158 (268)
T cd06624          82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKR  158 (268)
T ss_pred             EEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence            999999999999999764 344  7788889999999999999998   9999999999999986 67999999999876


Q ss_pred             cccCCcccccccccCCCCcccccccccCC--CCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccc
Q 041921          671 LTLNQSKTIKTAIRGTKGYVAPEWFRNSK--ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLN  748 (814)
Q Consensus       671 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  748 (814)
                      .......  .....++..|+|||.+....  ++.++||||||++++||++|+.||..........   +  .   .+...
T Consensus       159 ~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~---~--~---~~~~~  228 (268)
T cd06624         159 LAGINPC--TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM---F--K---VGMFK  228 (268)
T ss_pred             cccCCCc--cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH---h--h---hhhhc
Confidence            5432211  12345789999999986543  7889999999999999999999986432211110   0  0   00000


Q ss_pred             eeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          749 VLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       749 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                          ...  ..+....+++.+++.+||+.+|.+|||+.++++
T Consensus       229 ----~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         229 ----IHP--EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             ----cCC--CCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence                000  011234467889999999999999999999876

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1e-33  Score=302.88  Aligned_cols=256  Identities=23%  Similarity=0.323  Sum_probs=205.1

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEec
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  599 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  599 (814)
                      ++.+.++||.|++|.||+|...  .+++.|++|.+........+.+.+|+.+++.++|+||+++++++...+..++|+||
T Consensus        20 ~y~~~~~lg~g~~g~vy~~~~~--~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   97 (296)
T cd06655          20 KYTRYEKIGQGASGTVFTAIDV--ATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY   97 (296)
T ss_pred             eEEEEEEEecCCCeEEEEEEEc--CCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence            3556688999999999999864  35788999999765455566789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcccc
Q 041921          600 LNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI  679 (814)
Q Consensus       600 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  679 (814)
                      +++++|..++... .+++.++..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++.......... 
T Consensus        98 ~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~-  172 (296)
T cd06655          98 LAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR-  172 (296)
T ss_pred             cCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccccC-
Confidence            9999999988654 588999999999999999999998   99999999999999999999999999988665432211 


Q ss_pred             cccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccC
Q 041921          680 KTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMN  759 (814)
Q Consensus       680 ~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  759 (814)
                       ....++..|+|||.+.+..++.++|||||||++|||++|+.||..........      . +.......       ...
T Consensus       173 -~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~------~-~~~~~~~~-------~~~  237 (296)
T cd06655         173 -STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------L-IATNGTPE-------LQN  237 (296)
T ss_pred             -CCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------H-HHhcCCcc-------cCC
Confidence             23458889999999998889999999999999999999999997554322110      0 00110000       011


Q ss_pred             cHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhcCcC
Q 041921          760 DIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ--MLEGVVE  797 (814)
Q Consensus       760 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~--~L~~~~~  797 (814)
                      .......+.+++.+||+.+|.+|||+.++++  .+....+
T Consensus       238 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~  277 (296)
T cd06655         238 PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKP  277 (296)
T ss_pred             cccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhccc
Confidence            1223456888999999999999999999974  3444333

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-34  Score=310.16  Aligned_cols=244  Identities=28%  Similarity=0.385  Sum_probs=202.8

Q ss_pred             ceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEecCCCCCH
Q 041921          526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTL  605 (814)
Q Consensus       526 ~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  605 (814)
                      +||+|.||+||.|...  .....+|||.+.....+..+-+.+|+.+.++++|.|||+++|.+.++...-|.||.+++|||
T Consensus       582 VLGKGTYG~VYA~RD~--~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL  659 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDM--DTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL  659 (1226)
T ss_pred             EeecCceeEEEeeccc--cceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence            4999999999999865  36789999999877666677799999999999999999999999999999999999999999


Q ss_pred             HHHhcCC-CCC--ChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc-CCCcEEEeecCCccccccCCcccccc
Q 041921          606 ASFLFGN-LKP--NWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLD-DYYTARISDFGLAKLLTLNQSKTIKT  681 (814)
Q Consensus       606 ~~~l~~~-~~l--~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~-~~~~~kl~DfGla~~~~~~~~~~~~~  681 (814)
                      .++|... +++  ++...--+..||++||.|||++   .|+|||||-+||||+ -.|.+||+|||-++.+..-.  ....
T Consensus       660 SsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin--P~TE  734 (1226)
T KOG4279|consen  660 SSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN--PCTE  734 (1226)
T ss_pred             HHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCC--cccc
Confidence            9999875 555  6777788999999999999999   999999999999997 56899999999998765432  2335


Q ss_pred             cccCCCCcccccccccC--CCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccC
Q 041921          682 AIRGTKGYVAPEWFRNS--KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMN  759 (814)
Q Consensus       682 ~~~gt~~y~aPE~~~~~--~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  759 (814)
                      .+-||..|||||++..+  .|..++|||||||.+.||.||++||........+.+        +-|..    ...+  +.
T Consensus       735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMF--------kVGmy----KvHP--~i  800 (1226)
T KOG4279|consen  735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMF--------KVGMY----KVHP--PI  800 (1226)
T ss_pred             ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhh--------hhcce----ecCC--CC
Confidence            56799999999999766  488999999999999999999999964433222221        11211    1111  22


Q ss_pred             cHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          760 DIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       760 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      +.+...+...++++|+.++|.+||+++++++
T Consensus       801 Peelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  801 PEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             cHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            4567788899999999999999999999985

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=8.6e-34  Score=300.55  Aligned_cols=249  Identities=27%  Similarity=0.374  Sum_probs=200.3

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEE
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY  597 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  597 (814)
                      +.+...+.||+|+||.||+|....  .+..||+|.+.... ....+.+.+|+.++++++||||+++++++..++..++|+
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNR--TKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM   81 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcC--CCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence            345556789999999999998753  46789999886432 233457899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcc
Q 041921          598 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSK  677 (814)
Q Consensus       598 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  677 (814)
                      ||+++++|.+++.. ..+++..+..++.|+++|+.|||+.   +++|+||+|+||++++++.++|+|||++..+......
T Consensus        82 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~  157 (277)
T cd06642          82 EYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK  157 (277)
T ss_pred             EccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcchh
Confidence            99999999998864 4678899999999999999999998   9999999999999999999999999998765432211


Q ss_pred             cccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccc
Q 041921          678 TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEA  757 (814)
Q Consensus       678 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  757 (814)
                        .....++..|+|||.+.+..++.++||||||++++||++|+.|+.........       ..+..+..     +    
T Consensus       158 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-------~~~~~~~~-----~----  219 (277)
T cd06642         158 --RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL-------FLIPKNSP-----P----  219 (277)
T ss_pred             --hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH-------hhhhcCCC-----C----
Confidence              12345788999999999888999999999999999999999998643222110       01111110     0    


Q ss_pred             cCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          758 MNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       758 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                      .........+.+++.+|++.+|.+||+|.++++.
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         220 TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            0112345678899999999999999999999973

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-33  Score=295.12  Aligned_cols=252  Identities=23%  Similarity=0.306  Sum_probs=204.2

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEec
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  599 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  599 (814)
                      .+.+.+.||+|+||.||+|....  .+..+++|.+........+.+.+|+.++++++||||+++++++.+.+..+++|||
T Consensus         4 ~~~~~~~l~~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           4 DYELIQRIGSGTYGDVYKARDIA--TGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             ceEEEEEecCCCceEEEEeEecC--CCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            45677899999999999998753  4567999998765455567899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccc
Q 041921          600 LNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT  678 (814)
Q Consensus       600 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  678 (814)
                      +++++|.+++... ..++......++.|++.||+|||+.   +|+|+||+|+||++++++.+||+|||++......... 
T Consensus        82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-  157 (262)
T cd06613          82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK-  157 (262)
T ss_pred             CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhhhc-
Confidence            9999999999776 7789999999999999999999998   9999999999999999999999999998765432211 


Q ss_pred             ccccccCCCCcccccccccC---CCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcc
Q 041921          679 IKTAIRGTKGYVAPEWFRNS---KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDK  755 (814)
Q Consensus       679 ~~~~~~gt~~y~aPE~~~~~---~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  755 (814)
                       .....++..|+|||.+.+.   .++.++||||||++++||++|+.||......+...       ........   ..  
T Consensus       158 -~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~-------~~~~~~~~---~~--  224 (262)
T cd06613         158 -RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF-------LISKSNFP---PP--  224 (262)
T ss_pred             -cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH-------HHHhccCC---Cc--
Confidence             1334578899999999776   78999999999999999999999987543222110       01111000   00  


Q ss_pred             cccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          756 EAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       756 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      ..........++.+++.+|++.+|.+|||+++++.
T Consensus       225 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         225 KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            01112345677899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-34  Score=310.30  Aligned_cols=239  Identities=26%  Similarity=0.317  Sum_probs=197.7

Q ss_pred             ccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhcc-CCCCccceeeeecccccceEEE
Q 041921          522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRLLVY  597 (814)
Q Consensus       522 ~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  597 (814)
                      .|.++||+|.||.|+++.++.  +++.+|||.+++..   ....+..+.|..++... +||.|++|+..+...+++++||
T Consensus       371 ~~l~vLGkGsFGkV~lae~k~--~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvm  448 (694)
T KOG0694|consen  371 RLLAVLGRGSFGKVLLAELKG--TNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVM  448 (694)
T ss_pred             EEEEEeccCcCceEEEEEEcC--CCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEE
Confidence            456889999999999999874  56699999998643   23345678888888777 5999999999999999999999


Q ss_pred             ecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcc
Q 041921          598 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSK  677 (814)
Q Consensus       598 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  677 (814)
                      ||+.+|++.. +.....+++....-++..|+-||.|||++   +||+||||.+|||||.+|.+||+|||+++....... 
T Consensus       449 ey~~Ggdm~~-~~~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~-  523 (694)
T KOG0694|consen  449 EYVAGGDLMH-HIHTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGD-  523 (694)
T ss_pred             EecCCCcEEE-EEecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccCCCCC-
Confidence            9999999433 33446788898999999999999999999   999999999999999999999999999985442221 


Q ss_pred             cccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccc
Q 041921          678 TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEA  757 (814)
Q Consensus       678 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  757 (814)
                       ....++||+.|||||++.+..|+...|.|||||+||||+.|..||.+...++.       .+.+....          .
T Consensus       524 -~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~-------FdsI~~d~----------~  585 (694)
T KOG0694|consen  524 -RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV-------FDSIVNDE----------V  585 (694)
T ss_pred             -ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH-------HHHHhcCC----------C
Confidence             23678999999999999999999999999999999999999999987665542       22222211          1


Q ss_pred             cCcHHHHHHHHHHHHHccccCCCCCCCH
Q 041921          758 MNDIECLGKLVMVSIWCIQEDPSLRPTM  785 (814)
Q Consensus       758 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~  785 (814)
                      .++.-...+...++.+.|.++|++|.-+
T Consensus       586 ~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  586 RYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             CCCCcccHHHHHHHHHHhccCcccccCC
Confidence            2344556778889999999999999866

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=9.7e-34  Score=299.21  Aligned_cols=248  Identities=25%  Similarity=0.367  Sum_probs=195.1

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhcc-CCCCccceeeeeccc------cc
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEG------QN  592 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------~~  592 (814)
                      .+.+.+.||+|+||.||+|....  .+..||+|.+... .....++..|+.++.++ +|+||+++++++...      ..
T Consensus         7 ~y~~~~~lg~g~~g~vy~~~~~~--~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (272)
T cd06637           7 IFELVELVGNGTYGQVYKGRHVK--TGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ   83 (272)
T ss_pred             hhhHHHheeecCCeEEEEEEEcC--CCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence            45566889999999999998753  5678999998653 34456788999999998 799999999998653      35


Q ss_pred             ceEEEecCCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccc
Q 041921          593 RLLVYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKL  670 (814)
Q Consensus       593 ~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~  670 (814)
                      .+++|||+++++|.+++...  ..+++..+..++.|++.||+|||+.   +|+|+||||+||++++++.+||+|||++..
T Consensus        84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~~  160 (272)
T cd06637          84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  160 (272)
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence            78999999999999999763  4678999999999999999999998   999999999999999999999999999986


Q ss_pred             cccCCcccccccccCCCCcccccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcC
Q 041921          671 LTLNQSKTIKTAIRGTKGYVAPEWFR-----NSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG  745 (814)
Q Consensus       671 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  745 (814)
                      .......  .....|+..|+|||++.     ...++.++|||||||++|||++|+.||..........      . ....
T Consensus       161 ~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~------~-~~~~  231 (272)
T cd06637         161 LDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF------L-IPRN  231 (272)
T ss_pred             ccccccc--CCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH------H-HhcC
Confidence            5432211  13456889999999986     3357889999999999999999999986433211110      0 0111


Q ss_pred             ccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          746 KLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       746 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      ....        .........+.+++.+||+.+|.+|||+.++++
T Consensus       232 ~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         232 PAPR--------LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             CCCC--------CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            1000        011123457889999999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.5e-33  Score=294.90  Aligned_cols=248  Identities=25%  Similarity=0.364  Sum_probs=202.2

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEec
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  599 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  599 (814)
                      .+.+.+.||+|+||.||+|....  .+..+++|.+.....  .+++.+|++++++++|+||+++++++.+....++++||
T Consensus         4 ~y~~~~~i~~g~~~~v~~~~~~~--~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           4 VFDILEKLGEGSYGSVYKAIHKE--TGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             cchhhhhhcCCCCeEEEEEEEcC--CCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            45667889999999999999763  467899999865422  67899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccc
Q 041921          600 LNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT  678 (814)
Q Consensus       600 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  678 (814)
                      +++++|.+++.. ...+++.....++.|++.||.|||+.   +++|+||+|+||++++++.+||+|||++......... 
T Consensus        80 ~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~-  155 (256)
T cd06612          80 CGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK-  155 (256)
T ss_pred             CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCccc-
Confidence            999999999975 45689999999999999999999998   9999999999999999999999999998876543211 


Q ss_pred             ccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCccccc
Q 041921          679 IKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAM  758 (814)
Q Consensus       679 ~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  758 (814)
                       .....++..|+|||.+.+..++.++||||||++++||++|+.||..........       ......       .....
T Consensus       156 -~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~-------~~~~~~-------~~~~~  220 (256)
T cd06612         156 -RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF-------MIPNKP-------PPTLS  220 (256)
T ss_pred             -cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh-------hhccCC-------CCCCC
Confidence             123447889999999998899999999999999999999999987543221100       000000       00111


Q ss_pred             CcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          759 NDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       759 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      .+......+.+++.+|++.+|.+|||++++++
T Consensus       221 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         221 DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            12234467889999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1e-33  Score=299.17  Aligned_cols=255  Identities=24%  Similarity=0.409  Sum_probs=198.2

Q ss_pred             ccccceeeeeeeeEEEEEEec-CCCceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeecccc------c
Q 041921          522 NFKEEVGRGSFGIVYKGVIQT-RTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ------N  592 (814)
Q Consensus       522 ~~~~~LG~G~~g~Vy~~~~~~-~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~  592 (814)
                      .+.+.||+|+||.||+|.+.. ...+..||||.+....  ....+++.+|+.++++++||||+++++++...+      .
T Consensus         2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   81 (273)
T cd05074           2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI   81 (273)
T ss_pred             cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccc
Confidence            456789999999999998763 2346899999886432  234557889999999999999999999886532      2


Q ss_pred             ceEEEecCCCCCHHHHhcCC------CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecC
Q 041921          593 RLLVYEFLNNGTLASFLFGN------LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFG  666 (814)
Q Consensus       593 ~~lv~e~~~~gsL~~~l~~~------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfG  666 (814)
                      .++++||+++++|.+++...      ..+++....+++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg  158 (273)
T cd05074          82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFG  158 (273)
T ss_pred             eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECccc
Confidence            36889999999999887532      2467888999999999999999998   99999999999999999999999999


Q ss_pred             CccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcC
Q 041921          667 LAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNG  745 (814)
Q Consensus       667 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  745 (814)
                      +++...............++..|++||.+....++.++||||||+++|||++ |+.||......+   +    ...+..+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~---~----~~~~~~~  231 (273)
T cd05074         159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---I----YNYLIKG  231 (273)
T ss_pred             ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---H----HHHHHcC
Confidence            9987654322211122345678999999998889999999999999999999 888886432211   1    1111111


Q ss_pred             ccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 041921          746 KLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV  795 (814)
Q Consensus       746 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~  795 (814)
                      ..       .  ......+..+.+++.+|++.+|++|||+.++++.|+++
T Consensus       232 ~~-------~--~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         232 NR-------L--KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             Cc-------C--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            10       0  01122446889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2e-33  Score=295.98  Aligned_cols=249  Identities=27%  Similarity=0.384  Sum_probs=200.2

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccc---------hHhHHHHHHhhhccCCCCccceeeeecccc
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG---------EREFKNEVFVIGQTHHKNLVRLLGFCDEGQ  591 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~---------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  591 (814)
                      +.+.+.||+|++|.||+|....  .+..+++|.+.......         .+.+.+|+.++++++||||+++++++.+.+
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   79 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNAS--SGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDAD   79 (267)
T ss_pred             ccccceeecCCCeEEEEEEecC--CCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Confidence            4567889999999999998653  46789999886432211         245889999999999999999999999999


Q ss_pred             cceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcccc
Q 041921          592 NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLL  671 (814)
Q Consensus       592 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~  671 (814)
                      ..++|+||+++++|.+++.....+++.....++.|++.||+|||+.   +++|+||+|+||++++++.+||+|||+++..
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~~  156 (267)
T cd06628          80 HLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKL  156 (267)
T ss_pred             ccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence            9999999999999999998877889999999999999999999998   9999999999999999999999999999876


Q ss_pred             ccCCcc----cccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCcc
Q 041921          672 TLNQSK----TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL  747 (814)
Q Consensus       672 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  747 (814)
                      ......    .......++..|+|||.+.+..++.++||||||++++||++|+.||........      +.. ....  
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~~-~~~~--  227 (267)
T cd06628         157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA------IFK-IGEN--  227 (267)
T ss_pred             ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH------HHH-Hhcc--
Confidence            532111    111234578899999999988899999999999999999999999975422110      011 1111  


Q ss_pred             ceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          748 NVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       748 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                         ..+.    .+......+.+++.+||+.+|.+||++.++++
T Consensus       228 ---~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         228 ---ASPE----IPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             ---CCCc----CCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence               0001    11234567889999999999999999999886

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1e-33  Score=318.48  Aligned_cols=256  Identities=23%  Similarity=0.322  Sum_probs=188.5

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeeccc--------
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEG--------  590 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------  590 (814)
                      ..|.+.++||+|+||.||+|....  .+..||||++...    .....+|+.++++++||||+++++++...        
T Consensus        66 ~~y~~~~~LG~G~fg~Vy~~~~~~--~~~~vAiK~i~~~----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         66 KSYKLGNIIGNGSFGVVYEAICID--TSEKVAIKKVLQD----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             CeEEEeEEEEeCCCEEEEEEEECC--CCCEEEEEEEecC----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            346778899999999999999753  5678999988542    22345799999999999999999876321        


Q ss_pred             ccceEEEecCCCCCHHHHhc----CCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC-cEEEeec
Q 041921          591 QNRLLVYEFLNNGTLASFLF----GNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYY-TARISDF  665 (814)
Q Consensus       591 ~~~~lv~e~~~~gsL~~~l~----~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~-~~kl~Df  665 (814)
                      ...++||||+++ +|.+++.    ....+++.....++.||+.||+|||+.   +|+||||||+|||++.++ .+||+||
T Consensus       140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeecc
Confidence            135689999985 6766654    346688999999999999999999998   999999999999999654 7999999


Q ss_pred             CCccccccCCcccccccccCCCCcccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhc
Q 041921          666 GLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN  744 (814)
Q Consensus       666 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  744 (814)
                      |+++.+......   ....||+.|+|||++.+. .++.++|||||||++|||++|..||......+...  . +.+....
T Consensus       216 Gla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~--~-i~~~~~~  289 (440)
T PTZ00036        216 GSAKNLLAGQRS---VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLV--R-IIQVLGT  289 (440)
T ss_pred             ccchhccCCCCc---ccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH--H-HHHHhCC
Confidence            999866533221   234689999999988654 68999999999999999999999997654322111  0 1111000


Q ss_pred             C----------ccceeecC-----cccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          745 G----------KLNVLVGE-----DKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       745 ~----------~~~~~~~~-----~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      .          ....+.-+     .+....+...+.++.+++.+||+.||.+|||+.|+++
T Consensus       290 p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        290 PTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             CCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence            0          00000000     0000011123467889999999999999999999983

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.1e-33  Score=311.65  Aligned_cols=256  Identities=18%  Similarity=0.237  Sum_probs=197.8

Q ss_pred             HHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhccCCCCccceeeeeccccc
Q 041921          516 LEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQN  592 (814)
Q Consensus       516 l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  592 (814)
                      +....+.+.+.||+|+||.||++....  .++.+|+|.+....   ....+.+.+|+.+++.++||||+++++.+.++..
T Consensus        40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~--~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (371)
T cd05622          40 MKAEDYEVVKVIGRGAFGEVQLVRHKS--TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY  117 (371)
T ss_pred             cchhhcEEEEEEeecCCeEEEEEEECC--CCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence            334567778899999999999998763  57789999986421   2233457889999999999999999999999999


Q ss_pred             ceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccc
Q 041921          593 RLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLT  672 (814)
Q Consensus       593 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~  672 (814)
                      .++||||+++|+|.+++... .++...+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus       118 ~~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~  193 (371)
T cd05622         118 LYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN  193 (371)
T ss_pred             EEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeEcC
Confidence            99999999999999998654 477888889999999999999998   99999999999999999999999999998765


Q ss_pred             cCCcccccccccCCCCcccccccccCC----CCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccc
Q 041921          673 LNQSKTIKTAIRGTKGYVAPEWFRNSK----ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLN  748 (814)
Q Consensus       673 ~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  748 (814)
                      ...... .....||+.|+|||++....    ++.++|||||||++|||++|+.||........       ...+....- 
T Consensus       194 ~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-------~~~i~~~~~-  264 (371)
T cd05622         194 KEGMVR-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT-------YSKIMNHKN-  264 (371)
T ss_pred             cCCccc-ccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH-------HHHHHcCCC-
Confidence            332211 13456999999999987543    78899999999999999999999975432211       111111110 


Q ss_pred             eeecCcccccCcHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 041921          749 VLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSL--RPTMKKVLQM  791 (814)
Q Consensus       749 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~--RPt~~~vl~~  791 (814)
                           ....+........+.+++..||+.++.+  ||+++++++.
T Consensus       265 -----~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         265 -----SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             -----cccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence                 0001111234566778899999854443  7899998874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-33  Score=304.65  Aligned_cols=255  Identities=27%  Similarity=0.320  Sum_probs=212.6

Q ss_pred             HHHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccccc---chHhHHHHHHhhhccC-CCCccceeeeeccc
Q 041921          515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTH-HKNLVRLLGFCDEG  590 (814)
Q Consensus       515 ~l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~  590 (814)
                      +-....|.+.++||+|.||.||+++.+.  ++..+|+|.+.+....   ....+.+|+.+|+++. |||||.+.+.+++.
T Consensus        31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~--tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~  108 (382)
T KOG0032|consen   31 EDIKEKYELGRELGRGQFGVVYLCREKS--TGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP  108 (382)
T ss_pred             ccccccEEehhhhCCCCceEEEEEEecC--CCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC
Confidence            3345567788999999999999999764  5889999999764433   3357999999999998 99999999999999


Q ss_pred             ccceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC----CCcEEEeecC
Q 041921          591 QNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDD----YYTARISDFG  666 (814)
Q Consensus       591 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~----~~~~kl~DfG  666 (814)
                      ...++|||++.+|.|.+.|... .+++.....++.|++.+++|||+.   +|+||||||+|+|+..    ++.+|++|||
T Consensus       109 ~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG  184 (382)
T KOG0032|consen  109 DSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFG  184 (382)
T ss_pred             CeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence            9999999999999999999776 488899999999999999999998   9999999999999963    3579999999


Q ss_pred             CccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCc
Q 041921          667 LAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK  746 (814)
Q Consensus       667 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  746 (814)
                      ++......   ......+||+.|+|||++....++..+||||+||++|.|++|..||......+..       ..+..+.
T Consensus       185 la~~~~~~---~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~-------~~i~~~~  254 (382)
T KOG0032|consen  185 LAKFIKPG---ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIF-------LAILRGD  254 (382)
T ss_pred             CceEccCC---ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHH-------HHHHcCC
Confidence            99987762   2235678999999999999999999999999999999999999999876543321       1333343


Q ss_pred             cceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          747 LNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       747 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                      ..      ...+.-....+.+.+++..++..||.+|+|+.++++.
T Consensus       255 ~~------f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  255 FD------FTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             CC------CCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence            31      1111223446778889999999999999999999983

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-35  Score=288.16  Aligned_cols=246  Identities=23%  Similarity=0.318  Sum_probs=211.2

Q ss_pred             cccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEecCCC
Q 041921          523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN  602 (814)
Q Consensus       523 ~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  602 (814)
                      +.++||+|.||+|||+.++.  .++.||||++..  ....+++..|+.++++.+.|++|+++|.+.....+++|||||..
T Consensus        37 i~~KLGEGSYGSV~KAIH~E--sG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA  112 (502)
T KOG0574|consen   37 IVGKLGEGSYGSVHKAIHRE--SGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA  112 (502)
T ss_pred             HHHHhcCCcchHHHHHHHhc--cCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence            45789999999999999874  788999999864  44678999999999999999999999999999999999999999


Q ss_pred             CCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcccccc
Q 041921          603 GTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKT  681 (814)
Q Consensus       603 gsL~~~l~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  681 (814)
                      |+..+++.- ++++.+.++..++..-++||+|||..   .=+|||||+.|||++.+|.+||+|||.+..+.......  .
T Consensus       113 GSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKR--N  187 (502)
T KOG0574|consen  113 GSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKR--N  187 (502)
T ss_pred             CcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHHhh--C
Confidence            999999975 47889999999999999999999997   78999999999999999999999999998776432222  4


Q ss_pred             cccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCcH
Q 041921          682 AIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDI  761 (814)
Q Consensus       682 ~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  761 (814)
                      .+.||+-|||||+++.-.|..++||||||+...||.-|++||....+...              .......+.+....+.
T Consensus       188 TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA--------------IFMIPT~PPPTF~KPE  253 (502)
T KOG0574|consen  188 TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA--------------IFMIPTKPPPTFKKPE  253 (502)
T ss_pred             ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce--------------eEeccCCCCCCCCChH
Confidence            56799999999999999999999999999999999999999975433211              1122233444445567


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          762 ECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       762 ~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                      ....++-++++.||-++|++|-|+.++++.
T Consensus       254 ~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  254 EWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             hhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            788999999999999999999999887753

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.9e-33  Score=301.80  Aligned_cols=261  Identities=22%  Similarity=0.308  Sum_probs=196.9

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEE
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY  597 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  597 (814)
                      ..|.+.++||+|+||.||+|....  .+..||+|.+.... ......+.+|+.++++++||||+++++++...+..++|+
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~   83 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKL--TDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF   83 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcC--CCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence            345667889999999999998653  56789999986432 223446788999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCc
Q 041921          598 EFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS  676 (814)
Q Consensus       598 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  676 (814)
                      ||++ ++|.+++... ..+++.....++.|+++||.|||+.   +|+|+||||+||++++++.+||+|||++........
T Consensus        84 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  159 (301)
T cd07873          84 EYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  159 (301)
T ss_pred             eccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence            9997 5898888654 5678899999999999999999998   999999999999999999999999999876443221


Q ss_pred             ccccccccCCCCcccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhh---cCccceeec
Q 041921          677 KTIKTAIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR---NGKLNVLVG  752 (814)
Q Consensus       677 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  752 (814)
                      .  .....++..|+|||.+.+. .++.++||||||++++||++|+.||......+...   .+.....   ......+..
T Consensus       160 ~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  234 (301)
T cd07873         160 T--YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLH---FIFRILGTPTEETWPGILS  234 (301)
T ss_pred             c--ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHcCCCChhhchhhhc
Confidence            1  1233468899999988654 57889999999999999999999997554322111   1111100   000000000


Q ss_pred             ---------Ccccc----cCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          753 ---------EDKEA----MNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       753 ---------~~~~~----~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                               +....    .........+.+++.+||+.||.+|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         235 NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                     00000    001123456789999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2.3e-33  Score=298.98  Aligned_cols=258  Identities=25%  Similarity=0.300  Sum_probs=191.5

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc--cchHhHHHHHHhhhcc---CCCCccceeeeecc-----c
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ--DGEREFKNEVFVIGQT---HHKNLVRLLGFCDE-----G  590 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~  590 (814)
                      |.+.++||+|+||.||+|....  .++.||+|.++....  .....+.+|+.+++++   +||||+++++++..     .
T Consensus         2 y~~~~~lg~g~~g~v~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~   79 (288)
T cd07863           2 YEPVAEIGVGAYGTVYKARDPH--SGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE   79 (288)
T ss_pred             ceEeeEEeecCCeEEEEEEECC--CCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence            5667899999999999998753  578899998864321  2233566777777665   69999999998864     2


Q ss_pred             ccceEEEecCCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCc
Q 041921          591 QNRLLVYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLA  668 (814)
Q Consensus       591 ~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla  668 (814)
                      ...++|+||+++ +|.+++...  ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus        80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~  155 (288)
T cd07863          80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLA  155 (288)
T ss_pred             ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCcc
Confidence            457899999985 888888654  4578999999999999999999998   9999999999999999999999999999


Q ss_pred             cccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhc---C
Q 041921          669 KLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN---G  745 (814)
Q Consensus       669 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~  745 (814)
                      +........   ....++..|+|||.+.+..++.++|||||||+++||++|+.||......+.  + ..+......   .
T Consensus       156 ~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~--~-~~~~~~~~~~~~~  229 (288)
T cd07863         156 RIYSCQMAL---TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ--L-GKIFDLIGLPPED  229 (288)
T ss_pred             ccccCcccC---CCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH--H-HHHHHHhCCCChh
Confidence            866432211   334578999999999988999999999999999999999999865433211  1 011111100   0


Q ss_pred             ccce-------eecCccc---ccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          746 KLNV-------LVGEDKE---AMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       746 ~~~~-------~~~~~~~---~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      ....       ...+...   .....+..+.+.+++.+||+.||.+|||+.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0000       0000000   0001123567789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.8e-33  Score=304.30  Aligned_cols=196  Identities=22%  Similarity=0.401  Sum_probs=160.7

Q ss_pred             cceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecc--cccceEEEecCCC
Q 041921          525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDE--GQNRLLVYEFLNN  602 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~  602 (814)
                      .+||+|+||.||+|...+...+..||+|.+...  .....+.+|+.++++++||||+++++++..  +...++|+||+++
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~   84 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT--GISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH   84 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCC--CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence            579999999999999876556789999998653  233467899999999999999999998843  4567899999875


Q ss_pred             CCHHHHhcC---------CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE----cCCCcEEEeecCCcc
Q 041921          603 GTLASFLFG---------NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILL----DDYYTARISDFGLAK  669 (814)
Q Consensus       603 gsL~~~l~~---------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll----~~~~~~kl~DfGla~  669 (814)
                       +|.+++..         ...+++..+..++.||+.||.|||+.   +|+||||||+|||+    +.++.+||+|||+++
T Consensus        85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07867          85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence             77777642         12467888999999999999999998   99999999999999    566789999999998


Q ss_pred             ccccCCcc-cccccccCCCCcccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 041921          670 LLTLNQSK-TIKTAIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIISCRKSFDIE  726 (814)
Q Consensus       670 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~s~Gvvl~elltg~~p~~~~  726 (814)
                      ........ .......+|..|+|||.+.+. .++.++||||||++++||+||+.||...
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            76533221 111334689999999998764 5789999999999999999999999643

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-33  Score=297.85  Aligned_cols=248  Identities=26%  Similarity=0.384  Sum_probs=201.9

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEe
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE  598 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  598 (814)
                      .+.+.+.||.|++|.||+|....  .+..|++|.+.... ......+.+|+.+++.++|+||+++++++.++...++|+|
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKR--TNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME   79 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECC--CCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence            35567889999999999999753  57889999986432 3344578999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccc
Q 041921          599 FLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT  678 (814)
Q Consensus       599 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  678 (814)
                      |+++++|.+++... .+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||+++.+...... 
T Consensus        80 ~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-  154 (274)
T cd06609          80 YCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK-  154 (274)
T ss_pred             eeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccccc-
Confidence            99999999999765 789999999999999999999998   9999999999999999999999999999877543211 


Q ss_pred             ccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCccccc
Q 041921          679 IKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAM  758 (814)
Q Consensus       679 ~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  758 (814)
                       .....++..|+|||.+.+..++.++||||||+++|||++|+.||........       ...+..+....+     .  
T Consensus       155 -~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~-------~~~~~~~~~~~~-----~--  219 (274)
T cd06609         155 -RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV-------LFLIPKNNPPSL-----E--  219 (274)
T ss_pred             -cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH-------HHHhhhcCCCCC-----c--
Confidence             1334578899999999988899999999999999999999999965432111       111111111111     0  


Q ss_pred             CcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          759 NDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       759 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                       .......+.+++.+||+.+|++|||++++++
T Consensus       220 -~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         220 -GNKFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             -ccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence             1114567889999999999999999999976

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2.7e-33  Score=299.18  Aligned_cols=251  Identities=20%  Similarity=0.295  Sum_probs=199.8

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEe
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE  598 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  598 (814)
                      ..|.+.++||+|+||.||+|....  .+..+++|.+........+++..|+.+++.++|+||+++++.+..+...++|||
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   89 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKE--TGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE   89 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECC--CCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence            346677899999999999998753  567899999876555556778999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcc
Q 041921          599 FLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSK  677 (814)
Q Consensus       599 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  677 (814)
                      |+++++|..++.. ...+++..+..++.|++.+|.|||+.   +++||||||+||+++.++.+||+|||++.........
T Consensus        90 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~  166 (292)
T cd06644          90 FCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR  166 (292)
T ss_pred             cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccccc
Confidence            9999999988765 35689999999999999999999998   9999999999999999999999999998754322111


Q ss_pred             cccccccCCCCcccccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeec
Q 041921          678 TIKTAIRGTKGYVAPEWFR-----NSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVG  752 (814)
Q Consensus       678 ~~~~~~~gt~~y~aPE~~~-----~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  752 (814)
                        .....++..|+|||.+.     ...++.++|||||||++|||++|+.||........      ... .......    
T Consensus       167 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~------~~~-~~~~~~~----  233 (292)
T cd06644         167 --RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV------LLK-IAKSEPP----  233 (292)
T ss_pred             --cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH------HHH-HhcCCCc----
Confidence              13345788999999984     34567899999999999999999999864332110      111 1111100    


Q ss_pred             CcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          753 EDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       753 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                         ....+.....++.+++.+||+.+|++||+++++++
T Consensus       234 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         234 ---TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             ---cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence               00112233456889999999999999999999976

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.3e-33  Score=295.27  Aligned_cols=248  Identities=23%  Similarity=0.307  Sum_probs=200.4

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEeccc-cccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEec
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV-FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  599 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  599 (814)
                      +.+.++||+|+||.||++....  .+..+++|.++.. .....+.+.+|+.++++++|+||+++++.+.+++..++++||
T Consensus         2 y~~~~~lg~g~~g~v~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   79 (255)
T cd08219           2 YNVLRVVGEGSFGRALLVQHVN--SDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY   79 (255)
T ss_pred             ceEEEEeeccCCeEEEEEEEcC--CCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence            4567899999999999998653  5778999988542 233446788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcc
Q 041921          600 LNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSK  677 (814)
Q Consensus       600 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  677 (814)
                      +++++|.+++...  ..++......++.|++.||.|||+.   +|+|+||||+||++++++.++|+|||++.........
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~  156 (255)
T cd08219          80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY  156 (255)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence            9999999988643  4578888999999999999999998   9999999999999999999999999998766432211


Q ss_pred             cccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccc
Q 041921          678 TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEA  757 (814)
Q Consensus       678 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  757 (814)
                        .....++..|+|||.+.+..++.++|+||||+++++|++|+.||........       ...+..+....+       
T Consensus       157 --~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~-------~~~~~~~~~~~~-------  220 (255)
T cd08219         157 --ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL-------ILKVCQGSYKPL-------  220 (255)
T ss_pred             --cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH-------HHHHhcCCCCCC-------
Confidence              1334588899999999988899999999999999999999999975432111       111112221111       


Q ss_pred             cCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          758 MNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       758 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                        +......+.+++.+||+.+|++|||+.+++..
T Consensus       221 --~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         221 --PSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             --CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence              11234567899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=3.8e-33  Score=298.98  Aligned_cols=260  Identities=22%  Similarity=0.269  Sum_probs=198.5

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEecccccc-----chHhHHHHHHhhhccCCCCccceeeeecccccceE
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD-----GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL  595 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  595 (814)
                      +.+.+.||+|++|.||+|....  .+..|+||++......     ....+..|++++++++|+||+++++++.+.+..++
T Consensus         2 y~~~~~lg~g~~~~vy~~~~~~--~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l   79 (298)
T cd07841           2 YEKGKKLGEGTYAVVYKARDKE--TGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINL   79 (298)
T ss_pred             ceeeeeeeeccccEEEEEEECC--CCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEE
Confidence            4566789999999999999653  4679999999754322     23457789999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhcCCC-CCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccC
Q 041921          596 VYEFLNNGTLASFLFGNL-KPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN  674 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~  674 (814)
                      ||||+ +++|.+++.... .+++..+..++.||++||.|||+.   +|+|+||+|+||+++.++.+||+|||++......
T Consensus        80 v~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~  155 (298)
T cd07841          80 VFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSP  155 (298)
T ss_pred             EEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence            99999 999999998765 789999999999999999999998   9999999999999999999999999999876543


Q ss_pred             CcccccccccCCCCccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcC--------
Q 041921          675 QSKTIKTAIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG--------  745 (814)
Q Consensus       675 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--------  745 (814)
                      ....  ....++..|+|||.+.+ ..++.++||||||++++||++|..+|......+.  + ..........        
T Consensus       156 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~--~-~~~~~~~~~~~~~~~~~~  230 (298)
T cd07841         156 NRKM--THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ--L-GKIFEALGTPTEENWPGV  230 (298)
T ss_pred             Cccc--cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH--H-HHHHHHcCCCchhhhhhc
Confidence            2111  22346788999998854 4678999999999999999999877764433211  1 0111110000        


Q ss_pred             -ccceeecCccc-----ccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          746 -KLNVLVGEDKE-----AMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       746 -~~~~~~~~~~~-----~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                       ...........     ..........+.+++.+||+.+|++|||++++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         231 TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             ccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence             00000000000     00012235778899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.1e-33  Score=321.74  Aligned_cols=262  Identities=21%  Similarity=0.272  Sum_probs=190.6

Q ss_pred             HhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCC------CCccceeeeeccc-
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHH------KNLVRLLGFCDEG-  590 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~~~~-  590 (814)
                      ...|.+.++||+|+||+||+|....  .+..||||+++... ...+++..|+.++++++|      .+++++++++..+ 
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~--~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~  204 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRK--RKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET  204 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcC--CCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC
Confidence            3456777899999999999998753  56789999986432 233455667777766654      4588888888654 


Q ss_pred             ccceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC------------
Q 041921          591 QNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYY------------  658 (814)
Q Consensus       591 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~------------  658 (814)
                      .+.++|||++ +++|.+++.....+++..+..|+.||+.||.|||++  .+|+||||||+|||++.++            
T Consensus       205 ~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~  281 (467)
T PTZ00284        205 GHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNRALP  281 (467)
T ss_pred             ceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccccccccccC
Confidence            5688999987 678999988878899999999999999999999973  2899999999999998665            


Q ss_pred             ----cEEEeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhH
Q 041921          659 ----TARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL  734 (814)
Q Consensus       659 ----~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~  734 (814)
                          .+||+|||++......     .....||..|+|||++.+..++.++|||||||++|||++|+.||......+....
T Consensus       282 ~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~  356 (467)
T PTZ00284        282 PDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL  356 (467)
T ss_pred             CCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence                4999999987643221     1345799999999999999999999999999999999999999976543221111


Q ss_pred             HH---------HHHH--------Hhh-cCccceeecCcc-------cccCcHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 041921          735 TD---------WAFD--------CYR-NGKLNVLVGEDK-------EAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVL  789 (814)
Q Consensus       735 ~~---------~~~~--------~~~-~~~~~~~~~~~~-------~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl  789 (814)
                      ..         |...        .+. .+.+....++..       ...........+++|+.+||+.||.+|||++|++
T Consensus       357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L  436 (467)
T PTZ00284        357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT  436 (467)
T ss_pred             HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence            11         1000        000 000000000000       0000011235678999999999999999999998


Q ss_pred             H
Q 041921          790 Q  790 (814)
Q Consensus       790 ~  790 (814)
                      +
T Consensus       437 ~  437 (467)
T PTZ00284        437 T  437 (467)
T ss_pred             c
Confidence            7

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2.5e-33  Score=298.23  Aligned_cols=249  Identities=26%  Similarity=0.293  Sum_probs=197.0

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc---cchHhHHHHHHhhhccCCCCccceeeeecccccceEEE
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ---DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY  597 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  597 (814)
                      +...+.||+|+||.||++....  .++.+|||.+.....   .....+..|+.++++++|+|++++++.+.+.+..++||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~   79 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRA--TGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL   79 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcC--CCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEE
Confidence            3456789999999999998763  577999999864322   12345788999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCC
Q 041921          598 EFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ  675 (814)
Q Consensus       598 e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~  675 (814)
                      ||+++++|.+++...  ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||++.......
T Consensus        80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05630          80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  156 (285)
T ss_pred             EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence            999999999998643  4588899999999999999999998   99999999999999999999999999987654322


Q ss_pred             cccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcc
Q 041921          676 SKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDK  755 (814)
Q Consensus       676 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  755 (814)
                      ..   ....|+..|+|||.+.+..++.++||||||+++|||++|+.||...........   .........  .      
T Consensus       157 ~~---~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~---~~~~~~~~~--~------  222 (285)
T cd05630         157 TI---KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE---VERLVKEVQ--E------  222 (285)
T ss_pred             cc---cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHH---HHhhhhhhh--h------
Confidence            11   234689999999999999999999999999999999999999975432110000   000000000  0      


Q ss_pred             cccCcHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 041921          756 EAMNDIECLGKLVMVSIWCIQEDPSLRPT-----MKKVLQ  790 (814)
Q Consensus       756 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-----~~~vl~  790 (814)
                        .........+.+++..||+.||++|||     ++++++
T Consensus       223 --~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         223 --EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             --hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence              011123456789999999999999999     888876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=4.3e-33  Score=291.52  Aligned_cols=250  Identities=31%  Similarity=0.521  Sum_probs=202.1

Q ss_pred             cccceeeeeeeeEEEEEEecCC--CceEEEEEEecccccc-chHhHHHHHHhhhccCCCCccceeeeecccccceEEEec
Q 041921          523 FKEEVGRGSFGIVYKGVIQTRT--STTAVAVKKLDRVFQD-GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  599 (814)
Q Consensus       523 ~~~~LG~G~~g~Vy~~~~~~~~--~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  599 (814)
                      +.+.||+|+||.||++......  ....||+|.+...... ..+.+..|+..+..++|+||+++++++.+.+..+++|||
T Consensus         3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~   82 (258)
T smart00219        3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY   82 (258)
T ss_pred             ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence            5678999999999999986422  2478999999755433 456899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCCCC--CChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcc
Q 041921          600 LNNGTLASFLFGNLK--PNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSK  677 (814)
Q Consensus       600 ~~~gsL~~~l~~~~~--l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  677 (814)
                      +++++|.+++.....  +++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++.........
T Consensus        83 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~  159 (258)
T smart00219       83 MEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY  159 (258)
T ss_pred             cCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence            999999999976543  89999999999999999999998   9999999999999999999999999999876544222


Q ss_pred             cccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeecCccc
Q 041921          678 TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKE  756 (814)
Q Consensus       678 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  756 (814)
                      .. ....++..|+|||.+....++.++||||+|++++||++ |+.||.......       ..+....+...        
T Consensus       160 ~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~--------  223 (258)
T smart00219      160 KK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE-------VLEYLKKGYRL--------  223 (258)
T ss_pred             cc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHhcCCCC--------
Confidence            11 12336789999999988889999999999999999998 788876432211       11111222111        


Q ss_pred             ccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 041921          757 AMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQML  792 (814)
Q Consensus       757 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L  792 (814)
                       ......+.++.+++.+|++.+|++|||+.++++.|
T Consensus       224 -~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      224 -PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             -CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence             01112456788999999999999999999999875

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.9e-33  Score=293.85  Aligned_cols=245  Identities=29%  Similarity=0.473  Sum_probs=197.2

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEe
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE  598 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  598 (814)
                      ..+.+.+.||+|+||.||++..    .+..+|+|.++..  ...+.+.+|+.++++++|||++++++++..+ ..++|||
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~----~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e   78 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY----TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVME   78 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc----CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEE
Confidence            3467788999999999999874    3667999998643  2345789999999999999999999998654 5799999


Q ss_pred             cCCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCc
Q 041921          599 FLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS  676 (814)
Q Consensus       599 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  676 (814)
                      |+++++|.+++...  ..+++..+..++.|+++||.|||+.   +++||||||+||+++.++.+||+|||++....... 
T Consensus        79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-  154 (254)
T cd05083          79 LMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-  154 (254)
T ss_pred             CCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC-
Confidence            99999999999754  3578899999999999999999998   99999999999999999999999999987643221 


Q ss_pred             ccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcc
Q 041921          677 KTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDK  755 (814)
Q Consensus       677 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  755 (814)
                          .....+..|+|||.+.+..++.++|+||||++++||++ |+.||......+.       ......+...       
T Consensus       155 ----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-------~~~~~~~~~~-------  216 (254)
T cd05083         155 ----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV-------KECVEKGYRM-------  216 (254)
T ss_pred             ----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHH-------HHHHhCCCCC-------
Confidence                12234568999999998899999999999999999998 9999865432221       1111121100       


Q ss_pred             cccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 041921          756 EAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEG  794 (814)
Q Consensus       756 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~  794 (814)
                        ......+..+.+++.+|++.+|.+||+++++++.|++
T Consensus       217 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         217 --EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             --CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence              0112245678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.9e-33  Score=305.91  Aligned_cols=254  Identities=20%  Similarity=0.220  Sum_probs=194.3

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhccCCCCccceeeeecccccceEE
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV  596 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  596 (814)
                      .+.+.++||+|+||.||++....  .+..+|+|.+.+..   ......+.+|+.++..++|+||+++++.+.+.+..++|
T Consensus         2 ~y~~~~~lG~G~fg~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   79 (332)
T cd05623           2 DFEILKVIGRGAFGEVAVVKLKN--ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLV   79 (332)
T ss_pred             CceEEEEEEeCCCeEEEEEEECC--CCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEE
Confidence            35677899999999999999763  56789999986421   22234588899999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCC
Q 041921          597 YEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ  675 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~  675 (814)
                      |||+++|+|.+++.. ...+++.....++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++.......
T Consensus        80 ~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~  156 (332)
T cd05623          80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG  156 (332)
T ss_pred             EeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence            999999999999976 36688999999999999999999998   99999999999999999999999999987654322


Q ss_pred             cccccccccCCCCcccccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCcccee
Q 041921          676 SKTIKTAIRGTKGYVAPEWFR-----NSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVL  750 (814)
Q Consensus       676 ~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  750 (814)
                      .. ......||+.|+|||++.     ...++.++|||||||++|||++|+.||......+.      . ..+........
T Consensus       157 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~------~-~~i~~~~~~~~  228 (332)
T cd05623         157 TV-QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET------Y-GKIMNHKERFQ  228 (332)
T ss_pred             cc-eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHH------H-HHHhCCCcccc
Confidence            21 113356999999999986     34678899999999999999999999975432211      1 11111110000


Q ss_pred             ecCcccccCcHHHHHHHHHHHHHcccc--CCCCCCCHHHHHHH
Q 041921          751 VGEDKEAMNDIECLGKLVMVSIWCIQE--DPSLRPTMKKVLQM  791 (814)
Q Consensus       751 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~--dp~~RPt~~~vl~~  791 (814)
                      ...     ........+.+++.+|+..  ++..|++++++++.
T Consensus       229 ~p~-----~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         229 FPA-----QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             CCC-----ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            000     0112345677788887754  44447899999766

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=3.4e-33  Score=297.18  Aligned_cols=249  Identities=25%  Similarity=0.292  Sum_probs=196.8

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc---cchHhHHHHHHhhhccCCCCccceeeeecccccceEEE
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ---DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY  597 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  597 (814)
                      +...+.||+|+||+||+|....  .++.+|+|.+.....   .....+.+|++++++++|+|++++.+.+..++..++||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~   79 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRA--TGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVL   79 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECC--CCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEE
Confidence            3455789999999999998753  577899999864321   22345788999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCC
Q 041921          598 EFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ  675 (814)
Q Consensus       598 e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~  675 (814)
                      ||+++++|.+++...  ..+++.....++.|++.||.|||+.   +|+||||||+||++++++.+||+|||++.......
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05632          80 TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE  156 (285)
T ss_pred             EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence            999999999888643  4689999999999999999999998   99999999999999999999999999987654321


Q ss_pred             cccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcc
Q 041921          676 SKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDK  755 (814)
Q Consensus       676 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  755 (814)
                      ..   ....|+..|+|||.+.+..++.++|+||||++++||++|..||.........   ..+..........       
T Consensus       157 ~~---~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~---~~~~~~~~~~~~~-------  223 (285)
T cd05632         157 SI---RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR---EEVDRRVLETEEV-------  223 (285)
T ss_pred             cc---cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhhhccccc-------
Confidence            11   2346899999999999889999999999999999999999999754322111   1111111111110       


Q ss_pred             cccCcHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 041921          756 EAMNDIECLGKLVMVSIWCIQEDPSLRPT-----MKKVLQ  790 (814)
Q Consensus       756 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-----~~~vl~  790 (814)
                         ........+.+++..|++.+|++||+     +.++++
T Consensus       224 ---~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         224 ---YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             ---cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence               11123456788999999999999999     666665

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-33  Score=304.23  Aligned_cols=254  Identities=19%  Similarity=0.219  Sum_probs=193.7

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccc---cccchHhHHHHHHhhhccCCCCccceeeeecccccceEE
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV---FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV  596 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  596 (814)
                      .|.+.+.||+|+||.||++....  .+..||||.+...   .....+.+.+|+.++..++|+||+++++++.+++..++|
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   79 (331)
T cd05597           2 DFEILKVIGRGAFGEVAVVKMKN--TGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLV   79 (331)
T ss_pred             CceEEEEEEecCCeEEEEEEECC--CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEE
Confidence            35677899999999999998763  5678999998642   122334588999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCC
Q 041921          597 YEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ  675 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~  675 (814)
                      |||+++++|.+++.. ...+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++..+....
T Consensus        80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (331)
T cd05597          80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG  156 (331)
T ss_pred             EecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence            999999999999976 45688899999999999999999998   99999999999999999999999999987654332


Q ss_pred             cccccccccCCCCccccccccc-----CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCcccee
Q 041921          676 SKTIKTAIRGTKGYVAPEWFRN-----SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVL  750 (814)
Q Consensus       676 ~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  750 (814)
                      ... .....||+.|+|||.+..     ..++.++|||||||++|||++|+.||......+.      ............+
T Consensus       157 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~------~~~i~~~~~~~~~  229 (331)
T cd05597         157 TVQ-SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIMNHKEHFQF  229 (331)
T ss_pred             Ccc-ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH------HHHHHcCCCcccC
Confidence            211 123458999999999863     4578899999999999999999999975432211      0111111100000


Q ss_pred             ecCcccccCcHHHHHHHHHHHHHcccc--CCCCCCCHHHHHHH
Q 041921          751 VGEDKEAMNDIECLGKLVMVSIWCIQE--DPSLRPTMKKVLQM  791 (814)
Q Consensus       751 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~--dp~~RPt~~~vl~~  791 (814)
                       ..     ........+.+++.+|+..  ++..||+++++++.
T Consensus       230 -~~-----~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         230 -PP-----DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             -CC-----ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence             00     0111345667777776644  44458899988865

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.5e-33  Score=306.42  Aligned_cols=254  Identities=19%  Similarity=0.227  Sum_probs=195.1

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhccCCCCccceeeeecccccceEE
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV  596 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  596 (814)
                      .+.+.++||+|+||.||++....  .+..||+|.+....   ......+.+|..++..++|+||+++++++.+.+..++|
T Consensus         2 ~y~i~~~lG~G~fg~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv   79 (331)
T cd05624           2 DFEIIKVIGRGAFGEVAVVKMKH--TERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLV   79 (331)
T ss_pred             CceEEEEEeeCCCeEEEEEEECC--CCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence            35677899999999999998753  56789999986421   22234578899999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCC
Q 041921          597 YEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ  675 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~  675 (814)
                      |||+++|+|.+++.. ...+++.....++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++.......
T Consensus        80 ~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  156 (331)
T cd05624          80 MDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG  156 (331)
T ss_pred             EeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence            999999999999976 46788899999999999999999998   99999999999999999999999999998665432


Q ss_pred             cccccccccCCCCccccccccc-----CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCcccee
Q 041921          676 SKTIKTAIRGTKGYVAPEWFRN-----SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVL  750 (814)
Q Consensus       676 ~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  750 (814)
                      ... .....||+.|+|||.+.+     ..++.++||||||+++|||++|+.||......+.       ...+........
T Consensus       157 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~-------~~~i~~~~~~~~  228 (331)
T cd05624         157 TVQ-SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET-------YGKIMNHEERFQ  228 (331)
T ss_pred             cee-eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHH-------HHHHHcCCCccc
Confidence            211 123469999999999875     4678899999999999999999999975432211       111111110000


Q ss_pred             ecCcccccCcHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 041921          751 VGEDKEAMNDIECLGKLVMVSIWCIQEDPSL--RPTMKKVLQM  791 (814)
Q Consensus       751 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~--RPt~~~vl~~  791 (814)
                      ...     .....++++.+++.+|++..+.+  |++++++++.
T Consensus       229 ~p~-----~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         229 FPS-----HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             CCC-----ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            000     01123467788888888765544  5688888754

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.3e-33  Score=300.46  Aligned_cols=264  Identities=25%  Similarity=0.348  Sum_probs=200.3

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccccc--chHhHHHHHHhhhccCCCCccceeeeecccccceEEE
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD--GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY  597 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  597 (814)
                      ++.+.++||+|+||.||+|....  .++.+|+|++......  ..+.+.+|+++++.++||||+++++++..+...++|+
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   79 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKE--TGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF   79 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECC--CCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence            45677899999999999999753  4678999988643222  3456889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcc
Q 041921          598 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSK  677 (814)
Q Consensus       598 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  677 (814)
                      ||+++++|..+......+++..+..++.|+++||+|||+.   +|+|+||+|+||++++++.++|+|||++.........
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~  156 (286)
T cd07846          80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV  156 (286)
T ss_pred             ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccc
Confidence            9999999998887766789999999999999999999998   9999999999999999999999999998876443221


Q ss_pred             cccccccCCCCccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhh-hhHHHHHH-------HHhhcCcc-
Q 041921          678 TIKTAIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAF-------DCYRNGKL-  747 (814)
Q Consensus       678 ~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~-~~~~~~~~-------~~~~~~~~-  747 (814)
                        .....++..|+|||.+.+ ..++.++||||||++++||++|+.||......+. ..+.....       .......+ 
T Consensus       157 --~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07846         157 --YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF  234 (286)
T ss_pred             --cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHh
Confidence              133457889999999865 4578899999999999999999998864432111 11100000       00000000 


Q ss_pred             ceeecCccccc-----CcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          748 NVLVGEDKEAM-----NDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       748 ~~~~~~~~~~~-----~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      .....+.....     ........+.+++.+||+.+|.+||+++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            00000000000     01123567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=5.6e-33  Score=305.70  Aligned_cols=262  Identities=24%  Similarity=0.284  Sum_probs=193.8

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccc--cccchHhHHHHHHhhhccCCCCccceeeeecccc-----
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV--FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ-----  591 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  591 (814)
                      ..|.+.+.||+|+||.||++...  ..+..||||++...  .......+.+|+.+++.++||||+++++++...+     
T Consensus        21 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          21 KRYQQLKPIGSGAQGIVCAAFDT--VLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hceEEEEEeecCCCEEEEEEEEc--CCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            45677789999999999999865  35789999998643  2233456889999999999999999999886443     


Q ss_pred             -cceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccc
Q 041921          592 -NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKL  670 (814)
Q Consensus       592 -~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~  670 (814)
                       ..++||||+++ +|...+..  .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~  172 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART  172 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCccc
Confidence             46899999975 56665543  477888889999999999999998   999999999999999999999999999976


Q ss_pred             cccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhh-H---------------
Q 041921          671 LTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI-L---------------  734 (814)
Q Consensus       671 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~-~---------------  734 (814)
                      ......   .....||..|+|||.+.+..++.++||||||+++|||++|+.||......+... .               
T Consensus       173 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (359)
T cd07876         173 ACTNFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL  249 (359)
T ss_pred             cccCcc---CCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence            433221   133468999999999999999999999999999999999999997543211000 0               


Q ss_pred             HHHHHHHhhcC-cc-----ceeecC---cccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          735 TDWAFDCYRNG-KL-----NVLVGE---DKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       735 ~~~~~~~~~~~-~~-----~~~~~~---~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                      ...+....... ..     ......   .............+.+++.+||+.||++|||+.|+++.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence            00000000000 00     000000   00000111224568899999999999999999999873

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.1e-33  Score=305.29  Aligned_cols=193  Identities=23%  Similarity=0.333  Sum_probs=163.8

Q ss_pred             HHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceE
Q 041921          516 LEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL  595 (814)
Q Consensus       516 l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  595 (814)
                      +....|.+.+.||+|+||.||+|....  .+..||+|.....      ....|+.++++++|+||+++++++.+....++
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~--~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  134 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPG--QPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCM  134 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECC--CCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEE
Confidence            344457788899999999999999753  4678899975432      34679999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccC
Q 041921          596 VYEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN  674 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~  674 (814)
                      |+|++. ++|.+++.. ...+++..+..|+.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus       135 v~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  210 (357)
T PHA03209        135 VLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA  210 (357)
T ss_pred             EEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence            999985 588888764 46789999999999999999999998   9999999999999999999999999998754322


Q ss_pred             CcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCC
Q 041921          675 QSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSF  723 (814)
Q Consensus       675 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~  723 (814)
                      ..   .....||..|+|||.+.+..++.++|||||||++|||+++..++
T Consensus       211 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        211 PA---FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             cc---cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            11   13356899999999999999999999999999999999966554

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=3.5e-33  Score=297.18  Aligned_cols=264  Identities=23%  Similarity=0.316  Sum_probs=201.1

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEE
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY  597 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  597 (814)
                      .+.+.+.||+|++|.||+|....  +++.||+|++....  ....+.+.+|+.++++++|+||+++++++......++||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   79 (286)
T cd07847           2 KYEKLSKIGEGSYGVVFKCRNRE--TGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF   79 (286)
T ss_pred             ceeeeeeecccCCeEEEEEEECC--CCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence            35667889999999999999753  57889999886432  223456889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcc
Q 041921          598 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSK  677 (814)
Q Consensus       598 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  677 (814)
                      ||+++++|..++.....+++..+..++.|+++||+|||+.   +++|+||||+||+++.++.+||+|||++.........
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  156 (286)
T cd07847          80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD  156 (286)
T ss_pred             eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCccc
Confidence            9999999998887777789999999999999999999998   9999999999999999999999999999876543211


Q ss_pred             cccccccCCCCccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHH-HHHH-------HhhcCc-c
Q 041921          678 TIKTAIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD-WAFD-------CYRNGK-L  747 (814)
Q Consensus       678 ~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~-~~~~-------~~~~~~-~  747 (814)
                        .....++..|+|||.+.+ ..++.++||||||++++||++|+.||......+...... ....       .+.... .
T Consensus       157 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07847         157 --YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF  234 (286)
T ss_pred             --ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence              123447889999999875 457899999999999999999999997544322111100 0000       000000 0


Q ss_pred             ceeecCcccccCc-----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          748 NVLVGEDKEAMND-----IECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       748 ~~~~~~~~~~~~~-----~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      .....+.......     ......+.+++.+||+.+|++|||+.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            0001111111011     122467889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-33  Score=297.73  Aligned_cols=251  Identities=23%  Similarity=0.299  Sum_probs=201.3

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEec
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  599 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  599 (814)
                      .+.+.++||+|++|.||++....  .+..+++|.+........+.+..|++++++++|+||+++++++.++...++||||
T Consensus         6 ~~~i~~~l~~g~~~~v~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           6 IWEIIGELGDGAFGKVYKAQHKE--TGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             HHHHHHHhcCCCCceEEEEEEcC--CCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            46677889999999999998753  5678999998765445556799999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccc
Q 041921          600 LNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT  678 (814)
Q Consensus       600 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  678 (814)
                      +++++|.+++... ..+++.....++.|++.||.|||+.   +|+|+||+|+||+++.++.++|+|||++......... 
T Consensus        84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-  159 (280)
T cd06611          84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK-  159 (280)
T ss_pred             cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcccccc-
Confidence            9999999998764 5689999999999999999999998   9999999999999999999999999998765432211 


Q ss_pred             ccccccCCCCcccccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecC
Q 041921          679 IKTAIRGTKGYVAPEWFR-----NSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGE  753 (814)
Q Consensus       679 ~~~~~~gt~~y~aPE~~~-----~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  753 (814)
                       .....++..|+|||.+.     ...++.++||||||+++|||++|+.||.......  .+     ..+..+....+   
T Consensus       160 -~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~--~~-----~~~~~~~~~~~---  228 (280)
T cd06611         160 -RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR--VL-----LKILKSEPPTL---  228 (280)
T ss_pred             -cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH--HH-----HHHhcCCCCCc---
Confidence             13345889999999874     3457789999999999999999999997543221  11     11111111100   


Q ss_pred             cccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          754 DKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       754 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                          ..+......+.+++..||+.+|.+||++.++++.
T Consensus       229 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         229 ----DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             ----CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence                1112234578899999999999999999999764

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=3.5e-33  Score=303.22  Aligned_cols=256  Identities=17%  Similarity=0.208  Sum_probs=193.2

Q ss_pred             cccceeee--eeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEe
Q 041921          523 FKEEVGRG--SFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE  598 (814)
Q Consensus       523 ~~~~LG~G--~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  598 (814)
                      +.++||+|  +|++||++...  .++..||||++....  ....+.+.+|+.+++.++||||+++++++..++..++|+|
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e   79 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYK--PTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS   79 (327)
T ss_pred             hhhhccccccceEEEEEEeec--ccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEe
Confidence            45789999  78999999876  367899999996532  2233467889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCc
Q 041921          599 FLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS  676 (814)
Q Consensus       599 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  676 (814)
                      |+++++|.+++...  ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.++++||+..........
T Consensus        80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~  156 (327)
T cd08227          80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ  156 (327)
T ss_pred             ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence            99999999999653  4588999999999999999999998   999999999999999999999999986543321110


Q ss_pred             -c----cccccccCCCCccccccccc--CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccce
Q 041921          677 -K----TIKTAIRGTKGYVAPEWFRN--SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNV  749 (814)
Q Consensus       677 -~----~~~~~~~gt~~y~aPE~~~~--~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  749 (814)
                       .    .......++..|+|||++.+  ..++.++|||||||+++||++|+.||........  ..    .. ..+.+..
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~----~~-~~~~~~~  229 (327)
T cd08227         157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LL----EK-LNGTVPC  229 (327)
T ss_pred             cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HH----HH-hcCCccc
Confidence             0    00122346778999999976  4688999999999999999999999964322110  00    00 0000000


Q ss_pred             eec------------------------------------CcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          750 LVG------------------------------------EDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       750 ~~~------------------------------------~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      ..+                                    .....+........+.+++.+||+.||++|||++++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         230 LLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             cccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence            000                                    00000111233567889999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=2.9e-33  Score=298.76  Aligned_cols=245  Identities=27%  Similarity=0.393  Sum_probs=197.6

Q ss_pred             cceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEecCCCCC
Q 041921          525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGT  604 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  604 (814)
                      .+||+|+||.||++....  .+..||||++........+.+.+|+.+++.++|+||+++++.+...+..++||||+++++
T Consensus        28 ~~lg~g~~g~v~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~  105 (292)
T cd06658          28 IKIGEGSTGIVCIATEKH--TGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA  105 (292)
T ss_pred             hcccCCCCeEEEEEEECC--CCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCc
Confidence            569999999999998653  567899999875544555678999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccccccccc
Q 041921          605 LASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIR  684 (814)
Q Consensus       605 L~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~  684 (814)
                      |.+++.. ..+++.....++.||+.||.|||+.   +|+||||||+||++++++.+||+|||++.........  .....
T Consensus       106 L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~--~~~~~  179 (292)
T cd06658         106 LTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RKSLV  179 (292)
T ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc--Cceee
Confidence            9998854 4578999999999999999999998   9999999999999999999999999998765432221  13345


Q ss_pred             CCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCcHHHH
Q 041921          685 GTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECL  764 (814)
Q Consensus       685 gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  764 (814)
                      ++..|+|||.+.+..++.++||||||++++||++|+.||........  +     ..+...     ......  ......
T Consensus       180 ~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~-----~~~~~~-----~~~~~~--~~~~~~  245 (292)
T cd06658         180 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA--M-----RRIRDN-----LPPRVK--DSHKVS  245 (292)
T ss_pred             cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--H-----HHHHhc-----CCCccc--cccccC
Confidence            88999999999888899999999999999999999999875432211  0     111111     001110  111234


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          765 GKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       765 ~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                      ..+.+++.+|++.+|.+|||++++++.
T Consensus       246 ~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         246 SVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            567789999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4.6e-33  Score=294.08  Aligned_cols=255  Identities=25%  Similarity=0.347  Sum_probs=198.9

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc---c-------chHhHHHHHHhhhccCCCCccceeeeeccc
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ---D-------GEREFKNEVFVIGQTHHKNLVRLLGFCDEG  590 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~---~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  590 (814)
                      +...+.||+|+||.||+|....  .+..||||.++....   .       ..+.+..|+.++.+++|+|++++++++...
T Consensus         3 ~~~~~~lg~g~~~~vy~~~~~~--~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   80 (272)
T cd06629           3 WVKGELIGKGTYGRVYLALNVT--TGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTE   80 (272)
T ss_pred             eeecceecccCceEEEEEeecC--CCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccC
Confidence            3456789999999999998653  467899998753211   1       123578899999999999999999999999


Q ss_pred             ccceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccc
Q 041921          591 QNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKL  670 (814)
Q Consensus       591 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~  670 (814)
                      +..++|+||+++++|.+++.....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||+++.
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~~  157 (272)
T cd06629          81 EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKK  157 (272)
T ss_pred             CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccccc
Confidence            99999999999999999998888889999999999999999999998   999999999999999999999999999986


Q ss_pred             cccCCcccccccccCCCCcccccccccCC--CCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccc
Q 041921          671 LTLNQSKTIKTAIRGTKGYVAPEWFRNSK--ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLN  748 (814)
Q Consensus       671 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  748 (814)
                      ..............++..|+|||.+....  ++.++|+||||++++|+++|..||......+      ....... ....
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~-~~~~  230 (272)
T cd06629         158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA------AMFKLGN-KRSA  230 (272)
T ss_pred             ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH------HHHHhhc-cccC
Confidence            54322222223455889999999987654  7899999999999999999999986332211      0111111 1101


Q ss_pred             eeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          749 VLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       749 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                      .....    ......+..+.+++.+|++.+|.+|||++++++.
T Consensus       231 ~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         231 PPIPP----DVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             CcCCc----cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            00111    1112345788899999999999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=5.5e-33  Score=291.95  Aligned_cols=252  Identities=27%  Similarity=0.397  Sum_probs=201.9

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEecccccc--chHhHHHHHHhhhccCCCCccceeeeecccccceEEEe
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD--GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE  598 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  598 (814)
                      |...+.||+|+||.||+|....  ++..|++|.++.....  ..+++..|+.++++++|+||+++++++.+.+..++|+|
T Consensus         2 y~~~~~lg~G~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (264)
T cd06626           2 WQRGNKIGGGTFGKVYTAVNLD--TGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME   79 (264)
T ss_pred             ceeeeEeecCCCcEEEEEEECC--CCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence            5567899999999999998653  5678999998754332  45679999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccc
Q 041921          599 FLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT  678 (814)
Q Consensus       599 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  678 (814)
                      |+++++|.+++.....+++..+..++.|+++||.|||+.   +|+|+||+|+||++++++.+||+|||++..........
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~  156 (264)
T cd06626          80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM  156 (264)
T ss_pred             cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence            999999999998877789999999999999999999998   99999999999999999999999999988765432221


Q ss_pred             c--cccccCCCCcccccccccCC---CCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecC
Q 041921          679 I--KTAIRGTKGYVAPEWFRNSK---ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGE  753 (814)
Q Consensus       679 ~--~~~~~gt~~y~aPE~~~~~~---~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  753 (814)
                      .  .....++..|+|||.+....   .+.++||||||++++|+++|+.||.........     ... ...+       .
T Consensus       157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~-----~~~-~~~~-------~  223 (264)
T cd06626         157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQI-----MFH-VGAG-------H  223 (264)
T ss_pred             cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHH-----HHH-HhcC-------C
Confidence            1  12345788999999998766   889999999999999999999999643211100     000 0111       1


Q ss_pred             cccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          754 DKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       754 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      ....+........+.+++.+|++.+|.+|||+.++++
T Consensus       224 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         224 KPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             CCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            1111112223566789999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=6.4e-33  Score=293.87  Aligned_cols=248  Identities=27%  Similarity=0.366  Sum_probs=201.0

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEe
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE  598 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  598 (814)
                      .+...++||.|+||.||+|....  .+..||||.+.... ......+.+|+.++++++|+||+++++++.++...++|||
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNR--TQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME   82 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEcc--CCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence            34456789999999999998653  46789999886432 3345678999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccc
Q 041921          599 FLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT  678 (814)
Q Consensus       599 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  678 (814)
                      |+++++|.+++.. ..+++.....++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++......... 
T Consensus        83 ~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~-  157 (277)
T cd06640          83 YLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK-  157 (277)
T ss_pred             cCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCccc-
Confidence            9999999999865 4578888899999999999999998   9999999999999999999999999999766433211 


Q ss_pred             ccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCccccc
Q 041921          679 IKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAM  758 (814)
Q Consensus       679 ~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  758 (814)
                       .....++..|+|||.+.+..++.++|+||||++++||++|..|+.........       .....+..         ..
T Consensus       158 -~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-------~~~~~~~~---------~~  220 (277)
T cd06640         158 -RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL-------FLIPKNNP---------PT  220 (277)
T ss_pred             -cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh-------hhhhcCCC---------CC
Confidence             12345788999999998888999999999999999999999998754322111       00111110         11


Q ss_pred             CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          759 NDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       759 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                      .....+..+.+++.+||+.+|.+||+++++++.
T Consensus       221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         221 LTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             CchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            123456778899999999999999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=3.6e-33  Score=293.67  Aligned_cols=250  Identities=23%  Similarity=0.334  Sum_probs=198.3

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc------cchHhHHHHHHhhhccCCCCccceeeeecccccce
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ------DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRL  594 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  594 (814)
                      +...+.||+|+||.||+|...   .+..+|||.++....      .....+.+|++++++++|+||+++++++.+.+..+
T Consensus         2 ~~~~~~ig~g~~~~v~~~~~~---~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   78 (265)
T cd06631           2 WTKGEVLGKGAYGTVYCGLTN---QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTIS   78 (265)
T ss_pred             ccccceEeccCCeEEEEEEEc---CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEE
Confidence            345678999999999999764   467899998864221      12245889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccC
Q 041921          595 LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN  674 (814)
Q Consensus       595 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~  674 (814)
                      +++||+++++|.+++.....+++..+..++.|++.||+|||+.   +|+|+||+|+||++++++.+||+|||++......
T Consensus        79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  155 (265)
T cd06631          79 IFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV  155 (265)
T ss_pred             EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence            9999999999999998777788999999999999999999998   9999999999999999999999999998765321


Q ss_pred             Cc----ccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCcccee
Q 041921          675 QS----KTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVL  750 (814)
Q Consensus       675 ~~----~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  750 (814)
                      ..    ........++..|+|||.+.+..++.++||||||++++||++|+.||..........     ......+...  
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~-----~~~~~~~~~~--  228 (265)
T cd06631         156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF-----YIGAHRGLMP--  228 (265)
T ss_pred             cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHH-----HhhhccCCCC--
Confidence            11    111123458899999999998889999999999999999999999996432211100     0000001110  


Q ss_pred             ecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          751 VGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       751 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                         .    .......++.+++.+||+.+|.+||++.++++
T Consensus       229 ---~----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         229 ---R----LPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             ---C----CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence               0    11224567889999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.1e-33  Score=311.20  Aligned_cols=251  Identities=22%  Similarity=0.277  Sum_probs=195.0

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEE
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY  597 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  597 (814)
                      +.+.+.||+|+||.||++....  .+..||||.++...   ......+..|+.++.+++|+||+++++.+.+.+..++||
T Consensus         3 f~~~~~lG~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           3 FESLKVIGRGAFGEVRLVQKKD--TGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             ceEEEEEeeCCCEEEEEEEECC--CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            4556889999999999998763  57789999986432   223456888999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcc
Q 041921          598 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSK  677 (814)
Q Consensus       598 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  677 (814)
                      ||+++|+|.+++.....+++.....++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++..+......
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~  157 (360)
T cd05627          81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT  157 (360)
T ss_pred             eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence            9999999999998888899999999999999999999998   9999999999999999999999999998754321100


Q ss_pred             ---------------------------------cccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 041921          678 ---------------------------------TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFD  724 (814)
Q Consensus       678 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~  724 (814)
                                                       .......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~  237 (360)
T cd05627         158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC  237 (360)
T ss_pred             ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence                                             00113469999999999999999999999999999999999999997


Q ss_pred             cccchhhhhHHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCC---HHHHHH
Q 041921          725 IEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPT---MKKVLQ  790 (814)
Q Consensus       725 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt---~~~vl~  790 (814)
                      .....+.       ...+..........      .......++.+++.+++. +|.+|++   +.++++
T Consensus       238 ~~~~~~~-------~~~i~~~~~~~~~p------~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~  292 (360)
T cd05627         238 SETPQET-------YRKVMNWKETLVFP------PEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKS  292 (360)
T ss_pred             CCCHHHH-------HHHHHcCCCceecC------CCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence            5443221       11111111001011      111123456677777664 9999985   556554

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-34  Score=308.58  Aligned_cols=241  Identities=23%  Similarity=0.267  Sum_probs=188.6

Q ss_pred             eeeeeeeeEEEEEEecCCCceEEEEEEeccccc---cchHhHHHHHHhhhcc---CCCCccceeeeecccccceEEEecC
Q 041921          527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ---DGEREFKNEVFVIGQT---HHKNLVRLLGFCDEGQNRLLVYEFL  600 (814)
Q Consensus       527 LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~  600 (814)
                      ||+|+||+||+|....  .+..||||.+.....   .....+..|..++.+.   +||||+++++.+.+.+..++||||+
T Consensus         1 lG~G~~g~Vy~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~   78 (330)
T cd05586           1 IGKGTFGQVYQVRKKD--TRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYM   78 (330)
T ss_pred             CCCCCceEEEEEEECC--CCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCC
Confidence            7999999999998653  577899999864221   1223345566666655   6999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccccc
Q 041921          601 NNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIK  680 (814)
Q Consensus       601 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  680 (814)
                      ++++|..++.....+++.....++.||++||+|||+.   +|+||||||+|||++.++.+||+|||++.........  .
T Consensus        79 ~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~--~  153 (330)
T cd05586          79 SGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT--T  153 (330)
T ss_pred             CCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCC--c
Confidence            9999999998888899999999999999999999998   9999999999999999999999999998754322211  1


Q ss_pred             ccccCCCCcccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccC
Q 041921          681 TAIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMN  759 (814)
Q Consensus       681 ~~~~gt~~y~aPE~~~~~-~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  759 (814)
                      ....||..|+|||.+.+. .++.++|||||||++|||++|+.||......+       ....+..+.....         
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~-------~~~~i~~~~~~~~---------  217 (330)
T cd05586         154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ-------MYRNIAFGKVRFP---------  217 (330)
T ss_pred             cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH-------HHHHHHcCCCCCC---------
Confidence            345699999999998754 47899999999999999999999997543221       1122222221110         


Q ss_pred             cHHHHHHHHHHHHHccccCCCCCC----CHHHHHH
Q 041921          760 DIECLGKLVMVSIWCIQEDPSLRP----TMKKVLQ  790 (814)
Q Consensus       760 ~~~~~~~l~~l~~~Cl~~dp~~RP----t~~~vl~  790 (814)
                      .......+.+++.+||+.||.+||    ++.++++
T Consensus       218 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         218 KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence            011345677899999999999998    4566554

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=4.4e-33  Score=293.75  Aligned_cols=253  Identities=25%  Similarity=0.356  Sum_probs=198.8

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc----------ccchHhHHHHHHhhhc-cCCCCccceeeeecc
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF----------QDGEREFKNEVFVIGQ-THHKNLVRLLGFCDE  589 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~----------~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~  589 (814)
                      +.+.+.||+|+||.||+|..... .+..+|+|.+....          .....++..|+.++.+ ++||||+++++++.+
T Consensus         2 y~~~~~ig~G~~~~v~~~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           2 YAVLEHLGSGAFGCVYKVRKKNN-GQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             chhhhhhcCCCCceEEEEEEcCC-CCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            45567899999999999998642 36789999875321          1223457778887765 799999999999999


Q ss_pred             cccceEEEecCCCCCHHHHhcC----CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeec
Q 041921          590 GQNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDF  665 (814)
Q Consensus       590 ~~~~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~Df  665 (814)
                      ++..+++|||+++++|.+++..    ...+++..+++++.|++.||.|||+.  .+++|+||+|+||+++.++.+||+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEecc
Confidence            9999999999999999998743    35678889999999999999999963  27999999999999999999999999


Q ss_pred             CCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcC
Q 041921          666 GLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG  745 (814)
Q Consensus       666 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  745 (814)
                      |++.......   ......++..|+|||.+.+..++.++||||||+++|||++|+.||.......   .    ...+.++
T Consensus       159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~---~----~~~~~~~  228 (269)
T cd08528         159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS---L----ATKIVEA  228 (269)
T ss_pred             cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH---H----HHHHhhc
Confidence            9998755432   1234568899999999998889999999999999999999999986432211   0    1111111


Q ss_pred             ccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 041921          746 KLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEG  794 (814)
Q Consensus       746 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~  794 (814)
                      .....        ........+.+++.+|++.||++||++.|+..+|++
T Consensus       229 ~~~~~--------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~  269 (269)
T cd08528         229 VYEPL--------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD  269 (269)
T ss_pred             cCCcC--------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence            11110        011234678899999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=4.1e-33  Score=293.50  Aligned_cols=249  Identities=21%  Similarity=0.280  Sum_probs=192.3

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc-----cchHhHHHHHHhhhccCCCCccceeeeeccc--ccc
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ-----DGEREFKNEVFVIGQTHHKNLVRLLGFCDEG--QNR  593 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  593 (814)
                      +...+.||+|+||.||+|....  .+..|++|++.....     +....+.+|+.++++++||||+++++++.+.  ...
T Consensus         4 ~~~~~~lg~g~~g~vy~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           4 WRRGKLLGQGAFGRVYLCYDVD--TGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             ccccceecCCCCEEEEEEEEcC--CCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            4456889999999999998653  467899998854321     2234688899999999999999999988653  567


Q ss_pred             eEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcccccc
Q 041921          594 LLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTL  673 (814)
Q Consensus       594 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~  673 (814)
                      ++++||+++++|.+++.....+++.....++.|++.||+|||+.   +|+|+||+|+||+++.++.+||+|||+++....
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~  158 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQT  158 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence            89999999999999998777789999999999999999999988   999999999999999999999999999986543


Q ss_pred             CCcc-cccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeec
Q 041921          674 NQSK-TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVG  752 (814)
Q Consensus       674 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  752 (814)
                      .... .......++..|+|||.+.+..++.++||||||++++||++|+.||......+      .+........     .
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~------~~~~~~~~~~-----~  227 (266)
T cd06651         159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA------AIFKIATQPT-----N  227 (266)
T ss_pred             ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH------HHHHHhcCCC-----C
Confidence            2111 11123458889999999998889999999999999999999999997432211      0111111110     0


Q ss_pred             CcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          753 EDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       753 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      +.    .+......+.+++ +|+..+|++||+|+||++
T Consensus       228 ~~----~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         228 PQ----LPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             CC----CchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            11    1112234445555 788899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=6.2e-33  Score=305.95  Aligned_cols=262  Identities=24%  Similarity=0.277  Sum_probs=194.3

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeeccc------
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEG------  590 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  590 (814)
                      ..|.+.+.||+|+||.||++....  .+..||||++....  ......+.+|+.+++.++||||+++++++...      
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          24 KRYQNLKPIGSGAQGIVCAAYDAI--LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             cceeEEEEeecCCCeEEEEEEECC--CCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            456777899999999999998653  56789999986432  23345688999999999999999999987543      


Q ss_pred             ccceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccc
Q 041921          591 QNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKL  670 (814)
Q Consensus       591 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~  670 (814)
                      ...++||||+++ +|.+++..  .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~  175 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART  175 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCccc
Confidence            356999999975 67776643  477888899999999999999998   999999999999999999999999999986


Q ss_pred             cccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhh-HH--------H-----
Q 041921          671 LTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI-LT--------D-----  736 (814)
Q Consensus       671 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~-~~--------~-----  736 (814)
                      ......   .....+|..|+|||.+.+..++.++|||||||++|||++|+.||......+... ..        +     
T Consensus       176 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (364)
T cd07875         176 AGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL  252 (364)
T ss_pred             cCCCCc---ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence            543221   133468999999999999999999999999999999999999997543221100 00        0     


Q ss_pred             --HHHHHhhcC-cc-----ceeecC---cccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          737 --WAFDCYRNG-KL-----NVLVGE---DKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       737 --~~~~~~~~~-~~-----~~~~~~---~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                        .+.....+. ..     ..+...   .............+.+++.+||+.||.+|||+.++++.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence              000000000 00     000000   00000111224578899999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.3e-33  Score=292.52  Aligned_cols=247  Identities=28%  Similarity=0.395  Sum_probs=199.9

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc-----ccchHhHHHHHHhhhccCCCCccceeeeecccccceE
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF-----QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL  595 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  595 (814)
                      +...+.||+|++|.||+|....  ++..|++|.+....     .+..+.+.+|+.++++++|+||+++++++.++...++
T Consensus         2 ~~~~~~ig~g~~~~vy~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l   79 (258)
T cd06632           2 WRKGELLGSGSFGSVYEGLNLD--DGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYI   79 (258)
T ss_pred             ccccceeeecCCceEEEEEEcC--CCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEE
Confidence            4456789999999999998753  46789999886432     1234578999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCC
Q 041921          596 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ  675 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~  675 (814)
                      ++||+++++|.+++.....+++..+..++.|+++||+|||+.   +|+|+||+|+||+++.++.+||+|||++.......
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~  156 (258)
T cd06632          80 FLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS  156 (258)
T ss_pred             EEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence            999999999999998877789999999999999999999998   99999999999999999999999999988754332


Q ss_pred             cccccccccCCCCcccccccccCC-CCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCc
Q 041921          676 SKTIKTAIRGTKGYVAPEWFRNSK-ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGED  754 (814)
Q Consensus       676 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  754 (814)
                         ......++..|+|||.+.... ++.++|+||||++++||++|+.||......+.      ............     
T Consensus       157 ---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~------~~~~~~~~~~~~-----  222 (258)
T cd06632         157 ---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA------VFKIGRSKELPP-----  222 (258)
T ss_pred             ---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH------HHHHHhcccCCC-----
Confidence               113345888999999987766 89999999999999999999999865432110      111111011100     


Q ss_pred             ccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          755 KEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       755 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                          .+......+.+++.+||+.+|.+||+++++++
T Consensus       223 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         223 ----IPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             ----cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence                11123467788999999999999999999975

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=6e-33  Score=290.40  Aligned_cols=249  Identities=24%  Similarity=0.344  Sum_probs=202.9

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEeccc--cccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEe
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV--FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE  598 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  598 (814)
                      |.+.+.||+|+||.||.+...  .++..+++|++...  .....+++.+|+.++++++|+||+++++++.+.+..+++||
T Consensus         2 y~~~~~ig~g~~g~v~~~~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e   79 (256)
T cd08221           2 YIPIRVLGKGAFGEATLYRRT--EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME   79 (256)
T ss_pred             ceEeeEecccCCceEEEEEEc--CCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence            556789999999999988865  35678999987643  23445678999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCc
Q 041921          599 FLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS  676 (814)
Q Consensus       599 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  676 (814)
                      |+++++|.+++...  ..+++..+..++.|++++|.|||+.   +++|+||+|+||++++++.+||+|||++........
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~  156 (256)
T cd08221          80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS  156 (256)
T ss_pred             ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence            99999999999764  4678999999999999999999998   999999999999999999999999999987654332


Q ss_pred             ccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCccc
Q 041921          677 KTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKE  756 (814)
Q Consensus       677 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  756 (814)
                        ......++..|+|||.+.+...+.++||||||++++||++|+.||......+.      . ..+..+....       
T Consensus       157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~------~-~~~~~~~~~~-------  220 (256)
T cd08221         157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNL------V-VKIVQGNYTP-------  220 (256)
T ss_pred             --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHH------H-HHHHcCCCCC-------
Confidence              11334589999999999888889999999999999999999999865432211      1 1111221111       


Q ss_pred             ccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 041921          757 AMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQML  792 (814)
Q Consensus       757 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L  792 (814)
                        .......++.+++.+|++.+|.+||+++++++.+
T Consensus       221 --~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         221 --VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             --CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence              1123456788999999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-33  Score=297.63  Aligned_cols=265  Identities=24%  Similarity=0.317  Sum_probs=202.8

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEE
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY  597 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  597 (814)
                      ++.+.++||+|++|.||+|....  .+..|+||+++...  ....+.+.+|++++++++|+||+++++++..++..++|+
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   79 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKA--TGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF   79 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCC--CCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence            45677899999999999998763  46789999886432  233467899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcc
Q 041921          598 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSK  677 (814)
Q Consensus       598 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  677 (814)
                      ||++++.|..++.....+++.....++.||+.||.|||+.   +++|+||+|+||++++++.+||+|||++.........
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~  156 (288)
T cd07833          80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS  156 (288)
T ss_pred             ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc
Confidence            9999988887776667789999999999999999999998   9999999999999999999999999999876654321


Q ss_pred             cccccccCCCCcccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHh---------hcCcc
Q 041921          678 TIKTAIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY---------RNGKL  747 (814)
Q Consensus       678 ~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~---------~~~~~  747 (814)
                      .. ....++..|+|||++... .++.++||||||++++||++|+.||......+............         .....
T Consensus       157 ~~-~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07833         157 PL-TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF  235 (288)
T ss_pred             cc-cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence            11 334578899999999887 78999999999999999999999987543321111000000000         00000


Q ss_pred             ce--eecCc----ccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          748 NV--LVGED----KEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       748 ~~--~~~~~----~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      ..  .....    .....+.....++.+++.+||+.+|++|||++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            00  00000    000011123678999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=4.7e-33  Score=296.13  Aligned_cols=258  Identities=24%  Similarity=0.309  Sum_probs=194.4

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEe
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE  598 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  598 (814)
                      +.+.+.||+|++|.||+|....  .+..||||+++...  ....+.+.+|+.++++++||||+++++++.++...++|+|
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (285)
T cd07861           2 YTKIEKIGEGTYGVVYKGRNKK--TGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE   79 (285)
T ss_pred             ceEeeEecccCceEEEEEEECC--CCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence            4566889999999999999753  56789999886432  2234578899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhcCC---CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCC
Q 041921          599 FLNNGTLASFLFGN---LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ  675 (814)
Q Consensus       599 ~~~~gsL~~~l~~~---~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~  675 (814)
                      |++ ++|.+++...   ..+++..+..++.|+++||+|||+.   +|+|+||||+||+++.++.+||+|||++.......
T Consensus        80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  155 (285)
T cd07861          80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV  155 (285)
T ss_pred             cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence            997 6888888543   5678999999999999999999998   99999999999999999999999999987654322


Q ss_pred             cccccccccCCCCcccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhh---cCc-----
Q 041921          676 SKTIKTAIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR---NGK-----  746 (814)
Q Consensus       676 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~-----  746 (814)
                      ..  .....++..|+|||.+.+. .++.++||||||++++||+||+.||..........  ... +...   +..     
T Consensus       156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~--~~~-~~~~~~~~~~~~~~~  230 (285)
T cd07861         156 RV--YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLF--RIF-RILGTPTEDVWPGVT  230 (285)
T ss_pred             cc--ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH--HHH-HHhCCCChhhhhcch
Confidence            11  1233468899999988654 57889999999999999999999997543321100  000 0000   000     


Q ss_pred             --------cceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          747 --------LNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       747 --------~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                              ......... .........++.+++.+||+.||.+|||+.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         231 SLPDYKNTFPKWKKGSL-RSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             hhHHHHhhccccCcchh-HHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence                    000000000 0001123467789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=6.6e-33  Score=298.12  Aligned_cols=255  Identities=19%  Similarity=0.266  Sum_probs=201.6

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEE
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY  597 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  597 (814)
                      +.+.+.||+|+||.||++....  .++.|++|.+....   ......+.+|+.+++.++||||+++++.+.+++..++||
T Consensus         3 y~~~~~l~~g~~~~v~~~~~~~--~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           3 FETIKLISNGAYGAVYLVRHKE--TRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             ceEeeEeecCCCeeEEEEEECC--CCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            4566889999999999998753  56789999886532   223456889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCc-
Q 041921          598 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS-  676 (814)
Q Consensus       598 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~-  676 (814)
                      ||+++++|.+++.....+++.....++.|++.||.|||+.   +++||||||+||+++.++.+||+|||+++....... 
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~  157 (305)
T cd05609          81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT  157 (305)
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence            9999999999998877889999999999999999999998   999999999999999999999999999874211100 


Q ss_pred             ------------ccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhc
Q 041921          677 ------------KTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN  744 (814)
Q Consensus       677 ------------~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  744 (814)
                                  ........++..|+|||.+....++.++|+||||+++|||++|..||......+       .......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~-------~~~~~~~  230 (305)
T cd05609         158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE-------LFGQVIS  230 (305)
T ss_pred             cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHh
Confidence                        001112357889999999988889999999999999999999999996433221       1111111


Q ss_pred             CccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 041921          745 GKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEG  794 (814)
Q Consensus       745 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~  794 (814)
                      +....   +..    ....+..+.+++.+||+.+|++||++.++.++|+.
T Consensus       231 ~~~~~---~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         231 DDIEW---PEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             cccCC---CCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            11111   000    11245668899999999999999998777777765

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=5.6e-33  Score=305.31  Aligned_cols=262  Identities=24%  Similarity=0.273  Sum_probs=193.9

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeeccc------
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEG------  590 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  590 (814)
                      ..|.+.+.||+|+||.||++...  ..+..||||++....  ......+.+|+.+++.++||||+++++++...      
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          17 KRYQNLKPIGSGAQGIVCAAYDA--VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hceeEEEEeeecCCEEEEEEEec--CCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            35667789999999999999864  357789999986532  22345678899999999999999999987543      


Q ss_pred             ccceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccc
Q 041921          591 QNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKL  670 (814)
Q Consensus       591 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~  670 (814)
                      ...++||||+++ +|.+.+..  .+++..+..++.|+++||.|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~~~  168 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART  168 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCccccc
Confidence            346899999975 66666643  478888899999999999999998   999999999999999999999999999986


Q ss_pred             cccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhh-HH--------------
Q 041921          671 LTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI-LT--------------  735 (814)
Q Consensus       671 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~-~~--------------  735 (814)
                      ......   .....||..|+|||.+.+..++.++|||||||+++||++|+.||......+... ..              
T Consensus       169 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (355)
T cd07874         169 AGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  245 (355)
T ss_pred             CCCccc---cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence            543221   133468999999999999899999999999999999999999997543211100 00              


Q ss_pred             -HHHHHHhhcC-ccceeecCc------c--cccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          736 -DWAFDCYRNG-KLNVLVGED------K--EAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       736 -~~~~~~~~~~-~~~~~~~~~------~--~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                       .......... ....+..+.      .  ...........+.+++.+||+.||++|||+.|+++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence             0000000000 000000000      0  000111234678899999999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-33  Score=293.04  Aligned_cols=246  Identities=22%  Similarity=0.358  Sum_probs=207.6

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEE
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY  597 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  597 (814)
                      -|.+.+.||+|.|..|-+|.+--  .|..||||.+.+..  ......+..|++.|+.++|||||+|+++......+|||.
T Consensus        19 LYDLekTlG~GHFAVVKLArHVF--TGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL   96 (864)
T KOG4717|consen   19 LYDLEKTLGRGHFAVVKLARHVF--TGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL   96 (864)
T ss_pred             eehhhhhhcCCceehhhhhhhhc--ccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence            45667889999999999887653  57899999997643  333457899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE-cCCCcEEEeecCCccccccCC
Q 041921          598 EFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILL-DDYYTARISDFGLAKLLTLNQ  675 (814)
Q Consensus       598 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll-~~~~~~kl~DfGla~~~~~~~  675 (814)
                      |.-.+|+|.+||..+ ..+.+....+++.||+.|+.|+|+.   .++||||||+||.+ ..-|-+||.|||++-.+.+..
T Consensus        97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~  173 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK  173 (864)
T ss_pred             EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence            999999999999765 6789999999999999999999998   99999999999877 567899999999998887665


Q ss_pred             cccccccccCCCCcccccccccCCCC-cchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCc
Q 041921          676 SKTIKTAIRGTKGYVAPEWFRNSKIT-AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGED  754 (814)
Q Consensus       676 ~~~~~~~~~gt~~y~aPE~~~~~~~s-~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  754 (814)
                      ..   +..+|+..|-|||++.+..|. ++.||||||||||-|++|+.||+.....+               .+..++|..
T Consensus       174 kL---~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE---------------TLTmImDCK  235 (864)
T KOG4717|consen  174 KL---TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE---------------TLTMIMDCK  235 (864)
T ss_pred             hh---hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh---------------hhhhhhccc
Confidence            43   557899999999999999886 67999999999999999999997554432               122333333


Q ss_pred             ccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          755 KEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       755 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      ..  .+.....++.+||..||..||.+|.+.++|+.
T Consensus       236 Yt--vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  236 YT--VPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             cc--CchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence            22  24456788999999999999999999999975

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=6.6e-33  Score=290.20  Aligned_cols=248  Identities=25%  Similarity=0.347  Sum_probs=199.0

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeecc-cccceEEE
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDE-GQNRLLVY  597 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~  597 (814)
                      |.+.+.||+|++|.||++....  +++.+++|++....  ....+.+.+|++++++++|+|++++++.+.. +...+++|
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~   79 (257)
T cd08223           2 YCFVRVVGKGSYGEVSLVRHRT--DGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM   79 (257)
T ss_pred             ceEEEEecCCCCeEEEEEEEcC--CCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence            5677899999999999999753  46789999986432  2344568899999999999999999988764 44578999


Q ss_pred             ecCCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCC
Q 041921          598 EFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ  675 (814)
Q Consensus       598 e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~  675 (814)
                      ||+++++|.+++...  ..+++.++..++.|++.||++||+.   +|+|+||||+||+++.++.++|+|||++..+....
T Consensus        80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~  156 (257)
T cd08223          80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC  156 (257)
T ss_pred             cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence            999999999999763  4588999999999999999999998   99999999999999999999999999998664322


Q ss_pred             cccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcc
Q 041921          676 SKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDK  755 (814)
Q Consensus       676 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  755 (814)
                      .  ......+++.|+|||.+.+..++.++||||||++++||++|+.||.......      ... .+..+.+..      
T Consensus       157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~------~~~-~~~~~~~~~------  221 (257)
T cd08223         157 D--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS------LVY-RIIEGKLPP------  221 (257)
T ss_pred             C--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH------HHH-HHHhcCCCC------
Confidence            2  1133458899999999999999999999999999999999999986432211      111 111222111      


Q ss_pred             cccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          756 EAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       756 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                         ........+.+++.+|++.+|.+|||+.++++.
T Consensus       222 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         222 ---MPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             ---CccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence               112345678899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=7.7e-33  Score=296.23  Aligned_cols=246  Identities=24%  Similarity=0.343  Sum_probs=198.6

Q ss_pred             ccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEecCCCC
Q 041921          524 KEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNG  603 (814)
Q Consensus       524 ~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  603 (814)
                      ..+||+|+||.||++....  ++..|++|.+........+.+.+|+.++..++||||+++++++..++..++|+||++++
T Consensus        26 ~~~ig~g~~g~v~~~~~~~--~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~  103 (297)
T cd06659          26 YIKIGEGSTGIVCIAREKH--SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGG  103 (297)
T ss_pred             hhhcCCCCceeEEEEEEcC--CCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCC
Confidence            3479999999999998653  56789999986544445567889999999999999999999999999999999999999


Q ss_pred             CHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcccccccc
Q 041921          604 TLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAI  683 (814)
Q Consensus       604 sL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~  683 (814)
                      +|..++.. ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++.........  ....
T Consensus       104 ~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~--~~~~  177 (297)
T cd06659         104 ALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKSL  177 (297)
T ss_pred             CHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccccc--ccce
Confidence            99997754 4578999999999999999999998   9999999999999999999999999998765433211  1335


Q ss_pred             cCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCcHHH
Q 041921          684 RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIEC  763 (814)
Q Consensus       684 ~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  763 (814)
                      .++..|+|||.+.+..++.++||||||++++||++|+.||......+..       ..+.......     .  ......
T Consensus       178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~-------~~~~~~~~~~-----~--~~~~~~  243 (297)
T cd06659         178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM-------KRLRDSPPPK-----L--KNAHKI  243 (297)
T ss_pred             ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHhccCCCC-----c--cccCCC
Confidence            6889999999999888999999999999999999999999754332211       1111111000     0  011123


Q ss_pred             HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          764 LGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       764 ~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                      ...+.+++.+|++.+|.+||+++++++.
T Consensus       244 ~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         244 SPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             CHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            4567889999999999999999999983

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.2e-33  Score=298.58  Aligned_cols=250  Identities=22%  Similarity=0.226  Sum_probs=199.0

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEecccccc---chHhHHHHHHhhhccCCCCccceeeeecccccceEEE
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY  597 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  597 (814)
                      +.+.+.||+|++|.||++....  .+..+|+|.+......   ..+.+..|+++++.++|+||+++++.+.+.+..++||
T Consensus         3 y~~~~~ig~g~~g~vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           3 FKKIKLLGKGDVGRVFLVRLKG--TGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             eEEeeeecCCccEEEEEEEEcC--CCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            4566789999999999998763  5789999999653222   3456889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCC
Q 041921          598 EFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ  675 (814)
Q Consensus       598 e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~  675 (814)
                      ||+.+++|.+++...  ..+++.....++.|+++||+|||+.   +++|+||||+||+++.++.++|+|||++.......
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  157 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP  157 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence            999999999998754  5688999999999999999999998   99999999999999999999999999987543221


Q ss_pred             cc---------------------------cccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccc
Q 041921          676 SK---------------------------TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMG  728 (814)
Q Consensus       676 ~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~  728 (814)
                      ..                           .......|+..|+|||.+.+..++.++||||||+++|+|++|+.||.....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~  237 (316)
T cd05574         158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR  237 (316)
T ss_pred             cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence            10                           001123578899999999988899999999999999999999999975433


Q ss_pred             hhhhhHHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCC----HHHHHH
Q 041921          729 EEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPT----MKKVLQ  790 (814)
Q Consensus       729 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt----~~~vl~  790 (814)
                      ...  +     ..+....        ............+.+++.+||+.+|++|||    ++++++
T Consensus       238 ~~~--~-----~~~~~~~--------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         238 DET--F-----SNILKKE--------VTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             HHH--H-----HHHhcCC--------ccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            211  1     1111111        111111125678999999999999999999    666665

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=6.1e-33  Score=290.31  Aligned_cols=247  Identities=22%  Similarity=0.317  Sum_probs=200.5

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEeccc--cccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEe
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV--FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE  598 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  598 (814)
                      |.+.++||+|+||.+|++....  +++.+++|++...  .....+++.+|+.++++++||||+++++++.+.+..++|+|
T Consensus         2 y~~~~~lg~g~~g~~~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08218           2 YVKVKKIGEGSFGKAILVKSKE--DGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD   79 (256)
T ss_pred             ceEEEEeccCCceEEEEEEEcC--CCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence            5567899999999999998753  5778999998642  22334578999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCc
Q 041921          599 FLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS  676 (814)
Q Consensus       599 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  676 (814)
                      |+++++|.+++...  ..+++..+.+++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++........
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~  156 (256)
T cd08218          80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE  156 (256)
T ss_pred             cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence            99999999998754  3578889999999999999999998   999999999999999999999999999986643221


Q ss_pred             ccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCccc
Q 041921          677 KTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKE  756 (814)
Q Consensus       677 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  756 (814)
                      .  .....|+..|+|||.+.+...+.++|+||||++++||++|+.||......+      .+... ..+...        
T Consensus       157 ~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~------~~~~~-~~~~~~--------  219 (256)
T cd08218         157 L--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN------LVLKI-IRGSYP--------  219 (256)
T ss_pred             h--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH------HHHHH-hcCCCC--------
Confidence            1  123457889999999998889999999999999999999999986433221      11111 111111        


Q ss_pred             ccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          757 AMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       757 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                       .........+.+++.+|++.+|.+||+|.+|++
T Consensus       220 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         220 -PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             -CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence             012234567889999999999999999999987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.3e-32  Score=292.89  Aligned_cols=250  Identities=22%  Similarity=0.360  Sum_probs=198.0

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccc-cccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEe
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV-FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE  598 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  598 (814)
                      .+++.+.||+|+||.||++....  .+..+|+|.+... ......++.+|+.++++++|+||+++++.+...+..++|+|
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~--~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRP--TGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME   79 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcC--CCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence            35677899999999999998753  5788999988643 22334578999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhcCC---CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCC
Q 041921          599 FLNNGTLASFLFGN---LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ  675 (814)
Q Consensus       599 ~~~~gsL~~~l~~~---~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~  675 (814)
                      |+++++|..++...   ..+++..+..++.|++.||.|||+.  .+|+|+||||+||+++.++.+||+|||++..+....
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  157 (286)
T cd06622          80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL  157 (286)
T ss_pred             ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence            99999999998763   3689999999999999999999963  289999999999999999999999999987653221


Q ss_pred             cccccccccCCCCcccccccccCC------CCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccce
Q 041921          676 SKTIKTAIRGTKGYVAPEWFRNSK------ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNV  749 (814)
Q Consensus       676 ~~~~~~~~~gt~~y~aPE~~~~~~------~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  749 (814)
                      .    ....++..|+|||.+.+..      ++.++|+|||||+++||++|+.||..........    ....+..+... 
T Consensus       158 ~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~----~~~~~~~~~~~-  228 (286)
T cd06622         158 A----KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFA----QLSAIVDGDPP-  228 (286)
T ss_pred             c----ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHH----HHHHHhhcCCC-
Confidence            1    2335788999999986543      4789999999999999999999996433211110    01111111111 


Q ss_pred             eecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          750 LVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       750 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                              ........++.+++.+|++.+|.+||+++++++
T Consensus       229 --------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         229 --------TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             --------CCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence                    112235677889999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.6e-32  Score=288.40  Aligned_cols=251  Identities=27%  Similarity=0.356  Sum_probs=205.9

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc-cchHhHHHHHHhhhccCCCCccceeeeecccccceEEEec
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  599 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  599 (814)
                      +++.+.||+|++|.||+++...  .+..|+||++..... ...+++.+|+..+.+++|+||+++++++......++|+||
T Consensus         3 ~~~~~~i~~g~~~~v~~~~~~~--~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           3 LERVKVLGQGSSGVVYKVRHKP--TGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             ceeeeeeeecCCeEEEEEEEcC--CCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            4567899999999999999764  578899999875433 3456799999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccc
Q 041921          600 LNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHE-DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT  678 (814)
Q Consensus       600 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  678 (814)
                      +++++|.+++.....+++..+..++.|+++||.|||+ .   +++|+||+|+||+++.++.++|+|||++..........
T Consensus        81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~  157 (264)
T cd06623          81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC  157 (264)
T ss_pred             cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCCcc
Confidence            9999999999887888999999999999999999999 7   99999999999999999999999999998765433221


Q ss_pred             ccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCccccc
Q 041921          679 IKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAM  758 (814)
Q Consensus       679 ~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  758 (814)
                        ....++..|+|||.+.+..++.++|+||||+++|||++|+.||..........+..    .+......         .
T Consensus       158 --~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~----~~~~~~~~---------~  222 (264)
T cd06623         158 --NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQ----AICDGPPP---------S  222 (264)
T ss_pred             --cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHH----HHhcCCCC---------C
Confidence              23457889999999998889999999999999999999999986543211111111    11111110         0


Q ss_pred             CcHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          759 NDIE-CLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       759 ~~~~-~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                      .... .+..+.+++.+||+.+|++||++.++++.
T Consensus       223 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         223 LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            1112 45788999999999999999999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.1e-32  Score=289.91  Aligned_cols=249  Identities=21%  Similarity=0.276  Sum_probs=194.3

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--c---cchHhHHHHHHhhhccCCCCccceeeeeccc--ccc
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--Q---DGEREFKNEVFVIGQTHHKNLVRLLGFCDEG--QNR  593 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  593 (814)
                      +.+.+.||+|+||.||+|....  .+..|+||.+....  .   ...+.+.+|+.++++++||||+++++++.+.  ...
T Consensus         4 ~~~~~~l~~g~~g~v~~~~~~~--~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           4 WRLGKLLGQGAFGRVYLCYDAD--TGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             ceEeeEEecCCceEEEEEEEcC--CCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            4567889999999999998653  56789999875321  1   1234688899999999999999999988764  457


Q ss_pred             eEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcccccc
Q 041921          594 LLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTL  673 (814)
Q Consensus       594 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~  673 (814)
                      ++++||+++++|.+++.....+++....+++.|++.||.|||+.   +|+|+||||+||+++.++.++|+|||++.....
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~  158 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQT  158 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence            79999999999999998777788899999999999999999998   999999999999999999999999999886543


Q ss_pred             CCcc-cccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeec
Q 041921          674 NQSK-TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVG  752 (814)
Q Consensus       674 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  752 (814)
                      .... .......++..|+|||.+.+..++.++||||||+++|||++|+.||........      .........      
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~~~------  226 (265)
T cd06652         159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA------IFKIATQPT------  226 (265)
T ss_pred             ccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH------HHHHhcCCC------
Confidence            2111 111234588899999999888899999999999999999999999864322111      011110100      


Q ss_pred             CcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          753 EDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       753 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                         ....+......+.+++.+|+. +|.+||+++++++
T Consensus       227 ---~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         227 ---NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             ---CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence               011123345677788888885 8999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=5.6e-33  Score=324.69  Aligned_cols=263  Identities=23%  Similarity=0.300  Sum_probs=201.2

Q ss_pred             CHHHHHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccc--cccchHhHHHHHHhhhccCCCCccceeeeecc
Q 041921          512 SYKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV--FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDE  589 (814)
Q Consensus       512 ~~~~l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  589 (814)
                      ...++....|.+.++||+|+||+||++....  .+..+|+|.+...  .......|..|+.++++++|||||++++++.+
T Consensus         6 ~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~--tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d   83 (1021)
T PTZ00266          6 DDGESRLNEYEVIKKIGNGRFGEVFLVKHKR--TQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLN   83 (1021)
T ss_pred             cCCccccCCEEEEEEEecCCCeEEEEEEECC--CCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEe
Confidence            3345556678888999999999999999763  5678899988642  22334568999999999999999999998754


Q ss_pred             --cccceEEEecCCCCCHHHHhcCC----CCCChhhHHHHHHHHHHHHHHhhhcCC----CCeeecCCCCCcEEEcC---
Q 041921          590 --GQNRLLVYEFLNNGTLASFLFGN----LKPNWNLRTNIAFQIARGLLYLHEDCR----AQIIHCDIKPQNILLDD---  656 (814)
Q Consensus       590 --~~~~~lv~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~~l~yLH~~~~----~~i~H~dlkp~NIll~~---  656 (814)
                        ....+|||||+++++|.++|...    ..+++..++.|+.||+.||.|||+...    .+|+||||||+||||+.   
T Consensus        84 e~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~  163 (1021)
T PTZ00266         84 KANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR  163 (1021)
T ss_pred             cCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcc
Confidence              35688999999999999998652    568999999999999999999998521    25999999999999964   


Q ss_pred             --------------CCcEEEeecCCccccccCCcccccccccCCCCccccccccc--CCCCcchhhHHHHHHHHHHHhCC
Q 041921          657 --------------YYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRN--SKITAKVDVYSFGVLLLEIISCR  720 (814)
Q Consensus       657 --------------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~Dv~s~Gvvl~elltg~  720 (814)
                                    ...+||+|||++..+.....   .....||+.|+|||++..  ..++.++|||||||+||||++|+
T Consensus       164 ~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk  240 (1021)
T PTZ00266        164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK  240 (1021)
T ss_pred             ccccccccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCC
Confidence                          23489999999986643221   134568999999999854  45889999999999999999999


Q ss_pred             CCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHH--HHHhcC
Q 041921          721 KSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVL--QMLEGV  795 (814)
Q Consensus       721 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl--~~L~~~  795 (814)
                      .||.......     . +...+..+.       .+.   .......+.+|+..||+.+|.+||++.+++  ..+..+
T Consensus       241 ~PF~~~~~~~-----q-li~~lk~~p-------~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i  301 (1021)
T PTZ00266        241 TPFHKANNFS-----Q-LISELKRGP-------DLP---IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV  301 (1021)
T ss_pred             CCCCcCCcHH-----H-HHHHHhcCC-------CCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence            9996433211     1 111111111       000   011246788999999999999999999998  444433

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=7.4e-33  Score=294.50  Aligned_cols=260  Identities=21%  Similarity=0.286  Sum_probs=194.7

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEe
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE  598 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  598 (814)
                      |.+.++||+|+||.||+|....  .+..+++|+++...  ......+.+|+.++++++|+||+++++++.+....++|+|
T Consensus         2 y~~~~~l~~g~~~~vy~~~~~~--~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (284)
T cd07839           2 YEKLEKIGEGTYGTVFKAKNRE--THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE   79 (284)
T ss_pred             ceeEEEecccCCeEEEEEEECC--CCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence            5567889999999999999763  56789999886422  2233567889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcc
Q 041921          599 FLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSK  677 (814)
Q Consensus       599 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  677 (814)
                      |++ ++|.+++.. ...+++.....++.||++||.|||+.   +|+|+||||+||+++.++.+||+|||+++........
T Consensus        80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~  155 (284)
T cd07839          80 YCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC  155 (284)
T ss_pred             cCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC
Confidence            997 478877764 46689999999999999999999998   9999999999999999999999999999865432211


Q ss_pred             cccccccCCCCcccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCc------ccee
Q 041921          678 TIKTAIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK------LNVL  750 (814)
Q Consensus       678 ~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~~~  750 (814)
                        .....++..|+|||.+.+. .++.++||||||++++||++|+.|+........ .+ ..+.+......      +...
T Consensus       156 --~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd07839         156 --YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QL-KRIFRLLGTPTEESWPGVSKL  231 (284)
T ss_pred             --cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH-HH-HHHHHHhCCCChHHhHHhhhc
Confidence              1234578899999998765 468999999999999999999988643322111 00 11111110000      0000


Q ss_pred             ec----Ccccc-----cCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          751 VG----EDKEA-----MNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       751 ~~----~~~~~-----~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      .+    +....     ........++.+++.+||+.||.+|||++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            00    00000     001123567889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=5.7e-33  Score=292.10  Aligned_cols=251  Identities=24%  Similarity=0.388  Sum_probs=201.0

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEec
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  599 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  599 (814)
                      +.+.+.||+|++|.||++....  .++.+++|.+.... ....+++.+|++++++++||||+++++.+..+...++++||
T Consensus         3 ~~~~~~ig~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           3 LEYLGELGAGNSGVVSKVLHRP--TGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             chHHHHhcCCCCeEEEEEEEcC--CCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            4566789999999999998753  57789999986543 23456789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcc
Q 041921          600 LNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHE-DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSK  677 (814)
Q Consensus       600 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  677 (814)
                      +++++|.+++... ..++......++.|+++||+|||+ .   +++|+||||+||++++++.++|+|||.+.........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~  157 (265)
T cd06605          81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK  157 (265)
T ss_pred             cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh
Confidence            9999999999876 778889999999999999999999 7   9999999999999999999999999998765432211


Q ss_pred             cccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccc
Q 041921          678 TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEA  757 (814)
Q Consensus       678 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  757 (814)
                          ...++..|+|||.+.+..++.++||||||+++++|++|+.||......... ..... +.......        ..
T Consensus       158 ----~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~~-~~~~~~~~--------~~  223 (265)
T cd06605         158 ----TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG-IFELL-QYIVNEPP--------PR  223 (265)
T ss_pred             ----cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc-HHHHH-HHHhcCCC--------CC
Confidence                155888999999999889999999999999999999999998654221111 11111 11111110        00


Q ss_pred             cCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          758 MNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       758 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      .........+.+++..|+..+|.+|||+.++++
T Consensus       224 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         224 LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            001114567889999999999999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.1e-32  Score=289.64  Aligned_cols=251  Identities=26%  Similarity=0.376  Sum_probs=199.5

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEeccc--cccchHhHHHHHHhhhccCCCCccceeeeecc--cccceEE
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV--FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDE--GQNRLLV  596 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv  596 (814)
                      |.+.+.||.|+||.||++....  .+..+++|.+...  .....+++..|+.++++++|+||+++++++..  ....+++
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (265)
T cd08217           2 YEVLETIGKGSFGTVRKVRRKS--DGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV   79 (265)
T ss_pred             ceeeeeeccCCCeEEEEeeecC--CCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence            4566889999999999998653  5678999988642  23334568899999999999999999997754  4457899


Q ss_pred             EecCCCCCHHHHhcC----CCCCChhhHHHHHHHHHHHHHHhhhcC--CCCeeecCCCCCcEEEcCCCcEEEeecCCccc
Q 041921          597 YEFLNNGTLASFLFG----NLKPNWNLRTNIAFQIARGLLYLHEDC--RAQIIHCDIKPQNILLDDYYTARISDFGLAKL  670 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~~l~yLH~~~--~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~  670 (814)
                      |||+++++|.+++..    ...+++.....++.|+++||.|||..+  ..+++|+||+|+||++++++.+||+|||++..
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~  159 (265)
T cd08217          80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI  159 (265)
T ss_pred             ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence            999999999999865    356889999999999999999999321  23999999999999999999999999999987


Q ss_pred             cccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCcccee
Q 041921          671 LTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVL  750 (814)
Q Consensus       671 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  750 (814)
                      ........  ....++..|+|||.+....++.++||||||+++++|++|+.||.......   +    .+.+..+.... 
T Consensus       160 ~~~~~~~~--~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~----~~~~~~~~~~~-  229 (265)
T cd08217         160 LGHDSSFA--KTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ---L----ASKIKEGKFRR-  229 (265)
T ss_pred             ccCCcccc--cccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH---H----HHHHhcCCCCC-
Confidence            65433211  33468999999999998889999999999999999999999997543211   1    12222222111 


Q ss_pred             ecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          751 VGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       751 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                              .+......+.+++.+|++.+|.+|||+.+|++.
T Consensus       230 --------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         230 --------IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             --------CccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                    122345678899999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-32  Score=282.29  Aligned_cols=249  Identities=23%  Similarity=0.294  Sum_probs=203.0

Q ss_pred             ccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEe
Q 041921          522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE  598 (814)
Q Consensus       522 ~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  598 (814)
                      ++.+.||+|.-|+||++.+..  .....|+|.+.+..   .+.....+.|-+||+.++||.|+.|++.+..++..+|+||
T Consensus        80 ~llk~LG~GdiG~VyL~~l~~--t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me  157 (459)
T KOG0610|consen   80 RLLKRLGCGDIGTVYLVELRG--TNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME  157 (459)
T ss_pred             HHHHHcCCCCceeEEEEEecC--CCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence            345789999999999999874  45899999997643   2334567889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccC--
Q 041921          599 FLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN--  674 (814)
Q Consensus       599 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~--  674 (814)
                      ||+||+|..+++..  +.+++...+-++..|+-||+|||-.   |||.|||||+||||.++|.+.|+||.|+......  
T Consensus       158 yCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt  234 (459)
T KOG0610|consen  158 YCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT  234 (459)
T ss_pred             cCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence            99999999999765  6788999999999999999999998   9999999999999999999999999987543110  


Q ss_pred             ------------------------------C-cc---------------------cccccccCCCCcccccccccCCCCc
Q 041921          675 ------------------------------Q-SK---------------------TIKTAIRGTKGYVAPEWFRNSKITA  702 (814)
Q Consensus       675 ------------------------------~-~~---------------------~~~~~~~gt~~y~aPE~~~~~~~s~  702 (814)
                                                    . ..                     .....++||-.|+|||++.+.....
T Consensus       235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgs  314 (459)
T KOG0610|consen  235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGS  314 (459)
T ss_pred             eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCc
Confidence                                          0 00                     0012356999999999999999999


Q ss_pred             chhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCC
Q 041921          703 KVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLR  782 (814)
Q Consensus       703 ~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~R  782 (814)
                      +.|.|+|||++|||+.|..||.+...++.               +..++...+..+........+.+||+..|.+||.+|
T Consensus       315 AVDWWtfGIflYEmLyG~TPFKG~~~~~T---------------l~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kR  379 (459)
T KOG0610|consen  315 AVDWWTFGIFLYEMLYGTTPFKGSNNKET---------------LRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKR  379 (459)
T ss_pred             hhhHHHHHHHHHHHHhCCCCcCCCCchhh---------------HHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhh
Confidence            99999999999999999999986654331               112223333333444566788999999999999999


Q ss_pred             CC----HHHHHH
Q 041921          783 PT----MKKVLQ  790 (814)
Q Consensus       783 Pt----~~~vl~  790 (814)
                      .-    +.||-+
T Consensus       380 lg~~rGA~eIK~  391 (459)
T KOG0610|consen  380 LGSKRGAAEIKR  391 (459)
T ss_pred             hccccchHHhhc
Confidence            97    677653

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.6e-32  Score=292.21  Aligned_cols=251  Identities=26%  Similarity=0.368  Sum_probs=193.8

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhcc-CCCCccceeeeec-----cccc
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQT-HHKNLVRLLGFCD-----EGQN  592 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~-----~~~~  592 (814)
                      .++.+.+.||+|+||.||++....  .+..+++|.+... .....++.+|+.++.++ +|+||+++++++.     .+..
T Consensus        18 ~~~~~~~~lg~g~~~~vy~~~~~~--~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   94 (286)
T cd06638          18 DTWEIIETIGKGTYGKVFKVLNKK--NGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQ   94 (286)
T ss_pred             cceeeeeeeccCCCcEEEEEEECC--CCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCe
Confidence            345566889999999999998753  5678999987643 22345788999999999 6999999999874     3456


Q ss_pred             ceEEEecCCCCCHHHHhcC----CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCc
Q 041921          593 RLLVYEFLNNGTLASFLFG----NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLA  668 (814)
Q Consensus       593 ~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla  668 (814)
                      .++||||+++++|.+++..    ...+++..+..++.|+++||.|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus        95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~  171 (286)
T cd06638          95 LWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVS  171 (286)
T ss_pred             EEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEccCCce
Confidence            8999999999999998753    35678888999999999999999998   9999999999999999999999999998


Q ss_pred             cccccCCcccccccccCCCCccccccccc-----CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhh
Q 041921          669 KLLTLNQSKTIKTAIRGTKGYVAPEWFRN-----SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR  743 (814)
Q Consensus       669 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  743 (814)
                      ..+......  .....|+..|+|||.+..     ..++.++|||||||++|||++|+.|+........  +    .. ..
T Consensus       172 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~--~----~~-~~  242 (286)
T cd06638         172 AQLTSTRLR--RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA--L----FK-IP  242 (286)
T ss_pred             eecccCCCc--cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH--H----hh-cc
Confidence            866432211  133458999999998853     4578899999999999999999999864432110  0    00 00


Q ss_pred             cCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          744 NGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       744 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                      ........       .+......+.+++.+||+.+|.+|||+.|+++.
T Consensus       243 ~~~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         243 RNPPPTLH-------QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             ccCCCccc-------CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            11000000       111134568899999999999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.6e-32  Score=292.14  Aligned_cols=245  Identities=25%  Similarity=0.360  Sum_probs=199.0

Q ss_pred             ccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEecCCCC
Q 041921          524 KEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNG  603 (814)
Q Consensus       524 ~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  603 (814)
                      -+.||+|++|.||++....  .+..+++|++........+.+.+|+.+++.++|+||+++++++...+..++++||++++
T Consensus        24 ~~~lg~g~~g~v~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~  101 (285)
T cd06648          24 FVKIGEGSTGIVCIATDKS--TGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGG  101 (285)
T ss_pred             ceEeccCCCeEEEEEEECC--CCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCC
Confidence            3589999999999998653  56789999986554445567899999999999999999999999999999999999999


Q ss_pred             CHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcccccccc
Q 041921          604 TLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAI  683 (814)
Q Consensus       604 sL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~  683 (814)
                      +|.+++.. ..+++..+..++.|++.||+|||+.   +|+||||+|+||+++.++.++|+|||++.........  ....
T Consensus       102 ~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~--~~~~  175 (285)
T cd06648         102 ALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR--RKSL  175 (285)
T ss_pred             CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc--cccc
Confidence            99999877 5688999999999999999999998   9999999999999999999999999988755432211  1234


Q ss_pred             cCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCcHHH
Q 041921          684 RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIEC  763 (814)
Q Consensus       684 ~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  763 (814)
                      .|+..|+|||.+.+..++.++||||||++++||++|+.||........       ......+....     .  ......
T Consensus       176 ~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~-------~~~~~~~~~~~-----~--~~~~~~  241 (285)
T cd06648         176 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA-------MKRIRDNLPPK-----L--KNLHKV  241 (285)
T ss_pred             cCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH-------HHHHHhcCCCC-----C--cccccC
Confidence            588999999999888899999999999999999999999864332111       11111111100     0  011124


Q ss_pred             HHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          764 LGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       764 ~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      ...+.+++.+||+.+|.+|||+.++++
T Consensus       242 ~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         242 SPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             CHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            467899999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.5e-32  Score=287.34  Aligned_cols=247  Identities=25%  Similarity=0.370  Sum_probs=198.8

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEeccc--cccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEe
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV--FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE  598 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  598 (814)
                      |.+.+.||+|++|.||++....  .+..++||.+...  .....+.+.+|++++++++||||+++++.+..++..++|+|
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08220           2 YEKIRVVGRGAFGIVHLCRRKA--DQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME   79 (256)
T ss_pred             ceEEEEecccCceEEEEEEEcC--CCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence            5567899999999999998653  5788999998643  22345678999999999999999999999998999999999


Q ss_pred             cCCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC-CcEEEeecCCccccccCC
Q 041921          599 FLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDY-YTARISDFGLAKLLTLNQ  675 (814)
Q Consensus       599 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~-~~~kl~DfGla~~~~~~~  675 (814)
                      |+++++|.+++...  ..+++..+..++.|++++|+|||+.   +++|+||+|+||+++++ ..+||+|||++.......
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence            99999999999764  4578899999999999999999998   99999999999999854 468999999998765432


Q ss_pred             cccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcc
Q 041921          676 SKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDK  755 (814)
Q Consensus       676 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  755 (814)
                      ..   ....++..|+|||.+.....+.++||||||+++++|++|+.||........      +... ..+....      
T Consensus       157 ~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~------~~~~-~~~~~~~------  220 (256)
T cd08220         157 KA---YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL------VLKI-MSGTFAP------  220 (256)
T ss_pred             cc---cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH------HHHH-HhcCCCC------
Confidence            21   234578899999999988899999999999999999999999865432211      1111 1111110      


Q ss_pred             cccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          756 EAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       756 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                         ........+.+++.+||+.+|.+|||+.++++.
T Consensus       221 ---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         221 ---ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             ---CCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence               111245678899999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.8e-32  Score=292.80  Aligned_cols=251  Identities=25%  Similarity=0.348  Sum_probs=202.0

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEe
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE  598 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  598 (814)
                      .++.+.+.||+|+||.||++....  ++..|++|.+........+.+.+|+.++++++||||+++++++...+..++|+|
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~--~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e   96 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVA--TGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME   96 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcC--CCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence            355667889999999999998543  467899999865444455678999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccc
Q 041921          599 FLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT  678 (814)
Q Consensus       599 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  678 (814)
                      |+++++|.+++... .+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||++......... 
T Consensus        97 ~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~-  171 (293)
T cd06647          97 YLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-  171 (293)
T ss_pred             cCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccccccc-
Confidence            99999999998654 478889999999999999999998   9999999999999999999999999998765543221 


Q ss_pred             ccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCccccc
Q 041921          679 IKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAM  758 (814)
Q Consensus       679 ~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  758 (814)
                       .....++..|+|||.+....++.++||||||+++||+++|+.||..........      ....        .......
T Consensus       172 -~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~------~~~~--------~~~~~~~  236 (293)
T cd06647         172 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIAT--------NGTPELQ  236 (293)
T ss_pred             -cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee------ehhc--------CCCCCCC
Confidence             133458889999999988889999999999999999999999997543321100      0000        0011111


Q ss_pred             CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          759 NDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       759 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                      ........+.+++.+||+.+|.+||++.++++.
T Consensus       237 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         237 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            122234578899999999999999999999865

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.7e-32  Score=289.00  Aligned_cols=253  Identities=25%  Similarity=0.387  Sum_probs=199.9

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc------cchHhHHHHHHhhhccCCCCccceeeeecccccce
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ------DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRL  594 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  594 (814)
                      +...+.||+|++|.||++...  .++..+|+|.+.....      ...+.+..|+.++++++|+||+++++++.+.+..+
T Consensus         2 ~~~~~~lg~g~~~~v~~~~~~--~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (268)
T cd06630           2 WLKGQQLGTGAFSSCYQARDV--KTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFN   79 (268)
T ss_pred             ccccceecCcCceEEEEEEEc--CCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEE
Confidence            345678999999999999864  3577899998864321      12357899999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC-cEEEeecCCcccccc
Q 041921          595 LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYY-TARISDFGLAKLLTL  673 (814)
Q Consensus       595 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~-~~kl~DfGla~~~~~  673 (814)
                      +|+||+++++|.+++.....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++ .+||+|||++.....
T Consensus        80 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~  156 (268)
T cd06630          80 LFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA  156 (268)
T ss_pred             EEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence            9999999999999998877889999999999999999999998   999999999999998775 599999999877654


Q ss_pred             CCcc--cccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceee
Q 041921          674 NQSK--TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLV  751 (814)
Q Consensus       674 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  751 (814)
                      ....  .......++..|+|||.+.+..++.++||||+|++++||++|..||..........   ...+......     
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~---~~~~~~~~~~-----  228 (268)
T cd06630         157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLA---LIFKIASATT-----  228 (268)
T ss_pred             ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHH---HHHHHhccCC-----
Confidence            3211  11123457889999999988889999999999999999999999986433211111   1111100000     


Q ss_pred             cCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          752 GEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       752 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                          ....+......+.+++.+|++.+|.+|||+.++++
T Consensus       229 ----~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         229 ----APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             ----CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence                01112234567889999999999999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-32  Score=290.13  Aligned_cols=247  Identities=24%  Similarity=0.369  Sum_probs=197.4

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc-ccchHhHHHHHHhhhccC---CCCccceeeeecccccceEE
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQTH---HKNLVRLLGFCDEGQNRLLV  596 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv  596 (814)
                      |.+.+.||+|+||.||+|....  .+..+++|.+.... .....++.+|+.++++++   |||++++++++.++...++|
T Consensus         3 y~~~~~l~~g~~g~v~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv   80 (277)
T cd06917           3 YQRLELIGRGAYGAVYRGKHVP--TGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII   80 (277)
T ss_pred             hhhhhheeccCCceEEEEEEcC--CCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence            4556789999999999999753  56789999886432 334457889999999986   99999999999999999999


Q ss_pred             EecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCc
Q 041921          597 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS  676 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  676 (814)
                      |||+++++|.+++... .+++.....++.|++.||.|||+.   +|+|+||+|+||++++++.++|+|||++..+.....
T Consensus        81 ~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06917          81 MEYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS  156 (277)
T ss_pred             EecCCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence            9999999999998654 688999999999999999999998   999999999999999999999999999987654332


Q ss_pred             ccccccccCCCCcccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcc
Q 041921          677 KTIKTAIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDK  755 (814)
Q Consensus       677 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  755 (814)
                      .  .....|+..|+|||.+.++ .++.++||||||+++|||++|+.||.........       ..+.....     +..
T Consensus       157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~-------~~~~~~~~-----~~~  222 (277)
T cd06917         157 K--RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM-------MLIPKSKP-----PRL  222 (277)
T ss_pred             c--cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh-------hccccCCC-----CCC
Confidence            1  1334688999999988654 5688999999999999999999999754321110       00011100     011


Q ss_pred             cccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          756 EAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       756 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      .   ......++.+++.+||+.+|.+||++.++++
T Consensus       223 ~---~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         223 E---DNGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             C---cccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            1   1114467889999999999999999999976

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.6e-32  Score=288.91  Aligned_cols=255  Identities=25%  Similarity=0.395  Sum_probs=202.6

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEe
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE  598 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  598 (814)
                      .+.+.+.||.|+||+||+|....  ++..+++|++.... ....+.+.+|+++++.++|+||+++++.+..++..++|+|
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   79 (267)
T cd06610           2 DYELIEVIGVGATAVVYAAICLP--NNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP   79 (267)
T ss_pred             cceeeeeecCCCCeEEEEEEEcC--CCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence            35677899999999999998653  56789999986432 2345679999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhcCC---CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCC
Q 041921          599 FLNNGTLASFLFGN---LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ  675 (814)
Q Consensus       599 ~~~~gsL~~~l~~~---~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~  675 (814)
                      ++++++|.+++...   ..+++.....++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++..+....
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~  156 (267)
T cd06610          80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG  156 (267)
T ss_pred             ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence            99999999999753   4588999999999999999999998   99999999999999999999999999998765433


Q ss_pred             ccc--ccccccCCCCcccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeec
Q 041921          676 SKT--IKTAIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVG  752 (814)
Q Consensus       676 ~~~--~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  752 (814)
                      ...  ......++..|+|||.+... .++.++|+||||++++||++|+.||......+.      ..+.... ....+ .
T Consensus       157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~------~~~~~~~-~~~~~-~  228 (267)
T cd06610         157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV------LMLTLQN-DPPSL-E  228 (267)
T ss_pred             cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh------HHHHhcC-CCCCc-C
Confidence            221  12334588999999998877 789999999999999999999999975433211      1111111 10000 0


Q ss_pred             CcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          753 EDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       753 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                         ...........+.+++.+|++.+|++|||++++++
T Consensus       229 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         229 ---TGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             ---CccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence               00011234577889999999999999999999986

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2.3e-32  Score=289.61  Aligned_cols=248  Identities=26%  Similarity=0.377  Sum_probs=199.2

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEe
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE  598 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  598 (814)
                      .+.+.++||+|+||.||+|....  .+..+|||.+.... ....+.+.+|+.++.+++||||+++++++.++...++|||
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   82 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNR--TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME   82 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECC--CCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence            44566789999999999998643  56789999876432 2334568899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccc
Q 041921          599 FLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT  678 (814)
Q Consensus       599 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  678 (814)
                      |+++++|.+++.. ..+++.....++.|++.++.|||+.   +++|+||+|+||+++.++.++|+|||++..+...... 
T Consensus        83 ~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~-  157 (277)
T cd06641          83 YLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-  157 (277)
T ss_pred             eCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchhh-
Confidence            9999999999864 4578999999999999999999998   9999999999999999999999999998765432211 


Q ss_pred             ccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCccccc
Q 041921          679 IKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAM  758 (814)
Q Consensus       679 ~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  758 (814)
                       .....++..|+|||.+.+..++.++|+||||++++||++|..|+........       ...+..+....         
T Consensus       158 -~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-------~~~~~~~~~~~---------  220 (277)
T cd06641         158 -RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKV-------LFLIPKNNPPT---------  220 (277)
T ss_pred             -hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHH-------HHHHhcCCCCC---------
Confidence             1234578899999999888899999999999999999999999864332111       11111111100         


Q ss_pred             CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          759 NDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       759 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                      ........+.+++.+|++.+|.+||+++++++.
T Consensus       221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         221 LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            112234668899999999999999999999984

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=3.4e-32  Score=288.50  Aligned_cols=243  Identities=24%  Similarity=0.258  Sum_probs=188.6

Q ss_pred             ceeeeeeeeEEEEEEecCCCceEEEEEEeccccc---cchHhHHHHHHhhh---ccCCCCccceeeeecccccceEEEec
Q 041921          526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ---DGEREFKNEVFVIG---QTHHKNLVRLLGFCDEGQNRLLVYEF  599 (814)
Q Consensus       526 ~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~---~l~h~niv~l~~~~~~~~~~~lv~e~  599 (814)
                      .||+|+||.||++....  .+..+|+|.+.....   .....+.+|..++.   ..+||||+.+.+++..++..++||||
T Consensus         1 ~lg~G~~g~Vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~   78 (279)
T cd05633           1 IIGRGGFGEVYGCRKAD--TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDL   78 (279)
T ss_pred             CcccCCCeEEEEEEECC--CCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEec
Confidence            48999999999998653  577999998864321   11223444544333   34799999999999999999999999


Q ss_pred             CCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcccc
Q 041921          600 LNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI  679 (814)
Q Consensus       600 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  679 (814)
                      +++++|.+++.....+++.....++.|++.||.|||+.   +|+|+||||+||+++.++.++|+|||++........   
T Consensus        79 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~---  152 (279)
T cd05633          79 MNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---  152 (279)
T ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc---
Confidence            99999999998888899999999999999999999998   999999999999999999999999999875532211   


Q ss_pred             cccccCCCCccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCccccc
Q 041921          680 KTAIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAM  758 (814)
Q Consensus       680 ~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  758 (814)
                       ....|+..|+|||.+.+ ..++.++||||||++++||++|+.||..........+    .......      ..    .
T Consensus       153 -~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~----~~~~~~~------~~----~  217 (279)
T cd05633         153 -HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTLTV------NV----E  217 (279)
T ss_pred             -cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHH----HHHhhcC------Cc----C
Confidence             23458999999999864 5688999999999999999999999975433221111    1110000      00    1


Q ss_pred             CcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 041921          759 NDIECLGKLVMVSIWCIQEDPSLRP-----TMKKVLQM  791 (814)
Q Consensus       759 ~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~~vl~~  791 (814)
                      .+.....++.+++.+||+.||.+||     |++++++.
T Consensus       218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            1223456788999999999999999     69999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.1e-32  Score=291.20  Aligned_cols=261  Identities=22%  Similarity=0.306  Sum_probs=199.7

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEe
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE  598 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  598 (814)
                      |.+.+.||+|++|.||+|....  .+..|+||++....  ......+.+|+.++++++|+||+++++++..+...++|+|
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e   79 (286)
T cd07832           2 YKILGRIGEGAHGIVFKAKDRE--TGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME   79 (286)
T ss_pred             ceEEeecccCCCcEEEEEEECC--CCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence            5677899999999999999753  47789999986543  2334678999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcc
Q 041921          599 FLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSK  677 (814)
Q Consensus       599 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  677 (814)
                      |+ +++|.+++.. ...+++..+..++.||++||+|||+.   +++|+||||+||+++.++.++|+|||++.........
T Consensus        80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~  155 (286)
T cd07832          80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR  155 (286)
T ss_pred             cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence            99 9999999865 35689999999999999999999998   9999999999999999999999999999876543221


Q ss_pred             cccccccCCCCcccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCc----------
Q 041921          678 TIKTAIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK----------  746 (814)
Q Consensus       678 ~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----------  746 (814)
                       ......++..|+|||.+.+. .++.++||||+|++++||++|+.+|......+.   ...+...+....          
T Consensus       156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07832         156 -LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ---LAIVFRTLGTPNEETWPGLTSL  231 (286)
T ss_pred             -ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHH---HHHHHHHcCCCChHHHhhccCc
Confidence             11334588999999998654 468999999999999999999877764432111   011111111000          


Q ss_pred             --cceeecCccc----ccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          747 --LNVLVGEDKE----AMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       747 --~~~~~~~~~~----~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                        ...+..+...    .....+....+.+++.+||+.+|.+|||++++++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             chhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence              0000000000    00011234788999999999999999999999863

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.7e-32  Score=292.61  Aligned_cols=242  Identities=26%  Similarity=0.289  Sum_probs=199.8

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEE
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY  597 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  597 (814)
                      |.+.+.||+|++|.||++....  .++.+|+|.+....   ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus         3 y~~~~~ig~g~~~~vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           3 FEFIKTLGTGSFGRVMLVRHKG--SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             eEEEEEeecCCCeEEEEEEEcC--CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            5677899999999999999764  56889999986432   223456889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcc
Q 041921          598 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSK  677 (814)
Q Consensus       598 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  677 (814)
                      ||+++++|.+++.....++...+..++.|+++||.|||+.   +|+|+||+|+||+++.++.+||+|||++.......  
T Consensus        81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~--  155 (290)
T cd05580          81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT--  155 (290)
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCCC--
Confidence            9999999999998888899999999999999999999998   99999999999999999999999999998765431  


Q ss_pred             cccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccc
Q 041921          678 TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEA  757 (814)
Q Consensus       678 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  757 (814)
                         ....+++.|+|||.+.+...+.++||||||++++||++|+.||.......       .......+...         
T Consensus       156 ---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~---------  216 (290)
T cd05580         156 ---YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ-------IYEKILEGKVR---------  216 (290)
T ss_pred             ---CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHhcCCcc---------
Confidence               33458899999999988888999999999999999999999997543211       11111122111         


Q ss_pred             cCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHH
Q 041921          758 MNDIECLGKLVMVSIWCIQEDPSLRP-----TMKKVL  789 (814)
Q Consensus       758 ~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~~vl  789 (814)
                       .+......+.+++.+||+.+|.+||     +++|++
T Consensus       217 -~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~  252 (290)
T cd05580         217 -FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK  252 (290)
T ss_pred             -CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence             0112246788999999999999999     667666

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2.8e-32  Score=291.16  Aligned_cols=249  Identities=26%  Similarity=0.380  Sum_probs=193.9

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhcc-CCCCccceeeeeccc-----ccc
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEG-----QNR  593 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-----~~~  593 (814)
                      .+.+.+.||+|+||.||++....  +++.+|+|.+... .....++.+|+.++.++ +|||++++++++...     ...
T Consensus        23 ~y~~~~~l~~g~~~~vy~~~~~~--~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~   99 (291)
T cd06639          23 TWEIIETIGKGTYGKVYKVTNKK--DGSLAAVKILDPI-SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL   99 (291)
T ss_pred             CeEEEEEeecCCCeEEEEEEECC--CCCEEEEEEeccc-ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCee
Confidence            34556789999999999998753  5778999988643 22345678899999998 899999999998653     357


Q ss_pred             eEEEecCCCCCHHHHhcC----CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcc
Q 041921          594 LLVYEFLNNGTLASFLFG----NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAK  669 (814)
Q Consensus       594 ~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~  669 (814)
                      ++|+||+++++|.+++..    ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++.
T Consensus       100 ~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~dfg~~~  176 (291)
T cd06639         100 WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSA  176 (291)
T ss_pred             EEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEeecccch
Confidence            999999999999998853    35688999999999999999999998   99999999999999999999999999988


Q ss_pred             ccccCCcccccccccCCCCcccccccccC-----CCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhc
Q 041921          670 LLTLNQSKTIKTAIRGTKGYVAPEWFRNS-----KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN  744 (814)
Q Consensus       670 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  744 (814)
                      .........  ....++..|+|||.+...     .++.++|||||||++|||++|+.||........  +    .. +..
T Consensus       177 ~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~--~----~~-~~~  247 (291)
T cd06639         177 QLTSTRLRR--NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT--L----FK-IPR  247 (291)
T ss_pred             hcccccccc--cCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH--H----HH-Hhc
Confidence            654322111  234588899999998643     368899999999999999999999875432111  1    11 111


Q ss_pred             CccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          745 GKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       745 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      +....+.       ...+....+.+++.+|++.+|++||++.++++
T Consensus       248 ~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         248 NPPPTLL-------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             CCCCCCC-------cccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            1111111       11223457889999999999999999999986

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-33  Score=297.42  Aligned_cols=240  Identities=26%  Similarity=0.340  Sum_probs=196.2

Q ss_pred             cceeeeeeeeEEEEEEecCCCceEEEEEEeccccccc---hHhHHHHHHhhhccCCCCccceeeeecccccceEEEecCC
Q 041921          525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG---EREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLN  601 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  601 (814)
                      ++||+|.||.||-|....  ....||||++.-...+.   -.++..|+..|.+++|||+|.+.|++..+...+||||||-
T Consensus        32 rEIGHGSFGAVYfArd~~--n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYCl  109 (948)
T KOG0577|consen   32 REIGHGSFGAVYFARDVR--NSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCL  109 (948)
T ss_pred             HHhcCCccceeEEeeccC--ccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHh
Confidence            579999999999998653  56799999996433322   2468999999999999999999999999999999999994


Q ss_pred             CCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccccc
Q 041921          602 NGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIK  680 (814)
Q Consensus       602 ~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  680 (814)
                       ||-.++|.- .+++.+.++..|..+.++||+|||+.   +.||||||+.|||+++.|.|||+|||.+..+.+.      
T Consensus       110 -GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA------  179 (948)
T KOG0577|consen  110 -GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA------  179 (948)
T ss_pred             -ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCch------
Confidence             477777753 46778889999999999999999998   9999999999999999999999999999876643      


Q ss_pred             ccccCCCCcccccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccc
Q 041921          681 TAIRGTKGYVAPEWFR---NSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEA  757 (814)
Q Consensus       681 ~~~~gt~~y~aPE~~~---~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  757 (814)
                      ..++||+.|||||++.   .+.|+-|+||||||+.-.||.-.++|+........       .-.+...       +. ..
T Consensus       180 nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA-------LYHIAQN-------es-Pt  244 (948)
T KOG0577|consen  180 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-------LYHIAQN-------ES-PT  244 (948)
T ss_pred             hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHH-------HHHHHhc-------CC-CC
Confidence            4578999999999884   56899999999999999999999999754332110       0001111       11 11


Q ss_pred             cCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          758 MNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       758 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                      ....+..+.++.++..||++-|.+|||.+++++.
T Consensus       245 Lqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  245 LQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             CCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence            1245778899999999999999999999998764

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-32  Score=291.61  Aligned_cols=261  Identities=20%  Similarity=0.310  Sum_probs=194.0

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc-cchHhHHHHHHhhhccCCCCccceeeeecccccceEEEe
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE  598 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  598 (814)
                      .+.+.+.||+|++|.||+|....  .+..||||.+..... .....+.+|++++++++|+||+++++++.+++..++|||
T Consensus         6 ~y~~~~~lg~g~~~~vy~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (291)
T cd07844           6 TYKKLDKLGEGSYATVYKGRSKL--TGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE   83 (291)
T ss_pred             ceeEEEEEeecCCeEEEEEEEcC--CCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence            45667899999999999998653  567899999864322 223457789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcc
Q 041921          599 FLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSK  677 (814)
Q Consensus       599 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  677 (814)
                      |+++ +|.+++... ..+++.....++.|+++||.|||+.   +|+|+||||+||+++.++.+||+|||+++........
T Consensus        84 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~  159 (291)
T cd07844          84 YLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT  159 (291)
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCCcc
Confidence            9985 899988754 4678899999999999999999998   9999999999999999999999999998754322111


Q ss_pred             cccccccCCCCccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcC---cc------
Q 041921          678 TIKTAIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG---KL------  747 (814)
Q Consensus       678 ~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~------  747 (814)
                        .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.........  ...+.+.....   ..      
T Consensus       160 --~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  235 (291)
T cd07844         160 --YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQ--LHKIFRVLGTPTEETWPGVSSN  235 (291)
T ss_pred             --ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH--HHHHHHhcCCCChhhhhhhhhc
Confidence              122346789999998865 45789999999999999999999999644321110  01111111000   00      


Q ss_pred             ---cee----ecCc-c-cccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          748 ---NVL----VGED-K-EAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       748 ---~~~----~~~~-~-~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                         ...    .... . ...........+.+++.+||+.+|.+|||+.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence               000    0000 0 00001112267789999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.6e-33  Score=301.98  Aligned_cols=261  Identities=23%  Similarity=0.272  Sum_probs=191.4

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc--cchHhHHHHHHhhhccCCCCccceeeeeccc------
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ--DGEREFKNEVFVIGQTHHKNLVRLLGFCDEG------  590 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  590 (814)
                      ..|.+.+.||+|+||.||+|....  .+..||||++.....  ...+.+.+|+.++++++||||+++++++...      
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07878          15 ERYQNLTPVGSGAYGSVCSAYDTR--LRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF   92 (343)
T ss_pred             hhhhhheecccCCCeEEEEEEECC--CCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence            345667889999999999998653  567899999864321  2335678899999999999999999987543      


Q ss_pred             ccceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccc
Q 041921          591 QNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKL  670 (814)
Q Consensus       591 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~  670 (814)
                      ...++++|++ +++|.+++.. ..+++..+..++.||++||.|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus        93 ~~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~  167 (343)
T cd07878          93 NEVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQ  167 (343)
T ss_pred             CcEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCcccee
Confidence            3468999987 7799887754 4688999999999999999999998   999999999999999999999999999986


Q ss_pred             cccCCcccccccccCCCCccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhh-hHHHH-------HHHH
Q 041921          671 LTLNQSKTIKTAIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA-ILTDW-------AFDC  741 (814)
Q Consensus       671 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~-~~~~~-------~~~~  741 (814)
                      .....     ....||..|+|||++.+ ..++.++|||||||+++||++|+.||......... .+...       ....
T Consensus       168 ~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (343)
T cd07878         168 ADDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKK  242 (343)
T ss_pred             cCCCc-----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            54321     33468999999999876 56889999999999999999999999654321110 00000       0000


Q ss_pred             hhcCccceeecCcccccC------cHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          742 YRNGKLNVLVGEDKEAMN------DIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       742 ~~~~~~~~~~~~~~~~~~------~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                      +.................      .......+.+++.+||+.||.+|||+.++++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         243 ISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             cchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            000000000000000000      00112357799999999999999999999853

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2.6e-32  Score=293.78  Aligned_cols=245  Identities=25%  Similarity=0.321  Sum_probs=194.4

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc---cchHhHHHHHHhhhccCCCCccceeeeecccccceEE
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ---DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV  596 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  596 (814)
                      .+.+.++||+|+||.||+|....  .++.|++|.+.....   +..+++.+|+++++.++||||+++.+++.+.+..++|
T Consensus        16 ~y~~~~~lg~g~~g~vy~~~~~~--~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv   93 (307)
T cd06607          16 LFTDLREIGHGSFGAVYFARDVR--TNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV   93 (307)
T ss_pred             hhhhheeecCCCCeEEEEEEEcC--CCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence            35667889999999999998753  567899998864322   2335688999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCC
Q 041921          597 YEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ  675 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~  675 (814)
                      +||++ |+|.+++.. ...+++..+..++.|++.||.|||+.   +|+|+||+|+||++++++.+||+|||++...... 
T Consensus        94 ~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-  168 (307)
T cd06607          94 MEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-  168 (307)
T ss_pred             HHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence            99997 577666653 45689999999999999999999998   9999999999999999999999999998765432 


Q ss_pred             cccccccccCCCCcccccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeec
Q 041921          676 SKTIKTAIRGTKGYVAPEWFR---NSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVG  752 (814)
Q Consensus       676 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  752 (814)
                           ....++..|+|||.+.   ...++.++||||||+++|||++|+.||........      ... ......     
T Consensus       169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~------~~~-~~~~~~-----  231 (307)
T cd06607         169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYH-IAQNDS-----  231 (307)
T ss_pred             -----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH------HHH-HhcCCC-----
Confidence                 2345788999999874   45688899999999999999999999864332111      011 111100     


Q ss_pred             CcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          753 EDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       753 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                         ...........+.+++.+||+.+|.+||++.++++.
T Consensus       232 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         232 ---PTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             ---CCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence               001122345678999999999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.5e-32  Score=288.28  Aligned_cols=254  Identities=26%  Similarity=0.319  Sum_probs=197.9

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc-cchHhHHHHHHhhhccCCCCccceeeeeccc--ccceEEE
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEG--QNRLLVY  597 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  597 (814)
                      +.+.++||.|++|.||++....  .+..+|+|.+..... ....++.+|++++++++||||+++++++.+.  ...++||
T Consensus         3 ~~~~~~lg~g~~~~v~~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           3 IVELSRLGEGAGGSVTKCRLKN--TGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             eEEEEEeccCCceEEEEEEECC--CCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            3456789999999999999763  578899998864322 3456789999999999999999999988553  4679999


Q ss_pred             ecCCCCCHHHHhcC----CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcccccc
Q 041921          598 EFLNNGTLASFLFG----NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTL  673 (814)
Q Consensus       598 e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~  673 (814)
                      ||+++++|.+++..    ...++......++.|+++||+|||+.   +++|+||+|+||++++++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            99999999988753    34578889999999999999999998   999999999999999999999999999875543


Q ss_pred             CCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccch--hhhhHHHHHHHHhhcCccceee
Q 041921          674 NQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGE--EYAILTDWAFDCYRNGKLNVLV  751 (814)
Q Consensus       674 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  751 (814)
                      ...    ....++..|+|||.+.+..++.++||||||+++|||++|+.||......  .......+    ........+.
T Consensus       158 ~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~  229 (287)
T cd06621         158 SLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSY----IVNMPNPELK  229 (287)
T ss_pred             ccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHH----HhcCCchhhc
Confidence            221    2344788999999999889999999999999999999999999755321  11111111    1111111111


Q ss_pred             cCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          752 GEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       752 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      ..   ..........+.+++.+||+.+|++|||+.|+++
T Consensus       230 ~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         230 DE---PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             cC---CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            10   0111234577899999999999999999999987

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.9e-32  Score=291.00  Aligned_cols=249  Identities=24%  Similarity=0.373  Sum_probs=193.7

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhcc-CCCCccceeeeecc------cc
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQT-HHKNLVRLLGFCDE------GQ  591 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~------~~  591 (814)
                      ..+.+.+.||+|+||.||+|....  .++.+|+|.+... .....++..|+.++.++ +|+||+++++++..      ..
T Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~--~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   92 (282)
T cd06636          16 GIFELVEVVGNGTYGQVYKGRHVK--TGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDD   92 (282)
T ss_pred             hhhhhheeeccCCCeEEEEEEEcC--CCcEEEEEEEecC-hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCC
Confidence            345566899999999999999753  5678999988643 23345688899999998 79999999999853      45


Q ss_pred             cceEEEecCCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcc
Q 041921          592 NRLLVYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAK  669 (814)
Q Consensus       592 ~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~  669 (814)
                      ..+++|||+++++|.+++...  ..+++..+..++.|++.||.|||+.   +|+|+||+|+||++++++.++|+|||++.
T Consensus        93 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~dfg~~~  169 (282)
T cd06636          93 QLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA  169 (282)
T ss_pred             EEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence            679999999999999999653  4577888899999999999999998   99999999999999999999999999987


Q ss_pred             ccccCCcccccccccCCCCcccccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhc
Q 041921          670 LLTLNQSKTIKTAIRGTKGYVAPEWFR-----NSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN  744 (814)
Q Consensus       670 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  744 (814)
                      ........  .....|+..|+|||.+.     ...++.++||||||+++|||++|+.||.........      .. ...
T Consensus       170 ~~~~~~~~--~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~------~~-~~~  240 (282)
T cd06636         170 QLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL------FL-IPR  240 (282)
T ss_pred             hhhccccC--CCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh------hh-Hhh
Confidence            65432211  13345889999999885     346788999999999999999999999643321110      00 000


Q ss_pred             CccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          745 GKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       745 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      ..        ............+.+++.+||+.||.+|||+.++++
T Consensus       241 ~~--------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         241 NP--------PPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             CC--------CCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            00        000111234567899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=3.7e-32  Score=290.20  Aligned_cols=261  Identities=20%  Similarity=0.263  Sum_probs=192.6

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEe
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE  598 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  598 (814)
                      .|.+.+.||+|+||.||+|....  .+..|++|.+.... ......+.+|+.+++.++|+||+++.+++.++...++|+|
T Consensus         6 ~y~~~~~ig~g~~~~v~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e   83 (291)
T cd07870           6 SYLNLEKLGEGSYATVYKGISRI--NGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE   83 (291)
T ss_pred             eeEEEEEEEecCCEEEEEEEEcC--CCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence            35567889999999999998753  46789999986433 2223467889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcc
Q 041921          599 FLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSK  677 (814)
Q Consensus       599 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  677 (814)
                      |+. ++|.+++.. ...+.+.....++.|++.||.|||+.   +|+|+||||+||+++.++++||+|||+++........
T Consensus        84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  159 (291)
T cd07870          84 YMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT  159 (291)
T ss_pred             ccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC
Confidence            996 677666654 35577888889999999999999998   9999999999999999999999999998754322111


Q ss_pred             cccccccCCCCcccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhc------------
Q 041921          678 TIKTAIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN------------  744 (814)
Q Consensus       678 ~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------------  744 (814)
                        .....++..|+|||.+.+. .++.++||||||++++||++|+.||......... +.+ ++..+..            
T Consensus       160 --~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~  235 (291)
T cd07870         160 --YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQ-LEK-IWTVLGVPTEDTWPGVSKL  235 (291)
T ss_pred             --CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHH-HHH-HHHHcCCCChhhhhhhhhc
Confidence              1233478899999998754 5788999999999999999999999754332111 100 1110000            


Q ss_pred             -CccceeecCccc-----ccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          745 -GKLNVLVGEDKE-----AMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       745 -~~~~~~~~~~~~-----~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                       ............     ..........+.+++.+|++.||++|||+.+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence             000000000000     0001112457788999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.3e-32  Score=298.94  Aligned_cols=199  Identities=29%  Similarity=0.405  Sum_probs=171.3

Q ss_pred             HhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccC-C-----CCccceeeeecccc
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTH-H-----KNLVRLLGFCDEGQ  591 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~  591 (814)
                      .-+|.+.+.||+|.||.|-||...  ..++.||||.+++. ..-.++...|+.+|..++ |     -|+|++++++...+
T Consensus       185 ~~rY~V~e~LGkGtFGQVvk~~d~--~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~  261 (586)
T KOG0667|consen  185 AYRYEVLEVLGKGSFGQVVKAYDH--KTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN  261 (586)
T ss_pred             EEEEEEEEEecccccceeEEEEec--CCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc
Confidence            337888999999999999999965  46789999999864 233456788999999996 4     38999999999999


Q ss_pred             cceEEEecCCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC--CCcEEEeecCC
Q 041921          592 NRLLVYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDD--YYTARISDFGL  667 (814)
Q Consensus       592 ~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~--~~~~kl~DfGl  667 (814)
                      |.|||+|.+ ..+|.++|+.+  ..++....+.|+.||+.||.+||+.   +|||+||||+||||.+  ...+||+|||.
T Consensus       262 HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGS  337 (586)
T KOG0667|consen  262 HLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGS  337 (586)
T ss_pred             ceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccc
Confidence            999999998 55999999876  5678999999999999999999998   9999999999999974  34799999999


Q ss_pred             ccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccc
Q 041921          668 AKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMG  728 (814)
Q Consensus       668 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~  728 (814)
                      +.......     ....-+.-|.|||++.+.+|+.+.||||||||+.||++|...|.+...
T Consensus       338 Sc~~~q~v-----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne  393 (586)
T KOG0667|consen  338 SCFESQRV-----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE  393 (586)
T ss_pred             ccccCCcc-----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence            98655332     234467889999999999999999999999999999999888876544

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-32  Score=287.96  Aligned_cols=250  Identities=26%  Similarity=0.383  Sum_probs=196.7

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhcc-CCCCccceeeeecccc------
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQ------  591 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~------  591 (814)
                      ..+.+.+.||+|++|.||+|....  .++.+++|.+.... ...+++.+|+.+++++ +|+||+++++++.+..      
T Consensus         6 ~~y~~~~~l~~g~~~~v~~~~~~~--~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           6 GIFELVEVIGEGTYGKVYKARHKK--TGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             hheeheeeecCCCCeEEEEEEECC--CCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            456677899999999999999753  46789999886543 3456799999999999 7999999999996644      


Q ss_pred             cceEEEecCCCCCHHHHhcC----CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCC
Q 041921          592 NRLLVYEFLNNGTLASFLFG----NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGL  667 (814)
Q Consensus       592 ~~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGl  667 (814)
                      ..++||||+++++|.+++..    ...+++..+..++.|+++||.|||+.   +++|+||+|+||++++++.+||+|||+
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~  159 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGV  159 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCcc
Confidence            48999999999999998864    35688999999999999999999998   999999999999999999999999999


Q ss_pred             ccccccCCcccccccccCCCCccccccccc-----CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHh
Q 041921          668 AKLLTLNQSKTIKTAIRGTKGYVAPEWFRN-----SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY  742 (814)
Q Consensus       668 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  742 (814)
                      +.........  .....++..|+|||.+..     ..++.++||||||++++||++|+.||.......  .+    .+ .
T Consensus       160 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~----~~-~  230 (275)
T cd06608         160 SAQLDSTLGR--RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR--AL----FK-I  230 (275)
T ss_pred             ceecccchhh--hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH--HH----HH-h
Confidence            8765432211  133458899999998753     346789999999999999999999996432211  11    11 1


Q ss_pred             hcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          743 RNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       743 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      ..+..       ............+.+++.+||+.||++|||+.++++
T Consensus       231 ~~~~~-------~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         231 PRNPP-------PTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             hccCC-------CCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            11111       111112235568889999999999999999999986

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2.8e-32  Score=290.46  Aligned_cols=248  Identities=27%  Similarity=0.404  Sum_probs=201.4

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEecC
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL  600 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  600 (814)
                      +.+.+.||+|++|.||+|....  .+..+++|.+..... ..+.+.+|++.+++++|+|++++++++......++|+||+
T Consensus        21 ~~~~~~l~~g~~~~v~~~~~~~--~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   97 (286)
T cd06614          21 YKNLEKIGEGASGEVYKATDRA--TGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYM   97 (286)
T ss_pred             chHhHhccCCCCeEEEEEEEcc--CCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEecc
Confidence            4456789999999999999763  467899999975433 4567899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCC-CCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcccc
Q 041921          601 NNGTLASFLFGNL-KPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI  679 (814)
Q Consensus       601 ~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  679 (814)
                      ++++|.+++.... .+++..+..++.|++.||+|||+.   +|+|+||+|+||+++.++.++|+|||++.........  
T Consensus        98 ~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--  172 (286)
T cd06614          98 DGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK--  172 (286)
T ss_pred             CCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccchhh--
Confidence            9999999998876 889999999999999999999997   9999999999999999999999999988755432211  


Q ss_pred             cccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccC
Q 041921          680 KTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMN  759 (814)
Q Consensus       680 ~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  759 (814)
                      .....++..|+|||.+.+..++.++||||||+++|||++|+.||.........       ..........       ...
T Consensus       173 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~-------~~~~~~~~~~-------~~~  238 (286)
T cd06614         173 RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL-------FLITTKGIPP-------LKN  238 (286)
T ss_pred             hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHHhcCCCC-------Ccc
Confidence            12334788999999998888999999999999999999999998754332110       0011111110       011


Q ss_pred             cHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          760 DIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       760 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      .......+.+++.+|++.+|.+|||+.++++
T Consensus       239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         239 PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             hhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            1124567889999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=5.9e-32  Score=281.52  Aligned_cols=248  Identities=25%  Similarity=0.385  Sum_probs=203.5

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEecC
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL  600 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  600 (814)
                      +...+.||+|++|.||++....  ++..+++|++........+++.+|++.+++++|+|++++++++..+...++++||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~   79 (253)
T cd05122           2 FEILEKIGKGGFGEVYKARHKR--TGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC   79 (253)
T ss_pred             ceeeeeeccCCceEEEEEEECC--CCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence            3456789999999999999753  56789999997655445678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcccc
Q 041921          601 NNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI  679 (814)
Q Consensus       601 ~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  679 (814)
                      ++++|.+++... ..+++..+..++.|++++|.|||+.   +++|+||+|+||++++++.++|+|||.+........   
T Consensus        80 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---  153 (253)
T cd05122          80 SGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---  153 (253)
T ss_pred             CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc---
Confidence            999999999776 6789999999999999999999997   999999999999999999999999999887654432   


Q ss_pred             cccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccC
Q 041921          680 KTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMN  759 (814)
Q Consensus       680 ~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  759 (814)
                      .....++..|+|||.+.....+.++||||||+++++|++|+.|+..........      . ........       ...
T Consensus       154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~------~-~~~~~~~~-------~~~  219 (253)
T cd05122         154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF------K-IATNGPPG-------LRN  219 (253)
T ss_pred             ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHH------H-HHhcCCCC-------cCc
Confidence            133458889999999988889999999999999999999999987543211110      0 00111111       111


Q ss_pred             cHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          760 DIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       760 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      .......+.+++.+|++.+|++|||+.++++
T Consensus       220 ~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         220 PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1122567889999999999999999999886

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.2e-32  Score=286.50  Aligned_cols=247  Identities=25%  Similarity=0.297  Sum_probs=201.3

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEE
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY  597 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  597 (814)
                      +.+.+.||+|+||.||++....  .+..+++|.+....   ....+.+.+|++++++++||||+++++++.++...++|+
T Consensus         2 y~~~~~i~~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   79 (258)
T cd05578           2 FELLRVIGKGAFGKVCIVQKRD--TKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVV   79 (258)
T ss_pred             ceEEEEeccCCCceEEEEEEcc--CCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEE
Confidence            4567899999999999998653  56789999986432   234567999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcc
Q 041921          598 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSK  677 (814)
Q Consensus       598 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  677 (814)
                      ||+++++|.+++.....+++.....++.|+++||.|||+.   +++|+||+|+||++++++.++|+|||++........ 
T Consensus        80 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~-  155 (258)
T cd05578          80 DLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL-  155 (258)
T ss_pred             eCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc-
Confidence            9999999999998777889999999999999999999998   999999999999999999999999999887654321 


Q ss_pred             cccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccc
Q 041921          678 TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEA  757 (814)
Q Consensus       678 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  757 (814)
                        .....++..|+|||.+.+...+.++|+||||+++++|++|+.||..........    .........          .
T Consensus       156 --~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~----------~  219 (258)
T cd05578         156 --TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQ----IRAKQETAD----------V  219 (258)
T ss_pred             --ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHH----HHHHhcccc----------c
Confidence              133458889999999988889999999999999999999999997654321111    111111100          0


Q ss_pred             cCcHHHHHHHHHHHHHccccCCCCCCCH--HHHH
Q 041921          758 MNDIECLGKLVMVSIWCIQEDPSLRPTM--KKVL  789 (814)
Q Consensus       758 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~--~~vl  789 (814)
                      ..+...+..+.+++.+||+.+|.+||++  +|++
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         220 LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             cCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            1112234788899999999999999999  5543

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-32  Score=288.99  Aligned_cols=259  Identities=24%  Similarity=0.279  Sum_probs=197.5

Q ss_pred             ccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeeccc--ccceEEE
Q 041921          522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEG--QNRLLVY  597 (814)
Q Consensus       522 ~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  597 (814)
                      .+.++||+|++|.||+|....  .+..+++|++....  ......+.+|++++++++|+|++++++++.+.  +..++|+
T Consensus         2 ~~~~~l~~g~~~~vy~~~~~~--~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   79 (287)
T cd07840           2 EKIAQIGEGTYGQVYKARNKK--TGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF   79 (287)
T ss_pred             eeeEEeccCCCeEEEEEEECC--CCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence            456789999999999999763  46789999997643  23345688999999999999999999999887  7899999


Q ss_pred             ecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCc
Q 041921          598 EFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS  676 (814)
Q Consensus       598 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  676 (814)
                      ||+++ +|.+++... ..+++..+..++.|+++||+|||+.   +++|+||+|+||++++++.+||+|||++........
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~  155 (287)
T cd07840          80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS  155 (287)
T ss_pred             ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence            99975 898888765 5789999999999999999999998   999999999999999999999999999987654432


Q ss_pred             ccccccccCCCCccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcC---cccee--
Q 041921          677 KTIKTAIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG---KLNVL--  750 (814)
Q Consensus       677 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~--  750 (814)
                      .. .....++..|+|||.+.+ ..++.++||||||++++||++|+.||..........   .+.+....-   .....  
T Consensus       156 ~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  231 (287)
T cd07840         156 AD-YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLE---KIFELCGSPTDENWPGVSK  231 (287)
T ss_pred             cc-ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHHHhCCCchhhcccccc
Confidence            11 133446788999998764 467899999999999999999999997554322111   111111000   00000  


Q ss_pred             ------ecCc------ccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          751 ------VGED------KEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       751 ------~~~~------~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                            ....      ........+...+.+++.+||+.+|.+||+++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                  0000      000000112567899999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.5e-32  Score=288.56  Aligned_cols=248  Identities=27%  Similarity=0.367  Sum_probs=199.6

Q ss_pred             eeeeeeeeEEEEEEecCCCceEEEEEEeccccc---cchHhHHHHHHhhhccCCCCccceeeeecccccceEEEecCCCC
Q 041921          527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ---DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNG  603 (814)
Q Consensus       527 LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  603 (814)
                      ||+|+||.||++....  .+..+++|.+.....   ...+.+.+|++++++++|+||+++++.+..++..++++||++++
T Consensus         1 lg~g~~~~vy~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (265)
T cd05579           1 ISKGAYGRVFLAKKKS--TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGG   78 (265)
T ss_pred             CCCCCceEEEEEEECC--CCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCC
Confidence            6899999999999763  467899999865332   34457899999999999999999999999999999999999999


Q ss_pred             CHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcc------
Q 041921          604 TLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSK------  677 (814)
Q Consensus       604 sL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~------  677 (814)
                      +|.+++.....+++..+..++.||++||+|||+.   +++|+||+|+||++++++.++|+|||++.........      
T Consensus        79 ~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  155 (265)
T cd05579          79 DLASLLENVGSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE  155 (265)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence            9999998777889999999999999999999998   9999999999999999999999999998765433211      


Q ss_pred             cccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccc
Q 041921          678 TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEA  757 (814)
Q Consensus       678 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  757 (814)
                      .......++..|+|||.+.....+.++||||||++++||++|..||......+.       ......+....        
T Consensus       156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-------~~~~~~~~~~~--------  220 (265)
T cd05579         156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI-------FQNILNGKIEW--------  220 (265)
T ss_pred             ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHhcCCcCC--------
Confidence            111334578899999999888899999999999999999999999975443221       11111111110        


Q ss_pred             cCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 041921          758 MNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEG  794 (814)
Q Consensus       758 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~  794 (814)
                      +........+.+++.+|++.+|.+|||+.++.+.|+.
T Consensus       221 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~  257 (265)
T cd05579         221 PEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH  257 (265)
T ss_pred             CccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence            0111135778899999999999999999777777653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=4.6e-32  Score=288.37  Aligned_cols=258  Identities=24%  Similarity=0.321  Sum_probs=193.5

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEe
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE  598 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  598 (814)
                      +...+.||.|++|.||+|....  .+..|+||++....  ......+.+|++++++++||||+++++++.+++..++|||
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (284)
T cd07860           2 FQKVEKIGEGTYGVVYKARNKL--TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   79 (284)
T ss_pred             ceeeeeecCCCceEEEEEEECC--CCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence            3456789999999999998753  56789999886432  2233568899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhcC--CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCc
Q 041921          599 FLNNGTLASFLFG--NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS  676 (814)
Q Consensus       599 ~~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  676 (814)
                      |+. ++|.+++..  ...+++..+..++.|+++||+|||+.   +++|+||+|+||+++.++.+||+|||++........
T Consensus        80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~  155 (284)
T cd07860          80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  155 (284)
T ss_pred             ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence            996 689888865  35678999999999999999999998   999999999999999999999999999876543221


Q ss_pred             ccccccccCCCCcccccccccCC-CCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcC----------
Q 041921          677 KTIKTAIRGTKGYVAPEWFRNSK-ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG----------  745 (814)
Q Consensus       677 ~~~~~~~~gt~~y~aPE~~~~~~-~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----------  745 (814)
                      .  .....++..|+|||.+.+.. ++.++||||||++++||+||+.||.......  .+.... +.....          
T Consensus       156 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~-~~~~~~~~~~~~~~~~  230 (284)
T cd07860         156 T--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIF-RTLGTPDEVVWPGVTS  230 (284)
T ss_pred             c--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHH-HHhCCCChhhhhhhhH
Confidence            1  12234688999999887644 6889999999999999999999986543211  111100 000000          


Q ss_pred             ------ccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          746 ------KLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       746 ------~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                            ........... .........+.+++.+|++.||.+|||++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         231 LPDYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HHHHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence                  00000000000 000112356788999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=5.4e-32  Score=292.59  Aligned_cols=250  Identities=25%  Similarity=0.314  Sum_probs=196.2

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc---cchHhHHHHHHhhhccCCCCccceeeeecccccceEEE
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ---DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY  597 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  597 (814)
                      +...+.||+|+||.||++....  ++..+|+|.+.....   ....++.+|++++++++|+|++++++++.+++..++||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  104 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVR--TNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM  104 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcC--CCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence            4456789999999999998753  567899999864322   22346889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCc
Q 041921          598 EFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS  676 (814)
Q Consensus       598 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  676 (814)
                      ||+++ +|.+++.. ...+++..+..++.|++.||.|||+.   +|+|+||+|+||+++.++.+||+|||++......  
T Consensus       105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~--  178 (317)
T cd06635         105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA--  178 (317)
T ss_pred             eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc--
Confidence            99975 77777654 46689999999999999999999998   9999999999999999999999999998754322  


Q ss_pred             ccccccccCCCCcccccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecC
Q 041921          677 KTIKTAIRGTKGYVAPEWFR---NSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGE  753 (814)
Q Consensus       677 ~~~~~~~~gt~~y~aPE~~~---~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  753 (814)
                          ....++..|+|||.+.   .+.++.++||||||++++||++|+.||........  +    ......+..      
T Consensus       179 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~----~~~~~~~~~------  242 (317)
T cd06635         179 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--L----YHIAQNESP------  242 (317)
T ss_pred             ----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH--H----HHHHhccCC------
Confidence                2345788999999874   45688999999999999999999999864322111  1    111111110      


Q ss_pred             cccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 041921          754 DKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE  797 (814)
Q Consensus       754 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~  797 (814)
                         ..........+.+++.+|++.+|.+||++.++++.+--...
T Consensus       243 ---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~  283 (317)
T cd06635         243 ---TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE  283 (317)
T ss_pred             ---CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence               01112344578899999999999999999999987644433

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=4.2e-32  Score=285.09  Aligned_cols=243  Identities=23%  Similarity=0.277  Sum_probs=196.6

Q ss_pred             eeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEecCCCC
Q 041921          527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNG  603 (814)
Q Consensus       527 LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  603 (814)
                      ||.|++|.||+++...  .+..+++|.+....   ....+.+.+|+.++++++||||+++++++.++...++|+||++++
T Consensus         1 lg~g~~~~v~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (262)
T cd05572           1 LGVGGFGRVELVKVKS--KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGG   78 (262)
T ss_pred             CCCCCceEEEEEEECC--CCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCC
Confidence            6899999999999753  57789999986432   223457999999999999999999999999999999999999999


Q ss_pred             CHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcccccccc
Q 041921          604 TLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAI  683 (814)
Q Consensus       604 sL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~  683 (814)
                      +|.+++.....+++..+..++.|+++||+|||+.   +++|+||+|+||+++.++.++|+|||++........   ....
T Consensus        79 ~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~---~~~~  152 (262)
T cd05572          79 ELWTILRDRGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK---TWTF  152 (262)
T ss_pred             cHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccc---cccc
Confidence            9999998877789999999999999999999998   999999999999999999999999999987654321   1234


Q ss_pred             cCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCcHHH
Q 041921          684 RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIEC  763 (814)
Q Consensus       684 ~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  763 (814)
                      .++..|+|||.+....++.++|+||||+++|||++|..||.....+....    . .....+..      ..  ..+...
T Consensus       153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~-~~~~~~~~------~~--~~~~~~  219 (262)
T cd05572         153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEI----Y-NDILKGNG------KL--EFPNYI  219 (262)
T ss_pred             cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHH----H-HHHhccCC------CC--CCCccc
Confidence            57889999999988889999999999999999999999997554211111    1 11111000      00  111122


Q ss_pred             HHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 041921          764 LGKLVMVSIWCIQEDPSLRPT-----MKKVLQ  790 (814)
Q Consensus       764 ~~~l~~l~~~Cl~~dp~~RPt-----~~~vl~  790 (814)
                      ...+.+++.+||+.+|.+||+     ++|+++
T Consensus       220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            568899999999999999999     666654

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=2.8e-32  Score=291.45  Aligned_cols=263  Identities=19%  Similarity=0.221  Sum_probs=187.5

Q ss_pred             HHHHhhhccccceeeeeeeeEEEEEEecCCC-ceEEEEEEeccccccch-----------HhHHHHHHhhhccCCCCccc
Q 041921          515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTS-TTAVAVKKLDRVFQDGE-----------REFKNEVFVIGQTHHKNLVR  582 (814)
Q Consensus       515 ~l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~-~~~vavK~l~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~  582 (814)
                      ++....+.+.++||+|+||.||+|....... ...+++|..........           .....+...+..++|+|+++
T Consensus         8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~   87 (294)
T PHA02882          8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK   87 (294)
T ss_pred             ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence            4455677888999999999999999764311 33455554322111110           11223344566778999999


Q ss_pred             eeeeecccc----cceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC
Q 041921          583 LLGFCDEGQ----NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYY  658 (814)
Q Consensus       583 l~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~  658 (814)
                      +++++....    ..++++|++.. ++.+.+......++.....|+.|+++||+|||+.   +|+||||||+|||++.++
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~  163 (294)
T PHA02882         88 YYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNN  163 (294)
T ss_pred             EEEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCC
Confidence            999765543    23677777643 6666665555567888899999999999999998   999999999999999999


Q ss_pred             cEEEeecCCccccccCCc-----ccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhh
Q 041921          659 TARISDFGLAKLLTLNQS-----KTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI  733 (814)
Q Consensus       659 ~~kl~DfGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~  733 (814)
                      .++|+|||+++.+.....     ........||+.|+|||.+.+..++.++|||||||+++||++|+.||..........
T Consensus       164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~  243 (294)
T PHA02882        164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI  243 (294)
T ss_pred             cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence            999999999987643221     111133469999999999999999999999999999999999999997553221100


Q ss_pred             ---HHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 041921          734 ---LTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE  793 (814)
Q Consensus       734 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~  793 (814)
                         ..++ ...+..+++.           ....+..+.+++..|++.+|++||++.++++.|+
T Consensus       244 ~~~~~~~-~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        244 HAAKCDF-IKRLHEGKIK-----------IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HHhHHHH-HHHhhhhhhc-----------cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence               0011 1112222111           1122467889999999999999999999999874

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-32  Score=288.93  Aligned_cols=257  Identities=25%  Similarity=0.339  Sum_probs=195.1

Q ss_pred             ccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEec
Q 041921          522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  599 (814)
Q Consensus       522 ~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  599 (814)
                      .+.++||.|++|.||+|....  ++..|++|++....  ......+.+|++++++++|+|++++++++.+++..+++|||
T Consensus         2 ~~~~~l~~g~~~~vy~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~   79 (283)
T cd07835           2 QKVEKIGEGTYGVVYKARDKL--TGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF   79 (283)
T ss_pred             chheEecCCCCeEEEEEEEcC--CCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence            456789999999999999754  57789999886432  22335688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCCC--CCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcc
Q 041921          600 LNNGTLASFLFGNL--KPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSK  677 (814)
Q Consensus       600 ~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  677 (814)
                      ++ ++|.+++....  .+++..+..++.|+++||.|||+.   +++|+||+|+||+++.++.++|+|||++.........
T Consensus        80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~  155 (283)
T cd07835          80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT  155 (283)
T ss_pred             cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence            95 68999987664  689999999999999999999998   9999999999999999999999999999765432211


Q ss_pred             cccccccCCCCcccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhc-C----------
Q 041921          678 TIKTAIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN-G----------  745 (814)
Q Consensus       678 ~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~----------  745 (814)
                        .....++..|+|||.+.+. .++.++||||||+++|||++|+.||........  +.... +.... .          
T Consensus       156 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~  230 (283)
T cd07835         156 --YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ--LFRIF-RTLGTPDEDVWPGVTSL  230 (283)
T ss_pred             --cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHH-HHhCCCChHHhhhhhhc
Confidence              1223468899999987654 578899999999999999999999975433211  00100 00000 0          


Q ss_pred             -----ccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          746 -----KLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       746 -----~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                           .......... ..........+.+++.+|++.+|.+|||++++++
T Consensus       231 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         231 PDYKPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhhhhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                 0000000000 0001123367889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-32  Score=292.51  Aligned_cols=265  Identities=20%  Similarity=0.292  Sum_probs=195.1

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhccCCCCccceeeeeccc--ccceE
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEG--QNRLL  595 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  595 (814)
                      +.+.++||+|++|.||+|.......+..||+|.+....   ....+.+.+|+.++.+++||||+++++++.+.  +..++
T Consensus         2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   81 (316)
T cd07842           2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL   81 (316)
T ss_pred             ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence            45678899999999999998643357899999997632   33345678899999999999999999999887  78999


Q ss_pred             EEecCCCCCHHHHhcCC-----CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC----CCcEEEeecC
Q 041921          596 VYEFLNNGTLASFLFGN-----LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDD----YYTARISDFG  666 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~~-----~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~----~~~~kl~DfG  666 (814)
                      ||||+++ +|.+++...     ..++......++.|++.||.|||+.   +|+||||||+||+++.    ++.+||+|||
T Consensus        82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg  157 (316)
T cd07842          82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLG  157 (316)
T ss_pred             EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence            9999975 666665422     3578889999999999999999998   9999999999999999    9999999999


Q ss_pred             CccccccCCcc-cccccccCCCCcccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcccchh-------hhhHHHH
Q 041921          667 LAKLLTLNQSK-TIKTAIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-------YAILTDW  737 (814)
Q Consensus       667 la~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~-------~~~~~~~  737 (814)
                      ++......... .......++..|+|||.+.+. .++.++||||||++++||++|+.||.......       ...+.. 
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~-  236 (316)
T cd07842         158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER-  236 (316)
T ss_pred             cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH-
Confidence            99876433221 111234578899999988664 57899999999999999999999997543321       000100 


Q ss_pred             HHHHhhcC------------ccce---eec-CcccccCcH-------HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          738 AFDCYRNG------------KLNV---LVG-EDKEAMNDI-------ECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       738 ~~~~~~~~------------~~~~---~~~-~~~~~~~~~-------~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      +...+...            ....   ... .........       ....++.+++.+||+.||++|||+.++++
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            00100000            0000   000 000000000       23456889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=6.6e-32  Score=288.60  Aligned_cols=263  Identities=19%  Similarity=0.228  Sum_probs=195.5

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeeccc--ccceE
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEG--QNRLL  595 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  595 (814)
                      .+.+.+.||+|+||.||+|....  .+..+++|.++...  ......+.+|+.++.+++||||+++++++...  ...++
T Consensus         6 ~y~~~~~lg~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l   83 (293)
T cd07843           6 EYEKLNRIEEGTYGVVYRARDKK--TGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM   83 (293)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECC--CCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence            45667899999999999999753  56789999986432  22233577899999999999999999998777  78999


Q ss_pred             EEecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccC
Q 041921          596 VYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN  674 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~  674 (814)
                      |+||+++ +|.+++... ..+++.....++.||++||+|||+.   +++|+||||+||+++.++.+||+|||++......
T Consensus        84 v~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  159 (293)
T cd07843          84 VMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSP  159 (293)
T ss_pred             EehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence            9999974 999888764 4589999999999999999999998   9999999999999999999999999999876543


Q ss_pred             CcccccccccCCCCcccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhh-HHHH-------HHHHhhc-
Q 041921          675 QSKTIKTAIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI-LTDW-------AFDCYRN-  744 (814)
Q Consensus       675 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~-~~~~-------~~~~~~~-  744 (814)
                      ....  ....++..|+|||.+.+. .++.++|+||||++++||++|+.||.......... +...       .+..+.. 
T Consensus       160 ~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
T cd07843         160 LKPY--TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL  237 (293)
T ss_pred             cccc--ccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence            2111  234478899999988754 46899999999999999999999997543321110 0000       0000000 


Q ss_pred             -----CccceeecCcccccCcHH-HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          745 -----GKLNVLVGEDKEAMNDIE-CLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       745 -----~~~~~~~~~~~~~~~~~~-~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                           .................. ....+.+++..||+.+|++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence                 000000000000000111 3567889999999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.1e-31  Score=280.71  Aligned_cols=250  Identities=26%  Similarity=0.361  Sum_probs=203.7

Q ss_pred             ccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc--cchHhHHHHHHhhhccCCCCccceeeeeccc--ccceEEE
Q 041921          522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ--DGEREFKNEVFVIGQTHHKNLVRLLGFCDEG--QNRLLVY  597 (814)
Q Consensus       522 ~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  597 (814)
                      ...+.||+|++|.||+|....  ++..|++|.+.....  ...+.+.+|+.++++++|+||+++++.+.+.  ...++++
T Consensus         3 ~~~~~i~~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           3 TRGELLGRGSFGSVYLALDKD--TGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             eeeeEeeecCceEEEEEEECC--CCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            455789999999999998763  577899999865432  3456799999999999999999999999888  8899999


Q ss_pred             ecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcc
Q 041921          598 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSK  677 (814)
Q Consensus       598 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  677 (814)
                      ||+++++|.+++.....+++..+..++.|++++|+|||+.   +++|+||+|+||+++.++.++|+|||.+.........
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  157 (260)
T cd06606          81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG  157 (260)
T ss_pred             EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence            9999999999998877899999999999999999999997   9999999999999999999999999999877654321


Q ss_pred             cccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccc
Q 041921          678 TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEA  757 (814)
Q Consensus       678 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  757 (814)
                      .......++..|+|||.+.....+.++||||||+++++|++|+.||.......     .........+..         .
T Consensus       158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~---------~  223 (260)
T cd06606         158 EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM-----AALYKIGSSGEP---------P  223 (260)
T ss_pred             ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-----HHHHhccccCCC---------c
Confidence            11133558889999999988889999999999999999999999997544111     111111100010         0


Q ss_pred             cCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          758 MNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       758 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      ..+......+.+++.+|++.+|.+||++.++++
T Consensus       224 ~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         224 EIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             CCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            112223578899999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-32  Score=317.25  Aligned_cols=263  Identities=26%  Similarity=0.396  Sum_probs=211.4

Q ss_pred             HHHHhhhccccceeeeeeeeEEEEEEecCC-----CceEEEEEEecccccc-chHhHHHHHHhhhcc-CCCCccceeeee
Q 041921          515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRT-----STTAVAVKKLDRVFQD-GEREFKNEVFVIGQT-HHKNLVRLLGFC  587 (814)
Q Consensus       515 ~l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~-----~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~~~~  587 (814)
                      |+......+.+.||+|+||.|++|......     ....||||.++..... ..+.+..|+++|+.+ +|+||+.++|+|
T Consensus       292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~  371 (609)
T KOG0200|consen  292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC  371 (609)
T ss_pred             eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence            344444456779999999999999876432     2568999999765433 456799999999999 799999999999


Q ss_pred             cccccceEEEecCCCCCHHHHhcCCC----------------CCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCc
Q 041921          588 DEGQNRLLVYEFLNNGTLASFLFGNL----------------KPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQN  651 (814)
Q Consensus       588 ~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~N  651 (814)
                      .+....++|.||+..|+|.++|+..+                .+.....+.++.|||.|++||++.   +++||||.++|
T Consensus       372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRN  448 (609)
T KOG0200|consen  372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARN  448 (609)
T ss_pred             ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhhhh
Confidence            99999999999999999999998655                377788899999999999999998   99999999999


Q ss_pred             EEEcCCCcEEEeecCCccccccCCccccc-ccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccch
Q 041921          652 ILLDDYYTARISDFGLAKLLTLNQSKTIK-TAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGE  729 (814)
Q Consensus       652 Ill~~~~~~kl~DfGla~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~  729 (814)
                      ||+..+..+||+|||+++........... +...-...|||||.+....++.|+|||||||+||||+| |..|+......
T Consensus       449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~  528 (609)
T KOG0200|consen  449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT  528 (609)
T ss_pred             EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence            99999999999999999966544332211 11013456999999999999999999999999999999 88888642211


Q ss_pred             hhhhHHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 041921          730 EYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV  795 (814)
Q Consensus       730 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~  795 (814)
                      .     + +.+.+++|.-         ...+..+..+++++++.||+.+|++||++.++++.|+..
T Consensus       529 ~-----~-l~~~l~~G~r---------~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  529 E-----E-LLEFLKEGNR---------MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             H-----H-HHHHHhcCCC---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence            1     1 1234444432         223445678899999999999999999999999999873

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=3.4e-32  Score=284.76  Aligned_cols=248  Identities=23%  Similarity=0.367  Sum_probs=198.7

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEeccc--cccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEe
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV--FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE  598 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  598 (814)
                      +.+.+.||+|+||.||+|....  ++..+++|.+...  .....+.+.+|+.++++++|+||+++++.+.+....++|+|
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   79 (257)
T cd08225           2 YEIIKKIGEGSFGKIYLAKAKS--DSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME   79 (257)
T ss_pred             ceEEEEecCCCcceEEEEEEcC--CCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence            4567889999999999999764  5678999998643  12344578899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC-cEEEeecCCccccccCC
Q 041921          599 FLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYY-TARISDFGLAKLLTLNQ  675 (814)
Q Consensus       599 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~-~~kl~DfGla~~~~~~~  675 (814)
                      |+++++|.+++...  ..+++..+..++.|+++||.|||+.   +++|+||||+||++++++ .+||+|||.+.......
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM  156 (257)
T ss_pred             cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence            99999999998754  3578999999999999999999998   999999999999999875 46999999998765332


Q ss_pred             cccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcc
Q 041921          676 SKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDK  755 (814)
Q Consensus       676 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  755 (814)
                      ..  .....|+..|+|||.+.+..++.++||||||++++||++|..||......+      ...... .+....      
T Consensus       157 ~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~-~~~~~~------  221 (257)
T cd08225         157 EL--AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ------LVLKIC-QGYFAP------  221 (257)
T ss_pred             cc--ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHh-cccCCC------
Confidence            11  123458889999999988889999999999999999999999986433211      111111 111111      


Q ss_pred             cccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          756 EAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       756 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                         ........+.+++.+|++.+|++|||+.++++.
T Consensus       222 ---~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         222 ---ISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             ---CCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence               011234578899999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.98  E-value=8.7e-32  Score=287.28  Aligned_cols=244  Identities=25%  Similarity=0.367  Sum_probs=197.0

Q ss_pred             cceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEecCCCCC
Q 041921          525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGT  604 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  604 (814)
                      .+||+|+||.||++....  ++..||||++..........+.+|+.++++++|+||+++++++...+..++||||+++++
T Consensus        26 ~~lg~g~~g~v~~~~~~~--~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  103 (292)
T cd06657          26 IKIGEGSTGIVCIATVKS--SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA  103 (292)
T ss_pred             HHcCCCCCeEEEEEEEcC--CCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence            579999999999998753  578999999865444455678999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccccccccc
Q 041921          605 LASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIR  684 (814)
Q Consensus       605 L~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~  684 (814)
                      |.+++.. ..+++.....++.|++.+|+|||+.   +++|+||+|+||+++.++.++|+|||++.........  .....
T Consensus       104 L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~--~~~~~  177 (292)
T cd06657         104 LTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKSLV  177 (292)
T ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccccc--ccccc
Confidence            9998754 4578999999999999999999998   9999999999999999999999999998765432211  13345


Q ss_pred             CCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCcHHHH
Q 041921          685 GTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECL  764 (814)
Q Consensus       685 gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  764 (814)
                      ++..|+|||.+.+..++.++|+||||++++||++|..||.........       ........     ....  ......
T Consensus       178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~-------~~~~~~~~-----~~~~--~~~~~~  243 (292)
T cd06657         178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM-------KMIRDNLP-----PKLK--NLHKVS  243 (292)
T ss_pred             cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHHhhCC-----cccC--CcccCC
Confidence            889999999998888999999999999999999999998754322111       11111100     0000  011234


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          765 GKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       765 ~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      ..+.+++.+||+.+|.+||++.++++
T Consensus       244 ~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         244 PSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             HHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            56788999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.98  E-value=8.2e-32  Score=286.40  Aligned_cols=260  Identities=22%  Similarity=0.334  Sum_probs=196.0

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc-cchHhHHHHHHhhhccCCCCccceeeeecccccceEEEec
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  599 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  599 (814)
                      +.+.++||+|++|.||+|+...  ++..||||.++.... .....+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   79 (284)
T cd07836           2 FKQLEKLGEGTYATVYKGRNRT--TGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY   79 (284)
T ss_pred             ceEeeeeccCCceEEEEEEECC--CCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence            4567899999999999999753  577899999875432 2345678899999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCC---CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCc
Q 041921          600 LNNGTLASFLFGN---LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS  676 (814)
Q Consensus       600 ~~~gsL~~~l~~~---~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  676 (814)
                      +++ +|.+++...   ..+++..+..++.|++.||.|||+.   +++|+||||+||++++++.++|+|||++........
T Consensus        80 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~  155 (284)
T cd07836          80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN  155 (284)
T ss_pred             CCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence            985 888887653   3578999999999999999999998   999999999999999999999999999976543221


Q ss_pred             ccccccccCCCCcccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhh-HHHH-------HHHHhhcCcc
Q 041921          677 KTIKTAIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI-LTDW-------AFDCYRNGKL  747 (814)
Q Consensus       677 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~-~~~~-------~~~~~~~~~~  747 (814)
                      .  .....++..|++||.+.+. .++.++||||||++++||++|+.||......+... ..+.       .+..+..  .
T Consensus       156 ~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~  231 (284)
T cd07836         156 T--FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ--L  231 (284)
T ss_pred             c--cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhc--C
Confidence            1  1233478899999988654 57889999999999999999999997554322111 0000       0000000  0


Q ss_pred             ceeecCccc------ccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          748 NVLVGEDKE------AMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       748 ~~~~~~~~~------~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      ..+......      ..........+.+++.+|++.+|.+||+++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         232 PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            000000000      0001123567889999999999999999999875

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.98  E-value=5.5e-33  Score=292.77  Aligned_cols=252  Identities=24%  Similarity=0.396  Sum_probs=199.4

Q ss_pred             HHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEec--cccccchHhHHHHHHhhhcc-CCCCccceeeeecccccc
Q 041921          517 EGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLD--RVFQDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNR  593 (814)
Q Consensus       517 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~--~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  593 (814)
                      ....|++.++||+||.+.||++.-.   +.+-+|+|++.  ..+.+...-|.+|+..|.++ .|.+||+|++|-..++.+
T Consensus       359 kg~~Yeilk~iG~GGSSkV~kV~~s---~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l  435 (677)
T KOG0596|consen  359 KGREYEILKQIGSGGSSKVFKVLNS---DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL  435 (677)
T ss_pred             CcchhhHHHhhcCCCcceeeeeecC---CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence            3455667789999999999999854   45677888774  34455566799999999999 599999999999999999


Q ss_pred             eEEEecCCCCCHHHHhcCCCC--CChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcccc
Q 041921          594 LLVYEFLNNGTLASFLFGNLK--PNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLL  671 (814)
Q Consensus       594 ~lv~e~~~~gsL~~~l~~~~~--l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~  671 (814)
                      |||||| ...+|..+|.....  +.| .+..+..|++.++.++|++   +|||.||||.|+|+.. |.+||+|||+|..+
T Consensus       436 YmvmE~-Gd~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI  509 (677)
T KOG0596|consen  436 YMVMEC-GDIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAI  509 (677)
T ss_pred             EEEeec-ccccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhccc
Confidence            999997 46699999987632  335 7778999999999999999   9999999999999975 59999999999999


Q ss_pred             ccCCcccccccccCCCCcccccccccC-----------CCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHH
Q 041921          672 TLNQSKTIKTAIRGTKGYVAPEWFRNS-----------KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD  740 (814)
Q Consensus       672 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  740 (814)
                      ..+.........+||..||+||.+...           ++++++||||+|||||+|+.|+.||....     .  .|.  
T Consensus       510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-----n--~~a--  580 (677)
T KOG0596|consen  510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-----N--QIA--  580 (677)
T ss_pred             CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-----H--HHH--
Confidence            888776666677899999999988422           36789999999999999999999996211     1  111  


Q ss_pred             HhhcCccceeecCcccccC-cHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          741 CYRNGKLNVLVGEDKEAMN-DIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       741 ~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                           ++..+.++.-..+. ......+++++++.||+.||.+|||..++|+.
T Consensus       581 -----Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  581 -----KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             -----HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence                 23334444322211 11222338999999999999999999999864

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=4e-33  Score=295.74  Aligned_cols=250  Identities=21%  Similarity=0.321  Sum_probs=202.4

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEecC
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL  600 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  600 (814)
                      .++...||.|+||.||||+-+  ..+..-|-|.+........++++-|+++|+..+||+||+|++.+..++.++|+.|||
T Consensus        34 WeIiGELGDGAFGKVyKA~nk--et~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC  111 (1187)
T KOG0579|consen   34 WEIIGELGDGAFGKVYKAVNK--ETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC  111 (1187)
T ss_pred             HHHHhhhcCccchhhhhhhcc--cchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence            345567999999999999855  344556778777666677788999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcccc
Q 041921          601 NNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI  679 (814)
Q Consensus       601 ~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  679 (814)
                      +||-.+.++.+ ...+...++.-++.|++.||.|||++   .|||||||+.|||++-+|.++|+|||.+.......  ..
T Consensus       112 ~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~--qk  186 (1187)
T KOG0579|consen  112 GGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR--QK  186 (1187)
T ss_pred             CCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhHH--hh
Confidence            99999998866 46789999999999999999999999   99999999999999999999999999986543221  12


Q ss_pred             cccccCCCCcccccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCc
Q 041921          680 KTAIRGTKGYVAPEWFR-----NSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGED  754 (814)
Q Consensus       680 ~~~~~gt~~y~aPE~~~-----~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  754 (814)
                      ...+.||+.|||||+..     ..+|+.++||||||+.|.||.-+.+|.....+..      .+. .+..       .+.
T Consensus       187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR------Vll-KiaK-------SeP  252 (1187)
T KOG0579|consen  187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------VLL-KIAK-------SEP  252 (1187)
T ss_pred             hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH------HHH-HHhh-------cCC
Confidence            25578999999999874     5689999999999999999999998875332211      111 1111       112


Q ss_pred             ccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          755 KEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       755 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                      +....+......+.+++..||.+||..||+++++++.
T Consensus       253 PTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  253 PTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             CcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence            2222344567788899999999999999999998853

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.98  E-value=4.5e-32  Score=309.70  Aligned_cols=269  Identities=19%  Similarity=0.264  Sum_probs=186.6

Q ss_pred             HHHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEE------------------EeccccccchHhHHHHHHhhhccC
Q 041921          515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVK------------------KLDRVFQDGEREFKNEVFVIGQTH  576 (814)
Q Consensus       515 ~l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK------------------~l~~~~~~~~~~~~~E~~~l~~l~  576 (814)
                      +.....|.+.++||+|+||+||++.++... +...++|                  ++.. .......+.+|+.++++++
T Consensus       144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~  221 (501)
T PHA03210        144 DEFLAHFRVIDDLPAGAFGKIFICALRAST-EEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLN  221 (501)
T ss_pred             hhhhhccEEEeEecCCCCcceEEEEEeccc-hhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCC
Confidence            334567888899999999999998765321 1111211                  1111 1123346889999999999


Q ss_pred             CCCccceeeeecccccceEEEecCCCCCHHHHhcCC-----CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCc
Q 041921          577 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN-----LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQN  651 (814)
Q Consensus       577 h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~N  651 (814)
                      |+||+++++++.+.+..++|+|++. ++|.+++...     ..........|+.||+.||.|||+.   +|+||||||+|
T Consensus       222 HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~N  297 (501)
T PHA03210        222 HENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLEN  297 (501)
T ss_pred             CCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHH
Confidence            9999999999999999999999985 5677766432     2233556678999999999999998   99999999999


Q ss_pred             EEEcCCCcEEEeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCC-CCcccchh
Q 041921          652 ILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKS-FDIEMGEE  730 (814)
Q Consensus       652 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p-~~~~~~~~  730 (814)
                      ||++.++.+||+|||+++.+....... .....||..|+|||++.+..++.++|||||||++|||++|..+ +.......
T Consensus       298 ILl~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~  376 (501)
T PHA03210        298 IFLNCDGKIVLGDFGTAMPFEKEREAF-DYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKP  376 (501)
T ss_pred             EEECCCCCEEEEeCCCceecCcccccc-cccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCH
Confidence            999999999999999998765432211 1335699999999999999999999999999999999998754 43222221


Q ss_pred             hhhHHHHHH-----------------HHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          731 YAILTDWAF-----------------DCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       731 ~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      ...+...+.                 +.+....+...................+.+++.+||+.||.+|||+.|+++
T Consensus       377 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        377 GKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             HHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            111111110                 000000000000000000000112245667889999999999999999986

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.98  E-value=1.1e-31  Score=284.92  Aligned_cols=258  Identities=21%  Similarity=0.275  Sum_probs=192.4

Q ss_pred             ccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc-ccchHhHHHHHHhhhccC-CCCccceeeeeccc--ccceEEE
Q 041921          522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQTH-HKNLVRLLGFCDEG--QNRLLVY  597 (814)
Q Consensus       522 ~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~  597 (814)
                      .+.++||+|+||.||+|....  ++..+|+|+++... .........|+.++.++. |+|++++++++.+.  +..++|+
T Consensus         2 ~~~~~lg~g~~~~v~~~~~~~--~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~   79 (282)
T cd07831           2 KILGKIGEGTFSEVLKAQSRK--TGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF   79 (282)
T ss_pred             ceEeeccccccceEEEEEEcC--CCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence            466889999999999998753  56789999987532 222234567888888885 99999999999877  8899999


Q ss_pred             ecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCc
Q 041921          598 EFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS  676 (814)
Q Consensus       598 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  676 (814)
                      ||++ ++|.+++... ..+++..+..++.|++.||+|||+.   +++|+||+|+||+++. +.+||+|||++........
T Consensus        80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~  154 (282)
T cd07831          80 ELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP  154 (282)
T ss_pred             ecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence            9997 5787777653 5789999999999999999999998   9999999999999999 9999999999987643322


Q ss_pred             ccccccccCCCCccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhh-hHH--------HHHHHHhhcCc
Q 041921          677 KTIKTAIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA-ILT--------DWAFDCYRNGK  746 (814)
Q Consensus       677 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~-~~~--------~~~~~~~~~~~  746 (814)
                      .   ....++..|+|||.+.. ..++.++|||||||+++||++|..||......+.. ...        .+ ........
T Consensus       155 ~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  230 (282)
T cd07831         155 Y---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEV-LKKFRKSR  230 (282)
T ss_pred             c---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHH-HHhhcccc
Confidence            1   22457889999997654 56788999999999999999999999754432210 000        00 01111111


Q ss_pred             cceeecCcccc----cCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          747 LNVLVGEDKEA----MNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       747 ~~~~~~~~~~~----~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      ......+....    ......+..+.+++.+||+.+|++|||++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            11000000000    001234688999999999999999999999986

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.98  E-value=7.9e-33  Score=272.14  Aligned_cols=282  Identities=21%  Similarity=0.285  Sum_probs=204.1

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCc--eEEEEEEeccccc--cchHhHHHHHHhhhccCCCCccceeeeecc-cccce
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTST--TAVAVKKLDRVFQ--DGEREFKNEVFVIGQTHHKNLVRLLGFCDE-GQNRL  594 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~--~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~  594 (814)
                      .|+...+||+|.||.||||+-.+.++.  ..+|||+++....  .-.....+|+.+++.++||||+.|..++.+ +...+
T Consensus        25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~  104 (438)
T KOG0666|consen   25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVW  104 (438)
T ss_pred             HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEE
Confidence            355678899999999999987666653  3899999975422  223457899999999999999999999877 77889


Q ss_pred             EEEecCCCCCHHHHhcCC-----CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC----CcEEEeec
Q 041921          595 LVYEFLNNGTLASFLFGN-----LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDY----YTARISDF  665 (814)
Q Consensus       595 lv~e~~~~gsL~~~l~~~-----~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~----~~~kl~Df  665 (814)
                      |++||.++ +|..+|+.+     ..++......|+.||+.|+.|||++   -|+||||||.||||..+    |.|||+||
T Consensus       105 l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaDl  180 (438)
T KOG0666|consen  105 LLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIADL  180 (438)
T ss_pred             EEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeecc
Confidence            99999977 777777532     5678888999999999999999999   99999999999999877    99999999


Q ss_pred             CCccccccCCcc-cccccccCCCCcccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcccchh------hhhHHHH
Q 041921          666 GLAKLLTLNQSK-TIKTAIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIISCRKSFDIEMGEE------YAILTDW  737 (814)
Q Consensus       666 Gla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~------~~~~~~~  737 (814)
                      |+++++...-.. .....++-|+.|.|||.+.+. .|+.+.|||+.|||+.||+|-.+.|......-      ..+....
T Consensus       181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r  260 (438)
T KOG0666|consen  181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR  260 (438)
T ss_pred             cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence            999988643221 122445679999999998876 58999999999999999999998886543210      0111111


Q ss_pred             HHHHhhc---Ccc---ceeecC-------cccccCc---HH-------HHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 041921          738 AFDCYRN---GKL---NVLVGE-------DKEAMND---IE-------CLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEG  794 (814)
Q Consensus       738 ~~~~~~~---~~~---~~~~~~-------~~~~~~~---~~-------~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~  794 (814)
                      +...+..   .+.   +.+.+-       ....-.+   ..       .....++++..+|+.||.+|.|+++.++-- .
T Consensus       261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~-y  339 (438)
T KOG0666|consen  261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP-Y  339 (438)
T ss_pred             HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc-c
Confidence            2221111   000   000000       0000000   00       112366788889999999999999988754 3


Q ss_pred             CcCCCCCCCCCC
Q 041921          795 VVEVSVPPNPYP  806 (814)
Q Consensus       795 ~~~~~~p~~p~~  806 (814)
                      ..+-+.||.|..
T Consensus       340 F~~d~lpp~pt~  351 (438)
T KOG0666|consen  340 FTEDPLPPLPTS  351 (438)
T ss_pred             cccCCCCCCccc
Confidence            555566766643

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.98  E-value=6.9e-32  Score=294.45  Aligned_cols=267  Identities=23%  Similarity=0.351  Sum_probs=196.8

Q ss_pred             HhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccc--cccchHhHHHHHHhhhcc-CCCCccceeeeeccc--cc
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV--FQDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEG--QN  592 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~  592 (814)
                      ...+.+.+.||+|+||.||+|....  .+..++||++...  .......+..|+.+++++ +|+||+++++++...  ..
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~   83 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRR--TKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD   83 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcC--CCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence            3456677899999999999998753  4678999988542  122334677899999999 999999999988653  35


Q ss_pred             ceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccc
Q 041921          593 RLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLT  672 (814)
Q Consensus       593 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~  672 (814)
                      .++|+||++ ++|..++... .+++..+..++.||+.||+|||+.   +|+|+||||+||+++.++.+||+|||++....
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~  158 (337)
T cd07852          84 IYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLS  158 (337)
T ss_pred             EEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence            799999997 5999988766 778999999999999999999998   99999999999999999999999999998765


Q ss_pred             cCCcc---cccccccCCCCccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhh-HHHHH-------HH
Q 041921          673 LNQSK---TIKTAIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI-LTDWA-------FD  740 (814)
Q Consensus       673 ~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~-~~~~~-------~~  740 (814)
                      .....   .......|+..|+|||.+.+ ...+.++||||||++++||++|+.||.......... .....       ..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
T cd07852         159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE  238 (337)
T ss_pred             cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            43221   12233568999999998755 457889999999999999999999996543321100 00000       00


Q ss_pred             Hhh----cCccceeecCccc--ccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          741 CYR----NGKLNVLVGEDKE--AMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       741 ~~~----~~~~~~~~~~~~~--~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                      .+.    ...+.........  .........++.+++.+||+.+|.+|||+.++++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            000    0000000000000  00011135678999999999999999999999864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.98  E-value=9.4e-32  Score=281.14  Aligned_cols=246  Identities=27%  Similarity=0.349  Sum_probs=201.5

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEe
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE  598 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  598 (814)
                      +.+.++||+|++|.||++...  .++..+++|.+....  .....++.+|+.++++++|+||+++.+++.+....++|+|
T Consensus         2 y~~~~~i~~g~~~~v~~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (256)
T cd08530           2 FKVLKKLGKGSYGSVYKVKRL--SDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME   79 (256)
T ss_pred             ceEeeeecCCCceeEEEEEEC--CCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence            456788999999999999865  356789999986432  2334568899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhcC----CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccC
Q 041921          599 FLNNGTLASFLFG----NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN  674 (814)
Q Consensus       599 ~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~  674 (814)
                      |+++++|.+++..    ...+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.+||+|||++......
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~  156 (256)
T cd08530          80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN  156 (256)
T ss_pred             hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence            9999999999865    35678899999999999999999998   9999999999999999999999999999876544


Q ss_pred             CcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCc
Q 041921          675 QSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGED  754 (814)
Q Consensus       675 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  754 (814)
                      ..    ....++..|+|||.+.+..++.++|+||||++++||++|+.||......+.       ...+..+....     
T Consensus       157 ~~----~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~-------~~~~~~~~~~~-----  220 (256)
T cd08530         157 MA----KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDL-------RYKVQRGKYPP-----  220 (256)
T ss_pred             Cc----ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHhcCCCCC-----
Confidence            11    224578899999999998899999999999999999999999975433221       11111221111     


Q ss_pred             ccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          755 KEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       755 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                          ........+.+++.+|++.+|.+|||+.++++.
T Consensus       221 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         221 ----IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             ----CchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence                112455778999999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=1.1e-31  Score=281.68  Aligned_cols=245  Identities=24%  Similarity=0.290  Sum_probs=192.1

Q ss_pred             cceeeeeeeeEEEEEEecCCCceEEEEEEeccccc---cchHhHHHHHHh-hhccCCCCccceeeeecccccceEEEecC
Q 041921          525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ---DGEREFKNEVFV-IGQTHHKNLVRLLGFCDEGQNRLLVYEFL  600 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e~~  600 (814)
                      +.||+|+||.||+|....  .++.||||.+.....   .....+..|..+ ....+|+|++++++++.+++..++|+||+
T Consensus         2 ~~l~~g~~~~v~~a~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   79 (260)
T cd05611           2 KPISKGAFGSVYLAKKRS--TGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYL   79 (260)
T ss_pred             ccCCcCCCeeEEEEEecC--CCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEecc
Confidence            468999999999998753  467899999864321   112234445444 44558999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccccc
Q 041921          601 NNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIK  680 (814)
Q Consensus       601 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  680 (814)
                      ++++|.+++.....+++..+..++.|+++||.|||+.   +++|+||+|+||+++.++.+||+|||++......      
T Consensus        80 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~------  150 (260)
T cd05611          80 NGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN------  150 (260)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceecccc------
Confidence            9999999998877889999999999999999999998   9999999999999999999999999998754321      


Q ss_pred             ccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCc
Q 041921          681 TAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMND  760 (814)
Q Consensus       681 ~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  760 (814)
                      ....++..|+|||.+.+..++.++||||||++++||++|..||.......       ....+..+....      .....
T Consensus       151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~------~~~~~  217 (260)
T cd05611         151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA-------VFDNILSRRINW------PEEVK  217 (260)
T ss_pred             ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHhcccCC------CCccc
Confidence            23457889999999988888999999999999999999999997543322       111111111110      00011


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 041921          761 IECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE  793 (814)
Q Consensus       761 ~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~  793 (814)
                      ......+.+++.+||+.+|++||++.++.+.|+
T Consensus       218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~  250 (260)
T cd05611         218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS  250 (260)
T ss_pred             ccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence            124567889999999999999998876666654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.98  E-value=7.5e-32  Score=294.02  Aligned_cols=264  Identities=23%  Similarity=0.313  Sum_probs=198.7

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccc--cccchHhHHHHHHhhhccCCCCccceeeeeccc-----cc
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV--FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEG-----QN  592 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  592 (814)
                      .|.+.+.||+|+||+||+|...  ..+..||||.+...  .......+..|+.+++.++|+||+++++++...     ..
T Consensus         6 ~y~~~~~lg~G~~~~vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           6 KYVPIKPIGRGAYGIVCSAKNS--ETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ceeEEEEeccCCCeEEEEEEec--CCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            3556678999999999999865  35789999998643  222345678899999999999999999988654     34


Q ss_pred             ceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccc
Q 041921          593 RLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLT  672 (814)
Q Consensus       593 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~  672 (814)
                      .++|+||+. ++|.+++.....+++.....++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++....
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~  159 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTS  159 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence            799999996 68999998878899999999999999999999998   99999999999999999999999999998664


Q ss_pred             cCCcccccccccCCCCccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhh--------
Q 041921          673 LNQSKTIKTAIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR--------  743 (814)
Q Consensus       673 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------  743 (814)
                      ....  ......++..|+|||.+.. ..++.++||||||++++||++|+.||.........   ..+.....        
T Consensus       160 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~  234 (337)
T cd07858         160 EKGD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQL---KLITELLGSPSEEDLG  234 (337)
T ss_pred             CCcc--cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHH---HHHHHHhCCCChHHhh
Confidence            3321  1133457889999998865 46889999999999999999999999654321111   00111000        


Q ss_pred             ---cCccceee-------cCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HhcC
Q 041921          744 ---NGKLNVLV-------GEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM--LEGV  795 (814)
Q Consensus       744 ---~~~~~~~~-------~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~--L~~~  795 (814)
                         ........       ..... ........++.+++.+||+.+|++|||++++++.  ++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         235 FIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             hcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence               00000000       00000 0011245678899999999999999999999865  5543

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=1.8e-31  Score=278.54  Aligned_cols=247  Identities=26%  Similarity=0.407  Sum_probs=202.2

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc--cchHhHHHHHHhhhccCCCCccceeeeecccccceEEEe
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ--DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE  598 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  598 (814)
                      +.+.+.||+|++|.||++....  .+..+++|.+.....  ...+.+.+|++++++++|+|++++++++.+....++++|
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (254)
T cd06627           2 YQLGDLIGRGAFGVVYKGLNLE--TGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE   79 (254)
T ss_pred             ceeeeEEcccCCeEEEEEEEcC--CCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence            4567899999999999998653  467899999976533  344679999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccc
Q 041921          599 FLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT  678 (814)
Q Consensus       599 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  678 (814)
                      |+++++|.+++.....+++..+..++.|++.+|.|||+.   +|+|+||+|+||+++.++.++|+|||++......... 
T Consensus        80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-  155 (254)
T cd06627          80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-  155 (254)
T ss_pred             cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-
Confidence            999999999998878899999999999999999999998   9999999999999999999999999999876543321 


Q ss_pred             ccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCccccc
Q 041921          679 IKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAM  758 (814)
Q Consensus       679 ~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  758 (814)
                       .....++..|+|||.+.+...+.++|||+||+++++|++|+.|+.......  .    .+... .....         .
T Consensus       156 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~--~----~~~~~-~~~~~---------~  218 (254)
T cd06627         156 -DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA--A----LFRIV-QDDHP---------P  218 (254)
T ss_pred             -ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH--H----HHHHh-ccCCC---------C
Confidence             123457889999999988888999999999999999999999986433211  0    01111 11100         0


Q ss_pred             CcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          759 NDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       759 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      .+......+.+++.+||+.+|++|||+.+++.
T Consensus       219 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         219 LPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            11123467889999999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.98  E-value=1.6e-31  Score=287.93  Aligned_cols=265  Identities=20%  Similarity=0.264  Sum_probs=192.7

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeecccc------
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ------  591 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  591 (814)
                      .+.+.++||+|+||.||+|....  .+..||||.+....  ......+.+|+.++++++||||+++++++....      
T Consensus        13 ~y~~~~~lg~g~~~~v~~~~~~~--~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          13 KYEKLAKIGQGTFGEVFKARHKK--TKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             heEEEEEeecCCCEEEEEEEECC--CCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            46677899999999999998653  57899999886432  222335678999999999999999999986654      


Q ss_pred             --cceEEEecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCc
Q 041921          592 --NRLLVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLA  668 (814)
Q Consensus       592 --~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla  668 (814)
                        ..++||||+.+ +|.+++... ..+++.....++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++
T Consensus        91 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~  166 (310)
T cd07865          91 KGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLA  166 (310)
T ss_pred             CceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCCc
Confidence              34999999975 788777654 4689999999999999999999998   9999999999999999999999999999


Q ss_pred             cccccCCcc--cccccccCCCCcccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcC
Q 041921          669 KLLTLNQSK--TIKTAIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG  745 (814)
Q Consensus       669 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  745 (814)
                      .........  .......++..|+|||.+.+. .++.++||||||++++||++|+.||..............+.......
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (310)
T cd07865         167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE  246 (310)
T ss_pred             ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            866432221  111234578899999988654 46889999999999999999999987554332211111111000000


Q ss_pred             cccee---------ecCcccc------cCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          746 KLNVL---------VGEDKEA------MNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       746 ~~~~~---------~~~~~~~------~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      .....         ..+....      .........+.+++.+||+.||.+|||++++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            00000         0000000      000012346678999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.98  E-value=1.8e-31  Score=286.45  Aligned_cols=264  Identities=23%  Similarity=0.281  Sum_probs=195.5

Q ss_pred             HHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeecccc---
Q 041921          517 EGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ---  591 (814)
Q Consensus       517 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---  591 (814)
                      ....+.+.+.||+|+||.||+|....  .+..|+||.++...  ......+.+|++++++++||||+++++++.+..   
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~--~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~   82 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKD--TGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL   82 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECC--CCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence            34556677899999999999999864  46789999986432  223346788999999999999999999987654   


Q ss_pred             -------cceEEEecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEe
Q 041921          592 -------NRLLVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARIS  663 (814)
Q Consensus       592 -------~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~  663 (814)
                             ..++|+||+++ +|..++... ..+++..+..++.|++.||+|||+.   +|+|+||||+||++++++.+||+
T Consensus        83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~  158 (302)
T cd07864          83 DFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLA  158 (302)
T ss_pred             hccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeC
Confidence                   78999999986 676766654 5689999999999999999999998   99999999999999999999999


Q ss_pred             ecCCccccccCCcccccccccCCCCccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHh
Q 041921          664 DFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY  742 (814)
Q Consensus       664 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  742 (814)
                      |||++........... ....++..|+|||.+.+ ..++.++||||||++++||++|+.||......+.  + ..+.+..
T Consensus       159 dfg~~~~~~~~~~~~~-~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~--~-~~~~~~~  234 (302)
T cd07864         159 DFGLARLYNSEESRPY-TNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQ--L-ELISRLC  234 (302)
T ss_pred             cccccccccCCccccc-ccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH--H-HHHHHHh
Confidence            9999987654322111 22345778999998864 4578899999999999999999999975432211  1 1111111


Q ss_pred             hcCcc---ceee--------cCcccc-----cCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          743 RNGKL---NVLV--------GEDKEA-----MNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       743 ~~~~~---~~~~--------~~~~~~-----~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      .....   ..+.        +.....     ......+..+.+++..||+.+|.+|||++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             CCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            11000   0000        000000     000113567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.98  E-value=3e-31  Score=291.30  Aligned_cols=263  Identities=23%  Similarity=0.265  Sum_probs=195.4

Q ss_pred             HhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccc--cccchHhHHHHHHhhhccCCCCccceeeeeccc-----
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV--FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEG-----  590 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----  590 (814)
                      ...+...+.||+|+||.||+|....  .+..||||.+...  ......++.+|+.++++++|+||+++++++...     
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   92 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTV--TGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE   92 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECC--CCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence            3456667899999999999998653  5779999998642  223345678899999999999999999988543     


Q ss_pred             -ccceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcc
Q 041921          591 -QNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAK  669 (814)
Q Consensus       591 -~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~  669 (814)
                       ...++|+||+. ++|.+.+...  ++......++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        93 ~~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~  166 (353)
T cd07850          93 FQDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR  166 (353)
T ss_pred             cCcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccce
Confidence             35699999996 4888877644  78888999999999999999998   99999999999999999999999999998


Q ss_pred             ccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhh-hHH--------H----
Q 041921          670 LLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA-ILT--------D----  736 (814)
Q Consensus       670 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~-~~~--------~----  736 (814)
                      .......   .....++..|+|||.+.+..++.++||||||+++++|++|+.||......... .+.        +    
T Consensus       167 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (353)
T cd07850         167 TAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR  243 (353)
T ss_pred             eCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            6543221   12345788999999999999999999999999999999999999654321100 000        0    


Q ss_pred             ---HHHHHhhcCc------cceeecCc----ccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          737 ---WAFDCYRNGK------LNVLVGED----KEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       737 ---~~~~~~~~~~------~~~~~~~~----~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                         ..........      +..+....    ............+.+++.+||+.||++|||+.|+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence               0000000000      00000000    0000012345678899999999999999999999853

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.98  E-value=8.9e-32  Score=293.40  Aligned_cols=267  Identities=23%  Similarity=0.317  Sum_probs=196.0

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccceeeeeccc-----ccc
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEG-----QNR  593 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~  593 (814)
                      .+.+.++||+|+||.||+|...  ..+..||||.+.... ......+..|+.++++++|+||+++++++...     ...
T Consensus         6 ~y~i~~~lg~G~~g~vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           6 RYQNLSYIGEGAYGMVCSATHK--PTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ceEEEEEEEecCCeEEEEEEEc--CCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            4667789999999999999865  357789999986432 22345688899999999999999999987543     357


Q ss_pred             eEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcccccc
Q 041921          594 LLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTL  673 (814)
Q Consensus       594 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~  673 (814)
                      ++|+||+++ +|.+++.. ..+++.....++.|+++||.|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus        84 ~lv~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~  158 (336)
T cd07849          84 YIVQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADP  158 (336)
T ss_pred             EEEehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence            899999975 88777743 4688999999999999999999998   999999999999999999999999999986543


Q ss_pred             CCccc-ccccccCCCCccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcC---ccc
Q 041921          674 NQSKT-IKTAIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG---KLN  748 (814)
Q Consensus       674 ~~~~~-~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~  748 (814)
                      ..... ......|+..|+|||.+.+ ..++.++||||||++++||++|+.||........   ...+...+...   ...
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~  235 (336)
T cd07849         159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ---LNLILGVLGTPSQEDLN  235 (336)
T ss_pred             cccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCCHHHHH
Confidence            22111 1123458899999998754 5688999999999999999999999964322110   00011111000   000


Q ss_pred             eeec-----------Cccccc---CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HhcCc
Q 041921          749 VLVG-----------EDKEAM---NDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM--LEGVV  796 (814)
Q Consensus       749 ~~~~-----------~~~~~~---~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~--L~~~~  796 (814)
                      .+..           ......   .......++.+++.+||+.+|++|||+.++++.  |+...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~  299 (336)
T cd07849         236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH  299 (336)
T ss_pred             HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence            0000           000000   001234678899999999999999999999876  65543

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.98  E-value=1.2e-31  Score=285.05  Aligned_cols=248  Identities=23%  Similarity=0.336  Sum_probs=189.7

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc-ccchHhHHHHHHh-hhccCCCCccceeeeecccccceEEEe
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF-QDGEREFKNEVFV-IGQTHHKNLVRLLGFCDEGQNRLLVYE  598 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e  598 (814)
                      +.+.+.||+|+||.||++...  .++..||+|+++... .....++..|+.+ ++..+||||+++++++..++..+++||
T Consensus         3 ~~~~~~ig~g~~g~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           3 LEVIEELGRGAYGVVDKMRHV--PTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             ceEEEEecccCCeEEEEEEEc--CCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            456788999999999999875  357899999986532 2233456666665 566689999999999999999999999


Q ss_pred             cCCCCCHHHHhcC----CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccC
Q 041921          599 FLNNGTLASFLFG----NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN  674 (814)
Q Consensus       599 ~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~  674 (814)
                      |++ ++|.+++..    ...+++.....++.|++.||+|||++  .+++||||||+||+++.++.+||+|||++......
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS  157 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            996 688777753    24678999999999999999999974  37999999999999999999999999998865432


Q ss_pred             CcccccccccCCCCccccccccc----CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCcccee
Q 041921          675 QSKTIKTAIRGTKGYVAPEWFRN----SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVL  750 (814)
Q Consensus       675 ~~~~~~~~~~gt~~y~aPE~~~~----~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  750 (814)
                      ..   .+...++..|+|||.+.+    ..++.++|+||||++++||++|+.||....... ..    ..... .+....+
T Consensus       158 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~----~~~~~-~~~~~~~  228 (283)
T cd06617         158 VA---KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF-QQ----LKQVV-EEPSPQL  228 (283)
T ss_pred             cc---cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH-HH----HHHHH-hcCCCCC
Confidence            11   123457889999998864    456889999999999999999999986422111 11    11111 1110000


Q ss_pred             ecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          751 VGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       751 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                              .....+..+.+++.+||+.+|.+||++.++++
T Consensus       229 --------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         229 --------PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             --------CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                    01123567889999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.98  E-value=1.2e-31  Score=285.94  Aligned_cols=250  Identities=26%  Similarity=0.377  Sum_probs=191.4

Q ss_pred             cccceeeeeeeeEEEEEEecCCCceEEEEEEecccc-ccchHhHHHHHHhhhccC-CCCccceeeeecccccceEEEecC
Q 041921          523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQTH-HKNLVRLLGFCDEGQNRLLVYEFL  600 (814)
Q Consensus       523 ~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~  600 (814)
                      +.++||+|+||.||++....  .+..+|+|.+.... ......+.+|+.++.++. |+||+++++++..+...++++||+
T Consensus         8 ~~~~lg~G~~g~vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~   85 (288)
T cd06616           8 DLGEIGRGAFGTVNKMLHKP--SGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELM   85 (288)
T ss_pred             HHHHhCCCCceEEEEEEECC--CCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecc
Confidence            45689999999999998753  57899999986432 234457889999999996 999999999999989999999998


Q ss_pred             CCCCHHHHh---c--CCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCC
Q 041921          601 NNGTLASFL---F--GNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ  675 (814)
Q Consensus       601 ~~gsL~~~l---~--~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~  675 (814)
                      +. +|.++.   .  ....+++.....++.|+++||+|||+.  .+|+||||||+||+++.++.+||+|||+++......
T Consensus        86 ~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  162 (288)
T cd06616          86 DI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI  162 (288)
T ss_pred             cC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC
Confidence            64 554432   2  235688999999999999999999974  289999999999999999999999999997654322


Q ss_pred             cccccccccCCCCcccccccccC---CCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeec
Q 041921          676 SKTIKTAIRGTKGYVAPEWFRNS---KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVG  752 (814)
Q Consensus       676 ~~~~~~~~~gt~~y~aPE~~~~~---~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  752 (814)
                      ..   ....++..|+|||.+.+.   .++.++||||||++++||++|+.||.....     ..+...+.. .+....   
T Consensus       163 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~-~~~~~~---  230 (288)
T cd06616         163 AK---TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVV-KGDPPI---  230 (288)
T ss_pred             cc---ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhhc-CCCCCc---
Confidence            11   233578899999998766   688999999999999999999999864321     001111111 111111   


Q ss_pred             CcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          753 EDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       753 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                        ...........++.+++.+|++.+|++|||+++|++.
T Consensus       231 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         231 --LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             --CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              1111112356678999999999999999999999863

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.98  E-value=1.8e-31  Score=285.45  Aligned_cols=260  Identities=22%  Similarity=0.285  Sum_probs=191.5

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc--cchHhHHHHHHhhhcc-CCCCccceeeeeccccc----
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ--DGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQN----  592 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~----  592 (814)
                      .+.+.+.||+|+||.||+|....  ++..||||.++....  .....+.+|+.+++++ +|+||+++++++...+.    
T Consensus         2 ~y~~~~~lg~g~~g~vy~~~~~~--~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~   79 (295)
T cd07837           2 AYEKLEKIGEGTYGKVYKARDKN--TGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP   79 (295)
T ss_pred             CceEeeEecccCCeEEEEEEECC--CCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence            35567889999999999999753  577899998764322  2235688899999999 46999999999877665    


Q ss_pred             -ceEEEecCCCCCHHHHhcCC-----CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC-CCcEEEeec
Q 041921          593 -RLLVYEFLNNGTLASFLFGN-----LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDD-YYTARISDF  665 (814)
Q Consensus       593 -~~lv~e~~~~gsL~~~l~~~-----~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~-~~~~kl~Df  665 (814)
                       .++||||+++ +|.+++...     ..+++.....++.||++||.|||+.   +|+||||+|+||+++. ++.+||+||
T Consensus        80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~df  155 (295)
T cd07837          80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADL  155 (295)
T ss_pred             eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeec
Confidence             7999999986 788887542     3578999999999999999999998   9999999999999998 899999999


Q ss_pred             CCccccccCCcccccccccCCCCccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhc
Q 041921          666 GLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN  744 (814)
Q Consensus       666 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  744 (814)
                      |+++.+.......  ....+++.|+|||.+.+ ..++.++||||||++++||++|..||......+.  +.. +...+..
T Consensus       156 g~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~--~~~-~~~~~~~  230 (295)
T cd07837         156 GLGRAFSIPVKSY--THEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ--LLH-IFKLLGT  230 (295)
T ss_pred             ccceecCCCcccc--CCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH--HHH-HHHHhCC
Confidence            9987654321111  22346788999998865 4578999999999999999999999865432111  000 1111110


Q ss_pred             Cccce---eec-------Cc----ccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          745 GKLNV---LVG-------ED----KEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       745 ~~~~~---~~~-------~~----~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      .....   ...       +.    ...........++.+++.+||+.+|.+||+++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         231 PTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             CChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            00000   000       00    000001124567889999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.98  E-value=1.6e-31  Score=283.07  Aligned_cols=243  Identities=27%  Similarity=0.321  Sum_probs=192.1

Q ss_pred             eeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEecCCCC
Q 041921          527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNG  603 (814)
Q Consensus       527 LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  603 (814)
                      ||+|+||+||++....  .+..+++|.+....   ....+.+..|++++++++||||+++++.+...+..++|+||++++
T Consensus         1 lg~g~~g~vy~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (277)
T cd05577           1 LGKGGFGEVCACQVKA--TGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGG   78 (277)
T ss_pred             CCCCCceeEEEEEEcC--CCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCC
Confidence            6899999999998653  57789999886422   223345788999999999999999999999999999999999999


Q ss_pred             CHHHHhcCCC--CCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcccccc
Q 041921          604 TLASFLFGNL--KPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKT  681 (814)
Q Consensus       604 sL~~~l~~~~--~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  681 (814)
                      +|.+++....  .+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.+||+|||++.........   .
T Consensus        79 ~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~---~  152 (277)
T cd05577          79 DLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKI---K  152 (277)
T ss_pred             cHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCCcc---c
Confidence            9999997654  688999999999999999999998   9999999999999999999999999998765432111   2


Q ss_pred             cccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCcH
Q 041921          682 AIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDI  761 (814)
Q Consensus       682 ~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  761 (814)
                      ...++..|+|||.+.+..++.++||||||+++++|++|+.||.........   ..+.    ......    ..  ....
T Consensus       153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~----~~~~~~----~~--~~~~  219 (277)
T cd05577         153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK---EELK----RRTLEM----AV--EYPD  219 (277)
T ss_pred             cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH---HHHH----hccccc----cc--cCCc
Confidence            345788999999998888999999999999999999999999654321100   0000    110000    00  0112


Q ss_pred             HHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 041921          762 ECLGKLVMVSIWCIQEDPSLRP-----TMKKVLQ  790 (814)
Q Consensus       762 ~~~~~l~~l~~~Cl~~dp~~RP-----t~~~vl~  790 (814)
                      .....+.+++.+||+.+|.+||     ++.++++
T Consensus       220 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         220 KFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             cCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            2356788999999999999999     6666764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.97  E-value=2.2e-31  Score=286.82  Aligned_cols=261  Identities=26%  Similarity=0.277  Sum_probs=193.5

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc--cchHhHHHHHHhhhccCCCCccceeeeeccc--ccceE
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ--DGEREFKNEVFVIGQTHHKNLVRLLGFCDEG--QNRLL  595 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  595 (814)
                      .+.+.++||+|+||.||+|....  .+..||+|.++....  .....+.+|+.++++++|+||+++++++.+.  +..++
T Consensus         8 ~y~~~~~ig~g~~~~v~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           8 EFEKLNRIGEGTYGIVYRARDTT--SGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ceeEeeeeeecCCEEEEEEEECC--CCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            45667889999999999999753  577899999864322  2233567899999999999999999998654  45799


Q ss_pred             EEecCCCCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccC
Q 041921          596 VYEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN  674 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~  674 (814)
                      |+||+.+ +|.+++.. ...+++..+..++.|+++||+|||+.   +++||||||+||++++++.+||+|||++......
T Consensus        86 v~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~  161 (309)
T cd07845          86 VMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP  161 (309)
T ss_pred             EEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence            9999975 78888765 36689999999999999999999998   9999999999999999999999999999876543


Q ss_pred             CcccccccccCCCCccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcC--------
Q 041921          675 QSKTIKTAIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG--------  745 (814)
Q Consensus       675 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--------  745 (814)
                      ....  ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+...   .+.......        
T Consensus       162 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~---~~~~~~~~~~~~~~~~~  236 (309)
T cd07845         162 AKPM--TPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLD---LIIQLLGTPNESIWPGF  236 (309)
T ss_pred             cCCC--CcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHhcCCCChhhchhh
Confidence            2111  22345788999999865 457899999999999999999999997544322111   011111000        


Q ss_pred             ---cc-ceeecCcccccC----cHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          746 ---KL-NVLVGEDKEAMN----DIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       746 ---~~-~~~~~~~~~~~~----~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                         .. ............    .......+.+++.+||+.||++|||++++++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence               00 000000000000    01125667889999999999999999999853

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=2.5e-31  Score=282.50  Aligned_cols=261  Identities=24%  Similarity=0.349  Sum_probs=195.5

Q ss_pred             ccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc-cchHhHHHHHHhhhccC-CCCccceeeeecccccceEEEec
Q 041921          522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ-DGEREFKNEVFVIGQTH-HKNLVRLLGFCDEGQNRLLVYEF  599 (814)
Q Consensus       522 ~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  599 (814)
                      .+.+.||+|++|+||+|+...  .+..|+||++..... .......+|+..+.+++ |+||+++++++.+++..++||||
T Consensus         2 ~~~~~ig~g~~g~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~   79 (283)
T cd07830           2 KVIKQLGDGTFGSVYLARNKE--TGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY   79 (283)
T ss_pred             eeheeeccCCceEEEEEEECC--CCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence            467889999999999999753  467899999865432 22234567899999998 99999999999999999999999


Q ss_pred             CCCCCHHHHhcCCC--CCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcc
Q 041921          600 LNNGTLASFLFGNL--KPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSK  677 (814)
Q Consensus       600 ~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  677 (814)
                      + +++|.+++....  .+++..+..++.|++.+|.|||+.   +++|+||+|+||++++++.++|+|||++.........
T Consensus        80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~  155 (283)
T cd07830          80 M-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY  155 (283)
T ss_pred             C-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCCc
Confidence            9 889999887654  789999999999999999999998   9999999999999999999999999999866432221


Q ss_pred             cccccccCCCCcccccccc-cCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhh-hHHH---------HHHHHhhcCc
Q 041921          678 TIKTAIRGTKGYVAPEWFR-NSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA-ILTD---------WAFDCYRNGK  746 (814)
Q Consensus       678 ~~~~~~~gt~~y~aPE~~~-~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~-~~~~---------~~~~~~~~~~  746 (814)
                         ....++..|+|||.+. ...++.++|+||||++++||++|+.||......+.. ....         |.........
T Consensus       156 ---~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07830         156 ---TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK  232 (283)
T ss_pred             ---CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence               2345788999999875 446789999999999999999999998654332211 0000         0000000001


Q ss_pred             cceeecCcccc---cCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          747 LNVLVGEDKEA---MNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       747 ~~~~~~~~~~~---~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                      +..........   .........+.+++.+|++.+|++|||++|++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            11000000000   0001124678899999999999999999998753

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.97  E-value=2.4e-31  Score=283.50  Aligned_cols=257  Identities=21%  Similarity=0.231  Sum_probs=201.0

Q ss_pred             hccccceeeeeeeeEEEEEEecC-CCceEEEEEEecccc----ccchHhHHHHHHhhhcc-CCCCccceeeeecccccce
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTR-TSTTAVAVKKLDRVF----QDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRL  594 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~-~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  594 (814)
                      +.+.+.||+|++|.||++..... ..+..||||.++...    ....+.+.+|+.++.++ +|+||+++++.+..+...+
T Consensus         2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~   81 (288)
T cd05583           2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH   81 (288)
T ss_pred             ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence            45678899999999999986532 356789999886432    12335688999999999 6999999999999999999


Q ss_pred             EEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccC
Q 041921          595 LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN  674 (814)
Q Consensus       595 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~  674 (814)
                      +||||+++++|.+++.....+++.....++.|++++|.|||+.   +++|+||+|+||+++.++.++|+|||+++.+...
T Consensus        82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  158 (288)
T cd05583          82 LILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE  158 (288)
T ss_pred             EEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence            9999999999999998777788999999999999999999998   9999999999999999999999999998865543


Q ss_pred             CcccccccccCCCCcccccccccCC--CCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeec
Q 041921          675 QSKTIKTAIRGTKGYVAPEWFRNSK--ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVG  752 (814)
Q Consensus       675 ~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  752 (814)
                      .... .....++..|+|||.+.+..  .+.++||||||++++||++|..||.......  ...+...... ...      
T Consensus       159 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~-~~~------  228 (288)
T cd05583         159 EEER-AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEISRRIL-KSK------  228 (288)
T ss_pred             cccc-cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHHHHHH-ccC------
Confidence            2211 12345889999999987654  7889999999999999999999986432211  1111111111 110      


Q ss_pred             CcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 041921          753 EDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEG  794 (814)
Q Consensus       753 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~  794 (814)
                      .    ..+......+.+++.+||+.+|++|||+.++.+.|+.
T Consensus       229 ~----~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         229 P----PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             C----CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence            0    0111234567889999999999999999999888865

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.97  E-value=1.8e-31  Score=287.34  Aligned_cols=249  Identities=23%  Similarity=0.299  Sum_probs=194.9

Q ss_pred             HHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccc---cccchHhHHHHHHhhhccCCCCccceeeeecccccc
Q 041921          517 EGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV---FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNR  593 (814)
Q Consensus       517 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  593 (814)
                      ...++...+.||+|+||.||+|....  .+..+++|.+...   .....+++.+|+++++.++|+|++++.+++......
T Consensus        13 ~~~~~~~~~~lg~g~~g~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   90 (308)
T cd06634          13 PEKLFSDLREIGHGSFGAVYFARDVR--NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTA   90 (308)
T ss_pred             cHHHHHHHHheeeCCCEEEEEEEEcC--CCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCee
Confidence            34445556789999999999999753  5678999988632   222335688899999999999999999999999999


Q ss_pred             eEEEecCCCCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccc
Q 041921          594 LLVYEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLT  672 (814)
Q Consensus       594 ~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~  672 (814)
                      ++|+||+. ++|.+++.. ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||++....
T Consensus        91 ~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  166 (308)
T cd06634          91 WLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA  166 (308)
T ss_pred             EEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeec
Confidence            99999997 578777653 45678899999999999999999998   99999999999999999999999999987654


Q ss_pred             cCCcccccccccCCCCcccccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccce
Q 041921          673 LNQSKTIKTAIRGTKGYVAPEWFR---NSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNV  749 (814)
Q Consensus       673 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  749 (814)
                      ..      ....++..|+|||.+.   ....+.++||||||++++||++|+.|+......+.      ... +..+....
T Consensus       167 ~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~-~~~~~~~~  233 (308)
T cd06634         167 PA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYH-IAQNESPA  233 (308)
T ss_pred             Cc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH------HHH-HhhcCCCC
Confidence            32      2345788999999874   35678899999999999999999999864322111      001 11111100


Q ss_pred             eecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 041921          750 LVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQML  792 (814)
Q Consensus       750 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L  792 (814)
                              .........+.+++.+||+.+|.+||++.++++..
T Consensus       234 --------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~  268 (308)
T cd06634         234 --------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  268 (308)
T ss_pred             --------cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence                    01123446688999999999999999999998764

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.97  E-value=2.6e-31  Score=284.13  Aligned_cols=260  Identities=25%  Similarity=0.341  Sum_probs=192.5

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEE
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY  597 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  597 (814)
                      .+.+.++||+|++|.||+|....  +++.|++|++....  ....+.+.+|++++++++|+||+++++++.+....++|+
T Consensus         3 ~y~~~~~l~~g~~~~v~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (294)
T PLN00009          3 QYEKVEKIGEGTYGVVYKARDRV--TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF   80 (294)
T ss_pred             ceEEEEEecCCCCEEEEEEEecC--CCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence            35667899999999999998753  56789999886432  233456889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhcCCC--CCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC-CCcEEEeecCCccccccC
Q 041921          598 EFLNNGTLASFLFGNL--KPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDD-YYTARISDFGLAKLLTLN  674 (814)
Q Consensus       598 e~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~-~~~~kl~DfGla~~~~~~  674 (814)
                      ||++ ++|.+++....  ..++.....++.||+.||+|||+.   +++|+||+|+||+++. ++.+||+|||++......
T Consensus        81 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         81 EYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP  156 (294)
T ss_pred             eccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence            9996 57887775543  346777889999999999999998   9999999999999985 567999999999765432


Q ss_pred             CcccccccccCCCCcccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccce----
Q 041921          675 QSKTIKTAIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNV----  749 (814)
Q Consensus       675 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----  749 (814)
                      ...  .....++..|+|||.+.+. .++.++||||||++++||+||+.||......+.  +.. ............    
T Consensus       157 ~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~--~~~-~~~~~~~~~~~~~~~~  231 (294)
T PLN00009        157 VRT--FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE--LFK-IFRILGTPNEETWPGV  231 (294)
T ss_pred             ccc--cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-HHHHhCCCChhhcccc
Confidence            211  1233578899999988664 578999999999999999999999975433211  100 111111000000    


Q ss_pred             --eec-----Ccccc----cCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          750 --LVG-----EDKEA----MNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       750 --~~~-----~~~~~----~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                        +.+     +....    ........++.+++.+|++.+|++||++.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence              000     00000    001123466889999999999999999999986

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.7e-31  Score=279.31  Aligned_cols=250  Identities=21%  Similarity=0.264  Sum_probs=195.8

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccc-----cccchHhHHHHHHhhhccCCCCccceeeeeccc--cc
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV-----FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEG--QN  592 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~  592 (814)
                      .+.+.+.||+|+||.||+|...  ..+..|++|.+...     ..+....+.+|++++++++|+||+++++++.+.  ..
T Consensus         3 ~~~~~~~lg~g~~g~v~~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   80 (264)
T cd06653           3 NWRLGKLLGRGAFGEVYLCYDA--DTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKK   80 (264)
T ss_pred             ceeeeeeEccCCCeEEEEEEEc--CCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCE
Confidence            3567789999999999999865  35778999987432     122335688999999999999999999998664  45


Q ss_pred             ceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccc
Q 041921          593 RLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLT  672 (814)
Q Consensus       593 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~  672 (814)
                      .++++||+++++|.+++.....+++....+++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||+++...
T Consensus        81 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  157 (264)
T cd06653          81 LSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQ  157 (264)
T ss_pred             EEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence            789999999999999998777788999999999999999999998   99999999999999999999999999998654


Q ss_pred             cCCc-ccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceee
Q 041921          673 LNQS-KTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLV  751 (814)
Q Consensus       673 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  751 (814)
                      .... ........++..|+|||.+.+..++.++|+||||++++||++|+.||........      +.+......     
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~~~-----  226 (264)
T cd06653         158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA------IFKIATQPT-----  226 (264)
T ss_pred             cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH------HHHHHcCCC-----
Confidence            3211 1111234588999999999988899999999999999999999999964322111      111111110     


Q ss_pred             cCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          752 GEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       752 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                          ....+....+.+.+++.+|++ +|..||+..+++.
T Consensus       227 ----~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         227 ----KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             ----CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence                011122345678899999999 5799999998775

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.97  E-value=2.3e-31  Score=282.72  Aligned_cols=258  Identities=22%  Similarity=0.329  Sum_probs=198.5

Q ss_pred             ccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc--cchHhHHHHHHhhhccCCCCccceeeeecccccceEEEec
Q 041921          522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ--DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  599 (814)
Q Consensus       522 ~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  599 (814)
                      ...+.||+|++|.||++....  ++..+++|++.....  .....+..|+.++++++|+||+++++++..+...++|+||
T Consensus         2 ~~~~~i~~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (283)
T cd05118           2 QKLGKIGEGTYGVVYKARDKL--TGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF   79 (283)
T ss_pred             ccceeeecCCCceEEEEEcCC--CCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence            455789999999999998753  578899999865432  2345788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccc
Q 041921          600 LNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT  678 (814)
Q Consensus       600 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  678 (814)
                      +++ +|.+++... ..+++..+..++.|+++||.|||+.   +|+|+||+|+||+++.++.+||+|||.+......... 
T Consensus        80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~-  154 (283)
T cd05118          80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP-  154 (283)
T ss_pred             cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccc-
Confidence            975 888877653 6789999999999999999999998   9999999999999999999999999999877654311 


Q ss_pred             ccccccCCCCcccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcC---ccceeec--
Q 041921          679 IKTAIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG---KLNVLVG--  752 (814)
Q Consensus       679 ~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~--  752 (814)
                       .....++..|+|||.+.+. ..+.++|+||||+++++|++|+.||......+...   .....+...   ....+..  
T Consensus       155 -~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  230 (283)
T cd05118         155 -YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLF---KIFRTLGTPDPEVWPKFTSLA  230 (283)
T ss_pred             -ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHcCCCchHhcccchhhh
Confidence             1234578899999998776 78999999999999999999999986544322110   011111000   0000000  


Q ss_pred             ----------Cccc-ccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          753 ----------EDKE-AMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       753 ----------~~~~-~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                                .... .........++.+++..||+.||.+||++++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence                      0000 0011235678999999999999999999999986

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.97  E-value=1.9e-31  Score=290.48  Aligned_cols=266  Identities=21%  Similarity=0.331  Sum_probs=197.8

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeecc----ccc
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDE----GQN  592 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~  592 (814)
                      ..+.+.+.||+|++|.||+|....  .+..|++|++....  ....+.+.+|+.++++++||||+++++++..    ...
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~--~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTR--SGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD   82 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcC--CCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence            345667889999999999998653  57799999986532  2334567889999999999999999998753    346


Q ss_pred             ceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccc
Q 041921          593 RLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLT  672 (814)
Q Consensus       593 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~  672 (814)
                      .++|+||+. ++|.+++.....+++.....++.||++||.|||+.   +|+||||||+||++++++.+||+|||++....
T Consensus        83 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~  158 (334)
T cd07855          83 VYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLS  158 (334)
T ss_pred             EEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence            799999996 68999998777799999999999999999999998   99999999999999999999999999997654


Q ss_pred             cCCcc--cccccccCCCCccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHH--------HHHHH
Q 041921          673 LNQSK--TIKTAIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD--------WAFDC  741 (814)
Q Consensus       673 ~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~--------~~~~~  741 (814)
                      .....  .......++..|+|||.+.. ..++.++||||||++++||++|+.||.............        .....
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~  238 (334)
T cd07855         159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR  238 (334)
T ss_pred             ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhh
Confidence            32211  11123468899999999865 468899999999999999999999996543221100000        00000


Q ss_pred             hhcCccceeecC-cccccC-----cHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          742 YRNGKLNVLVGE-DKEAMN-----DIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       742 ~~~~~~~~~~~~-~~~~~~-----~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      .....+...... ......     ......++.+++.+||+.+|.+|||++++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             hchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            000111100000 000000     1123678899999999999999999999886

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.97  E-value=3.6e-31  Score=280.57  Aligned_cols=242  Identities=24%  Similarity=0.261  Sum_probs=188.5

Q ss_pred             ceeeeeeeeEEEEEEecCCCceEEEEEEeccccc---cchHhHHHHHH---hhhccCCCCccceeeeecccccceEEEec
Q 041921          526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ---DGEREFKNEVF---VIGQTHHKNLVRLLGFCDEGQNRLLVYEF  599 (814)
Q Consensus       526 ~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~---~l~~l~h~niv~l~~~~~~~~~~~lv~e~  599 (814)
                      .||+|+||.||++....  .++.||+|.+.....   .....+..|..   .++...||||+++.+++.+.+..++|+||
T Consensus         1 ~ig~g~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   78 (278)
T cd05606           1 IIGRGGFGEVYGCRKAD--TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDL   78 (278)
T ss_pred             CcccCCCeEEEEEEEec--CCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEec
Confidence            48999999999998653  577999998864321   11222444443   34445799999999999999999999999


Q ss_pred             CCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcccc
Q 041921          600 LNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI  679 (814)
Q Consensus       600 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  679 (814)
                      +++++|..++.....+++..+..++.|+++||.|||+.   +|+||||||+||+++.++.+||+|||++..+.....   
T Consensus        79 ~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~---  152 (278)
T cd05606          79 MNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---  152 (278)
T ss_pred             CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC---
Confidence            99999999998778899999999999999999999998   999999999999999999999999999875543221   


Q ss_pred             cccccCCCCcccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCccccc
Q 041921          680 KTAIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAM  758 (814)
Q Consensus       680 ~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  758 (814)
                       ....|+..|+|||.+.++ .++.++||||+|++++||++|+.||...........    ........        ..  
T Consensus       153 -~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~--------~~--  217 (278)
T cd05606         153 -HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTLTMA--------VE--  217 (278)
T ss_pred             -cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH----HHHhhccC--------CC--
Confidence             234589999999998754 688999999999999999999999975432211111    11110000        00  


Q ss_pred             CcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 041921          759 NDIECLGKLVMVSIWCIQEDPSLRP-----TMKKVLQ  790 (814)
Q Consensus       759 ~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~~vl~  790 (814)
                      .+.....++.+++.+|++.+|.+||     ++.++++
T Consensus       218 ~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         218 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence            1112356788999999999999999     9999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.6e-31  Score=290.68  Aligned_cols=268  Identities=23%  Similarity=0.329  Sum_probs=204.8

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeecccc-----cc
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ-----NR  593 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~  593 (814)
                      +.+.+.||+|++|.||+|....  .+..++||++....  ....+.+.+|+.+++.++|+||+++++++....     ..
T Consensus         2 y~i~~~ig~g~~~~v~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (330)
T cd07834           2 YELLKPIGSGAYGVVCSAVDKR--TGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV   79 (330)
T ss_pred             ceeeeeecCCCCeEEEEEEeCC--CCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence            5667899999999999999653  47789999987643  334467899999999999999999999998765     78


Q ss_pred             eEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcccccc
Q 041921          594 LLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTL  673 (814)
Q Consensus       594 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~  673 (814)
                      ++||||++ ++|.+++.....+++..+..++.|+++||+|||+.   +|+|+||||+||+++.++.++|+|||++.....
T Consensus        80 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~  155 (330)
T cd07834          80 YIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDP  155 (330)
T ss_pred             EEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence            99999998 48999998877899999999999999999999998   999999999999999999999999999987654


Q ss_pred             CCcc-cccccccCCCCcccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhh--------
Q 041921          674 NQSK-TIKTAIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR--------  743 (814)
Q Consensus       674 ~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------  743 (814)
                      .... .......++..|+|||.+.+. .++.++|+||||+++++|++|+.||......+...   .+.....        
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~---~i~~~~~~~~~~~~~  232 (330)
T cd07834         156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLN---LIVEVLGTPSEEDLK  232 (330)
T ss_pred             cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHH---HHHHhcCCCChhHhh
Confidence            3210 111334578899999999887 78999999999999999999999997554322110   0111000        


Q ss_pred             ---cCccceeecC-ccccc-----CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HhcCcC
Q 041921          744 ---NGKLNVLVGE-DKEAM-----NDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM--LEGVVE  797 (814)
Q Consensus       744 ---~~~~~~~~~~-~~~~~-----~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~--L~~~~~  797 (814)
                         .......+.. .....     ........+.+++.+||+.+|.+|||++++++.  ++++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~  297 (330)
T cd07834         233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD  297 (330)
T ss_pred             hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence               0000000000 00000     011235678899999999999999999999974  555444

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=2.1e-32  Score=276.69  Aligned_cols=260  Identities=22%  Similarity=0.333  Sum_probs=210.9

Q ss_pred             HHHhhhccccceeeeeeeeEEEEEEecCC---CceEEEEEEecccccc-chHhHHHHHHhhhccCCCCccceeeeeccc-
Q 041921          516 LEGATNNFKEEVGRGSFGIVYKGVIQTRT---STTAVAVKKLDRVFQD-GEREFKNEVFVIGQTHHKNLVRLLGFCDEG-  590 (814)
Q Consensus       516 l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~---~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-  590 (814)
                      +.+.+......+-+|.||.||.|.+.+.+   +.+.|.||.++....+ ....+..|...+..+.|||+..+.+++.++ 
T Consensus       281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~  360 (563)
T KOG1024|consen  281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDY  360 (563)
T ss_pred             hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeecc
Confidence            33444445567999999999999887533   3457788887654322 334688999999999999999999999764 


Q ss_pred             ccceEEEecCCCCCHHHHhc-----CC---CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEE
Q 041921          591 QNRLLVYEFLNNGTLASFLF-----GN---LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARI  662 (814)
Q Consensus       591 ~~~~lv~e~~~~gsL~~~l~-----~~---~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl  662 (814)
                      ...+.+|.++.-|+|..||.     +.   +.+...+...++.|++.|++|||..   +|+|.||..+|.++|+..++||
T Consensus       361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVkl  437 (563)
T KOG1024|consen  361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKL  437 (563)
T ss_pred             CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEe
Confidence            56789999999999999997     21   4456667778999999999999998   9999999999999999999999


Q ss_pred             eecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHH
Q 041921          663 SDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDC  741 (814)
Q Consensus       663 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~  741 (814)
                      +|=.+++.+-+............+..||+||.+.+..++.++|||||||+||||+| |+.|+....+.+..       ..
T Consensus       438 tDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~-------~y  510 (563)
T KOG1024|consen  438 TDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME-------HY  510 (563)
T ss_pred             ccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH-------HH
Confidence            99999998877766655555557889999999999999999999999999999999 99999755544321       12


Q ss_pred             hhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 041921          742 YRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEG  794 (814)
Q Consensus       742 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~  794 (814)
                      +.+|         .+...+..++++|..++.-||...|++||++++++.-|.+
T Consensus       511 lkdG---------yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse  554 (563)
T KOG1024|consen  511 LKDG---------YRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE  554 (563)
T ss_pred             Hhcc---------ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence            2222         2223456788999999999999999999999999988865

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.97  E-value=2.7e-31  Score=289.57  Aligned_cols=260  Identities=22%  Similarity=0.255  Sum_probs=195.4

Q ss_pred             cccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccc--------------hHhHHHHHHhhhccCCCCccceeeeec
Q 041921          523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG--------------EREFKNEVFVIGQTHHKNLVRLLGFCD  588 (814)
Q Consensus       523 ~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~~~~~  588 (814)
                      +.+.||+|+||.||+|...  ..++.||||.+.......              ...+.+|++++++++|+||+++++++.
T Consensus        13 ~~~~ig~G~~g~vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   90 (335)
T PTZ00024         13 KGAHLGEGTYGKVEKAYDT--LTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYV   90 (335)
T ss_pred             hhhcccCCCceeEEEEEEC--CCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEe
Confidence            4567999999999999865  357889999886432211              124778999999999999999999999


Q ss_pred             ccccceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCc
Q 041921          589 EGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLA  668 (814)
Q Consensus       589 ~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla  668 (814)
                      .++..++||||+. ++|.+++.....+++.....++.|+++||.|||+.   +|+|+||+|+||+++.++.+||+|||++
T Consensus        91 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~dfg~~  166 (335)
T PTZ00024         91 EGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLA  166 (335)
T ss_pred             cCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECCccce
Confidence            9999999999997 69999998777889999999999999999999998   9999999999999999999999999999


Q ss_pred             cccccCCc------------ccccccccCCCCcccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHH
Q 041921          669 KLLTLNQS------------KTIKTAIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILT  735 (814)
Q Consensus       669 ~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~  735 (814)
                      ........            ........++..|+|||.+.+. .++.++||||||++++||++|+.||......+.  + 
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~--~-  243 (335)
T PTZ00024        167 RRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ--L-  243 (335)
T ss_pred             eecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--H-
Confidence            86651110            0111223467889999998764 468899999999999999999999975543221  1 


Q ss_pred             HHHHHHhhcCccc---ee--------ecCcc---cccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          736 DWAFDCYRNGKLN---VL--------VGEDK---EAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       736 ~~~~~~~~~~~~~---~~--------~~~~~---~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                      ..+..........   ..        .....   ..........++.+++.+||+.+|++|||+++++..
T Consensus       244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~  313 (335)
T PTZ00024        244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH  313 (335)
T ss_pred             HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence            1111111110000   00        00000   000011235678899999999999999999999863

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.97  E-value=4e-31  Score=276.38  Aligned_cols=248  Identities=26%  Similarity=0.387  Sum_probs=202.4

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc--cchHhHHHHHHhhhccCCCCccceeeeecccccceEEEe
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ--DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE  598 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  598 (814)
                      +.+.+.||+|++|.||++....  ++..+++|++.....  ...+++.+|++++++++|+|++++++.+......++|+|
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e   79 (258)
T cd08215           2 YEIIKQIGKGSFGKVYLVRRKS--DGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME   79 (258)
T ss_pred             ceEEeeeccCCCeEEEEEEEcC--CCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence            4566789999999999999753  567899999875432  445678999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhcCC----CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccC
Q 041921          599 FLNNGTLASFLFGN----LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN  674 (814)
Q Consensus       599 ~~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~  674 (814)
                      |+++++|.+++...    ..+++..+..++.+++.||.|||+.   +++|+||+|+||++++++.++|+|||++......
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  156 (258)
T cd08215          80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST  156 (258)
T ss_pred             ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence            99999999999763    6789999999999999999999998   9999999999999999999999999999876543


Q ss_pred             CcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCc
Q 041921          675 QSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGED  754 (814)
Q Consensus       675 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  754 (814)
                      ..  ......|+..|+|||.+....++.++||||+|+++++|++|+.||......+      .. ..........+    
T Consensus       157 ~~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~-~~~~~~~~~~~----  223 (258)
T cd08215         157 VD--LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE------LA-LKILKGQYPPI----  223 (258)
T ss_pred             cc--eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH------HH-HHHhcCCCCCC----
Confidence            31  1133458889999999988889999999999999999999999986443211      11 11111111111    


Q ss_pred             ccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          755 KEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       755 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                           +......+.+++.+||..+|++|||+.++++.
T Consensus       224 -----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         224 -----PSQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             -----CCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                 11344678899999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.97  E-value=2.7e-31  Score=290.23  Aligned_cols=271  Identities=22%  Similarity=0.294  Sum_probs=197.0

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeecccc------c
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ------N  592 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~  592 (814)
                      +...+.||+|+||.||+|+...  .+..||||++....  ......+.+|+.++++++|+||+++++++....      .
T Consensus        17 y~~~~~ig~g~~g~v~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   94 (342)
T cd07879          17 YTSLKQVGSGAYGSVCSAIDKR--TGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD   94 (342)
T ss_pred             eEEEEEeeecCCeEEEEEEeCC--CCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence            4445789999999999998653  57789999986432  222356889999999999999999999986543      4


Q ss_pred             ceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccc
Q 041921          593 RLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLT  672 (814)
Q Consensus       593 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~  672 (814)
                      .++|+||+.. +|..++.  ..+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||+++...
T Consensus        95 ~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~  168 (342)
T cd07879          95 FYLVMPYMQT-DLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHAD  168 (342)
T ss_pred             EEEEeccccc-CHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence            5899999864 7777653  3578899999999999999999998   99999999999999999999999999987653


Q ss_pred             cCCcccccccccCCCCccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHH----------HHH
Q 041921          673 LNQSKTIKTAIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA----------FDC  741 (814)
Q Consensus       673 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~----------~~~  741 (814)
                      ...     ....++..|+|||.+.+ ..++.++||||||++++||++|+.||........  +....          ...
T Consensus       169 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~  241 (342)
T cd07879         169 AEM-----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ--LTQILKVTGVPGPEFVQK  241 (342)
T ss_pred             CCC-----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCCHHHHHH
Confidence            221     23457889999999876 4688999999999999999999999975432111  00000          000


Q ss_pred             hhcCccceeecCccccc-C-----cHHHHHHHHHHHHHccccCCCCCCCHHHHH--HHHhcCcCCCCCCCCCC
Q 041921          742 YRNGKLNVLVGEDKEAM-N-----DIECLGKLVMVSIWCIQEDPSLRPTMKKVL--QMLEGVVEVSVPPNPYP  806 (814)
Q Consensus       742 ~~~~~~~~~~~~~~~~~-~-----~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl--~~L~~~~~~~~p~~p~~  806 (814)
                      +................ .     .......+.+++.+||+.||.+||++++++  ..++.+.+.+..+.|..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~~~~~~  314 (342)
T cd07879         242 LEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEETEQQP  314 (342)
T ss_pred             hcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccccCCCCc
Confidence            00000000000000000 0     011235678999999999999999999999  44777766654444443

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.97  E-value=5e-32  Score=262.06  Aligned_cols=247  Identities=22%  Similarity=0.350  Sum_probs=192.2

Q ss_pred             cccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc-cchHhHHHHHHhhhccC-CCCccceeeeecccccceEEEecC
Q 041921          523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ-DGEREFKNEVFVIGQTH-HKNLVRLLGFCDEGQNRLLVYEFL  600 (814)
Q Consensus       523 ~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~  600 (814)
                      +...||.|..|.|+++....  .+..+|||.+..... +..+.++..+.++.+-+ +|.||+.+|||..+....+.||.|
T Consensus        96 ~l~dlGsGtcG~V~k~~~rs--~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM  173 (391)
T KOG0983|consen   96 NLGDLGSGTCGQVWKMRFRS--TGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM  173 (391)
T ss_pred             hHHhhcCCCccceEEEEEcc--cceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence            34679999999999999874  578999999976543 33355777777776664 899999999999999999999998


Q ss_pred             CCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcccc
Q 041921          601 NNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI  679 (814)
Q Consensus       601 ~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  679 (814)
                      .. .++.+|... .++++...-++...+++||.||.++  .+|+|||+||+|||+|+.|++||+|||++..+......  
T Consensus       174 s~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh--  248 (391)
T KOG0983|consen  174 ST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH--  248 (391)
T ss_pred             HH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceeeccccc--
Confidence            43 455555443 5577777788999999999999876  59999999999999999999999999999877654433  


Q ss_pred             cccccCCCCccccccccc---CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCccc
Q 041921          680 KTAIRGTKGYVAPEWFRN---SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKE  756 (814)
Q Consensus       680 ~~~~~gt~~y~aPE~~~~---~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  756 (814)
                       +...|-+.|||||.+.-   .+|+.++||||||+.|+||.||+.||.....+-. .     ...+.+.       +.+.
T Consensus       249 -trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe-~-----ltkvln~-------ePP~  314 (391)
T KOG0983|consen  249 -TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE-V-----LTKVLNE-------EPPL  314 (391)
T ss_pred             -ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH-H-----HHHHHhc-------CCCC
Confidence             44568899999999853   4688999999999999999999999976443211 1     1111111       1112


Q ss_pred             ccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          757 AMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       757 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      .+........+++++..||++|+.+||...++++
T Consensus       315 L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  315 LPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             CCcccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence            2222235678889999999999999999988875

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.97  E-value=5e-31  Score=284.45  Aligned_cols=242  Identities=26%  Similarity=0.341  Sum_probs=190.1

Q ss_pred             cccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc---cchHhHHHHHHhhhccCCCCccceeeeecccccceEEEec
Q 041921          523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ---DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  599 (814)
Q Consensus       523 ~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  599 (814)
                      ..++||+|+||.||+|+...  .+..|++|++.....   ...+.+.+|++++++++|||++++++++.+.+..++||||
T Consensus        25 ~~~~lg~g~~g~v~~~~~~~--~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          25 GLHEIGHGSFGAVYFATNSH--TNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             cceeeccCCCeEEEEEEECC--CCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            34679999999999998653  577899999864322   2234688899999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccc
Q 041921          600 LNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT  678 (814)
Q Consensus       600 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  678 (814)
                      +. ++|.+++.. ...+++..+..++.|++.+|.|||+.   +++|+||+|+||+++.++.+||+|||++......    
T Consensus       103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~----  174 (313)
T cd06633         103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA----  174 (313)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCCC----
Confidence            96 577777654 45689999999999999999999998   9999999999999999999999999998643221    


Q ss_pred             ccccccCCCCcccccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcc
Q 041921          679 IKTAIRGTKGYVAPEWFR---NSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDK  755 (814)
Q Consensus       679 ~~~~~~gt~~y~aPE~~~---~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  755 (814)
                        ....|+..|+|||.+.   ...++.++||||||++++||++|..|+........      ........ ....     
T Consensus       175 --~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~------~~~~~~~~-~~~~-----  240 (313)
T cd06633         175 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQND-SPTL-----  240 (313)
T ss_pred             --CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHHhcC-CCCC-----
Confidence              2345888999999984   45688899999999999999999999865432111      11111111 1000     


Q ss_pred             cccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          756 EAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       756 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                         ........+.+++.+||+.+|.+||++.++++.
T Consensus       241 ---~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         241 ---QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             ---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               111233568889999999999999999999854

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.97  E-value=5.8e-31  Score=280.20  Aligned_cols=257  Identities=26%  Similarity=0.334  Sum_probs=192.8

Q ss_pred             ccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc--cchHhHHHHHHhhhcc---CCCCccceeeeeccccc----
Q 041921          522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ--DGEREFKNEVFVIGQT---HHKNLVRLLGFCDEGQN----  592 (814)
Q Consensus       522 ~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~----  592 (814)
                      .+.++||+|+||.||+|....  .+..+|+|++.....  .....+.+|+.++.++   +|+||+++++++...+.    
T Consensus         2 ~~~~~l~~g~~~~v~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~   79 (287)
T cd07838           2 EELAEIGEGAYGTVYKARDLN--TGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL   79 (287)
T ss_pred             eEEEEecccCceEEEEEEECC--CCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence            456789999999999999863  477899999964322  2234566787776655   69999999999987776    


Q ss_pred             -ceEEEecCCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcc
Q 041921          593 -RLLVYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAK  669 (814)
Q Consensus       593 -~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~  669 (814)
                       .+++|||+.+ +|.+++...  ..+++..+..++.|+++||.|||+.   +++|+||+|+||+++.++.+||+|||++.
T Consensus        80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~  155 (287)
T cd07838          80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLAR  155 (287)
T ss_pred             eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcce
Confidence             8999999974 898888654  3589999999999999999999998   99999999999999999999999999998


Q ss_pred             ccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhc-Cccc
Q 041921          670 LLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN-GKLN  748 (814)
Q Consensus       670 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~  748 (814)
                      ........   ....++..|+|||.+.+..++.++||||||++++||++|+.||......+.  +.. +.+.... +...
T Consensus       156 ~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~--~~~-~~~~~~~~~~~~  229 (287)
T cd07838         156 IYSFEMAL---TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ--LDK-IFDVIGLPSEEE  229 (287)
T ss_pred             eccCCccc---ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH--HHH-HHHHcCCCChHh
Confidence            76433221   223478899999999988899999999999999999999999875443221  111 1111100 0000


Q ss_pred             e---------eecCccc---ccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          749 V---------LVGEDKE---AMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       749 ~---------~~~~~~~---~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      .         .......   ..........+.+++.+||+.||.+||++.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            0         0000000   0011234567789999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.97  E-value=3e-31  Score=281.31  Aligned_cols=249  Identities=24%  Similarity=0.299  Sum_probs=201.6

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccc---cccchHhHHHHHHhhhccC-CCCccceeeeecccccceE
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV---FQDGEREFKNEVFVIGQTH-HKNLVRLLGFCDEGQNRLL  595 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l  595 (814)
                      .|.+.+.||+|++|.||++....  ++..|++|.+...   .....+.+..|++++++++ |+||+++++++.+++..++
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l   79 (280)
T cd05581           2 DFKFGKIIGEGSFSTVVLAKEKE--TNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYF   79 (280)
T ss_pred             CceEeeeecCCCceEEEEEEEcC--CCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEE
Confidence            35677899999999999999753  5778999988642   2233457889999999998 9999999999999999999


Q ss_pred             EEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCC
Q 041921          596 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ  675 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~  675 (814)
                      ||||+++++|.+++.....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        80 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~  156 (280)
T cd05581          80 VLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS  156 (280)
T ss_pred             EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence            999999999999998888899999999999999999999998   99999999999999999999999999988665432


Q ss_pred             cc------------------cccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHH
Q 041921          676 SK------------------TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW  737 (814)
Q Consensus       676 ~~------------------~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~  737 (814)
                      ..                  .......++..|+|||.+....++.++||||||++++++++|+.||.......  .    
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~----  230 (280)
T cd05581         157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL--T----  230 (280)
T ss_pred             ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH--H----
Confidence            11                  11123457889999999988889999999999999999999999997543211  0    


Q ss_pred             HHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCH----HHHHH
Q 041921          738 AFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTM----KKVLQ  790 (814)
Q Consensus       738 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~----~~vl~  790 (814)
                       .+......          ...+....+.+.+++.+||+.+|.+|||+    +++++
T Consensus       231 -~~~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         231 -FQKILKLE----------YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             -HHHHHhcC----------CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence             11111110          01112235678899999999999999999    66654

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.97  E-value=3.3e-31  Score=283.60  Aligned_cols=251  Identities=23%  Similarity=0.354  Sum_probs=191.9

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc-ccchHhHHHHHHhhhccC-CCCccceeeeecccccceEEE
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQTH-HKNLVRLLGFCDEGQNRLLVY  597 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  597 (814)
                      .+.+.+.||+|++|.||+|....  .+..||||.++... .....++..|+.++.+.+ |+||+++++++.++...+++|
T Consensus        16 ~~~~~~~lg~g~~~~v~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          16 DLENLGEIGSGTCGQVYKMRFKK--TGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             hheeeeEeeccCCeEEEEEEECC--CCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            35667899999999999999763  47889999986532 223445677777776664 999999999999999999999


Q ss_pred             ecCCCCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCc
Q 041921          598 EFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS  676 (814)
Q Consensus       598 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  676 (814)
                      ||+++ +|.+++.. ...+++..+..++.|+++||+|||+.  .+|+||||+|+||++++++.+||+|||++..+.....
T Consensus        94 e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~  170 (296)
T cd06618          94 ELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA  170 (296)
T ss_pred             eccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence            99854 77776654 35688999999999999999999973  2899999999999999999999999999876543222


Q ss_pred             ccccccccCCCCcccccccccCC----CCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeec
Q 041921          677 KTIKTAIRGTKGYVAPEWFRNSK----ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVG  752 (814)
Q Consensus       677 ~~~~~~~~gt~~y~aPE~~~~~~----~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  752 (814)
                      .   ....++..|+|||.+.+..    ++.++||||||++++||++|+.||....... ..    ....... ....   
T Consensus       171 ~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~----~~~~~~~-~~~~---  238 (296)
T cd06618         171 K---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-EV----LTKILQE-EPPS---  238 (296)
T ss_pred             c---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH-HH----HHHHhcC-CCCC---
Confidence            1   2234788999999987553    7889999999999999999999996432211 01    1111111 1100   


Q ss_pred             CcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          753 EDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       753 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                          .........++.+++.+||+.+|.+||++.++++.
T Consensus       239 ----~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         239 ----LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             ----CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                00111245678999999999999999999999764

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.97  E-value=9e-31  Score=275.73  Aligned_cols=240  Identities=21%  Similarity=0.255  Sum_probs=186.1

Q ss_pred             ccccc--eeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhcc-CCCCccceeeeecccccceEEEe
Q 041921          522 NFKEE--VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRLLVYE  598 (814)
Q Consensus       522 ~~~~~--LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  598 (814)
                      .+.+.  ||+|+||.||++....  .+..+++|.+......   +.  |+.....+ +|+||+++++.+...+..++|||
T Consensus        17 ~~~~~~~lg~g~~g~v~~~~~~~--~~~~~~~k~~~~~~~~---~~--e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e   89 (267)
T PHA03390         17 EIVKKLKLIDGKFGKVSVLKHKP--TQKLFVQKIIKAKNFN---AI--EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMD   89 (267)
T ss_pred             ccccceeecCCCceEEEEEEEcC--CCcEEEEEEEehhhcc---hh--hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEE
Confidence            34444  5999999999998653  5678899988643211   11  22222222 79999999999999999999999


Q ss_pred             cCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC-cEEEeecCCccccccCCcc
Q 041921          599 FLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYY-TARISDFGLAKLLTLNQSK  677 (814)
Q Consensus       599 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~-~~kl~DfGla~~~~~~~~~  677 (814)
                      |+++++|.+++.....+++.....++.|+++||.|||+.   +++||||||+||+++.++ .++|+|||++......   
T Consensus        90 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~---  163 (267)
T PHA03390         90 YIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP---  163 (267)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC---
Confidence            999999999998877899999999999999999999998   999999999999999888 9999999998765422   


Q ss_pred             cccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccc
Q 041921          678 TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEA  757 (814)
Q Consensus       678 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  757 (814)
                         ....++..|+|||.+.+..++.++||||||++++||++|+.||.....+. .....+... . ....          
T Consensus       164 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~-~-~~~~----------  227 (267)
T PHA03390        164 ---SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKR-Q-QKKL----------  227 (267)
T ss_pred             ---ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHh-h-cccC----------
Confidence               22357899999999998889999999999999999999999997443222 111111111 0 1100          


Q ss_pred             cCcHHHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 041921          758 MNDIECLGKLVMVSIWCIQEDPSLRPT-MKKVLQ  790 (814)
Q Consensus       758 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt-~~~vl~  790 (814)
                      .........+.+++.+||+.+|.+||+ ++++++
T Consensus       228 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        228 PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            011134567889999999999999996 688874

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=7.9e-32  Score=265.86  Aligned_cols=266  Identities=24%  Similarity=0.317  Sum_probs=210.1

Q ss_pred             cCHHHHHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhcc-CCCCccceeeeecc
Q 041921          511 FSYKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQT-HHKNLVRLLGFCDE  589 (814)
Q Consensus       511 ~~~~~l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  589 (814)
                      -+++|+.+-|   ++.||+|+++.|-.++--  ..+..+|||.+.+..........+|++++... .|+||+.|+++|++
T Consensus        73 g~F~d~YkLt---~e~LGeGAyasVqtcv~i--~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd  147 (463)
T KOG0607|consen   73 GKFEDMYKLT---SELLGEGAYASVQTCVSI--QTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFED  147 (463)
T ss_pred             chHHHHHHhH---HHHhcCccceeeeeeeee--ccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc
Confidence            3466666655   468999999999887643  36789999999887666777899999999988 59999999999999


Q ss_pred             cccceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC---cEEEeecC
Q 041921          590 GQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYY---TARISDFG  666 (814)
Q Consensus       590 ~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~---~~kl~DfG  666 (814)
                      +...|||||-|.+|+|..+|+.+..+++.+..++..+|+.||.|||..   +|.|||+||+|||-....   -+||+||.
T Consensus       148 d~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfD  224 (463)
T KOG0607|consen  148 DTRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFD  224 (463)
T ss_pred             cceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccc
Confidence            999999999999999999999999999999999999999999999998   999999999999997544   48999998


Q ss_pred             CccccccCCc-----ccccccccCCCCcccccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCcccchh------
Q 041921          667 LAKLLTLNQS-----KTIKTAIRGTKGYVAPEWFR-----NSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE------  730 (814)
Q Consensus       667 la~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~------  730 (814)
                      +..-+.....     .......+|+..|||||+..     ...|+.++|.||||||||-|++|..||.+..+++      
T Consensus       225 LgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrG  304 (463)
T KOG0607|consen  225 LGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRG  304 (463)
T ss_pred             cccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCC
Confidence            8765432211     11123467899999999863     2357889999999999999999999998664422      


Q ss_pred             --hhhHHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          731 --YAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       731 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                        ...=....+..+.+|+.+.. +.     .-.....+..+++...+..++.+|.++..+++
T Consensus       305 e~Cr~CQ~~LFesIQEGkYeFP-dk-----dWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  305 EVCRVCQNKLFESIQEGKYEFP-DK-----DWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             CccHHHHHHHHHHHhccCCcCC-hh-----hhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence              12222334555666654321 11     11234556667788888899999999999886

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.97  E-value=8.2e-31  Score=284.80  Aligned_cols=259  Identities=23%  Similarity=0.289  Sum_probs=190.8

Q ss_pred             cceeee--eeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEecC
Q 041921          525 EEVGRG--SFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL  600 (814)
Q Consensus       525 ~~LG~G--~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  600 (814)
                      ++||+|  +||+||++...  ..+..||||.+....  ....+.+.+|+.+++.++||||+++++++..++..++|+||+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~   81 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHT--PTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFM   81 (328)
T ss_pred             HHhCCcccCceeEEEEEEc--CCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecc
Confidence            456666  89999999864  357899999886432  223456889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccc
Q 041921          601 NNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT  678 (814)
Q Consensus       601 ~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  678 (814)
                      .+++|.+++...  ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++++||+.+..........
T Consensus        82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~  158 (328)
T cd08226          82 AYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA  158 (328)
T ss_pred             cCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence            999999998764  4578888899999999999999998   99999999999999999999999998654332211100


Q ss_pred             -----ccccccCCCCcccccccccC--CCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHH------------
Q 041921          679 -----IKTAIRGTKGYVAPEWFRNS--KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF------------  739 (814)
Q Consensus       679 -----~~~~~~gt~~y~aPE~~~~~--~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~------------  739 (814)
                           ......++..|+|||.+.+.  .++.++||||||++++||++|+.||.........  .....            
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~  236 (328)
T cd08226         159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML--LQKLKGPPYSPLDITTF  236 (328)
T ss_pred             cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHH--HHHhcCCCCCCcccccc
Confidence                 00112346679999999764  4789999999999999999999999754321110  00000            


Q ss_pred             ----HH-------hhc----Cc-----cceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          740 ----DC-------YRN----GK-----LNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       740 ----~~-------~~~----~~-----~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                          ..       ...    ..     ....................+.+++.+||+.||++|||++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence                00       000    00     00011111111223346678999999999999999999999974

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.97  E-value=1.2e-30  Score=281.70  Aligned_cols=260  Identities=16%  Similarity=0.170  Sum_probs=191.0

Q ss_pred             cccceeeeeeeeEEEEEEecCCCceEEEEEEeccc--cccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEecC
Q 041921          523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV--FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL  600 (814)
Q Consensus       523 ~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  600 (814)
                      +++.+|.|+++.||++..    .+..||||++...  .....+.+..|++++++++|+||+++++++.+.+..+++|||+
T Consensus         6 i~~~~~~~~~v~~~~~~~----~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~   81 (314)
T cd08216           6 IGKCFEDLMIVHLAKHKP----TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLM   81 (314)
T ss_pred             hhHhhcCCceEEEEEecC----CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEecc
Confidence            344556666666665543    5789999998653  2344567999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCc--
Q 041921          601 NNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS--  676 (814)
Q Consensus       601 ~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~--  676 (814)
                      ++++|.+++...  ..+++.....++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||.+........  
T Consensus        82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~  158 (314)
T cd08216          82 AYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ  158 (314)
T ss_pred             CCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccc
Confidence            999999999753  4578888899999999999999998   999999999999999999999999998875532211  


Q ss_pred             ---ccccccccCCCCccccccccc--CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHH----hhcC--
Q 041921          677 ---KTIKTAIRGTKGYVAPEWFRN--SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC----YRNG--  745 (814)
Q Consensus       677 ---~~~~~~~~gt~~y~aPE~~~~--~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~----~~~~--  745 (814)
                         ........++..|+|||.+..  ..++.++||||||++++||++|+.||.......  ...+.....    +...  
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~  236 (314)
T cd08216         159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTY  236 (314)
T ss_pred             cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCch
Confidence               011123347788999999875  357899999999999999999999997533211  111100000    0000  


Q ss_pred             -----ccce----eecC----cccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          746 -----KLNV----LVGE----DKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       746 -----~~~~----~~~~----~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                           ....    ....    ............++.+++.+||+.||++|||++++++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             hhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence                 0000    0000    00111122345678899999999999999999999863

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.97  E-value=1.2e-30  Score=278.50  Aligned_cols=253  Identities=22%  Similarity=0.249  Sum_probs=196.0

Q ss_pred             hccccceeeeeeeeEEEEEEecC-CCceEEEEEEecccc----ccchHhHHHHHHhhhcc-CCCCccceeeeecccccce
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTR-TSTTAVAVKKLDRVF----QDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRL  594 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~-~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  594 (814)
                      +.+.+.||+|+||.||++..... .++..||+|.+....    ....+.+.+|+.++.++ +|+||+++.+.+..+...+
T Consensus         2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (290)
T cd05613           2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH   81 (290)
T ss_pred             ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence            45678899999999999986421 357789999986432    12335688899999999 6999999999999988999


Q ss_pred             EEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccC
Q 041921          595 LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN  674 (814)
Q Consensus       595 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~  674 (814)
                      +|+||+++++|.+++.....+++.....++.|+++||.|||+.   +++||||+|+|||++.++.+||+|||++......
T Consensus        82 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  158 (290)
T cd05613          82 LILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED  158 (290)
T ss_pred             EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence            9999999999999998877888999999999999999999998   9999999999999999999999999999865433


Q ss_pred             CcccccccccCCCCcccccccccC--CCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeec
Q 041921          675 QSKTIKTAIRGTKGYVAPEWFRNS--KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVG  752 (814)
Q Consensus       675 ~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  752 (814)
                      ..... ....|+..|+|||.+...  ..+.++||||||++++||++|+.||.......  .............       
T Consensus       159 ~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~~-------  228 (290)
T cd05613         159 EVERA-YSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN--SQAEISRRILKSE-------  228 (290)
T ss_pred             ccccc-ccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc--cHHHHHHHhhccC-------
Confidence            22111 234588999999998753  46789999999999999999999986432211  1111111111110       


Q ss_pred             CcccccCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 041921          753 EDKEAMNDIECLGKLVMVSIWCIQEDPSLRP-----TMKKVLQ  790 (814)
Q Consensus       753 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~~vl~  790 (814)
                        .  +.+......+.+++.+|++.+|++||     +++++++
T Consensus       229 --~--~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         229 --P--PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             --C--CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence              0  01112346778999999999999997     6666665

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.97  E-value=6e-31  Score=286.36  Aligned_cols=265  Identities=22%  Similarity=0.270  Sum_probs=192.9

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc--cchHhHHHHHHhhhcc-CCCCccceeeeeccc----ccc
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ--DGEREFKNEVFVIGQT-HHKNLVRLLGFCDEG----QNR  593 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~~  593 (814)
                      +.+.+.||+|+||.||++.......+..+|||++.....  ...+.+.+|+.+++++ +||||+++++++...    ...
T Consensus         2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~   81 (332)
T cd07857           2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL   81 (332)
T ss_pred             ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence            456788999999999999976543377899999864322  2245678899999999 599999999875432    456


Q ss_pred             eEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcccccc
Q 041921          594 LLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTL  673 (814)
Q Consensus       594 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~  673 (814)
                      ++++||+. ++|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus        82 ~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~  157 (332)
T cd07857          82 YLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSE  157 (332)
T ss_pred             EEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCceeccc
Confidence            78888886 68999998888899999999999999999999998   999999999999999999999999999986653


Q ss_pred             CCcc--cccccccCCCCccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhH---------HHHHHHH
Q 041921          674 NQSK--TIKTAIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL---------TDWAFDC  741 (814)
Q Consensus       674 ~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~---------~~~~~~~  741 (814)
                      ....  .......|+..|+|||.+.+ ..++.++||||||+++++|++|+.||...........         .+. ...
T Consensus       158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~  236 (332)
T cd07857         158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET-LSR  236 (332)
T ss_pred             ccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH-HHh
Confidence            2211  11123468999999998765 4688999999999999999999999875432110000         000 000


Q ss_pred             hhcCcccee---ecCccc---ccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          742 YRNGKLNVL---VGEDKE---AMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       742 ~~~~~~~~~---~~~~~~---~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      +........   ......   ..........+.+++.+||+.+|.+|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             hhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            000000000   000000   0000112457889999999999999999999863

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=8.4e-31  Score=278.21  Aligned_cols=260  Identities=25%  Similarity=0.335  Sum_probs=197.8

Q ss_pred             ccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEec
Q 041921          522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  599 (814)
Q Consensus       522 ~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  599 (814)
                      .+.+.||+|++|.||+|+...  .++.+++|.+....  ....+.+..|+.++++++|+||+++++++.+....++|+||
T Consensus         2 ~~~~~ig~g~~~~vy~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (282)
T cd07829           2 EKLEKLGEGTYGVVYKARDKK--TGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY   79 (282)
T ss_pred             eeehcccccCcceEEEeeecC--CCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence            345789999999999999763  47789999987543  33345688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccc
Q 041921          600 LNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT  678 (814)
Q Consensus       600 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  678 (814)
                      ++ ++|.+++... ..+++..+..++.|+++||+|||+.   +|+|+||+|+||++++++.+||+|||++..........
T Consensus        80 ~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~  155 (282)
T cd07829          80 CD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY  155 (282)
T ss_pred             cC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcccc
Confidence            98 5899999876 5789999999999999999999998   99999999999999999999999999998765432211


Q ss_pred             ccccccCCCCcccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhh-HHH-------HHHHHhhc-----
Q 041921          679 IKTAIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI-LTD-------WAFDCYRN-----  744 (814)
Q Consensus       679 ~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~-~~~-------~~~~~~~~-----  744 (814)
                        ....++..|+|||.+.+. .++.++||||||++++||++|+.||......+... +..       ..+..+..     
T Consensus       156 --~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
T cd07829         156 --THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK  233 (282)
T ss_pred             --CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence              223457789999998766 78999999999999999999999986543221100 000       00000000     


Q ss_pred             CccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          745 GKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       745 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      ............ .........+.+++.+||+.+|++||++++++.
T Consensus       234 ~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         234 PTFPKFPPKDLE-KVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             ccccccCccchH-HhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            000000000000 000112567899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.97  E-value=5.9e-31  Score=283.68  Aligned_cols=263  Identities=23%  Similarity=0.278  Sum_probs=191.8

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccccc--chHhHHHHHHhhhccCCCCccceeeeecccc-----
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD--GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ-----  591 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  591 (814)
                      ..+.+.++||+|+||.||+|....  ++..++||++......  ....+.+|++++++++|+||+++++++.+..     
T Consensus         8 ~~y~~~~~lg~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   85 (311)
T cd07866           8 RDYEILGKLGEGTFGEVYKARQIK--TGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR   85 (311)
T ss_pred             ccEEEEEEeccCCCEEEEEEEECC--CCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence            345677889999999999999653  5678999988643222  2346788999999999999999999875433     


Q ss_pred             ---cceEEEecCCCCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCC
Q 041921          592 ---NRLLVYEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGL  667 (814)
Q Consensus       592 ---~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGl  667 (814)
                         ..++|+||+.. +|...+.. ...+++..+..++.|+++||.|||+.   +|+|+||||+||++++++.+||+|||+
T Consensus        86 ~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~  161 (311)
T cd07866          86 KRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGL  161 (311)
T ss_pred             cCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCcc
Confidence               35899999875 67666654 45789999999999999999999998   999999999999999999999999999


Q ss_pred             ccccccCCccc---------ccccccCCCCcccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHH
Q 041921          668 AKLLTLNQSKT---------IKTAIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW  737 (814)
Q Consensus       668 a~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~  737 (814)
                      ++.........         ..+...++..|+|||.+.+. .++.++||||||++++||++|+.||..........   .
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~---~  238 (311)
T cd07866         162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLH---L  238 (311)
T ss_pred             chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHH---H
Confidence            98654332111         11233568889999987654 57899999999999999999999987544322111   1


Q ss_pred             HHHHhhc---Cc------cceeec--CcccccC-----cHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          738 AFDCYRN---GK------LNVLVG--EDKEAMN-----DIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       738 ~~~~~~~---~~------~~~~~~--~~~~~~~-----~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      +......   ..      +.....  .......     .......+.+++.+||+.+|++|||+.+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            1111100   00      000000  0000000     0112357889999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-31  Score=290.69  Aligned_cols=200  Identities=30%  Similarity=0.450  Sum_probs=172.3

Q ss_pred             ccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccch-HhHHHHHHhhhccCCCCccceeeeecccc------cce
Q 041921          522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE-REFKNEVFVIGQTHHKNLVRLLGFCDEGQ------NRL  594 (814)
Q Consensus       522 ~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~  594 (814)
                      ...+.||+|+||.||+|..+  ..|..||||.++....... +....|++++++++|+|||++++.-.+..      ...
T Consensus        16 ~~~e~LG~Ga~g~V~rgrnk--etG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   16 EMDERLGKGAFGNVYRGRNK--ETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             eehhhhcCCccceeeeeccc--ccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            34578999999999999854  4789999999987554433 45788999999999999999999876544      568


Q ss_pred             EEEecCCCCCHHHHhcCC---CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc--C--CCcEEEeecCC
Q 041921          595 LVYEFLNNGTLASFLFGN---LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLD--D--YYTARISDFGL  667 (814)
Q Consensus       595 lv~e~~~~gsL~~~l~~~---~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~--~--~~~~kl~DfGl  667 (814)
                      +|||||.+|||+..|.+.   ..+++.+.+.++.+++.||.|||++   +|+||||||.||++-  .  .-..||+|||.
T Consensus        94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            999999999999999864   6789999999999999999999998   999999999999994  2  33479999999


Q ss_pred             ccccccCCcccccccccCCCCccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcccch
Q 041921          668 AKLLTLNQSKTIKTAIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIISCRKSFDIEMGE  729 (814)
Q Consensus       668 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~  729 (814)
                      |+-+..+.   ..+..+||..|++||.+.. +.++..+|.|||||++||..||..||.+..+.
T Consensus       171 Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p  230 (732)
T KOG4250|consen  171 ARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP  230 (732)
T ss_pred             cccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence            99876544   3367889999999999995 78899999999999999999999999765543

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=2.1e-31  Score=286.33  Aligned_cols=247  Identities=24%  Similarity=0.347  Sum_probs=203.2

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccccc--chHhHHHHHHhhhccCCCCccceeeeecccccceEE
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD--GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV  596 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  596 (814)
                      ..+.+.+.||+|.|+.|..|++..  .+..||||.+++..-.  ..+.+.+|+.+|..++|||||+++.+......+++|
T Consensus        56 g~y~i~~tig~g~f~~V~La~~~~--t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   56 GLYVIIKTIGKGNFAKVKLARHIL--TGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             cceeeeeeeccceeEEEEeeEecC--CCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            345567889999999999999875  5789999999764322  234589999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCc
Q 041921          597 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS  676 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  676 (814)
                      |||+.+|.+.+||..+..........++.|+..|++|||++   .|+|||||++||||+.+.++||+|||++..+.....
T Consensus       134 ~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~  210 (596)
T KOG0586|consen  134 MEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLM  210 (596)
T ss_pred             EEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeeccccc
Confidence            99999999999999988888888899999999999999999   999999999999999999999999999988774432


Q ss_pred             ccccccccCCCCcccccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcc
Q 041921          677 KTIKTAIRGTKGYVAPEWFRNSKI-TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDK  755 (814)
Q Consensus       677 ~~~~~~~~gt~~y~aPE~~~~~~~-s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  755 (814)
                         ....+|++.|.|||++.+.++ .+++|+||+|++||-|+.|..||++..-.+-       ......+++.       
T Consensus       211 ---lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L-------r~rvl~gk~r-------  273 (596)
T KOG0586|consen  211 ---LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL-------RPRVLRGKYR-------  273 (596)
T ss_pred             ---ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccc-------cchheeeeec-------
Confidence               255789999999999998876 4789999999999999999999985432110       0111111111       


Q ss_pred             cccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          756 EAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       756 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                         .+.....++-++++++|-.+|.+|++++++.+
T Consensus       274 ---Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  274 ---IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             ---ccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence               11122345557888889999999999999875

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.97  E-value=6.7e-31  Score=275.59  Aligned_cols=246  Identities=23%  Similarity=0.327  Sum_probs=191.5

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEeccc-----cccchHhHHHHHHhhhccCCCCccceeeeecccccceE
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV-----FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL  595 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  595 (814)
                      |.+.++||+|+||.||++.....  +..+++|.++..     ......++..|+.++++++||||+++++++.+....++
T Consensus         2 y~i~~~ig~g~~g~v~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (260)
T cd08222           2 YILQQRLGKGSFGTVYLVKDKKA--VAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCI   79 (260)
T ss_pred             ceeeeeecCCCCceEEEEEecCC--CCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEE
Confidence            56778999999999999987542  333444444321     12233457789999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhcC----CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcccc
Q 041921          596 VYEFLNNGTLASFLFG----NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLL  671 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~  671 (814)
                      |+||+++++|.+++..    ...+++..+..++.|+++||.|||+.   +++|+||+|+||++++ +.+||+|||++...
T Consensus        80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~  155 (260)
T cd08222          80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLL  155 (260)
T ss_pred             EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeec
Confidence            9999999999998853    35689999999999999999999998   9999999999999986 46999999998776


Q ss_pred             ccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceee
Q 041921          672 TLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLV  751 (814)
Q Consensus       672 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  751 (814)
                      ......  .....++..|+|||.+....++.++|+||||+++++|++|..||.......      .. .....+....  
T Consensus       156 ~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~------~~-~~~~~~~~~~--  224 (260)
T cd08222         156 MGSCDL--ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS------VV-LRIVEGPTPS--  224 (260)
T ss_pred             CCCccc--ccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HH-HHHHcCCCCC--
Confidence            433221  123457889999999988888999999999999999999999986432111      11 1111111111  


Q ss_pred             cCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          752 GEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       752 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                             .+......+.+++.+|++.+|++||++.++++
T Consensus       225 -------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         225 -------LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             -------CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence                   12244567889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=2.5e-32  Score=312.75  Aligned_cols=247  Identities=27%  Similarity=0.372  Sum_probs=199.6

Q ss_pred             ccceeeeeeeeEEEEEEecCCCceEEEEEEeccc--cccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEecCC
Q 041921          524 KEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV--FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLN  601 (814)
Q Consensus       524 ~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  601 (814)
                      +..||.|.||.||.|.-.  +.|...|+|.+.-.  .....+...+|+.++..++|||+|+++|+-.+.+..+|.||||.
T Consensus      1240 g~~Ig~G~fG~VYtavN~--~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~ 1317 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNL--DTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCE 1317 (1509)
T ss_pred             ccccCCcceeeeEEeecC--CccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhc
Confidence            457999999999999855  46778899987532  23445678999999999999999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCc--ccc
Q 041921          602 NGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS--KTI  679 (814)
Q Consensus       602 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~--~~~  679 (814)
                      +|+|.+.+...+..++.....+..|++.|++|||++   +|+||||||.||+|+.+|.+|++|||.|..+.....  ...
T Consensus      1318 ~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~e 1394 (1509)
T KOG4645|consen 1318 GGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGE 1394 (1509)
T ss_pred             cCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchhcCCHH
Confidence            999999998888888888888999999999999999   999999999999999999999999999988765421  111


Q ss_pred             cccccCCCCcccccccccC---CCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHH-HhhcCccceeecCcc
Q 041921          680 KTAIRGTKGYVAPEWFRNS---KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD-CYRNGKLNVLVGEDK  755 (814)
Q Consensus       680 ~~~~~gt~~y~aPE~~~~~---~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  755 (814)
                      .....||+.|||||++.+.   ....++||||+|||++||+||++||.....       +|+.. .+..|..       +
T Consensus      1395 l~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-------e~aIMy~V~~gh~-------P 1460 (1509)
T KOG4645|consen 1395 LQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-------EWAIMYHVAAGHK-------P 1460 (1509)
T ss_pred             HHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-------hhHHHhHHhccCC-------C
Confidence            1346799999999999654   355789999999999999999999963322       22221 1122221       1


Q ss_pred             cccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          756 EAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       756 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                      ..  +.....+-.+++..||+.||++|-++.++++.
T Consensus      1461 q~--P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1461 QI--PERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             CC--chhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence            11  22255667789999999999999988877764

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.97  E-value=7.5e-33  Score=266.97  Aligned_cols=249  Identities=24%  Similarity=0.311  Sum_probs=195.8

Q ss_pred             cceeeeeeeeEEEEEEecCCCceEEEEEEeccccc-cchHhHHHHHHhhhcc-CCCCccceeeeecccccceEEEecCCC
Q 041921          525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ-DGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRLLVYEFLNN  602 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  602 (814)
                      ..||.|+||+|+|-.++  ..++.+|||+++.... ...++++.|.+...+- ++||||+++|.+..+...++.||.| .
T Consensus        70 g~iG~G~fG~V~KM~hk--~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d  146 (361)
T KOG1006|consen   70 GEIGNGAFGTVNKMLHK--PSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-D  146 (361)
T ss_pred             HHhcCCcchhhhhhhcC--ccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-h
Confidence            47999999999998876  4789999999976443 5556788888776555 7999999999999999999999999 4


Q ss_pred             CCHHHHhc-----CCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcc
Q 041921          603 GTLASFLF-----GNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSK  677 (814)
Q Consensus       603 gsL~~~l~-----~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  677 (814)
                      .||+.+-.     ....+++...-+|....++||.||...  ..|+|||+||+|||++..|.+||+|||++..+..+...
T Consensus       147 ~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAk  224 (361)
T KOG1006|consen  147 ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAK  224 (361)
T ss_pred             hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHHHHHh
Confidence            46665432     246688888889999999999999876  58999999999999999999999999999876543322


Q ss_pred             cccccccCCCCccccccccc--CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcc
Q 041921          678 TIKTAIRGTKGYVAPEWFRN--SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDK  755 (814)
Q Consensus       678 ~~~~~~~gt~~y~aPE~~~~--~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  755 (814)
                         +.-.|-..|||||.+..  ..++.++||||||+.|+|+.||+.|+......     .+.+ ..+..|....+.... 
T Consensus       225 ---T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv-----feql-~~Vv~gdpp~l~~~~-  294 (361)
T KOG1006|consen  225 ---TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV-----FEQL-CQVVIGDPPILLFDK-  294 (361)
T ss_pred             ---hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH-----HHHH-HHHHcCCCCeecCcc-
Confidence               34458889999999864  35889999999999999999999999755431     1111 223334444333221 


Q ss_pred             cccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          756 EAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       756 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                         ...+....+++++-.|+.+|-++||...++.++
T Consensus       295 ---~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  295 ---ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             ---cccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence               123466788999999999999999999988753

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.4e-30  Score=269.50  Aligned_cols=237  Identities=28%  Similarity=0.294  Sum_probs=194.0

Q ss_pred             eeeeeeeeEEEEEEecCCCceEEEEEEecccccc---chHhHHHHHHhhhccCCCCccceeeeecccccceEEEecCCCC
Q 041921          527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNG  603 (814)
Q Consensus       527 LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  603 (814)
                      ||+|+||.||++....  .+..+++|.+......   ....+..|+.++++++|+||+++++.+..+...++||||++++
T Consensus         1 lg~G~~~~v~~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~   78 (250)
T cd05123           1 LGKGSFGKVLLVRKKD--TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGG   78 (250)
T ss_pred             CCCCCceEEEEEEECC--CCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCC
Confidence            6899999999998753  5678999988653322   3457899999999999999999999999999999999999999


Q ss_pred             CHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcccccccc
Q 041921          604 TLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAI  683 (814)
Q Consensus       604 sL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~  683 (814)
                      +|.+++.....+++.....++.|+++||.|||+.   +++|+||+|+||+++.++.++|+|||++........  .....
T Consensus        79 ~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~  153 (250)
T cd05123          79 ELFSHLSKEGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNTF  153 (250)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCC--cccCC
Confidence            9999998877889999999999999999999997   999999999999999999999999999987654321  11345


Q ss_pred             cCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCcHHH
Q 041921          684 RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIEC  763 (814)
Q Consensus       684 ~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  763 (814)
                      .++..|+|||.+.+...+.++|+||||++++||++|+.||.......   .    .+....+..        .  .+...
T Consensus       154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~----~~~~~~~~~--------~--~~~~~  216 (250)
T cd05123         154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE---I----YEKILKDPL--------R--FPEFL  216 (250)
T ss_pred             cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---H----HHHHhcCCC--------C--CCCCC
Confidence            57889999999988888999999999999999999999996443211   1    111111111        0  11122


Q ss_pred             HHHHHHHHHHccccCCCCCCCHHH
Q 041921          764 LGKLVMVSIWCIQEDPSLRPTMKK  787 (814)
Q Consensus       764 ~~~l~~l~~~Cl~~dp~~RPt~~~  787 (814)
                      ...+.+++.+||..||++||++++
T Consensus       217 ~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         217 SPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CHHHHHHHHHHhcCCHhhCCCccc
Confidence            567889999999999999999955

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.5e-30  Score=284.33  Aligned_cols=268  Identities=23%  Similarity=0.272  Sum_probs=195.8

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeecccc-----
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ-----  591 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  591 (814)
                      .+|.+.+.||+|+||.||++...  ..+..||||++....  ......+.+|+.++++++|+||+++++++..+.     
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          15 DRYRDLKQVGSGAYGTVCSALDR--RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cceEEEEEeeecCCeEEEEEEEC--CCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            34566788999999999999865  357889999985422  222346889999999999999999999886543     


Q ss_pred             -cceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccc
Q 041921          592 -NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKL  670 (814)
Q Consensus       592 -~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~  670 (814)
                       ..++|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||++..
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~~~  167 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQ  167 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccccc
Confidence             358999998 6799888764 4688999999999999999999998   999999999999999999999999999986


Q ss_pred             cccCCcccccccccCCCCccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhh-hhHHH-------HHHHH
Q 041921          671 LTLNQSKTIKTAIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTD-------WAFDC  741 (814)
Q Consensus       671 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~-~~~~~-------~~~~~  741 (814)
                      .....     ....++..|+|||.+.+ ..++.++|+||||+++++|++|+.||........ .....       .....
T Consensus       168 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (343)
T cd07880         168 TDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQK  242 (343)
T ss_pred             cccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence            54321     23457889999999876 4588999999999999999999999975432110 00000       00000


Q ss_pred             hhcCccceeecC--ccc----ccCcHHHHHHHHHHHHHccccCCCCCCCHHHHH--HHHhcCcCC
Q 041921          742 YRNGKLNVLVGE--DKE----AMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVL--QMLEGVVEV  798 (814)
Q Consensus       742 ~~~~~~~~~~~~--~~~----~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl--~~L~~~~~~  798 (814)
                      +...........  ...    ..........+.+++.+|++.||.+|||+.+++  ..++...+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~  307 (343)
T cd07880         243 LQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP  307 (343)
T ss_pred             hcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCc
Confidence            000000000000  000    000112345688999999999999999999998  455554444

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.97  E-value=4.8e-31  Score=301.01  Aligned_cols=246  Identities=29%  Similarity=0.395  Sum_probs=186.7

Q ss_pred             cceeeeeeeeEEEEEEecCCCceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccceeeeecc--------------
Q 041921          525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDE--------------  589 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------------  589 (814)
                      +.||+||||.|||++-+  =+++.+|||++.-.. .+....+.+|+.++++++|||||+++....+              
T Consensus       485 ~lLGkGGFG~VvkVRNK--lDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~  562 (1351)
T KOG1035|consen  485 ELLGKGGFGSVVKVRNK--LDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASD  562 (1351)
T ss_pred             HHhcCCCCceEEEEeec--ccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccc
Confidence            46999999999999844  478999999997543 3334568899999999999999998854100              


Q ss_pred             --------------------------------------------------------------------------------
Q 041921          590 --------------------------------------------------------------------------------  589 (814)
Q Consensus       590 --------------------------------------------------------------------------------  589 (814)
                                                                                                      
T Consensus       563 ~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~  642 (1351)
T KOG1035|consen  563 SESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVIL  642 (1351)
T ss_pred             hhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCcccc
Confidence                                                                                            


Q ss_pred             -----------------c--------ccceEEEecCCCCCHHHHhcCCCCC-ChhhHHHHHHHHHHHHHHhhhcCCCCee
Q 041921          590 -----------------G--------QNRLLVYEFLNNGTLASFLFGNLKP-NWNLRTNIAFQIARGLLYLHEDCRAQII  643 (814)
Q Consensus       590 -----------------~--------~~~~lv~e~~~~gsL~~~l~~~~~l-~~~~~~~i~~~ia~~l~yLH~~~~~~i~  643 (814)
                                       +        ..+||-||||+...|.+++..+... .....++++++|++||+|+|+.   +||
T Consensus       643 d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~---giI  719 (1351)
T KOG1035|consen  643 DDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ---GII  719 (1351)
T ss_pred             CcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC---cee
Confidence                             0        1136778999998888888766544 4677789999999999999999   999


Q ss_pred             ecCCCCCcEEEcCCCcEEEeecCCcccccc----------------CCcccccccccCCCCcccccccccC---CCCcch
Q 041921          644 HCDIKPQNILLDDYYTARISDFGLAKLLTL----------------NQSKTIKTAIRGTKGYVAPEWFRNS---KITAKV  704 (814)
Q Consensus       644 H~dlkp~NIll~~~~~~kl~DfGla~~~~~----------------~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~~  704 (814)
                      ||||||.||+++++..|||+|||+|.....                .......+..+||.-|+|||.+.+.   .|+.|+
T Consensus       720 HRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~Ki  799 (1351)
T KOG1035|consen  720 HRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKI  799 (1351)
T ss_pred             eccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchh
Confidence            999999999999999999999999987220                0111123567899999999999765   499999


Q ss_pred             hhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCC
Q 041921          705 DVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPT  784 (814)
Q Consensus       705 Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt  784 (814)
                      |+||+|||++||+.   ||...+..      ..+...++.+.+...  +.    ...+....-.+++.++++.||.+|||
T Consensus       800 DmYSLGIVlFEM~y---PF~TsMER------a~iL~~LR~g~iP~~--~~----f~~~~~~~e~slI~~Ll~hdP~kRPt  864 (1351)
T KOG1035|consen  800 DMYSLGIVLFEMLY---PFGTSMER------ASILTNLRKGSIPEP--AD----FFDPEHPEEASLIRWLLSHDPSKRPT  864 (1351)
T ss_pred             hhHHHHHHHHHHhc---cCCchHHH------HHHHHhcccCCCCCC--cc----cccccchHHHHHHHHHhcCCCccCCC
Confidence            99999999999985   45543321      123344555554433  11    12233344567899999999999999


Q ss_pred             HHHHHH
Q 041921          785 MKKVLQ  790 (814)
Q Consensus       785 ~~~vl~  790 (814)
                      +.|+|+
T Consensus       865 A~eLL~  870 (1351)
T KOG1035|consen  865 ATELLN  870 (1351)
T ss_pred             HHHHhh
Confidence            999985

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.97  E-value=1e-30  Score=285.71  Aligned_cols=265  Identities=21%  Similarity=0.258  Sum_probs=191.8

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeeccc--------
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEG--------  590 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------  590 (814)
                      .++.+.+.||+|+||.||+|...  ..+..|++|++........+.+.+|++++++++||||+++++++...        
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~--~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDS--DCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV   82 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEEC--CCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence            45667789999999999999865  35789999998765555566789999999999999999999876543        


Q ss_pred             ------ccceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc-CCCcEEEe
Q 041921          591 ------QNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLD-DYYTARIS  663 (814)
Q Consensus       591 ------~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~-~~~~~kl~  663 (814)
                            ...++|+||++ ++|.+++.. ..+++.....++.||+.||.|||+.   +|+||||||+||+++ ++..+||+
T Consensus        83 ~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~  157 (342)
T cd07854          83 GSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIG  157 (342)
T ss_pred             ccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEEC
Confidence                  34689999997 589888864 3578899999999999999999998   999999999999997 55678999


Q ss_pred             ecCCccccccCCcc-cccccccCCCCccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhh-HHHH---
Q 041921          664 DFGLAKLLTLNQSK-TIKTAIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI-LTDW---  737 (814)
Q Consensus       664 DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~-~~~~---  737 (814)
                      |||++..+...... .......++..|+|||.+.. ..++.++|||||||+++||++|+.||......+... ....   
T Consensus       158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~  237 (342)
T cd07854         158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV  237 (342)
T ss_pred             CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            99999765432111 11122347889999998754 567889999999999999999999996543311100 0000   


Q ss_pred             ----HHHHhhcCccceeecCcccccC-----cHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          738 ----AFDCYRNGKLNVLVGEDKEAMN-----DIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       738 ----~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                          ......................     ......++.+++.+||+.||.+|||++++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence                0000000000000000000000     0123457889999999999999999999984

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-31  Score=275.05  Aligned_cols=240  Identities=26%  Similarity=0.297  Sum_probs=194.1

Q ss_pred             ccceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEecC
Q 041921          524 KEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL  600 (814)
Q Consensus       524 ~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  600 (814)
                      -++||+|+||.||-+....  .++.+|.|++.+..   .+++...++|-.+|.+++.+.||.+--.+...+.++||+..|
T Consensus       190 ~RvlGkGGFGEV~acqvra--TGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlM  267 (591)
T KOG0986|consen  190 YRVLGKGGFGEVCACQVRA--TGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLM  267 (591)
T ss_pred             eEEEecccccceeEEEEec--chhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEee
Confidence            3689999999999988764  67889999886432   334456789999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccc
Q 041921          601 NNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT  678 (814)
Q Consensus       601 ~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  678 (814)
                      .+|+|.-+|...  ..+++....-++.+|+-||.+||..   +|+.||+||+|||||+.|+++|+|.|||..+...... 
T Consensus       268 NGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~-  343 (591)
T KOG0986|consen  268 NGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPI-  343 (591)
T ss_pred             cCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCCCcc-
Confidence            999999988765  4788888999999999999999998   9999999999999999999999999999987765433 


Q ss_pred             ccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCccccc
Q 041921          679 IKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAM  758 (814)
Q Consensus       679 ~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  758 (814)
                        ...+||.+|||||++.+..|+...|.||+||+||||+.|+.||.........   +-+.+++.+..          ..
T Consensus       344 --~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~---eEvdrr~~~~~----------~e  408 (591)
T KOG0986|consen  344 --RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR---EEVDRRTLEDP----------EE  408 (591)
T ss_pred             --ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH---HHHHHHHhcch----------hh
Confidence              4457999999999999999999999999999999999999999643221100   00111111111          11


Q ss_pred             CcHHHHHHHHHHHHHccccCCCCCCC
Q 041921          759 NDIECLGKLVMVSIWCIQEDPSLRPT  784 (814)
Q Consensus       759 ~~~~~~~~l~~l~~~Cl~~dp~~RPt  784 (814)
                      .+....+++..+....|++||++|.-
T Consensus       409 y~~kFS~eakslc~~LL~Kdp~~RLG  434 (591)
T KOG0986|consen  409 YSDKFSEEAKSLCEGLLTKDPEKRLG  434 (591)
T ss_pred             cccccCHHHHHHHHHHHccCHHHhcc
Confidence            22344566667777788999998864

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.97  E-value=5e-30  Score=278.31  Aligned_cols=260  Identities=23%  Similarity=0.299  Sum_probs=192.1

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccc--cccchHhHHHHHHhhhccCCCCccceeeeecc-cccceEE
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV--FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDE-GQNRLLV  596 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv  596 (814)
                      .|.+.+.||+|+||.||++...  ..+..||||++...  .....+.+..|+.++.+++||||+++.+++.. ....++|
T Consensus        11 ~y~~~~~ig~g~~g~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv   88 (328)
T cd07856          11 RYVDLQPVGMGAFGLVCSARDQ--LTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFV   88 (328)
T ss_pred             ceEEEEeecccCCeEEEEEEEC--CCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEE
Confidence            3556688999999999999865  35778999988542  22234578899999999999999999998865 5678899


Q ss_pred             EecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCc
Q 041921          597 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS  676 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  676 (814)
                      +||+ +++|.+++... .+++.....++.|+++||.|||+.   +|+|+||+|+||++++++.+||+|||++....... 
T Consensus        89 ~e~~-~~~L~~~~~~~-~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~-  162 (328)
T cd07856          89 TELL-GTDLHRLLTSR-PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQM-  162 (328)
T ss_pred             eehh-ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccccCCCc-
Confidence            9998 56898888643 467788889999999999999998   99999999999999999999999999987543211 


Q ss_pred             ccccccccCCCCccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhh-HHHH-------HHHHhhcC-c
Q 041921          677 KTIKTAIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI-LTDW-------AFDCYRNG-K  746 (814)
Q Consensus       677 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~-~~~~-------~~~~~~~~-~  746 (814)
                          ....++..|+|||.+.+ ..++.++||||||++++||++|+.||.......... +.+.       ..+.+..+ .
T Consensus       163 ----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (328)
T cd07856         163 ----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENT  238 (328)
T ss_pred             ----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhh
Confidence                22357889999998866 568999999999999999999999996543321110 0000       00000000 0


Q ss_pred             cceeecCcccccCc-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          747 LNVLVGEDKEAMND-----IECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       747 ~~~~~~~~~~~~~~-----~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                      .............+     ......+.+++.+||+.+|++|||+++++..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         239 LRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             HHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00000000000001     1134678899999999999999999998765

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.9e-30  Score=283.60  Aligned_cols=259  Identities=23%  Similarity=0.273  Sum_probs=192.8

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccc--cccchHhHHHHHHhhhccCCCCccceeeeeccccc-----
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV--FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQN-----  592 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  592 (814)
                      .|.+.+.||+|++|.||+|....  ++..||||++...  .....+.+.+|+.++++++|+||+++++++...+.     
T Consensus        16 ~y~~~~~ig~g~~g~vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07851          16 RYQNLSPVGSGAYGQVCSAFDTK--TGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ   93 (343)
T ss_pred             ceEEEEEeccCCceEEEEEEECC--CCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence            35567889999999999999753  5678999998642  12233567889999999999999999998866554     


Q ss_pred             -ceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcccc
Q 041921          593 -RLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLL  671 (814)
Q Consensus       593 -~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~  671 (814)
                       .++|+||+ +++|.+++.. ..+++..+..++.|+++||.|||+.   +|+|+||+|+||++++++.+||+|||++...
T Consensus        94 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~  168 (343)
T cd07851          94 DVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHT  168 (343)
T ss_pred             cEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccccccccc
Confidence             89999998 5699998865 4689999999999999999999998   9999999999999999999999999999865


Q ss_pred             ccCCcccccccccCCCCccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhh-hhHHH-------HHHHHh
Q 041921          672 TLNQSKTIKTAIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTD-------WAFDCY  742 (814)
Q Consensus       672 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~-~~~~~-------~~~~~~  742 (814)
                      ....     ....++..|+|||.+.+ ..++.++||||||++++||++|+.||........ ..+..       .....+
T Consensus       169 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  243 (343)
T cd07851         169 DDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI  243 (343)
T ss_pred             cccc-----cCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Confidence            4321     33457889999999865 3678999999999999999999999964432211 00000       000000


Q ss_pred             hcCccceeecCcc-cccC-----cHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          743 RNGKLNVLVGEDK-EAMN-----DIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       743 ~~~~~~~~~~~~~-~~~~-----~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      ........+.... ....     ......++.+++.+||+.+|.+|||+.+|++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         244 SSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             cchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            0000000000000 0000     0112567899999999999999999999976

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.97  E-value=3.4e-30  Score=281.76  Aligned_cols=259  Identities=24%  Similarity=0.294  Sum_probs=188.8

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeeccc------cc
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEG------QN  592 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  592 (814)
                      +.+.+.||+|+||.||+|...  ..+..||+|++....  ....+.+.+|+.++.+++|+||+++++++...      ..
T Consensus        19 y~~~~~lg~G~~g~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (345)
T cd07877          19 YQNLSPVGSGAYGSVCAAFDT--KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND   96 (345)
T ss_pred             eEEEEEeeecCCeEEEEEEEc--CCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccccc
Confidence            445678999999999999864  357799999986532  22345688899999999999999999987543      34


Q ss_pred             ceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccc
Q 041921          593 RLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLT  672 (814)
Q Consensus       593 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~  672 (814)
                      .+++++++ +++|.+++... .+++..+..++.|+++||+|||+.   +|+||||||+||++++++.+||+|||++....
T Consensus        97 ~~lv~~~~-~~~L~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~  171 (345)
T cd07877          97 VYLVTHLM-GADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTD  171 (345)
T ss_pred             EEEEehhc-ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEeccccccccc
Confidence            67788876 78998887654 588999999999999999999998   99999999999999999999999999987643


Q ss_pred             cCCcccccccccCCCCccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhh-hhHHH-------HHHHHhh
Q 041921          673 LNQSKTIKTAIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTD-------WAFDCYR  743 (814)
Q Consensus       673 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~-~~~~~-------~~~~~~~  743 (814)
                      ...     ....++..|+|||.+.+ ..++.++||||||++++||++|+.||........ .....       .....+.
T Consensus       172 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (345)
T cd07877         172 DEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS  246 (345)
T ss_pred             ccc-----cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcc
Confidence            221     23457889999999866 5688899999999999999999999864332110 00000       0000000


Q ss_pred             cCccceee---cCccc---ccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          744 NGKLNVLV---GEDKE---AMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       744 ~~~~~~~~---~~~~~---~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                      ........   .....   .........++.+++.+|++.+|.+||++.++++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         247 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             cHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            00000000   00000   00000124567899999999999999999998754

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-30  Score=281.00  Aligned_cols=239  Identities=26%  Similarity=0.310  Sum_probs=195.7

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhcc-CCCCccceeeeecccccceEEE
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRLLVY  597 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  597 (814)
                      ..|.+...+|.|+|+.|-.+.+..  ..+..+||.+.+.    ..+-.+|+.++.+. +||||+++.+.+.++.+.++||
T Consensus       322 ~~y~~~~~~~~gs~s~~~~~~~~~--t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~  395 (612)
T KOG0603|consen  322 ESYEFREELGEGSFSAVKYCESSP--TDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM  395 (612)
T ss_pred             hhhccccccCCCCccceeeeeccc--cccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence            345677789999999999988764  5678889988654    23446677666666 7999999999999999999999


Q ss_pred             ecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE-cCCCcEEEeecCCccccccCCc
Q 041921          598 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILL-DDYYTARISDFGLAKLLTLNQS  676 (814)
Q Consensus       598 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll-~~~~~~kl~DfGla~~~~~~~~  676 (814)
                      |.+.++-|.+.+....... .++..|+.+|+.|+.|||++   +++||||||+|||+ ++.++++|+|||.++.....- 
T Consensus       396 e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~-  470 (612)
T KOG0603|consen  396 ELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSC-  470 (612)
T ss_pred             hhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchhh-
Confidence            9999998888887665555 77778999999999999998   99999999999999 588999999999999876541 


Q ss_pred             ccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCccc
Q 041921          677 KTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKE  756 (814)
Q Consensus       677 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  756 (814)
                          ...+-|..|.|||++....+++++|+||||++||+|++|+.||......      ..+..++..++..        
T Consensus       471 ----~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------~ei~~~i~~~~~s--------  532 (612)
T KOG0603|consen  471 ----DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------IEIHTRIQMPKFS--------  532 (612)
T ss_pred             ----cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch------HHHHHhhcCCccc--------
Confidence                2345688999999999999999999999999999999999999765443      1123333333332        


Q ss_pred             ccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          757 AMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       757 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                          ....+...+|+.+||+.||.+||+|.++..
T Consensus       533 ----~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  533 ----ECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             ----cccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence                234567788999999999999999999864

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=3.6e-30  Score=234.16  Aligned_cols=260  Identities=21%  Similarity=0.281  Sum_probs=190.8

Q ss_pred             ccceeeeeeeeEEEEEEecCCCceEEEEEEecc--ccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEecCC
Q 041921          524 KEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLN  601 (814)
Q Consensus       524 ~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  601 (814)
                      .|+||+|.+|+||||.-.  +..+.||+|+.+-  .++.......+|+-+++.++|+|||++++....++...+|+|||.
T Consensus         7 mekigegtygtvfkarn~--~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cd   84 (292)
T KOG0662|consen    7 MEKIGEGTYGTVFKARNR--ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD   84 (292)
T ss_pred             HHhhcCCcceeeEecccC--CccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhh
Confidence            478999999999999854  4678999998853  334445678999999999999999999999999999999999994


Q ss_pred             CCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccccc
Q 041921          602 NGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIK  680 (814)
Q Consensus       602 ~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  680 (814)
                       .+|..|..+ ++.++.+....++.|+++||.++|++   .+.|||+||.|.|++.+|++|++|||+++.++....  ..
T Consensus        85 -qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvr--cy  158 (292)
T KOG0662|consen   85 -QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR--CY  158 (292)
T ss_pred             -HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceE--ee
Confidence             578888765 46788899999999999999999998   999999999999999999999999999998764321  11


Q ss_pred             ccccCCCCcccccccccC-CCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCcc---ceeecCcc
Q 041921          681 TAIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKL---NVLVGEDK  755 (814)
Q Consensus       681 ~~~~gt~~y~aPE~~~~~-~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  755 (814)
                      ...+-|..|.+|.++-+. -++...|+||.||++.|+.. |++.|.+...+++....-+......++..   ..+.+-.+
T Consensus       159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~  238 (292)
T KOG0662|consen  159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKP  238 (292)
T ss_pred             eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcc
Confidence            334568899999998776 58899999999999999998 55555544333322221122211222211   11111111


Q ss_pred             cccCc---------HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          756 EAMND---------IECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       756 ~~~~~---------~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                      --..+         +.....=.+++...+.-+|..|.++++.++.
T Consensus       239 yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  239 YPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             cCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence            00000         1111222345555566699999999988763

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=4.8e-30  Score=265.19  Aligned_cols=221  Identities=20%  Similarity=0.155  Sum_probs=177.7

Q ss_pred             eeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEecCCCCCHHHHh
Q 041921          530 GSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL  609 (814)
Q Consensus       530 G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l  609 (814)
                      |.+|.||++....  +++.+|+|++....     .+..|...+....||||+++++++.+.+..++||||+++++|.+++
T Consensus         4 g~~~~v~~~~~~~--~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l   76 (237)
T cd05576           4 GVIDKVLLVMDTR--TQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI   76 (237)
T ss_pred             cccceEEEEEEcc--CCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence            8899999998653  57789999986532     3344555555667999999999999999999999999999999999


Q ss_pred             cCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcccccccccCCCCc
Q 041921          610 FGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGY  689 (814)
Q Consensus       610 ~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y  689 (814)
                      .....+++.....++.|+++||.|||+.   +|+||||||+||+++.++.++++|||.+..+....     ....++..|
T Consensus        77 ~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~y  148 (237)
T cd05576          77 SKFLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENMY  148 (237)
T ss_pred             HHhcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCccc
Confidence            8777789999999999999999999998   99999999999999999999999999876554321     223456789


Q ss_pred             ccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCcHHHHHHHHH
Q 041921          690 VAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVM  769 (814)
Q Consensus       690 ~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  769 (814)
                      +|||.+....++.++||||+|++++||++|+.|+.......            ...  .     ..  ..+......+.+
T Consensus       149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~~~--~-----~~--~~~~~~~~~~~~  207 (237)
T cd05576         149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------NTH--T-----TL--NIPEWVSEEARS  207 (237)
T ss_pred             cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------ccc--c-----cc--CCcccCCHHHHH
Confidence            99999988889999999999999999999998764221100            000  0     00  011123467889


Q ss_pred             HHHHccccCCCCCCCHH
Q 041921          770 VSIWCIQEDPSLRPTMK  786 (814)
Q Consensus       770 l~~~Cl~~dp~~RPt~~  786 (814)
                      ++.+|++.||++||++.
T Consensus       208 li~~~l~~dp~~R~~~~  224 (237)
T cd05576         208 LLQQLLQFNPTERLGAG  224 (237)
T ss_pred             HHHHHccCCHHHhcCCC
Confidence            99999999999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.97  E-value=1.6e-29  Score=297.70  Aligned_cols=145  Identities=27%  Similarity=0.363  Sum_probs=129.6

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc---cchHhHHHHHHhhhccCCCCccceeeeecccccceEE
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ---DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV  596 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  596 (814)
                      .|.+.++||+|+||.||+|....  .+..||||.++....   .....+..|+.++..++|+||+++++++......+||
T Consensus         5 ~y~i~~~LG~G~fg~Vy~a~~~~--~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           5 EFVIVKPISRGAFGKVYLGRKKN--NSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             CEEEEEEEecCCCeEEEEEEECC--CCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            45667899999999999999763  577899999864321   2235688999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcc
Q 041921          597 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAK  669 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~  669 (814)
                      |||+++++|.+++.....+++...+.|+.||+.||.|||..   +|+||||||+||||+.++.+||+|||+++
T Consensus        83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999999998777788999999999999999999998   99999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=8.6e-31  Score=273.27  Aligned_cols=243  Identities=27%  Similarity=0.421  Sum_probs=192.0

Q ss_pred             ccceeeeeeeeEEEEEEecCCCceEEEEEEeccc--cccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEecCC
Q 041921          524 KEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV--FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLN  601 (814)
Q Consensus       524 ~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  601 (814)
                      .|.||.|.||+||-|+++.  .++.||||.+.+.  ..+.+.++++|+.+|++++||.||.+.-.|+..+..++|||-+.
T Consensus       569 devLGSGQFG~VYgg~hRk--tGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~  646 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRK--TGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH  646 (888)
T ss_pred             HhhccCCcceeeecceecc--cCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc
Confidence            3679999999999999874  6889999999753  34556789999999999999999999999999999999999996


Q ss_pred             CCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC---CcEEEeecCCccccccCCcc
Q 041921          602 NGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDY---YTARISDFGLAKLLTLNQSK  677 (814)
Q Consensus       602 ~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~---~~~kl~DfGla~~~~~~~~~  677 (814)
                      +.-|+-+|.+ ..++++..-.-++.||+-||.|||.+   +|+|+||||+|||+.+.   -++||+|||+|+.+.+....
T Consensus       647 GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR  723 (888)
T KOG4236|consen  647 GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR  723 (888)
T ss_pred             chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence            6556555544 47788888888999999999999998   99999999999999643   57999999999998865332


Q ss_pred             cccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccc
Q 041921          678 TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEA  757 (814)
Q Consensus       678 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  757 (814)
                         ..++||+.|+|||+++++.|+..-|+||.|||+|--++|..||....+     +.    +.+.+...  +.-+.+  
T Consensus       724 ---rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd-----In----dQIQNAaF--MyPp~P--  787 (888)
T KOG4236|consen  724 ---RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED-----IN----DQIQNAAF--MYPPNP--  787 (888)
T ss_pred             ---hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc-----hh----HHhhcccc--ccCCCc--
Confidence               557899999999999999999999999999999999999999974322     11    11111111  111111  


Q ss_pred             cCcHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 041921          758 MNDIECLGKLVMVSIWCIQEDPSLRPTMKKVL  789 (814)
Q Consensus       758 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl  789 (814)
                        -.+.....+++|...||..-++|-|...-+
T Consensus       788 --W~eis~~AidlIn~LLqVkm~kRysvdk~l  817 (888)
T KOG4236|consen  788 --WSEISPEAIDLINNLLQVKMRKRYSVDKSL  817 (888)
T ss_pred             --hhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence              113344566777777777777787765543

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.96  E-value=7.5e-31  Score=266.39  Aligned_cols=271  Identities=21%  Similarity=0.297  Sum_probs=209.8

Q ss_pred             ccccCHHHHHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccC-C-C----Ccc
Q 041921          508 LRCFSYKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTH-H-K----NLV  581 (814)
Q Consensus       508 ~~~~~~~~l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h-~----niv  581 (814)
                      .-.|...|....+|.+...+|+|.||.|-++....  .+..||||.++.+. .-.+..+-|+++++++. + |    -+|
T Consensus        78 H~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~--~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv  154 (415)
T KOG0671|consen   78 HYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRE--TKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCV  154 (415)
T ss_pred             eEEEEeccccccceehhhhhcCCcccceEEEeecC--CCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEE
Confidence            45667778888899999999999999999998764  37899999998753 33456788999999994 2 2    277


Q ss_pred             ceeeeecccccceEEEecCCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC---
Q 041921          582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDD---  656 (814)
Q Consensus       582 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~---  656 (814)
                      .+.+++.-.++.+||+|.+ +-|+.++|..+  .+.+...+..|+.|+++++++||+.   +++|.||||+|||+.+   
T Consensus       155 ~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~  230 (415)
T KOG0671|consen  155 QMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEY  230 (415)
T ss_pred             eeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccce
Confidence            8888999999999999987 56999999876  5678899999999999999999998   9999999999999942   


Q ss_pred             -----------------CCcEEEeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhC
Q 041921          657 -----------------YYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISC  719 (814)
Q Consensus       657 -----------------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg  719 (814)
                                       +..+||+|||.|..-....     ...+.|..|.|||++.+-.++.++||||+||||.|+.||
T Consensus       231 ~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG  305 (415)
T KOG0671|consen  231 FKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTG  305 (415)
T ss_pred             EEEeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeecc
Confidence                             3458999999998755443     456689999999999999999999999999999999999


Q ss_pred             CCCCCcccchhhhhHHHHH--------------HHHhhcCccc-----------eeecCcc----cccCcHHHHHHHHHH
Q 041921          720 RKSFDIEMGEEYAILTDWA--------------FDCYRNGKLN-----------VLVGEDK----EAMNDIECLGKLVMV  770 (814)
Q Consensus       720 ~~p~~~~~~~~~~~~~~~~--------------~~~~~~~~~~-----------~~~~~~~----~~~~~~~~~~~l~~l  770 (814)
                      ...|.....-+.-.+.+.+              .+....+++.           ...+...    .......+..+|.+|
T Consensus       306 ~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDL  385 (415)
T KOG0671|consen  306 ETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDL  385 (415)
T ss_pred             ceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHH
Confidence            9999866532221111111              1111122111           0000000    011123567789999


Q ss_pred             HHHccccCCCCCCCHHHHHH
Q 041921          771 SIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       771 ~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      +..+|..||.+|+|+.|+++
T Consensus       386 l~~mL~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  386 LRRMLEFDPARRITLREALS  405 (415)
T ss_pred             HHHHHccCccccccHHHHhc
Confidence            99999999999999999975

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.3e-30  Score=266.81  Aligned_cols=266  Identities=25%  Similarity=0.337  Sum_probs=201.7

Q ss_pred             ccCHHHHHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEec--cccccch-----HhHHHHHHhhhccCCCCccc
Q 041921          510 CFSYKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLD--RVFQDGE-----REFKNEVFVIGQTHHKNLVR  582 (814)
Q Consensus       510 ~~~~~~l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~--~~~~~~~-----~~~~~E~~~l~~l~h~niv~  582 (814)
                      .|...-+...+|-+.+.||+|+|+.||||..-.  ..+.||||.-.  +......     +...+|..+.+.+.||.||+
T Consensus       454 QFkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~--EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVK  531 (775)
T KOG1151|consen  454 QFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLT--EQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVK  531 (775)
T ss_pred             hhccCcchHHHHHHHHHhccccHHHHHHhcccc--hhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeee
Confidence            344444556667777889999999999998653  45677777653  2211111     23678999999999999999


Q ss_pred             eeeeec-ccccceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc---CCC
Q 041921          583 LLGFCD-EGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLD---DYY  658 (814)
Q Consensus       583 l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~---~~~  658 (814)
                      +++++. +.+..|-|.||+++.+|+-||+.++..++++...|+.||+.||.||.+. .++|||-||||.||||.   ..|
T Consensus       532 lYDyfslDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacG  610 (775)
T KOG1151|consen  532 LYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACG  610 (775)
T ss_pred             eeeeeeeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccc
Confidence            999985 4566889999999999999999999999999999999999999999975 67999999999999995   568


Q ss_pred             cEEEeecCCccccccCCccc-----ccccccCCCCccccccccc----CCCCcchhhHHHHHHHHHHHhCCCCCCcccch
Q 041921          659 TARISDFGLAKLLTLNQSKT-----IKTAIRGTKGYVAPEWFRN----SKITAKVDVYSFGVLLLEIISCRKSFDIEMGE  729 (814)
Q Consensus       659 ~~kl~DfGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~----~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~  729 (814)
                      .+||.|||+++.+..+....     ...-..||..|++||++--    .+++.|.||||.|||+|..+.|+.||......
T Consensus       611 eIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ  690 (775)
T KOG1151|consen  611 EIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ  690 (775)
T ss_pred             eeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH
Confidence            89999999999987654332     1233569999999998853    35789999999999999999999999865432


Q ss_pred             hhhhHHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 041921          730 EYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVL  789 (814)
Q Consensus       730 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl  789 (814)
                      .. .+        .+..+-...  ....+..+....+...+|.+||+...++|....++.
T Consensus       691 Qd-IL--------qeNTIlkAt--EVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  691 QD-IL--------QENTILKAT--EVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             HH-HH--------hhhchhcce--eccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence            21 11        111111111  111122233445677899999999999998766654

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.96  E-value=4.6e-29  Score=257.88  Aligned_cols=239  Identities=28%  Similarity=0.365  Sum_probs=195.0

Q ss_pred             eeeeEEEEEEecCCCceEEEEEEeccccccc-hHhHHHHHHhhhccCCCCccceeeeecccccceEEEecCCCCCHHHHh
Q 041921          531 SFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG-EREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL  609 (814)
Q Consensus       531 ~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l  609 (814)
                      +||.||+|+...  ++..+++|.+....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++
T Consensus         1 ~~g~v~~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~   78 (244)
T smart00220        1 SFGKVYLARDKK--TGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL   78 (244)
T ss_pred             CceEEEEEEECC--CCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence            579999999763  46789999997654444 678999999999999999999999999999999999999999999999


Q ss_pred             cCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcccccccccCCCCc
Q 041921          610 FGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGY  689 (814)
Q Consensus       610 ~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y  689 (814)
                      .....+++..+..++.++++++.|||+.   +++|+||+|+||++++++.++|+|||.+.......   ......++..|
T Consensus        79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~  152 (244)
T smart00220       79 KKRGRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEY  152 (244)
T ss_pred             HhccCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCC
Confidence            8766689999999999999999999998   99999999999999999999999999998766432   11334578899


Q ss_pred             ccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCcHHHHHHHHH
Q 041921          690 VAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVM  769 (814)
Q Consensus       690 ~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  769 (814)
                      ++||.+....++.++|||+||+++++|++|..||.......  .    ..+....+.....       ........++.+
T Consensus       153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~--~----~~~~~~~~~~~~~-------~~~~~~~~~~~~  219 (244)
T smart00220      153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL--E----LFKKIGKPKPPFP-------PPEWKISPEAKD  219 (244)
T ss_pred             CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH--H----HHHHHhccCCCCc-------cccccCCHHHHH
Confidence            99999988889999999999999999999999986522111  1    1111111111100       000004468889


Q ss_pred             HHHHccccCCCCCCCHHHHHH
Q 041921          770 VSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       770 l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      ++.+|+..+|++||++.++++
T Consensus       220 ~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      220 LIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHccCCchhccCHHHHhh
Confidence            999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.96  E-value=7.4e-30  Score=250.28  Aligned_cols=261  Identities=22%  Similarity=0.224  Sum_probs=199.0

Q ss_pred             cceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhcc-CCCCccceeeeecc----cccceEEEec
Q 041921          525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQT-HHKNLVRLLGFCDE----GQNRLLVYEF  599 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~~lv~e~  599 (814)
                      ++||-|-.|.|-.+..+.  .++.+|+|.|...     ...++|+++.-.. .|||||.+++++.+    .+.+++|||.
T Consensus        68 qvLG~GinGkV~~C~~k~--T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~  140 (400)
T KOG0604|consen   68 QVLGAGINGKVVQCVHKR--TQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMEC  140 (400)
T ss_pred             hhhccccCCceEEEEecc--chhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeec
Confidence            679999999999988764  6778999988642     2456788776665 69999999999865    3456799999


Q ss_pred             CCCCCHHHHhcCCC--CCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc---CCCcEEEeecCCccccccC
Q 041921          600 LNNGTLASFLFGNL--KPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLD---DYYTARISDFGLAKLLTLN  674 (814)
Q Consensus       600 ~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~---~~~~~kl~DfGla~~~~~~  674 (814)
                      |++|.|...+.+++  .+++.+...|+.||..|+.|||+.   +|.||||||+|+|..   .+..+||+|||+|+.-...
T Consensus       141 meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~  217 (400)
T KOG0604|consen  141 MEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEP  217 (400)
T ss_pred             ccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccccccccCCC
Confidence            99999999998764  488999999999999999999998   999999999999997   4567999999999865432


Q ss_pred             CcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCc
Q 041921          675 QSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGED  754 (814)
Q Consensus       675 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  754 (814)
                      .   .....+-|+.|.|||++...+++...|+||+||++|-|++|..||-...+..   +..-..++++.|.....    
T Consensus       218 ~---~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a---ispgMk~rI~~gqy~FP----  287 (400)
T KOG0604|consen  218 G---DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---ISPGMKRRIRTGQYEFP----  287 (400)
T ss_pred             c---cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc---CChhHHhHhhccCccCC----
Confidence            1   1244668999999999999999999999999999999999999997544321   11112344444443221    


Q ss_pred             ccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCCCCCCCCCC
Q 041921          755 KEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVPPNPYPF  807 (814)
Q Consensus       755 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~~~~p~~p~~~  807 (814)
                        .+.-....+...++++..|..+|.+|.|+++++..==-......|..|..-
T Consensus       288 --~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tpl~t  338 (400)
T KOG0604|consen  288 --EPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTPLST  338 (400)
T ss_pred             --ChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCCCchh
Confidence              111224566777888889999999999999998542222233344444433

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=5.2e-29  Score=276.16  Aligned_cols=249  Identities=24%  Similarity=0.350  Sum_probs=204.9

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhcc-CCCCccceeeeecc-----cccc
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQT-HHKNLVRLLGFCDE-----GQNR  593 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-----~~~~  593 (814)
                      +..|.+.||.|.+|.||+++...  .++..|||.+... ....+++..|.++++.. +|||++.++|++..     ++++
T Consensus        20 ~~ei~evig~Gtygkv~k~k~~~--~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqL   96 (953)
T KOG0587|consen   20 IFEIIEVIGNGTYGKVYKGRHVK--TGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQL   96 (953)
T ss_pred             ccEEEEEEeeccceeEEEEeeee--cCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeE
Confidence            44577899999999999998765  4556666666543 44566788899999988 79999999999853     5679


Q ss_pred             eEEEecCCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcccc
Q 041921          594 LLVYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLL  671 (814)
Q Consensus       594 ~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~  671 (814)
                      +||||||.+||..++++..  ..+.|..+.-|++.++.|+.+||.+   .++|||||-.|||++.++.|||.|||++..+
T Consensus        97 WLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSaQl  173 (953)
T KOG0587|consen   97 WLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  173 (953)
T ss_pred             EEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeeeeee
Confidence            9999999999999998764  6788999999999999999999998   9999999999999999999999999999887


Q ss_pred             ccCCcccccccccCCCCcccccccccC-----CCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCc
Q 041921          672 TLNQSKTIKTAIRGTKGYVAPEWFRNS-----KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK  746 (814)
Q Consensus       672 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  746 (814)
                      .......  ....||+.|||||++...     .|+.++|+||||++..||--|.+|+....+...-              
T Consensus       174 dsT~grR--nT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraL--------------  237 (953)
T KOG0587|consen  174 DSTVGRR--NTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRAL--------------  237 (953)
T ss_pred             ecccccc--cCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhh--------------
Confidence            6543322  456799999999998643     4677899999999999999999998755443211              


Q ss_pred             cceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          747 LNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       747 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      +...-.+.+....+.....++.++|..||.+|-+.||++.++++
T Consensus       238 F~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  238 FLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             ccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            12233445555567788999999999999999999999998875

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=5.5e-30  Score=253.14  Aligned_cols=238  Identities=24%  Similarity=0.266  Sum_probs=190.8

Q ss_pred             ccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchH---hHHHHHHhhhccCCCCccceeeeecccccceEEEe
Q 041921          522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGER---EFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE  598 (814)
Q Consensus       522 ~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~---~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  598 (814)
                      .|.+.||+|.||.|-++.-+  ..++.+|+|.+++...-..+   .-..|-++|+..+||.+..|.-.+...+++|+|||
T Consensus       171 dfLKvLGkGTFGKVIL~rEK--at~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMe  248 (516)
T KOG0690|consen  171 DFLKVLGKGTFGKVILCREK--ATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVME  248 (516)
T ss_pred             hHHHHhcCCccceEEEEeec--ccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEE
Confidence            45688999999999998754  46889999999764322222   34678899999999999999999999999999999


Q ss_pred             cCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccc
Q 041921          599 FLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT  678 (814)
Q Consensus       599 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  678 (814)
                      |..+|.|.-+|...+.+++...+-+-..|+.||.|||+.   +|+.||||.+|.|+|.+|.+||+|||+++.--...  .
T Consensus       249 yanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g--~  323 (516)
T KOG0690|consen  249 YANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYG--D  323 (516)
T ss_pred             EccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhccccc--c
Confidence            999999999998888888888888999999999999998   99999999999999999999999999997432211  1


Q ss_pred             ccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCccccc
Q 041921          679 IKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAM  758 (814)
Q Consensus       679 ~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  758 (814)
                      ....++||+.|+|||++....|..+.|.|.+|||+|||++|+.||.....+..       +..+.-+.+.        - 
T Consensus       324 t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kL-------FeLIl~ed~k--------F-  387 (516)
T KOG0690|consen  324 TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKL-------FELILMEDLK--------F-  387 (516)
T ss_pred             eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHH-------HHHHHhhhcc--------C-
Confidence            22568899999999999999999999999999999999999999975433321       1111111111        1 


Q ss_pred             CcHHHHHHHHHHHHHccccCCCCCC
Q 041921          759 NDIECLGKLVMVSIWCIQEDPSLRP  783 (814)
Q Consensus       759 ~~~~~~~~l~~l~~~Cl~~dp~~RP  783 (814)
                       +.....+...++...|.+||.+|.
T Consensus       388 -Pr~ls~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  388 -PRTLSPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             -CccCCHHHHHHHHHHhhcChHhhc
Confidence             111223445566677899999995

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.96  E-value=2.4e-28  Score=273.16  Aligned_cols=258  Identities=21%  Similarity=0.239  Sum_probs=177.3

Q ss_pred             hhhccccceeeeeeeeEEEEEEec--------------CCCceEEEEEEeccccccchHh--------------HHHHHH
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQT--------------RTSTTAVAVKKLDRVFQDGERE--------------FKNEVF  570 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~--------------~~~~~~vavK~l~~~~~~~~~~--------------~~~E~~  570 (814)
                      ..+.+.++||+|+||+||+|.+..              ...++.||||++........++              +..|+.
T Consensus       145 d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~  224 (507)
T PLN03224        145 DDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAY  224 (507)
T ss_pred             cCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHH
Confidence            345667899999999999997521              1235679999986433222222              344677


Q ss_pred             hhhccCCCCc-----cceeeeecc--------cccceEEEecCCCCCHHHHhcCC------------------------C
Q 041921          571 VIGQTHHKNL-----VRLLGFCDE--------GQNRLLVYEFLNNGTLASFLFGN------------------------L  613 (814)
Q Consensus       571 ~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~------------------------~  613 (814)
                      ++.+++|.++     ++++++|..        ....+|||||+++++|.++|+..                        .
T Consensus       225 ~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~  304 (507)
T PLN03224        225 MCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQD  304 (507)
T ss_pred             HHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccc
Confidence            7777776654     677887753        35679999999999999998642                        1


Q ss_pred             CCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcccccccccCCCCccccc
Q 041921          614 KPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE  693 (814)
Q Consensus       614 ~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE  693 (814)
                      .+++..+..++.|++++|.|||+.   +|+||||||+|||++.++.+||+|||++..+........ ....+++.|+|||
T Consensus       305 ~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~-~~g~~tp~Y~aPE  380 (507)
T PLN03224        305 KRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNP-LYGMLDPRYSPPE  380 (507)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCc-cccCCCcceeChh
Confidence            235677889999999999999998   999999999999999999999999999976543322111 1223578999999


Q ss_pred             ccccCCC----------------------CcchhhHHHHHHHHHHHhCCC-CCCcccch--h----hhhHHHHHHHHhhc
Q 041921          694 WFRNSKI----------------------TAKVDVYSFGVLLLEIISCRK-SFDIEMGE--E----YAILTDWAFDCYRN  744 (814)
Q Consensus       694 ~~~~~~~----------------------s~~~Dv~s~Gvvl~elltg~~-p~~~~~~~--~----~~~~~~~~~~~~~~  744 (814)
                      .+.....                      ..+.||||+||+++||+++.. |+......  +    ...+..  |+.+..
T Consensus       381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~--~r~~~~  458 (507)
T PLN03224        381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNR--WRMYKG  458 (507)
T ss_pred             hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHH--HHhhcc
Confidence            8754321                      134799999999999999875 55422110  0    001111  111111


Q ss_pred             CccceeecCcccccCcHHHHHHHHHHHHHccccCC---CCCCCHHHHHH
Q 041921          745 GKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDP---SLRPTMKKVLQ  790 (814)
Q Consensus       745 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp---~~RPt~~~vl~  790 (814)
                      ....        ........+...+++.++|.++|   .+|+|++|+++
T Consensus       459 ~~~~--------~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        459 QKYD--------FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             cCCC--------cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            1111        01111234667888899998765   78999999985

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=4e-30  Score=246.00  Aligned_cols=265  Identities=20%  Similarity=0.276  Sum_probs=193.2

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEec--cccccchHhHHHHHHhhhccCCCCccceeeeeccc--------
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLD--RVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEG--------  590 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------  590 (814)
                      |.-..+||+|.||.||+|...+  .++.||+|+.-  .....-.....+|+.+|..++|+|++.+++.|...        
T Consensus        19 yek~~kigqGtfgeVFkAr~~n--~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   19 YEKLAKIGQGTFGEVFKARSKN--TGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             HHHHHhcCCchHHHHHHHhhcC--ccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            3334579999999999998654  56778888663  22222334578999999999999999999999542        


Q ss_pred             ccceEEEecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcc
Q 041921          591 QNRLLVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAK  669 (814)
Q Consensus       591 ~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~  669 (814)
                      ...+|||+++++ +|..+|... .+++..++.+++.++..||.|+|..   .|+|||+||.|+|++.++.+||+|||+++
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar  172 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLAR  172 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecccccc
Confidence            236899999976 888888766 6789999999999999999999998   99999999999999999999999999998


Q ss_pred             ccccCCc--ccccccccCCCCcccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCc
Q 041921          670 LLTLNQS--KTIKTAIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK  746 (814)
Q Consensus       670 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  746 (814)
                      .+.....  ....+..+-|..|.+||.+.+. .++++.|||+.|||+.||+|+.+.++.........+.......+..+.
T Consensus       173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev  252 (376)
T KOG0669|consen  173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV  252 (376)
T ss_pred             ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence            7654322  1222445569999999988765 689999999999999999999998876654333222221111111110


Q ss_pred             c---------ceeecCcc-cc--cCcHHH------HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          747 L---------NVLVGEDK-EA--MNDIEC------LGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       747 ~---------~~~~~~~~-~~--~~~~~~------~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                      .         +.+-.+.+ ..  ..-.+.      -.+.++++..++..||.+||++.+++..
T Consensus       253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence            0         00000000 00  000111      2356788888999999999999888753

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.96  E-value=2.5e-28  Score=280.33  Aligned_cols=259  Identities=20%  Similarity=0.215  Sum_probs=165.7

Q ss_pred             hhhccccceeeeeeeeEEEEEEecC--CCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeee------eccc
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTR--TSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGF------CDEG  590 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~--~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~~~  590 (814)
                      ..+.+.++||+|+||.||+|++...  ..+..||||++.....  .+.+..|  .+....+.++..++..      +.++
T Consensus       132 ~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~  207 (566)
T PLN03225        132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKE  207 (566)
T ss_pred             CCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccccC
Confidence            4566778999999999999998642  1167899998864321  1111111  1222222333322221      2456


Q ss_pred             ccceEEEecCCCCCHHHHhcCCCC--------------------CChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCC
Q 041921          591 QNRLLVYEFLNNGTLASFLFGNLK--------------------PNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQ  650 (814)
Q Consensus       591 ~~~~lv~e~~~~gsL~~~l~~~~~--------------------l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~  650 (814)
                      ...+|||||+++++|.+++.....                    .....+..++.||+.||.|||+.   +|+||||||+
T Consensus       208 ~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~  284 (566)
T PLN03225        208 DEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQ  284 (566)
T ss_pred             CceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHH
Confidence            678999999999999999865321                    11233457999999999999998   9999999999


Q ss_pred             cEEEcC-CCcEEEeecCCccccccCCcccccccccCCCCcccccccccC----------------------CCCcchhhH
Q 041921          651 NILLDD-YYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNS----------------------KITAKVDVY  707 (814)
Q Consensus       651 NIll~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~s~~~Dv~  707 (814)
                      |||+++ ++.+||+|||+++.+....... .....+++.|+|||.+...                      .+..++|||
T Consensus       285 NILl~~~~~~~KL~DFGlA~~l~~~~~~~-~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw  363 (566)
T PLN03225        285 NIIFSEGSGSFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY  363 (566)
T ss_pred             HEEEeCCCCcEEEEeCCCccccccccccC-CcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence            999985 6799999999998665432221 1345689999999965322                      234567999


Q ss_pred             HHHHHHHHHHhCCCCCCcccchhhh-------hHHHHHHHHhhcCccceeecCcccc--cCcHHHHHHHHHHHHHccccC
Q 041921          708 SFGVLLLEIISCRKSFDIEMGEEYA-------ILTDWAFDCYRNGKLNVLVGEDKEA--MNDIECLGKLVMVSIWCIQED  778 (814)
Q Consensus       708 s~Gvvl~elltg~~p~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~l~~~Cl~~d  778 (814)
                      ||||+||||+++..+++.....-..       .+..|.  ......    .......  ...........+|+.+||+.|
T Consensus       364 SlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~--~~~~~~----~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d  437 (566)
T PLN03225        364 SAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWR--KLVEPR----ASPDLRRGFEVLDLDGGAGWELLKSMMRFK  437 (566)
T ss_pred             HHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHH--Hhhccc----cchhhhhhhhhccccchHHHHHHHHHccCC
Confidence            9999999999977665421110000       000110  000000    0000000  000001224558999999999


Q ss_pred             CCCCCCHHHHHHH
Q 041921          779 PSLRPTMKKVLQM  791 (814)
Q Consensus       779 p~~RPt~~~vl~~  791 (814)
                      |++|||+.++++.
T Consensus       438 P~kR~ta~e~L~H  450 (566)
T PLN03225        438 GRQRISAKAALAH  450 (566)
T ss_pred             cccCCCHHHHhCC
Confidence            9999999999874

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=3.9e-29  Score=283.23  Aligned_cols=267  Identities=20%  Similarity=0.251  Sum_probs=206.0

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccc---cccchHhHHHHHHhhhccCCCCccceeeeecccccceEE
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV---FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV  596 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  596 (814)
                      .+.+.+.||+|+||.|..+++..  .++.+|.|++.+.   ......-|+.|-.+|..-+.+=|+.+.-.|.+++++|||
T Consensus        76 DfeilKvIGrGaFGEV~lVr~k~--t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlV  153 (1317)
T KOG0612|consen   76 DFEILKVIGRGAFGEVALVRHKS--TEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLV  153 (1317)
T ss_pred             hhHHHHHhcccccceeEEEEeec--cccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEE
Confidence            34556889999999999999864  5778999999763   233344588898999888899999999999999999999


Q ss_pred             EecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCc
Q 041921          597 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS  676 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  676 (814)
                      ||||+||+|-.++....+++.....-++..|+-||.-||+-   |+|||||||+|||||..|++||+|||.+..+..+..
T Consensus       154 MdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~  230 (1317)
T KOG0612|consen  154 MDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGT  230 (1317)
T ss_pred             EecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHhcCCCCc
Confidence            99999999999998888899999999999999999999998   999999999999999999999999999988876544


Q ss_pred             ccccccccCCCCccccccccc-----CCCCcchhhHHHHHHHHHHHhCCCCCCcccchh-hhhHHHHHHHHhhcCcccee
Q 041921          677 KTIKTAIRGTKGYVAPEWFRN-----SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLNVL  750 (814)
Q Consensus       677 ~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  750 (814)
                      ... ...+|||.|++||+++.     +.|.+.+|.||+||++|||+.|..||....-.+ +..+        -+.     
T Consensus       231 V~s-~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KI--------m~h-----  296 (1317)
T KOG0612|consen  231 VRS-SVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKI--------MNH-----  296 (1317)
T ss_pred             EEe-ccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHH--------hch-----
Confidence            332 45679999999999953     468899999999999999999999997543222 1111        111     


Q ss_pred             ecCcccccCcHHHHHHHHHHHHHccccCCCCCCC---HHHHHHHH-------hcCcCCCCCCCCCCC
Q 041921          751 VGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPT---MKKVLQML-------EGVVEVSVPPNPYPF  807 (814)
Q Consensus       751 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt---~~~vl~~L-------~~~~~~~~p~~p~~~  807 (814)
                       ...+..+...+.+++..+||++.+. +|+.|-.   .+++-..-       +++.+..+|-.|..-
T Consensus       297 -k~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPevs  361 (1317)
T KOG0612|consen  297 -KESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEVS  361 (1317)
T ss_pred             -hhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcCC
Confidence             0011112223355666677776544 6777776   77775421       345555555566443

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.3e-28  Score=250.40  Aligned_cols=244  Identities=26%  Similarity=0.319  Sum_probs=194.3

Q ss_pred             HHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc-c--chHhHHHHHHhhhcc-CCCCccceeeeecccc
Q 041921          516 LEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ-D--GEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQ  591 (814)
Q Consensus       516 l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~-~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  591 (814)
                      +.....+|..+||+|.||.|-+|..+  +....+|||.|++... +  ..+--+.|-++|+.. +-|.++++..++..-+
T Consensus       346 i~~tDFnFl~VlGKGSFGKVlLaerk--gtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmD  423 (683)
T KOG0696|consen  346 IKATDFNFLMVLGKGSFGKVLLAERK--GTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD  423 (683)
T ss_pred             eeecccceEEEeccCccceeeeeccc--CcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhh
Confidence            34445578899999999999999854  4567899999975321 1  112235677777777 5678999999999999


Q ss_pred             cceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcccc
Q 041921          592 NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLL  671 (814)
Q Consensus       592 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~  671 (814)
                      .+++||||+.+|+|--+++.-+.+.+....-+|..||-||-+||+.   +|+.||||..|||||.+|.+||+|||+++.-
T Consensus       424 RLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn  500 (683)
T KOG0696|consen  424 RLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  500 (683)
T ss_pred             heeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccccc
Confidence            9999999999999999998888888888999999999999999998   9999999999999999999999999998743


Q ss_pred             ccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceee
Q 041921          672 TLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLV  751 (814)
Q Consensus       672 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  751 (814)
                      -.+.  ......+||+.|+|||++.-++|...+|.|||||+||||+.|+.||+++..++.       .+.+.+..     
T Consensus       501 i~~~--~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el-------F~aI~ehn-----  566 (683)
T KOG0696|consen  501 IFDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL-------FQAIMEHN-----  566 (683)
T ss_pred             ccCC--cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH-------HHHHHHcc-----
Confidence            2221  122457899999999999999999999999999999999999999987655431       22222221     


Q ss_pred             cCcccccCcHHHHHHHHHHHHHccccCCCCCC
Q 041921          752 GEDKEAMNDIECLGKLVMVSIWCIQEDPSLRP  783 (814)
Q Consensus       752 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RP  783 (814)
                           ...+.....+...+....|.+.|.+|.
T Consensus       567 -----vsyPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  567 -----VSYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             -----CcCcccccHHHHHHHHHHhhcCCcccc
Confidence                 122334455666777778888888884

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2.5e-29  Score=242.88  Aligned_cols=262  Identities=26%  Similarity=0.362  Sum_probs=197.4

Q ss_pred             ccceeeeeeeeEEEEEEecCCCceEEEEEEecccccc--chHhHHHHHHhhhccCCCCccceeeeeccc-----ccceEE
Q 041921          524 KEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD--GEREFKNEVFVIGQTHHKNLVRLLGFCDEG-----QNRLLV  596 (814)
Q Consensus       524 ~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~lv  596 (814)
                      .+-||.|+||.||..+.+.  +++.|++|++.+....  ..+.+.+|+++|.-++|.|++..++...-.     .++|++
T Consensus        58 DRPIGYGAFGVVWsVTDPR--dgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   58 DRPIGYGAFGVVWSVTDPR--SGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCcccccceeEEEeccCCC--CccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence            4679999999999998764  6889999999765332  345688999999999999999998876543     357888


Q ss_pred             EecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCc
Q 041921          597 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS  676 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  676 (814)
                      +|.|. .+|..+|-+...++...+.-+..||++||+|||+.   +|.||||||.|.|++.+..+||+|||+++....+..
T Consensus       136 TELmQ-SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~  211 (449)
T KOG0664|consen  136 TELMQ-SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR  211 (449)
T ss_pred             HHHHH-hhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchhhh
Confidence            99884 58999998888999999999999999999999998   999999999999999999999999999998776665


Q ss_pred             ccccccccCCCCcccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHH-HH-------HHHHhhcCcc
Q 041921          677 KTIKTAIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILT-DW-------AFDCYRNGKL  747 (814)
Q Consensus       677 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~-~~-------~~~~~~~~~~  747 (814)
                      ..+ +..+-|..|.|||.+.+. .|+.+.||||.||++.||+..+..|....+.++-.+. +.       ..+.--+|.-
T Consensus       212 ~hM-TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk  290 (449)
T KOG0664|consen  212 LNM-THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAK  290 (449)
T ss_pred             hhh-HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhH
Confidence            544 455578899999999876 6899999999999999999999998766553322211 10       0011111111


Q ss_pred             ceeecCccc---------ccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 041921          748 NVLVGEDKE---------AMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQML  792 (814)
Q Consensus       748 ~~~~~~~~~---------~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L  792 (814)
                      ..++.....         .......-.+...+...++..||.+|.+.++.+..+
T Consensus       291 ~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  291 NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence            111110000         001111223344666778999999999999887665

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.95  E-value=1e-28  Score=272.57  Aligned_cols=238  Identities=29%  Similarity=0.400  Sum_probs=184.4

Q ss_pred             cceeeeeeee-EEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhcc-CCCCccceeeeecccccceEEEecCCC
Q 041921          525 EEVGRGSFGI-VYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRLLVYEFLNN  602 (814)
Q Consensus       525 ~~LG~G~~g~-Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  602 (814)
                      +.+|.|.-|+ ||+|...    +++||||++-..   ...-..+|+..|+.- +|||||++++.-.+....||..|.| .
T Consensus       515 eilG~Gs~Gt~Vf~G~ye----~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~  586 (903)
T KOG1027|consen  515 EILGYGSNGTVVFRGVYE----GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-A  586 (903)
T ss_pred             HHcccCCCCcEEEEEeeC----CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-h
Confidence            5689999876 6999985    789999998532   334568899999888 7999999999999999999999999 4


Q ss_pred             CCHHHHhcCC-CC---CChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC-----CCcEEEeecCCcccccc
Q 041921          603 GTLASFLFGN-LK---PNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDD-----YYTARISDFGLAKLLTL  673 (814)
Q Consensus       603 gsL~~~l~~~-~~---l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~-----~~~~kl~DfGla~~~~~  673 (814)
                      .+|.+++... ..   ......+.+..|+++||+|||+.   +|+||||||.||||+.     ..+++|+|||+++.+..
T Consensus       587 ~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~  663 (903)
T KOG1027|consen  587 CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG  663 (903)
T ss_pred             hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence            5999999874 11   11133467889999999999997   9999999999999975     35799999999998876


Q ss_pred             CCccc-ccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhC-CCCCCcccchhhhhHHHHHHHHhhcCccceee
Q 041921          674 NQSKT-IKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISC-RKSFDIEMGEEYAILTDWAFDCYRNGKLNVLV  751 (814)
Q Consensus       674 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  751 (814)
                      +...- ......||.+|+|||.+....-+.++||||+|||+|+.++| .+||...-..+..         +..+......
T Consensus       664 ~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~N---------Il~~~~~L~~  734 (903)
T KOG1027|consen  664 GKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQAN---------ILTGNYTLVH  734 (903)
T ss_pred             CcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhh---------hhcCccceee
Confidence            65432 22456699999999999998888899999999999999995 8999743222111         1111111110


Q ss_pred             cCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 041921          752 GEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVL  789 (814)
Q Consensus       752 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl  789 (814)
                           .....++  +..+||.+|+.++|..||++.+|+
T Consensus       735 -----L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL  765 (903)
T KOG1027|consen  735 -----LEPLPDC--EAKDLISRMLNPDPQLRPSATDVL  765 (903)
T ss_pred             -----eccCchH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence                 0011122  678999999999999999999987

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=7.5e-29  Score=258.34  Aligned_cols=237  Identities=22%  Similarity=0.242  Sum_probs=194.6

Q ss_pred             cceeeeeeeeEEEEEEecCCCceEEEEEEecc---ccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEecCC
Q 041921          525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDR---VFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLN  601 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  601 (814)
                      ..||-|+||.|=++.....  ....|+|.+++   +.....+....|-.+|...+.|.||+++..+.+.+..|++||-|-
T Consensus       426 aTLGvGgFGRVELV~~~~~--~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaCl  503 (732)
T KOG0614|consen  426 ATLGVGGFGRVELVKVNSQ--KATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACL  503 (732)
T ss_pred             hhcccCccceEEEEEeccc--chHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhc
Confidence            3599999999999887632  22477777754   334445568899999999999999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcccccc
Q 041921          602 NGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKT  681 (814)
Q Consensus       602 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  681 (814)
                      +|.|...|.+++.++.....-++..+++|+.|||..   +|+.|||||+|.+++.+|-+||.|||+|+.+......   .
T Consensus       504 GGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KT---w  577 (732)
T KOG0614|consen  504 GGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKT---W  577 (732)
T ss_pred             CchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccCCce---e
Confidence            999999999999999999999999999999999998   9999999999999999999999999999988765432   5


Q ss_pred             cccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCcH
Q 041921          682 AIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDI  761 (814)
Q Consensus       682 ~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  761 (814)
                      .++||+.|.|||++.++..+.++|.||||++++||++|++||....+.....+       +..|.- .+.       .+.
T Consensus       578 TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~-------ILkGid-~i~-------~Pr  642 (732)
T KOG0614|consen  578 TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNL-------ILKGID-KIE-------FPR  642 (732)
T ss_pred             eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHH-------HHhhhh-hhh-------ccc
Confidence            58899999999999999999999999999999999999999987665432221       122210 000       111


Q ss_pred             HHHHHHHHHHHHccccCCCCCCC
Q 041921          762 ECLGKLVMVSIWCIQEDPSLRPT  784 (814)
Q Consensus       762 ~~~~~l~~l~~~Cl~~dp~~RPt  784 (814)
                      .......+++++....+|.+|.-
T Consensus       643 ~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  643 RITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             ccchhHHHHHHHHHhcCcHhhhc
Confidence            22344566777778899999975

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.95  E-value=5.4e-28  Score=225.30  Aligned_cols=197  Identities=27%  Similarity=0.380  Sum_probs=163.9

Q ss_pred             ccceeeeeeeeEEEEEEecCCCceEEEEEEeccc-cccchHhHHHHHHhhhcc-CCCCccceeeeecccccceEEEecCC
Q 041921          524 KEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV-FQDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRLLVYEFLN  601 (814)
Q Consensus       524 ~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  601 (814)
                      .++||+|++|.|=+-.+.  ..+...|+|++... ..+..+....|+.+..+- .+|.+|.++|........++.||.|.
T Consensus        51 i~elGrGayG~vekmrh~--~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~  128 (282)
T KOG0984|consen   51 IEELGRGAYGVVEKMRHI--QSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD  128 (282)
T ss_pred             hhhhcCCccchhhheeec--cCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh
Confidence            468999999999887765  46889999999643 344456688888776665 79999999999999999999999984


Q ss_pred             CCCHHHHh----cCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcc
Q 041921          602 NGTLASFL----FGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSK  677 (814)
Q Consensus       602 ~gsL~~~l----~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  677 (814)
                       .||+.+-    ......++...-+|+..+++||.|||++  ..++|||+||+|||++.+|++|++|||++..+..+-..
T Consensus       129 -tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAk  205 (282)
T KOG0984|consen  129 -TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAK  205 (282)
T ss_pred             -hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhhhHH
Confidence             4776654    3457788999999999999999999997  68999999999999999999999999999877644322


Q ss_pred             cccccccCCCCcccccccc----cCCCCcchhhHHHHHHHHHHHhCCCCCCcccc
Q 041921          678 TIKTAIRGTKGYVAPEWFR----NSKITAKVDVYSFGVLLLEIISCRKSFDIEMG  728 (814)
Q Consensus       678 ~~~~~~~gt~~y~aPE~~~----~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~  728 (814)
                         +.-.|-..|||||.+.    ...|+.|+||||||+.+.||.+++.||+....
T Consensus       206 ---t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t  257 (282)
T KOG0984|consen  206 ---TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT  257 (282)
T ss_pred             ---HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence               2234778999999885    33689999999999999999999999975543

>PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity

Probab=99.94  E-value=4.1e-28  Score=216.58  Aligned_cols=103  Identities=37%  Similarity=0.537  Sum_probs=74.1

Q ss_pred             CCeEEEEecCCCCCCCCC--CCceEEEccCCcEEEeCCCCceEeee-ccCCCc--eeEEEEecCcCEEEEeCCCCceeec
Q 041921           80 EKTVVWYTDNKDQNPAVP--RGSQVKLTADQGLVLNDPQGKQVWSS-KIDIGT--VAVGHMNDTGNFVLASSSSGRLWDS  154 (814)
Q Consensus        80 ~~t~vW~Anr~~~~~~~~--~~~~l~~~~~G~Lvl~~~~g~~vWst-~~~~~~--~~~a~LldsGNlVl~~~~~~~lWQS  154 (814)
                      ++||||+|||+.  |..+  ...+|.|+.||+|||+|..++++|+| ++.+.+  ...|+|+|+|||||++..+.+||||
T Consensus         1 ~~tvvW~an~~~--p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~~~~lW~S   78 (114)
T PF01453_consen    1 PRTVVWVANRNS--PLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDSSGNVLWQS   78 (114)
T ss_dssp             ---------TTE--EEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEETTSEEEEES
T ss_pred             Cccccccccccc--ccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEeecceEEEee
Confidence            369999999992  3323  45899999999999999999999999 566544  6799999999999999999999999


Q ss_pred             ccCCccccccCCcccc----c--cceeecccCCCCC
Q 041921          155 FSNPTDTLLLGQMMET----E--QGLFSRKSENNFS  184 (814)
Q Consensus       155 Fd~PtDtlLpg~~l~~----~--~~l~S~~s~~d~s  184 (814)
                      |||||||+||||+|+.    +  ..++||++.+|||
T Consensus        79 f~~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps  114 (114)
T PF01453_consen   79 FDYPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS  114 (114)
T ss_dssp             TTSSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred             cCCCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence            9999999999999876    2  3599999999996

Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B ....

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.94  E-value=7.1e-26  Score=228.20  Aligned_cols=211  Identities=36%  Similarity=0.553  Sum_probs=183.5

Q ss_pred             eeeeeeeeEEEEEEecCCCceEEEEEEecccccc-chHhHHHHHHhhhccCCCCccceeeeecccccceEEEecCCCCCH
Q 041921          527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD-GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTL  605 (814)
Q Consensus       527 LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  605 (814)
                      ||+|.+|.||++....  .+..+++|.+...... ..+.+.+|+..+++++|++++++++++......++++|++++++|
T Consensus         1 l~~g~~~~v~~~~~~~--~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l   78 (215)
T cd00180           1 LGEGGFGTVYLARDKK--TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL   78 (215)
T ss_pred             CCcCCceEEEEEEecC--CCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence            6899999999999753  4788999999754332 346799999999999999999999999999999999999999999


Q ss_pred             HHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC-CCcEEEeecCCccccccCCcccccccc
Q 041921          606 ASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDD-YYTARISDFGLAKLLTLNQSKTIKTAI  683 (814)
Q Consensus       606 ~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~-~~~~kl~DfGla~~~~~~~~~~~~~~~  683 (814)
                      .+++... ..+++..+..++.++++++.+||+.   +++|+||+|.||+++. ++.++|+|||.+........  .....
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~  153 (215)
T cd00180          79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI  153 (215)
T ss_pred             HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence            9999765 5788999999999999999999998   9999999999999999 89999999999987654321  11234


Q ss_pred             cCCCCcccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCcHH
Q 041921          684 RGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIE  762 (814)
Q Consensus       684 ~gt~~y~aPE~~~~~-~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  762 (814)
                      .+...|++||.+... ..+.+.|+|++|+++++|                                              
T Consensus       154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------  187 (215)
T cd00180         154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------  187 (215)
T ss_pred             cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence            578899999999877 788999999999999998                                              


Q ss_pred             HHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 041921          763 CLGKLVMVSIWCIQEDPSLRPTMKKVLQML  792 (814)
Q Consensus       763 ~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L  792 (814)
                        ..+.+++..|++.+|.+||++.++++.|
T Consensus       188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 --PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             --HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence              5677899999999999999999998753

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=7.1e-27  Score=231.78  Aligned_cols=244  Identities=24%  Similarity=0.313  Sum_probs=193.4

Q ss_pred             cccceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhcc-CCCCccceeeeecccccceEEEe
Q 041921          523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRLLVYE  598 (814)
Q Consensus       523 ~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  598 (814)
                      +..+||+|.|+.|-.+.+..  ..+.+|+|.+++..   .+..+-.+.|-.+..+. +||.+|.+..++..+..+++|.|
T Consensus       254 ll~vigrgsyakvl~~~~~~--t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvie  331 (593)
T KOG0695|consen  254 LLRVIGRGSYAKVLLVRLKK--TDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIE  331 (593)
T ss_pred             eeeeecCcchhhhhheehcc--cceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEE
Confidence            44689999999999998763  56788999886532   22333466777777666 79999999999999999999999


Q ss_pred             cCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccc
Q 041921          599 FLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT  678 (814)
Q Consensus       599 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  678 (814)
                      |+++|+|--++...++++++...-+...|.-||.|||+.   +|+.||||..|||+|..|.+||.|+|+.+.--...  .
T Consensus       332 yv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l~~g--d  406 (593)
T KOG0695|consen  332 YVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG--D  406 (593)
T ss_pred             EecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCCCCC--c
Confidence            999999988888888899998888999999999999998   99999999999999999999999999987432221  2


Q ss_pred             ccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCccc-chhhhhHHHHHHHHhhcCccceeecCcccc
Q 041921          679 IKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEM-GEEYAILTDWAFDCYRNGKLNVLVGEDKEA  757 (814)
Q Consensus       679 ~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  757 (814)
                      ....++||+.|+|||.+++..|....|.|++||+++||+.|+.||+.-. .....+-..+.++.+.+..+...       
T Consensus       407 ~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqirip-------  479 (593)
T KOG0695|consen  407 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIP-------  479 (593)
T ss_pred             ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccccc-------
Confidence            2256889999999999999999999999999999999999999997432 12223333455555555443321       


Q ss_pred             cCcHHHHHHHHHHHHHccccCCCCCC
Q 041921          758 MNDIECLGKLVMVSIWCIQEDPSLRP  783 (814)
Q Consensus       758 ~~~~~~~~~l~~l~~~Cl~~dp~~RP  783 (814)
                         .....+...+++.-|.+||.+|.
T Consensus       480 ---rslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  480 ---RSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             ---ceeehhhHHHHHHhhcCCcHHhc
Confidence               12223445667777899999884

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=3.4e-26  Score=238.40  Aligned_cols=142  Identities=26%  Similarity=0.381  Sum_probs=116.4

Q ss_pred             ccccCHHHHHH-hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccC-----C---C
Q 041921          508 LRCFSYKELEG-ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTH-----H---K  578 (814)
Q Consensus       508 ~~~~~~~~l~~-~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----h---~  578 (814)
                      .......|+.. ++|.+.++||-|.|++||++...  ...+.||+|..+.. +.-.+....||++|++++     |   .
T Consensus        66 YHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDt--q~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~  142 (590)
T KOG1290|consen   66 YHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDT--QNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKK  142 (590)
T ss_pred             CceeeccccccCceEEEEEeccccccceeEEEeec--cCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCc
Confidence            33445556666 89999999999999999999965  46789999998753 333455789999999984     3   3


Q ss_pred             Cccceeeeecc----cccceEEEecCCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcE
Q 041921          579 NLVRLLGFCDE----GQNRLLVYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNI  652 (814)
Q Consensus       579 niv~l~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NI  652 (814)
                      +||+|+++|..    +.|.+||+|++ +.+|..+|...  +.++...+.+|+.||+.||.|||.+|  +|||.||||+||
T Consensus       143 ~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENv  219 (590)
T KOG1290|consen  143 CVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENV  219 (590)
T ss_pred             eeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCccee
Confidence            69999999954    67899999998 55777777543  77899999999999999999999986  899999999999


Q ss_pred             EEc
Q 041921          653 LLD  655 (814)
Q Consensus       653 ll~  655 (814)
                      |+.
T Consensus       220 Ll~  222 (590)
T KOG1290|consen  220 LLC  222 (590)
T ss_pred             eee
Confidence            994

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=1.7e-26  Score=246.10  Aligned_cols=199  Identities=25%  Similarity=0.338  Sum_probs=170.1

Q ss_pred             ceeeeeeeeEEEEEEecCCCceEEEEEEeccccccc---hHhHHHHHHhhhccCCCCccceeeeecccccceEEEecCCC
Q 041921          526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG---EREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN  602 (814)
Q Consensus       526 ~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  602 (814)
                      .||-|+||.|.++.-.+  ....+|.|.|++.+--.   ....+.|-.||+.-..+=||+|+-.|.+++.+|+||+|+++
T Consensus       636 ~iGvGAFGeV~Lv~KvD--T~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPG  713 (1034)
T KOG0608|consen  636 TIGVGAFGEVCLVRKVD--TRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPG  713 (1034)
T ss_pred             eecccccceeEEEeecc--hhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCC
Confidence            49999999999987553  35678999997654322   23478899999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCC-------
Q 041921          603 GTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ-------  675 (814)
Q Consensus       603 gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~-------  675 (814)
                      |++-.+|...+.+.+...+-++..+..|+++.|..   |+|||||||+|||||.+|.+||.||||+.-++-..       
T Consensus       714 GDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~  790 (1034)
T KOG0608|consen  714 GDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQE  790 (1034)
T ss_pred             ccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceeccccccccC
Confidence            99999999999999999999999999999999998   99999999999999999999999999986442100       


Q ss_pred             ------------------cc---------------cccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCC
Q 041921          676 ------------------SK---------------TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKS  722 (814)
Q Consensus       676 ------------------~~---------------~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p  722 (814)
                                        +.               ......+||..|+|||++....++..+|.||.|||||||+.|+.|
T Consensus       791 gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~p  870 (1034)
T KOG0608|consen  791 GDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPP  870 (1034)
T ss_pred             CCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCC
Confidence                              00               001124699999999999999999999999999999999999999


Q ss_pred             CCcccch
Q 041921          723 FDIEMGE  729 (814)
Q Consensus       723 ~~~~~~~  729 (814)
                      |....+.
T Consensus       871 f~~~tp~  877 (1034)
T KOG0608|consen  871 FLADTPG  877 (1034)
T ss_pred             ccCCCCC
Confidence            9866553

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.93  E-value=1.6e-26  Score=244.80  Aligned_cols=193  Identities=23%  Similarity=0.343  Sum_probs=166.7

Q ss_pred             cccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--------ccchHhHHHHHHhhhccC---CCCccceeeeecccc
Q 041921          523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--------QDGEREFKNEVFVIGQTH---HKNLVRLLGFCDEGQ  591 (814)
Q Consensus       523 ~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~  591 (814)
                      ..+.||+|+||.|+.++++.  ....|+||.+.+..        ....-..-.|+.+|+.++   |+||++++.+|++++
T Consensus       565 tlq~lG~GAyGkV~lai~K~--n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd  642 (772)
T KOG1152|consen  565 TLQPLGEGAYGKVNLAIHKE--NNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDD  642 (772)
T ss_pred             eeeeccccccceEEEeeecc--cceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCC
Confidence            34679999999999999875  46789999886421        111123678999999997   999999999999999


Q ss_pred             cceEEEecC-CCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccc
Q 041921          592 NRLLVYEFL-NNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKL  670 (814)
Q Consensus       592 ~~~lv~e~~-~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~  670 (814)
                      ..+|++|-. ++-+|.++|.-...+++.+..-|+.||+.|+++||++   +|+|||||-+||.++.+|-+||+|||.+..
T Consensus       643 ~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfgsaa~  719 (772)
T KOG1152|consen  643 YYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFGSAAY  719 (772)
T ss_pred             eeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeeccchhh
Confidence            999999975 5679999999999999999999999999999999999   999999999999999999999999999987


Q ss_pred             cccCCcccccccccCCCCcccccccccCCCC-cchhhHHHHHHHHHHHhCCCCCC
Q 041921          671 LTLNQSKTIKTAIRGTKGYVAPEWFRNSKIT-AKVDVYSFGVLLLEIISCRKSFD  724 (814)
Q Consensus       671 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~~Dv~s~Gvvl~elltg~~p~~  724 (814)
                      .....-    ..++||.+|.|||++.+.+|- ..-|||++|++||.++....||.
T Consensus       720 ~ksgpf----d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  720 TKSGPF----DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             hcCCCc----ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            665432    457899999999999998875 45899999999999998888763

>cd00028 B_lectin Bulb-type mannose-specific lectin

Probab=99.93  E-value=1.7e-25  Score=202.00  Aligned_cols=114  Identities=31%  Similarity=0.480  Sum_probs=98.8

Q ss_pred             ceeecCCCCCceecCCCcEEEeEeeccCCCCCCCcEEEEEEecccCCCeEEEEecCCCCCCCCCCCceEEEccCCcEEEe
Q 041921           34 ATLTAGTSSSPWLSPSGDFAFGFHQLDEENNTNDLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLTADQGLVLN  113 (814)
Q Consensus        34 ~~l~~~~~~~~lvS~~g~F~lGF~~~~~~~~~~~~~~lgiw~~~~~~~t~vW~Anr~~~~~~~~~~~~l~~~~~G~Lvl~  113 (814)
                      +.|.+++   +|+|+++.|++|||.+..   .. .++.+|||.+++ .++||.||++.   |....++|.|+.||+|+|+
T Consensus         2 ~~l~~~~---~l~s~~~~f~~G~~~~~~---q~-~dgnlv~~~~~~-~~~vW~snt~~---~~~~~~~l~l~~dGnLvl~   70 (116)
T cd00028           2 NPLSSGQ---TLVSSGSLFELGFFKLIM---QS-RDYNLILYKGSS-RTVVWVANRDN---PSGSSCTLTLQSDGNLVIY   70 (116)
T ss_pred             cCcCCCC---EEEeCCCcEEEecccCCC---CC-CeEEEEEEeCCC-CeEEEECCCCC---CCCCCEEEEEecCCCeEEE
Confidence            3566665   789999999999999853   11 379999999887 79999999983   3566789999999999999


Q ss_pred             CCCCceEeeeccCC-CceeEEEEecCcCEEEEeCCCCceeecccCC
Q 041921          114 DPQGKQVWSSKIDI-GTVAVGHMNDTGNFVLASSSSGRLWDSFSNP  158 (814)
Q Consensus       114 ~~~g~~vWst~~~~-~~~~~a~LldsGNlVl~~~~~~~lWQSFd~P  158 (814)
                      |.+|.+||+|++++ ....+|+|+|+|||||++.++.+||||||||
T Consensus        71 ~~~g~~vW~S~~~~~~~~~~~~L~ddGnlvl~~~~~~~~W~Sf~~P  116 (116)
T cd00028          71 DGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYDSDGNFLWQSFDYP  116 (116)
T ss_pred             cCCCcEEEEecccCCCCceEEEEeCCCCEEEECCCCCEEEcCCCCC
Confidence            99999999999886 4567899999999999999999999999999

The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses.

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.93  E-value=1.1e-25  Score=212.79  Aligned_cols=254  Identities=18%  Similarity=0.312  Sum_probs=189.8

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccC-CCCccceeeeecccc--cceE
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTH-HKNLVRLLGFCDEGQ--NRLL  595 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~~l  595 (814)
                      ..|++.+++|+|-++.||.|..-.  +.+.++||.++..   ..+.+.+|+.+|..+. ||||++|++...+..  ...|
T Consensus        38 ddYeivrk~GRGKYSEVFeg~~~~--~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL  112 (338)
T KOG0668|consen   38 DDYEIVRKVGRGKYSEVFEGINIT--NNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL  112 (338)
T ss_pred             chHHHHHHHcCccHhhHhcccccC--CCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence            346677899999999999998442  5678999999865   4567899999999997 999999999987654  5679


Q ss_pred             EEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc-CCCcEEEeecCCccccccC
Q 041921          596 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLD-DYYTARISDFGLAKLLTLN  674 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~-~~~~~kl~DfGla~~~~~~  674 (814)
                      |+||+.+.+...+.   +.++...+.-.+.++++||.|+|+.   ||+|||+||.|+++| +...++|+|.|+|..+.+.
T Consensus       113 iFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~  186 (338)
T KOG0668|consen  113 IFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  186 (338)
T ss_pred             HhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence            99999998876654   3456667778999999999999998   999999999999999 4567999999999998876


Q ss_pred             CcccccccccCCCCccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhh--hHH---------HHHHH--
Q 041921          675 QSKTIKTAIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA--ILT---------DWAFD--  740 (814)
Q Consensus       675 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~--~~~---------~~~~~--  740 (814)
                      ....   ..+.+.-|-.||.+-. +.++..-|+|||||+|.+|+..+.||.........  .+.         .++..  
T Consensus       187 ~eYn---VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~  263 (338)
T KOG0668|consen  187 KEYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQ  263 (338)
T ss_pred             ceee---eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHc
Confidence            5543   3346677889998865 45788899999999999999999998644332111  110         01100  


Q ss_pred             ------------HhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          741 ------------CYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       741 ------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                                  .........++.....    .-...+.++++...|..|-.+|||+.|.+.
T Consensus       264 i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~----hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  264 IDLDPQFEDILGRHSRKPWSRFINSENQ----HLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             cCCChhHhhHhhccccccHHHhCCcccc----ccCChHHHHHHHHHHhhccccccchHHHhc
Confidence                        0000111111111111    112356778888889999999999999864

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.93  E-value=7.2e-25  Score=223.97  Aligned_cols=198  Identities=30%  Similarity=0.463  Sum_probs=172.6

Q ss_pred             ccccceeeeeeeeEEEEEEecCCCceEEEEEEecccccc-chHhHHHHHHhhhccCCCCccceeeeecccccceEEEecC
Q 041921          522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD-GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL  600 (814)
Q Consensus       522 ~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  600 (814)
                      .+.+.||+|++|.||++....  .+..+++|.+...... ..+.+.+|++.+++++|+|++++++++......++++|++
T Consensus         2 ~~~~~i~~g~~~~v~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   79 (225)
T smart00221        2 ELGKKLGEGAFGKVYLARDKG--TGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC   79 (225)
T ss_pred             ceeeEeecCCCeEEEEEEEcC--CCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence            456789999999999999763  4678999999765444 5678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCC-CChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcccc
Q 041921          601 NNGTLASFLFGNLK-PNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI  679 (814)
Q Consensus       601 ~~gsL~~~l~~~~~-l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  679 (814)
                      ++++|.+++..... +++.....++.+++.++.+||+.   +++|+||+|+||+++.++.++|+|||++......... .
T Consensus        80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~  155 (225)
T smart00221       80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-L  155 (225)
T ss_pred             CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-c
Confidence            99999999987766 89999999999999999999998   9999999999999999999999999999877654311 1


Q ss_pred             cccccCCCCccccccc-ccCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 041921          680 KTAIRGTKGYVAPEWF-RNSKITAKVDVYSFGVLLLEIISCRKSFDI  725 (814)
Q Consensus       680 ~~~~~gt~~y~aPE~~-~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~  725 (814)
                      .....++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus       156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            1234577889999998 666788899999999999999999999964

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.92  E-value=8.6e-26  Score=224.45  Aligned_cols=267  Identities=24%  Similarity=0.278  Sum_probs=191.2

Q ss_pred             ceeeeeeeeEEEEEEecCCCceEEEEEEeccc--cccchHhHHHHHHhhhccCCCCccceeeeecc------cccceEEE
Q 041921          526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV--FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDE------GQNRLLVY  597 (814)
Q Consensus       526 ~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~~~lv~  597 (814)
                      .+|.|.- .|-.+..  .-.+++||+|++...  .....+...+|..++..++|+|+++++.++.-      -.+.++||
T Consensus        24 p~~~g~~-~v~~a~D--~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~  100 (369)
T KOG0665|consen   24 PIGSGAQ-IVVAAFD--QVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVM  100 (369)
T ss_pred             ccCCCCc-eEEecch--hhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHH
Confidence            3566665 4444432  235789999998542  22334567899999999999999999999853      34679999


Q ss_pred             ecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcc
Q 041921          598 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSK  677 (814)
Q Consensus       598 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  677 (814)
                      |+| ..+|...+.  ..++-.....|..|++.|++|||+.   +|+||||||+||++..+..+||.|||+++.-..+   
T Consensus       101 e~m-~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~---  171 (369)
T KOG0665|consen  101 ELM-DANLCQVIL--MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD---  171 (369)
T ss_pred             Hhh-hhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcccCcc---
Confidence            999 458888776  4567788889999999999999998   9999999999999999999999999999865543   


Q ss_pred             cccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhh----------------hHHHHHHHH
Q 041921          678 TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA----------------ILTDWAFDC  741 (814)
Q Consensus       678 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~----------------~~~~~~~~~  741 (814)
                      -..+..+.|.-|.|||++.+..+.+.+||||+||++.||++|+..|.+..--++.                .+..-+...
T Consensus       172 ~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~y  251 (369)
T KOG0665|consen  172 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNY  251 (369)
T ss_pred             cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHH
Confidence            2235677899999999998888999999999999999999999988643211100                011111111


Q ss_pred             hhcC------ccce-eecCcc--cccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--Hh---cCcCCCCCCCC
Q 041921          742 YRNG------KLNV-LVGEDK--EAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM--LE---GVVEVSVPPNP  804 (814)
Q Consensus       742 ~~~~------~~~~-~~~~~~--~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~--L~---~~~~~~~p~~p  804 (814)
                      ++..      ...+ +.|...  ..+.+......+.+++.+||-.+|++|.++.++|+.  ++   ...++++|++|
T Consensus       252 v~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~~~ev~ap~pe  328 (369)
T KOG0665|consen  252 VENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYDPDEVEAPPPE  328 (369)
T ss_pred             hhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeecccccccCCCCc
Confidence            1100      0000 111100  111122345567889999999999999999999864  33   44455666655

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.92  E-value=7.4e-26  Score=236.72  Aligned_cols=274  Identities=21%  Similarity=0.243  Sum_probs=208.1

Q ss_pred             ccccccCHHHHHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccC------CCC
Q 041921          506 TNLRCFSYKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTH------HKN  579 (814)
Q Consensus       506 ~~~~~~~~~~l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~------h~n  579 (814)
                      .+.-.+.+.|+...+|.+..-.|+|-|++|-+|....  .+..||||.+.+. +...+.=+.|+++|++|+      --|
T Consensus       419 EGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~--r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~H  495 (752)
T KOG0670|consen  419 EGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQA--RGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFH  495 (752)
T ss_pred             cceEEEehhhhhcceeEEEeccccceeeeeeeccccC--CCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhH
Confidence            3455677889999999999999999999999998664  5669999999864 223344578999999996      348


Q ss_pred             ccceeeeecccccceEEEecCCCCCHHHHhcCC---CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC
Q 041921          580 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN---LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDD  656 (814)
Q Consensus       580 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~---~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~  656 (814)
                      +++|+..|...+|+|||||-+ ..+|.+.|...   ..|....+..++.|+.-||..|...   +|+|.||||.||||++
T Consensus       496 clrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE  571 (752)
T KOG0670|consen  496 CLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNE  571 (752)
T ss_pred             HHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEecc
Confidence            999999999999999999987 55899999754   4577888999999999999999987   9999999999999996


Q ss_pred             C-CcEEEeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHH
Q 041921          657 Y-YTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILT  735 (814)
Q Consensus       657 ~-~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~  735 (814)
                      . ..+||||||.|........    +.+.-+.-|.|||++.+.+|+...|+||.||.||||.||+..|.+.......-+.
T Consensus       572 ~k~iLKLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~  647 (752)
T KOG0670|consen  572 SKNILKLCDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLF  647 (752)
T ss_pred             CcceeeeccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHH
Confidence            5 5689999999976654332    3333466799999999999999999999999999999999999754332211000


Q ss_pred             -H----HHHHHhhcCcc-------------------------ceeecCcc-------------cccCcHHHHHHHHHHHH
Q 041921          736 -D----WAFDCYRNGKL-------------------------NVLVGEDK-------------EAMNDIECLGKLVMVSI  772 (814)
Q Consensus       736 -~----~~~~~~~~~~~-------------------------~~~~~~~~-------------~~~~~~~~~~~l~~l~~  772 (814)
                       +    +....++.|.+                         ..+....+             ..........++.+|+.
T Consensus       648 me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLd  727 (752)
T KOG0670|consen  648 MELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLD  727 (752)
T ss_pred             HHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHH
Confidence             0    00011111110                         00000000             00122446778899999


Q ss_pred             HccccCCCCCCCHHHHHH
Q 041921          773 WCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       773 ~Cl~~dp~~RPt~~~vl~  790 (814)
                      .|+..||++|.|..++|+
T Consensus       728 kml~LdP~KRit~nqAL~  745 (752)
T KOG0670|consen  728 KMLILDPEKRITVNQALK  745 (752)
T ss_pred             HHhccChhhcCCHHHHhc
Confidence            999999999999998875

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.92  E-value=8.2e-26  Score=243.33  Aligned_cols=250  Identities=22%  Similarity=0.277  Sum_probs=200.8

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEecC
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL  600 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  600 (814)
                      |.+..++|.|.+|.|||++...  .+...|||.++-.......-.+.|+-+++.-+|||||.++|-+...+..++.|||+
T Consensus        17 yellqrvgsgTygdvyKaRd~~--s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEyc   94 (829)
T KOG0576|consen   17 YELLQRVGSGTYGDVYKARDKR--SGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYC   94 (829)
T ss_pred             hhheeeecCCcccchhhhcccc--cCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEec
Confidence            3455789999999999998654  56778888877655556667889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccccc
Q 041921          601 NNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIK  680 (814)
Q Consensus       601 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  680 (814)
                      .+|+|.+.-+....+++.++....+..++||+|||+.   +=+|||||-.|||+++.+.+|++|||.+..+...-..  .
T Consensus        95 gggslQdiy~~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati~K--r  169 (829)
T KOG0576|consen   95 GGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAK--R  169 (829)
T ss_pred             CCCcccceeeecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhhhhh--h
Confidence            9999999999889999999999999999999999998   8899999999999999999999999998776543221  2


Q ss_pred             ccccCCCCccccccc---ccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccc
Q 041921          681 TAIRGTKGYVAPEWF---RNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEA  757 (814)
Q Consensus       681 ~~~~gt~~y~aPE~~---~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  757 (814)
                      ....||+.|||||+.   +.+.+..++|||++|+...|+---..|.....+.....+.       .    +...+ .+..
T Consensus       170 ksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~Lm-------T----kS~~q-pp~l  237 (829)
T KOG0576|consen  170 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLM-------T----KSGFQ-PPTL  237 (829)
T ss_pred             hcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHh-------h----ccCCC-CCcc
Confidence            456799999999987   4567899999999999999998777665433322211110       0    11111 1122


Q ss_pred             cCcHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 041921          758 MNDIECLGKLVMVSIWCIQEDPSLRPTMKKVL  789 (814)
Q Consensus       758 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl  789 (814)
                      .......+.+.++++.|+-++|++|||++.++
T Consensus       238 kDk~kws~~fh~fvK~altknpKkRptaeklL  269 (829)
T KOG0576|consen  238 KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLL  269 (829)
T ss_pred             cCCccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence            23445677888999999999999999997665

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.91  E-value=7.9e-25  Score=225.94  Aligned_cols=197  Identities=26%  Similarity=0.379  Sum_probs=163.9

Q ss_pred             ccccceeeeeeeeEEEEEEecC-CCceEEEEEEeccccccchHhHHHHHHhhhcc-CCCCccceeeeecccccceEEEec
Q 041921          522 NFKEEVGRGSFGIVYKGVIQTR-TSTTAVAVKKLDRVFQDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRLLVYEF  599 (814)
Q Consensus       522 ~~~~~LG~G~~g~Vy~~~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~  599 (814)
                      ...++||+|.|++||++++... .....||+|.+...  .....+.+|++.|..+ -+.||+++.+++..+++..+|+||
T Consensus        39 ~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~  116 (418)
T KOG1167|consen   39 KVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPY  116 (418)
T ss_pred             hhhccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecc
Confidence            4467899999999999998752 24678999999754  4566799999999999 599999999999999999999999


Q ss_pred             CCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc-CCCcEEEeecCCccccccCC---
Q 041921          600 LNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLD-DYYTARISDFGLAKLLTLNQ---  675 (814)
Q Consensus       600 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~-~~~~~kl~DfGla~~~~~~~---  675 (814)
                      +++....+++.+   ++......++..+.+||+++|.+   +|+||||||+|+|.+ ..+.-.|.|||+|.......   
T Consensus       117 ~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~  190 (418)
T KOG1167|consen  117 FEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTE  190 (418)
T ss_pred             cCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHHHHHhhhhhh
Confidence            999999998864   55788889999999999999999   999999999999998 56788999999997221000   


Q ss_pred             ---------------------------------------cccccccccCCCCcccccccc-cCCCCcchhhHHHHHHHHH
Q 041921          676 ---------------------------------------SKTIKTAIRGTKGYVAPEWFR-NSKITAKVDVYSFGVLLLE  715 (814)
Q Consensus       676 ---------------------------------------~~~~~~~~~gt~~y~aPE~~~-~~~~s~~~Dv~s~Gvvl~e  715 (814)
                                                             .........||+||.|||++. ....++++||||.|||++.
T Consensus       191 ~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Ls  270 (418)
T KOG1167|consen  191 HSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLS  270 (418)
T ss_pred             hhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeeh
Confidence                                                   000011235999999999885 4567899999999999999


Q ss_pred             HHhCCCCCCcc
Q 041921          716 IISCRKSFDIE  726 (814)
Q Consensus       716 lltg~~p~~~~  726 (814)
                      +++++.||...
T Consensus       271 lls~~~PFf~a  281 (418)
T KOG1167|consen  271 LLSRRYPFFKA  281 (418)
T ss_pred             hhccccccccC
Confidence            99999998644

>smart00108 B_lectin Bulb-type mannose-specific lectin

Probab=99.91  E-value=3.2e-24  Score=193.13  Aligned_cols=112  Identities=32%  Similarity=0.490  Sum_probs=96.3

Q ss_pred             ceeecCCCCCceecCCCcEEEeEeeccCCCCCCCcEEEEEEecccCCCeEEEEecCCCCCCCCCCCceEEEccCCcEEEe
Q 041921           34 ATLTAGTSSSPWLSPSGDFAFGFHQLDEENNTNDLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLTADQGLVLN  113 (814)
Q Consensus        34 ~~l~~~~~~~~lvS~~g~F~lGF~~~~~~~~~~~~~~lgiw~~~~~~~t~vW~Anr~~~~~~~~~~~~l~~~~~G~Lvl~  113 (814)
                      +.|..++   .|+|+++.|++|||.+..     ..++.+|||+..+ .++||.||++   .++..++.|.|+.||+|+|+
T Consensus         2 ~~l~~~~---~l~s~~~~f~~G~~~~~~-----q~dgnlV~~~~~~-~~~vW~snt~---~~~~~~~~l~l~~dGnLvl~   69 (114)
T smart00108        2 NTLSSGQ---TLVSGNSLFELGFFTLIM-----QNDYNLILYKSSS-RTVVWVANRD---NPVSDSCTLTLQSDGNLVLY   69 (114)
T ss_pred             cccCCCC---EEecCCCcEeeeccccCC-----CCCEEEEEEECCC-CcEEEECCCC---CCCCCCEEEEEeCCCCEEEE
Confidence            3455665   789999999999998852     2479999999887 8999999998   34444588999999999999


Q ss_pred             CCCCceEeeeccC-CCceeEEEEecCcCEEEEeCCCCceeecccC
Q 041921          114 DPQGKQVWSSKID-IGTVAVGHMNDTGNFVLASSSSGRLWDSFSN  157 (814)
Q Consensus       114 ~~~g~~vWst~~~-~~~~~~a~LldsGNlVl~~~~~~~lWQSFd~  157 (814)
                      |.+|.+||+|++. +.+..+++|+|+|||||++..+.+|||||||
T Consensus        70 ~~~g~~vW~S~t~~~~~~~~~~L~ddGnlvl~~~~~~~~W~Sf~~  114 (114)
T smart00108       70 DGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYDSDGNFLWQSFDY  114 (114)
T ss_pred             eCCCCEEEEecccCCCCceEEEEeCCCCEEEECCCCCEEeCCCCC
Confidence            9999999999987 4556789999999999999999999999997

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.90  E-value=5e-24  Score=206.69  Aligned_cols=248  Identities=18%  Similarity=0.285  Sum_probs=181.4

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhcc-CCCCccceeee-ecccccceEEE
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQT-HHKNLVRLLGF-CDEGQNRLLVY  597 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-~~~~~~~~lv~  597 (814)
                      .|.+.+.||+|.||.+-++.++.  ....+++|-+... ....++|.+|..---.+ .|.||+.-++. +...+..++++
T Consensus        25 ~y~I~k~lgeG~FgkIlL~eHr~--s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   25 VYTINKQLGEGRFGKILLAEHRQ--SKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhHHHHhcccceeeEEeeeccC--CceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            35667889999999999999874  5678999988653 34567899998655555 68999988764 56666778999


Q ss_pred             ecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc--CCCcEEEeecCCccccccCC
Q 041921          598 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLD--DYYTARISDFGLAKLLTLNQ  675 (814)
Q Consensus       598 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~--~~~~~kl~DfGla~~~~~~~  675 (814)
                      ||+|.|+|..-+... .+.+....+++.|++.||.|+|++   +++|||||.+||||-  +..++||+|||+.+..+..-
T Consensus       102 E~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV  177 (378)
T KOG1345|consen  102 EFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV  177 (378)
T ss_pred             ccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCcee
Confidence            999999999887653 466777889999999999999999   999999999999993  44589999999987654321


Q ss_pred             cccccccccCCCCcccccccccC-----CCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCcccee
Q 041921          676 SKTIKTAIRGTKGYVAPEWFRNS-----KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVL  750 (814)
Q Consensus       676 ~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  750 (814)
                           .....+..|.+||.....     ...+..|||.||++++..+||+.||+.....+..   -|-+..+..++...+
T Consensus       178 -----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~---Y~~~~~w~~rk~~~~  249 (378)
T KOG1345|consen  178 -----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKP---YWEWEQWLKRKNPAL  249 (378)
T ss_pred             -----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCch---HHHHHHHhcccCccC
Confidence                 223356789999987533     3567899999999999999999999843322211   223344444433321


Q ss_pred             ecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 041921          751 VGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKV  788 (814)
Q Consensus       751 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~v  788 (814)
                      .+.      -....+++.++.++-+.+++++|--..++
T Consensus       250 P~~------F~~fs~~a~r~Fkk~lt~~~~drcki~~~  281 (378)
T KOG1345|consen  250 PKK------FNPFSEKALRLFKKSLTPRFKDRCKIWTA  281 (378)
T ss_pred             chh------hcccCHHHHHHHHHhcCCcccccchhHHH
Confidence            111      01233556667777788888888433333

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.90  E-value=3.2e-24  Score=259.10  Aligned_cols=195  Identities=19%  Similarity=0.228  Sum_probs=138.9

Q ss_pred             ccCC-CCccceeeee-------cccccceEEEecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeee
Q 041921          574 QTHH-KNLVRLLGFC-------DEGQNRLLVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIH  644 (814)
Q Consensus       574 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H  644 (814)
                      .++| +||.++++++       .+....++++|++ .++|.++|... ..+++..+..++.||++||.|||++   +|+|
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---gIvH  103 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQ---GIVV  103 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhC---Ceee
Confidence            4556 6888888877       2334567788887 56999999753 5689999999999999999999998   9999


Q ss_pred             cCCCCCcEEEcC-------------------CCcEEEeecCCccccccCCc--------------ccccccccCCCCccc
Q 041921          645 CDIKPQNILLDD-------------------YYTARISDFGLAKLLTLNQS--------------KTIKTAIRGTKGYVA  691 (814)
Q Consensus       645 ~dlkp~NIll~~-------------------~~~~kl~DfGla~~~~~~~~--------------~~~~~~~~gt~~y~a  691 (814)
                      |||||+||||+.                   ++.+|++|||+++.......              ........||+.|||
T Consensus       104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A  183 (793)
T PLN00181        104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS  183 (793)
T ss_pred             ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence            999999999965                   44556666666654211000              000012357889999


Q ss_pred             ccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHH
Q 041921          692 PEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVS  771 (814)
Q Consensus       692 PE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  771 (814)
                      ||++.+..++.++|||||||+||||++|..|+.....    .+..     +....    ..+.     ......+...++
T Consensus       184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~-----~~~~~----~~~~-----~~~~~~~~~~~~  245 (793)
T PLN00181        184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSS-----LRHRV----LPPQ-----ILLNWPKEASFC  245 (793)
T ss_pred             hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHH-----HHHhh----cChh-----hhhcCHHHHHHH
Confidence            9999999999999999999999999998887642110    1100     11000    0000     011233456788


Q ss_pred             HHccccCCCCCCCHHHHHH
Q 041921          772 IWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       772 ~~Cl~~dp~~RPt~~~vl~  790 (814)
                      .+||+++|.+||+|.|+++
T Consensus       246 ~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        246 LWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHhCCCChhhCcChHHHhh
Confidence            8999999999999999976

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.89  E-value=4.7e-23  Score=202.43  Aligned_cols=166  Identities=23%  Similarity=0.201  Sum_probs=125.8

Q ss_pred             CCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcccccc
Q 041921          603 GTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKT  681 (814)
Q Consensus       603 gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  681 (814)
                      |+|.+++... ..+++..++.|+.|+++||.|||+.   +      ||+|||++.++.+|+  ||++.......      
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------   63 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ------   63 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc------
Confidence            6899999864 5689999999999999999999997   4      999999999999999  99988654321      


Q ss_pred             cccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCcH
Q 041921          682 AIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDI  761 (814)
Q Consensus       682 ~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  761 (814)
                       ..||+.|||||++.+..++.++|||||||++|||++|+.||....... ..+.... .......      + .......
T Consensus        64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-~~~~~~~-~~~~~~~------~-~~~~~~~  133 (176)
T smart00750       64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-AILEILL-NGMPADD------P-RDRSNLE  133 (176)
T ss_pred             -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-HHHHHHH-HHhccCC------c-cccccHH
Confidence             258899999999999999999999999999999999999986443211 1111111 1110000      0 0001111


Q ss_pred             HHH--HHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 041921          762 ECL--GKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV  795 (814)
Q Consensus       762 ~~~--~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~  795 (814)
                      ...  .++.+++.+||+.+|.+||++.++++.+..+
T Consensus       134 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      134 SVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             HHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence            222  2689999999999999999999999988543

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.88  E-value=1.6e-23  Score=202.83  Aligned_cols=253  Identities=21%  Similarity=0.333  Sum_probs=193.2

Q ss_pred             HHHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEec--cccccchHhHHHHHHhhhccCCCCccceeeeeccccc
Q 041921          515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLD--RVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQN  592 (814)
Q Consensus       515 ~l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  592 (814)
                      .+.-...++..+|.+...|..|+|.++    +..+++|.+.  .......++|.+|.-.|+.+.||||++++|.|....+
T Consensus       186 gid~~~lnl~tkl~e~hsgelwrgrwq----gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppn  261 (448)
T KOG0195|consen  186 GIDVSSLNLITKLAESHSGELWRGRWQ----GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPN  261 (448)
T ss_pred             CcchhhhhhhhhhccCCCccccccccc----CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCC
Confidence            334444566778999999999999997    3446667663  3444455789999999999999999999999999999


Q ss_pred             ceEEEecCCCCCHHHHhcCCC--CCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEe--ecCCc
Q 041921          593 RLLVYEFLNNGTLASFLFGNL--KPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARIS--DFGLA  668 (814)
Q Consensus       593 ~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~--DfGla  668 (814)
                      ..++..||+.|+|...|++..  ..+..+..+++.++|+|++|||+. .+-|..--|..+.|++|++.+++|+  |--++
T Consensus       262 lv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfs  340 (448)
T KOG0195|consen  262 LVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFS  340 (448)
T ss_pred             ceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceee
Confidence            999999999999999999863  357778899999999999999986 2345555799999999999888875  21111


Q ss_pred             cccccCCcccccccccCCCCcccccccccCCCC---cchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcC
Q 041921          669 KLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKIT---AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG  745 (814)
Q Consensus       669 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s---~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  745 (814)
                      ..        . ......+.||+||.++.++.+   .++|+|||++++|||.|...||....+.+.....          
T Consensus       341 fq--------e-~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki----------  401 (448)
T KOG0195|consen  341 FQ--------E-VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI----------  401 (448)
T ss_pred             ee--------c-cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh----------
Confidence            10        0 122356789999999877543   5799999999999999999999865543322110          


Q ss_pred             ccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 041921          746 KLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV  796 (814)
Q Consensus       746 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~  796 (814)
                           .-+.+....++.....+.+++.-|+.+||.+||.+..|+-+||++.
T Consensus       402 -----aleglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  402 -----ALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             -----hhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence                 0111222223345567888888999999999999999999998764

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.86  E-value=3.3e-21  Score=206.88  Aligned_cols=167  Identities=21%  Similarity=0.116  Sum_probs=127.5

Q ss_pred             HhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc-----ccchHhHHHHHHhhhccCCCCccceeeeeccccc
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF-----QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQN  592 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  592 (814)
                      ...|.+.+.||+|+||+||+|.+... .+..||||++....     ....+.|.+|++++++++|+|+++.+..   ...
T Consensus        17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~-~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~   92 (365)
T PRK09188         17 SARFVETAVLKRDVFSTVERGYFAGD-PGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGK   92 (365)
T ss_pred             cCCceEccEEeecCcEEEEEEEEcCC-CCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCC
Confidence            44577789999999999999987532 35668999875321     1224568999999999999999863322   245


Q ss_pred             ceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCC-CCCcEEEcCCCcEEEeecCCcccc
Q 041921          593 RLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDI-KPQNILLDDYYTARISDFGLAKLL  671 (814)
Q Consensus       593 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dl-kp~NIll~~~~~~kl~DfGla~~~  671 (814)
                      .+|||||+++++|... ....      ...++.|++++|.|||+.   +|+|||| ||+|||++.++.+||+|||+++.+
T Consensus        93 ~~LVmE~~~G~~L~~~-~~~~------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~  162 (365)
T PRK09188         93 DGLVRGWTEGVPLHLA-RPHG------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLASVF  162 (365)
T ss_pred             cEEEEEccCCCCHHHh-Cccc------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccceec
Confidence            7999999999999732 1111      246889999999999998   9999999 999999999999999999999977


Q ss_pred             ccCCcccc------cccccCCCCcccccccccC
Q 041921          672 TLNQSKTI------KTAIRGTKGYVAPEWFRNS  698 (814)
Q Consensus       672 ~~~~~~~~------~~~~~gt~~y~aPE~~~~~  698 (814)
                      ........      .+...+++.|+|||.+...
T Consensus       163 ~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        163 RRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             ccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            64321111      1345688899999998543

>PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation

Probab=99.85  E-value=3.5e-21  Score=171.75  Aligned_cols=110  Identities=29%  Similarity=0.598  Sum_probs=89.9

Q ss_pred             eeccccCCCCCCCCcceeeecCCccEEEEeeCCceeeeeeeecccCCceEEEEEEecCccEEEEEecCCCCCCeEEEEec
Q 041921          215 YTSGTYDPANSSNSGYRVMFNESGYMYILRRNGGRFDLTTERVVPAADFYYRATLNFDGVFAQYFYPKNGNGNWSVAWSE  294 (814)
Q Consensus       215 ~~sg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~L~~dG~l~~y~~~~~~~~~W~~~~~~  294 (814)
                      ||+|+|++..  +.+.+.+.....+.|.+..+.++.++++.  ..+.+.++|++||.+|++++|.|. +..+.|.+.|++
T Consensus         1 wrsG~WnG~~--f~g~p~~~~~~~~~~~fv~~~~e~~~t~~--~~~~s~~~r~~ld~~G~l~~~~w~-~~~~~W~~~~~~   75 (110)
T PF00954_consen    1 WRSGPWNGQR--FSGIPEMSSNSLYNYSFVSNNEEVYYTYS--LSNSSVLSRLVLDSDGQLQRYIWN-ESTQSWSVFWSA   75 (110)
T ss_pred             CCccccCCeE--ECCcccccccceeEEEEEECCCeEEEEEe--cCCCceEEEEEEeeeeEEEEEEEe-cCCCcEEEEEEe
Confidence            8999999874  34444444444566777788888877765  346678999999999999999995 567899999999


Q ss_pred             cCCcccccCCCCCCCCCCCCcccccCCCCCCccccCCCCCcCC
Q 041921          295 PENICVDIGGGLGSGACGYNSICTLDSDRRPRCACPKGYSLLD  337 (814)
Q Consensus       295 p~~~C~~~~~~~~~~~CG~~g~C~~~~~~~~~C~C~~GF~~~~  337 (814)
                      |.|+||+      |+.||+||+|+.  +..|.|.||+||+|++
T Consensus        76 p~d~Cd~------y~~CG~~g~C~~--~~~~~C~Cl~GF~P~n  110 (110)
T PF00954_consen   76 PKDQCDV------YGFCGPNGICNS--NNSPKCSCLPGFEPKN  110 (110)
T ss_pred             cccCCCC------ccccCCccEeCC--CCCCceECCCCcCCCc
Confidence            9999999      899999999964  5788999999999975

This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.84  E-value=8.6e-20  Score=196.92  Aligned_cols=261  Identities=20%  Similarity=0.220  Sum_probs=191.1

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCC----CCccceeeee-cccccce
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHH----KNLVRLLGFC-DEGQNRL  594 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~  594 (814)
                      .+.+.++||+|+||.||++...... ...+|+|............+..|+.++..+.+    +++..++... ..+...+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~-~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~   97 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEK-NKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF   97 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCC-CeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence            5677889999999999999976432 45678777765433333378889999888863    6899999988 4777889


Q ss_pred             EEEecCCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC-----CcEEEeecCC
Q 041921          595 LVYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDY-----YTARISDFGL  667 (814)
Q Consensus       595 lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~-----~~~kl~DfGl  667 (814)
                      +||+.+ +.+|.++....  +.++..+.++|+.|++.+|.+||+.   +++||||||.|+++...     ..+.|.|||+
T Consensus        98 iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl  173 (322)
T KOG1164|consen   98 IVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL  173 (322)
T ss_pred             EEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence            999986 77999988543  6789999999999999999999998   99999999999999854     4699999999


Q ss_pred             cc--ccccCCcc------cccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccch-hhhhHHHHH
Q 041921          668 AK--LLTLNQSK------TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGE-EYAILTDWA  738 (814)
Q Consensus       668 a~--~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~-~~~~~~~~~  738 (814)
                      ++  .+......      ......+||.+|.+++...+...+++.|+||++.++.|++.|..||...... ....+... 
T Consensus       174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~-  252 (322)
T KOG1164|consen  174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD-  252 (322)
T ss_pred             CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH-
Confidence            99  33222211      1113456999999999999999999999999999999999999999654321 11111100 


Q ss_pred             HHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 041921          739 FDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV  798 (814)
Q Consensus       739 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~~  798 (814)
                         ..    ......     .....+..+.++...+-..+..++|....+...|+.....
T Consensus       253 ---~~----~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~  300 (322)
T KOG1164|consen  253 ---PR----KLLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS  300 (322)
T ss_pred             ---hh----hhcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence               00    000000     0111223444455445557999999999999888665433

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.84  E-value=2.3e-21  Score=221.92  Aligned_cols=254  Identities=22%  Similarity=0.299  Sum_probs=190.0

Q ss_pred             cccceeeeeeeeEEEEEEecCCCceEEEEEEecc-c-cccchH----hHHHHHHhhhccCCCCccceeeeecccccceEE
Q 041921          523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDR-V-FQDGER----EFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV  596 (814)
Q Consensus       523 ~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~-~-~~~~~~----~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  596 (814)
                      ..+.+|.|++|.|+.......  ....+.|.... . .....+    .+..|+.+-..++|+|++..+....+.....-+
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~--~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~  399 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSD--LKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQS  399 (601)
T ss_pred             ccceeeecccCceEEEEecCC--CccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhh
Confidence            356799999998877665432  22222232210 0 111111    256677788889999999988888777776666


Q ss_pred             EecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCc
Q 041921          597 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS  676 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  676 (814)
                      |||++. +|..++.+...+....+..++.|+.+|+.|||+.   +|.|||+|++|++++.++.+||+|||.+..+.....
T Consensus       400 mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e  475 (601)
T KOG0590|consen  400 MEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE  475 (601)
T ss_pred             hhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence            999999 9999998887888899999999999999999998   999999999999999999999999999998776554


Q ss_pred             c--cccccccCCCCcccccccccCCCCcc-hhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecC
Q 041921          677 K--TIKTAIRGTKGYVAPEWFRNSKITAK-VDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGE  753 (814)
Q Consensus       677 ~--~~~~~~~gt~~y~aPE~~~~~~~s~~-~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  753 (814)
                      .  ......+|+..|+|||.+....+.+. .||||.|+++..|++|+.||......+...     ......+....... 
T Consensus       476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-----~~~~~~~~~~~~~~-  549 (601)
T KOG0590|consen  476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-----KTNNYSDQRNIFEG-  549 (601)
T ss_pred             hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-----hhhccccccccccC-
Confidence            4  44466789999999999999998865 999999999999999999997655443221     00000001111111 


Q ss_pred             cccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          754 DKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       754 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                        ........+.+...++.++|+.+|.+|.|+++|++
T Consensus       550 --~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  550 --PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             --hHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence              11112345667788999999999999999999985

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.82  E-value=5.1e-19  Score=191.42  Aligned_cols=258  Identities=28%  Similarity=0.360  Sum_probs=196.2

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEecccccc---chHhHHHHHHhhhccCCC-CccceeeeecccccceEE
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHK-NLVRLLGFCDEGQNRLLV  596 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv  596 (814)
                      +.+.+.||.|+|+.||++...     ..+++|.+......   ....+.+|+.+++.+.|+ +++++..++......+++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~   76 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR-----KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLV   76 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec-----cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEE
Confidence            345678999999999999865     67889988654333   356799999999999988 799999999777778999


Q ss_pred             EecCCCCCHHHHhcCCC---CCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC-cEEEeecCCccccc
Q 041921          597 YEFLNNGTLASFLFGNL---KPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYY-TARISDFGLAKLLT  672 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~~~---~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~-~~kl~DfGla~~~~  672 (814)
                      +|++.+++|.+++....   .+.......++.|++.++.|+|+.   +++|||+||+||+++... .++++|||+++.+.
T Consensus        77 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~  153 (384)
T COG0515          77 MEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLP  153 (384)
T ss_pred             EecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecC
Confidence            99999999998777664   688889999999999999999998   899999999999999988 79999999998665


Q ss_pred             cCCccc----ccccccCCCCccccccccc---CCCCcchhhHHHHHHHHHHHhCCCCCCcccch-hhhhHHHHHHHHhhc
Q 041921          673 LNQSKT----IKTAIRGTKGYVAPEWFRN---SKITAKVDVYSFGVLLLEIISCRKSFDIEMGE-EYAILTDWAFDCYRN  744 (814)
Q Consensus       673 ~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~  744 (814)
                      ......    ......|+..|+|||.+..   .......|+|++|++++++++|..|+...... ....    ....+..
T Consensus       154 ~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~----~~~~~~~  229 (384)
T COG0515         154 DPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQ----TLKIILE  229 (384)
T ss_pred             CCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHH----HHHHHHh
Confidence            443221    2245679999999999987   57889999999999999999999997654321 0011    1111111


Q ss_pred             CccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          745 GKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       745 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                      .... .................+.+++..|+..+|..|.++.+....
T Consensus       230 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         230 LPTP-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             cCCc-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            1111 000000000002234567788899999999999999887654

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.81  E-value=1.7e-20  Score=212.92  Aligned_cols=252  Identities=23%  Similarity=0.260  Sum_probs=183.4

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc-ccchHhHHHHHHh--hhccCCCCccceeeeecccccceEE
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF-QDGEREFKNEVFV--IGQTHHKNLVRLLGFCDEGQNRLLV  596 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~~~~~~lv  596 (814)
                      ...+.+.||.+.|=.|.+|+++   +| .|+||.+-+.. .-..+.|.++++-  ...++|||.+++.-.-..++..|||
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~---eG-~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylv   99 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDR---EG-LVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLV   99 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCC---Cc-eEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHH
Confidence            4566788999999999999976   34 48888885433 3344555554433  4556899999999888888888999


Q ss_pred             EecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccc--cC
Q 041921          597 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLT--LN  674 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~--~~  674 (814)
                      -+|..+ +|.|.|..++-+...+..-|+.|++.||.-+|..   +|.|||||.+||||+...-+.|+||..-+...  ++
T Consensus       100 Rqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD  175 (1431)
T KOG1240|consen  100 RQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED  175 (1431)
T ss_pred             HHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence            999866 8999998888888889999999999999999998   99999999999999999999999998765432  22


Q ss_pred             Ccccc---cccccCCCCccccccccc----------CC-CCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHH
Q 041921          675 QSKTI---KTAIRGTKGYVAPEWFRN----------SK-ITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAF  739 (814)
Q Consensus       675 ~~~~~---~~~~~gt~~y~aPE~~~~----------~~-~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~  739 (814)
                      .....   ....+.-.+|+|||.+-.          .. .+++.||||+||++.||++ |+++|....-           
T Consensus       176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL-----------  244 (1431)
T KOG1240|consen  176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQL-----------  244 (1431)
T ss_pred             CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHH-----------
Confidence            11111   111233458999997632          12 6789999999999999999 7888753210           


Q ss_pred             HHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 041921          740 DCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV  795 (814)
Q Consensus       740 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~  795 (814)
                      -.++.+. .......++...+    ..+++++..|++.||++|.++++.++.-.++
T Consensus       245 ~aYr~~~-~~~~e~~Le~Ied----~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~  295 (1431)
T KOG1240|consen  245 LAYRSGN-ADDPEQLLEKIED----VSLRNLILSMIQRDPSKRLSAEDYLQKYRGL  295 (1431)
T ss_pred             HhHhccC-ccCHHHHHHhCcC----ccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence            0112221 0000000111111    2577899999999999999999999886554

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.80  E-value=4.6e-19  Score=177.13  Aligned_cols=201  Identities=21%  Similarity=0.313  Sum_probs=168.3

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhcc-CCCCccceeeeecccccceEEEe
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRLLVYE  598 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  598 (814)
                      -+.++++||+|.||..+.|+--  -..++||||.-...  ....++..|....+.+ ..+.|...+-|..++.+-.||+|
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl--~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid  104 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNL--YNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID  104 (449)
T ss_pred             cceeccccccCcceeeeccccc--ccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence            3556889999999999999732  35789999976432  2345788899888888 57999999999999999999999


Q ss_pred             cCCCCCHHHHhc-CCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC-----CCcEEEeecCCccccc
Q 041921          599 FLNNGTLASFLF-GNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDD-----YYTARISDFGLAKLLT  672 (814)
Q Consensus       599 ~~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~-----~~~~kl~DfGla~~~~  672 (814)
                      .+ +-||++++. ..+.++.++...||.|++.-++|+|++   .+|.|||||+|+||..     ...+.|+|||+|+.+.
T Consensus       105 LL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr  180 (449)
T KOG1165|consen  105 LL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR  180 (449)
T ss_pred             hh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence            88 779999875 457899999999999999999999998   9999999999999963     3458999999999876


Q ss_pred             cCCccc-----ccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccc
Q 041921          673 LNQSKT-----IKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMG  728 (814)
Q Consensus       673 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~  728 (814)
                      ......     .....-||.+||+-....+.+.+.+.|+-|+|-++++.+-|..||.+...
T Consensus       181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA  241 (449)
T KOG1165|consen  181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA  241 (449)
T ss_pred             CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence            543321     12345599999999999999999999999999999999999999986544

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.80  E-value=5.1e-19  Score=169.28  Aligned_cols=206  Identities=22%  Similarity=0.263  Sum_probs=170.8

Q ss_pred             HHHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCC-CCccceeeeecccccc
Q 041921          515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHH-KNLVRLLGFCDEGQNR  593 (814)
Q Consensus       515 ~l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~  593 (814)
                      .|....|.+.++||.|.||.+|.|..-.  .+..||||.-+..  ....++..|..+...++| ..|..+..|..+...-
T Consensus        11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~--~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn   86 (341)
T KOG1163|consen   11 LIVGGKYKLVRKIGSGSFGDIYLGISIT--SGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYN   86 (341)
T ss_pred             heeccceEEEEeecCCchhheeeeeecc--CCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence            3455667888999999999999998653  6889999987543  233468889999999976 6788888899999999


Q ss_pred             eEEEecCCCCCHHHHhc-CCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC---CCcEEEeecCCcc
Q 041921          594 LLVYEFLNNGTLASFLF-GNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDD---YYTARISDFGLAK  669 (814)
Q Consensus       594 ~lv~e~~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~---~~~~kl~DfGla~  669 (814)
                      .|||+.+ +-||++++. -.+.++.++.+.++-|++.-++|+|..   +++||||||+|+|..-   ...+.++|||+++
T Consensus        87 vlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK  162 (341)
T KOG1163|consen   87 VLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK  162 (341)
T ss_pred             eeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchh
Confidence            9999987 779998875 346788999999999999999999998   9999999999999963   4568999999999


Q ss_pred             ccccCCccc-----ccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccc
Q 041921          670 LLTLNQSKT-----IKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMG  728 (814)
Q Consensus       670 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~  728 (814)
                      .+....+..     ......||.+|.+-....+...+.+.|+-|+|.+|.++.-|..||++..+
T Consensus       163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka  226 (341)
T KOG1163|consen  163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA  226 (341)
T ss_pred             hhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence            876543221     11345699999988888778889999999999999999999999987654

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.79  E-value=3.9e-19  Score=193.84  Aligned_cols=218  Identities=26%  Similarity=0.452  Sum_probs=164.9

Q ss_pred             hhccCCCCccceeeeecccccceEEEecCCCCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHhhhcCCCCe-eecCCCC
Q 041921          572 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCRAQI-IHCDIKP  649 (814)
Q Consensus       572 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i-~H~dlkp  649 (814)
                      |+.+.|.|+.+++|.+.++...++|.+|+..|+|.+.+.. ...++|.....++++|++||+|||..   .| .|+.+++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l~s   77 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGALKS   77 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeeecc
Confidence            4578999999999999999999999999999999999987 57789999999999999999999987   44 9999999


Q ss_pred             CcEEEcCCCcEEEeecCCccccccCCcccccccccCCCCcccccccccC-------CCCcchhhHHHHHHHHHHHhCCCC
Q 041921          650 QNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNS-------KITAKVDVYSFGVLLLEIISCRKS  722 (814)
Q Consensus       650 ~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~s~~~Dv~s~Gvvl~elltg~~p  722 (814)
                      +|.++|..+.+||+|||+.................-..-|.|||.++..       ..+.++||||||++++|+++.+.|
T Consensus        78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~  157 (484)
T KOG1023|consen   78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP  157 (484)
T ss_pred             ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence            9999999999999999998876431111111112234579999998763       146789999999999999999999


Q ss_pred             CCcccchhhhhHHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 041921          723 FDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV  798 (814)
Q Consensus       723 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~~  798 (814)
                      |.........  .+.+.. ++.+. .....+....  ..+..+.+..++..||..+|.+||+++.+-..++.+...
T Consensus       158 ~~~~~~~~~~--~eii~~-~~~~~-~~~~rP~i~~--~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~  227 (484)
T KOG1023|consen  158 FDLRNLVEDP--DEIILR-VKKGG-SNPFRPSIEL--LNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG  227 (484)
T ss_pred             cccccccCCh--HHHHHH-HHhcC-CCCcCcchhh--hhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence            9764332211  111222 22211 1111111111  114445789999999999999999999999988776543

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.77  E-value=9.1e-19  Score=173.03  Aligned_cols=139  Identities=14%  Similarity=0.119  Sum_probs=108.3

Q ss_pred             ccceeeeeeeeEEEEEEecCCCceEEEEEEecccccc--c-------hHh-----------------HHHHHHhhhccCC
Q 041921          524 KEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD--G-------ERE-----------------FKNEVFVIGQTHH  577 (814)
Q Consensus       524 ~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~--~-------~~~-----------------~~~E~~~l~~l~h  577 (814)
                      .+.||+|++|.||+|...   +++.||||.++.....  .       ...                 ...|+..+.++.|
T Consensus         2 ~~~ig~G~~~~Vy~a~~~---~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~   78 (190)
T cd05147           2 NGCISTGKEANVYHATTA---NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVT   78 (190)
T ss_pred             CCccccccceEEEEEECC---CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHH
Confidence            367999999999999875   5789999999653211  1       011                 2349999999988


Q ss_pred             CCccceeeeecccccceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHh-hhcCCCCeeecCCCCCcEEEcC
Q 041921          578 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYL-HEDCRAQIIHCDIKPQNILLDD  656 (814)
Q Consensus       578 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yL-H~~~~~~i~H~dlkp~NIll~~  656 (814)
                      +++.....+..  ...+|||||+++++|...+.....++......++.|++.+|.++ |+.   +|+||||||+|||++ 
T Consensus        79 ~~v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-  152 (190)
T cd05147          79 AGIPCPEPILL--KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-  152 (190)
T ss_pred             CCCCCCcEEEe--cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-
Confidence            87744333322  23489999999988766544456788889999999999999999 676   999999999999998 


Q ss_pred             CCcEEEeecCCcccc
Q 041921          657 YYTARISDFGLAKLL  671 (814)
Q Consensus       657 ~~~~kl~DfGla~~~  671 (814)
                      ++.++|+|||++...
T Consensus       153 ~~~v~LiDFG~a~~~  167 (190)
T cd05147         153 DGKLYIIDVSQSVEH  167 (190)
T ss_pred             CCcEEEEEccccccC
Confidence            478999999998743

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.77  E-value=9.6e-19  Score=174.51  Aligned_cols=175  Identities=13%  Similarity=0.110  Sum_probs=134.2

Q ss_pred             HHHHHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHh---------HHHHHHhhhccCCCCccce
Q 041921          513 YKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE---------FKNEVFVIGQTHHKNLVRL  583 (814)
Q Consensus       513 ~~~l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~---------~~~E~~~l~~l~h~niv~l  583 (814)
                      .+++...++...+.||.|+||.||....    +...+|||.+........+.         +.+|+..+.+++|++|..+
T Consensus        25 ~~~~l~~~y~~~~~l~~~~f~~v~l~~~----~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~  100 (232)
T PRK10359         25 FDDFLSYNIKTIKVFRNIDDTKVSLIDT----DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASL  100 (232)
T ss_pred             HHHHhhCceEEEEEecCCCceEEEEEec----CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcc
Confidence            3466777888889999999999998543    25579999997543333322         6789999999999999999


Q ss_pred             eeeeccc--------ccceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc
Q 041921          584 LGFCDEG--------QNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLD  655 (814)
Q Consensus       584 ~~~~~~~--------~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~  655 (814)
                      ..++...        ...+|||||+++.+|.++..    ++    .....+++.+|..+|+.   +++|||+||+||+++
T Consensus       101 ~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~----~~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~  169 (232)
T PRK10359        101 NDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE----IS----EDVKAKIKASIESLHQH---GMVSGDPHKGNFIVS  169 (232)
T ss_pred             eEeeeecccccccccCCeEEEEEEECCccHHHhhh----cc----HHHHHHHHHHHHHHHHc---CCccCCCChHHEEEe
Confidence            8886532        35789999999999988742    22    23566999999999998   999999999999999


Q ss_pred             CCCcEEEeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHH
Q 041921          656 DYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEII  717 (814)
Q Consensus       656 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ell  717 (814)
                      +++ ++|+|||............              .+.....+..++|+|+||+.+.-+.
T Consensus       170 ~~g-i~liDfg~~~~~~e~~a~d--------------~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        170 KNG-LRIIDLSGKRCTAQRKAKD--------------RIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             CCC-EEEEECCCcccccchhhHH--------------HHHHHhHhcccccccceeEeehHHH
Confidence            988 9999999887553222111              1333345667899999999887654

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.75  E-value=8.8e-18  Score=166.73  Aligned_cols=140  Identities=16%  Similarity=0.076  Sum_probs=110.2

Q ss_pred             ccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccc--------------------------hHhHHHHHHhhhccCC
Q 041921          524 KEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG--------------------------EREFKNEVFVIGQTHH  577 (814)
Q Consensus       524 ~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~--------------------------~~~~~~E~~~l~~l~h  577 (814)
                      .+.||+|++|.||+|...   +++.||||.++......                          ...+..|...+.++.|
T Consensus         2 ~~~ig~G~~~~Vy~a~~~---~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~   78 (190)
T cd05145           2 NGCISTGKEANVYHARTG---DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYE   78 (190)
T ss_pred             CceeecCCCcEEEEEEcC---CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHh
Confidence            467999999999999865   57899999987532110                          1123578899999999


Q ss_pred             CCccceeeeecccccceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCcEEEcC
Q 041921          578 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHE-DCRAQIIHCDIKPQNILLDD  656 (814)
Q Consensus       578 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~i~H~dlkp~NIll~~  656 (814)
                      +++.....+...  ..+|||||++++++.........++......++.|++.++.++|+ .   +|+||||||+||+++ 
T Consensus        79 ~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~-  152 (190)
T cd05145          79 AGVPVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH-  152 (190)
T ss_pred             CCCCCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-
Confidence            987554444332  348999999988654433334556778889999999999999999 7   999999999999999 


Q ss_pred             CCcEEEeecCCccccc
Q 041921          657 YYTARISDFGLAKLLT  672 (814)
Q Consensus       657 ~~~~kl~DfGla~~~~  672 (814)
                      ++.++|+|||++....
T Consensus       153 ~~~~~liDFG~a~~~~  168 (190)
T cd05145         153 DGKPYIIDVSQAVELD  168 (190)
T ss_pred             CCCEEEEEcccceecC
Confidence            7899999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.74  E-value=1.7e-17  Score=170.53  Aligned_cols=229  Identities=20%  Similarity=0.222  Sum_probs=147.0

Q ss_pred             ccccceeeeeeeeEEEEEEecCCCceEEEEEEeccc---cccchHhHHHHHHhhhccCC----------CCccceeeeec
Q 041921          522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV---FQDGEREFKNEVFVIGQTHH----------KNLVRLLGFCD  588 (814)
Q Consensus       522 ~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h----------~niv~l~~~~~  588 (814)
                      ..++.||.|+++.||.+++..  .++++|||...-.   .....+++++|.-.+..+.+          -.++-.++...
T Consensus        15 ~~~~~i~~g~~~~v~~v~d~~--t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   15 VRGRIIGKGGFSIVFEVTDVE--TGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEETTEEEEEEEETT--TTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEccccccCCceEEEEEEEcc--CCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            345789999999999999764  5788999987432   22234567777766655432          22322222221


Q ss_pred             ---------cc---c-----cceEEEecCCCCCHHHHhc---CC-C---CCChhhHHHHHHHHHHHHHHhhhcCCCCeee
Q 041921          589 ---------EG---Q-----NRLLVYEFLNNGTLASFLF---GN-L---KPNWNLRTNIAFQIARGLLYLHEDCRAQIIH  644 (814)
Q Consensus       589 ---------~~---~-----~~~lv~e~~~~gsL~~~l~---~~-~---~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H  644 (814)
                               ..   .     ..+++|+-+ .++|.+++.   .. .   .+....++.+..|+++.+++||+.   +++|
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVH  168 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVH  168 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEe
Confidence                     11   1     235677776 568877754   22 1   234556677889999999999999   9999


Q ss_pred             cCCCCCcEEEcCCCcEEEeecCCccccccCCcccccccccCCCCccccccccc--------CCCCcchhhHHHHHHHHHH
Q 041921          645 CDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRN--------SKITAKVDVYSFGVLLLEI  716 (814)
Q Consensus       645 ~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~~~Dv~s~Gvvl~el  716 (814)
                      +||+|+|++++.+|.++|+||+...........     ...+..|.+||....        ..++.+.|.|++|+++|.|
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l  243 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL  243 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred             cccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence            999999999999999999999877654432211     234577999997643        2578899999999999999


Q ss_pred             HhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCC
Q 041921          717 ISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLR  782 (814)
Q Consensus       717 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~R  782 (814)
                      ++++.||.....+.....                    .-.... +.++.+..++..+|+.+|.+|
T Consensus       244 WC~~lPf~~~~~~~~~~~--------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  244 WCGRLPFGLSSPEADPEW--------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHSS-STCCCGGGSTSGG--------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HHccCCCCCCCccccccc--------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            999999986543221110                    111223 677888999999999999988

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.71  E-value=3.3e-17  Score=159.75  Aligned_cols=183  Identities=16%  Similarity=0.063  Sum_probs=137.2

Q ss_pred             ccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccc----hHhHHHHHHhhhccC-CCCccceeeeecccccceEEEe
Q 041921          524 KEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG----EREFKNEVFVIGQTH-HKNLVRLLGFCDEGQNRLLVYE  598 (814)
Q Consensus       524 ~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~----~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  598 (814)
                      .+.|++|+||+||.+.-    .+.+++.+.+.....-.    ...+.+|+++|++++ |+++++++++    +..+++||
T Consensus         7 ~~~l~~~~f~~v~~~~~----~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme   78 (218)
T PRK12274          7 NEPLKSDTFGRILLVRG----GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS   78 (218)
T ss_pred             ceeecCCCcceEEEeec----CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence            46799999999996543    46788878776543211    124789999999995 5889999886    45699999


Q ss_pred             cCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCC-CCCcEEEcCCCcEEEeecCCccccccCCcc
Q 041921          599 FLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDI-KPQNILLDDYYTARISDFGLAKLLTLNQSK  677 (814)
Q Consensus       599 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dl-kp~NIll~~~~~~kl~DfGla~~~~~~~~~  677 (814)
                      |+.+.+|...+..       ....++.|++++|.++|+.   +|+|||| ||+|||++.++.++|+|||++.........
T Consensus        79 yI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~  148 (218)
T PRK12274         79 YLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW  148 (218)
T ss_pred             eecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence            9999998754321       1245788999999999998   9999999 799999999999999999999865433210


Q ss_pred             -------cc----cccccCCCCcccccccccC-CCC-cchhhHHHHHHHHHHHhCCCCCC
Q 041921          678 -------TI----KTAIRGTKGYVAPEWFRNS-KIT-AKVDVYSFGVLLLEIISCRKSFD  724 (814)
Q Consensus       678 -------~~----~~~~~gt~~y~aPE~~~~~-~~s-~~~Dv~s~Gvvl~elltg~~p~~  724 (814)
                             ..    ......++.|++|+...-. ..+ ...+.++-|.-+|.++|++.+.-
T Consensus       149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~  208 (218)
T PRK12274        149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW  208 (218)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence                   00    0112357788888754322 233 56899999999999999998764

>PRK10345 hypothetical protein; Provisional

Probab=99.69  E-value=1.8e-16  Score=157.96  Aligned_cols=134  Identities=19%  Similarity=0.240  Sum_probs=103.9

Q ss_pred             ccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhcc-----CCCCccceeeeecccc---cce-
Q 041921          524 KEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQT-----HHKNLVRLLGFCDEGQ---NRL-  594 (814)
Q Consensus       524 ~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~~~-  594 (814)
                      .+.||+|+||.||.  ++.  ... .+||++........+++.+|+.++..+     .||||++++|++.++.   ..+ 
T Consensus         7 ~~~LG~G~~~~Vy~--hp~--~~~-k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~   81 (210)
T PRK10345          7 QSPLGTGRHRKCYA--HPE--DAQ-RCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD   81 (210)
T ss_pred             cceecCCCceEEEE--CCC--CcC-eEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence            35799999999995  442  233 368887654444567899999999999     5799999999998764   323 


Q ss_pred             EEEec--CCCCCHHHHhcCCCCCChhhHHHHHHHHHHHH-HHhhhcCCCCeeecCCCCCcEEEcC----CCcEEEeecCC
Q 041921          595 LVYEF--LNNGTLASFLFGNLKPNWNLRTNIAFQIARGL-LYLHEDCRAQIIHCDIKPQNILLDD----YYTARISDFGL  667 (814)
Q Consensus       595 lv~e~--~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l-~yLH~~~~~~i~H~dlkp~NIll~~----~~~~kl~DfGl  667 (814)
                      +|+||  +++++|.+++... .+++.  ..++.|++.++ +|||++   +|+||||||+|||++.    +..++|+||+-
T Consensus        82 ~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G  155 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNIG  155 (210)
T ss_pred             EEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence            78999  5589999999664 34444  35677888777 999998   9999999999999973    34899999543


Q ss_pred             c
Q 041921          668 A  668 (814)
Q Consensus       668 a  668 (814)
                      +
T Consensus       156 ~  156 (210)
T PRK10345        156 E  156 (210)
T ss_pred             C
Confidence            3

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.69  E-value=1.6e-16  Score=185.26  Aligned_cols=201  Identities=24%  Similarity=0.227  Sum_probs=163.3

Q ss_pred             CHHHHHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccC---CCCccceeeeec
Q 041921          512 SYKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTH---HKNLVRLLGFCD  588 (814)
Q Consensus       512 ~~~~l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~  588 (814)
                      +.-++....+.+.++||+|+||+||+|+..   +++.||+|.-+...   .-+|.--.+++.||+   -+-|..+.....
T Consensus       691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~---~~~~~alK~e~P~~---~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~  764 (974)
T KOG1166|consen  691 TEFEVGGEKFCISKEIGEGSYGSVYVATHS---NGKLVALKVEKPPN---PWEFYICLQVMERLKPQMLPSIMHISSAHV  764 (974)
T ss_pred             ceeeecceeEEEEeeeccccceEEEEeecC---CCcEEEEEeecCCC---ceeeeehHHHHHhhchhhhcchHHHHHHHc
Confidence            344566677778899999999999999976   38899999876432   234555555666666   123444444445


Q ss_pred             ccccceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc-------CCCcEE
Q 041921          589 EGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLD-------DYYTAR  661 (814)
Q Consensus       589 ~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~-------~~~~~k  661 (814)
                      -.+..+||+||.+.|+|.+++...+..+|.....++.|+++.+.+||..   +|||+||||+|.||.       +..-++
T Consensus       765 ~~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~  841 (974)
T KOG1166|consen  765 FQNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLY  841 (974)
T ss_pred             cCCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceE
Confidence            5677899999999999999999889999999999999999999999998   999999999999994       345689


Q ss_pred             EeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCC
Q 041921          662 ISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRK  721 (814)
Q Consensus       662 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~  721 (814)
                      |+|||.+..+..-..........+|-.+-.+|...+.+.+..+|.|.++.+++-|+.|+.
T Consensus       842 lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  842 LIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             EEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            999999986654433333456778999999999999999999999999999999999874

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.68  E-value=1.1e-17  Score=182.15  Aligned_cols=189  Identities=26%  Similarity=0.264  Sum_probs=156.0

Q ss_pred             ceeeeeeeeEEEEEEe-cCCCceEEEEEEeccccccc--hHhHHHHHHhhhccC-CCCccceeeeecccccceEEEecCC
Q 041921          526 EVGRGSFGIVYKGVIQ-TRTSTTAVAVKKLDRVFQDG--EREFKNEVFVIGQTH-HKNLVRLLGFCDEGQNRLLVYEFLN  601 (814)
Q Consensus       526 ~LG~G~~g~Vy~~~~~-~~~~~~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~  601 (814)
                      .+|+|.||.|+.+.-- ....+...|.|.+.+.....  ...-..|-.++...+ ||.++++.-.+..+...+++.+|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            3688999999865322 22245667777775432211  113456777888886 9999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcccccc
Q 041921          602 NGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKT  681 (814)
Q Consensus       602 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  681 (814)
                      +|.|...+.................++-++.++|+.   +|+|||+|++||+++.+|.+++.|||+++..-....     
T Consensus        81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-----  152 (612)
T KOG0603|consen   81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-----  152 (612)
T ss_pred             cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhh-----
Confidence            999999998888888888888888999999999998   999999999999999999999999999986553322     


Q ss_pred             cccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 041921          682 AIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDI  725 (814)
Q Consensus       682 ~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~  725 (814)
                       .+||..|||||++.  .....+|.||||++++||+||..||..
T Consensus       153 -~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  153 -ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             -cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence             27999999999998  567889999999999999999999975

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.65  E-value=5.1e-16  Score=158.79  Aligned_cols=196  Identities=22%  Similarity=0.255  Sum_probs=132.3

Q ss_pred             cCCCCccceeeeecc---------------------------cccceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHH
Q 041921          575 THHKNLVRLLGFCDE---------------------------GQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQI  627 (814)
Q Consensus       575 l~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i  627 (814)
                      -+|||||++.++|.+                           ....|+||...+ .+|+.|+..+.. +.....-|+.|+
T Consensus       273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~~-s~r~~~~~laQl  350 (598)
T KOG4158|consen  273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRHR-SYRTGRVILAQL  350 (598)
T ss_pred             CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCCC-chHHHHHHHHHH
Confidence            378888888877643                           334678888764 489999976644 445556688999


Q ss_pred             HHHHHHhhhcCCCCeeecCCCCCcEEEc--CC--CcEEEeecCCcccccc--CC--cccccccccCCCCcccccccccCC
Q 041921          628 ARGLLYLHEDCRAQIIHCDIKPQNILLD--DY--YTARISDFGLAKLLTL--NQ--SKTIKTAIRGTKGYVAPEWFRNSK  699 (814)
Q Consensus       628 a~~l~yLH~~~~~~i~H~dlkp~NIll~--~~--~~~kl~DfGla~~~~~--~~--~~~~~~~~~gt~~y~aPE~~~~~~  699 (814)
                      ++|+.|||.+   +|.|||+|.+|||+.  ++  -.+.|+|||++-.-..  .+  ...-.-...|...-||||+....+
T Consensus       351 LEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P  427 (598)
T KOG4158|consen  351 LEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP  427 (598)
T ss_pred             HHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence            9999999998   999999999999994  33  3478999998643211  00  000001234778899999986543


Q ss_pred             ------CCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHH
Q 041921          700 ------ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIW  773 (814)
Q Consensus       700 ------~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  773 (814)
                            --.|+|.|+.|.+.||+++.+.||......-   +.   .+.+++..+..+         +..++..+.+++..
T Consensus       428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~---L~---~r~Yqe~qLPal---------p~~vpp~~rqlV~~  492 (598)
T KOG4158|consen  428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML---LD---TRTYQESQLPAL---------PSRVPPVARQLVFD  492 (598)
T ss_pred             CCceeeccchhhhhhhhhhHHHHhccCCcccccchhe---ec---hhhhhhhhCCCC---------cccCChHHHHHHHH
Confidence                  1258999999999999999999996421100   00   011222222211         22344567788888


Q ss_pred             ccccCCCCCCCHHHHHH
Q 041921          774 CIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       774 Cl~~dp~~RPt~~~vl~  790 (814)
                      .|++||++||+..-...
T Consensus       493 lL~r~pskRvsp~iAAN  509 (598)
T KOG4158|consen  493 LLKRDPSKRVSPNIAAN  509 (598)
T ss_pred             HhcCCccccCCccHHHh
Confidence            89999999998754433

>smart00090 RIO RIO-like kinase

Probab=99.65  E-value=7.3e-16  Score=157.65  Aligned_cols=142  Identities=17%  Similarity=0.172  Sum_probs=109.6

Q ss_pred             hccccceeeeeeeeEEEEE-EecCCCceEEEEEEecccccc------------------------chHhHHHHHHhhhcc
Q 041921          521 NNFKEEVGRGSFGIVYKGV-IQTRTSTTAVAVKKLDRVFQD------------------------GEREFKNEVFVIGQT  575 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~-~~~~~~~~~vavK~l~~~~~~------------------------~~~~~~~E~~~l~~l  575 (814)
                      +.+.+.||+|++|.||+|. ..  ..++.||||.++.....                        ....+..|+.++.++
T Consensus        30 ~~i~~~Lg~G~~g~Vy~a~~~~--~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L  107 (237)
T smart00090       30 SAIGGCISTGKEANVYHALDFD--GSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL  107 (237)
T ss_pred             HHhCCeeccCcceeEEEEEecC--CCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            4567889999999999998 32  25789999998643210                        012356899999999


Q ss_pred             CCC--CccceeeeecccccceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCC-eeecCCCCCcE
Q 041921          576 HHK--NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ-IIHCDIKPQNI  652 (814)
Q Consensus       576 ~h~--niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~-i~H~dlkp~NI  652 (814)
                      .+.  .+++++++    ...++||||+++.+|...+.....+.......++.|++.++.+||+.   + |+||||||+||
T Consensus       108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~NI  180 (237)
T smart00090      108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYNI  180 (237)
T ss_pred             HhcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhhE
Confidence            763  34445543    23589999999988877654444455566778999999999999998   8 99999999999


Q ss_pred             EEcCCCcEEEeecCCccccc
Q 041921          653 LLDDYYTARISDFGLAKLLT  672 (814)
Q Consensus       653 ll~~~~~~kl~DfGla~~~~  672 (814)
                      +++ +++++|+|||.+....
T Consensus       181 li~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      181 LVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             EEE-CCCEEEEEChhhhccC
Confidence            999 8899999999987543

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.64  E-value=1.2e-15  Score=154.46  Aligned_cols=134  Identities=19%  Similarity=0.245  Sum_probs=112.6

Q ss_pred             cceeeeeeeeEEEEEEecCCCceEEEEEEecccccc--------chHhHHHHHHhhhccCCCCccceeeeecccccceEE
Q 041921          525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD--------GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV  596 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  596 (814)
                      +.||+|++|.||+|...    +..++||+.......        ....+.+|+.++..++|+++.....++.+.+..+++
T Consensus         2 ~~l~~G~~~~vy~~~~~----~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv   77 (211)
T PRK14879          2 KLIKRGAEAEIYLGDFL----GIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIV   77 (211)
T ss_pred             cccccCceEEEEEEeeC----CCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEE
Confidence            57999999999999863    557888876532211        123578899999999999998888887777889999


Q ss_pred             EecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccc
Q 041921          597 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKL  670 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~  670 (814)
                      |||+++++|.+++.....    .+..++.+++.+|.++|+.   +++|+|++|+|||++ ++.++|+|||++..
T Consensus        78 ~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         78 MEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            999999999999865432    7889999999999999998   999999999999999 78999999999864

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.62  E-value=1.9e-15  Score=151.62  Aligned_cols=130  Identities=19%  Similarity=0.283  Sum_probs=106.7

Q ss_pred             ceeeeeeeeEEEEEEecCCCceEEEEEEecccccc--------chHhHHHHHHhhhccCCCCccceeeeecccccceEEE
Q 041921          526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD--------GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY  597 (814)
Q Consensus       526 ~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  597 (814)
                      .||+|++|.||+|.+.    +..|++|........        ....+.+|++++..++|+++.....++...+..++||
T Consensus         1 ~ig~G~~~~vy~~~~~----~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~   76 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFL----GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVM   76 (199)
T ss_pred             CCCCCceEEEEEeecC----CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEE
Confidence            4899999999999853    567888886432111        1245778999999999988766666666677789999


Q ss_pred             ecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccc
Q 041921          598 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKL  670 (814)
Q Consensus       598 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~  670 (814)
                      ||+++++|.+++.....       .++.+++++|.+||+.   +++|+|++|+||+++ ++.++++|||++..
T Consensus        77 e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        77 EYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             EEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            99999999998754321       7899999999999998   999999999999999 78999999999875

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.61  E-value=3.8e-16  Score=167.00  Aligned_cols=170  Identities=25%  Similarity=0.352  Sum_probs=128.7

Q ss_pred             cceEEEecCCCCCHHHHhcCC---CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCc
Q 041921          592 NRLLVYEFLNNGTLASFLFGN---LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLA  668 (814)
Q Consensus       592 ~~~lv~e~~~~gsL~~~l~~~---~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla  668 (814)
                      ..++.|+++...+|.+||.++   ...++...+.++.|++.|+.|   +   +.+|+|+||.||+...+..+||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence            467999999999999999755   456788889999999999999   4   8999999999999999999999999998


Q ss_pred             cccccCC----cccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhh
Q 041921          669 KLLTLNQ----SKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYR  743 (814)
Q Consensus       669 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  743 (814)
                      .......    ....++...||..||+||.+.+..++.|+||||||++|+||+. -...+..          .-+..-++
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er----------~~t~~d~r  473 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER----------IATLTDIR  473 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH----------HHhhhhhh
Confidence            8766544    1223355679999999999999999999999999999999997 3333321          11122234


Q ss_pred             cCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHH
Q 041921          744 NGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMK  786 (814)
Q Consensus       744 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~  786 (814)
                      ++.+....    .. ..    ..-..++.+++.+.|.+||++.
T Consensus       474 ~g~ip~~~----~~-d~----p~e~~ll~~lls~~p~~RP~~~  507 (516)
T KOG1033|consen  474 DGIIPPEF----LQ-DY----PEEYTLLQQLLSPSPEERPSAI  507 (516)
T ss_pred             cCCCChHH----hh-cC----cHHHHHHHHhcCCCcccCchHH
Confidence            44433110    00 11    1223577788999999999443

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.60  E-value=6.9e-15  Score=147.20  Aligned_cols=137  Identities=17%  Similarity=0.159  Sum_probs=107.4

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEecccccc----------------------chHhHHHHHHhhhccCCC
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD----------------------GEREFKNEVFVIGQTHHK  578 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~----------------------~~~~~~~E~~~l~~l~h~  578 (814)
                      +.+.+.||+|+||.||++...   ++..||||.+......                      ....+..|+.++..+.|+
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   93 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP---DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEE   93 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC---CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHc
Confidence            566789999999999999864   5789999986532100                      112357788889888887


Q ss_pred             C--ccceeeeecccccceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC
Q 041921          579 N--LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDD  656 (814)
Q Consensus       579 n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~  656 (814)
                      +  ++..++.    ...++||||+++++|......      .....++.+++.++.++|+.   +|+|+||||+||++++
T Consensus        94 ~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~~  160 (198)
T cd05144          94 GFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVDD  160 (198)
T ss_pred             CCCCCceeec----CCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEcC
Confidence            4  4455442    345899999999999775431      34567889999999999997   9999999999999999


Q ss_pred             CCcEEEeecCCcccccc
Q 041921          657 YYTARISDFGLAKLLTL  673 (814)
Q Consensus       657 ~~~~kl~DfGla~~~~~  673 (814)
                      ++.++|+|||++.....
T Consensus       161 ~~~~~liDfg~~~~~~~  177 (198)
T cd05144         161 DEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             CCcEEEEECCccccCCC
Confidence            99999999999976554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.59  E-value=5.3e-15  Score=170.65  Aligned_cols=133  Identities=16%  Similarity=0.227  Sum_probs=108.6

Q ss_pred             cccceeeeeeeeEEEEEEecCCCceEEEEEEe-ccc-cc------cchHhHHHHHHhhhccCCCCccceeeeecccccce
Q 041921          523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKL-DRV-FQ------DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRL  594 (814)
Q Consensus       523 ~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l-~~~-~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  594 (814)
                      ..++||+|+||.||+|.+..    ..+++|+. .+. ..      ...+.+.+|++++.+++|++++....++.+....+
T Consensus       337 ~~~~iG~G~~g~Vy~~~~~~----~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~  412 (535)
T PRK09605        337 PDHLIGKGAEADIKKGEYLG----RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT  412 (535)
T ss_pred             ccceeccCCcEEEEEEeecC----ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence            46789999999999998752    22333332 111 11      11245889999999999999998888888777889


Q ss_pred             EEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcccc
Q 041921          595 LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLL  671 (814)
Q Consensus       595 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~  671 (814)
                      +||||+++++|.+++.        ....++.+++++|.+||+.   +++||||||+|||+ +++.++|+|||+++..
T Consensus       413 lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        413 IVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             EEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            9999999999999875        4577999999999999998   99999999999999 6779999999998753

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.50  E-value=1.6e-13  Score=130.63  Aligned_cols=134  Identities=22%  Similarity=0.180  Sum_probs=113.8

Q ss_pred             ccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCC--CCccceeeeecccccceEEEecCC
Q 041921          524 KEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHH--KNLVRLLGFCDEGQNRLLVYEFLN  601 (814)
Q Consensus       524 ~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~  601 (814)
                      .+.||+|.++.||++...    +..++||.......  ...+..|+..+..++|  .++++++.+....+..++++||++
T Consensus         3 ~~~i~~g~~~~v~~~~~~----~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~   76 (155)
T cd05120           3 IKLLKGGLTNRVYLLGTK----DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE   76 (155)
T ss_pred             ceecccccccceEEEEec----CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecC
Confidence            367999999999999974    36789998865432  4578999999999976  589999999888888999999999


Q ss_pred             CCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccc
Q 041921          602 NGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKL  670 (814)
Q Consensus       602 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~  670 (814)
                      ++.+..+       +......++.++++++++||.....+++|+|++|+||+++..+.+++.|||.+..
T Consensus        77 g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          77 GETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             CeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            8877654       5567778999999999999986445799999999999999989999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.49  E-value=1.4e-13  Score=136.46  Aligned_cols=137  Identities=18%  Similarity=0.163  Sum_probs=95.9

Q ss_pred             ccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccc--hHh----------------------HHHHHHhhhccCCCC
Q 041921          524 KEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG--ERE----------------------FKNEVFVIGQTHHKN  579 (814)
Q Consensus       524 ~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~--~~~----------------------~~~E~~~l~~l~h~n  579 (814)
                      .+.||+|+||.||+|...   +++.||||.+.......  ...                      ...|...+.++.+..
T Consensus         2 ~~~lg~G~~g~Vy~a~~~---~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~   78 (187)
T cd05119           2 GGPIGTGKEADVYLALDG---DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAG   78 (187)
T ss_pred             CcccccccceeEEEEECC---CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcC
Confidence            467999999999999865   57789999886432111  111                      134555555554432


Q ss_pred             --ccceeeeecccccceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCcEEEcC
Q 041921          580 --LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHE-DCRAQIIHCDIKPQNILLDD  656 (814)
Q Consensus       580 --iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~i~H~dlkp~NIll~~  656 (814)
                        +.+.+++    ...++||||++++.+........... .....++.+++.++.++|. .   +|+|+||||+||+++ 
T Consensus        79 ~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~-  149 (187)
T cd05119          79 VPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD-  149 (187)
T ss_pred             CCCCceEec----CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-
Confidence              4444443    24689999999954321111110111 5677899999999999998 6   999999999999999 


Q ss_pred             CCcEEEeecCCccccc
Q 041921          657 YYTARISDFGLAKLLT  672 (814)
Q Consensus       657 ~~~~kl~DfGla~~~~  672 (814)
                      ++.++|+|||.+....
T Consensus       150 ~~~~~liDfg~a~~~~  165 (187)
T cd05119         150 DGKVYIIDVPQAVEID  165 (187)
T ss_pred             CCcEEEEECccccccc
Confidence            8899999999987544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.46  E-value=3.9e-13  Score=137.86  Aligned_cols=135  Identities=17%  Similarity=0.113  Sum_probs=104.0

Q ss_pred             ccee-eeeeeeEEEEEEecCCCceEEEEEEecccc-------------ccchHhHHHHHHhhhccCCCCc--cceeeeec
Q 041921          525 EEVG-RGSFGIVYKGVIQTRTSTTAVAVKKLDRVF-------------QDGEREFKNEVFVIGQTHHKNL--VRLLGFCD  588 (814)
Q Consensus       525 ~~LG-~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~  588 (814)
                      ..|| .|+.|+||++...    +..++||++....             ......+.+|++++.+++|++|  ++.+++..
T Consensus        37 ~~lg~~~g~gtv~~v~~~----~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~  112 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP----GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARV  112 (239)
T ss_pred             ceeecCCCCccEEEEEeC----CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeee
Confidence            4687 8889999998764    5678888875311             1122457889999999998875  67777654


Q ss_pred             cccc----ceEEEecCCC-CCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEe
Q 041921          589 EGQN----RLLVYEFLNN-GTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARIS  663 (814)
Q Consensus       589 ~~~~----~~lv~e~~~~-gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~  663 (814)
                      ....    .++|+|++++ .+|.+++... .++.    ..+.+++.+|.+||+.   +|+|+||||+|||++.++.++|+
T Consensus       113 ~~~~~~~~~~lV~e~l~G~~~L~~~l~~~-~l~~----~~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LI  184 (239)
T PRK01723        113 VRHGLFYRADILIERIEGARDLVALLQEA-PLSE----EQWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLI  184 (239)
T ss_pred             eecCcceeeeEEEEecCCCCCHHHHHhcC-CCCH----HHHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEE
Confidence            4322    2599999997 6999888653 3332    3467899999999998   99999999999999998899999


Q ss_pred             ecCCcccc
Q 041921          664 DFGLAKLL  671 (814)
Q Consensus       664 DfGla~~~  671 (814)
                      |||.+...
T Consensus       185 Dfg~~~~~  192 (239)
T PRK01723        185 DFDRGELR  192 (239)
T ss_pred             ECCCcccC
Confidence            99988753

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.45  E-value=6.5e-14  Score=160.05  Aligned_cols=210  Identities=21%  Similarity=0.274  Sum_probs=139.1

Q ss_pred             ccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEecCCCC
Q 041921          524 KEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNG  603 (814)
Q Consensus       524 ~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  603 (814)
                      .+.|..|++|.||...+..  ..+.+|+|.-+...     -+++   ++.....|.+|                     |
T Consensus        88 IklisngAygavylvrh~~--trqrfa~kiNkq~l-----ilRn---ilt~a~npfvv---------------------g  136 (1205)
T KOG0606|consen   88 IKLISNGAYGAVYLVRHKE--TRQRFAMKINKQNL-----ILRN---ILTFAGNPFVV---------------------G  136 (1205)
T ss_pred             eEeeccCCCCceeeeeccc--cccchhhcccccch-----hhhc---cccccCCccee---------------------c
Confidence            3678899999999998753  45677773322110     0011   11111222222                     4


Q ss_pred             CHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCc-------
Q 041921          604 TLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS-------  676 (814)
Q Consensus       604 sL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~-------  676 (814)
                      +=...++..+.++...        +.+++|||+.   +|+|||+||+|.+|+.-|.+|+.|||+++.......       
T Consensus       137 Dc~tllk~~g~lPvdm--------vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~  205 (1205)
T KOG0606|consen  137 DCATLLKNIGPLPVDM--------VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGH  205 (1205)
T ss_pred             hhhhhcccCCCCcchh--------hHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcc
Confidence            4444455444444332        7789999998   999999999999999999999999999875432111       


Q ss_pred             ------ccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCcccee
Q 041921          677 ------KTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVL  750 (814)
Q Consensus       677 ------~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  750 (814)
                            +.....++||+.|+|||++..+.|....|.|++|+|+||.+-|+.||..+.+++...      ..+.+. + ..
T Consensus       206 I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg------~visd~-i-~w  277 (1205)
T KOG0606|consen  206 IEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG------QVISDD-I-EW  277 (1205)
T ss_pred             hHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHh------hhhhhh-c-cc
Confidence                  011133579999999999999999999999999999999999999999887655221      111111 0 00


Q ss_pred             ecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 041921          751 VGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVL  789 (814)
Q Consensus       751 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl  789 (814)
                      .+      .+.....++.+++...|+.+|.+|--....+
T Consensus       278 pE------~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~  310 (1205)
T KOG0606|consen  278 PE------EDEALPPEAQDLIEQLLRQNPLCRLGTGGAL  310 (1205)
T ss_pred             cc------cCcCCCHHHHHHHHHHHHhChHhhcccchhh
Confidence            01      1223345667788888999999996333333

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.45  E-value=1.4e-14  Score=166.27  Aligned_cols=254  Identities=23%  Similarity=0.331  Sum_probs=185.9

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccC-CCCccceeeeecccccceEE
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTH-HKNLVRLLGFCDEGQNRLLV  596 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv  596 (814)
                      .+.+.+.||+|.|+.|-..... ......+|+|.+....  .........|..+-..+. |+|++.+++...+.+..+++
T Consensus        21 ~~~~~~~ig~gs~~~~~~~~~~-~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   21 QYKLSRSIGKGSFSSSALASNS-RDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             cccccccccccccchhhhhhhc-CCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            4455677999999999877643 2335577777775442  122233455777777775 99999999999999999999


Q ss_pred             EecCCCCCHHHHh-cCCC-CCChhhHHHHHHHHHHHHHHhh-hcCCCCeeecCCCCCcEEEcCCC-cEEEeecCCccccc
Q 041921          597 YEFLNNGTLASFL-FGNL-KPNWNLRTNIAFQIARGLLYLH-EDCRAQIIHCDIKPQNILLDDYY-TARISDFGLAKLLT  672 (814)
Q Consensus       597 ~e~~~~gsL~~~l-~~~~-~l~~~~~~~i~~~ia~~l~yLH-~~~~~~i~H~dlkp~NIll~~~~-~~kl~DfGla~~~~  672 (814)
                      .||..++++.+.+ +... ..+......+..|+..++.|+| ..   ++.|+||||+|.+++..+ ..+++|||+|..+.
T Consensus       100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~  176 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYR  176 (601)
T ss_pred             cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence            9999999999888 4443 5566667788999999999999 76   999999999999999999 99999999999887


Q ss_pred             c-CCcccccccccC-CCCcccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccce
Q 041921          673 L-NQSKTIKTAIRG-TKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNV  749 (814)
Q Consensus       673 ~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  749 (814)
                      . ..........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+.......... ..|.-..   +... 
T Consensus       177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~-~~~~~~~---~~~~-  251 (601)
T KOG0590|consen  177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY-SSWKSNK---GRFT-  251 (601)
T ss_pred             ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc-eeecccc---cccc-
Confidence            7 444444355668 9999999999874 45678999999999999999999987544322110 0111000   0000 


Q ss_pred             eecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 041921          750 LVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVL  789 (814)
Q Consensus       750 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl  789 (814)
                             ............++...++..+|+.|.+.+++.
T Consensus       252 -------~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  252 -------QLPWNSISDQAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             -------cCccccCChhhhhcccccccCCchhcccccccc
Confidence                   000112223455677778889999999887764

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.32  E-value=1.5e-12  Score=130.90  Aligned_cols=198  Identities=20%  Similarity=0.273  Sum_probs=136.3

Q ss_pred             HhhhccCCCCccceeeeecccc-----cceEEEecCCCCCHHHHhcCC----CCCChhhHHHHHHHHHHHHHHhhhcCCC
Q 041921          570 FVIGQTHHKNLVRLLGFCDEGQ-----NRLLVYEFLNNGTLASFLFGN----LKPNWNLRTNIAFQIARGLLYLHEDCRA  640 (814)
Q Consensus       570 ~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~~l~yLH~~~~~  640 (814)
                      ..|-.+-|.|||++..|..+.+     +..++.|||..|+|..+|++.    ..+......+++-||..||.|||+ |.+
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~P  197 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDP  197 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCC
Confidence            3445567999999999986543     467899999999999999864    446667778899999999999998 578


Q ss_pred             CeeecCCCCCcEEEcCCCcEEEeecCCccccccC---CcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHH
Q 041921          641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN---QSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEII  717 (814)
Q Consensus       641 ~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ell  717 (814)
                      .|+|+++..+.|++..++-+|+.--. -......   ..........+-++|.|||.=.....+.++|||+||+..+||.
T Consensus       198 piihgnlTc~tifiq~ngLIkig~~a-p~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGSVA-PDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA  276 (458)
T ss_pred             ccccCCcchhheeecCCceEEecccC-ccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence            99999999999999999888875311 1111110   0011112234678999999987778888999999999999998


Q ss_pred             hCCCC-CCcccch-hhhhHHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          718 SCRKS-FDIEMGE-EYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       718 tg~~p-~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      -+..- ....... .....    .      .........+           -..++..|++..|..||+|.+++.
T Consensus       277 ilEiq~tnseS~~~~ee~i----a------~~i~~len~l-----------qr~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  277 ILEIQSTNSESKVEVEENI----A------NVIIGLENGL-----------QRGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             HheeccCCCcceeehhhhh----h------hheeeccCcc-----------ccCcCcccccCCCCCCcchhhhhc
Confidence            76543 2111110 00000    0      0000011111           124667899999999999988764

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.26  E-value=1.6e-11  Score=137.05  Aligned_cols=139  Identities=21%  Similarity=0.207  Sum_probs=98.4

Q ss_pred             ceeeeeeeeEEEEEEecCCCceEEEEEEeccccccch----------------------------------------HhH
Q 041921          526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE----------------------------------------REF  565 (814)
Q Consensus       526 ~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~----------------------------------------~~~  565 (814)
                      .||.|++|.||+|++.   +++.||||..+.......                                        -+|
T Consensus       124 plasaSigQVh~A~l~---~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf  200 (437)
T TIGR01982       124 PLAAASIAQVHRARLV---DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL  200 (437)
T ss_pred             ceeeeehhheEEEEec---CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence            5999999999999987   578999999865321100                                        024


Q ss_pred             HHHHHhhhccC----CCCccceeeee-cccccceEEEecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHH-HHHHhhhcC
Q 041921          566 KNEVFVIGQTH----HKNLVRLLGFC-DEGQNRLLVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIAR-GLLYLHEDC  638 (814)
Q Consensus       566 ~~E~~~l~~l~----h~niv~l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~-~l~yLH~~~  638 (814)
                      ..|...+.+++    |.+-+.+-..+ ......+|||||+++++|.++.... ...   .+.+++.++++ .+..+|.. 
T Consensus       201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~-  276 (437)
T TIGR01982       201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRD-  276 (437)
T ss_pred             HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhC-
Confidence            45555555552    22223322222 2345679999999999998876432 111   34567777766 46788887 


Q ss_pred             CCCeeecCCCCCcEEEcCCCcEEEeecCCcccccc
Q 041921          639 RAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTL  673 (814)
Q Consensus       639 ~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~  673 (814)
                        +++|+|+||.||+++++++++++|||++..+..
T Consensus       277 --g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       277 --GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             --CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence              999999999999999999999999999987653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions []

Probab=99.18  E-value=1.6e-11  Score=97.86  Aligned_cols=56  Identities=27%  Similarity=0.557  Sum_probs=48.3

Q ss_pred             eeeEEeecCCCCCCccccc-CccChhhHHHhhcCCCcccccccCC----CceeeeccCCCC
Q 041921          365 FDFHELKNINWPQSDYERF-KPYNEVQCKNTCLSDCFCAAVIFND----GSCWFKKLPLSN  420 (814)
Q Consensus       365 ~~f~~~~~~~~~~~~~~~~-~~~s~~~C~~~Cl~~CsC~a~~~~~----~~c~~~~~~l~~  420 (814)
                      ++|+++++|++|+++...+ .++++++|+..||+||||+||+|.+    ++|++|...|.|
T Consensus         5 d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~~~~~C~lW~~~L~d   65 (66)
T PF08276_consen    5 DGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLSGGGGCLLWYGDLVD   65 (66)
T ss_pred             CEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccCCCCEEEEEcCEeec
Confidence            5799999999999866554 6799999999999999999999973    579999876654

These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.14  E-value=1.9e-10  Score=111.94  Aligned_cols=130  Identities=19%  Similarity=0.116  Sum_probs=96.6

Q ss_pred             cceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCcc-ceeeeecccccceEEEecCCCC
Q 041921          525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLV-RLLGFCDEGQNRLLVYEFLNNG  603 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~g  603 (814)
                      +.|+.|..+.||++...    +..+++|....... ....+..|+.++..+.+.+++ +++.+.  ....++||||+++.
T Consensus         4 ~~l~~G~~~~vy~~~~~----~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~   76 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA----NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGS   76 (170)
T ss_pred             eecCCcccCceEEEEEC----CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCC
Confidence            46888999999998863    66899998754321 233578899999998765554 455443  23468999999998


Q ss_pred             CHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcC--CCCeeecCCCCCcEEEcCCCcEEEeecCCccc
Q 041921          604 TLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDC--RAQIIHCDIKPQNILLDDYYTARISDFGLAKL  670 (814)
Q Consensus       604 sL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~--~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~  670 (814)
                      ++.+.        ......++.+++++|+.||...  ...++|+|++|.||+++ ++.++++||+.+..
T Consensus        77 ~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          77 ELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             ccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            87643        1112356789999999999872  23469999999999999 66899999998753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins

Probab=99.13  E-value=8.1e-11  Score=99.82  Aligned_cols=72  Identities=24%  Similarity=0.475  Sum_probs=59.3

Q ss_pred             ceeeEEeecCCCCCCcccccCccChhhHHHhhcCCCcccccccC--CCceeeeccCCCCCcccccccCceeEEec
Q 041921          364 LFDFHELKNINWPQSDYERFKPYNEVQCKNTCLSDCFCAAVIFN--DGSCWFKKLPLSNGMTDSRIAGKAFIKYK  436 (814)
Q Consensus       364 ~~~f~~~~~~~~~~~~~~~~~~~s~~~C~~~Cl~~CsC~a~~~~--~~~c~~~~~~l~~g~~~~~~~~~~ylk~~  436 (814)
                      .++|+.+.++++|+..+.. .++++++|++.|++||+|+||+|.  +++|++|..++.+...........|+|++
T Consensus        11 ~~~f~~~~~~~~~~~~~~~-~~~s~~~C~~~Cl~nCsC~a~~~~~~~~~C~~~~~~~~~~~~~~~~~~~~yiKv~   84 (84)
T cd01098          11 TDGFLKLPDVKLPDNASAI-TAISLEECREACLSNCSCTAYAYNNGSGGCLLWNGLLNNLRSLSSGGGTLYLRLA   84 (84)
T ss_pred             CCEEEEeCCeeCCCchhhh-ccCCHHHHHHHHhcCCCcceeeecCCCCeEEEEeceecceEeecCCCcEEEEEeC
Confidence            4579999999999876654 788999999999999999999996  47899999888876654444577888863

PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.12  E-value=9.6e-11  Score=128.55  Aligned_cols=256  Identities=23%  Similarity=0.247  Sum_probs=181.3

Q ss_pred             HHHHHHhhhccccceee--eeeeeEEEEEEecCCCceEEEEEEeccccc--cchHhHHHHHHhhhcc-CCCCccceeeee
Q 041921          513 YKELEGATNNFKEEVGR--GSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ--DGEREFKNEVFVIGQT-HHKNLVRLLGFC  587 (814)
Q Consensus       513 ~~~l~~~~~~~~~~LG~--G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~  587 (814)
                      ..+....+-.+.+.+|.  |.+|.||.+......+...+|+|+-+....  .....=.+|+...+++ .|+|.++.....
T Consensus       108 ~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~  187 (524)
T KOG0601|consen  108 FDSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW  187 (524)
T ss_pred             ccchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc
Confidence            33455555667788999  999999999874445678889888432211  2222335566666666 599999988888


Q ss_pred             cccccceEEEecCCCCCHHHHhcCCCC-CChhhHHHHHHHHHH----HHHHhhhcCCCCeeecCCCCCcEEEcCC-CcEE
Q 041921          588 DEGQNRLLVYEFLNNGTLASFLFGNLK-PNWNLRTNIAFQIAR----GLLYLHEDCRAQIIHCDIKPQNILLDDY-YTAR  661 (814)
Q Consensus       588 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-l~~~~~~~i~~~ia~----~l~yLH~~~~~~i~H~dlkp~NIll~~~-~~~k  661 (814)
                      ...+..++-+|++. .+|..+.+.... ++....+.+..+...    ||.++|..   .++|-|+||.||+...+ ...+
T Consensus       188 e~~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~  263 (524)
T KOG0601|consen  188 EGSGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCK  263 (524)
T ss_pred             ccCCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceee
Confidence            88999999999885 788888776533 677777788888888    99999998   99999999999999988 8899


Q ss_pred             EeecCCccccccCCcccc---cccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHH
Q 041921          662 ISDFGLAKLLTLNQSKTI---KTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA  738 (814)
Q Consensus       662 l~DfGla~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  738 (814)
                      +.|||+...+........   .....|...|++||.+++ .++.+.|+|++|.++.|..++.......--      ..  
T Consensus       264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~------~~--  334 (524)
T KOG0601|consen  264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKN------SS--  334 (524)
T ss_pred             cCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCC------CC--
Confidence            999999988876542211   112247778999998864 568899999999999999998776542200      01  


Q ss_pred             HHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 041921          739 FDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVL  789 (814)
Q Consensus       739 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl  789 (814)
                      |..++.+-+..        +.......++...+..+++.+|..|++.+.+.
T Consensus       335 W~~~r~~~ip~--------e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~  377 (524)
T KOG0601|consen  335 WSQLRQGYIPL--------EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT  377 (524)
T ss_pred             ccccccccCch--------hhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence            11111111100        00111123444477889999999999876654

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.08  E-value=8.5e-10  Score=122.09  Aligned_cols=165  Identities=18%  Similarity=0.210  Sum_probs=121.8

Q ss_pred             CceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEecCCCCCHHHHhcCCCCCChhhHHHHH
Q 041921          545 STTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA  624 (814)
Q Consensus       545 ~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~  624 (814)
                      ++.+|.|...+...........+-++.|+.++||||++++.....+...|||+|.+  ..|..++....   .....-.+
T Consensus        36 ~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~---~~~v~~Gl  110 (690)
T KOG1243|consen   36 DGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG---KEEVCLGL  110 (690)
T ss_pred             cCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH---HHHHHHHH
Confidence            56677777776544433455778889999999999999999999999999999976  34555554332   44556678


Q ss_pred             HHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcccccccccCCCCcccccccccCCCCcch
Q 041921          625 FQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKV  704 (814)
Q Consensus       625 ~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~  704 (814)
                      .||+.||.|||+.+  +++|++|....|+|+..|+.||++|.++........  ......--..|..|+.+....  ...
T Consensus       111 ~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~--~s~  184 (690)
T KOG1243|consen  111 FQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE--WSI  184 (690)
T ss_pred             HHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--cch
Confidence            99999999999763  899999999999999999999999988754332111  001111223456666543222  346


Q ss_pred             hhHHHHHHHHHHHhCC
Q 041921          705 DVYSFGVLLLEIISCR  720 (814)
Q Consensus       705 Dv~s~Gvvl~elltg~  720 (814)
                      |.|.||++++|++.|.
T Consensus       185 D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  185 DSWGLGCLIEELFNGS  200 (690)
T ss_pred             hhhhHHHHHHHHhCcc
Confidence            9999999999999993

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.00  E-value=4.9e-10  Score=126.38  Aligned_cols=141  Identities=16%  Similarity=0.129  Sum_probs=89.5

Q ss_pred             cceeeeeeeeEEEEEEecCCCceEEEEEEeccccccc----------------------------------h------Hh
Q 041921          525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG----------------------------------E------RE  564 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~----------------------------------~------~~  564 (814)
                      +.||.|++|.||+|++.+  +++.||||.++....+.                                  .      -+
T Consensus       125 ~PlasaSiaQVh~A~l~~--~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD  202 (537)
T PRK04750        125 KPLASASIAQVHFARLKD--NGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELD  202 (537)
T ss_pred             hhhcCCCccEEEEEEECC--CCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhC
Confidence            359999999999999873  37899999997432100                                  0      12


Q ss_pred             HHHHHHhhhccC----CCCccceeeeecc-cccceEEEecCCCCCHHHHh--cCCCCCChhhHHHHHHHHHHH-HHHhhh
Q 041921          565 FKNEVFVIGQTH----HKNLVRLLGFCDE-GQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARG-LLYLHE  636 (814)
Q Consensus       565 ~~~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l--~~~~~l~~~~~~~i~~~ia~~-l~yLH~  636 (814)
                      |..|...+.+++    +.+.+.+-.++.+ ....+|||||++++.+.++-  ...+ .+   +..++...++. +.-++.
T Consensus       203 ~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g-~d---~~~la~~~v~~~~~Qif~  278 (537)
T PRK04750        203 LMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG-TD---MKLLAERGVEVFFTQVFR  278 (537)
T ss_pred             HHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC-CC---HHHHHHHHHHHHHHHHHh
Confidence            444554444442    3333333333322 45678999999999998742  2211 11   11222222221 112223


Q ss_pred             cCCCCeeecCCCCCcEEEcCCC----cEEEeecCCccccccC
Q 041921          637 DCRAQIIHCDIKPQNILLDDYY----TARISDFGLAKLLTLN  674 (814)
Q Consensus       637 ~~~~~i~H~dlkp~NIll~~~~----~~kl~DfGla~~~~~~  674 (814)
                      .   +++|+|+||.||+++.++    ++++.|||++..+...
T Consensus       279 ~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~  317 (537)
T PRK04750        279 D---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE  317 (537)
T ss_pred             C---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence            3   999999999999999887    9999999999877543

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.99  E-value=8e-09  Score=110.73  Aligned_cols=167  Identities=20%  Similarity=0.253  Sum_probs=131.1

Q ss_pred             eeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeec----ccccceEEEecCCC-CCHH
Q 041921          532 FGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCD----EGQNRLLVYEFLNN-GTLA  606 (814)
Q Consensus       532 ~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~lv~e~~~~-gsL~  606 (814)
                      -.+.||++...  +|..+++|+++....+.......-++.++++.|.|+|++.+++.    .+..+++||+|.|+ ++|.
T Consensus       289 ~~Ttyk~~s~~--DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~  366 (655)
T KOG3741|consen  289 SITTYKATSNV--DGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY  366 (655)
T ss_pred             cceeEeeeecc--CCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence            35789998653  67899999996544444434456678899999999999999886    34568999999986 6787


Q ss_pred             HHhcCC---------------CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcccc
Q 041921          607 SFLFGN---------------LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLL  671 (814)
Q Consensus       607 ~~l~~~---------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~  671 (814)
                      ++-+..               ...++...+.++.|+..||.++|+.   |+.-+-|.+++||++.+.+++|+..|+..++
T Consensus       367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl  443 (655)
T KOG3741|consen  367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVL  443 (655)
T ss_pred             HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeee
Confidence            765422               2346788999999999999999998   9999999999999999999999999998877


Q ss_pred             ccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCC
Q 041921          672 TLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKS  722 (814)
Q Consensus       672 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p  722 (814)
                      ..+....                ++   -..+-|.=.||.+++.|.||...
T Consensus       444 ~~d~~~~----------------le---~~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  444 QEDPTEP----------------LE---SQQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             cCCCCcc----------------hh---HHhhhhHHHHHHHHHHHhhcccc
Confidence            6554111                11   12357999999999999999654

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.93  E-value=6.6e-09  Score=105.88  Aligned_cols=142  Identities=18%  Similarity=0.230  Sum_probs=108.4

Q ss_pred             cceeeeeeeeEEEEEEecCCCceEEEEEEeccccc-cchHhHHHHHHhhhccCC--CCccceeeeecccc---cceEEEe
Q 041921          525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ-DGEREFKNEVFVIGQTHH--KNLVRLLGFCDEGQ---NRLLVYE  598 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~---~~~lv~e  598 (814)
                      +.|+.|..+.||++...   ++..+++|....... ....++..|+++++.+++  .++.+++.+.....   ..++|||
T Consensus         4 ~~l~~G~~n~~~~v~~~---~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e   80 (223)
T cd05154           4 RQLSGGQSNLTYLLTAG---GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME   80 (223)
T ss_pred             eecCCCccceEEEEEec---CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence            46889999999999874   246888998754322 134578999999999976  44677888876643   5689999


Q ss_pred             cCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcC----------------------------------------
Q 041921          599 FLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDC----------------------------------------  638 (814)
Q Consensus       599 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~----------------------------------------  638 (814)
                      |+++.++.+.+.. ..++...+..++.+++++|..||+..                                        
T Consensus        81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            9999888775532 34566777788888888888888521                                        


Q ss_pred             -------------CCCeeecCCCCCcEEEcC--CCcEEEeecCCccc
Q 041921          639 -------------RAQIIHCDIKPQNILLDD--YYTARISDFGLAKL  670 (814)
Q Consensus       639 -------------~~~i~H~dlkp~NIll~~--~~~~kl~DfGla~~  670 (814)
                                   ...++|+|+++.||++++  ++.+.|+||+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                         245899999999999998  66689999988753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.91  E-value=1.2e-09  Score=120.07  Aligned_cols=243  Identities=19%  Similarity=0.177  Sum_probs=171.7

Q ss_pred             cccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHh--HHHHHHhhhcc-CCCCccceeeeecccccceEEEec
Q 041921          523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE--FKNEVFVIGQT-HHKNLVRLLGFCDEGQNRLLVYEF  599 (814)
Q Consensus       523 ~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~--~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~  599 (814)
                      +...||.|.|+.|++...+ ..++..+++|.+.+.......+  -..|+.+...+ .|.++++....+....+.++=-||
T Consensus       269 ~v~~i~~~~~~~~~~~~~r-~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~  347 (524)
T KOG0601|consen  269 LVSKISDGNFSSVFKVSKR-PEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEF  347 (524)
T ss_pred             eeEEccCCccccceeeeec-CCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhh
Confidence            3457999999999998744 3457788999887644333322  24455555555 588899888888888888899999


Q ss_pred             CCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC-CcEEEeecCCccccccCCccc
Q 041921          600 LNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDY-YTARISDFGLAKLLTLNQSKT  678 (814)
Q Consensus       600 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~-~~~kl~DfGla~~~~~~~~~~  678 (814)
                      +.++++...+.-...++...++++..|++.++.++|+.   .++|+|+||+||++..+ +..++.|||++..+....   
T Consensus       348 ~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~---  421 (524)
T KOG0601|consen  348 CEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS---  421 (524)
T ss_pred             hcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccccccceec---
Confidence            99999888775556678888999999999999999987   99999999999999876 888999999986533221   


Q ss_pred             ccccccCCCCcc--cccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCccc
Q 041921          679 IKTAIRGTKGYV--APEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKE  756 (814)
Q Consensus       679 ~~~~~~gt~~y~--aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  756 (814)
                        ....+.-+++  +++......+-.+.|+++||.-+.|.+++.........          +..+..+....       
T Consensus       422 --~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~----------~~~i~~~~~p~-------  482 (524)
T KOG0601|consen  422 --GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ----------SLTIRSGDTPN-------  482 (524)
T ss_pred             --ccccccccccccchhhccccccccccccccccccccccccCcccCccccc----------ceeeecccccC-------
Confidence              1112333444  55555666788899999999999999987754321100          11111221111       


Q ss_pred             ccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 041921          757 AMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEG  794 (814)
Q Consensus       757 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~  794 (814)
                         .......+..++..++.+++..||.+.++....+-
T Consensus       483 ---~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~  517 (524)
T KOG0601|consen  483 ---LPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF  517 (524)
T ss_pred             ---CCchHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence               11112455566667888999999998887665543

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.90  E-value=1.3e-08  Score=95.91  Aligned_cols=131  Identities=20%  Similarity=0.320  Sum_probs=101.5

Q ss_pred             cceeeeeeeeEEEEEEecCCCceEEEEEEe-cccccc-------chHhHHHHHHhhhccCCCCccceeeeecccccceEE
Q 041921          525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKL-DRVFQD-------GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV  596 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l-~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  596 (814)
                      ..+.+|+=+.+|.+.+.    +..+++|.- .+.-..       ....-.+|..++.+++--.|....-+..+.....|+
T Consensus         2 ~~i~~GAEa~i~~~~~~----g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~   77 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL----GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIV   77 (204)
T ss_pred             chhhCCcceeEEeeecc----CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEE
Confidence            35788999999988664    334555533 221110       112467899999999877777777778888899999


Q ss_pred             EecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccc
Q 041921          597 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKL  670 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~  670 (814)
                      |||.++..|.+.+...       +..++..+-.-+.-||..   +|+|+||.++||++.... +.++||||+..
T Consensus        78 me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          78 MEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             EEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999999999998665       356777788888899998   999999999999998775 99999999874

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=98.89  E-value=1.6e-08  Score=99.07  Aligned_cols=140  Identities=16%  Similarity=0.210  Sum_probs=97.8

Q ss_pred             cceeeeeeeeEEEEEEecCC----CceEEEEEEeccccc----------c-----------c-hHhH----HHHHHhhhc
Q 041921          525 EEVGRGSFGIVYKGVIQTRT----STTAVAVKKLDRVFQ----------D-----------G-EREF----KNEVFVIGQ  574 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~----~~~~vavK~l~~~~~----------~-----------~-~~~~----~~E~~~l~~  574 (814)
                      ..||.|-=+.||.|.-.+..    .+..+|||..+....          +           . .+.+    .+|...|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            46888999999999754211    246899997752110          0           0 1123    389999999


Q ss_pred             cCC--CCccceeeeecccccceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHh-hhcCCCCeeecCCCCCc
Q 041921          575 THH--KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYL-HEDCRAQIIHCDIKPQN  651 (814)
Q Consensus       575 l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yL-H~~~~~~i~H~dlkp~N  651 (814)
                      +..  -+++.++++    ...+|||||+.+..+..-......++......+..+++.+|..| |..   +|+|+||++.|
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDLs~~N  155 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADLSEYN  155 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHH
Confidence            854  466677764    56789999998754422111122334455667889999999999 776   99999999999


Q ss_pred             EEEcCCCcEEEeecCCccccc
Q 041921          652 ILLDDYYTARISDFGLAKLLT  672 (814)
Q Consensus       652 Ill~~~~~~kl~DfGla~~~~  672 (814)
                      |++++ +.+.|+|||.+....
T Consensus       156 IL~~~-~~v~iIDF~qav~~~  175 (197)
T cd05146         156 MLWHD-GKVWFIDVSQSVEPT  175 (197)
T ss_pred             EEEEC-CcEEEEECCCceeCC
Confidence            99974 689999999886543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.80  E-value=4.7e-08  Score=91.61  Aligned_cols=141  Identities=21%  Similarity=0.274  Sum_probs=105.0

Q ss_pred             ccceeeeeeeeEEEEEEecCCCceEEEEEEe-ccccc-------cchHhHHHHHHhhhccCCCCccceeeeecccccceE
Q 041921          524 KEEVGRGSFGIVYKGVIQTRTSTTAVAVKKL-DRVFQ-------DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL  595 (814)
Q Consensus       524 ~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l-~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  595 (814)
                      .+.|-||+=+.|+++...    ++...||.- .+...       -..+...+|.+.+.+.+--.|.-..-++.+...-.|
T Consensus        12 l~likQGAEArv~~~~~~----Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i   87 (229)
T KOG3087|consen   12 LELIKQGAEARVPRGSFS----GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQI   87 (229)
T ss_pred             ceeeeccceeeEeeeccC----CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeE
Confidence            357889999999999875    555555533 22111       122457889999999877677666667777788889


Q ss_pred             EEecCCC-CCHHHHhcCC-CCCChhh-HHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC---cEEEeecCCcc
Q 041921          596 VYEFLNN-GTLASFLFGN-LKPNWNL-RTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYY---TARISDFGLAK  669 (814)
Q Consensus       596 v~e~~~~-gsL~~~l~~~-~~l~~~~-~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~---~~kl~DfGla~  669 (814)
                      +|||+++ .++.+++... ....... ...++.+|-+.+.-||.+   +|+|+||..+||++..++   .+.++|||++.
T Consensus        88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~  164 (229)
T KOG3087|consen   88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSS  164 (229)
T ss_pred             EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchh
Confidence            9999977 5788888754 2222333 368889999999999999   999999999999997544   45899999986


Q ss_pred             cc
Q 041921          670 LL  671 (814)
Q Consensus       670 ~~  671 (814)
                      ..
T Consensus       165 ~s  166 (229)
T KOG3087|consen  165 VS  166 (229)
T ss_pred             cc
Confidence            43

>cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins

Probab=98.78  E-value=6.4e-09  Score=85.61  Aligned_cols=64  Identities=13%  Similarity=0.166  Sum_probs=51.9

Q ss_pred             eeEEeecCCCCCCcccccCccChhhHHHhhcC---CCcccccccC--CCceeeeccCC-CCCcccccccCceeEE
Q 041921          366 DFHELKNINWPQSDYERFKPYNEVQCKNTCLS---DCFCAAVIFN--DGSCWFKKLPL-SNGMTDSRIAGKAFIK  434 (814)
Q Consensus       366 ~f~~~~~~~~~~~~~~~~~~~s~~~C~~~Cl~---~CsC~a~~~~--~~~c~~~~~~l-~~g~~~~~~~~~~ylk  434 (814)
                      .|+++.+|++|++..     +++++|++.|++   ||||+||+|.  +.+|++|...+ .+.+.....+..+|+|
T Consensus        10 ~fl~~~~~klpd~~~-----~s~~eC~~~Cl~~~~nCsC~Aya~~~~~~gC~~W~~~l~~d~~~~~~~g~~Ly~r   79 (80)
T cd00129          10 TTLIKIALKIKTTKA-----NTADECANRCEKNGLPFSCKAFVFAKARKQCLWFPFNSMSGVRKEFSHGFDLYEN   79 (80)
T ss_pred             eEEEeecccCCcccc-----cCHHHHHHHHhcCCCCCCceeeeccCCCCCeEEecCcchhhHHhccCCCceeEeE
Confidence            489999999998754     689999999999   9999999995  35799998888 6665555555667765

Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.77  E-value=4e-09  Score=121.63  Aligned_cols=244  Identities=21%  Similarity=0.216  Sum_probs=156.9

Q ss_pred             ceeeeeeeeEEEEEEecCCCceEEEEEEe-ccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEecCCCCC
Q 041921          526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGT  604 (814)
Q Consensus       526 ~LG~G~~g~Vy~~~~~~~~~~~~vavK~l-~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  604 (814)
                      -+-+|.++.++.+.-...+...+..+.++ ........+....+-.++...+||-+++..--+.......|+++|+.+++
T Consensus       811 p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~  890 (1205)
T KOG0606|consen  811 PSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGGD  890 (1205)
T ss_pred             cccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccCC
Confidence            46667777776654332221122211111 11111122233333333333445555555544555677899999999999


Q ss_pred             HHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccC----------
Q 041921          605 LASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN----------  674 (814)
Q Consensus       605 L~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~----------  674 (814)
                      |...|+.....+.......+..+..++.+||..   .+.|+|++|.|++...++..+++||+.......-          
T Consensus       891 ~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~  967 (1205)
T KOG0606|consen  891 LPSKLHNSGCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPS  967 (1205)
T ss_pred             chhhhhcCCCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccccccCcCCccccc
Confidence            999998877666666666677788999999986   6899999999999999999999999843322100          


Q ss_pred             -----------Cc-----c---cccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHH
Q 041921          675 -----------QS-----K---TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILT  735 (814)
Q Consensus       675 -----------~~-----~---~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~  735 (814)
                                 ..     .   .......+|+.|.+||.+.+......+|.|++|++++|.++|..||....++..    
T Consensus       968 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~---- 1043 (1205)
T KOG0606|consen  968 SSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQI---- 1043 (1205)
T ss_pred             ccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhh----
Confidence                       00     0   001234589999999999999999999999999999999999999986655431    


Q ss_pred             HHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHH
Q 041921          736 DWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMK  786 (814)
Q Consensus       736 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~  786 (814)
                         .+.+..+.+.-...       ..+...+..+++..-+..+|.+|-.|.
T Consensus      1044 ---f~ni~~~~~~~p~g-------~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1044 ---FENILNRDIPWPEG-------PEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             ---hhccccCCCCCCCC-------ccccChhhhhhhhhhhccCchhccCcc
Confidence               22222222221111       222334445566666788888887765

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.70  E-value=1.6e-07  Score=97.56  Aligned_cols=130  Identities=15%  Similarity=0.073  Sum_probs=96.0

Q ss_pred             eEEEEEEecCCCceEEEEEEecccccc-ch----------HhHHHHHHhhhccCCCCc--cceeeeecc-----cccceE
Q 041921          534 IVYKGVIQTRTSTTAVAVKKLDRVFQD-GE----------REFKNEVFVIGQTHHKNL--VRLLGFCDE-----GQNRLL  595 (814)
Q Consensus       534 ~Vy~~~~~~~~~~~~vavK~l~~~~~~-~~----------~~~~~E~~~l~~l~h~ni--v~l~~~~~~-----~~~~~l  595 (814)
                      .|.+..+.    ++.+.||+....... ..          ..+.+|...+.++...+|  ++++++...     ....+|
T Consensus        37 rvvr~~~~----g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~L  112 (268)
T PRK15123         37 RTLRFELA----GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFI  112 (268)
T ss_pred             eEEEEEEC----CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEE
Confidence            35666653    568999977432211 01          147889999988854444  455666543     235689


Q ss_pred             EEecCCCC-CHHHHhcC--CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC-------CCcEEEeec
Q 041921          596 VYEFLNNG-TLASFLFG--NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDD-------YYTARISDF  665 (814)
Q Consensus       596 v~e~~~~g-sL~~~l~~--~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~-------~~~~kl~Df  665 (814)
                      |+|++++. +|.+++..  ....+...+..++.++++.+.-||+.   +|+|+|++++|||++.       +..+.|+||
T Consensus       113 Vte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl  189 (268)
T PRK15123        113 ITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLKLSVIDL  189 (268)
T ss_pred             EEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCceEEEEEC
Confidence            99999986 89999853  23445667789999999999999999   9999999999999975       568999999


Q ss_pred             CCccc
Q 041921          666 GLAKL  670 (814)
Q Consensus       666 Gla~~  670 (814)
                      +.+..
T Consensus       190 ~r~~~  194 (268)
T PRK15123        190 HRAQI  194 (268)
T ss_pred             Ccccc
Confidence            98753

>smart00108 B_lectin Bulb-type mannose-specific lectin

Probab=98.64  E-value=1.1e-07  Score=85.61  Aligned_cols=76  Identities=28%  Similarity=0.443  Sum_probs=59.2

Q ss_pred             EEEccCCcEEEeCCC-CceEeeeccCCC--ceeEEEEecCcCEEEEeCCCCceeecccCCccccccCCccccccceeecc
Q 041921          102 VKLTADQGLVLNDPQ-GKQVWSSKIDIG--TVAVGHMNDTGNFVLASSSSGRLWDSFSNPTDTLLLGQMMETEQGLFSRK  178 (814)
Q Consensus       102 l~~~~~G~Lvl~~~~-g~~vWst~~~~~--~~~~a~LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg~~l~~~~~l~S~~  178 (814)
                      +.+..||+||+++.. +.+||++++...  ....+.|.++|||||++.++.++|+|=     |- .              
T Consensus        24 ~~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~-----t~-~--------------   83 (114)
T smart00108       24 LIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGDGRVVWSSN-----TT-G--------------   83 (114)
T ss_pred             cCCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCCCCEEEEec-----cc-C--------------
Confidence            445578999999765 589999998643  225789999999999999888999971     11 1              


Q ss_pred             cCCCCCCCceeEEEccCCceeEEe
Q 041921          179 SENNFSRGRFQFRLLEDGNLVLNI  202 (814)
Q Consensus       179 s~~d~s~G~~~~~~~~~g~~~~~~  202 (814)
                           ..|.|.+.|+++|+++++-
T Consensus        84 -----~~~~~~~~L~ddGnlvl~~  102 (114)
T smart00108       84 -----ANGNYVLVLLDDGNLVIYD  102 (114)
T ss_pred             -----CCCceEEEEeCCCCEEEEC
Confidence                 3467899999999998864

>cd00028 B_lectin Bulb-type mannose-specific lectin

Probab=98.58  E-value=2e-07  Score=84.12  Aligned_cols=86  Identities=27%  Similarity=0.425  Sum_probs=64.8

Q ss_pred             EEcc-CCcEEEeCCC-CceEeeeccCC--CceeEEEEecCcCEEEEeCCCCceeecccCCccccccCCccccccceeecc
Q 041921          103 KLTA-DQGLVLNDPQ-GKQVWSSKIDI--GTVAVGHMNDTGNFVLASSSSGRLWDSFSNPTDTLLLGQMMETEQGLFSRK  178 (814)
Q Consensus       103 ~~~~-~G~Lvl~~~~-g~~vWst~~~~--~~~~~a~LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg~~l~~~~~l~S~~  178 (814)
                      .+.. ||+||+++.. +++||++|+..  .....+.|.++|||||++.++.++|||=-.                     
T Consensus        25 ~~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~~~---------------------   83 (116)
T cd00028          25 IMQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGSGTVVWSSNTT---------------------   83 (116)
T ss_pred             CCCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcCCCcEEEEeccc---------------------
Confidence            3444 8999999764 58999999864  244678999999999999988899987421                     


Q ss_pred             cCCCCCCCceeEEEccCCceeEEeeccCCCccccceeeccc
Q 041921          179 SENNFSRGRFQFRLLEDGNLVLNIANLATGFAYDAYYTSGT  219 (814)
Q Consensus       179 s~~d~s~G~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~sg~  219 (814)
                          .+.|.+.+.|+++|+++++-.++      .+.|.|..
T Consensus        84 ----~~~~~~~~~L~ddGnlvl~~~~~------~~~W~Sf~  114 (116)
T cd00028          84 ----RVNGNYVLVLLDDGNLVLYDSDG------NFLWQSFD  114 (116)
T ss_pred             ----CCCCceEEEEeCCCCEEEECCCC------CEEEcCCC
Confidence                02467899999999999875432      34677654

The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses.

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.53  E-value=7.6e-07  Score=87.05  Aligned_cols=125  Identities=22%  Similarity=0.215  Sum_probs=80.8

Q ss_pred             EEEEEEecCCCceEEEEEEeccccc-------------c-------------chHhHHHHHHhhhccCCC--Cccceeee
Q 041921          535 VYKGVIQTRTSTTAVAVKKLDRVFQ-------------D-------------GEREFKNEVFVIGQTHHK--NLVRLLGF  586 (814)
Q Consensus       535 Vy~~~~~~~~~~~~vavK~l~~~~~-------------~-------------~~~~~~~E~~~l~~l~h~--niv~l~~~  586 (814)
                      ||.|...   ++..+|||..+....             .             ......+|.+.|.++..-  ++++++.+
T Consensus         2 Vy~~~~~---~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~   78 (188)
T PF01163_consen    2 VYHAIDP---DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY   78 (188)
T ss_dssp             EEEEEEC---TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE
T ss_pred             EEEEECC---CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE
Confidence            8888865   577999997753100             0             012367899999999765  56677655


Q ss_pred             ecccccceEEEecCC--CCCHHHHhcCCCCCChhhHHHHHHHHHHHHHH-hhhcCCCCeeecCCCCCcEEEcCCCcEEEe
Q 041921          587 CDEGQNRLLVYEFLN--NGTLASFLFGNLKPNWNLRTNIAFQIARGLLY-LHEDCRAQIIHCDIKPQNILLDDYYTARIS  663 (814)
Q Consensus       587 ~~~~~~~~lv~e~~~--~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~y-LH~~~~~~i~H~dlkp~NIll~~~~~~kl~  663 (814)
                      .    ...|||||++  +..+..+....  ++......++.+++..+.. +|..   +|+|+|+.+.||+++++ .+.|+
T Consensus        79 ~----~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iI  148 (188)
T PF01163_consen   79 N----RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYII  148 (188)
T ss_dssp             E----TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE-
T ss_pred             e----CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEEE
Confidence            3    4589999998  55554433211  1134556778888885555 4666   99999999999999988 99999


Q ss_pred             ecCCccccc
Q 041921          664 DFGLAKLLT  672 (814)
Q Consensus       664 DfGla~~~~  672 (814)
                      |||.+....
T Consensus       149 Df~qav~~~  157 (188)
T PF01163_consen  149 DFGQAVDSS  157 (188)
T ss_dssp             -GTTEEETT
T ss_pred             ecCcceecC
Confidence            999876543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.50  E-value=1.2e-06  Score=87.98  Aligned_cols=107  Identities=20%  Similarity=0.203  Sum_probs=86.9

Q ss_pred             hHhHHHHHHhhhccCC--CCccceeeeecccc----cceEEEecCCC-CCHHHHhcCCCCCChhhHHHHHHHHHHHHHHh
Q 041921          562 EREFKNEVFVIGQTHH--KNLVRLLGFCDEGQ----NRLLVYEFLNN-GTLASFLFGNLKPNWNLRTNIAFQIARGLLYL  634 (814)
Q Consensus       562 ~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~----~~~lv~e~~~~-gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yL  634 (814)
                      .....+|...+.+++.  -..++.+++.....    ..+||+|++++ .+|.+++.....++...+..++.++++.++-|
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l  134 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL  134 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence            3457888888888854  34566777765532    34799999988 48999998755577778889999999999999


Q ss_pred             hhcCCCCeeecCCCCCcEEEcCCC---cEEEeecCCcccc
Q 041921          635 HEDCRAQIIHCDIKPQNILLDDYY---TARISDFGLAKLL  671 (814)
Q Consensus       635 H~~~~~~i~H~dlkp~NIll~~~~---~~kl~DfGla~~~  671 (814)
                      |+.   +|+|+|+++.|||++.+.   .+.++||+-++..
T Consensus       135 H~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  135 HDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            999   999999999999999876   8999999977643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.49  E-value=1.7e-06  Score=85.03  Aligned_cols=136  Identities=16%  Similarity=0.109  Sum_probs=103.7

Q ss_pred             eeeeeeeeEEEEEEecCCCceEEEEEEecccc------ccchHhHHHHHHhhhccCCC--Cccceeeeecc-----cccc
Q 041921          527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF------QDGEREFKNEVFVIGQTHHK--NLVRLLGFCDE-----GQNR  593 (814)
Q Consensus       527 LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~-----~~~~  593 (814)
                      -|+||.+.|++-.+.    +..+-+|+-.+..      +-....|.+|+..|.++..-  .+.+++ ++..     ....
T Consensus        26 ~~rgG~SgV~r~~~~----g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA  100 (216)
T PRK09902         26 YRRNGMSGVQCVERN----GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRA  100 (216)
T ss_pred             cCCCCcceEEEEEeC----CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEE
Confidence            466999999998775    3468899875211      23456799999999999643  345555 3321     1235


Q ss_pred             eEEEecCCC-CCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCc--EEEeecCCc
Q 041921          594 LLVYEFLNN-GTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYT--ARISDFGLA  668 (814)
Q Consensus       594 ~lv~e~~~~-gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~--~kl~DfGla  668 (814)
                      +||+|-+++ .+|.+++.+.  .+.+...+..++.++++.++-||+.   ++.|+|+.+.||+++.++.  ++++||.-+
T Consensus       101 ~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~  177 (216)
T PRK09902        101 LLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKS  177 (216)
T ss_pred             EEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhcc
Confidence            799997764 6999998663  4567788899999999999999998   9999999999999986666  999999766


Q ss_pred             cc
Q 041921          669 KL  670 (814)
Q Consensus       669 ~~  670 (814)
                      +.
T Consensus       178 r~  179 (216)
T PRK09902        178 RR  179 (216)
T ss_pred             ch
Confidence            53

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.44  E-value=3.9e-06  Score=88.26  Aligned_cols=256  Identities=14%  Similarity=0.134  Sum_probs=149.1

Q ss_pred             ccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhcc-CCCCccceeeee------cc-cccc
Q 041921          522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQT-HHKNLVRLLGFC------DE-GQNR  593 (814)
Q Consensus       522 ~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~------~~-~~~~  593 (814)
                      ..+..||+|+-+.+|..  .   +-..-+-|...........+   .++.|... .||-+-.-+.+=      -+ ....
T Consensus        14 ~~gr~LgqGgea~ly~l--~---e~~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~i   85 (637)
T COG4248          14 PPGRPLGQGGEADLYTL--G---EVRDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVI   85 (637)
T ss_pred             CCCccccCCccceeeec--c---hhhchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCcccee
Confidence            34678999999999943  2   11222234443322222212   22333333 555433211111      11 2224


Q ss_pred             eEEEecCCCC-CHHHHhc------CCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecC
Q 041921          594 LLVYEFLNNG-TLASFLF------GNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFG  666 (814)
Q Consensus       594 ~lv~e~~~~g-sL~~~l~------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfG  666 (814)
                      -++|..+++. ....++.      +....+|...++.++.+|.+.+.||..   +.+-+|++++|+||++++.+.|.|-.
T Consensus        86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsD  162 (637)
T COG4248          86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSD  162 (637)
T ss_pred             EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccc
Confidence            5677766553 3333332      124568999999999999999999998   99999999999999999999999844


Q ss_pred             CccccccCCcccccccccCCCCcccccccc-----cCCCCcchhhHHHHHHHHHHHhC-CCCCCcccc--hhhhhHHHHH
Q 041921          667 LAKLLTLNQSKTIKTAIRGTKGYVAPEWFR-----NSKITAKVDVYSFGVLLLEIISC-RKSFDIEMG--EEYAILTDWA  738 (814)
Q Consensus       667 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~Dv~s~Gvvl~elltg-~~p~~~~~~--~~~~~~~~~~  738 (814)
                      .-.+-..   .......+|...|.+||.-.     +..-+...|.|.||+++++++.| ++||.+...  .......   
T Consensus       163 sfqi~~n---g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E---  236 (637)
T COG4248         163 SFQINAN---GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE---  236 (637)
T ss_pred             ceeeccC---CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch---
Confidence            3222111   11113346889999999764     33456789999999999999985 999975321  1100000   


Q ss_pred             HHHhhcCccceeec------CcccccCcHHHHHHHHHHHHHcccc--CCCCCCCHHHHHHHHhcC
Q 041921          739 FDCYRNGKLNVLVG------EDKEAMNDIECLGKLVMVSIWCIQE--DPSLRPTMKKVLQMLEGV  795 (814)
Q Consensus       739 ~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~l~~~Cl~~--dp~~RPt~~~vl~~L~~~  795 (814)
                       ..+..|......+      +.+....-.-.+..+..+..+|+..  ++.-|||++..+..|..+
T Consensus       237 -~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al  300 (637)
T COG4248         237 -TDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL  300 (637)
T ss_pred             -hhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence             0011111111111      1111111112234555666778864  366899999888777553

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.42  E-value=6.8e-08  Score=107.70  Aligned_cols=150  Identities=19%  Similarity=0.276  Sum_probs=101.3

Q ss_pred             HHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcc-------cccccccCCCCccccccccc
Q 041921          625 FQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSK-------TIKTAIRGTKGYVAPEWFRN  697 (814)
Q Consensus       625 ~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~  697 (814)
                      .+++.|+.|+|..  .+++|++|.|++|.++.++..||+.|+.+.........       ...........|.|||++..
T Consensus       106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            4556999999976  68999999999999999999999999987654431111       11111235668999999998


Q ss_pred             CCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccc
Q 041921          698 SKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQ  776 (814)
Q Consensus       698 ~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~  776 (814)
                      ...+.++|+||+|++++.+.. |+..+............             ...+.....-...+.+.++.+=+.+.+.
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~-------------~~~~~~~~~~~s~~~p~el~~~l~k~l~  250 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS-------------RNLLNAGAFGYSNNLPSELRESLKKLLN  250 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhh-------------hcccccccccccccCcHHHHHHHHHHhc
Confidence            888999999999999999995 44444332221111110             0001111111123445667777777899


Q ss_pred             cCCCCCCCHHHHH
Q 041921          777 EDPSLRPTMKKVL  789 (814)
Q Consensus       777 ~dp~~RPt~~~vl  789 (814)
                      .++..||++.++.
T Consensus       251 ~~~~~rp~~~~l~  263 (700)
T KOG2137|consen  251 GDSAVRPTLDLLL  263 (700)
T ss_pred             CCcccCcchhhhh
Confidence            9999999776654

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.31  E-value=3.1e-06  Score=84.93  Aligned_cols=134  Identities=16%  Similarity=0.135  Sum_probs=93.9

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc----------------------cchHhHHHHHHhhhccCCC
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ----------------------DGEREFKNEVFVIGQTHHK  578 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~----------------------~~~~~~~~E~~~l~~l~h~  578 (814)
                      +.++++||.|-=+.||.|..+   .+.+++||.-+....                      ......++|.++|.++.-.
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~---~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~  169 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP---KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPE  169 (304)
T ss_pred             HhhccccccCccceEEEEECC---CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhc
Confidence            456789999999999999976   578899985532110                      0112367888999988655


Q ss_pred             --CccceeeeecccccceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC
Q 041921          579 --NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDD  656 (814)
Q Consensus       579 --niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~  656 (814)
                        .+.+.+++    +...+|||+.++-.|...-     ++......|+..|++-+.-+-..   +|+|+|+.+-||++++
T Consensus       170 G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~  237 (304)
T COG0478         170 GVKVPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTE  237 (304)
T ss_pred             CCCCCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEec
Confidence              67777655    4558999999886665432     12333334444444444444444   9999999999999999


Q ss_pred             CCcEEEeecCCcc
Q 041921          657 YYTARISDFGLAK  669 (814)
Q Consensus       657 ~~~~kl~DfGla~  669 (814)
                      +|.+.++||--+.
T Consensus       238 dg~~~vIDwPQ~v  250 (304)
T COG0478         238 DGDIVVIDWPQAV  250 (304)
T ss_pred             CCCEEEEeCcccc
Confidence            9999999997554

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.20  E-value=5.6e-06  Score=93.13  Aligned_cols=142  Identities=19%  Similarity=0.258  Sum_probs=90.6

Q ss_pred             cceeeeeeeeEEEEEEecCCCceEEEEEEeccccccch------------------------------H----------h
Q 041921          525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE------------------------------R----------E  564 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~------------------------------~----------~  564 (814)
                      +-|+.++-|.||+|++.   +|+.||||..+....+..                              +          +
T Consensus       131 ~PiAsASIaQVH~A~L~---sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElD  207 (517)
T COG0661         131 EPIASASIAQVHRAVLK---SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELD  207 (517)
T ss_pred             CchhhhhHhhheeEEec---CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhC
Confidence            34899999999999998   488999999875322110                              0          1


Q ss_pred             HHHHHHhhhccC-----CCCccceeeeecccccceEEEecCCCCCHHHHhc-CCCCCChhhHHHHHHHHHHHHHHhhhcC
Q 041921          565 FKNEVFVIGQTH-----HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF-GNLKPNWNLRTNIAFQIARGLLYLHEDC  638 (814)
Q Consensus       565 ~~~E~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~  638 (814)
                      +..|...+.+++     .+++.-..-|..-.....|+|||++|-.+.++.. +....+.   ..++..++++  |+.+-.
T Consensus       208 y~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~---k~ia~~~~~~--f~~q~~  282 (517)
T COG0661         208 YRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDR---KELAELLVRA--FLRQLL  282 (517)
T ss_pred             HHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCH---HHHHHHHHHH--HHHHHH
Confidence            334444444432     2222222222233567899999999998888742 1233442   2333333332  111111


Q ss_pred             CCCeeecCCCCCcEEEcCCCcEEEeecCCccccccC
Q 041921          639 RAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN  674 (814)
Q Consensus       639 ~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~  674 (814)
                      ..++.|.|.+|.||+++.++++.+.|||+...+.+.
T Consensus       283 ~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         283 RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             hcCccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence            228999999999999999999999999998876543

>PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity

Probab=98.05  E-value=5.1e-05  Score=67.92  Aligned_cols=100  Identities=25%  Similarity=0.406  Sum_probs=66.6

Q ss_pred             ceecCCCcEEEeEeeccCCCCCCCcEEEEEEecccCCCeEEEEecCCCCCCCCCCCceEEEccCCcEEEeCCCCceEeee
Q 041921           44 PWLSPSGDFAFGFHQLDEENNTNDLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLTADQGLVLNDPQGKQVWSS  123 (814)
Q Consensus        44 ~lvS~~g~F~lGF~~~~~~~~~~~~~~lgiw~~~~~~~t~vW~Anr~~~~~~~~~~~~l~~~~~G~Lvl~~~~g~~vWst  123 (814)
                      ++.+.+|.+.|-|-..|         -|-|.-.   ..+++|..+...  -.....+.+.|..||||||+|.++.++|+|
T Consensus        13 p~~~~s~~~~L~l~~dG---------nLvl~~~---~~~~iWss~~t~--~~~~~~~~~~L~~~GNlvl~d~~~~~lW~S   78 (114)
T PF01453_consen   13 PLTSSSGNYTLILQSDG---------NLVLYDS---NGSVIWSSNNTS--GRGNSGCYLVLQDDGNLVLYDSSGNVLWQS   78 (114)
T ss_dssp             EEEECETTEEEEEETTS---------EEEEEET---TTEEEEE--S-T--TSS-SSEEEEEETTSEEEEEETTSEEEEES
T ss_pred             ccccccccccceECCCC---------eEEEEcC---CCCEEEEecccC--CccccCeEEEEeCCCCEEEEeecceEEEee
Confidence            45555588888886544         3666432   257799884321  111156889999999999999999999999


Q ss_pred             ccCCCceeEEEEec--CcCEEEEeCCCCceeecccCCc
Q 041921          124 KIDIGTVAVGHMND--TGNFVLASSSSGRLWDSFSNPT  159 (814)
Q Consensus       124 ~~~~~~~~~a~Lld--sGNlVl~~~~~~~lWQSFd~Pt  159 (814)
                      .. ....+.+..++  .||++ ......+.|.|=+.|.
T Consensus        79 f~-~ptdt~L~~q~l~~~~~~-~~~~~~~sw~s~~dps  114 (114)
T PF01453_consen   79 FD-YPTDTLLPGQKLGDGNVT-GKNDSLTSWSSNTDPS  114 (114)
T ss_dssp             TT-SSS-EEEEEET--TSEEE-EESTSSEEEESS----
T ss_pred             cC-CCccEEEeccCcccCCCc-cccceEEeECCCCCCC
Confidence            43 34556677777  89998 7677778999877663

Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B ....

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.98  E-value=2.4e-05  Score=76.87  Aligned_cols=102  Identities=25%  Similarity=0.401  Sum_probs=83.0

Q ss_pred             HHHHHhhhccCC-CCccceeeeecccccceEEEecCCCCCHHHH---hcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCC
Q 041921          566 KNEVFVIGQTHH-KNLVRLLGFCDEGQNRLLVYEFLNNGTLASF---LFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ  641 (814)
Q Consensus       566 ~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~---l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~  641 (814)
                      .+|..++..+++ +++++++|+|-    .+++.||.+.+++...   +..-...+|..|.+||.++++.+.+|++.....
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            357788888876 69999999993    4789999987765421   222235689999999999999999999865556


Q ss_pred             eeecCCCCCcEEEcCCCcEEEeecCCcccc
Q 041921          642 IIHCDIKPQNILLDDYYTARISDFGLAKLL  671 (814)
Q Consensus       642 i~H~dlkp~NIll~~~~~~kl~DfGla~~~  671 (814)
                      +.-.|++++|+-+++++++|++|...+...
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            888999999999999999999999876544

Proteins in this uncharacterised family are described as transmembrane proteins.

>smart00473 PAN_AP divergent subfamily of APPLE domains

Probab=97.96  E-value=1.3e-05  Score=66.51  Aligned_cols=58  Identities=21%  Similarity=0.400  Sum_probs=45.8

Q ss_pred             eeeEEeecCCCCCCcccccCccChhhHHHhhcC-CCcccccccC--CCceeeec-cCCCCCc
Q 041921          365 FDFHELKNINWPQSDYERFKPYNEVQCKNTCLS-DCFCAAVIFN--DGSCWFKK-LPLSNGM  422 (814)
Q Consensus       365 ~~f~~~~~~~~~~~~~~~~~~~s~~~C~~~Cl~-~CsC~a~~~~--~~~c~~~~-~~l~~g~  422 (814)
                      ..|+.++++.+++.........++++|++.|+. +|+|.||.|.  ++.|+++. .++.+..
T Consensus         4 ~~f~~~~~~~l~~~~~~~~~~~s~~~C~~~C~~~~~~C~s~~y~~~~~~C~l~~~~~~~~~~   65 (78)
T smart00473        4 DCFVRLPNTKLPGFSRIVISVASLEECASKCLNSNCSCRSFTYNNGTKGCLLWSESSLGDAR   65 (78)
T ss_pred             ceeEEecCccCCCCcceeEcCCCHHHHHHHhCCCCCceEEEEEcCCCCEEEEeeCCccccce
Confidence            358999999998654433467899999999999 9999999996  57799997 5554443

Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions.

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=97.89  E-value=0.00012  Score=74.55  Aligned_cols=136  Identities=15%  Similarity=0.186  Sum_probs=83.6

Q ss_pred             cceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCC--ccceeeeecccccceEEEecCCC
Q 041921          525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKN--LVRLLGFCDEGQNRLLVYEFLNN  602 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~  602 (814)
                      +.||+|..+.||+..      +...++|......  ......+|.+++..+..-.  +.+.+++....+...+|||+++|
T Consensus         7 ~~i~~G~t~~~y~~~------~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G   78 (226)
T TIGR02172         7 TQTGEGGNGESYTHK------TGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVG   78 (226)
T ss_pred             eeecCCCCcceeEec------CCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCC
Confidence            568999999999831      2356677765422  3445788999999986543  46778888777778899999998


Q ss_pred             CC-HHHHh---------------------cCC--CCCChhhHH-HHHH----------HHHH-HHHHhhhc-CCCCeeec
Q 041921          603 GT-LASFL---------------------FGN--LKPNWNLRT-NIAF----------QIAR-GLLYLHED-CRAQIIHC  645 (814)
Q Consensus       603 gs-L~~~l---------------------~~~--~~l~~~~~~-~i~~----------~ia~-~l~yLH~~-~~~~i~H~  645 (814)
                      .. +...+                     +.-  .......+. ++..          .+.+ ...+|... ....++|+
T Consensus        79 ~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~Hg  158 (226)
T TIGR02172        79 KRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHG  158 (226)
T ss_pred             ccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEec
Confidence            63 22111                     110  011111000 0000          0111 11222211 13457899


Q ss_pred             CCCCCcEEEcCCCcEEEeecCCcc
Q 041921          646 DIKPQNILLDDYYTARISDFGLAK  669 (814)
Q Consensus       646 dlkp~NIll~~~~~~kl~DfGla~  669 (814)
                      |+.|.||++++++ +.|+||+.+.
T Consensus       159 D~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       159 DFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCCCCcEEEcCCC-cEEEechhcC
Confidence            9999999999887 9999998765

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.89  E-value=6.4e-05  Score=84.36  Aligned_cols=138  Identities=19%  Similarity=0.243  Sum_probs=87.7

Q ss_pred             cceeeeeeeeEEEEEEecCCCceEEEEEEeccccccc-------------------------------------hHhHHH
Q 041921          525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG-------------------------------------EREFKN  567 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~-------------------------------------~~~~~~  567 (814)
                      +.||.-..|.||+|+++   +++.||||.-+....+.                                     +-+|..
T Consensus       167 ~piaaASlaQVhrA~L~---~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~  243 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLK---NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTK  243 (538)
T ss_pred             chhhhcchhheEEEEec---CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHH
Confidence            35999999999999998   48899999876432211                                     012445


Q ss_pred             HHHhhhcc----CCCC------ccceeeeecccccceEEEecCCCCCHHHHh--cCCCCCChhhHHHHHHHHHHHHHHhh
Q 041921          568 EVFVIGQT----HHKN------LVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLH  635 (814)
Q Consensus       568 E~~~l~~l----~h~n------iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l--~~~~~l~~~~~~~i~~~ia~~l~yLH  635 (814)
                      |.+...+.    +|-+      |.+++  ..-...+.|+||||+|..+.+.-  .+. .++..   .|+..+.++  |++
T Consensus       244 EA~Nae~~~~~f~~~~~~~~V~VP~Vy--~~~st~RVLtME~~~G~~i~Dl~~i~~~-gi~~~---~i~~~l~~~--~~~  315 (538)
T KOG1235|consen  244 EAKNAERFRENFKDFSLLTYVLVPKVY--WDLSTKRVLTMEYVDGIKINDLDAIDKR-GISPH---DILNKLVEA--YLE  315 (538)
T ss_pred             HHHhHHHHHHHHHhcccccceeCCeeh--hhcCcceEEEEEecCCccCCCHHHHHHc-CCCHH---HHHHHHHHH--HHH
Confidence            55444443    3444      22222  22345789999999998776643  222 23333   333333332  222


Q ss_pred             hcCCCCeeecCCCCCcEEEcC----CCcEEEeecCCcccccc
Q 041921          636 EDCRAQIIHCDIKPQNILLDD----YYTARISDFGLAKLLTL  673 (814)
Q Consensus       636 ~~~~~~i~H~dlkp~NIll~~----~~~~kl~DfGla~~~~~  673 (814)
                      .-...|++|+|-+|.||+++.    +.++.+.|||+...+..
T Consensus       316 qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  316 QIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             HHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            222238999999999999983    67899999999876553

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.85  E-value=0.00014  Score=75.33  Aligned_cols=136  Identities=14%  Similarity=0.054  Sum_probs=82.6

Q ss_pred             eeeeee-eeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccC-CCCccceeeeecccccceEEEecCCCCC
Q 041921          527 VGRGSF-GIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTH-HKNLVRLLGFCDEGQNRLLVYEFLNNGT  604 (814)
Q Consensus       527 LG~G~~-g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gs  604 (814)
                      |-.|.. ..||+....    +..+.||......   ..++..|++++..+. +--+.+++++...++..++|||++++.+
T Consensus         6 ~~~g~~~~~v~~~~~~----~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~   78 (244)
T cd05150           6 VTEGQSGATVYRLDGK----NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVP   78 (244)
T ss_pred             cCCCCCcCeEEEEcCC----CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCcc
Confidence            334444 788987642    3567788775432   345778888888883 4456677887776667899999999987


Q ss_pred             HHHHh-------------------cCCC----CCC--hhhHHHHHH--------------------HHHHHHHHhhh---
Q 041921          605 LASFL-------------------FGNL----KPN--WNLRTNIAF--------------------QIARGLLYLHE---  636 (814)
Q Consensus       605 L~~~l-------------------~~~~----~l~--~~~~~~i~~--------------------~ia~~l~yLH~---  636 (814)
                      |....                   +...    ...  ...+..-..                    .+...+..|-.   
T Consensus        79 l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  158 (244)
T cd05150          79 AAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRP  158 (244)
T ss_pred             HhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCC
Confidence            76432                   1100    000  000000000                    01111222211   


Q ss_pred             -cCCCCeeecCCCCCcEEEcCCCcEEEeecCCcc
Q 041921          637 -DCRAQIIHCDIKPQNILLDDYYTARISDFGLAK  669 (814)
Q Consensus       637 -~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~  669 (814)
                       ...+.++|+|+.|.|||++++..+.|+||+.+.
T Consensus       159 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         159 AEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             CcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence             123468999999999999998778899998764

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=97.81  E-value=0.00013  Score=72.16  Aligned_cols=139  Identities=14%  Similarity=0.107  Sum_probs=86.8

Q ss_pred             HHHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHh---------HHHHHHhhhccCCC---Cccc
Q 041921          515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE---------FKNEVFVIGQTHHK---NLVR  582 (814)
Q Consensus       515 ~l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~---------~~~E~~~l~~l~h~---niv~  582 (814)
                      ++....+...+++-......|.+-..    ++...++|..+.......+.         ..+++..+.+++..   ....
T Consensus        27 ~i~~~~~~~~kv~k~~~r~~ValIei----~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~  102 (229)
T PF06176_consen   27 KILDNNYKIIKVFKNTKRNYVALIEI----DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPAD  102 (229)
T ss_pred             HHHhCCceEEEeecCCCccEEEEEEE----CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccc
Confidence            44445555556666666666666554    35778888776533222222         23344444444322   2222


Q ss_pred             eeeee-----cccccceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC
Q 041921          583 LLGFC-----DEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDY  657 (814)
Q Consensus       583 l~~~~-----~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~  657 (814)
                      ++.+.     .-....+|+|||++|..|.++..    ++.    .++..+++++.-||..   |+.|+|.+|.|++++++
T Consensus       103 ~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~  171 (229)
T PF06176_consen  103 PYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN  171 (229)
T ss_pred             ceeeeeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC
Confidence            22222     22344579999999988766531    111    3556677889999998   99999999999999965


Q ss_pred             CcEEEeecCCcc
Q 041921          658 YTARISDFGLAK  669 (814)
Q Consensus       658 ~~~kl~DfGla~  669 (814)
                       .++++||+..+
T Consensus       172 -~i~iID~~~k~  182 (229)
T PF06176_consen  172 -GIRIIDTQGKR  182 (229)
T ss_pred             -cEEEEECcccc
Confidence             59999998655

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.71  E-value=0.0003  Score=70.34  Aligned_cols=136  Identities=20%  Similarity=0.197  Sum_probs=88.9

Q ss_pred             ceeeeeeeeEEEEEEecCCCceEEEEEEeccccccch-------------------Hh-----HHHHHHhhhccC--CCC
Q 041921          526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE-------------------RE-----FKNEVFVIGQTH--HKN  579 (814)
Q Consensus       526 ~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~-------------------~~-----~~~E~~~l~~l~--h~n  579 (814)
                      .|+.|--+.||+|.-.   ++..+|||..+.......                   ++     ..+|+..|.++.  +-.
T Consensus        55 ~istGKEA~Vy~a~~~---~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr  131 (268)
T COG1718          55 CISTGKEANVYLAETG---DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR  131 (268)
T ss_pred             eecCCcceEEEeeccC---CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence            4777778889998753   578999998864221110                   11     245666666663  445


Q ss_pred             ccceeeeecccccceEEEecCCCCCHHH-HhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC
Q 041921          580 LVRLLGFCDEGQNRLLVYEFLNNGTLAS-FLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYY  658 (814)
Q Consensus       580 iv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~  658 (814)
                      +.+.+++.    +-.|||||+....+.. .|.+ ..+.......+..++++.+.-|-..  .+++|+||..-|||+. ++
T Consensus       132 vP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~--a~LVHgDLSEyNiL~~-~~  203 (268)
T COG1718         132 VPEPIAFR----NNVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKE--AGLVHGDLSEYNILVH-DG  203 (268)
T ss_pred             CCCceeec----CCeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHh--cCcccccchhhheEEE-CC
Confidence            55556554    3479999997642111 1111 1122224566677777777777652  2899999999999999 88


Q ss_pred             cEEEeecCCccccc
Q 041921          659 TARISDFGLAKLLT  672 (814)
Q Consensus       659 ~~kl~DfGla~~~~  672 (814)
                      .+.|+|++-+....
T Consensus       204 ~p~iID~~QaV~~~  217 (268)
T COG1718         204 EPYIIDVSQAVTID  217 (268)
T ss_pred             eEEEEECccccccC
Confidence            99999999876544

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=97.70  E-value=0.00022  Score=73.01  Aligned_cols=139  Identities=21%  Similarity=0.166  Sum_probs=82.3

Q ss_pred             cceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCC--Cccceeeeeccc---ccceEEEec
Q 041921          525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHK--NLVRLLGFCDEG---QNRLLVYEF  599 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~---~~~~lv~e~  599 (814)
                      +.|+.|..+.||+....    +..+++|.....  .....+..|..+++.+...  .+.+++.+....   ...+++|++
T Consensus         3 ~~l~~G~~n~~~~v~~~----~~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~   76 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTD----DGRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEY   76 (239)
T ss_dssp             EEEEESSSSEEEEEEET----TSEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEE
T ss_pred             ccCCCCCeeeEEEEEEC----CcEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEE
Confidence            46889999999998864    248889987543  3456788898888888543  356777654332   235799999


Q ss_pred             CCCCCHHH----------------Hhc---CC----CCCChhh---------HHHH------------HHHHHH-HHHHh
Q 041921          600 LNNGTLAS----------------FLF---GN----LKPNWNL---------RTNI------------AFQIAR-GLLYL  634 (814)
Q Consensus       600 ~~~gsL~~----------------~l~---~~----~~l~~~~---------~~~i------------~~~ia~-~l~yL  634 (814)
                      +++..+..                .+.   ..    ....+..         ....            ...+.+ .+..+
T Consensus        77 i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (239)
T PF01636_consen   77 IPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQEL  156 (239)
T ss_dssp             ESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHH
T ss_pred             eccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHH
Confidence            99988777                111   11    1111100         0000            111222 33333


Q ss_pred             hhc----CCCCeeecCCCCCcEEEc-CCCcEEEeecCCcc
Q 041921          635 HED----CRAQIIHCDIKPQNILLD-DYYTARISDFGLAK  669 (814)
Q Consensus       635 H~~----~~~~i~H~dlkp~NIll~-~~~~~kl~DfGla~  669 (814)
                      ++.    ....++|+|+.|.||+++ +++.+.|+||+.+.
T Consensus       157 ~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  157 EALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             HhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence            321    345799999999999999 66667899998765

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=97.66  E-value=6.6e-06  Score=90.98  Aligned_cols=182  Identities=17%  Similarity=0.135  Sum_probs=126.5

Q ss_pred             ccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCC-ccceeeeecccccceEEEecCCC
Q 041921          524 KEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKN-LVRLLGFCDEGQNRLLVYEFLNN  602 (814)
Q Consensus       524 ~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~~~  602 (814)
                      -+..++++++.++|..-.   ..+.+.++.+..     ..+..-++++|.+++||| .+..++-+..+....++++++..
T Consensus       247 fh~fvK~altknpKkRpt---aeklL~h~fvs~-----~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~  318 (829)
T KOG0576|consen  247 FHNFVKGALTKNPKKRPT---AEKLLQHPFVSQ-----TLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICST  318 (829)
T ss_pred             HHHHHHHHhcCCCccCCC---hhhheeceeecc-----chhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcC
Confidence            355788999999987632   122333333322     245677889999999999 66777777777788899999877


Q ss_pred             C-CHHHHh-cCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccccc
Q 041921          603 G-TLASFL-FGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIK  680 (814)
Q Consensus       603 g-sL~~~l-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  680 (814)
                      + +-..-. .....+...+...+.+.-.+++++||+.   .=+|+|    ||+..+ ...|..||+....+.+...   .
T Consensus       319 ~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~---~  387 (829)
T KOG0576|consen  319 GRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTMK---P  387 (829)
T ss_pred             CccccccCChhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCcccc---c
Confidence            6 211111 0111223334445666677899999976   447888    777665 5889999999887765431   1


Q ss_pred             ccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 041921          681 TAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFD  724 (814)
Q Consensus       681 ~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~  724 (814)
                      ....+++.++|||+.....+..+.|+|++|+-..++--|-.|-.
T Consensus       388 ~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  388 RTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             ccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence            44568999999999999999999999999987777766666643

>PLN02876 acyl-CoA dehydrogenase

Probab=97.57  E-value=0.00068  Score=82.63  Aligned_cols=80  Identities=13%  Similarity=0.227  Sum_probs=56.7

Q ss_pred             cceeeeeeeeEEEEEEecCCCceEEEEEEecccc-ccchHhHHHHHHhhhccC-CCCc--cceeeeeccc---ccceEEE
Q 041921          525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQTH-HKNL--VRLLGFCDEG---QNRLLVY  597 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-h~ni--v~l~~~~~~~---~~~~lv~  597 (814)
                      +.|+.|.+..+|+...........+++|+..... ......+.+|.++++.+. |.++  .+++.+|.+.   ...++||
T Consensus        44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVM  123 (822)
T PLN02876         44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIM  123 (822)
T ss_pred             EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEE
Confidence            5688999999999876532222467777764322 123456889999999995 6655  7888888764   4578999


Q ss_pred             ecCCCCC
Q 041921          598 EFLNNGT  604 (814)
Q Consensus       598 e~~~~gs  604 (814)
                      ||+++..
T Consensus       124 E~v~G~~  130 (822)
T PLN02876        124 EYLEGRI  130 (822)
T ss_pred             EecCCcc
Confidence            9998764

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.45  E-value=0.0012  Score=65.09  Aligned_cols=130  Identities=18%  Similarity=0.244  Sum_probs=89.4

Q ss_pred             cceeeeeeeeEEEEEEecCCCceEEEEEEecccc----------------ccchHhHHHHHHhhhccC------CCCccc
Q 041921          525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF----------------QDGEREFKNEVFVIGQTH------HKNLVR  582 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~----------------~~~~~~~~~E~~~l~~l~------h~niv~  582 (814)
                      ..||+|+.-.||.  ++   ......||......                ....++..+|+.....+.      +.+|.+
T Consensus         7 ~~i~~G~~R~cy~--HP---~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r   81 (199)
T PF10707_consen    7 DLIAQGGERDCYQ--HP---DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR   81 (199)
T ss_pred             cccccCCCceEEE--CC---CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence            4699999999994  44   34456777775543                122456666766555554      889999


Q ss_pred             eeeeecccccceEEEecCCC------CCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC
Q 041921          583 LLGFCDEGQNRLLVYEFLNN------GTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDD  656 (814)
Q Consensus       583 l~~~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~  656 (814)
                      ++|+..++...-+|+|.+.+      -+|.+++.+.. ++.    .+...+-+-..||-++   .|+.+|++|+||++..
T Consensus        82 ~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~-~~~----~~~~~L~~f~~~l~~~---~Iv~~dl~~~NIv~~~  153 (199)
T PF10707_consen   82 FYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG-LTE----ELRQALDEFKRYLLDH---HIVIRDLNPHNIVVQR  153 (199)
T ss_pred             EeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC-ccH----HHHHHHHHHHHHHHHc---CCeecCCCcccEEEEe
Confidence            99999999999999998643      36888885443 333    2333334455666666   8999999999999963


Q ss_pred             C--C--cEEEee-cCC
Q 041921          657 Y--Y--TARISD-FGL  667 (814)
Q Consensus       657 ~--~--~~kl~D-fGl  667 (814)
                      .  +  .+.|+| ||-
T Consensus       154 ~~~~~~~lvlIDG~G~  169 (199)
T PF10707_consen  154 RDSGEFRLVLIDGLGE  169 (199)
T ss_pred             cCCCceEEEEEeCCCC
Confidence            2  2  567776 443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.43  E-value=0.0011  Score=62.75  Aligned_cols=126  Identities=19%  Similarity=0.334  Sum_probs=84.3

Q ss_pred             cccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccc-eeeeecccccceEEEecCC
Q 041921          523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVR-LLGFCDEGQNRLLVYEFLN  601 (814)
Q Consensus       523 ~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~~~~lv~e~~~  601 (814)
                      ..+.|++|.+|.||+|.+.    +..+|+|.-+..  .....+..|.++|..++-.++-+ ++.|..+    .+.|||+.
T Consensus        26 v~~~L~KG~~s~Vyl~~~~----~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~   95 (201)
T COG2112          26 VEKELAKGTTSVVYLGEWR----GGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYID   95 (201)
T ss_pred             hhhhhhcccccEEEEeecc----CceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhc
Confidence            3467999999999999985    558888877643  34567999999999998776654 4444332    34499998


Q ss_pred             CCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCC-C-cEEEcCCCcEEEeecCCcc
Q 041921          602 NGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKP-Q-NILLDDYYTARISDFGLAK  669 (814)
Q Consensus       602 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp-~-NIll~~~~~~kl~DfGla~  669 (814)
                      +-.|.+.-...   +    .+-...+++.---|..   .+|-|+.|.- . ||++.+. .+.|+||.-|.
T Consensus        96 G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~---~GI~H~El~~~~k~vlv~~~-~~~iIDFd~At  154 (201)
T COG2112          96 GRPLGKLEIGG---D----RKHLLRVLEKAYKLDR---LGIEHGELSRPWKNVLVNDR-DVYIIDFDSAT  154 (201)
T ss_pred             Ccchhhhhhcc---c----HHHHHHHHHHHHHHHH---hccchhhhcCCceeEEecCC-cEEEEEccchh
Confidence            88887654321   1    1222333444222332   3888888764 4 5555544 99999999876

>PRK10593 hypothetical protein; Provisional

Probab=97.34  E-value=0.0025  Score=67.76  Aligned_cols=75  Identities=8%  Similarity=0.048  Sum_probs=53.6

Q ss_pred             cceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCC---CCccceeeeecc---cccceEEEe
Q 041921          525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHH---KNLVRLLGFCDE---GQNRLLVYE  598 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~---~~~~~lv~e  598 (814)
                      +.||.|..+.||+....   ++ .+.+|..+.  ......+..|.+.++.+.-   ..+.++++++..   .+..+||||
T Consensus        20 ~~i~~G~~~~vy~~~~~---~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE   93 (297)
T PRK10593         20 ECISEQPYAALWALYDS---QG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE   93 (297)
T ss_pred             eecCCccceeEEEEEcC---CC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence            46999999999987643   22 455565432  1123578999999988843   468888988754   356899999


Q ss_pred             cCCCCCH
Q 041921          599 FLNNGTL  605 (814)
Q Consensus       599 ~~~~gsL  605 (814)
                      ++++.++
T Consensus        94 ~i~G~~~  100 (297)
T PRK10593         94 RLRGVSV  100 (297)
T ss_pred             ccCCEec
Confidence            9998654

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.25  E-value=0.002  Score=66.16  Aligned_cols=73  Identities=16%  Similarity=0.178  Sum_probs=44.0

Q ss_pred             cceeeeeee-eEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCC---Cccceeeeecccc---cceEEE
Q 041921          525 EEVGRGSFG-IVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHK---NLVRLLGFCDEGQ---NRLLVY  597 (814)
Q Consensus       525 ~~LG~G~~g-~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~---~~~lv~  597 (814)
                      +.|+.|+.. .||+..       ..+++|..+.  ......+..|.+++..+...   .+.++++.....+   ..+++|
T Consensus         3 ~~~~~gG~~n~vy~~~-------~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~   73 (235)
T cd05155           3 EPVDSGGTDNATFRLG-------DDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVY   73 (235)
T ss_pred             eeccCCCcccceEEcC-------CceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEE
Confidence            346666665 488641       1355665443  22345788999999887532   3445555443322   347899


Q ss_pred             ecCCCCCHH
Q 041921          598 EFLNNGTLA  606 (814)
Q Consensus       598 e~~~~gsL~  606 (814)
                      |++++.++.
T Consensus        74 ~~i~G~~l~   82 (235)
T cd05155          74 RWLEGETAT   82 (235)
T ss_pred             EeecCCCCC
Confidence            999986653

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins

Probab=97.10  E-value=0.00041  Score=56.61  Aligned_cols=48  Identities=23%  Similarity=0.488  Sum_probs=37.3

Q ss_pred             EeecCCCCCCcccccCccChhhHHHhhcCCCcccccccC--CCceeeecc
Q 041921          369 ELKNINWPQSDYERFKPYNEVQCKNTCLSDCFCAAVIFN--DGSCWFKKL  416 (814)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~s~~~C~~~Cl~~CsC~a~~~~--~~~c~~~~~  416 (814)
                      .+++++++..+.......+.++|+..|+.+|+|.||.|.  .+.|+++..
T Consensus         8 ~~~~~~~~g~d~~~~~~~s~~~Cq~~C~~~~~C~afT~~~~~~~C~lk~~   57 (73)
T cd01100           8 QGSNVDFRGGDLSTVFASSAEQCQAACTADPGCLAFTYNTKSKKCFLKSS   57 (73)
T ss_pred             ccCCCccccCCcceeecCCHHHHHHHcCCCCCceEEEEECCCCeEEcccC
Confidence            335667776666544567899999999999999999985  467998865

PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.08  E-value=0.0016  Score=77.49  Aligned_cols=196  Identities=19%  Similarity=0.148  Sum_probs=135.1

Q ss_pred             HHHHHHhhhccCCCCccceeeeecccccc----eEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCC
Q 041921          565 FKNEVFVIGQTHHKNLVRLLGFCDEGQNR----LLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRA  640 (814)
Q Consensus       565 ~~~E~~~l~~l~h~niv~l~~~~~~~~~~----~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~  640 (814)
                      ...|+..+.++.|+|++.+++|-.+....    .+..|++..-++...+..-...+....+.+..++.+||+|+|+.   
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~---  305 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSL---  305 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHh---
Confidence            45577778888999999999998664432    34567888889999998888889999999999999999999987   


Q ss_pred             CeeecCCCCC---cEEEcCCCcEEEe--ecCCccccccCCcccccccccCCCCcccccccccCCCC--cchhhHHHHHHH
Q 041921          641 QIIHCDIKPQ---NILLDDYYTARIS--DFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKIT--AKVDVYSFGVLL  713 (814)
Q Consensus       641 ~i~H~dlkp~---NIll~~~~~~kl~--DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s--~~~Dv~s~Gvvl  713 (814)
                      ...|.-+..+   +...+..+.+.++  ||+.++.+......   ....-+..+.+||........  ...|+|.+|..+
T Consensus       306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~  382 (1351)
T KOG1035|consen  306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL  382 (1351)
T ss_pred             ccceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence            4444444444   4445566667766  88877765432221   112234557788877655444  457999999999


Q ss_pred             HHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 041921          714 LEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQML  792 (814)
Q Consensus       714 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L  792 (814)
                      ..+..|..+-.....                  +..+.+.        .....+.+....|+..++++|++..+++...
T Consensus       383 ~~~~~~~~i~~~~~~------------------~~~~l~~--------~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~  435 (1351)
T KOG1035|consen  383 LQLSQGEDISEKSAV------------------PVSLLDV--------LSTSELLDALPKCLDEDSEERLSALELLTHP  435 (1351)
T ss_pred             hhhhhcCcccccccc------------------hhhhhcc--------ccchhhhhhhhhhcchhhhhccchhhhhhch
Confidence            999887655321100                  0000000        0111456677789999999999999998765

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.04  E-value=0.024  Score=62.21  Aligned_cols=75  Identities=15%  Similarity=0.131  Sum_probs=51.9

Q ss_pred             cceeeeeeeeEEEEEEecCCCceEEEEEEecccc-------ccchHhHHHHHHhhhccC---CCCccceeeeecccccce
Q 041921          525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF-------QDGEREFKNEVFVIGQTH---HKNLVRLLGFCDEGQNRL  594 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-------~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~  594 (814)
                      +.||.|.+..||++...+  +++.|+||.-....       ....+.+..|.+.|..+.   -.++++++.+.  .+..+
T Consensus        32 ~elggGn~N~VyrV~~~~--g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~  107 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTE--GGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAV  107 (401)
T ss_pred             eEcCCCceEEEEEEEeCC--CCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCE
Confidence            579999999999998752  22589999854211       123455677888877762   24567777773  35678


Q ss_pred             EEEecCCCC
Q 041921          595 LVYEFLNNG  603 (814)
Q Consensus       595 lv~e~~~~g  603 (814)
                      +|||++++.
T Consensus       108 lVME~L~~~  116 (401)
T PRK09550        108 TVMEDLSDH  116 (401)
T ss_pred             EEEecCCCc
Confidence            999999864

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=96.97  E-value=0.0058  Score=59.88  Aligned_cols=133  Identities=28%  Similarity=0.373  Sum_probs=92.1

Q ss_pred             ccccCHHHHHHhhhccccceeeeee-eeEEEEEEecCCCceEEEEEEeccc-----------cc----------cchHhH
Q 041921          508 LRCFSYKELEGATNNFKEEVGRGSF-GIVYKGVIQTRTSTTAVAVKKLDRV-----------FQ----------DGEREF  565 (814)
Q Consensus       508 ~~~~~~~~l~~~~~~~~~~LG~G~~-g~Vy~~~~~~~~~~~~vavK~l~~~-----------~~----------~~~~~~  565 (814)
                      +..|+..   ....+|-+.||+|.- |.|||+.+.    +..+|+|.++..           ..          .-...|
T Consensus        29 L~~F~~h---~~~I~flefLg~g~~~~~V~kv~I~----g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF  101 (207)
T PF13095_consen   29 LEPFTHH---GDDIEFLEFLGHGSHDGYVFKVEID----GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPF  101 (207)
T ss_pred             cCCcCCC---CCcEeeeeecCCCCceeEEEEEEEC----CeEEEEEEeeccccCCCccccccccccccccchhhhhcChH
Confidence            4455552   267778899999999 999999985    679999993210           00          011248


Q ss_pred             HHHHHhhhccC---CCCc--cceeeeeccc------------------ccceEEEecCCCCCHHHHhcCCCCCChhhHHH
Q 041921          566 KNEVFVIGQTH---HKNL--VRLLGFCDEG------------------QNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN  622 (814)
Q Consensus       566 ~~E~~~l~~l~---h~ni--v~l~~~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~  622 (814)
                      ..|.+...+++   +.++  |+.+||..-.                  ..+.||.||.+...             ....+
T Consensus       102 ~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~~  168 (207)
T PF13095_consen  102 NCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQIR  168 (207)
T ss_pred             HHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccchh
Confidence            89999988885   4466  8888887321                  01246777765533             12233


Q ss_pred             HHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCc
Q 041921          623 IAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLA  668 (814)
Q Consensus       623 i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla  668 (814)
                      =+.+|.+-+..+|..   +|+-+|+++.|..     .-||+|||.+
T Consensus       169 ~~~~~~~dl~~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  169 DIPQMLRDLKILHKL---GIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHHHHHHHHHHHC---CeeeccCcccccc-----CCEEEecccC
Confidence            455677778889988   9999999999985     4589999854

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=96.96  E-value=0.006  Score=62.59  Aligned_cols=75  Identities=19%  Similarity=0.172  Sum_probs=45.3

Q ss_pred             cceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCc-cceeeeecccccceEEEecCCCC
Q 041921          525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNL-VRLLGFCDEGQNRLLVYEFLNNG  603 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g  603 (814)
                      +.|..|-...+|+....+. .+..+++|..... .........|+.++..+....+ +++++...    ..+||||+++.
T Consensus         4 ~~l~gG~tN~~~~v~~~~~-~~~~~vlR~~~~~-~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~   77 (235)
T cd05157           4 KRFTGGITNKLVKVSNKED-NQDAVLVRVYGNK-TELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGR   77 (235)
T ss_pred             EEcCCcccceEEEEEcCCC-CCCeEEEEEccCC-ccceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCC
Confidence            3566777889998864310 1457788866532 1112233578888888854444 44444332    24899999986


Q ss_pred             CH
Q 041921          604 TL  605 (814)
Q Consensus       604 sL  605 (814)
                      ++
T Consensus        78 ~l   79 (235)
T cd05157          78 TL   79 (235)
T ss_pred             cC
Confidence            65

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02721 ycfN_thiK thiamine kinase

Probab=96.96  E-value=0.0047  Score=64.34  Aligned_cols=135  Identities=12%  Similarity=0.092  Sum_probs=76.3

Q ss_pred             eeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCc-cceeeeecccccceEEEecCCCCCH
Q 041921          527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNL-VRLLGFCDEGQNRLLVYEFLNNGTL  605 (814)
Q Consensus       527 LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gsL  605 (814)
                      +..|-...+|+...    ++..+++|........-.-....|..+++.+....+ .+++..+.    ..+|+||+++..+
T Consensus         4 ~~~G~tn~~y~~~~----~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~   75 (256)
T TIGR02721         4 LSGGLTNRSWRIEH----PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVI   75 (256)
T ss_pred             CCCcCcCCeEEEEe----CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccc
Confidence            45577788998763    355777886543222111245778888888864434 34454432    3689999998665


Q ss_pred             HHH-----------------hcCCCC----CChhhH-HHHHHH---------HHHHHHHhhhc-----CCCCeeecCCCC
Q 041921          606 ASF-----------------LFGNLK----PNWNLR-TNIAFQ---------IARGLLYLHED-----CRAQIIHCDIKP  649 (814)
Q Consensus       606 ~~~-----------------l~~~~~----l~~~~~-~~i~~~---------ia~~l~yLH~~-----~~~~i~H~dlkp  649 (814)
                      ...                 ||....    ++...+ .....+         +.+.+..+...     ....++|+|+.|
T Consensus        76 ~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~  155 (256)
T TIGR02721        76 TLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHA  155 (256)
T ss_pred             ccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCc
Confidence            321                 121111    111111 111111         11112222111     134689999999


Q ss_pred             CcEEEcCCCcEEEeecCCccc
Q 041921          650 QNILLDDYYTARISDFGLAKL  670 (814)
Q Consensus       650 ~NIll~~~~~~kl~DfGla~~  670 (814)
                      .||++++++ +.|+||..+..
T Consensus       156 ~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       156 YNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             CcEEEeCCC-CEEEeccccCc
Confidence            999999876 78999987753

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=96.77  E-value=0.005  Score=65.66  Aligned_cols=138  Identities=17%  Similarity=0.157  Sum_probs=82.5

Q ss_pred             cceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCC--ccceeeee------cccccceEE
Q 041921          525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKN--LVRLLGFC------DEGQNRLLV  596 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~------~~~~~~~lv  596 (814)
                      +.|..|....+|+....    +..+++|....   ....++..|++++..+++..  +.+++...      ..++..++|
T Consensus        20 ~~i~~G~~n~~y~v~~~----~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l   92 (296)
T cd05153          20 EGISAGIENTNYFVTTD----SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAAL   92 (296)
T ss_pred             ecccCccccceEEEEeC----CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEE
Confidence            35777877889987643    33678887754   23445677888887775432  44554421      223456899


Q ss_pred             EecCCCCCHHH----H----------hcC----CC-------CCChhhHH----------HHHHHHHHHHHHhhh----c
Q 041921          597 YEFLNNGTLAS----F----------LFG----NL-------KPNWNLRT----------NIAFQIARGLLYLHE----D  637 (814)
Q Consensus       597 ~e~~~~gsL~~----~----------l~~----~~-------~l~~~~~~----------~i~~~ia~~l~yLH~----~  637 (814)
                      ++++++..+..    .          |+.    ..       ...|....          .....+..++.++..    .
T Consensus        93 ~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~  172 (296)
T cd05153          93 VEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSD  172 (296)
T ss_pred             EEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhc
Confidence            99998866422    0          110    00       01222111          111223344555543    2


Q ss_pred             CCCCeeecCCCCCcEEEcCCCcEEEeecCCcc
Q 041921          638 CRAQIIHCDIKPQNILLDDYYTARISDFGLAK  669 (814)
Q Consensus       638 ~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~  669 (814)
                      ...+++|+|+.|.||+++++..+.|.||+.+.
T Consensus       173 ~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         173 LPRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            23479999999999999998777899998765

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.47  E-value=0.02  Score=60.10  Aligned_cols=31  Identities=29%  Similarity=0.542  Sum_probs=25.7

Q ss_pred             CCeeecCCCCCcEEEcCCCc-EEEeecCCccc
Q 041921          640 AQIIHCDIKPQNILLDDYYT-ARISDFGLAKL  670 (814)
Q Consensus       640 ~~i~H~dlkp~NIll~~~~~-~kl~DfGla~~  670 (814)
                      +.++|+|+++.||+++++++ .-|.||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            45899999999999997555 46999998754

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=96.45  E-value=0.017  Score=61.80  Aligned_cols=140  Identities=22%  Similarity=0.280  Sum_probs=80.1

Q ss_pred             ceeeeeeeeEEEEEEecC----CCceEEEEEEeccccccchHhHHHHHHhhhccCCCCc-cceeeeecccccceEEEecC
Q 041921          526 EVGRGSFGIVYKGVIQTR----TSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNL-VRLLGFCDEGQNRLLVYEFL  600 (814)
Q Consensus       526 ~LG~G~~g~Vy~~~~~~~----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~  600 (814)
                      .|..|--..+|+......    ..+..+++|...... ....+...|.+++..+....+ .++++++..    .+|+||+
T Consensus         5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i   79 (302)
T cd05156           5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFI   79 (302)
T ss_pred             EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhee
Confidence            455566678888875421    124678888765432 233456778888888754333 355555532    3589998


Q ss_pred             CCCCHHHH-----------------hcCCC-CC--------C--hhhHHH--------------------------HHHH
Q 041921          601 NNGTLASF-----------------LFGNL-KP--------N--WNLRTN--------------------------IAFQ  626 (814)
Q Consensus       601 ~~gsL~~~-----------------l~~~~-~l--------~--~~~~~~--------------------------i~~~  626 (814)
                      ++..+...                 ||... ..        +  |.....                          +...
T Consensus        80 ~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (302)
T cd05156          80 PSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLED  159 (302)
T ss_pred             CCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHH
Confidence            88665331                 11110 00        0  111100                          1112


Q ss_pred             HHHHHHHhhh------cCCCCeeecCCCCCcEEEcCC----CcEEEeecCCccc
Q 041921          627 IARGLLYLHE------DCRAQIIHCDIKPQNILLDDY----YTARISDFGLAKL  670 (814)
Q Consensus       627 ia~~l~yLH~------~~~~~i~H~dlkp~NIll~~~----~~~kl~DfGla~~  670 (814)
                      +...+..|..      .....++|+|+.+.||+++++    +.++++||..+..
T Consensus       160 ~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~  213 (302)
T cd05156         160 EAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY  213 (302)
T ss_pred             HHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence            2223334432      234578999999999999974    8899999988753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=95.61  E-value=0.068  Score=56.27  Aligned_cols=135  Identities=20%  Similarity=0.257  Sum_probs=70.5

Q ss_pred             cceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccC---CCCccceeeeecccccceEEEecCC
Q 041921          525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTH---HKNLVRLLGFCDEGQNRLLVYEFLN  601 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~  601 (814)
                      +.|+.|....+|+..    .++..+.||.-..   .....|..|.+-|+.+.   --.+++++++....+..+||+||++
T Consensus        23 ~~v~GG~i~~a~~~~----~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~   95 (288)
T PF03881_consen   23 EPVSGGDINEAYRLD----TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE   95 (288)
T ss_dssp             EEE--SSSSEEEEEE----TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred             EecCCCChhheEEEE----CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence            458888889999866    2567888888752   23456888888777773   4567889998877778899999998


Q ss_pred             CCC--------HHH---HhcC-C--CC-------------------CChhh-----HHHHH--------------HHHHH
Q 041921          602 NGT--------LAS---FLFG-N--LK-------------------PNWNL-----RTNIA--------------FQIAR  629 (814)
Q Consensus       602 ~gs--------L~~---~l~~-~--~~-------------------l~~~~-----~~~i~--------------~~ia~  629 (814)
                      .+.        |..   .|+. .  ..                   -+|..     |+.-.              .++.+
T Consensus        96 ~~~~~~~~~~~lg~~LA~LH~~~~~~~FGf~~~~~~G~~~q~N~w~~~W~~Ff~~~RL~~~l~~~~~~~~~~~~~~~l~~  175 (288)
T PF03881_consen   96 MGSPSPPDWEELGRQLAALHQWSPAGKFGFPVDTYIGSLPQPNTWTDSWEEFFAEQRLRPQLELAREKGGLDAELERLVE  175 (288)
T ss_dssp             -----CCHHHHHHHHHHHHHH-T--SSBB-SS-EEETTEEE----BS-HHHHHHHHCCHHHHHHHHHCTSS-CHHHHHHH
T ss_pred             CCCCCchhHHHHHHHHHHHhhhcCCCCcCCCcCCcccCcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCchhHHHHHHH
Confidence            761        111   1122 1  10                   12221     11111              11222


Q ss_pred             HHH-Hhhh-cCCCCeeecCCCCCcEEEcCCCcEEEeecC
Q 041921          630 GLL-YLHE-DCRAQIIHCDIKPQNILLDDYYTARISDFG  666 (814)
Q Consensus       630 ~l~-yLH~-~~~~~i~H~dlkp~NIll~~~~~~kl~DfG  666 (814)
                      .+. .|+. ...+.++|+||.+.|++++.++.+.|.|=.
T Consensus       176 ~~~~~l~~~~~~PsLlHGDLW~GN~~~~~~g~p~l~DPa  214 (288)
T PF03881_consen  176 RLPSLLPGREPKPSLLHGDLWSGNVGFDADGEPVLFDPA  214 (288)
T ss_dssp             HHHHCCTTS----EEE-SS-SGGGEEEETTE-EEE-S--
T ss_pred             HHHHHhcCCCCCceeeEcCccccceeecCCCCceeeccc
Confidence            221 1221 235679999999999999999989998844

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PLN02236 choline kinase

Probab=95.51  E-value=0.094  Score=57.06  Aligned_cols=139  Identities=19%  Similarity=0.183  Sum_probs=78.9

Q ss_pred             eeeeeeeeEEEEEEecCC--CceEEEEEEeccccccchHhHHHHHHhhhccCCCCcc-ceeeeecccccceEEEecCCCC
Q 041921          527 VGRGSFGIVYKGVIQTRT--STTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLV-RLLGFCDEGQNRLLVYEFLNNG  603 (814)
Q Consensus       527 LG~G~~g~Vy~~~~~~~~--~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~g  603 (814)
                      |-.|-.-.+|+.......  .+..+++|....... ..-.-..|..++..+...++- ++++++..+    .|+||+++.
T Consensus        44 l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~-~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g~  118 (344)
T PLN02236         44 LKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE-LFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHAR  118 (344)
T ss_pred             cCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC-eeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCCC
Confidence            444667788887654221  235788887754322 222336788888888654444 556665432    579998776


Q ss_pred             CHHHH-----------------hcCCC------CCChhhHHHHHHH-----------------HHHHHHHhh----h-cC
Q 041921          604 TLASF-----------------LFGNL------KPNWNLRTNIAFQ-----------------IARGLLYLH----E-DC  638 (814)
Q Consensus       604 sL~~~-----------------l~~~~------~l~~~~~~~i~~~-----------------ia~~l~yLH----~-~~  638 (814)
                      +|..-                 +|...      ...|....++..+                 +...+..|.    . ..
T Consensus       119 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~  198 (344)
T PLN02236        119 TLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQ  198 (344)
T ss_pred             CCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCC
Confidence            65321                 12111      0112222222211                 111222222    1 22


Q ss_pred             CCCeeecCCCCCcEEEcC-CCcEEEeecCCccc
Q 041921          639 RAQIIHCDIKPQNILLDD-YYTARISDFGLAKL  670 (814)
Q Consensus       639 ~~~i~H~dlkp~NIll~~-~~~~kl~DfGla~~  670 (814)
                      ...++|+|+++.||++++ +..+.++||..+..
T Consensus       199 ~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        199 EIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             CceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            346899999999999986 46899999988764

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=95.49  E-value=0.14  Score=54.80  Aligned_cols=138  Identities=15%  Similarity=0.202  Sum_probs=78.4

Q ss_pred             ceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCC--Cccceeeee------cccccceEEE
Q 041921          526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHK--NLVRLLGFC------DEGQNRLLVY  597 (814)
Q Consensus       526 ~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~------~~~~~~~lv~  597 (814)
                      .++.|.-..+|+....   ++ ..++|..+..  ....+...|++++..+...  .+++++...      ...+..++++
T Consensus        29 ~~~~G~~n~~y~v~t~---~~-~~vLK~~~~~--~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~  102 (307)
T TIGR00938        29 GIAEGVENSNYLLTTD---VG-RYILTLYEKR--VKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV  102 (307)
T ss_pred             ccCCccccceEEEEeC---CC-cEEEEEecCC--CCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence            4677777889987643   23 4667766432  1234556667777666432  244444422      1234568999


Q ss_pred             ecCCCCCHH-----------HH---hcCC-C-----------CCChhhHH------------HHHHHHHHHHHHhhh---
Q 041921          598 EFLNNGTLA-----------SF---LFGN-L-----------KPNWNLRT------------NIAFQIARGLLYLHE---  636 (814)
Q Consensus       598 e~~~~gsL~-----------~~---l~~~-~-----------~l~~~~~~------------~i~~~ia~~l~yLH~---  636 (814)
                      ||++|..+.           ..   ++.. .           ...|....            .....+.+.+.++..   
T Consensus       103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~  182 (307)
T TIGR00938       103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP  182 (307)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence            999875431           11   1110 0           01121110            011123344555532   


Q ss_pred             -cCCCCeeecCCCCCcEEEcCCCcEEEeecCCcc
Q 041921          637 -DCRAQIIHCDIKPQNILLDDYYTARISDFGLAK  669 (814)
Q Consensus       637 -~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~  669 (814)
                       ....+++|+|+++.||++++++...|+||+.+.
T Consensus       183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             hcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence             234589999999999999988777899998764

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=95.37  E-value=0.013  Score=60.70  Aligned_cols=132  Identities=13%  Similarity=0.106  Sum_probs=85.9

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEeccc--c-----cc---------------chHhHHHHHHhhhccCC-
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV--F-----QD---------------GEREFKNEVFVIGQTHH-  577 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~-----~~---------------~~~~~~~E~~~l~~l~h-  577 (814)
                      +.+++.||-|-=+-+|.+...   .+.+.++|.-+-.  +     ..               ..-...+|...|+.+.. 
T Consensus        94 ~svGnqIGVGKESDIY~v~d~---~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~  170 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADE---EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYER  170 (465)
T ss_pred             hhhccccccccccceEEEecC---CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHc
Confidence            456789999999999999865   4666766633210  0     00               01124677778877743 


Q ss_pred             -CCccceeeeecccccceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC
Q 041921          578 -KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDD  656 (814)
Q Consensus       578 -~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~  656 (814)
                       --+++.+++    +..++|||++.+-.|...-+-   .+...   +...+..-+.-|-.+   |+||+|+.-=||++++
T Consensus       171 gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v---~d~~~---ly~~lm~~Iv~la~~---GlIHgDFNEFNimv~d  237 (465)
T KOG2268|consen  171 GFPVPKPIDH----NRHCVVMELVDGYPLRQVRHV---EDPPT---LYDDLMGLIVRLANH---GLIHGDFNEFNIMVKD  237 (465)
T ss_pred             CCCCCCcccc----cceeeHHHhhcccceeeeeec---CChHH---HHHHHHHHHHHHHHc---CceecccchheeEEec
Confidence             234555544    355899999988777654321   12222   223333334444444   9999999999999999


Q ss_pred             CCcEEEeecCCc
Q 041921          657 YYTARISDFGLA  668 (814)
Q Consensus       657 ~~~~kl~DfGla  668 (814)
                      ++.++++||--.
T Consensus       238 d~~i~vIDFPQm  249 (465)
T KOG2268|consen  238 DDKIVVIDFPQM  249 (465)
T ss_pred             CCCEEEeechHh
Confidence            999999999643

>PRK05231 homoserine kinase; Provisional

Probab=95.34  E-value=0.2  Score=53.96  Aligned_cols=31  Identities=26%  Similarity=0.364  Sum_probs=26.5

Q ss_pred             CCCeeecCCCCCcEEEcCCCcEEEeecCCcc
Q 041921          639 RAQIIHCDIKPQNILLDDYYTARISDFGLAK  669 (814)
Q Consensus       639 ~~~i~H~dlkp~NIll~~~~~~kl~DfGla~  669 (814)
                      ..+++|+|++|.||+++++...-|+||+.+.
T Consensus       186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             CcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            4589999999999999977556899999875

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.31  E-value=0.057  Score=53.09  Aligned_cols=139  Identities=19%  Similarity=0.234  Sum_probs=86.6

Q ss_pred             eEEEEEEecccccc-chHhHHHHHHhhhccCCCCccceeeeecccccceEEEecCCCCCHHHHhcCCCCCChhhHHHHHH
Q 041921          547 TAVAVKKLDRVFQD-GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF  625 (814)
Q Consensus       547 ~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~  625 (814)
                      .+..+|+++...-. ...-|.++..++++++  .|+++..  .+....-++.|+|..-.            ... ..++.
T Consensus        86 G~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~N--Dn~~~yGvIlE~Cy~~~------------i~~-~N~i~  148 (308)
T PF07387_consen   86 GPLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKN--DNNYKYGVILERCYKIK------------INF-SNFIT  148 (308)
T ss_pred             chhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeec--CCCceeEEEEeeccCcc------------cch-hHHHH
Confidence            46777888654443 4456788888888875  3555552  13334558888874311            111 11222


Q ss_pred             HHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcccccccccCCCCcccccccccCCCCcchh
Q 041921          626 QIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVD  705 (814)
Q Consensus       626 ~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~D  705 (814)
                      .-+++|.-.|+. +.+.+|+|..|+||+-|..|.+||.|-+....              .+.-|.--|+   ...+.++.
T Consensus       149 agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~--------------~~V~~vN~~Y---~~lT~~aE  210 (308)
T PF07387_consen  149 AGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE--------------NQVNMVNIEY---ESLTQEAE  210 (308)
T ss_pred             HhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhhh--------------heeeEEeeec---cccChHHH
Confidence            224677888864 45899999999999999999999999764321              0011111111   23467788


Q ss_pred             hHHHHHHHHHHHhCC
Q 041921          706 VYSFGVLLLEIISCR  720 (814)
Q Consensus       706 v~s~Gvvl~elltg~  720 (814)
                      +=+|=.-+++++...
T Consensus       211 ~~~fv~s~l~~v~~~  225 (308)
T PF07387_consen  211 VKVFVKSCLKLVEKQ  225 (308)
T ss_pred             HHHHHHHHHHHHHHH
Confidence            888877788877644

The function of this family is unknown.

>PLN02756 S-methyl-5-thioribose kinase

Probab=95.29  E-value=0.21  Score=54.83  Aligned_cols=73  Identities=16%  Similarity=0.205  Sum_probs=48.3

Q ss_pred             ccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc-------cchHhHHHHHHhhhccC---CCCccceeeeecccccc
Q 041921          524 KEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ-------DGEREFKNEVFVIGQTH---HKNLVRLLGFCDEGQNR  593 (814)
Q Consensus       524 ~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~-------~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~  593 (814)
                      .+.||.|....||+....    +..++||+-.....       .....-..|.+.|+.+.   ..++++++.++.  +..
T Consensus        37 ~~eiggGn~N~VyrV~~~----~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~  110 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS----SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMA  110 (418)
T ss_pred             EEEcCCCceeeEEEEEcC----CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCC
Confidence            357899999999997642    34688997752111       12233344566665553   247888888887  456


Q ss_pred             eEEEecCCC
Q 041921          594 LLVYEFLNN  602 (814)
Q Consensus       594 ~lv~e~~~~  602 (814)
                      +++||++++
T Consensus       111 vlvME~L~~  119 (418)
T PLN02756        111 LIGMRYLEP  119 (418)
T ss_pred             EEEEeecCC
Confidence            788999966

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=95.15  E-value=0.17  Score=53.65  Aligned_cols=127  Identities=20%  Similarity=0.277  Sum_probs=73.6

Q ss_pred             ceEEEEEEecc--ccccchHhHHHHHHhhhccCC--CCccceeeeecccc--cceEEEecCCCCCHH-------------
Q 041921          546 TTAVAVKKLDR--VFQDGEREFKNEVFVIGQTHH--KNLVRLLGFCDEGQ--NRLLVYEFLNNGTLA-------------  606 (814)
Q Consensus       546 ~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~--~~~lv~e~~~~gsL~-------------  606 (814)
                      +++.++. ...  ..........+|..+|+.+.-  .-+...++.|.++.  ..+.||+|.++..+.             
T Consensus        48 ~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~~  126 (321)
T COG3173          48 GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQFA  126 (321)
T ss_pred             CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchHHHH
Confidence            4556666 321  122233456778888877743  34556677787766  678999999873222             


Q ss_pred             -----HHhc---CC--------CC---------CChhhHHHH--------HHHHHHHHHHhhhcC-----CCCeeecCCC
Q 041921          607 -----SFLF---GN--------LK---------PNWNLRTNI--------AFQIARGLLYLHEDC-----RAQIIHCDIK  648 (814)
Q Consensus       607 -----~~l~---~~--------~~---------l~~~~~~~i--------~~~ia~~l~yLH~~~-----~~~i~H~dlk  648 (814)
                           ++|.   .-        ..         -.|...++.        +-....-..+|+++.     .+.++|+|++
T Consensus       127 ~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~  206 (321)
T COG3173         127 LDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYR  206 (321)
T ss_pred             HHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcc
Confidence                 1111   00        00         011111110        011222334444332     3469999999


Q ss_pred             CCcEEEcCCCcEEEeecCCcccccc
Q 041921          649 PQNILLDDYYTARISDFGLAKLLTL  673 (814)
Q Consensus       649 p~NIll~~~~~~kl~DfGla~~~~~  673 (814)
                      +.||++++...+-|.||+++.+-.+
T Consensus       207 ~gNlii~~~~~~gVlDwe~~~lGDP  231 (321)
T COG3173         207 PGNLIIDPGRPTGVLDWELATLGDP  231 (321)
T ss_pred             cCCEEEeCCCeeEEEeccccccCCc
Confidence            9999999988899999999876543

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=94.97  E-value=0.011  Score=72.22  Aligned_cols=156  Identities=12%  Similarity=-0.033  Sum_probs=108.0

Q ss_pred             HHHHHhhhccCCCCccceeeee--cccccceEEEecCCCCCHHHHhcCC----CCCChhhHHHHHHHHHHHHHHhhhcC-
Q 041921          566 KNEVFVIGQTHHKNLVRLLGFC--DEGQNRLLVYEFLNNGTLASFLFGN----LKPNWNLRTNIAFQIARGLLYLHEDC-  638 (814)
Q Consensus       566 ~~E~~~l~~l~h~niv~l~~~~--~~~~~~~lv~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~~l~yLH~~~-  638 (814)
                      ..|...++..+|+++.....-.  .+..+.+.+++|+..|.+.+.|...    ..++.........+......-+|+.. 
T Consensus      1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred             hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence            3444455566788776554433  2345678899999999999988643    22333333333333344444545432 


Q ss_pred             -CCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHH
Q 041921          639 -RAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEII  717 (814)
Q Consensus       639 -~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ell  717 (814)
                       ..-.+|+++|+-|.++..+.++|+.++|+.+...+...  ......+++-|+.|+....-+++.++|+|..++.+++..
T Consensus      1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~s--f~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLS--FFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred             CCccchhhhhhhhccceecCCcccccccccccccCchHh--hhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence             23468999999999999999999999999984333221  113445777899999988888999999999999999988


Q ss_pred             hCCCCC
Q 041921          718 SCRKSF  723 (814)
Q Consensus       718 tg~~p~  723 (814)
                      -|..+|
T Consensus      1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred             cccHHH
Confidence            777665

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=94.92  E-value=0.067  Score=57.38  Aligned_cols=60  Identities=22%  Similarity=0.277  Sum_probs=42.0

Q ss_pred             ceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc
Q 041921          593 RLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLD  655 (814)
Q Consensus       593 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~  655 (814)
                      ..|+=+|+++-++..++.....+ ++.+.+++.-.++|+.-+-..  .+.+|.|++|.||++.
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~~~~p-e~l~kkva~lg~~AllkMl~v--DNFvHaDlHPGNVlir  379 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKWKSQP-EALVKKVAKLGVNALLKMLIV--DNFVHADLHPGNVLIR  379 (565)
T ss_pred             ceeeeeccccccHHhhhhcccCh-HHHHHHHHHHHHHHHHHHHHh--hcceecccCCCcEEEE
Confidence            45667788899999888765433 355566666555655443322  2799999999999995

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=94.48  E-value=0.11  Score=52.12  Aligned_cols=30  Identities=30%  Similarity=0.489  Sum_probs=21.4

Q ss_pred             CeeecCCCCCcEEE-cCCCcEEEeecCCccc
Q 041921          641 QIIHCDIKPQNILL-DDYYTARISDFGLAKL  670 (814)
Q Consensus       641 ~i~H~dlkp~NIll-~~~~~~kl~DfGla~~  670 (814)
                      .+.|+|+.+.|||+ +.++.++++||..+..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            57899999999999 8899999999988753

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=94.43  E-value=0.43  Score=51.51  Aligned_cols=81  Identities=20%  Similarity=0.169  Sum_probs=49.3

Q ss_pred             cceeeeeeeeEEEEEEecCCCceEEEEEEecccc-------ccchHhHHHHHHhhhccC--CCC-ccceeeeecccccce
Q 041921          525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF-------QDGEREFKNEVFVIGQTH--HKN-LVRLLGFCDEGQNRL  594 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-------~~~~~~~~~E~~~l~~l~--h~n-iv~l~~~~~~~~~~~  594 (814)
                      ++||.|....||++..+  .++..|+||.-....       +-..+...-|.+.|....  .|. +++++.+  +.+...
T Consensus         1 ~EigdGnlN~VfrV~~~--~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~   76 (370)
T TIGR01767         1 QEVGDGNLNLVFHVYDQ--EGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAV   76 (370)
T ss_pred             CcCCCCceEEEEEEEcC--CCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccce
Confidence            36899999999999864  223689999764211       222334556667776652  343 4445443  445566


Q ss_pred             EEEecCCC-CCHHHHh
Q 041921          595 LVYEFLNN-GTLASFL  609 (814)
Q Consensus       595 lv~e~~~~-gsL~~~l  609 (814)
                      +|||+++. ..|+..|
T Consensus        77 ~vMEdL~~~~ilR~~L   92 (370)
T TIGR01767        77 TVMEDLSHHKIARKGL   92 (370)
T ss_pred             ehHhhCccchHHHHHH
Confidence            89999864 3344444

This enzyme is involved in the methionine salvage pathway in certain bacteria.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	814
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-54
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		5e-53
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		6e-42
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		9e-42
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		9e-42
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-41
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-41
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		9e-39
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		4e-25
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		6e-25
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-24
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		3e-24
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		4e-21
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		5e-21
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		8e-21
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		9e-21
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		9e-21
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		9e-21
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-20
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-20
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-20
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-20
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-20
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-20
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-20
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-20
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-20
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-20
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-20
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-20
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-20
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-20
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		3e-20
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-20
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-20
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-20
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		3e-20
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-20
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-20
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-20
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-20
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		3e-20
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-20
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-20
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-20
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-20
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-20
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		4e-20
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-20
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		6e-20
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-20
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		6e-20
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-20
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		8e-20
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		8e-20
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		8e-20
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		8e-20
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		8e-20
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		8e-20
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		8e-20
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		8e-20
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		9e-20
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		9e-20
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-19
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-19
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-19
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-19
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-19
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-19
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-19
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-19
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-19
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-19
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-19
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-19
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-19
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-19
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-19
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-19
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-19
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-19
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-19
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-19
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		3e-19
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-19
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		3e-19
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		3e-19
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-19
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-19
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		4e-19
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		4e-19
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		4e-19
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		4e-19
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		4e-19
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		4e-19
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		4e-19
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		4e-19
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		5e-19
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		5e-19
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		5e-19
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		5e-19
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		6e-19
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		6e-19
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		6e-19
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		6e-19
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		6e-19
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		7e-19
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		7e-19
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		7e-19
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		7e-19
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		7e-19
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		7e-19
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		7e-19
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		7e-19
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		7e-19
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		7e-19
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		7e-19
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		8e-19
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		8e-19
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		8e-19
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		8e-19
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		8e-19
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		8e-19
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		9e-19
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		9e-19
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		9e-19
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		9e-19
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		9e-19
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		9e-19
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		9e-19
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-18
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		1e-18
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-18
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-18
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-18
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-18
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-18
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-18
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-18
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-18
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-18
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-18
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-18
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-18
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-18
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-18
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-18
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-18
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		3e-18
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-18
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-18
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		3e-18
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		3e-18
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-18
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-18
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		4e-18
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		4e-18
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		4e-18
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		5e-18
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		7e-18
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		8e-18
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		9e-18
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		9e-18
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-17
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-17
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-17
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-17
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-17
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-17
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-17
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-17
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-17
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-17
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		3e-17
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		3e-17
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-17
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-17
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-17
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-17
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		4e-17
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		4e-17
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		4e-17
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		5e-17
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		5e-17
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		5e-17
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-17
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-17
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		6e-17
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		6e-17
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		6e-17
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		7e-17
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		7e-17
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		7e-17
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		8e-17
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		8e-17
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		9e-17
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-16
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-16
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-16
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-16
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-16
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-16
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-16
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-16
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-16
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-16
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-16
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-16
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		4e-16
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		4e-16
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		5e-16
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		5e-16
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		5e-16
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		5e-16
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-16
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		5e-16
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		6e-16
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-16
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		6e-16
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		7e-16
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		7e-16
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		7e-16
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		7e-16
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		7e-16
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		7e-16
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		7e-16
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		7e-16
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		8e-16
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		8e-16
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		8e-16
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		8e-16
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		8e-16
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		8e-16
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		8e-16
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		8e-16
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		9e-16
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		9e-16
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		9e-16
4fl3_A	635	Structural And Biophysical Characterization Of The		9e-16
4fl2_A	636	Structural And Biophysical Characterization Of The		9e-16
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		9e-16
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-15
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-15
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-15
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-15
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-15
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-15
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-15
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-15
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-15
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-15
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-15
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-15
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-15
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-15
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-15
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-15
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-15
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-15
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-15
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-15
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-15
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-15
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-15
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-15
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-15
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		3e-15
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		4e-15
3a7f_A	303	Human Mst3 Kinase Length = 303		4e-15
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		4e-15
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-15
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-15
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		4e-15
3a4o_X	286	Lyn Kinase Domain Length = 286		4e-15
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		4e-15
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-15
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-15
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		5e-15
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		5e-15
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		6e-15
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		6e-15
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		6e-15
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		6e-15
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		6e-15
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-15
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		6e-15
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-15
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		6e-15
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		7e-15
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		7e-15
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		7e-15
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		7e-15
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		7e-15
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		7e-15
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		7e-15
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		7e-15
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		7e-15
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		8e-15
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-15
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		8e-15
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		8e-15
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		8e-15
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		8e-15
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		8e-15
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		9e-15
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		9e-15
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		9e-15
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		9e-15
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		9e-15
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		9e-15
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		9e-15
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-14
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-14
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-14
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-14
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-14
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-14
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-14
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-14
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-14
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-14
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-14
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-14
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-14
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-14
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-14
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-14
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-14
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-14
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-14
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-14
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-14
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-14
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-14
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-14
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-14
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-14
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-14
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-14
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-14
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-14
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-14
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-14
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-14
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-14
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-14
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-14
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-14
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-14
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-14
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-14
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-14
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-14
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-14
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-14
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-14
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-14
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-14
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-14
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-14
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-14
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-14
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-14
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-14
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-14
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-14
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-14
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-14
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		3e-14
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		3e-14
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-14
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-14
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		3e-14
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		3e-14
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-14
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		3e-14
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		3e-14
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		3e-14
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		3e-14
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-14
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		4e-14
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		4e-14
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		4e-14
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-14
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		4e-14
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		4e-14
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		4e-14
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		4e-14
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		4e-14
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-14
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		6e-14
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		6e-14
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-14
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		6e-14
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		6e-14
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		7e-14
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		7e-14
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		7e-14
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		8e-14
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		8e-14
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		8e-14
3b2t_A	311	Structure Of Phosphotransferase Length = 311		8e-14
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		9e-14
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		9e-14
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		9e-14
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-13
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-13
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-13
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-13
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-13
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-13
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-13
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-13
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-13
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-13
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-13
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-13
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-13
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-13
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-13
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-13
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-13
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-13
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-13
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-13
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-13
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-13
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-13
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-13
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-13
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		3e-13
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		3e-13
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		3e-13
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-13
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		4e-13
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		4e-13
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		5e-13
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		5e-13
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		5e-13
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		5e-13
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		5e-13
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-13
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		5e-13
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		5e-13
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-13
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		5e-13
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		6e-13
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		6e-13
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		6e-13
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		6e-13
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		6e-13
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-13
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		7e-13
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		7e-13
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		7e-13
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		7e-13
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		7e-13
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		7e-13
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		7e-13
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		8e-13
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		8e-13
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		8e-13
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		8e-13
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		8e-13
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		8e-13
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		8e-13
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		8e-13
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		8e-13
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		8e-13
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		9e-13
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		9e-13
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-12
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-12
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-12
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-12
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-12
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-12
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-12
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-12
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-12
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-12
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-12
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-12
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-12
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-12
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-12
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-12
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-12
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-12
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-12
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-12
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-12
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		1e-12
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-12
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-12
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-12
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-12
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-12
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-12
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-12
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-12
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-12
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-12
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-12
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-12
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-12
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-12
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-12
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-12
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-12
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-12
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-12
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-12
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-12
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-12
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-12
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-12
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-12
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-12
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-12
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-12
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-12
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-12
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-12
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-12
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-12
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-12
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-12
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-12
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-12
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-12
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-12
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-12
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-12
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-12
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-12
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-12
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-12
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		3e-12
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		3e-12
3hec_A	348	P38 In Complex With Imatinib Length = 348		3e-12
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-12
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		3e-12
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-12
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		3e-12
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		3e-12
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		3e-12
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-12
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		3e-12
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		3e-12
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		3e-12
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-12
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		3e-12
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-12
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		3e-12
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		3e-12
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		3e-12
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		3e-12
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		3e-12
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		3e-12
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-12
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-12
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		4e-12
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		4e-12
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		4e-12
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		4e-12
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		4e-12
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		4e-12
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		4e-12
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		4e-12
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		4e-12
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		4e-12
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		4e-12
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		4e-12
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		4e-12
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		4e-12
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		4e-12
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		4e-12
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		4e-12
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		4e-12
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		5e-12
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		5e-12
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-12
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		5e-12
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		5e-12
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		5e-12
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		5e-12
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		5e-12
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		5e-12
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		5e-12
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		5e-12
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		5e-12
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-12
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		6e-12
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		6e-12
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		6e-12
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		7e-12
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-12
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		7e-12
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		7e-12
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		8e-12
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-12
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		8e-12
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		8e-12
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		8e-12
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		8e-12
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		8e-12
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		8e-12
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		8e-12
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		9e-12
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		9e-12
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		9e-12
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		9e-12
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		9e-12
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		1e-11
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-11
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-11
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-11
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-11
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-11
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-11
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-11
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-11
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-11
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-11
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-11
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-11
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-11
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-11
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-11
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-11
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-11
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-11
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-11
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-11
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-11
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-11
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-11
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-11
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-11
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-11
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-11
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-11
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		2e-11
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-11
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-11
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-11
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-11
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-11
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-11
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-11
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-11
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-11
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-11
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-11
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		3e-11
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		3e-11
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-11
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-11
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		3e-11
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-11
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-11
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-11
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		3e-11
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-11
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		4e-11
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		4e-11
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		4e-11
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		4e-11
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		4e-11
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		4e-11
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		5e-11
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-11
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		5e-11
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		5e-11
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		5e-11
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		5e-11
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		5e-11
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		5e-11
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-11
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		5e-11
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		6e-11
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		6e-11
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		6e-11
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		6e-11
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		6e-11
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		6e-11
4exu_A	371	Mapk13, Inactive Form Length = 371		6e-11
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		6e-11
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		6e-11
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		7e-11
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		7e-11
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		7e-11
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		7e-11
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		7e-11
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		7e-11
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		7e-11
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		7e-11
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		7e-11
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		7e-11
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		8e-11
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		8e-11
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		8e-11
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		8e-11
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		8e-11
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		8e-11
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		8e-11
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		8e-11
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-11
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		8e-11
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		9e-11
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		9e-11
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		9e-11
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		9e-11
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		9e-11
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		9e-11
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-10
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-10
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-10
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-10
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-10
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-10
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-10
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-10
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-10
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		1e-10
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-10
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-10
3soa_A	444	Full-Length Human Camkii Length = 444		1e-10
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-10
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-10
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-10
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-10
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		1e-10
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-10
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-10
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-10
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-10
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-10
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-10
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-10
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-10
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-10
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-10
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-10
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-10
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-10
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-10
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-10
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-10
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-10
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-10
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-10
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-10
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-10
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-10
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-10
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-10
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		3e-10
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-10
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		3e-10
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-10
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-10
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		3e-10
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-10
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		4e-10
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-10
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-10
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		4e-10
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		5e-10
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		5e-10
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		5e-10
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		5e-10
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		6e-10
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		6e-10
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-10
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		7e-10
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		7e-10
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		7e-10
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		7e-10
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		8e-10
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		8e-10
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-09
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-09
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		1e-09
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-09
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-09
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-09
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-09
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-09
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-09
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-09
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-09
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-09
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-09
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-09
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-09
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-09
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-09
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-09
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-09
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-09
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		3e-09
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		4e-09
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		4e-09
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		4e-09
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		4e-09
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		4e-09
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		6e-09
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		6e-09
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-09
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		6e-09
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		6e-09
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		6e-09
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		7e-09
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		7e-09
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		8e-09
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		8e-09
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		8e-09
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-08
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-08
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		1e-08
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-08
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-08
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-08
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-08
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-08
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		2e-08
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-08
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-08
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-08
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-08
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-08
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-08
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-08
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-08
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-08
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-08
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-08
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-08
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		3e-08
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		3e-08
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		3e-08
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-08
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		4e-08
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		4e-08
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		4e-08
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		4e-08
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		4e-08
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-08
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		4e-08
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		4e-08
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-08
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		5e-08
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		5e-08
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		5e-08
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		5e-08
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		5e-08
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		5e-08
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		5e-08
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-08
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		5e-08
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		5e-08
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		5e-08
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		5e-08
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		5e-08
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		5e-08
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-08
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		6e-08
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		6e-08
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		6e-08
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		6e-08
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-08
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		6e-08
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-08
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		6e-08
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		6e-08
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		6e-08
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		6e-08
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		7e-08
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		7e-08
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		7e-08
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		7e-08
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		7e-08
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		7e-08
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		7e-08
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		7e-08
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		7e-08
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		7e-08
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		7e-08
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		7e-08
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		8e-08
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		8e-08
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		8e-08
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		8e-08
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		8e-08
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		8e-08
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		8e-08
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		8e-08
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		9e-08
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		1e-07
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-07
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-07
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-07
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-07
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		1e-07
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-07
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-07
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-07
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-07
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-07
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-07
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-07
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-07
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-07
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		1e-07
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-07
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-07
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-07
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-07
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-07
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-07
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-07
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-07
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-07
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-07
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-07
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-07
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-07
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-07
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-07
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-07
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-07
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-07
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-07
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-07
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-07
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		2e-07
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-07
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		3e-07
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		3e-07
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-07
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-07
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		4e-07
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-07
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		4e-07
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		4e-07
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		4e-07
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		4e-07
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		4e-07
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		4e-07
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		4e-07
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		4e-07
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		5e-07
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		5e-07
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		5e-07
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		5e-07
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		5e-07
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		6e-07
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		6e-07
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		6e-07
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		6e-07
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		6e-07
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		7e-07
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		7e-07
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		7e-07
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		7e-07
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		7e-07
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		7e-07
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		7e-07
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		8e-07
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		8e-07
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		8e-07
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		8e-07
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		8e-07
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		8e-07
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		8e-07
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		8e-07
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		8e-07
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		9e-07
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		9e-07
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		9e-07
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		9e-07
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		9e-07
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		9e-07
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		9e-07
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-06
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		1e-06
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-06
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-06
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-06
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-06
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-06
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-06
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-06
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-06
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-06
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-06
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		5e-06

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  210 bits (535), Expect = 2e-54,   Method: Compositional matrix adjust.
 Identities = 121/297 (40%), Positives = 177/297 (59%), Gaps = 13/297 (4%)
Query: 507 NLRCFSYKELEGATNNF--KEEVGRGSFGIVYKGVIQTRTSTTAVAVKKL-DRVFQDGER 563
            L+ FS +EL+ A++NF  K  +GRG FG VYKG +      T VAVK+L +   Q GE 
Sbjct: 24  QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRL---ADGTLVAVKRLKEERXQGGEL 80
Query: 564 EFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP----NWNL 619
           +F+ EV +I    H+NL+RL GFC     RLLVY ++ NG++AS L    +     +W  
Sbjct: 81  QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPK 140
Query: 620 RTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI 679
           R  IA   ARGL YLH+ C  +IIH D+K  NILLD+ + A + DFGLAKL+   +   +
Sbjct: 141 RQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY-KDXHV 199
Query: 680 KTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIE--MGEEYAILTDW 737
             A+RGT G++APE+    K + K DV+ +GV+LLE+I+ +++FD+     ++  +L DW
Sbjct: 200 XXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 259
Query: 738 AFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEG 794
                +  KL  LV  D +     E + +L+ V++ C Q  P  RP M +V++MLEG
Sbjct: 260 VKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 316

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  206 bits (523), Expect = 5e-53,   Method: Compositional matrix adjust.
 Identities = 119/297 (40%), Positives = 175/297 (58%), Gaps = 13/297 (4%)
Query: 507 NLRCFSYKELEGATNNF--KEEVGRGSFGIVYKGVIQTRTSTTAVAVKKL-DRVFQDGER 563
            L+ FS +EL+ A++NF  K  +GRG FG VYKG +        VAVK+L +   Q GE 
Sbjct: 16  QLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRL---ADGXLVAVKRLKEERTQGGEL 72
Query: 564 EFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP----NWNL 619
           +F+ EV +I    H+NL+RL GFC     RLLVY ++ NG++AS L    +     +W  
Sbjct: 73  QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPK 132
Query: 620 RTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI 679
           R  IA   ARGL YLH+ C  +IIH D+K  NILLD+ + A + DFGLAKL+   +   +
Sbjct: 133 RQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY-KDXHV 191
Query: 680 KTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIE--MGEEYAILTDW 737
             A+RG  G++APE+    K + K DV+ +GV+LLE+I+ +++FD+     ++  +L DW
Sbjct: 192 XXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251
Query: 738 AFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEG 794
                +  KL  LV  D +     E + +L+ V++ C Q  P  RP M +V++MLEG
Sbjct: 252 VKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  169 bits (428), Expect = 6e-42,   Method: Compositional matrix adjust.
 Identities = 117/306 (38%), Positives = 168/306 (54%), Gaps = 29/306 (9%)
Query: 505 ETNLRCFSYKELEGATNNFKE--------EVGRGSFGIVYKGVIQTRTSTTAVAVKKL-- 554
           +T    FS+ EL+  TNNF E        ++G G FG+VYKG +    + T VAVKKL  
Sbjct: 9   DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV----NNTTVAVKKLAA 64
Query: 555 --DRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTL---ASFL 609
             D   ++ +++F  E+ V+ +  H+NLV LLGF  +G +  LVY ++ NG+L    S L
Sbjct: 65  MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124
Query: 610 FGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAK 669
            G    +W++R  IA   A G+ +LHE+     IH DIK  NILLD+ +TA+ISDFGLA+
Sbjct: 125 DGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLAR 181
Query: 670 LLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGE 729
                    + + I GT  Y+APE  R  +IT K D+YSFGV+LLEII+   + D E  E
Sbjct: 182 ASEKFAQTVMXSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVD-EHRE 239
Query: 730 EYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSI--WCIQEDPSLRPTMKK 787
              +L            +   +  DK+ MND +      M S+   C+ E  + RP +KK
Sbjct: 240 PQLLLDIKEEIEDEEKTIEDYI--DKK-MNDADSTSVEAMYSVASQCLHEKKNKRPDIKK 296
Query: 788 VLQMLE 793
           V Q+L+
Sbjct: 297 VQQLLQ 302

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  168 bits (426), Expect = 9e-42,   Method: Compositional matrix adjust.
 Identities = 113/308 (36%), Positives = 165/308 (53%), Gaps = 17/308 (5%)
Query: 497 NSPDDGTIETNLRCF-SYK----ELEGATNNFKEE--VGRGSFGIVYKGVIQTRTSTTAV 549
           NS +D    + L  F SY+    +LE ATNNF  +  +G G FG VYKGV++       V
Sbjct: 10  NSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR---DGAKV 66
Query: 550 AVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL 609
           A+K+       G  EF+ E+  +    H +LV L+GFCDE    +L+Y+++ NG L   L
Sbjct: 67  ALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHL 126
Query: 610 FGNLKP----NWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDF 665
           +G+  P    +W  R  I    ARGL YLH   RA IIH D+K  NILLD+ +  +I+DF
Sbjct: 127 YGSDLPTMSMSWEQRLEICIGAARGLHYLH--TRA-IIHRDVKSINILLDENFVPKITDF 183
Query: 666 GLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDI 725
           G++K  T      +   ++GT GY+ PE+F   ++T K DVYSFGV+L E++  R +   
Sbjct: 184 GISKKGTELDQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQ 243
Query: 726 EMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTM 785
            +  E   L +WA + + NG+L  +V  +       E L K    ++ C+      RP+M
Sbjct: 244 SLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSM 303
Query: 786 KKVLQMLE 793
             VL  LE
Sbjct: 304 GDVLWKLE 311

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  168 bits (426), Expect = 9e-42,   Method: Compositional matrix adjust.
 Identities = 117/306 (38%), Positives = 167/306 (54%), Gaps = 29/306 (9%)
Query: 505 ETNLRCFSYKELEGATNNFKE--------EVGRGSFGIVYKGVIQTRTSTTAVAVKKL-- 554
           +T    FS+ EL+  TNNF E        ++G G FG+VYKG +    + T VAVKKL  
Sbjct: 9   DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV----NNTTVAVKKLAA 64
Query: 555 --DRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTL---ASFL 609
             D   ++ +++F  E+ V+ +  H+NLV LLGF  +G +  LVY ++ NG+L    S L
Sbjct: 65  MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124
Query: 610 FGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAK 669
            G    +W++R  IA   A G+ +LHE+     IH DIK  NILLD+ +TA+ISDFGLA+
Sbjct: 125 DGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLAR 181
Query: 670 LLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGE 729
                    +   I GT  Y+APE  R  +IT K D+YSFGV+LLEII+   + D E  E
Sbjct: 182 ASEKFAQTVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVD-EHRE 239
Query: 730 EYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSI--WCIQEDPSLRPTMKK 787
              +L            +   +  DK+ MND +      M S+   C+ E  + RP +KK
Sbjct: 240 PQLLLDIKEEIEDEEKTIEDYI--DKK-MNDADSTSVEAMYSVASQCLHEKKNKRPDIKK 296
Query: 788 VLQMLE 793
           V Q+L+
Sbjct: 297 VQQLLQ 302

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  168 bits (425), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 117/306 (38%), Positives = 167/306 (54%), Gaps = 29/306 (9%)
Query: 505 ETNLRCFSYKELEGATNNFKE--------EVGRGSFGIVYKGVIQTRTSTTAVAVKKL-- 554
           +T    FS+ EL+  TNNF E        ++G G FG+VYKG +    + T VAVKKL  
Sbjct: 3   DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV----NNTTVAVKKLAA 58
Query: 555 --DRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTL---ASFL 609
             D   ++ +++F  E+ V+ +  H+NLV LLGF  +G +  LVY ++ NG+L    S L
Sbjct: 59  MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 118
Query: 610 FGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAK 669
            G    +W++R  IA   A G+ +LHE+     IH DIK  NILLD+ +TA+ISDFGLA+
Sbjct: 119 DGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLAR 175
Query: 670 LLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGE 729
                    +   I GT  Y+APE  R  +IT K D+YSFGV+LLEII+   + D E  E
Sbjct: 176 ASEKFAQXVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVD-EHRE 233
Query: 730 EYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSI--WCIQEDPSLRPTMKK 787
              +L            +   +  DK+ MND +      M S+   C+ E  + RP +KK
Sbjct: 234 PQLLLDIKEEIEDEEKTIEDYI--DKK-MNDADSTSVEAMYSVASQCLHEKKNKRPDIKK 290
Query: 788 VLQMLE 793
           V Q+L+
Sbjct: 291 VQQLLQ 296

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  168 bits (425), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 113/308 (36%), Positives = 165/308 (53%), Gaps = 17/308 (5%)
Query: 497 NSPDDGTIETNLRCF-SYK----ELEGATNNFKEE--VGRGSFGIVYKGVIQTRTSTTAV 549
           NS +D    + L  F SY+    +LE ATNNF  +  +G G FG VYKGV++       V
Sbjct: 10  NSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR---DGAKV 66
Query: 550 AVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL 609
           A+K+       G  EF+ E+  +    H +LV L+GFCDE    +L+Y+++ NG L   L
Sbjct: 67  ALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHL 126
Query: 610 FGNLKP----NWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDF 665
           +G+  P    +W  R  I    ARGL YLH   RA IIH D+K  NILLD+ +  +I+DF
Sbjct: 127 YGSDLPTMSMSWEQRLEICIGAARGLHYLH--TRA-IIHRDVKSINILLDENFVPKITDF 183
Query: 666 GLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDI 725
           G++K  T      +   ++GT GY+ PE+F   ++T K DVYSFGV+L E++  R +   
Sbjct: 184 GISKKGTELGQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQ 243
Query: 726 EMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTM 785
            +  E   L +WA + + NG+L  +V  +       E L K    ++ C+      RP+M
Sbjct: 244 SLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSM 303
Query: 786 KKVLQMLE 793
             VL  LE
Sbjct: 304 GDVLWKLE 311

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  158 bits (400), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 110/303 (36%), Positives = 157/303 (51%), Gaps = 25/303 (8%)
Query: 506 TNLRCFSYKELEGATNNFKE--------EVGRGSFGIVYKGVIQTRTSTTAVAVKKL--- 554
           T    FS+ EL+  TNNF E        + G G FG+VYKG +    + T VAVKKL   
Sbjct: 1   TRFHSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYV----NNTTVAVKKLAAM 56
Query: 555 -DRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTL---ASFLF 610
            D   ++ +++F  E+ V  +  H+NLV LLGF  +G +  LVY +  NG+L    S L 
Sbjct: 57  VDITTEELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLD 116
Query: 611 GNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKL 670
           G    +W+ R  IA   A G+ +LHE+     IH DIK  NILLD+ +TA+ISDFGLA+ 
Sbjct: 117 GTPPLSWHXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARA 173
Query: 671 LTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 730
                     + I GT  Y APE  R  +IT K D+YSFGV+LLEII+   + D     +
Sbjct: 174 SEKFAQXVXXSRIVGTTAYXAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQ 232
Query: 731 YAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
             +      +       + +  +  +A  D   +     V+  C+ E  + RP +KKV Q
Sbjct: 233 LLLDIKEEIEDEEKTIEDYIDKKXNDA--DSTSVEAXYSVASQCLHEKKNKRPDIKKVQQ 290
Query: 791 MLE 793
           +L+
Sbjct: 291 LLQ 293

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  113 bits (283), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 84/287 (29%), Positives = 142/287 (49%), Gaps = 29/287 (10%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGER--EFKNEVFVIGQTHHKN 579
           N KE++G GSFG V++         + VAVK L       ER  EF  EV ++ +  H N
Sbjct: 40  NIKEKIGAGSFGTVHRA----EWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPN 95
Query: 580 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPNWNLRTNIAFQIARGLLYLHE 636
           +V  +G   +  N  +V E+L+ G+L   L       + +   R ++A+ +A+G+ YLH 
Sbjct: 96  IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH- 154
Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR 696
           +    I+H D+K  N+L+D  YT ++ DFGL++L       +   A  GT  ++APE  R
Sbjct: 155 NRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAA--GTPEWMAPEVLR 212
Query: 697 NSKITAKVDVYSFGVLLLEIISCRKSF-DIEMGEEYAILTDWAFDCYRNGKLNVLVGEDK 755
           +     K DVYSFGV+L E+ + ++ + ++   +  A +    F C R   L +    + 
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAV---GFKCKR---LEIPRNLNP 266
Query: 756 EAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVPP 802
           +    IE           C   +P  RP+   ++ +L  +++ +VPP
Sbjct: 267 QVAAIIEG----------CWTNEPWKRPSFATIMDLLRPLIKSAVPP 303

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  112 bits (281), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 85/289 (29%), Positives = 144/289 (49%), Gaps = 33/289 (11%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGER--EFKNEVFVIGQTHHKN 579
           N KE++G GSFG V++         + VAVK L       ER  EF  EV ++ +  H N
Sbjct: 40  NIKEKIGAGSFGTVHRA----EWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPN 95
Query: 580 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPNWNLRTNIAFQIARGLLYLHE 636
           +V  +G   +  N  +V E+L+ G+L   L       + +   R ++A+ +A+G+ YLH 
Sbjct: 96  IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH- 154
Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLL--TLNQSKTIKTAIRGTKGYVAPEW 694
           +    I+H ++K  N+L+D  YT ++ DFGL++L   T   SK+      GT  ++APE 
Sbjct: 155 NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA----GTPEWMAPEV 210
Query: 695 FRNSKITAKVDVYSFGVLLLEIISCRKSF-DIEMGEEYAILTDWAFDCYRNGKLNVLVGE 753
            R+     K DVYSFGV+L E+ + ++ + ++   +  A +    F C R   L +    
Sbjct: 211 LRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAV---GFKCKR---LEIPRNL 264
Query: 754 DKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVPP 802
           + +    IE           C   +P  RP+   ++ +L  +++ +VPP
Sbjct: 265 NPQVAAIIEG----------CWTNEPWKRPSFATIMDLLRPLIKSAVPP 303

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score =  111 bits (277), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 91/290 (31%), Positives = 148/290 (51%), Gaps = 36/290 (12%)
Query: 507 NLRCFSYKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFK 566
           +L    YKE+E      +E VGRG+FG+V K   + +     VA+K+++   +   + F 
Sbjct: 2   SLHMIDYKEIE-----VEEVVGRGAFGVVCKAKWRAKD----VAIKQIES--ESERKAFI 50
Query: 567 NEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK-PNWNLRTNIAF 625
            E+  + + +H N+V+L G C       LV E+   G+L + L G    P +     +++
Sbjct: 51  VELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW 108
Query: 626 --QIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTA-RISDFGLAKLLTLNQSKTIKTA 682
             Q ++G+ YLH      +IH D+KP N+LL    T  +I DFG     T    +T  T 
Sbjct: 109 CLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFG-----TACDIQTHMTN 163
Query: 683 IRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 742
            +G+  ++APE F  S  + K DV+S+G++L E+I+ RK FD   G  + I+  WA    
Sbjct: 164 NKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM--WAV--- 218
Query: 743 RNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQML 792
            NG    L+   K     IE L    M   W   +DPS RP+M+++++++
Sbjct: 219 HNGTRPPLI---KNLPKPIESL----MTRCW--SKDPSQRPSMEEIVKIM 259

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score =  110 bits (276), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 91/290 (31%), Positives = 148/290 (51%), Gaps = 36/290 (12%)
Query: 507 NLRCFSYKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFK 566
           +L    YKE+E      +E VGRG+FG+V K   + +     VA+K+++   +   + F 
Sbjct: 1   SLHMIDYKEIE-----VEEVVGRGAFGVVCKAKWRAKD----VAIKQIES--ESERKAFI 49
Query: 567 NEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK-PNWNLRTNIAF 625
            E+  + + +H N+V+L G C       LV E+   G+L + L G    P +     +++
Sbjct: 50  VELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW 107
Query: 626 --QIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTA-RISDFGLAKLLTLNQSKTIKTA 682
             Q ++G+ YLH      +IH D+KP N+LL    T  +I DFG     T    +T  T 
Sbjct: 108 CLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFG-----TACDIQTHMTN 162
Query: 683 IRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 742
            +G+  ++APE F  S  + K DV+S+G++L E+I+ RK FD   G  + I+  WA    
Sbjct: 163 NKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM--WAV--- 217
Query: 743 RNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQML 792
            NG    L+   K     IE L    M   W   +DPS RP+M+++++++
Sbjct: 218 HNGTRPPLI---KNLPKPIESL----MTRCW--SKDPSQRPSMEEIVKIM 258

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score =  100 bits (248), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 113/204 (55%), Gaps = 11/204 (5%)
Query: 522 NFKEEVGRGSFGIVYKG-VIQTRTSTTAVAVKKLDRVFQDGE-REFKNEVFVIGQTHHKN 579
           +F E +GRG FG VY G ++         AVK L+R+   GE  +F  E  ++    H N
Sbjct: 32  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 91
Query: 580 LVRLLGFCDEGQ-NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF--QIARGLLYLHE 636
           ++ LLG C   + + L+V  ++ +G L +F+  N   N  ++  I F  Q+A+G+ YL  
Sbjct: 92  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKYL-- 148
Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI--KTAIRGTKGYVAPEW 694
               + +H D+  +N +LD+ +T +++DFGLA+ +   +  ++  KT  +    ++A E 
Sbjct: 149 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALES 207
Query: 695 FRNSKITAKVDVYSFGVLLLEIIS 718
            +  K T K DV+SFGVLL E+++
Sbjct: 208 LQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  100 bits (248), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 98/217 (45%), Gaps = 13/217 (5%)
Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ 574
           E++ A    +E +G G FG VY+            A    D          + E  +   
Sbjct: 3   EIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAM 62
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYL 634
             H N++ L G C +  N  LV EF   G L   L G   P  ++  N A QIARG+ YL
Sbjct: 63  LKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPP-DILVNWAVQIARGMNYL 121
Query: 635 HEDCRAQIIHCDIKPQNILLDDYY--------TARISDFGLAKLLTLNQSKTIKTAIRGT 686
           H++    IIH D+K  NIL+              +I+DFGLA+       +T K +  G 
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR----EWHRTTKMSAAGA 177
Query: 687 KGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSF 723
             ++APE  R S  +   DV+S+GVLL E+++    F
Sbjct: 178 YAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF 214

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 99.0 bits (245), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 113/204 (55%), Gaps = 11/204 (5%)
Query: 522 NFKEEVGRGSFGIVYKG-VIQTRTSTTAVAVKKLDRVFQDGE-REFKNEVFVIGQTHHKN 579
           +F E +GRG FG VY G ++         AVK L+R+   GE  +F  E  ++    H N
Sbjct: 51  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 110
Query: 580 LVRLLGFCDEGQ-NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF--QIARGLLYLHE 636
           ++ LLG C   + + L+V  ++ +G L +F+  N   N  ++  I F  Q+A+G+ YL  
Sbjct: 111 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKYL-- 167
Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI--KTAIRGTKGYVAPEW 694
               + +H D+  +N +LD+ +T +++DFGLA+ +   +  ++  KT  +    ++A E 
Sbjct: 168 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 226
Query: 695 FRNSKITAKVDVYSFGVLLLEIIS 718
            +  K T K DV+SFGVLL E+++
Sbjct: 227 LQTQKFTTKSDVWSFGVLLWELMT 250

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 99.0 bits (245), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 113/204 (55%), Gaps = 11/204 (5%)
Query: 522 NFKEEVGRGSFGIVYKG-VIQTRTSTTAVAVKKLDRVFQDGE-REFKNEVFVIGQTHHKN 579
           +F E +GRG FG VY G ++         AVK L+R+   GE  +F  E  ++    H N
Sbjct: 30  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89
Query: 580 LVRLLGFCDEGQ-NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF--QIARGLLYLHE 636
           ++ LLG C   + + L+V  ++ +G L +F+  N   N  ++  I F  Q+A+G+ YL  
Sbjct: 90  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKYL-- 146
Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI--KTAIRGTKGYVAPEW 694
               + +H D+  +N +LD+ +T +++DFGLA+ +   +  ++  KT  +    ++A E 
Sbjct: 147 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 205
Query: 695 FRNSKITAKVDVYSFGVLLLEIIS 718
            +  K T K DV+SFGVLL E+++
Sbjct: 206 LQTQKFTTKSDVWSFGVLLWELMT 229

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 99.0 bits (245), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 113/204 (55%), Gaps = 11/204 (5%)
Query: 522 NFKEEVGRGSFGIVYKG-VIQTRTSTTAVAVKKLDRVFQDGE-REFKNEVFVIGQTHHKN 579
           +F E +GRG FG VY G ++         AVK L+R+   GE  +F  E  ++    H N
Sbjct: 31  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 90
Query: 580 LVRLLGFCDEGQ-NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF--QIARGLLYLHE 636
           ++ LLG C   + + L+V  ++ +G L +F+  N   N  ++  I F  Q+A+G+ YL  
Sbjct: 91  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKYL-- 147
Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI--KTAIRGTKGYVAPEW 694
               + +H D+  +N +LD+ +T +++DFGLA+ +   +  ++  KT  +    ++A E 
Sbjct: 148 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 206
Query: 695 FRNSKITAKVDVYSFGVLLLEIIS 718
            +  K T K DV+SFGVLL E+++
Sbjct: 207 LQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 99.0 bits (245), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 113/204 (55%), Gaps = 11/204 (5%)
Query: 522 NFKEEVGRGSFGIVYKG-VIQTRTSTTAVAVKKLDRVFQDGE-REFKNEVFVIGQTHHKN 579
           +F E +GRG FG VY G ++         AVK L+R+   GE  +F  E  ++    H N
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 580 LVRLLGFCDEGQ-NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF--QIARGLLYLHE 636
           ++ LLG C   + + L+V  ++ +G L +F+  N   N  ++  I F  Q+A+G+ YL  
Sbjct: 88  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKYL-- 144
Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI--KTAIRGTKGYVAPEW 694
               + +H D+  +N +LD+ +T +++DFGLA+ +   +  ++  KT  +    ++A E 
Sbjct: 145 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 203
Query: 695 FRNSKITAKVDVYSFGVLLLEIIS 718
            +  K T K DV+SFGVLL E+++
Sbjct: 204 LQTQKFTTKSDVWSFGVLLWELMT 227

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 140/294 (47%), Gaps = 34/294 (11%)
Query: 514 KELEGATNNFKEEVGRGSFGIVYKGVIQTR-TSTTAVAVKKLDRVFQDGER-EFKNEVFV 571
           KE++ +    +E +G G FG V +G ++      + VA+K L   + + +R EF +E  +
Sbjct: 11  KEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASI 70
Query: 572 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPNWNLRTNIAF 625
           +GQ  H N++RL G        +++ EF+ NG L SFL      F  ++    LR     
Sbjct: 71  MGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRG---- 126
Query: 626 QIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRG 685
            IA G+ YL E      +H D+  +NIL++     ++SDFGL++ L  N S   +T+  G
Sbjct: 127 -IASGMRYLAE---MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLG 182
Query: 686 TK---GYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 742
            K    + APE     K T+  D +S+G+++ E++S         GE         +D  
Sbjct: 183 GKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMS--------FGERP------YWDMS 228
Query: 743 RNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 796
               +N  + +D       +C   L  + + C Q+D + RP   +V+  L+ ++
Sbjct: 229 NQDVINA-IEQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKMI 281

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 113/204 (55%), Gaps = 11/204 (5%)
Query: 522 NFKEEVGRGSFGIVYKG-VIQTRTSTTAVAVKKLDRVFQDGE-REFKNEVFVIGQTHHKN 579
           +F E +GRG FG VY G ++         AVK L+R+   GE  +F  E  ++    H N
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 580 LVRLLGFCDEGQ-NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF--QIARGLLYLHE 636
           ++ LLG C   + + L+V  ++ +G L +F+  N   N  ++  I F  Q+A+G+ YL  
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKYL-- 149
Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI--KTAIRGTKGYVAPEW 694
               + +H D+  +N +LD+ +T +++DFGLA+ +   +  ++  KT  +    ++A E 
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 208
Query: 695 FRNSKITAKVDVYSFGVLLLEIIS 718
            +  K T K DV+SFGVLL E+++
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 113/204 (55%), Gaps = 11/204 (5%)
Query: 522 NFKEEVGRGSFGIVYKG-VIQTRTSTTAVAVKKLDRVFQDGE-REFKNEVFVIGQTHHKN 579
           +F E +GRG FG VY G ++         AVK L+R+   GE  +F  E  ++    H N
Sbjct: 52  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 111
Query: 580 LVRLLGFCDEGQ-NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF--QIARGLLYLHE 636
           ++ LLG C   + + L+V  ++ +G L +F+  N   N  ++  I F  Q+A+G+ YL  
Sbjct: 112 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKYL-- 168
Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI--KTAIRGTKGYVAPEW 694
               + +H D+  +N +LD+ +T +++DFGLA+ +   +  ++  KT  +    ++A E 
Sbjct: 169 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 227
Query: 695 FRNSKITAKVDVYSFGVLLLEIIS 718
            +  K T K DV+SFGVLL E+++
Sbjct: 228 LQTQKFTTKSDVWSFGVLLWELMT 251

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 113/204 (55%), Gaps = 11/204 (5%)
Query: 522 NFKEEVGRGSFGIVYKG-VIQTRTSTTAVAVKKLDRVFQDGE-REFKNEVFVIGQTHHKN 579
           +F E +GRG FG VY G ++         AVK L+R+   GE  +F  E  ++    H N
Sbjct: 25  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 84
Query: 580 LVRLLGFCDEGQ-NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF--QIARGLLYLHE 636
           ++ LLG C   + + L+V  ++ +G L +F+  N   N  ++  I F  Q+A+G+ YL  
Sbjct: 85  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKYL-- 141
Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI--KTAIRGTKGYVAPEW 694
               + +H D+  +N +LD+ +T +++DFGLA+ +   +  ++  KT  +    ++A E 
Sbjct: 142 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 200
Query: 695 FRNSKITAKVDVYSFGVLLLEIIS 718
            +  K T K DV+SFGVLL E+++
Sbjct: 201 LQTQKFTTKSDVWSFGVLLWELMT 224

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 113/204 (55%), Gaps = 11/204 (5%)
Query: 522 NFKEEVGRGSFGIVYKG-VIQTRTSTTAVAVKKLDRVFQDGE-REFKNEVFVIGQTHHKN 579
           +F E +GRG FG VY G ++         AVK L+R+   GE  +F  E  ++    H N
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 580 LVRLLGFCDEGQ-NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF--QIARGLLYLHE 636
           ++ LLG C   + + L+V  ++ +G L +F+  N   N  ++  I F  Q+A+G+ YL  
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKYL-- 149
Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI--KTAIRGTKGYVAPEW 694
               + +H D+  +N +LD+ +T +++DFGLA+ +   +  ++  KT  +    ++A E 
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 208
Query: 695 FRNSKITAKVDVYSFGVLLLEIIS 718
            +  K T K DV+SFGVLL E+++
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 113/204 (55%), Gaps = 11/204 (5%)
Query: 522 NFKEEVGRGSFGIVYKG-VIQTRTSTTAVAVKKLDRVFQDGE-REFKNEVFVIGQTHHKN 579
           +F E +GRG FG VY G ++         AVK L+R+   GE  +F  E  ++    H N
Sbjct: 32  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 91
Query: 580 LVRLLGFCDEGQ-NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF--QIARGLLYLHE 636
           ++ LLG C   + + L+V  ++ +G L +F+  N   N  ++  I F  Q+A+G+ YL  
Sbjct: 92  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKYL-- 148
Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI--KTAIRGTKGYVAPEW 694
               + +H D+  +N +LD+ +T +++DFGLA+ +   +  ++  KT  +    ++A E 
Sbjct: 149 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 207
Query: 695 FRNSKITAKVDVYSFGVLLLEIIS 718
            +  K T K DV+SFGVLL E+++
Sbjct: 208 LQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 137/289 (47%), Gaps = 28/289 (9%)
Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ 574
           E+E      K ++G G +G VY+GV +  + T AV   K D +  +   EF  E  V+ +
Sbjct: 14  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKE 70
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLL 632
             H NLV+LLG C       ++ EF+  G L  +L      + N  +   +A QI+  + 
Sbjct: 71  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 130
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 692
           YL    +   IH D+  +N L+ + +  +++DFGL++L+T   + T     +    + AP
Sbjct: 131 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAP 186
Query: 693 EWFRNSKITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDCYRNGKLNVL 750
           E    +K + K DV++FGVLL EI +   S    I++ + Y +L        ++ ++   
Sbjct: 187 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-------KDYRMERP 239
Query: 751 VGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 799
            G          C  K+  +   C Q +PS RP+  ++ Q  E + + S
Sbjct: 240 EG----------CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 278

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 137/289 (47%), Gaps = 28/289 (9%)
Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ 574
           E+E      K ++G G +G VY+GV +  + T AV   K D +  +   EF  E  V+ +
Sbjct: 10  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKE 66
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLL 632
             H NLV+LLG C       ++ EF+  G L  +L      + N  +   +A QI+  + 
Sbjct: 67  IKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 126
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 692
           YL    +   IH D+  +N L+ + +  +++DFGL++L+T   + T     +    + AP
Sbjct: 127 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAP 182
Query: 693 EWFRNSKITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDCYRNGKLNVL 750
           E    +K + K DV++FGVLL EI +   S    I++ + Y +L        ++ ++   
Sbjct: 183 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-------KDYRMERP 235
Query: 751 VGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 799
            G          C  K+  +   C Q +PS RP+  ++ Q  E + + S
Sbjct: 236 EG----------CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 274

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 137/289 (47%), Gaps = 28/289 (9%)
Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ 574
           E+E      K ++G G +G VY+GV +  + T AV   K D +  +   EF  E  V+ +
Sbjct: 13  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKE 69
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLL 632
             H NLV+LLG C       ++ EF+  G L  +L      + N  +   +A QI+  + 
Sbjct: 70  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 129
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 692
           YL    +   IH D+  +N L+ + +  +++DFGL++L+T   + T     +    + AP
Sbjct: 130 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 185
Query: 693 EWFRNSKITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDCYRNGKLNVL 750
           E    +K + K DV++FGVLL EI +   S    I++ + Y +L        ++ ++   
Sbjct: 186 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-------KDYRMERP 238
Query: 751 VGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 799
            G          C  K+  +   C Q +PS RP+  ++ Q  E + + S
Sbjct: 239 EG----------CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 277

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 113/204 (55%), Gaps = 11/204 (5%)
Query: 522 NFKEEVGRGSFGIVYKG-VIQTRTSTTAVAVKKLDRVFQDGE-REFKNEVFVIGQTHHKN 579
           +F E +GRG FG VY G ++         AVK L+R+   GE  +F  E  ++    H N
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 580 LVRLLGFCDEGQ-NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF--QIARGLLYLHE 636
           ++ LLG C   + + L+V  ++ +G L +F+  N   N  ++  I F  Q+A+G+ +L  
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKFL-- 208
Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI--KTAIRGTKGYVAPEW 694
               + +H D+  +N +LD+ +T +++DFGLA+ +   +  ++  KT  +    ++A E 
Sbjct: 209 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 267
Query: 695 FRNSKITAKVDVYSFGVLLLEIIS 718
            +  K T K DV+SFGVLL E+++
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELMT 291

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 139/294 (47%), Gaps = 34/294 (11%)
Query: 514 KELEGATNNFKEEVGRGSFGIVYKGVIQTR-TSTTAVAVKKLDRVFQDGER-EFKNEVFV 571
           KE++ +    +E +G G FG V +G ++      + VA+K L   + + +R EF +E  +
Sbjct: 9   KEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASI 68
Query: 572 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPNWNLRTNIAF 625
           +GQ  H N++RL G        +++ EF+ NG L SFL      F  ++    LR     
Sbjct: 69  MGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRG---- 124
Query: 626 QIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRG 685
            IA G+ YL E      +H D+  +NIL++     ++SDFGL++ L  N S    T+  G
Sbjct: 125 -IASGMRYLAE---MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLG 180
Query: 686 TK---GYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 742
            K    + APE     K T+  D +S+G+++ E++S         GE         +D  
Sbjct: 181 GKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMS--------FGERP------YWDMS 226
Query: 743 RNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 796
               +N  + +D       +C   L  + + C Q+D + RP   +V+  L+ ++
Sbjct: 227 NQDVINA-IEQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKMI 279

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 113/204 (55%), Gaps = 11/204 (5%)
Query: 522 NFKEEVGRGSFGIVYKG-VIQTRTSTTAVAVKKLDRVFQDGE-REFKNEVFVIGQTHHKN 579
           +F E +GRG FG VY G ++         AVK L+R+   GE  +F  E  ++    H N
Sbjct: 34  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 93
Query: 580 LVRLLGFCDEGQ-NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF--QIARGLLYLHE 636
           ++ LLG C   + + L+V  ++ +G L +F+  N   N  ++  I F  Q+A+G+ +L  
Sbjct: 94  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKFL-- 150
Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI--KTAIRGTKGYVAPEW 694
               + +H D+  +N +LD+ +T +++DFGLA+ +   +  ++  KT  +    ++A E 
Sbjct: 151 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALES 209
Query: 695 FRNSKITAKVDVYSFGVLLLEIIS 718
            +  K T K DV+SFGVLL E+++
Sbjct: 210 LQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 137/289 (47%), Gaps = 28/289 (9%)
Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ 574
           E+E      K ++G G +G VY+GV +  + T AV   K D +  +   EF  E  V+ +
Sbjct: 14  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKE 70
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLL 632
             H NLV+LLG C       ++ EF+  G L  +L      + N  +   +A QI+  + 
Sbjct: 71  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 130
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 692
           YL    +   IH D+  +N L+ + +  +++DFGL++L+T   + T     +    + AP
Sbjct: 131 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 186
Query: 693 EWFRNSKITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDCYRNGKLNVL 750
           E    +K + K DV++FGVLL EI +   S    I++ + Y +L        ++ ++   
Sbjct: 187 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-------KDYRMERP 239
Query: 751 VGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 799
            G          C  K+  +   C Q +PS RP+  ++ Q  E + + S
Sbjct: 240 EG----------CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 278

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 113/204 (55%), Gaps = 11/204 (5%)
Query: 522 NFKEEVGRGSFGIVYKG-VIQTRTSTTAVAVKKLDRVFQDGE-REFKNEVFVIGQTHHKN 579
           +F E +GRG FG VY G ++         AVK L+R+   GE  +F  E  ++    H N
Sbjct: 38  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 97
Query: 580 LVRLLGFCDEGQ-NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF--QIARGLLYLHE 636
           ++ LLG C   + + L+V  ++ +G L +F+  N   N  ++  I F  Q+A+G+ +L  
Sbjct: 98  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKFL-- 154
Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI--KTAIRGTKGYVAPEW 694
               + +H D+  +N +LD+ +T +++DFGLA+ +   +  ++  KT  +    ++A E 
Sbjct: 155 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 213
Query: 695 FRNSKITAKVDVYSFGVLLLEIIS 718
            +  K T K DV+SFGVLL E+++
Sbjct: 214 LQTQKFTTKSDVWSFGVLLWELMT 237

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 79/287 (27%), Positives = 136/287 (47%), Gaps = 28/287 (9%)
Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ 574
           E+E      K ++G G +G VY+GV +  + T AV   K D +  +   EF  E  V+ +
Sbjct: 14  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKE 70
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLL 632
             H NLV+LLG C       ++ EF+  G L  +L      + N  +   +A QI+  + 
Sbjct: 71  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 130
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 692
           YL    +   IH D+  +N L+ + +  +++DFGL++L+T   + T     +    + AP
Sbjct: 131 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 186
Query: 693 EWFRNSKITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDCYRNGKLNVL 750
           E    +K + K DV++FGVLL EI +   S    I++ + Y +L        ++ ++   
Sbjct: 187 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-------KDYRMERP 239
Query: 751 VGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 797
            G          C  K+  +   C Q +PS RP+  ++ Q  E + +
Sbjct: 240 EG----------CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 276

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 113/204 (55%), Gaps = 11/204 (5%)
Query: 522 NFKEEVGRGSFGIVYKG-VIQTRTSTTAVAVKKLDRVFQDGE-REFKNEVFVIGQTHHKN 579
           +F E +GRG FG VY G ++         AVK L+R+   GE  +F  E  ++    H N
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 580 LVRLLGFCDEGQ-NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF--QIARGLLYLHE 636
           ++ LLG C   + + L+V  ++ +G L +F+  N   N  ++  I F  Q+A+G+ +L  
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKFL-- 149
Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI--KTAIRGTKGYVAPEW 694
               + +H D+  +N +LD+ +T +++DFGLA+ +   +  ++  KT  +    ++A E 
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 208
Query: 695 FRNSKITAKVDVYSFGVLLLEIIS 718
            +  K T K DV+SFGVLL E+++
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 83/308 (26%), Positives = 140/308 (45%), Gaps = 31/308 (10%)
Query: 496 RNSPDDGTIETNLRCFSYKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLD 555
           RN P    +  N   +   E+E      K ++G G +G VY+GV +  + T AV   K D
Sbjct: 239 RNKPTVYGVSPN---YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED 295
Query: 556 RVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF--GNL 613
            +  +   EF  E  V+ +  H NLV+LLG C       ++ EF+  G L  +L      
Sbjct: 296 TMEVE---EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ 352
Query: 614 KPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTL 673
           + N  +   +A QI+  + YL    +   IH ++  +N L+ + +  +++DFGL++L+T 
Sbjct: 353 EVNAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT- 408
Query: 674 NQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEY 731
             + T     +    + APE    +K + K DV++FGVLL EI +   S    I++ + Y
Sbjct: 409 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 468
Query: 732 AILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM 791
            +L                  +D        C  K+  +   C Q +PS RP+  ++ Q 
Sbjct: 469 ELLE-----------------KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQA 511
Query: 792 LEGVVEVS 799
            E + + S
Sbjct: 512 FETMFQES 519

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 113/204 (55%), Gaps = 11/204 (5%)
Query: 522 NFKEEVGRGSFGIVYKG-VIQTRTSTTAVAVKKLDRVFQDGE-REFKNEVFVIGQTHHKN 579
           +F E +GRG FG VY G ++         AVK L+R+   GE  +F  E  ++    H N
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 580 LVRLLGFCDEGQ-NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF--QIARGLLYLHE 636
           ++ LLG C   + + L+V  ++ +G L +F+  N   N  ++  I F  Q+A+G+ +L  
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKFL-- 149
Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI--KTAIRGTKGYVAPEW 694
               + +H D+  +N +LD+ +T +++DFGLA+ +   +  ++  KT  +    ++A E 
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 208
Query: 695 FRNSKITAKVDVYSFGVLLLEIIS 718
            +  K T K DV+SFGVLL E+++
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 135/290 (46%), Gaps = 30/290 (10%)
Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ 574
           E+E      K ++G G +G VY+GV +  + T AV   K D +  +   EF  E  V+ +
Sbjct: 9   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKE 65
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLL 632
             H NLV+LLG C       ++ EF+  G L  +L      + N  +   +A QI+  + 
Sbjct: 66  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 125
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 692
           YL    +   IH D+  +N L+ + +  +++DFGL++L+T   + T     +    + AP
Sbjct: 126 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 181
Query: 693 EWFRNSKITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDCYRNGKLNVL 750
           E    +K + K DV++FGVLL EI +   S    I++ + Y +L                
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL---------------- 225
Query: 751 VGEDKEAMNDIE-CLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 799
             E    M   E C  K+  +   C Q +PS RP+  ++ Q  E + + S
Sbjct: 226 --EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 79/287 (27%), Positives = 136/287 (47%), Gaps = 28/287 (9%)
Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ 574
           E+E      K ++G G +G VY+GV +  + T AV   K D +  +   EF  E  V+ +
Sbjct: 14  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKE 70
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLL 632
             H NLV+LLG C       ++ EF+  G L  +L      + N  +   +A QI+  + 
Sbjct: 71  IKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 130
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 692
           YL    +   IH D+  +N L+ + +  +++DFGL++L+T   + T     +    + AP
Sbjct: 131 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 186
Query: 693 EWFRNSKITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDCYRNGKLNVL 750
           E    +K + K DV++FGVLL EI +   S    I++ + Y +L        ++ ++   
Sbjct: 187 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-------KDYRMERP 239
Query: 751 VGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 797
            G          C  K+  +   C Q +PS RP+  ++ Q  E + +
Sbjct: 240 EG----------CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 276

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 113/204 (55%), Gaps = 11/204 (5%)
Query: 522 NFKEEVGRGSFGIVYKG-VIQTRTSTTAVAVKKLDRVFQDGE-REFKNEVFVIGQTHHKN 579
           +F E +GRG FG VY G ++         AVK L+R+   GE  +F  E  ++    H N
Sbjct: 31  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 90
Query: 580 LVRLLGFCDEGQ-NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF--QIARGLLYLHE 636
           ++ LLG C   + + L+V  ++ +G L +F+  N   N  ++  I F  Q+A+G+ +L  
Sbjct: 91  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKFL-- 147
Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI--KTAIRGTKGYVAPEW 694
               + +H D+  +N +LD+ +T +++DFGLA+ +   +  ++  KT  +    ++A E 
Sbjct: 148 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 206
Query: 695 FRNSKITAKVDVYSFGVLLLEIIS 718
            +  K T K DV+SFGVLL E+++
Sbjct: 207 LQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 137/289 (47%), Gaps = 28/289 (9%)
Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ 574
           E+E      K ++G G +G VY+GV +  + T AV   K D +  +   EF  E  V+ +
Sbjct: 22  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKE 78
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLL 632
             H NLV+LLG C       ++ EF+  G L  +L      + N  +   +A QI+  + 
Sbjct: 79  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 138
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 692
           YL    +   IH D+  +N L+ + +  +++DFGL++L+T   + T     +    + AP
Sbjct: 139 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 194
Query: 693 EWFRNSKITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDCYRNGKLNVL 750
           E    +K + K DV++FGVLL EI +   S    I++ + Y +L        ++ ++   
Sbjct: 195 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-------KDYRMERP 247
Query: 751 VGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 799
            G          C  K+  +   C Q +PS RP+  ++ Q  E + + S
Sbjct: 248 EG----------CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 286

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 137/289 (47%), Gaps = 28/289 (9%)
Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ 574
           E+E      K ++G G +G VY+GV +  + T AV   K D +  +   EF  E  V+ +
Sbjct: 10  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKE 66
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLL 632
             H NLV+LLG C       ++ EF+  G L  +L      + N  +   +A QI+  + 
Sbjct: 67  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 126
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 692
           YL    +   IH D+  +N L+ + +  +++DFGL++L+T   + T     +    + AP
Sbjct: 127 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAPAGAKFPIKWTAP 182
Query: 693 EWFRNSKITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDCYRNGKLNVL 750
           E    +K + K DV++FGVLL EI +   S    I++ + Y +L        ++ ++   
Sbjct: 183 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-------KDYRMERP 235
Query: 751 VGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 799
            G          C  K+  +   C Q +PS RP+  ++ Q  E + + S
Sbjct: 236 EG----------CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 274

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 113/204 (55%), Gaps = 11/204 (5%)
Query: 522 NFKEEVGRGSFGIVYKG-VIQTRTSTTAVAVKKLDRVFQDGE-REFKNEVFVIGQTHHKN 579
           +F E +GRG FG VY G ++         AVK L+R+   GE  +F  E  ++    H N
Sbjct: 34  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 93
Query: 580 LVRLLGFCDEGQ-NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF--QIARGLLYLHE 636
           ++ LLG C   + + L+V  ++ +G L +F+  N   N  ++  I F  Q+A+G+ +L  
Sbjct: 94  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKFL-- 150
Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI--KTAIRGTKGYVAPEW 694
               + +H D+  +N +LD+ +T +++DFGLA+ +   +  ++  KT  +    ++A E 
Sbjct: 151 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 209
Query: 695 FRNSKITAKVDVYSFGVLLLEIIS 718
            +  K T K DV+SFGVLL E+++
Sbjct: 210 LQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 137/289 (47%), Gaps = 28/289 (9%)
Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ 574
           E+E      K ++G G +G VY+GV +  + T AV   K D +  +   EF  E  V+ +
Sbjct: 11  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKE 67
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLL 632
             H NLV+LLG C       ++ EF+  G L  +L      + N  +   +A QI+  + 
Sbjct: 68  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 127
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 692
           YL    +   IH D+  +N L+ + +  +++DFGL++L+T   + T     +    + AP
Sbjct: 128 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAPAGAKFPIKWTAP 183
Query: 693 EWFRNSKITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDCYRNGKLNVL 750
           E    +K + K DV++FGVLL EI +   S    I++ + Y +L        ++ ++   
Sbjct: 184 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-------KDYRMERP 236
Query: 751 VGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 799
            G          C  K+  +   C Q +PS RP+  ++ Q  E + + S
Sbjct: 237 EG----------CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 275

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 137/289 (47%), Gaps = 28/289 (9%)
Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ 574
           E+E      K ++G G +G VY+GV +  + T AV   K D +  +   EF  E  V+ +
Sbjct: 11  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKE 67
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLL 632
             H NLV+LLG C       ++ EF+  G L  +L      + N  +   +A QI+  + 
Sbjct: 68  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 127
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 692
           YL    +   IH D+  +N L+ + +  +++DFGL++L+T   + T     +    + AP
Sbjct: 128 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 183
Query: 693 EWFRNSKITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDCYRNGKLNVL 750
           E    +K + K DV++FGVLL EI +   S    I++ + Y +L        ++ ++   
Sbjct: 184 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-------KDYRMERP 236
Query: 751 VGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 799
            G          C  K+  +   C Q +PS RP+  ++ Q  E + + S
Sbjct: 237 EG----------CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 275

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 137/289 (47%), Gaps = 28/289 (9%)
Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ 574
           E+E      K ++G G +G VY+GV +  + T AV   K D +  +   EF  E  V+ +
Sbjct: 11  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKE 67
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLL 632
             H NLV+LLG C       ++ EF+  G L  +L      + N  +   +A QI+  + 
Sbjct: 68  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 127
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 692
           YL    +   IH D+  +N L+ + +  +++DFGL++L+T   + T     +    + AP
Sbjct: 128 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 183
Query: 693 EWFRNSKITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDCYRNGKLNVL 750
           E    +K + K DV++FGVLL EI +   S    I++ + Y +L        ++ ++   
Sbjct: 184 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-------KDYRMERP 236
Query: 751 VGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 799
            G          C  K+  +   C Q +PS RP+  ++ Q  E + + S
Sbjct: 237 EG----------CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 275

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 80/294 (27%), Positives = 142/294 (48%), Gaps = 36/294 (12%)
Query: 514 KELEGATNNFKEEVGRGSFGIVYKGVIQTRTST-TAVAVKKLDRVFQDGER-EFKNEVFV 571
           KEL+    +  + VG G FG V  G ++  +    +VA+K L   + + +R +F  E  +
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 572 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPNWNLRTNIAF 625
           +GQ  H N++RL G   + +  ++V E++ NG+L SFL      F  ++    LR     
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRG---- 155
Query: 626 QIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRG 685
            IA G+ YL +      +H D+  +NIL++     ++SDFGLA++L  +      T  RG
Sbjct: 156 -IASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTT--RG 209
Query: 686 TK---GYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 742
            K    + +PE     K T+  DV+S+G++L E++S  +    EM  +  I         
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA------- 262
Query: 743 RNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 796
                   V E       ++C   L  + + C Q+D + RP  ++++ +L+ ++
Sbjct: 263 --------VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 132/284 (46%), Gaps = 30/284 (10%)
Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ 574
           E+E      K ++G G +G VY+GV +  + T AV   K D +  +   EF  E  V+ +
Sbjct: 9   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKE 65
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLL 632
             H NLV+LLG C       ++ EF+  G L  +L      + N  +   +A QI+  + 
Sbjct: 66  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 125
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 692
           YL    +   IH D+  +N L+ + +  +++DFGL++L+T   + T     +    + AP
Sbjct: 126 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 181
Query: 693 EWFRNSKITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDCYRNGKLNVL 750
           E    +K + K DV++FGVLL EI +   S    I++ + Y +L                
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL---------------- 225
Query: 751 VGEDKEAMNDIE-CLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
             E    M   E C  K+  +   C Q +PS RP+  ++ Q  E
Sbjct: 226 --EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 267

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 78/287 (27%), Positives = 132/287 (45%), Gaps = 24/287 (8%)
Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ 574
           E+E      K ++G G FG VY+GV +  + T AV   K D +  +   EF  E  V+ +
Sbjct: 7   EMERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKE 63
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLL 632
             H NLV+LLG C       ++ EF+  G L  +L      + +  +   +A QI+  + 
Sbjct: 64  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 123
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 692
           YL    +   IH D+  +N L+ + +  +++DFGL++L+T   + T     +    + AP
Sbjct: 124 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAP 179
Query: 693 EWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVG 752
           E    +K + K DV++FGVLL EI +   S                +      ++  L+ 
Sbjct: 180 ESLAYNKFSIKSDVWAFGVLLWEIATYGMS---------------PYPGIDPSQVYELLE 224
Query: 753 EDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 799
           +D        C  K+  +   C Q +PS RP+  ++ Q  E + + S
Sbjct: 225 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 271

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 77/301 (25%), Positives = 142/301 (47%), Gaps = 51/301 (16%)
Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRT--STTAVAVKKLDRVFQDGER-EFKNEVFV 571
           E+  +    ++ +G G FG VYKG+++T +      VA+K L   + + +R +F  E  +
Sbjct: 40  EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 99
Query: 572 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPNWNLRTNIAF 625
           +GQ  H N++RL G   + +  +++ E++ NG L  FL      F  L+    LR     
Sbjct: 100 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRG---- 155
Query: 626 QIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRG 685
            IA G+ YL        +H D+  +NIL++     ++SDFGL+++L  +   T  T+  G
Sbjct: 156 -IAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS--G 209
Query: 686 TK---GYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 742
            K    + APE     K T+  DV+SFG+++ E+++            Y     W    +
Sbjct: 210 GKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMT------------YGERPYWELSNH 257
Query: 743 RNGKLNVLVGEDKEAMND-------IECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV 795
                     E  +A+ND       ++C   +  + + C Q++ + RP    ++ +L+ +
Sbjct: 258 ----------EVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307
Query: 796 V 796
           +
Sbjct: 308 I 308

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 142/294 (48%), Gaps = 36/294 (12%)
Query: 514 KELEGATNNFKEEVGRGSFGIVYKGVIQTRTST-TAVAVKKLDRVFQDGER-EFKNEVFV 571
           KEL+    +  + VG G FG V  G ++  +    +VA+K L   + + +R +F  E  +
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 572 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPNWNLRTNIAF 625
           +GQ  H N++RL G   + +  ++V E++ NG+L SFL      F  ++    LR     
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRG---- 155
Query: 626 QIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRG 685
            IA G+ YL +      +H D+  +NIL++     ++SDFGL+++L  +      T  RG
Sbjct: 156 -IASGMKYLSD---MGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT--RG 209
Query: 686 TK---GYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 742
            K    + +PE     K T+  DV+S+G++L E++S  +    EM  +  I         
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA------- 262
Query: 743 RNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 796
                   V E       ++C   L  + + C Q+D + RP  ++++ +L+ ++
Sbjct: 263 --------VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 82/299 (27%), Positives = 145/299 (48%), Gaps = 49/299 (16%)
Query: 526 EVGRGSFGIVYKGV---IQTRTSTTAVAVKKLDRVFQDGER-EFKNEVFVIGQTHHKNLV 581
           E+G+GSFG+VY+GV   +      T VA+K ++      ER EF NE  V+ + +  ++V
Sbjct: 17  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 76
Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK-----------PNWNLRTNIAFQIARG 630
           RLLG   +GQ  L++ E +  G L S+L  +L+           P+ +    +A +IA G
Sbjct: 77  RLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKMIQMAGEIADG 135
Query: 631 LLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKG-- 688
           + YL+ +   + +H D+  +N ++ + +T +I DFG+ +   + ++   +   +G KG  
Sbjct: 136 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIXETDXXR---KGGKGLL 187
Query: 689 ---YVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 745
              +++PE  ++   T   DV+SFGV+L EI               A L +  +    N 
Sbjct: 188 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------ATLAEQPYQGLSNE 232
Query: 746 KLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVL-----QMLEGVVEVS 799
           ++   V E         C   L+ +   C Q +P +RP+  +++     +M  G  EVS
Sbjct: 233 QVLRFVMEGGLLDKPDNCPDMLLELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 291

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 95.9 bits (237), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 142/294 (48%), Gaps = 36/294 (12%)
Query: 514 KELEGATNNFKEEVGRGSFGIVYKGVIQTRTST-TAVAVKKLDRVFQDGER-EFKNEVFV 571
           KEL+    +  + VG G FG V  G ++  +    +VA+K L   + + +R +F  E  +
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 572 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPNWNLRTNIAF 625
           +GQ  H N++RL G   + +  ++V E++ NG+L SFL      F  ++    LR     
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRG---- 155
Query: 626 QIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRG 685
            IA G+ YL +      +H D+  +NIL++     ++SDFGL+++L  +      T  RG
Sbjct: 156 -IASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT--RG 209
Query: 686 TK---GYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 742
            K    + +PE     K T+  DV+S+G++L E++S  +    EM  +  I         
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA------- 262
Query: 743 RNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 796
                   V E       ++C   L  + + C Q+D + RP  ++++ +L+ ++
Sbjct: 263 --------VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 95.9 bits (237), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 142/294 (48%), Gaps = 36/294 (12%)
Query: 514 KELEGATNNFKEEVGRGSFGIVYKGVIQTRTST-TAVAVKKLDRVFQDGER-EFKNEVFV 571
           KEL+    +  + VG G FG V  G ++  +    +VA+K L   + + +R +F  E  +
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 572 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPNWNLRTNIAF 625
           +GQ  H N++RL G   + +  ++V E++ NG+L SFL      F  ++    LR     
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRG---- 155
Query: 626 QIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRG 685
            IA G+ YL +      +H D+  +NIL++     ++SDFGL+++L  +      T  RG
Sbjct: 156 -IASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT--RG 209
Query: 686 TK---GYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 742
            K    + +PE     K T+  DV+S+G++L E++S  +    EM  +  I         
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA------- 262
Query: 743 RNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 796
                   V E       ++C   L  + + C Q+D + RP  ++++ +L+ ++
Sbjct: 263 --------VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 95.9 bits (237), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 142/294 (48%), Gaps = 36/294 (12%)
Query: 514 KELEGATNNFKEEVGRGSFGIVYKGVIQTRTST-TAVAVKKLDRVFQDGER-EFKNEVFV 571
           KEL+    +  + VG G FG V  G ++  +    +VA+K L   + + +R +F  E  +
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 572 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPNWNLRTNIAF 625
           +GQ  H N++RL G   + +  ++V E++ NG+L SFL      F  ++    LR     
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRG---- 155
Query: 626 QIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRG 685
            IA G+ YL +      +H D+  +NIL++     ++SDFGL+++L  +      T  RG
Sbjct: 156 -IASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT--RG 209
Query: 686 TK---GYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 742
            K    + +PE     K T+  DV+S+G++L E++S  +    EM  +  I         
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA------- 262
Query: 743 RNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 796
                   V E       ++C   L  + + C Q+D + RP  ++++ +L+ ++
Sbjct: 263 --------VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 95.9 bits (237), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 142/294 (48%), Gaps = 36/294 (12%)
Query: 514 KELEGATNNFKEEVGRGSFGIVYKGVIQTRTST-TAVAVKKLDRVFQDGER-EFKNEVFV 571
           KEL+    +  + VG G FG V  G ++  +    +VA+K L   + + +R +F  E  +
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 572 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPNWNLRTNIAF 625
           +GQ  H N++RL G   + +  ++V E++ NG+L SFL      F  ++    LR     
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRG---- 155
Query: 626 QIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRG 685
            IA G+ YL +      +H D+  +NIL++     ++SDFGL+++L  +      T  RG
Sbjct: 156 -IASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT--RG 209
Query: 686 TK---GYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 742
            K    + +PE     K T+  DV+S+G++L E++S  +    EM  +  I         
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA------- 262
Query: 743 RNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 796
                   V E       ++C   L  + + C Q+D + RP  ++++ +L+ ++
Sbjct: 263 --------VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 95.9 bits (237), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 77/287 (26%), Positives = 132/287 (45%), Gaps = 24/287 (8%)
Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ 574
           E+E      K ++G G +G VY+GV +  + T AV   K D +  +   EF  E  V+ +
Sbjct: 7   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKE 63
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLL 632
             H NLV+LLG C       ++ EF+  G L  +L      + +  +   +A QI+  + 
Sbjct: 64  IKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 123
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 692
           YL    +   IH D+  +N L+ + +  +++DFGL++L+T   + T     +    + AP
Sbjct: 124 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAP 179
Query: 693 EWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVG 752
           E    +K + K DV++FGVLL EI +   S                +      ++  L+ 
Sbjct: 180 ESLAYNKFSIKSDVWAFGVLLWEIATYGMS---------------PYPGIDPSQVYELLE 224
Query: 753 EDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 799
           +D        C  K+  +   C Q +PS RP+  ++ Q  E + + S
Sbjct: 225 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 271

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 95.9 bits (237), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 137/289 (47%), Gaps = 28/289 (9%)
Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ 574
           E+E      K ++G G +G VY+GV +  + T AV   K D +  +   EF  E  V+ +
Sbjct: 14  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKE 70
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLL 632
             H NLV+LLG C       ++ EF+  G L  +L      + +  +   +A QI+  + 
Sbjct: 71  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 130
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 692
           YL    +   IH D+  +N L+ + +  +++DFGL++L+T   + T     +    + AP
Sbjct: 131 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 186
Query: 693 EWFRNSKITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDCYRNGKLNVL 750
           E    +K + K DV++FGVLL EI +   S    I++ + Y +L        ++ ++   
Sbjct: 187 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-------KDYRMERP 239
Query: 751 VGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 799
            G          C  K+  +   C Q +PS RP+  ++ Q  E + + S
Sbjct: 240 EG----------CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 278

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 95.9 bits (237), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 142/294 (48%), Gaps = 36/294 (12%)
Query: 514 KELEGATNNFKEEVGRGSFGIVYKGVIQTRTST-TAVAVKKLDRVFQDGER-EFKNEVFV 571
           KEL+    +  + VG G FG V  G ++  +    +VA+K L   + + +R +F  E  +
Sbjct: 38  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 97
Query: 572 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPNWNLRTNIAF 625
           +GQ  H N++RL G   + +  ++V E++ NG+L SFL      F  ++    LR     
Sbjct: 98  MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRG---- 153
Query: 626 QIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRG 685
            IA G+ YL +      +H D+  +NIL++     ++SDFGL+++L  +      T  RG
Sbjct: 154 -IASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT--RG 207
Query: 686 TK---GYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 742
            K    + +PE     K T+  DV+S+G++L E++S  +    EM  +  I         
Sbjct: 208 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA------- 260
Query: 743 RNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 796
                   V E       ++C   L  + + C Q+D + RP  ++++ +L+ ++
Sbjct: 261 --------VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 306

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 95.9 bits (237), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 142/294 (48%), Gaps = 36/294 (12%)
Query: 514 KELEGATNNFKEEVGRGSFGIVYKGVIQTRTST-TAVAVKKLDRVFQDGER-EFKNEVFV 571
           KEL+    +  + VG G FG V  G ++  +    +VA+K L   + + +R +F  E  +
Sbjct: 28  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 87
Query: 572 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPNWNLRTNIAF 625
           +GQ  H N++RL G   + +  ++V E++ NG+L SFL      F  ++    LR     
Sbjct: 88  MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRG---- 143
Query: 626 QIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRG 685
            IA G+ YL +      +H D+  +NIL++     ++SDFGL+++L  +      T  RG
Sbjct: 144 -IASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT--RG 197
Query: 686 TK---GYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 742
            K    + +PE     K T+  DV+S+G++L E++S  +    EM  +  I         
Sbjct: 198 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA------- 250
Query: 743 RNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 796
                   V E       ++C   L  + + C Q+D + RP  ++++ +L+ ++
Sbjct: 251 --------VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 296

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 95.9 bits (237), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 82/299 (27%), Positives = 144/299 (48%), Gaps = 49/299 (16%)
Query: 526 EVGRGSFGIVYKGV---IQTRTSTTAVAVKKLDRVFQDGER-EFKNEVFVIGQTHHKNLV 581
           E+G+GSFG+VY+GV   +      T VA+K ++      ER EF NE  V+ + +  ++V
Sbjct: 26  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 85
Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK-----------PNWNLRTNIAFQIARG 630
           RLLG   +GQ  L++ E +  G L S+L  +L+           P+ +    +A +IA G
Sbjct: 86  RLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKMIQMAGEIADG 144
Query: 631 LLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKG-- 688
           + YL+ +   + +H D+  +N ++ + +T +I DFG+ +   + ++   +   +G KG  
Sbjct: 145 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIXETDXXR---KGGKGLL 196
Query: 689 ---YVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 745
              +++PE  ++   T   DV+SFGV+L EI               A L +  +    N 
Sbjct: 197 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------ATLAEQPYQGLSNE 241
Query: 746 KLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVL-----QMLEGVVEVS 799
           ++   V E         C   L  +   C Q +P +RP+  +++     +M  G  EVS
Sbjct: 242 QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 300

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 95.5 bits (236), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 137/289 (47%), Gaps = 28/289 (9%)
Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ 574
           E+E      K ++G G +G VY+GV +  + T AV   K D +  +   EF  E  V+ +
Sbjct: 9   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKE 65
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLL 632
             H NLV+LLG C       ++ EF+  G L  +L      + +  +   +A QI+  + 
Sbjct: 66  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 125
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 692
           YL    +   IH D+  +N L+ + +  +++DFGL++L+T   + T     +    + AP
Sbjct: 126 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 181
Query: 693 EWFRNSKITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDCYRNGKLNVL 750
           E    +K + K DV++FGVLL EI +   S    I++ + Y +L        ++ ++   
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-------KDYRMERP 234
Query: 751 VGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 799
            G          C  K+  +   C Q +PS RP+  ++ Q  E + + S
Sbjct: 235 EG----------CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 95.5 bits (236), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 142/294 (48%), Gaps = 36/294 (12%)
Query: 514 KELEGATNNFKEEVGRGSFGIVYKGVIQTRTST-TAVAVKKLDRVFQDGER-EFKNEVFV 571
           KEL+    +  + VG G FG V  G ++  +    +VA+K L   + + +R +F  E  +
Sbjct: 11  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 70
Query: 572 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPNWNLRTNIAF 625
           +GQ  H N++RL G   + +  ++V E++ NG+L SFL      F  ++    LR     
Sbjct: 71  MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRG---- 126
Query: 626 QIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRG 685
            IA G+ YL +      +H D+  +NIL++     ++SDFGL+++L  +      T  RG
Sbjct: 127 -IASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT--RG 180
Query: 686 TK---GYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 742
            K    + +PE     K T+  DV+S+G++L E++S  +    EM  +  I         
Sbjct: 181 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA------- 233
Query: 743 RNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 796
                   V E       ++C   L  + + C Q+D + RP  ++++ +L+ ++
Sbjct: 234 --------VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 279

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 137/289 (47%), Gaps = 28/289 (9%)
Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ 574
           E+E      K ++G G +G VY+GV +  + T AV   K D +  +   EF  E  V+ +
Sbjct: 9   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKE 65
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLL 632
             H NLV+LLG C       ++ EF+  G L  +L      + +  +   +A QI+  + 
Sbjct: 66  IKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 125
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 692
           YL    +   IH D+  +N L+ + +  +++DFGL++L+T   + T     +    + AP
Sbjct: 126 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 181
Query: 693 EWFRNSKITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDCYRNGKLNVL 750
           E    +K + K DV++FGVLL EI +   S    I++ + Y +L        ++ ++   
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-------KDYRMERP 234
Query: 751 VGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 799
            G          C  K+  +   C Q +PS RP+  ++ Q  E + + S
Sbjct: 235 EG----------CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/298 (27%), Positives = 142/298 (47%), Gaps = 47/298 (15%)
Query: 526 EVGRGSFGIVYKGV---IQTRTSTTAVAVKKLDRVFQDGER-EFKNEVFVIGQTHHKNLV 581
           E+G+GSFG+VY+GV   +      T VA+K ++      ER EF NE  V+ + +  ++V
Sbjct: 32  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFL------FGN----LKPNWNLRTNIAFQIARGL 631
           RLLG   +GQ  L++ E +  G L S+L        N      P+ +    +A +IA G+
Sbjct: 92  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151
Query: 632 LYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKG--- 688
            YL+ +   + +H D+  +N ++ + +T +I DFG+ +   + ++   +   +G KG   
Sbjct: 152 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYR---KGGKGLLP 203
Query: 689 --YVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 746
             +++PE  ++   T   DV+SFGV+L EI               A L +  +    N +
Sbjct: 204 VRWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------ATLAEQPYQGLSNEQ 248
Query: 747 LNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVL-----QMLEGVVEVS 799
           +   V E         C   L  +   C Q +P +RP+  +++     +M  G  EVS
Sbjct: 249 VLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 306

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 141/294 (47%), Gaps = 36/294 (12%)
Query: 514 KELEGATNNFKEEVGRGSFGIVYKGVIQTRTST-TAVAVKKLDRVFQDGER-EFKNEVFV 571
           KEL+    +  + VG G FG V  G ++  +    +VA+K L   + + +R +F  E  +
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 572 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPNWNLRTNIAF 625
           +GQ  H N++RL G   + +  ++V E++ NG+L SFL      F  ++    LR     
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRG---- 155
Query: 626 QIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRG 685
            IA G+ YL +      +H D+  +NIL++     ++SDFGL ++L  +      T  RG
Sbjct: 156 -IASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTT--RG 209
Query: 686 TK---GYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 742
            K    + +PE     K T+  DV+S+G++L E++S  +    EM  +  I         
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA------- 262
Query: 743 RNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 796
                   V E       ++C   L  + + C Q+D + RP  ++++ +L+ ++
Sbjct: 263 --------VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 137/289 (47%), Gaps = 28/289 (9%)
Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ 574
           E+E      K ++G G +G VY+GV +  + T AV   K D +  +   EF  E  V+ +
Sbjct: 9   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKE 65
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLL 632
             H NLV+LLG C       ++ EF+  G L  +L      + +  +   +A QI+  + 
Sbjct: 66  IKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 125
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 692
           YL    +   IH D+  +N L+ + +  +++DFGL++L+T   + T     +    + AP
Sbjct: 126 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 181
Query: 693 EWFRNSKITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDCYRNGKLNVL 750
           E    +K + K DV++FGVLL EI +   S    I++ + Y +L        ++ ++   
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-------KDYRMERP 234
Query: 751 VGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 799
            G          C  K+  +   C Q +PS RP+  ++ Q  E + + S
Sbjct: 235 EG----------CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 137/289 (47%), Gaps = 28/289 (9%)
Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ 574
           E+E      K ++G G +G VY+GV +  + T AV   K D +  +   EF  E  V+ +
Sbjct: 9   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKE 65
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLL 632
             H NLV+LLG C       ++ EF+  G L  +L      + +  +   +A QI+  + 
Sbjct: 66  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 125
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 692
           YL    +   IH D+  +N L+ + +  +++DFGL++L+T   + T     +    + AP
Sbjct: 126 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 181
Query: 693 EWFRNSKITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDCYRNGKLNVL 750
           E    +K + K DV++FGVLL EI +   S    I++ + Y +L        ++ ++   
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-------KDYRMERP 234
Query: 751 VGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 799
            G          C  K+  +   C Q +PS RP+  ++ Q  E + + S
Sbjct: 235 EG----------CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 84/309 (27%), Positives = 141/309 (45%), Gaps = 33/309 (10%)
Query: 496 RNSPDDGTIETNLRCFSYKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLD 555
           RN P    +  N   +   E+E      K ++G G +G VY+GV +  + T AV   K D
Sbjct: 200 RNKPTIYGVSPN---YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED 256
Query: 556 RVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF--GNL 613
            +  +   EF  E  V+ +  H NLV+LLG C       ++ EF+  G L  +L      
Sbjct: 257 TMEVE---EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ 313
Query: 614 KPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTL 673
           + +  +   +A QI+  + YL    +   IH ++  +N L+ + +  +++DFGL++L+T 
Sbjct: 314 EVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT- 369
Query: 674 NQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEY 731
             + T     +    + APE    +K + K DV++FGVLL EI +   S    I++ + Y
Sbjct: 370 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 429
Query: 732 AILTDWAFDCYRNGKLNVLVGEDKEAMNDIE-CLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
            +L                  E    M   E C  K+  +   C Q +PS RP+  ++ Q
Sbjct: 430 ELL------------------EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471
Query: 791 MLEGVVEVS 799
             E + + S
Sbjct: 472 AFETMFQES 480

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 139/295 (47%), Gaps = 42/295 (14%)
Query: 526 EVGRGSFGIVYKG---VIQTRTSTTAVAVKKLDRVFQDGER-EFKNEVFVIGQTHHKNLV 581
           E+G+GSFG+VY+G    I    + T VAVK ++      ER EF NE  V+      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLF----------GNLKPNWNLRTNIAFQIARGL 631
           RLLG   +GQ  L+V E + +G L S+L           G   P       +A +IA G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 632 LYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKG--- 688
            YL+     + +H D+  +N ++   +T +I DFG+ +   + ++   +   +G KG   
Sbjct: 144 AYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIXETDXXR---KGGKGLLP 195
Query: 689 --YVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 746
             ++APE  ++   T   D++SFGV+L EI S               L +  +    N +
Sbjct: 196 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQ 240
Query: 747 LNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVP 801
           +   V +         C  ++  +   C Q +P++RPT  +++ +L+  +  S P
Sbjct: 241 VLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDDLHPSFP 295

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/298 (27%), Positives = 142/298 (47%), Gaps = 47/298 (15%)
Query: 526 EVGRGSFGIVYKGV---IQTRTSTTAVAVKKLDRVFQDGER-EFKNEVFVIGQTHHKNLV 581
           E+G+GSFG+VY+GV   +      T VA+K ++      ER EF NE  V+ + +  ++V
Sbjct: 22  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 81
Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFL------FGN----LKPNWNLRTNIAFQIARGL 631
           RLLG   +GQ  L++ E +  G L S+L        N      P+ +    +A +IA G+
Sbjct: 82  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 141
Query: 632 LYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKG--- 688
            YL+ +   + +H D+  +N ++ + +T +I DFG+ +   + ++   +   +G KG   
Sbjct: 142 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYR---KGGKGLLP 193
Query: 689 --YVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 746
             +++PE  ++   T   DV+SFGV+L EI               A L +  +    N +
Sbjct: 194 VRWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------ATLAEQPYQGLSNEQ 238
Query: 747 LNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVL-----QMLEGVVEVS 799
           +   V E         C   L  +   C Q +P +RP+  +++     +M  G  EVS
Sbjct: 239 VLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 296

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 138/295 (46%), Gaps = 42/295 (14%)
Query: 526 EVGRGSFGIVYKG---VIQTRTSTTAVAVKKLDRVFQDGER-EFKNEVFVIGQTHHKNLV 581
           E+G+GSFG+VY+G    I    + T VAVK ++      ER EF NE  V+      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLF----------GNLKPNWNLRTNIAFQIARGL 631
           RLLG   +GQ  L+V E + +G L S+L           G   P       +A +IA G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 632 LYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKG--- 688
            YL+     + +H D+  +N ++   +T +I DFG+ +   + ++   +   +G KG   
Sbjct: 144 AYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIXETDXXR---KGGKGLLP 195
Query: 689 --YVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 746
             ++APE  ++   T   D++SFGV+L EI S               L +  +    N +
Sbjct: 196 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQ 240
Query: 747 LNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVP 801
           +   V +         C  ++  +   C Q +P +RPT  +++ +L+  +  S P
Sbjct: 241 VLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 295

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 138/295 (46%), Gaps = 42/295 (14%)
Query: 526 EVGRGSFGIVYKG---VIQTRTSTTAVAVKKLDRVFQDGER-EFKNEVFVIGQTHHKNLV 581
           E+G+GSFG+VY+G    I    + T VAVK ++      ER EF NE  V+      ++V
Sbjct: 21  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 80
Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLF----------GNLKPNWNLRTNIAFQIARGL 631
           RLLG   +GQ  L+V E + +G L S+L           G   P       +A +IA G+
Sbjct: 81  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 140
Query: 632 LYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKG--- 688
            YL+     + +H D+  +N ++   +T +I DFG+ +   + ++   +   +G KG   
Sbjct: 141 AYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIXETDXXR---KGGKGLLP 192
Query: 689 --YVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 746
             ++APE  ++   T   D++SFGV+L EI S               L +  +    N +
Sbjct: 193 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQ 237
Query: 747 LNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVP 801
           +   V +         C  ++  +   C Q +P +RPT  +++ +L+  +  S P
Sbjct: 238 VLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 292

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/299 (27%), Positives = 144/299 (48%), Gaps = 49/299 (16%)
Query: 526 EVGRGSFGIVYKGV---IQTRTSTTAVAVKKLDRVFQDGER-EFKNEVFVIGQTHHKNLV 581
           E+G+GSFG+VY+GV   +      T VA+K ++      ER EF NE  V+ + +  ++V
Sbjct: 32  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK-----------PNWNLRTNIAFQIARG 630
           RLLG   +GQ  L++ E +  G L S+L  +L+           P+ +    +A +IA G
Sbjct: 92  RLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKMIQMAGEIADG 150
Query: 631 LLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKG-- 688
           + YL+ +   + +H D+  +N ++ + +T +I DFG+ +   + ++   +   +G KG  
Sbjct: 151 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYR---KGGKGLL 202
Query: 689 ---YVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 745
              +++PE  ++   T   DV+SFGV+L EI               A L +  +    N 
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------ATLAEQPYQGLSNE 247
Query: 746 KLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVL-----QMLEGVVEVS 799
           ++   V E         C   L  +   C Q +P +RP+  +++     +M  G  EVS
Sbjct: 248 QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 306

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/299 (27%), Positives = 144/299 (48%), Gaps = 49/299 (16%)
Query: 526 EVGRGSFGIVYKGV---IQTRTSTTAVAVKKLDRVFQDGER-EFKNEVFVIGQTHHKNLV 581
           E+G+GSFG+VY+GV   +      T VA+K ++      ER EF NE  V+ + +  ++V
Sbjct: 26  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 85
Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK-----------PNWNLRTNIAFQIARG 630
           RLLG   +GQ  L++ E +  G L S+L  +L+           P+ +    +A +IA G
Sbjct: 86  RLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKMIQMAGEIADG 144
Query: 631 LLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKG-- 688
           + YL+ +   + +H D+  +N ++ + +T +I DFG+ +   + ++   +   +G KG  
Sbjct: 145 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYR---KGGKGLL 196
Query: 689 ---YVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 745
              +++PE  ++   T   DV+SFGV+L EI               A L +  +    N 
Sbjct: 197 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------ATLAEQPYQGLSNE 241
Query: 746 KLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVL-----QMLEGVVEVS 799
           ++   V E         C   L  +   C Q +P +RP+  +++     +M  G  EVS
Sbjct: 242 QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 300

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 83/297 (27%), Positives = 137/297 (46%), Gaps = 46/297 (15%)
Query: 526 EVGRGSFGIVYKG---VIQTRTSTTAVAVKKLDRVFQDGER-EFKNEVFVIGQTHHKNLV 581
           E+G+GSFG+VY+G    I    + T VAVK ++      ER EF NE  V+      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLF----------GNLKPNWNLRTNIAFQIARGL 631
           RLLG   +GQ  L+V E + +G L S+L           G   P       +A +IA G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 632 LYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAI--RGTKG- 688
            YL+     + +H D+  +N ++   +T +I DFG+ +          +TA   +G KG 
Sbjct: 144 AYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTR-------DIYETAYYRKGGKGL 193
Query: 689 ----YVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 744
               ++APE  ++   T   D++SFGV+L EI S               L +  +    N
Sbjct: 194 LPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSN 238
Query: 745 GKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVP 801
            ++   V +         C  ++  +   C Q +P +RPT  +++ +L+  +  S P
Sbjct: 239 EQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 295

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/299 (27%), Positives = 144/299 (48%), Gaps = 49/299 (16%)
Query: 526 EVGRGSFGIVYKGV---IQTRTSTTAVAVKKLDRVFQDGER-EFKNEVFVIGQTHHKNLV 581
           E+G+GSFG+VY+GV   +      T VA+K ++      ER EF NE  V+ + +  ++V
Sbjct: 23  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 82
Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK-----------PNWNLRTNIAFQIARG 630
           RLLG   +GQ  L++ E +  G L S+L  +L+           P+ +    +A +IA G
Sbjct: 83  RLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKMIQMAGEIADG 141
Query: 631 LLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKG-- 688
           + YL+ +   + +H D+  +N ++ + +T +I DFG+ +   + ++   +   +G KG  
Sbjct: 142 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYR---KGGKGLL 193
Query: 689 ---YVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 745
              +++PE  ++   T   DV+SFGV+L EI               A L +  +    N 
Sbjct: 194 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------ATLAEQPYQGLSNE 238
Query: 746 KLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVL-----QMLEGVVEVS 799
           ++   V E         C   L  +   C Q +P +RP+  +++     +M  G  EVS
Sbjct: 239 QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 297

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/299 (27%), Positives = 144/299 (48%), Gaps = 49/299 (16%)
Query: 526 EVGRGSFGIVYKGV---IQTRTSTTAVAVKKLDRVFQDGER-EFKNEVFVIGQTHHKNLV 581
           E+G+GSFG+VY+GV   +      T VA+K ++      ER EF NE  V+ + +  ++V
Sbjct: 19  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 78
Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK-----------PNWNLRTNIAFQIARG 630
           RLLG   +GQ  L++ E +  G L S+L  +L+           P+ +    +A +IA G
Sbjct: 79  RLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKMIQMAGEIADG 137
Query: 631 LLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKG-- 688
           + YL+ +   + +H D+  +N ++ + +T +I DFG+ +   + ++   +   +G KG  
Sbjct: 138 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYR---KGGKGLL 189
Query: 689 ---YVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 745
              +++PE  ++   T   DV+SFGV+L EI               A L +  +    N 
Sbjct: 190 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------ATLAEQPYQGLSNE 234
Query: 746 KLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVL-----QMLEGVVEVS 799
           ++   V E         C   L  +   C Q +P +RP+  +++     +M  G  EVS
Sbjct: 235 QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 293

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/299 (27%), Positives = 144/299 (48%), Gaps = 49/299 (16%)
Query: 526 EVGRGSFGIVYKGV---IQTRTSTTAVAVKKLDRVFQDGER-EFKNEVFVIGQTHHKNLV 581
           E+G+GSFG+VY+GV   +      T VA+K ++      ER EF NE  V+ + +  ++V
Sbjct: 25  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 84
Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK-----------PNWNLRTNIAFQIARG 630
           RLLG   +GQ  L++ E +  G L S+L  +L+           P+ +    +A +IA G
Sbjct: 85  RLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKMIQMAGEIADG 143
Query: 631 LLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKG-- 688
           + YL+ +   + +H D+  +N ++ + +T +I DFG+ +   + ++   +   +G KG  
Sbjct: 144 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYR---KGGKGLL 195
Query: 689 ---YVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 745
              +++PE  ++   T   DV+SFGV+L EI               A L +  +    N 
Sbjct: 196 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------ATLAEQPYQGLSNE 240
Query: 746 KLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVL-----QMLEGVVEVS 799
           ++   V E         C   L  +   C Q +P +RP+  +++     +M  G  EVS
Sbjct: 241 QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 299

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 141/294 (47%), Gaps = 36/294 (12%)
Query: 514 KELEGATNNFKEEVGRGSFGIVYKGVIQTRTST-TAVAVKKLDRVFQDGER-EFKNEVFV 571
           KEL+    +  + VG G FG V  G ++  +    +VA+K L   + + +R +F  E  +
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 572 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPNWNLRTNIAF 625
           +GQ  H N++RL G   + +  ++V E + NG+L SFL      F  ++    LR     
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRG---- 155
Query: 626 QIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRG 685
            IA G+ YL +      +H D+  +NIL++     ++SDFGL+++L  +      T  RG
Sbjct: 156 -IASGMKYLSD---MGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT--RG 209
Query: 686 TK---GYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 742
            K    + +PE     K T+  DV+S+G++L E++S  +    EM  +  I         
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA------- 262
Query: 743 RNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 796
                   V E       ++C   L  + + C Q+D + RP  ++++ +L+ ++
Sbjct: 263 --------VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/299 (27%), Positives = 144/299 (48%), Gaps = 49/299 (16%)
Query: 526 EVGRGSFGIVYKGV---IQTRTSTTAVAVKKLDRVFQDGER-EFKNEVFVIGQTHHKNLV 581
           E+G+GSFG+VY+GV   +      T VA+K ++      ER EF NE  V+ + +  ++V
Sbjct: 54  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 113
Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK-----------PNWNLRTNIAFQIARG 630
           RLLG   +GQ  L++ E +  G L S+L  +L+           P+ +    +A +IA G
Sbjct: 114 RLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKMIQMAGEIADG 172
Query: 631 LLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKG-- 688
           + YL+ +   + +H D+  +N ++ + +T +I DFG+ +   + ++   +   +G KG  
Sbjct: 173 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYR---KGGKGLL 224
Query: 689 ---YVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 745
              +++PE  ++   T   DV+SFGV+L EI               A L +  +    N 
Sbjct: 225 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------ATLAEQPYQGLSNE 269
Query: 746 KLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVL-----QMLEGVVEVS 799
           ++   V E         C   L  +   C Q +P +RP+  +++     +M  G  EVS
Sbjct: 270 QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 328

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/299 (27%), Positives = 144/299 (48%), Gaps = 49/299 (16%)
Query: 526 EVGRGSFGIVYKGV---IQTRTSTTAVAVKKLDRVFQDGER-EFKNEVFVIGQTHHKNLV 581
           E+G+GSFG+VY+GV   +      T VA+K ++      ER EF NE  V+ + +  ++V
Sbjct: 25  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 84
Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK-----------PNWNLRTNIAFQIARG 630
           RLLG   +GQ  L++ E +  G L S+L  +L+           P+ +    +A +IA G
Sbjct: 85  RLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKMIQMAGEIADG 143
Query: 631 LLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKG-- 688
           + YL+ +   + +H D+  +N ++ + +T +I DFG+ +   + ++   +   +G KG  
Sbjct: 144 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYR---KGGKGLL 195
Query: 689 ---YVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 745
              +++PE  ++   T   DV+SFGV+L EI               A L +  +    N 
Sbjct: 196 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------ATLAEQPYQGLSNE 240
Query: 746 KLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVL-----QMLEGVVEVS 799
           ++   V E         C   L  +   C Q +P +RP+  +++     +M  G  EVS
Sbjct: 241 QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 299

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 141/294 (47%), Gaps = 36/294 (12%)
Query: 514 KELEGATNNFKEEVGRGSFGIVYKGVIQTRTST-TAVAVKKLDRVFQDGER-EFKNEVFV 571
           KEL+    +  + VG G FG V  G ++  +    +VA+K L   + + +R +F  E  +
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 572 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPNWNLRTNIAF 625
           +GQ  H N++RL G   + +  ++V E + NG+L SFL      F  ++    LR     
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRG---- 155
Query: 626 QIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRG 685
            IA G+ YL +      +H D+  +NIL++     ++SDFGL+++L  +      T  RG
Sbjct: 156 -IASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT--RG 209
Query: 686 TK---GYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 742
            K    + +PE     K T+  DV+S+G++L E++S  +    EM  +  I         
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA------- 262
Query: 743 RNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 796
                   V E       ++C   L  + + C Q+D + RP  ++++ +L+ ++
Sbjct: 263 --------VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 94.4 bits (233), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 134/285 (47%), Gaps = 34/285 (11%)
Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ 574
           E+   +   + ++G+G FG V+ G   T   TT VA+K L       E  F  E  V+ +
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMG---TWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKK 69
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR--TNIAFQIARGLL 632
             H+ LV+L     E +   +V E+++ G+L  FL G +     L    ++A QIA G+ 
Sbjct: 70  LRHEKLVQLYAVVSE-EPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMA 128
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK---GY 689
           Y+    R   +H D++  NIL+ +    +++DFGLA+L+  N+     TA +G K    +
Sbjct: 129 YVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEX----TARQGAKFPIKW 181
Query: 690 VAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLN 748
            APE     + T K DV+SFG+LL E+ +  R  +   +  E         D    G   
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGYRM 234
Query: 749 VLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
               E  E+++D+ C          C ++DP  RPT + +   LE
Sbjct: 235 PCPPECPESLHDLMCQ---------CWRKDPEERPTFEYLQAFLE 270

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 77/287 (26%), Positives = 132/287 (45%), Gaps = 24/287 (8%)
Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ 574
           E+E      K ++G G +G VY+GV +  + T AV   K D +  +   EF  E  V+ +
Sbjct: 7   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKE 63
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLL 632
             H NLV+LLG C       ++ EF+  G L  +L      + +  +   +A QI+  + 
Sbjct: 64  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 123
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 692
           YL    +   IH D+  +N L+ + +  +++DFGL++L+T   + T     +    + AP
Sbjct: 124 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTFTAHAGAKFPIKWTAP 179
Query: 693 EWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVG 752
           E    +K + K DV++FGVLL EI +   S                +      ++  L+ 
Sbjct: 180 ESLAYNKFSIKSDVWAFGVLLWEIATYGMS---------------PYPGIDPSQVYELLE 224
Query: 753 EDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 799
           +D        C  K+  +   C Q +PS RP+  ++ Q  E + + S
Sbjct: 225 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 271

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 138/295 (46%), Gaps = 42/295 (14%)
Query: 526 EVGRGSFGIVYKG---VIQTRTSTTAVAVKKLDRVFQDGER-EFKNEVFVIGQTHHKNLV 581
           E+G+GSFG+VY+G    I    + T VAVK ++      ER EF NE  V+      ++V
Sbjct: 23  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 82
Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLF----------GNLKPNWNLRTNIAFQIARGL 631
           RLLG   +GQ  L+V E + +G L S+L           G   P       +A +IA G+
Sbjct: 83  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 142
Query: 632 LYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKG--- 688
            YL+     + +H D+  +N ++   +T +I DFG+ +   + ++   +   +G KG   
Sbjct: 143 AYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYR---KGGKGLLP 194
Query: 689 --YVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 746
             ++APE  ++   T   D++SFGV+L EI S               L +  +    N +
Sbjct: 195 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQ 239
Query: 747 LNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVP 801
           +   V +         C  ++  +   C Q +P +RPT  +++ +L+  +  S P
Sbjct: 240 VLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 294

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 141/294 (47%), Gaps = 36/294 (12%)
Query: 514 KELEGATNNFKEEVGRGSFGIVYKGVIQTRTST-TAVAVKKLDRVFQDGER-EFKNEVFV 571
           KEL+    +  + VG G FG V  G ++  +    +VA+K L   + + +R +F  E  +
Sbjct: 11  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 70
Query: 572 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPNWNLRTNIAF 625
           +GQ  H N++RL G   + +  ++V E + NG+L SFL      F  ++    LR     
Sbjct: 71  MGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRG---- 126
Query: 626 QIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRG 685
            IA G+ YL +      +H D+  +NIL++     ++SDFGL+++L  +      T  RG
Sbjct: 127 -IASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT--RG 180
Query: 686 TK---GYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 742
            K    + +PE     K T+  DV+S+G++L E++S  +    EM  +  I         
Sbjct: 181 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA------- 233
Query: 743 RNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 796
                   V E       ++C   L  + + C Q+D + RP  ++++ +L+ ++
Sbjct: 234 --------VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 279

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 134/285 (47%), Gaps = 34/285 (11%)
Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ 574
           E+   +   + ++G+G FG V+ G   T   TT VA+K L       E  F  E  V+ +
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMG---TWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKK 69
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR--TNIAFQIARGLL 632
             H+ LV+L     E +   +V E+++ G+L  FL G +     L    ++A QIA G+ 
Sbjct: 70  IRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMA 128
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK---GY 689
           Y+    R   +H D++  NIL+ +    +++DFGLA+L+  N+     TA +G K    +
Sbjct: 129 YVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY----TARQGAKFPIKW 181
Query: 690 VAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLN 748
            APE     + T K DV+SFG+LL E+ +  R  +   +  E         D    G   
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGYRM 234
Query: 749 VLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
               E  E+++D+ C          C ++DP  RPT + +   LE
Sbjct: 235 PCPPECPESLHDLMCQ---------CWRKDPEERPTFEYLQAFLE 270

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 138/295 (46%), Gaps = 42/295 (14%)
Query: 526 EVGRGSFGIVYKG---VIQTRTSTTAVAVKKLDRVFQDGER-EFKNEVFVIGQTHHKNLV 581
           E+G+GSFG+VY+G    I    + T VAVK ++      ER EF NE  V+      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLF----------GNLKPNWNLRTNIAFQIARGL 631
           RLLG   +GQ  L+V E + +G L S+L           G   P       +A +IA G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 632 LYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKG--- 688
            YL+     + +H D+  +N ++   +T +I DFG+ +   + ++   +   +G KG   
Sbjct: 144 AYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYR---KGGKGLLP 195
Query: 689 --YVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 746
             ++APE  ++   T   D++SFGV+L EI S               L +  +    N +
Sbjct: 196 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQ 240
Query: 747 LNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVP 801
           +   V +         C  ++  +   C Q +P +RPT  +++ +L+  +  S P
Sbjct: 241 VLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 295

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 134/285 (47%), Gaps = 34/285 (11%)
Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ 574
           E+   +   + ++G+G FG V+ G   T   TT VA+K L       E  F  E  V+ +
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMG---TWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKK 69
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR--TNIAFQIARGLL 632
             H+ LV+L     E +   +V E+++ G+L  FL G +     L    ++A QIA G+ 
Sbjct: 70  LRHEKLVQLYAVVSE-EPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMA 128
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK---GY 689
           Y+    R   +H D++  NIL+ +    +++DFGLA+L+  N+     TA +G K    +
Sbjct: 129 YVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY----TARQGAKFPIKW 181
Query: 690 VAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLN 748
            APE     + T K DV+SFG+LL E+ +  R  +   +  E         D    G   
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGYRM 234
Query: 749 VLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
               E  E+++D+ C          C ++DP  RPT + +   LE
Sbjct: 235 PCPPECPESLHDLMCQ---------CWRKDPEERPTFEYLQAFLE 270

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 107/206 (51%), Gaps = 15/206 (7%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLD-RVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           + +G G++G V   V   R +  AVAVK +D +   D     K E+ +    +H+N+V+ 
Sbjct: 13  QTLGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKF 70
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA----FQIARGLLYLHEDCR 639
            G   EG  + L  E+ + G L    F  ++P+  +    A     Q+  G++YLH    
Sbjct: 71  YGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---G 123
Query: 640 AQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSK 699
             I H DIKP+N+LLD+    +ISDFGLA +   N  + +   + GT  YVAPE  +  +
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 183
Query: 700 ITAK-VDVYSFGVLLLEIISCRKSFD 724
             A+ VDV+S G++L  +++    +D
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 134/285 (47%), Gaps = 34/285 (11%)
Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ 574
           E+   +   + ++G+G FG V+ G   T   TT VA+K L       E  F  E  V+ +
Sbjct: 5   EIPRESLRLEVKLGQGCFGEVWMG---TWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKK 60
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR--TNIAFQIARGLL 632
             H+ LV+L     E +   +V E+++ G+L  FL G +     L    ++A QIA G+ 
Sbjct: 61  LRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMA 119
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK---GY 689
           Y+    R   +H D++  NIL+ +    +++DFGLA+L+  N+     TA +G K    +
Sbjct: 120 YVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY----TARQGAKFPIKW 172
Query: 690 VAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLN 748
            APE     + T K DV+SFG+LL E+ +  R  +   +  E         D    G   
Sbjct: 173 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGYRM 225
Query: 749 VLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
               E  E+++D+ C          C ++DP  RPT + +   LE
Sbjct: 226 PCPPECPESLHDLMCQ---------CWRKDPEERPTFEYLQAFLE 261

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 82/299 (27%), Positives = 144/299 (48%), Gaps = 49/299 (16%)
Query: 526 EVGRGSFGIVYKGV---IQTRTSTTAVAVKKLDRVFQDGER-EFKNEVFVIGQTHHKNLV 581
           E+G+GSFG+VY+GV   +      T VA+K ++      ER EF NE  V+ + +  ++V
Sbjct: 19  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 78
Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK-----------PNWNLRTNIAFQIARG 630
           RLLG   +GQ  L++ E +  G L S+L  +L+           P+ +    +A +IA G
Sbjct: 79  RLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKMIQMAGEIADG 137
Query: 631 LLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKG-- 688
           + YL+ +   + +H D+  +N  + + +T +I DFG+ +   + ++   +   +G KG  
Sbjct: 138 MAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTR--DIYETDYYR---KGGKGLL 189
Query: 689 ---YVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 745
              +++PE  ++   T   DV+SFGV+L EI               A L +  +    N 
Sbjct: 190 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------ATLAEQPYQGLSNE 234
Query: 746 KLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVL-----QMLEGVVEVS 799
           ++   V E         C   L+ +   C Q +P +RP+  +++     +M  G  EVS
Sbjct: 235 QVLRFVMEGGLLDKPDNCPDMLLELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 293

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 134/285 (47%), Gaps = 34/285 (11%)
Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ 574
           E+   +   + ++G+G FG V+ G   T   TT VA+K L       E  F  E  V+ +
Sbjct: 3   EIPRESLRLEVKLGQGCFGEVWMG---TWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKK 58
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR--TNIAFQIARGLL 632
             H+ LV+L     E +   +V E+++ G+L  FL G +     L    ++A QIA G+ 
Sbjct: 59  LRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMA 117
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK---GY 689
           Y+    R   +H D++  NIL+ +    +++DFGLA+L+  N+     TA +G K    +
Sbjct: 118 YVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY----TARQGAKFPIKW 170
Query: 690 VAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLN 748
            APE     + T K DV+SFG+LL E+ +  R  +   +  E         D    G   
Sbjct: 171 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGYRM 223
Query: 749 VLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
               E  E+++D+ C          C ++DP  RPT + +   LE
Sbjct: 224 PCPPECPESLHDLMCQ---------CWRKDPEERPTFEYLQAFLE 259

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 106/197 (53%), Gaps = 9/197 (4%)
Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE-REFKNEVFVIGQTHHKNLVRLL 584
           E+G G+FG V +GV + R     VA+K L +  +  +  E   E  ++ Q  +  +VRL+
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLK--PNWNLRTNIAFQIARGLLYLHEDCRAQI 642
           G C + +  +LV E    G L  FL G  +  P  N+   +  Q++ G+ YL E      
Sbjct: 77  GVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNV-AELLHQVSMGMKYLEEK---NF 131
Query: 643 IHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS-KTIKTAIRGTKGYVAPEWFRNSKIT 701
           +H D+  +N+LL + + A+ISDFGL+K L  + S  T ++A +    + APE     K +
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 191
Query: 702 AKVDVYSFGVLLLEIIS 718
           ++ DV+S+GV + E +S
Sbjct: 192 SRSDVWSYGVTMWEALS 208

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 107/206 (51%), Gaps = 15/206 (7%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLD-RVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           + +G G++G V   V   R +  AVAVK +D +   D     K E+ +    +H+N+V+ 
Sbjct: 12  QTLGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKF 69
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA----FQIARGLLYLHEDCR 639
            G   EG  + L  E+ + G L    F  ++P+  +    A     Q+  G++YLH    
Sbjct: 70  YGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG--- 122
Query: 640 AQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSK 699
             I H DIKP+N+LLD+    +ISDFGLA +   N  + +   + GT  YVAPE  +  +
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 700 ITAK-VDVYSFGVLLLEIISCRKSFD 724
             A+ VDV+S G++L  +++    +D
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 134/285 (47%), Gaps = 34/285 (11%)
Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ 574
           E+   +   + ++G+G FG V+ G   T   TT VA+K L       E  F  E  V+ +
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMG---TWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKK 69
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR--TNIAFQIARGLL 632
             H+ LV+L     E +   +V E+++ G+L  FL G +     L    ++A QIA G+ 
Sbjct: 70  LRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMA 128
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK---GY 689
           Y+    R   +H D++  NIL+ +    +++DFGLA+L+  N+     TA +G K    +
Sbjct: 129 YVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY----TARQGAKFPIKW 181
Query: 690 VAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLN 748
            APE     + T K DV+SFG+LL E+ +  R  +   +  E         D    G   
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGYRM 234
Query: 749 VLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
               E  E+++D+ C          C ++DP  RPT + +   LE
Sbjct: 235 PCPPECPESLHDLMCQ---------CWRKDPEERPTFEYLQAFLE 270

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 108/209 (51%), Gaps = 15/209 (7%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLD-RVFQDGEREFKNEVFVIGQTHHKNL 580
           +  + +G G++G V   V   R +  AVAVK +D +   D     K E+ +    +H+N+
Sbjct: 10  DLVQTLGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENV 67
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA----FQIARGLLYLHE 636
           V+  G   EG  + L  E+ + G L    F  ++P+  +    A     Q+  G++YLH 
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH- 122
Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR 696
                I H DIKP+N+LLD+    +ISDFGLA +   N  + +   + GT  YVAPE  +
Sbjct: 123 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 697 NSKITAK-VDVYSFGVLLLEIISCRKSFD 724
             +  A+ VDV+S G++L  +++    +D
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 108/209 (51%), Gaps = 15/209 (7%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLD-RVFQDGEREFKNEVFVIGQTHHKNL 580
           +  + +G G++G V   V   R +  AVAVK +D +   D     K E+ +    +H+N+
Sbjct: 9   DLVQTLGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA----FQIARGLLYLHE 636
           V+  G   EG  + L  E+ + G L    F  ++P+  +    A     Q+  G++YLH 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH- 121
Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR 696
                I H DIKP+N+LLD+    +ISDFGLA +   N  + +   + GT  YVAPE  +
Sbjct: 122 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 697 NSKITAK-VDVYSFGVLLLEIISCRKSFD 724
             +  A+ VDV+S G++L  +++    +D
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 108/209 (51%), Gaps = 15/209 (7%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLD-RVFQDGEREFKNEVFVIGQTHHKNL 580
           +  + +G G++G V   V   R +  AVAVK +D +   D     K E+ +    +H+N+
Sbjct: 9   DLVQTLGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA----FQIARGLLYLHE 636
           V+  G   EG  + L  E+ + G L    F  ++P+  +    A     Q+  G++YLH 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR 696
                I H DIKP+N+LLD+    +ISDFGLA +   N  + +   + GT  YVAPE  +
Sbjct: 123 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 697 NSKITAK-VDVYSFGVLLLEIISCRKSFD 724
             +  A+ VDV+S G++L  +++    +D
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 133/285 (46%), Gaps = 34/285 (11%)
Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ 574
           E+   +   + ++G+G FG V+ G   T   TT VA+K L       E  F  E  V+ +
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMG---TWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKK 69
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR--TNIAFQIARGLL 632
             H+ LV+L     E +   +V E+++ G L  FL G +     L    ++A QIA G+ 
Sbjct: 70  LRHEKLVQLYAVVSE-EPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMA 128
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK---GY 689
           Y+    R   +H D++  NIL+ +    +++DFGLA+L+  N+     TA +G K    +
Sbjct: 129 YVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY----TARQGAKFPIKW 181
Query: 690 VAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLN 748
            APE     + T K DV+SFG+LL E+ +  R  +   +  E         D    G   
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGYRM 234
Query: 749 VLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
               E  E+++D+ C          C ++DP  RPT + +   LE
Sbjct: 235 PCPPECPESLHDLMCQ---------CWRKDPEERPTFEYLQAFLE 270

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 93.2 bits (230), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 107/206 (51%), Gaps = 15/206 (7%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLD-RVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           + +G G++G V   V   R +  AVAVK +D +   D     K E+ +    +H+N+V+ 
Sbjct: 12  QTLGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 69
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA----FQIARGLLYLHEDCR 639
            G   EG  + L  E+ + G L    F  ++P+  +    A     Q+  G++YLH    
Sbjct: 70  YGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG--- 122
Query: 640 AQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSK 699
             I H DIKP+N+LLD+    +ISDFGLA +   N  + +   + GT  YVAPE  +  +
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 700 ITAK-VDVYSFGVLLLEIISCRKSFD 724
             A+ VDV+S G++L  +++    +D
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 93.2 bits (230), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 107/206 (51%), Gaps = 15/206 (7%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLD-RVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           + +G G++G V   V   R +  AVAVK +D +   D     K E+ +    +H+N+V+ 
Sbjct: 13  QTLGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 70
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA----FQIARGLLYLHEDCR 639
            G   EG  + L  E+ + G L    F  ++P+  +    A     Q+  G++YLH    
Sbjct: 71  YGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG--- 123
Query: 640 AQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSK 699
             I H DIKP+N+LLD+    +ISDFGLA +   N  + +   + GT  YVAPE  +  +
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 700 ITAK-VDVYSFGVLLLEIISCRKSFD 724
             A+ VDV+S G++L  +++    +D
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 93.2 bits (230), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 134/285 (47%), Gaps = 34/285 (11%)
Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ 574
           E+   +   + ++G+G FG V+ G   T   TT VA+K L       E  F  E  V+ +
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMG---TWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKK 69
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR--TNIAFQIARGLL 632
             H+ LV+L     E +   +V E+++ G+L  FL G +     L    ++A QIA G+ 
Sbjct: 70  LRHEKLVQLYAVVSE-EPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMA 128
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK---GY 689
           Y+    R   +H D++  NIL+ +    +++DFGLA+L+  N+     TA +G K    +
Sbjct: 129 YVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY----TARQGAKFPIKW 181
Query: 690 VAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLN 748
            APE     + T K DV+SFG+LL E+ +  R  +   +  E         D    G   
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGYRM 234
Query: 749 VLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
               E  E+++D+ C          C ++DP  RPT + +   LE
Sbjct: 235 PCPPECPESLHDLMCQ---------CWRKDPEERPTFEYLQAFLE 270

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 70/209 (33%), Positives = 105/209 (50%), Gaps = 17/209 (8%)
Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ 574
           E+   T    E +G G FG V+ G     T    VAVK L +     +  F  E  ++ Q
Sbjct: 17  EVPRETLKLVERLGAGQFGEVWMGYYNGHTK---VAVKSLKQGSMSPD-AFLAEANLMKQ 72
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF--GNLKPNWNLRTNIAFQIARGLL 632
             H+ LVRL     + +   ++ E++ NG+L  FL     +K   N   ++A QIA G+ 
Sbjct: 73  LQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 131
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK---GY 689
           ++ E      IH D++  NIL+ D  + +I+DFGLA+L+  N+     TA  G K    +
Sbjct: 132 FIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX----TAREGAKFPIKW 184
Query: 690 VAPEWFRNSKITAKVDVYSFGVLLLEIIS 718
            APE       T K DV+SFG+LL EI++
Sbjct: 185 TAPEAINYGTFTIKSDVWSFGILLTEIVT 213

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 107/206 (51%), Gaps = 15/206 (7%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLD-RVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           + +G G++G V   V   R +  AVAVK +D +   D     K E+ +    +H+N+V+ 
Sbjct: 12  QTLGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 69
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA----FQIARGLLYLHEDCR 639
            G   EG  + L  E+ + G L    F  ++P+  +    A     Q+  G++YLH    
Sbjct: 70  YGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG--- 122
Query: 640 AQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSK 699
             I H DIKP+N+LLD+    +ISDFGLA +   N  + +   + GT  YVAPE  +  +
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 700 ITAK-VDVYSFGVLLLEIISCRKSFD 724
             A+ VDV+S G++L  +++    +D
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 139/289 (48%), Gaps = 24/289 (8%)
Query: 514 KELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTA-VAVKKLDRVFQDGER-EFKNEVFV 571
           KE++ +    ++ +G G FG V  G ++        VA+K L   + + +R +F +E  +
Sbjct: 28  KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASI 87
Query: 572 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR-TNIAFQIARG 630
           +GQ  H N++ L G   +    +++ EF+ NG+L SFL  N      ++   +   IA G
Sbjct: 88  MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAG 147
Query: 631 LLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK--- 687
           + YL +      +H D+  +NIL++     ++SDFGL++ L  + S    T+  G K   
Sbjct: 148 MKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPI 204
Query: 688 GYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL 747
            + APE  +  K T+  DV+S+G+++ E++S            Y     W  D      +
Sbjct: 205 RWTAPEAIQYRKFTSASDVWSYGIVMWEVMS------------YGERPYW--DMTNQDVI 250
Query: 748 NVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 796
           N  + +D      ++C   L  + + C Q+D + RP   +++  L+ ++
Sbjct: 251 NA-IEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 298

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 108/209 (51%), Gaps = 15/209 (7%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLD-RVFQDGEREFKNEVFVIGQTHHKNL 580
           +  + +G G++G V   V   R +  AVAVK +D +   D     K E+ +    +H+N+
Sbjct: 10  DLVQTLGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA----FQIARGLLYLHE 636
           V+  G   EG  + L  E+ + G L    F  ++P+  +    A     Q+  G++YLH 
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR 696
                I H DIKP+N+LLD+    +ISDFGLA +   N  + +   + GT  YVAPE  +
Sbjct: 124 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 697 NSKITAK-VDVYSFGVLLLEIISCRKSFD 724
             +  A+ VDV+S G++L  +++    +D
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 108/209 (51%), Gaps = 15/209 (7%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLD-RVFQDGEREFKNEVFVIGQTHHKNL 580
           +  + +G G++G V   V   R +  AVAVK +D +   D     K E+ +    +H+N+
Sbjct: 10  DLVQTLGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA----FQIARGLLYLHE 636
           V+  G   EG  + L  E+ + G L    F  ++P+  +    A     Q+  G++YLH 
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR 696
                I H DIKP+N+LLD+    +ISDFGLA +   N  + +   + GT  YVAPE  +
Sbjct: 124 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 697 NSKITAK-VDVYSFGVLLLEIISCRKSFD 724
             +  A+ VDV+S G++L  +++    +D
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 103/199 (51%), Gaps = 11/199 (5%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLV 581
            F +E+G G FG+V+ G    +     VA+K + R     E +F  E  V+ +  H  LV
Sbjct: 13  TFVQEIGSGQFGLVHLGYWLNKDK---VAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 68
Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHEDCR 639
           +L G C E     LV+EF+ +G L+ +L    +  +   T   +   +  G+ YL E C 
Sbjct: 69  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEAC- 126
Query: 640 AQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSK 699
             +IH D+  +N L+ +    ++SDFG+ + + L+   T  T  +    + +PE F  S+
Sbjct: 127 --VIHRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWASPEVFSFSR 183
Query: 700 ITAKVDVYSFGVLLLEIIS 718
            ++K DV+SFGVL+ E+ S
Sbjct: 184 YSSKSDVWSFGVLMWEVFS 202

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 108/209 (51%), Gaps = 15/209 (7%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLD-RVFQDGEREFKNEVFVIGQTHHKNL 580
           +  + +G G++G V   V   R +  AVAVK +D +   D     K E+ +    +H+N+
Sbjct: 10  DLVQTLGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA----FQIARGLLYLHE 636
           V+  G   EG  + L  E+ + G L    F  ++P+  +    A     Q+  G++YLH 
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR 696
                I H DIKP+N+LLD+    +ISDFGLA +   N  + +   + GT  YVAPE  +
Sbjct: 124 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 697 NSKITAK-VDVYSFGVLLLEIISCRKSFD 724
             +  A+ VDV+S G++L  +++    +D
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 70/209 (33%), Positives = 105/209 (50%), Gaps = 17/209 (8%)
Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ 574
           E+   T    E +G G FG V+ G     T    VAVK L +     +  F  E  ++ Q
Sbjct: 18  EVPRETLKLVERLGAGQFGEVWMGYYNGHTK---VAVKSLKQGSMSPD-AFLAEANLMKQ 73
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF--GNLKPNWNLRTNIAFQIARGLL 632
             H+ LVRL     + +   ++ E++ NG+L  FL     +K   N   ++A QIA G+ 
Sbjct: 74  LQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 132
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK---GY 689
           ++ E      IH D++  NIL+ D  + +I+DFGLA+L+  N+     TA  G K    +
Sbjct: 133 FIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX----TAREGAKFPIKW 185
Query: 690 VAPEWFRNSKITAKVDVYSFGVLLLEIIS 718
            APE       T K DV+SFG+LL EI++
Sbjct: 186 TAPEAINYGTFTIKSDVWSFGILLTEIVT 214

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 70/209 (33%), Positives = 105/209 (50%), Gaps = 17/209 (8%)
Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ 574
           E+   T    E +G G FG V+ G     T    VAVK L +     +  F  E  ++ Q
Sbjct: 15  EVPRETLKLVERLGAGQFGEVWMGYYNGHTK---VAVKSLKQGSMSPD-AFLAEANLMKQ 70
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF--GNLKPNWNLRTNIAFQIARGLL 632
             H+ LVRL     + +   ++ E++ NG+L  FL     +K   N   ++A QIA G+ 
Sbjct: 71  LQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 129
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK---GY 689
           ++ E      IH D++  NIL+ D  + +I+DFGLA+L+  N+     TA  G K    +
Sbjct: 130 FIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX----TAREGAKFPIKW 182
Query: 690 VAPEWFRNSKITAKVDVYSFGVLLLEIIS 718
            APE       T K DV+SFG+LL EI++
Sbjct: 183 TAPEAINYGTFTIKSDVWSFGILLTEIVT 211

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 129/286 (45%), Gaps = 38/286 (13%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE-------REFKNEVFVIGQ 574
            +++++G+G FG+V+KG +    S   VA+K L     +GE       +EF+ EVF++  
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSV--VAIKSLILGDSEGETEMIEKFQEFQREVFIMSN 79
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-NWNLRTNIAFQIARGLLY 633
            +H N+V+L G         +V EF+  G L   L     P  W+++  +   IA G+ Y
Sbjct: 80  LNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEY 137
Query: 634 LHEDCRAQIIHCDIKPQNILLDDY-----YTARISDFGLAKLLTLNQSKTIKTAIRGTKG 688
           + ++    I+H D++  NI L          A+++DFGL++     QS    + + G   
Sbjct: 138 M-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQ 191
Query: 689 YVAPEWF--RNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 746
           ++APE         T K D YSF ++L  I++    FD     EY+       +  R   
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD-----EYSYGKIKFINMIREEG 246
Query: 747 LNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQML 792
           L   + ED        C  +L  V   C   DP  RP    +++ L
Sbjct: 247 LRPTIPED--------CPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 103/199 (51%), Gaps = 11/199 (5%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLV 581
            F +E+G G FG+V+ G    +     VA+K + R     E +F  E  V+ +  H  LV
Sbjct: 10  TFVQEIGSGQFGLVHLGYWLNKDK---VAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 65
Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHEDCR 639
           +L G C E     LV+EF+ +G L+ +L    +  +   T   +   +  G+ YL E C 
Sbjct: 66  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEAC- 123
Query: 640 AQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSK 699
             +IH D+  +N L+ +    ++SDFG+ + + L+   T  T  +    + +PE F  S+
Sbjct: 124 --VIHRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWASPEVFSFSR 180
Query: 700 ITAKVDVYSFGVLLLEIIS 718
            ++K DV+SFGVL+ E+ S
Sbjct: 181 YSSKSDVWSFGVLMWEVFS 199

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 70/209 (33%), Positives = 105/209 (50%), Gaps = 17/209 (8%)
Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ 574
           E+   T    E +G G FG V+ G     T    VAVK L +     +  F  E  ++ Q
Sbjct: 9   EVPRETLKLVERLGAGQFGEVWMGYYNGHTK---VAVKSLKQGSMSPD-AFLAEANLMKQ 64
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF--GNLKPNWNLRTNIAFQIARGLL 632
             H+ LVRL     + +   ++ E++ NG+L  FL     +K   N   ++A QIA G+ 
Sbjct: 65  LQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK---GY 689
           ++ E      IH D++  NIL+ D  + +I+DFGLA+L+  N+     TA  G K    +
Sbjct: 124 FIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX----TAREGAKFPIKW 176
Query: 690 VAPEWFRNSKITAKVDVYSFGVLLLEIIS 718
            APE       T K DV+SFG+LL EI++
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 70/209 (33%), Positives = 105/209 (50%), Gaps = 17/209 (8%)
Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ 574
           E+   T    E +G G FG V+ G     T    VAVK L +     +  F  E  ++ Q
Sbjct: 11  EVPRETLKLVERLGAGQFGEVWMGYYNGHTK---VAVKSLKQGSMSPD-AFLAEANLMKQ 66
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF--GNLKPNWNLRTNIAFQIARGLL 632
             H+ LVRL     + +   ++ E++ NG+L  FL     +K   N   ++A QIA G+ 
Sbjct: 67  LQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 125
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK---GY 689
           ++ E      IH D++  NIL+ D  + +I+DFGLA+L+  N+     TA  G K    +
Sbjct: 126 FIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX----TAREGAKFPIKW 178
Query: 690 VAPEWFRNSKITAKVDVYSFGVLLLEIIS 718
            APE       T K DV+SFG+LL EI++
Sbjct: 179 TAPEAINYGTFTIKSDVWSFGILLTEIVT 207

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 92.8 bits (229), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 133/285 (46%), Gaps = 34/285 (11%)
Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ 574
           E+   +   + ++G+G FG V+ G   T   TT VA+K L       E  F  E  V+ +
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMG---TWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKK 69
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR--TNIAFQIARGLL 632
             H+ LV+L     E +   +V E+++ G L  FL G +     L    ++A QIA G+ 
Sbjct: 70  LRHEKLVQLYAVVSE-EPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMA 128
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK---GY 689
           Y+    R   +H D++  NIL+ +    +++DFGLA+L+  N+     TA +G K    +
Sbjct: 129 YVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY----TARQGAKFPIKW 181
Query: 690 VAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLN 748
            APE     + T K DV+SFG+LL E+ +  R  +   +  E         D    G   
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGYRM 234
Query: 749 VLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
               E  E+++D+ C          C ++DP  RPT + +   LE
Sbjct: 235 PCPPECPESLHDLMCQ---------CWRKDPEERPTFEYLQAFLE 270

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 92.4 bits (228), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 103/199 (51%), Gaps = 11/199 (5%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLV 581
            F +E+G G FG+V+ G    +     VA+K + R     E +F  E  V+ +  H  LV
Sbjct: 8   TFVQEIGSGQFGLVHLGYWLNKDK---VAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHEDCR 639
           +L G C E     LV+EF+ +G L+ +L    +  +   T   +   +  G+ YL E C 
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEAC- 121
Query: 640 AQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSK 699
             +IH D+  +N L+ +    ++SDFG+ + + L+   T  T  +    + +PE F  S+
Sbjct: 122 --VIHRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWASPEVFSFSR 178
Query: 700 ITAKVDVYSFGVLLLEIIS 718
            ++K DV+SFGVL+ E+ S
Sbjct: 179 YSSKSDVWSFGVLMWEVFS 197

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 92.4 bits (228), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 108/209 (51%), Gaps = 15/209 (7%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLD-RVFQDGEREFKNEVFVIGQTHHKNL 580
           +  + +G G++G V   V   R +  AVAVK +D +   D     K E+ +    +H+N+
Sbjct: 9   DLVQTLGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA----FQIARGLLYLHE 636
           V+  G   EG  + L  E+ + G L    F  ++P+  +    A     Q+  G++YLH 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH- 121
Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR 696
                I H DIKP+N+LLD+    +ISDFGLA +   N  + +   + GT  YVAPE  +
Sbjct: 122 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 697 NSKITAK-VDVYSFGVLLLEIISCRKSFD 724
             +  A+ VDV+S G++L  +++    +D
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 92.4 bits (228), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 108/209 (51%), Gaps = 15/209 (7%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLD-RVFQDGEREFKNEVFVIGQTHHKNL 580
           +  + +G G++G V   V   R +  AVAVK +D +   D     K E+ +    +H+N+
Sbjct: 10  DLVQTLGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA----FQIARGLLYLHE 636
           V+  G   EG  + L  E+ + G L    F  ++P+  +    A     Q+  G++YLH 
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR 696
                I H DIKP+N+LLD+    +ISDFGLA +   N  + +   + GT  YVAPE  +
Sbjct: 124 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 697 NSKITAK-VDVYSFGVLLLEIISCRKSFD 724
             +  A+ VDV+S G++L  +++    +D
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 92.4 bits (228), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 108/209 (51%), Gaps = 15/209 (7%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLD-RVFQDGEREFKNEVFVIGQTHHKNL 580
           +  + +G G++G V   V   R +  AVAVK +D +   D     K E+ +    +H+N+
Sbjct: 8   DLVQTLGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA----FQIARGLLYLHE 636
           V+  G   EG  + L  E+ + G L    F  ++P+  +    A     Q+  G++YLH 
Sbjct: 66  VKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR 696
                I H DIKP+N+LLD+    +ISDFGLA +   N  + +   + GT  YVAPE  +
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 697 NSKITAK-VDVYSFGVLLLEIISCRKSFD 724
             +  A+ VDV+S G++L  +++    +D
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWD 207

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 92.4 bits (228), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 108/209 (51%), Gaps = 15/209 (7%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLD-RVFQDGEREFKNEVFVIGQTHHKNL 580
           +  + +G G++G V   V   R +  AVAVK +D +   D     K E+ +    +H+N+
Sbjct: 9   DLVQTLGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENV 66
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA----FQIARGLLYLHE 636
           V+  G   EG  + L  E+ + G L    F  ++P+  +    A     Q+  G++YLH 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR 696
                I H DIKP+N+LLD+    +ISDFGLA +   N  + +   + GT  YVAPE  +
Sbjct: 123 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 697 NSKITAK-VDVYSFGVLLLEIISCRKSFD 724
             +  A+ VDV+S G++L  +++    +D
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 92.4 bits (228), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 139/295 (47%), Gaps = 42/295 (14%)
Query: 526 EVGRGSFGIVYKG---VIQTRTSTTAVAVKKLDRVFQDGER-EFKNEVFVIGQTHHKNLV 581
           E+G+GSFG+VY+G    I    + T VAVK ++      ER EF NE  V+      ++V
Sbjct: 25  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 84
Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLF----------GNLKPNWNLRTNIAFQIARGL 631
           RLLG   +GQ  L+V E + +G L S+L           G   P       +A +IA G+
Sbjct: 85  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 144
Query: 632 LYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKG--- 688
            YL+     + +H ++  +N ++   +T +I DFG+ +   + ++   +   +G KG   
Sbjct: 145 AYLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYR---KGGKGLLP 196
Query: 689 --YVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 746
             ++APE  ++   T   D++SFGV+L EI S               L +  +    N +
Sbjct: 197 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQ 241
Query: 747 LNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVP 801
           +   V +         C  ++  +   C Q +P++RPT  +++ +L+  +  S P
Sbjct: 242 VLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDDLHPSFP 296

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 92.4 bits (228), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 70/209 (33%), Positives = 105/209 (50%), Gaps = 17/209 (8%)
Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ 574
           E+   T    E +G G FG V+ G     T    VAVK L +     +  F  E  ++ Q
Sbjct: 10  EVPRETLKLVERLGAGQFGEVWMGYYNGHTK---VAVKSLKQGSMSPD-AFLAEANLMKQ 65
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF--GNLKPNWNLRTNIAFQIARGLL 632
             H+ LVRL     + +   ++ E++ NG+L  FL     +K   N   ++A QIA G+ 
Sbjct: 66  LQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 124
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK---GY 689
           ++ E      IH D++  NIL+ D  + +I+DFGLA+L+  N+     TA  G K    +
Sbjct: 125 FIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX----TAREGAKFPIKW 177
Query: 690 VAPEWFRNSKITAKVDVYSFGVLLLEIIS 718
            APE       T K DV+SFG+LL EI++
Sbjct: 178 TAPEAINYGTFTIKSDVWSFGILLTEIVT 206

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 92.4 bits (228), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 108/209 (51%), Gaps = 15/209 (7%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLD-RVFQDGEREFKNEVFVIGQTHHKNL 580
           +  + +G G++G V   V   R +  AVAVK +D +   D     K E+ +    +H+N+
Sbjct: 10  DLVQTLGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA----FQIARGLLYLHE 636
           V+  G   EG  + L  E+ + G L    F  ++P+  +    A     Q+  G++YLH 
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH- 122
Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR 696
                I H DIKP+N+LLD+    +ISDFGLA +   N  + +   + GT  YVAPE  +
Sbjct: 123 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 697 NSKITAK-VDVYSFGVLLLEIISCRKSFD 724
             +  A+ VDV+S G++L  +++    +D
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 92.4 bits (228), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 70/209 (33%), Positives = 105/209 (50%), Gaps = 17/209 (8%)
Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ 574
           E+   T    E +G G FG V+ G     T    VAVK L +     +  F  E  ++ Q
Sbjct: 9   EVPRETLKLVERLGAGQFGEVWMGYYNGHTK---VAVKSLKQGSMSPD-AFLAEANLMKQ 64
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF--GNLKPNWNLRTNIAFQIARGLL 632
             H+ LVRL     + +   ++ E++ NG+L  FL     +K   N   ++A QIA G+ 
Sbjct: 65  LQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK---GY 689
           ++ E      IH D++  NIL+ D  + +I+DFGLA+L+  N+     TA  G K    +
Sbjct: 124 FIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX----TAREGAKFPIKW 176
Query: 690 VAPEWFRNSKITAKVDVYSFGVLLLEIIS 718
            APE       T K DV+SFG+LL EI++
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 92.4 bits (228), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 108/209 (51%), Gaps = 15/209 (7%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLD-RVFQDGEREFKNEVFVIGQTHHKNL 580
           +  + +G G++G V   V   R +  AVAVK +D +   D     K E+ +    +H+N+
Sbjct: 9   DLVQTLGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA----FQIARGLLYLHE 636
           V+  G   EG  + L  E+ + G L    F  ++P+  +    A     Q+  G++YLH 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH- 121
Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR 696
                I H DIKP+N+LLD+    +ISDFGLA +   N  + +   + GT  YVAPE  +
Sbjct: 122 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 697 NSKITAK-VDVYSFGVLLLEIISCRKSFD 724
             +  A+ VDV+S G++L  +++    +D
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 92.4 bits (228), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 133/285 (46%), Gaps = 34/285 (11%)
Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ 574
           E+   +   + ++G+G FG V+ G   T   TT VA+K L       E  F  E  V+ +
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMG---TWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKK 69
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR--TNIAFQIARGLL 632
             H+ LV+L     E +   +V E+++ G+L  FL G +     L    ++A QIA G+ 
Sbjct: 70  LRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMA 128
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK---GY 689
           Y+    R   +H D+   NIL+ +    +++DFGLA+L+  N+     TA +G K    +
Sbjct: 129 YVE---RMNYVHRDLAAANILVGENLVCKVADFGLARLIEDNEY----TARQGAKFPIKW 181
Query: 690 VAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLN 748
            APE     + T K DV+SFG+LL E+ +  R  +   +  E         D    G   
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGYRM 234
Query: 749 VLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
               E  E+++D+ C          C ++DP  RPT + +   LE
Sbjct: 235 PCPPECPESLHDLMCQ---------CWRKDPEERPTFEYLQAFLE 270

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 92.4 bits (228), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 108/209 (51%), Gaps = 15/209 (7%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLD-RVFQDGEREFKNEVFVIGQTHHKNL 580
           +  + +G G++G V   V   R +  AVAVK +D +   D     K E+ +    +H+N+
Sbjct: 9   DLVQTLGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA----FQIARGLLYLHE 636
           V+  G   EG  + L  E+ + G L    F  ++P+  +    A     Q+  G++YLH 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH- 121
Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR 696
                I H DIKP+N+LLD+    +ISDFGLA +   N  + +   + GT  YVAPE  +
Sbjct: 122 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 697 NSKITAK-VDVYSFGVLLLEIISCRKSFD 724
             +  A+ VDV+S G++L  +++    +D
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 108/209 (51%), Gaps = 15/209 (7%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLD-RVFQDGEREFKNEVFVIGQTHHKNL 580
           +  + +G G++G V   V   R +  AVAVK +D +   D     K E+ +    +H+N+
Sbjct: 9   DLVQTLGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA----FQIARGLLYLHE 636
           V+  G   EG  + L  E+ + G L    F  ++P+  +    A     Q+  G++YLH 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR 696
                I H DIKP+N+LLD+    +ISDFGLA +   N  + +   + GT  YVAPE  +
Sbjct: 123 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 697 NSKITAK-VDVYSFGVLLLEIISCRKSFD 724
             +  A+ VDV+S G++L  +++    +D
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 139/295 (47%), Gaps = 42/295 (14%)
Query: 526 EVGRGSFGIVYKG---VIQTRTSTTAVAVKKLDRVFQDGER-EFKNEVFVIGQTHHKNLV 581
           E+G+GSFG+VY+G    I    + T VAVK ++      ER EF NE  V+      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLF----------GNLKPNWNLRTNIAFQIARGL 631
           RLLG   +GQ  L+V E + +G L S+L           G   P       +A +IA G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 632 LYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKG--- 688
            YL+     + +H ++  +N ++   +T +I DFG+ +   + ++   +   +G KG   
Sbjct: 144 AYLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYR---KGGKGLLP 195
Query: 689 --YVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 746
             ++APE  ++   T   D++SFGV+L EI S               L +  +    N +
Sbjct: 196 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQ 240
Query: 747 LNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVP 801
           +   V +         C  ++  +   C Q +P++RPT  +++ +L+  +  S P
Sbjct: 241 VLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDDLHPSFP 295

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 108/209 (51%), Gaps = 15/209 (7%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLD-RVFQDGEREFKNEVFVIGQTHHKNL 580
           +  + +G G++G V   V   R +  AVAVK +D +   D     K E+ +    +H+N+
Sbjct: 9   DLVQTLGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA----FQIARGLLYLHE 636
           V+  G   EG  + L  E+ + G L    F  ++P+  +    A     Q+  G++YLH 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH- 121
Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR 696
                I H DIKP+N+LLD+    +ISDFGLA +   N  + +   + GT  YVAPE  +
Sbjct: 122 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 697 NSKITAK-VDVYSFGVLLLEIISCRKSFD 724
             +  A+ VDV+S G++L  +++    +D
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 70/209 (33%), Positives = 105/209 (50%), Gaps = 17/209 (8%)
Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ 574
           E+   T    E +G G FG V+ G     T    VAVK L +     +  F  E  ++ Q
Sbjct: 19  EVPRETLKLVERLGAGQFGEVWMGYYNGHTK---VAVKSLKQGSMSPD-AFLAEANLMKQ 74
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF--GNLKPNWNLRTNIAFQIARGLL 632
             H+ LVRL     + +   ++ E++ NG+L  FL     +K   N   ++A QIA G+ 
Sbjct: 75  LQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 133
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK---GY 689
           ++ E      IH D++  NIL+ D  + +I+DFGLA+L+  N+     TA  G K    +
Sbjct: 134 FIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY----TAREGAKFPIKW 186
Query: 690 VAPEWFRNSKITAKVDVYSFGVLLLEIIS 718
            APE       T K DV+SFG+LL EI++
Sbjct: 187 TAPEAINYGTFTIKSDVWSFGILLTEIVT 215

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 70/209 (33%), Positives = 105/209 (50%), Gaps = 17/209 (8%)
Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ 574
           E+   T    E +G G FG V+ G     T    VAVK L +     +  F  E  ++ Q
Sbjct: 14  EVPRETLKLVERLGAGQFGEVWMGYYNGHTK---VAVKSLKQGSMSPD-AFLAEANLMKQ 69
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF--GNLKPNWNLRTNIAFQIARGLL 632
             H+ LVRL     + +   ++ E++ NG+L  FL     +K   N   ++A QIA G+ 
Sbjct: 70  LQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 128
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK---GY 689
           ++ E      IH D++  NIL+ D  + +I+DFGLA+L+  N+     TA  G K    +
Sbjct: 129 FIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY----TAREGAKFPIKW 181
Query: 690 VAPEWFRNSKITAKVDVYSFGVLLLEIIS 718
            APE       T K DV+SFG+LL EI++
Sbjct: 182 TAPEAINYGTFTIKSDVWSFGILLTEIVT 210

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 81/274 (29%), Positives = 129/274 (47%), Gaps = 34/274 (12%)
Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLG 585
           ++G+G FG V+ G   T   TT VA+K L       E  F  E  V+ +  H+ LV+L  
Sbjct: 274 KLGQGCFGEVWMG---TWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYA 329
Query: 586 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR--TNIAFQIARGLLYLHEDCRAQII 643
              E +   +V E+++ G+L  FL G       L    ++A QIA G+ Y+    R   +
Sbjct: 330 VVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 385
Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVAPEWFRNSKI 700
           H D++  NIL+ +    +++DFGLA+L+  N+     TA +G K    + APE     + 
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEY----TARQGAKFPIKWTAPEAALYGRF 441
Query: 701 TAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMN 759
           T K DV+SFG+LL E+ +  R  +   +  E         D    G       E  E+++
Sbjct: 442 TIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGYRMPCPPECPESLH 494
Query: 760 DIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
           D+ C          C +++P  RPT + +   LE
Sbjct: 495 DLMCQ---------CWRKEPEERPTFEYLQAFLE 519

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 70/209 (33%), Positives = 105/209 (50%), Gaps = 17/209 (8%)
Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ 574
           E+   T    E +G G FG V+ G     T    VAVK L +     +  F  E  ++ Q
Sbjct: 15  EVPRETLKLVERLGAGQFGEVWMGYYNGHTK---VAVKSLKQGSMSPD-AFLAEANLMKQ 70
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF--GNLKPNWNLRTNIAFQIARGLL 632
             H+ LVRL     + +   ++ E++ NG+L  FL     +K   N   ++A QIA G+ 
Sbjct: 71  LQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 129
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK---GY 689
           ++ E      IH D++  NIL+ D  + +I+DFGLA+L+  N+     TA  G K    +
Sbjct: 130 FIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY----TAREGAKFPIKW 182
Query: 690 VAPEWFRNSKITAKVDVYSFGVLLLEIIS 718
            APE       T K DV+SFG+LL EI++
Sbjct: 183 TAPEAINYGTFTIKSDVWSFGILLTEIVT 211

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/282 (29%), Positives = 131/282 (46%), Gaps = 34/282 (12%)
Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLG 585
           ++G+G FG V+ G   T   TT VA+K L       E  F  E  V+ +  H+ LV+L  
Sbjct: 192 KLGQGCFGEVWMG---TWNGTTRVAIKTLKPGNMSPE-AFLQEAQVMKKLRHEKLVQLYA 247
Query: 586 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR--TNIAFQIARGLLYLHEDCRAQII 643
              E +   +V E+++ G+L  FL G +     L    ++A QIA G+ Y+    R   +
Sbjct: 248 VVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 303
Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVAPEWFRNSKI 700
           H D++  NIL+ +    +++DFGL +L+  N+     TA +G K    + APE     + 
Sbjct: 304 HRDLRAANILVGENLVCKVADFGLGRLIEDNEY----TARQGAKFPIKWTAPEAALYGRF 359
Query: 701 TAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMN 759
           T K DV+SFG+LL E+ +  R  +   +  E         D    G       E  E+++
Sbjct: 360 TIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGYRMPCPPECPESLH 412
Query: 760 DIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVP 801
           D+ C          C ++DP  RPT + +   LE     + P
Sbjct: 413 DLMCQ---------CWRKDPEERPTFEYLQAFLEDYFTSTEP 445

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 106/197 (53%), Gaps = 9/197 (4%)
Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE-REFKNEVFVIGQTHHKNLVRLL 584
           E+G G+FG V +GV + R     VA+K L +  +  +  E   E  ++ Q  +  +VRL+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLK--PNWNLRTNIAFQIARGLLYLHEDCRAQI 642
           G C + +  +LV E    G L  FL G  +  P  N+   +  Q++ G+ YL E      
Sbjct: 403 GVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNV-AELLHQVSMGMKYLEEK---NF 457
Query: 643 IHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS-KTIKTAIRGTKGYVAPEWFRNSKIT 701
           +H ++  +N+LL + + A+ISDFGL+K L  + S  T ++A +    + APE     K +
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 517
Query: 702 AKVDVYSFGVLLLEIIS 718
           ++ DV+S+GV + E +S
Sbjct: 518 SRSDVWSYGVTMWEALS 534

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 70/209 (33%), Positives = 105/209 (50%), Gaps = 17/209 (8%)
Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ 574
           E+   T    E +G G FG V+ G     T    VAVK L +     +  F  E  ++ Q
Sbjct: 9   EVPRETLKLVERLGAGQFGEVWMGYYNGHTK---VAVKSLKQGSMSPD-AFLAEANLMKQ 64
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF--GNLKPNWNLRTNIAFQIARGLL 632
             H+ LVRL     + +   ++ E++ NG+L  FL     +K   N   ++A QIA G+ 
Sbjct: 65  LQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK---GY 689
           ++ E      IH D++  NIL+ D  + +I+DFGLA+L+  N+     TA  G K    +
Sbjct: 124 FIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY----TAREGAKFPIKW 176
Query: 690 VAPEWFRNSKITAKVDVYSFGVLLLEIIS 718
            APE       T K DV+SFG+LL EI++
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 70/209 (33%), Positives = 105/209 (50%), Gaps = 17/209 (8%)
Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ 574
           E+   T    E +G G FG V+ G     T    VAVK L +     +  F  E  ++ Q
Sbjct: 4   EVPRETLKLVERLGAGQFGEVWMGYYNGHTK---VAVKSLKQGSMSPD-AFLAEANLMKQ 59
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF--GNLKPNWNLRTNIAFQIARGLL 632
             H+ LVRL     + +   ++ E++ NG+L  FL     +K   N   ++A QIA G+ 
Sbjct: 60  LQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 118
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK---GY 689
           ++ E      IH D++  NIL+ D  + +I+DFGLA+L+  N+     TA  G K    +
Sbjct: 119 FIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY----TAREGAKFPIKW 171
Query: 690 VAPEWFRNSKITAKVDVYSFGVLLLEIIS 718
            APE       T K DV+SFG+LL EI++
Sbjct: 172 TAPEAINYGTFTIKSDVWSFGILLTEIVT 200

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/299 (24%), Positives = 126/299 (42%), Gaps = 40/299 (13%)
Query: 523 FKEEVGRGSFGIVYKGV---IQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKN 579
            K E+G G+FG V+      +        VAVK L    +   ++F+ E  ++    H++
Sbjct: 45  LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 104
Query: 580 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN----------------I 623
           +VR  G C EG+  L+V+E++ +G L  FL  +  P+  L                   +
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSH-GPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 624 AFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAI 683
           A Q+A G++YL        +H D+  +N L+      +I DFG+++ +       +    
Sbjct: 164 ASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 220
Query: 684 RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR 743
                ++ PE     K T + DV+SFGV+L EI +  K         Y +    A DC  
Sbjct: 221 MLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQ------PWYQLSNTEAIDCIT 274
Query: 744 NGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVPP 802
            G         +E      C  ++  +   C Q +P  R ++K V   L+ + +   PP
Sbjct: 275 QG---------RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ--APP 322

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 103/199 (51%), Gaps = 11/199 (5%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLV 581
            F +E+G G FG+V+ G    +     VA+K + R     E +F  E  V+ +  H  LV
Sbjct: 10  TFVQEIGSGQFGLVHLGYWLNKDK---VAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 65
Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHEDCR 639
           +L G C E     LV+EF+ +G L+ +L    +  +   T   +   +  G+ YL E   
Sbjct: 66  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEE--- 121
Query: 640 AQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSK 699
           A +IH D+  +N L+ +    ++SDFG+ + + L+   T  T  +    + +PE F  S+
Sbjct: 122 ASVIHRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWASPEVFSFSR 180
Query: 700 ITAKVDVYSFGVLLLEIIS 718
            ++K DV+SFGVL+ E+ S
Sbjct: 181 YSSKSDVWSFGVLMWEVFS 199

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 100/199 (50%), Gaps = 11/199 (5%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLV 581
            F +E+G G FG+V+ G    +       +K+        E +F  E  V+ +  H  LV
Sbjct: 30  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGSM----SEDDFIEEAEVMMKLSHPKLV 85
Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHEDCR 639
           +L G C E     LV+EF+ +G L+ +L    +  +   T   +   +  G+ YL E C 
Sbjct: 86  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEAC- 143
Query: 640 AQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSK 699
             +IH D+  +N L+ +    ++SDFG+ + + L+   T  T  +    + +PE F  S+
Sbjct: 144 --VIHRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWASPEVFSFSR 200
Query: 700 ITAKVDVYSFGVLLLEIIS 718
            ++K DV+SFGVL+ E+ S
Sbjct: 201 YSSKSDVWSFGVLMWEVFS 219

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 82/285 (28%), Positives = 133/285 (46%), Gaps = 34/285 (11%)
Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ 574
           E+   +   + ++G+G FG V+ G   T   TT VA+K L       E  F  E  V+ +
Sbjct: 4   EIPRESLRLEVKLGQGCFGEVWMG---TWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKK 59
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR--TNIAFQIARGLL 632
             H+ LV+L     E +   +V E+++ G+L  FL G       L    ++A QIA G+ 
Sbjct: 60  LRHEKLVQLYAVVSE-EPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 118
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK---GY 689
           Y+    R   +H D++  NIL+ +    +++DFGLA+L+  N+     TA +G K    +
Sbjct: 119 YVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEX----TARQGAKFPIKW 171
Query: 690 VAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLN 748
            APE     + T K DV+SFG+LL E+ +  R  +   +  E         D    G   
Sbjct: 172 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGYRM 224
Query: 749 VLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
               E  E+++D+ C          C +++P  RPT + +   LE
Sbjct: 225 PCPPECPESLHDLMCQ---------CWRKEPEERPTFEYLQAFLE 260

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 102/199 (51%), Gaps = 11/199 (5%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLV 581
            F +E+G G FG+V+ G    +     VA+K + R     E +F  E  V+ +  H  LV
Sbjct: 11  TFVQEIGSGQFGLVHLGYWLNKDK---VAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 66
Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHEDCR 639
           +L G C E     LV EF+ +G L+ +L    +  +   T   +   +  G+ YL E C 
Sbjct: 67  QLYGVCLEQAPICLVTEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEAC- 124
Query: 640 AQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSK 699
             +IH D+  +N L+ +    ++SDFG+ + + L+   T  T  +    + +PE F  S+
Sbjct: 125 --VIHRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWASPEVFSFSR 181
Query: 700 ITAKVDVYSFGVLLLEIIS 718
            ++K DV+SFGVL+ E+ S
Sbjct: 182 YSSKSDVWSFGVLMWEVFS 200

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 127/286 (44%), Gaps = 38/286 (13%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE-------REFKNEVFVIGQ 574
            +++++G+G FG+V+KG +    S   VA+K L     +GE       +EF+ EVF++  
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSV--VAIKSLILGDSEGETEMIEKFQEFQREVFIMSN 79
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-NWNLRTNIAFQIARGLLY 633
            +H N+V+L G         +V EF+  G L   L     P  W+++  +   IA G+ Y
Sbjct: 80  LNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEY 137
Query: 634 LHEDCRAQIIHCDIKPQNILLDDY-----YTARISDFGLAKLLTLNQSKTIKTAIRGTKG 688
           + ++    I+H D++  NI L          A+++DFG     T  QS    + + G   
Sbjct: 138 M-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG-----TSQQSVHSVSGLLGNFQ 191
Query: 689 YVAPEWF--RNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 746
           ++APE         T K D YSF ++L  I++    FD     EY+       +  R   
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD-----EYSYGKIKFINMIREEG 246
Query: 747 LNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQML 792
           L   + ED        C  +L  V   C   DP  RP    +++ L
Sbjct: 247 LRPTIPED--------CPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 82/282 (29%), Positives = 131/282 (46%), Gaps = 34/282 (12%)
Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLG 585
           ++G+G FG V+ G   T   TT VA+K L       E  F  E  V+ +  H+ LV+L  
Sbjct: 191 KLGQGCFGEVWMG---TWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYA 246
Query: 586 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR--TNIAFQIARGLLYLHEDCRAQII 643
              E +   +V E+++ G+L  FL G       L    ++A QIA G+ Y+    R   +
Sbjct: 247 VVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 302
Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVAPEWFRNSKI 700
           H D++  NIL+ +    +++DFGLA+L+  N+     TA +G K    + APE     + 
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEY----TARQGAKFPIKWTAPEAALYGRF 358
Query: 701 TAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMN 759
           T K DV+SFG+LL E+ +  R  +   +  E         D    G       E  E+++
Sbjct: 359 TIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGYRMPCPPECPESLH 411
Query: 760 DIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVP 801
           D+ C          C +++P  RPT + +   LE     + P
Sbjct: 412 DLMCQ---------CWRKEPEERPTFEYLQAFLEDYFTSTEP 444

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 82/282 (29%), Positives = 131/282 (46%), Gaps = 34/282 (12%)
Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLG 585
           ++G+G FG V+ G   T   TT VA+K L       E  F  E  V+ +  H+ LV+L  
Sbjct: 191 KLGQGCFGEVWMG---TWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYA 246
Query: 586 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR--TNIAFQIARGLLYLHEDCRAQII 643
              E +   +V E+++ G+L  FL G       L    ++A QIA G+ Y+    R   +
Sbjct: 247 VVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 302
Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVAPEWFRNSKI 700
           H D++  NIL+ +    +++DFGLA+L+  N+     TA +G K    + APE     + 
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEY----TARQGAKFPIKWTAPEAALYGRF 358
Query: 701 TAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMN 759
           T K DV+SFG+LL E+ +  R  +   +  E         D    G       E  E+++
Sbjct: 359 TIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGYRMPCPPECPESLH 411
Query: 760 DIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVP 801
           D+ C          C +++P  RPT + +   LE     + P
Sbjct: 412 DLMCQ---------CWRKEPEERPTFEYLQAFLEDYFTSTEP 444

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 82/285 (28%), Positives = 133/285 (46%), Gaps = 34/285 (11%)
Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ 574
           E+   +   + ++G+G FG V+ G   T   TT VA+K L       E  F  E  V+ +
Sbjct: 11  EIPRESLRLEVKLGQGCFGEVWMG---TWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKK 66
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR--TNIAFQIARGLL 632
             H+ LV+L     E +   +V E++N G+L  FL G       L    +++ QIA G+ 
Sbjct: 67  LRHEKLVQLYAVVSE-EPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMA 125
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK---GY 689
           Y+    R   +H D++  NIL+ +    +++DFGLA+L+  N+     TA +G K    +
Sbjct: 126 YVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY----TARQGAKFPIKW 178
Query: 690 VAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLN 748
            APE     + T K DV+SFG+LL E+ +  R  +   +  E         D    G   
Sbjct: 179 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGYRM 231
Query: 749 VLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
               E  E+++D+ C          C +++P  RPT + +   LE
Sbjct: 232 PCPPECPESLHDLMCQ---------CWRKEPEERPTFEYLQAFLE 267

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 82/285 (28%), Positives = 133/285 (46%), Gaps = 34/285 (11%)
Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ 574
           E+   +   + ++G+G FG V+ G   T   TT VA+K L       E  F  E  V+ +
Sbjct: 11  EIPRESLRLEVKLGQGCFGEVWMG---TWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKK 66
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR--TNIAFQIARGLL 632
             H+ LV+L     E +   +V E++N G+L  FL G       L    +++ QIA G+ 
Sbjct: 67  LRHEKLVQLYAVVSE-EPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMA 125
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK---GY 689
           Y+    R   +H D++  NIL+ +    +++DFGLA+L+  N+     TA +G K    +
Sbjct: 126 YVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEW----TARQGAKFPIKW 178
Query: 690 VAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLN 748
            APE     + T K DV+SFG+LL E+ +  R  +   +  E         D    G   
Sbjct: 179 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGYRM 231
Query: 749 VLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
               E  E+++D+ C          C +++P  RPT + +   LE
Sbjct: 232 PCPPECPESLHDLMCQ---------CWRKEPEERPTFEYLQAFLE 267

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 74/299 (24%), Positives = 126/299 (42%), Gaps = 40/299 (13%)
Query: 523 FKEEVGRGSFGIVYKGV---IQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKN 579
            K E+G G+FG V+      +        VAVK L    +   ++F+ E  ++    H++
Sbjct: 16  LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 75
Query: 580 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN----------------I 623
           +VR  G C EG+  L+V+E++ +G L  FL  +  P+  L                   +
Sbjct: 76  IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSH-GPDAKLLAGGEDVAPGPLGLGQLLAV 134
Query: 624 AFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAI 683
           A Q+A G++YL        +H D+  +N L+      +I DFG+++ +       +    
Sbjct: 135 ASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 191
Query: 684 RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR 743
                ++ PE     K T + DV+SFGV+L EI +  K         Y +    A DC  
Sbjct: 192 MLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQ------PWYQLSNTEAIDCIT 245
Query: 744 NGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVPP 802
            G         +E      C  ++  +   C Q +P  R ++K V   L+ + +   PP
Sbjct: 246 QG---------RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ--APP 293

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 74/299 (24%), Positives = 126/299 (42%), Gaps = 40/299 (13%)
Query: 523 FKEEVGRGSFGIVYKGV---IQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKN 579
            K E+G G+FG V+      +        VAVK L    +   ++F+ E  ++    H++
Sbjct: 22  LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 81
Query: 580 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN----------------I 623
           +VR  G C EG+  L+V+E++ +G L  FL  +  P+  L                   +
Sbjct: 82  IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSH-GPDAKLLAGGEDVAPGPLGLGQLLAV 140
Query: 624 AFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAI 683
           A Q+A G++YL        +H D+  +N L+      +I DFG+++ +       +    
Sbjct: 141 ASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 197
Query: 684 RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR 743
                ++ PE     K T + DV+SFGV+L EI +  K         Y +    A DC  
Sbjct: 198 MLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQ------PWYQLSNTEAIDCIT 251
Query: 744 NGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVPP 802
            G         +E      C  ++  +   C Q +P  R ++K V   L+ + +   PP
Sbjct: 252 QG---------RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ--APP 299

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 107/209 (51%), Gaps = 15/209 (7%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLD-RVFQDGEREFKNEVFVIGQTHHKNL 580
           +  + +G G+ G V   V   R +  AVAVK +D +   D     K E+ +    +H+N+
Sbjct: 9   DLVQTLGEGAAGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA----FQIARGLLYLHE 636
           V+  G   EG  + L  E+ + G L    F  ++P+  +    A     Q+  G++YLH 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR 696
                I H DIKP+N+LLD+    +ISDFGLA +   N  + +   + GT  YVAPE  +
Sbjct: 123 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 697 NSKITAK-VDVYSFGVLLLEIISCRKSFD 724
             +  A+ VDV+S G++L  +++    +D
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 82/285 (28%), Positives = 133/285 (46%), Gaps = 34/285 (11%)
Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ 574
           E+   +   + ++G+G FG V+ G   T   TT VA+K L       E  F  E  V+ +
Sbjct: 7   EIPRESLRLEVKLGQGCFGEVWMG---TWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKK 62
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR--TNIAFQIARGLL 632
             H+ LV+L     E +   +V E+++ G+L  FL G       L    ++A QIA G+ 
Sbjct: 63  LRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 121
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK---GY 689
           Y+    R   +H D++  NIL+ +    +++DFGLA+L+  N+     TA +G K    +
Sbjct: 122 YVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY----TARQGAKFPIKW 174
Query: 690 VAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLN 748
            APE     + T K DV+SFG+LL E+ +  R  +   +  E         D    G   
Sbjct: 175 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGYRM 227
Query: 749 VLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
               E  E+++D+ C          C +++P  RPT + +   LE
Sbjct: 228 PCPPECPESLHDLMCQ---------CWRKEPEERPTFEYLQAFLE 263

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 82/282 (29%), Positives = 131/282 (46%), Gaps = 34/282 (12%)
Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLG 585
           ++G+G FG V+ G   T   TT VA+K L       E  F  E  V+ +  H+ LV+L  
Sbjct: 191 KLGQGCFGEVWMG---TWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYA 246
Query: 586 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR--TNIAFQIARGLLYLHEDCRAQII 643
              E +   +V E+++ G+L  FL G       L    ++A QIA G+ Y+    R   +
Sbjct: 247 VVSE-EPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 302
Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVAPEWFRNSKI 700
           H D++  NIL+ +    +++DFGLA+L+  N+     TA +G K    + APE     + 
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEY----TARQGAKFPIKWTAPEAALYGRF 358
Query: 701 TAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMN 759
           T K DV+SFG+LL E+ +  R  +   +  E         D    G       E  E+++
Sbjct: 359 TIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGYRMPCPPECPESLH 411
Query: 760 DIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVP 801
           D+ C          C +++P  RPT + +   LE     + P
Sbjct: 412 DLMCQ---------CWRKEPEERPTFEYLQAFLEDYFTSTEP 444

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 128/286 (44%), Gaps = 38/286 (13%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE-------REFKNEVFVIGQ 574
            +++++G+G FG+V+KG +    S   VA+K L     +GE       +EF+ EVF++  
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSV--VAIKSLILGDSEGETEMIEKFQEFQREVFIMSN 79
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-NWNLRTNIAFQIARGLLY 633
            +H N+V+L G         +V EF+  G L   L     P  W+++  +   IA G+ Y
Sbjct: 80  LNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEY 137
Query: 634 LHEDCRAQIIHCDIKPQNILLDDY-----YTARISDFGLAKLLTLNQSKTIKTAIRGTKG 688
           + ++    I+H D++  NI L          A+++DF L++     QS    + + G   
Sbjct: 138 M-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ-----QSVHSVSGLLGNFQ 191
Query: 689 YVAPEWF--RNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 746
           ++APE         T K D YSF ++L  I++    FD     EY+       +  R   
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD-----EYSYGKIKFINMIREEG 246
Query: 747 LNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQML 792
           L   + ED        C  +L  V   C   DP  RP    +++ L
Sbjct: 247 LRPTIPED--------CPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 76/293 (25%), Positives = 138/293 (47%), Gaps = 34/293 (11%)
Query: 514 KELEGATNNFKEEVGRGSFGIVYKGVIQTR-TSTTAVAVKKLDRVFQDGER-EFKNEVFV 571
           KE+E +    +  +G G FG V  G ++        VA+K L   + + +R +F  E  +
Sbjct: 17  KEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASI 76
Query: 572 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQ----- 626
           +GQ  H N++ L G   + +  ++V E++ NG+L +F    LK N    T I        
Sbjct: 77  MGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTF----LKKNDGQFTVIQLVGMLRG 132
Query: 627 IARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGT 686
           I+ G+ YL +      +H D+  +NIL++     ++SDFGL+++L  +      T  RG 
Sbjct: 133 ISAGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT--RGG 187
Query: 687 K---GYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR 743
           K    + APE     K T+  DV+S+G+++ E++S  +    EM  +  I          
Sbjct: 188 KIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWEMTNQDVIKA-------- 239
Query: 744 NGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 796
                  V E     + ++C   L  + + C Q++ + RP   +++ ML+ ++
Sbjct: 240 -------VEEGYRLPSPMDCPAALYQLMLDCWQKERNSRPKFDEIVNMLDKLI 285

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 105/209 (50%), Gaps = 17/209 (8%)
Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ 574
           E+   T    E +G G FG V+ G     T    VAVK L +     +  F  E  ++ Q
Sbjct: 5   EVPRETLKLVERLGAGQFGEVWMGYYNGHTK---VAVKSLKQGSMSPD-AFLAEANLMKQ 60
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF--GNLKPNWNLRTNIAFQIARGLL 632
             H+ LVRL     + +   ++ E++ NG+L  FL     +K   N   ++A QIA G+ 
Sbjct: 61  LQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 119
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK---GY 689
           ++ E      IH +++  NIL+ D  + +I+DFGLA+L+  N+     TA  G K    +
Sbjct: 120 FIEER---NYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEY----TAREGAKFPIKW 172
Query: 690 VAPEWFRNSKITAKVDVYSFGVLLLEIIS 718
            APE       T K DV+SFG+LL EI++
Sbjct: 173 TAPEAINYGTFTIKSDVWSFGILLTEIVT 201

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 73/289 (25%), Positives = 138/289 (47%), Gaps = 24/289 (8%)
Query: 514 KELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTA-VAVKKLDRVFQDGER-EFKNEVFV 571
           KE++ +    ++ +G G FG V  G ++        VA+K L   + + +R +F +E  +
Sbjct: 2   KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASI 61
Query: 572 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR-TNIAFQIARG 630
           +GQ  H N++ L G   +    +++ EF+ NG+L SFL  N      ++   +   IA G
Sbjct: 62  MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAG 121
Query: 631 LLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK--- 687
           + YL +      +H  +  +NIL++     ++SDFGL++ L  + S    T+  G K   
Sbjct: 122 MKYLAD---MNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPI 178
Query: 688 GYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL 747
            + APE  +  K T+  DV+S+G+++ E++S            Y     W  D      +
Sbjct: 179 RWTAPEAIQYRKFTSASDVWSYGIVMWEVMS------------YGERPYW--DMTNQDVI 224
Query: 748 NVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 796
           N  + +D      ++C   L  + + C Q+D + RP   +++  L+ ++
Sbjct: 225 NA-IEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 272

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 83/298 (27%), Positives = 138/298 (46%), Gaps = 49/298 (16%)
Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQT-HHKNL 580
           F++ +G G+FG V K  I+        A+K++ +   +D  R+F  E+ V+ +  HH N+
Sbjct: 19  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 78
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIA------------ 628
           + LLG C+      L  E+  +G L  FL    + +  L T+ AF IA            
Sbjct: 79  INLLGACEHRGYLYLAIEYAPHGNLLDFL----RKSRVLETDPAFAIANSTASTLSSQQL 134
Query: 629 --------RGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI- 679
                   RG+ YL +    Q IH D+  +NIL+ + Y A+I+DFGL++   +   KT+ 
Sbjct: 135 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 191
Query: 680 KTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF 739
           +  +R    ++A E    S  T   DV+S+GVLL EI+S         G  Y  +T    
Sbjct: 192 RLPVR----WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG-------GTPYCGMT---- 236
Query: 740 DCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 797
            C    +L   + +       + C  ++  +   C +E P  RP+  ++L  L  ++E
Sbjct: 237 -C---AELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 290

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 82/296 (27%), Positives = 126/296 (42%), Gaps = 36/296 (12%)
Query: 514 KELEGATNNFKEEVGRGSFGIVYKGVIQ---TRTSTTAVAVKKLDRVF-QDGEREFKNEV 569
           KE+          +G G+FG VY+G +       S   VAVK L  V+ +  E +F  E 
Sbjct: 40  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEA 99
Query: 570 FVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF---- 625
            +I + +H+N+VR +G   +   R ++ E +  G L SFL    +P  +  +++A     
Sbjct: 100 LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLL 158
Query: 626 ----QIARGLLYLHEDCRAQIIHCDIKPQNILLD---DYYTARISDFGLAK-LLTLNQSK 677
                IA G  YL E+     IH DI  +N LL        A+I DFG+A+ +   +  +
Sbjct: 159 HVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 215
Query: 678 TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW 737
               A+   K ++ PE F     T+K D +SFGVLL EI S               L   
Sbjct: 216 KGGCAMLPVK-WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS---------------LGYM 259
Query: 738 AFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
            +    N ++   V           C G +  +   C Q  P  RP    +L+ +E
Sbjct: 260 PYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 315

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 111/219 (50%), Gaps = 15/219 (6%)
Query: 505 ETNLRCFSYKELEGATNNFKEEVGRGSFGIVYKG--VIQTRTSTTAVAVKKLDRVF-QDG 561
           +  LR     EL+       + +G G+FG VYKG  V +  T    VA+K L+       
Sbjct: 6   QAQLRILKETELKRV-----KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKA 60
Query: 562 EREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNW--NL 619
             EF +E  ++    H +LVRLLG C     +L V + + +G L  ++  + K N    L
Sbjct: 61  NVEFMDEALIMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLEYVHEH-KDNIGSQL 118
Query: 620 RTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI 679
             N   QIA+G++YL E    +++H D+  +N+L+      +I+DFGLA+LL  ++ +  
Sbjct: 119 LLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYN 175
Query: 680 KTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS 718
               +    ++A E     K T + DV+S+GV + E+++
Sbjct: 176 ADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 214

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 83/298 (27%), Positives = 138/298 (46%), Gaps = 49/298 (16%)
Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQT-HHKNL 580
           F++ +G G+FG V K  I+        A+K++ +   +D  R+F  E+ V+ +  HH N+
Sbjct: 29  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIA------------ 628
           + LLG C+      L  E+  +G L  FL    + +  L T+ AF IA            
Sbjct: 89  INLLGACEHRGYLYLAIEYAPHGNLLDFL----RKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 629 --------RGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI- 679
                   RG+ YL +    Q IH D+  +NIL+ + Y A+I+DFGL++   +   KT+ 
Sbjct: 145 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 201
Query: 680 KTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF 739
           +  +R    ++A E    S  T   DV+S+GVLL EI+S         G  Y  +T    
Sbjct: 202 RLPVR----WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG-------GTPYCGMT---- 246
Query: 740 DCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 797
            C    +L   + +       + C  ++  +   C +E P  RP+  ++L  L  ++E
Sbjct: 247 -C---AELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 300

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 111/219 (50%), Gaps = 15/219 (6%)
Query: 505 ETNLRCFSYKELEGATNNFKEEVGRGSFGIVYKG--VIQTRTSTTAVAVKKLDRVF-QDG 561
           +  LR     EL+       + +G G+FG VYKG  V +  T    VA+K L+       
Sbjct: 29  QAQLRILKETELKRV-----KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKA 83
Query: 562 EREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNW--NL 619
             EF +E  ++    H +LVRLLG C     +L V + + +G L  ++  + K N    L
Sbjct: 84  NVEFMDEALIMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLEYVHEH-KDNIGSQL 141
Query: 620 RTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI 679
             N   QIA+G++YL E    +++H D+  +N+L+      +I+DFGLA+LL  ++ +  
Sbjct: 142 LLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYN 198
Query: 680 KTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS 718
               +    ++A E     K T + DV+S+GV + E+++
Sbjct: 199 ADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 237

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 139/293 (47%), Gaps = 34/293 (11%)
Query: 514 KELEGATNNFKEEVGRGSFGIVYKGVIQTR-TSTTAVAVKKLDRVFQDGER-EFKNEVFV 571
           KEL+ +    +  +G G FG V  G ++       AVA+K L   + + +R +F  E  +
Sbjct: 38  KELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASI 97
Query: 572 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPNWNLRTNIAF 625
           +GQ  H N+V L G    G+  ++V EF+ NG L +FL      F  ++    LR     
Sbjct: 98  MGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRG---- 153
Query: 626 QIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRG 685
            IA G+ YL +      +H D+  +NIL++     ++SDFGL++++  +  + + T   G
Sbjct: 154 -IAAGMRYLAD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVIE-DDPEAVYTTTGG 208
Query: 686 T--KGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR 743
                + APE  +  K T+  DV+S+G+++ E++S            Y     W      
Sbjct: 209 KIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS------------YGERPYWDMS--- 253
Query: 744 NGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 796
           N  +   + E       ++C   L  + + C Q++ + RP  ++++ +L+ ++
Sbjct: 254 NQDVIKAIEEGYRLPAPMDCPAGLHQLMLDCWQKERAERPKFEQIVGILDKMI 306

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ-DGEREFKNEVFVIGQTHHKNLVRL 583
           E++GRG+FG V+ G  + R   T VAVK        D + +F  E  ++ Q  H N+VRL
Sbjct: 120 EQIGRGNFGEVFSG--RLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQI----ARGLLYLHEDCR 639
           +G C + Q   +V E +  G   +FL         LR     Q+    A G+ YL   C 
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLESKC- 233
Query: 640 AQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK----GYVAPEWF 695
              IH D+  +N L+ +    +ISDFG+++     ++  +  A  G +     + APE  
Sbjct: 234 --CIHRDLAARNCLVTEKNVLKISDFGMSR----EEADGVXAASGGLRQVPVKWTAPEAL 287
Query: 696 RNSKITAKVDVYSFGVLLLEIIS 718
              + +++ DV+SFG+LL E  S
Sbjct: 288 NYGRYSSESDVWSFGILLWETFS 310

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 128/282 (45%), Gaps = 32/282 (11%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLL 584
           E +G+G FG   K  +  R +   + +K+L R  ++ +R F  EV V+    H N+++ +
Sbjct: 16  EVLGKGCFGQAIK--VTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFI 73
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
           G   + +    + E++  GTL   +   + +  W+ R + A  IA G+ YLH      II
Sbjct: 74  GVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS---MNII 130
Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQS-----KTIKTAIR-------GTKGYVA 691
           H D+   N L+ +     ++DFGLA+L+   ++     +++K   R       G   ++A
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 692 PEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLV 751
           PE         KVDV+SFG++L EII       +    +Y   T        +  LNV  
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIG-----RVNADPDYLPRT-------MDFGLNVRG 238
Query: 752 GEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
             D+    +  C      +++ C   DP  RP+  K+   LE
Sbjct: 239 FLDRYCPPN--CPPSFFPITVRCCDLDPEKRPSFVKLEHWLE 278

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ-DGEREFKNEVFVIGQTHHKNLVRL 583
           E++GRG+FG V+ G  + R   T VAVK        D + +F  E  ++ Q  H N+VRL
Sbjct: 120 EQIGRGNFGEVFSG--RLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQI----ARGLLYLHEDCR 639
           +G C + Q   +V E +  G   +FL         LR     Q+    A G+ YL   C 
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLESKC- 233
Query: 640 AQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK----GYVAPEWF 695
              IH D+  +N L+ +    +ISDFG+++     ++  +  A  G +     + APE  
Sbjct: 234 --CIHRDLAARNCLVTEKNVLKISDFGMSR----EEADGVYAASGGLRQVPVKWTAPEAL 287
Query: 696 RNSKITAKVDVYSFGVLLLEIIS 718
              + +++ DV+SFG+LL E  S
Sbjct: 288 NYGRYSSESDVWSFGILLWETFS 310

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 102/206 (49%), Gaps = 11/206 (5%)
Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ 574
           E+   T    E +G G  G V+ G     T    VAVK L +     +  F  E  ++ Q
Sbjct: 9   EVPRETLKLVERLGAGQAGEVWMGYYNGHTK---VAVKSLKQGSMSPD-AFLAEANLMKQ 64
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF--GNLKPNWNLRTNIAFQIARGLL 632
             H+ LVRL     + +   ++ E++ NG+L  FL     +K   N   ++A QIA G+ 
Sbjct: 65  LQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 692
           ++ E      IH D++  NIL+ D  + +I+DFGLA+L+  +   T +   +    + AP
Sbjct: 124 FIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DAEXTAREGAKFPIKWTAP 179
Query: 693 EWFRNSKITAKVDVYSFGVLLLEIIS 718
           E       T K DV+SFG+LL EI++
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 106/221 (47%), Gaps = 9/221 (4%)
Query: 500 DDGTIETNLRCFSYKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ 559
           D GT     +     E+E      K ++G G +G VY GV +  + T AV   K D +  
Sbjct: 13  DLGTENLYFQSMDKWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEV 72
Query: 560 DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNW 617
           +   EF  E  V+ +  H NLV+LLG C       +V E++  G L  +L      +   
Sbjct: 73  E---EFLKEAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTA 129
Query: 618 NLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSK 677
            +   +A QI+  + YL    +   IH D+  +N L+ + +  +++DFGL++L+T   + 
Sbjct: 130 VVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHVVKVADFGLSRLMT-GDTY 185
Query: 678 TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS 718
           T     +    + APE    +  + K DV++FGVLL EI +
Sbjct: 186 TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIAT 226

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/289 (24%), Positives = 137/289 (47%), Gaps = 26/289 (8%)
Query: 514 KELEGATNNFKEEVGRGSFGIVYKGVIQTR-TSTTAVAVKKLDRVFQDGER-EFKNEVFV 571
           KE++ +    ++ +G G FG V  G ++        VA+K L   + D +R +F +E  +
Sbjct: 24  KEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASI 83
Query: 572 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR-TNIAFQIARG 630
           +GQ  H N++ L G   + +  +++ E++ NG+L +FL  N      ++   +   I  G
Sbjct: 84  MGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSG 143
Query: 631 LLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK--- 687
           + YL +      +H D+  +NIL++     ++SDFG++++L  +      T  RG K   
Sbjct: 144 MKYLSD---MSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTT--RGGKIPI 198
Query: 688 GYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL 747
            + APE     K T+  DV+S+G+++ E++S            Y     W      N  +
Sbjct: 199 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMS------------YGERPYWDMS---NQDV 243
Query: 748 NVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 796
              + E       ++C   L  + + C Q++ S RP   +++ ML+ ++
Sbjct: 244 IKAIEEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLDKLI 292

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 140/292 (47%), Gaps = 36/292 (12%)
Query: 517 EGATNNFKEEVGRGSFGIVYKG-VIQTRTSTTAVAVKKLDRVFQDGERE-FKNEVFVIGQ 574
           E    +    +G+G FG+VY G  I    +    A+K L R+ +  + E F  E  ++  
Sbjct: 19  ERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRG 78
Query: 575 THHKNLVRLLGFC--DEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF--QIARG 630
            +H N++ L+G     EG   +L+  ++ +G L  F+    + N  ++  I+F  Q+ARG
Sbjct: 79  LNHPNVLALIGIMLPPEGLPHVLL-PYMCHGDLLQFIRSPQR-NPTVKDLISFGLQVARG 136
Query: 631 LLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLL------TLNQSKTIKTAIR 684
           + YL E    + +H D+  +N +LD+ +T +++DFGLA+ +      ++ Q +  +  ++
Sbjct: 137 MEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVK 193
Query: 685 GTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 744
            T    A E  +  + T K DV+SFGVLL E+++            Y  +    FD    
Sbjct: 194 WT----ALESLQTYRFTTKSDVWSFGVLLWELLT-------RGAPPYRHID--PFD---- 236
Query: 745 GKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 796
             L   + + +       C   L  V   C + DP++RPT + ++  +E +V
Sbjct: 237 --LTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIV 286

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 89/326 (27%), Positives = 149/326 (45%), Gaps = 58/326 (17%)
Query: 495 IRNSPDDGTIETNLRCFSYKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKL 554
           ++N+PD  TI        Y  L+     F++ +G G+FG V K  I+        A+K++
Sbjct: 7   VKNNPDP-TI--------YPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM 57
Query: 555 -DRVFQDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN 612
            +   +D  R+F  E+ V+ +  HH N++ LLG C+      L  E+  +G L  FL   
Sbjct: 58  KEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL--- 114
Query: 613 LKPNWNLRTNIAFQIA--------------------RGLLYLHEDCRAQIIHCDIKPQNI 652
            + +  L T+ AF IA                    RG+ YL +    Q IH ++  +NI
Sbjct: 115 -RKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRNLAARNI 170
Query: 653 LLDDYYTARISDFGLAKLLTLNQSKTI-KTAIRGTKGYVAPEWFRNSKITAKVDVYSFGV 711
           L+ + Y A+I+DFGL++   +   KT+ +  +R    ++A E    S  T   DV+S+GV
Sbjct: 171 LVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR----WMAIESLNYSVYTTNSDVWSYGV 226
Query: 712 LLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVS 771
           LL EI+S         G  Y  +T     C    +L   + +       + C  ++  + 
Sbjct: 227 LLWEIVSLG-------GTPYCGMT-----C---AELYEKLPQGYRLEKPLNCDDEVYDLM 271
Query: 772 IWCIQEDPSLRPTMKKVLQMLEGVVE 797
             C +E P  RP+  ++L  L  ++E
Sbjct: 272 RQCWREKPYERPSFAQILVSLNRMLE 297

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 82/296 (27%), Positives = 125/296 (42%), Gaps = 36/296 (12%)
Query: 514 KELEGATNNFKEEVGRGSFGIVYKGVIQ---TRTSTTAVAVKKLDRVF-QDGEREFKNEV 569
           KE+          +G G+FG VY+G +       S   VAVK L  V  +  E +F  E 
Sbjct: 40  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEA 99
Query: 570 FVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF---- 625
            +I + +H+N+VR +G   +   R ++ E +  G L SFL    +P  +  +++A     
Sbjct: 100 LIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLL 158
Query: 626 ----QIARGLLYLHEDCRAQIIHCDIKPQNILLD---DYYTARISDFGLAK-LLTLNQSK 677
                IA G  YL E+     IH DI  +N LL        A+I DFG+A+ +   +  +
Sbjct: 159 HVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 215
Query: 678 TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW 737
               A+   K ++ PE F     T+K D +SFGVLL EI S               L   
Sbjct: 216 KGGCAMLPVK-WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS---------------LGYM 259
Query: 738 AFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
            +    N ++   V           C G +  +   C Q  P  RP    +L+ +E
Sbjct: 260 PYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 315

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 71/289 (24%), Positives = 137/289 (47%), Gaps = 26/289 (8%)
Query: 514 KELEGATNNFKEEVGRGSFGIVYKGVIQTR-TSTTAVAVKKLDRVFQDGER-EFKNEVFV 571
           KE++ +    ++ +G G FG V  G ++        VA+K L   + D +R +F +E  +
Sbjct: 3   KEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASI 62
Query: 572 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR-TNIAFQIARG 630
           +GQ  H N++ L G   + +  +++ E++ NG+L +FL  N      ++   +   I  G
Sbjct: 63  MGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSG 122
Query: 631 LLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK--- 687
           + YL +      +H D+  +NIL++     ++SDFG++++L  +      T  RG K   
Sbjct: 123 MKYLSD---MSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTT--RGGKIPI 177
Query: 688 GYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL 747
            + APE     K T+  DV+S+G+++ E++S            Y     W      N  +
Sbjct: 178 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMS------------YGERPYWDMS---NQDV 222
Query: 748 NVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 796
              + E       ++C   L  + + C Q++ S RP   +++ ML+ ++
Sbjct: 223 IKAIEEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLDKLI 271

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 139/288 (48%), Gaps = 34/288 (11%)
Query: 522 NFKEEVGRGSFGIVYKGV---IQTRTSTTAVAVKKLDRVFQDGERE-FKNEVFVIGQT-H 576
            F + +G G+FG V +     +    +   VAVK L       E+E   +E+ ++     
Sbjct: 41  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 100
Query: 577 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWN--------LRTNIAF--Q 626
           H+N+V LLG C  G   L++ E+   G L +FL    + + +        LR  + F  Q
Sbjct: 101 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQ 160
Query: 627 IARGLLYL-HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRG 685
           +A+G+ +L  ++C    IH D+  +N+LL + + A+I DFGLA+ +  + +  +K   R 
Sbjct: 161 VAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 216
Query: 686 TKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 745
              ++APE   +   T + DV+S+G+LL EI      F + +     IL +  F  Y+  
Sbjct: 217 PVKWMAPESIFDCVYTVQSDVWSYGILLWEI------FSLGLNPYPGILVNSKF--YKLV 268
Query: 746 KLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
           K    + +   A  +I      +M + W +  +P+ RPT +++   L+
Sbjct: 269 KDGYQMAQPAFAPKNIYS----IMQACWAL--EPTHRPTFQQICSFLQ 310

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 71/289 (24%), Positives = 137/289 (47%), Gaps = 26/289 (8%)
Query: 514 KELEGATNNFKEEVGRGSFGIVYKGVIQTR-TSTTAVAVKKLDRVFQDGER-EFKNEVFV 571
           KE++ +    ++ +G G FG V  G ++        VA+K L   + D +R +F +E  +
Sbjct: 9   KEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASI 68
Query: 572 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR-TNIAFQIARG 630
           +GQ  H N++ L G   + +  +++ E++ NG+L +FL  N      ++   +   I  G
Sbjct: 69  MGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSG 128
Query: 631 LLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK--- 687
           + YL +      +H D+  +NIL++     ++SDFG++++L  +      T  RG K   
Sbjct: 129 MKYLSD---MSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTT--RGGKIPI 183
Query: 688 GYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL 747
            + APE     K T+  DV+S+G+++ E++S            Y     W      N  +
Sbjct: 184 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMS------------YGERPYWDMS---NQDV 228
Query: 748 NVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 796
              + E       ++C   L  + + C Q++ S RP   +++ ML+ ++
Sbjct: 229 IKAIEEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLDKLI 277

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 82/296 (27%), Positives = 125/296 (42%), Gaps = 36/296 (12%)
Query: 514 KELEGATNNFKEEVGRGSFGIVYKGVIQ---TRTSTTAVAVKKLDRVF-QDGEREFKNEV 569
           KE+          +G G+FG VY+G +       S   VAVK L  V  +  E +F  E 
Sbjct: 40  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEA 99
Query: 570 FVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF---- 625
            +I + +H+N+VR +G   +   R ++ E +  G L SFL    +P  +  +++A     
Sbjct: 100 LIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFL-RETRPRPSQPSSLAMLDLL 158
Query: 626 ----QIARGLLYLHEDCRAQIIHCDIKPQNILLD---DYYTARISDFGLAK-LLTLNQSK 677
                IA G  YL E+     IH DI  +N LL        A+I DFG+A+ +   +  +
Sbjct: 159 HVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 215
Query: 678 TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW 737
               A+   K ++ PE F     T+K D +SFGVLL EI S               L   
Sbjct: 216 KGGCAMLPVK-WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS---------------LGYM 259
Query: 738 AFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
            +    N ++   V           C G +  +   C Q  P  RP    +L+ +E
Sbjct: 260 PYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 315

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 139/288 (48%), Gaps = 34/288 (11%)
Query: 522 NFKEEVGRGSFGIVYKGV---IQTRTSTTAVAVKKLDRVFQDGERE-FKNEVFVIGQT-H 576
            F + +G G+FG V +     +    +   VAVK L       E+E   +E+ ++     
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 577 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWN--------LRTNIAF--Q 626
           H+N+V LLG C  G   L++ E+   G L +FL    + + +        LR  + F  Q
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQ 168
Query: 627 IARGLLYL-HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRG 685
           +A+G+ +L  ++C    IH D+  +N+LL + + A+I DFGLA+ +  + +  +K   R 
Sbjct: 169 VAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 224
Query: 686 TKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 745
              ++APE   +   T + DV+S+G+LL EI      F + +     IL +  F  Y+  
Sbjct: 225 PVKWMAPESIFDCVYTVQSDVWSYGILLWEI------FSLGLNPYPGILVNSKF--YKLV 276
Query: 746 KLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
           K    + +   A  +I      +M + W ++  P+ RPT +++   L+
Sbjct: 277 KDGYQMAQPAFAPKNIYS----IMQACWALE--PTHRPTFQQICSFLQ 318

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 82/296 (27%), Positives = 125/296 (42%), Gaps = 36/296 (12%)
Query: 514 KELEGATNNFKEEVGRGSFGIVYKGVIQ---TRTSTTAVAVKKLDRVF-QDGEREFKNEV 569
           KE+          +G G+FG VY+G +       S   VAVK L  V  +  E +F  E 
Sbjct: 26  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEA 85
Query: 570 FVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF---- 625
            +I + +H+N+VR +G   +   R ++ E +  G L SFL    +P  +  +++A     
Sbjct: 86  LIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLL 144
Query: 626 ----QIARGLLYLHEDCRAQIIHCDIKPQNILLD---DYYTARISDFGLAK-LLTLNQSK 677
                IA G  YL E+     IH DI  +N LL        A+I DFG+A+ +   +  +
Sbjct: 145 HVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 201
Query: 678 TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW 737
               A+   K ++ PE F     T+K D +SFGVLL EI S               L   
Sbjct: 202 KGGCAMLPVK-WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS---------------LGYM 245
Query: 738 AFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
            +    N ++   V           C G +  +   C Q  P  RP    +L+ +E
Sbjct: 246 PYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 301

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 82/296 (27%), Positives = 125/296 (42%), Gaps = 36/296 (12%)
Query: 514 KELEGATNNFKEEVGRGSFGIVYKGVIQ---TRTSTTAVAVKKLDRVF-QDGEREFKNEV 569
           KE+          +G G+FG VY+G +       S   VAVK L  V  +  E +F  E 
Sbjct: 17  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEA 76
Query: 570 FVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF---- 625
            +I + +H+N+VR +G   +   R ++ E +  G L SFL    +P  +  +++A     
Sbjct: 77  LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLL 135
Query: 626 ----QIARGLLYLHEDCRAQIIHCDIKPQNILLD---DYYTARISDFGLAK-LLTLNQSK 677
                IA G  YL E+     IH DI  +N LL        A+I DFG+A+ +   +  +
Sbjct: 136 HVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 192
Query: 678 TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW 737
               A+   K ++ PE F     T+K D +SFGVLL EI S               L   
Sbjct: 193 KGGCAMLPVK-WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS---------------LGYM 236
Query: 738 AFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
            +    N ++   V           C G +  +   C Q  P  RP    +L+ +E
Sbjct: 237 PYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 292

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 104/212 (49%), Gaps = 9/212 (4%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKL---DRVFQDGEREFKNEVFVIGQTHHKNLV 581
           +++G G    VY  + +       VA+K +    R  ++  + F+ EV    Q  H+N+V
Sbjct: 17  DKLGGGGMSTVY--LAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIV 74
Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ 641
            ++   +E     LV E++   TL+ ++  +   + +   N   QI  G+ + H+    +
Sbjct: 75  SMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD---MR 131
Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKIT 701
           I+H DIKPQNIL+D   T +I DFG+AK L+   S T    + GT  Y +PE  +     
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPEQAKGEATD 190
Query: 702 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI 733
              D+YS G++L E++     F+ E     AI
Sbjct: 191 ECTDIYSIGIVLYEMLVGEPPFNGETAVSIAI 222

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 82/296 (27%), Positives = 125/296 (42%), Gaps = 36/296 (12%)
Query: 514 KELEGATNNFKEEVGRGSFGIVYKGVIQ---TRTSTTAVAVKKLDRVF-QDGEREFKNEV 569
           KE+          +G G+FG VY+G +       S   VAVK L  V  +  E +F  E 
Sbjct: 25  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEA 84
Query: 570 FVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF---- 625
            +I + +H+N+VR +G   +   R ++ E +  G L SFL    +P  +  +++A     
Sbjct: 85  LIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFL-RETRPRPSQPSSLAMLDLL 143
Query: 626 ----QIARGLLYLHEDCRAQIIHCDIKPQNILLD---DYYTARISDFGLAK-LLTLNQSK 677
                IA G  YL E+     IH DI  +N LL        A+I DFG+A+ +   +  +
Sbjct: 144 HVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 200
Query: 678 TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW 737
               A+   K ++ PE F     T+K D +SFGVLL EI S               L   
Sbjct: 201 KGGCAMLPVK-WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS---------------LGYM 244
Query: 738 AFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
            +    N ++   V           C G +  +   C Q  P  RP    +L+ +E
Sbjct: 245 PYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 300

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 82/296 (27%), Positives = 125/296 (42%), Gaps = 36/296 (12%)
Query: 514 KELEGATNNFKEEVGRGSFGIVYKGVIQ---TRTSTTAVAVKKLDRVF-QDGEREFKNEV 569
           KE+          +G G+FG VY+G +       S   VAVK L  V  +  E +F  E 
Sbjct: 25  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEA 84
Query: 570 FVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF---- 625
            +I + +H+N+VR +G   +   R ++ E +  G L SFL    +P  +  +++A     
Sbjct: 85  LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLL 143
Query: 626 ----QIARGLLYLHEDCRAQIIHCDIKPQNILLD---DYYTARISDFGLAK-LLTLNQSK 677
                IA G  YL E+     IH DI  +N LL        A+I DFG+A+ +   +  +
Sbjct: 144 HVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 200
Query: 678 TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW 737
               A+   K ++ PE F     T+K D +SFGVLL EI S               L   
Sbjct: 201 KGGCAMLPVK-WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS---------------LGYM 244
Query: 738 AFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
            +    N ++   V           C G +  +   C Q  P  RP    +L+ +E
Sbjct: 245 PYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 300

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 82/296 (27%), Positives = 125/296 (42%), Gaps = 36/296 (12%)
Query: 514 KELEGATNNFKEEVGRGSFGIVYKGVIQ---TRTSTTAVAVKKLDRVF-QDGEREFKNEV 569
           KE+          +G G+FG VY+G +       S   VAVK L  V  +  E +F  E 
Sbjct: 32  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEA 91
Query: 570 FVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF---- 625
            +I + +H+N+VR +G   +   R ++ E +  G L SFL    +P  +  +++A     
Sbjct: 92  LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLL 150
Query: 626 ----QIARGLLYLHEDCRAQIIHCDIKPQNILLD---DYYTARISDFGLAK-LLTLNQSK 677
                IA G  YL E+     IH DI  +N LL        A+I DFG+A+ +   +  +
Sbjct: 151 HVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 207
Query: 678 TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW 737
               A+   K ++ PE F     T+K D +SFGVLL EI S               L   
Sbjct: 208 KGGCAMLPVK-WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS---------------LGYM 251
Query: 738 AFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
            +    N ++   V           C G +  +   C Q  P  RP    +L+ +E
Sbjct: 252 PYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 307

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 82/296 (27%), Positives = 125/296 (42%), Gaps = 36/296 (12%)
Query: 514 KELEGATNNFKEEVGRGSFGIVYKGVIQ---TRTSTTAVAVKKLDRVF-QDGEREFKNEV 569
           KE+          +G G+FG VY+G +       S   VAVK L  V  +  E +F  E 
Sbjct: 26  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEA 85
Query: 570 FVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF---- 625
            +I + +H+N+VR +G   +   R ++ E +  G L SFL    +P  +  +++A     
Sbjct: 86  LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLL 144
Query: 626 ----QIARGLLYLHEDCRAQIIHCDIKPQNILLD---DYYTARISDFGLAK-LLTLNQSK 677
                IA G  YL E+     IH DI  +N LL        A+I DFG+A+ +   +  +
Sbjct: 145 HVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 201
Query: 678 TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW 737
               A+   K ++ PE F     T+K D +SFGVLL EI S               L   
Sbjct: 202 KGGCAMLPVK-WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS---------------LGYM 245
Query: 738 AFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
            +    N ++   V           C G +  +   C Q  P  RP    +L+ +E
Sbjct: 246 PYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 301

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 137/295 (46%), Gaps = 36/295 (12%)
Query: 502 GTIETNLRCFSYKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD- 560
           G ++   R F   EL        + +G G FG V+KGV      +  + V    +V +D 
Sbjct: 1   GAMKVLARIFKETELRKL-----KVLGSGVFGTVHKGVWIPEGESIKIPV--CIKVIEDK 53
Query: 561 -GEREFK---NEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF---GNL 613
            G + F+   + +  IG   H ++VRLLG C  G +  LV ++L  G+L   +    G L
Sbjct: 54  SGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGAL 112
Query: 614 KPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTL 673
            P   L  N   QIA+G+ YL E     ++H ++  +N+LL      +++DFG+A LL  
Sbjct: 113 GPQ--LLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167
Query: 674 NQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI 733
           +  + + +  +    ++A E     K T + DV+S+GV + E+++          E YA 
Sbjct: 168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFG-------AEPYAG 220
Query: 734 LTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKV 788
           L        R  ++  L+ + +       C   + MV + C   D ++RPT K++
Sbjct: 221 L--------RLAEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKEL 267

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 77/294 (26%), Positives = 135/294 (45%), Gaps = 40/294 (13%)
Query: 522 NFKEEVGRGSFGIVYKGV---IQTRTSTTAVAVKKLDRVFQDGERE-FKNEVFVIGQT-H 576
            F + +G G+FG V +     +    +   VAVK L       E+E   +E+ ++     
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 577 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF----------- 625
           H+N+V LLG C  G   L++ E+   G L +FL     P      N +            
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDL 168
Query: 626 -----QIARGLLYL-HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI 679
                Q+A+G+ +L  ++C    IH D+  +N+LL + + A+I DFGLA+ +  + +  +
Sbjct: 169 LHFSSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 224
Query: 680 KTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF 739
           K   R    ++APE   +   T + DV+S+G+LL EI      F + +     IL +  F
Sbjct: 225 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI------FSLGLNPYPGILVNSKF 278
Query: 740 DCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
             Y+  K    + +   A  +I      +M + W +  +P+ RPT +++   L+
Sbjct: 279 --YKLVKDGYQMAQPAFAPKNIYS----IMQACWAL--EPTHRPTFQQICSFLQ 324

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 80/283 (28%), Positives = 121/283 (42%), Gaps = 36/283 (12%)
Query: 527 VGRGSFGIVYKGVIQ---TRTSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVR 582
           +G G+FG VY+G +       S   VAVK L  V  +  E +F  E  +I + +H+N+VR
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF--------QIARGLLYL 634
            +G   +   R ++ E +  G L SFL    +P  +  +++A          IA G  YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197
Query: 635 HEDCRAQIIHCDIKPQNILLD---DYYTARISDFGLAK-LLTLNQSKTIKTAIRGTKGYV 690
            E+     IH DI  +N LL        A+I DFG+A+ +      +    A+   K ++
Sbjct: 198 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVK-WM 253
Query: 691 APEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVL 750
            PE F     T+K D +SFGVLL EI S               L    +    N ++   
Sbjct: 254 PPEAFMEGIFTSKTDTWSFGVLLWEIFS---------------LGYMPYPSKSNQEVLEF 298
Query: 751 VGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
           V           C G +  +   C Q  P  RP    +L+ +E
Sbjct: 299 VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 341

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 80/283 (28%), Positives = 121/283 (42%), Gaps = 36/283 (12%)
Query: 527 VGRGSFGIVYKGVIQ---TRTSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVR 582
           +G G+FG VY+G +       S   VAVK L  V  +  E +F  E  +I + +H+N+VR
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF--------QIARGLLYL 634
            +G   +   R ++ E +  G L SFL    +P  +  +++A          IA G  YL
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQYL 174
Query: 635 HEDCRAQIIHCDIKPQNILLD---DYYTARISDFGLAK-LLTLNQSKTIKTAIRGTKGYV 690
            E+     IH DI  +N LL        A+I DFG+A+ +      +    A+   K ++
Sbjct: 175 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVK-WM 230
Query: 691 APEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVL 750
            PE F     T+K D +SFGVLL EI S               L    +    N ++   
Sbjct: 231 PPEAFMEGIFTSKTDTWSFGVLLWEIFS---------------LGYMPYPSKSNQEVLEF 275
Query: 751 VGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
           V           C G +  +   C Q  P  RP    +L+ +E
Sbjct: 276 VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 318

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 80/283 (28%), Positives = 122/283 (43%), Gaps = 36/283 (12%)
Query: 527 VGRGSFGIVYKGVIQ---TRTSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVR 582
           +G G+FG VY+G +       S   VAVK L  V  +  E +F  E  +I + +H+N+VR
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF--------QIARGLLYL 634
            +G   +   R ++ E +  G L SFL    +P  +  +++A          IA G  YL
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQYL 173
Query: 635 HEDCRAQIIHCDIKPQNILLD---DYYTARISDFGLAK-LLTLNQSKTIKTAIRGTKGYV 690
            E+     IH DI  +N LL        A+I DFG+A+ +   +  +    A+   K ++
Sbjct: 174 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK-WM 229
Query: 691 APEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVL 750
            PE F     T+K D +SFGVLL EI S               L    +    N ++   
Sbjct: 230 PPEAFMEGIFTSKTDTWSFGVLLWEIFS---------------LGYMPYPSKSNQEVLEF 274
Query: 751 VGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
           V           C G +  +   C Q  P  RP    +L+ +E
Sbjct: 275 VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 317

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 82/296 (27%), Positives = 125/296 (42%), Gaps = 36/296 (12%)
Query: 514 KELEGATNNFKEEVGRGSFGIVYKGVIQ---TRTSTTAVAVKKLDRVF-QDGEREFKNEV 569
           KE+          +G G+FG VY+G +       S   VAVK L  V  +  E +F  E 
Sbjct: 26  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEA 85
Query: 570 FVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF---- 625
            +I + +H+N+VR +G   +   R ++ E +  G L SFL    +P  +  +++A     
Sbjct: 86  LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLL 144
Query: 626 ----QIARGLLYLHEDCRAQIIHCDIKPQNILLD---DYYTARISDFGLAK-LLTLNQSK 677
                IA G  YL E+     IH DI  +N LL        A+I DFG+A+ +   +  +
Sbjct: 145 HVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYR 201
Query: 678 TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW 737
               A+   K ++ PE F     T+K D +SFGVLL EI S               L   
Sbjct: 202 KGGCAMLPVK-WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS---------------LGYM 245
Query: 738 AFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
            +    N ++   V           C G +  +   C Q  P  RP    +L+ +E
Sbjct: 246 PYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 301

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 129/270 (47%), Gaps = 31/270 (11%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD--GEREFK---NEVFVIGQTHHKNLV 581
           +G G FG V+KGV      +  + V    +V +D  G + F+   + +  IG   H ++V
Sbjct: 39  LGSGVFGTVHKGVWIPEGESIKIPV--CIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPNWNLRTNIAFQIARGLLYLHEDC 638
           RLLG C  G +  LV ++L  G+L   +    G L P   L  N   QIA+G+ YL E  
Sbjct: 97  RLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQ--LLLNWGVQIAKGMYYLEEHG 153
Query: 639 RAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNS 698
              ++H ++  +N+LL      +++DFG+A LL  +  + + +  +    ++A E     
Sbjct: 154 ---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG 210
Query: 699 KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAM 758
           K T + DV+S+GV + E+++          E YA L        R  ++  L+ + +   
Sbjct: 211 KYTHQSDVWSYGVTVWELMTFG-------AEPYAGL--------RLAEVPDLLEKGERLA 255
Query: 759 NDIECLGKLVMVSIWCIQEDPSLRPTMKKV 788
               C   + MV + C   D ++RPT K++
Sbjct: 256 QPQICTIDVYMVMVKCWMIDENIRPTFKEL 285

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 79/291 (27%), Positives = 135/291 (46%), Gaps = 36/291 (12%)
Query: 522 NFKEEVGRGSFGIVYKGV---IQTRTSTTAVAVKKLDRVFQDGERE-FKNEVFVIGQT-H 576
            F + +G G+FG V +     +    +   VAVK L       E+E   +E+ ++     
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 577 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIA------RG 630
           H+N+V LLG C  G   L++ E+   G L +FL    + +  L T+ AF IA      R 
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFL---RRKSRVLETDPAFAIANSTASTRD 165
Query: 631 LLYLHEDCRAQI--------IHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTA 682
           LL+        +        IH D+  +N+LL + + A+I DFGLA+ +  + +  +K  
Sbjct: 166 LLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 225
Query: 683 IRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 742
            R    ++APE   +   T + DV+S+G+LL EI      F + +     IL +  F  Y
Sbjct: 226 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI------FSLGLNPYPGILVNSKF--Y 277
Query: 743 RNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
           +  K    + +   A  +I      +M + W +  +P+ RPT +++   L+
Sbjct: 278 KLVKDGYQMAQPAFAPKNIYS----IMQACWAL--EPTHRPTFQQICSFLQ 322

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 79/291 (27%), Positives = 135/291 (46%), Gaps = 36/291 (12%)
Query: 522 NFKEEVGRGSFGIVYKGV---IQTRTSTTAVAVKKLDRVFQDGERE-FKNEVFVIGQT-H 576
            F + +G G+FG V +     +    +   VAVK L       E+E   +E+ ++     
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 577 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIA------RG 630
           H+N+V LLG C  G   L++ E+   G L +FL    + +  L T+ AF IA      R 
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFL---RRKSRVLETDPAFAIANSTLSTRD 165
Query: 631 LLYLHEDCRAQI--------IHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTA 682
           LL+        +        IH D+  +N+LL + + A+I DFGLA+ +  + +  +K  
Sbjct: 166 LLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 225
Query: 683 IRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 742
            R    ++APE   +   T + DV+S+G+LL EI      F + +     IL +  F  Y
Sbjct: 226 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI------FSLGLNPYPGILVNSKF--Y 277
Query: 743 RNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
           +  K    + +   A  +I      +M + W +  +P+ RPT +++   L+
Sbjct: 278 KLVKDGYQMAQPAFAPKNIYS----IMQACWAL--EPTHRPTFQQICSFLQ 322

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 80/283 (28%), Positives = 122/283 (43%), Gaps = 36/283 (12%)
Query: 527 VGRGSFGIVYKGVIQ---TRTSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVR 582
           +G G+FG VY+G +       S   VAVK L  V  +  E +F  E  +I + +H+N+VR
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF--------QIARGLLYL 634
            +G   +   R ++ E +  G L SFL    +P  +  +++A          IA G  YL
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQYL 183
Query: 635 HEDCRAQIIHCDIKPQNILLD---DYYTARISDFGLAK-LLTLNQSKTIKTAIRGTKGYV 690
            E+     IH DI  +N LL        A+I DFG+A+ +   +  +    A+   K ++
Sbjct: 184 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK-WM 239
Query: 691 APEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVL 750
            PE F     T+K D +SFGVLL EI S               L    +    N ++   
Sbjct: 240 PPEAFMEGIFTSKTDTWSFGVLLWEIFS---------------LGYMPYPSKSNQEVLEF 284
Query: 751 VGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
           V           C G +  +   C Q  P  RP    +L+ +E
Sbjct: 285 VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 327

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 103/215 (47%), Gaps = 25/215 (11%)
Query: 528 GRGSFGIVYKGVIQTRTSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQTHHKNLVRLLGF 586
            RG FG V+K   Q      AV +  L D+     ERE    +F      H+NL++ +  
Sbjct: 24  ARGRFGCVWKA--QLMNDFVAVKIFPLQDKQSWQSERE----IFSTPGMKHENLLQFIAA 77
Query: 587 CDEGQNR----LLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHED---CR 639
              G N      L+  F + G+L  +L GN+   WN   ++A  ++RGL YLHED   CR
Sbjct: 78  EKRGSNLEVELWLITAFHDKGSLTDYLKGNII-TWNELCHVAETMSRGLSYLHEDVPWCR 136
Query: 640 AQ-----IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 694
            +     I H D K +N+LL    TA ++DFGLA      +         GT+ Y+APE 
Sbjct: 137 GEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEV 196
Query: 695 FRNS-----KITAKVDVYSFGVLLLEIISCRKSFD 724
              +         ++D+Y+ G++L E++S  K+ D
Sbjct: 197 LEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAAD 231

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 83/293 (28%), Positives = 129/293 (44%), Gaps = 58/293 (19%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGF 586
           +G G FG V+ G   T    T VA+K L       E  F  E  ++ +  H  LV+L   
Sbjct: 17  LGNGQFGEVWMG---TWNGNTKVAIKTLKPGTMSPE-SFLEEAQIMKKLKHDKLVQLYAV 72
Query: 587 CDEGQNRLLVYEFLNNGTLASFLFGN----LK-PNWNLRTNIAFQIARGLLYLHEDCRAQ 641
             E +   +V E++N G+L  FL       LK PN     ++A Q+A G+ Y+    R  
Sbjct: 73  VSE-EPIYIVTEYMNKGSLLDFLKDGEGRALKLPNL---VDMAAQVAAGMAYIE---RMN 125
Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVAPEWFRNS 698
            IH D++  NIL+ +    +I+DFGLA+L+  N+     TA +G K    + APE     
Sbjct: 126 YIHRDLRSANILVGNGLICKIADFGLARLIEDNEX----TARQGAKFPIKWTAPEAALYG 181
Query: 699 KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAM 758
           + T K DV+SFG+LL E+++                          G++      ++E +
Sbjct: 182 RFTIKSDVWSFGILLTELVT-------------------------KGRVPYPGMNNREVL 216
Query: 759 NDIE----------CLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVP 801
             +E          C   L  + I C ++DP  RPT + +   LE     + P
Sbjct: 217 EQVERGYRMPCPQDCPISLHELMIHCWKKDPEERPTFEYLQSFLEDYFTATEP 269

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/293 (23%), Positives = 126/293 (43%), Gaps = 34/293 (11%)
Query: 523 FKEEVGRGSFGIVYKGV---IQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKN 579
            K E+G G+FG V+      +        VAVK L     +  ++F  E  ++    H++
Sbjct: 17  LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 76
Query: 580 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN-----LKPNWNLRT--------NIAFQ 626
           +V+  G C EG   ++V+E++ +G L  FL  +     L    N  T        +IA Q
Sbjct: 77  IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQ 136
Query: 627 IARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGT 686
           IA G++YL        +H D+  +N L+ +    +I DFG+++ +       +       
Sbjct: 137 IAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 193
Query: 687 KGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 746
             ++ PE     K T + DV+S GV+L EI +  K         Y +  +   +C   G+
Sbjct: 194 IRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ------PWYQLSNNEVIECITQGR 247
Query: 747 LNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 799
           +               C  ++  + + C Q +P +R  +K +  +L+ + + S
Sbjct: 248 V---------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKAS 291

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Composition-based stats.
 Identities = 72/288 (25%), Positives = 129/288 (44%), Gaps = 28/288 (9%)
Query: 513 YKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVI 572
           + EL+       +E+G G FG+V  G  + +     VAVK + +     E EF  E   +
Sbjct: 2   HMELKREEITLLKELGSGQFGVVKLGKWKGQYD---VAVKMI-KEGSMSEDEFFQEAQTM 57
Query: 573 GQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN---LKPNWNLRTNIAFQIAR 629
            +  H  LV+  G C +     +V E+++NG L ++L  +   L+P+  L   + + +  
Sbjct: 58  MKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLE--MCYDVCE 115
Query: 630 GLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGY 689
           G+ +L      Q IH D+  +N L+D     ++SDFG+ + + L+         +    +
Sbjct: 116 GMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYV-LDDQYVSSVGTKFPVKW 171
Query: 690 VAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNV 749
            APE F   K ++K DV++FG+L+ E+ S               L    +D Y N ++ +
Sbjct: 172 SAPEVFHYFKYSSKSDVWAFGILMWEVFS---------------LGKMPYDLYTNSEVVL 216
Query: 750 LVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 797
            V +             +  +   C  E P  RPT +++L  +E + E
Sbjct: 217 KVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 105/212 (49%), Gaps = 15/212 (7%)
Query: 513 YKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGER--EFKNEVF 570
           Y E+E +       +G GSFG VYKG          VAVK L  V    E+   F+NEV 
Sbjct: 30  YWEIEASEVMLSTRIGSGSFGTVYKGKWHG-----DVAVKILKVVDPTPEQFQAFRNEVA 84
Query: 571 VIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL-FGNLKPNWNLRTNIAFQIAR 629
           V+ +T H N++  +G+  +  N  +V ++    +L   L     K       +IA Q A+
Sbjct: 85  VLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQ 143
Query: 630 GLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGY 689
           G+ YLH      IIH D+K  NI L +  T +I DFGLA + +            G+  +
Sbjct: 144 GMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLW 200
Query: 690 VAPEWFR---NSKITAKVDVYSFGVLLLEIIS 718
           +APE  R   N+  + + DVYS+G++L E+++
Sbjct: 201 MAPEVIRMQDNNPFSFQSDVYSYGIVLYELMT 232

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 130/268 (48%), Gaps = 27/268 (10%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLD-RVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           E +G+GSFG V+KG I  RT    VA+K +D    +D   + + E+ V+ Q     + + 
Sbjct: 29  ERIGKGSFGEVFKG-IDNRTQQV-VAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKY 86
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
            G   +G    ++ E+L  G+    L       + + T +  +I +GL YLH + +   I
Sbjct: 87  YGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK-EILKGLDYLHSEKK---I 142
Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK 703
           H DIK  N+LL +    +++DFG+A  LT  Q K  +    GT  ++APE  + S   +K
Sbjct: 143 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK--RNTFVGTPFWMAPEVIQQSAYDSK 200
Query: 704 VDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMND-IE 762
            D++S G+  +E+       + +M     +     F   +N     LVG+  ++  + I+
Sbjct: 201 ADIWSLGITAIELAKGEPP-NSDMHPMRVL-----FLIPKNNP-PTLVGDFTKSFKEFID 253
Query: 763 CLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
                      C+ +DPS RPT K++L+
Sbjct: 254 A----------CLNKDPSFRPTAKELLK 271

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 102/207 (49%), Gaps = 22/207 (10%)
Query: 528 GRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFC 587
            RG FG V+K   Q      AV +  +    Q  + E+  EV+ +    H+N+++ +G  
Sbjct: 33  ARGRFGCVWKA--QLLNEYVAVKIFPIQDK-QSWQNEY--EVYSLPGMKHENILQFIGAE 87
Query: 588 DEGQ----NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDC----- 638
             G     +  L+  F   G+L+ FL  N+  +WN   +IA  +ARGL YLHED      
Sbjct: 88  KRGTSVDVDLWLITAFHEKGSLSDFLKANV-VSWNELCHIAETMARGLAYLHEDIPGLKD 146
Query: 639 --RAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR 696
             +  I H DIK +N+LL +  TA I+DFGLA      +S        GT+ Y+APE   
Sbjct: 147 GHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLE 206
Query: 697 NS-----KITAKVDVYSFGVLLLEIIS 718
            +         ++D+Y+ G++L E+ S
Sbjct: 207 GAINFQRDAFLRIDMYAMGLVLWELAS 233

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 85/303 (28%), Positives = 140/303 (46%), Gaps = 44/303 (14%)
Query: 522 NFKEEVGRGSFGIVYK----GVIQTRTSTTAVAVKKLDRVFQDGE-REFKNEV-FVIGQT 575
           N  + +GRG+FG V +    G+ +T T  T VAVK L       E R   +E+  +I   
Sbjct: 31  NLGKPLGRGAFGQVIEADAFGIDKTATCRT-VAVKMLKEGATHSEHRALMSELKILIHIG 89
Query: 576 HHKNLVRLLGFCDE-GQNRLLVYEFLNNGTLASFL------FGNLKPNWNLRTNI----- 623
           HH N+V LLG C + G   +++ EF   G L+++L      F   K   +L  +      
Sbjct: 90  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEH 149
Query: 624 ----AFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI 679
               +FQ+A+G+ +L      + IH D+  +NILL +    +I DFGLA+ +  +     
Sbjct: 150 LICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVR 206
Query: 680 KTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDW 737
           K   R    ++APE   +   T + DV+SFGVLL EI S   S    +++ EE+      
Sbjct: 207 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF------ 260
Query: 738 AFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 797
              C R  +   +   D           ++    + C   +PS RPT  ++++ L  +++
Sbjct: 261 ---CRRLKEGTRMRAPDYTT-------PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310
Query: 798 VSV 800
            + 
Sbjct: 311 ANA 313

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 86/297 (28%), Positives = 138/297 (46%), Gaps = 43/297 (14%)
Query: 527 VGRGSFGIVYK----GVIQTRTSTTAVAVKKLDRVFQDGE-REFKNEV-FVIGQTHHKNL 580
           +GRG+FG V +    G+ +T T  T VAVK L       E R   +E+  +I   HH N+
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRT-VAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 95
Query: 581 VRLLGFCDE-GQNRLLVYEFLNNGTLASFL------FGNLKPN------WNLRTNI--AF 625
           V LLG C + G   +++ EF   G L+++L      F   KP         L   I  +F
Sbjct: 96  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSF 155
Query: 626 QIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRG 685
           Q+A+G+ +L      + IH D+  +NILL +    +I DFGLA+ +  +     K   R 
Sbjct: 156 QVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 686 TKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDCYR 743
              ++APE   +   T + DV+SFGVLL EI S   S    +++ EE+         C R
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF---------CRR 263
Query: 744 NGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSV 800
             +   +   D           ++    + C   +PS RPT  ++++ L  +++ + 
Sbjct: 264 LKEGTRMRAPDYTT-------PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 83/300 (27%), Positives = 142/300 (47%), Gaps = 41/300 (13%)
Query: 522 NFKEEVGRGSFGIVYK----GVIQTRTSTTAVAVKKLDRVFQDGE-REFKNEV-FVIGQT 575
           N  + +GRG+FG V +    G+ +T T  T VAVK L       E R   +E+  +I   
Sbjct: 30  NLGKPLGRGAFGQVIEADAFGIDKTATXRT-VAVKMLKEGATHSEHRALMSELKILIHIG 88
Query: 576 HHKNLVRLLGFCDE-GQNRLLVYEFLNNGTLASFL---------FGNLKPNWNLRTNI-- 623
           HH N+V LLG C + G   +++ EF   G L+++L         + +L  ++    ++  
Sbjct: 89  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIC 148
Query: 624 -AFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTA 682
            +FQ+A+G+ +L      + IH D+  +NILL +    +I DFGLA+ +  +     K  
Sbjct: 149 YSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 205
Query: 683 IRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFD 740
            R    ++APE   +   T + DV+SFGVLL EI S   S    +++ EE+         
Sbjct: 206 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--------- 256
Query: 741 CYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSV 800
           C R  +   +   D           ++    + C   +PS RPT  ++++ L  +++ + 
Sbjct: 257 CRRLKEGTRMRAPDYTT-------PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 309

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 103/202 (50%), Gaps = 9/202 (4%)
Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTT--AVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNL 580
           F +++G+G+FG V           T   VAVKKL    ++  R+F+ E+ ++    H N+
Sbjct: 17  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 76
Query: 581 VRLLGFCDEG--QNRLLVYEFLNNGTLASFLFGNLKPNWNLR-TNIAFQIARGLLYLHED 637
           V+  G C     +N  L+ E+L  G+L  +L  + +   +++      QI +G+ YL   
Sbjct: 77  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYL--- 133
Query: 638 CRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN-QSKTIKTAIRGTKGYVAPEWFR 696
              + IH D+  +NIL+++    +I DFGL K+L  + +   +K        + APE   
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 697 NSKITAKVDVYSFGVLLLEIIS 718
            SK +   DV+SFGV+L E+ +
Sbjct: 194 ESKFSVASDVWSFGVVLYELFT 215

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 103/204 (50%), Gaps = 11/204 (5%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGE-REFKNEVFVIGQTHHKNLVRL 583
           +G+GSF  VY+   ++  +   VA+K +D+  +++ G  +  +NEV +  Q  H +++ L
Sbjct: 19  LGKGSFAGVYRA--ESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILEL 76
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-NWNLRTNIAFQIARGLLYLHEDCRAQI 642
             + ++     LV E  +NG +  +L   +KP + N   +   QI  G+LYLH      I
Sbjct: 77  YNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH---GI 133
Query: 643 IHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITA 702
           +H D+   N+LL      +I+DFGLA  L +   K     + GT  Y++PE    S    
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK--HYTLCGTPNYISPEIATRSAHGL 191
Query: 703 KVDVYSFGVLLLEIISCRKSFDIE 726
           + DV+S G +   ++  R  FD +
Sbjct: 192 ESDVWSLGCMFYTLLIGRPPFDTD 215

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 103/200 (51%), Gaps = 15/200 (7%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGER--EFKNEVFVIGQTHHKNLVR 582
           + +G GSFG VYKG          VAVK L+      ++   FKNEV V+ +T H N++ 
Sbjct: 18  QRIGSGSFGTVYKGKWHG-----DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 72
Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQ 641
            +G+  + Q   +V ++    +L   L  +  K       +IA Q ARG+ YLH      
Sbjct: 73  FMGYSTKPQ-LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS--- 128
Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR---NS 698
           IIH D+K  NI L +  T +I DFGLA + +          + G+  ++APE  R   ++
Sbjct: 129 IIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 188
Query: 699 KITAKVDVYSFGVLLLEIIS 718
             + + DVY+FG++L E+++
Sbjct: 189 PYSFQSDVYAFGIVLYELMT 208

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 75/302 (24%), Positives = 133/302 (44%), Gaps = 40/302 (13%)
Query: 514 KELEGATNNFKEEVGRGSFGIVYKGVI---QTRTSTTAVAVKKL-DRVFQDGEREFKNEV 569
           KE+  +   F EE+G   FG VYKG +        T AVA+K L D+       EF++E 
Sbjct: 4   KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEA 63
Query: 570 FVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--------FGNLKPNWNLRT 621
            +  +  H N+V LLG   + Q   +++ + ++G L  FL         G+   +  +++
Sbjct: 64  MLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 123
Query: 622 --------NIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAK-LLT 672
                   ++  QIA G+ YL       ++H D+  +N+L+ D    +ISD GL + +  
Sbjct: 124 ALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYA 180
Query: 673 LNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA 732
            +  K +  ++   + ++APE     K +   D++S+GV+L E+ S            Y 
Sbjct: 181 ADYYKLLGNSLLPIR-WMAPEAIMYGKFSIDSDIWSYGVVLWEVFS------------YG 227
Query: 733 ILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQML 792
           +     +  Y N  +  ++   +      +C   +  + I C  E PS RP  K +   L
Sbjct: 228 LQ---PYCGYSNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 284
Query: 793 EG 794
Sbjct: 285 RA 286

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 80/301 (26%), Positives = 140/301 (46%), Gaps = 47/301 (15%)
Query: 522 NFKEEVGRGSFGIVYKGV---IQTRTSTTAVAVKKLDRVFQDGERE-FKNEVFVIGQT-H 576
            F + +G G+FG V +     +    +   VAVK L       E+E   +E+ ++     
Sbjct: 34  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 93
Query: 577 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF--------GNLKPNWN---------- 618
           H+N+V LLG C  G   L++ E+   G L +FL          +L P  +          
Sbjct: 94  HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGR 153
Query: 619 ---LRTNIAF--QIARGLLYL-HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLT 672
              LR  + F  Q+A+G+ +L  ++C    IH D+  +N+LL + + A+I DFGLA+ + 
Sbjct: 154 PLELRDLLHFSSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIM 209
Query: 673 LNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA 732
            + +  +K   R    ++APE   +   T + DV+S+G+LL EI      F + +     
Sbjct: 210 NDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI------FSLGLNPYPG 263
Query: 733 ILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQML 792
           IL +  F  Y+  K    + +   A  +I      +M + W +  +P+ RPT +++   L
Sbjct: 264 ILVNSKF--YKLVKDGYQMAQPAFAPKNIYS----IMQACWAL--EPTHRPTFQQICSFL 315
Query: 793 E 793
           +
Sbjct: 316 Q 316

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 101/197 (51%), Gaps = 7/197 (3%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG--EREFKNEVFVIGQTHHKNLVR 582
           +E+G G+FG V KG  Q +     VAVK L     D   + E   E  V+ Q  +  +VR
Sbjct: 33  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 92
Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQI 642
           ++G C E ++ +LV E    G L  +L  N          +  Q++ G+ YL E   +  
Sbjct: 93  MIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE---SNF 148
Query: 643 IHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS-KTIKTAIRGTKGYVAPEWFRNSKIT 701
           +H D+  +N+LL   + A+ISDFGL+K L  +++    +T  +    + APE     K +
Sbjct: 149 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 208
Query: 702 AKVDVYSFGVLLLEIIS 718
           +K DV+SFGVL+ E  S
Sbjct: 209 SKSDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 101/197 (51%), Gaps = 7/197 (3%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG--EREFKNEVFVIGQTHHKNLVR 582
           +E+G G+FG V KG  Q +     VAVK L     D   + E   E  V+ Q  +  +VR
Sbjct: 33  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 92
Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQI 642
           ++G C E ++ +LV E    G L  +L  N          +  Q++ G+ YL E   +  
Sbjct: 93  MIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE---SNF 148
Query: 643 IHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS-KTIKTAIRGTKGYVAPEWFRNSKIT 701
           +H D+  +N+LL   + A+ISDFGL+K L  +++    +T  +    + APE     K +
Sbjct: 149 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 208
Query: 702 AKVDVYSFGVLLLEIIS 718
           +K DV+SFGVL+ E  S
Sbjct: 209 SKSDVWSFGVLMWEAFS 225

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 101/197 (51%), Gaps = 7/197 (3%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG--EREFKNEVFVIGQTHHKNLVR 582
           +E+G G+FG V KG  Q +     VAVK L     D   + E   E  V+ Q  +  +VR
Sbjct: 17  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 76
Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQI 642
           ++G C E ++ +LV E    G L  +L  N          +  Q++ G+ YL E   +  
Sbjct: 77  MIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE---SNF 132
Query: 643 IHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSK-TIKTAIRGTKGYVAPEWFRNSKIT 701
           +H D+  +N+LL   + A+ISDFGL+K L  +++    +T  +    + APE     K +
Sbjct: 133 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINYYKFS 192
Query: 702 AKVDVYSFGVLLLEIIS 718
           +K DV+SFGVL+ E  S
Sbjct: 193 SKSDVWSFGVLMWEAFS 209

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 103/202 (50%), Gaps = 9/202 (4%)
Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTT--AVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNL 580
           F +++G+G+FG V           T   VAVKKL    ++  R+F+ E+ ++    H N+
Sbjct: 21  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 80
Query: 581 VRLLGFCDEG--QNRLLVYEFLNNGTLASFLFGNLKPNWNLR-TNIAFQIARGLLYLHED 637
           V+  G C     +N  L+ E+L  G+L  +L  + +   +++      QI +G+ YL   
Sbjct: 81  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL--- 137
Query: 638 CRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN-QSKTIKTAIRGTKGYVAPEWFR 696
              + IH D+  +NIL+++    +I DFGL K+L  + +   +K        + APE   
Sbjct: 138 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 197
Query: 697 NSKITAKVDVYSFGVLLLEIIS 718
            SK +   DV+SFGV+L E+ +
Sbjct: 198 ESKFSVASDVWSFGVVLYELFT 219

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 102/202 (50%), Gaps = 9/202 (4%)
Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTT--AVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNL 580
           F  ++G+G+FG V           T   VAVKKL    ++  R+F+ E+ ++    H N+
Sbjct: 17  FLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 76
Query: 581 VRLLGFCDEG--QNRLLVYEFLNNGTLASFLFGNLKPNWNLR-TNIAFQIARGLLYLHED 637
           V+  G C     +N  L+ EFL  G+L  +L  + +   +++      QI +G+ YL   
Sbjct: 77  VKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYL--- 133
Query: 638 CRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN-QSKTIKTAIRGTKGYVAPEWFR 696
              + IH D+  +NIL+++    +I DFGL K+L  + +   +K        + APE   
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 697 NSKITAKVDVYSFGVLLLEIIS 718
            SK +   DV+SFGV+L E+ +
Sbjct: 194 ESKFSVASDVWSFGVVLYELFT 215

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 77/299 (25%), Positives = 133/299 (44%), Gaps = 48/299 (16%)
Query: 527 VGRGSFGIVYKGV---IQTRTSTTAVAVKKLDRVFQDGE-REFKNEVFVIGQTHHKNLVR 582
           +G G FG V K     ++ R   T VAVK L       E R+  +E  V+ Q +H ++++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK-------------------PNWNLRT-- 621
           L G C +    LL+ E+   G+L  FL  + K                   P+    T  
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 622 ---NIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT 678
              + A+QI++G+ YL E    +++H D+  +NIL+ +    +ISDFGL++ +    S  
Sbjct: 151 DLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXV 207
Query: 679 IKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDW 737
            ++  R    ++A E   +   T + DV+SFGVLL EI++         G  Y  I  + 
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG-------GNPYPGIPPER 260
Query: 738 AFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 796
            F+  + G                 C  ++  + + C +++P  RP    + + LE ++
Sbjct: 261 LFNLLKTG---------HRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 101/197 (51%), Gaps = 7/197 (3%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG--EREFKNEVFVIGQTHHKNLVR 582
           +E+G G+FG V KG  Q +     VAVK L     D   + E   E  V+ Q  +  +VR
Sbjct: 31  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 90
Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQI 642
           ++G C E ++ +LV E    G L  +L  N          +  Q++ G+ YL E   +  
Sbjct: 91  MIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE---SNF 146
Query: 643 IHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS-KTIKTAIRGTKGYVAPEWFRNSKIT 701
           +H D+  +N+LL   + A+ISDFGL+K L  +++    +T  +    + APE     K +
Sbjct: 147 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 206
Query: 702 AKVDVYSFGVLLLEIIS 718
           +K DV+SFGVL+ E  S
Sbjct: 207 SKSDVWSFGVLMWEAFS 223

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 103/202 (50%), Gaps = 9/202 (4%)
Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTT--AVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNL 580
           F +++G+G+FG V           T   VAVKKL    ++  R+F+ E+ ++    H N+
Sbjct: 19  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 78
Query: 581 VRLLGFCDEG--QNRLLVYEFLNNGTLASFLFGNLKPNWNLR-TNIAFQIARGLLYLHED 637
           V+  G C     +N  L+ E+L  G+L  +L  + +   +++      QI +G+ YL   
Sbjct: 79  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL--- 135
Query: 638 CRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS-KTIKTAIRGTKGYVAPEWFR 696
              + IH D+  +NIL+++    +I DFGL K+L  ++    +K        + APE   
Sbjct: 136 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 195
Query: 697 NSKITAKVDVYSFGVLLLEIIS 718
            SK +   DV+SFGV+L E+ +
Sbjct: 196 ESKFSVASDVWSFGVVLYELFT 217

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 103/202 (50%), Gaps = 9/202 (4%)
Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTT--AVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNL 580
           F +++G+G+FG V           T   VAVKKL    ++  R+F+ E+ ++    H N+
Sbjct: 45  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104
Query: 581 VRLLGFCDEG--QNRLLVYEFLNNGTLASFLFGNLKPNWNLR-TNIAFQIARGLLYLHED 637
           V+  G C     +N  L+ E+L  G+L  +L  + +   +++      QI +G+ YL   
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL--- 161
Query: 638 CRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN-QSKTIKTAIRGTKGYVAPEWFR 696
              + IH D+  +NIL+++    +I DFGL K+L  + +   +K        + APE   
Sbjct: 162 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 221
Query: 697 NSKITAKVDVYSFGVLLLEIIS 718
            SK +   DV+SFGV+L E+ +
Sbjct: 222 ESKFSVASDVWSFGVVLYELFT 243

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 103/202 (50%), Gaps = 9/202 (4%)
Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTT--AVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNL 580
           F +++G+G+FG V           T   VAVKKL    ++  R+F+ E+ ++    H N+
Sbjct: 20  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 79
Query: 581 VRLLGFCDEG--QNRLLVYEFLNNGTLASFLFGNLKPNWNLR-TNIAFQIARGLLYLHED 637
           V+  G C     +N  L+ E+L  G+L  +L  + +   +++      QI +G+ YL   
Sbjct: 80  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL--- 136
Query: 638 CRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN-QSKTIKTAIRGTKGYVAPEWFR 696
              + IH D+  +NIL+++    +I DFGL K+L  + +   +K        + APE   
Sbjct: 137 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 196
Query: 697 NSKITAKVDVYSFGVLLLEIIS 718
            SK +   DV+SFGV+L E+ +
Sbjct: 197 ESKFSVASDVWSFGVVLYELFT 218

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 110/226 (48%), Gaps = 25/226 (11%)
Query: 514 KELEGATNNFKEEVGRGSFGIVYKGVI---QTRTSTTAVAVKKL-DRVFQDGEREFKNEV 569
           KE+  +   F EE+G   FG VYKG +        T AVA+K L D+       EF++E 
Sbjct: 21  KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEA 80
Query: 570 FVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--------FGNLKPNWNLRT 621
            +  +  H N+V LLG   + Q   +++ + ++G L  FL         G+   +  +++
Sbjct: 81  MLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 140
Query: 622 --------NIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAK-LLT 672
                   ++  QIA G+ YL       ++H D+  +N+L+ D    +ISD GL + +  
Sbjct: 141 ALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYA 197
Query: 673 LNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS 718
            +  K +  ++   + ++APE     K +   D++S+GV+L E+ S
Sbjct: 198 ADYYKLLGNSLLPIR-WMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 103/202 (50%), Gaps = 9/202 (4%)
Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTT--AVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNL 580
           F +++G+G+FG V           T   VAVKKL    ++  R+F+ E+ ++    H N+
Sbjct: 17  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 76
Query: 581 VRLLGFCDEG--QNRLLVYEFLNNGTLASFLFGNLKPNWNLR-TNIAFQIARGLLYLHED 637
           V+  G C     +N  L+ E+L  G+L  +L  + +   +++      QI +G+ YL   
Sbjct: 77  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL--- 133
Query: 638 CRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS-KTIKTAIRGTKGYVAPEWFR 696
              + IH D+  +NIL+++    +I DFGL K+L  ++    +K        + APE   
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 697 NSKITAKVDVYSFGVLLLEIIS 718
            SK +   DV+SFGV+L E+ +
Sbjct: 194 ESKFSVASDVWSFGVVLYELFT 215

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 103/202 (50%), Gaps = 9/202 (4%)
Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTT--AVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNL 580
           F +++G+G+FG V           T   VAVKKL    ++  R+F+ E+ ++    H N+
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 581 VRLLGFCDEG--QNRLLVYEFLNNGTLASFLFGNLKPNWNLR-TNIAFQIARGLLYLHED 637
           V+  G C     +N  L+ E+L  G+L  +L  + +   +++      QI +G+ YL   
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL--- 130
Query: 638 CRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN-QSKTIKTAIRGTKGYVAPEWFR 696
              + IH D+  +NIL+++    +I DFGL K+L  + +   +K        + APE   
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 190
Query: 697 NSKITAKVDVYSFGVLLLEIIS 718
            SK +   DV+SFGV+L E+ +
Sbjct: 191 ESKFSVASDVWSFGVVLYELFT 212

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 103/202 (50%), Gaps = 9/202 (4%)
Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTT--AVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNL 580
           F +++G+G+FG V           T   VAVKKL    ++  R+F+ E+ ++    H N+
Sbjct: 18  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 77
Query: 581 VRLLGFCDEG--QNRLLVYEFLNNGTLASFLFGNLKPNWNLR-TNIAFQIARGLLYLHED 637
           V+  G C     +N  L+ E+L  G+L  +L  + +   +++      QI +G+ YL   
Sbjct: 78  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL--- 134
Query: 638 CRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS-KTIKTAIRGTKGYVAPEWFR 696
              + IH D+  +NIL+++    +I DFGL K+L  ++    +K        + APE   
Sbjct: 135 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 194
Query: 697 NSKITAKVDVYSFGVLLLEIIS 718
            SK +   DV+SFGV+L E+ +
Sbjct: 195 ESKFSVASDVWSFGVVLYELFT 216

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 81/303 (26%), Positives = 137/303 (45%), Gaps = 44/303 (14%)
Query: 522 NFKEEVGRGSFGIVYK----GVIQTRTSTTAVAVKKLDRVFQDGERE-FKNEVFVIGQT- 575
           +F + +G G+FG V +    G+I++  + T VAVK L       ERE   +E+ V+    
Sbjct: 49  SFGKTLGAGAFGKVVEATAYGLIKSDAAMT-VAVKMLKPSAHLTEREALMSELKVLSYLG 107
Query: 576 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA----------- 624
           +H N+V LLG C  G   L++ E+   G L +FL          +T+ A           
Sbjct: 108 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 167
Query: 625 -------FQIARGLLYL-HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS 676
                  +Q+A+G+ +L  ++C    IH D+  +NILL      +I DFGLA+ +  + +
Sbjct: 168 EDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARHIKNDSN 223
Query: 677 KTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD 736
             +K   R    ++APE   N   T + DV+S+G+ L E+ S   S    M  +      
Sbjct: 224 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD------ 277
Query: 737 WAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 796
                    K   ++ E    ++      ++  +   C   DP  RPT K+++Q++E  +
Sbjct: 278 --------SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 329
Query: 797 EVS 799
             S
Sbjct: 330 SES 332

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 101/197 (51%), Gaps = 7/197 (3%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG--EREFKNEVFVIGQTHHKNLVR 582
           +E+G G+FG V KG  Q +     VAVK L     D   + E   E  V+ Q  +  +VR
Sbjct: 17  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 76
Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQI 642
           ++G C E ++ +LV E    G L  +L  N          +  Q++ G+ YL E   +  
Sbjct: 77  MIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE---SNF 132
Query: 643 IHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS-KTIKTAIRGTKGYVAPEWFRNSKIT 701
           +H D+  +N+LL   + A+ISDFGL+K L  +++    +T  +    + APE     K +
Sbjct: 133 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 192
Query: 702 AKVDVYSFGVLLLEIIS 718
           +K DV+SFGVL+ E  S
Sbjct: 193 SKSDVWSFGVLMWEAFS 209

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 103/202 (50%), Gaps = 9/202 (4%)
Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTT--AVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNL 580
           F +++G+G+FG V           T   VAVKKL    ++  R+F+ E+ ++    H N+
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 581 VRLLGFCDEG--QNRLLVYEFLNNGTLASFLFGNLKPNWNLR-TNIAFQIARGLLYLHED 637
           V+  G C     +N  L+ E+L  G+L  +L  + +   +++      QI +G+ YL   
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL--- 130
Query: 638 CRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS-KTIKTAIRGTKGYVAPEWFR 696
              + IH D+  +NIL+++    +I DFGL K+L  ++    +K        + APE   
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 190
Query: 697 NSKITAKVDVYSFGVLLLEIIS 718
            SK +   DV+SFGV+L E+ +
Sbjct: 191 ESKFSVASDVWSFGVVLYELFT 212

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 103/202 (50%), Gaps = 9/202 (4%)
Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTT--AVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNL 580
           F +++G+G+FG V           T   VAVKKL    ++  R+F+ E+ ++    H N+
Sbjct: 12  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 71
Query: 581 VRLLGFCDEG--QNRLLVYEFLNNGTLASFLFGNLKPNWNLR-TNIAFQIARGLLYLHED 637
           V+  G C     +N  L+ E+L  G+L  +L  + +   +++      QI +G+ YL   
Sbjct: 72  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL--- 128
Query: 638 CRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN-QSKTIKTAIRGTKGYVAPEWFR 696
              + IH D+  +NIL+++    +I DFGL K+L  + +   +K        + APE   
Sbjct: 129 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 188
Query: 697 NSKITAKVDVYSFGVLLLEIIS 718
            SK +   DV+SFGV+L E+ +
Sbjct: 189 ESKFSVASDVWSFGVVLYELFT 210

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 103/202 (50%), Gaps = 9/202 (4%)
Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTT--AVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNL 580
           F +++G+G+FG V           T   VAVKKL    ++  R+F+ E+ ++    H N+
Sbjct: 13  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 72
Query: 581 VRLLGFCDEG--QNRLLVYEFLNNGTLASFLFGNLKPNWNLR-TNIAFQIARGLLYLHED 637
           V+  G C     +N  L+ E+L  G+L  +L  + +   +++      QI +G+ YL   
Sbjct: 73  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL--- 129
Query: 638 CRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS-KTIKTAIRGTKGYVAPEWFR 696
              + IH D+  +NIL+++    +I DFGL K+L  ++    +K        + APE   
Sbjct: 130 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 189
Query: 697 NSKITAKVDVYSFGVLLLEIIS 718
            SK +   DV+SFGV+L E+ +
Sbjct: 190 ESKFSVASDVWSFGVVLYELFT 211

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 101/197 (51%), Gaps = 7/197 (3%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG--EREFKNEVFVIGQTHHKNLVR 582
           +E+G G+FG V KG  Q +     VAVK L     D   + E   E  V+ Q  +  +VR
Sbjct: 11  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 70
Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQI 642
           ++G C E ++ +LV E    G L  +L  N          +  Q++ G+ YL E   +  
Sbjct: 71  MIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE---SNF 126
Query: 643 IHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS-KTIKTAIRGTKGYVAPEWFRNSKIT 701
           +H D+  +N+LL   + A+ISDFGL+K L  +++    +T  +    + APE     K +
Sbjct: 127 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 186
Query: 702 AKVDVYSFGVLLLEIIS 718
           +K DV+SFGVL+ E  S
Sbjct: 187 SKSDVWSFGVLMWEAFS 203

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 111/216 (51%), Gaps = 23/216 (10%)
Query: 522 NFKEEVGRGSFGIVYK----GVIQTRTSTTAVAVKKLDRVFQDGE-REFKNEV-FVIGQT 575
           N  + +GRG+FG V +    G+ +T T  T VAVK L       E R   +E+  +I   
Sbjct: 30  NLGKPLGRGAFGQVIEADAFGIDKTATXRT-VAVKMLKEGATHSEHRALMSELKILIHIG 88
Query: 576 HHKNLVRLLGFCDE-GQNRLLVYEFLNNGTLASFL---------FGNLKPNWNLRTNI-- 623
           HH N+V LLG C + G   +++ EF   G L+++L         + +L  ++    ++  
Sbjct: 89  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIX 148
Query: 624 -AFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTA 682
            +FQ+A+G+ +L      + IH D+  +NILL +    +I DFGLA+ +  +     K  
Sbjct: 149 YSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGD 205
Query: 683 IRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS 718
            R    ++APE   +   T + DV+SFGVLL EI S
Sbjct: 206 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 81/303 (26%), Positives = 137/303 (45%), Gaps = 44/303 (14%)
Query: 522 NFKEEVGRGSFGIVYK----GVIQTRTSTTAVAVKKLDRVFQDGERE-FKNEVFVIGQT- 575
           +F + +G G+FG V +    G+I++  + T VAVK L       ERE   +E+ V+    
Sbjct: 26  SFGKTLGAGAFGKVVEATAYGLIKSDAAMT-VAVKMLKPSAHLTEREALMSELKVLSYLG 84
Query: 576 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA----------- 624
           +H N+V LLG C  G   L++ E+   G L +FL          +T+ A           
Sbjct: 85  NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 625 -------FQIARGLLYL-HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS 676
                  +Q+A+G+ +L  ++C    IH D+  +NILL      +I DFGLA+ +  + +
Sbjct: 145 EDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200
Query: 677 KTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD 736
             +K   R    ++APE   N   T + DV+S+G+ L E+ S   S    M  +      
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD------ 254
Query: 737 WAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 796
                    K   ++ E    ++      ++  +   C   DP  RPT K+++Q++E  +
Sbjct: 255 --------SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306
Query: 797 EVS 799
             S
Sbjct: 307 SES 309

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 101/197 (51%), Gaps = 7/197 (3%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG--EREFKNEVFVIGQTHHKNLVR 582
           +E+G G+FG V KG  Q +     VAVK L     D   + E   E  V+ Q  +  +VR
Sbjct: 23  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82
Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQI 642
           ++G C E ++ +LV E    G L  +L  N          +  Q++ G+ YL E   +  
Sbjct: 83  MIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE---SNF 138
Query: 643 IHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS-KTIKTAIRGTKGYVAPEWFRNSKIT 701
           +H D+  +N+LL   + A+ISDFGL+K L  +++    +T  +    + APE     K +
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 198
Query: 702 AKVDVYSFGVLLLEIIS 718
           +K DV+SFGVL+ E  S
Sbjct: 199 SKSDVWSFGVLMWEAFS 215

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 103/202 (50%), Gaps = 9/202 (4%)
Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTT--AVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNL 580
           F +++G+G+FG V           T   VAVKKL    ++  R+F+ E+ ++    H N+
Sbjct: 32  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 91
Query: 581 VRLLGFCDEG--QNRLLVYEFLNNGTLASFLFGNLKPNWNLR-TNIAFQIARGLLYLHED 637
           V+  G C     +N  L+ E+L  G+L  +L  + +   +++      QI +G+ YL   
Sbjct: 92  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL--- 148
Query: 638 CRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN-QSKTIKTAIRGTKGYVAPEWFR 696
              + IH D+  +NIL+++    +I DFGL K+L  + +   +K        + APE   
Sbjct: 149 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 208
Query: 697 NSKITAKVDVYSFGVLLLEIIS 718
            SK +   DV+SFGV+L E+ +
Sbjct: 209 ESKFSVASDVWSFGVVLYELFT 230

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 103/202 (50%), Gaps = 9/202 (4%)
Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTT--AVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNL 580
           F +++G+G+FG V           T   VAVKKL    ++  R+F+ E+ ++    H N+
Sbjct: 32  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 91
Query: 581 VRLLGFCDEG--QNRLLVYEFLNNGTLASFLFGNLKPNWNLR-TNIAFQIARGLLYLHED 637
           V+  G C     +N  L+ E+L  G+L  +L  + +   +++      QI +G+ YL   
Sbjct: 92  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL--- 148
Query: 638 CRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS-KTIKTAIRGTKGYVAPEWFR 696
              + IH D+  +NIL+++    +I DFGL K+L  ++    +K        + APE   
Sbjct: 149 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 208
Query: 697 NSKITAKVDVYSFGVLLLEIIS 718
            SK +   DV+SFGV+L E+ +
Sbjct: 209 ESKFSVASDVWSFGVVLYELFT 230

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 101/197 (51%), Gaps = 7/197 (3%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG--EREFKNEVFVIGQTHHKNLVR 582
           +E+G G+FG V KG  Q +     VAVK L     D   + E   E  V+ Q  +  +VR
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQI 642
           ++G C E ++ +LV E    G L  +L  N          +  Q++ G+ YL E   +  
Sbjct: 73  MIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE---SNF 128
Query: 643 IHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS-KTIKTAIRGTKGYVAPEWFRNSKIT 701
           +H D+  +N+LL   + A+ISDFGL+K L  +++    +T  +    + APE     K +
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 188
Query: 702 AKVDVYSFGVLLLEIIS 718
           +K DV+SFGVL+ E  S
Sbjct: 189 SKSDVWSFGVLMWEAFS 205

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 101/197 (51%), Gaps = 7/197 (3%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG--EREFKNEVFVIGQTHHKNLVR 582
           +E+G G+FG V KG  Q +     VAVK L     D   + E   E  V+ Q  +  +VR
Sbjct: 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 434
Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQI 642
           ++G C E ++ +LV E    G L  +L  N          +  Q++ G+ YL E   +  
Sbjct: 435 MIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE---SNF 490
Query: 643 IHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS-KTIKTAIRGTKGYVAPEWFRNSKIT 701
           +H D+  +N+LL   + A+ISDFGL+K L  +++    +T  +    + APE     K +
Sbjct: 491 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 550
Query: 702 AKVDVYSFGVLLLEIIS 718
           +K DV+SFGVL+ E  S
Sbjct: 551 SKSDVWSFGVLMWEAFS 567

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 101/197 (51%), Gaps = 7/197 (3%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG--EREFKNEVFVIGQTHHKNLVR 582
           +E+G G+FG V KG  Q +     VAVK L     D   + E   E  V+ Q  +  +VR
Sbjct: 376 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 435
Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQI 642
           ++G C E ++ +LV E    G L  +L  N          +  Q++ G+ YL E   +  
Sbjct: 436 MIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE---SNF 491
Query: 643 IHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS-KTIKTAIRGTKGYVAPEWFRNSKIT 701
           +H D+  +N+LL   + A+ISDFGL+K L  +++    +T  +    + APE     K +
Sbjct: 492 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 551
Query: 702 AKVDVYSFGVLLLEIIS 718
           +K DV+SFGVL+ E  S
Sbjct: 552 SKSDVWSFGVLMWEAFS 568

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 77/299 (25%), Positives = 132/299 (44%), Gaps = 48/299 (16%)
Query: 527 VGRGSFGIVYKGV---IQTRTSTTAVAVKKLDRVFQDGE-REFKNEVFVIGQTHHKNLVR 582
           +G G FG V K     ++ R   T VAVK L       E R+  +E  V+ Q +H ++++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK-------------------PNWNLRT-- 621
           L G C +    LL+ E+   G+L  FL  + K                   P+    T  
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 622 ---NIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT 678
              + A+QI++G+ YL E     ++H D+  +NIL+ +    +ISDFGL++ +    S  
Sbjct: 151 DLISFAWQISQGMQYLAE---MSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXV 207
Query: 679 IKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDW 737
            ++  R    ++A E   +   T + DV+SFGVLL EI++         G  Y  I  + 
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG-------GNPYPGIPPER 260
Query: 738 AFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 796
            F+  + G                 C  ++  + + C +++P  RP    + + LE ++
Sbjct: 261 LFNLLKTG---------HRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 77/299 (25%), Positives = 133/299 (44%), Gaps = 48/299 (16%)
Query: 527 VGRGSFGIVYKGV---IQTRTSTTAVAVKKLDRVFQDGE-REFKNEVFVIGQTHHKNLVR 582
           +G G FG V K     ++ R   T VAVK L       E R+  +E  V+ Q +H ++++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK-------------------PNWNLRT-- 621
           L G C +    LL+ E+   G+L  FL  + K                   P+    T  
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 622 ---NIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT 678
              + A+QI++G+ YL E    +++H D+  +NIL+ +    +ISDFGL++ +    S  
Sbjct: 151 DLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207
Query: 679 IKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDW 737
            ++  R    ++A E   +   T + DV+SFGVLL EI++         G  Y  I  + 
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG-------GNPYPGIPPER 260
Query: 738 AFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 796
            F+  + G                 C  ++  + + C +++P  RP    + + LE ++
Sbjct: 261 LFNLLKTG---------HRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 102/200 (51%), Gaps = 15/200 (7%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGER--EFKNEVFVIGQTHHKNLVR 582
           + +G GSFG VYKG          VAVK L+      ++   FKNEV V+ +T H N++ 
Sbjct: 30  QRIGSGSFGTVYKGKWHG-----DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 84
Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQ 641
            +G+  + Q   +V ++    +L   L  +  K       +IA Q ARG+ YLH      
Sbjct: 85  FMGYSTKPQ-LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS--- 140
Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR---NS 698
           IIH D+K  NI L +  T +I DFGLA   +          + G+  ++APE  R   ++
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 699 KITAKVDVYSFGVLLLEIIS 718
             + + DVY+FG++L E+++
Sbjct: 201 PYSFQSDVYAFGIVLYELMT 220

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/243 (28%), Positives = 116/243 (47%), Gaps = 17/243 (6%)
Query: 498 SPDDGTIETNLRCFSYKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV 557
           S ++G  E++L  + Y   E   N  +  +G+G++GIVY G  +  ++   +A+K++   
Sbjct: 4   STEEGDCESDLLEYDY---EYDENGDRVVLGKGTYGIVYAG--RDLSNQVRIAIKEIPER 58
Query: 558 FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNW 617
                +    E+ +     HKN+V+ LG   E     +  E +  G+L++ L     P  
Sbjct: 59  DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLK 118
Query: 618 NLRTNIAF---QIARGLLYLHEDCRAQIIHCDIKPQNILLDDYY-TARISDFGLAKLLTL 673
           +    I F   QI  GL YLH++   QI+H DIK  N+L++ Y    +ISDFG +K L  
Sbjct: 119 DNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175
Query: 674 NQSKTIKTAIRGTKGYVAPEWFRNSK--ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY 731
               T      GT  Y+APE             D++S G  ++E+ + +  F  E+GE  
Sbjct: 176 INPCT--ETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF-YELGEPQ 232
Query: 732 AIL 734
           A +
Sbjct: 233 AAM 235

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 81/303 (26%), Positives = 137/303 (45%), Gaps = 44/303 (14%)
Query: 522 NFKEEVGRGSFGIVYK----GVIQTRTSTTAVAVKKLDRVFQDGERE-FKNEVFVIGQT- 575
           +F + +G G+FG V +    G+I++  + T VAVK L       ERE   +E+ V+    
Sbjct: 49  SFGKTLGAGAFGKVVEATAYGLIKSDAAMT-VAVKMLKPSAHLTEREALMSELKVLSYLG 107
Query: 576 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA----------- 624
           +H N+V LLG C  G   L++ E+   G L +FL          +T+ A           
Sbjct: 108 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 167
Query: 625 -------FQIARGLLYL-HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS 676
                  +Q+A+G+ +L  ++C    IH D+  +NILL      +I DFGLA+ +  + +
Sbjct: 168 EDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIKNDSN 223
Query: 677 KTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD 736
             +K   R    ++APE   N   T + DV+S+G+ L E+ S   S    M  +      
Sbjct: 224 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD------ 277
Query: 737 WAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 796
                    K   ++ E    ++      ++  +   C   DP  RPT K+++Q++E  +
Sbjct: 278 --------SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 329
Query: 797 EVS 799
             S
Sbjct: 330 SES 332

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 114/233 (48%), Gaps = 33/233 (14%)
Query: 518 GATNNFK--EEVGRGSFGIVYKGVIQTRTSTTAVAVKK--LDRVFQDGEREFKNEVFVIG 573
           G+  NF+  E++G G++G+VYK   + + +   VA+KK  LD   +        E+ ++ 
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 60
Query: 574 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTL----ASFLFGNLKPNWNLRTNIAFQIAR 629
           + +H N+V+LL          LV+EFL+        AS L G   P   L  +  FQ+ +
Sbjct: 61  ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLP---LIKSYLFQLLQ 117
Query: 630 GLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGY 689
           GL + H     +++H D+KPQN+L++     +++DFGLA        +     +R     
Sbjct: 118 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA--------RAFGVPVRTYXHE 166
Query: 690 VAPEWFRNSKI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAI 733
           V   W+R  +I       +  VD++S G +  E+++ R  F  D E+ + + I
Sbjct: 167 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 219

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 114/233 (48%), Gaps = 33/233 (14%)
Query: 518 GATNNFK--EEVGRGSFGIVYKGVIQTRTSTTAVAVKK--LDRVFQDGEREFKNEVFVIG 573
           G+  NF+  E++G G++G+VYK   + + +   VA+KK  LD   +        E+ ++ 
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 59
Query: 574 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTL----ASFLFGNLKPNWNLRTNIAFQIAR 629
           + +H N+V+LL          LV+EFL+        AS L G   P   L  +  FQ+ +
Sbjct: 60  ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQ 116
Query: 630 GLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGY 689
           GL + H     +++H D+KPQN+L++     +++DFGLA        +     +R     
Sbjct: 117 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA--------RAFGVPVRTYXHE 165
Query: 690 VAPEWFRNSKI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAI 733
           V   W+R  +I       +  VD++S G +  E+++ R  F  D E+ + + I
Sbjct: 166 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 218

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 114/233 (48%), Gaps = 33/233 (14%)
Query: 518 GATNNFK--EEVGRGSFGIVYKGVIQTRTSTTAVAVKK--LDRVFQDGEREFKNEVFVIG 573
           G+  NF+  E++G G++G+VYK   + + +   VA+KK  LD   +        E+ ++ 
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 60
Query: 574 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTL----ASFLFGNLKPNWNLRTNIAFQIAR 629
           + +H N+V+LL          LV+EFL+        AS L G   P   L  +  FQ+ +
Sbjct: 61  ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQ 117
Query: 630 GLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGY 689
           GL + H     +++H D+KPQN+L++     +++DFGLA        +     +R     
Sbjct: 118 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA--------RAFGVPVRTYXHE 166
Query: 690 VAPEWFRNSKI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAI 733
           V   W+R  +I       +  VD++S G +  E+++ R  F  D E+ + + I
Sbjct: 167 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 219

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 114/233 (48%), Gaps = 33/233 (14%)
Query: 518 GATNNFK--EEVGRGSFGIVYKGVIQTRTSTTAVAVKK--LDRVFQDGEREFKNEVFVIG 573
           G+  NF+  E++G G++G+VYK   + + +   VA+KK  LD   +        E+ ++ 
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 59
Query: 574 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTL----ASFLFGNLKPNWNLRTNIAFQIAR 629
           + +H N+V+LL          LV+EFL+        AS L G   P   L  +  FQ+ +
Sbjct: 60  ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQ 116
Query: 630 GLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGY 689
           GL + H     +++H D+KPQN+L++     +++DFGLA        +     +R     
Sbjct: 117 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA--------RAFGVPVRTYXHE 165
Query: 690 VAPEWFRNSKI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAI 733
           V   W+R  +I       +  VD++S G +  E+++ R  F  D E+ + + I
Sbjct: 166 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 218

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 81/303 (26%), Positives = 137/303 (45%), Gaps = 44/303 (14%)
Query: 522 NFKEEVGRGSFGIVYK----GVIQTRTSTTAVAVKKLDRVFQDGERE-FKNEVFVIGQT- 575
           +F + +G G+FG V +    G+I++  + T VAVK L       ERE   +E+ V+    
Sbjct: 44  SFGKTLGAGAFGKVVEATAYGLIKSDAAMT-VAVKMLKPSAHLTEREALMSELKVLSYLG 102
Query: 576 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA----------- 624
           +H N+V LLG C  G   L++ E+   G L +FL          +T+ A           
Sbjct: 103 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 162
Query: 625 -------FQIARGLLYL-HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS 676
                  +Q+A+G+ +L  ++C    IH D+  +NILL      +I DFGLA+ +  + +
Sbjct: 163 EDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIKNDSN 218
Query: 677 KTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD 736
             +K   R    ++APE   N   T + DV+S+G+ L E+ S   S    M  +      
Sbjct: 219 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD------ 272
Query: 737 WAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 796
                    K   ++ E    ++      ++  +   C   DP  RPT K+++Q++E  +
Sbjct: 273 --------SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 324
Query: 797 EVS 799
             S
Sbjct: 325 SES 327

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 114/233 (48%), Gaps = 33/233 (14%)
Query: 518 GATNNFK--EEVGRGSFGIVYKGVIQTRTSTTAVAVKK--LDRVFQDGEREFKNEVFVIG 573
           G+  NF+  E++G G++G+VYK   + + +   VA+KK  LD   +        E+ ++ 
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 60
Query: 574 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTL----ASFLFGNLKPNWNLRTNIAFQIAR 629
           + +H N+V+LL          LV+EFL+        AS L G   P   L  +  FQ+ +
Sbjct: 61  ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQ 117
Query: 630 GLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGY 689
           GL + H     +++H D+KPQN+L++     +++DFGLA        +     +R     
Sbjct: 118 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA--------RAFGVPVRTYXHE 166
Query: 690 VAPEWFRNSKI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAI 733
           V   W+R  +I       +  VD++S G +  E+++ R  F  D E+ + + I
Sbjct: 167 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 219

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 114/233 (48%), Gaps = 33/233 (14%)
Query: 518 GATNNFK--EEVGRGSFGIVYKGVIQTRTSTTAVAVKK--LDRVFQDGEREFKNEVFVIG 573
           G+  NF+  E++G G++G+VYK   + + +   VA+KK  LD   +        E+ ++ 
Sbjct: 4   GSMENFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 61
Query: 574 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTL----ASFLFGNLKPNWNLRTNIAFQIAR 629
           + +H N+V+LL          LV+EFL+        AS L G   P   L  +  FQ+ +
Sbjct: 62  ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQ 118
Query: 630 GLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGY 689
           GL + H     +++H D+KPQN+L++     +++DFGLA        +     +R     
Sbjct: 119 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA--------RAFGVPVRTYXHE 167
Query: 690 VAPEWFRNSKI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAI 733
           V   W+R  +I       +  VD++S G +  E+++ R  F  D E+ + + I
Sbjct: 168 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 220

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/299 (24%), Positives = 138/299 (46%), Gaps = 37/299 (12%)
Query: 509 RCFSYKELEGATNNFKEEVGRGSFGIVYKGVIQTR-TSTTAVAVKKLDRVFQDGER-EFK 566
           R F+ +E+E +  + ++ +G G  G V  G ++        VA+K L   + + +R +F 
Sbjct: 40  RSFT-REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFL 98
Query: 567 NEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPNWNLR 620
           +E  ++GQ  H N++RL G    G+  ++V E++ NG+L +FL      F  ++    LR
Sbjct: 99  SEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLR 158
Query: 621 TNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIK 680
                 +  G+ YL +      +H D+  +N+L+D     ++SDFGL+++L  +      
Sbjct: 159 G-----VGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXT 210
Query: 681 TAIRGTK---GYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW 737
           T   G K    + APE       ++  DV+SFGV++ E+++            Y     W
Sbjct: 211 TT--GGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA------------YGERPYW 256
Query: 738 AFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 796
                 N  +   V E       + C   L  + + C  +D + RP   +++ +L+ ++
Sbjct: 257 NMT---NRDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI 312

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 114/233 (48%), Gaps = 33/233 (14%)
Query: 518 GATNNFK--EEVGRGSFGIVYKGVIQTRTSTTAVAVKK--LDRVFQDGEREFKNEVFVIG 573
           G+  NF+  E++G G++G+VYK   + + +   VA+KK  LD   +        E+ ++ 
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 58
Query: 574 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTL----ASFLFGNLKPNWNLRTNIAFQIAR 629
           + +H N+V+LL          LV+EFL+        AS L G   P   L  +  FQ+ +
Sbjct: 59  ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQ 115
Query: 630 GLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGY 689
           GL + H     +++H D+KPQN+L++     +++DFGLA        +     +R     
Sbjct: 116 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA--------RAFGVPVRTYTHE 164
Query: 690 VAPEWFRNSKI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAI 733
           V   W+R  +I       +  VD++S G +  E+++ R  F  D E+ + + I
Sbjct: 165 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 217

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/299 (24%), Positives = 138/299 (46%), Gaps = 37/299 (12%)
Query: 509 RCFSYKELEGATNNFKEEVGRGSFGIVYKGVIQTR-TSTTAVAVKKLDRVFQDGER-EFK 566
           R F+ +E+E +  + ++ +G G  G V  G ++        VA+K L   + + +R +F 
Sbjct: 40  RSFT-REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFL 98
Query: 567 NEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPNWNLR 620
           +E  ++GQ  H N++RL G    G+  ++V E++ NG+L +FL      F  ++    LR
Sbjct: 99  SEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLR 158
Query: 621 TNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIK 680
                 +  G+ YL +      +H D+  +N+L+D     ++SDFGL+++L  +      
Sbjct: 159 G-----VGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYT 210
Query: 681 TAIRGTK---GYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW 737
           T   G K    + APE       ++  DV+SFGV++ E+++            Y     W
Sbjct: 211 TT--GGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA------------YGERPYW 256
Query: 738 AFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 796
                 N  +   V E       + C   L  + + C  +D + RP   +++ +L+ ++
Sbjct: 257 NMT---NRDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI 312

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 114/233 (48%), Gaps = 33/233 (14%)
Query: 518 GATNNFK--EEVGRGSFGIVYKGVIQTRTSTTAVAVKK--LDRVFQDGEREFKNEVFVIG 573
           G+  NF+  E++G G++G+VYK   + + +   VA+KK  LD   +        E+ ++ 
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 58
Query: 574 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTL----ASFLFGNLKPNWNLRTNIAFQIAR 629
           + +H N+V+LL          LV+EFL+        AS L G   P   L  +  FQ+ +
Sbjct: 59  ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQ 115
Query: 630 GLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGY 689
           GL + H     +++H D+KPQN+L++     +++DFGLA        +     +R     
Sbjct: 116 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA--------RAFGVPVRTYXHE 164
Query: 690 VAPEWFRNSKI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAI 733
           V   W+R  +I       +  VD++S G +  E+++ R  F  D E+ + + I
Sbjct: 165 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 217

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 103/202 (50%), Gaps = 9/202 (4%)
Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTT--AVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNL 580
           F +++G+G+FG V           T   VAVKKL    ++  R+F+ E+ ++    H N+
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 581 VRLLGFCDEG--QNRLLVYEFLNNGTLASFLFGNLKPNWNLR-TNIAFQIARGLLYLHED 637
           V+  G C     +N  L+ E+L  G+L  +L  + +   +++      QI +G+ YL   
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL--- 130
Query: 638 CRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS-KTIKTAIRGTKGYVAPEWFR 696
              + IH D+  +NIL+++    +I DFGL K+L  ++    +K        + APE   
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT 190
Query: 697 NSKITAKVDVYSFGVLLLEIIS 718
            SK +   DV+SFGV+L E+ +
Sbjct: 191 ESKFSVASDVWSFGVVLYELFT 212

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 81/303 (26%), Positives = 137/303 (45%), Gaps = 44/303 (14%)
Query: 522 NFKEEVGRGSFGIVYK----GVIQTRTSTTAVAVKKLDRVFQDGERE-FKNEVFVIGQT- 575
           +F + +G G+FG V +    G+I++  + T VAVK L       ERE   +E+ V+    
Sbjct: 42  SFGKTLGAGAFGKVVEATAYGLIKSDAAMT-VAVKMLKPSAHLTEREALMSELKVLSYLG 100
Query: 576 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA----------- 624
           +H N+V LLG C  G   L++ E+   G L +FL          +T+ A           
Sbjct: 101 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 160
Query: 625 -------FQIARGLLYL-HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS 676
                  +Q+A+G+ +L  ++C    IH D+  +NILL      +I DFGLA+ +  + +
Sbjct: 161 EDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIKNDSN 216
Query: 677 KTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD 736
             +K   R    ++APE   N   T + DV+S+G+ L E+ S   S    M  +      
Sbjct: 217 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD------ 270
Query: 737 WAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 796
                    K   ++ E    ++      ++  +   C   DP  RPT K+++Q++E  +
Sbjct: 271 --------SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 322
Query: 797 EVS 799
             S
Sbjct: 323 SES 325

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 101/200 (50%), Gaps = 15/200 (7%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGER--EFKNEVFVIGQTHHKNLVR 582
           + +G GSFG VYKG          VAVK L+      ++   FKNEV V+ +T H N++ 
Sbjct: 30  QRIGSGSFGTVYKGKWHG-----DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 84
Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQ 641
            +G+    Q   +V ++    +L   L  +  K       +IA Q ARG+ YLH      
Sbjct: 85  FMGYSTAPQ-LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS--- 140
Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR---NS 698
           IIH D+K  NI L +  T +I DFGLA   +          + G+  ++APE  R   ++
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 699 KITAKVDVYSFGVLLLEIIS 718
             + + DVY+FG++L E+++
Sbjct: 201 PYSFQSDVYAFGIVLYELMT 220

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 115/233 (49%), Gaps = 33/233 (14%)
Query: 518 GATNNFK--EEVGRGSFGIVYKGVIQTRTSTTAVAVKK--LDRVFQDGEREFKNEVFVIG 573
           G+  NF+  E++G G++G+VYK   + + +   VA+KK  LD   +        E+ ++ 
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 59
Query: 574 QTHHKNLVRLLGFCDEGQNRLLVYEFLN----NGTLASFLFGNLKPNWNLRTNIAFQIAR 629
           + +H N+V+LL          LV+EFL+    +   AS L G   P   L  +  FQ+ +
Sbjct: 60  ELNHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLP---LIKSYLFQLLQ 116
Query: 630 GLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGY 689
           GL + H     +++H D+KPQN+L++     +++DFGLA        +     +R     
Sbjct: 117 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA--------RAFGVPVRTYXHE 165
Query: 690 VAPEWFRNSKI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAI 733
           V   W+R  +I       +  VD++S G +  E+++ R  F  D E+ + + I
Sbjct: 166 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 218

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 115/233 (49%), Gaps = 33/233 (14%)
Query: 518 GATNNFK--EEVGRGSFGIVYKGVIQTRTSTTAVAVKK--LDRVFQDGEREFKNEVFVIG 573
           G+  NF+  E++G G++G+VYK   + + +   VA+KK  LD   +        E+ ++ 
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 60
Query: 574 QTHHKNLVRLLGFCDEGQNRLLVYEFLN----NGTLASFLFGNLKPNWNLRTNIAFQIAR 629
           + +H N+V+LL          LV+EFL+    +   AS L G   P   L  +  FQ+ +
Sbjct: 61  ELNHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLP---LIKSYLFQLLQ 117
Query: 630 GLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGY 689
           GL + H     +++H D+KPQN+L++     +++DFGLA        +     +R     
Sbjct: 118 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA--------RAFGVPVRTYXHE 166
Query: 690 VAPEWFRNSKI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAI 733
           V   W+R  +I       +  VD++S G +  E+++ R  F  D E+ + + I
Sbjct: 167 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 219

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 100/202 (49%), Gaps = 14/202 (6%)
Query: 526 EVGRGSFGIVYKGVIQTRTSTTA--VAVKKLDRVFQDGER--EFKNEVFVIGQTHHKNLV 581
           ++G G FG V           T   VAVK L +    G    + K E+ ++   +H+N+V
Sbjct: 16  DLGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHIADLKKEIEILRNLYHENIV 74
Query: 582 RLLGFCDE--GQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNI--AFQIARGLLYLHED 637
           +  G C E  G    L+ EFL +G+L  +L  N K   NL+  +  A QI +G+ YL   
Sbjct: 75  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYLGS- 132
Query: 638 CRAQIIHCDIKPQNILLDDYYTARISDFGLAKLL-TLNQSKTIKTAIRGTKGYVAPEWFR 696
              Q +H D+  +N+L++  +  +I DFGL K + T  +  T+K        + APE   
Sbjct: 133 --RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLM 190
Query: 697 NSKITAKVDVYSFGVLLLEIIS 718
            SK     DV+SFGV L E+++
Sbjct: 191 QSKFYIASDVWSFGVTLHELLT 212

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 100/202 (49%), Gaps = 14/202 (6%)
Query: 526 EVGRGSFGIVYKGVIQTRTSTTA--VAVKKLDRVFQDGER--EFKNEVFVIGQTHHKNLV 581
           ++G G FG V           T   VAVK L +    G    + K E+ ++   +H+N+V
Sbjct: 28  DLGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 582 RLLGFCDE--GQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNI--AFQIARGLLYLHED 637
           +  G C E  G    L+ EFL +G+L  +L  N K   NL+  +  A QI +G+ YL   
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYLGS- 144
Query: 638 CRAQIIHCDIKPQNILLDDYYTARISDFGLAKLL-TLNQSKTIKTAIRGTKGYVAPEWFR 696
              Q +H D+  +N+L++  +  +I DFGL K + T  +  T+K        + APE   
Sbjct: 145 --RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLM 202
Query: 697 NSKITAKVDVYSFGVLLLEIIS 718
            SK     DV+SFGV L E+++
Sbjct: 203 QSKFYIASDVWSFGVTLHELLT 224

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 113/233 (48%), Gaps = 33/233 (14%)
Query: 518 GATNNFK--EEVGRGSFGIVYKGVIQTRTSTTAVAVKK--LDRVFQDGEREFKNEVFVIG 573
           G   NF+  E++G G++G+VYK   + + +   VA+KK  LD   +        E+ ++ 
Sbjct: 1   GHMENFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 58
Query: 574 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTL----ASFLFGNLKPNWNLRTNIAFQIAR 629
           + +H N+V+LL          LV+EFL+        AS L G   P   L  +  FQ+ +
Sbjct: 59  ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQ 115
Query: 630 GLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGY 689
           GL + H     +++H D+KPQN+L++     +++DFGLA        +     +R     
Sbjct: 116 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA--------RAFGVPVRTYXHE 164
Query: 690 VAPEWFRNSKI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAI 733
           V   W+R  +I       +  VD++S G +  E+++ R  F  D E+ + + I
Sbjct: 165 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 217

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 114/233 (48%), Gaps = 33/233 (14%)
Query: 518 GATNNFK--EEVGRGSFGIVYKGVIQTRTSTTAVAVKK--LDRVFQDGEREFKNEVFVIG 573
           G+  NF+  E++G G++G+VYK   + + +   VA+KK  LD   +        E+ ++ 
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 59
Query: 574 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTL----ASFLFGNLKPNWNLRTNIAFQIAR 629
           + +H N+V+LL          LV+EFL+        AS L G   P   L  +  FQ+ +
Sbjct: 60  ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQ 116
Query: 630 GLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGY 689
           GL + H     +++H D+KP+N+L++     +++DFGLA        +     +R     
Sbjct: 117 GLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLA--------RAFGVPVRTYXHE 165
Query: 690 VAPEWFRNSKI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAI 733
           V   W+R  +I       +  VD++S G +  E+++ R  F  D E+ + + I
Sbjct: 166 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 218

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 114/233 (48%), Gaps = 33/233 (14%)
Query: 518 GATNNFK--EEVGRGSFGIVYKGVIQTRTSTTAVAVKK--LDRVFQDGEREFKNEVFVIG 573
           G+  NF+  E++G G++G+VYK   + + +   VA+KK  LD   +        E+ ++ 
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 58
Query: 574 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTL----ASFLFGNLKPNWNLRTNIAFQIAR 629
           + +H N+V+LL          LV+EFL+        AS L G   P   L  +  FQ+ +
Sbjct: 59  ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQ 115
Query: 630 GLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGY 689
           GL + H     +++H D+KP+N+L++     +++DFGLA        +     +R     
Sbjct: 116 GLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLA--------RAFGVPVRTYXHE 164
Query: 690 VAPEWFRNSKI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAI 733
           V   W+R  +I       +  VD++S G +  E+++ R  F  D E+ + + I
Sbjct: 165 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 217

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 84/301 (27%), Positives = 137/301 (45%), Gaps = 49/301 (16%)
Query: 527 VGRGSFGIVYK----GVIQTRTSTTAVAVKKLDRVFQDGE-REFKNEV-FVIGQTHHKNL 580
           +GRG+FG V +    G+ +T T  T VAVK L       E R   +E+  +I   HH N+
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRT-VAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93
Query: 581 VRLLGFCDE-GQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA--------------- 624
           V LLG C + G   +++ EF   G L+++L    K N  +   +A               
Sbjct: 94  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS--KRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 625 ---FQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKT 681
              FQ+A+G+ +L      + IH D+  +NILL +    +I DFGLA+ +  +     K 
Sbjct: 152 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 208
Query: 682 AIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAF 739
             R    ++APE   +   T + DV+SFGVLL EI S   S    +++ EE+        
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF-------- 260
Query: 740 DCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 799
            C R  +   +   D           ++    + C   +PS RPT  ++++ L  +++ +
Sbjct: 261 -CRRLKEGTRMRAPDYTT-------PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312
Query: 800 V 800
Sbjct: 313 A 313

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 124/270 (45%), Gaps = 31/270 (11%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLD-RVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           E++G+GSFG V+KG I  RT    VA+K +D    +D   + + E+ V+ Q     + + 
Sbjct: 33  EKIGKGSFGEVFKG-IDNRTQK-VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKY 90
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF---QIARGLLYLHEDCRA 640
            G   +     ++ E+L  G+    L    +P     T IA    +I +GL YLH + + 
Sbjct: 91  YGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHSEKK- 145
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
             IH DIK  N+LL ++   +++DFG+A  LT  Q K  +    GT  ++APE  + S  
Sbjct: 146 --IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK--RNTFVGTPFWMAPEVIKQSAY 201
Query: 701 TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMND 760
            +K D++S G+  +E+             +   L          G  +  + E  EA   
Sbjct: 202 DSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEA--- 258
Query: 761 IECLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
                        C+ ++PS RPT K++L+
Sbjct: 259 -------------CLNKEPSFRPTAKELLK 275

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 126/270 (46%), Gaps = 31/270 (11%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLD-RVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           E++G+GSFG V+KG I  RT    VA+K +D    +D   + + E+ V+ Q     + + 
Sbjct: 28  EKIGKGSFGEVFKG-IDNRTQKV-VAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKY 85
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF---QIARGLLYLHEDCRA 640
            G   +     ++ E+L  G+    L    +P     T IA    +I +GL YLH + + 
Sbjct: 86  YGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHSEKK- 140
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
             IH DIK  N+LL ++   +++DFG+A  LT  Q K  +    GT  ++APE  + S  
Sbjct: 141 --IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK--RNXFVGTPFWMAPEVIKQSAY 196
Query: 701 TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMND 760
            +K D++S G+  +E+         E+     +     F   +N    +     K     
Sbjct: 197 DSKADIWSLGITAIELARGEPPHS-ELHPMKVL-----FLIPKNNPPTLEGNYSKPLKEF 250
Query: 761 IECLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
           +E           C+ ++PS RPT K++L+
Sbjct: 251 VEA----------CLNKEPSFRPTAKELLK 270

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 106/223 (47%), Gaps = 16/223 (7%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLL 584
           EE+G G+FG+V++ V   + +      K ++  +   +   KNE+ ++ Q HH  L+ L 
Sbjct: 57  EELGSGAFGVVHRCV--EKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLH 114
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
              ++    +L+ EFL+ G L   +   + K +     N   Q   GL ++HE     I+
Sbjct: 115 DAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IV 171
Query: 644 HCDIKPQNILLD--DYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKIT 701
           H DIKP+NI+ +     + +I DFGLA  L  ++   + TA   T  + APE      + 
Sbjct: 172 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTA---TAEFAAPEIVDREPVG 228
Query: 702 AKVDVYSFGVLLLEIISCRKSF----DIEMGEEYAILTDWAFD 740
              D+++ GVL   ++S    F    D+E  +      DW FD
Sbjct: 229 FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVK-RCDWEFD 270

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 125/297 (42%), Gaps = 43/297 (14%)
Query: 527 VGRGSFG-IVYKGVI------QTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKN 579
           +G G+FG +V    I        R +  AV + K D   +D          +     HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 580 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN----------------I 623
           ++ LLG C +     ++ E+ + G L  +L     P      N                 
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 624 AFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAI 683
           A+Q+ARG+ YL      + IH D+  +N+L+ +    +I+DFGLA+ +         T  
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 684 RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAFDCY 742
           R    ++APE   +   T + DV+SFGVLL EI +         G  Y  +  +  F   
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG-------GSPYPGVPVEELFKLL 265
Query: 743 RNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 799
           + G        DK +     C  +L M+   C    PS RPT K++++ L+ +V ++
Sbjct: 266 KEGHRM-----DKPS----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 313

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 84/301 (27%), Positives = 137/301 (45%), Gaps = 49/301 (16%)
Query: 527 VGRGSFGIVYK----GVIQTRTSTTAVAVKKLDRVFQDGE-REFKNEV-FVIGQTHHKNL 580
           +GRG+FG V +    G+ +T T  T VAVK L       E R   +E+  +I   HH N+
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRT-VAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 84
Query: 581 VRLLGFCDE-GQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA--------------- 624
           V LLG C + G   +++ EF   G L+++L    K N  +   +A               
Sbjct: 85  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS--KRNEFVPYKVAPEDLYKDFLTLEHLI 142
Query: 625 ---FQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKT 681
              FQ+A+G+ +L      + IH D+  +NILL +    +I DFGLA+ +  +     K 
Sbjct: 143 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 199
Query: 682 AIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAF 739
             R    ++APE   +   T + DV+SFGVLL EI S   S    +++ EE+        
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF-------- 251
Query: 740 DCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 799
            C R  +   +   D           ++    + C   +PS RPT  ++++ L  +++ +
Sbjct: 252 -CRRLKEGTRMRAPDYTT-------PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 303
Query: 800 V 800
Sbjct: 304 A 304

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 102/209 (48%), Gaps = 16/209 (7%)
Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ 574
           E+   +    +++G G FG V+ G      ++T VAVK L +      + F  E  ++  
Sbjct: 8   EIPRESIKLVKKLGAGQFGEVWMGYY---NNSTKVAVKTL-KPGTMSVQAFLEEANLMKT 63
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF--QIARGLL 632
             H  LVRL     + +   ++ EF+  G+L  FL  +      L   I F  QIA G+ 
Sbjct: 64  LQHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMA 123
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK---GY 689
           Y+    R   IH D++  N+L+ +    +I+DFGLA+++  N+     TA  G K    +
Sbjct: 124 YIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY----TAREGAKFPIKW 176
Query: 690 VAPEWFRNSKITAKVDVYSFGVLLLEIIS 718
            APE       T K +V+SFG+LL EI++
Sbjct: 177 TAPEAINFGCFTIKSNVWSFGILLYEIVT 205

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 100/209 (47%), Gaps = 16/209 (7%)
Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ 574
           E+   +    + +G G FG V+ G      ++T VAVK L +      + F  E  ++  
Sbjct: 9   EIPRESIKLVKRLGAGQFGEVWMGYY---NNSTKVAVKTL-KPGTMSVQAFLEEANLMKT 64
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF--QIARGLL 632
             H  LVRL       +   ++ E++  G+L  FL  +      L   I F  QIA G+ 
Sbjct: 65  LQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMA 124
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK---GY 689
           Y+    R   IH D++  N+L+ +    +I+DFGLA+++  N+     TA  G K    +
Sbjct: 125 YIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY----TAREGAKFPIKW 177
Query: 690 VAPEWFRNSKITAKVDVYSFGVLLLEIIS 718
            APE       T K DV+SFG+LL EI++
Sbjct: 178 TAPEAINFGCFTIKSDVWSFGILLYEIVT 206

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 103/202 (50%), Gaps = 9/202 (4%)
Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTT--AVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNL 580
           F +++G+G+FG V           T   VAVKKL    ++  R+F+ E+ ++    H N+
Sbjct: 15  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 74
Query: 581 VRLLGFCDEG--QNRLLVYEFLNNGTLASFLFGNLKPNWNLR-TNIAFQIARGLLYLHED 637
           V+  G C     +N  L+ E+L  G+L  +L  + +   +++      QI +G+ YL   
Sbjct: 75  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL--- 131
Query: 638 CRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS-KTIKTAIRGTKGYVAPEWFR 696
              + IH ++  +NIL+++    +I DFGL K+L  ++    +K        + APE   
Sbjct: 132 GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLT 191
Query: 697 NSKITAKVDVYSFGVLLLEIIS 718
            SK +   DV+SFGV+L E+ +
Sbjct: 192 ESKFSVASDVWSFGVVLYELFT 213

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 126/270 (46%), Gaps = 31/270 (11%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLD-RVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           E++G+GSFG V+KG I  RT    VA+K +D    +D   + + E+ V+ Q     + + 
Sbjct: 13  EKIGKGSFGEVFKG-IDNRTQK-VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKY 70
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF---QIARGLLYLHEDCRA 640
            G   +     ++ E+L  G+    L    +P     T IA    +I +GL YLH + + 
Sbjct: 71  YGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHSEKK- 125
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
             IH DIK  N+LL ++   +++DFG+A  LT  Q K  +    GT  ++APE  + S  
Sbjct: 126 --IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK--RNTFVGTPFWMAPEVIKQSAY 181
Query: 701 TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMND 760
            +K D++S G+  +E+         E+     +     F   +N    +     K     
Sbjct: 182 DSKADIWSLGITAIELARGEPPHS-ELHPMKVL-----FLIPKNNPPTLEGNYSKPLKEF 235
Query: 761 IECLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
           +E           C+ ++PS RPT K++L+
Sbjct: 236 VEA----------CLNKEPSFRPTAKELLK 255

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 84/301 (27%), Positives = 137/301 (45%), Gaps = 49/301 (16%)
Query: 527 VGRGSFGIVYK----GVIQTRTSTTAVAVKKLDRVFQDGE-REFKNEV-FVIGQTHHKNL 580
           +GRG+FG V +    G+ +T T  T VAVK L       E R   +E+  +I   HH N+
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRT-VAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 84
Query: 581 VRLLGFCDE-GQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA--------------- 624
           V LLG C + G   +++ EF   G L+++L    K N  +   +A               
Sbjct: 85  VNLLGACTKPGGPLMVITEFCKFGNLSTYLRS--KRNEFVPYKVAPEDLYKDFLTLEHLI 142
Query: 625 ---FQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKT 681
              FQ+A+G+ +L      + IH D+  +NILL +    +I DFGLA+ +  +     K 
Sbjct: 143 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 199
Query: 682 AIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAF 739
             R    ++APE   +   T + DV+SFGVLL EI S   S    +++ EE+        
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF-------- 251
Query: 740 DCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 799
            C R  +   +   D           ++    + C   +PS RPT  ++++ L  +++ +
Sbjct: 252 -CRRLKEGTRMRAPDYTT-------PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 303
Query: 800 V 800
Sbjct: 304 A 304

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 84/301 (27%), Positives = 137/301 (45%), Gaps = 49/301 (16%)
Query: 527 VGRGSFGIVYK----GVIQTRTSTTAVAVKKLDRVFQDGE-REFKNEV-FVIGQTHHKNL 580
           +GRG+FG V +    G+ +T T  T VAVK L       E R   +E+  +I   HH N+
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRT-VAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93
Query: 581 VRLLGFCDE-GQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA--------------- 624
           V LLG C + G   +++ EF   G L+++L    K N  +   +A               
Sbjct: 94  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS--KRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 625 ---FQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKT 681
              FQ+A+G+ +L      + IH D+  +NILL +    +I DFGLA+ +  +     K 
Sbjct: 152 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKG 208
Query: 682 AIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAF 739
             R    ++APE   +   T + DV+SFGVLL EI S   S    +++ EE+        
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF-------- 260
Query: 740 DCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 799
            C R  +   +   D           ++    + C   +PS RPT  ++++ L  +++ +
Sbjct: 261 -CRRLKEGTRMRAPDYTT-------PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312
Query: 800 V 800
Sbjct: 313 A 313

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 105/214 (49%), Gaps = 22/214 (10%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTA--VAVKKLDRVFQDGEREFKNEVFVIGQTHHKN 579
            +  ++G+G+FG V           T   VAVK+L     D +R+F+ E+ ++   H   
Sbjct: 14  KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDF 73
Query: 580 LVRLLG--FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHED 637
           +V+  G  +    Q+  LV E+L +G L  FL          R       +R LLY  + 
Sbjct: 74  IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL---------QRHRARLDASRLLLYSSQI 124
Query: 638 CRA-------QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS-KTIKTAIRGTKGY 689
           C+        + +H D+  +NIL++     +I+DFGLAKLL L++    ++   +    +
Sbjct: 125 CKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFW 184
Query: 690 VAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKS 722
            APE   ++  + + DV+SFGV+L E+ + C KS
Sbjct: 185 YAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS 218

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 105/214 (49%), Gaps = 22/214 (10%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTA--VAVKKLDRVFQDGEREFKNEVFVIGQTHHKN 579
            +  ++G+G+FG V           T   VAVK+L     D +R+F+ E+ ++   H   
Sbjct: 26  KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDF 85
Query: 580 LVRLLG--FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHED 637
           +V+  G  +    Q+  LV E+L +G L  FL          R       +R LLY  + 
Sbjct: 86  IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL---------QRHRARLDASRLLLYSSQI 136
Query: 638 CRA-------QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS-KTIKTAIRGTKGY 689
           C+        + +H D+  +NIL++     +I+DFGLAKLL L++    ++   +    +
Sbjct: 137 CKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFW 196
Query: 690 VAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKS 722
            APE   ++  + + DV+SFGV+L E+ + C KS
Sbjct: 197 YAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS 230

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 105/214 (49%), Gaps = 22/214 (10%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTA--VAVKKLDRVFQDGEREFKNEVFVIGQTHHKN 579
            +  ++G+G+FG V           T   VAVK+L     D +R+F+ E+ ++   H   
Sbjct: 13  KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDF 72
Query: 580 LVRLLG--FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHED 637
           +V+  G  +    Q+  LV E+L +G L  FL          R       +R LLY  + 
Sbjct: 73  IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL---------QRHRARLDASRLLLYSSQI 123
Query: 638 CRA-------QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS-KTIKTAIRGTKGY 689
           C+        + +H D+  +NIL++     +I+DFGLAKLL L++    ++   +    +
Sbjct: 124 CKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFW 183
Query: 690 VAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKS 722
            APE   ++  + + DV+SFGV+L E+ + C KS
Sbjct: 184 YAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS 217

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 71/292 (24%), Positives = 125/292 (42%), Gaps = 37/292 (12%)
Query: 523 FKEEVGRGSFGIVYKGVIQTRTST---TAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKN 579
            K E+G G+FG V+       + T     VAVK L        ++F+ E  ++    H++
Sbjct: 19  LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 580 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN--------------LKPNWNLRT--NI 623
           +V+  G C +G   ++V+E++ +G L  FL  +               K    L    +I
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 624 AFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAI 683
           A QIA G++YL        +H D+  +N L+      +I DFG+++ +       +    
Sbjct: 139 ASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 195
Query: 684 RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR 743
                ++ PE     K T + DV+SFGV+L EI +  K    ++     I      +C  
Sbjct: 196 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI------ECIT 249
Query: 744 NGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV 795
            G+    V E         C  ++  V + C Q +P  R  +K++ ++L  +
Sbjct: 250 QGR----VLERPRV-----CPKEVYDVMLGCWQREPQQRLNIKEIYKILHAL 292

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 125/297 (42%), Gaps = 43/297 (14%)
Query: 527 VGRGSFG-IVYKGVI------QTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKN 579
           +G G+FG +V    I        R +  AV + K D   +D          +     HKN
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 580 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN----------------I 623
           ++ LLG C +     ++ E+ + G L  +L     P      N                 
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 624 AFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAI 683
           A+Q+ARG+ YL      + IH D+  +N+L+ +    +I+DFGLA+ +         T  
Sbjct: 197 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 684 RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAFDCY 742
           R    ++APE   +   T + DV+SFGVLL EI +         G  Y  +  +  F   
Sbjct: 254 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG-------GSPYPGVPVEELFKLL 306
Query: 743 RNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 799
           + G        DK +     C  +L M+   C    PS RPT K++++ L+ +V ++
Sbjct: 307 KEGHRM-----DKPS----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 354

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 84/299 (28%), Positives = 136/299 (45%), Gaps = 45/299 (15%)
Query: 527 VGRGSFGIVYK----GVIQTRTSTTAVAVKKLDRVFQDGE-REFKNEV-FVIGQTHHKNL 580
           +GRG+FG V +    G+ +T T  T VAVK L       E R   +E+  +I   HH N+
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRT-VAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 95
Query: 581 VRLLGFCDE-GQNRLLVYEFLNNGTLASFLFGN--------------LKPNWNLRTNI-- 623
           V LLG C + G   +++ EF   G L+++L                  K    L   I  
Sbjct: 96  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICY 155
Query: 624 AFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAI 683
           +FQ+A+G+ +L      + IH D+  +NILL +    +I DFGLA+ +  +     K   
Sbjct: 156 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 212
Query: 684 RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDC 741
           R    ++APE   +   T + DV+SFGVLL EI S   S    +++ EE+         C
Sbjct: 213 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF---------C 263
Query: 742 YRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSV 800
            R  +   +   D           ++    + C   +PS RPT  ++++ L  +++ + 
Sbjct: 264 RRLKEGTRMRAPDYTT-------PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 315

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 114/233 (48%), Gaps = 33/233 (14%)
Query: 518 GATNNFK--EEVGRGSFGIVYKGVIQTRTSTTAVAVKK--LDRVFQDGEREFKNEVFVIG 573
           G+  NF+  E++G G++G+VYK   + + +   VA+KK  LD   +        E+ ++ 
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 60
Query: 574 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTL----ASFLFGNLKPNWNLRTNIAFQIAR 629
           + +H N+V+LL          LV+EFL+        AS L G   P   L  +  FQ+ +
Sbjct: 61  ELNHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLP---LIKSYLFQLLQ 117
Query: 630 GLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGY 689
           GL + H     +++H D+KP+N+L++     +++DFGLA        +     +R     
Sbjct: 118 GLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLA--------RAFGVPVRTYXHE 166
Query: 690 VAPEWFRNSKI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAI 733
           V   W+R  +I       +  VD++S G +  E+++ R  F  D E+ + + I
Sbjct: 167 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 219

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 105/214 (49%), Gaps = 22/214 (10%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTA--VAVKKLDRVFQDGEREFKNEVFVIGQTHHKN 579
            +  ++G+G+FG V           T   VAVK+L     D +R+F+ E+ ++   H   
Sbjct: 10  KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDF 69
Query: 580 LVRLLGFC-DEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHED 637
           +V+  G     G+  L LV E+L +G L  FL          R       +R LLY  + 
Sbjct: 70  IVKYRGVSYGPGRPELRLVMEYLPSGCLRDFL---------QRHRARLDASRLLLYSSQI 120
Query: 638 CRA-------QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS-KTIKTAIRGTKGY 689
           C+        + +H D+  +NIL++     +I+DFGLAKLL L++    ++   +    +
Sbjct: 121 CKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFW 180
Query: 690 VAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKS 722
            APE   ++  + + DV+SFGV+L E+ + C KS
Sbjct: 181 YAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS 214

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 126/270 (46%), Gaps = 31/270 (11%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLD-RVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           E++G+GSFG V+KG I  RT    VA+K +D    +D   + + E+ V+ Q     + + 
Sbjct: 13  EKIGKGSFGEVFKG-IDNRTQKV-VAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKY 70
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF---QIARGLLYLHEDCRA 640
            G   +     ++ E+L  G+    L    +P     T IA    +I +GL YLH + + 
Sbjct: 71  YGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHSEKK- 125
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
             IH DIK  N+LL ++   +++DFG+A  LT  Q K  +    GT  ++APE  + S  
Sbjct: 126 --IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK--RNXFVGTPFWMAPEVIKQSAY 181
Query: 701 TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMND 760
            +K D++S G+  +E+         E+     +     F   +N    +     K     
Sbjct: 182 DSKADIWSLGITAIELARGEPPHS-ELHPMKVL-----FLIPKNNPPTLEGNYSKPLKEF 235
Query: 761 IECLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
           +E           C+ ++PS RPT K++L+
Sbjct: 236 VEA----------CLNKEPSFRPTAKELLK 255

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 113/232 (48%), Gaps = 33/232 (14%)
Query: 519 ATNNFK--EEVGRGSFGIVYKGVIQTRTSTTAVAVKK--LDRVFQDGEREFKNEVFVIGQ 574
           +  NF+  E++G G++G+VYK   + + +   VA+KK  LD   +        E+ ++ +
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 58
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTL----ASFLFGNLKPNWNLRTNIAFQIARG 630
            +H N+V+LL          LV+EFL+        AS L G   P   L  +  FQ+ +G
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQG 115
Query: 631 LLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYV 690
           L + H     +++H D+KPQN+L++     +++DFGLA        +     +R     V
Sbjct: 116 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA--------RAFGVPVRTYXHEV 164
Query: 691 APEWFRNSKI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAI 733
              W+R  +I       +  VD++S G +  E+++ R  F  D E+ + + I
Sbjct: 165 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 216

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 79.7 bits (195), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 114/233 (48%), Gaps = 33/233 (14%)
Query: 518 GATNNFK--EEVGRGSFGIVYKGVIQTRTSTTAVAVKK--LDRVFQDGEREFKNEVFVIG 573
           G+  NF+  E++G G++G+VYK   + + +   VA+KK  LD   +        E+ ++ 
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 58
Query: 574 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTL----ASFLFGNLKPNWNLRTNIAFQIAR 629
           + +H N+V+LL          LV+EFL+        AS L G   P   L  +  FQ+ +
Sbjct: 59  ELNHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLP---LIKSYLFQLLQ 115
Query: 630 GLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGY 689
           GL + H     +++H D+KP+N+L++     +++DFGLA        +     +R     
Sbjct: 116 GLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLA--------RAFGVPVRTYXHE 164
Query: 690 VAPEWFRNSKI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAI 733
           V   W+R  +I       +  VD++S G +  E+++ R  F  D E+ + + I
Sbjct: 165 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 217

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 79.7 bits (195), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 113/232 (48%), Gaps = 33/232 (14%)
Query: 519 ATNNFK--EEVGRGSFGIVYKGVIQTRTSTTAVAVKK--LDRVFQDGEREFKNEVFVIGQ 574
           +  NF+  E++G G++G+VYK   + + +   VA+KK  LD   +        E+ ++ +
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 58
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTL----ASFLFGNLKPNWNLRTNIAFQIARG 630
            +H N+V+LL          LV+EFL+        AS L G   P   L  +  FQ+ +G
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQG 115
Query: 631 LLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYV 690
           L + H     +++H D+KPQN+L++     +++DFGLA        +     +R     V
Sbjct: 116 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA--------RAFGVPVRTYXHEV 164
Query: 691 APEWFRNSKI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAI 733
              W+R  +I       +  VD++S G +  E+++ R  F  D E+ + + I
Sbjct: 165 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 216

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 79.7 bits (195), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/193 (31%), Positives = 91/193 (47%), Gaps = 10/193 (5%)
Query: 526 EVGRGSFGIVYKGVIQTRTST-TAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLL 584
           ++G GS GIV    I T   T   VAVKK+D   Q       NEV ++   HH N+V + 
Sbjct: 52  KIGEGSTGIV---CIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMY 108
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIH 644
                G    +V EFL  G L   +  + + N      +   + R L YLH      +IH
Sbjct: 109 SSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIH 164
Query: 645 CDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKV 704
            DIK  +ILL      ++SDFG    ++    K  +  + GT  ++APE         +V
Sbjct: 165 RDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RKXLVGTPYWMAPEVISRLPYGTEV 222
Query: 705 DVYSFGVLLLEII 717
           D++S G++++E+I
Sbjct: 223 DIWSLGIMVIEMI 235

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 113/232 (48%), Gaps = 33/232 (14%)
Query: 519 ATNNFK--EEVGRGSFGIVYKGVIQTRTSTTAVAVKK--LDRVFQDGEREFKNEVFVIGQ 574
           +  NF+  E++G G++G+VYK   + + +   VA+KK  LD   +        E+ ++ +
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 58
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTL----ASFLFGNLKPNWNLRTNIAFQIARG 630
            +H N+V+LL          LV+EFL+        AS L G   P   L  +  FQ+ +G
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQG 115
Query: 631 LLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYV 690
           L + H     +++H D+KPQN+L++     +++DFGLA        +     +R     V
Sbjct: 116 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA--------RAFGVPVRTYXHEV 164
Query: 691 APEWFRNSKI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAI 733
              W+R  +I       +  VD++S G +  E+++ R  F  D E+ + + I
Sbjct: 165 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 216

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 113/232 (48%), Gaps = 33/232 (14%)
Query: 519 ATNNFK--EEVGRGSFGIVYKGVIQTRTSTTAVAVKK--LDRVFQDGEREFKNEVFVIGQ 574
           +  NF+  E++G G++G+VYK   + + +   VA+KK  LD   +        E+ ++ +
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 58
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTL----ASFLFGNLKPNWNLRTNIAFQIARG 630
            +H N+V+LL          LV+EFL+        AS L G   P   L  +  FQ+ +G
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQG 115
Query: 631 LLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYV 690
           L + H     +++H D+KPQN+L++     +++DFGLA        +     +R     V
Sbjct: 116 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA--------RAFGVPVRTYXHEV 164
Query: 691 APEWFRNSKI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAI 733
              W+R  +I       +  VD++S G +  E+++ R  F  D E+ + + I
Sbjct: 165 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 216

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 75/306 (24%), Positives = 133/306 (43%), Gaps = 36/306 (11%)
Query: 502 GTIETNLRCFSYKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG 561
           G +E+  R ++ ++ E         +G+G FG VY  + + + S   +A+K L +   + 
Sbjct: 1   GAMESKKRQWALEDFE-----IGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEK 53
Query: 562 ---EREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWN 618
              E + + EV +     H N++RL G+  +     L+ E+   GT+   L    K +  
Sbjct: 54  AGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ 113
Query: 619 LRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT 678
                  ++A  L Y H     ++IH DIKP+N+LL      +I+DFG     +++   +
Sbjct: 114 RTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSS 166
Query: 679 IKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDW 737
            +T + GT  Y+ PE         KVD++S GVL  E +  +  F+    +E Y  ++  
Sbjct: 167 RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 226
Query: 738 AFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 797
            F                    D    G   ++S   ++ +PS RP +++VL+       
Sbjct: 227 EF-----------------TFPDFVTEGARDLIS-RLLKHNPSQRPMLREVLEHPWITAN 268
Query: 798 VSVPPN 803
            S P N
Sbjct: 269 SSKPSN 274

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 107/217 (49%), Gaps = 18/217 (8%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKN----EVFVIGQTHHKNLVR 582
           VG GS+G+V K   + + +   VA+KK   +  D ++  K     E+ ++ Q  H+NLV 
Sbjct: 33  VGEGSYGMVMK--CRNKDTGRIVAIKKF--LESDDDKMVKKIAMREIKLLKQLRHENLVN 88
Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASF-LFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ 641
           LL  C + +   LV+EF+++  L    LF N   ++ +     FQI  G+ + H      
Sbjct: 89  LLEVCKKKKRWYLVFEFVDHTILDDLELFPN-GLDYQVVQKYLFQIINGIGFCHS---HN 144
Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR-NSKI 700
           IIH DIKP+NIL+      ++ DFG A+  TL     +      T+ Y APE    + K 
Sbjct: 145 IIHRDIKPENILVSQSGVVKLCDFGFAR--TLAAPGEVYDDEVATRWYRAPELLVGDVKY 202
Query: 701 TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAILT 735
              VDV++ G L+ E+      F  D ++ + Y I+ 
Sbjct: 203 GKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMM 239

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 112/230 (48%), Gaps = 33/230 (14%)
Query: 521 NNFK--EEVGRGSFGIVYKGVIQTRTSTTAVAVKK--LDRVFQDGEREFKNEVFVIGQTH 576
            NF+  E++G G++G+VYK   + + +   VA+KK  LD   +        E+ ++ + +
Sbjct: 10  ENFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 67
Query: 577 HKNLVRLLGFCDEGQNRLLVYEFLNNGTL----ASFLFGNLKPNWNLRTNIAFQIARGLL 632
           H N+V+LL          LV+EFL+        AS L G   P   L  +  FQ+ +GL 
Sbjct: 68  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLA 124
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 692
           + H     +++H D+KPQN+L++     +++DFGLA        +     +R     V  
Sbjct: 125 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA--------RAFGVPVRTYTHEVVT 173
Query: 693 EWFRNSKI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAI 733
            W+R  +I       +  VD++S G +  E+++ R  F  D E+ + + I
Sbjct: 174 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 223

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 112/224 (50%), Gaps = 21/224 (9%)
Query: 521 NNFK--EEVGRGSFGIVYKGVIQTRTSTTAVAVKK--LDRVFQDGEREFKNEVFVIGQTH 576
            NF+  E++G G++G+VYK   + + +   VA+KK  LD   +        E+ ++ + +
Sbjct: 10  ENFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 67
Query: 577 HKNLVRLLGFCDEGQNRLLVYEFLNNGTL----ASFLFGNLKPNWNLRTNIAFQIARGLL 632
           H N+V+LL          LV+EFL+        AS L G   P   L  +  FQ+ +GL 
Sbjct: 68  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLA 124
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 692
           + H     +++H D+KPQN+L++     +++DFGLA+   +         +  T  Y AP
Sbjct: 125 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAP 179
Query: 693 EWFRNSK-ITAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAI 733
           E     K  +  VD++S G +  E+++ R  F  D E+ + + I
Sbjct: 180 EILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 223

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 114/224 (50%), Gaps = 32/224 (14%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ---DGEREFKNEVFVIGQTHHKNLV 581
           +++G+G++GIV+K +   R +   VAVKK+   FQ   D +R F+  + +   + H+N+V
Sbjct: 15  KKLGKGAYGIVWKSI--DRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIV 72
Query: 582 RLLGF--CDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCR 639
            LL     D  ++  LV++++     A      L+P    +  + +Q+ + + YLH    
Sbjct: 73  NLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVH--KQYVVYQLIKVIKYLHS--- 127
Query: 640 AQIIHCDIKPQNILLDDYYTARISDFGLAKL------------LTLNQS-------KTIK 680
             ++H D+KP NILL+     +++DFGL++             L++N++       + I 
Sbjct: 128 GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPIL 187
Query: 681 TAIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIISCRKSF 723
           T    T+ Y APE    S K T  +D++S G +L EI+  +  F
Sbjct: 188 TDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIF 231

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 84/301 (27%), Positives = 137/301 (45%), Gaps = 49/301 (16%)
Query: 527 VGRGSFGIVYK----GVIQTRTSTTAVAVKKLDRVFQDGE-REFKNEV-FVIGQTHHKNL 580
           +GRG+FG V +    G+ +T T  T VAVK L       E R   +E+  +I   HH N+
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRT-VAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93
Query: 581 VRLLGFCDE-GQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA--------------- 624
           V LLG C + G   +++ EF   G L+++L    K N  +   +A               
Sbjct: 94  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS--KRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 625 ---FQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKT 681
              FQ+A+G+ +L      + IH D+  +NILL +    +I DFGLA+ +  +     K 
Sbjct: 152 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 208
Query: 682 AIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAF 739
             R    ++APE   +   T + DV+SFGVLL EI S   S    +++ EE+        
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF-------- 260
Query: 740 DCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 799
            C R  +   +   D           ++    + C   +PS RPT  ++++ L  +++ +
Sbjct: 261 -CRRLKEGTRMRAPDYTT-------PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312
Query: 800 V 800
Sbjct: 313 A 313

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 120/268 (44%), Gaps = 31/268 (11%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG---EREFKNEVFVIGQTHHKNLVRL 583
           +G+G FG VY  + + + S   +A+K L +   +    E + + EV +     H N++RL
Sbjct: 42  LGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 99
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
            G+  +     L+ E+   GT+   L    K +         ++A  L Y H     ++I
Sbjct: 100 YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVI 156
Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK 703
           H DIKP+N+LL      +I+DFG     +++   + +T + GT  Y+ PE         K
Sbjct: 157 HRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEK 212
Query: 704 VDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLNVLVGEDKEAMNDIE 762
           VD++S GVL  E +  +  F+    +E Y  ++   F                    D  
Sbjct: 213 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-----------------TFPDFV 255
Query: 763 CLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
             G   ++S   ++ +PS RP +++VL+
Sbjct: 256 TEGARDLIS-RLLKHNPSQRPMLREVLE 282

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 112/230 (48%), Gaps = 33/230 (14%)
Query: 521 NNFK--EEVGRGSFGIVYKGVIQTRTSTTAVAVKK--LDRVFQDGEREFKNEVFVIGQTH 576
            NF+  E++G G++G+VYK   + + +   VA+KK  LD   +        E+ ++ + +
Sbjct: 2   ENFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 59
Query: 577 HKNLVRLLGFCDEGQNRLLVYEFLNNGTL----ASFLFGNLKPNWNLRTNIAFQIARGLL 632
           H N+V+LL          LV+EFL+        AS L G   P   L  +  FQ+ +GL 
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLA 116
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 692
           + H     +++H D+KPQN+L++     +++DFGLA        +     +R     V  
Sbjct: 117 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA--------RAFGVPVRTYXHEVVT 165
Query: 693 EWFRNSKI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAI 733
            W+R  +I       +  VD++S G +  E+++ R  F  D E+ + + I
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 215

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 112/230 (48%), Gaps = 33/230 (14%)
Query: 521 NNFK--EEVGRGSFGIVYKGVIQTRTSTTAVAVKK--LDRVFQDGEREFKNEVFVIGQTH 576
            NF+  E++G G++G+VYK   + + +   VA+KK  LD   +        E+ ++ + +
Sbjct: 3   ENFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 577 HKNLVRLLGFCDEGQNRLLVYEFLNNGTL----ASFLFGNLKPNWNLRTNIAFQIARGLL 632
           H N+V+LL          LV+EFL+        AS L G   P   L  +  FQ+ +GL 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLA 117
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 692
           + H     +++H D+KPQN+L++     +++DFGLA        +     +R     V  
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA--------RAFGVPVRTYTHEVVT 166
Query: 693 EWFRNSKI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAI 733
            W+R  +I       +  VD++S G +  E+++ R  F  D E+ + + I
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 216

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 112/230 (48%), Gaps = 33/230 (14%)
Query: 521 NNFK--EEVGRGSFGIVYKGVIQTRTSTTAVAVKK--LDRVFQDGEREFKNEVFVIGQTH 576
            NF+  E++G G++G+VYK   + + +   VA+KK  LD   +        E+ ++ + +
Sbjct: 2   ENFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 59
Query: 577 HKNLVRLLGFCDEGQNRLLVYEFLNNGTL----ASFLFGNLKPNWNLRTNIAFQIARGLL 632
           H N+V+LL          LV+EFL+        AS L G   P   L  +  FQ+ +GL 
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLA 116
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 692
           + H     +++H D+KPQN+L++     +++DFGLA        +     +R     V  
Sbjct: 117 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA--------RAFGVPVRTYTHEVVT 165
Query: 693 EWFRNSKI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAI 733
            W+R  +I       +  VD++S G +  E+++ R  F  D E+ + + I
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 215

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 112/230 (48%), Gaps = 33/230 (14%)
Query: 521 NNFK--EEVGRGSFGIVYKGVIQTRTSTTAVAVKK--LDRVFQDGEREFKNEVFVIGQTH 576
            NF+  E++G G++G+VYK   + + +   VA+KK  LD   +        E+ ++ + +
Sbjct: 2   ENFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 59
Query: 577 HKNLVRLLGFCDEGQNRLLVYEFLNNGTL----ASFLFGNLKPNWNLRTNIAFQIARGLL 632
           H N+V+LL          LV+EFL+        AS L G   P   L  +  FQ+ +GL 
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLA 116
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 692
           + H     +++H D+KPQN+L++     +++DFGLA        +     +R     V  
Sbjct: 117 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA--------RAFGVPVRTYXHEVVT 165
Query: 693 EWFRNSKI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAI 733
            W+R  +I       +  VD++S G +  E+++ R  F  D E+ + + I
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 215

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 112/230 (48%), Gaps = 33/230 (14%)
Query: 521 NNFK--EEVGRGSFGIVYKGVIQTRTSTTAVAVKK--LDRVFQDGEREFKNEVFVIGQTH 576
            NF+  E++G G++G+VYK   + + +   VA+KK  LD   +        E+ ++ + +
Sbjct: 2   ENFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 59
Query: 577 HKNLVRLLGFCDEGQNRLLVYEFLNNGTL----ASFLFGNLKPNWNLRTNIAFQIARGLL 632
           H N+V+LL          LV+EFL+        AS L G   P   L  +  FQ+ +GL 
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLA 116
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 692
           + H     +++H D+KPQN+L++     +++DFGLA        +     +R     V  
Sbjct: 117 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA--------RAFGVPVRTYTHEVVT 165
Query: 693 EWFRNSKI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAI 733
            W+R  +I       +  VD++S G +  E+++ R  F  D E+ + + I
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 215

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 112/230 (48%), Gaps = 33/230 (14%)
Query: 521 NNFK--EEVGRGSFGIVYKGVIQTRTSTTAVAVKK--LDRVFQDGEREFKNEVFVIGQTH 576
            NF+  E++G G++G+VYK   + + +   VA+KK  LD   +        E+ ++ + +
Sbjct: 3   ENFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 577 HKNLVRLLGFCDEGQNRLLVYEFLNNGTL----ASFLFGNLKPNWNLRTNIAFQIARGLL 632
           H N+V+LL          LV+EFL+        AS L G   P   L  +  FQ+ +GL 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLA 117
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 692
           + H     +++H D+KPQN+L++     +++DFGLA        +     +R     V  
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA--------RAFGVPVRTYTHEVVT 166
Query: 693 EWFRNSKI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAI 733
            W+R  +I       +  VD++S G +  E+++ R  F  D E+ + + I
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 216

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 112/214 (52%), Gaps = 16/214 (7%)
Query: 519 ATNNFK--EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFK-NEVFVIGQT 575
           +++ FK  E++G G++  VYKG+   +T+   VA+K++    ++G       E+ ++ + 
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGL--NKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL 60
Query: 576 HHKNLVRLLGFCDEGQNRLLVYEFLNNGT---LASFLFGNLKP--NWNLRTNIAFQIARG 630
            H+N+VRL           LV+EF++N     + S   GN       NL     +Q+ +G
Sbjct: 61  KHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG 120
Query: 631 LLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYV 690
           L + HE+   +I+H D+KPQN+L++     ++ DFGLA+   +  +      +  T  Y 
Sbjct: 121 LAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV--TLWYR 175
Query: 691 APEWFRNSKI-TAKVDVYSFGVLLLEIISCRKSF 723
           AP+    S+  +  +D++S G +L E+I+ +  F
Sbjct: 176 APDVLMGSRTYSTSIDIWSCGCILAEMITGKPLF 209

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 101/200 (50%), Gaps = 15/200 (7%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGER--EFKNEVFVIGQTHHKNLVR 582
           + +G GSFG VYKG          VAVK L+      ++   FKNEV V+ +T H N++ 
Sbjct: 19  QRIGSGSFGTVYKGKWHG-----DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 73
Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFL-FGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ 641
            +G+  + Q   +V ++    +L   L     K       +IA Q A+G+ YLH      
Sbjct: 74  FMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--- 129
Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR---NS 698
           IIH D+K  NI L +  T +I DFGLA + +          + G+  ++APE  R    +
Sbjct: 130 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 189
Query: 699 KITAKVDVYSFGVLLLEIIS 718
             + + DVY+FG++L E+++
Sbjct: 190 PYSFQSDVYAFGIVLYELMT 209

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 112/230 (48%), Gaps = 33/230 (14%)
Query: 521 NNFK--EEVGRGSFGIVYKGVIQTRTSTTAVAVKK--LDRVFQDGEREFKNEVFVIGQTH 576
            NF+  E++G G++G+VYK   + + +   VA+KK  LD   +        E+ ++ + +
Sbjct: 7   ENFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 577 HKNLVRLLGFCDEGQNRLLVYEFLNNGTL----ASFLFGNLKPNWNLRTNIAFQIARGLL 632
           H N+V+LL          LV+EFL+        AS L G   P   L  +  FQ+ +GL 
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLA 121
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 692
           + H     +++H D+KPQN+L++     +++DFGLA        +     +R     V  
Sbjct: 122 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA--------RAFGVPVRTYTHEVVT 170
Query: 693 EWFRNSKI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAI 733
            W+R  +I       +  VD++S G +  E+++ R  F  D E+ + + I
Sbjct: 171 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 220

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 68/266 (25%), Positives = 118/266 (44%), Gaps = 27/266 (10%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG-EREFKNEVFVIGQTHHKNLVRLLG 585
           +G+G FG VY    + R    A+ V    ++ + G E + + EV +     H N++RL G
Sbjct: 13  LGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 72
Query: 586 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHC 645
           +  +     L+ E+   GT+   L    K +         ++A  L Y H     ++IH 
Sbjct: 73  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHR 129
Query: 646 DIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVD 705
           DIKP+N+LL      +I+DFG     +++   + +T + GT  Y+ PE         KVD
Sbjct: 130 DIKPENLLLGSAGELKIADFGW----SVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVD 185
Query: 706 VYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECL 764
           ++S GVL  E +  +  F+    +E Y  ++   F                    D    
Sbjct: 186 LWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-----------------TFPDFVTE 228
Query: 765 GKLVMVSIWCIQEDPSLRPTMKKVLQ 790
           G   ++S   ++ +PS RP +++VL+
Sbjct: 229 GARDLIS-RLLKHNPSQRPMLREVLE 253

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 112/230 (48%), Gaps = 33/230 (14%)
Query: 521 NNFK--EEVGRGSFGIVYKGVIQTRTSTTAVAVKK--LDRVFQDGEREFKNEVFVIGQTH 576
            NF+  E++G G++G+VYK   + + +   VA+KK  LD   +        E+ ++ + +
Sbjct: 3   ENFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 577 HKNLVRLLGFCDEGQNRLLVYEFLNNGTL----ASFLFGNLKPNWNLRTNIAFQIARGLL 632
           H N+V+LL          LV+EFL+        AS L G   P   L  +  FQ+ +GL 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLA 117
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 692
           + H     +++H D+KPQN+L++     +++DFGLA        +     +R     V  
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA--------RAFGVPVRTYTHEVVT 166
Query: 693 EWFRNSKI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAI 733
            W+R  +I       +  VD++S G +  E+++ R  F  D E+ + + I
Sbjct: 167 LWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 216

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 84/301 (27%), Positives = 137/301 (45%), Gaps = 49/301 (16%)
Query: 527 VGRGSFGIVYK----GVIQTRTSTTAVAVKKLDRVFQDGE-REFKNEV-FVIGQTHHKNL 580
           +GRG+FG V +    G+ +T T  T VAVK L       E R   +E+  +I   HH N+
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRT-VAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 130
Query: 581 VRLLGFCDE-GQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA--------------- 624
           V LLG C + G   +++ EF   G L+++L    K N  +   +A               
Sbjct: 131 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS--KRNEFVPYKVAPEDLYKDFLTLEHLI 188
Query: 625 ---FQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKT 681
              FQ+A+G+ +L      + IH D+  +NILL +    +I DFGLA+ +  +     K 
Sbjct: 189 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 245
Query: 682 AIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAF 739
             R    ++APE   +   T + DV+SFGVLL EI S   S    +++ EE+        
Sbjct: 246 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF-------- 297
Query: 740 DCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 799
            C R  +   +   D           ++    + C   +PS RPT  ++++ L  +++ +
Sbjct: 298 -CRRLKEGTRMRAPDYTT-------PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349
Query: 800 V 800
Sbjct: 350 A 350

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 101/200 (50%), Gaps = 15/200 (7%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGER--EFKNEVFVIGQTHHKNLVR 582
           + +G GSFG VYKG          VAVK L+      ++   FKNEV V+ +T H N++ 
Sbjct: 19  QRIGSGSFGTVYKGKWHG-----DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 73
Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFL-FGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ 641
            +G+  + Q   +V ++    +L   L     K       +IA Q A+G+ YLH      
Sbjct: 74  FMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--- 129
Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR---NS 698
           IIH D+K  NI L +  T +I DFGLA + +          + G+  ++APE  R    +
Sbjct: 130 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 189
Query: 699 KITAKVDVYSFGVLLLEIIS 718
             + + DVY+FG++L E+++
Sbjct: 190 PYSFQSDVYAFGIVLYELMT 209

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 108/228 (47%), Gaps = 29/228 (12%)
Query: 521 NNFK--EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHK 578
            NF+  E++G G++G+VYK   +      A+   +LD   +        E+ ++ + +H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 579 NLVRLLGFCDEGQNRLLVYEFLNNGTL----ASFLFGNLKPNWNLRTNIAFQIARGLLYL 634
           N+V+LL          LV+EFL+        AS L G   P   L  +  FQ+ +GL + 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFC 119
Query: 635 HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 694
           H     +++H D+KPQN+L++     +++DFGLA        +     +R     V   W
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLA--------RAFGVPVRTYTHEVVTLW 168
Query: 695 FRNSKI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAI 733
           +R  +I       +  VD++S G +  E+++ R  F  D E+ + + I
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 216

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 108/228 (47%), Gaps = 29/228 (12%)
Query: 521 NNFK--EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHK 578
            NF+  E++G G++G+VYK   +      A+   +LD   +        E+ ++ + +H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 579 NLVRLLGFCDEGQNRLLVYEFLNNGTL----ASFLFGNLKPNWNLRTNIAFQIARGLLYL 634
           N+V+LL          LV+EFL+        AS L G   P   L  +  FQ+ +GL + 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFC 118
Query: 635 HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 694
           H     +++H D+KPQN+L++     +++DFGLA        +     +R     V   W
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLA--------RAFGVPVRTYTHEVVTLW 167
Query: 695 FRNSKI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAI 733
           +R  +I       +  VD++S G +  E+++ R  F  D E+ + + I
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 215

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 84/301 (27%), Positives = 137/301 (45%), Gaps = 49/301 (16%)
Query: 527 VGRGSFGIVYK----GVIQTRTSTTAVAVKKLDRVFQDGE-REFKNEV-FVIGQTHHKNL 580
           +GRG+FG V +    G+ +T T  T VAVK L       E R   +E+  +I   HH N+
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRT-VAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 84
Query: 581 VRLLGFCDE-GQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA--------------- 624
           V LLG C + G   +++ EF   G L+++L    K N  +   +A               
Sbjct: 85  VNLLGACTKPGGPLMVITEFCKFGNLSTYLRS--KRNEFVPYKVAPEDLYKDFLTLEHLI 142
Query: 625 ---FQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKT 681
              FQ+A+G+ +L      + IH D+  +NILL +    +I DFGLA+ +  +     K 
Sbjct: 143 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 199
Query: 682 AIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAF 739
             R    ++APE   +   T + DV+SFGVLL EI S   S    +++ EE+        
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF-------- 251
Query: 740 DCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 799
            C R  +   +   D           ++    + C   +PS RPT  ++++ L  +++ +
Sbjct: 252 -CRRLKEGTRMRAPDYTT-------PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 303
Query: 800 V 800
Sbjct: 304 A 304

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 125/297 (42%), Gaps = 43/297 (14%)
Query: 527 VGRGSFG-IVYKGVI------QTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKN 579
           +G G+FG +V    I        R +  AV + K D   +D          +     HKN
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 580 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN----------------I 623
           ++ LLG C +     ++ E+ + G L  +L     P      N                 
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 624 AFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAI 683
           A+Q+ARG+ YL      + IH D+  +N+L+ +    +I+DFGLA+ +         T  
Sbjct: 148 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 204
Query: 684 RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAFDCY 742
           R    ++APE   +   T + DV+SFGVLL EI +         G  Y  +  +  F   
Sbjct: 205 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG-------GSPYPGVPVEELFKLL 257
Query: 743 RNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 799
           + G        DK +     C  +L M+   C    PS RPT K++++ L+ +V ++
Sbjct: 258 KEGHRM-----DKPS----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 305

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 125/297 (42%), Gaps = 43/297 (14%)
Query: 527 VGRGSFG-IVYKGVI------QTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKN 579
           +G G+FG +V    I        R +  AV + K D   +D          +     HKN
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 580 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN----------------I 623
           ++ LLG C +     ++ E+ + G L  +L     P      N                 
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 624 AFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAI 683
           A+Q+ARG+ YL      + IH D+  +N+L+ +    +I+DFGLA+ +         T  
Sbjct: 145 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 201
Query: 684 RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAFDCY 742
           R    ++APE   +   T + DV+SFGVLL EI +         G  Y  +  +  F   
Sbjct: 202 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG-------GSPYPGVPVEELFKLL 254
Query: 743 RNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 799
           + G        DK +     C  +L M+   C    PS RPT K++++ L+ +V ++
Sbjct: 255 KEGHRM-----DKPS----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 302

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 84/301 (27%), Positives = 137/301 (45%), Gaps = 49/301 (16%)
Query: 527 VGRGSFGIVYK----GVIQTRTSTTAVAVKKLDRVFQDGE-REFKNEV-FVIGQTHHKNL 580
           +GRG+FG V +    G+ +T T  T VAVK L       E R   +E+  +I   HH N+
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRT-VAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 84
Query: 581 VRLLGFCDE-GQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA--------------- 624
           V LLG C + G   +++ EF   G L+++L    K N  +   +A               
Sbjct: 85  VNLLGACTKPGGPLMVITEFCKFGNLSTYL--RSKRNEFVPYKVAPEDLYKDFLTLEHLI 142
Query: 625 ---FQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKT 681
              FQ+A+G+ +L      + IH D+  +NILL +    +I DFGLA+ +  +     K 
Sbjct: 143 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 199
Query: 682 AIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAF 739
             R    ++APE   +   T + DV+SFGVLL EI S   S    +++ EE+        
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF-------- 251
Query: 740 DCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 799
            C R  +   +   D           ++    + C   +PS RPT  ++++ L  +++ +
Sbjct: 252 -CRRLKEGTRMRAPDYTT-------PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 303
Query: 800 V 800
Sbjct: 304 A 304

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 101/200 (50%), Gaps = 15/200 (7%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGER--EFKNEVFVIGQTHHKNLVR 582
           + +G GSFG VYKG          VAVK L+      ++   FKNEV V+ +T H N++ 
Sbjct: 42  QRIGSGSFGTVYKGKWHG-----DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 96
Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFL-FGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ 641
            +G+  + Q   +V ++    +L   L     K       +IA Q A+G+ YLH      
Sbjct: 97  FMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--- 152
Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR---NS 698
           IIH D+K  NI L +  T +I DFGLA + +          + G+  ++APE  R    +
Sbjct: 153 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 212
Query: 699 KITAKVDVYSFGVLLLEIIS 718
             + + DVY+FG++L E+++
Sbjct: 213 PYSFQSDVYAFGIVLYELMT 232

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/306 (24%), Positives = 132/306 (43%), Gaps = 36/306 (11%)
Query: 502 GTIETNLRCFSYKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG 561
           G +E+  R ++ ++ E         +G+G FG VY  + + + S   +A+K L +   + 
Sbjct: 1   GAMESKKRQWALEDFE-----IGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEK 53
Query: 562 ---EREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWN 618
              E + + EV +     H N++RL G+  +     L+ E+   G +   L    K +  
Sbjct: 54  AGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQ 113
Query: 619 LRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT 678
                  ++A  L Y H     ++IH DIKP+N+LL      +I+DFG     +++   +
Sbjct: 114 RTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSS 166
Query: 679 IKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDW 737
            +T + GT  Y+ PE         KVD++S GVL  E +  +  F+    +E Y  ++  
Sbjct: 167 RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 226
Query: 738 AFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 797
            F                    D    G   ++S   ++ +PS RP +++VL+       
Sbjct: 227 EF-----------------TFPDFVTEGARDLIS-RLLKHNPSQRPMLREVLEHPWITAN 268
Query: 798 VSVPPN 803
            S P N
Sbjct: 269 SSKPSN 274

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 95/197 (48%), Gaps = 17/197 (8%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLL 584
           + +G+G FG V  G    R +  AV   K D   Q     F  E  V+ Q  H NLV+LL
Sbjct: 27  QTIGKGEFGDVMLG--DYRGNKVAVKCIKNDATAQ----AFLAEASVMTQLRHSNLVQLL 80
Query: 585 GFCDEGQNRL-LVYEFLNNGTLASFLF--GNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ 641
           G   E +  L +V E++  G+L  +L   G      +     +  +   + YL  +    
Sbjct: 81  GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---N 137
Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKIT 701
            +H D+  +N+L+ +   A++SDFGL K  +  Q  T K  ++ T    APE  R  K +
Sbjct: 138 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-TGKLPVKWT----APEALREKKFS 192
Query: 702 AKVDVYSFGVLLLEIIS 718
            K DV+SFG+LL EI S
Sbjct: 193 TKSDVWSFGILLWEIYS 209

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 14/214 (6%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGF 586
           +G+G++GIVY G  +  ++   +A+K++        +    E+ +     HKN+V+ LG 
Sbjct: 16  LGKGTYGIVYAG--RDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 73
Query: 587 CDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF---QIARGLLYLHEDCRAQII 643
             E     +  E +  G+L++ L     P  +    I F   QI  GL YLH++   QI+
Sbjct: 74  FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIV 130
Query: 644 HCDIKPQNILLDDYY-TARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSK--I 700
           H DIK  N+L++ Y    +ISDFG +K L      T      GT  Y+APE         
Sbjct: 131 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCT--ETFTGTLQYMAPEIIDKGPRGY 188
Query: 701 TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL 734
               D++S G  ++E+ + +  F  E+GE  A +
Sbjct: 189 GKAADIWSLGCTIIEMATGKPPF-YELGEPQAAM 221

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 100/214 (46%), Gaps = 21/214 (9%)
Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ 574
           E++     F +E+G G FG+V  G  + +       +K+        E EF  E  V+  
Sbjct: 20  EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM----SEDEFIEEAKVMMN 75
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYL 634
             H+ LV+L G C + +   ++ E++ NG L ++L               FQ  + L   
Sbjct: 76  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL---------REMRHRFQTQQLLEMC 126
Query: 635 HEDCRA-------QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK 687
            + C A       Q +H D+  +N L++D    ++SDFGL++ + L+  +T     +   
Sbjct: 127 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV-LDDEETSSVGSKFPV 185
Query: 688 GYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRK 721
            +  PE    SK ++K D+++FGVL+ EI S  K
Sbjct: 186 RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK 219

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 122/281 (43%), Gaps = 31/281 (11%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG---EREFKNEVFVIGQTHHKNLVRL 583
           +G+G FG VY  + + + S   +A+K L +   +    E + + EV +     H N++RL
Sbjct: 17  LGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
            G+  +     L+ E+   GT+   L    K +         ++A  L Y H     ++I
Sbjct: 75  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVI 131
Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK 703
           H DIKP+N+LL      +I+DFG     + +   + +T + GT  Y+ PE         K
Sbjct: 132 HRDIKPENLLLGSAGELKIADFGW----SCHAPSSRRTTLSGTLDYLPPEMIEGRMHDEK 187
Query: 704 VDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLNVLVGEDKEAMNDIE 762
           VD++S GVL  E +  +  F+    +E Y  ++   F                    D  
Sbjct: 188 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-----------------TFPDFV 230
Query: 763 CLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVPPN 803
             G   ++S   ++ +PS RP +++VL+        S P N
Sbjct: 231 TEGARDLIS-RLLKHNPSQRPMLREVLEHPWITANSSKPSN 270

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 123/281 (43%), Gaps = 31/281 (11%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG---EREFKNEVFVIGQTHHKNLVRL 583
           +G+G FG VY  + + + S   +A+K L +   +    E + + EV +     H N++RL
Sbjct: 21  LGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
            G+  +     L+ E+   GT+   L    K +         ++A  L Y H     ++I
Sbjct: 79  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVI 135
Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK 703
           H DIKP+N+LL      +I+DFG     +++   + +T + GT  Y+ PE         K
Sbjct: 136 HRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRTTLCGTLDYLPPEXIEGRXHDEK 191
Query: 704 VDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLNVLVGEDKEAMNDIE 762
           VD++S GVL  E +  +  F+    +E Y  ++   F                    D  
Sbjct: 192 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-----------------TFPDFV 234
Query: 763 CLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVPPN 803
             G   ++S   ++ +PS RP +++VL+        S P N
Sbjct: 235 TEGARDLIS-RLLKHNPSQRPXLREVLEHPWITANSSKPSN 274

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 101/200 (50%), Gaps = 15/200 (7%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGER--EFKNEVFVIGQTHHKNLVR 582
           + +G GSFG VYKG          VAVK L+      ++   FKNEV V+ +T H N++ 
Sbjct: 16  QRIGSGSFGTVYKGKWHG-----DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 70
Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFL-FGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ 641
            +G+  + Q   +V ++    +L   L     K       +IA Q A+G+ YLH      
Sbjct: 71  FMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--- 126
Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR---NS 698
           IIH D+K  NI L +  T +I DFGLA + +          + G+  ++APE  R    +
Sbjct: 127 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 186
Query: 699 KITAKVDVYSFGVLLLEIIS 718
             + + DVY+FG++L E+++
Sbjct: 187 PYSFQSDVYAFGIVLYELMT 206

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 125/297 (42%), Gaps = 43/297 (14%)
Query: 527 VGRGSFG-IVYKGVI------QTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKN 579
           +G G+FG +V    I        R +  AV + K D   +D          +     HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 580 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN----------------I 623
           ++ LLG C +     ++ E+ + G L  +L     P      N                 
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 624 AFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAI 683
           A+Q+ARG+ YL      + IH D+  +N+L+ +    +I+DFGLA+ +         T  
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 684 RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAFDCY 742
           R    ++APE   +   T + DV+SFGVLL EI +         G  Y  +  +  F   
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG-------GSPYPGVPVEELFKLL 265
Query: 743 RNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 799
           + G        DK +     C  +L M+   C    PS RPT K++++ L+ +V ++
Sbjct: 266 KEGHRM-----DKPS----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 313

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 101/200 (50%), Gaps = 15/200 (7%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGER--EFKNEVFVIGQTHHKNLVR 582
           + +G GSFG VYKG          VAVK L+      ++   FKNEV V+ +T H N++ 
Sbjct: 14  QRIGSGSFGTVYKG-----KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 68
Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFL-FGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ 641
            +G+  + Q   +V ++    +L   L     K       +IA Q A+G+ YLH      
Sbjct: 69  FMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--- 124
Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR---NS 698
           IIH D+K  NI L +  T +I DFGLA + +          + G+  ++APE  R    +
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 699 KITAKVDVYSFGVLLLEIIS 718
             + + DVY+FG++L E+++
Sbjct: 185 PYSFQSDVYAFGIVLYELMT 204

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 112/230 (48%), Gaps = 33/230 (14%)
Query: 521 NNFK--EEVGRGSFGIVYKGVIQTRTSTTAVAVKK--LDRVFQDGEREFKNEVFVIGQTH 576
            NF+  E++G G++G+VYK   + + +   VA+KK  LD   +        E+ ++ + +
Sbjct: 3   ENFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 577 HKNLVRLLGFCDEGQNRLLVYEFLNNGTL----ASFLFGNLKPNWNLRTNIAFQIARGLL 632
           H N+V+LL          LV+EFL+        AS L G   P   L  +  FQ+ +GL 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLS 117
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 692
           + H     +++H D+KPQN+L++     +++DFGLA        +     +R     V  
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA--------RAFGVPVRTYTHEVVT 166
Query: 693 EWFRNSKI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAI 733
            W+R  +I       +  VD++S G +  E+++ R  F  D E+ + + I
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 216

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 125/297 (42%), Gaps = 43/297 (14%)
Query: 527 VGRGSFG-IVYKGVI------QTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKN 579
           +G G+FG +V    I        R +  AV + K D   +D          +     HKN
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 580 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN----------------I 623
           ++ LLG C +     ++ E+ + G L  +L     P      N                 
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 624 AFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAI 683
           A+Q+ARG+ YL      + IH D+  +N+L+ +    +I+DFGLA+ +         T  
Sbjct: 149 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 205
Query: 684 RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAFDCY 742
           R    ++APE   +   T + DV+SFGVLL EI +         G  Y  +  +  F   
Sbjct: 206 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG-------GSPYPGVPVEELFKLL 258
Query: 743 RNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 799
           + G        DK +     C  +L M+   C    PS RPT K++++ L+ +V ++
Sbjct: 259 KEGHRM-----DKPS----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 306

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 101/200 (50%), Gaps = 15/200 (7%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGER--EFKNEVFVIGQTHHKNLVR 582
           + +G GSFG VYKG          VAVK L+      ++   FKNEV V+ +T H N++ 
Sbjct: 41  QRIGSGSFGTVYKGKWHG-----DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 95
Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFL-FGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ 641
            +G+  + Q   +V ++    +L   L     K       +IA Q A+G+ YLH      
Sbjct: 96  FMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--- 151
Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR---NS 698
           IIH D+K  NI L +  T +I DFGLA + +          + G+  ++APE  R    +
Sbjct: 152 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 211
Query: 699 KITAKVDVYSFGVLLLEIIS 718
             + + DVY+FG++L E+++
Sbjct: 212 PYSFQSDVYAFGIVLYELMT 231

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 125/297 (42%), Gaps = 43/297 (14%)
Query: 527 VGRGSFG-IVYKGVI------QTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKN 579
           +G G+FG +V    I        R +  AV + K D   +D          +     HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 580 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN----------------I 623
           ++ LLG C +     ++ E+ + G L  +L     P      N                 
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 624 AFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAI 683
           A+Q+ARG+ YL      + IH D+  +N+L+ +    +I+DFGLA+ +         T  
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 684 RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAFDCY 742
           R    ++APE   +   T + DV+SFGVLL EI +         G  Y  +  +  F   
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG-------GSPYPGVPVEELFKLL 265
Query: 743 RNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 799
           + G        DK +     C  +L M+   C    PS RPT K++++ L+ +V ++
Sbjct: 266 KEGHRM-----DKPS----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 313

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 123/281 (43%), Gaps = 31/281 (11%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG---EREFKNEVFVIGQTHHKNLVRL 583
           +G+G FG VY  + + + S   +A+K L +   +    E + + EV +     H N++RL
Sbjct: 16  LGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
            G+  +     L+ E+   GT+   L    K +         ++A  L Y H     ++I
Sbjct: 74  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVI 130
Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK 703
           H DIKP+N+LL      +I+DFG     +++   + +T + GT  Y+ PE         K
Sbjct: 131 HRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEK 186
Query: 704 VDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLNVLVGEDKEAMNDIE 762
           VD++S GVL  E +  +  F+    +E Y  ++   F                    D  
Sbjct: 187 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-----------------TFPDFV 229
Query: 763 CLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVPPN 803
             G   ++S   ++ +PS RP +++VL+        S P N
Sbjct: 230 TEGARDLIS-RLLKHNPSQRPMLREVLEHPWITANSSKPSN 269

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 123/281 (43%), Gaps = 31/281 (11%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG---EREFKNEVFVIGQTHHKNLVRL 583
           +G+G FG VY  + + + S   +A+K L +   +    E + + EV +     H N++RL
Sbjct: 19  LGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
            G+  +     L+ E+   GT+   L    K +         ++A  L Y H     ++I
Sbjct: 77  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVI 133
Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK 703
           H DIKP+N+LL      +I+DFG     +++   + + A+ GT  Y+ PE         K
Sbjct: 134 HRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLPPEMIEGRMHDEK 189
Query: 704 VDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLNVLVGEDKEAMNDIE 762
           VD++S GVL  E +  +  F+    +E Y  ++   F                    D  
Sbjct: 190 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-----------------TFPDFV 232
Query: 763 CLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVPPN 803
             G   ++S   ++ +PS RP +++VL+        S P N
Sbjct: 233 TEGARDLIS-RLLKHNPSQRPMLREVLEHPWITANSSKPSN 272

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 95/197 (48%), Gaps = 17/197 (8%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLL 584
           + +G+G FG V  G    R +  AV   K D   Q     F  E  V+ Q  H NLV+LL
Sbjct: 199 QTIGKGEFGDVMLG--DYRGNKVAVKCIKNDATAQ----AFLAEASVMTQLRHSNLVQLL 252
Query: 585 GFCDEGQNRL-LVYEFLNNGTLASFLF--GNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ 641
           G   E +  L +V E++  G+L  +L   G      +     +  +   + YL  +    
Sbjct: 253 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---N 309
Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKIT 701
            +H D+  +N+L+ +   A++SDFGL K  +  Q  T K  ++ T    APE  R  K +
Sbjct: 310 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-TGKLPVKWT----APEALREKKFS 364
Query: 702 AKVDVYSFGVLLLEIIS 718
            K DV+SFG+LL EI S
Sbjct: 365 TKSDVWSFGILLWEIYS 381

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 120/268 (44%), Gaps = 31/268 (11%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG---EREFKNEVFVIGQTHHKNLVRL 583
           +G+G FG VY  + + + S   +A+K L +   +    E + + EV +     H N++RL
Sbjct: 16  LGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
            G+  +     L+ E+   GT+   L    K +         ++A  L Y H     ++I
Sbjct: 74  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVI 130
Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK 703
           H DIKP+N+LL      +I+DFG     +++   + +T + GT  Y+ PE         K
Sbjct: 131 HRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTELCGTLDYLPPEMIEGRMHDEK 186
Query: 704 VDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLNVLVGEDKEAMNDIE 762
           VD++S GVL  E +  +  F+    +E Y  ++   F                    D  
Sbjct: 187 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-----------------TFPDFV 229
Query: 763 CLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
             G   ++S   ++ +PS RP +++VL+
Sbjct: 230 TEGARDLIS-RLLKHNPSQRPMLREVLE 256

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 120/268 (44%), Gaps = 31/268 (11%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG---EREFKNEVFVIGQTHHKNLVRL 583
           +G+G FG VY  + + + S   +A+K L +   +    E + + EV +     H N++RL
Sbjct: 33  LGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 90
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
            G+  +     L+ E+   GT+   L    K +         ++A  L Y H     ++I
Sbjct: 91  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVI 147
Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK 703
           H DIKP+N+LL      +I+DFG     +++   + +T + GT  Y+ PE         K
Sbjct: 148 HRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEK 203
Query: 704 VDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLNVLVGEDKEAMNDIE 762
           VD++S GVL  E +  +  F+    +E Y  ++   F                    D  
Sbjct: 204 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-----------------TFPDFV 246
Query: 763 CLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
             G   ++S   ++ +PS RP +++VL+
Sbjct: 247 TEGARDLIS-RLLKHNPSQRPMLREVLE 273

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 101/209 (48%), Gaps = 17/209 (8%)
Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ 574
           E+   +   ++++G G FG V+   + T    T VAVK +       E  F  E  V+  
Sbjct: 184 EIPRESLKLEKKLGAGQFGEVW---MATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKT 239
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF--QIARGLL 632
             H  LV+L     + +   ++ EF+  G+L  FL  +      L   I F  QIA G+ 
Sbjct: 240 LQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMA 298
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK---GY 689
           ++ +      IH D++  NIL+      +I+DFGLA+++  N+     TA  G K    +
Sbjct: 299 FIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY----TAREGAKFPIKW 351
Query: 690 VAPEWFRNSKITAKVDVYSFGVLLLEIIS 718
            APE       T K DV+SFG+LL+EI++
Sbjct: 352 TAPEAINFGSFTIKSDVWSFGILLMEIVT 380

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 123/281 (43%), Gaps = 31/281 (11%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG---EREFKNEVFVIGQTHHKNLVRL 583
           +G+G FG VY  + + + S   +A+K L +   +    E + + EV +     H N++RL
Sbjct: 19  LGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
            G+  +     L+ E+   GT+   L    K +         ++A  L Y H     ++I
Sbjct: 77  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVI 133
Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK 703
           H DIKP+N+LL      +I+DFG     +++   + +T + GT  Y+ PE         K
Sbjct: 134 HRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEK 189
Query: 704 VDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLNVLVGEDKEAMNDIE 762
           VD++S GVL  E +  +  F+    +E Y  ++   F                    D  
Sbjct: 190 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-----------------TFPDFV 232
Query: 763 CLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVPPN 803
             G   ++S   ++ +PS RP +++VL+        S P N
Sbjct: 233 TEGARDLIS-RLLKHNPSQRPMLREVLEHPWITANSSKPSN 272

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 96/202 (47%), Gaps = 10/202 (4%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD-GEREFKNEVFVIGQTHHKNLVRLLG 585
           +GRG FG V+   ++      A       R+ +  G +    E  ++ + H + +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 586 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF----QIARGLLYLHEDCRAQ 641
             +   +  LV   +N G +   ++   + N   +   A     QI  GL +LH+     
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RN 309
Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKIT 701
           II+ D+KP+N+LLDD    RISD GLA  L   Q+KT   A  GT G++APE     +  
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA--GTPGFMAPELLLGEEYD 367
Query: 702 AKVDVYSFGVLLLEIISCRKSF 723
             VD ++ GV L E+I+ R  F
Sbjct: 368 FSVDYFALGVTLYEMIAARGPF 389

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 120/268 (44%), Gaps = 31/268 (11%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG---EREFKNEVFVIGQTHHKNLVRL 583
           +G+G FG VY  + + + S   +A+K L +   +    E + + EV +     H N++RL
Sbjct: 20  LGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 77
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
            G+  +     L+ E+   GT+   L    K +         ++A  L Y H     ++I
Sbjct: 78  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVI 134
Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK 703
           H DIKP+N+LL      +I+DFG     +++   + +T + GT  Y+ PE         K
Sbjct: 135 HRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEK 190
Query: 704 VDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLNVLVGEDKEAMNDIE 762
           VD++S GVL  E +  +  F+    +E Y  ++   F                    D  
Sbjct: 191 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-----------------TFPDFV 233
Query: 763 CLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
             G   ++S   ++ +PS RP +++VL+
Sbjct: 234 TEGARDLIS-RLLKHNPSQRPMLREVLE 260

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 100/200 (50%), Gaps = 15/200 (7%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGER--EFKNEVFVIGQTHHKNLVR 582
           + +G GSFG VYKG          VAVK L+      ++   FKNEV V+ +T H N++ 
Sbjct: 14  QRIGSGSFGTVYKG-----KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 68
Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFL-FGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ 641
            +G+    Q   +V ++    +L   L     K       +IA Q A+G+ YLH      
Sbjct: 69  FMGYSTAPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--- 124
Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR---NS 698
           IIH D+K  NI L +  T +I DFGLA + +          + G+  ++APE  R    +
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 699 KITAKVDVYSFGVLLLEIIS 718
             + + DVY+FG++L E+++
Sbjct: 185 PYSFQSDVYAFGIVLYELMT 204

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 78/297 (26%), Positives = 130/297 (43%), Gaps = 43/297 (14%)
Query: 527 VGRGSFGIVYK----GVIQTR-TSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQT-HHKN 579
           +G G+FG V      G+ + +      VAVK L D   +    +  +E+ ++     HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 580 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNI---------------- 623
           ++ LLG C +     ++ E+ + G L  +L     P      +I                
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 624 AFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAI 683
            +Q+ARG+ YL      + IH D+  +N+L+ +    RI+DFGLA+ +         T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNG 219
Query: 684 RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAFDCY 742
           R    ++APE   +   T + DV+SFGVL+ EI +         G  Y  I  +  F   
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG-------GSPYPGIPVEELFKLL 272
Query: 743 RNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 799
           + G        DK A     C  +L M+   C    PS RPT K++++ L+ ++ ++
Sbjct: 273 KEGHRM-----DKPA----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 320

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 113/233 (48%), Gaps = 33/233 (14%)
Query: 518 GATNNFK--EEVGRGSFGIVYKGVIQTRTSTTAVAVKK--LDRVFQDGEREFKNEVFVIG 573
           G+  NF+  E++G G++G+VYK   + + +   VA+KK  LD   +        E+ ++ 
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 60
Query: 574 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTL----ASFLFGNLKPNWNLRTNIAFQIAR 629
           + +H N+V+LL          LV+E ++        AS L G   P   L  +  FQ+ +
Sbjct: 61  ELNHPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLP---LIKSYLFQLLQ 117
Query: 630 GLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGY 689
           GL + H     +++H D+KPQN+L++     +++DFGLA        +     +R     
Sbjct: 118 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA--------RAFGVPVRTYXHE 166
Query: 690 VAPEWFRNSKI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAI 733
           V   W+R  +I       +  VD++S G +  E+++ R  F  D E+ + + I
Sbjct: 167 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 219

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 96/202 (47%), Gaps = 10/202 (4%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTA-VAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLG 585
           +GRG FG V+   ++      A   + K     + G +    E  ++ + H + +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 586 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF----QIARGLLYLHEDCRAQ 641
             +   +  LV   +N G +   ++   + N   +   A     QI  GL +LH+     
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RN 309
Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKIT 701
           II+ D+KP+N+LLDD    RISD GLA  L   Q+KT   A  GT G++APE     +  
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA--GTPGFMAPELLLGEEYD 367
Query: 702 AKVDVYSFGVLLLEIISCRKSF 723
             VD ++ GV L E+I+ R  F
Sbjct: 368 FSVDYFALGVTLYEMIAARGPF 389

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 130/297 (43%), Gaps = 43/297 (14%)
Query: 527 VGRGSFGIVYK----GVIQTR-TSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQT-HHKN 579
           +G G+FG V      G+ + +      VAVK L D   +    +  +E+ ++     HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 580 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNI---------------- 623
           ++ LLG C +     ++ E+ + G L  +L     P      +I                
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 624 AFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAI 683
            +Q+ARG+ YL      + IH D+  +N+L+ +    +I+DFGLA+ +         T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 684 RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAFDCY 742
           R    ++APE   +   T + DV+SFGVL+ EI +         G  Y  I  +  F   
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG-------GSPYPGIPVEELFKLL 272
Query: 743 RNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 799
           + G        DK A     C  +L M+   C    PS RPT K++++ L+ ++ ++
Sbjct: 273 KEGHRM-----DKPA----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 320

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 27/217 (12%)
Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ 574
           E++     F +E+G G FG+V  G  + +       +K+        E EF  E  V+  
Sbjct: 5   EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM----SEDEFIEEAKVMMN 60
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYL 634
             H+ LV+L G C + +   ++ E++ NG L ++L               FQ  + L   
Sbjct: 61  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL---------REMRHRFQTQQLLEMC 111
Query: 635 HEDCRA-------QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK 687
            + C A       Q +H D+  +N L++D    ++SDFGL++ +  ++     T+ RG+K
Sbjct: 112 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY----TSSRGSK 167
Query: 688 ---GYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRK 721
               +  PE    SK ++K D+++FGVL+ EI S  K
Sbjct: 168 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK 204

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 98/196 (50%), Gaps = 15/196 (7%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLD-RVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           + +G+GSFG VYKG+     +   VA+K +D    +D   + + E+ V+ Q     + R 
Sbjct: 25  DRIGKGSFGEVYKGI--DNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRY 82
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF---QIARGLLYLHEDCRA 640
            G   +     ++ E+L  G+    L    KP     T IA    +I +GL YLH + + 
Sbjct: 83  FGSYLKSTKLWIIMEYLGGGSALDLL----KPGPLEETYIATILREILKGLDYLHSERK- 137
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
             IH DIK  N+LL +    +++DFG+A  LT  Q K  +    GT  ++APE  + S  
Sbjct: 138 --IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK--RNXFVGTPFWMAPEVIKQSAY 193
Query: 701 TAKVDVYSFGVLLLEI 716
             K D++S G+  +E+
Sbjct: 194 DFKADIWSLGITAIEL 209

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 96/202 (47%), Gaps = 10/202 (4%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD-GEREFKNEVFVIGQTHHKNLVRLLG 585
           +GRG FG V+   ++      A       R+ +  G +    E  ++ + H + +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 586 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF----QIARGLLYLHEDCRAQ 641
             +   +  LV   +N G +   ++   + N   +   A     QI  GL +LH+     
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RN 309
Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKIT 701
           II+ D+KP+N+LLDD    RISD GLA  L   Q+KT   A  GT G++APE     +  
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA--GTPGFMAPELLLGEEYD 367
Query: 702 AKVDVYSFGVLLLEIISCRKSF 723
             VD ++ GV L E+I+ R  F
Sbjct: 368 FSVDYFALGVTLYEMIAARGPF 389

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 96/202 (47%), Gaps = 10/202 (4%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTA-VAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLG 585
           +GRG FG V+   ++      A   + K     + G +    E  ++ + H + +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 586 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF----QIARGLLYLHEDCRAQ 641
             +   +  LV   +N G +   ++   + N   +   A     QI  GL +LH+     
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RN 309
Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKIT 701
           II+ D+KP+N+LLDD    RISD GLA  L   Q+KT   A  GT G++APE     +  
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA--GTPGFMAPELLLGEEYD 367
Query: 702 AKVDVYSFGVLLLEIISCRKSF 723
             VD ++ GV L E+I+ R  F
Sbjct: 368 FSVDYFALGVTLYEMIAARGPF 389

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 101/209 (48%), Gaps = 17/209 (8%)
Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ 574
           E+   +   ++++G G FG V+   + T    T VAVK +       E  F  E  V+  
Sbjct: 11  EIPRESLKLEKKLGAGQFGEVW---MATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKT 66
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF--QIARGLL 632
             H  LV+L     + +   ++ EF+  G+L  FL  +      L   I F  QIA G+ 
Sbjct: 67  LQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMA 125
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK---GY 689
           ++ +      IH D++  NIL+      +I+DFGLA+++  N+     TA  G K    +
Sbjct: 126 FIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY----TAREGAKFPIKW 178
Query: 690 VAPEWFRNSKITAKVDVYSFGVLLLEIIS 718
            APE       T K DV+SFG+LL+EI++
Sbjct: 179 TAPEAINFGSFTIKSDVWSFGILLMEIVT 207

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 130/297 (43%), Gaps = 43/297 (14%)
Query: 527 VGRGSFGIVYK----GVIQTR-TSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQT-HHKN 579
           +G G+FG V      G+ + +      VAVK L D   +    +  +E+ ++     HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 580 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNI---------------- 623
           ++ LLG C +     ++ E+ + G L  +L     P      +I                
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 624 AFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAI 683
            +Q+ARG+ YL      + IH D+  +N+L+ +    +I+DFGLA+ +         T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 684 RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAFDCY 742
           R    ++APE   +   T + DV+SFGVL+ EI +         G  Y  I  +  F   
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG-------GSPYPGIPVEELFKLL 272
Query: 743 RNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 799
           + G        DK A     C  +L M+   C    PS RPT K++++ L+ ++ ++
Sbjct: 273 KEGHRM-----DKPA----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 320

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 78/297 (26%), Positives = 127/297 (42%), Gaps = 43/297 (14%)
Query: 527 VGRGSFG-IVYKGVI------QTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKN 579
           +G G+FG +V    I        R +  AV + K D   +D          +     HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 580 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPN----WNLRTN------------I 623
           ++ LLG C +     ++ E+ + G L  +L     P     +N   N             
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 624 AFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAI 683
           A+Q+ARG+ YL      + IH D+  +N+L+ +    +I+DFGLA+ +         T  
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 684 RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAFDCY 742
           R    ++APE   +   T + DV+SFGVLL EI +         G  Y  +  +  F   
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG-------GSPYPGVPVEELFKLL 265
Query: 743 RNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 799
           + G        DK +     C  +L M+   C    PS RPT K++++ L+ +V ++
Sbjct: 266 KEGHRM-----DKPS----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 313

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 113/232 (48%), Gaps = 33/232 (14%)
Query: 519 ATNNFK--EEVGRGSFGIVYKGVIQTRTSTTAVAVKK--LDRVFQDGEREFKNEVFVIGQ 574
           +  NF+  E++G G++G+VYK   + + +   VA+KK  LD   +        E+ ++ +
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 58
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTL----ASFLFGNLKPNWNLRTNIAFQIARG 630
            +H N+V+LL          LV+EFL+        AS L G   P   L  +  FQ+ +G
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLP---LIKSYLFQLLQG 115
Query: 631 LLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYV 690
           L + H     +++H D+KP+N+L++     +++DFGLA        +     +R     V
Sbjct: 116 LAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLA--------RAFGVPVRTYXHEV 164
Query: 691 APEWFRNSKI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAI 733
              W+R  +I       +  VD++S G +  E+++ R  F  D E+ + + I
Sbjct: 165 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 216

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/267 (25%), Positives = 120/267 (44%), Gaps = 29/267 (10%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG---EREFKNEVFVIGQTHHKNLVRL 583
           +G+G FG VY  + + + S   +A+K L +   +    E + + EV +     H N++RL
Sbjct: 16  LGKGKFGNVY--LAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
            G+  +     L+ E+   GT+   L    K +         ++A  L Y H     ++I
Sbjct: 74  YGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---KVI 130
Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK 703
           H DIKP+N+LL      +I+DFG     +++   + + A+ GT  Y+ PE         K
Sbjct: 131 HRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLPPEMIEGRMHDEK 186
Query: 704 VDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIEC 763
           VD++S GVL  E +  +  F+    +          D Y+       +   +    D   
Sbjct: 187 VDLWSLGVLCYEFLVGKPPFEANTYQ----------DTYKR------ISRVEFTFPDFVT 230
Query: 764 LGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
            G   ++S   ++ +PS RP +++VL+
Sbjct: 231 EGARDLIS-RLLKHNPSQRPMLREVLE 256

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 123/281 (43%), Gaps = 31/281 (11%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG---EREFKNEVFVIGQTHHKNLVRL 583
           +G+G FG VY  + + + S   +A+K L +   +    E + + EV +     H N++RL
Sbjct: 21  LGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
            G+  +     L+ E+   GT+   L    K +         ++A  L Y H     ++I
Sbjct: 79  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVI 135
Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK 703
           H DIKP+N+LL      +I+DFG     +++   + +T + GT  Y+ PE         K
Sbjct: 136 HRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEK 191
Query: 704 VDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLNVLVGEDKEAMNDIE 762
           VD++S GVL  E +  +  F+    +E Y  ++   F                    D  
Sbjct: 192 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-----------------TFPDFV 234
Query: 763 CLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVPPN 803
             G   ++S   ++ +PS RP +++VL+        S P N
Sbjct: 235 TEGARDLIS-RLLKHNPSQRPMLREVLEHPWITANSSKPSN 274

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 120/268 (44%), Gaps = 31/268 (11%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG---EREFKNEVFVIGQTHHKNLVRL 583
           +G+G FG VY  + + + S   +A+K L +   +    E + + EV +     H N++RL
Sbjct: 16  LGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
            G+  +     L+ E+   GT+   L    K +         ++A  L Y H     ++I
Sbjct: 74  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVI 130
Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK 703
           H DIKP+N+LL      +I+DFG     +++   + +T + GT  Y+ PE         K
Sbjct: 131 HRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTXLCGTLDYLPPEMIEGRMHDEK 186
Query: 704 VDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLNVLVGEDKEAMNDIE 762
           VD++S GVL  E +  +  F+    +E Y  ++   F                    D  
Sbjct: 187 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-----------------TFPDFV 229
Query: 763 CLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
             G   ++S   ++ +PS RP +++VL+
Sbjct: 230 TEGARDLIS-RLLKHNPSQRPMLREVLE 256

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 95/197 (48%), Gaps = 17/197 (8%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLL 584
           + +G+G FG V  G    R +  AV   K D   Q     F  E  V+ Q  H NLV+LL
Sbjct: 12  QTIGKGEFGDVMLG--DYRGNKVAVKCIKNDATAQ----AFLAEASVMTQLRHSNLVQLL 65
Query: 585 GFCDEGQNRL-LVYEFLNNGTLASFLF--GNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ 641
           G   E +  L +V E++  G+L  +L   G      +     +  +   + YL  +    
Sbjct: 66  GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---N 122
Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKIT 701
            +H D+  +N+L+ +   A++SDFGL K  +  Q  T K  ++ T    APE  R  K +
Sbjct: 123 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-TGKLPVKWT----APEALREKKFS 177
Query: 702 AKVDVYSFGVLLLEIIS 718
            K DV+SFG+LL EI S
Sbjct: 178 TKSDVWSFGILLWEIYS 194

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/293 (23%), Positives = 128/293 (43%), Gaps = 36/293 (12%)
Query: 502 GTIETNLRCFSYKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG 561
           G +E+  R ++ ++ E         +G+G FG VY  + + + S   +A+K L +   + 
Sbjct: 1   GAMESKKRQWALEDFE-----IGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEK 53
Query: 562 ---EREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWN 618
              E + + EV +     H N++RL G+  +     L+ E+   G +   L    K +  
Sbjct: 54  AGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQ 113
Query: 619 LRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT 678
                  ++A  L Y H     ++IH DIKP+N+LL      +I+DFG     +++   +
Sbjct: 114 RTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSS 166
Query: 679 IKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDW 737
            +  + GT  Y+ PE         KVD++S GVL  E +  +  F+    +E Y  ++  
Sbjct: 167 RRXXLXGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 226
Query: 738 AFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
            F                    D    G   ++S   ++ +PS RP +++VL+
Sbjct: 227 EF-----------------TFPDFVTEGARDLIS-RLLKHNPSQRPMLREVLE 261

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 120/268 (44%), Gaps = 31/268 (11%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG---EREFKNEVFVIGQTHHKNLVRL 583
           +G+G FG VY  + + + S   +A+K L +   +    E + + EV +     H N++RL
Sbjct: 16  LGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
            G+  +     L+ E+   GT+   L    K +         ++A  L Y H     ++I
Sbjct: 74  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVI 130
Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK 703
           H DIKP+N+LL      +I+DFG     +++   + + A+ GT  Y+ PE         K
Sbjct: 131 HRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLPPEMIEGRMHDEK 186
Query: 704 VDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLNVLVGEDKEAMNDIE 762
           VD++S GVL  E +  +  F+    +E Y  ++   F                    D  
Sbjct: 187 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-----------------TFPDFV 229
Query: 763 CLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
             G   ++S   ++ +PS RP +++VL+
Sbjct: 230 TEGARDLIS-RLLKHNPSQRPMLREVLE 256

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 120/268 (44%), Gaps = 31/268 (11%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG---EREFKNEVFVIGQTHHKNLVRL 583
           +G+G FG VY  + + + S   +A+K L +   +    E + + EV +     H N++RL
Sbjct: 15  LGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 72
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
            G+  +     L+ E+   GT+   L    K +         ++A  L Y H     ++I
Sbjct: 73  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVI 129
Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK 703
           H DIKP+N+LL      +I+DFG     +++   + +T + GT  Y+ PE         K
Sbjct: 130 HRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEK 185
Query: 704 VDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLNVLVGEDKEAMNDIE 762
           VD++S GVL  E +  +  F+    +E Y  ++   F                    D  
Sbjct: 186 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-----------------TFPDFV 228
Query: 763 CLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
             G   ++S   ++ +PS RP +++VL+
Sbjct: 229 TEGARDLIS-RLLKHNPSQRPMLREVLE 255

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 98/195 (50%), Gaps = 12/195 (6%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG-EREFKNEVFVIGQTHHKNL 580
           +F++ +G G+F  V   + + + +   VA+K + +   +G E   +NE+ V+ +  H N+
Sbjct: 21  DFRDVLGTGAFSEVI--LAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNI 78
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           V L    + G +  L+ + ++ G L   +           + + FQ+   + YLH+    
Sbjct: 79  VALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHD---L 135
Query: 641 QIIHCDIKPQNIL---LDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRN 697
            I+H D+KP+N+L   LD+     ISDFGL+K+       ++ +   GT GYVAPE    
Sbjct: 136 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLAQ 192
Query: 698 SKITAKVDVYSFGVL 712
              +  VD +S GV+
Sbjct: 193 KPYSKAVDCWSIGVI 207

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 123/281 (43%), Gaps = 31/281 (11%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG---EREFKNEVFVIGQTHHKNLVRL 583
           +G+G FG VY  + + + S   +A+K L +   +    E + + EV +     H N++RL
Sbjct: 17  LGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
            G+  +     L+ E+   GT+   L    K +         ++A  L Y H     ++I
Sbjct: 75  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVI 131
Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK 703
           H DIKP+N+LL      +I+DFG     +++   + +T + GT  Y+ PE         K
Sbjct: 132 HRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEK 187
Query: 704 VDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLNVLVGEDKEAMNDIE 762
           VD++S GVL  E +  +  F+    +E Y  ++   F                    D  
Sbjct: 188 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-----------------TFPDFV 230
Query: 763 CLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVPPN 803
             G   ++S   ++ +PS RP +++VL+        S P N
Sbjct: 231 TEGARDLIS-RLLKHNPSQRPMLREVLEHPWITANSSKPSN 270

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 99/214 (46%), Gaps = 21/214 (9%)
Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ 574
           E++     F +E+G G FG+V  G  + +       +K+        E EF  E  V+  
Sbjct: 20  EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM----SEDEFIEEAKVMMN 75
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYL 634
             H+ LV+L G C + +   ++ E++ NG L ++L               FQ  + L   
Sbjct: 76  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL---------REMRHRFQTQQLLEMC 126
Query: 635 HEDCRA-------QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK 687
            + C A       Q +H D+  +N L++D    ++SDFGL++ + L+   T     +   
Sbjct: 127 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSVGSKFPV 185
Query: 688 GYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRK 721
            +  PE    SK ++K D+++FGVL+ EI S  K
Sbjct: 186 RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK 219

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 99/218 (45%), Gaps = 11/218 (5%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE---FKNEVFVIGQTHHKNLVRL 583
           +G+GSFG V+    +      A+   K D V  D + E    +  V  +    H  L  +
Sbjct: 26  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-WEHPFLTHM 84
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
                  +N   V E+LN G L   +    K + +  T  A +I  GL +LH      I+
Sbjct: 85  FCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS---KGIV 141
Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK 703
           + D+K  NILLD     +I+DFG+ K   L  +KT      GT  Y+APE     K    
Sbjct: 142 YRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NEFCGTPDYIAPEILLGQKYNHS 199
Query: 704 VDVYSFGVLLLEIISCRKSFDIEMGEE--YAILTDWAF 739
           VD +SFGVLL E++  +  F  +  EE  ++I  D  F
Sbjct: 200 VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPF 237

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 78/297 (26%), Positives = 127/297 (42%), Gaps = 43/297 (14%)
Query: 527 VGRGSFG-IVYKGVI------QTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKN 579
           +G G+FG +V    I        R +  AV + K D   +D          +     HKN
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 580 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPN----WNLRTN------------I 623
           ++ LLG C +     ++ E+ + G L  +L     P     +N   N             
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 624 AFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAI 683
           A+Q+ARG+ YL      + IH D+  +N+L+ +    +I+DFGLA+ +         T  
Sbjct: 141 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 684 RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAFDCY 742
           R    ++APE   +   T + DV+SFGVLL EI +         G  Y  +  +  F   
Sbjct: 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG-------GSPYPGVPVEELFKLL 250
Query: 743 RNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 799
           + G        DK +     C  +L M+   C    PS RPT K++++ L+ +V ++
Sbjct: 251 KEGHRM-----DKPS----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 298

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 131/297 (44%), Gaps = 43/297 (14%)
Query: 527 VGRGSFGIVYK----GVIQTR-TSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQT-HHKN 579
           +G G+FG V      G+ + +      VAVK L D   ++   +  +E+ ++     HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 580 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNI---------------- 623
           ++ LLG C +     ++ E+ + G L  +L     P      +I                
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 624 AFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAI 683
            +Q+ARG+ YL      + IH D+  +N+L+ +    +I+DFGLA+ +         T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 684 RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAFDCY 742
           R    ++APE   +   T + DV+SFGVL+ EI +         G  Y  I  +  F   
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG-------GSPYPGIPVEELFKLL 272
Query: 743 RNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 799
           + G        DK A     C  +L M+   C    PS RPT K++++ L+ ++ ++
Sbjct: 273 KEGHRM-----DKPA----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 320

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 99/218 (45%), Gaps = 11/218 (5%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE---FKNEVFVIGQTHHKNLVRL 583
           +G+GSFG V+    +      A+   K D V  D + E    +  V  +   H   L  +
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH-PFLTHM 83
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
                  +N   V E+LN G L   +    K + +  T  A +I  GL +LH      I+
Sbjct: 84  FCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS---KGIV 140
Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK 703
           + D+K  NILLD     +I+DFG+ K   L  +KT      GT  Y+APE     K    
Sbjct: 141 YRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NXFCGTPDYIAPEILLGQKYNHS 198
Query: 704 VDVYSFGVLLLEIISCRKSFDIEMGEE--YAILTDWAF 739
           VD +SFGVLL E++  +  F  +  EE  ++I  D  F
Sbjct: 199 VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPF 236

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 72/237 (30%), Positives = 107/237 (45%), Gaps = 37/237 (15%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE-FKNE--VFVIGQTHHKNLV 581
           E +GRG +G VYKG +  R     VAVK    VF    R+ F NE  ++ +    H N+ 
Sbjct: 19  ELIGRGRYGAVYKGSLDER----PVAVK----VFSFANRQNFINEKNIYRVPLMEHDNIA 70
Query: 582 RLLG-----FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHE 636
           R +        D     LLV E+  NG+L  +L  +   +W     +A  + RGL YLH 
Sbjct: 71  RFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS-DWVSSCRLAHSVTRGLAYLHT 129
Query: 637 DC------RAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN------QSKTIKTAIR 684
           +       +  I H D+  +N+L+ +  T  ISDFGL+  LT N      +      +  
Sbjct: 130 ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEV 189
Query: 685 GTKGYVAPEWFRNS-------KITAKVDVYSFGVLLLEI-ISCRKSFDIEMGEEYAI 733
           GT  Y+APE    +           +VD+Y+ G++  EI + C   F  E   EY +
Sbjct: 190 GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQM 246

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 120/268 (44%), Gaps = 31/268 (11%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG---EREFKNEVFVIGQTHHKNLVRL 583
           +G+G FG VY  + + + S   +A+K L +   +    E + + EV +     H N++RL
Sbjct: 19  LGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
            G+  +     L+ E+   GT+   L    K +         ++A  L Y H     ++I
Sbjct: 77  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVI 133
Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK 703
           H DIKP+N+LL      +I+DFG     +++   + +T + GT  Y+ PE         K
Sbjct: 134 HRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEK 189
Query: 704 VDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLNVLVGEDKEAMNDIE 762
           VD++S GVL  E +  +  F+    +E Y  ++   F                    D  
Sbjct: 190 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-----------------TFPDFV 232
Query: 763 CLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
             G   ++S   ++ +PS RP +++VL+
Sbjct: 233 TEGARDLIS-RLLKHNPSQRPMLREVLE 259

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 123/281 (43%), Gaps = 31/281 (11%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG---EREFKNEVFVIGQTHHKNLVRL 583
           +G+G FG VY  + + + S   +A+K L +   +    E + + EV +     H N++RL
Sbjct: 16  LGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
            G+  +     L+ E+   GT+   L    K +         ++A  L Y H     ++I
Sbjct: 74  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVI 130
Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK 703
           H DIKP+N+LL      +I+DFG     +++   + +T + GT  Y+ PE         K
Sbjct: 131 HRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEK 186
Query: 704 VDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLNVLVGEDKEAMNDIE 762
           VD++S GVL  E +  +  F+    +E Y  ++   F                    D  
Sbjct: 187 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-----------------TFPDFV 229
Query: 763 CLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVPPN 803
             G   ++S   ++ +PS RP +++VL+        S P N
Sbjct: 230 TEGARDLIS-RLLKHNPSQRPMLREVLEHPWITANSSKPSN 269

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 120/268 (44%), Gaps = 31/268 (11%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG---EREFKNEVFVIGQTHHKNLVRL 583
           +G+G FG VY  + + + S   +A+K L +   +    E + + EV +     H N++RL
Sbjct: 16  LGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
            G+  +     L+ E+   GT+   L    K +         ++A  L Y H     ++I
Sbjct: 74  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVI 130
Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK 703
           H DIKP+N+LL      +I+DFG     +++   + +T + GT  Y+ PE         K
Sbjct: 131 HRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEK 186
Query: 704 VDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLNVLVGEDKEAMNDIE 762
           VD++S GVL  E +  +  F+    +E Y  ++   F                    D  
Sbjct: 187 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-----------------TFPDFV 229
Query: 763 CLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
             G   ++S   ++ +PS RP +++VL+
Sbjct: 230 TEGARDLIS-RLLKHNPSQRPMLREVLE 256

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 98/195 (50%), Gaps = 12/195 (6%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG-EREFKNEVFVIGQTHHKNL 580
           +F++ +G G+F  V   + + + +   VA+K + +   +G E   +NE+ V+ +  H N+
Sbjct: 21  DFRDVLGTGAFSEVI--LAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNI 78
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           V L    + G +  L+ + ++ G L   +           + + FQ+   + YLH+    
Sbjct: 79  VALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHD---L 135
Query: 641 QIIHCDIKPQNIL---LDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRN 697
            I+H D+KP+N+L   LD+     ISDFGL+K+       ++ +   GT GYVAPE    
Sbjct: 136 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLAQ 192
Query: 698 SKITAKVDVYSFGVL 712
              +  VD +S GV+
Sbjct: 193 KPYSKAVDCWSIGVI 207

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 97/194 (50%), Gaps = 8/194 (4%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLL 584
           E++G+G+ G VY  +     +   VA+++++   Q  +    NE+ V+ +  + N+V  L
Sbjct: 26  EKIGQGASGTVYTAM--DVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYL 83
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIH 644
                G    +V E+L  G+L   +         +   +  +  + L +LH +   Q+IH
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALEFLHSN---QVIH 139
Query: 645 CDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKV 704
            DIK  NILL    + +++DFG    +T  QSK  ++ + GT  ++APE         KV
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKV 197
Query: 705 DVYSFGVLLLEIIS 718
           D++S G++ +E+I 
Sbjct: 198 DIWSLGIMAIEMIE 211

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 100/200 (50%), Gaps = 15/200 (7%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGER--EFKNEVFVIGQTHHKNLVR 582
           + +G GSFG VYKG          VAVK L+      ++   FKNEV V+ +T H N++ 
Sbjct: 14  QRIGSGSFGTVYKGKWHG-----DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 68
Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFL-FGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ 641
            +G+  + Q   +V ++    +L   L     K       +IA Q A+G+ YLH      
Sbjct: 69  FMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--- 124
Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR---NS 698
           IIH D+K  NI L +  T +I DFGLA   +          + G+  ++APE  R    +
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 699 KITAKVDVYSFGVLLLEIIS 718
             + + DVY+FG++L E+++
Sbjct: 185 PYSFQSDVYAFGIVLYELMT 204

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 95/197 (48%), Gaps = 17/197 (8%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLL 584
           + +G+G FG V  G    R +  AV   K D   Q     F  E  V+ Q  H NLV+LL
Sbjct: 18  QTIGKGEFGDVMLG--DYRGNKVAVKCIKNDATAQ----AFLAEASVMTQLRHSNLVQLL 71
Query: 585 GFCDEGQNRL-LVYEFLNNGTLASFLF--GNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ 641
           G   E +  L +V E++  G+L  +L   G      +     +  +   + YL  +    
Sbjct: 72  GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---N 128
Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKIT 701
            +H D+  +N+L+ +   A++SDFGL K  +  Q  T K  ++    + APE  R +  +
Sbjct: 129 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-TGKLPVK----WTAPEALREAAFS 183
Query: 702 AKVDVYSFGVLLLEIIS 718
            K DV+SFG+LL EI S
Sbjct: 184 TKSDVWSFGILLWEIYS 200

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 100/200 (50%), Gaps = 15/200 (7%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGER--EFKNEVFVIGQTHHKNLVR 582
           + +G GSFG VYKG          VAVK L+      ++   FKNEV V+ +T H N++ 
Sbjct: 42  QRIGSGSFGTVYKGKWHG-----DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 96
Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFL-FGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ 641
            +G+  + Q   +V ++    +L   L     K       +IA Q A+G+ YLH      
Sbjct: 97  FMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--- 152
Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR---NS 698
           IIH D+K  NI L +  T +I DFGLA   +          + G+  ++APE  R    +
Sbjct: 153 IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 212
Query: 699 KITAKVDVYSFGVLLLEIIS 718
             + + DVY+FG++L E+++
Sbjct: 213 PYSFQSDVYAFGIVLYELMT 232

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 101/214 (47%), Gaps = 21/214 (9%)
Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ 574
           E++     F +E+G G FG+V  G  + +       +K+        E EF  E  V+  
Sbjct: 11  EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM----SEDEFIEEAKVMMN 66
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYL 634
             H+ LV+L G C + +   ++ E++ NG L ++L         +R    FQ  + L   
Sbjct: 67  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR-------EMRHR--FQTQQLLEMC 117
Query: 635 HEDCRA-------QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK 687
            + C A       Q +H D+  +N L++D    ++SDFGL++ + L+   T     +   
Sbjct: 118 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSVGSKFPV 176
Query: 688 GYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRK 721
            +  PE    SK ++K D+++FGVL+ EI S  K
Sbjct: 177 RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK 210

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 97/194 (50%), Gaps = 8/194 (4%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLL 584
           E++G+G+ G VY  +     +   VA+++++   Q  +    NE+ V+ +  + N+V  L
Sbjct: 26  EKIGQGASGTVYTAM--DVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYL 83
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIH 644
                G    +V E+L  G+L   +         +   +  +  + L +LH +   Q+IH
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALEFLHSN---QVIH 139
Query: 645 CDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKV 704
            DIK  NILL    + +++DFG    +T  QSK  ++ + GT  ++APE         KV
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSXMVGTPYWMAPEVVTRKAYGPKV 197
Query: 705 DVYSFGVLLLEIIS 718
           D++S G++ +E+I 
Sbjct: 198 DIWSLGIMAIEMIE 211

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 100/200 (50%), Gaps = 15/200 (7%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGER--EFKNEVFVIGQTHHKNLVR 582
           + +G GSFG VYKG          VAVK L+      ++   FKNEV V+ +T H N++ 
Sbjct: 34  QRIGSGSFGTVYKGKWHG-----DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 88
Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFL-FGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ 641
            +G+  + Q   +V ++    +L   L     K       +IA Q A+G+ YLH      
Sbjct: 89  FMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--- 144
Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR---NS 698
           IIH D+K  NI L +  T +I DFGLA   +          + G+  ++APE  R    +
Sbjct: 145 IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 204
Query: 699 KITAKVDVYSFGVLLLEIIS 718
             + + DVY+FG++L E+++
Sbjct: 205 PYSFQSDVYAFGIVLYELMT 224

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 97/194 (50%), Gaps = 8/194 (4%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLL 584
           E++G+G+ G VY  +     +   VA+++++   Q  +    NE+ V+ +  + N+V  L
Sbjct: 26  EKIGQGASGTVYTAM--DVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYL 83
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIH 644
                G    +V E+L  G+L   +         +   +  +  + L +LH +   Q+IH
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALEFLHSN---QVIH 139
Query: 645 CDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKV 704
            DIK  NILL    + +++DFG    +T  QSK  ++ + GT  ++APE         KV
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSEMVGTPYWMAPEVVTRKAYGPKV 197
Query: 705 DVYSFGVLLLEIIS 718
           D++S G++ +E+I 
Sbjct: 198 DIWSLGIMAIEMIE 211

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 99/214 (46%), Gaps = 21/214 (9%)
Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ 574
           E++     F +E+G G FG+V  G  + +       +K+        E EF  E  V+  
Sbjct: 5   EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM----SEDEFIEEAKVMMN 60
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYL 634
             H+ LV+L G C + +   ++ E++ NG L ++L               FQ  + L   
Sbjct: 61  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL---------REMRHRFQTQQLLEMC 111
Query: 635 HEDCRA-------QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK 687
            + C A       Q +H D+  +N L++D    ++SDFGL++ + L+   T     +   
Sbjct: 112 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSVGSKFPV 170
Query: 688 GYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRK 721
            +  PE    SK ++K D+++FGVL+ EI S  K
Sbjct: 171 RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK 204

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 130/297 (43%), Gaps = 43/297 (14%)
Query: 527 VGRGSFGIVYK----GVIQTR-TSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQT-HHKN 579
           +G G+FG V      G+ + +      VAVK L D   +    +  +E+ ++     HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 580 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNI---------------- 623
           ++ LLG C +     ++ E+ + G L  +L     P      +I                
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 624 AFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAI 683
            +Q+ARG+ YL      + IH D+  +N+L+ +    +I+DFGLA+ +         T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 684 RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAFDCY 742
           R    ++APE   +   T + DV+SFGVL+ EI +         G  Y  I  +  F   
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG-------GSPYPGIPVEELFKLL 272
Query: 743 RNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 799
           + G        DK A     C  +L M+   C    PS RPT K++++ L+ ++ ++
Sbjct: 273 KEGHRM-----DKPA----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 320

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 98/195 (50%), Gaps = 12/195 (6%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG-EREFKNEVFVIGQTHHKNL 580
           +F++ +G G+F  V   + + + +   VA+K + +   +G E   +NE+ V+ +  H N+
Sbjct: 21  DFRDVLGTGAFSEVI--LAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNI 78
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           V L    + G +  L+ + ++ G L   +           + + FQ+   + YLH+    
Sbjct: 79  VALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHD---L 135
Query: 641 QIIHCDIKPQNIL---LDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRN 697
            I+H D+KP+N+L   LD+     ISDFGL+K+       ++ +   GT GYVAPE    
Sbjct: 136 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLAQ 192
Query: 698 SKITAKVDVYSFGVL 712
              +  VD +S GV+
Sbjct: 193 KPYSKAVDCWSIGVI 207

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 99/214 (46%), Gaps = 21/214 (9%)
Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ 574
           E++     F +E+G G FG+V  G  + +       +K+        E EF  E  V+  
Sbjct: 4   EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM----SEDEFIEEAKVMMN 59
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYL 634
             H+ LV+L G C + +   ++ E++ NG L ++L               FQ  + L   
Sbjct: 60  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL---------REMRHRFQTQQLLEMC 110
Query: 635 HEDCRA-------QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK 687
            + C A       Q +H D+  +N L++D    ++SDFGL++ + L+   T     +   
Sbjct: 111 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSVGSKFPV 169
Query: 688 GYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRK 721
            +  PE    SK ++K D+++FGVL+ EI S  K
Sbjct: 170 RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK 203

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 97/194 (50%), Gaps = 8/194 (4%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLL 584
           E++G+G+ G VY  +     +   VA+++++   Q  +    NE+ V+ +  + N+V  L
Sbjct: 27  EKIGQGASGTVYTAM--DVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYL 84
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIH 644
                G    +V E+L  G+L   +         +   +  +  + L +LH +   Q+IH
Sbjct: 85  DSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALEFLHSN---QVIH 140
Query: 645 CDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKV 704
            DIK  NILL    + +++DFG    +T  QSK  ++ + GT  ++APE         KV
Sbjct: 141 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSXMVGTPYWMAPEVVTRKAYGPKV 198
Query: 705 DVYSFGVLLLEIIS 718
           D++S G++ +E+I 
Sbjct: 199 DIWSLGIMAIEMIE 212

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 98/195 (50%), Gaps = 12/195 (6%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG-EREFKNEVFVIGQTHHKNL 580
           +F++ +G G+F  V   + + + +   VA+K + +   +G E   +NE+ V+ +  H N+
Sbjct: 21  DFRDVLGTGAFSEVI--LAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNI 78
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           V L    + G +  L+ + ++ G L   +           + + FQ+   + YLH+    
Sbjct: 79  VALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHD---L 135
Query: 641 QIIHCDIKPQNIL---LDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRN 697
            I+H D+KP+N+L   LD+     ISDFGL+K+       ++ +   GT GYVAPE    
Sbjct: 136 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLAQ 192
Query: 698 SKITAKVDVYSFGVL 712
              +  VD +S GV+
Sbjct: 193 KPYSKAVDCWSIGVI 207

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 80/293 (27%), Positives = 135/293 (46%), Gaps = 41/293 (13%)
Query: 527 VGRGSFGIVYKGVIQTRTSTT---AVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G G FG V +G ++    T+   AV   KLD   Q    EF +E   +    H N++RL
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 584 LGFCDEGQNR-----LLVYEFLNNGTLASF-LFGNLK---PNWNLRTNIAFQ--IARGLL 632
           LG C E  ++     +++  F+  G L ++ L+  L+    +  L+T + F   IA G+ 
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLL----TLNQSKTIKTAIRGTKG 688
           YL        +H D+  +N +L D  T  ++DFGL+K +       Q +  K  ++    
Sbjct: 162 YL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK---- 214
Query: 689 YVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLN 748
           ++A E   +   T+K DV++FGV + EI +  +      G +   + D+    +R  +  
Sbjct: 215 WIAIESLADRVYTSKSDVWAFGVTMWEIAT--RGMTPYPGVQNHEMYDYLLHGHRLKQ-- 270
Query: 749 VLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVP 801
               ED        CL +L  +   C + DP  RPT   +   LE ++E S+P
Sbjct: 271 ---PED--------CLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE-SLP 311

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 130/297 (43%), Gaps = 43/297 (14%)
Query: 527 VGRGSFGIVYK----GVIQTR-TSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQT-HHKN 579
           +G G+FG V      G+ + +      VAVK L D   +    +  +E+ ++     HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 580 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNI---------------- 623
           ++ LLG C +     ++ E+ + G L  +L     P      +I                
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 624 AFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAI 683
            +Q+ARG+ YL      + IH D+  +N+L+ +    +I+DFGLA+ +         T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 684 RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAFDCY 742
           R    ++APE   +   T + DV+SFGVL+ EI +         G  Y  I  +  F   
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG-------GSPYPGIPVEELFKLL 272
Query: 743 RNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 799
           + G        DK A     C  +L M+   C    PS RPT K++++ L+ ++ ++
Sbjct: 273 KEGHRM-----DKPA----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 320

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 99/200 (49%), Gaps = 13/200 (6%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGEREFKN-EVFVIGQTHHKNLVRL 583
           +G GSFG V+  +I++R +    A+K L +  V +  + E  N E  ++    H  ++R+
Sbjct: 14  LGTGSFGRVH--LIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 71
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
            G   + Q   ++ +++  G L S L  + +    +    A ++   L YLH      II
Sbjct: 72  WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS---KDII 128
Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK 703
           + D+KP+NILLD     +I+DFG AK +       +   + GT  Y+APE          
Sbjct: 129 YRDLKPENILLDKNGHIKITDFGFAKYVP-----DVTYXLCGTPDYIAPEVVSTKPYNKS 183
Query: 704 VDVYSFGVLLLEIISCRKSF 723
           +D +SFG+L+ E+++    F
Sbjct: 184 IDWWSFGILIYEMLAGYTPF 203

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 70/281 (24%), Positives = 123/281 (43%), Gaps = 31/281 (11%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG---EREFKNEVFVIGQTHHKNLVRL 583
           +G+G FG VY  + + + S   +A+K L +   +    E + + EV +     H N++RL
Sbjct: 18  LGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 75
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
            G+  +     L+ E+   GT+   L    K +         ++A  L Y H     ++I
Sbjct: 76  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVI 132
Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK 703
           H DIKP+N+LL      +I++FG     +++   + +T + GT  Y+ PE         K
Sbjct: 133 HRDIKPENLLLGSAGELKIANFGW----SVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEK 188
Query: 704 VDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLNVLVGEDKEAMNDIE 762
           VD++S GVL  E +  +  F+    +E Y  ++   F                    D  
Sbjct: 189 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-----------------TFPDFV 231
Query: 763 CLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVPPN 803
             G   ++S   ++ +PS RP +++VL+        S P N
Sbjct: 232 TEGARDLIS-RLLKHNPSQRPMLREVLEHPWITANSSKPSN 271

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 78/299 (26%), Positives = 131/299 (43%), Gaps = 47/299 (15%)
Query: 527 VGRGSFGIVYK----GVIQTR-TSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQT-HHKN 579
           +G G+FG V      G+ + +      VAVK L D   +    +  +E+ ++     HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 580 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNI---------------- 623
           ++ LLG C +     ++ E+ + G L  +L     P      +I                
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 624 AFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAI 683
            +Q+ARG+ YL      + IH D+  +N+L+ +    +I+DFGLA+   +N     K   
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDYYKNTT 217
Query: 684 RG--TKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAFD 740
            G     ++APE   +   T + DV+SFGVL+ EI +         G  Y  I  +  F 
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG-------GSPYPGIPVEELFK 270
Query: 741 CYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 799
             + G        DK A     C  +L M+   C    PS RPT K++++ L+ ++ ++
Sbjct: 271 LLKEGHRM-----DKPA----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 320

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 95/203 (46%), Gaps = 19/203 (9%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE-FKNEVFVIGQTHHKNL 580
            F  E+GRGSF  VYKG + T T+      +  DR     ER+ FK E   +    H N+
Sbjct: 29  KFDIEIGRGSFKTVYKG-LDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNI 87
Query: 581 VRLLGFCDEGQNR-------LLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLY 633
           VR   F D  ++        +LV E   +GTL ++L         +  +   QI +GL +
Sbjct: 88  VR---FYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQF 144
Query: 634 LHEDCRAQIIHCDIKPQNILLDDYY-TARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 692
           LH      IIH D+K  NI +     + +I D GLA L   + +K    A+ GT  + AP
Sbjct: 145 LHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK----AVIGTPEFXAP 199
Query: 693 EWFRNSKITAKVDVYSFGVLLLE 715
           E +   K    VDVY+FG   LE
Sbjct: 200 EXY-EEKYDESVDVYAFGXCXLE 221

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 70/281 (24%), Positives = 122/281 (43%), Gaps = 31/281 (11%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG---EREFKNEVFVIGQTHHKNLVRL 583
           +G+G FG VY  + + + S   +A+K L +   +    E + + EV +     H N++RL
Sbjct: 18  LGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 75
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
            G+  +     L+ E+   GT+   L    K +         ++A  L Y H     ++I
Sbjct: 76  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVI 132
Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK 703
           H DIKP+N+LL      +I+DFG     +++   + +  + GT  Y+ PE         K
Sbjct: 133 HRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPPEMIEGRMHDEK 188
Query: 704 VDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLNVLVGEDKEAMNDIE 762
           VD++S GVL  E +  +  F+    +E Y  ++   F                    D  
Sbjct: 189 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-----------------TFPDFV 231
Query: 763 CLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVPPN 803
             G   ++S   ++ +PS RP +++VL+        S P N
Sbjct: 232 TEGARDLIS-RLLKHNPSQRPMLREVLEHPWITANSSKPSN 271

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 70/281 (24%), Positives = 122/281 (43%), Gaps = 31/281 (11%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG---EREFKNEVFVIGQTHHKNLVRL 583
           +G+G FG VY  + + + S   +A+K L +   +    E + + EV +     H N++RL
Sbjct: 17  LGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
            G+  +     L+ E+   GT+   L    K +         ++A  L Y H     ++I
Sbjct: 75  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVI 131
Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK 703
           H DIKP+N+LL      +I+DFG     +++   + +  + GT  Y+ PE         K
Sbjct: 132 HRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRDTLCGTLDYLPPEMIEGRMHDEK 187
Query: 704 VDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLNVLVGEDKEAMNDIE 762
           VD++S GVL  E +  +  F+    +E Y  ++   F                    D  
Sbjct: 188 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-----------------TFPDFV 230
Query: 763 CLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVPPN 803
             G   ++S   ++ +PS RP +++VL+        S P N
Sbjct: 231 TEGARDLIS-RLLKHNPSQRPMLREVLEHPWITANSSKPSN 270

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 120/268 (44%), Gaps = 31/268 (11%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG---EREFKNEVFVIGQTHHKNLVRL 583
           +G+G FG VY  + + + S   +A+K L +   +    E + + EV +     H N++RL
Sbjct: 19  LGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
            G+  +     L+ E+   GT+   L    K +         ++A  L Y H     ++I
Sbjct: 77  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVI 133
Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK 703
           H DIKP+N+LL      +I++FG     +++   + +T + GT  Y+ PE         K
Sbjct: 134 HRDIKPENLLLGSAGELKIANFGW----SVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEK 189
Query: 704 VDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLNVLVGEDKEAMNDIE 762
           VD++S GVL  E +  +  F+    +E Y  ++   F                    D  
Sbjct: 190 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-----------------TFPDFV 232
Query: 763 CLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
             G   ++S   ++ +PS RP +++VL+
Sbjct: 233 TEGARDLIS-RLLKHNPSQRPMLREVLE 259

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 119/268 (44%), Gaps = 31/268 (11%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG---EREFKNEVFVIGQTHHKNLVRL 583
           +G+G FG VY  + + + S   +A+K L +   +    E + + EV +     H N++RL
Sbjct: 42  LGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 99
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
            G+  +     L+ E+   GT+   L    K +         ++A  L Y H     ++I
Sbjct: 100 YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVI 156
Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK 703
           H DIKP+N+LL      +I+DFG     +++   + +  + GT  Y+ PE         K
Sbjct: 157 HRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRDDLCGTLDYLPPEMIEGRMHDEK 212
Query: 704 VDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLNVLVGEDKEAMNDIE 762
           VD++S GVL  E +  +  F+    +E Y  ++   F                    D  
Sbjct: 213 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-----------------TFPDFV 255
Query: 763 CLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
             G   ++S   ++ +PS RP +++VL+
Sbjct: 256 TEGARDLIS-RLLKHNPSQRPMLREVLE 282

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 119/268 (44%), Gaps = 31/268 (11%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG---EREFKNEVFVIGQTHHKNLVRL 583
           +G+G FG VY  + + + S   +A+K L +   +    E + + EV +     H N++RL
Sbjct: 16  LGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
            G+  +     L+ E+   GT+   L    K +         ++A  L Y H     ++I
Sbjct: 74  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVI 130
Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK 703
           H DIKP+N+LL      +I+DFG     +++   + +  + GT  Y+ PE         K
Sbjct: 131 HRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPPEMIEGRMHDEK 186
Query: 704 VDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLNVLVGEDKEAMNDIE 762
           VD++S GVL  E +  +  F+    +E Y  ++   F                    D  
Sbjct: 187 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-----------------TFPDFV 229
Query: 763 CLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
             G   ++S   ++ +PS RP +++VL+
Sbjct: 230 TEGARDLIS-RLLKHNPSQRPMLREVLE 256

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 105/207 (50%), Gaps = 23/207 (11%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           +G+G FG V     Q R +    A KKL++       GE    NE  ++ + + + +V L
Sbjct: 192 LGKGGFGEVC--ACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDC----- 638
             +  E ++ L +   L NG       G+LK +        F  AR + Y  E C     
Sbjct: 250 -AYAYETKDALCLVLTLMNG-------GDLKFHIYHMGQAGFPEARAVFYAAEICCGLED 301
Query: 639 --RAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR 696
             R +I++ D+KP+NILLDD+   RISD GLA  + + + +TIK  + GT GY+APE  +
Sbjct: 302 LHRERIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRV-GTVGYMAPEVVK 358
Query: 697 NSKITAKVDVYSFGVLLLEIISCRKSF 723
           N + T   D ++ G LL E+I+ +  F
Sbjct: 359 NERYTFSPDWWALGCLLYEMIAGQSPF 385

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 129/297 (43%), Gaps = 43/297 (14%)
Query: 527 VGRGSFGIVYK----GVIQTR-TSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQT-HHKN 579
           +G G FG V      G+ + +      VAVK L D   +    +  +E+ ++     HKN
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 580 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNI---------------- 623
           ++ LLG C +     ++ E+ + G L  +L     P      +I                
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 624 AFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAI 683
            +Q+ARG+ YL      + IH D+  +N+L+ +    +I+DFGLA+ +         T  
Sbjct: 152 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 208
Query: 684 RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAFDCY 742
           R    ++APE   +   T + DV+SFGVL+ EI +         G  Y  I  +  F   
Sbjct: 209 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG-------GSPYPGIPVEELFKLL 261
Query: 743 RNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 799
           + G        DK A     C  +L M+   C    PS RPT K++++ L+ ++ ++
Sbjct: 262 KEGHRM-----DKPA----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 309

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 129/297 (43%), Gaps = 43/297 (14%)
Query: 527 VGRGSFGIVYK----GVIQTR-TSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQT-HHKN 579
           +G G FG V      G+ + +      VAVK L D   +    +  +E+ ++     HKN
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 580 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNI---------------- 623
           ++ LLG C +     ++ E+ + G L  +L     P      +I                
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 624 AFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAI 683
            +Q+ARG+ YL      + IH D+  +N+L+ +    +I+DFGLA+ +         T  
Sbjct: 150 TYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 206
Query: 684 RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAFDCY 742
           R    ++APE   +   T + DV+SFGVL+ EI +         G  Y  I  +  F   
Sbjct: 207 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG-------GSPYPGIPVEELFKLL 259
Query: 743 RNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 799
           + G        DK A     C  +L M+   C    PS RPT K++++ L+ ++ ++
Sbjct: 260 KEGHRM-----DKPA----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 307

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 129/297 (43%), Gaps = 43/297 (14%)
Query: 527 VGRGSFGIVYK----GVIQTR-TSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQT-HHKN 579
           +G G FG V      G+ + +      VAVK L D   +    +  +E+ ++     HKN
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 580 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNI---------------- 623
           ++ LLG C +     ++ E+ + G L  +L     P      +I                
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 624 AFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAI 683
            +Q+ARG+ YL      + IH D+  +N+L+ +    +I+DFGLA+ +         T  
Sbjct: 155 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 211
Query: 684 RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAFDCY 742
           R    ++APE   +   T + DV+SFGVL+ EI +         G  Y  I  +  F   
Sbjct: 212 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG-------GSPYPGIPVEELFKLL 264
Query: 743 RNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 799
           + G        DK A     C  +L M+   C    PS RPT K++++ L+ ++ ++
Sbjct: 265 KEGHRM-----DKPA----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 312

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 105/207 (50%), Gaps = 23/207 (11%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           +G+G FG V     Q R +    A KKL++       GE    NE  ++ + + + +V L
Sbjct: 192 LGKGGFGEVC--ACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDC----- 638
             +  E ++ L +   L NG       G+LK +        F  AR + Y  E C     
Sbjct: 250 -AYAYETKDALCLVLTLMNG-------GDLKFHIYHMGQAGFPEARAVFYAAEICCGLED 301
Query: 639 --RAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR 696
             R +I++ D+KP+NILLDD+   RISD GLA  + + + +TIK  + GT GY+APE  +
Sbjct: 302 LHRERIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRV-GTVGYMAPEVVK 358
Query: 697 NSKITAKVDVYSFGVLLLEIISCRKSF 723
           N + T   D ++ G LL E+I+ +  F
Sbjct: 359 NERYTFSPDWWALGCLLYEMIAGQSPF 385

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 21/207 (10%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLV 581
            F +E+G G FG+V  G  + +       +K+        E EF  E  V+    H+ LV
Sbjct: 7   TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLV 62
Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRA- 640
           +L G C + +   ++ E++ NG L ++L         +R    FQ  + L    + C A 
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLR-------EMRHR--FQTQQLLEMCKDVCEAM 113
Query: 641 ------QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 694
                 Q +H D+  +N L++D    ++SDFGL++ + L+   T     +    +  PE 
Sbjct: 114 EYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWSPPEV 172
Query: 695 FRNSKITAKVDVYSFGVLLLEIISCRK 721
              SK ++K D+++FGVL+ EI S  K
Sbjct: 173 LMYSKFSSKSDIWAFGVLMWEIYSLGK 199

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 12/207 (5%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG---EREFKNEVFVIGQTHHKNLVRL 583
           +G+G FG VY  + + R S   +A+K L +   +    E + + EV +     H N++RL
Sbjct: 20  LGKGKFGNVY--LARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRL 77
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
            G+  +     L+ E+   GT+   L    + +         ++A  L Y H     ++I
Sbjct: 78  YGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSK---RVI 134
Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK 703
           H DIKP+N+LL      +I+DFG     +++   + +T + GT  Y+ PE         K
Sbjct: 135 HRDIKPENLLLGSNGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEK 190
Query: 704 VDVYSFGVLLLEIISCRKSFDIEMGEE 730
           VD++S GVL  E +     F+    +E
Sbjct: 191 VDLWSLGVLCYEFLVGMPPFEAHTYQE 217

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 111/230 (48%), Gaps = 33/230 (14%)
Query: 521 NNFK--EEVGRGSFGIVYKGVIQTRTSTTAVAVKK--LDRVFQDGEREFKNEVFVIGQTH 576
            NF+  E++G G++G+VYK   + + +   VA+KK  LD   +        E+ ++ + +
Sbjct: 2   ENFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 59
Query: 577 HKNLVRLLGFCDEGQNRLLVYEFLNNGTL----ASFLFGNLKPNWNLRTNIAFQIARGLL 632
           H N+V+LL          LV+E ++        AS L G   P   L  +  FQ+ +GL 
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLP---LIKSYLFQLLQGLA 116
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 692
           + H     +++H D+KPQN+L++     +++DFGLA        +     +R     V  
Sbjct: 117 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA--------RAFGVPVRTYTHEVVT 165
Query: 693 EWFRNSKI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAI 733
            W+R  +I       +  VD++S G +  E+++ R  F  D E+ + + I
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 215

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 119/268 (44%), Gaps = 31/268 (11%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG---EREFKNEVFVIGQTHHKNLVRL 583
           +G+G FG VY  + + + S   +A+K L +   +    E + + EV +     H N++RL
Sbjct: 19  LGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
            G+  +     L+ E+   GT+   L    K +         ++A  L Y H     ++I
Sbjct: 77  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVI 133
Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK 703
           H DIKP+N+LL      +I+DFG     +++   + +  + GT  Y+ PE         K
Sbjct: 134 HRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRDDLCGTLDYLPPEMIEGRMHDEK 189
Query: 704 VDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLNVLVGEDKEAMNDIE 762
           VD++S GVL  E +  +  F+    +E Y  ++   F                    D  
Sbjct: 190 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-----------------TFPDFV 232
Query: 763 CLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
             G   ++S   ++ +PS RP +++VL+
Sbjct: 233 TEGARDLIS-RLLKHNPSQRPMLREVLE 259

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 119/268 (44%), Gaps = 31/268 (11%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG---EREFKNEVFVIGQTHHKNLVRL 583
           +G+G FG VY  + + + S   +A+K L +   +    E + + EV +     H N++RL
Sbjct: 19  LGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
            G+  +     L+ E+   GT+   L    K +         ++A  L Y H     ++I
Sbjct: 77  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVI 133
Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK 703
           H DIKP+N+LL      +I+DFG     +++   + +  + GT  Y+ PE         K
Sbjct: 134 HRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPPEMIEGRMHDEK 189
Query: 704 VDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLNVLVGEDKEAMNDIE 762
           VD++S GVL  E +  +  F+    +E Y  ++   F                    D  
Sbjct: 190 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-----------------TFPDFV 232
Query: 763 CLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
             G   ++S   ++ +PS RP +++VL+
Sbjct: 233 TEGARDLIS-RLLKHNPSQRPMLREVLE 259

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 102/206 (49%), Gaps = 19/206 (9%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE-----FKNEVFVIGQTHHKN 579
           E+VG G++G+VYK      +    VA+K   R+  D E E        E+ ++ + HH N
Sbjct: 27  EKVGEGTYGVVYKA---KDSQGRIVALK---RIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 580 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNI-AFQIARGLLYLHEDC 638
           +V L+      +   LV+EF+    L   L  N     + +  I  +Q+ RG+ + H+  
Sbjct: 81  IVSLIDVIHSERCLTLVFEFMEKD-LKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH- 138
Query: 639 RAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNS 698
             +I+H D+KPQN+L++     +++DFGLA+   +         +  T  Y AP+    S
Sbjct: 139 --RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV--TLWYRAPDVLMGS 194
Query: 699 -KITAKVDVYSFGVLLLEIISCRKSF 723
            K +  VD++S G +  E+I+ +  F
Sbjct: 195 KKYSTSVDIWSIGCIFAEMITGKPLF 220

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 129/297 (43%), Gaps = 43/297 (14%)
Query: 527 VGRGSFGIVYK----GVIQTRT-STTAVAVKKL-DRVFQDGEREFKNEVFVIGQT-HHKN 579
           +G G FG V      G+ + +      VAVK L D   +    +  +E+ ++     HKN
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 580 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNI---------------- 623
           ++ LLG C +     ++ E+ + G L  +L     P      +I                
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 624 AFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAI 683
            +Q+ARG+ YL      + IH D+  +N+L+ +    +I+DFGLA+ +         T  
Sbjct: 209 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 684 RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA-ILTDWAFDCY 742
           R    ++APE   +   T + DV+SFGVL+ EI +         G  Y  I  +  F   
Sbjct: 266 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG-------GSPYPGIPVEELFKLL 318
Query: 743 RNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 799
           + G        DK A     C  +L M+   C    PS RPT K++++ L+ ++ ++
Sbjct: 319 KEGH-----RMDKPA----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 102/206 (49%), Gaps = 19/206 (9%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE-----FKNEVFVIGQTHHKN 579
           E+VG G++G+VYK      +    VA+K   R+  D E E        E+ ++ + HH N
Sbjct: 27  EKVGEGTYGVVYKA---KDSQGRIVALK---RIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 580 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNI-AFQIARGLLYLHEDC 638
           +V L+      +   LV+EF+    L   L  N     + +  I  +Q+ RG+ + H+  
Sbjct: 81  IVSLIDVIHSERCLTLVFEFMEKD-LKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH- 138
Query: 639 RAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNS 698
             +I+H D+KPQN+L++     +++DFGLA+   +         +  T  Y AP+    S
Sbjct: 139 --RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV--TLWYRAPDVLMGS 194
Query: 699 -KITAKVDVYSFGVLLLEIISCRKSF 723
            K +  VD++S G +  E+I+ +  F
Sbjct: 195 KKYSTSVDIWSIGCIFAEMITGKPLF 220

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 91/192 (47%), Gaps = 8/192 (4%)
Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLG 585
           ++G GS GIV   +   R+S   VAVKK+D   Q       NEV ++    H+N+V +  
Sbjct: 81  KIGEGSTGIVC--IATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN 138
Query: 586 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHC 645
               G    +V EFL  G L   +  + + N      +   + + L  LH      +IH 
Sbjct: 139 SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIHR 194
Query: 646 DIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVD 705
           DIK  +ILL      ++SDFG    ++    +  +  + GT  ++APE         +VD
Sbjct: 195 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKXLVGTPYWMAPELISRLPYGPEVD 252
Query: 706 VYSFGVLLLEII 717
           ++S G++++E++
Sbjct: 253 IWSLGIMVIEMV 264

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 97/194 (50%), Gaps = 8/194 (4%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLL 584
           E++G+G+ G VY  +     +   VA+++++   Q  +    NE+ V+ +  + N+V  L
Sbjct: 27  EKIGQGASGTVYTAM--DVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYL 84
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIH 644
                G    +V E+L  G+L   +         +   +  +  + L +LH +   Q+IH
Sbjct: 85  DSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALEFLHSN---QVIH 140
Query: 645 CDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKV 704
            +IK  NILL    + +++DFG    +T  QSK  ++ + GT  ++APE         KV
Sbjct: 141 RNIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKV 198
Query: 705 DVYSFGVLLLEIIS 718
           D++S G++ +E+I 
Sbjct: 199 DIWSLGIMAIEMIE 212

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 93/193 (48%), Gaps = 10/193 (5%)
Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLG 585
           ++G GS GIV   +   R+S   VAVKK+D   Q       NEV ++    H+N+V +  
Sbjct: 158 KIGEGSTGIVC--IATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN 215
Query: 586 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ-IIH 644
               G    +V EFL  G L   +  + + N      +   + + L  LH    AQ +IH
Sbjct: 216 SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLH----AQGVIH 270
Query: 645 CDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKV 704
            DIK  +ILL      ++SDFG    ++    +  +  + GT  ++APE         +V
Sbjct: 271 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKXLVGTPYWMAPELISRLPYGPEV 328
Query: 705 DVYSFGVLLLEII 717
           D++S G++++E++
Sbjct: 329 DIWSLGIMVIEMV 341

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/248 (26%), Positives = 119/248 (47%), Gaps = 19/248 (7%)
Query: 522 NFKEEVGRGSFGIVYKGVIQT---RTSTTAVAVKKLD-RVFQDGEREFKNEVFVIGQTHH 577
           + KEE+G+G+F +V + V +T     +   +  KKL  R FQ  ERE +    +  +  H
Sbjct: 9   DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREAR----ICRKLQH 64
Query: 578 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHED 637
            N+VRL     E     LV++ +  G L   +      +    ++   QI   + Y H +
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124
Query: 638 CRAQIIHCDIKPQNILLDDY---YTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 694
               I+H ++KP+N+LL         +++DFGLA  + +N S+       GT GY++PE 
Sbjct: 125 ---GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWH-GFAGTPGYLSPEV 178
Query: 695 FRNSKITAKVDVYSFGVLLLEIISCRKSF-DIEMGEEYAILTDWAFDCYRNGKLNVLVGE 753
            +    +  VD+++ GV+L  ++     F D +    YA +   A+D Y + + + +  E
Sbjct: 179 LKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD-YPSPEWDTVTPE 237
Query: 754 DKEAMNDI 761
            K  ++ +
Sbjct: 238 AKSLIDSM 245

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 93/193 (48%), Gaps = 10/193 (5%)
Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLG 585
           ++G GS GIV   +   R+S   VAVKK+D   Q       NEV ++    H+N+V +  
Sbjct: 38  KIGEGSTGIVC--IATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN 95
Query: 586 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ-IIH 644
               G    +V EFL  G L   +  + + N      +   + + L  LH    AQ +IH
Sbjct: 96  SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLH----AQGVIH 150
Query: 645 CDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKV 704
            DIK  +ILL      ++SDFG    ++    +  +  + GT  ++APE         +V
Sbjct: 151 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKXLVGTPYWMAPELISRLPYGPEV 208
Query: 705 DVYSFGVLLLEII 717
           D++S G++++E++
Sbjct: 209 DIWSLGIMVIEMV 221

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 134/283 (47%), Gaps = 38/283 (13%)
Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFK----NEVFVIGQTH---HK 578
           E+G G++G V+K     +     VA+K++ RV Q GE         EV V+       H 
Sbjct: 18  EIGEGAYGKVFKAR-DLKNGGRFVALKRV-RV-QTGEEGMPLSTIREVAVLRHLETFEHP 74
Query: 579 NLVRLLGFC-----DEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGL 631
           N+VRL   C     D      LV+E ++   L ++L    +P     T  ++ FQ+ RGL
Sbjct: 75  NVVRLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYLDKVPEPGVPTETIKDMMFQLLRGL 133
Query: 632 LYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVA 691
            +LH     +++H D+KPQNIL+      +++DFGLA++ +   +    T++  T  Y A
Sbjct: 134 DFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA---LTSVVVTLWYRA 187
Query: 692 PEWFRNSKITAKVDVYSFGVLLLEIIS----CRKSFDI-EMGEEYAIL-----TDWAFDC 741
           PE    S     VD++S G +  E+       R S D+ ++G+   ++      DW  D 
Sbjct: 188 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 247
Query: 742 Y--RNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLR 782
              R    +      ++ + DI+ LGK +++   C+  +P+ R
Sbjct: 248 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLK--CLTFNPAKR 288

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 93/193 (48%), Gaps = 10/193 (5%)
Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLG 585
           ++G GS GIV   +   R+S   VAVKK+D   Q       NEV ++    H+N+V +  
Sbjct: 27  KIGEGSTGIVC--IATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN 84
Query: 586 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ-IIH 644
               G    +V EFL  G L   +  + + N      +   + + L  LH    AQ +IH
Sbjct: 85  SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLH----AQGVIH 139
Query: 645 CDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKV 704
            DIK  +ILL      ++SDFG    ++    +  +  + GT  ++APE         +V
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKXLVGTPYWMAPELISRLPYGPEV 197
Query: 705 DVYSFGVLLLEII 717
           D++S G++++E++
Sbjct: 198 DIWSLGIMVIEMV 210

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 93/193 (48%), Gaps = 10/193 (5%)
Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLG 585
           ++G GS GIV   +   R+S   VAVKK+D   Q       NEV ++    H+N+V +  
Sbjct: 31  KIGEGSTGIVC--IATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN 88
Query: 586 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ-IIH 644
               G    +V EFL  G L   +  + + N      +   + + L  LH    AQ +IH
Sbjct: 89  SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLH----AQGVIH 143
Query: 645 CDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKV 704
            DIK  +ILL      ++SDFG    ++    +  +  + GT  ++APE         +V
Sbjct: 144 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKXLVGTPYWMAPELISRLPYGPEV 201
Query: 705 DVYSFGVLLLEII 717
           D++S G++++E++
Sbjct: 202 DIWSLGIMVIEMV 214

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 93/193 (48%), Gaps = 10/193 (5%)
Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLG 585
           ++G GS GIV   +   R+S   VAVKK+D   Q       NEV ++    H+N+V +  
Sbjct: 36  KIGEGSTGIVC--IATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN 93
Query: 586 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ-IIH 644
               G    +V EFL  G L   +  + + N      +   + + L  LH    AQ +IH
Sbjct: 94  SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLH----AQGVIH 148
Query: 645 CDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKV 704
            DIK  +ILL      ++SDFG    ++    +  +  + GT  ++APE         +V
Sbjct: 149 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKXLVGTPYWMAPELISRLPYGPEV 206
Query: 705 DVYSFGVLLLEII 717
           D++S G++++E++
Sbjct: 207 DIWSLGIMVIEMV 219

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/248 (26%), Positives = 119/248 (47%), Gaps = 19/248 (7%)
Query: 522 NFKEEVGRGSFGIVYKGVIQT---RTSTTAVAVKKLD-RVFQDGEREFKNEVFVIGQTHH 577
           + KEE+G+G+F +V + V +T     +   +  KKL  R FQ  ERE +    +  +  H
Sbjct: 8   DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREAR----ICRKLQH 63
Query: 578 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHED 637
            N+VRL     E     LV++ +  G L   +      +    ++   QI   + Y H +
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 123
Query: 638 CRAQIIHCDIKPQNILLDDY---YTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 694
               I+H ++KP+N+LL         +++DFGLA  + +N S+       GT GY++PE 
Sbjct: 124 ---GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWH-GFAGTPGYLSPEV 177
Query: 695 FRNSKITAKVDVYSFGVLLLEIISCRKSF-DIEMGEEYAILTDWAFDCYRNGKLNVLVGE 753
            +    +  VD+++ GV+L  ++     F D +    YA +   A+D Y + + + +  E
Sbjct: 178 LKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD-YPSPEWDTVTPE 236
Query: 754 DKEAMNDI 761
            K  ++ +
Sbjct: 237 AKSLIDSM 244

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 94/195 (48%), Gaps = 12/195 (6%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQTHHKNL 580
            FKE +G G+F  V   + + + +    AVK +  +  +  E   +NE+ V+ +  H+N+
Sbjct: 25  EFKETLGTGAFSEVV--LAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENI 82
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           V L    +   +  LV + ++ G L   +           + +  Q+   + YLH   R 
Sbjct: 83  VALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLH---RM 139
Query: 641 QIIHCDIKPQNILL---DDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRN 697
            I+H D+KP+N+L    D+     ISDFGL+K+    +   + TA  GT GYVAPE    
Sbjct: 140 GIVHRDLKPENLLYYSQDEESKIMISDFGLSKME--GKGDVMSTAC-GTPGYVAPEVLAQ 196
Query: 698 SKITAKVDVYSFGVL 712
              +  VD +S GV+
Sbjct: 197 KPYSKAVDCWSIGVI 211

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/248 (26%), Positives = 119/248 (47%), Gaps = 19/248 (7%)
Query: 522 NFKEEVGRGSFGIVYKGVIQT---RTSTTAVAVKKLD-RVFQDGEREFKNEVFVIGQTHH 577
           + KEE+G+G+F +V + V +T     +   +  KKL  R FQ  ERE +    +  +  H
Sbjct: 9   DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREAR----ICRKLQH 64
Query: 578 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHED 637
            N+VRL     E     LV++ +  G L   +      +    ++   QI   + Y H +
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124
Query: 638 CRAQIIHCDIKPQNILLDDY---YTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 694
               I+H ++KP+N+LL         +++DFGLA  + +N S+       GT GY++PE 
Sbjct: 125 ---GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWH-GFAGTPGYLSPEV 178
Query: 695 FRNSKITAKVDVYSFGVLLLEIISCRKSF-DIEMGEEYAILTDWAFDCYRNGKLNVLVGE 753
            +    +  VD+++ GV+L  ++     F D +    YA +   A+D Y + + + +  E
Sbjct: 179 LKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD-YPSPEWDTVTPE 237
Query: 754 DKEAMNDI 761
            K  ++ +
Sbjct: 238 AKSLIDSM 245

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 104/212 (49%), Gaps = 28/212 (13%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR---VFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G+GSFG V   ++Q   +    A+K +++   V ++  R    E+ ++    H  LV L
Sbjct: 23  IGKGSFGKV--CIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRA--- 640
                + ++  +V + L  G L           ++L+ N+ F+     L++ E   A   
Sbjct: 81  WYSFQDEEDMFMVVDLLLGGDL----------RYHLQQNVHFKEETVKLFICELVMALDY 130
Query: 641 ----QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR 696
               +IIH D+KP NILLD++    I+DF +A +L     +T  T + GTK Y+APE F 
Sbjct: 131 LQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP---RETQITTMAGTKPYMAPEMFS 187
Query: 697 NSK---ITAKVDVYSFGVLLLEIISCRKSFDI 725
           + K    +  VD +S GV   E++  R+ + I
Sbjct: 188 SRKGAGYSFAVDWWSLGVTAYELLRGRRPYHI 219

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 24/212 (11%)
Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFK----NEVFVIGQTH---HK 578
           E+G G++G V+K     +     VA+K++ RV Q GE         EV V+       H 
Sbjct: 18  EIGEGAYGKVFKAR-DLKNGGRFVALKRV-RV-QTGEEGMPLSTIREVAVLRHLETFEHP 74
Query: 579 NLVRLLGFC-----DEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGL 631
           N+VRL   C     D      LV+E ++   L ++L    +P     T  ++ FQ+ RGL
Sbjct: 75  NVVRLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYLDKVPEPGVPTETIKDMMFQLLRGL 133
Query: 632 LYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVA 691
            +LH     +++H D+KPQNIL+      +++DFGLA++ +   +    T++  T  Y A
Sbjct: 134 DFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA---LTSVVVTLWYRA 187
Query: 692 PEWFRNSKITAKVDVYSFGVLLLEIISCRKSF 723
           PE    S     VD++S G +  E+   +  F
Sbjct: 188 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF 219

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 134/283 (47%), Gaps = 38/283 (13%)
Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFK----NEVFVIGQTH---HK 578
           E+G G++G V+K     +     VA+K++ RV Q GE         EV V+       H 
Sbjct: 18  EIGEGAYGKVFKAR-DLKNGGRFVALKRV-RV-QTGEEGMPLSTIREVAVLRHLETFEHP 74
Query: 579 NLVRLLGFC-----DEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGL 631
           N+VRL   C     D      LV+E ++   L ++L    +P     T  ++ FQ+ RGL
Sbjct: 75  NVVRLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYLDKVPEPGVPTETIKDMMFQLLRGL 133
Query: 632 LYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVA 691
            +LH     +++H D+KPQNIL+      +++DFGLA++ +   +    T++  T  Y A
Sbjct: 134 DFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA---LTSVVVTLWYRA 187
Query: 692 PEWFRNSKITAKVDVYSFGVLLLEIIS----CRKSFDI-EMGEEYAIL-----TDWAFDC 741
           PE    S     VD++S G +  E+       R S D+ ++G+   ++      DW  D 
Sbjct: 188 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 247
Query: 742 Y--RNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLR 782
              R    +      ++ + DI+ LGK +++   C+  +P+ R
Sbjct: 248 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLK--CLTFNPAKR 288

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/248 (26%), Positives = 119/248 (47%), Gaps = 19/248 (7%)
Query: 522 NFKEEVGRGSFGIVYKGVIQT---RTSTTAVAVKKLD-RVFQDGEREFKNEVFVIGQTHH 577
           + KEE+G+G+F +V + V +T     +   +  KKL  R FQ  ERE +    +  +  H
Sbjct: 32  DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREAR----ICRKLQH 87
Query: 578 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHED 637
            N+VRL     E     LV++ +  G L   +      +    ++   QI   + Y H +
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 147
Query: 638 CRAQIIHCDIKPQNILLDDY---YTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 694
               I+H ++KP+N+LL         +++DFGLA  + +N S+       GT GY++PE 
Sbjct: 148 ---GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWH-GFAGTPGYLSPEV 201
Query: 695 FRNSKITAKVDVYSFGVLLLEIISCRKSF-DIEMGEEYAILTDWAFDCYRNGKLNVLVGE 753
            +    +  VD+++ GV+L  ++     F D +    YA +   A+D Y + + + +  E
Sbjct: 202 LKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD-YPSPEWDTVTPE 260
Query: 754 DKEAMNDI 761
            K  ++ +
Sbjct: 261 AKSLIDSM 268

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 129/297 (43%), Gaps = 43/297 (14%)
Query: 527 VGRGSFGIVYK----GVIQTR-TSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQT-HHKN 579
           +G G+FG V      G+ + +      VAVK L D   +    +  +E+ ++     HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 580 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNI---------------- 623
           ++ LLG C +     ++  + + G L  +L     P      +I                
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 624 AFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAI 683
            +Q+ARG+ YL      + IH D+  +N+L+ +    +I+DFGLA+ +         T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 684 RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAFDCY 742
           R    ++APE   +   T + DV+SFGVL+ EI +         G  Y  I  +  F   
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG-------GSPYPGIPVEELFKLL 272
Query: 743 RNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 799
           + G        DK A     C  +L M+   C    PS RPT K++++ L+ ++ ++
Sbjct: 273 KEGHRM-----DKPA----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 320

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 95/193 (49%), Gaps = 10/193 (5%)
Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLG 585
           ++G GS GIV   + + + S   VAVK +D   Q       NEV ++    H N+V +  
Sbjct: 52  KIGEGSTGIV--CLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYK 109
Query: 586 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ-IIH 644
               G+   ++ EFL  G L   +   ++ N      +   + + L YLH    AQ +IH
Sbjct: 110 SYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLH----AQGVIH 164
Query: 645 CDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKV 704
            DIK  +ILL      ++SDFG    ++ +  K  +  + GT  ++APE    S    +V
Sbjct: 165 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKXLVGTPYWMAPEVISRSLYATEV 222
Query: 705 DVYSFGVLLLEII 717
           D++S G++++E++
Sbjct: 223 DIWSLGIMVIEMV 235

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 95/197 (48%), Gaps = 10/197 (5%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLL 584
           +++G G++G V     +      A+ + +   V      +   EV V+    H N+++L 
Sbjct: 43  KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY 102
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIH 644
            F ++ +N  LV E    G L   +   +K N      I  Q+  G+ YLH   +  I+H
Sbjct: 103 DFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLH---KHNIVH 159
Query: 645 CDIKPQNILLDDYYT---ARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKIT 701
            D+KP+N+LL+        +I DFGL+ +   NQ K  +    GT  Y+APE  R  K  
Sbjct: 160 RDLKPENLLLESKEKDALIKIVDFGLSAVFE-NQKKMKERL--GTAYYIAPEVLRK-KYD 215
Query: 702 AKVDVYSFGVLLLEIIS 718
            K DV+S GV+L  +++
Sbjct: 216 EKCDVWSIGVILFILLA 232

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 105/216 (48%), Gaps = 19/216 (8%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLV 581
             + E+GRG+  IVY+   + + +    A+K L +     ++  + E+ V+ +  H N++
Sbjct: 56  EVESELGRGATSIVYR--CKQKGTQKPYALKVLKKTVD--KKIVRTEIGVLLRLSHPNII 111
Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ 641
           +L    +      LV E +  G L   +      +     +   QI   + YLHE+    
Sbjct: 112 KLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN---G 168
Query: 642 IIHCDIKPQNILLDDYYTA------RISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
           I+H D+KP+N+L   Y T       +I+DFGL+K++   + + +   + GT GY APE  
Sbjct: 169 IVHRDLKPENLL---YATPAPDAPLKIADFGLSKIV---EHQVLMKTVCGTPGYCAPEIL 222
Query: 696 RNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY 731
           R      +VD++S G++   ++   + F  E G+++
Sbjct: 223 RGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF 258

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 101/219 (46%), Gaps = 9/219 (4%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFK-NEVFVIGQTHHKNL 580
            F   +G+GSFG V    ++      AV V K D + QD + E    E  ++    +   
Sbjct: 26  EFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPF 85
Query: 581 VRLLGFCDEGQNRLL-VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCR 639
           +  L  C +  +RL  V EF+N G L   +  + + +       A +I   L++LH+   
Sbjct: 86  LTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHD--- 142
Query: 640 AQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSK 699
             II+ D+K  N+LLD     +++DFG+ K    N   T      GT  Y+APE  +   
Sbjct: 143 KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTT--ATFCGTPDYIAPEILQEML 200
Query: 700 ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY--AILTD 736
               VD ++ GVLL E++     F+ E  ++   AIL D
Sbjct: 201 YGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND 239

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 129/297 (43%), Gaps = 43/297 (14%)
Query: 527 VGRGSFGIVYK----GVIQTR-TSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQT-HHKN 579
           +G G+FG V      G+ + +      VAVK L D   +    +  +E+ ++     HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 580 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNI---------------- 623
           ++ LLG C +     ++  + + G L  +L     P      +I                
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 624 AFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAI 683
            +Q+ARG+ YL      + IH D+  +N+L+ +    +I+DFGLA+ +         T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 684 RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAFDCY 742
           R    ++APE   +   T + DV+SFGVL+ EI +         G  Y  I  +  F   
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG-------GSPYPGIPVEELFKLL 272
Query: 743 RNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 799
           + G        DK A     C  +L M+   C    PS RPT K++++ L+ ++ ++
Sbjct: 273 KEGHRM-----DKPA----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 320

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 98/212 (46%), Gaps = 11/212 (5%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLV 581
           +  EE+G G+FG+V++  +  R +    A K +    +  +   + E+  +    H  LV
Sbjct: 160 DIHEELGTGAFGVVHR--VTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 217
Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNL-KPNWNLRTNIAFQIARGLLYLHEDCRA 640
            L    ++    +++YEF++ G L   +     K + +       Q+ +GL ++HE+   
Sbjct: 218 NLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN--- 274
Query: 641 QIIHCDIKPQNILLDDYYT--ARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNS 698
             +H D+KP+NI+     +   ++ DFGL   L   QS  + T   GT  + APE     
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAEGK 331
Query: 699 KITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 730
            +    D++S GVL   ++S    F  E  +E
Sbjct: 332 PVGYYTDMWSVGVLSYILLSGLSPFGGENDDE 363

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 104/215 (48%), Gaps = 39/215 (18%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           VG G++G V      T+T    VAVKKL R FQ     +R ++ E+ ++    H+N++ L
Sbjct: 37  VGSGAYGSVC-AAFDTKTGLR-VAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 93
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTN----IAFQIARGLLYLH 635
           L      ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H
Sbjct: 94  LDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 149
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
               A IIH D+KP N+ +++    +I DFGLA+           TA   T GYVA  W+
Sbjct: 150 S---ADIIHRDLKPSNLAVNEDCELKILDFGLAR----------HTADEMT-GYVATRWY 195
Query: 696 RNSKIT-------AKVDVYSFGVLLLEIISCRKSF 723
           R  +I          VD++S G ++ E+++ R  F
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 230

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 104/215 (48%), Gaps = 39/215 (18%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           VG G++G V      T+T    VAVKKL R FQ     +R ++ E+ ++    H+N++ L
Sbjct: 37  VGSGAYGSVC-AAFDTKTGLR-VAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 93
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTN----IAFQIARGLLYLH 635
           L      ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H
Sbjct: 94  LDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 149
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
               A IIH D+KP N+ +++    +I DFGLA+           TA   T GYVA  W+
Sbjct: 150 S---ADIIHRDLKPSNLAVNEDCELKILDFGLAR----------HTADEMT-GYVATRWY 195
Query: 696 RNSKIT-------AKVDVYSFGVLLLEIISCRKSF 723
           R  +I          VD++S G ++ E+++ R  F
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 230

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 103/198 (52%), Gaps = 12/198 (6%)
Query: 527 VGRGSFGIVYKG--VIQTRTSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G G+FG VYKG  + +       VA+K+L +       +E  +E +V+    + ++ RL
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 86
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           LG C     +L++ + +  G L  ++     N+   + L  N   QIA+G+ YL ED R 
Sbjct: 87  LGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYL-EDRR- 141
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            ++H D+  +N+L+      +I+DFGLAKLL   + +      +    ++A E   +   
Sbjct: 142 -LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 200
Query: 701 TAKVDVYSFGVLLLEIIS 718
           T + DV+S+GV + E+++
Sbjct: 201 THQSDVWSYGVTVWELMT 218

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 96/199 (48%), Gaps = 17/199 (8%)
Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDR-VFQDGEREFKNEVFVIGQTHHKNLV 581
           FK ++G G+FG V+  +++ R+S     +K +++   Q    + + E+ V+    H N++
Sbjct: 26  FKRKLGSGAFGDVH--LVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR----TNIAFQIARGLLYLHED 637
           ++    ++  N  +V E    G L   +         L       +  Q+   L Y H  
Sbjct: 84  KIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ 143
Query: 638 CRAQIIHCDIKPQNILLDD---YYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 694
               ++H D+KP+NIL  D   +   +I DFGLA+L    +S    T   GT  Y+APE 
Sbjct: 144 ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF---KSDEHSTNAAGTALYMAPEV 197
Query: 695 FRNSKITAKVDVYSFGVLL 713
           F+   +T K D++S GV++
Sbjct: 198 FKRD-VTFKCDIWSAGVVM 215

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 12/207 (5%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG---EREFKNEVFVIGQTHHKNLVRL 583
           +G+G FG VY  + + R S   +A+K L +   +    E + + EV +     H N++RL
Sbjct: 20  LGKGKFGNVY--LARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRL 77
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
            G+  +     L+ E+   GT+   L    + +         ++A  L Y H     ++I
Sbjct: 78  YGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSK---RVI 134
Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK 703
           H DIKP+N+LL      +I+DFG     +++   + +  + GT  Y+ PE         K
Sbjct: 135 HRDIKPENLLLGSNGELKIADFG----WSVHAPSSRRDTLCGTLDYLPPEMIEGRMHDEK 190
Query: 704 VDVYSFGVLLLEIISCRKSFDIEMGEE 730
           VD++S GVL  E +     F+    +E
Sbjct: 191 VDLWSLGVLCYEFLVGMPPFEAHTYQE 217

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 103/198 (52%), Gaps = 12/198 (6%)
Query: 527 VGRGSFGIVYKG--VIQTRTSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G G+FG VYKG  + +       VA+K+L +       +E  +E +V+    + ++ RL
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           LG C     +L++ + +  G L  ++     N+   + L  N   QIA+G+ YL ED R 
Sbjct: 85  LGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYL-EDRR- 139
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            ++H D+  +N+L+      +I+DFGLAKLL   + +      +    ++A E   +   
Sbjct: 140 -LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 198
Query: 701 TAKVDVYSFGVLLLEIIS 718
           T + DV+S+GV + E+++
Sbjct: 199 THQSDVWSYGVTVWELMT 216

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 103/198 (52%), Gaps = 12/198 (6%)
Query: 527 VGRGSFGIVYKG--VIQTRTSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G G+FG VYKG  + +       VA+K+L +       +E  +E +V+    + ++ RL
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 83
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           LG C     +L++ + +  G L  ++     N+   + L  N   QIA+G+ YL ED R 
Sbjct: 84  LGICLTSTVQLIM-QLMPFGXLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYL-EDRR- 138
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            ++H D+  +N+L+      +I+DFGLAKLL   + +      +    ++A E   +   
Sbjct: 139 -LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 197
Query: 701 TAKVDVYSFGVLLLEIIS 718
           T + DV+S+GV + E+++
Sbjct: 198 THQSDVWSYGVTVWELMT 215

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 103/198 (52%), Gaps = 12/198 (6%)
Query: 527 VGRGSFGIVYKG--VIQTRTSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G G+FG VYKG  + +       VA+K+L +       +E  +E +V+    + ++ RL
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           LG C     +L++ + +  G L  ++     N+   + L  N   QIA+G+ YL ED R 
Sbjct: 86  LGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYL-EDRR- 140
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            ++H D+  +N+L+      +I+DFGLAKLL   + +      +    ++A E   +   
Sbjct: 141 -LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 199
Query: 701 TAKVDVYSFGVLLLEIIS 718
           T + DV+S+GV + E+++
Sbjct: 200 THQSDVWSYGVTVWELMT 217

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 109/209 (52%), Gaps = 25/209 (11%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGER-EFKNEVFVIGQTHHKNLVRL 583
           +++G G++  VYKG  +++ +   VA+K++    ++G       EV ++    H N+V L
Sbjct: 8   DKLGEGTYATVYKG--KSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTL 65
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ 641
                  ++  LV+E+L+   L  +L   GN+    N++  + FQ+ RGL Y H   R +
Sbjct: 66  HDIIHTEKSLTLVFEYLDKD-LKQYLDDCGNIINMHNVKLFL-FQLLRGLAYCH---RQK 120
Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI- 700
           ++H D+KPQN+L+++    +++DFGLA+      +K+I T     +  V   W+R   I 
Sbjct: 121 VLHRDLKPQNLLINERGELKLADFGLAR------AKSIPTKTYDNE--VVTLWYRPPDIL 172
Query: 701 ------TAKVDVYSFGVLLLEIISCRKSF 723
                 + ++D++  G +  E+ + R  F
Sbjct: 173 LGSTDYSTQIDMWGVGCIFYEMATGRPLF 201

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 103/198 (52%), Gaps = 12/198 (6%)
Query: 527 VGRGSFGIVYKG--VIQTRTSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G G+FG VYKG  + +       VA+K+L +       +E  +E +V+    + ++ RL
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 83
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           LG C     +L++ + +  G L  ++     N+   + L  N   QIA+G+ YL ED R 
Sbjct: 84  LGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYL-EDRR- 138
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            ++H D+  +N+L+      +I+DFGLAKLL   + +      +    ++A E   +   
Sbjct: 139 -LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 197
Query: 701 TAKVDVYSFGVLLLEIIS 718
           T + DV+S+GV + E+++
Sbjct: 198 THQSDVWSYGVTVWELMT 215

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 104/215 (48%), Gaps = 39/215 (18%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           VG G++G V      T+T    VAVKKL R FQ     +R ++ E+ ++    H+N++ L
Sbjct: 37  VGSGAYGSVC-AAFDTKTGLR-VAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 93
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTN----IAFQIARGLLYLH 635
           L      ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H
Sbjct: 94  LDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 149
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
               A IIH D+KP N+ +++    +I DFGLA+           TA   T GYVA  W+
Sbjct: 150 S---ADIIHRDLKPSNLAVNEDCELKILDFGLAR----------HTADEMT-GYVATRWY 195
Query: 696 RNSKIT-------AKVDVYSFGVLLLEIISCRKSF 723
           R  +I          VD++S G ++ E+++ R  F
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 230

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 104/217 (47%), Gaps = 25/217 (11%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE-FKNEVFVIGQTHHKNL 580
             KE +G G FG V + + Q   +   VA+K+  +      RE +  E+ ++ + +H N+
Sbjct: 18  EMKERLGTGGFGYVLRWIHQD--TGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 75
Query: 581 VRLLGFCDEGQN------RLLVYEFLNNGTLASFL--FGN---LKPNWNLRTNIAFQIAR 629
           V      D  Q        LL  E+   G L  +L  F N   LK    +RT ++  I+ 
Sbjct: 76  VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG-PIRTLLS-DISS 133
Query: 630 GLLYLHEDCRAQIIHCDIKPQNILLD---DYYTARISDFGLAKLLTLNQSKTIKTAIRGT 686
            L YLHE+   +IIH D+KP+NI+L         +I D G AK   L+Q + + T   GT
Sbjct: 134 ALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK--ELDQGE-LCTEFVGT 187
Query: 687 KGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSF 723
             Y+APE     K T  VD +SFG L  E I+  + F
Sbjct: 188 LQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 224

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 104/217 (47%), Gaps = 25/217 (11%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE-FKNEVFVIGQTHHKNL 580
             KE +G G FG V + + Q   +   VA+K+  +      RE +  E+ ++ + +H N+
Sbjct: 17  EMKERLGTGGFGYVLRWIHQD--TGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 581 VRLLGFCDEGQN------RLLVYEFLNNGTLASFL--FGN---LKPNWNLRTNIAFQIAR 629
           V      D  Q        LL  E+   G L  +L  F N   LK    +RT ++  I+ 
Sbjct: 75  VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG-PIRTLLS-DISS 132
Query: 630 GLLYLHEDCRAQIIHCDIKPQNILLD---DYYTARISDFGLAKLLTLNQSKTIKTAIRGT 686
            L YLHE+   +IIH D+KP+NI+L         +I D G AK   L+Q + + T   GT
Sbjct: 133 ALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK--ELDQGE-LCTEFVGT 186
Query: 687 KGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSF 723
             Y+APE     K T  VD +SFG L  E I+  + F
Sbjct: 187 LQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 223

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 98/212 (46%), Gaps = 11/212 (5%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLV 581
           +  EE+G G+FG+V++  +  R +    A K +    +  +   + E+  +    H  LV
Sbjct: 54  DIHEELGTGAFGVVHR--VTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 111
Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNL-KPNWNLRTNIAFQIARGLLYLHEDCRA 640
            L    ++    +++YEF++ G L   +     K + +       Q+ +GL ++HE+   
Sbjct: 112 NLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN--- 168
Query: 641 QIIHCDIKPQNILLDDYYT--ARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNS 698
             +H D+KP+NI+     +   ++ DFGL   L   QS  + T   GT  + APE     
Sbjct: 169 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAEGK 225
Query: 699 KITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 730
            +    D++S GVL   ++S    F  E  +E
Sbjct: 226 PVGYYTDMWSVGVLSYILLSGLSPFGGENDDE 257

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 106/218 (48%), Gaps = 22/218 (10%)
Query: 517 EGATNNF-----KEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFV 571
           +GA N+F      E +G G FG V+K   +T T     A     R  +D E E KNE+ V
Sbjct: 82  QGAVNSFYTVSKTEILGGGRFGQVHK-CEETATGLKLAAKIIKTRGMKDKE-EVKNEISV 139
Query: 572 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAF--QI 627
           + Q  H NL++L    +   + +LV E+++ G L   +   +  ++NL     I F  QI
Sbjct: 140 MNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRI---IDESYNLTELDTILFMKQI 196
Query: 628 ARGLLYLHEDCRAQIIHCDIKPQNILL--DDYYTARISDFGLAKLLTLNQSKTIKTAIRG 685
             G+ ++H+     I+H D+KP+NIL    D    +I DFGLA+     +   +     G
Sbjct: 197 CEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF---G 250
Query: 686 TKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSF 723
           T  ++APE      ++   D++S GV+   ++S    F
Sbjct: 251 TPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPF 288

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 102/198 (51%), Gaps = 12/198 (6%)
Query: 527 VGRGSFGIVYKG--VIQTRTSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G G+FG VYKG  + +       VA+K+L +       +E  +E +V+    + ++ RL
Sbjct: 29  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 88
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           LG C     +L+  + +  G L  ++     N+   + L  N   QIA+G+ YL ED R 
Sbjct: 89  LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYL-EDRR- 143
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            ++H D+  +N+L+      +I+DFGLAKLL   + +      +    ++A E   +   
Sbjct: 144 -LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 202
Query: 701 TAKVDVYSFGVLLLEIIS 718
           T + DV+S+GV + E+++
Sbjct: 203 THQSDVWSYGVTVWELMT 220

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 103/198 (52%), Gaps = 12/198 (6%)
Query: 527 VGRGSFGIVYKG--VIQTRTSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G G+FG VYKG  + +       VA+K+L +       +E  +E +V+    + ++ RL
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           LG C     +L++ + +  G L  ++     N+   + L  N   QIA+G+ YL ED R 
Sbjct: 83  LGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYL-EDRR- 137
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            ++H D+  +N+L+      +I+DFGLAKLL   + +      +    ++A E   +   
Sbjct: 138 -LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 196
Query: 701 TAKVDVYSFGVLLLEIIS 718
           T + DV+S+GV + E+++
Sbjct: 197 THQSDVWSYGVTVWELMT 214

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 13/204 (6%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG--EREFKNEVFVIGQTHHKNLVRLL 584
           +G G++G+V       R   T VA+KK+         +R  + E+ ++ +  H+N++ + 
Sbjct: 51  IGEGAYGMVSSAYDHVRK--TRVAIKKISPFEHQTYCQRTLR-EIQILLRFRHENVIGIR 107
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF---QIARGLLYLHEDCRAQ 641
                     +   ++    + + L+  LK       +I +   QI RGL Y+H    A 
Sbjct: 108 DILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHS---AN 164
Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT-IKTAIRGTKGYVAPEWFRNSK- 699
           ++H D+KP N+L++     +I DFGLA++       T   T    T+ Y APE   NSK 
Sbjct: 165 VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNSKG 224
Query: 700 ITAKVDVYSFGVLLLEIISCRKSF 723
            T  +D++S G +L E++S R  F
Sbjct: 225 YTKSIDIWSVGCILAEMLSNRPIF 248

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 102/198 (51%), Gaps = 12/198 (6%)
Query: 527 VGRGSFGIVYKG--VIQTRTSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G G+FG VYKG  + +       VA+K+L +       +E  +E +V+    + ++ RL
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           LG C     +L+  + +  G L  ++     N+   + L  N   QIA+G+ YL ED R 
Sbjct: 85  LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYL-EDRR- 139
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            ++H D+  +N+L+      +I+DFGLAKLL   + +      +    ++A E   +   
Sbjct: 140 -LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 198
Query: 701 TAKVDVYSFGVLLLEIIS 718
           T + DV+S+GV + E+++
Sbjct: 199 THQSDVWSYGVTVWELMT 216

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 102/198 (51%), Gaps = 12/198 (6%)
Query: 527 VGRGSFGIVYKG--VIQTRTSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G G+FG VYKG  + +       VA+K+L +       +E  +E +V+    + ++ RL
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           LG C     +L+  + +  G L  ++     N+   + L  N   QIA+G+ YL ED R 
Sbjct: 86  LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYL-EDRR- 140
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            ++H D+  +N+L+      +I+DFGLAKLL   + +      +    ++A E   +   
Sbjct: 141 -LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 199
Query: 701 TAKVDVYSFGVLLLEIIS 718
           T + DV+S+GV + E+++
Sbjct: 200 THQSDVWSYGVTVWELMT 217

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 102/198 (51%), Gaps = 12/198 (6%)
Query: 527 VGRGSFGIVYKG--VIQTRTSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G G+FG VYKG  + +       VA+K+L +       +E  +E +V+    + ++ RL
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           LG C     +L+  + +  G L  ++     N+   + L  N   QIA+G+ YL ED R 
Sbjct: 86  LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYL-EDRR- 140
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            ++H D+  +N+L+      +I+DFGLAKLL   + +      +    ++A E   +   
Sbjct: 141 -LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 199
Query: 701 TAKVDVYSFGVLLLEIIS 718
           T + DV+S+GV + E+++
Sbjct: 200 THQSDVWSYGVTVWELMT 217

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 102/198 (51%), Gaps = 12/198 (6%)
Query: 527 VGRGSFGIVYKG--VIQTRTSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G G+FG VYKG  + +       VA+K+L +       +E  +E +V+    + ++ RL
Sbjct: 48  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 107
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           LG C     +L+  + +  G L  ++     N+   + L  N   QIA+G+ YL ED R 
Sbjct: 108 LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYL-EDRR- 162
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            ++H D+  +N+L+      +I+DFGLAKLL   + +      +    ++A E   +   
Sbjct: 163 -LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 221
Query: 701 TAKVDVYSFGVLLLEIIS 718
           T + DV+S+GV + E+++
Sbjct: 222 THQSDVWSYGVTVWELMT 239

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 96/197 (48%), Gaps = 14/197 (7%)
Query: 527 VGRGSFGIVYKGV-IQTRTSTTAVAVKKLDRVFQDGERE-FKNEVFVIGQTHHKNLVRLL 584
           +G G FG V++G+ +       AVA+K       D  RE F  E   + Q  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNI--AFQIARGLLYLHEDCRAQI 642
           G   E     ++ E    G L SFL    K + +L + I  A+Q++  L YL      + 
Sbjct: 78  GVITENPV-WIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESK---RF 132
Query: 643 IHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK--GYVAPEWFRNSKI 700
           +H DI  +N+L+      ++ DFGL++ +   +  T   A +G     ++APE     + 
Sbjct: 133 VHRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTXXKASKGKLPIKWMAPESINFRRF 189
Query: 701 TAKVDVYSFGVLLLEII 717
           T+  DV+ FGV + EI+
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 98/205 (47%), Gaps = 15/205 (7%)
Query: 527 VGRGSFGIV---YKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G G++G+V   Y  V + R +   ++  +     Q   RE K    ++ +  H+N++ +
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIK----ILLRFRHENIIGI 106
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF---QIARGLLYLHEDCRA 640
                      +   +L    + + L+  LK       +I +   QI RGL Y+H    A
Sbjct: 107 NDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---A 163
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT-IKTAIRGTKGYVAPEWFRNSK 699
            ++H D+KP N+LL+     +I DFGLA++   +   T   T    T+ Y APE   NSK
Sbjct: 164 NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 223
Query: 700 -ITAKVDVYSFGVLLLEIISCRKSF 723
             T  +D++S G +L E++S R  F
Sbjct: 224 GYTKSIDIWSVGCILAEMLSNRPIF 248

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 102/198 (51%), Gaps = 12/198 (6%)
Query: 527 VGRGSFGIVYKG--VIQTRTSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G G+FG VYKG  + +       VA+K+L +       +E  +E +V+    + ++ RL
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           LG C     +L+  + +  G L  ++     N+   + L  N   QIA+G+ YL ED R 
Sbjct: 86  LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYL-EDRR- 140
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            ++H D+  +N+L+      +I+DFGLAKLL   + +      +    ++A E   +   
Sbjct: 141 -LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 199
Query: 701 TAKVDVYSFGVLLLEIIS 718
           T + DV+S+GV + E+++
Sbjct: 200 THQSDVWSYGVTVWELMT 217

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 107/221 (48%), Gaps = 27/221 (12%)
Query: 519 ATNNFKE--EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFK----NEVFVI 572
           AT+ ++   E+G G++G VYK   +   S   VA+K + RV  +GE         EV ++
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKA--RDPHSGHFVALKSV-RV-PNGEEGLPISTVREVALL 57
Query: 573 GQTH---HKNLVRLLGFC-----DEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--N 622
            +     H N+VRL+  C     D      LV+E ++   L ++L     P     T  +
Sbjct: 58  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQD-LRTYLDKAPPPGLPAETIKD 116
Query: 623 IAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTA 682
           +  Q  RGL +LH +C   I+H D+KP+NIL+    T +++DFGLA++ +   +      
Sbjct: 117 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA---LAP 170
Query: 683 IRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSF 723
           +  T  Y APE    S     VD++S G +  E+   +  F
Sbjct: 171 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLF 211

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 102/198 (51%), Gaps = 12/198 (6%)
Query: 527 VGRGSFGIVYKG--VIQTRTSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G G+FG VYKG  + +       VA+K+L +       +E  +E +V+    + ++ RL
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           LG C     +L+  + +  G L  ++     N+   + L  N   QIA+G+ YL ED R 
Sbjct: 83  LGICLTSTVQLIT-QLMPFGXLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYL-EDRR- 137
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            ++H D+  +N+L+      +I+DFGLAKLL   + +      +    ++A E   +   
Sbjct: 138 -LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 196
Query: 701 TAKVDVYSFGVLLLEIIS 718
           T + DV+S+GV + E+++
Sbjct: 197 THQSDVWSYGVTVWELMT 214

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 90/192 (46%), Gaps = 8/192 (4%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLL 584
           EE+G+G+F +V + V +T T   A  +    ++     ++ + E  +     H N+VRL 
Sbjct: 37  EELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 96
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIH 644
               E     LV++ +  G L   +      +    ++   QI   + ++H+     I+H
Sbjct: 97  DSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIHQH---DIVH 153
Query: 645 CDIKPQNILLDDY---YTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKIT 701
            D+KP+N+LL         +++DFGLA  +   Q      A  GT GY++PE  R     
Sbjct: 154 RDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFA--GTPGYLSPEVLRKDPYG 211
Query: 702 AKVDVYSFGVLL 713
             VD+++ GV+L
Sbjct: 212 KPVDIWACGVIL 223

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 102/215 (47%), Gaps = 20/215 (9%)
Query: 521 NNF----KEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTH 576
           NNF     +E+GRG F +V + + ++     A    K  R  QD   E  +E+ V+    
Sbjct: 27  NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELA- 85
Query: 577 HKNLVRLLGFCDEGQNR---LLVYEFLNNGTLASFLFGNLKP--NWNLRTNIAFQIARGL 631
            K+  R++   +  +N    +L+ E+   G + S     L    + N    +  QI  G+
Sbjct: 86  -KSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGV 144
Query: 632 LYLHEDCRAQIIHCDIKPQNILLDDYYT---ARISDFGLAKLLTLNQSKTIKTAIRGTKG 688
            YLH++    I+H D+KPQNILL   Y     +I DFG+++   +  +  ++  I GT  
Sbjct: 145 YYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR--KIGHACELR-EIMGTPE 198
Query: 689 YVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSF 723
           Y+APE      IT   D+++ G++   +++    F
Sbjct: 199 YLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPF 233

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 102/198 (51%), Gaps = 12/198 (6%)
Query: 527 VGRGSFGIVYKG--VIQTRTSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G G+FG VYKG  + +       VA+K+L +       +E  +E +V+    + ++ RL
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           LG C     +L+  + +  G L  ++     N+   + L  N   QIA+G+ YL ED R 
Sbjct: 90  LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYL-EDRR- 144
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            ++H D+  +N+L+      +I+DFGLAKLL   + +      +    ++A E   +   
Sbjct: 145 -LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 203
Query: 701 TAKVDVYSFGVLLLEIIS 718
           T + DV+S+GV + E+++
Sbjct: 204 THQSDVWSYGVTVWELMT 221

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 98/195 (50%), Gaps = 16/195 (8%)
Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGEREFKNEVFVIGQTHHKNL 580
           F E +G G+F  V+  +++ R +    A+K + +   F+D   E  NE+ V+ +  H+N+
Sbjct: 13  FMEVLGSGAFSEVF--LVKQRLTGKLFALKCIKKSPAFRDSSLE--NEIAVLKKIKHENI 68
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           V L    +   +  LV + ++ G L   +           + +  Q+   + YLHE+   
Sbjct: 69  VTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN--- 125
Query: 641 QIIHCDIKPQNILL---DDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRN 697
            I+H D+KP+N+L    ++     I+DFGL+K+    Q+  + TA  GT GYVAPE    
Sbjct: 126 GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM---EQNGIMSTAC-GTPGYVAPEVLAQ 181
Query: 698 SKITAKVDVYSFGVL 712
              +  VD +S GV+
Sbjct: 182 KPYSKAVDCWSIGVI 196

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 102/198 (51%), Gaps = 12/198 (6%)
Query: 527 VGRGSFGIVYKG--VIQTRTSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G G+FG VYKG  + +       VA+K+L +       +E  +E +V+    + ++ RL
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           LG C     +L+  + +  G L  ++     N+   + L  N   QIA+G+ YL ED R 
Sbjct: 83  LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYL-EDRR- 137
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            ++H D+  +N+L+      +I+DFGLAKLL   + +      +    ++A E   +   
Sbjct: 138 -LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 196
Query: 701 TAKVDVYSFGVLLLEIIS 718
           T + DV+S+GV + E+++
Sbjct: 197 THQSDVWSYGVTVWELMT 214

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 102/198 (51%), Gaps = 12/198 (6%)
Query: 527 VGRGSFGIVYKG--VIQTRTSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G G+FG VYKG  + +       VA+K+L +       +E  +E +V+    + ++ RL
Sbjct: 33  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 92
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           LG C     +L+  + +  G L  ++     N+   + L  N   QIA+G+ YL ED R 
Sbjct: 93  LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYL-EDRR- 147
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            ++H D+  +N+L+      +I+DFGLAKLL   + +      +    ++A E   +   
Sbjct: 148 -LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 206
Query: 701 TAKVDVYSFGVLLLEIIS 718
           T + DV+S+GV + E+++
Sbjct: 207 THQSDVWSYGVTVWELMT 224

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 39/215 (18%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           VG G++G V      T+T    VAVKKL R FQ     +R ++ E+ ++    H+N++ L
Sbjct: 30  VGSGAYGSVC-AAFDTKTGLR-VAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 86
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTN----IAFQIARGLLYLH 635
           L      ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H
Sbjct: 87  LDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIH 142
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
               A IIH D+KP N+ +++    +I DFGLA+      +           GYVA  W+
Sbjct: 143 S---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMT-----------GYVATRWY 188
Query: 696 RNSKIT-------AKVDVYSFGVLLLEIISCRKSF 723
           R  +I          VD++S G ++ E+++ R  F
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 96/197 (48%), Gaps = 14/197 (7%)
Query: 527 VGRGSFGIVYKGV-IQTRTSTTAVAVKKLDRVFQDGERE-FKNEVFVIGQTHHKNLVRLL 584
           +G G FG V++G+ +       AVA+K       D  RE F  E   + Q  H ++V+L+
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNI--AFQIARGLLYLHEDCRAQI 642
           G   E     ++ E    G L SFL    K + +L + I  A+Q++  L YL      + 
Sbjct: 106 GVITENPV-WIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESK---RF 160
Query: 643 IHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK--GYVAPEWFRNSKI 700
           +H DI  +N+L+      ++ DFGL++ +   +  T   A +G     ++APE     + 
Sbjct: 161 VHRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESINFRRF 217
Query: 701 TAKVDVYSFGVLLLEII 717
           T+  DV+ FGV + EI+
Sbjct: 218 TSASDVWMFGVCMWEIL 234

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 102/198 (51%), Gaps = 12/198 (6%)
Query: 527 VGRGSFGIVYKG--VIQTRTSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G G+FG VYKG  + +       VA+K+L +       +E  +E +V+    + ++ RL
Sbjct: 17  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 76
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           LG C     +L+  + +  G L  ++     N+   + L  N   QIA+G+ YL ED R 
Sbjct: 77  LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYL-EDRR- 131
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            ++H D+  +N+L+      +I+DFGLAKLL   + +      +    ++A E   +   
Sbjct: 132 -LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 190
Query: 701 TAKVDVYSFGVLLLEIIS 718
           T + DV+S+GV + E+++
Sbjct: 191 THQSDVWSYGVTVWELMT 208

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 96/197 (48%), Gaps = 14/197 (7%)
Query: 527 VGRGSFGIVYKGV-IQTRTSTTAVAVKKLDRVFQDGERE-FKNEVFVIGQTHHKNLVRLL 584
           +G G FG V++G+ +       AVA+K       D  RE F  E   + Q  H ++V+L+
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNI--AFQIARGLLYLHEDCRAQI 642
           G   E     ++ E    G L SFL    K + +L + I  A+Q++  L YL      + 
Sbjct: 83  GVITENPV-WIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESK---RF 137
Query: 643 IHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK--GYVAPEWFRNSKI 700
           +H DI  +N+L+      ++ DFGL++ +   +  T   A +G     ++APE     + 
Sbjct: 138 VHRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESINFRRF 194
Query: 701 TAKVDVYSFGVLLLEII 717
           T+  DV+ FGV + EI+
Sbjct: 195 TSASDVWMFGVCMWEIL 211

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 14/207 (6%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR-VFQDGERE-FKNEVFVIGQTHHKNLVRLL 584
           +G GS+G   K  I+ ++    +  K+LD     + E++   +EV ++ +  H N+VR  
Sbjct: 14  IGTGSYGRCQK--IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 585 GFCDEGQNRLL--VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ- 641
               +  N  L  V E+   G LAS +    K    L      ++   L    ++C  + 
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 642 -----IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR 696
                ++H D+KP N+ LD     ++ DFGLA++  LN   +   A  GT  Y++PE   
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKAFVGTPYYMSPEQMN 189
Query: 697 NSKITAKVDVYSFGVLLLEIISCRKSF 723
                 K D++S G LL E+ +    F
Sbjct: 190 RMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 96/197 (48%), Gaps = 14/197 (7%)
Query: 527 VGRGSFGIVYKGV-IQTRTSTTAVAVKKLDRVFQDGERE-FKNEVFVIGQTHHKNLVRLL 584
           +G G FG V++G+ +       AVA+K       D  RE F  E   + Q  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNI--AFQIARGLLYLHEDCRAQI 642
           G   E     ++ E    G L SFL    K + +L + I  A+Q++  L YL      + 
Sbjct: 78  GVITENPV-WIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESK---RF 132
Query: 643 IHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK--GYVAPEWFRNSKI 700
           +H DI  +N+L+      ++ DFGL++ +   +  T   A +G     ++APE     + 
Sbjct: 133 VHRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESINFRRF 189
Query: 701 TAKVDVYSFGVLLLEII 717
           T+  DV+ FGV + EI+
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 87/189 (46%), Gaps = 22/189 (11%)
Query: 563 REFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN 622
            E  NE+ ++    H N+++L    ++ +   LV EF   G L   +    K +     N
Sbjct: 91  EEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAAN 150
Query: 623 IAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDD---YYTARISDFGLAKLLTLNQSKTI 679
           I  QI  G+ YLH   +  I+H DIKP+NILL++       +I DFGL+       SK  
Sbjct: 151 IMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF----SKDY 203
Query: 680 KTAIR-GTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSF----------DIEMG 728
           K   R GT  Y+APE  +  K   K DV+S GV++  ++     F           +E G
Sbjct: 204 KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKG 262
Query: 729 EEYAILTDW 737
           + Y    DW
Sbjct: 263 KYYFDFNDW 271

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 96/197 (48%), Gaps = 14/197 (7%)
Query: 527 VGRGSFGIVYKGV-IQTRTSTTAVAVKKLDRVFQDGERE-FKNEVFVIGQTHHKNLVRLL 584
           +G G FG V++G+ +       AVA+K       D  RE F  E   + Q  H ++V+L+
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNI--AFQIARGLLYLHEDCRAQI 642
           G   E     ++ E    G L SFL    K + +L + I  A+Q++  L YL      + 
Sbjct: 81  GVITENPV-WIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESK---RF 135
Query: 643 IHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK--GYVAPEWFRNSKI 700
           +H DI  +N+L+      ++ DFGL++ +   +  T   A +G     ++APE     + 
Sbjct: 136 VHRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESINFRRF 192
Query: 701 TAKVDVYSFGVLLLEII 717
           T+  DV+ FGV + EI+
Sbjct: 193 TSASDVWMFGVCMWEIL 209

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 7/211 (3%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKN-EVFVIGQTHHKNL 580
           NF   +G+GSFG V     +      A+ + K D V QD + E    E  V+        
Sbjct: 22  NFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPF 81
Query: 581 VRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCR 639
           +  L  C +  +RL  V E++N G L   +    K         A +I+ GL +LH   +
Sbjct: 82  LTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLH---K 138
Query: 640 AQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSK 699
             II+ D+K  N++LD     +I+DFG+ K   ++   T +    GT  Y+APE      
Sbjct: 139 RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFC--GTPDYIAPEIIAYQP 196
Query: 700 ITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 730
               VD +++GVLL E+++ +  FD E  +E
Sbjct: 197 YGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE 227

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 102/198 (51%), Gaps = 12/198 (6%)
Query: 527 VGRGSFGIVYKG--VIQTRTSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G G+FG VYKG  + +       VA+K+L +       +E  +E +V+    + ++ RL
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           LG C     +L+  + +  G L  ++     N+   + L  N   QIA+G+ YL ED R 
Sbjct: 83  LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYL-EDRR- 137
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            ++H D+  +N+L+      +I+DFGLAKLL   + +      +    ++A E   +   
Sbjct: 138 -LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 196
Query: 701 TAKVDVYSFGVLLLEIIS 718
           T + DV+S+GV + E+++
Sbjct: 197 THQSDVWSYGVTVWELMT 214

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 107/221 (48%), Gaps = 27/221 (12%)
Query: 519 ATNNFKE--EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFK----NEVFVI 572
           AT+ ++   E+G G++G VYK   +   S   VA+K + RV  +GE         EV ++
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKA--RDPHSGHFVALKSV-RV-PNGEEGLPISTVREVALL 57
Query: 573 GQTH---HKNLVRLLGFC-----DEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--N 622
            +     H N+VRL+  C     D      LV+E ++   L ++L     P     T  +
Sbjct: 58  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQD-LRTYLDKAPPPGLPAETIKD 116
Query: 623 IAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTA 682
           +  Q  RGL +LH +C   I+H D+KP+NIL+    T +++DFGLA++ +   +      
Sbjct: 117 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA---LDP 170
Query: 683 IRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSF 723
           +  T  Y APE    S     VD++S G +  E+   +  F
Sbjct: 171 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLF 211

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 96/197 (48%), Gaps = 14/197 (7%)
Query: 527 VGRGSFGIVYKGV-IQTRTSTTAVAVKKLDRVFQDGERE-FKNEVFVIGQTHHKNLVRLL 584
           +G G FG V++G+ +       AVA+K       D  RE F  E   + Q  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNI--AFQIARGLLYLHEDCRAQI 642
           G   E     ++ E    G L SFL    K + +L + I  A+Q++  L YL      + 
Sbjct: 78  GVITENPV-WIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESK---RF 132
Query: 643 IHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK--GYVAPEWFRNSKI 700
           +H DI  +N+L+      ++ DFGL++ +   +  T   A +G     ++APE     + 
Sbjct: 133 VHRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESINFRRF 189
Query: 701 TAKVDVYSFGVLLLEII 717
           T+  DV+ FGV + EI+
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 15/205 (7%)
Query: 527 VGRGSFGIV---YKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G G++G+V   Y  V + R +   ++  +     Q   RE K    ++ +  H+N++ +
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIK----ILLRFRHENIIGI 86
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF---QIARGLLYLHEDCRA 640
                      +   ++    + + L+  LK       +I +   QI RGL Y+H    A
Sbjct: 87  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---A 143
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT-IKTAIRGTKGYVAPEWFRNSK 699
            ++H D+KP N+LL+     +I DFGLA++   +   T   T    T+ Y APE   NSK
Sbjct: 144 NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 700 -ITAKVDVYSFGVLLLEIISCRKSF 723
             T  +D++S G +L E++S R  F
Sbjct: 204 GYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 96/197 (48%), Gaps = 14/197 (7%)
Query: 527 VGRGSFGIVYKGV-IQTRTSTTAVAVKKLDRVFQDGERE-FKNEVFVIGQTHHKNLVRLL 584
           +G G FG V++G+ +       AVA+K       D  RE F  E   + Q  H ++V+L+
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNI--AFQIARGLLYLHEDCRAQI 642
           G   E     ++ E    G L SFL    K + +L + I  A+Q++  L YL      + 
Sbjct: 80  GVITENPV-WIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESK---RF 134
Query: 643 IHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK--GYVAPEWFRNSKI 700
           +H DI  +N+L+      ++ DFGL++ +   +  T   A +G     ++APE     + 
Sbjct: 135 VHRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESINFRRF 191
Query: 701 TAKVDVYSFGVLLLEII 717
           T+  DV+ FGV + EI+
Sbjct: 192 TSASDVWMFGVCMWEIL 208

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 39/215 (18%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           VG G++G V      T+T    VAVKKL R FQ     +R ++ E+ ++    H+N++ L
Sbjct: 30  VGSGAYGSVC-AAFDTKTGLR-VAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 86
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTN----IAFQIARGLLYLH 635
           L      ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H
Sbjct: 87  LDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIH 142
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
               A IIH D+KP N+ +++    +I DFGLA+      +           GYVA  W+
Sbjct: 143 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWY 188
Query: 696 RNSKIT-------AKVDVYSFGVLLLEIISCRKSF 723
           R  +I          VD++S G ++ E+++ R  F
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 111/236 (47%), Gaps = 19/236 (8%)
Query: 492 KKWIRNSPDDGTIETNLRCFSYKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAV 551
           +K + NS   GT +   R F+  + E         +G+G FG VY  + + + S   VA+
Sbjct: 3   QKVMENS--SGTPDILTRHFTIDDFE-----IGRPLGKGKFGNVY--LAREKKSHFIVAL 53
Query: 552 KKL--DRVFQDG-EREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASF 608
           K L   ++ ++G E + + E+ +    HH N++RL  +  + +   L+ E+   G L   
Sbjct: 54  KVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKE 113
Query: 609 LFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLA 668
           L  +   +      I  ++A  L+Y H     ++IH DIKP+N+LL      +I+DFG  
Sbjct: 114 LQKSCTFDEQRTATIMEELADALMYCHGK---KVIHRDIKPENLLLGLKGELKIADFG-- 168
Query: 669 KLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFD 724
              +++     +  + GT  Y+ PE         KVD++  GVL  E++     F+
Sbjct: 169 --WSVHAPSLRRKTMCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFE 222

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 96/197 (48%), Gaps = 14/197 (7%)
Query: 527 VGRGSFGIVYKGV-IQTRTSTTAVAVKKLDRVFQDGERE-FKNEVFVIGQTHHKNLVRLL 584
           +G G FG V++G+ +       AVA+K       D  RE F  E   + Q  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNI--AFQIARGLLYLHEDCRAQI 642
           G   E     ++ E    G L SFL    K + +L + I  A+Q++  L YL      + 
Sbjct: 78  GVITENPV-WIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESK---RF 132
Query: 643 IHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK--GYVAPEWFRNSKI 700
           +H DI  +N+L+      ++ DFGL++ +   +  T   A +G     ++APE     + 
Sbjct: 133 VHRDIAARNVLVSATDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESINFRRF 189
Query: 701 TAKVDVYSFGVLLLEII 717
           T+  DV+ FGV + EI+
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 124/282 (43%), Gaps = 35/282 (12%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLL 584
           E +G+G FG VY G         A+ +  ++R  +D  + FK EV    QT H+N+V  +
Sbjct: 39  ELIGKGRFGQVYHGRWH---GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLF-GNLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
           G C    +  ++       TL S +    +  + N    IA +I +G+ YLH      I+
Sbjct: 96  GACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---IL 152
Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKG---YVAPEWFRNSK- 699
           H D+K +N+  D+     I+DFGL  +  + Q+   +  +R   G   ++APE  R    
Sbjct: 153 HKDLKSKNVFYDNGKVV-ITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSP 211
Query: 700 --------ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLV 751
                    +   DV++ G +  E+ +    F  +  E  AI+  W         L+  +
Sbjct: 212 DTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE--AII--WQMGTGMKPNLSQ-I 266
Query: 752 GEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
           G  KE  +        +++  W  +++   RPT  K++ MLE
Sbjct: 267 GMGKEISD--------ILLFCWAFEQEE--RPTFTKLMDMLE 298

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 104/223 (46%), Gaps = 28/223 (12%)
Query: 519 ATNNFKE--EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQT- 575
           AT+ ++   E+G G++G VYK   +   S   VA+K + RV   G       +  + +  
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKA--RDPHSGHFVALKSV-RVPNGGGGGGGLPISTVREVA 63
Query: 576 --------HHKNLVRLLGFC-----DEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT- 621
                    H N+VRL+  C     D      LV+E ++   L ++L     P     T 
Sbjct: 64  LLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQD-LRTYLDKAPPPGLPAETI 122
Query: 622 -NIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIK 680
            ++  Q  RGL +LH +C   I+H D+KP+NIL+    T +++DFGLA++ +   +    
Sbjct: 123 KDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA---L 176
Query: 681 TAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSF 723
           T +  T  Y APE    S     VD++S G +  E+   +  F
Sbjct: 177 TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLF 219

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 39/215 (18%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           VG G++G V      T+T    VAVKKL R FQ     +R ++ E+ ++    H+N++ L
Sbjct: 41  VGSGAYGSVC-AAFDTKTGLR-VAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 97
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTN----IAFQIARGLLYLH 635
           L      ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H
Sbjct: 98  LDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 153
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
               A IIH D+KP N+ +++    +I DFGLA+      +           GYVA  W+
Sbjct: 154 S---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMT-----------GYVATRWY 199
Query: 696 RNSKIT-------AKVDVYSFGVLLLEIISCRKSF 723
           R  +I          VD++S G ++ E+++ R  F
Sbjct: 200 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 234

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 96/197 (48%), Gaps = 14/197 (7%)
Query: 527 VGRGSFGIVYKGV-IQTRTSTTAVAVKKLDRVFQDGERE-FKNEVFVIGQTHHKNLVRLL 584
           +G G FG V++G+ +       AVA+K       D  RE F  E   + Q  H ++V+L+
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNI--AFQIARGLLYLHEDCRAQI 642
           G   E     ++ E    G L SFL    K + +L + I  A+Q++  L YL      + 
Sbjct: 75  GVITENPV-WIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESK---RF 129
Query: 643 IHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK--GYVAPEWFRNSKI 700
           +H DI  +N+L+      ++ DFGL++ +   +  T   A +G     ++APE     + 
Sbjct: 130 VHRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESINFRRF 186
Query: 701 TAKVDVYSFGVLLLEII 717
           T+  DV+ FGV + EI+
Sbjct: 187 TSASDVWMFGVCMWEIL 203

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 15/205 (7%)
Query: 527 VGRGSFGIV---YKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G G++G+V   Y  V + R +   ++  +     Q   RE K    ++ +  H+N++ +
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIK----ILLRFRHENIIGI 86
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF---QIARGLLYLHEDCRA 640
                      +   ++    + + L+  LK       +I +   QI RGL Y+H    A
Sbjct: 87  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---A 143
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT-IKTAIRGTKGYVAPEWFRNSK 699
            ++H D+KP N+LL+     +I DFGLA++   +   T   T    T+ Y APE   NSK
Sbjct: 144 NVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 700 -ITAKVDVYSFGVLLLEIISCRKSF 723
             T  +D++S G +L E++S R  F
Sbjct: 204 GYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 103/209 (49%), Gaps = 15/209 (7%)
Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKN 579
            +E +G GSFG V K     +T    VA+K + R      D     + E+  +    H +
Sbjct: 13  IRETLGEGSFGKV-KLATHYKTQQK-VALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70
Query: 580 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCR 639
           +++L        + ++V E+   G L  ++    +   +       QI   + Y H   R
Sbjct: 71  IIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCH---R 126
Query: 640 AQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSK 699
            +I+H D+KP+N+LLDD    +I+DFGL+ ++T      +KT+  G+  Y APE   N K
Sbjct: 127 HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT--DGNFLKTSC-GSPNYAAPEVI-NGK 182
Query: 700 ITA--KVDVYSFGVLLLEIISCRKSFDIE 726
           + A  +VDV+S G++L  ++  R  FD E
Sbjct: 183 LYAGPEVDVWSCGIVLYVMLVGRLPFDDE 211

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 39/215 (18%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           VG G++G V      T+T    VAVKKL R FQ     +R ++ E+ ++    H+N++ L
Sbjct: 35  VGSGAYGSVC-AAFDTKTGLR-VAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 91
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTN----IAFQIARGLLYLH 635
           L      ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H
Sbjct: 92  LDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 147
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
               A IIH D+KP N+ +++    +I DFGLA+      +           GYVA  W+
Sbjct: 148 S---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMT-----------GYVATRWY 193
Query: 696 RNSKIT-------AKVDVYSFGVLLLEIISCRKSF 723
           R  +I          VD++S G ++ E+++ R  F
Sbjct: 194 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 228

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 98/196 (50%), Gaps = 8/196 (4%)
Query: 527 VGRGSFGIVYKGV--IQTRTSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G G+FG VYKG+           VA+K L +       +E  +E +V+       + RL
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRL 84
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNL-KPNWNLRTNIAFQIARGLLYLHEDCRAQI 642
           LG C     +L V + +  G L   +  N  +       N   QIA+G+ YL ED R  +
Sbjct: 85  LGICLTSTVQL-VTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYL-EDVR--L 140
Query: 643 IHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITA 702
           +H D+  +N+L+      +I+DFGLA+LL +++++      +    ++A E     + T 
Sbjct: 141 VHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRRFTH 200
Query: 703 KVDVYSFGVLLLEIIS 718
           + DV+S+GV + E+++
Sbjct: 201 QSDVWSYGVTVWELMT 216

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 107/221 (48%), Gaps = 27/221 (12%)
Query: 519 ATNNFKE--EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFK----NEVFVI 572
           AT+ ++   E+G G++G VYK   +   S   VA+K + RV  +GE         EV ++
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKA--RDPHSGHFVALKSV-RV-PNGEEGLPISTVREVALL 57
Query: 573 GQTH---HKNLVRLLGFC-----DEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--N 622
            +     H N+VRL+  C     D      LV+E ++   L ++L     P     T  +
Sbjct: 58  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQD-LRTYLDKAPPPGLPAETIKD 116
Query: 623 IAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTA 682
           +  Q  RGL +LH +C   I+H D+KP+NIL+    T +++DFGLA++ +  Q       
Sbjct: 117 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY-QMALFPVV 172
Query: 683 IRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSF 723
           +  T  Y APE    S     VD++S G +  E+   +  F
Sbjct: 173 V--TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLF 211

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 97/206 (47%), Gaps = 21/206 (10%)
Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ 574
           E+   +   ++++G G FG V+   + T    T VAVK +       E  F  E  V+  
Sbjct: 178 EIPRESLKLEKKLGAGQFGEVW---MATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKT 233
Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF--QIARGLL 632
             H  LV+L     + +   ++ EF+  G+L  FL  +      L   I F  QIA G+ 
Sbjct: 234 LQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMA 292
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 692
           ++ +      IH D++  NIL+      +I+DFGLA++         K  I+ T    AP
Sbjct: 293 FIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARV-------GAKFPIKWT----AP 338
Query: 693 EWFRNSKITAKVDVYSFGVLLLEIIS 718
           E       T K DV+SFG+LL+EI++
Sbjct: 339 EAINFGSFTIKSDVWSFGILLMEIVT 364

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 15/205 (7%)
Query: 527 VGRGSFGIV---YKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G G++G+V   Y  V + R +   ++  +     Q   RE K    ++ +  H+N++ +
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIK----ILLRFRHENIIGI 86
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF---QIARGLLYLHEDCRA 640
                      +   ++    + + L+  LK       +I +   QI RGL Y+H    A
Sbjct: 87  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---A 143
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT-IKTAIRGTKGYVAPEWFRNSK 699
            ++H D+KP N+LL+     +I DFGLA++   +   T   T    T+ Y APE   NSK
Sbjct: 144 NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 700 -ITAKVDVYSFGVLLLEIISCRKSF 723
             T  +D++S G +L E++S R  F
Sbjct: 204 GYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 102/209 (48%), Gaps = 27/209 (12%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           VG G++G V      T+T    VAVKKL R FQ     +R ++ E+ ++    H+N++ L
Sbjct: 30  VGSGAYGSVC-AAFDTKTGLR-VAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 86
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTN----IAFQIARGLLYLH 635
           L      ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H
Sbjct: 87  LDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 142
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
               A IIH D+KP N+ +++    +I DFGLA+      +    T    T+ Y APE  
Sbjct: 143 S---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIM 194
Query: 696 RNS-KITAKVDVYSFGVLLLEIISCRKSF 723
            N+      VD++S G ++ E+++ R  F
Sbjct: 195 LNAMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 39/215 (18%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           VG G++G V      T+T    VAVKKL R FQ     +R ++ E+ ++    H+N++ L
Sbjct: 36  VGSGAYGSVC-AAFDTKTGLR-VAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 92
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTN----IAFQIARGLLYLH 635
           L      ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H
Sbjct: 93  LDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 148
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
               A IIH D+KP N+ +++    +I DFGLA+      +           GYVA  W+
Sbjct: 149 S---ADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMT-----------GYVATRWY 194
Query: 696 RNSKIT-------AKVDVYSFGVLLLEIISCRKSF 723
           R  +I          VD++S G ++ E+++ R  F
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 229

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 101/198 (51%), Gaps = 12/198 (6%)
Query: 527 VGRGSFGIVYKG--VIQTRTSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G G+FG VYKG  + +       VA+K+L +       +E  +E +V+    + ++ RL
Sbjct: 20  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 79
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           LG C     +L+  + +  G L  ++     N+   + L  N   QIA G+ YL ED R 
Sbjct: 80  LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAEGMNYL-EDRR- 134
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            ++H D+  +N+L+      +I+DFGLAKLL   + +      +    ++A E   +   
Sbjct: 135 -LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 193
Query: 701 TAKVDVYSFGVLLLEIIS 718
           T + DV+S+GV + E+++
Sbjct: 194 THQSDVWSYGVTVWELMT 211

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 15/205 (7%)
Query: 527 VGRGSFGIV---YKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G G++G+V   Y  V + R +   ++  +     Q   RE K    ++ +  H+N++ +
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIK----ILLRFRHENIIGI 94
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF---QIARGLLYLHEDCRA 640
                      +   ++    + + L+  LK       +I +   QI RGL Y+H    A
Sbjct: 95  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---A 151
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT-IKTAIRGTKGYVAPEWFRNSK 699
            ++H D+KP N+LL+     +I DFGLA++   +   T   T    T+ Y APE   NSK
Sbjct: 152 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 211
Query: 700 -ITAKVDVYSFGVLLLEIISCRKSF 723
             T  +D++S G +L E++S R  F
Sbjct: 212 GYTKSIDIWSVGCILAEMLSNRPIF 236

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 15/205 (7%)
Query: 527 VGRGSFGIV---YKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G G++G+V   Y  V + R +   ++  +     Q   RE K    ++ +  H+N++ +
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIK----ILLRFRHENIIGI 86
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF---QIARGLLYLHEDCRA 640
                      +   ++    + + L+  LK       +I +   QI RGL Y+H    A
Sbjct: 87  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---A 143
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT-IKTAIRGTKGYVAPEWFRNSK 699
            ++H D+KP N+LL+     +I DFGLA++   +   T   T    T+ Y APE   NSK
Sbjct: 144 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 700 -ITAKVDVYSFGVLLLEIISCRKSF 723
             T  +D++S G +L E++S R  F
Sbjct: 204 GYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 15/205 (7%)
Query: 527 VGRGSFGIV---YKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G G++G+V   Y  V + R +   ++  +     Q   RE K    ++ +  H+N++ +
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIK----ILLRFRHENIIGI 88
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF---QIARGLLYLHEDCRA 640
                      +   ++    + + L+  LK       +I +   QI RGL Y+H    A
Sbjct: 89  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---A 145
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT-IKTAIRGTKGYVAPEWFRNSK 699
            ++H D+KP N+LL+     +I DFGLA++   +   T   T    T+ Y APE   NSK
Sbjct: 146 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 205
Query: 700 -ITAKVDVYSFGVLLLEIISCRKSF 723
             T  +D++S G +L E++S R  F
Sbjct: 206 GYTKSIDIWSVGCILAEMLSNRPIF 230

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 39/215 (18%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           VG G++G V      T+T    VAVKKL R FQ     +R ++ E+ ++    H+N++ L
Sbjct: 32  VGSGAYGSVC-AAFDTKTGLR-VAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 88
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTN----IAFQIARGLLYLH 635
           L      ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H
Sbjct: 89  LDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 144
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
               A IIH D+KP N+ +++    +I DFGLA+      +           GYVA  W+
Sbjct: 145 S---ADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMT-----------GYVATRWY 190
Query: 696 RNSKIT-------AKVDVYSFGVLLLEIISCRKSF 723
           R  +I          VD++S G ++ E+++ R  F
Sbjct: 191 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 225

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 15/205 (7%)
Query: 527 VGRGSFGIV---YKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G G++G+V   Y  V + R +   ++  +     Q   RE K    ++ +  H+N++ +
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIK----ILLRFRHENIIGI 86
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF---QIARGLLYLHEDCRA 640
                      +   ++    + + L+  LK       +I +   QI RGL Y+H    A
Sbjct: 87  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---A 143
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT-IKTAIRGTKGYVAPEWFRNSK 699
            ++H D+KP N+LL+     +I DFGLA++   +   T   T    T+ Y APE   NSK
Sbjct: 144 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 700 -ITAKVDVYSFGVLLLEIISCRKSF 723
             T  +D++S G +L E++S R  F
Sbjct: 204 GYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/306 (23%), Positives = 139/306 (45%), Gaps = 50/306 (16%)
Query: 522 NFKEEVGRGSFGIVYKGV---IQTRTSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQTHH 577
            +  ++G G+FG V++     +      T VAVK L +    D + +F+ E  ++ +  +
Sbjct: 50  EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN 109
Query: 578 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNW-------NLRTN-------- 622
            N+V+LLG C  G+   L++E++  G L  FL  ++ P+        +L T         
Sbjct: 110 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFL-RSMSPHTVCSLSHSDLSTRARVSSPGP 168
Query: 623 ----------IAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAK-LL 671
                     IA Q+A G+ YL E    + +H D+  +N L+ +    +I+DFGL++ + 
Sbjct: 169 PPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIY 225
Query: 672 TLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY 731
           + +  K         + ++ PE    ++ T + DV+++GV+L EI      F   +   Y
Sbjct: 226 SADYYKADGNDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLWEI------FSYGLQPYY 278
Query: 732 AILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM 791
            +  +      R+G  N+L   +        C  +L  +   C  + P+ RP+   + ++
Sbjct: 279 GMAHEEVIYYVRDG--NILACPEN-------CPLELYNLMRLCWSKLPADRPSFCSIHRI 329
Query: 792 LEGVVE 797
           L+ + E
Sbjct: 330 LQRMCE 335

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 15/205 (7%)
Query: 527 VGRGSFGIV---YKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G G++G+V   Y  V + R +   ++  +     Q   RE K    ++ +  H+N++ +
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIK----ILLRFRHENIIGI 106
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF---QIARGLLYLHEDCRA 640
                      +   ++    + + L+  LK       +I +   QI RGL Y+H    A
Sbjct: 107 NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---A 163
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT-IKTAIRGTKGYVAPEWFRNSK 699
            ++H D+KP N+LL+     +I DFGLA++   +   T   T    T+ Y APE   NSK
Sbjct: 164 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 223
Query: 700 -ITAKVDVYSFGVLLLEIISCRKSF 723
             T  +D++S G +L E++S R  F
Sbjct: 224 GYTKSIDIWSVGCILAEMLSNRPIF 248

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 39/215 (18%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           VG G++G V      T+T    VAVKKL R FQ     +R ++ E+ ++    H+N++ L
Sbjct: 42  VGSGAYGSVC-AAFDTKTGLR-VAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 98
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTN----IAFQIARGLLYLH 635
           L      ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H
Sbjct: 99  LDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 154
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
               A IIH D+KP N+ +++    +I DFGLA+      +           GYVA  W+
Sbjct: 155 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWY 200
Query: 696 RNSKIT-------AKVDVYSFGVLLLEIISCRKSF 723
           R  +I          VD++S G ++ E+++ R  F
Sbjct: 201 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 235

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 39/215 (18%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           VG G++G V      T+T    VAVKKL R FQ     +R ++ E+ ++    H+N++ L
Sbjct: 42  VGSGAYGSVC-AAFDTKTGLR-VAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 98
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTN----IAFQIARGLLYLH 635
           L      ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H
Sbjct: 99  LDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 154
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
               A IIH D+KP N+ +++    +I DFGLA+      +           GYVA  W+
Sbjct: 155 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWY 200
Query: 696 RNSKIT-------AKVDVYSFGVLLLEIISCRKSF 723
           R  +I          VD++S G ++ E+++ R  F
Sbjct: 201 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 235

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/256 (26%), Positives = 114/256 (44%), Gaps = 36/256 (14%)
Query: 495 IRNSPDDGTIETNLRCFSYK---ELEGATNNFKEEVGRGSFGIVYKGV---IQTRTSTTA 548
           +  S D+     + R + Y    E       F + +G G+FG V       I     +  
Sbjct: 18  VTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQ 77
Query: 549 VAVKKLDRVFQDGERE-FKNEVFVIGQT-HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLA 606
           VAVK L       ERE   +E+ ++ Q   H+N+V LLG C       L++E+   G L 
Sbjct: 78  VAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLL 137
Query: 607 SFL-------------FGNLK-----PNWNLRT-----NIAFQIARGLLYLH-EDCRAQI 642
           ++L             + N K      + N+ T       A+Q+A+G+ +L  + C    
Sbjct: 138 NYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSC---- 193
Query: 643 IHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITA 702
           +H D+  +N+L+      +I DFGLA+ +  + +  ++   R    ++APE       T 
Sbjct: 194 VHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTI 253
Query: 703 KVDVYSFGVLLLEIIS 718
           K DV+S+G+LL EI S
Sbjct: 254 KSDVWSYGILLWEIFS 269

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 39/215 (18%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           +G G++G V      T+T    VAVKKL R FQ     +R ++ E+ ++    H+N++ L
Sbjct: 35  IGSGAYGSVC-AAFDTKTGLR-VAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 91
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTN----IAFQIARGLLYLH 635
           L      ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H
Sbjct: 92  LDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 147
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
               A IIH D+KP N+ +++    +I DFGLA+      +           GYVA  W+
Sbjct: 148 S---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMT-----------GYVATRWY 193
Query: 696 RNSKIT-------AKVDVYSFGVLLLEIISCRKSF 723
           R  +I          VD++S G ++ E+++ R  F
Sbjct: 194 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 228

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 15/205 (7%)
Query: 527 VGRGSFGIV---YKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G G++G+V   Y  + + R +   ++  +     Q   RE K    ++ +  H+N++ +
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIK----ILLRFRHENIIGI 90
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF---QIARGLLYLHEDCRA 640
                      +   ++    + + L+  LK       +I +   QI RGL Y+H    A
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---A 147
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT-IKTAIRGTKGYVAPEWFRNSK 699
            ++H D+KP N+LL+     +I DFGLA++   +   T   T    T+ Y APE   NSK
Sbjct: 148 NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 700 -ITAKVDVYSFGVLLLEIISCRKSF 723
             T  +D++S G +L E++S R  F
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 39/215 (18%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           VG G++G V      T+T    VAVKKL R FQ     +R ++ E+ ++    H+N++ L
Sbjct: 50  VGSGAYGSVC-AAFDTKTGLR-VAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 106
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTN----IAFQIARGLLYLH 635
           L      ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H
Sbjct: 107 LDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 162
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
               A IIH D+KP N+ +++    +I DFGLA+      +           GYVA  W+
Sbjct: 163 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWY 208
Query: 696 RNSKIT-------AKVDVYSFGVLLLEIISCRKSF 723
           R  +I          VD++S G ++ E+++ R  F
Sbjct: 209 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 243

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 39/215 (18%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           VG G++G V      T+T    VAVKKL R FQ     +R ++ E+ ++    H+N++ L
Sbjct: 30  VGSGAYGSVC-AAFDTKTGLR-VAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 86
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTN----IAFQIARGLLYLH 635
           L      ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H
Sbjct: 87  LDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 142
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
               A IIH D+KP N+ +++    +I DFGLA+      +           GYVA  W+
Sbjct: 143 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWY 188
Query: 696 RNSKIT-------AKVDVYSFGVLLLEIISCRKSF 723
           R  +I          VD++S G ++ E+++ R  F
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 91/207 (43%), Gaps = 24/207 (11%)
Query: 525 EEVGRGSFGIVYKG---VIQTRTSTTAVAVKKLDRVFQ-DGEREFKNEVFVIGQTHHKNL 580
           E++G GSFG+V +G       +T + AV   K D + Q +   +F  EV  +    H+NL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTL--------ASFLFGNLKPNWNLRTNIAFQIARGLL 632
           +RL G       ++ V E    G+L          FL G L       +  A Q+A G+ 
Sbjct: 84  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTL-------SRYAVQVAEGMG 135
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK-GYVA 691
           YL      + IH D+  +N+LL      +I DFGL + L  N    +    R     + A
Sbjct: 136 YLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCA 192
Query: 692 PEWFRNSKITAKVDVYSFGVLLLEIIS 718
           PE  +    +   D + FGV L E+ +
Sbjct: 193 PESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 39/215 (18%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           VG G++G V      T+T    VAVKKL R FQ     +R ++ E+ ++    H+N++ L
Sbjct: 41  VGSGAYGSVC-AAFDTKTGLR-VAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 97
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTN----IAFQIARGLLYLH 635
           L      ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H
Sbjct: 98  LDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 153
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
               A IIH D+KP N+ +++    +I DFGLA+      +           GYVA  W+
Sbjct: 154 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWY 199
Query: 696 RNSKIT-------AKVDVYSFGVLLLEIISCRKSF 723
           R  +I          VD++S G ++ E+++ R  F
Sbjct: 200 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 234

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 39/215 (18%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           VG G++G V      T+T    VAVKKL R FQ     +R ++ E+ ++    H+N++ L
Sbjct: 49  VGSGAYGSVC-AAFDTKTGLR-VAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 105
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTN----IAFQIARGLLYLH 635
           L      ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H
Sbjct: 106 LDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 161
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
               A IIH D+KP N+ +++    +I DFGLA+      +           GYVA  W+
Sbjct: 162 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWY 207
Query: 696 RNSKIT-------AKVDVYSFGVLLLEIISCRKSF 723
           R  +I          VD++S G ++ E+++ R  F
Sbjct: 208 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 242

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 39/215 (18%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           VG G++G V      T+T    VAVKKL R FQ     +R ++ E+ ++    H+N++ L
Sbjct: 30  VGSGAYGSVC-AAFDTKTGLR-VAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 86
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTN----IAFQIARGLLYLH 635
           L      ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H
Sbjct: 87  LDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 142
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
               A IIH D+KP N+ +++    +I DFGLA+      +           GYVA  W+
Sbjct: 143 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWY 188
Query: 696 RNSKIT-------AKVDVYSFGVLLLEIISCRKSF 723
           R  +I          VD++S G ++ E+++ R  F
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 39/215 (18%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           VG G++G V      T+T    VAVKKL R FQ     +R ++ E+ ++    H+N++ L
Sbjct: 32  VGSGAYGSVC-AAFDTKTGLR-VAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 88
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTN----IAFQIARGLLYLH 635
           L      ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H
Sbjct: 89  LDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 144
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
               A IIH D+KP N+ +++    +I DFGLA+      +           GYVA  W+
Sbjct: 145 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWY 190
Query: 696 RNSKIT-------AKVDVYSFGVLLLEIISCRKSF 723
           R  +I          VD++S G ++ E+++ R  F
Sbjct: 191 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 225

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 103/207 (49%), Gaps = 24/207 (11%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ-THHKNLVRL 583
           E VG G++G VYKG       T  +A  K+  V  D E E K E+ ++ + +HH+N+   
Sbjct: 30  ELVGNGTYGQVYKG---RHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATY 86
Query: 584 LG-FCDEGQNRL-----LVYEFLNNGTLASFLFGNLKPNWNLRTNIAF---QIARGLLYL 634
            G F  +    +     LV EF   G++   L  N K N      IA+   +I RGL +L
Sbjct: 87  YGAFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNTLKEEWIAYICREILRGLSHL 145
Query: 635 HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 694
           H+    ++IH DIK QN+LL +    ++ DFG++    L+++   +    GT  ++APE 
Sbjct: 146 HQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMAPEV 200
Query: 695 F---RNSKITA--KVDVYSFGVLLLEI 716
                N   T   K D++S G+  +E+
Sbjct: 201 IACDENPDATYDFKSDLWSLGITAIEM 227

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 39/215 (18%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           VG G++G V      T+T    VAVKKL R FQ     +R ++ E+ ++    H+N++ L
Sbjct: 32  VGSGAYGSVC-AAFDTKTGLR-VAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 88
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTN----IAFQIARGLLYLH 635
           L      ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H
Sbjct: 89  LDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 144
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
               A IIH D+KP N+ +++    +I DFGLA+      +           GYVA  W+
Sbjct: 145 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWY 190
Query: 696 RNSKIT-------AKVDVYSFGVLLLEIISCRKSF 723
           R  +I          VD++S G ++ E+++ R  F
Sbjct: 191 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 225

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 39/215 (18%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           VG G++G V      T+T    VAVKKL R FQ     +R ++ E+ ++    H+N++ L
Sbjct: 30  VGSGAYGSVC-AAFDTKTGLR-VAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 86
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTN----IAFQIARGLLYLH 635
           L      ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H
Sbjct: 87  LDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 142
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
               A IIH D+KP N+ +++    +I DFGLA+      +           GYVA  W+
Sbjct: 143 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWY 188
Query: 696 RNSKIT-------AKVDVYSFGVLLLEIISCRKSF 723
           R  +I          VD++S G ++ E+++ R  F
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 39/215 (18%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           VG G++G V      T+T    VAVKKL R FQ     +R ++ E+ ++    H+N++ L
Sbjct: 53  VGSGAYGSVC-AAFDTKTGLR-VAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 109
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTN----IAFQIARGLLYLH 635
           L      ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H
Sbjct: 110 LDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 165
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
               A IIH D+KP N+ +++    +I DFGLA+      +           GYVA  W+
Sbjct: 166 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWY 211
Query: 696 RNSKIT-------AKVDVYSFGVLLLEIISCRKSF 723
           R  +I          VD++S G ++ E+++ R  F
Sbjct: 212 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 246

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 39/215 (18%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           VG G++G V      T+T    VAVKKL R FQ     +R ++ E+ ++    H+N++ L
Sbjct: 36  VGSGAYGSVC-AAFDTKTGLR-VAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 92
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTN----IAFQIARGLLYLH 635
           L      ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H
Sbjct: 93  LDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 148
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
               A IIH D+KP N+ +++    +I DFGLA+      +           GYVA  W+
Sbjct: 149 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWY 194
Query: 696 RNSKIT-------AKVDVYSFGVLLLEIISCRKSF 723
           R  +I          VD++S G ++ E+++ R  F
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 229

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 39/215 (18%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           VG G++G V      T+T    VAVKKL R FQ     +R ++ E+ ++    H+N++ L
Sbjct: 30  VGSGAYGSVC-AAFDTKTGLR-VAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 86
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTN----IAFQIARGLLYLH 635
           L      ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H
Sbjct: 87  LDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 142
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
               A IIH D+KP N+ +++    +I DFGLA+      +           GYVA  W+
Sbjct: 143 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWY 188
Query: 696 RNSKIT-------AKVDVYSFGVLLLEIISCRKSF 723
           R  +I          VD++S G ++ E+++ R  F
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 39/215 (18%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           VG G++G V      T+T    VAVKKL R FQ     +R ++ E+ ++    H+N++ L
Sbjct: 35  VGSGAYGSVC-AAFDTKTGLR-VAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 91
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTN----IAFQIARGLLYLH 635
           L      ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H
Sbjct: 92  LDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 147
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
               A IIH D+KP N+ +++    +I DFGLA+      +           GYVA  W+
Sbjct: 148 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWY 193
Query: 696 RNSKIT-------AKVDVYSFGVLLLEIISCRKSF 723
           R  +I          VD++S G ++ E+++ R  F
Sbjct: 194 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 228

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 39/215 (18%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           VG G++G V      T+T    VAVKKL R FQ     +R ++ E+ ++    H+N++ L
Sbjct: 29  VGSGAYGSVC-AAFDTKTGLR-VAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 85
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTN----IAFQIARGLLYLH 635
           L      ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H
Sbjct: 86  LDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 141
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
               A IIH D+KP N+ +++    +I DFGLA+      +           GYVA  W+
Sbjct: 142 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWY 187
Query: 696 RNSKIT-------AKVDVYSFGVLLLEIISCRKSF 723
           R  +I          VD++S G ++ E+++ R  F
Sbjct: 188 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 222

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 39/215 (18%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           VG G++G V      T+T    VAVKKL R FQ     +R ++ E+ ++    H+N++ L
Sbjct: 49  VGSGAYGSVC-AAFDTKTGHR-VAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 105
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTN----IAFQIARGLLYLH 635
           L      ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H
Sbjct: 106 LDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 161
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
               A IIH D+KP N+ +++    +I DFGLA+      +           GYVA  W+
Sbjct: 162 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWY 207
Query: 696 RNSKIT-------AKVDVYSFGVLLLEIISCRKSF 723
           R  +I          VD++S G ++ E+++ R  F
Sbjct: 208 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 242

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 39/215 (18%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           VG G++G V      T+T    VAVKKL R FQ     +R ++ E+ ++    H+N++ L
Sbjct: 50  VGSGAYGSVC-AAFDTKTGHR-VAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 106
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTN----IAFQIARGLLYLH 635
           L      ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H
Sbjct: 107 LDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 162
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
               A IIH D+KP N+ +++    +I DFGLA+      +           GYVA  W+
Sbjct: 163 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWY 208
Query: 696 RNSKIT-------AKVDVYSFGVLLLEIISCRKSF 723
           R  +I          VD++S G ++ E+++ R  F
Sbjct: 209 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 243

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 15/205 (7%)
Query: 527 VGRGSFGIV---YKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G G++G+V   Y  V + R +   ++  +     Q   RE K    ++    H+N++ +
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIK----ILLAFRHENIIGI 88
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF---QIARGLLYLHEDCRA 640
                      +   ++    + + L+  LK       +I +   QI RGL Y+H    A
Sbjct: 89  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---A 145
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT-IKTAIRGTKGYVAPEWFRNSK 699
            ++H D+KP N+LL+     +I DFGLA++   +   T   T    T+ Y APE   NSK
Sbjct: 146 NVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 205
Query: 700 -ITAKVDVYSFGVLLLEIISCRKSF 723
             T  +D++S G +L E++S R  F
Sbjct: 206 GYTKSIDIWSVGCILAEMLSNRPIF 230

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 39/215 (18%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           VG G++G V      T+T    VAVKKL R FQ     +R ++ E+ ++    H+N++ L
Sbjct: 32  VGSGAYGSVC-AAFDTKTGLR-VAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 88
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTN----IAFQIARGLLYLH 635
           L      ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H
Sbjct: 89  LDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 144
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
               A IIH D+KP N+ +++    +I DFGLA+      +           GYVA  W+
Sbjct: 145 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWY 190
Query: 696 RNSKIT-------AKVDVYSFGVLLLEIISCRKSF 723
           R  +I          VD++S G ++ E+++ R  F
Sbjct: 191 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 225

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 39/215 (18%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           VG G++G V      T+T    VAVKKL R FQ     +R ++ E+ ++    H+N++ L
Sbjct: 35  VGSGAYGSVC-AAFDTKTGLR-VAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 91
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTN----IAFQIARGLLYLH 635
           L      ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H
Sbjct: 92  LDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 147
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
               A IIH D+KP N+ +++    +I DFGLA+      +           GYVA  W+
Sbjct: 148 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWY 193
Query: 696 RNSKIT-------AKVDVYSFGVLLLEIISCRKSF 723
           R  +I          VD++S G ++ E+++ R  F
Sbjct: 194 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 228

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 101/215 (46%), Gaps = 39/215 (18%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           VG G++G V      T+T    VAVKKL R FQ     +R ++ E+ ++    H+N++ L
Sbjct: 53  VGSGAYGSVC-AAFDTKTGLR-VAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 109
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTN----IAFQIARGLLYLH 635
           L      ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H
Sbjct: 110 LDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 165
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
               A IIH D+KP N+ +++    +I DFGLA           +       GYVA  W+
Sbjct: 166 S---ADIIHRDLKPSNLAVNEDCELKILDFGLA-----------RHTDDEMXGYVATRWY 211
Query: 696 RNSKIT-------AKVDVYSFGVLLLEIISCRKSF 723
           R  +I          VD++S G ++ E+++ R  F
Sbjct: 212 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 246

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 101/195 (51%), Gaps = 12/195 (6%)
Query: 530 GSFGIVYKG--VIQTRTSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQTHHKNLVRLLGF 586
           G+FG VYKG  + +       VA+K+L +       +E  +E +V+    + ++ RLLG 
Sbjct: 33  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 92
Query: 587 CDEGQNRLLVYEFLNNGTLASFLF---GNLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
           C     +L++ + +  G L  ++     N+   + L  N   QIA+G+ YL ED R  ++
Sbjct: 93  CLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYL-EDRR--LV 146
Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK 703
           H D+  +N+L+      +I+DFGLAKLL   + +      +    ++A E   +   T +
Sbjct: 147 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ 206
Query: 704 VDVYSFGVLLLEIIS 718
            DV+S+GV + E+++
Sbjct: 207 SDVWSYGVTVWELMT 221

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 39/215 (18%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           VG G++G V      T+T    VAVKKL R FQ     +R ++ E+ ++    H+N++ L
Sbjct: 30  VGSGAYGSVC-AAFDTKTGLR-VAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 86
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTN----IAFQIARGLLYLH 635
           L      ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H
Sbjct: 87  LDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 142
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
               A IIH D+KP N+ +++    +I DFGLA+      +           GYVA  W+
Sbjct: 143 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWY 188
Query: 696 RNSKIT-------AKVDVYSFGVLLLEIISCRKSF 723
           R  +I          VD++S G ++ E+++ R  F
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 39/215 (18%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           VG G++G V      T+T    VAVKKL R FQ     +R ++ E+ ++    H+N++ L
Sbjct: 28  VGSGAYGSVC-AAFDTKTGLR-VAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 84
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTN----IAFQIARGLLYLH 635
           L      ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H
Sbjct: 85  LDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 140
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
               A IIH D+KP N+ +++    +I DFGLA+      +           GYVA  W+
Sbjct: 141 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWY 186
Query: 696 RNSKIT-------AKVDVYSFGVLLLEIISCRKSF 723
           R  +I          VD++S G ++ E+++ R  F
Sbjct: 187 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 221

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 39/215 (18%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           VG G++G V      T+T    VAVKKL R FQ     +R ++ E+ ++    H+N++ L
Sbjct: 30  VGSGAYGSVC-AAFDTKTGHR-VAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 86
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTN----IAFQIARGLLYLH 635
           L      ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H
Sbjct: 87  LDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 142
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
               A IIH D+KP N+ +++    +I DFGLA+      +           GYVA  W+
Sbjct: 143 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWY 188
Query: 696 RNSKIT-------AKVDVYSFGVLLLEIISCRKSF 723
           R  +I          VD++S G ++ E+++ R  F
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 39/215 (18%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           VG G++G V      T+T    VAVKKL R FQ     +R ++ E+ ++    H+N++ L
Sbjct: 30  VGSGAYGSVC-AAFDTKTGLR-VAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 86
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTN----IAFQIARGLLYLH 635
           L      ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H
Sbjct: 87  LDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 142
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
               A IIH D+KP N+ +++    +I DFGLA+      +           GYVA  W+
Sbjct: 143 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWY 188
Query: 696 RNSKIT-------AKVDVYSFGVLLLEIISCRKSF 723
           R  +I          VD++S G ++ E+++ R  F
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 39/215 (18%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           VG G++G V      T+T    VAVKKL R FQ     +R ++ E+ ++    H+N++ L
Sbjct: 30  VGSGAYGSVC-AAFDTKTGLR-VAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 86
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTN----IAFQIARGLLYLH 635
           L      ++     E  N+  L + L G    N+  +  L  +    + +QI RGL Y+H
Sbjct: 87  LDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRGLKYIH 142
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
               A IIH D+KP N+ +++    +I DFGL +      +           GYVA  W+
Sbjct: 143 S---ADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMT-----------GYVATRWY 188
Query: 696 RNSKIT-------AKVDVYSFGVLLLEIISCRKSF 723
           R  +I          VD++S G ++ E+++ R  F
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 39/215 (18%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           VG G++G V      T+T    VAVKKL R FQ     +R ++ E+ ++    H+N++ L
Sbjct: 40  VGSGAYGSVC-AAFDTKTGHR-VAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 96
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTN----IAFQIARGLLYLH 635
           L      ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H
Sbjct: 97  LDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 152
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
               A IIH D+KP N+ +++    +I DFGLA+      +           GYVA  W+
Sbjct: 153 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWY 198
Query: 696 RNSKIT-------AKVDVYSFGVLLLEIISCRKSF 723
           R  +I          VD++S G ++ E+++ R  F
Sbjct: 199 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 233

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 39/215 (18%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           VG G++G V      T+T    VAVKKL R FQ     +R ++ E+ ++    H+N++ L
Sbjct: 37  VGSGAYGSVC-AAFDTKTGLR-VAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 93
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTN----IAFQIARGLLYLH 635
           L      ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H
Sbjct: 94  LDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 149
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
               A IIH D+KP N+ +++    +I DFGLA+      +           GYVA  W+
Sbjct: 150 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWY 195
Query: 696 RNSKIT-------AKVDVYSFGVLLLEIISCRKSF 723
           R  +I          VD++S G ++ E+++ R  F
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 230

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 39/215 (18%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           VG G++G V      T+T    VAVKKL R FQ     +R ++ E+ ++    H+N++ L
Sbjct: 26  VGSGAYGSVC-AAFDTKTGLR-VAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 82
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTN----IAFQIARGLLYLH 635
           L      ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H
Sbjct: 83  LDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 138
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
               A IIH D+KP N+ +++    +I DFGLA+      +           GYVA  W+
Sbjct: 139 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWY 184
Query: 696 RNSKIT-------AKVDVYSFGVLLLEIISCRKSF 723
           R  +I          VD++S G ++ E+++ R  F
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 219

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 96/197 (48%), Gaps = 14/197 (7%)
Query: 527 VGRGSFGIVYKGV-IQTRTSTTAVAVKKLDRVFQDGERE-FKNEVFVIGQTHHKNLVRLL 584
           +G G FG V++G+ +       AVA+K       D  RE F  E   + Q  H ++V+L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNI--AFQIARGLLYLHEDCRAQI 642
           G   E     ++ E    G L SFL    K + +L + I  A+Q++  L YL      + 
Sbjct: 458 GVITENPV-WIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLES---KRF 512
Query: 643 IHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK--GYVAPEWFRNSKI 700
           +H DI  +N+L+      ++ DFGL++ +   +  T   A +G     ++APE     + 
Sbjct: 513 VHRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESINFRRF 569
Query: 701 TAKVDVYSFGVLLLEII 717
           T+  DV+ FGV + EI+
Sbjct: 570 TSASDVWMFGVCMWEIL 586

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 39/215 (18%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           VG G++G V      T+T    VAVKKL R FQ     +R ++ E+ ++    H+N++ L
Sbjct: 36  VGSGAYGSVC-AAFDTKTGLR-VAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 92
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTN----IAFQIARGLLYLH 635
           L      ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H
Sbjct: 93  LDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 148
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
               A IIH D+KP N+ +++    +I DFGLA+      +           GYVA  W+
Sbjct: 149 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWY 194
Query: 696 RNSKIT-------AKVDVYSFGVLLLEIISCRKSF 723
           R  +I          VD++S G ++ E+++ R  F
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 229

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 39/215 (18%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ---DGEREFKNEVFVIGQTHHKNLVRL 583
           VG G++G V      T+T    VAVKKL R FQ     +R ++ E+ ++    H+N++ L
Sbjct: 36  VGSGAYGSVC-AAFDTKTGHR-VAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 92
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTN----IAFQIARGLLYLH 635
           L      ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H
Sbjct: 93  LDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 148
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
               A IIH D+KP N+ +++    +I DFGLA+      +           GYVA  W+
Sbjct: 149 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWY 194
Query: 696 RNSKIT-------AKVDVYSFGVLLLEIISCRKSF 723
           R  +I          VD++S G ++ E+++ R  F
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 229

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 39/215 (18%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           VG G++G V      T+T    VAVKKL R FQ     +R ++ E+ ++    H+N++ L
Sbjct: 26  VGSGAYGSVC-AAFDTKTGHR-VAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 82
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTN----IAFQIARGLLYLH 635
           L      ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H
Sbjct: 83  LDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 138
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
               A IIH D+KP N+ +++    +I DFGLA+      +           GYVA  W+
Sbjct: 139 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWY 184
Query: 696 RNSKIT-------AKVDVYSFGVLLLEIISCRKSF 723
           R  +I          VD++S G ++ E+++ R  F
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 219

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 39/215 (18%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           VG G++G V      T+T    VAVKKL R FQ     +R ++ E+ ++    H+N++ L
Sbjct: 30  VGSGAYGSVC-AAFDTKTGLR-VAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 86
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTN----IAFQIARGLLYLH 635
           L      ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H
Sbjct: 87  LDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 142
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
               A IIH D+KP N+ +++    +I DFGLA+      +           GYVA  W+
Sbjct: 143 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWY 188
Query: 696 RNSKIT-------AKVDVYSFGVLLLEIISCRKSF 723
           R  +I          VD++S G ++ E+++ R  F
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 39/215 (18%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           VG G++G V      T+T    VAVKKL R FQ     +R ++ E+ ++    H+N++ L
Sbjct: 27  VGSGAYGSVC-AAFDTKTGLR-VAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 83
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTN----IAFQIARGLLYLH 635
           L      ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H
Sbjct: 84  LDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 139
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
               A IIH D+KP N+ +++    +I DFGLA+      +           GYVA  W+
Sbjct: 140 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWY 185
Query: 696 RNSKIT-------AKVDVYSFGVLLLEIISCRKSF 723
           R  +I          VD++S G ++ E+++ R  F
Sbjct: 186 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 220

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 99/202 (49%), Gaps = 9/202 (4%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREF-KNEVFVIGQTHHKNLVRLLG 585
           +GRGS+  V    ++      A+ V K + V  D + ++ + E  V  Q  +   +  L 
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119
Query: 586 FCDEGQNRLL-VYEFLNNGTLASFLFGNLK-PNWNLRTNIAFQIARGLLYLHEDCRAQII 643
            C + ++RL  V E++N G L   +    K P  + R   A +I+  L YLHE     II
Sbjct: 120 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHE---RGII 175
Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK 703
           + D+K  N+LLD     +++D+G+ K   L    T  T   GT  Y+APE  R       
Sbjct: 176 YRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSTFC-GTPNYIAPEILRGEDYGFS 233
Query: 704 VDVYSFGVLLLEIISCRKSFDI 725
           VD ++ GVL+ E+++ R  FDI
Sbjct: 234 VDWWALGVLMFEMMAGRSPFDI 255

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 15/205 (7%)
Query: 527 VGRGSFGIV---YKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G G++G+V   Y  + + R +   ++  +     Q   RE K    ++ +  H+N++ +
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIK----ILLRFRHENIIGI 90
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF---QIARGLLYLHEDCRA 640
                      +   ++    + + L+  LK       +I +   QI RGL Y+H    A
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---A 147
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT-IKTAIRGTKGYVAPEWFRNSK 699
            ++H D+KP N+LL+     +I DFGLA++   +   T   T    T+ Y APE   NSK
Sbjct: 148 NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 700 -ITAKVDVYSFGVLLLEIISCRKSF 723
             T  +D++S G +L E++S R  F
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 39/215 (18%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           VG G++G V      T+T    VAVKKL R FQ     +R ++ E+ ++    H+N++ L
Sbjct: 27  VGSGAYGSVC-AAFDTKTGLR-VAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 83
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTN----IAFQIARGLLYLH 635
           L      ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H
Sbjct: 84  LDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 139
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
               A IIH D+KP N+ +++    +I DFGLA+      +           GYVA  W+
Sbjct: 140 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWY 185
Query: 696 RNSKIT-------AKVDVYSFGVLLLEIISCRKSF 723
           R  +I          VD++S G ++ E+++ R  F
Sbjct: 186 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 220

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 102/198 (51%), Gaps = 12/198 (6%)
Query: 527 VGRGSFGIVYKG--VIQTRTSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G G+FG VYKG  + +       VA+K+L +       +E  +E +V+    + ++ RL
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           LG C     +L++ + +  G L  ++     N+   + L  N   QIA+G+ YL ED R 
Sbjct: 85  LGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYL-EDRR- 139
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            ++H D+  +N+L+      +I+DFG AKLL   + +      +    ++A E   +   
Sbjct: 140 -LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 198
Query: 701 TAKVDVYSFGVLLLEIIS 718
           T + DV+S+GV + E+++
Sbjct: 199 THQSDVWSYGVTVWELMT 216

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 15/205 (7%)
Query: 527 VGRGSFGIV---YKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G G++G+V   Y  V + R +   ++  +     Q   RE K    ++    H+N++ +
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIK----ILLAFRHENIIGI 88
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF---QIARGLLYLHEDCRA 640
                      +   ++    + + L+  LK       +I +   QI RGL Y+H    A
Sbjct: 89  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---A 145
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT-IKTAIRGTKGYVAPEWFRNSK 699
            ++H D+KP N+LL+     +I DFGLA++   +   T   T    T+ Y APE   NSK
Sbjct: 146 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 205
Query: 700 -ITAKVDVYSFGVLLLEIISCRKSF 723
             T  +D++S G +L E++S R  F
Sbjct: 206 GYTKSIDIWSVGCILAEMLSNRPIF 230

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 91/207 (43%), Gaps = 24/207 (11%)
Query: 525 EEVGRGSFGIVYKG---VIQTRTSTTAVAVKKLDRVFQ-DGEREFKNEVFVIGQTHHKNL 580
           E++G GSFG+V +G       +T + AV   K D + Q +   +F  EV  +    H+NL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTL--------ASFLFGNLKPNWNLRTNIAFQIARGLL 632
           +RL G       ++ V E    G+L          FL G L       +  A Q+A G+ 
Sbjct: 74  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTL-------SRYAVQVAEGMG 125
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK-GYVA 691
           YL      + IH D+  +N+LL      +I DFGL + L  N    +    R     + A
Sbjct: 126 YLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCA 182
Query: 692 PEWFRNSKITAKVDVYSFGVLLLEIIS 718
           PE  +    +   D + FGV L E+ +
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 96/197 (48%), Gaps = 14/197 (7%)
Query: 527 VGRGSFGIVYKGV-IQTRTSTTAVAVKKLDRVFQDGERE-FKNEVFVIGQTHHKNLVRLL 584
           +G G FG V++G+ +       AVA+K       D  RE F  E   + Q  H ++V+L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNI--AFQIARGLLYLHEDCRAQI 642
           G   E     ++ E    G L SFL    K + +L + I  A+Q++  L YL      + 
Sbjct: 458 GVITENPV-WIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLES---KRF 512
Query: 643 IHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK--GYVAPEWFRNSKI 700
           +H DI  +N+L+      ++ DFGL++ +   +  T   A +G     ++APE     + 
Sbjct: 513 VHRDIAARNVLVSATDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESINFRRF 569
Query: 701 TAKVDVYSFGVLLLEII 717
           T+  DV+ FGV + EI+
Sbjct: 570 TSASDVWMFGVCMWEIL 586

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 14/207 (6%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR-VFQDGERE-FKNEVFVIGQTHHKNLVRLL 584
           +G GS+G   K  I+ ++    +  K+LD     + E++   +EV ++ +  H N+VR  
Sbjct: 14  IGTGSYGRCQK--IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 585 GFCDEGQNRLL--VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ- 641
               +  N  L  V E+   G LAS +    K    L      ++   L    ++C  + 
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 642 -----IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR 696
                ++H D+KP N+ LD     ++ DFGLA++  LN   +      GT  Y++PE   
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKTFVGTPYYMSPEQMN 189
Query: 697 NSKITAKVDVYSFGVLLLEIISCRKSF 723
                 K D++S G LL E+ +    F
Sbjct: 190 RMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 102/198 (51%), Gaps = 12/198 (6%)
Query: 527 VGRGSFGIVYKG--VIQTRTSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G G+FG VYKG  + +       VA+K+L +       +E  +E +V+    + ++ RL
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           LG C     +L++ + +  G L  ++     N+   + L  N   QIA+G+ YL ED R 
Sbjct: 85  LGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYL-EDRR- 139
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            ++H D+  +N+L+      +I+DFG AKLL   + +      +    ++A E   +   
Sbjct: 140 -LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 198
Query: 701 TAKVDVYSFGVLLLEIIS 718
           T + DV+S+GV + E+++
Sbjct: 199 THQSDVWSYGVTVWELMT 216

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 101/209 (48%), Gaps = 27/209 (12%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           VG G++G V      T+T    VAVKKL R FQ     +R ++ E+ ++    H+N++ L
Sbjct: 30  VGSGAYGSVC-AAFDTKTGLR-VAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 86
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTN----IAFQIARGLLYLH 635
           L      ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H
Sbjct: 87  LDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 142
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
               A IIH D+KP N+ +++    +I DFGLA+      +    T    T+ Y APE  
Sbjct: 143 S---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGXVATRWYRAPEIM 194
Query: 696 RN-SKITAKVDVYSFGVLLLEIISCRKSF 723
            N       VD++S G ++ E+++ R  F
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 91/207 (43%), Gaps = 24/207 (11%)
Query: 525 EEVGRGSFGIVYKG---VIQTRTSTTAVAVKKLDRVFQ-DGEREFKNEVFVIGQTHHKNL 580
           E++G GSFG+V +G       +T + AV   K D + Q +   +F  EV  +    H+NL
Sbjct: 18  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTL--------ASFLFGNLKPNWNLRTNIAFQIARGLL 632
           +RL G       ++ V E    G+L          FL G L       +  A Q+A G+ 
Sbjct: 78  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTL-------SRYAVQVAEGMG 129
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK-GYVA 691
           YL      + IH D+  +N+LL      +I DFGL + L  N    +    R     + A
Sbjct: 130 YLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 186
Query: 692 PEWFRNSKITAKVDVYSFGVLLLEIIS 718
           PE  +    +   D + FGV L E+ +
Sbjct: 187 PESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 91/207 (43%), Gaps = 24/207 (11%)
Query: 525 EEVGRGSFGIVYKG---VIQTRTSTTAVAVKKLDRVFQ-DGEREFKNEVFVIGQTHHKNL 580
           E++G GSFG+V +G       +T + AV   K D + Q +   +F  EV  +    H+NL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTL--------ASFLFGNLKPNWNLRTNIAFQIARGLL 632
           +RL G       ++ V E    G+L          FL G L       +  A Q+A G+ 
Sbjct: 84  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTL-------SRYAVQVAEGMG 135
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK-GYVA 691
           YL      + IH D+  +N+LL      +I DFGL + L  N    +    R     + A
Sbjct: 136 YLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 192
Query: 692 PEWFRNSKITAKVDVYSFGVLLLEIIS 718
           PE  +    +   D + FGV L E+ +
Sbjct: 193 PESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 39/215 (18%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           VG G++G V      T+T    VAVKKL R FQ     +R ++ E+ ++    H+N++ L
Sbjct: 26  VGSGAYGSVC-AAFDTKTGHR-VAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 82
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTN----IAFQIARGLLYLH 635
           L      ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H
Sbjct: 83  LDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRGLKYIH 138
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
               A IIH D+KP N+ +++    +I DFGLA+      +           GYVA  W+
Sbjct: 139 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWY 184
Query: 696 RNSKIT-------AKVDVYSFGVLLLEIISCRKSF 723
           R  +I          VD++S G ++ E+++ R  F
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 219

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 96/196 (48%), Gaps = 11/196 (5%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE-FKNEVFVIGQTHHKNLVRLLG 585
           +G+GSFG V     +      AV V    +V Q  ++E    EV ++ Q  H N+++L  
Sbjct: 40  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 99
Query: 586 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHC 645
           F ++     LV E    G L   +    + +      I  Q+  G+ Y+H++   +I+H 
Sbjct: 100 FFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN---KIVHR 156
Query: 646 DIKPQNILLDDY---YTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITA 702
           D+KP+N+LL+        RI DFGL+       SK +K  I GT  Y+APE    +    
Sbjct: 157 DLKPENLLLESKSKDANIRIIDFGLS--THFEASKKMKDKI-GTAYYIAPEVLHGT-YDE 212
Query: 703 KVDVYSFGVLLLEIIS 718
           K DV+S GV+L  ++S
Sbjct: 213 KCDVWSTGVILYILLS 228

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 101/197 (51%), Gaps = 11/197 (5%)
Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGER-EFKNEVFVIGQTHHKNLVRLL 584
           E+G G+ G+V K  +Q R S   +A K +    +   R +   E+ V+ + +   +V   
Sbjct: 23  ELGAGNGGVVTK--VQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFY 80
Query: 585 G-FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
           G F  +G+  + + E ++ G+L   L    +    +   ++  + RGL YL E  + QI+
Sbjct: 81  GAFYSDGEISICM-EHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLRE--KHQIM 137
Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK 703
           H D+KP NIL++     ++ DFG++  L      ++  +  GT+ Y+APE  + +  + +
Sbjct: 138 HRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMAPERLQGTHYSVQ 193
Query: 704 VDVYSFGVLLLEIISCR 720
            D++S G+ L+E+   R
Sbjct: 194 SDIWSMGLSLVELAVGR 210

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 98/209 (46%), Gaps = 24/209 (11%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE---REFKNEVFVIGQTHHKNLV 581
           E++G G++G V+K   + R +   VA+K++ R+  D E        E+ ++ +  HKN+V
Sbjct: 8   EKIGEGTYGTVFKA--KNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKHKNIV 64
Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ 641
           RL       +   LV+EF +      F   N   +  +  +  FQ+ +GL + H      
Sbjct: 65  RLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS---RN 121
Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI- 700
           ++H D+KPQN+L++     +++DFGLA+   +         +R     V   W+R   + 
Sbjct: 122 VLHRDLKPQNLLINRNGELKLADFGLARAFGI--------PVRCYSAEVVTLWYRPPDVL 173
Query: 701 ------TAKVDVYSFGVLLLEIISCRKSF 723
                 +  +D++S G +  E+ +  +  
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAARPL 202

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 100/195 (51%), Gaps = 12/195 (6%)
Query: 530 GSFGIVYKG--VIQTRTSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQTHHKNLVRLLGF 586
           G+FG VYKG  + +       VA+K+L +       +E  +E +V+    + ++ RLLG 
Sbjct: 33  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 92
Query: 587 CDEGQNRLLVYEFLNNGTLASFLF---GNLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
           C     +L+  + +  G L  ++     N+   + L  N   QIA+G+ YL ED R  ++
Sbjct: 93  CLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYL-EDRR--LV 146
Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK 703
           H D+  +N+L+      +I+DFGLAKLL   + +      +    ++A E   +   T +
Sbjct: 147 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ 206
Query: 704 VDVYSFGVLLLEIIS 718
            DV+S+GV + E+++
Sbjct: 207 SDVWSYGVTVWELMT 221

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 102/198 (51%), Gaps = 12/198 (6%)
Query: 527 VGRGSFGIVYKG--VIQTRTSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G G+FG VYKG  + +       VA+K+L +       +E  +E +V+    + ++ RL
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 86
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           LG C     +L++ + +  G L  ++     N+   + L  N   QIA+G+ YL ED R 
Sbjct: 87  LGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYL-EDRR- 141
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            ++H D+  +N+L+      +I+DFG AKLL   + +      +    ++A E   +   
Sbjct: 142 -LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 200
Query: 701 TAKVDVYSFGVLLLEIIS 718
           T + DV+S+GV + E+++
Sbjct: 201 THQSDVWSYGVTVWELMT 218

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 100/195 (51%), Gaps = 12/195 (6%)
Query: 530 GSFGIVYKG--VIQTRTSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQTHHKNLVRLLGF 586
           G+FG VYKG  + +       VA+K+L +       +E  +E +V+    + ++ RLLG 
Sbjct: 26  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 85
Query: 587 CDEGQNRLLVYEFLNNGTLASFLF---GNLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
           C     +L+  + +  G L  ++     N+   + L  N   QIA+G+ YL ED R  ++
Sbjct: 86  CLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYL-EDRR--LV 139
Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK 703
           H D+  +N+L+      +I+DFGLAKLL   + +      +    ++A E   +   T +
Sbjct: 140 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ 199
Query: 704 VDVYSFGVLLLEIIS 718
            DV+S+GV + E+++
Sbjct: 200 SDVWSYGVTVWELMT 214

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 106/209 (50%), Gaps = 22/209 (10%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDR-------VFQDGEREFKNEVFVIGQTHH 577
           + +G G+FG V  G  +   +   VAVK L+R       V     RE +N    +    H
Sbjct: 22  DTLGVGTFGKVKVG--KHELTGHKVAVKILNRQKIRSLDVVGKIRREIQN----LKLFRH 75
Query: 578 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHED 637
            ++++L        +  +V E+++ G L  ++  N + +      +  QI  G+ Y H  
Sbjct: 76  PHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCH-- 133
Query: 638 CRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRN 697
            R  ++H D+KP+N+LLD +  A+I+DFGL+ +++    + ++ +  G+  Y APE   +
Sbjct: 134 -RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS--DGEFLRXSC-GSPNYAAPEVI-S 188
Query: 698 SKITA--KVDVYSFGVLLLEIISCRKSFD 724
            ++ A  +VD++S GV+L  ++     FD
Sbjct: 189 GRLYAGPEVDIWSSGVILYALLCGTLPFD 217

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 15/205 (7%)
Query: 527 VGRGSFGIV---YKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G G++G+V   Y  + + R +   ++  +     Q   RE K    ++ +  H+N++ +
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIK----ILLRFRHENIIGI 84
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF---QIARGLLYLHEDCRA 640
                      +   ++    + + L+  LK       +I +   QI RGL Y+H    A
Sbjct: 85  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---A 141
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT-IKTAIRGTKGYVAPEWFRNSK 699
            ++H D+KP N+LL+     +I DFGLA++   +   T   T    T+ Y APE   NSK
Sbjct: 142 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 201
Query: 700 -ITAKVDVYSFGVLLLEIISCRKSF 723
             T  +D++S G +L E++S R  F
Sbjct: 202 GYTKSIDIWSVGCILAEMLSNRPIF 226

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 15/205 (7%)
Query: 527 VGRGSFGIV---YKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G G++G+V   Y  + + R +   ++  +     Q   RE K    ++ +  H+N++ +
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIK----ILLRFRHENIIGI 84
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF---QIARGLLYLHEDCRA 640
                      +   ++    + + L+  LK       +I +   QI RGL Y+H    A
Sbjct: 85  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---A 141
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT-IKTAIRGTKGYVAPEWFRNSK 699
            ++H D+KP N+LL+     +I DFGLA++   +   T   T    T+ Y APE   NSK
Sbjct: 142 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 201
Query: 700 -ITAKVDVYSFGVLLLEIISCRKSF 723
             T  +D++S G +L E++S R  F
Sbjct: 202 GYTKSIDIWSVGCILAEMLSNRPIF 226

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 101/198 (51%), Gaps = 12/198 (6%)
Query: 527 VGRGSFGIVYKG--VIQTRTSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G G+FG VYKG  + +       VA+K+L +       +E  +E +V+    + ++ RL
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           LG C     +L+  + +  G L  ++     N+   + L  N   QIA+G+ YL ED R 
Sbjct: 85  LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYL-EDRR- 139
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            ++H D+  +N+L+      +I+DFG AKLL   + +      +    ++A E   +   
Sbjct: 140 -LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 198
Query: 701 TAKVDVYSFGVLLLEIIS 718
           T + DV+S+GV + E+++
Sbjct: 199 THQSDVWSYGVTVWELMT 216

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 91/207 (43%), Gaps = 24/207 (11%)
Query: 525 EEVGRGSFGIVYKG---VIQTRTSTTAVAVKKLDRVFQ-DGEREFKNEVFVIGQTHHKNL 580
           E++G GSFG+V +G       +T + AV   K D + Q +   +F  EV  +    H+NL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTL--------ASFLFGNLKPNWNLRTNIAFQIARGLL 632
           +RL G       ++ V E    G+L          FL G L       +  A Q+A G+ 
Sbjct: 74  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTL-------SRYAVQVAEGMG 125
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK-GYVA 691
           YL      + IH D+  +N+LL      +I DFGL + L  N    +    R     + A
Sbjct: 126 YLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 692 PEWFRNSKITAKVDVYSFGVLLLEIIS 718
           PE  +    +   D + FGV L E+ +
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 15/205 (7%)
Query: 527 VGRGSFGIV---YKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G G++G+V   Y  + + R +   ++  +     Q   RE K    ++ +  H+N++ +
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIK----ILLRFRHENIIGI 91
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF---QIARGLLYLHEDCRA 640
                      +   ++    + + L+  LK       +I +   QI RGL Y+H    A
Sbjct: 92  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---A 148
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT-IKTAIRGTKGYVAPEWFRNSK 699
            ++H D+KP N+LL+     +I DFGLA++   +   T   T    T+ Y APE   NSK
Sbjct: 149 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 208
Query: 700 -ITAKVDVYSFGVLLLEIISCRKSF 723
             T  +D++S G +L E++S R  F
Sbjct: 209 GYTKSIDIWSVGCILAEMLSNRPIF 233

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 15/205 (7%)
Query: 527 VGRGSFGIV---YKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G G++G+V   Y  + + R +   ++  +     Q   RE K    ++ +  H+N++ +
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIK----ILLRFRHENIIGI 92
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF---QIARGLLYLHEDCRA 640
                      +   ++    + + L+  LK       +I +   QI RGL Y+H    A
Sbjct: 93  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---A 149
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT-IKTAIRGTKGYVAPEWFRNSK 699
            ++H D+KP N+LL+     +I DFGLA++   +   T   T    T+ Y APE   NSK
Sbjct: 150 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 209
Query: 700 -ITAKVDVYSFGVLLLEIISCRKSF 723
             T  +D++S G +L E++S R  F
Sbjct: 210 GYTKSIDIWSVGCILAEMLSNRPIF 234

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 15/205 (7%)
Query: 527 VGRGSFGIV---YKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G G++G+V   Y  + + R +   ++  +     Q   RE K    ++ +  H+N++ +
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIK----ILLRFRHENIIGI 83
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF---QIARGLLYLHEDCRA 640
                      +   ++    + + L+  LK       +I +   QI RGL Y+H    A
Sbjct: 84  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---A 140
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT-IKTAIRGTKGYVAPEWFRNSK 699
            ++H D+KP N+LL+     +I DFGLA++   +   T   T    T+ Y APE   NSK
Sbjct: 141 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 200
Query: 700 -ITAKVDVYSFGVLLLEIISCRKSF 723
             T  +D++S G +L E++S R  F
Sbjct: 201 GYTKSIDIWSVGCILAEMLSNRPIF 225

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 15/205 (7%)
Query: 527 VGRGSFGIV---YKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G G++G+V   Y  + + R +   ++  +     Q   RE K    ++ +  H+N++ +
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIK----ILLRFRHENIIGI 90
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF---QIARGLLYLHEDCRA 640
                      +   ++    + + L+  LK       +I +   QI RGL Y+H    A
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---A 147
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT-IKTAIRGTKGYVAPEWFRNSK 699
            ++H D+KP N+LL+     +I DFGLA++   +   T   T    T+ Y APE   NSK
Sbjct: 148 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 700 -ITAKVDVYSFGVLLLEIISCRKSF 723
             T  +D++S G +L E++S R  F
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 101/198 (51%), Gaps = 12/198 (6%)
Query: 527 VGRGSFGIVYKG--VIQTRTSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G G+FG VYKG  + +       VA+K+L +       +E  +E +V+    + ++ RL
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           LG C     +L+  + +  G L  ++     N+   + L  N   QIA+G+ YL ED R 
Sbjct: 90  LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYL-EDRR- 144
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            ++H D+  +N+L+      +I+DFG AKLL   + +      +    ++A E   +   
Sbjct: 145 -LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 203
Query: 701 TAKVDVYSFGVLLLEIIS 718
           T + DV+S+GV + E+++
Sbjct: 204 THQSDVWSYGVTVWELMT 221

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 14/207 (6%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR-VFQDGERE-FKNEVFVIGQTHHKNLVRLL 584
           +G GS+G   K  I+ ++    +  K+LD     + E++   +EV ++ +  H N+VR  
Sbjct: 14  IGTGSYGRCQK--IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 585 GFCDEGQNRLL--VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ- 641
               +  N  L  V E+   G LAS +    K    L      ++   L    ++C  + 
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 642 -----IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR 696
                ++H D+KP N+ LD     ++ DFGLA++  LN  +       GT  Y++PE   
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDEDFAKEFVGTPYYMSPEQMN 189
Query: 697 NSKITAKVDVYSFGVLLLEIISCRKSF 723
                 K D++S G LL E+ +    F
Sbjct: 190 RMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 96/196 (48%), Gaps = 11/196 (5%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE-FKNEVFVIGQTHHKNLVRLLG 585
           +G+GSFG V     +      AV V    +V Q  ++E    EV ++ Q  H N+++L  
Sbjct: 57  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 116
Query: 586 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHC 645
           F ++     LV E    G L   +    + +      I  Q+  G+ Y+H++   +I+H 
Sbjct: 117 FFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN---KIVHR 173
Query: 646 DIKPQNILLDDY---YTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITA 702
           D+KP+N+LL+        RI DFGL+       SK +K  I GT  Y+APE    +    
Sbjct: 174 DLKPENLLLESKSKDANIRIIDFGLS--THFEASKKMKDKI-GTAYYIAPEVLHGT-YDE 229
Query: 703 KVDVYSFGVLLLEIIS 718
           K DV+S GV+L  ++S
Sbjct: 230 KCDVWSTGVILYILLS 245

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 98/210 (46%), Gaps = 23/210 (10%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKK---LDRVFQDGEREFKNEVFVIGQTHHKNLV 581
           +++G GSFG   K ++   T      V K   + R+      E + EV V+    H N+V
Sbjct: 30  QKIGEGSFG---KAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIV 86
Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRA- 640
           +     +E  +  +V ++   G L   +        N +  + FQ  + L +  + C A 
Sbjct: 87  QYRESFEENGSLYIVMDYCEGGDLFKRI--------NAQKGVLFQEDQILDWFVQICLAL 138
Query: 641 ------QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 694
                 +I+H DIK QNI L    T ++ DFG+A++  LN +  +  A  GT  Y++PE 
Sbjct: 139 KHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARV--LNSTVELARACIGTPYYLSPEI 196
Query: 695 FRNSKITAKVDVYSFGVLLLEIISCRKSFD 724
             N     K D+++ G +L E+ + + +F+
Sbjct: 197 CENKPYNNKSDIWALGCVLYELCTLKHAFE 226

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 105/209 (50%), Gaps = 23/209 (11%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLV 581
           + VG G++G V   V   RT    VA+KKL R FQ     +R ++ E+ ++    H+N++
Sbjct: 31  QPVGSGAYGAVCSAV-DGRTGAK-VAIKKLYRPFQSELFAKRAYR-ELRLLKHMRHENVI 87
Query: 582 RLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLH 635
            LL         D+  +  LV  F+  GT    L  + K   +    + +Q+ +GL Y+H
Sbjct: 88  GLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH 145
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
               A IIH D+KP N+ +++    +I DFGLA+     Q+ +       T+ Y APE  
Sbjct: 146 A---AGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMXGXVVTRWYRAPEVI 197
Query: 696 RN-SKITAKVDVYSFGVLLLEIISCRKSF 723
            N  + T  VD++S G ++ E+I+ +  F
Sbjct: 198 LNWMRYTQTVDIWSVGCIMAEMITGKTLF 226

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 96/196 (48%), Gaps = 11/196 (5%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE-FKNEVFVIGQTHHKNLVRLLG 585
           +G+GSFG V     +      AV V    +V Q  ++E    EV ++ Q  H N+++L  
Sbjct: 58  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 117
Query: 586 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHC 645
           F ++     LV E    G L   +    + +      I  Q+  G+ Y+H++   +I+H 
Sbjct: 118 FFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN---KIVHR 174
Query: 646 DIKPQNILLDDY---YTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITA 702
           D+KP+N+LL+        RI DFGL+       SK +K  I GT  Y+APE    +    
Sbjct: 175 DLKPENLLLESKSKDANIRIIDFGLS--THFEASKKMKDKI-GTAYYIAPEVLHGT-YDE 230
Query: 703 KVDVYSFGVLLLEIIS 718
           K DV+S GV+L  ++S
Sbjct: 231 KCDVWSTGVILYILLS 246

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 15/205 (7%)
Query: 527 VGRGSFGIV---YKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G G++G+V   Y  + + R +   ++  +     Q   RE K    ++ +  H+N++ +
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIK----ILLRFRHENIIGI 90
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF---QIARGLLYLHEDCRA 640
                      +   ++    + + L+  LK       +I +   QI RGL Y+H    A
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---A 147
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT-IKTAIRGTKGYVAPEWFRNSK 699
            ++H D+KP N+LL+     +I DFGLA++   +   T   T    T+ Y APE   NSK
Sbjct: 148 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 700 -ITAKVDVYSFGVLLLEIISCRKSF 723
             T  +D++S G +L E++S R  F
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 96/196 (48%), Gaps = 11/196 (5%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE-FKNEVFVIGQTHHKNLVRLLG 585
           +G+GSFG V     +      AV V    +V Q  ++E    EV ++ Q  H N+++L  
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 586 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHC 645
           F ++     LV E    G L   +    + +      I  Q+  G+ Y+H++   +I+H 
Sbjct: 94  FFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN---KIVHR 150
Query: 646 DIKPQNILLDDY---YTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITA 702
           D+KP+N+LL+        RI DFGL+       SK +K  I GT  Y+APE    +    
Sbjct: 151 DLKPENLLLESKSKDANIRIIDFGLS--THFEASKKMKDKI-GTAYYIAPEVLHGT-YDE 206
Query: 703 KVDVYSFGVLLLEIIS 718
           K DV+S GV+L  ++S
Sbjct: 207 KCDVWSTGVILYILLS 222

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 104/205 (50%), Gaps = 15/205 (7%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKNLVRL 583
           +G GSFG V K    T T+   VA+K +++      D +   + E+  +    H ++++L
Sbjct: 21  LGEGSFGKV-KLAYHT-TTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 78
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
                     ++V E+  N  L  ++    K +         QI   + Y H   R +I+
Sbjct: 79  YDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQIISAVEYCH---RHKIV 134
Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITA- 702
           H D+KP+N+LLD++   +I+DFGL+ ++T      +KT+  G+  Y APE   + K+ A 
Sbjct: 135 HRDLKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKTSC-GSPNYAAPEVI-SGKLYAG 190
Query: 703 -KVDVYSFGVLLLEIISCRKSFDIE 726
            +VDV+S GV+L  ++  R  FD E
Sbjct: 191 PEVDVWSCGVILYVMLCRRLPFDDE 215

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 101/198 (51%), Gaps = 12/198 (6%)
Query: 527 VGRGSFGIVYKG--VIQTRTSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G G+FG VYKG  + +       VA+K+L +       +E  +E +V+    + ++ RL
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           LG C     +L+  + +  G L  ++     N+   + L  N   QIA+G+ YL ED R 
Sbjct: 83  LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYL-EDRR- 137
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            ++H D+  +N+L+      +I+DFG AKLL   + +      +    ++A E   +   
Sbjct: 138 -LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 196
Query: 701 TAKVDVYSFGVLLLEIIS 718
           T + DV+S+GV + E+++
Sbjct: 197 THQSDVWSYGVTVWELMT 214

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 104/205 (50%), Gaps = 15/205 (7%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKNLVRL 583
           +G GSFG V K    T T+   VA+K +++      D +   + E+  +    H ++++L
Sbjct: 22  LGEGSFGKV-KLAYHT-TTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 79
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
                     ++V E+  N  L  ++    K +         QI   + Y H   R +I+
Sbjct: 80  YDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQIISAVEYCH---RHKIV 135
Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITA- 702
           H D+KP+N+LLD++   +I+DFGL+ ++T      +KT+  G+  Y APE   + K+ A 
Sbjct: 136 HRDLKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKTSC-GSPNYAAPEVI-SGKLYAG 191
Query: 703 -KVDVYSFGVLLLEIISCRKSFDIE 726
            +VDV+S GV+L  ++  R  FD E
Sbjct: 192 PEVDVWSCGVILYVMLCRRLPFDDE 216

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 91/207 (43%), Gaps = 24/207 (11%)
Query: 525 EEVGRGSFGIVYKG---VIQTRTSTTAVAVKKLDRVFQ-DGEREFKNEVFVIGQTHHKNL 580
           E++G GSFG+V +G       +T + AV   K D + Q +   +F  EV  +    H+NL
Sbjct: 18  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTL--------ASFLFGNLKPNWNLRTNIAFQIARGLL 632
           +RL G       ++ V E    G+L          FL G L       +  A Q+A G+ 
Sbjct: 78  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTL-------SRYAVQVAEGMG 129
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK-GYVA 691
           YL      + IH D+  +N+LL      +I DFGL + L  N    +    R     + A
Sbjct: 130 YLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 186
Query: 692 PEWFRNSKITAKVDVYSFGVLLLEIIS 718
           PE  +    +   D + FGV L E+ +
Sbjct: 187 PESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 104/205 (50%), Gaps = 15/205 (7%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKNLVRL 583
           +G GSFG V K    T T+   VA+K +++      D +   + E+  +    H ++++L
Sbjct: 16  LGEGSFGKV-KLAYHT-TTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 73
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
                     ++V E+  N  L  ++    K +         QI   + Y H   R +I+
Sbjct: 74  YDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQIISAVEYCH---RHKIV 129
Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITA- 702
           H D+KP+N+LLD++   +I+DFGL+ ++T      +KT+  G+  Y APE   + K+ A 
Sbjct: 130 HRDLKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKTSC-GSPNYAAPEVI-SGKLYAG 185
Query: 703 -KVDVYSFGVLLLEIISCRKSFDIE 726
            +VDV+S GV+L  ++  R  FD E
Sbjct: 186 PEVDVWSCGVILYVMLCRRLPFDDE 210

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 91/207 (43%), Gaps = 24/207 (11%)
Query: 525 EEVGRGSFGIVYKG---VIQTRTSTTAVAVKKLDRVFQ-DGEREFKNEVFVIGQTHHKNL 580
           E++G GSFG+V +G       +T + AV   K D + Q +   +F  EV  +    H+NL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTL--------ASFLFGNLKPNWNLRTNIAFQIARGLL 632
           +RL G       ++ V E    G+L          FL G L       +  A Q+A G+ 
Sbjct: 74  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTL-------SRYAVQVAEGMG 125
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK-GYVA 691
           YL      + IH D+  +N+LL      +I DFGL + L  N    +    R     + A
Sbjct: 126 YLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 692 PEWFRNSKITAKVDVYSFGVLLLEIIS 718
           PE  +    +   D + FGV L E+ +
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 97/196 (49%), Gaps = 10/196 (5%)
Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG--EREFKNEVFVIGQTHHKNLVRL 583
           ++G GS+G+V+K   + R +   VA+KK      D   ++    E+ ++ Q  H NLV L
Sbjct: 10  KIGEGSYGVVFK--CRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNL 67
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
           L      +   LV+E+ ++  L            +L  +I +Q  + + + H   +   I
Sbjct: 68  LEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH---KHNCI 124
Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR-NSKITA 702
           H D+KP+NIL+  +   ++ DFG A+LLT   S      +  T+ Y +PE    +++   
Sbjct: 125 HRDVKPENILITKHSVIKLCDFGFARLLT-GPSDYYDDEV-ATRWYRSPELLVGDTQYGP 182
Query: 703 KVDVYSFGVLLLEIIS 718
            VDV++ G +  E++S
Sbjct: 183 PVDVWAIGCVFAELLS 198

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 91/199 (45%), Gaps = 8/199 (4%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG-EREFKNEVFVIGQTHHKNLVRLLG 585
           +G+G FG VY    +      A+ V    ++ ++G E + + E+ +     H N++R+  
Sbjct: 23  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 82
Query: 586 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHC 645
           +  + +   L+ EF   G L   L  + + +         ++A  L Y HE    ++IH 
Sbjct: 83  YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHE---RKVIHR 139
Query: 646 DIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVD 705
           DIKP+N+L+      +I+DFG     +++     +  + GT  Y+ PE         KVD
Sbjct: 140 DIKPENLLMGYKGELKIADFG----WSVHAPSLRRRXMCGTLDYLPPEMIEGKTHDEKVD 195
Query: 706 VYSFGVLLLEIISCRKSFD 724
           ++  GVL  E +     FD
Sbjct: 196 LWCAGVLCYEFLVGMPPFD 214

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 39/215 (18%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           VG G++G V      T+T    VAVKKL + FQ     +R ++ E+ ++    H+N++ L
Sbjct: 42  VGSGAYGSVC-AAFDTKTGLR-VAVKKLSKPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 98
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTN----IAFQIARGLLYLH 635
           L      ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H
Sbjct: 99  LDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 154
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
               A IIH D+KP N+ +++    +I DFGLA+      +           GYVA  W+
Sbjct: 155 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWY 200
Query: 696 RNSKIT-------AKVDVYSFGVLLLEIISCRKSF 723
           R  +I          VD++S G ++ E+++ R  F
Sbjct: 201 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 235

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 39/215 (18%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           VG G++G V      T+T    VAVKKL R FQ     +R ++ E+ ++    H+N++ L
Sbjct: 30  VGSGAYGSVC-AAFDTKTGLR-VAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 86
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTN----IAFQIARGLLYLH 635
           L      ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H
Sbjct: 87  LDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 142
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
               A IIH D+KP N+ +++    +I D+GLA+      +           GYVA  W+
Sbjct: 143 S---ADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMT-----------GYVATRWY 188
Query: 696 RNSKIT-------AKVDVYSFGVLLLEIISCRKSF 723
           R  +I          VD++S G ++ E+++ R  F
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 104/205 (50%), Gaps = 15/205 (7%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKNLVRL 583
           +G GSFG V K    T T+   VA+K +++      D +   + E+  +    H ++++L
Sbjct: 12  LGEGSFGKV-KLAYHT-TTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 69
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
                     ++V E+  N  L  ++    K +         QI   + Y H   R +I+
Sbjct: 70  YDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQIISAVEYCH---RHKIV 125
Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITA- 702
           H D+KP+N+LLD++   +I+DFGL+ ++T      +KT+  G+  Y APE   + K+ A 
Sbjct: 126 HRDLKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKTSC-GSPNYAAPEVI-SGKLYAG 181
Query: 703 -KVDVYSFGVLLLEIISCRKSFDIE 726
            +VDV+S GV+L  ++  R  FD E
Sbjct: 182 PEVDVWSCGVILYVMLCRRLPFDDE 206

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 15/205 (7%)
Query: 527 VGRGSFGIV---YKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G G++G+V   Y  + + R +   ++  +     Q   RE K    ++ +  H+N++ +
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIK----ILLRFRHENIIGI 90
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF---QIARGLLYLHEDCRA 640
                      +   ++    + + L+  LK       +I +   QI RGL Y+H    A
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIHS---A 147
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT-IKTAIRGTKGYVAPEWFRNSK 699
            ++H D+KP N+LL+     +I DFGLA++   +   T   T    T+ Y APE   NSK
Sbjct: 148 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 700 -ITAKVDVYSFGVLLLEIISCRKSF 723
             T  +D++S G +L E++S R  F
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 101/198 (51%), Gaps = 12/198 (6%)
Query: 527 VGRGSFGIVYKG--VIQTRTSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G G+FG VYKG  + +       VA+ +L +       +E  +E +V+    + ++ RL
Sbjct: 57  LGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVCRL 116
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           LG C     +L+  + +  G L  ++     N+   + L  N   QIA+G+ YL ED R 
Sbjct: 117 LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYL-EDRR- 171
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            ++H D+  +N+L+      +I+DFGLAKLL   + +      +    ++A E   +   
Sbjct: 172 -LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 230
Query: 701 TAKVDVYSFGVLLLEIIS 718
           T + DV+S+GV + E+++
Sbjct: 231 THQSDVWSYGVTVWELMT 248

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 104/203 (51%), Gaps = 27/203 (13%)
Query: 527 VGRGSFGIV---YKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNL 580
           +G G+ GIV   Y  +++       VA+KKL R FQ+    +R ++ E+ ++   +HKN+
Sbjct: 32  IGSGAQGIVCAAYDAILERN-----VAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNI 85
Query: 581 VRLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYL 634
           + LL         +E Q+  +V E ++   L+  +   ++ +    + + +Q+  G+ +L
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMD-ANLSQVI--QMELDHERMSYLLYQMLVGIKHL 142
Query: 635 HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 694
           H    A IIH D+KP NI++    T +I DFGLA+      +  + T    T+ Y APE 
Sbjct: 143 HS---AGIIHRDLKPSNIVVKSDATLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEV 196
Query: 695 FRNSKITAKVDVYSFGVLLLEII 717
                    VD++S GV++ E+I
Sbjct: 197 ILGMGYKENVDIWSVGVIMGEMI 219

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 91/199 (45%), Gaps = 8/199 (4%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG-EREFKNEVFVIGQTHHKNLVRLLG 585
           +G+G FG VY    +      A+ V    ++ ++G E + + E+ +     H N++R+  
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 586 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHC 645
           +  + +   L+ EF   G L   L  + + +         ++A  L Y HE    ++IH 
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHE---RKVIHR 138
Query: 646 DIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVD 705
           DIKP+N+L+      +I+DFG     +++     +  + GT  Y+ PE         KVD
Sbjct: 139 DIKPENLLMGYKGELKIADFG----WSVHAPSLRRRXMCGTLDYLPPEMIEGKTHDEKVD 194
Query: 706 VYSFGVLLLEIISCRKSFD 724
           ++  GVL  E +     FD
Sbjct: 195 LWCAGVLCYEFLVGMPPFD 213

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 127/281 (45%), Gaps = 17/281 (6%)
Query: 526 EVGRGSFGIVYKGVIQTRTSTTA--VAVKKLDRVFQDGERE-FKNEVFVIGQTHHKNLVR 582
           ++G G FG V           T   VAVK L        R  +K E+ ++   +H+++++
Sbjct: 38  DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIK 97
Query: 583 LLGFC-DEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIAF--QIARGLLYLHEDC 638
             G C D G   L LV E++  G+L  +L    + +  L   + F  QI  G+ YLH   
Sbjct: 98  YKGCCEDAGAASLQLVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQQICEGMAYLHAQ- 153
Query: 639 RAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTL-NQSKTIKTAIRGTKGYVAPEWFRN 697
               IH D+  +N+LLD+    +I DFGLAK +   ++   ++        + APE  + 
Sbjct: 154 --HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKE 211
Query: 698 SKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKE 756
            K     DV+SFGV L E+++ C  S       ++  L   A       +L  L+   + 
Sbjct: 212 YKFYYASDVWSFGVTLYELLTHCDSSQSPPT--KFLELIGIAQGQMTVLRLTELLERGER 269
Query: 757 AMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 797
                +C  ++  +   C + + S RPT + ++ +L+ V E
Sbjct: 270 LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 99/202 (49%), Gaps = 9/202 (4%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREF-KNEVFVIGQTHHKNLVRLLG 585
           +GRGS+  V    ++      A+ V K + V  D + ++ + E  V  Q  +   +  L 
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 586 FCDEGQNRLL-VYEFLNNGTLASFLFGNLK-PNWNLRTNIAFQIARGLLYLHEDCRAQII 643
            C + ++RL  V E++N G L   +    K P  + R   A +I+  L YLHE     II
Sbjct: 77  SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHE---RGII 132
Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK 703
           + D+K  N+LLD     +++D+G+ K   L    T  +   GT  Y+APE  R       
Sbjct: 133 YRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTT-SXFCGTPNYIAPEILRGEDYGFS 190
Query: 704 VDVYSFGVLLLEIISCRKSFDI 725
           VD ++ GVL+ E+++ R  FDI
Sbjct: 191 VDWWALGVLMFEMMAGRSPFDI 212

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 94/201 (46%), Gaps = 11/201 (5%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE--REFKNEVFVIGQTHHKNLVRLL 584
           +G+G+F  V   + +   +   VAVK +D+   +    ++   EV ++   +H N+V+L 
Sbjct: 22  IGKGNFAKV--KLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIH 644
              +  +   LV E+ + G +  +L  + +           QI   + Y H+     I+H
Sbjct: 80  EVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF---IVH 136
Query: 645 CDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITA-K 703
            D+K +N+LLD     +I+DFG +   T         A  G   Y APE F+  K    +
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFSNEFTFGNK---LDAFCGAPPYAAPELFQGKKYDGPE 193
Query: 704 VDVYSFGVLLLEIISCRKSFD 724
           VDV+S GV+L  ++S    FD
Sbjct: 194 VDVWSLGVILYTLVSGSLPFD 214

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 98/200 (49%), Gaps = 21/200 (10%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           +G G+ GIV             VAVKKL R FQ+    +R ++ E+ ++   +HKN++ L
Sbjct: 32  IGSGAQGIVCAAF--DTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISL 88
Query: 584 LGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHED 637
           L         +E Q+  LV E ++   L   +   L  +    + + +Q+  G+ +LH  
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIHMEL--DHERMSYLLYQMLCGIKHLHS- 144
Query: 638 CRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRN 697
             A IIH D+KP NI++    T +I DFGLA+    N    + T    T+ Y APE    
Sbjct: 145 --AGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN---FMMTPYVVTRYYRAPEVILG 199
Query: 698 SKITAKVDVYSFGVLLLEII 717
               A VD++S G ++ E++
Sbjct: 200 MGYAANVDIWSVGCIMGELV 219

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 94/213 (44%), Gaps = 35/213 (16%)
Query: 527 VGRGSFGIV---YKGVIQTRTSTTAVAVKKLDRVFQD--GEREFKNEVFVIGQTHHKNLV 581
           VG G++G V   Y   ++ +     VAVKKL R FQ     R    E+ ++    H+N++
Sbjct: 36  VGSGAYGSVCSAYDARLRQK-----VAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVI 90
Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN----IAFQIARGLLYLHED 637
            LL       +     E     TL      N+  +  L       + +Q+ RGL Y+H  
Sbjct: 91  GLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHS- 149
Query: 638 CRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRN 697
             A IIH D+KP N+ +++    RI DFGLA           + A     GYVA  W+R 
Sbjct: 150 --AGIIHRDLKPSNVAVNEDSELRILDFGLA-----------RQADEEMTGYVATRWYRA 196
Query: 698 SKIT-------AKVDVYSFGVLLLEIISCRKSF 723
            +I          VD++S G ++ E++  +  F
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLQGKALF 229

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 99/202 (49%), Gaps = 9/202 (4%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREF-KNEVFVIGQTHHKNLVRLLG 585
           +GRGS+  V    ++      A+ V K + V  D + ++ + E  V  Q  +   +  L 
Sbjct: 28  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 87
Query: 586 FCDEGQNRLL-VYEFLNNGTLASFLFGNLK-PNWNLRTNIAFQIARGLLYLHEDCRAQII 643
            C + ++RL  V E++N G L   +    K P  + R   A +I+  L YLHE     II
Sbjct: 88  SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHE---RGII 143
Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK 703
           + D+K  N+LLD     +++D+G+ K   L    T  +   GT  Y+APE  R       
Sbjct: 144 YRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTT-SXFCGTPNYIAPEILRGEDYGFS 201
Query: 704 VDVYSFGVLLLEIISCRKSFDI 725
           VD ++ GVL+ E+++ R  FDI
Sbjct: 202 VDWWALGVLMFEMMAGRSPFDI 223

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 39/215 (18%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           VG G++G V      T+T    VAVKKL R FQ     +R ++ E+ ++    H+N++ L
Sbjct: 30  VGSGAYGSVC-AAFDTKTGHR-VAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 86
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTN----IAFQIARGLLYLH 635
           L      ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H
Sbjct: 87  LDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 142
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
               A IIH D+KP N+ +++    +I DFGLA+      +           G+VA  W+
Sbjct: 143 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMA-----------GFVATRWY 188
Query: 696 RNSKIT-------AKVDVYSFGVLLLEIISCRKSF 723
           R  +I          VD++S G ++ E+++ R  F
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 39/215 (18%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           VG G++G V      T+T    VAVKKL R FQ     +R ++ E+ ++    H+N++ L
Sbjct: 30  VGSGAYGSVC-AAFDTKTGHR-VAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 86
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTN----IAFQIARGLLYLH 635
           L      ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H
Sbjct: 87  LDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 142
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
               A IIH D+KP N+ +++    +I DFGLA+      +           G+VA  W+
Sbjct: 143 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMA-----------GFVATRWY 188
Query: 696 RNSKIT-------AKVDVYSFGVLLLEIISCRKSF 723
           R  +I          VD++S G ++ E+++ R  F
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 97/197 (49%), Gaps = 14/197 (7%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE--REFKNEVFVIGQTHHKNLVRLL 584
           +G+GSFG V K   + R +    AVK +++     +       EV ++ +  H N+++L 
Sbjct: 30  LGKGSFGEVLK--CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIH 644
              ++  +  +V E    G L   +    + + +    I  Q+  G+ Y+H   +  I+H
Sbjct: 88  EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMH---KHNIVH 144
Query: 645 CDIKPQNILLDDYYT---ARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKIT 701
            D+KP+NILL+        +I DFGL+      Q+  +K  I GT  Y+APE  R +   
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLST--CFQQNTKMKDRI-GTAYYIAPEVLRGT-YD 200
Query: 702 AKVDVYSFGVLLLEIIS 718
            K DV+S GV+L  ++S
Sbjct: 201 EKCDVWSAGVILYILLS 217

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 99/202 (49%), Gaps = 9/202 (4%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREF-KNEVFVIGQTHHKNLVRLLG 585
           +GRGS+  V    ++      A+ V K + V  D + ++ + E  V  Q  +   +  L 
Sbjct: 13  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 72
Query: 586 FCDEGQNRLL-VYEFLNNGTLASFLFGNLK-PNWNLRTNIAFQIARGLLYLHEDCRAQII 643
            C + ++RL  V E++N G L   +    K P  + R   A +I+  L YLHE     II
Sbjct: 73  SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHE---RGII 128
Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK 703
           + D+K  N+LLD     +++D+G+ K   L    T  +   GT  Y+APE  R       
Sbjct: 129 YRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTT-SXFCGTPNYIAPEILRGEDYGFS 186
Query: 704 VDVYSFGVLLLEIISCRKSFDI 725
           VD ++ GVL+ E+++ R  FDI
Sbjct: 187 VDWWALGVLMFEMMAGRSPFDI 208

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 39/215 (18%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           VG G++G V      T+T    VAVKKL R FQ     +R ++ E+ ++    H+N++ L
Sbjct: 26  VGSGAYGSVC-AAFDTKTGHR-VAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 82
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTN----IAFQIARGLLYLH 635
           L      ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H
Sbjct: 83  LDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 138
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
               A IIH D+KP N+ +++    +I DFGLA+      +           G+VA  W+
Sbjct: 139 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMA-----------GFVATRWY 184
Query: 696 RNSKIT-------AKVDVYSFGVLLLEIISCRKSF 723
           R  +I          VD++S G ++ E+++ R  F
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 219

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 39/215 (18%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           VG G++G V         S   +AVKKL R FQ     +R ++ E+ ++    H+N++ L
Sbjct: 59  VGSGAYGSVCSSY--DVKSGLKIAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 115
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTN----IAFQIARGLLYLH 635
           L       +     E  N+  L + L G    N+     L  +    + +QI RGL Y+H
Sbjct: 116 LDVFTPATS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 171
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
               A IIH D+KP N+ +++    +I DFGLA+      +           GYVA  W+
Sbjct: 172 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWY 217
Query: 696 RNSKIT-------AKVDVYSFGVLLLEIISCRKSF 723
           R  +I          VD++S G ++ E+++ R  F
Sbjct: 218 RAPEIMLNWMHYNMTVDIWSVGCIMAELLTGRTLF 252

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 104/203 (51%), Gaps = 27/203 (13%)
Query: 527 VGRGSFGIV---YKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNL 580
           +G G+ GIV   Y  +++       VA+KKL R FQ+    +R ++ E+ ++   +HKN+
Sbjct: 32  IGSGAQGIVVAAYDAILERN-----VAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNI 85
Query: 581 VRLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYL 634
           + LL         +E Q+  +V E ++   L+  +   ++ +    + + +Q+  G+ +L
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMD-ANLSQVI--QMELDHERMSYLLYQMLVGIKHL 142
Query: 635 HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 694
           H    A IIH D+KP NI++    T +I DFGLA+      +  + T    T+ Y APE 
Sbjct: 143 HS---AGIIHRDLKPSNIVVKSDATLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEV 196
Query: 695 FRNSKITAKVDVYSFGVLLLEII 717
                    VD++S GV++ E+I
Sbjct: 197 ILGMGYKENVDIWSVGVIMGEMI 219

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 20/210 (9%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGER------EFKNEVFVIGQTHHK 578
           EE+G G F +V K   + +++    A K + +      R      + + EV ++ +  H 
Sbjct: 17  EELGSGQFAVVKK--CREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 579 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDC 638
           N++ L    +   + +L+ E +  G L  FL           T    QI  G+ YLH   
Sbjct: 75  NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS-- 132
Query: 639 RAQIIHCDIKPQNILLDDYYTAR----ISDFGLAKLLTL-NQSKTIKTAIRGTKGYVAPE 693
             QI H D+KP+NI+L D    +    I DFGLA  +   N+ K I     GT  +VAPE
Sbjct: 133 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI----FGTPAFVAPE 187
Query: 694 WFRNSKITAKVDVYSFGVLLLEIISCRKSF 723
                 +  + D++S GV+   ++S    F
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 97/197 (49%), Gaps = 14/197 (7%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE--REFKNEVFVIGQTHHKNLVRLL 584
           +G+GSFG V K   + R +    AVK +++     +       EV ++ +  H N+++L 
Sbjct: 30  LGKGSFGEVLK--CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIH 644
              ++  +  +V E    G L   +    + + +    I  Q+  G+ Y+H   +  I+H
Sbjct: 88  EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMH---KHNIVH 144
Query: 645 CDIKPQNILLDDYYT---ARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKIT 701
            D+KP+NILL+        +I DFGL+      Q+  +K  I GT  Y+APE  R +   
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLST--CFQQNTKMKDRI-GTAYYIAPEVLRGT-YD 200
Query: 702 AKVDVYSFGVLLLEIIS 718
            K DV+S GV+L  ++S
Sbjct: 201 EKCDVWSAGVILYILLS 217

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 16/207 (7%)
Query: 523 FKEEVGRGSFGIVYKGVIQT-----RTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHH 577
           F E +G+G+F  ++KGV +      +   T V +K LD+  ++    F     ++ +  H
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 578 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN---LKPNWNLRTNIAFQIARGLLYL 634
           K+LV   G C  G   +LV EF+  G+L ++L  N   +   W L   +A Q+A  + +L
Sbjct: 72  KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLE--VAKQLAAAMHFL 129
Query: 635 HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI--KTAIRGTKGYVAP 692
            E+    +IH ++  +NILL      +  +    KL     S T+  K  ++    +V P
Sbjct: 130 EENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPP 186
Query: 693 EWFRNSK-ITAKVDVYSFGVLLLEIIS 718
           E   N K +    D +SFG  L EI S
Sbjct: 187 ECIENPKNLNLATDKWSFGTTLWEICS 213

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 97/197 (49%), Gaps = 14/197 (7%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE--REFKNEVFVIGQTHHKNLVRLL 584
           +G+GSFG V K   + R +    AVK +++     +       EV ++ +  H N+++L 
Sbjct: 30  LGKGSFGEVLK--CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIH 644
              ++  +  +V E    G L   +    + + +    I  Q+  G+ Y+H   +  I+H
Sbjct: 88  EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMH---KHNIVH 144
Query: 645 CDIKPQNILLDDYYT---ARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKIT 701
            D+KP+NILL+        +I DFGL+      Q+  +K  I GT  Y+APE  R +   
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLST--CFQQNTKMKDRI-GTAYYIAPEVLRGT-YD 200
Query: 702 AKVDVYSFGVLLLEIIS 718
            K DV+S GV+L  ++S
Sbjct: 201 EKCDVWSAGVILYILLS 217

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 27/209 (12%)
Query: 527 VGRGSFGIV---YKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNL 580
           +G G+ GIV   Y  V+        VA+KKL R FQ+    +R ++ E+ ++   +HKN+
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN-----VAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNI 85
Query: 581 VRLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYL 634
           + LL         +E Q+  LV E ++   L   +   L  +    + + +Q+  G+ +L
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMD-ANLXQVIQMEL--DHERMSYLLYQMLXGIKHL 142
Query: 635 HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 694
           H    A IIH D+KP NI++    T +I DFGLA+      +  + T    T+ Y APE 
Sbjct: 143 HS---AGIIHRDLKPSNIVVKSDXTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEV 196
Query: 695 FRNSKITAKVDVYSFGVLLLEIISCRKSF 723
                    VD++S G ++ E++  +  F
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMVRHKILF 225

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 20/210 (9%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGER------EFKNEVFVIGQTHHK 578
           EE+G G F +V K   + +++    A K + +      R      + + EV ++ +  H 
Sbjct: 17  EELGSGQFAVVKK--CREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 579 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDC 638
           N++ L    +   + +L+ E +  G L  FL           T    QI  G+ YLH   
Sbjct: 75  NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH--- 131
Query: 639 RAQIIHCDIKPQNILLDDYYTA----RISDFGLAKLLTL-NQSKTIKTAIRGTKGYVAPE 693
             QI H D+KP+NI+L D        +I DFGLA  +   N+ K     I GT  +VAPE
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN----IFGTPEFVAPE 187
Query: 694 WFRNSKITAKVDVYSFGVLLLEIISCRKSF 723
                 +  + D++S GV+   ++S    F
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/285 (25%), Positives = 130/285 (45%), Gaps = 31/285 (10%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLV 581
             +E +G G+  +V       +    A+    L++  Q    E   E+  + Q HH N+V
Sbjct: 18  ELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIV 76
Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLF-----GNLKPNWNLRTNIAF---QIARGLLY 633
                        LV + L+ G++   +      G  K      + IA    ++  GL Y
Sbjct: 77  SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 136
Query: 634 LHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLT----LNQSKTIKTAIRGTKGY 689
           LH++ +   IH D+K  NILL +  + +I+DFG++  L     + ++K  KT + GT  +
Sbjct: 137 LHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV-GTPCW 192
Query: 690 VAPEWFRNSK-ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLN 748
           +APE     +    K D++SFG+  +E+ +    +      +  +LT       +N   +
Sbjct: 193 MAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT------LQNDPPS 246
Query: 749 VLVG-EDKEAMNDIECLGKLV--MVSIWCIQEDPSLRPTMKKVLQ 790
           +  G +DKE +      GK    M+S+ C+Q+DP  RPT  ++L+
Sbjct: 247 LETGVQDKEMLKK---YGKSFRKMISL-CLQKDPEKRPTAAELLR 287

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 27/209 (12%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           VG G++G V      T+T    VAVKKL R FQ     +R ++ E+ ++    H+N++ L
Sbjct: 50  VGSGAYGSVC-AAFDTKTGHR-VAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 106
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTN----IAFQIARGLLYLH 635
           L      ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H
Sbjct: 107 LDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 162
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
               A IIH D+KP N+ +++    +I DFGLA+      +         T+ Y APE  
Sbjct: 163 S---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMXGXVATRWYRAPEIM 214
Query: 696 RN-SKITAKVDVYSFGVLLLEIISCRKSF 723
            N       VD++S G ++ E+++ R  F
Sbjct: 215 LNWMHYNQTVDIWSVGCIMAELLTGRTLF 243

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/285 (25%), Positives = 130/285 (45%), Gaps = 31/285 (10%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLV 581
             +E +G G+  +V       +    A+    L++  Q    E   E+  + Q HH N+V
Sbjct: 13  ELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIV 71
Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLF-----GNLKPNWNLRTNIAF---QIARGLLY 633
                        LV + L+ G++   +      G  K      + IA    ++  GL Y
Sbjct: 72  SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 131
Query: 634 LHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLT----LNQSKTIKTAIRGTKGY 689
           LH++ +   IH D+K  NILL +  + +I+DFG++  L     + ++K  KT + GT  +
Sbjct: 132 LHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV-GTPCW 187
Query: 690 VAPEWFRNSK-ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLN 748
           +APE     +    K D++SFG+  +E+ +    +      +  +LT       +N   +
Sbjct: 188 MAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT------LQNDPPS 241
Query: 749 VLVG-EDKEAMNDIECLGKLV--MVSIWCIQEDPSLRPTMKKVLQ 790
           +  G +DKE +      GK    M+S+ C+Q+DP  RPT  ++L+
Sbjct: 242 LETGVQDKEMLKK---YGKSFRKMISL-CLQKDPEKRPTAAELLR 282

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 20/210 (9%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGER------EFKNEVFVIGQTHHK 578
           EE+G G F +V K   + +++    A K + +      R      + + EV ++ +  H 
Sbjct: 16  EELGSGQFAVVKK--CREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 73
Query: 579 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDC 638
           N++ L    +   + +L+ E +  G L  FL           T    QI  G+ YLH   
Sbjct: 74  NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS-- 131
Query: 639 RAQIIHCDIKPQNILLDDYYTA----RISDFGLAKLLTL-NQSKTIKTAIRGTKGYVAPE 693
             QI H D+KP+NI+L D        +I DFGLA  +   N+ K     I GT  +VAPE
Sbjct: 132 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN----IFGTPEFVAPE 186
Query: 694 WFRNSKITAKVDVYSFGVLLLEIISCRKSF 723
                 +  + D++S GV+   ++S    F
Sbjct: 187 IVNYEPLGLEADMWSIGVITYILLSGASPF 216

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 20/210 (9%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGER------EFKNEVFVIGQTHHK 578
           EE+G G F +V K   + +++    A K + +      R      + + EV ++ +  H 
Sbjct: 17  EELGSGQFAVVKK--CREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 579 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDC 638
           N++ L    +   + +L+ E +  G L  FL           T    QI  G+ YLH   
Sbjct: 75  NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS-- 132
Query: 639 RAQIIHCDIKPQNILLDDYYTA----RISDFGLAKLLTL-NQSKTIKTAIRGTKGYVAPE 693
             QI H D+KP+NI+L D        +I DFGLA  +   N+ K     I GT  +VAPE
Sbjct: 133 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN----IFGTPEFVAPE 187
Query: 694 WFRNSKITAKVDVYSFGVLLLEIISCRKSF 723
                 +  + D++S GV+   ++S    F
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 20/210 (9%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGER------EFKNEVFVIGQTHHK 578
           EE+G G F +V K   + +++    A K + +      R      + + EV ++ +  H 
Sbjct: 16  EELGSGQFAVVKK--CREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 73
Query: 579 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDC 638
           N++ L    +   + +L+ E +  G L  FL           T    QI  G+ YLH   
Sbjct: 74  NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS-- 131
Query: 639 RAQIIHCDIKPQNILLDDYYTA----RISDFGLAKLLTL-NQSKTIKTAIRGTKGYVAPE 693
             QI H D+KP+NI+L D        +I DFGLA  +   N+ K     I GT  +VAPE
Sbjct: 132 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN----IFGTPEFVAPE 186
Query: 694 WFRNSKITAKVDVYSFGVLLLEIISCRKSF 723
                 +  + D++S GV+   ++S    F
Sbjct: 187 IVNYEPLGLEADMWSIGVITYILLSGASPF 216

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 20/210 (9%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGER------EFKNEVFVIGQTHHK 578
           EE+G G F +V K   + +++    A K + +      R      + + EV ++ +  H 
Sbjct: 17  EELGSGKFAVVKK--CREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 579 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDC 638
           N++ L    +   + +L+ E +  G L  FL           T    QI  G+ YLH   
Sbjct: 75  NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS-- 132
Query: 639 RAQIIHCDIKPQNILLDDYYTA----RISDFGLAKLLTL-NQSKTIKTAIRGTKGYVAPE 693
             QI H D+KP+NI+L D        +I DFGLA  +   N+ K     I GT  +VAPE
Sbjct: 133 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN----IFGTPEFVAPE 187
Query: 694 WFRNSKITAKVDVYSFGVLLLEIISCRKSF 723
                 +  + D++S GV+   ++S    F
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 129/281 (45%), Gaps = 17/281 (6%)
Query: 526 EVGRGSFGIVYKGVIQTRTSTTA--VAVKKLDRVFQDGERE-FKNEVFVIGQTHHKNLVR 582
           ++G G FG V           T   VAVK L        R  +K E+ ++   +H+++++
Sbjct: 21  DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIK 80
Query: 583 LLGFC-DEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIAF--QIARGLLYLHEDC 638
             G C D+G+  L LV E++  G+L  +L    + +  L   + F  QI  G+ YLH   
Sbjct: 81  YKGCCEDQGEKSLQLVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQQICEGMAYLHSQ- 136
Query: 639 RAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTL-NQSKTIKTAIRGTKGYVAPEWFRN 697
               IH ++  +N+LLD+    +I DFGLAK +   ++   ++        + APE  + 
Sbjct: 137 --HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 194
Query: 698 SKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKE 756
            K     DV+SFGV L E+++ C  S       ++  L   A       +L  L+   + 
Sbjct: 195 YKFYYASDVWSFGVTLYELLTHCDSSQSPPT--KFLELIGIAQGQMTVLRLTELLERGER 252
Query: 757 AMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 797
                +C  ++  +   C + + S RPT + ++ +L+ V E
Sbjct: 253 LPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKTVHE 293

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 16/207 (7%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLV 581
             KE++G GS+ +  + +   + +    AVK +D+  +D   E +    ++    H N++
Sbjct: 25  EVKEDIGVGSYSVCKRCI--HKATNMEFAVKIIDKSKRDPTEEIE---ILLRYGQHPNII 79
Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ 641
            L    D+G+   +V E +  G L   +      +    + + F I + + YLH    AQ
Sbjct: 80  TLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLH----AQ 135
Query: 642 -IIHCDIKPQNILLDDYY----TARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR 696
            ++H D+KP NIL  D      + RI DFG AK L       +      T  +VAPE   
Sbjct: 136 GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCY--TANFVAPEVLE 193
Query: 697 NSKITAKVDVYSFGVLLLEIISCRKSF 723
                A  D++S GVLL  +++    F
Sbjct: 194 RQGYDAACDIWSLGVLLYTMLTGYTPF 220

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 96/202 (47%), Gaps = 24/202 (11%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE---REFKNEVFVIGQTHHKNLV 581
           E++G G++G V+K   + R +   VA+K++ R+  D E        E+ ++ +  HKN+V
Sbjct: 8   EKIGEGTYGTVFKA--KNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKHKNIV 64
Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ 641
           RL       +   LV+EF +      F   N   +  +  +  FQ+ +GL + H      
Sbjct: 65  RLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS---RN 121
Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI- 700
           ++H D+KPQN+L++     ++++FGLA+   +         +R     V   W+R   + 
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGI--------PVRCYSAEVVTLWYRPPDVL 173
Query: 701 ------TAKVDVYSFGVLLLEI 716
                 +  +D++S G +  E+
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAEL 195

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 20/210 (9%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGER------EFKNEVFVIGQTHHK 578
           EE+G G F +V K   + +++    A K + +      R      + + EV ++ +  H 
Sbjct: 17  EELGSGQFAVVKK--CREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 579 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDC 638
           N++ L    +   + +L+ E +  G L  FL           T    QI  G+ YLH   
Sbjct: 75  NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS-- 132
Query: 639 RAQIIHCDIKPQNILLDDYYTA----RISDFGLAKLLTL-NQSKTIKTAIRGTKGYVAPE 693
             QI H D+KP+NI+L D        +I DFGLA  +   N+ K     I GT  +VAPE
Sbjct: 133 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN----IFGTPEFVAPE 187
Query: 694 WFRNSKITAKVDVYSFGVLLLEIISCRKSF 723
                 +  + D++S GV+   ++S    F
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 15/205 (7%)
Query: 527 VGRGSFGIV---YKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G G++G+V   Y  + + R +   ++  +     Q   RE K    ++ +  H+N++ +
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIK----ILLRFRHENIIGI 90
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF---QIARGLLYLHEDCRA 640
                      +   ++    + + L+  LK       +I +   QI RGL Y+H    A
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---A 147
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT-IKTAIRGTKGYVAPEWFRNSK 699
            ++H D+KP N+LL+     +I DFGLA++   +   T        T+ Y APE   NSK
Sbjct: 148 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSK 207
Query: 700 -ITAKVDVYSFGVLLLEIISCRKSF 723
             T  +D++S G +L E++S R  F
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 15/205 (7%)
Query: 527 VGRGSFGIV---YKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G G++G+V   Y  + + R +   ++  +     Q   RE K    ++ +  H+N++ +
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIK----ILLRFRHENIIGI 91
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF---QIARGLLYLHEDCRA 640
                      +   ++    + + L+  LK       +I +   QI RGL Y+H    A
Sbjct: 92  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---A 148
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT-IKTAIRGTKGYVAPEWFRNSK 699
            ++H D+KP N+LL+     +I DFGLA++   +   T        T+ Y APE   NSK
Sbjct: 149 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSK 208
Query: 700 -ITAKVDVYSFGVLLLEIISCRKSF 723
             T  +D++S G +L E++S R  F
Sbjct: 209 GYTKSIDIWSVGCILAEMLSNRPIF 233

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 20/210 (9%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGER------EFKNEVFVIGQTHHK 578
           EE+G G F +V K   + +++    A K + +      R      + + EV ++ +  H 
Sbjct: 17  EELGSGQFAVVKK--CREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 579 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDC 638
           N++ L    +   + +L+ E +  G L  FL           T    QI  G+ YLH   
Sbjct: 75  NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS-- 132
Query: 639 RAQIIHCDIKPQNILLDDYYTA----RISDFGLAKLLTL-NQSKTIKTAIRGTKGYVAPE 693
             QI H D+KP+NI+L D        +I DFGLA  +   N+ K     I GT  +VAPE
Sbjct: 133 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN----IFGTPEFVAPE 187
Query: 694 WFRNSKITAKVDVYSFGVLLLEIISCRKSF 723
                 +  + D++S GV+   ++S    F
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 129/281 (45%), Gaps = 17/281 (6%)
Query: 526 EVGRGSFGIVYKGVIQTRTSTTA--VAVKKLDRVFQDGERE-FKNEVFVIGQTHHKNLVR 582
           ++G G FG V           T   VAVK L        R  +K E+ ++   +H+++++
Sbjct: 21  DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIK 80
Query: 583 LLGFC-DEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIAF--QIARGLLYLHEDC 638
             G C D+G+  L LV E++  G+L  +L    + +  L   + F  QI  G+ YLH   
Sbjct: 81  YKGCCEDQGEKSLQLVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQQICEGMAYLHAQ- 136
Query: 639 RAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTL-NQSKTIKTAIRGTKGYVAPEWFRN 697
               IH ++  +N+LLD+    +I DFGLAK +   ++   ++        + APE  + 
Sbjct: 137 --HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 194
Query: 698 SKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKE 756
            K     DV+SFGV L E+++ C  S       ++  L   A       +L  L+   + 
Sbjct: 195 YKFYYASDVWSFGVTLYELLTHCDSSQSPPT--KFLELIGIAQGQMTVLRLTELLERGER 252
Query: 757 AMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 797
                +C  ++  +   C + + S RPT + ++ +L+ V E
Sbjct: 253 LPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKTVHE 293

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 20/210 (9%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGER------EFKNEVFVIGQTHHK 578
           EE+G G F +V K   + +++    A K + +      R      + + EV ++ +  H 
Sbjct: 17  EELGSGQFAVVKK--CREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 579 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDC 638
           N++ L    +   + +L+ E +  G L  FL           T    QI  G+ YLH   
Sbjct: 75  NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS-- 132
Query: 639 RAQIIHCDIKPQNILLDDYYTA----RISDFGLAKLLTL-NQSKTIKTAIRGTKGYVAPE 693
             QI H D+KP+NI+L D        +I DFGLA  +   N+ K     I GT  +VAPE
Sbjct: 133 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN----IFGTPEFVAPE 187
Query: 694 WFRNSKITAKVDVYSFGVLLLEIISCRKSF 723
                 +  + D++S GV+   ++S    F
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 20/210 (9%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGER------EFKNEVFVIGQTHHK 578
           EE+G G F +V K   + +++    A K + +      R      + + EV ++ +  H 
Sbjct: 17  EELGSGQFAVVKK--CREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 579 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDC 638
           N++ L    +   + +L+ E +  G L  FL           T    QI  G+ YLH   
Sbjct: 75  NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS-- 132
Query: 639 RAQIIHCDIKPQNILLDDYYTA----RISDFGLAKLLTL-NQSKTIKTAIRGTKGYVAPE 693
             QI H D+KP+NI+L D        +I DFGLA  +   N+ K     I GT  +VAPE
Sbjct: 133 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN----IFGTPEFVAPE 187
Query: 694 WFRNSKITAKVDVYSFGVLLLEIISCRKSF 723
                 +  + D++S GV+   ++S    F
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 97/202 (48%), Gaps = 13/202 (6%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE--REFKNEVFVIGQTHHKNLVRLL 584
           +G+G+F  V   + +   +   VAVK +D+   +    ++   EV ++   +H N+V+L 
Sbjct: 22  IGKGNFAKV--KLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIH 644
              +  +   LV E+ + G +  +L  + +           QI   + Y H+     I+H
Sbjct: 80  EVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF---IVH 136
Query: 645 CDIKPQNILLDDYYTARISDFGLAKLLTL-NQSKTIKTAIRGTKGYVAPEWFRNSKITA- 702
            D+K +N+LLD     +I+DFG +   T  N+  T      G+  Y APE F+  K    
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC----GSPPYAAPELFQGKKYDGP 192
Query: 703 KVDVYSFGVLLLEIISCRKSFD 724
           +VDV+S GV+L  ++S    FD
Sbjct: 193 EVDVWSLGVILYTLVSGSLPFD 214

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 97/202 (48%), Gaps = 13/202 (6%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE--REFKNEVFVIGQTHHKNLVRLL 584
           +G+G+F  V   + +   +   VAVK +D+   +    ++   EV ++   +H N+V+L 
Sbjct: 22  IGKGNFAKV--KLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIH 644
              +  +   LV E+ + G +  +L  + +           QI   + Y H+     I+H
Sbjct: 80  EVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF---IVH 136
Query: 645 CDIKPQNILLDDYYTARISDFGLAKLLTL-NQSKTIKTAIRGTKGYVAPEWFRNSKITA- 702
            D+K +N+LLD     +I+DFG +   T  N+  T      G+  Y APE F+  K    
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC----GSPPYAAPELFQGKKYDGP 192
Query: 703 KVDVYSFGVLLLEIISCRKSFD 724
           +VDV+S GV+L  ++S    FD
Sbjct: 193 EVDVWSLGVILYTLVSGSLPFD 214

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 20/210 (9%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGER------EFKNEVFVIGQTHHK 578
           EE+G G F +V K   + +++    A K + +      R      + + EV ++ +  H 
Sbjct: 17  EELGSGQFAVVKK--CREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 579 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDC 638
           N++ L    +   + +L+ E +  G L  FL           T    QI  G+ YLH   
Sbjct: 75  NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS-- 132
Query: 639 RAQIIHCDIKPQNILLDDYYTA----RISDFGLAKLLTL-NQSKTIKTAIRGTKGYVAPE 693
             QI H D+KP+NI+L D        +I DFGLA  +   N+ K     I GT  +VAPE
Sbjct: 133 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN----IFGTPEFVAPE 187
Query: 694 WFRNSKITAKVDVYSFGVLLLEIISCRKSF 723
                 +  + D++S GV+   ++S    F
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 20/210 (9%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGER------EFKNEVFVIGQTHHK 578
           EE+G G F +V K   + +++    A K + +      R      + + EV ++ +  H 
Sbjct: 17  EELGSGVFAVVKK--CREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 579 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDC 638
           N++ L    +   + +L+ E +  G L  FL           T    QI  G+ YLH   
Sbjct: 75  NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS-- 132
Query: 639 RAQIIHCDIKPQNILLDDYYTA----RISDFGLAKLLTL-NQSKTIKTAIRGTKGYVAPE 693
             QI H D+KP+NI+L D        +I DFGLA  +   N+ K     I GT  +VAPE
Sbjct: 133 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN----IFGTPEFVAPE 187
Query: 694 WFRNSKITAKVDVYSFGVLLLEIISCRKSF 723
                 +  + D++S GV+   ++S    F
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 20/210 (9%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGER------EFKNEVFVIGQTHHK 578
           EE+G G F +V K   + +++    A K + +      R      + + EV ++ +  H 
Sbjct: 17  EELGSGQFAVVKK--CREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 579 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDC 638
           N++ L    +   + +L+ E +  G L  FL           T    QI  G+ YLH   
Sbjct: 75  NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS-- 132
Query: 639 RAQIIHCDIKPQNILLDDYYTA----RISDFGLAKLLTL-NQSKTIKTAIRGTKGYVAPE 693
             QI H D+KP+NI+L D        +I DFGLA  +   N+ K     I GT  +VAPE
Sbjct: 133 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN----IFGTPEFVAPE 187
Query: 694 WFRNSKITAKVDVYSFGVLLLEIISCRKSF 723
                 +  + D++S GV+   ++S    F
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 107/207 (51%), Gaps = 14/207 (6%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV---FQDGEREFKNEVFVIGQTHHKNLV 581
           + +G G+FG V  G  + + +   VAVK L+R      D   + K E+  +    H +++
Sbjct: 17  DTLGVGTFGKVKIG--EHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHII 74
Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ 641
           +L        +  +V E+++ G L  ++  + +        +  QI   + Y H   R  
Sbjct: 75  KLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCH---RHM 131
Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKIT 701
           ++H D+KP+N+LLD +  A+I+DFGL+ +++    + ++T+  G+  Y APE   + ++ 
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMS--DGEFLRTSC-GSPNYAAPEVI-SGRLY 187
Query: 702 A--KVDVYSFGVLLLEIISCRKSFDIE 726
           A  +VD++S GV+L  ++     FD E
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLPFDDE 214

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 93/201 (46%), Gaps = 11/201 (5%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE--REFKNEVFVIGQTHHKNLVRLL 584
           +G+G+F  V   + +   +   VAVK +D+   +    ++   EV +    +H N+V+L 
Sbjct: 22  IGKGNFAKV--KLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLF 79
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIH 644
              +  +   LV E+ + G +  +L  + +           QI   + Y H+     I+H
Sbjct: 80  EVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQKF---IVH 136
Query: 645 CDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITA-K 703
            D+K +N+LLD     +I+DFG +   T         A  G   Y APE F+  K    +
Sbjct: 137 RDLKAENLLLDADXNIKIADFGFSNEFTFGNK---LDAFCGAPPYAAPELFQGKKYDGPE 193
Query: 704 VDVYSFGVLLLEIISCRKSFD 724
           VDV+S GV+L  ++S    FD
Sbjct: 194 VDVWSLGVILYTLVSGSLPFD 214

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 27/209 (12%)
Query: 527 VGRGSFGIV---YKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNL 580
           +G G+ GIV   Y  V+        VA+KKL R FQ+    +R ++ E+ ++   +HKN+
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN-----VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNI 85
Query: 581 VRLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYL 634
           + LL         +E Q+  LV E ++   L   +   L  +    + + +Q+  G+ +L
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMD-ANLXQVIQMEL--DHERMSYLLYQMLXGIKHL 142
Query: 635 HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 694
           H    A IIH D+KP NI++    T +I DFGLA+      +  + T    T+ Y APE 
Sbjct: 143 HS---AGIIHRDLKPSNIVVKSDXTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEV 196
Query: 695 FRNSKITAKVDVYSFGVLLLEIISCRKSF 723
                    VD++S G ++ E++  +  F
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMVRHKILF 225

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 16/207 (7%)
Query: 523 FKEEVGRGSFGIVYKGVIQT-----RTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHH 577
           F E +G+G+F  ++KGV +      +   T V +K LD+  ++    F     ++ +  H
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 578 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN---LKPNWNLRTNIAFQIARGLLYL 634
           K+LV   G C  G   +LV EF+  G+L ++L  N   +   W L   +A Q+A  + +L
Sbjct: 72  KHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLE--VAKQLAWAMHFL 129
Query: 635 HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI--KTAIRGTKGYVAP 692
            E+    +IH ++  +NILL      +  +    KL     S T+  K  ++    +V P
Sbjct: 130 EENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPP 186
Query: 693 EWFRNSK-ITAKVDVYSFGVLLLEIIS 718
           E   N K +    D +SFG  L EI S
Sbjct: 187 ECIENPKNLNLATDKWSFGTTLWEICS 213

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 97/201 (48%), Gaps = 11/201 (5%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE--REFKNEVFVIGQTHHKNLVRLL 584
           +G+G+F  V   + +   +   VA+K +D+   +    ++   EV ++   +H N+V+L 
Sbjct: 23  IGKGNFAKV--KLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 80
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIH 644
              +  +   L+ E+ + G +  +L  + +       +   QI   + Y H+    +I+H
Sbjct: 81  EVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQ---KRIVH 137
Query: 645 CDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITA-K 703
            D+K +N+LLD     +I+DFG +   T+        A  G   Y APE F+  K    +
Sbjct: 138 RDLKAENLLLDADMNIKIADFGFSNEFTVGGK---LDAFCGAPPYAAPELFQGKKYDGPE 194
Query: 704 VDVYSFGVLLLEIISCRKSFD 724
           VDV+S GV+L  ++S    FD
Sbjct: 195 VDVWSLGVILYTLVSGSLPFD 215

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 39/215 (18%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           VG G++G V      T+T    VAVKKL R FQ     +R ++ E+ ++    H+N++ L
Sbjct: 30  VGSGAYGSVC-AAFDTKTGLR-VAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 86
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTN----IAFQIARGLLYLH 635
           L      ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H
Sbjct: 87  LDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 142
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
               A IIH D+KP N+ +++    +I D GLA+      +           GYVA  W+
Sbjct: 143 S---ADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMT-----------GYVATRWY 188
Query: 696 RNSKIT-------AKVDVYSFGVLLLEIISCRKSF 723
           R  +I          VD++S G ++ E+++ R  F
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 27/209 (12%)
Query: 527 VGRGSFGIV---YKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNL 580
           +G G+ GIV   Y  V+        VA+KKL R FQ+    +R ++ E+ ++   +HKN+
Sbjct: 25  IGSGAQGIVCAAYDAVLDRN-----VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNI 78
Query: 581 VRLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYL 634
           + LL         +E Q+  LV E ++   L   +   L  +    + + +Q+  G+ +L
Sbjct: 79  ISLLNVFTPQKTLEEFQDVYLVMELMD-ANLXQVIQMEL--DHERMSYLLYQMLXGIKHL 135
Query: 635 HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 694
           H    A IIH D+KP NI++    T +I DFGLA+      +  + T    T+ Y APE 
Sbjct: 136 HS---AGIIHRDLKPSNIVVKSDXTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEV 189
Query: 695 FRNSKITAKVDVYSFGVLLLEIISCRKSF 723
                    VD++S G ++ E++  +  F
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMVRHKILF 218

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 20/210 (9%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGER------EFKNEVFVIGQTHHK 578
           EE+G G F +V K   + +++    A K + +      R      + + EV ++ +  H 
Sbjct: 17  EELGSGQFAVVKK--CREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 579 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDC 638
           N++ L    +   + +L+ E +  G L  FL           T    QI  G+ YLH   
Sbjct: 75  NVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS-- 132
Query: 639 RAQIIHCDIKPQNILLDDYYTA----RISDFGLAKLLTL-NQSKTIKTAIRGTKGYVAPE 693
             QI H D+KP+NI+L D        +I DFGLA  +   N+ K     I GT  +VAPE
Sbjct: 133 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN----IFGTPEFVAPE 187
Query: 694 WFRNSKITAKVDVYSFGVLLLEIISCRKSF 723
                 +  + D++S GV+   ++S    F
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 103/209 (49%), Gaps = 27/209 (12%)
Query: 527 VGRGSFGIV---YKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNL 580
           +G G+ GIV   Y  V+        VA+KKL R FQ+    +R ++ E+ ++   +HKN+
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN-----VAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNI 85
Query: 581 VRLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYL 634
           + LL         +E Q+  LV E ++   L   +   ++ +    + + +Q+  G+ +L
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMD-ANLXQVI--QMELDHERMSYLLYQMLCGIKHL 142
Query: 635 HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 694
           H    A IIH D+KP NI++    T +I DFGLA+      +  + T    T+ Y APE 
Sbjct: 143 HS---AGIIHRDLKPSNIVVKSDXTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEV 196
Query: 695 FRNSKITAKVDVYSFGVLLLEIISCRKSF 723
                    VD++S G ++ E++  +  F
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMVRHKILF 225

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 100/206 (48%), Gaps = 13/206 (6%)
Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE--REFKNEVFVIGQTHHKNL 580
            ++ +G+G+F  V   + +   +   VAVK +D+   +    ++   EV ++   +H N+
Sbjct: 19  LQKTIGKGNFAKV--KLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNI 76
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           V+L    +  +   LV E+ + G +  +L  + +           QI   + Y H+    
Sbjct: 77  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKY-- 134
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTL-NQSKTIKTAIRGTKGYVAPEWFRNSK 699
            I+H D+K +N+LLD     +I+DFG +   T+ N+  T      G+  Y APE F+  K
Sbjct: 135 -IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFC----GSPPYAAPELFQGKK 189
Query: 700 ITA-KVDVYSFGVLLLEIISCRKSFD 724
               +VDV+S GV+L  ++S    FD
Sbjct: 190 YDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 39/215 (18%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           VG G++G V      T+T    VAVKKL R FQ     +R ++ E+ ++    H+N++ L
Sbjct: 30  VGSGAYGSVC-AAFDTKTGLR-VAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 86
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTN----IAFQIARGLLYLH 635
           L      ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H
Sbjct: 87  LDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 142
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
               A IIH D+KP N+ +++    +I  FGLA+      +           GYVA  W+
Sbjct: 143 S---ADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMT-----------GYVATRWY 188
Query: 696 RNSKIT-------AKVDVYSFGVLLLEIISCRKSF 723
           R  +I          VD++S G ++ E+++ R  F
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/241 (23%), Positives = 109/241 (45%), Gaps = 10/241 (4%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLL 584
           EE+G+G+F +V + V        A  +    ++     ++ + E  +     H N+VRL 
Sbjct: 28  EELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 87
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIH 644
               E  +  L+++ +  G L   +      +    ++   QI   +L+ H+     ++H
Sbjct: 88  DSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQ---MGVVH 144
Query: 645 CDIKPQNILLDDYY---TARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKIT 701
            D+KP+N+LL         +++DFGLA  +   Q      A  GT GY++PE  R     
Sbjct: 145 RDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA--GTPGYLSPEVLRKDPYG 202
Query: 702 AKVDVYSFGVLLLEIISCRKSF-DIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMND 760
             VD+++ GV+L  ++     F D +    Y  +   A+D + + + + +  E K+ +N 
Sbjct: 203 KPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYD-FPSPEWDTVTPEAKDLINK 261
Query: 761 I 761
           +
Sbjct: 262 M 262

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 39/215 (18%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           VG G++G V      T+T    VAVKKL R FQ     +R ++ E+ ++    H+N++ L
Sbjct: 30  VGSGAYGSVC-AAFDTKTGLR-VAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 86
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTN----IAFQIARGLLYLH 635
           L      ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H
Sbjct: 87  LDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 142
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
               A IIH D+KP N+ +++    +I D GLA+      +           GYVA  W+
Sbjct: 143 S---ADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMT-----------GYVATRWY 188
Query: 696 RNSKIT-------AKVDVYSFGVLLLEIISCRKSF 723
           R  +I          VD++S G ++ E+++ R  F
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 103/209 (49%), Gaps = 27/209 (12%)
Query: 527 VGRGSFGIV---YKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNL 580
           +G G+ GIV   Y  V+        VA+KKL R FQ+    +R ++ E+ ++   +HKN+
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN-----VAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNI 85
Query: 581 VRLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYL 634
           + LL         +E Q+  LV E ++   L   +   ++ +    + + +Q+  G+ +L
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVI--QMELDHERMSYLLYQMLCGIKHL 142
Query: 635 HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 694
           H    A IIH D+KP NI++    T +I DFGLA+      +  + T    T+ Y APE 
Sbjct: 143 HS---AGIIHRDLKPSNIVVKSDXTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEV 196
Query: 695 FRNSKITAKVDVYSFGVLLLEIISCRKSF 723
                    VD++S G ++ E++  +  F
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMVRHKILF 225

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 93/213 (43%), Gaps = 35/213 (16%)
Query: 527 VGRGSFGIV---YKGVIQTRTSTTAVAVKKLDRVFQD--GEREFKNEVFVIGQTHHKNLV 581
           VG G++G V   Y   ++ +     VAVKKL R FQ     R    E+ ++    H+N++
Sbjct: 36  VGSGAYGSVCSAYDARLRQK-----VAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVI 90
Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN----IAFQIARGLLYLHED 637
            LL       +     E     TL      N+     L       + +Q+ RGL Y+H  
Sbjct: 91  GLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHS- 149
Query: 638 CRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRN 697
             A IIH D+KP N+ +++    RI DFGLA           + A     GYVA  W+R 
Sbjct: 150 --AGIIHRDLKPSNVAVNEDSELRILDFGLA-----------RQADEEMTGYVATRWYRA 196
Query: 698 SKIT-------AKVDVYSFGVLLLEIISCRKSF 723
            +I          VD++S G ++ E++  +  F
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLQGKALF 229

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 101/214 (47%), Gaps = 36/214 (16%)
Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVR 582
            VG G++G V   +   + S   VA+KKL R FQ     +R ++ E+ ++    H+N++ 
Sbjct: 31  HVGSGAYGSVCSAI--DKRSGEKVAIKKLSRPFQSEIFAKRAYR-ELLLLKHMQHENVIG 87
Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN------IAFQIARGLLYLHE 636
           LL       +    Y+F     +  F+  +L+    L+ +      + +Q+ +GL Y+H 
Sbjct: 88  LLDVFTPASSLRNFYDFY---LVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHS 144
Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR 696
              A ++H D+KP N+ +++    +I DFGLA           + A     GYV   W+R
Sbjct: 145 ---AGVVHRDLKPGNLAVNEDCELKILDFGLA-----------RHADAEMTGYVVTRWYR 190
Query: 697 NSKIT-------AKVDVYSFGVLLLEIISCRKSF 723
             ++          VD++S G ++ E+++ +  F
Sbjct: 191 APEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF 224

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 103/209 (49%), Gaps = 27/209 (12%)
Query: 527 VGRGSFGIV---YKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNL 580
           +G G+ GIV   Y  V+        VA+KKL R FQ+    +R ++ E+ ++   +HKN+
Sbjct: 70  IGSGAQGIVCAAYDAVLDRN-----VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNI 123
Query: 581 VRLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYL 634
           + LL         +E Q+  LV E ++   L   +   ++ +    + + +Q+  G+ +L
Sbjct: 124 ISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVI--QMELDHERMSYLLYQMLCGIKHL 180
Query: 635 HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 694
           H    A IIH D+KP NI++    T +I DFGLA+      +  + T    T+ Y APE 
Sbjct: 181 HS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEV 234
Query: 695 FRNSKITAKVDVYSFGVLLLEIISCRKSF 723
                    VD++S G ++ E++  +  F
Sbjct: 235 ILGMGYKENVDIWSVGCIMGEMVRHKILF 263

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 98/200 (49%), Gaps = 21/200 (10%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           +G G+ GIV             VAVKKL R FQ+    +R ++ E+ ++   +HKN++ L
Sbjct: 30  IGSGAQGIVCAAF--DTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISL 86
Query: 584 LGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHED 637
           L         +E Q+  LV E ++   L   +   L  +    + + +Q+  G+ +LH  
Sbjct: 87  LNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIHMEL--DHERMSYLLYQMLCGIKHLHS- 142
Query: 638 CRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRN 697
             A IIH D+KP NI++    T +I DFGLA+  + N    + T    T+ Y APE    
Sbjct: 143 --AGIIHRDLKPSNIVVKSDCTLKILDFGLARTASTN---FMMTPYVVTRYYRAPEVILG 197
Query: 698 SKITAKVDVYSFGVLLLEII 717
                 VD++S G ++ E++
Sbjct: 198 MGYKENVDIWSVGCIMGELV 217

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 39/215 (18%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           VG G++G V      T+T    VAVKKL R FQ     +R ++ E+ ++    H+N++ L
Sbjct: 30  VGSGAYGSVC-AAFDTKTGHR-VAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 86
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTN----IAFQIARGLLYLH 635
           L      ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H
Sbjct: 87  LDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 142
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
               A IIH D+KP N+ +++    +I DF LA+      +           GYVA  W+
Sbjct: 143 S---ADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMT-----------GYVATRWY 188
Query: 696 RNSKIT-------AKVDVYSFGVLLLEIISCRKSF 723
           R  +I          VD++S G ++ E+++ R  F
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 39/215 (18%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRL 583
           VG G++G V      T+T    VAVKKL R FQ     +R ++ E+ ++    H+N++ L
Sbjct: 30  VGSGAYGSVC-AAFDTKTGLR-VAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 86
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTN----IAFQIARGLLYLH 635
           L      ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H
Sbjct: 87  LDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 142
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
               A IIH D+KP N+ +++    +I D GLA+      +           GYVA  W+
Sbjct: 143 S---ADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMT-----------GYVATRWY 188
Query: 696 RNSKIT-------AKVDVYSFGVLLLEIISCRKSF 723
           R  +I          VD++S G ++ E+++ R  F
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 97/199 (48%), Gaps = 17/199 (8%)
Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLG 585
           E+G G+FG VYK   Q + ++   A K +D   ++   ++  E+ ++    H N+V+LL 
Sbjct: 44  ELGDGAFGKVYKA--QNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLD 101
Query: 586 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF-QIARGLLYLHEDCRAQIIH 644
                 N  ++ EF   G + + +    +P    +  +   Q    L YLH++   +IIH
Sbjct: 102 AFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIH 158
Query: 645 CDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI--KTAIRGTKGYVAPEWF-----RN 697
            D+K  NIL       +++DFG++       ++TI  + +  GT  ++APE       ++
Sbjct: 159 RDLKAGNILFTLDGDIKLADFGVSA----KNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 214
Query: 698 SKITAKVDVYSFGVLLLEI 716
                K DV+S G+ L+E+
Sbjct: 215 RPYDYKADVWSLGITLIEM 233

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 97/202 (48%), Gaps = 13/202 (6%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE--REFKNEVFVIGQTHHKNLVRLL 584
           +G+G+F  V   + +   +   VAV+ +D+   +    ++   EV ++   +H N+V+L 
Sbjct: 22  IGKGNFAKV--KLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIH 644
              +  +   LV E+ + G +  +L  + +           QI   + Y H+     I+H
Sbjct: 80  EVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF---IVH 136
Query: 645 CDIKPQNILLDDYYTARISDFGLAKLLTL-NQSKTIKTAIRGTKGYVAPEWFRNSKITA- 702
            D+K +N+LLD     +I+DFG +   T  N+  T      G+  Y APE F+  K    
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC----GSPPYAAPELFQGKKYDGP 192
Query: 703 KVDVYSFGVLLLEIISCRKSFD 724
           +VDV+S GV+L  ++S    FD
Sbjct: 193 EVDVWSLGVILYTLVSGSLPFD 214

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 103/203 (50%), Gaps = 27/203 (13%)
Query: 527 VGRGSFGIV---YKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNL 580
           +G G+ GIV   Y  +++       VA+KKL R FQ+    +R ++ E+ ++   +HKN+
Sbjct: 32  IGSGAQGIVCAAYDAILERN-----VAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNI 85
Query: 581 VRLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYL 634
           + LL         +E Q+  +V E ++   L+  +   ++ +    + + +Q+  G+ +L
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMD-ANLSQVI--QMELDHERMSYLLYQMLVGIKHL 142
Query: 635 HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 694
           H    A IIH D+KP NI++    T +I DFGLA+      +  + T    T+ Y APE 
Sbjct: 143 HS---AGIIHRDLKPSNIVVKSDATLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEV 196
Query: 695 FRNSKITAKVDVYSFGVLLLEII 717
                    VD++S G ++ E+I
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMI 219

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 100/203 (49%), Gaps = 25/203 (12%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKN-EVFVIGQTHHKNLVRL-L 584
           +G GSFG+VY+   +   S   VA+KK   V QD  + FKN E+ ++ +  H N+VRL  
Sbjct: 28  IGNGSFGVVYQA--KLCDSGELVAIKK---VLQD--KRFKNRELQIMRKLDHCNIVRLRY 80
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA--------FQIARGLLYLHE 636
            F   G+ + +VY  L    +   ++   +     +  +         +Q+ R L Y+H 
Sbjct: 81  FFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 637 DCRAQIIHCDIKPQNILLD-DYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW- 694
                I H DIKPQN+LLD D    ++ DFG AK L   +          ++ Y APE  
Sbjct: 141 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC---SRYYRAPELI 194
Query: 695 FRNSKITAKVDVYSFGVLLLEII 717
           F  +  T+ +DV+S G +L E++
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELL 217

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 96/215 (44%), Gaps = 16/215 (7%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD----GEREFKNEVFVIGQTHHKNL 580
           EE+G G F IV K   +      A    K  R+          E + EV ++ +  H N+
Sbjct: 32  EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNI 91
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           + L    +   + +L+ E ++ G L  FL        +  T    QI  G+ YLH     
Sbjct: 92  ITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS---K 148
Query: 641 QIIHCDIKPQNILLDDYYTA----RISDFGLA-KLLTLNQSKTIKTAIRGTKGYVAPEWF 695
           +I H D+KP+NI+L D        ++ DFG+A K+   N+ K I     GT  +VAPE  
Sbjct: 149 RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNI----FGTPEFVAPEIV 204
Query: 696 RNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 730
               +  + D++S GV+   ++S    F  E  +E
Sbjct: 205 NYEPLGLEADMWSIGVITYILLSGASPFLGETKQE 239

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 93/213 (43%), Gaps = 35/213 (16%)
Query: 527 VGRGSFGIV---YKGVIQTRTSTTAVAVKKLDRVFQD--GEREFKNEVFVIGQTHHKNLV 581
           VG G++G V   Y   ++ +     VAVKKL R FQ     R    E+ ++    H+N++
Sbjct: 28  VGSGAYGSVCSAYDARLRQK-----VAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVI 82
Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN----IAFQIARGLLYLHED 637
            LL       +     E     TL      N+     L       + +Q+ RGL Y+H  
Sbjct: 83  GLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHS- 141
Query: 638 CRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRN 697
             A IIH D+KP N+ +++    RI DFGLA           + A     GYVA  W+R 
Sbjct: 142 --AGIIHRDLKPSNVAVNEDCELRILDFGLA-----------RQADEEMTGYVATRWYRA 188
Query: 698 SKIT-------AKVDVYSFGVLLLEIISCRKSF 723
            +I          VD++S G ++ E++  +  F
Sbjct: 189 PEIMLNWMHYNQTVDIWSVGCIMAELLQGKALF 221

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 103/209 (49%), Gaps = 27/209 (12%)
Query: 527 VGRGSFGIV---YKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNL 580
           +G G+ GIV   Y  V+        VA+KKL R FQ+    +R ++ E+ ++   +HKN+
Sbjct: 70  IGSGAQGIVCAAYDAVLDRN-----VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNI 123
Query: 581 VRLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYL 634
           + LL         +E Q+  LV E ++   L   +   ++ +    + + +Q+  G+ +L
Sbjct: 124 ISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVI--QMELDHERMSYLLYQMLCGIKHL 180
Query: 635 HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 694
           H    A IIH D+KP NI++    T +I DFGLA+      +  + T    T+ Y APE 
Sbjct: 181 HS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEV 234
Query: 695 FRNSKITAKVDVYSFGVLLLEIISCRKSF 723
                    VD++S G ++ E++  +  F
Sbjct: 235 ILGMGYKENVDIWSVGCIMGEMVRHKILF 263

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 85/300 (28%), Positives = 130/300 (43%), Gaps = 63/300 (21%)
Query: 527 VGRGSFG-IVYKGVIQTRTSTTAVAVKKLDRVFQD-GEREFKNEVFVIGQTHHKNLVRLL 584
           +G GS G +V++G  Q R     VAVK++   F D    E K    +     H N++R  
Sbjct: 23  LGYGSSGTVVFQGSFQGR----PVAVKRMLIDFCDIALMEIK---LLTESDDHPNVIRY- 74
Query: 585 GFCDEGQNRLLVYEF-LNNGTLASFLFGNLKPNWNLRTNIAF-------QIARGLLYLHE 636
            +C E  +R L     L N  L   +      + NL+    +       QIA G+ +LH 
Sbjct: 75  -YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 133
Query: 637 DCRAQIIHCDIKPQNILL--DDYYTAR-----------ISDFGLAKLLTLNQS--KTIKT 681
               +IIH D+KPQNIL+     +TA            ISDFGL K L   QS  +T   
Sbjct: 134 ---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN 190
Query: 682 AIRGTKGYVAPEWFRNS-------KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL 734
              GT G+ APE    S       ++T  +D++S G +   I+S  K      G++Y+  
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH---PFGDKYS-- 245
Query: 735 TDWAFDCYRNGKLNVLVG----EDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
                      + N++ G    ++ + ++D   + +   +    I  DP  RPT  KVL+
Sbjct: 246 ----------RESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 88/192 (45%), Gaps = 8/192 (4%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLL 584
           E++G+G+F +V + V        A  +    ++     ++ + E  +     H N+VRL 
Sbjct: 10  EDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLH 69
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIH 644
               E     LV++ +  G L   +      +    ++   QI   +L+ H+     ++H
Sbjct: 70  DSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQ---MGVVH 126
Query: 645 CDIKPQNILLDDY---YTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKIT 701
            D+KP+N+LL         +++DFGLA  +  +Q      A  GT GY++PE  R     
Sbjct: 127 RDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFA--GTPGYLSPEVLRKEAYG 184
Query: 702 AKVDVYSFGVLL 713
             VD+++ GV+L
Sbjct: 185 KPVDIWACGVIL 196

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 95/211 (45%), Gaps = 7/211 (3%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKN-EVFVIGQTHHKNL 580
           NF   +G+GSFG V     +      AV + K D V QD + E    E  V+        
Sbjct: 344 NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPF 403
Query: 581 VRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCR 639
           +  L  C +  +RL  V E++N G L   +    +         A +IA GL +L     
Sbjct: 404 LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS--- 460
Query: 640 AQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSK 699
             II+ D+K  N++LD     +I+DFG+ K    +   T      GT  Y+APE      
Sbjct: 461 KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT--KXFCGTPDYIAPEIIAYQP 518
Query: 700 ITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 730
               VD ++FGVLL E+++ +  F+ E  +E
Sbjct: 519 YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 549

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 94/201 (46%), Gaps = 11/201 (5%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE--REFKNEVFVIGQTHHKNLVRLL 584
           +G+G+F  V   + +   +   VAV+ +D+   +    ++   EV ++   +H N+V+L 
Sbjct: 22  IGKGNFAKV--KLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIH 644
              +  +   LV E+ + G +  +L  + +           QI   + Y H+     I+H
Sbjct: 80  EVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF---IVH 136
Query: 645 CDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITA-K 703
            D+K +N+LLD     +I+DFG +   T            G+  Y APE F+  K    +
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFSNEFTFGNK---LDEFCGSPPYAAPELFQGKKYDGPE 193
Query: 704 VDVYSFGVLLLEIISCRKSFD 724
           VDV+S GV+L  ++S    FD
Sbjct: 194 VDVWSLGVILYTLVSGSLPFD 214

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 103/203 (50%), Gaps = 27/203 (13%)
Query: 527 VGRGSFGIV---YKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNL 580
           +G G+ GIV   Y  +++       VA+KKL R FQ+    +R ++ E+ ++   +HKN+
Sbjct: 32  IGSGAQGIVCAAYDAILERN-----VAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNI 85
Query: 581 VRLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYL 634
           + LL         +E Q+  +V E ++   L+  +   ++ +    + + +Q+  G+ +L
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMD-ANLSQVI--QMELDHERMSYLLYQMLCGIKHL 142
Query: 635 HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 694
           H    A IIH D+KP NI++    T +I DFGLA+      +  + T    T+ Y APE 
Sbjct: 143 HS---AGIIHRDLKPSNIVVKSDATLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEV 196
Query: 695 FRNSKITAKVDVYSFGVLLLEII 717
                    VD++S G ++ E+I
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMI 219

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 99/203 (48%), Gaps = 25/203 (12%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKN-EVFVIGQTHHKNLVRL-L 584
           +G GSFG+VY+  +    S   VA+KK   V QD  + FKN E+ ++ +  H N+VRL  
Sbjct: 62  IGNGSFGVVYQAKLCD--SGELVAIKK---VLQD--KRFKNRELQIMRKLDHCNIVRLRY 114
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA--------FQIARGLLYLHE 636
            F   G+ +  VY  L    +   ++   +     +  +         +Q+ R L Y+H 
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 174
Query: 637 DCRAQIIHCDIKPQNILLD-DYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW- 694
                I H DIKPQN+LLD D    ++ DFG AK L   +          ++ Y APE  
Sbjct: 175 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC---SRYYRAPELI 228
Query: 695 FRNSKITAKVDVYSFGVLLLEII 717
           F  +  T+ +DV+S G +L E++
Sbjct: 229 FGATDYTSSIDVWSAGCVLAELL 251

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 96/215 (44%), Gaps = 16/215 (7%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD----GEREFKNEVFVIGQTHHKNL 580
           EE+G G F IV K   +      A    K  R+          E + EV ++ +  H N+
Sbjct: 18  EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 77
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           + L    +   + +L+ E ++ G L  FL        +  T    QI  G+ YLH     
Sbjct: 78  ITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS---K 134
Query: 641 QIIHCDIKPQNILLDDYYTA----RISDFGLA-KLLTLNQSKTIKTAIRGTKGYVAPEWF 695
           +I H D+KP+NI+L D        ++ DFG+A K+   N+ K I     GT  +VAPE  
Sbjct: 135 RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNI----FGTPEFVAPEIV 190
Query: 696 RNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 730
               +  + D++S GV+   ++S    F  E  +E
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASPFLGETKQE 225

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 27/209 (12%)
Query: 527 VGRGSFGIV---YKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNL 580
           +G G+ GIV   Y  V+        VA+KKL R FQ+    +R ++ E+ ++   +HKN+
Sbjct: 33  IGSGAQGIVCAAYDAVLDRN-----VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNI 86
Query: 581 VRLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYL 634
           + LL         +E Q+  LV E ++   L   +   L  +    + + +Q+  G+ +L
Sbjct: 87  ISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMEL--DHERMSYLLYQMLCGIKHL 143
Query: 635 HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 694
           H    A IIH D+KP NI++    T +I DFGLA+      +  + T    T+ Y APE 
Sbjct: 144 HS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEV 197
Query: 695 FRNSKITAKVDVYSFGVLLLEIISCRKSF 723
                    VD++S G ++ E++  +  F
Sbjct: 198 ILGMGYKENVDIWSVGCIMGEMVRHKILF 226

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 97/201 (48%), Gaps = 11/201 (5%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE--REFKNEVFVIGQTHHKNLVRLL 584
           +G+G+F  V   + +   +   VA+K +D+   +    ++   EV ++   +H N+V+L 
Sbjct: 20  IGKGNFAKV--KLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 77
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIH 644
              +  +   L+ E+ + G +  +L  + +       +   QI   + Y H+    +I+H
Sbjct: 78  EVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQ---KRIVH 134
Query: 645 CDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITA-K 703
            D+K +N+LLD     +I+DFG +   T+           G+  Y APE F+  K    +
Sbjct: 135 RDLKAENLLLDADMNIKIADFGFSNEFTVGGK---LDTFCGSPPYAAPELFQGKKYDGPE 191
Query: 704 VDVYSFGVLLLEIISCRKSFD 724
           VDV+S GV+L  ++S    FD
Sbjct: 192 VDVWSLGVILYTLVSGSLPFD 212

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 27/209 (12%)
Query: 527 VGRGSFGIV---YKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNL 580
           +G G+ GIV   Y  V+        VA+KKL R FQ+    +R ++ E+ ++   +HKN+
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN-----VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNI 85
Query: 581 VRLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYL 634
           + LL         +E Q+  LV E ++   L   +   L  +    + + +Q+  G+ +L
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMEL--DHERMSYLLYQMLCGIKHL 142
Query: 635 HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 694
           H    A IIH D+KP NI++    T +I DFGLA+      +  + T    T+ Y APE 
Sbjct: 143 HS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEV 196
Query: 695 FRNSKITAKVDVYSFGVLLLEIISCRKSF 723
                    VD++S G ++ E++  +  F
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMVRHKILF 225

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 27/209 (12%)
Query: 527 VGRGSFGIV---YKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNL 580
           +G G+ GIV   Y  V+        VA+KKL R FQ+    +R ++ E+ ++   +HKN+
Sbjct: 33  IGSGAQGIVCAAYDAVLDRN-----VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNI 86
Query: 581 VRLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYL 634
           + LL         +E Q+  LV E ++   L   +   L  +    + + +Q+  G+ +L
Sbjct: 87  ISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMEL--DHERMSYLLYQMLCGIKHL 143
Query: 635 HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 694
           H    A IIH D+KP NI++    T +I DFGLA+      +  + T    T+ Y APE 
Sbjct: 144 HS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEV 197
Query: 695 FRNSKITAKVDVYSFGVLLLEIISCRKSF 723
                    VD++S G ++ E++  +  F
Sbjct: 198 ILGMGYKENVDIWSVGCIMGEMVRHKILF 226

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 93/196 (47%), Gaps = 11/196 (5%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE-FKNEVFVIGQTHHKNLVRLLG 585
           +G+GSFG V     +      AV V    +V Q  ++E    EV ++ Q  H N+ +L  
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLYE 93
Query: 586 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHC 645
           F ++     LV E    G L   +    + +      I  Q+  G+ Y H++   +I+H 
Sbjct: 94  FFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYXHKN---KIVHR 150
Query: 646 DIKPQNILLDDY---YTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITA 702
           D+KP+N+LL+        RI DFGL+       SK  K  I GT  Y+APE    +    
Sbjct: 151 DLKPENLLLESKSKDANIRIIDFGLS--THFEASKKXKDKI-GTAYYIAPEVLHGT-YDE 206
Query: 703 KVDVYSFGVLLLEIIS 718
           K DV+S GV+L  ++S
Sbjct: 207 KCDVWSTGVILYILLS 222

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 27/209 (12%)
Query: 527 VGRGSFGIV---YKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNL 580
           +G G+ GIV   Y  V+        VA+KKL R FQ+    +R ++ E+ ++   +HKN+
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN-----VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNI 85
Query: 581 VRLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYL 634
           + LL         +E Q+  LV E ++   L   +   L  +    + + +Q+  G+ +L
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMEL--DHERMSYLLYQMLCGIKHL 142
Query: 635 HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 694
           H    A IIH D+KP NI++    T +I DFGLA+      +  + T    T+ Y APE 
Sbjct: 143 HS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEV 196
Query: 695 FRNSKITAKVDVYSFGVLLLEIISCRKSF 723
                    VD++S G ++ E++  +  F
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMVRHKILF 225

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 96/215 (44%), Gaps = 16/215 (7%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD----GEREFKNEVFVIGQTHHKNL 580
           EE+G G F IV K   +      A    K  R+          E + EV ++ +  H N+
Sbjct: 11  EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 70
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           + L    +   + +L+ E ++ G L  FL        +  T    QI  G+ YLH     
Sbjct: 71  ITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS---K 127
Query: 641 QIIHCDIKPQNILLDDYYTA----RISDFGLA-KLLTLNQSKTIKTAIRGTKGYVAPEWF 695
           +I H D+KP+NI+L D        ++ DFG+A K+   N+ K I     GT  +VAPE  
Sbjct: 128 RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNI----FGTPEFVAPEIV 183
Query: 696 RNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 730
               +  + D++S GV+   ++S    F  E  +E
Sbjct: 184 NYEPLGLEADMWSIGVITYILLSGASPFLGETKQE 218

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 121/281 (43%), Gaps = 40/281 (14%)
Query: 524 KEEVGRGSFG-IVYKGVIQTRTSTTAVAVKK-LDRVFQDGEREFKNEVFVIGQTHHKNLV 581
           K+ +G G+ G IVY+G+   R     VAVK+ L   F   +RE +    +     H N++
Sbjct: 29  KDVLGHGAEGTIVYRGMFDNRD----VAVKRILPECFSFADREVQ---LLRESDEHPNVI 81
Query: 582 RLLGFCDEGQNRLLVYEF-LNNGTLASFLFGNLKPNWNLR-TNIAFQIARGLLYLHEDCR 639
           R   FC E   +       L   TL  ++      +  L    +  Q   GL +LH    
Sbjct: 82  RY--FCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS--- 136
Query: 640 AQIIHCDIKPQNILL-----DDYYTARISDFGLAKLLTL-NQSKTIKTAIRGTKGYVAPE 693
             I+H D+KP NIL+          A ISDFGL K L +   S + ++ + GT+G++APE
Sbjct: 137 LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196
Query: 694 WFRN---SKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNV 749
                     T  VD++S G +   +IS     F   +  +  IL            L+ 
Sbjct: 197 MLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGAC-------SLDC 249
Query: 750 LVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
           L  E  E +   E + K++ +       DP  RP+ K VL+
Sbjct: 250 LHPEKHEDVIARELIEKMIAM-------DPQKRPSAKHVLK 283

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 27/209 (12%)
Query: 527 VGRGSFGIV---YKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNL 580
           +G G+ GIV   Y  V+        VA+KKL R FQ+    +R ++ E+ ++   +HKN+
Sbjct: 31  IGSGAQGIVCAAYDAVLDRN-----VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNI 84
Query: 581 VRLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYL 634
           + LL         +E Q+  LV E ++   L   +   L  +    + + +Q+  G+ +L
Sbjct: 85  ISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMEL--DHERMSYLLYQMLCGIKHL 141
Query: 635 HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 694
           H    A IIH D+KP NI++    T +I DFGLA+      +  + T    T+ Y APE 
Sbjct: 142 HS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEV 195
Query: 695 FRNSKITAKVDVYSFGVLLLEIISCRKSF 723
                    VD++S G ++ E++  +  F
Sbjct: 196 ILGMGYKENVDIWSVGCIMGEMVRHKILF 224

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 103/203 (50%), Gaps = 27/203 (13%)
Query: 527 VGRGSFGIV---YKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNL 580
           +G G+ GIV   Y  +++       VA+KKL R FQ+    +R ++ E+ ++   +HKN+
Sbjct: 32  IGSGAQGIVCAAYDAILERN-----VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNI 85
Query: 581 VRLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYL 634
           + LL         +E Q+  +V E ++   L+  +   ++ +    + + +Q+  G+ +L
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMD-ANLSQVI--QMELDHERMSYLLYQMLCGIKHL 142
Query: 635 HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 694
           H    A IIH D+KP NI++    T +I DFGLA+      +  + T    T+ Y APE 
Sbjct: 143 HS---AGIIHRDLKPSNIVVKSDATLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEV 196
Query: 695 FRNSKITAKVDVYSFGVLLLEII 717
                    VD++S G ++ E+I
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMI 219

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 96/197 (48%), Gaps = 11/197 (5%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLL 584
           E++G G++G+VYK        T A+   +L++  +        E+ ++ +  H N+V+L 
Sbjct: 8   EKIGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 585 GFCDEGQNRLLVYEFLNNG--TLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQI 642
                 +  +LV+E L+     L     G L+       +   Q+  G+ Y H+    ++
Sbjct: 67  DVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESV--TAKSFLLQLLNGIAYCHD---RRV 121
Query: 643 IHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNS-KIT 701
           +H D+KPQN+L++     +I+DFGLA+   +   K     +  T  Y AP+    S K +
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV--TLWYRAPDVLMGSKKYS 179
Query: 702 AKVDVYSFGVLLLEIIS 718
             +D++S G +  E+++
Sbjct: 180 TTIDIWSVGCIFAEMVN 196

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 95/211 (45%), Gaps = 7/211 (3%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKN-EVFVIGQTHHKNL 580
           NF   +G+GSFG V     +      AV + K D V QD + E    E  V+        
Sbjct: 23  NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPF 82
Query: 581 VRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCR 639
           +  L  C +  +RL  V E++N G L   +    +         A +IA GL +L     
Sbjct: 83  LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS--- 139
Query: 640 AQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSK 699
             II+ D+K  N++LD     +I+DFG+ K    +   T      GT  Y+APE      
Sbjct: 140 KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT--KXFCGTPDYIAPEIIAYQP 197
Query: 700 ITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 730
               VD ++FGVLL E+++ +  F+ E  +E
Sbjct: 198 YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 228

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 100/214 (46%), Gaps = 36/214 (16%)
Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVR 582
            VG G++G V   +   + S   VA+KKL R FQ     +R ++ E+ ++    H+N++ 
Sbjct: 49  HVGSGAYGSVCSAI--DKRSGEKVAIKKLSRPFQSEIFAKRAYR-ELLLLKHMQHENVIG 105
Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN------IAFQIARGLLYLHE 636
           LL       +    Y+F     +  F+  +L+    +  +      + +Q+ +GL Y+H 
Sbjct: 106 LLDVFTPASSLRNFYDFY---LVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHS 162
Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR 696
              A ++H D+KP N+ +++    +I DFGLA           + A     GYV   W+R
Sbjct: 163 ---AGVVHRDLKPGNLAVNEDCELKILDFGLA-----------RHADAEMTGYVVTRWYR 208
Query: 697 NSKIT-------AKVDVYSFGVLLLEIISCRKSF 723
             ++          VD++S G ++ E+++ +  F
Sbjct: 209 APEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF 242

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 95/197 (48%), Gaps = 13/197 (6%)
Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLG 585
           E+G G+FG VYK   Q + ++   A K +D   ++   ++  E+ ++    H N+V+LL 
Sbjct: 44  ELGDGAFGKVYKA--QNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLD 101
Query: 586 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF-QIARGLLYLHEDCRAQIIH 644
                 N  ++ EF   G + + +    +P    +  +   Q    L YLH++   +IIH
Sbjct: 102 AFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIH 158
Query: 645 CDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF-----RNSK 699
            D+K  NIL       +++DFG++   T    +  + +  GT  ++APE       ++  
Sbjct: 159 RDLKAGNILFTLDGDIKLADFGVSAKNTRXIQR--RDSFIGTPYWMAPEVVMCETSKDRP 216
Query: 700 ITAKVDVYSFGVLLLEI 716
              K DV+S G+ L+E+
Sbjct: 217 YDYKADVWSLGITLIEM 233

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 96/197 (48%), Gaps = 11/197 (5%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLL 584
           E++G G++G+VYK        T A+   +L++  +        E+ ++ +  H N+V+L 
Sbjct: 8   EKIGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 585 GFCDEGQNRLLVYEFLNNG--TLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQI 642
                 +  +LV+E L+     L     G L+       +   Q+  G+ Y H+    ++
Sbjct: 67  DVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESV--TAKSFLLQLLNGIAYCHD---RRV 121
Query: 643 IHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNS-KIT 701
           +H D+KPQN+L++     +I+DFGLA+   +   K     +  T  Y AP+    S K +
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV--TLWYRAPDVLMGSKKYS 179
Query: 702 AKVDVYSFGVLLLEIIS 718
             +D++S G +  E+++
Sbjct: 180 TTIDIWSVGCIFAEMVN 196

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 96/211 (45%), Gaps = 29/211 (13%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV-FQDGE----REFKNEVFVIGQTHHKN 579
           E +G+G+F +V + +   R +    AVK +D   F         + K E  +     H +
Sbjct: 30  EVIGKGAFSVVRRCI--NRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87
Query: 580 LVRLLGFCDEGQNRLLVYEFLNNGTL---------ASFLFGNLKPNWNLRTNIAFQIARG 630
           +V LL          +V+EF++   L         A F++     +  +R     QI   
Sbjct: 88  IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR-----QILEA 142
Query: 631 LLYLHEDCRAQIIHCDIKPQNILL---DDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK 687
           L Y H++    IIH D+KP+N+LL   ++    ++ DFG+A  + L +S  +     GT 
Sbjct: 143 LRYCHDN---NIIHRDVKPENVLLASKENSAPVKLGDFGVA--IQLGESGLVAGGRVGTP 197
Query: 688 GYVAPEWFRNSKITAKVDVYSFGVLLLEIIS 718
            ++APE  +       VDV+  GV+L  ++S
Sbjct: 198 HFMAPEVVKREPYGKPVDVWGCGVILFILLS 228

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 100/203 (49%), Gaps = 25/203 (12%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKN-EVFVIGQTHHKNLVRL-L 584
           +G GSFG+VY+  +    S   VA+KK   V QD  + FKN E+ ++ +  H N+VRL  
Sbjct: 56  IGNGSFGVVYQAKLCD--SGELVAIKK---VLQD--KRFKNRELQIMRKLDHCNIVRLRY 108
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA--------FQIARGLLYLHE 636
            F   G+ +  VY  L    +   ++   +     +  +         +Q+ R L Y+H 
Sbjct: 109 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 168
Query: 637 DCRAQIIHCDIKPQNILLD-DYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW- 694
                I H DIKPQN+LLD D    ++ DFG AK L   +      +   ++ Y APE  
Sbjct: 169 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRYYRAPELI 222
Query: 695 FRNSKITAKVDVYSFGVLLLEII 717
           F  +  T+ +DV+S G +L E++
Sbjct: 223 FGATDYTSSIDVWSAGCVLAELL 245

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 27/209 (12%)
Query: 527 VGRGSFGIV---YKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNL 580
           +G G+ GIV   Y  V+        VA+KKL R FQ+    +R ++ E+ ++   +HKN+
Sbjct: 26  IGSGAQGIVCAAYDAVLDRN-----VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNI 79
Query: 581 VRLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYL 634
           + LL         +E Q+  LV E ++   L   +   L  +    + + +Q+  G+ +L
Sbjct: 80  ISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMEL--DHERMSYLLYQMLCGIKHL 136
Query: 635 HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 694
           H    A IIH D+KP NI++    T +I DFGLA+      +  + T    T+ Y APE 
Sbjct: 137 HS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEV 190
Query: 695 FRNSKITAKVDVYSFGVLLLEIISCRKSF 723
                    VD++S G ++ E++  +  F
Sbjct: 191 ILGMGYKENVDIWSVGCIMGEMVRHKILF 219

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 100/203 (49%), Gaps = 25/203 (12%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKN-EVFVIGQTHHKNLVRL-L 584
           +G GSFG+VY+  +    S   VA+KK   V QD  + FKN E+ ++ +  H N+VRL  
Sbjct: 62  IGNGSFGVVYQAKLCD--SGELVAIKK---VLQD--KRFKNRELQIMRKLDHCNIVRLRY 114
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA--------FQIARGLLYLHE 636
            F   G+ +  VY  L    +   ++   +     +  +         +Q+ R L Y+H 
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 174
Query: 637 DCRAQIIHCDIKPQNILLD-DYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW- 694
                I H DIKPQN+LLD D    ++ DFG AK L   +      +   ++ Y APE  
Sbjct: 175 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRYYRAPELI 228
Query: 695 FRNSKITAKVDVYSFGVLLLEII 717
           F  +  T+ +DV+S G +L E++
Sbjct: 229 FGATDYTSSIDVWSAGCVLAELL 251

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 100/203 (49%), Gaps = 25/203 (12%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKN-EVFVIGQTHHKNLVRL-L 584
           +G GSFG+VY+  +    S   VA+KK   V QD  + FKN E+ ++ +  H N+VRL  
Sbjct: 64  IGNGSFGVVYQAKLCD--SGELVAIKK---VLQD--KRFKNRELQIMRKLDHCNIVRLRY 116
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA--------FQIARGLLYLHE 636
            F   G+ +  VY  L    +   ++   +     +  +         +Q+ R L Y+H 
Sbjct: 117 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 176
Query: 637 DCRAQIIHCDIKPQNILLD-DYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW- 694
                I H DIKPQN+LLD D    ++ DFG AK L   +      +   ++ Y APE  
Sbjct: 177 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRYYRAPELI 230
Query: 695 FRNSKITAKVDVYSFGVLLLEII 717
           F  +  T+ +DV+S G +L E++
Sbjct: 231 FGATDYTSSIDVWSAGCVLAELL 253

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 103/209 (49%), Gaps = 27/209 (12%)
Query: 527 VGRGSFGIV---YKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNL 580
           +G G+ GIV   Y  V+        VA+KKL R FQ+    +R ++ E+ ++   +HKN+
Sbjct: 25  IGSGAQGIVCAAYDAVLDRN-----VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNI 78
Query: 581 VRLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYL 634
           + LL         +E Q+  LV E ++   L   +   ++ +    + + +Q+  G+ +L
Sbjct: 79  ISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVI--QMELDHERMSYLLYQMLCGIKHL 135
Query: 635 HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 694
           H    A IIH D+KP NI++    T +I DFGLA+      +  + T    T+ Y APE 
Sbjct: 136 HS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEV 189
Query: 695 FRNSKITAKVDVYSFGVLLLEIISCRKSF 723
                    VD++S G ++ E++  +  F
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMVRHKILF 218

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 106/207 (51%), Gaps = 28/207 (13%)
Query: 527 VGRGSFGIV---YKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNL 580
           +G G+ GIV   Y  +++       VA+KKL R FQ+    +R ++ E+ ++   +HKN+
Sbjct: 32  IGSGAQGIVCAAYDAILERN-----VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNI 85
Query: 581 VRLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYL 634
           + LL         +E Q+  +V E ++   L   +   ++ +    + + +Q+  G+ +L
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVI--QMELDHERMSYLLYQMLCGIKHL 142
Query: 635 HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 694
           H    A IIH D+KP NI++    T +I DFGLA+  T   S  ++  +  T+ Y APE 
Sbjct: 143 HS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMEPEV-VTRYYRAPEV 196
Query: 695 FRNSKITAKVDVYSFGVLLLEIISCRK 721
                    VD++S G ++ E++ C K
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMV-CHK 222

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 103/209 (49%), Gaps = 27/209 (12%)
Query: 527 VGRGSFGIV---YKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNL 580
           +G G+ GIV   Y  V+        VA+KKL R FQ+    +R ++ E+ ++   +HKN+
Sbjct: 26  IGSGAQGIVCAAYDAVLDRN-----VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNI 79
Query: 581 VRLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYL 634
           + LL         +E Q+  LV E ++   L   +   ++ +    + + +Q+  G+ +L
Sbjct: 80  ISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVI--QMELDHERMSYLLYQMLCGIKHL 136
Query: 635 HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 694
           H    A IIH D+KP NI++    T +I DFGLA+      +  + T    T+ Y APE 
Sbjct: 137 HS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEV 190
Query: 695 FRNSKITAKVDVYSFGVLLLEIISCRKSF 723
                    VD++S G ++ E++  +  F
Sbjct: 191 ILGMGYKENVDIWSVGCIMGEMVRHKILF 219

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 100/203 (49%), Gaps = 25/203 (12%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKN-EVFVIGQTHHKNLVRL-L 584
           +G GSFG+VY+  +    S   VA+KK   V QD  + FKN E+ ++ +  H N+VRL  
Sbjct: 66  IGNGSFGVVYQAKLCD--SGELVAIKK---VLQD--KRFKNRELQIMRKLDHCNIVRLRY 118
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA--------FQIARGLLYLHE 636
            F   G+ +  VY  L    +   ++   +     +  +         +Q+ R L Y+H 
Sbjct: 119 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 178
Query: 637 DCRAQIIHCDIKPQNILLD-DYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW- 694
                I H DIKPQN+LLD D    ++ DFG AK L   +      +   ++ Y APE  
Sbjct: 179 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRYYRAPELI 232
Query: 695 FRNSKITAKVDVYSFGVLLLEII 717
           F  +  T+ +DV+S G +L E++
Sbjct: 233 FGATDYTSSIDVWSAGCVLAELL 255

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 100/203 (49%), Gaps = 25/203 (12%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKN-EVFVIGQTHHKNLVRL-L 584
           +G GSFG+VY+  +    S   VA+KK   V QD  + FKN E+ ++ +  H N+VRL  
Sbjct: 107 IGNGSFGVVYQAKLCD--SGELVAIKK---VLQD--KRFKNRELQIMRKLDHCNIVRLRY 159
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA--------FQIARGLLYLHE 636
            F   G+ +  VY  L    +   ++   +     +  +         +Q+ R L Y+H 
Sbjct: 160 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 219
Query: 637 DCRAQIIHCDIKPQNILLD-DYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW- 694
                I H DIKPQN+LLD D    ++ DFG AK L   +      +   ++ Y APE  
Sbjct: 220 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRYYRAPELI 273
Query: 695 FRNSKITAKVDVYSFGVLLLEII 717
           F  +  T+ +DV+S G +L E++
Sbjct: 274 FGATDYTSSIDVWSAGCVLAELL 296

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 99/203 (48%), Gaps = 25/203 (12%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKN-EVFVIGQTHHKNLVRL-L 584
           +G GSFG+VY+  +    S   VA+KK   V QD  + FKN E+ ++ +  H N+VRL  
Sbjct: 47  IGNGSFGVVYQAKLCD--SGELVAIKK---VLQD--KRFKNRELQIMRKLDHCNIVRLRY 99
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA--------FQIARGLLYLHE 636
            F   G+ +  VY  L    +   ++   +     +  +         +Q+ R L Y+H 
Sbjct: 100 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 159
Query: 637 DCRAQIIHCDIKPQNILLD-DYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW- 694
                I H DIKPQN+LLD D    ++ DFG AK L   +          ++ Y APE  
Sbjct: 160 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC---SRYYRAPELI 213
Query: 695 FRNSKITAKVDVYSFGVLLLEII 717
           F  +  T+ +DV+S G +L E++
Sbjct: 214 FGATDYTSSIDVWSAGCVLAELL 236

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 99/203 (48%), Gaps = 25/203 (12%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKN-EVFVIGQTHHKNLVRL-L 584
           +G GSFG+VY+  +    S   VA+KK   V QD  + FKN E+ ++ +  H N+VRL  
Sbjct: 40  IGNGSFGVVYQAKLCD--SGELVAIKK---VLQD--KRFKNRELQIMRKLDHCNIVRLRY 92
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA--------FQIARGLLYLHE 636
            F   G+ +  VY  L    +   ++   +     +  +         +Q+ R L Y+H 
Sbjct: 93  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 152
Query: 637 DCRAQIIHCDIKPQNILLD-DYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW- 694
                I H DIKPQN+LLD D    ++ DFG AK L   +          ++ Y APE  
Sbjct: 153 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC---SRYYRAPELI 206
Query: 695 FRNSKITAKVDVYSFGVLLLEII 717
           F  +  T+ +DV+S G +L E++
Sbjct: 207 FGATDYTSSIDVWSAGCVLAELL 229

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 103/203 (50%), Gaps = 27/203 (13%)
Query: 527 VGRGSFGIV---YKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNL 580
           +G G+ GIV   Y  +++       VA+KKL R FQ+    +R ++ E+ ++   +HKN+
Sbjct: 32  IGSGAQGIVCAAYDAILERN-----VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNI 85
Query: 581 VRLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYL 634
           + LL         +E Q+  +V E ++   L+  +   ++ +    + + +Q+  G+ +L
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMD-ANLSQVI--QMELDHERMSYLLYQMLCGIKHL 142
Query: 635 HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 694
           H    A IIH D+KP NI++    T +I DFGLA+      +  + T    T+ Y APE 
Sbjct: 143 HS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEV 196
Query: 695 FRNSKITAKVDVYSFGVLLLEII 717
                    VD++S G ++ E+I
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMI 219

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 99/203 (48%), Gaps = 25/203 (12%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKN-EVFVIGQTHHKNLVRL-L 584
           +G GSFG+VY+  +    S   VA+KK   V QD  + FKN E+ ++ +  H N+VRL  
Sbjct: 40  IGNGSFGVVYQAKLCD--SGELVAIKK---VLQD--KRFKNRELQIMRKLDHCNIVRLRY 92
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA--------FQIARGLLYLHE 636
            F   G+ +  VY  L    +   ++   +     +  +         +Q+ R L Y+H 
Sbjct: 93  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 152
Query: 637 DCRAQIIHCDIKPQNILLD-DYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW- 694
                I H DIKPQN+LLD D    ++ DFG AK L   +          ++ Y APE  
Sbjct: 153 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC---SRYYRAPELI 206
Query: 695 FRNSKITAKVDVYSFGVLLLEII 717
           F  +  T+ +DV+S G +L E++
Sbjct: 207 FGATDYTSSIDVWSAGCVLAELL 229

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 106/207 (51%), Gaps = 14/207 (6%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV---FQDGEREFKNEVFVIGQTHHKNLV 581
           + +G G+FG V  G  + + +   VAVK L+R      D   + K E+  +    H +++
Sbjct: 17  DTLGVGTFGKVKIG--EHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHII 74
Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ 641
           +L        +  +V E+++ G L  ++  + +        +  QI   + Y H   R  
Sbjct: 75  KLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCH---RHM 131
Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKIT 701
           ++H D+KP+N+LLD +  A+I+DFGL+ +++    + ++ +  G+  Y APE   + ++ 
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMS--DGEFLRDSC-GSPNYAAPEVI-SGRLY 187
Query: 702 A--KVDVYSFGVLLLEIISCRKSFDIE 726
           A  +VD++S GV+L  ++     FD E
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLPFDDE 214

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 102/213 (47%), Gaps = 19/213 (8%)
Query: 524 KEEVGRGSFGIVYKGVIQTRTSTTAVAVKKL--DRVFQDGEREFKN----EVFVIGQTH- 576
           K+ +GRG   +V + V +      AV + ++  +R+  +   E +     E  ++ Q   
Sbjct: 99  KDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAG 158
Query: 577 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHE 636
           H +++ L+   +      LV++ +  G L  +L   +  +     +I   +   + +LH 
Sbjct: 159 HPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHA 218
Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR 696
           +    I+H D+KP+NILLDD    R+SDFG +    L   + ++  + GT GY+APE  +
Sbjct: 219 N---NIVHRDLKPENILLDDNMQIRLSDFGFS--CHLEPGEKLRE-LCGTPGYLAPEILK 272
Query: 697 NSKITA------KVDVYSFGVLLLEIISCRKSF 723
            S          +VD+++ GV+L  +++    F
Sbjct: 273 CSMDETHPGYGKEVDLWACGVILFTLLAGSPPF 305

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 99/203 (48%), Gaps = 25/203 (12%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKN-EVFVIGQTHHKNLVRL-L 584
           +G GSFG+VY+  +    S   VA+KK   V QD  + FKN E+ ++ +  H N+VRL  
Sbjct: 36  IGNGSFGVVYQAKLCD--SGELVAIKK---VLQD--KRFKNRELQIMRKLDHCNIVRLRY 88
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA--------FQIARGLLYLHE 636
            F   G+ +  VY  L    +   ++   +     +  +         +Q+ R L Y+H 
Sbjct: 89  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 148
Query: 637 DCRAQIIHCDIKPQNILLD-DYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW- 694
                I H DIKPQN+LLD D    ++ DFG AK L   +          ++ Y APE  
Sbjct: 149 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC---SRYYRAPELI 202
Query: 695 FRNSKITAKVDVYSFGVLLLEII 717
           F  +  T+ +DV+S G +L E++
Sbjct: 203 FGATDYTSSIDVWSAGCVLAELL 225

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 99/203 (48%), Gaps = 25/203 (12%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKN-EVFVIGQTHHKNLVRL-L 584
           +G GSFG+VY+   +   S   VA+KK   V QD  + FKN E+ ++ +  H N+VRL  
Sbjct: 32  IGNGSFGVVYQA--KLCDSGELVAIKK---VLQD--KRFKNRELQIMRKLDHCNIVRLRY 84
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA--------FQIARGLLYLHE 636
            F   G+ +  VY  L    +   ++   +     +  +         +Q+ R L Y+H 
Sbjct: 85  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 144
Query: 637 DCRAQIIHCDIKPQNILLD-DYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW- 694
                I H DIKPQN+LLD D    ++ DFG AK L   +          ++ Y APE  
Sbjct: 145 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC---SRYYRAPELI 198
Query: 695 FRNSKITAKVDVYSFGVLLLEII 717
           F  +  T+ +DV+S G +L E++
Sbjct: 199 FGATDYTSSIDVWSAGCVLAELL 221

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 99/219 (45%), Gaps = 35/219 (15%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGF 586
           +G+G+FG V K   +    +   A+KK+ R  ++      +EV ++   +H+ +VR    
Sbjct: 14  LGQGAFGQVVKA--RNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVVRYYAA 70
Query: 587 CDEGQN-------------RLLVYEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLL 632
             E +N               +  E+  NGTL   +   NL    +    +  QI   L 
Sbjct: 71  WLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALS 130
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAK-------LLTLN------QSKTI 679
           Y+H      IIH D+KP NI +D+    +I DFGLAK       +L L+       S  +
Sbjct: 131 YIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 680 KTAIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEII 717
            +AI GT  YVA E    +     K+D+YS G++  E+I
Sbjct: 188 TSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 38/132 (28%), Positives = 69/132 (52%), Gaps = 8/132 (6%)
Query: 595 LVYEFLNNGTLASFLF--GNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNI 652
           +V E+++  TL   +   G + P   +   +     + L + H++    IIH D+KP NI
Sbjct: 93  IVMEYVDGVTLRDIVHTEGPMTPKRAI--EVIADACQALNFSHQNG---IIHRDVKPANI 147
Query: 653 LLDDYYTARISDFGLAKLLTLNQSKTIKTA-IRGTKGYVAPEWFRNSKITAKVDVYSFGV 711
           L+      ++ DFG+A+ +  + +   +TA + GT  Y++PE  R   + A+ DVYS G 
Sbjct: 148 LISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGC 207
Query: 712 LLLEIISCRKSF 723
           +L E+++    F
Sbjct: 208 VLYEVLTGEPPF 219

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 98/205 (47%), Gaps = 19/205 (9%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE--REFKNEVFVIGQTHHKNLVRLL 584
           +G+G+F  V   + +   +   VAVK +D+   +    ++   EV ++   +H N+V+L 
Sbjct: 15  IGKGNFAKV--KLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 72
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNW--NLRTNIAF-QIARGLLYLHEDCRAQ 641
              +  +   LV E+ + G +  +L  +    W         F QI   + Y H+     
Sbjct: 73  EVIETEKTLYLVMEYASGGEVFDYLVAH---GWMKEKEARAKFRQIVSAVQYCHQKF--- 126
Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTL-NQSKTIKTAIRGTKGYVAPEWFRNSKI 700
           I+H D+K +N+LLD     +I+DFG +   T  N+  T      G+  Y APE F+  K 
Sbjct: 127 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC----GSPPYAAPELFQGKKY 182
Query: 701 TA-KVDVYSFGVLLLEIISCRKSFD 724
              +VDV+S GV+L  ++S    FD
Sbjct: 183 DGPEVDVWSLGVILYTLVSGSLPFD 207

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 100/203 (49%), Gaps = 25/203 (12%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKN-EVFVIGQTHHKNLVRL-L 584
           +G GSFG+VY+  +    S   VA+KK   V QD  + FKN E+ ++ +  H N+VRL  
Sbjct: 33  IGNGSFGVVYQAKLCD--SGELVAIKK---VLQD--KRFKNRELQIMRKLDHCNIVRLRY 85
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA--------FQIARGLLYLHE 636
            F   G+ +  VY  L    +   ++   +     +  +         +Q+ R L Y+H 
Sbjct: 86  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 145
Query: 637 DCRAQIIHCDIKPQNILLD-DYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW- 694
                I H DIKPQN+LLD D    ++ DFG AK L   +      +   ++ Y APE  
Sbjct: 146 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRYYRAPELI 199
Query: 695 FRNSKITAKVDVYSFGVLLLEII 717
           F  +  T+ +DV+S G +L E++
Sbjct: 200 FGATDYTSSIDVWSAGCVLAELL 222

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 96/197 (48%), Gaps = 11/197 (5%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLL 584
           E++G G++G+VYK        T A+   +L++  +        E+ ++ +  H N+V+L 
Sbjct: 8   EKIGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 585 GFCDEGQNRLLVYEFLNNG--TLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQI 642
                 +  +LV+E L+     L     G L+       +   Q+  G+ Y H+    ++
Sbjct: 67  DVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESV--TAKSFLLQLLNGIAYCHD---RRV 121
Query: 643 IHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNS-KIT 701
           +H D+KPQN+L++     +I+DFGLA+   +   K     +  T  Y AP+    S K +
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV--TLWYRAPDVLMGSKKYS 179
Query: 702 AKVDVYSFGVLLLEIIS 718
             +D++S G +  E+++
Sbjct: 180 TTIDIWSVGCIFAEMVN 196

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 99/203 (48%), Gaps = 25/203 (12%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKN-EVFVIGQTHHKNLVRL-L 584
           +G GSFG+VY+   +   S   VA+KK   V QD  + FKN E+ ++ +  H N+VRL  
Sbjct: 29  IGNGSFGVVYQA--KLCDSGELVAIKK---VLQD--KRFKNRELQIMRKLDHCNIVRLRY 81
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA--------FQIARGLLYLHE 636
            F   G+ +  VY  L    +   ++   +     +  +         +Q+ R L Y+H 
Sbjct: 82  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 141
Query: 637 DCRAQIIHCDIKPQNILLD-DYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW- 694
                I H DIKPQN+LLD D    ++ DFG AK L   +          ++ Y APE  
Sbjct: 142 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC---SRYYRAPELI 195
Query: 695 FRNSKITAKVDVYSFGVLLLEII 717
           F  +  T+ +DV+S G +L E++
Sbjct: 196 FGATDYTSSIDVWSAGCVLAELL 218

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 99/203 (48%), Gaps = 25/203 (12%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKN-EVFVIGQTHHKNLVRL-L 584
           +G GSFG+VY+   +   S   VA+KK   V QD  + FKN E+ ++ +  H N+VRL  
Sbjct: 28  IGNGSFGVVYQA--KLCDSGELVAIKK---VLQD--KRFKNRELQIMRKLDHCNIVRLRY 80
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA--------FQIARGLLYLHE 636
            F   G+ +  VY  L    +   ++   +     +  +         +Q+ R L Y+H 
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 637 DCRAQIIHCDIKPQNILLD-DYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW- 694
                I H DIKPQN+LLD D    ++ DFG AK L   +          ++ Y APE  
Sbjct: 141 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC---SRYYRAPELI 194
Query: 695 FRNSKITAKVDVYSFGVLLLEII 717
           F  +  T+ +DV+S G +L E++
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELL 217

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 100/203 (49%), Gaps = 25/203 (12%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKN-EVFVIGQTHHKNLVRL-L 584
           +G GSFG+VY+  +    S   VA+KK   V QD  + FKN E+ ++ +  H N+VRL  
Sbjct: 41  IGNGSFGVVYQAKLCD--SGELVAIKK---VLQD--KRFKNRELQIMRKLDHCNIVRLRY 93
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA--------FQIARGLLYLHE 636
            F   G+ +  VY  L    +   ++   +     +  +         +Q+ R L Y+H 
Sbjct: 94  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 153
Query: 637 DCRAQIIHCDIKPQNILLD-DYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW- 694
                I H DIKPQN+LLD D    ++ DFG AK L   +      +   ++ Y APE  
Sbjct: 154 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRYYRAPELI 207
Query: 695 FRNSKITAKVDVYSFGVLLLEII 717
           F  +  T+ +DV+S G +L E++
Sbjct: 208 FGATDYTSSIDVWSAGCVLAELL 230

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 102/203 (50%), Gaps = 27/203 (13%)
Query: 527 VGRGSFGIV---YKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNL 580
           +G G+ GIV   Y  +++       VA+KKL R FQ+    +R ++ E+ ++   +HKN+
Sbjct: 33  IGSGAQGIVCAAYDAILERN-----VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNI 86
Query: 581 VRLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYL 634
           + LL         +E Q+  +V E ++   L   +   ++ +    + + +Q+  G+ +L
Sbjct: 87  IGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVI--QMELDHERMSYLLYQMLCGIKHL 143
Query: 635 HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 694
           H    A IIH D+KP NI++    T +I DFGLA+      +  + T    T+ Y APE 
Sbjct: 144 HS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEV 197
Query: 695 FRNSKITAKVDVYSFGVLLLEII 717
                    VD++S G ++ E+I
Sbjct: 198 ILGMGYKENVDIWSVGCIMGEMI 220

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 108/222 (48%), Gaps = 15/222 (6%)
Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGER-EFKNEVFVIGQTHHKNLVRLL 584
           E+G G+ G+V+K  +  + S   +A K +    +   R +   E+ V+ + +   +V   
Sbjct: 75  ELGAGNGGVVFK--VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFY 132
Query: 585 G-FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
           G F  +G+  + + E ++ G+L   L    +    +   ++  + +GL YL E  + +I+
Sbjct: 133 GAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE--KHKIM 189
Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK 703
           H D+KP NIL++     ++ DFG++  L      ++  +  GT+ Y++PE  + +  + +
Sbjct: 190 HRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMSPERLQGTHYSVQ 245
Query: 704 VDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 745
            D++S G+ L+E+   R        +E  ++    F C   G
Sbjct: 246 SDIWSMGLSLVEMAVGRYPIPPPDAKELELM----FGCQVEG 283

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 102/203 (50%), Gaps = 27/203 (13%)
Query: 527 VGRGSFGIV---YKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNL 580
           +G G+ GIV   Y  +++       VA+KKL R FQ+    +R ++ E+ ++   +HKN+
Sbjct: 32  IGSGAQGIVCAAYDAILERN-----VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNI 85
Query: 581 VRLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYL 634
           + LL         +E Q+  +V E ++   L   +   ++ +    + + +Q+  G+ +L
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVI--QMELDHERMSYLLYQMLCGIKHL 142
Query: 635 HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 694
           H    A IIH D+KP NI++    T +I DFGLA+      +  + T    T+ Y APE 
Sbjct: 143 HS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEV 196
Query: 695 FRNSKITAKVDVYSFGVLLLEII 717
                    VD++S G ++ E+I
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMI 219

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 94/197 (47%), Gaps = 13/197 (6%)
Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLG 585
           E+G G+FG VYK   Q + ++   A K +D   ++   ++  E+ ++    H N+V+LL 
Sbjct: 44  ELGDGAFGKVYKA--QNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLD 101
Query: 586 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF-QIARGLLYLHEDCRAQIIH 644
                 N  ++ EF   G + + +    +P    +  +   Q    L YLH++   +IIH
Sbjct: 102 AFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIH 158
Query: 645 CDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF-----RNSK 699
            D+K  NIL       +++DFG++   T    +  +    GT  ++APE       ++  
Sbjct: 159 RDLKAGNILFTLDGDIKLADFGVSAKNTRXIQR--RDXFIGTPYWMAPEVVMCETSKDRP 216
Query: 700 ITAKVDVYSFGVLLLEI 716
              K DV+S G+ L+E+
Sbjct: 217 YDYKADVWSLGITLIEM 233

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 99/203 (48%), Gaps = 25/203 (12%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKN-EVFVIGQTHHKNLVRL-L 584
           +G GSFG+VY+   +   S   VA+KK   V QD  + FKN E+ ++ +  H N+VRL  
Sbjct: 28  IGNGSFGVVYQA--KLCDSGELVAIKK---VLQD--KRFKNRELQIMRKLDHCNIVRLRY 80
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA--------FQIARGLLYLHE 636
            F   G+ +  VY  L    +   ++   +     +  +         +Q+ R L Y+H 
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 637 DCRAQIIHCDIKPQNILLD-DYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW- 694
                I H DIKPQN+LLD D    ++ DFG AK L   +          ++ Y APE  
Sbjct: 141 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC---SRYYRAPELI 194
Query: 695 FRNSKITAKVDVYSFGVLLLEII 717
           F  +  T+ +DV+S G +L E++
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELL 217

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 101/197 (51%), Gaps = 11/197 (5%)
Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGER-EFKNEVFVIGQTHHKNLVRLL 584
           E+G G+ G+V+K  +  + S   +A K +    +   R +   E+ V+ + +   +V   
Sbjct: 13  ELGAGNGGVVFK--VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFY 70
Query: 585 G-FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
           G F  +G+  + + E ++ G+L   L    +    +   ++  + +GL YL E  + +I+
Sbjct: 71  GAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE--KHKIM 127
Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK 703
           H D+KP NIL++     ++ DFG++  L      ++  +  GT+ Y++PE  + +  + +
Sbjct: 128 HRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMSPERLQGTHYSVQ 183
Query: 704 VDVYSFGVLLLEIISCR 720
            D++S G+ L+E+   R
Sbjct: 184 SDIWSMGLSLVEMAVGR 200

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 108/209 (51%), Gaps = 13/209 (6%)
Query: 516 LEGATNNFKE--EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGER-EFKNEVFVI 572
           +E   ++F++  E+G G+ G+V+K  +  + S   +A K +    +   R +   E+ V+
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFK--VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL 58
Query: 573 GQTHHKNLVRLLG-FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGL 631
            + +   +V   G F  +G+  + + E ++ G+L   L    +    +   ++  + +GL
Sbjct: 59  HECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGL 117
Query: 632 LYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVA 691
            YL E  + +I+H D+KP NIL++     ++ DFG++  L      ++  +  GT+ Y++
Sbjct: 118 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMS 171
Query: 692 PEWFRNSKITAKVDVYSFGVLLLEIISCR 720
           PE  + +  + + D++S G+ L+E+   R
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 108/209 (51%), Gaps = 13/209 (6%)
Query: 516 LEGATNNFKE--EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGER-EFKNEVFVI 572
           +E   ++F++  E+G G+ G+V+K  +  + S   +A K +    +   R +   E+ V+
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFK--VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL 58
Query: 573 GQTHHKNLVRLLG-FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGL 631
            + +   +V   G F  +G+  + + E ++ G+L   L    +    +   ++  + +GL
Sbjct: 59  HECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGL 117
Query: 632 LYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVA 691
            YL E  + +I+H D+KP NIL++     ++ DFG++  L      ++  +  GT+ Y++
Sbjct: 118 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMS 171
Query: 692 PEWFRNSKITAKVDVYSFGVLLLEIISCR 720
           PE  + +  + + D++S G+ L+E+   R
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 103/211 (48%), Gaps = 19/211 (9%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ---DGEREFKNEVFVIGQTHHKNLV 581
           E +G G++G+V     + R +   VA+KK+   F    + +R  + E+ ++    H N++
Sbjct: 61  ETIGNGAYGVVSSA--RRRLTGQQVAIKKIPNAFDVVTNAKRTLR-ELKILKHFKHDNII 117
Query: 582 RLLGFCD------EGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLH 635
            +           E ++  +V + + +  L   +  +            +Q+ RGL Y+H
Sbjct: 118 AIKDILRPTVPYGEFKSVYVVLDLMESD-LHQIIHSSQPLTLEHVRYFLYQLLRGLKYMH 176
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN--QSKTIKTAIRGTKGYVAPE 693
               AQ+IH D+KP N+L+++    +I DFG+A+ L  +  + +   T    T+ Y APE
Sbjct: 177 S---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPE 233
Query: 694 WFRN-SKITAKVDVYSFGVLLLEIISCRKSF 723
              +  + T  +D++S G +  E+++ R+ F
Sbjct: 234 LMLSLHEYTQAIDLWSVGCIFGEMLARRQLF 264

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 102/203 (50%), Gaps = 27/203 (13%)
Query: 527 VGRGSFGIV---YKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNL 580
           +G G+ GIV   Y  +++       VA+KKL R FQ+    +R ++ E+ ++   +HKN+
Sbjct: 32  IGSGAQGIVCAAYDAILERN-----VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNI 85
Query: 581 VRLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYL 634
           + LL         +E Q+  +V E ++   L   +   ++ +    + + +Q+  G+ +L
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVI--QMELDHERMSYLLYQMLCGIKHL 142
Query: 635 HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 694
           H    A IIH D+KP NI++    T +I DFGLA+    +   T +     T+ Y APE 
Sbjct: 143 HS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEVV---TRYYRAPEV 196
Query: 695 FRNSKITAKVDVYSFGVLLLEII 717
                    VD++S G ++ E+I
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMI 219

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 69/132 (52%), Gaps = 8/132 (6%)
Query: 595 LVYEFLNNGTLASFLF--GNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNI 652
           +V E+++  TL   +   G + P   +   +     + L + H++    IIH D+KP NI
Sbjct: 93  IVMEYVDGVTLRDIVHTEGPMTPKRAI--EVIADACQALNFSHQNG---IIHRDVKPANI 147
Query: 653 LLDDYYTARISDFGLAKLLTLNQSKTIKTA-IRGTKGYVAPEWFRNSKITAKVDVYSFGV 711
           ++      ++ DFG+A+ +  + +   +TA + GT  Y++PE  R   + A+ DVYS G 
Sbjct: 148 MISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGC 207
Query: 712 LLLEIISCRKSF 723
           +L E+++    F
Sbjct: 208 VLYEVLTGEPPF 219

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 102/203 (50%), Gaps = 27/203 (13%)
Query: 527 VGRGSFGIV---YKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNL 580
           +G G+ GIV   Y  +++       VA+KKL R FQ+    +R ++ E+ ++   +HKN+
Sbjct: 32  IGSGAQGIVCAAYDAILERN-----VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNI 85
Query: 581 VRLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYL 634
           + LL         +E Q+  +V E ++   L   +   ++ +    + + +Q+  G+ +L
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVI--QMELDHERMSYLLYQMLCGIKHL 142
Query: 635 HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 694
           H    A IIH D+KP NI++    T +I DFGLA+      +  + T    T+ Y APE 
Sbjct: 143 HS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEV 196
Query: 695 FRNSKITAKVDVYSFGVLLLEII 717
                    VD++S G ++ E+I
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMI 219

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/241 (22%), Positives = 109/241 (45%), Gaps = 10/241 (4%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLL 584
           EE+G+G+F +V + V        A  +    ++     ++ + E  +     H N+VRL 
Sbjct: 17  EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 76
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIH 644
               E  +  L+++ +  G L   +      +    ++   QI   +L+ H+     ++H
Sbjct: 77  DSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQ---MGVVH 133
Query: 645 CDIKPQNILLDDYY---TARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKIT 701
            ++KP+N+LL         +++DFGLA  +   Q      A  GT GY++PE  R     
Sbjct: 134 RNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA--GTPGYLSPEVLRKDPYG 191
Query: 702 AKVDVYSFGVLLLEIISCRKSF-DIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMND 760
             VD+++ GV+L  ++     F D +    Y  +   A+D + + + + +  E K+ +N 
Sbjct: 192 KPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYD-FPSPEWDTVTPEAKDLINK 250
Query: 761 I 761
           +
Sbjct: 251 M 251

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 69/132 (52%), Gaps = 8/132 (6%)
Query: 595 LVYEFLNNGTLASFLF--GNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNI 652
           +V E+++  TL   +   G + P   +   +     + L + H++    IIH D+KP NI
Sbjct: 93  IVMEYVDGVTLRDIVHTEGPMTPKRAI--EVIADACQALNFSHQNG---IIHRDVKPANI 147
Query: 653 LLDDYYTARISDFGLAKLLTLNQSKTIKTA-IRGTKGYVAPEWFRNSKITAKVDVYSFGV 711
           ++      ++ DFG+A+ +  + +   +TA + GT  Y++PE  R   + A+ DVYS G 
Sbjct: 148 MISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGC 207
Query: 712 LLLEIISCRKSF 723
           +L E+++    F
Sbjct: 208 VLYEVLTGEPPF 219

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 101/197 (51%), Gaps = 11/197 (5%)
Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGER-EFKNEVFVIGQTHHKNLVRLL 584
           E+G G+ G+V+K  +  + S   +A K +    +   R +   E+ V+ + +   +V   
Sbjct: 13  ELGAGNGGVVFK--VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFY 70
Query: 585 G-FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
           G F  +G+  + + E ++ G+L   L    +    +   ++  + +GL YL E  + +I+
Sbjct: 71  GAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE--KHKIM 127
Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK 703
           H D+KP NIL++     ++ DFG++  L      ++  +  GT+ Y++PE  + +  + +
Sbjct: 128 HRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMSPERLQGTHYSVQ 183
Query: 704 VDVYSFGVLLLEIISCR 720
            D++S G+ L+E+   R
Sbjct: 184 SDIWSMGLSLVEMAVGR 200

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 26/214 (12%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKN-EVFVIGQTHHKNLVRLLG 585
           +G GSFG+V++  +     +  VA+KK   V QD  + FKN E+ ++    H N+V L  
Sbjct: 48  IGNGSFGVVFQAKL---VESDEVAIKK---VLQD--KRFKNRELQIMRIVKHPNVVDLKA 99
Query: 586 FCDEGQNRL------LVYEFLNNGTL-ASFLFGNLKPNWN--LRTNIAFQIARGLLYLHE 636
           F     ++       LV E++      AS  +  LK      L     +Q+ R L Y+H 
Sbjct: 100 FFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS 159
Query: 637 DCRAQIIHCDIKPQNILLDDYY-TARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW- 694
                I H DIKPQN+LLD      ++ DFG AK+L   +          ++ Y APE  
Sbjct: 160 ---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXIC---SRYYRAPELI 213
Query: 695 FRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMG 728
           F  +  T  +D++S G ++ E++  +  F  E G
Sbjct: 214 FGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG 247

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 98/200 (49%), Gaps = 10/200 (5%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLL 584
           E++G GS+G VYK +   + +   VA+K++    +   +E   E+ ++ Q    ++V+  
Sbjct: 35  EKLGEGSYGSVYKAI--HKETGQIVAIKQVP--VESDLQEIIKEISIMQQCDSPHVVKYY 90
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFL-FGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
           G   +  +  +V E+   G+++  +   N     +    I     +GL YLH     + I
Sbjct: 91  GSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMRKI 147
Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK 703
           H DIK  NILL+    A+++DFG+A  LT   +K  +  + GT  ++APE  +       
Sbjct: 148 HRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAK--RNXVIGTPFWMAPEVIQEIGYNCV 205
Query: 704 VDVYSFGVLLLEIISCRKSF 723
            D++S G+  +E+   +  +
Sbjct: 206 ADIWSLGITAIEMAEGKPPY 225

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 106/207 (51%), Gaps = 28/207 (13%)
Query: 527 VGRGSFGIV---YKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNL 580
           +G G+ GIV   Y  +++       VA+KKL R FQ+    +R ++ E+ ++   +HKN+
Sbjct: 32  IGSGAQGIVCAAYDAILERN-----VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNI 85
Query: 581 VRLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYL 634
           + LL         +E Q+  +V E ++   L   +   ++ +    + + +Q+  G+ +L
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVI--QMELDHERMSYLLYQMLCGIKHL 142
Query: 635 HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 694
           H    A IIH D+KP NI++    T +I DFGLA+  T   S  ++  +  T+ Y APE 
Sbjct: 143 HS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMEPEV-VTRYYRAPEV 196
Query: 695 FRNSKITAKVDVYSFGVLLLEIISCRK 721
                    VD++S G ++ E++ C K
Sbjct: 197 ILGMGYKENVDLWSVGCIMGEMV-CHK 222

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 94/196 (47%), Gaps = 10/196 (5%)
Query: 527 VGRGSFGIVYKGV-IQTRTSTTAVAVKKLDR-VFQDGEREFKNEVFVIGQTHHKNLVRLL 584
           +G G FG VY+GV    +     VAVK   +    D + +F +E  ++    H ++V+L+
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF--QIARGLLYLHEDCRAQI 642
           G  +E +   ++ E    G L  +L  N K +  + T + +  QI + + YL        
Sbjct: 80  GIIEE-EPTWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLES---INC 134
Query: 643 IHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITA 702
           +H DI  +NIL+      ++ DFGL++ +  ++     +  R    +++PE     + T 
Sbjct: 135 VHRDIAVRNILVASPECVKLGDFGLSRYIE-DEDYYKASVTRLPIKWMSPESINFRRFTT 193
Query: 703 KVDVYSFGVLLLEIIS 718
             DV+ F V + EI+S
Sbjct: 194 ASDVWMFAVCMWEILS 209

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 100/203 (49%), Gaps = 25/203 (12%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKN-EVFVIGQTHHKNLVRL-L 584
           +G GSFG+VY+   +   S   VA+KK   V QD  + FKN E+ ++ +  H N+VRL  
Sbjct: 28  IGNGSFGVVYQA--KLCDSGELVAIKK---VLQD--KRFKNRELQIMRKLDHCNIVRLRY 80
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA--------FQIARGLLYLHE 636
            F   G+ +  VY  L    +   ++   +     +  +         +Q+ R L Y+H 
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 637 DCRAQIIHCDIKPQNILLD-DYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW- 694
                I H DIKPQN+LLD D    ++ DFG AK L   +      +   ++ Y APE  
Sbjct: 141 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRYYRAPELI 194
Query: 695 FRNSKITAKVDVYSFGVLLLEII 717
           F  +  T+ +DV+S G +L E++
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELL 217

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 108/209 (51%), Gaps = 13/209 (6%)
Query: 516 LEGATNNFKE--EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGER-EFKNEVFVI 572
           +E   ++F++  E+G G+ G+V+K  +  + S   +A K +    +   R +   E+ V+
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFK--VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL 58
Query: 573 GQTHHKNLVRLLG-FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGL 631
            + +   +V   G F  +G+  + + E ++ G+L   L    +    +   ++  + +GL
Sbjct: 59  HECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGL 117
Query: 632 LYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVA 691
            YL E  + +I+H D+KP NIL++     ++ DFG++  L      ++  +  GT+ Y++
Sbjct: 118 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMS 171
Query: 692 PEWFRNSKITAKVDVYSFGVLLLEIISCR 720
           PE  + +  + + D++S G+ L+E+   R
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 69/132 (52%), Gaps = 8/132 (6%)
Query: 595 LVYEFLNNGTLASFLF--GNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNI 652
           +V E+++  TL   +   G + P   +   +     + L + H++    IIH D+KP NI
Sbjct: 93  IVMEYVDGVTLRDIVHTEGPMTPKRAI--EVIADACQALNFSHQNG---IIHRDVKPANI 147
Query: 653 LLDDYYTARISDFGLAKLLTLNQSKTIKTA-IRGTKGYVAPEWFRNSKITAKVDVYSFGV 711
           ++      ++ DFG+A+ +  + +   +TA + GT  Y++PE  R   + A+ DVYS G 
Sbjct: 148 MISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGC 207
Query: 712 LLLEIISCRKSF 723
           +L E+++    F
Sbjct: 208 VLYEVLTGEPPF 219

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 95/211 (45%), Gaps = 22/211 (10%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAV------KKLDRVFQDG--EREFKNEVFVIGQTH 576
           EE+G G F IV K     R  +T +        K+  R  + G    E + EV ++ Q  
Sbjct: 18  EELGSGQFAIVKK----CREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 577 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHE 636
           H N++ L    +   + +L+ E ++ G L  FL      +    T+   QI  G+ YLH 
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH- 132
Query: 637 DCRAQIIHCDIKPQNILLDDYYTA----RISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 692
               +I H D+KP+NI+L D        ++ DFGLA    +      K  I GT  +VAP
Sbjct: 133 --TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH--EIEDGVEFKN-IFGTPEFVAP 187
Query: 693 EWFRNSKITAKVDVYSFGVLLLEIISCRKSF 723
           E      +  + D++S GV+   ++S    F
Sbjct: 188 EIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 94/196 (47%), Gaps = 10/196 (5%)
Query: 527 VGRGSFGIVYKGV-IQTRTSTTAVAVKKLDR-VFQDGEREFKNEVFVIGQTHHKNLVRLL 584
           +G G FG VY+GV    +     VAVK   +    D + +F +E  ++    H ++V+L+
Sbjct: 32  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 91
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF--QIARGLLYLHEDCRAQI 642
           G  +E +   ++ E    G L  +L  N K +  + T + +  QI + + YL        
Sbjct: 92  GIIEE-EPTWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLES---INC 146
Query: 643 IHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITA 702
           +H DI  +NIL+      ++ DFGL++ +  ++     +  R    +++PE     + T 
Sbjct: 147 VHRDIAVRNILVASPECVKLGDFGLSRYIE-DEDYYKASVTRLPIKWMSPESINFRRFTT 205
Query: 703 KVDVYSFGVLLLEIIS 718
             DV+ F V + EI+S
Sbjct: 206 ASDVWMFAVCMWEILS 221

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 69/132 (52%), Gaps = 8/132 (6%)
Query: 595 LVYEFLNNGTLASFLF--GNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNI 652
           +V E+++  TL   +   G + P   +   +     + L + H++    IIH D+KP NI
Sbjct: 93  IVMEYVDGVTLRDIVHTEGPMTPKRAI--EVIADACQALNFSHQNG---IIHRDVKPANI 147
Query: 653 LLDDYYTARISDFGLAKLLTLNQSKTIKTA-IRGTKGYVAPEWFRNSKITAKVDVYSFGV 711
           ++      ++ DFG+A+ +  + +   +TA + GT  Y++PE  R   + A+ DVYS G 
Sbjct: 148 MISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGC 207
Query: 712 LLLEIISCRKSF 723
           +L E+++    F
Sbjct: 208 VLYEVLTGEPPF 219

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 104/207 (50%), Gaps = 28/207 (13%)
Query: 527 VGRGSFGIV---YKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNL 580
           +G G+ GIV   Y  +++       VA+KKL R FQ+    +R ++ E+ ++   +HKN+
Sbjct: 37  IGSGAQGIVCAAYDAILERN-----VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNI 90
Query: 581 VRLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYL 634
           + LL         +E Q+  +V E ++   L   +   ++ +    + + +Q+  G+ +L
Sbjct: 91  IGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVI--QMELDHERMSYLLYQMLCGIKHL 147
Query: 635 HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 694
           H    A IIH D+KP NI++    T +I DFGLA+      +  + T    T+ Y APE 
Sbjct: 148 HS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEV 201
Query: 695 FRNSKITAKVDVYSFGVLLLEIISCRK 721
                    VD++S G ++ E++ C K
Sbjct: 202 ILGMGYKENVDLWSVGCIMGEMV-CHK 227

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 94/196 (47%), Gaps = 10/196 (5%)
Query: 527 VGRGSFGIVYKGV-IQTRTSTTAVAVKKLDR-VFQDGEREFKNEVFVIGQTHHKNLVRLL 584
           +G G FG VY+GV    +     VAVK   +    D + +F +E  ++    H ++V+L+
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 75
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF--QIARGLLYLHEDCRAQI 642
           G  +E +   ++ E    G L  +L  N K +  + T + +  QI + + YL        
Sbjct: 76  GIIEE-EPTWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLES---INC 130
Query: 643 IHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITA 702
           +H DI  +NIL+      ++ DFGL++ +  ++     +  R    +++PE     + T 
Sbjct: 131 VHRDIAVRNILVASPECVKLGDFGLSRYIE-DEDYYKASVTRLPIKWMSPESINFRRFTT 189
Query: 703 KVDVYSFGVLLLEIIS 718
             DV+ F V + EI+S
Sbjct: 190 ASDVWMFAVCMWEILS 205

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 101/219 (46%), Gaps = 31/219 (14%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLL 584
           E +G G FG V+K   + R       +K++    +  ERE K     + +  H N+V   
Sbjct: 17  ELIGSGGFGQVFKA--KHRIDGKTYVIKRVKYNNEKAEREVK----ALAKLDHVNIVHYN 70
Query: 585 GFCD----------EGQNR------LLVYEFLNNGTLASFLFGNL--KPNWNLRTNIAFQ 626
           G  D          +  +R       +  EF + GTL  ++      K +  L   +  Q
Sbjct: 71  GCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQ 130
Query: 627 IARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGT 686
           I +G+ Y+H     ++I+ D+KP NI L D    +I DFGL   L  N  K  ++  +GT
Sbjct: 131 ITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLK-NDGKRXRS--KGT 184
Query: 687 KGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFD 724
             Y++PE   +     +VD+Y+ G++L E++  C  +F+
Sbjct: 185 LRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE 223

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 104/207 (50%), Gaps = 28/207 (13%)
Query: 527 VGRGSFGIV---YKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNL 580
           +G G+ GIV   Y  +++       VA+KKL R FQ+    +R ++ E+ ++   +HKN+
Sbjct: 26  IGSGAQGIVCAAYDAILERN-----VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNI 79
Query: 581 VRLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYL 634
           + LL         +E Q+  +V E ++   L   +   ++ +    + + +Q+  G+ +L
Sbjct: 80  IGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVI--QMELDHERMSYLLYQMLCGIKHL 136
Query: 635 HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 694
           H    A IIH D+KP NI++    T +I DFGLA+      +  + T    T+ Y APE 
Sbjct: 137 HS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEV 190
Query: 695 FRNSKITAKVDVYSFGVLLLEIISCRK 721
                    VD++S G ++ E++ C K
Sbjct: 191 ILGMGYKENVDLWSVGCIMGEMV-CHK 216

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 69/132 (52%), Gaps = 8/132 (6%)
Query: 595 LVYEFLNNGTLASFLF--GNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNI 652
           +V E+++  TL   +   G + P   +   +     + L + H++    IIH D+KP NI
Sbjct: 110 IVMEYVDGVTLRDIVHTEGPMTPKRAI--EVIADACQALNFSHQNG---IIHRDVKPANI 164
Query: 653 LLDDYYTARISDFGLAKLLTLNQSKTIKTA-IRGTKGYVAPEWFRNSKITAKVDVYSFGV 711
           ++      ++ DFG+A+ +  + +   +TA + GT  Y++PE  R   + A+ DVYS G 
Sbjct: 165 MISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGC 224
Query: 712 LLLEIISCRKSF 723
           +L E+++    F
Sbjct: 225 VLYEVLTGEPPF 236

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 73/150 (48%), Gaps = 10/150 (6%)
Query: 567 NEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQ 626
           +EV V+ Q  H N+++L  F ++ +N  LV E    G L   +    K +      I  Q
Sbjct: 70  DEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQ 129
Query: 627 IARGLLYLHEDCRAQIIHCDIKPQNILLDDY---YTARISDFGLAKLLTLNQSKTIKTAI 683
           +  G  YLH   +  I+H D+KP+N+LL+        +I DFGL+    +      +   
Sbjct: 130 VLSGTTYLH---KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERL-- 184
Query: 684 RGTKGYVAPEWFRNSKITAKVDVYSFGVLL 713
            GT  Y+APE  R  K   K DV+S GV+L
Sbjct: 185 -GTAYYIAPEVLRK-KYDEKCDVWSCGVIL 212

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 87/195 (44%), Gaps = 16/195 (8%)
Query: 524 KEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           KE++G GS+ +  + +   + +    AVK +D+  +D   E +    ++    H N++ L
Sbjct: 27  KEDIGVGSYSVCKRCI--HKATNXEFAVKIIDKSKRDPTEEIE---ILLRYGQHPNIITL 81
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ-I 642
               D+G+   +V E    G L   +      +    + + F I + + YLH    AQ +
Sbjct: 82  KDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVEYLH----AQGV 137
Query: 643 IHCDIKPQNILLDDYY----TARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNS 698
           +H D+KP NIL  D      + RI DFG AK L              T  +VAPE     
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCY--TANFVAPEVLERQ 195
Query: 699 KITAKVDVYSFGVLL 713
              A  D++S GVLL
Sbjct: 196 GYDAACDIWSLGVLL 210

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 73/150 (48%), Gaps = 10/150 (6%)
Query: 567 NEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQ 626
           +EV V+ Q  H N+++L  F ++ +N  LV E    G L   +    K +      I  Q
Sbjct: 53  DEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQ 112
Query: 627 IARGLLYLHEDCRAQIIHCDIKPQNILLDDY---YTARISDFGLAKLLTLNQSKTIKTAI 683
           +  G  YLH   +  I+H D+KP+N+LL+        +I DFGL+    +      +   
Sbjct: 113 VLSGTTYLH---KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERL-- 167
Query: 684 RGTKGYVAPEWFRNSKITAKVDVYSFGVLL 713
            GT  Y+APE  R  K   K DV+S GV+L
Sbjct: 168 -GTAYYIAPEVLRK-KYDEKCDVWSCGVIL 195

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 97/213 (45%), Gaps = 26/213 (12%)
Query: 514 KELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLD-RVFQDGEREFKNEVFVI 572
           +E+  AT+  +  +GRGSFG V++  ++ + +    AVKK+   VF+        E+   
Sbjct: 90  EEVHWATHQLR--LGRGSFGEVHR--MEDKQTGFQCAVKKVRLEVFR------AEELMAC 139
Query: 573 GQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF----QIA 628
                  +V L G   EG    +  E L  G+L   +    K    L  + A     Q  
Sbjct: 140 AGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLV----KEQGCLPEDRALYYLGQAL 195
Query: 629 RGLLYLHEDCRAQIIHCDIKPQNILLD-DYYTARISDFGLAKLLT---LNQSKTIKTAIR 684
            GL YLH     +I+H D+K  N+LL  D   A + DFG A  L    L +S      I 
Sbjct: 196 EGLEYLHSR---RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIP 252
Query: 685 GTKGYVAPEWFRNSKITAKVDVYSFGVLLLEII 717
           GT+ ++APE        AKVDV+S   ++L ++
Sbjct: 253 GTETHMAPEVVLGRSCDAKVDVWSSCCMMLHML 285

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 95/211 (45%), Gaps = 22/211 (10%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAV------KKLDRVFQDG--EREFKNEVFVIGQTH 576
           EE+G G F IV K     R  +T +        K+  R  + G    E + EV ++ Q  
Sbjct: 18  EELGSGQFAIVKK----CREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 577 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHE 636
           H N++ L    +   + +L+ E ++ G L  FL      +    T+   QI  G+ YLH 
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH- 132
Query: 637 DCRAQIIHCDIKPQNILLDDYYTA----RISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 692
               +I H D+KP+NI+L D        ++ DFGLA    +      K  I GT  +VAP
Sbjct: 133 --TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH--EIEDGVEFKN-IFGTPEFVAP 187
Query: 693 EWFRNSKITAKVDVYSFGVLLLEIISCRKSF 723
           E      +  + D++S GV+   ++S    F
Sbjct: 188 EIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 95/211 (45%), Gaps = 22/211 (10%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAV------KKLDRVFQDG--EREFKNEVFVIGQTH 576
           EE+G G F IV K     R  +T +        K+  R  + G    E + EV ++ Q  
Sbjct: 18  EELGSGQFAIVKK----CREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 577 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHE 636
           H N++ L    +   + +L+ E ++ G L  FL      +    T+   QI  G+ YLH 
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH- 132
Query: 637 DCRAQIIHCDIKPQNILLDDYYTA----RISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 692
               +I H D+KP+NI+L D        ++ DFGLA    +      K  I GT  +VAP
Sbjct: 133 --TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH--EIEDGVEFKN-IFGTPEFVAP 187
Query: 693 EWFRNSKITAKVDVYSFGVLLLEIISCRKSF 723
           E      +  + D++S GV+   ++S    F
Sbjct: 188 EIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 103/211 (48%), Gaps = 19/211 (9%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ---DGEREFKNEVFVIGQTHHKNLV 581
           E +G G++G+V     + R +   VA+KK+   F    + +R  + E+ ++    H N++
Sbjct: 60  ETIGNGAYGVVSSA--RRRLTGQQVAIKKIPNAFDVVTNAKRTLR-ELKILKHFKHDNII 116
Query: 582 RLLGFCD------EGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLH 635
            +           E ++  +V + + +  L   +  +            +Q+ RGL Y+H
Sbjct: 117 AIKDILRPTVPYGEFKSVYVVLDLMESD-LHQIIHSSQPLTLEHVRYFLYQLLRGLKYMH 175
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN--QSKTIKTAIRGTKGYVAPE 693
               AQ+IH D+KP N+L+++    +I DFG+A+ L  +  + +   T    T+ Y APE
Sbjct: 176 S---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPE 232
Query: 694 WFRN-SKITAKVDVYSFGVLLLEIISCRKSF 723
              +  + T  +D++S G +  E+++ R+ F
Sbjct: 233 LMLSLHEYTQAIDLWSVGCIFGEMLARRQLF 263

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 101/197 (51%), Gaps = 11/197 (5%)
Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGER-EFKNEVFVIGQTHHKNLVRLL 584
           E+G G+ G+V+K  +  + S   +A K +    +   R +   E+ V+ + +   +V   
Sbjct: 40  ELGAGNGGVVFK--VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFY 97
Query: 585 G-FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
           G F  +G+  + + E ++ G+L   L    +    +   ++  + +GL YL E  + +I+
Sbjct: 98  GAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE--KHKIM 154
Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK 703
           H D+KP NIL++     ++ DFG++  L      ++  +  GT+ Y++PE  + +  + +
Sbjct: 155 HRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMSPERLQGTHYSVQ 210
Query: 704 VDVYSFGVLLLEIISCR 720
            D++S G+ L+E+   R
Sbjct: 211 SDIWSMGLSLVEMAVGR 227

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 95/211 (45%), Gaps = 22/211 (10%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAV------KKLDRVFQDG--EREFKNEVFVIGQTH 576
           EE+G G F IV K     R  +T +        K+  R  + G    E + EV ++ Q  
Sbjct: 18  EELGSGQFAIVKK----CREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 577 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHE 636
           H N++ L    +   + +L+ E ++ G L  FL      +    T+   QI  G+ YLH 
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH- 132
Query: 637 DCRAQIIHCDIKPQNILLDDYYTA----RISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 692
               +I H D+KP+NI+L D        ++ DFGLA    +      K  I GT  +VAP
Sbjct: 133 --TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH--EIEDGVEFKN-IFGTPEFVAP 187
Query: 693 EWFRNSKITAKVDVYSFGVLLLEIISCRKSF 723
           E      +  + D++S GV+   ++S    F
Sbjct: 188 EIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 95/211 (45%), Gaps = 22/211 (10%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAV------KKLDRVFQDG--EREFKNEVFVIGQTH 576
           EE+G G F IV K     R  +T +        K+  R  + G    E + EV ++ Q  
Sbjct: 18  EELGSGQFAIVKK----CREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 577 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHE 636
           H N++ L    +   + +L+ E ++ G L  FL      +    T+   QI  G+ YLH 
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH- 132
Query: 637 DCRAQIIHCDIKPQNILLDDYYTA----RISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 692
               +I H D+KP+NI+L D        ++ DFGLA    +      K  I GT  +VAP
Sbjct: 133 --TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH--EIEDGVEFKN-IFGTPEFVAP 187
Query: 693 EWFRNSKITAKVDVYSFGVLLLEIISCRKSF 723
           E      +  + D++S GV+   ++S    F
Sbjct: 188 EIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 94/206 (45%), Gaps = 22/206 (10%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAV------KKLDRVFQDG--EREFKNEVFVIGQTH 576
           EE+G G F IV K     R  +T +        K+  R  + G    E + EV ++ Q  
Sbjct: 18  EELGSGQFAIVKK----CREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 577 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHE 636
           H N++ L    +   + +L+ E ++ G L  FL      +    T+   QI  G+ YLH 
Sbjct: 74  HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 637 DCRAQIIHCDIKPQNILLDDYYTA----RISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 692
               +I H D+KP+NI+L D        ++ DFGLA    +      K  I GT  +VAP
Sbjct: 134 ---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH--EIEDGVEFKN-IFGTPEFVAP 187
Query: 693 EWFRNSKITAKVDVYSFGVLLLEIIS 718
           E      +  + D++S GV+   ++S
Sbjct: 188 EIVNYEPLGLEADMWSIGVITYILLS 213

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 123/285 (43%), Gaps = 25/285 (8%)
Query: 526 EVGRGSFGIVYKGVIQTRTSTTA--VAVKKLDRVFQDGERE-FKNEVFVIGQTHHKNLVR 582
           ++G G FG V           T   VAVK L        R  ++ E+ ++   +H+++V+
Sbjct: 15  DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVK 74
Query: 583 LLGFC-DEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
             G C D+G+  + LV E++  G+L  +L  +      L    A QI  G+ YLH     
Sbjct: 75  YKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLL-FAQQICEGMAYLHAQ--- 130
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTL-NQSKTIKTAIRGTKGYVAPEWFRNSK 699
             IH  +  +N+LLD+    +I DFGLAK +   ++   ++        + APE  +  K
Sbjct: 131 HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECK 190
Query: 700 ITAKVDVYSFGVLLLEII-------SCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVG 752
                DV+SFGV L E++       S    F   +G     +T          +L  L+ 
Sbjct: 191 FYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVL--------RLTELLE 242
Query: 753 EDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 797
             +       C  ++  +   C + + S RPT + ++ +L+   E
Sbjct: 243 RGERLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLVPILQTAQE 287

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 83/296 (28%), Positives = 128/296 (43%), Gaps = 59/296 (19%)
Query: 527 VGRGSFG-IVYKGVIQTRTSTTAVAVKKLDRVFQD-GEREFKNEVFVIGQTHHKNLVRLL 584
           +G GS G +V++G  Q R     VAVK++   F D    E K    +     H N++R  
Sbjct: 41  LGYGSSGTVVFQGSFQGR----PVAVKRMLIDFCDIALMEIK---LLTESDDHPNVIRY- 92
Query: 585 GFCDEGQNRLLVYEF-LNNGTLASFLFGNLKPNWNLRTNIAF-------QIARGLLYLHE 636
            +C E  +R L     L N  L   +      + NL+    +       QIA G+ +LH 
Sbjct: 93  -YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 151
Query: 637 DCRAQIIHCDIKPQNILL--DDYYTAR-----------ISDFGLAKLLTLNQS--KTIKT 681
               +IIH D+KPQNIL+     +TA            ISDFGL K L   Q   +    
Sbjct: 152 ---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLN 208
Query: 682 AIRGTKGYVAPEWFRNS---KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA 738
              GT G+ APE    S   ++T  +D++S G +   I+S  K      G++Y+      
Sbjct: 209 NPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKH---PFGDKYS------ 259
Query: 739 FDCYRNGKLNVLVG----EDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
                  + N++ G    ++ + ++D   + +   +    I  DP  RPT  KVL+
Sbjct: 260 ------RESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 309

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 123/285 (43%), Gaps = 25/285 (8%)
Query: 526 EVGRGSFGIVYKGVIQTRTSTTA--VAVKKLDRVFQDGERE-FKNEVFVIGQTHHKNLVR 582
           ++G G FG V           T   VAVK L        R  ++ E+ ++   +H+++V+
Sbjct: 16  DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVK 75
Query: 583 LLGFC-DEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
             G C D+G+  + LV E++  G+L  +L  +      L    A QI  G+ YLH     
Sbjct: 76  YKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLL-FAQQICEGMAYLHAQ--- 131
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTL-NQSKTIKTAIRGTKGYVAPEWFRNSK 699
             IH  +  +N+LLD+    +I DFGLAK +   ++   ++        + APE  +  K
Sbjct: 132 HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECK 191
Query: 700 ITAKVDVYSFGVLLLEII-------SCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVG 752
                DV+SFGV L E++       S    F   +G     +T          +L  L+ 
Sbjct: 192 FYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVL--------RLTELLE 243
Query: 753 EDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 797
             +       C  ++  +   C + + S RPT + ++ +L+   E
Sbjct: 244 RGERLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLVPILQTAQE 288

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 83/296 (28%), Positives = 128/296 (43%), Gaps = 59/296 (19%)
Query: 527 VGRGSFG-IVYKGVIQTRTSTTAVAVKKLDRVFQD-GEREFKNEVFVIGQTHHKNLVRLL 584
           +G GS G +V++G  Q R     VAVK++   F D    E K    +     H N++R  
Sbjct: 41  LGYGSSGTVVFQGSFQGR----PVAVKRMLIDFCDIALMEIK---LLTESDDHPNVIRY- 92
Query: 585 GFCDEGQNRLLVYEF-LNNGTLASFLFGNLKPNWNLRTNIAF-------QIARGLLYLHE 636
            +C E  +R L     L N  L   +      + NL+    +       QIA G+ +LH 
Sbjct: 93  -YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 151
Query: 637 DCRAQIIHCDIKPQNILL--DDYYTAR-----------ISDFGLAKLLTLNQS--KTIKT 681
               +IIH D+KPQNIL+     +TA            ISDFGL K L   Q   +    
Sbjct: 152 ---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLN 208
Query: 682 AIRGTKGYVAPEWFRNS---KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA 738
              GT G+ APE    S   ++T  +D++S G +   I+S  K      G++Y+      
Sbjct: 209 NPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKH---PFGDKYS------ 259
Query: 739 FDCYRNGKLNVLVG----EDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
                  + N++ G    ++ + ++D   + +   +    I  DP  RPT  KVL+
Sbjct: 260 ------RESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 309

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 100/204 (49%), Gaps = 26/204 (12%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTA-----------VAVKKLDRVFQDGEREFKNEVFVIGQT 575
           +G+GSFG V+  +++  + + A             +K  DRV    ER+      ++ + 
Sbjct: 32  LGQGSFGKVF--LVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERD------ILVEV 83
Query: 576 HHKNLVRL-LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYL 634
           +H  +V+L   F  EG+   L+ +FL  G L + L    K       ++ F +A   L L
Sbjct: 84  NHPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLS---KEVMFTEEDVKFYLAELALAL 139
Query: 635 HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 694
                  II+ D+KP+NILLD+    +++DFGL+K    ++ K    +  GT  Y+APE 
Sbjct: 140 DHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY--SFCGTVEYMAPEV 197
Query: 695 FRNSKITAKVDVYSFGVLLLEIIS 718
                 T   D +SFGVL+ E+++
Sbjct: 198 VNRRGHTQSADWWSFGVLMFEMLT 221

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 103/203 (50%), Gaps = 24/203 (11%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKL---------DRVFQDGEREFKNEVFVIGQTHH 577
           +G+GSFG V+     TR  +  +   K+         DRV    ER+      ++   +H
Sbjct: 36  LGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERD------ILADVNH 89
Query: 578 KNLVRL-LGFCDEGQNRLLVYEFLNNGTLASFLFGNLK-PNWNLRTNIAFQIARGLLYLH 635
             +V+L   F  EG+   L+ +FL  G L + L   +     +++  +A ++A GL +LH
Sbjct: 90  PFVVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELALGLDHLH 147
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
                 II+ D+KP+NILLD+    +++DFGL+K    ++ K    +  GT  Y+APE  
Sbjct: 148 S---LGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAY--SFCGTVEYMAPEVV 202
Query: 696 RNSKITAKVDVYSFGVLLLEIIS 718
                +   D +S+GVL+ E+++
Sbjct: 203 NRQGHSHSADWWSYGVLMFEMLT 225

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 101/203 (49%), Gaps = 27/203 (13%)
Query: 527 VGRGSFGIV---YKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNL 580
           +G G+ GIV   Y  +++       VA+KKL R FQ+    +R ++ E+ ++   +HKN+
Sbjct: 34  IGSGAQGIVCAAYDAILERN-----VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNI 87
Query: 581 VRLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYL 634
           + LL         +E Q+  +V E ++   L   +   ++ +    + + +Q+  G+ +L
Sbjct: 88  IGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVI--QMELDHERMSYLLYQMLCGIKHL 144
Query: 635 HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 694
           H    A IIH D+KP NI++    T +I DFGLA+      +  +      T+ Y APE 
Sbjct: 145 HS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMVPFVVTRYYRAPEV 198
Query: 695 FRNSKITAKVDVYSFGVLLLEII 717
                    VD++S G ++ E+I
Sbjct: 199 ILGMGYKENVDIWSVGCIMGEMI 221

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 101/197 (51%), Gaps = 11/197 (5%)
Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGER-EFKNEVFVIGQTHHKNLVRLL 584
           E+G G+ G+V+K  +  + S   +A K +    +   R +   E+ V+ + +   +V   
Sbjct: 32  ELGAGNGGVVFK--VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFY 89
Query: 585 G-FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
           G F  +G+  + + E ++ G+L   L    +    +   ++  + +GL YL E  + +I+
Sbjct: 90  GAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE--KHKIM 146
Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK 703
           H D+KP NIL++     ++ DFG++  L      ++  +  GT+ Y++PE  + +  + +
Sbjct: 147 HRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMSPERLQGTHYSVQ 202
Query: 704 VDVYSFGVLLLEIISCR 720
            D++S G+ L+E+   R
Sbjct: 203 SDIWSMGLSLVEMAVGR 219

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 101/232 (43%), Gaps = 44/232 (18%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLL 584
           E +G G FG V+K   + R       ++++    +  ERE K     + +  H N+V   
Sbjct: 18  ELIGSGGFGQVFKA--KHRIDGKTYVIRRVKYNNEKAEREVK----ALAKLDHVNIVHYN 71
Query: 585 GFCD-----------------------EGQNR------LLVYEFLNNGTLASFLFGNL-- 613
           G  D                       +  +R       +  EF + GTL  ++      
Sbjct: 72  GCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE 131
Query: 614 KPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTL 673
           K +  L   +  QI +G+ Y+H     ++IH D+KP NI L D    +I DFGL   L  
Sbjct: 132 KLDKVLALELFEQITKGVDYIHS---KKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLK- 187
Query: 674 NQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFD 724
           N  K  +T  +GT  Y++PE   +     +VD+Y+ G++L E++  C  +F+
Sbjct: 188 NDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE 237

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 103/222 (46%), Gaps = 37/222 (16%)
Query: 522 NFKEEVGRGSFGIV---YKGVIQTRTSTTAVAVKKLDR--------------------VF 558
             K+E+G+GS+G+V   Y     T  +   ++ KKL R                    + 
Sbjct: 16  TLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQ 75
Query: 559 QDGERE-FKNEVFVIGQTHHKNLVRLLGFCDE-GQNRL-LVYEFLNNGTLASFLFGNLKP 615
             G  E    E+ ++ +  H N+V+L+   D+  ++ L +V+E +N G +       LKP
Sbjct: 76  PRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV--PTLKP 133
Query: 616 NWNLRTNIAFQ-IARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN 674
               +    FQ + +G+ YLH     +IIH DIKP N+L+ +    +I+DFG++      
Sbjct: 134 LSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSN--EFK 188
Query: 675 QSKTIKTAIRGTKGYVAPEWFRNSKIT---AKVDVYSFGVLL 713
            S  + +   GT  ++APE    ++       +DV++ GV L
Sbjct: 189 GSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 100/204 (49%), Gaps = 26/204 (12%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTA-----------VAVKKLDRVFQDGEREFKNEVFVIGQT 575
           +G+GSFG V+  +++  + + A             +K  DRV    ER+      ++ + 
Sbjct: 32  LGQGSFGKVF--LVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERD------ILVEV 83
Query: 576 HHKNLVRL-LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYL 634
           +H  +V+L   F  EG+   L+ +FL  G L + L    K       ++ F +A   L L
Sbjct: 84  NHPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLS---KEVMFTEEDVKFYLAELALAL 139
Query: 635 HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 694
                  II+ D+KP+NILLD+    +++DFGL+K    ++ K    +  GT  Y+APE 
Sbjct: 140 DHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY--SFCGTVEYMAPEV 197
Query: 695 FRNSKITAKVDVYSFGVLLLEIIS 718
                 T   D +SFGVL+ E+++
Sbjct: 198 VNRRGHTQSADWWSFGVLMFEMLT 221

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 100/204 (49%), Gaps = 26/204 (12%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTA-----------VAVKKLDRVFQDGEREFKNEVFVIGQT 575
           +G+GSFG V+  +++  + + A             +K  DRV    ER+      ++ + 
Sbjct: 33  LGQGSFGKVF--LVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERD------ILVEV 84
Query: 576 HHKNLVRL-LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYL 634
           +H  +V+L   F  EG+   L+ +FL  G L + L    K       ++ F +A   L L
Sbjct: 85  NHPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLS---KEVMFTEEDVKFYLAELALAL 140
Query: 635 HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 694
                  II+ D+KP+NILLD+    +++DFGL+K    ++ K    +  GT  Y+APE 
Sbjct: 141 DHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY--SFCGTVEYMAPEV 198
Query: 695 FRNSKITAKVDVYSFGVLLLEIIS 718
                 T   D +SFGVL+ E+++
Sbjct: 199 VNRRGHTQSADWWSFGVLMFEMLT 222

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 99/197 (50%), Gaps = 11/197 (5%)
Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGER-EFKNEVFVIGQTHHKNLVRLL 584
           E+G G+ G+V+K  +  + S   +A K +    +   R +   E+ V+ + +   +V   
Sbjct: 16  ELGAGNGGVVFK--VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFY 73
Query: 585 G-FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
           G F  +G+  + + E ++ G+L   L    +    +   ++  + +GL YL E  + +I+
Sbjct: 74  GAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE--KHKIM 130
Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK 703
           H D+KP NIL++     ++ DFG++  L       +     GT+ Y++PE  + +  + +
Sbjct: 131 HRDVKPSNILVNSRGEIKLCDFGVSGQLI----DEMANEFVGTRSYMSPERLQGTHYSVQ 186
Query: 704 VDVYSFGVLLLEIISCR 720
            D++S G+ L+E+   R
Sbjct: 187 SDIWSMGLSLVEMAVGR 203

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 93/215 (43%), Gaps = 8/215 (3%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREF-KNEVFVIGQTHHKNL 580
            F + +G GSF  V        +   A+ + +   + ++ +  +   E  V+ +  H   
Sbjct: 40  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 99
Query: 581 VRLLGFCDEGQNRLLV-YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCR 639
           V+L  FC +   +L     +  NG L  ++      +         +I   L YLH    
Sbjct: 100 VKLY-FCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH---G 155
Query: 640 AQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSK 699
             IIH D+KP+NILL++    +I+DFG AK+L+    +       GT  YV+PE      
Sbjct: 156 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 215
Query: 700 ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL 734
                D+++ G ++ ++++    F    G EY I 
Sbjct: 216 ACKSSDLWALGCIIYQLVAGLPPF--RAGNEYLIF 248

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 94/212 (44%), Gaps = 14/212 (6%)
Query: 519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKL---DRVFQDGEREFKNEVFVIGQT 575
           A    ++++GRG F  VY+           VA+KK+   D +      +   E+ ++ Q 
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAA--CLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL 89
Query: 576 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAF--QIARGL 631
           +H N+++      E     +V E  + G L+  +  F   K     RT   +  Q+   L
Sbjct: 90  NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSAL 149
Query: 632 LYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVA 691
            ++H     +++H DIKP N+ +      ++ D GL +  +     T   ++ GT  Y++
Sbjct: 150 EHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS--SKTTAAHSLVGTPYYMS 204
Query: 692 PEWFRNSKITAKVDVYSFGVLLLEIISCRKSF 723
           PE    +    K D++S G LL E+ + +  F
Sbjct: 205 PERIHENGYNFKSDIWSLGCLLYEMAALQSPF 236

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 91/214 (42%), Gaps = 6/214 (2%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREF-KNEVFVIGQTHHKNL 580
            F + +G GSF  V        +   A+ + +   + ++ +  +   E  V+ +  H   
Sbjct: 33  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           V+L     + +       +  NG L  ++      +         +I   L YLH     
Sbjct: 93  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG-- 150
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            IIH D+KP+NILL++    +I+DFG AK+L+    +    A  GT  YV+PE       
Sbjct: 151 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEKSA 209
Query: 701 TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL 734
               D+++ G ++ ++++    F    G EY I 
Sbjct: 210 CKSSDLWALGCIIYQLVAGLPPF--RAGNEYLIF 241

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 88/204 (43%), Gaps = 14/204 (6%)
Query: 524 KEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           KE +G GS+    + V   + +    AVK +D+  +D   E +    ++    H N++ L
Sbjct: 32  KETIGVGSYSECKRCV--HKATNMEYAVKVIDKSKRDPSEEIE---ILLRYGQHPNIITL 86
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
               D+G++  LV E +  G L   +      +    + +   I + + YLH      ++
Sbjct: 87  KDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQG---VV 143
Query: 644 HCDIKPQNILLDDYY----TARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSK 699
           H D+KP NIL  D        RI DFG AK L       +      T  +VAPE  +   
Sbjct: 144 HRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY--TANFVAPEVLKRQG 201
Query: 700 ITAKVDVYSFGVLLLEIISCRKSF 723
                D++S G+LL  +++    F
Sbjct: 202 YDEGCDIWSLGILLYTMLAGYTPF 225

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 98/219 (44%), Gaps = 35/219 (15%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGF 586
           +G+G+FG V K   +    +   A+KK+ R  ++      +EV ++   +H+ +VR    
Sbjct: 14  LGQGAFGQVVKA--RNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVVRYYAA 70
Query: 587 CDEGQN-------------RLLVYEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLL 632
             E +N               +  E+  N TL   +   NL    +    +  QI   L 
Sbjct: 71  WLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEALS 130
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAK-------LLTLN------QSKTI 679
           Y+H      IIH D+KP NI +D+    +I DFGLAK       +L L+       S  +
Sbjct: 131 YIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 680 KTAIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEII 717
            +AI GT  YVA E    +     K+D+YS G++  E+I
Sbjct: 188 TSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 92/214 (42%), Gaps = 6/214 (2%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREF-KNEVFVIGQTHHKNL 580
            F + +G GSF  V        +   A+ + +   + ++ +  +   E  V+ +  H   
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 94
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           V+L     + +       +  NG L  ++      +         +I   L YLH     
Sbjct: 95  VKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG-- 152
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            IIH D+KP+NILL++    +I+DFG AK+L+    +    +  GT  YV+PE       
Sbjct: 153 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 211
Query: 701 TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL 734
           +   D+++ G ++ ++++    F    G EY I 
Sbjct: 212 SKSSDLWALGCIIYQLVAGLPPF--RAGNEYLIF 243

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 99/203 (48%), Gaps = 25/203 (12%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKN-EVFVIGQTHHKNLVRL-L 584
           +G GSFG+VY+   +   S   VA+KK   V Q   + FKN E+ ++ +  H N+VRL  
Sbjct: 28  IGNGSFGVVYQA--KLCDSGELVAIKK---VLQG--KAFKNRELQIMRKLDHCNIVRLRY 80
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA--------FQIARGLLYLHE 636
            F   G+ +  VY  L    + + ++   +     +  +         +Q+ R L Y+H 
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 637 DCRAQIIHCDIKPQNILLD-DYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW- 694
                I H DIKPQN+LLD D    ++ DFG AK L   +          ++ Y APE  
Sbjct: 141 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC---SRYYRAPELI 194
Query: 695 FRNSKITAKVDVYSFGVLLLEII 717
           F  +  T+ +DV+S G +L E++
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELL 217

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 83/300 (27%), Positives = 128/300 (42%), Gaps = 63/300 (21%)
Query: 527 VGRGSFG-IVYKGVIQTRTSTTAVAVKKLDRVFQD-GEREFKNEVFVIGQTHHKNLVRLL 584
           +G GS G +V++G  Q R     VAVK++   F D    E K    +     H N++R  
Sbjct: 23  LGYGSSGTVVFQGSFQGR----PVAVKRMLIDFCDIALMEIK---LLTESDDHPNVIRY- 74
Query: 585 GFCDEGQNRLLVYEF-LNNGTLASFLFGNLKPNWNLRTNIAF-------QIARGLLYLHE 636
            +C E  +R L     L N  L   +      + NL+    +       QIA G+ +LH 
Sbjct: 75  -YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 133
Query: 637 DCRAQIIHCDIKPQNILL--DDYYTAR-----------ISDFGLAKLLTLNQS--KTIKT 681
               +IIH D+KPQNIL+     +TA            ISDFGL K L   Q   +    
Sbjct: 134 ---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLN 190
Query: 682 AIRGTKGYVAPEWFRNS-------KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL 734
              GT G+ APE    S       ++T  +D++S G +   I+S  K      G++Y+  
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH---PFGDKYS-- 245
Query: 735 TDWAFDCYRNGKLNVLVG----EDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
                      + N++ G    ++ + ++D   + +   +    I  DP  RPT  KVL+
Sbjct: 246 ----------RESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 96/214 (44%), Gaps = 21/214 (9%)
Query: 511 FSYKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLD-RVFQDGEREFKNEV 569
           + Y+E E      +  VGRGSFG V++  ++ + +    AVKK+   VF+        E+
Sbjct: 51  YEYRE-EVHWMTHQPRVGRGSFGEVHR--MKDKQTGFQCAVKKVRLEVFR------VEEL 101
Query: 570 FVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQI 627
                     +V L G   EG    +  E L  G+L   +   G L  +  L      Q 
Sbjct: 102 VACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRAL--YYLGQA 159
Query: 628 ARGLLYLHEDCRAQIIHCDIKPQNILLD-DYYTARISDFGLAKLLT---LNQSKTIKTAI 683
             GL YLH     +I+H D+K  N+LL  D   A + DFG A  L    L +S      I
Sbjct: 160 LEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYI 216
Query: 684 RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEII 717
            GT+ ++APE        AKVD++S   ++L ++
Sbjct: 217 PGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHML 250

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 26/213 (12%)
Query: 514 KELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLD-RVFQDGEREFKNEVFVI 572
           +E+  AT+  +  +GRGSFG V++  ++ + +    AVKK+   VF+        E+   
Sbjct: 71  EEVHWATHQLR--LGRGSFGEVHR--MEDKQTGFQCAVKKVRLEVFR------AEELMAC 120
Query: 573 GQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF----QIA 628
                  +V L G   EG    +  E L  G+L   +    K    L  + A     Q  
Sbjct: 121 AGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLV----KEQGCLPEDRALYYLGQAL 176
Query: 629 RGLLYLHEDCRAQIIHCDIKPQNILLD-DYYTARISDFGLAKLLT---LNQSKTIKTAIR 684
            GL YLH     +I+H D+K  N+LL  D   A + DFG A  L    L +       I 
Sbjct: 177 EGLEYLHSR---RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIP 233
Query: 685 GTKGYVAPEWFRNSKITAKVDVYSFGVLLLEII 717
           GT+ ++APE        AKVDV+S   ++L ++
Sbjct: 234 GTETHMAPEVVLGRSCDAKVDVWSSCCMMLHML 266

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 91/197 (46%), Gaps = 13/197 (6%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLD----RVFQDG-EREFKNEVFVIGQTHHKNLV 581
           +G G F  VYK   + + +   VA+KK+        +DG  R    E+ ++ +  H N++
Sbjct: 18  LGEGQFATVYKA--RDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ 641
            LL       N  LV++F+           +L    +          +GL YLH+     
Sbjct: 76  GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--- 132
Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI- 700
           I+H D+KP N+LLD+    +++DFGLAK             +  T+ Y APE    +++ 
Sbjct: 133 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV--TRWYRAPELLFGARMY 190
Query: 701 TAKVDVYSFGVLLLEII 717
              VD+++ G +L E++
Sbjct: 191 GVGVDMWAVGCILAELL 207

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 88/204 (43%), Gaps = 14/204 (6%)
Query: 524 KEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           KE +G GS+    + V   + +    AVK +D+  +D   E +    ++    H N++ L
Sbjct: 32  KETIGVGSYSECKRCV--HKATNMEYAVKVIDKSKRDPSEEIE---ILLRYGQHPNIITL 86
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
               D+G++  LV E +  G L   +      +    + +   I + + YLH      ++
Sbjct: 87  KDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQG---VV 143
Query: 644 HCDIKPQNILLDDYY----TARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSK 699
           H D+KP NIL  D        RI DFG AK L       +      T  +VAPE  +   
Sbjct: 144 HRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY--TANFVAPEVLKRQG 201
Query: 700 ITAKVDVYSFGVLLLEIISCRKSF 723
                D++S G+LL  +++    F
Sbjct: 202 YDEGCDIWSLGILLYTMLAGYTPF 225

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 96/214 (44%), Gaps = 21/214 (9%)
Query: 511 FSYKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLD-RVFQDGEREFKNEV 569
           + Y+E E      +  VGRGSFG V++  ++ + +    AVKK+   VF+        E+
Sbjct: 67  YEYRE-EVHWMTHQPRVGRGSFGEVHR--MKDKQTGFQCAVKKVRLEVFR------VEEL 117
Query: 570 FVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQI 627
                     +V L G   EG    +  E L  G+L   +   G L  +  L      Q 
Sbjct: 118 VACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRAL--YYLGQA 175
Query: 628 ARGLLYLHEDCRAQIIHCDIKPQNILLD-DYYTARISDFGLAKLLT---LNQSKTIKTAI 683
             GL YLH     +I+H D+K  N+LL  D   A + DFG A  L    L +S      I
Sbjct: 176 LEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYI 232
Query: 684 RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEII 717
            GT+ ++APE        AKVD++S   ++L ++
Sbjct: 233 PGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHML 266

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 96/205 (46%), Gaps = 22/205 (10%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLD-RVFQDGEREFKNEVFVIGQTHHKNLVRLLG 585
           +G GSF I  K V   + S  A AVK +  R+  + ++E        G   H N+V+L  
Sbjct: 19  LGEGSFSICRKCV--HKKSNQAFAVKIISKRMEANTQKEITALKLCEG---HPNIVKLHE 73
Query: 586 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLL----YLHEDCRAQ 641
              +  +  LV E LN G L    F  +K   +     A  I R L+    ++H+     
Sbjct: 74  VFHDQLHTFLVMELLNGGEL----FERIKKKKHFSETEASYIMRKLVSAVSHMHD---VG 126
Query: 642 IIHCDIKPQNILL---DDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNS 698
           ++H D+KP+N+L    +D    +I DFG A+L   + ++ +KT    T  Y APE    +
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD-NQPLKTPC-FTLHYAAPELLNQN 184
Query: 699 KITAKVDVYSFGVLLLEIISCRKSF 723
                 D++S GV+L  ++S +  F
Sbjct: 185 GYDESCDLWSLGVILYTMLSGQVPF 209

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 91/214 (42%), Gaps = 6/214 (2%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREF-KNEVFVIGQTHHKNL 580
            F + +G GSF  V        +   A+ + +   + ++ +  +   E  V+ +  H   
Sbjct: 36  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 95
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           V+L     + +       +  NG L  ++      +         +I   L YLH     
Sbjct: 96  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG-- 153
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            IIH D+KP+NILL++    +I+DFG AK+L+    +    +  GT  YV+PE       
Sbjct: 154 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 212
Query: 701 TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL 734
               D+++ G ++ ++++    F    G EY I 
Sbjct: 213 CKSSDLWALGCIIYQLVAGLPPF--RAGNEYLIF 244

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 99/203 (48%), Gaps = 25/203 (12%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKN-EVFVIGQTHHKNLVRL-L 584
           +G GSFG+VY+   +   S   VA+KK   V Q   + FKN E+ ++ +  H N+VRL  
Sbjct: 28  IGNGSFGVVYQA--KLCDSGELVAIKK---VLQG--KAFKNRELQIMRKLDHCNIVRLRY 80
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA--------FQIARGLLYLHE 636
            F   G+ +  VY  L    +   ++   +     +  +         +Q+ R L Y+H 
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 637 DCRAQIIHCDIKPQNILLD-DYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW- 694
                I H DIKPQN+LLD D    ++ DFG AK L   +      +   ++ Y APE  
Sbjct: 141 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRYYRAPELI 194
Query: 695 FRNSKITAKVDVYSFGVLLLEII 717
           F  +  T+ +DV+S G +L E++
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELL 217

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 71/287 (24%), Positives = 125/287 (43%), Gaps = 37/287 (12%)
Query: 527 VGRGSFGIVYKGVI-QTRTSTTAVAVK--KLDRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G+G FG V +  + Q   S   VAVK  K D +      EF  E   + +  H ++ +L
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 584 LGFCDEGQNR------LLVYEFLNNGTLASFLF----GNLKPNWNLRTNIAFQ--IARGL 631
           +G     + +      +++  F+ +G L +FL     G    N  L+T + F   IA G+
Sbjct: 91  VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 632 LYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVA 691
            YL        IH D+  +N +L +  T  ++DFGL++ +          A +    ++A
Sbjct: 151 EYLSS---RNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLA 207
Query: 692 PEWFRNSKITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDCYRNGKLNV 749
            E   ++  T   DV++FGV + EI++  ++    IE  E Y                N 
Sbjct: 208 LESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY----------------NY 251
Query: 750 LVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 796
           L+G ++      EC+ ++  +   C   DP  RP+   +   LE ++
Sbjct: 252 LIGGNR-LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENIL 297

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 99/203 (48%), Gaps = 25/203 (12%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKN-EVFVIGQTHHKNLVRL-L 584
           +G GSFG+VY+   +   S   VA+KK   V Q   + FKN E+ ++ +  H N+VRL  
Sbjct: 28  IGNGSFGVVYQA--KLCDSGELVAIKK---VLQG--KAFKNRELQIMRKLDHCNIVRLRY 80
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA--------FQIARGLLYLHE 636
            F   G+ +  VY  L    +   ++   +     +  +         +Q+ R L Y+H 
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 637 DCRAQIIHCDIKPQNILLD-DYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW- 694
                I H DIKPQN+LLD D    ++ DFG AK L   +      +   ++ Y APE  
Sbjct: 141 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRYYRAPELI 194
Query: 695 FRNSKITAKVDVYSFGVLLLEII 717
           F  +  T+ +DV+S G +L E++
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELL 217

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 90/214 (42%), Gaps = 6/214 (2%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREF-KNEVFVIGQTHHKNL 580
            F + +G GSF  V        +   A+ + +   + ++ +  +   E  V+ +  H   
Sbjct: 38  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 97
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           V+L     + +       +  NG L  ++      +         +I   L YLH     
Sbjct: 98  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG-- 155
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            IIH D+KP+NILL++    +I+DFG AK+L+    +       GT  YV+PE       
Sbjct: 156 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 214
Query: 701 TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL 734
               D+++ G ++ ++++    F    G EY I 
Sbjct: 215 CKSSDLWALGCIIYQLVAGLPPF--RAGNEYLIF 246

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 96/214 (44%), Gaps = 21/214 (9%)
Query: 511 FSYKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLD-RVFQDGEREFKNEV 569
           + Y+E E      +  +GRGSFG V++  ++ + +    AVKK+   VF+        E+
Sbjct: 65  YEYRE-EVHWMTHQPRLGRGSFGEVHR--MKDKQTGFQCAVKKVRLEVFR------VEEL 115
Query: 570 FVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQI 627
                     +V L G   EG    +  E L  G+L   +   G L  +  L      Q 
Sbjct: 116 VACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRAL--YYLGQA 173
Query: 628 ARGLLYLHEDCRAQIIHCDIKPQNILLD-DYYTARISDFGLAKLLT---LNQSKTIKTAI 683
             GL YLH     +I+H D+K  N+LL  D   A + DFG A  L    L +S      I
Sbjct: 174 LEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYI 230
Query: 684 RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEII 717
            GT+ ++APE        AKVD++S   ++L ++
Sbjct: 231 PGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHML 264

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/241 (23%), Positives = 108/241 (44%), Gaps = 10/241 (4%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLL 584
           EE+G+G+F +V + +        A  +    ++     ++ + E  +     H N+VRL 
Sbjct: 10  EELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 69
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIH 644
               E     LV++ +  G L   +      +    ++   QI   + + H +    I+H
Sbjct: 70  DSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLN---GIVH 126
Query: 645 CDIKPQNILLDDY---YTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKIT 701
            D+KP+N+LL         +++DFGLA  +  +Q      A  GT GY++PE  R     
Sbjct: 127 RDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFA--GTPGYLSPEVLRKDPYG 184
Query: 702 AKVDVYSFGVLLLEIISCRKSF-DIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMND 760
             VD+++ GV+L  ++     F D +    Y  +   A+D + + + + +  E K+ +N 
Sbjct: 185 KPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYD-FPSPEWDTVTPEAKDLINK 243
Query: 761 I 761
           +
Sbjct: 244 M 244

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 90/214 (42%), Gaps = 6/214 (2%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREF-KNEVFVIGQTHHKNL 580
            F + +G GSF  V        +   A+ + +   + ++ +  +   E  V+ +  H   
Sbjct: 36  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 95
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           V+L     + +       +  NG L  ++      +         +I   L YLH     
Sbjct: 96  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG-- 153
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            IIH D+KP+NILL++    +I+DFG AK+L+    +       GT  YV+PE       
Sbjct: 154 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 212
Query: 701 TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL 734
               D+++ G ++ ++++    F    G EY I 
Sbjct: 213 CKSSDLWALGCIIYQLVAGLPPF--RAGNEYLIF 244

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 90/214 (42%), Gaps = 6/214 (2%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREF-KNEVFVIGQTHHKNL 580
            F + +G GSF  V        +   A+ + +   + ++ +  +   E  V+ +  H   
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 94
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           V+L     + +       +  NG L  ++      +         +I   L YLH     
Sbjct: 95  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG-- 152
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            IIH D+KP+NILL++    +I+DFG AK+L+    +       GT  YV+PE       
Sbjct: 153 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 211
Query: 701 TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL 734
               D+++ G ++ ++++    F    G EY I 
Sbjct: 212 CKSSDLWALGCIIYQLVAGLPPF--RAGNEYLIF 243

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/241 (23%), Positives = 108/241 (44%), Gaps = 10/241 (4%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLL 584
           EE+G+G+F +V + +        A  +    ++     ++ + E  +     H N+VRL 
Sbjct: 10  EELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 69
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIH 644
               E     LV++ +  G L   +      +    ++   QI   + + H +    I+H
Sbjct: 70  DSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLN---GIVH 126
Query: 645 CDIKPQNILLDDY---YTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKIT 701
            D+KP+N+LL         +++DFGLA  +  +Q      A  GT GY++PE  R     
Sbjct: 127 RDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFA--GTPGYLSPEVLRKDPYG 184
Query: 702 AKVDVYSFGVLLLEIISCRKSF-DIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMND 760
             VD+++ GV+L  ++     F D +    Y  +   A+D + + + + +  E K+ +N 
Sbjct: 185 KPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYD-FPSPEWDTVTPEAKDLINK 243
Query: 761 I 761
           +
Sbjct: 244 M 244

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 90/214 (42%), Gaps = 6/214 (2%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREF-KNEVFVIGQTHHKNL 580
            F + +G GSF  V        +   A+ + +   + ++ +  +   E  V+ +  H   
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 94
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           V+L     + +       +  NG L  ++      +         +I   L YLH     
Sbjct: 95  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG-- 152
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            IIH D+KP+NILL++    +I+DFG AK+L+    +       GT  YV+PE       
Sbjct: 153 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 211
Query: 701 TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL 734
               D+++ G ++ ++++    F    G EY I 
Sbjct: 212 CKSSDLWALGCIIYQLVAGLPPF--RAGNEYLIF 243

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 90/214 (42%), Gaps = 6/214 (2%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREF-KNEVFVIGQTHHKNL 580
            F + +G GSF  V        +   A+ + +   + ++ +  +   E  V+ +  H   
Sbjct: 33  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           V+L     + +       +  NG L  ++      +         +I   L YLH     
Sbjct: 93  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG-- 150
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            IIH D+KP+NILL++    +I+DFG AK+L+    +       GT  YV+PE       
Sbjct: 151 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 209
Query: 701 TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL 734
               D+++ G ++ ++++    F    G EY I 
Sbjct: 210 CKSSDLWALGCIIYQLVAGLPPF--RAGNEYLIF 241

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 91/214 (42%), Gaps = 6/214 (2%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREF-KNEVFVIGQTHHKNL 580
            F + +G GSF  V        +   A+ + +   + ++ +  +   E  V+ +  H   
Sbjct: 32  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 91
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           V+L     + +       +  NG L  ++      +         +I   L YLH     
Sbjct: 92  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG-- 149
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            IIH D+KP+NILL++    +I+DFG AK+L+    +    +  GT  YV+PE       
Sbjct: 150 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 208
Query: 701 TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL 734
               D+++ G ++ ++++    F    G EY I 
Sbjct: 209 CKSSDLWALGCIIYQLVAGLPPF--RAGNEYLIF 240

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 90/214 (42%), Gaps = 6/214 (2%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREF-KNEVFVIGQTHHKNL 580
            F + +G GSF  V        +   A+ + +   + ++ +  +   E  V+ +  H   
Sbjct: 33  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           V+L     + +       +  NG L  ++      +         +I   L YLH     
Sbjct: 93  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG-- 150
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            IIH D+KP+NILL++    +I+DFG AK+L+    +       GT  YV+PE       
Sbjct: 151 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 209
Query: 701 TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL 734
               D+++ G ++ ++++    F    G EY I 
Sbjct: 210 CKSSDLWALGCIIYQLVAGLPPF--RAGNEYLIF 241

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 90/214 (42%), Gaps = 6/214 (2%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREF-KNEVFVIGQTHHKNL 580
            F + +G GSF  V        +   A+ + +   + ++ +  +   E  V+ +  H   
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 94
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           V+L     + +       +  NG L  ++      +         +I   L YLH     
Sbjct: 95  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG-- 152
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            IIH D+KP+NILL++    +I+DFG AK+L+    +       GT  YV+PE       
Sbjct: 153 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 211
Query: 701 TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL 734
               D+++ G ++ ++++    F    G EY I 
Sbjct: 212 CKSSDLWALGCIIYQLVAGLPPF--RAGNEYLIF 243

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 90/214 (42%), Gaps = 6/214 (2%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREF-KNEVFVIGQTHHKNL 580
            F + +G GSF  V        +   A+ + +   + ++ +  +   E  V+ +  H   
Sbjct: 13  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 72
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           V+L     + +       +  NG L  ++      +         +I   L YLH     
Sbjct: 73  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG-- 130
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            IIH D+KP+NILL++    +I+DFG AK+L+    +       GT  YV+PE       
Sbjct: 131 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 189
Query: 701 TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL 734
               D+++ G ++ ++++    F    G EY I 
Sbjct: 190 CKSSDLWALGCIIYQLVAGLPPF--RAGNEYLIF 221

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 90/214 (42%), Gaps = 6/214 (2%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREF-KNEVFVIGQTHHKNL 580
            F + +G GSF  V        +   A+ + +   + ++ +  +   E  V+ +  H   
Sbjct: 12  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 71
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           V+L     + +       +  NG L  ++      +         +I   L YLH     
Sbjct: 72  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG-- 129
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            IIH D+KP+NILL++    +I+DFG AK+L+    +       GT  YV+PE       
Sbjct: 130 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 188
Query: 701 TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL 734
               D+++ G ++ ++++    F    G EY I 
Sbjct: 189 CKSSDLWALGCIIYQLVAGLPPF--RAGNEYLIF 220

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 81/162 (50%), Gaps = 20/162 (12%)
Query: 564 EFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASF--LFGNLKPNWNLRT 621
           +FKNE+ +I    ++  +   G         ++YE++ N ++  F   F  L  N+    
Sbjct: 89  DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF- 147
Query: 622 NIAFQIARGLL--------YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTL 673
            I  Q+ + ++        Y+H +    I H D+KP NIL+D     ++SDFG ++ +  
Sbjct: 148 -IPIQVIKCIIKSVLNSFSYIHNE--KNICHRDVKPSNILMDKNGRVKLSDFGESEYMV- 203
Query: 674 NQSKTIKTAIRGTKGYVAPEWFRN--SKITAKVDVYSFGVLL 713
              K IK + RGT  ++ PE+F N  S   AKVD++S G+ L
Sbjct: 204 --DKKIKGS-RGTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 90/214 (42%), Gaps = 6/214 (2%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREF-KNEVFVIGQTHHKNL 580
            F + +G GSF  V        +   A+ + +   + ++ +  +   E  V+ +  H   
Sbjct: 10  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 69
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           V+L     + +       +  NG L  ++      +         +I   L YLH     
Sbjct: 70  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG-- 127
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            IIH D+KP+NILL++    +I+DFG AK+L+    +       GT  YV+PE       
Sbjct: 128 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 186
Query: 701 TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL 734
               D+++ G ++ ++++    F    G EY I 
Sbjct: 187 CKSSDLWALGCIIYQLVAGLPPF--RAGNEYLIF 218

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 90/214 (42%), Gaps = 6/214 (2%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREF-KNEVFVIGQTHHKNL 580
            F + +G GSF  V        +   A+ + +   + ++ +  +   E  V+ +  H   
Sbjct: 11  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 70
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           V+L     + +       +  NG L  ++      +         +I   L YLH     
Sbjct: 71  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG-- 128
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            IIH D+KP+NILL++    +I+DFG AK+L+    +       GT  YV+PE       
Sbjct: 129 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 187
Query: 701 TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL 734
               D+++ G ++ ++++    F    G EY I 
Sbjct: 188 CKSSDLWALGCIIYQLVAGLPPF--RAGNEYLIF 219

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 104/219 (47%), Gaps = 31/219 (14%)
Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVF----VIGQTHH-KNL 580
           E+G G+ G V+K  ++ R +   +AVK++ R    G +E    +     V+ ++H    +
Sbjct: 32  EMGSGTCGQVWK--MRFRKTGHVIAVKQMRR---SGNKEENKRILMDLDVVLKSHDCPYI 86
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHEDC 638
           V+  G      +  +  E +  GT A  L   ++     R    +   I + L YL E  
Sbjct: 87  VQCFGTFITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE-- 142
Query: 639 RAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNS 698
           +  +IH D+KP NILLD+    ++ DFG++  L  +++K  ++A  G   Y+APE     
Sbjct: 143 KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKD-RSA--GCAAYMAPERIDPP 199
Query: 699 KITA-----KVDVYSFGVLLLEIIS-------CRKSFDI 725
             T      + DV+S G+ L+E+ +       C+  F++
Sbjct: 200 DPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV 238

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 90/214 (42%), Gaps = 6/214 (2%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREF-KNEVFVIGQTHHKNL 580
            F + +G GSF  V        +   A+ + +   + ++ +  +   E  V+ +  H   
Sbjct: 32  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 91
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           V+L     + +       +  NG L  ++      +         +I   L YLH     
Sbjct: 92  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG-- 149
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            IIH D+KP+NILL++    +I+DFG AK+L+    +       GT  YV+PE       
Sbjct: 150 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 208
Query: 701 TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL 734
               D+++ G ++ ++++    F    G EY I 
Sbjct: 209 CKSSDLWALGCIIYQLVAGLPPF--RAGNEYLIF 240

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 90/214 (42%), Gaps = 6/214 (2%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREF-KNEVFVIGQTHHKNL 580
            F + +G GSF  V        +   A+ + +   + ++ +  +   E  V+ +  H   
Sbjct: 17  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 76
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           V+L     + +       +  NG L  ++      +         +I   L YLH     
Sbjct: 77  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG-- 134
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            IIH D+KP+NILL++    +I+DFG AK+L+    +       GT  YV+PE       
Sbjct: 135 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 193
Query: 701 TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL 734
               D+++ G ++ ++++    F    G EY I 
Sbjct: 194 CKSSDLWALGCIIYQLVAGLPPF--RAGNEYLIF 225

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 53/95 (55%), Gaps = 3/95 (3%)
Query: 624 AFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAI 683
           +FQ+ARG+ +L      + IH D+  +NILL +    +I DFGLA+ +  N     K   
Sbjct: 205 SFQVARGMEFLSS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDT 261
Query: 684 RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS 718
           R    ++APE   +   + K DV+S+GVLL EI S
Sbjct: 262 RLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/198 (23%), Positives = 89/198 (44%), Gaps = 12/198 (6%)
Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLG 585
           ++G G++G VYK +      T A+   +L+   +        EV ++ +  H+N++ L  
Sbjct: 41  KLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKS 100
Query: 586 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHC 645
                    L++E+  N  L  ++  N   +  +  +  +Q+  G+ + H     + +H 
Sbjct: 101 VIHHNHRLHLIFEYAEND-LKKYMDKNPDVSMRVIKSFLYQLINGVNFCHS---RRCLHR 156
Query: 646 DIKPQNILL-----DDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSK- 699
           D+KPQN+LL      +    +I DFGLA+   +   +     I  T  Y  PE    S+ 
Sbjct: 157 DLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII--TLWYRPPEILLGSRH 214
Query: 700 ITAKVDVYSFGVLLLEII 717
            +  VD++S   +  E++
Sbjct: 215 YSTSVDIWSIACIWAEML 232

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 55/109 (50%), Gaps = 5/109 (4%)
Query: 626 QIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRG 685
           +I   L YLH      IIH D+KP+NILL++    +I+DFG AK+L+    +       G
Sbjct: 138 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 194
Query: 686 TKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL 734
           T  YV+PE           D+++ G ++ ++++    F    G EY I 
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF--RAGNEYLIF 241

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 102/204 (50%), Gaps = 23/204 (11%)
Query: 528 GRGSFGIVYKGVIQTRTSTTAVAVKKL--DRVFQDGEREFKNEVFVIGQTHHKNLVRL-- 583
           G+G+FG V  G  + +++  +VA+KK+  D  F++ E +   ++ V+   HH N+V+L  
Sbjct: 32  GQGTFGTVQLG--KEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVL---HHPNIVQLQS 86
Query: 584 ----LGFCDEGQNRL-LVYEFLNNG---TLASFLFGNLKPNWNLRTNIAFQIARGLLYLH 635
               LG  D     L +V E++ +       ++    + P   L     FQ+ R +  LH
Sbjct: 87  YFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLH 146
Query: 636 EDCRAQIIHCDIKPQNILLDDYY-TARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 694
                 + H DIKP N+L+++   T ++ DFG AK L+ ++      A   ++ Y APE 
Sbjct: 147 LPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP---NVAYICSRYYRAPEL 202
Query: 695 -FRNSKITAKVDVYSFGVLLLEII 717
            F N   T  VD++S G +  E++
Sbjct: 203 IFGNQHYTTAVDIWSVGCIFAEMM 226

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 97/202 (48%), Gaps = 23/202 (11%)
Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLG 585
           E+G G+FG VYK   + + +    A K ++   ++   ++  E+ ++    H  +V+LLG
Sbjct: 26  ELGDGAFGKVYKA--KNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLG 83
Query: 586 FCDEGQNRLLVYEFLNNGTLASFLF----GNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ 641
                    ++ EF   G + + +     G  +P   +   +  Q+   L +LH     +
Sbjct: 84  AYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV---VCRQMLEALNFLHS---KR 137
Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAK--LLTLNQSKTIKTAIRGTKGYVAP-----EW 694
           IIH D+K  N+L+      R++DFG++   L TL +    + +  GT  ++AP     E 
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK----RDSFIGTPYWMAPEVVMCET 193
Query: 695 FRNSKITAKVDVYSFGVLLLEI 716
            +++    K D++S G+ L+E+
Sbjct: 194 MKDTPYDYKADIWSLGITLIEM 215

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 92/211 (43%), Gaps = 29/211 (13%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV-FQDGE----REFKNEVFVIGQTHHKN 579
           E +G+G F +V + +   R +    AVK +D   F         + K E  +     H +
Sbjct: 32  EVIGKGPFSVVRRCI--NRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 89
Query: 580 LVRLLGFCDEGQNRLLVYEFLNNGTL---------ASFLFGNLKPNWNLRTNIAFQIARG 630
           +V LL          +V+EF++   L         A F++     +  +R     QI   
Sbjct: 90  IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR-----QILEA 144
Query: 631 LLYLHEDCRAQIIHCDIKPQNILL---DDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK 687
           L Y H++    IIH D+KP  +LL   ++    ++  FG+A  + L +S  +     GT 
Sbjct: 145 LRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVA--IQLGESGLVAGGRVGTP 199
Query: 688 GYVAPEWFRNSKITAKVDVYSFGVLLLEIIS 718
            ++APE  +       VDV+  GV+L  ++S
Sbjct: 200 HFMAPEVVKREPYGKPVDVWGCGVILFILLS 230

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 97/202 (48%), Gaps = 23/202 (11%)
Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLG 585
           E+G G+FG VYK   + + +    A K ++   ++   ++  E+ ++    H  +V+LLG
Sbjct: 18  ELGDGAFGKVYKA--KNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLG 75
Query: 586 FCDEGQNRLLVYEFLNNGTLASFLF----GNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ 641
                    ++ EF   G + + +     G  +P   +   +  Q+   L +LH     +
Sbjct: 76  AYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV---VCRQMLEALNFLH---SKR 129
Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAK--LLTLNQSKTIKTAIRGTKGYVAP-----EW 694
           IIH D+K  N+L+      R++DFG++   L TL +    + +  GT  ++AP     E 
Sbjct: 130 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK----RDSFIGTPYWMAPEVVMCET 185
Query: 695 FRNSKITAKVDVYSFGVLLLEI 716
            +++    K D++S G+ L+E+
Sbjct: 186 MKDTPYDYKADIWSLGITLIEM 207

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 46/203 (22%), Positives = 86/203 (42%), Gaps = 4/203 (1%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREF-KNEVFVIGQTHHKNL 580
            F + +G GSF  V        +   A+ + +   + ++ +  +   E  V+ +  H   
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 94
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           V+L     + +       +  NG L  ++      +         +I   L YLH     
Sbjct: 95  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG-- 152
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            IIH D+KP+NILL++    +I+DFG AK+L+    +       GT  YV+PE       
Sbjct: 153 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 211
Query: 701 TAKVDVYSFGVLLLEIISCRKSF 723
               D+++ G ++ ++++    F
Sbjct: 212 XKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 92/211 (43%), Gaps = 29/211 (13%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV-FQDGE----REFKNEVFVIGQTHHKN 579
           E +G+G F +V + +   R +    AVK +D   F         + K E  +     H +
Sbjct: 30  EVIGKGPFSVVRRCI--NRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87
Query: 580 LVRLLGFCDEGQNRLLVYEFLNNGTL---------ASFLFGNLKPNWNLRTNIAFQIARG 630
           +V LL          +V+EF++   L         A F++     +  +R     QI   
Sbjct: 88  IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR-----QILEA 142
Query: 631 LLYLHEDCRAQIIHCDIKPQNILL---DDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK 687
           L Y H++    IIH D+KP  +LL   ++    ++  FG+A  + L +S  +     GT 
Sbjct: 143 LRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVA--IQLGESGLVAGGRVGTP 197
Query: 688 GYVAPEWFRNSKITAKVDVYSFGVLLLEIIS 718
            ++APE  +       VDV+  GV+L  ++S
Sbjct: 198 HFMAPEVVKREPYGKPVDVWGCGVILFILLS 228

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 46/203 (22%), Positives = 86/203 (42%), Gaps = 4/203 (1%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREF-KNEVFVIGQTHHKNL 580
            F + +G GSF  V        +   A+ + +   + ++ +  +   E  V+ +  H   
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 94
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           V+L     + +       +  NG L  ++      +         +I   L YLH     
Sbjct: 95  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG-- 152
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            IIH D+KP+NILL++    +I+DFG AK+L+    +       GT  YV+PE       
Sbjct: 153 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 211
Query: 701 TAKVDVYSFGVLLLEIISCRKSF 723
               D+++ G ++ ++++    F
Sbjct: 212 CKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 97/242 (40%), Gaps = 54/242 (22%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ----DGEREFKNEVFVIGQTHH 577
           + K  +G+GS+G+V   +     +  A+ +   +++ Q    D ER  K EV ++ + HH
Sbjct: 29  HLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVER-IKTEVRLMKKLHH 87
Query: 578 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK------------------PNWN- 618
            N+ RL    ++ Q   LV E  + G L   L   +                   P  N 
Sbjct: 88  PNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNE 147
Query: 619 ---------------------LRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILL--D 655
                                L +NI  QI   L YLH      I H DIKP+N L   +
Sbjct: 148 EAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTN 204
Query: 656 DYYTARISDFGLAK-LLTLNQSKTI-KTAIRGTKGYVAPEWFR--NSKITAKVDVYSFGV 711
             +  ++ DFGL+K    LN  +    T   GT  +VAPE     N     K D +S GV
Sbjct: 205 KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264
Query: 712 LL 713
           LL
Sbjct: 265 LL 266

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 85/201 (42%), Gaps = 13/201 (6%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE--FKNEVFVIGQTHHKN 579
           +F + +G+GSFG V     +      AV V +   + +  E +        ++    H  
Sbjct: 41  HFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPF 100
Query: 580 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN---LKPNWNLRTNIAFQIARGLLYLHE 636
           LV L            V +++N G L   L      L+P        A +IA  L YLH 
Sbjct: 101 LVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF---YAAEIASALGYLHS 157
Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR 696
                I++ D+KP+NILLD      ++DFGL K    + S T  +   GT  Y+APE   
Sbjct: 158 ---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTT--STFCGTPEYLAPEVLH 212
Query: 697 NSKITAKVDVYSFGVLLLEII 717
                  VD +  G +L E++
Sbjct: 213 KQPYDRTVDWWCLGAVLYEML 233

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 102/240 (42%), Gaps = 43/240 (17%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE-FKNEVFVIGQTHHKNLVRLLG 585
           +GRG FG+V++   + +      A+K++    ++  RE    EV  + +  H  +VR   
Sbjct: 13  LGRGGFGVVFEA--KNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 70
Query: 586 FCDEGQNRLLVYEFLNNGTLASFLF--------GNLKPNWNLRTNIA-----------FQ 626
              E        E L   +   +L+         NLK   N R  I             Q
Sbjct: 71  AWLEKNTT----EKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ 126
Query: 627 IARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN-QSKTIKTAIR- 684
           IA  + +LH      ++H D+KP NI        ++ DFGL   +  + + +T+ T +  
Sbjct: 127 IAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 685 --------GTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD 736
                   GTK Y++PE    +  + KVD++S G++L E++     F  +M E    LTD
Sbjct: 184 YARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM-ERVRTLTD 239

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 84/179 (46%), Gaps = 21/179 (11%)
Query: 624 AFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAI 683
           +FQ+A+G+ +L      + IH D+  +NILL +    +I DFGLA+ +  +     K   
Sbjct: 206 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 262
Query: 684 RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDC 741
           R    ++APE   +   T + DV+SFGVLL EI S   S    +++ EE+         C
Sbjct: 263 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF---------C 313
Query: 742 YRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSV 800
            R  +   +   D           ++    + C   +PS RPT  ++++ L  +++ + 
Sbjct: 314 RRLKEGTRMRAPDYTT-------PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 365

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 84/179 (46%), Gaps = 21/179 (11%)
Query: 624 AFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAI 683
           +FQ+A+G+ +L      + IH D+  +NILL +    +I DFGLA+ +  +     K   
Sbjct: 204 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 260
Query: 684 RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDC 741
           R    ++APE   +   T + DV+SFGVLL EI S   S    +++ EE+         C
Sbjct: 261 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF---------C 311
Query: 742 YRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSV 800
            R  +   +   D           ++    + C   +PS RPT  ++++ L  +++ + 
Sbjct: 312 RRLKEGTRMRAPDYTT-------PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 363

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 84/179 (46%), Gaps = 21/179 (11%)
Query: 624 AFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAI 683
           +FQ+A+G+ +L      + IH D+  +NILL +    +I DFGLA+ +  +     K   
Sbjct: 197 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 253
Query: 684 RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDC 741
           R    ++APE   +   T + DV+SFGVLL EI S   S    +++ EE+         C
Sbjct: 254 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF---------C 304
Query: 742 YRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSV 800
            R  +   +   D           ++    + C   +PS RPT  ++++ L  +++ + 
Sbjct: 305 RRLKEGTRMRAPDYTT-------PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 356

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 83/159 (52%), Gaps = 13/159 (8%)
Query: 566 KNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF 625
           + E+ ++ + +H  ++++  F D  ++  +V E +  G L   + GN +          +
Sbjct: 63  ETEIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 121
Query: 626 QIARGLLYLHEDCRAQIIHCDIKPQNILL---DDYYTARISDFGLAKLLTLNQSKTIKTA 682
           Q+   + YLHE+    IIH D+KP+N+LL   ++    +I+DFG +K+  L ++  ++T 
Sbjct: 122 QMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRT- 175
Query: 683 IRGTKGYVAPEWFRNSKITA---KVDVYSFGVLLLEIIS 718
           + GT  Y+APE   +         VD +S GV+L   +S
Sbjct: 176 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS 214

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 83/159 (52%), Gaps = 13/159 (8%)
Query: 566 KNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF 625
           + E+ ++ + +H  ++++  F D  ++  +V E +  G L   + GN +          +
Sbjct: 63  ETEIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 121
Query: 626 QIARGLLYLHEDCRAQIIHCDIKPQNILL---DDYYTARISDFGLAKLLTLNQSKTIKTA 682
           Q+   + YLHE+    IIH D+KP+N+LL   ++    +I+DFG +K+  L ++  ++T 
Sbjct: 122 QMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRT- 175
Query: 683 IRGTKGYVAPEWFRNSKITA---KVDVYSFGVLLLEIIS 718
           + GT  Y+APE   +         VD +S GV+L   +S
Sbjct: 176 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS 214

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/232 (22%), Positives = 104/232 (44%), Gaps = 45/232 (19%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD--GEREFKNEVFVIGQTHHKNLVRLL 584
           +G GS+G V +     +     VA+KK+ RVF+D    +    E+ ++ + +H ++V++L
Sbjct: 61  IGTGSYGHVCEAY--DKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVL 118
Query: 585 GFC-----DEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCR 639
                   ++     +V E  ++     F         +++T + + +  G+ Y+H    
Sbjct: 119 DIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKT-LLYNLLVGVKYVHS--- 174
Query: 640 AQIIHCDIKPQNILLDDYYTARISDFGLAK----------------------LLTLNQSK 677
           A I+H D+KP N L++   + ++ DFGLA+                      L+T   +K
Sbjct: 175 AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTK 234
Query: 678 TIKTAIRGTKGYVAPEWFRNSKI-------TAKVDVYSFGVLLLEIISCRKS 722
            +K   R   G+V   W+R  ++       T  +DV+S G +  E+++  K 
Sbjct: 235 NLK---RQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 84/179 (46%), Gaps = 21/179 (11%)
Query: 624 AFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAI 683
           +FQ+A+G+ +L      + IH D+  +NILL +    +I DFGLA+ +  +     K   
Sbjct: 199 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 255
Query: 684 RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDC 741
           R    ++APE   +   T + DV+SFGVLL EI S   S    +++ EE+         C
Sbjct: 256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF---------C 306
Query: 742 YRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSV 800
            R  +   +   D           ++    + C   +PS RPT  ++++ L  +++ + 
Sbjct: 307 RRLKEGTRMRAPDYTT-------PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 358

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 103/233 (44%), Gaps = 41/233 (17%)
Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD--GEREFKNEVFVIGQTHHKNL 580
            K  +GRGS+G VY  +   + +   VA+KK++R+F+D    +    E+ ++ +     +
Sbjct: 32  IKHLIGRGSYGYVY--LAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYI 89
Query: 581 VRLLGFCD-----EGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLH 635
           +RL          +     +V E  ++     F         +++T I + +  G  ++H
Sbjct: 90  IRLHDLIIPEDLLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVKT-ILYNLLLGEKFIH 148
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI---------------- 679
           E   + IIH D+KP N LL+   + +I DFGLA+  T+N  K I                
Sbjct: 149 E---SGIIHRDLKPANCLLNQDCSVKICDFGLAR--TINSDKDIHIVNDLEEKEENEEPG 203
Query: 680 ---KTAIRGTKGYVAPEWFRNSKI-------TAKVDVYSFGVLLLEIISCRKS 722
              K   +    +V   W+R  ++       T  +D++S G +  E+++  KS
Sbjct: 204 PHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKS 256

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 83/159 (52%), Gaps = 13/159 (8%)
Query: 566 KNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF 625
           + E+ ++ + +H  ++++  F D  ++  +V E +  G L   + GN +          +
Sbjct: 69  ETEIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 127
Query: 626 QIARGLLYLHEDCRAQIIHCDIKPQNILL---DDYYTARISDFGLAKLLTLNQSKTIKTA 682
           Q+   + YLHE+    IIH D+KP+N+LL   ++    +I+DFG +K+  L ++  ++T 
Sbjct: 128 QMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRT- 181
Query: 683 IRGTKGYVAPEWFRNSKITA---KVDVYSFGVLLLEIIS 718
           + GT  Y+APE   +         VD +S GV+L   +S
Sbjct: 182 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS 220

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 83/159 (52%), Gaps = 13/159 (8%)
Query: 566 KNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF 625
           + E+ ++ + +H  ++++  F D  ++  +V E +  G L   + GN +          +
Sbjct: 62  ETEIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 120
Query: 626 QIARGLLYLHEDCRAQIIHCDIKPQNILL---DDYYTARISDFGLAKLLTLNQSKTIKTA 682
           Q+   + YLHE+    IIH D+KP+N+LL   ++    +I+DFG +K+  L ++  ++T 
Sbjct: 121 QMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRT- 174
Query: 683 IRGTKGYVAPEWFRNSKITA---KVDVYSFGVLLLEIIS 718
           + GT  Y+APE   +         VD +S GV+L   +S
Sbjct: 175 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS 213

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 83/159 (52%), Gaps = 13/159 (8%)
Query: 566 KNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF 625
           + E+ ++ + +H  ++++  F D  ++  +V E +  G L   + GN +          +
Sbjct: 63  ETEIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 121
Query: 626 QIARGLLYLHEDCRAQIIHCDIKPQNILL---DDYYTARISDFGLAKLLTLNQSKTIKTA 682
           Q+   + YLHE+    IIH D+KP+N+LL   ++    +I+DFG +K+  L ++  ++T 
Sbjct: 122 QMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRT- 175
Query: 683 IRGTKGYVAPEWFRNSKITA---KVDVYSFGVLLLEIIS 718
           + GT  Y+APE   +         VD +S GV+L   +S
Sbjct: 176 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS 214

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 84/159 (52%), Gaps = 13/159 (8%)
Query: 566 KNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF 625
           + E+ ++ + +H  ++++  F D  ++  +V E +  G L   + GN +          +
Sbjct: 188 ETEIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 246
Query: 626 QIARGLLYLHEDCRAQIIHCDIKPQNILL---DDYYTARISDFGLAKLLTLNQSKTIKTA 682
           Q+   + YLHE+    IIH D+KP+N+LL   ++    +I+DFG +K+  L ++  ++T 
Sbjct: 247 QMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRT- 300
Query: 683 IRGTKGYVAPEWFRN---SKITAKVDVYSFGVLLLEIIS 718
           + GT  Y+APE   +   +     VD +S GV+L   +S
Sbjct: 301 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS 339

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 96/219 (43%), Gaps = 35/219 (15%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGF 586
           +G+G+FG V K   +    +   A+KK+ R  ++      +EV ++   +H+ +VR    
Sbjct: 14  LGQGAFGQVVKA--RNALDSRYYAIKKI-RHTEEKLSTILSEVXLLASLNHQYVVRYYAA 70
Query: 587 CDEGQN-------------RLLVYEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLL 632
             E +N               +  E+  N TL   +   NL    +    +  QI   L 
Sbjct: 71  WLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEALS 130
Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAK-------LLTLN------QSKTI 679
           Y+H      IIH ++KP NI +D+    +I DFGLAK       +L L+       S  +
Sbjct: 131 YIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 680 KTAIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEII 717
            +AI GT  YVA E    +     K+D YS G++  E I
Sbjct: 188 TSAI-GTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 84/159 (52%), Gaps = 13/159 (8%)
Query: 566 KNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF 625
           + E+ ++ + +H  ++++  F D  ++  +V E +  G L   + GN +          +
Sbjct: 202 ETEIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 260
Query: 626 QIARGLLYLHEDCRAQIIHCDIKPQNILL---DDYYTARISDFGLAKLLTLNQSKTIKTA 682
           Q+   + YLHE+    IIH D+KP+N+LL   ++    +I+DFG +K+  L ++  ++T 
Sbjct: 261 QMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRT- 314
Query: 683 IRGTKGYVAPEWFRN---SKITAKVDVYSFGVLLLEIIS 718
           + GT  Y+APE   +   +     VD +S GV+L   +S
Sbjct: 315 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS 353

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 58/107 (54%), Gaps = 9/107 (8%)
Query: 622 NIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKT 681
            IA  I + L +LH   +  +IH D+KP N+L++     ++ DFG++  L  + +KTI  
Sbjct: 157 KIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDA 214
Query: 682 AIRGTKGYVAPEWFR---NSK-ITAKVDVYSFGVLLLEIISCRKSFD 724
              G K Y+APE      N K  + K D++S G+ ++E+   R  +D
Sbjct: 215 ---GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYD 258

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 97/202 (48%), Gaps = 22/202 (10%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLL 584
           E++GRG FGIV++ V    TS+    + K  +V    +   K E+ ++    H+N++ L 
Sbjct: 11  EDLGRGEFGIVHRCV---ETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLH 67
Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-NWNLRTNIAF--QIARGLLYLHEDCRAQ 641
              +  +  ++++EF++   L  F   N      N R  +++  Q+   L +LH      
Sbjct: 68  ESFESMEELVMIFEFISG--LDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---N 122
Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTA-----IRGTKGYVAPEWFR 696
           I H DI+P+NI+   Y T R S     K++   Q++ +K       +     Y APE  +
Sbjct: 123 IGHFDIRPENII---YQTRRSSTI---KIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQ 176
Query: 697 NSKITAKVDVYSFGVLLLEIIS 718
           +  ++   D++S G L+  ++S
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLS 198

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 92/195 (47%), Gaps = 18/195 (9%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGER---EFKNEVFVIGQTHHKNLV 581
           +++G G+FG+    +++ + +   VAVK ++R    GE+     K E+       H N+V
Sbjct: 25  KDIGAGNFGVAR--LMRDKQANELVAVKYIER----GEKIDENVKREIINHRSLRHPNIV 78
Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ 641
           R         +  +V E+ + G L   +    + + +       Q+  G+ Y H     Q
Sbjct: 79  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAHA---MQ 135
Query: 642 IIHCDIKPQNILLDDYYTAR--ISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSK 699
           + H D+K +N LLD     R  I+DFG +K   L+     K+A+ GT  Y+APE     +
Sbjct: 136 VAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQP--KSAV-GTPAYIAPEVLLKKE 192
Query: 700 ITAKV-DVYSFGVLL 713
              KV DV+S GV L
Sbjct: 193 YDGKVADVWSCGVTL 207

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 105/216 (48%), Gaps = 15/216 (6%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE------FKNEVFVIGQTHHKNL 580
           +G G+FG V+  V + +     V   K ++V +D   E         E+ ++ +  H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 581 VRLLG-FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCR 639
           +++L  F ++G  +L++ +  +   L +F+  + + +  L + I  Q+   + YL     
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLR---L 148
Query: 640 AQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR-NS 698
             IIH DIK +NI++ + +T ++ DFG A    L + K   T   GT  Y APE    N 
Sbjct: 149 KDIIHRDIKDENIVIAEDFTIKLIDFGSAAY--LERGKLFYT-FCGTIEYCAPEVLMGNP 205
Query: 699 KITAKVDVYSFGVLLLEIISCRKSF-DIEMGEEYAI 733
               +++++S GV L  ++     F ++E   E AI
Sbjct: 206 YRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAI 241

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 89/198 (44%), Gaps = 19/198 (9%)
Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKN---EVFVIGQTHHKNLVR 582
           E+G GSFG VY    +   ++  VA+KK+    +    ++++   EV  + +  H N ++
Sbjct: 61  EIGHGSFGAVY--FARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 118
Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR-TNIAFQIARGLLYLHEDCRAQ 641
             G         LV E+   G+ +  L  + KP   +    +     +GL YLH      
Sbjct: 119 YRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---N 174
Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE---WFRNS 698
           +IH D+K  NILL +    ++ DFG A ++             GT  ++APE        
Sbjct: 175 MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVILAMDEG 228
Query: 699 KITAKVDVYSFGVLLLEI 716
           +   KVDV+S G+  +E+
Sbjct: 229 QYDGKVDVWSLGITCIEL 246

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGEREFK-NEVFVIGQTHHKNLVRL 583
           +G GSFG V   +++ + S    A+K LD+  V +  + E   NE  ++   +   LV+L
Sbjct: 70  LGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 127
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNL-KPNWNLRTNIAFQIARGLLYLHEDCRA 640
                +  N  +V E++  G + S L   G   +P+       A QI     YLH     
Sbjct: 128 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF---YAAQIVLTFEYLHS---L 181
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            +I+ D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE   +   
Sbjct: 182 DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGATWTLCGTPEYLAPEIILSKGY 236
Query: 701 TAKVDVYSFGVLLLEIISCRKSF 723
              VD ++ GVL+ E+ +    F
Sbjct: 237 NKAVDWWALGVLIYEMAAGYPPF 259

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/270 (21%), Positives = 112/270 (41%), Gaps = 35/270 (12%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE-FKNEVFVIGQTHHKNLVRLLG 585
           +G+G F   ++          A  +     + +  +RE    E+ +     H+++V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 586 FCDEGQNRLLVYEFLNNGTLASF-----LFGNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           F ++     +V E     +L             +  + LR     QI  G  YLH   R 
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-----QIVLGCQYLH---RN 160
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
           ++IH D+K  N+ L++    +I DFGLA  +  +  +  K  + GT  Y+APE       
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSKKGH 218
Query: 701 TAKVDVYSFGVLLLEIISCRKSFDIE-MGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMN 759
           + +VDV+S G ++  ++  +  F+   + E Y  +    +   ++  +N +     + M 
Sbjct: 219 SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH--INPVAASLIQKM- 275
Query: 760 DIECLGKLVMVSIWCIQEDPSLRPTMKKVL 789
                          +Q DP+ RPT+ ++L
Sbjct: 276 ---------------LQTDPTARPTINELL 290

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/270 (21%), Positives = 112/270 (41%), Gaps = 35/270 (12%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE-FKNEVFVIGQTHHKNLVRLLG 585
           +G+G F   ++          A  +     + +  +RE    E+ +     H+++V   G
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 586 FCDEGQNRLLVYEFLNNGTLASF-----LFGNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           F ++     +V E     +L             +  + LR     QI  G  YLH   R 
Sbjct: 107 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-----QIVLGCQYLH---RN 158
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
           ++IH D+K  N+ L++    +I DFGLA  +  +  +  K  + GT  Y+APE       
Sbjct: 159 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSKKGH 216
Query: 701 TAKVDVYSFGVLLLEIISCRKSFDIE-MGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMN 759
           + +VDV+S G ++  ++  +  F+   + E Y  +    +   ++  +N +     + M 
Sbjct: 217 SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH--INPVAASLIQKM- 273
Query: 760 DIECLGKLVMVSIWCIQEDPSLRPTMKKVL 789
                          +Q DP+ RPT+ ++L
Sbjct: 274 ---------------LQTDPTARPTINELL 288

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 113/271 (41%), Gaps = 39/271 (14%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE----REFKNEVFVIGQTHH--KNL 580
           +G G FG VY G+  +     A+   + DR+   GE         EV ++ +       +
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 581 VRLLGFCDEGQNRLLVYEFLNN-GTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCR 639
           +RLL + +   + +L+ E +     L  F+         L  +  +Q+   + + H +C 
Sbjct: 76  IRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH-NC- 133
Query: 640 AQIIHCDIKPQNILLD-DYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNS 698
             ++H DIK +NIL+D +    ++ DFG   LL      T+ T   GT+ Y  PEW R  
Sbjct: 134 -GVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYH 188
Query: 699 KITAK-VDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEA 757
           +   +   V+S G+LL +++      DI    +  I+    F   R              
Sbjct: 189 RYHGRSAAVWSLGILLYDMVCG----DIPFEHDEEIIRGQVFFRQRVSS----------- 233
Query: 758 MNDIECLGKLVMVSIWCIQEDPSLRPTMKKV 788
               EC   +     WC+   PS RPT +++
Sbjct: 234 ----ECQHLIR----WCLALRPSDRPTFEEI 256

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/270 (21%), Positives = 112/270 (41%), Gaps = 35/270 (12%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE-FKNEVFVIGQTHHKNLVRLLG 585
           +G+G F   ++          A  +     + +  +RE    E+ +     H+++V   G
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 586 FCDEGQNRLLVYEFLNNGTLASF-----LFGNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           F ++     +V E     +L             +  + LR     QI  G  YLH   R 
Sbjct: 89  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-----QIVLGCQYLH---RN 140
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
           ++IH D+K  N+ L++    +I DFGLA  +  +  +  K  + GT  Y+APE       
Sbjct: 141 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKTLCGTPNYIAPEVLSKKGH 198
Query: 701 TAKVDVYSFGVLLLEIISCRKSFDIE-MGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMN 759
           + +VDV+S G ++  ++  +  F+   + E Y  +    +   ++  +N +     + M 
Sbjct: 199 SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH--INPVAASLIQKM- 255
Query: 760 DIECLGKLVMVSIWCIQEDPSLRPTMKKVL 789
                          +Q DP+ RPT+ ++L
Sbjct: 256 ---------------LQTDPTARPTINELL 270

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGEREFK-NEVFVIGQTHHKNLVRL 583
           +G GSFG V   +++ + S    A+K LD+  V +  + E   NE  ++   +   LV+L
Sbjct: 49  LGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNL-KPNWNLRTNIAFQIARGLLYLHEDCRA 640
                +  N  +V E++  G + S L   G   +P+       A QI     YLH     
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF---YAAQIVLTFEYLHS---L 160
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            +I+ D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE   +   
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLXGTPEYLAPEIILSKGY 215
Query: 701 TAKVDVYSFGVLLLEIISCRKSF 723
              VD ++ GVL+ E+ +    F
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 19/203 (9%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGEREFK-NEVFVIGQTHHKNLVRL 583
           +G GSFG V   +++ + S    A+K LD+  V +  + E   NE  ++   +   LV+L
Sbjct: 49  LGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNL-KPNWNLRTNIAFQIARGLLYLHEDCRA 640
                +  N  +V E++  G + S L   G   +P+       A QI     YLH     
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF---YAAQIVLTFEYLHS---L 160
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            +I+ D+KP+N+L+D     +++DFG AK +   + +T   A  GT  Y+APE   +   
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV---KGRTWXLA--GTPEYLAPEIILSKGY 215
Query: 701 TAKVDVYSFGVLLLEIISCRKSF 723
              VD ++ GVL+ E+ +    F
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 98/227 (43%), Gaps = 21/227 (9%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAV-AVKKLDRVF----QDGEREFKNEVFVIGQTHHKNLV 581
           +G+G +G V++    T  +T  + A+K L +             K E  ++ +  H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA----FQIARGLLYLHED 637
            L+     G    L+ E+L+ G L    F  L+       + A     +I+  L +LH+ 
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGEL----FMQLEREGIFMEDTACFYLAEISMALGHLHQK 140
Query: 638 CRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRN 697
               II+ D+KP+NI+L+     +++DFGL K        T+     GT  Y+APE    
Sbjct: 141 G---IIYRDLKPENIMLNHQGHVKLTDFGLCKESI--HDGTVTHTFCGTIEYMAPEILMR 195
Query: 698 SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 744
           S     VD +S G L+ ++++    F    GE      D    C  N
Sbjct: 196 SGHNRAVDWWSLGALMYDMLTGAPPF---TGENRKKTIDKILKCKLN 239

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 73/306 (23%), Positives = 124/306 (40%), Gaps = 45/306 (14%)
Query: 495 IRNSPDDGTIETNLRCFSYKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKL 554
           +R +P +    T L     KE   +       +G G FG VY G+  +     A+   + 
Sbjct: 27  LRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK 86
Query: 555 DRVFQDGE----REFKNEVFVIGQTHH--KNLVRLLGFCDEGQNRLLVYEFLNNGTLASF 608
           DR+   GE         EV ++ +       ++RLL + +   + +L+   L        
Sbjct: 87  DRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEPVQD 143
Query: 609 LFGNLKPNWNLRTNIA----FQIARGLLYLHEDCRAQIIHCDIKPQNILLD-DYYTARIS 663
           LF  +     L+  +A    +Q+   + + H +C   ++H DIK +NIL+D +    ++ 
Sbjct: 144 LFDFITERGALQEELARSFFWQVLEAVRHCH-NC--GVLHRDIKDENILIDLNRGELKLI 200
Query: 664 DFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK-VDVYSFGVLLLEIISCRKS 722
           DFG   LL      T+ T   GT+ Y  PEW R  +   +   V+S G+LL +++     
Sbjct: 201 DFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--- 253
Query: 723 FDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLR 782
            DI    +  I+    F   R                  EC   +     WC+   PS R
Sbjct: 254 -DIPFEHDEEIIRGQVFFRQRVSS---------------ECQHLIR----WCLALRPSDR 293
Query: 783 PTMKKV 788
           PT +++
Sbjct: 294 PTFEEI 299

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 93/198 (46%), Gaps = 18/198 (9%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDR---VFQDGEREFKNEVFVIGQTHHK 578
           +F +++G G+FG+    +++ + +   VAVK ++R   + ++ +RE  N         H 
Sbjct: 23  DFVKDIGSGNFGVAR--LMRDKLTKELVAVKYIERGAAIDENVQREIINH----RSLRHP 76
Query: 579 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDC 638
           N+VR         +  ++ E+ + G L   +    + + +       Q+  G+ Y H   
Sbjct: 77  NIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHS-- 134
Query: 639 RAQIIHCDIKPQNILLDDYYTAR--ISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR 696
             QI H D+K +N LLD     R  I DFG +K   L+     K+ + GT  Y+APE   
Sbjct: 135 -MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--KSTV-GTPAYIAPEVLL 190
Query: 697 NSKITAKV-DVYSFGVLL 713
             +   K+ DV+S GV L
Sbjct: 191 RQEYDGKIADVWSCGVTL 208

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/270 (21%), Positives = 112/270 (41%), Gaps = 35/270 (12%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE-FKNEVFVIGQTHHKNLVRLLG 585
           +G+G F   ++          A  +     + +  +RE    E+ +     H+++V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 586 FCDEGQNRLLVYEFLNNGTLASF-----LFGNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           F ++     +V E     +L             +  + LR     QI  G  YLH   R 
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-----QIVLGCQYLH---RN 136
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
           ++IH D+K  N+ L++    +I DFGLA  +  +  +  K  + GT  Y+APE       
Sbjct: 137 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKTLCGTPNYIAPEVLSKKGH 194
Query: 701 TAKVDVYSFGVLLLEIISCRKSFDIE-MGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMN 759
           + +VDV+S G ++  ++  +  F+   + E Y  +    +   ++  +N +     + M 
Sbjct: 195 SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH--INPVAASLIQKM- 251
Query: 760 DIECLGKLVMVSIWCIQEDPSLRPTMKKVL 789
                          +Q DP+ RPT+ ++L
Sbjct: 252 ---------------LQTDPTARPTINELL 266

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 98/227 (43%), Gaps = 21/227 (9%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAV-AVKKLDRVF----QDGEREFKNEVFVIGQTHHKNLV 581
           +G+G +G V++    T  +T  + A+K L +             K E  ++ +  H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA----FQIARGLLYLHED 637
            L+     G    L+ E+L+ G L    F  L+       + A     +I+  L +LH+ 
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGEL----FMQLEREGIFMEDTACFYLAEISMALGHLHQK 140
Query: 638 CRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRN 697
               II+ D+KP+NI+L+     +++DFGL K        T+     GT  Y+APE    
Sbjct: 141 G---IIYRDLKPENIMLNHQGHVKLTDFGLCKESI--HDGTVTHXFCGTIEYMAPEILMR 195
Query: 698 SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 744
           S     VD +S G L+ ++++    F    GE      D    C  N
Sbjct: 196 SGHNRAVDWWSLGALMYDMLTGAPPF---TGENRKKTIDKILKCKLN 239

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 96/202 (47%), Gaps = 19/202 (9%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGERE-FKNEVFVIGQTHHKNLVRL 583
           +GRG+FG V   V++ + +    A+K L++  + +  E   F+ E  V+     K +  L
Sbjct: 82  IGRGAFGEV--AVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL 139
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ 641
                +  N  LV ++   G L + L  F +  P    R    F +A  ++ +    +  
Sbjct: 140 HYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMAR----FYLAEMVIAIDSVHQLH 195
Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIR-GTKGYVAPEWFR---- 696
            +H DIKP NIL+D     R++DFG    L L +  T+++++  GT  Y++PE  +    
Sbjct: 196 YVHRDIKPDNILMDMNGHIRLADFG--SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEG 253
Query: 697 -NSKITAKVDVYSFGVLLLEII 717
              +   + D +S GV + E++
Sbjct: 254 GKGRYGPECDWWSLGVCMYEML 275

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/270 (21%), Positives = 112/270 (41%), Gaps = 35/270 (12%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE-FKNEVFVIGQTHHKNLVRLLG 585
           +G+G F   ++          A  +     + +  +RE    E+ +     H+++V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 586 FCDEGQNRLLVYEFLNNGTLASF-----LFGNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           F ++     +V E     +L             +  + LR     QI  G  YLH   R 
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-----QIVLGCQYLH---RN 136
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
           ++IH D+K  N+ L++    +I DFGLA  +  +  +  K  + GT  Y+APE       
Sbjct: 137 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKTLCGTPNYIAPEVLSKKGH 194
Query: 701 TAKVDVYSFGVLLLEIISCRKSFDIE-MGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMN 759
           + +VDV+S G ++  ++  +  F+   + E Y  +    +   ++  +N +     + M 
Sbjct: 195 SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH--INPVAASLIQKM- 251
Query: 760 DIECLGKLVMVSIWCIQEDPSLRPTMKKVL 789
                          +Q DP+ RPT+ ++L
Sbjct: 252 ---------------LQTDPTARPTINELL 266

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 96/214 (44%), Gaps = 20/214 (9%)
Query: 524 KEEVGRGSFGIVYKGVIQTRTSTTAVAVKKL--------DRVFQDGEREFKNEVFVIGQT 575
           KE +GRG   +V + + +      AV +  +        + V +  E   K    +   +
Sbjct: 22  KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 81
Query: 576 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLH 635
            H N+++L    +      LV++ +  G L  +L   +  +      I   +   +  LH
Sbjct: 82  GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH 141
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
              +  I+H D+KP+NILLDD    +++DFG +    L+  + ++ ++ GT  Y+APE  
Sbjct: 142 ---KLNIVHRDLKPENILLDDDMNIKLTDFGFS--CQLDPGEKLR-SVCGTPSYLAPEII 195
Query: 696 RNSK------ITAKVDVYSFGVLLLEIISCRKSF 723
             S          +VD++S GV++  +++    F
Sbjct: 196 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 73/306 (23%), Positives = 124/306 (40%), Gaps = 45/306 (14%)
Query: 495 IRNSPDDGTIETNLRCFSYKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKL 554
           +R +P +    T L     KE   +       +G G FG VY G+  +     A+   + 
Sbjct: 12  LRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK 71
Query: 555 DRVFQDGE----REFKNEVFVIGQTHH--KNLVRLLGFCDEGQNRLLVYEFLNNGTLASF 608
           DR+   GE         EV ++ +       ++RLL + +   + +L+   L        
Sbjct: 72  DRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEPVQD 128
Query: 609 LFGNLKPNWNLRTNIA----FQIARGLLYLHEDCRAQIIHCDIKPQNILLD-DYYTARIS 663
           LF  +     L+  +A    +Q+   + + H +C   ++H DIK +NIL+D +    ++ 
Sbjct: 129 LFDFITERGALQEELARSFFWQVLEAVRHCH-NC--GVLHRDIKDENILIDLNRGELKLI 185
Query: 664 DFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK-VDVYSFGVLLLEIISCRKS 722
           DFG   LL      T+ T   GT+ Y  PEW R  +   +   V+S G+LL +++     
Sbjct: 186 DFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--- 238
Query: 723 FDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLR 782
            DI    +  I+    F   R                  EC   +     WC+   PS R
Sbjct: 239 -DIPFEHDEEIIRGQVFFRQRVSS---------------ECQHLIR----WCLALRPSDR 278
Query: 783 PTMKKV 788
           PT +++
Sbjct: 279 PTFEEI 284

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 114/274 (41%), Gaps = 45/274 (16%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE----REFKNEVFVIGQTHH--KNL 580
           +G G FG VY G+  +     A+   + DR+   GE         EV ++ +       +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA----FQIARGLLYLHE 636
           +RLL + +   + +L+   L        LF  +     L+  +A    +Q+   + + H 
Sbjct: 77  IRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH- 132
Query: 637 DCRAQIIHCDIKPQNILLD-DYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
           +C   ++H DIK +NIL+D +    ++ DFG   LL      T+ T   GT+ Y  PEW 
Sbjct: 133 NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 186
Query: 696 RNSKITAK-VDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGED 754
           R  +   +   V+S G+LL +++      DI    +  I+    F   R           
Sbjct: 187 RYHRYHGRSAAVWSLGILLYDMVCG----DIPFEHDEEIIRGQVFFRQRVSS-------- 234
Query: 755 KEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKV 788
                  EC   +     WC+   PS RPT +++
Sbjct: 235 -------ECQHLIR----WCLALRPSDRPTFEEI 257

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/191 (28%), Positives = 90/191 (47%), Gaps = 14/191 (7%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGF 586
           +GRGS+G V K  +Q  T     A KK+ + F +    FK E+ ++    H N++RL   
Sbjct: 34  IGRGSWGEV-KIAVQKGTRIRRAA-KKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET 91
Query: 587 CDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDC-RAQIIHC 645
            ++  +  LV E    G     LF  +      R + A +I + +L     C +  + H 
Sbjct: 92  FEDNTDIYLVMELCTGGE----LFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHR 147
Query: 646 DIKPQNIL-LDDYYTA--RISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITA 702
           D+KP+N L L D   +  ++ DFGLA        K ++T + GT  YV+P+         
Sbjct: 148 DLKPENFLFLTDSPDSPLKLIDFGLAA--RFKPGKMMRTKV-GTPYYVSPQVL-EGLYGP 203
Query: 703 KVDVYSFGVLL 713
           + D +S GV++
Sbjct: 204 ECDEWSAGVMM 214

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 73/306 (23%), Positives = 124/306 (40%), Gaps = 45/306 (14%)
Query: 495 IRNSPDDGTIETNLRCFSYKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKL 554
           +R +P +    T L     KE   +       +G G FG VY G+  +     A+   + 
Sbjct: 32  LRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK 91
Query: 555 DRVFQDGE----REFKNEVFVIGQTHH--KNLVRLLGFCDEGQNRLLVYEFLNNGTLASF 608
           DR+   GE         EV ++ +       ++RLL + +   + +L+   L        
Sbjct: 92  DRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEPVQD 148
Query: 609 LFGNLKPNWNLRTNIA----FQIARGLLYLHEDCRAQIIHCDIKPQNILLD-DYYTARIS 663
           LF  +     L+  +A    +Q+   + + H +C   ++H DIK +NIL+D +    ++ 
Sbjct: 149 LFDFITERGALQEELARSFFWQVLEAVRHCH-NC--GVLHRDIKDENILIDLNRGELKLI 205
Query: 664 DFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK-VDVYSFGVLLLEIISCRKS 722
           DFG   LL      T+ T   GT+ Y  PEW R  +   +   V+S G+LL +++     
Sbjct: 206 DFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--- 258
Query: 723 FDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLR 782
            DI    +  I+    F   R                  EC   +     WC+   PS R
Sbjct: 259 -DIPFEHDEEIIRGQVFFRQRVSX---------------ECQHLIR----WCLALRPSDR 298
Query: 783 PTMKKV 788
           PT +++
Sbjct: 299 PTFEEI 304

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 73/306 (23%), Positives = 124/306 (40%), Gaps = 45/306 (14%)
Query: 495 IRNSPDDGTIETNLRCFSYKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKL 554
           +R +P +    T L     KE   +       +G G FG VY G+  +     A+   + 
Sbjct: 27  LRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK 86
Query: 555 DRVFQDGE----REFKNEVFVIGQTHH--KNLVRLLGFCDEGQNRLLVYEFLNNGTLASF 608
           DR+   GE         EV ++ +       ++RLL + +   + +L+   L        
Sbjct: 87  DRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEPVQD 143
Query: 609 LFGNLKPNWNLRTNIA----FQIARGLLYLHEDCRAQIIHCDIKPQNILLD-DYYTARIS 663
           LF  +     L+  +A    +Q+   + + H +C   ++H DIK +NIL+D +    ++ 
Sbjct: 144 LFDFITERGALQEELARSFFWQVLEAVRHCH-NC--GVLHRDIKDENILIDLNRGELKLI 200
Query: 664 DFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK-VDVYSFGVLLLEIISCRKS 722
           DFG   LL      T+ T   GT+ Y  PEW R  +   +   V+S G+LL +++     
Sbjct: 201 DFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--- 253
Query: 723 FDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLR 782
            DI    +  I+    F   R                  EC   +     WC+   PS R
Sbjct: 254 -DIPFEHDEEIIRGQVFFRQRVSX---------------ECQHLIR----WCLALRPSDR 293
Query: 783 PTMKKV 788
           PT +++
Sbjct: 294 PTFEEI 299

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGEREFK-NEVFVIGQTHHKNLVRL 583
           +G GSFG V   +++ + S    A+K LD+  V +  + E   NE  ++   +   LV+L
Sbjct: 36  LGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 93
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNL-KPNWNLRTNIAFQIARGLLYLHEDCRA 640
                +  N  +V E++  G + S L   G   +P+       A QI     YLH     
Sbjct: 94  EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF---YAAQIVLTFEYLHS---L 147
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            +I+ D+KP+N+L+D+    +++DFG AK     + K     + GT  Y+APE   +   
Sbjct: 148 DLIYRDLKPENLLIDEQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGY 202
Query: 701 TAKVDVYSFGVLLLEIISCRKSF 723
              VD ++ GVL+ E+ +    F
Sbjct: 203 NKAVDWWALGVLIYEMAAGYPPF 225

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 73/306 (23%), Positives = 124/306 (40%), Gaps = 45/306 (14%)
Query: 495 IRNSPDDGTIETNLRCFSYKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKL 554
           +R +P +    T L     KE   +       +G G FG VY G+  +     A+   + 
Sbjct: 13  LRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK 72
Query: 555 DRVFQDGE----REFKNEVFVIGQTHH--KNLVRLLGFCDEGQNRLLVYEFLNNGTLASF 608
           DR+   GE         EV ++ +       ++RLL + +   + +L+   L        
Sbjct: 73  DRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEPVQD 129
Query: 609 LFGNLKPNWNLRTNIA----FQIARGLLYLHEDCRAQIIHCDIKPQNILLD-DYYTARIS 663
           LF  +     L+  +A    +Q+   + + H +C   ++H DIK +NIL+D +    ++ 
Sbjct: 130 LFDFITERGALQEELARSFFWQVLEAVRHCH-NC--GVLHRDIKDENILIDLNRGELKLI 186
Query: 664 DFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK-VDVYSFGVLLLEIISCRKS 722
           DFG   LL      T+ T   GT+ Y  PEW R  +   +   V+S G+LL +++     
Sbjct: 187 DFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--- 239
Query: 723 FDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLR 782
            DI    +  I+    F   R                  EC   +     WC+   PS R
Sbjct: 240 -DIPFEHDEEIIGGQVFFRQRVSS---------------ECQHLIR----WCLALRPSDR 279
Query: 783 PTMKKV 788
           PT +++
Sbjct: 280 PTFEEI 285

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 89/198 (44%), Gaps = 19/198 (9%)
Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKN---EVFVIGQTHHKNLVR 582
           E+G GSFG VY    +   ++  VA+KK+    +    ++++   EV  + +  H N ++
Sbjct: 22  EIGHGSFGAVY--FARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79
Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR-TNIAFQIARGLLYLHEDCRAQ 641
             G         LV E+   G+ +  L  + KP   +    +     +GL YLH      
Sbjct: 80  YRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---N 135
Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE---WFRNS 698
           +IH D+K  NILL +    ++ DFG A ++             GT  ++APE        
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVILAMDEG 189
Query: 699 KITAKVDVYSFGVLLLEI 716
           +   KVDV+S G+  +E+
Sbjct: 190 QYDGKVDVWSLGITCIEL 207

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/270 (21%), Positives = 112/270 (41%), Gaps = 35/270 (12%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE-FKNEVFVIGQTHHKNLVRLLG 585
           +G+G F   ++          A  +     + +  +RE    E+ +     H+++V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 586 FCDEGQNRLLVYEFLNNGTLASF-----LFGNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           F ++     +V E     +L             +  + LR     QI  G  YLH   R 
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-----QIVLGCQYLH---RN 134
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
           ++IH D+K  N+ L++    +I DFGLA  +  +  +  K  + GT  Y+APE       
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSKKGH 192
Query: 701 TAKVDVYSFGVLLLEIISCRKSFDIE-MGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMN 759
           + +VDV+S G ++  ++  +  F+   + E Y  +    +   ++  +N +     + M 
Sbjct: 193 SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH--INPVAASLIQKM- 249
Query: 760 DIECLGKLVMVSIWCIQEDPSLRPTMKKVL 789
                          +Q DP+ RPT+ ++L
Sbjct: 250 ---------------LQTDPTARPTINELL 264

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 73/306 (23%), Positives = 124/306 (40%), Gaps = 45/306 (14%)
Query: 495 IRNSPDDGTIETNLRCFSYKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKL 554
           +R +P +    T L     KE   +       +G G FG VY G+  +     A+   + 
Sbjct: 12  LRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK 71
Query: 555 DRVFQDGE----REFKNEVFVIGQTHH--KNLVRLLGFCDEGQNRLLVYEFLNNGTLASF 608
           DR+   GE         EV ++ +       ++RLL + +   + +L+   L        
Sbjct: 72  DRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEPVQD 128
Query: 609 LFGNLKPNWNLRTNIA----FQIARGLLYLHEDCRAQIIHCDIKPQNILLD-DYYTARIS 663
           LF  +     L+  +A    +Q+   + + H +C   ++H DIK +NIL+D +    ++ 
Sbjct: 129 LFDFITERGALQEELARSFFWQVLEAVRHCH-NC--GVLHRDIKDENILIDLNRGELKLI 185
Query: 664 DFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK-VDVYSFGVLLLEIISCRKS 722
           DFG   LL      T+ T   GT+ Y  PEW R  +   +   V+S G+LL +++     
Sbjct: 186 DFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--- 238
Query: 723 FDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLR 782
            DI    +  I+    F   R                  EC   +     WC+   PS R
Sbjct: 239 -DIPFEHDEEIIGGQVFFRQRVSS---------------ECQHLIR----WCLALRPSDR 278
Query: 783 PTMKKV 788
           PT +++
Sbjct: 279 PTFEEI 284

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGEREFK-NEVFVIGQTHHKNLVRL 583
           +G GSFG V   +++ + S    A+K LD+  V +  + E   NE  ++   +   LV+L
Sbjct: 70  LGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 127
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNL-KPNWNLRTNIAFQIARGLLYLHEDCRA 640
                +  N  +V E++  G + S L   G   +P+       A QI     YLH     
Sbjct: 128 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF---YAAQIVLTFEYLHS---L 181
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            +I+ D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE   +   
Sbjct: 182 DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGY 236
Query: 701 TAKVDVYSFGVLLLEIISCRKSF 723
              VD ++ GVL+ E+ +    F
Sbjct: 237 NKAVDWWALGVLIYEMAAGYPPF 259

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 114/274 (41%), Gaps = 45/274 (16%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE----REFKNEVFVIGQTHH--KNL 580
           +G G FG VY G+  +     A+   + DR+   GE         EV ++ +       +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA----FQIARGLLYLHE 636
           +RLL + +   + +L+   L        LF  +     L+  +A    +Q+   + + H 
Sbjct: 92  IRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH- 147
Query: 637 DCRAQIIHCDIKPQNILLD-DYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
           +C   ++H DIK +NIL+D +    ++ DFG   LL      T+ T   GT+ Y  PEW 
Sbjct: 148 NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 201
Query: 696 RNSKITAK-VDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGED 754
           R  +   +   V+S G+LL +++      DI    +  I+    F   R           
Sbjct: 202 RYHRYHGRSAAVWSLGILLYDMVCG----DIPFEHDEEIIRGQVFFRQRVSS-------- 249
Query: 755 KEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKV 788
                  EC   +     WC+   PS RPT +++
Sbjct: 250 -------ECQHLIR----WCLALRPSDRPTFEEI 272

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/191 (28%), Positives = 90/191 (47%), Gaps = 14/191 (7%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGF 586
           +GRGS+G V K  +Q  T     A KK+ + F +    FK E+ ++    H N++RL   
Sbjct: 17  IGRGSWGEV-KIAVQKGTRIRRAA-KKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET 74
Query: 587 CDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDC-RAQIIHC 645
            ++  +  LV E    G     LF  +      R + A +I + +L     C +  + H 
Sbjct: 75  FEDNTDIYLVMELCTGGE----LFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHR 130
Query: 646 DIKPQNIL-LDDYYTA--RISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITA 702
           D+KP+N L L D   +  ++ DFGLA        K ++T + GT  YV+P+         
Sbjct: 131 DLKPENFLFLTDSPDSPLKLIDFGLAA--RFKPGKMMRTKV-GTPYYVSPQVL-EGLYGP 186
Query: 703 KVDVYSFGVLL 713
           + D +S GV++
Sbjct: 187 ECDEWSAGVMM 197

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 73/306 (23%), Positives = 124/306 (40%), Gaps = 45/306 (14%)
Query: 495 IRNSPDDGTIETNLRCFSYKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKL 554
           +R +P +    T L     KE   +       +G G FG VY G+  +     A+   + 
Sbjct: 13  LRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK 72
Query: 555 DRVFQDGE----REFKNEVFVIGQTHH--KNLVRLLGFCDEGQNRLLVYEFLNNGTLASF 608
           DR+   GE         EV ++ +       ++RLL + +   + +L+   L        
Sbjct: 73  DRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEPVQD 129
Query: 609 LFGNLKPNWNLRTNIA----FQIARGLLYLHEDCRAQIIHCDIKPQNILLD-DYYTARIS 663
           LF  +     L+  +A    +Q+   + + H +C   ++H DIK +NIL+D +    ++ 
Sbjct: 130 LFDFITERGALQEELARSFFWQVLEAVRHCH-NC--GVLHRDIKDENILIDLNRGELKLI 186
Query: 664 DFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK-VDVYSFGVLLLEIISCRKS 722
           DFG   LL      T+ T   GT+ Y  PEW R  +   +   V+S G+LL +++     
Sbjct: 187 DFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--- 239
Query: 723 FDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLR 782
            DI    +  I+    F   R                  EC   +     WC+   PS R
Sbjct: 240 -DIPFEHDEEIIGGQVFFRQRVSS---------------ECQHLIR----WCLALRPSDR 279
Query: 783 PTMKKV 788
           PT +++
Sbjct: 280 PTFEEI 285

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 73/306 (23%), Positives = 124/306 (40%), Gaps = 45/306 (14%)
Query: 495 IRNSPDDGTIETNLRCFSYKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKL 554
           +R +P +    T L     KE   +       +G G FG VY G+  +     A+   + 
Sbjct: 12  LRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK 71
Query: 555 DRVFQDGE----REFKNEVFVIGQTHH--KNLVRLLGFCDEGQNRLLVYEFLNNGTLASF 608
           DR+   GE         EV ++ +       ++RLL + +   + +L+   L        
Sbjct: 72  DRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEPVQD 128
Query: 609 LFGNLKPNWNLRTNIA----FQIARGLLYLHEDCRAQIIHCDIKPQNILLD-DYYTARIS 663
           LF  +     L+  +A    +Q+   + + H +C   ++H DIK +NIL+D +    ++ 
Sbjct: 129 LFDFITERGALQEELARSFFWQVLEAVRHCH-NC--GVLHRDIKDENILIDLNRGELKLI 185
Query: 664 DFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK-VDVYSFGVLLLEIISCRKS 722
           DFG   LL      T+ T   GT+ Y  PEW R  +   +   V+S G+LL +++     
Sbjct: 186 DFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--- 238
Query: 723 FDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLR 782
            DI    +  I+    F   R                  EC   +     WC+   PS R
Sbjct: 239 -DIPFEHDEEIIGGQVFFRQRVSS---------------ECQHLIR----WCLALRPSDR 278
Query: 783 PTMKKV 788
           PT +++
Sbjct: 279 PTFEEI 284

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 95/214 (44%), Gaps = 20/214 (9%)
Query: 524 KEEVGRGSFGIVYKGVIQTRTSTTAVAVKKL--------DRVFQDGEREFKNEVFVIGQT 575
           KE +GRG   +V + + +      AV +  +        + V +  E   K    +   +
Sbjct: 9   KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 68
Query: 576 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLH 635
            H N+++L    +      LV++ +  G L  +L   +  +      I   +   +  LH
Sbjct: 69  GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH 128
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
              +  I+H D+KP+NILLDD    +++DFG +    L+  + ++  + GT  Y+APE  
Sbjct: 129 ---KLNIVHRDLKPENILLDDDMNIKLTDFGFS--CQLDPGEKLR-EVCGTPSYLAPEII 182
Query: 696 RNSK------ITAKVDVYSFGVLLLEIISCRKSF 723
             S          +VD++S GV++  +++    F
Sbjct: 183 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 216

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 114/274 (41%), Gaps = 45/274 (16%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE----REFKNEVFVIGQTHH--KNL 580
           +G G FG VY G+  +     A+   + DR+   GE         EV ++ +       +
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA----FQIARGLLYLHE 636
           +RLL + +   + +L+   L        LF  +     L+  +A    +Q+   + + H 
Sbjct: 91  IRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH- 146
Query: 637 DCRAQIIHCDIKPQNILLD-DYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
           +C   ++H DIK +NIL+D +    ++ DFG   LL      T+ T   GT+ Y  PEW 
Sbjct: 147 NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 200
Query: 696 RNSKITAK-VDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGED 754
           R  +   +   V+S G+LL +++      DI    +  I+    F   R           
Sbjct: 201 RYHRYHGRSAAVWSLGILLYDMVCG----DIPFEHDEEIIRGQVFFRQRVSS-------- 248
Query: 755 KEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKV 788
                  EC   +     WC+   PS RPT +++
Sbjct: 249 -------ECQHLIR----WCLALRPSDRPTFEEI 271

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/228 (22%), Positives = 100/228 (43%), Gaps = 34/228 (14%)
Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD--GEREFKNEVFVIGQTHHKNL 580
            K  +GRGS+G VY  +   + +   VA+KK++R+F+D    +    E+ ++ +     +
Sbjct: 30  IKHLIGRGSYGYVY--LAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYI 87
Query: 581 VRLLGFCDEGQ-----NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLH 635
           +RL                +V E  ++     F         +++T I + +  G  ++H
Sbjct: 88  IRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKT-ILYNLLLGENFIH 146
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI--------------KT 681
           E   + IIH D+KP N LL+   + ++ DFGLA+ +   +   I              K 
Sbjct: 147 E---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKN 203
Query: 682 AIRGTKGYVAPEWFRNSKI-------TAKVDVYSFGVLLLEIISCRKS 722
             +    +V   W+R  ++       T  +D++S G +  E+++  +S
Sbjct: 204 LKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 73/306 (23%), Positives = 124/306 (40%), Gaps = 45/306 (14%)
Query: 495 IRNSPDDGTIETNLRCFSYKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKL 554
           +R +P +    T L     KE   +       +G G FG VY G+  +     A+   + 
Sbjct: 13  LRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK 72
Query: 555 DRVFQDGE----REFKNEVFVIGQTHH--KNLVRLLGFCDEGQNRLLVYEFLNNGTLASF 608
           DR+   GE         EV ++ +       ++RLL + +   + +L+   L        
Sbjct: 73  DRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEPVQD 129
Query: 609 LFGNLKPNWNLRTNIA----FQIARGLLYLHEDCRAQIIHCDIKPQNILLD-DYYTARIS 663
           LF  +     L+  +A    +Q+   + + H +C   ++H DIK +NIL+D +    ++ 
Sbjct: 130 LFDFITERGALQEELARSFFWQVLEAVRHCH-NC--GVLHRDIKDENILIDLNRGELKLI 186
Query: 664 DFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK-VDVYSFGVLLLEIISCRKS 722
           DFG   LL      T+ T   GT+ Y  PEW R  +   +   V+S G+LL +++     
Sbjct: 187 DFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--- 239
Query: 723 FDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLR 782
            DI    +  I+    F   R                  EC   +     WC+   PS R
Sbjct: 240 -DIPFEHDEEIIGGQVFFRQRVSX---------------ECQHLIR----WCLALRPSDR 279
Query: 783 PTMKKV 788
           PT +++
Sbjct: 280 PTFEEI 285

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 107/226 (47%), Gaps = 27/226 (11%)
Query: 514 KELEGATNNFK--EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGERE-FKNE 568
           KE++    +F+  + +GRG+FG V   V++ + +    A+K L++  + +  E   F+ E
Sbjct: 67  KEMQLHREDFEIIKVIGRGAFGEV--AVVKMKNTERIYAMKILNKWEMLKRAETACFREE 124
Query: 569 --VFVIGQTHHKNLVRLLGFCDEGQNRL-LVYEFLNNGTLASFL--FGNLKPNWNLRTNI 623
             V V G       +  L +  + +N L LV ++   G L + L  F +  P    R   
Sbjct: 125 RDVLVNGDC---QWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMAR--- 178
Query: 624 AFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAI 683
            F I   +L +    +   +H DIKP N+LLD     R++DFG    L +N   T+++++
Sbjct: 179 -FYIGEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFG--SCLKMNDDGTVQSSV 235
Query: 684 R-GTKGYVAPEWFRN-----SKITAKVDVYSFGVLLLEIISCRKSF 723
             GT  Y++PE  +       K   + D +S GV + E++     F
Sbjct: 236 AVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 281

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 73/306 (23%), Positives = 124/306 (40%), Gaps = 45/306 (14%)
Query: 495 IRNSPDDGTIETNLRCFSYKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKL 554
           +R +P +    T L     KE   +       +G G FG VY G+  +     A+   + 
Sbjct: 13  LRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK 72
Query: 555 DRVFQDGE----REFKNEVFVIGQTHH--KNLVRLLGFCDEGQNRLLVYEFLNNGTLASF 608
           DR+   GE         EV ++ +       ++RLL + +   + +L+   L        
Sbjct: 73  DRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEPVQD 129
Query: 609 LFGNLKPNWNLRTNIA----FQIARGLLYLHEDCRAQIIHCDIKPQNILLD-DYYTARIS 663
           LF  +     L+  +A    +Q+   + + H +C   ++H DIK +NIL+D +    ++ 
Sbjct: 130 LFDFITERGALQEELARSFFWQVLEAVRHCH-NC--GVLHRDIKDENILIDLNRGELKLI 186
Query: 664 DFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK-VDVYSFGVLLLEIISCRKS 722
           DFG   LL      T+ T   GT+ Y  PEW R  +   +   V+S G+LL +++     
Sbjct: 187 DFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--- 239
Query: 723 FDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLR 782
            DI    +  I+    F   R                  EC   +     WC+   PS R
Sbjct: 240 -DIPFEHDEEIIGGQVFFRQRVSX---------------ECQHLIR----WCLALRPSDR 279
Query: 783 PTMKKV 788
           PT +++
Sbjct: 280 PTFEEI 285

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGEREFK-NEVFVIGQTHHKNLVRL 583
           +G GSFG V   +++ + S    A+K LD+  V +  + E   NE  ++   +   LV+L
Sbjct: 49  LGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNL-KPNWNLRTNIAFQIARGLLYLHEDCRA 640
                +  N  +V E++  G + S L   G   +P+       A QI     YLH     
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF---YAAQIVLTFEYLHS---L 160
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            +I+ D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE   +   
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 701 TAKVDVYSFGVLLLEIISCRKSF 723
              VD ++ GVL+ E+ +    F
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 73/306 (23%), Positives = 124/306 (40%), Gaps = 45/306 (14%)
Query: 495 IRNSPDDGTIETNLRCFSYKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKL 554
           +R +P +    T L     KE   +       +G G FG VY G+  +     A+   + 
Sbjct: 12  LRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK 71
Query: 555 DRVFQDGE----REFKNEVFVIGQTHH--KNLVRLLGFCDEGQNRLLVYEFLNNGTLASF 608
           DR+   GE         EV ++ +       ++RLL + +   + +L+   L        
Sbjct: 72  DRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEPVQD 128
Query: 609 LFGNLKPNWNLRTNIA----FQIARGLLYLHEDCRAQIIHCDIKPQNILLD-DYYTARIS 663
           LF  +     L+  +A    +Q+   + + H +C   ++H DIK +NIL+D +    ++ 
Sbjct: 129 LFDFITERGALQEELARSFFWQVLEAVRHCH-NC--GVLHRDIKDENILIDLNRGELKLI 185
Query: 664 DFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAK-VDVYSFGVLLLEIISCRKS 722
           DFG   LL      T+ T   GT+ Y  PEW R  +   +   V+S G+LL +++     
Sbjct: 186 DFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--- 238
Query: 723 FDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLR 782
            DI    +  I+    F   R                  EC   +     WC+   PS R
Sbjct: 239 -DIPFEHDEEIIGGQVFFRQRVSX---------------ECQHLIR----WCLALRPSDR 278
Query: 783 PTMKKV 788
           PT +++
Sbjct: 279 PTFEEI 284

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGEREFK-NEVFVIGQTHHKNLVRL 583
           +G GSFG V   +++ + S    A+K LD+  V +  + E   NE  ++   +   LV+L
Sbjct: 49  LGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNL-KPNWNLRTNIAFQIARGLLYLHEDCRA 640
                +  N  +V E++  G + S L   G   +P+       A QI     YLH     
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF---YAAQIVLTFEYLHS---L 160
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            +I+ D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE   +   
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 701 TAKVDVYSFGVLLLEIISCRKSF 723
              VD ++ GVL+ E+ +    F
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 114/274 (41%), Gaps = 45/274 (16%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE----REFKNEVFVIGQTHH--KNL 580
           +G G FG VY G+  +     A+   + DR+   GE         EV ++ +       +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA----FQIARGLLYLHE 636
           +RLL + +   + +L+   L        LF  +     L+  +A    +Q+   + + H 
Sbjct: 111 IRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH- 166
Query: 637 DCRAQIIHCDIKPQNILLD-DYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
           +C   ++H DIK +NIL+D +    ++ DFG   LL      T+ T   GT+ Y  PEW 
Sbjct: 167 NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 220
Query: 696 RNSKITAK-VDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGED 754
           R  +   +   V+S G+LL +++      DI    +  I+    F   R           
Sbjct: 221 RYHRYHGRSAAVWSLGILLYDMVCG----DIPFEHDEEIIRGQVFFRQRVSS-------- 268
Query: 755 KEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKV 788
                  EC   +     WC+   PS RPT +++
Sbjct: 269 -------ECQHLIR----WCLALRPSDRPTFEEI 291

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 114/274 (41%), Gaps = 45/274 (16%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE----REFKNEVFVIGQTHH--KNL 580
           +G G FG VY G+  +     A+   + DR+   GE         EV ++ +       +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA----FQIARGLLYLHE 636
           +RLL + +   + +L+   L        LF  +     L+  +A    +Q+   + + H 
Sbjct: 92  IRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH- 147
Query: 637 DCRAQIIHCDIKPQNILLD-DYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
           +C   ++H DIK +NIL+D +    ++ DFG   LL      T+ T   GT+ Y  PEW 
Sbjct: 148 NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 201
Query: 696 RNSKITAK-VDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGED 754
           R  +   +   V+S G+LL +++      DI    +  I+    F   R           
Sbjct: 202 RYHRYHGRSAAVWSLGILLYDMVCG----DIPFEHDEEIIRGQVFFRQRVSX-------- 249
Query: 755 KEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKV 788
                  EC   +     WC+   PS RPT +++
Sbjct: 250 -------ECQHLIR----WCLALRPSDRPTFEEI 272

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 107/226 (47%), Gaps = 27/226 (11%)
Query: 514 KELEGATNNFK--EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGERE-FKNE 568
           KE++    +F+  + +GRG+FG V   V++ + +    A+K L++  + +  E   F+ E
Sbjct: 83  KEMQLHREDFEIIKVIGRGAFGEV--AVVKMKNTERIYAMKILNKWEMLKRAETACFREE 140
Query: 569 --VFVIGQTHHKNLVRLLGFCDEGQNRL-LVYEFLNNGTLASFL--FGNLKPNWNLRTNI 623
             V V G       +  L +  + +N L LV ++   G L + L  F +  P    R   
Sbjct: 141 RDVLVNGDC---QWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMAR--- 194
Query: 624 AFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAI 683
            F I   +L +    +   +H DIKP N+LLD     R++DFG    L +N   T+++++
Sbjct: 195 -FYIGEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFG--SCLKMNDDGTVQSSV 251
Query: 684 R-GTKGYVAPEWFRN-----SKITAKVDVYSFGVLLLEIISCRKSF 723
             GT  Y++PE  +       K   + D +S GV + E++     F
Sbjct: 252 AVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 297

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 90/195 (46%), Gaps = 18/195 (9%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGER---EFKNEVFVIGQTHHKNLV 581
           +++G G+FG+    +++ + S   VAVK ++R    GE+     K E+       H N+V
Sbjct: 25  KDIGSGNFGVAR--LMRDKQSNELVAVKYIER----GEKIAANVKREIINHRSLRHPNIV 78
Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ 641
           R         +  +V E+ + G L   +    + + +       Q+  G+ Y H     Q
Sbjct: 79  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA---MQ 135
Query: 642 IIHCDIKPQNILLDDYYTAR--ISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSK 699
           + H D+K +N LLD     R  I DFG +K   L+     K+ + GT  Y+APE     +
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--KSTV-GTPAYIAPEVLLKKE 192
Query: 700 ITAKV-DVYSFGVLL 713
              KV DV+S GV L
Sbjct: 193 YDGKVADVWSCGVTL 207

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 92/199 (46%), Gaps = 16/199 (8%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVK---KLDRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +GRG+FG V   +++ + S    A+K   K + + +     F  E  ++   +   +V+L
Sbjct: 83  IGRGAFGEVQ--LVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 140
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA-FQIARGLLYLHEDCRAQI 642
                + +   +V E++  G L      NL  N+++    A F  A  +L L       +
Sbjct: 141 FCAFQDDKYLYMVMEYMPGGDLV-----NLMSNYDVPEKWAKFYTAEVVLALDAIHSMGL 195
Query: 643 IHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR----NS 698
           IH D+KP N+LLD +   +++DFG    +         TA+ GT  Y++PE  +    + 
Sbjct: 196 IHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAV-GTPDYISPEVLKSQGGDG 254
Query: 699 KITAKVDVYSFGVLLLEII 717
               + D +S GV L E++
Sbjct: 255 YYGRECDWWSVGVFLFEML 273

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 114/274 (41%), Gaps = 45/274 (16%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE----REFKNEVFVIGQTHH--KNL 580
           +G G FG VY G+  +     A+   + DR+   GE         EV ++ +       +
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA----FQIARGLLYLHE 636
           +RLL + +   + +L+   L        LF  +     L+  +A    +Q+   + + H 
Sbjct: 76  IRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH- 131
Query: 637 DCRAQIIHCDIKPQNILLD-DYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
           +C   ++H DIK +NIL+D +    ++ DFG   LL      T+ T   GT+ Y  PEW 
Sbjct: 132 NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 185
Query: 696 RNSKITAK-VDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGED 754
           R  +   +   V+S G+LL +++      DI    +  I+    F   R           
Sbjct: 186 RYHRYHGRSAAVWSLGILLYDMVCG----DIPFEHDEEIIRGQVFFRQRVSS-------- 233
Query: 755 KEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKV 788
                  EC   +     WC+   PS RPT +++
Sbjct: 234 -------ECQHLIR----WCLALRPSDRPTFEEI 256

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGEREFK-NEVFVIGQTHHKNLVRL 583
           +G GSFG V   +++ + S    A+K LD+  V +  + E   NE  ++   +   LV+L
Sbjct: 49  LGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNL-KPNWNLRTNIAFQIARGLLYLHEDCRA 640
                +  N  +V E++  G + S L   G   +P+       A QI     YLH     
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF---YAAQIVLTFEYLHS---L 160
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            +I+ D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE   +   
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 701 TAKVDVYSFGVLLLEIISCRKSF 723
              VD ++ GVL+ E+ +    F
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 95/214 (44%), Gaps = 20/214 (9%)
Query: 524 KEEVGRGSFGIVYKGVIQTRTSTTAVAVKKL--------DRVFQDGEREFKNEVFVIGQT 575
           KE +GRG   +V + + +      AV +  +        + V +  E   K    +   +
Sbjct: 22  KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 81
Query: 576 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLH 635
            H N+++L    +      LV++ +  G L  +L   +  +      I   +   +  LH
Sbjct: 82  GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH 141
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
              +  I+H D+KP+NILLDD    +++DFG +    L+  + ++  + GT  Y+APE  
Sbjct: 142 ---KLNIVHRDLKPENILLDDDMNIKLTDFGFS--CQLDPGEKLR-EVCGTPSYLAPEII 195
Query: 696 RNSK------ITAKVDVYSFGVLLLEIISCRKSF 723
             S          +VD++S GV++  +++    F
Sbjct: 196 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGEREFK-NEVFVIGQTHHKNLVRL 583
           +G GSFG V   +++ + S    A+K LD+  V +  + E   NE  ++   +   LV+L
Sbjct: 49  LGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNL-KPNWNLRTNIAFQIARGLLYLHEDCRA 640
                +  N  +V E++  G + S L   G   +P+       A QI     YLH     
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF---YAAQIVLTFEYLHS---L 160
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            +I+ D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE   +   
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 701 TAKVDVYSFGVLLLEIISCRKSF 723
              VD ++ GVL+ E+ +    F
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGEREFK-NEVFVIGQTHHKNLVRL 583
           +G GSFG V   +++ + S    A+K LD+  V +  + E   NE  ++   +   LV+L
Sbjct: 49  LGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNL-KPNWNLRTNIAFQIARGLLYLHEDCRA 640
                +  N  +V E++  G + S L   G   +P+       A QI     YLH     
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF---YAAQIVLTFEYLHS---L 160
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            +I+ D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE   +   
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 701 TAKVDVYSFGVLLLEIISCRKSF 723
              VD ++ GVL+ E+ +    F
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGEREFK-NEVFVIGQTHHKNLVRL 583
           +G GSFG V   +++ + S    A+K LD+  V +  + E   NE  ++   +   LV+L
Sbjct: 50  LGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNL-KPNWNLRTNIAFQIARGLLYLHEDCRA 640
                +  N  +V E++  G + S L   G   +P+       A QI     YLH     
Sbjct: 108 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF---YAAQIVLTFEYLHS---L 161
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            +I+ D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE   +   
Sbjct: 162 DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 701 TAKVDVYSFGVLLLEIISCRKSF 723
              VD ++ GVL+ E+ +    F
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGEREFK-NEVFVIGQTHHKNLVRL 583
           +G GSFG V   +++ + S    A+K LD+  V +  + E   NE  ++   +   LV+L
Sbjct: 49  LGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNL-KPNWNLRTNIAFQIARGLLYLHEDCRA 640
                +  N  +V E++  G + S L   G   +P+       A QI     YLH     
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF---YAAQIVLTFEYLHS---L 160
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            +I+ D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE   +   
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 701 TAKVDVYSFGVLLLEIISCRKSF 723
              VD ++ GVL+ E+ +    F
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 114/274 (41%), Gaps = 45/274 (16%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE----REFKNEVFVIGQTHH--KNL 580
           +G G FG VY G+  +     A+   + DR+   GE         EV ++ +       +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA----FQIARGLLYLHE 636
           +RLL + +   + +L+   L        LF  +     L+  +A    +Q+   + + H 
Sbjct: 77  IRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH- 132
Query: 637 DCRAQIIHCDIKPQNILLD-DYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
           +C   ++H DIK +NIL+D +    ++ DFG   LL      T+ T   GT+ Y  PEW 
Sbjct: 133 NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 186
Query: 696 RNSKITAK-VDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGED 754
           R  +   +   V+S G+LL +++      DI    +  I+    F   R           
Sbjct: 187 RYHRYHGRSAAVWSLGILLYDMVCG----DIPFEHDEEIIRGQVFFRQRVSS-------- 234
Query: 755 KEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKV 788
                  EC   +     WC+   PS RPT +++
Sbjct: 235 -------ECQHLIR----WCLALRPSDRPTFEEI 257

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 114/274 (41%), Gaps = 45/274 (16%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE----REFKNEVFVIGQTHH--KNL 580
           +G G FG VY G+  +     A+   + DR+   GE         EV ++ +       +
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA----FQIARGLLYLHE 636
           +RLL + +   + +L+   L        LF  +     L+  +A    +Q+   + + H 
Sbjct: 91  IRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH- 146
Query: 637 DCRAQIIHCDIKPQNILLD-DYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
           +C   ++H DIK +NIL+D +    ++ DFG   LL      T+ T   GT+ Y  PEW 
Sbjct: 147 NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 200
Query: 696 RNSKITAK-VDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGED 754
           R  +   +   V+S G+LL +++      DI    +  I+    F   R           
Sbjct: 201 RYHRYHGRSAAVWSLGILLYDMVCG----DIPFEHDEEIIRGQVFFRQRVSX-------- 248
Query: 755 KEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKV 788
                  EC   +     WC+   PS RPT +++
Sbjct: 249 -------ECQHLIR----WCLALRPSDRPTFEEI 271

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGEREFK-NEVFVIGQTHHKNLVRL 583
           +G GSFG V   +++ + S    A+K LD+  V +  + E   NE  ++   +   LV+L
Sbjct: 49  LGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNL-KPNWNLRTNIAFQIARGLLYLHEDCRA 640
                +  N  +V E++  G + S L   G   +P+       A QI     YLH     
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF---YAAQIVLTFEYLHS---L 160
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            +I+ D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE   +   
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 701 TAKVDVYSFGVLLLEIISCRKSF 723
              VD ++ GVL+ E+ +    F
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 90/195 (46%), Gaps = 18/195 (9%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGER---EFKNEVFVIGQTHHKNLV 581
           +++G G+FG+    +++ + S   VAVK ++R    GE+     K E+       H N+V
Sbjct: 24  KDIGSGNFGVAR--LMRDKQSNELVAVKYIER----GEKIDENVKREIINHRSLRHPNIV 77
Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ 641
           R         +  +V E+ + G L   +    + + +       Q+  G+ Y H     Q
Sbjct: 78  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA---MQ 134
Query: 642 IIHCDIKPQNILLDDYYTAR--ISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSK 699
           + H D+K +N LLD     R  I DFG +K   L+     K+ + GT  Y+APE     +
Sbjct: 135 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--KSTV-GTPAYIAPEVLLKKE 191
Query: 700 ITAKV-DVYSFGVLL 713
              KV DV+S GV L
Sbjct: 192 YDGKVADVWSCGVTL 206

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGEREFK-NEVFVIGQTHHKNLVRL 583
           +G GSFG V   +++ + S    A+K LD+  V +  + E   NE  ++   +   LV+L
Sbjct: 49  LGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNL-KPNWNLRTNIAFQIARGLLYLHEDCRA 640
                +  N  +V E++  G + S L   G   +P+       A QI     YLH     
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF---YAAQIVLTFEYLHS---L 160
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            +I+ D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE   +   
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 701 TAKVDVYSFGVLLLEIISCRKSF 723
              VD ++ GVL+ E+ +    F
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 114/274 (41%), Gaps = 45/274 (16%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE----REFKNEVFVIGQTHH--KNL 580
           +G G FG VY G+  +     A+   + DR+   GE         EV ++ +       +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA----FQIARGLLYLHE 636
           +RLL + +   + +L+   L        LF  +     L+  +A    +Q+   + + H 
Sbjct: 77  IRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH- 132
Query: 637 DCRAQIIHCDIKPQNILLD-DYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
           +C   ++H DIK +NIL+D +    ++ DFG   LL      T+ T   GT+ Y  PEW 
Sbjct: 133 NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 186
Query: 696 RNSKITAK-VDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGED 754
           R  +   +   V+S G+LL +++      DI    +  I+    F   R           
Sbjct: 187 RYHRYHGRSAAVWSLGILLYDMVCG----DIPFEHDEEIIRGQVFFRQRVSS-------- 234
Query: 755 KEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKV 788
                  EC   +     WC+   PS RPT +++
Sbjct: 235 -------ECQHLIR----WCLALRPSDRPTFEEI 257

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 69/139 (49%), Gaps = 22/139 (15%)
Query: 622 NIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS-KTIK 680
           +I  QIA  + +LH      ++H D+KP NI        ++ DFGL   +  ++  +T+ 
Sbjct: 168 HIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 224
Query: 681 TAIR---------GTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY 731
           T +          GTK Y++PE    +  + KVD++S G++L E++    SF  +M E  
Sbjct: 225 TPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY---SFSTQM-ERV 280
Query: 732 AILTDWAFDCYRNGKLNVL 750
            I+TD      RN K  +L
Sbjct: 281 RIITD-----VRNLKFPLL 294

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGEREFK-NEVFVIGQTHHKNLVRL 583
           +G GSFG V   +++ + S    A+K LD+  V +  + E   NE  ++   +   LV+L
Sbjct: 49  LGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNL-KPNWNLRTNIAFQIARGLLYLHEDCRA 640
                +  N  +V E++  G + S L   G   +P+       A QI     YLH     
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARF---YAAQIVLTFEYLHS---L 160
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            +I+ D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE   +   
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 701 TAKVDVYSFGVLLLEIISCRKSF 723
              VD ++ GVL+ E+ +    F
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 114/274 (41%), Gaps = 45/274 (16%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE----REFKNEVFVIGQTHH--KNL 580
           +G G FG VY G+  +     A+   + DR+   GE         EV ++ +       +
Sbjct: 39  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 98
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA----FQIARGLLYLHE 636
           +RLL + +   + +L+   L        LF  +     L+  +A    +Q+   + + H 
Sbjct: 99  IRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH- 154
Query: 637 DCRAQIIHCDIKPQNILLD-DYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
           +C   ++H DIK +NIL+D +    ++ DFG   LL      T+ T   GT+ Y  PEW 
Sbjct: 155 NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 208
Query: 696 RNSKITAK-VDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGED 754
           R  +   +   V+S G+LL +++      DI    +  I+    F   R           
Sbjct: 209 RYHRYHGRSAAVWSLGILLYDMVCG----DIPFEHDEEIIRGQVFFRQRVSX-------- 256
Query: 755 KEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKV 788
                  EC   +     WC+   PS RPT +++
Sbjct: 257 -------ECQHLIR----WCLALRPSDRPTFEEI 279

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 57/107 (53%), Gaps = 9/107 (8%)
Query: 622 NIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKT 681
            IA  I + L +LH   +  +IH D+KP N+L++     ++ DFG++  L  + +K I  
Sbjct: 113 KIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA 170
Query: 682 AIRGTKGYVAPEWFR---NSK-ITAKVDVYSFGVLLLEIISCRKSFD 724
              G K Y+APE      N K  + K D++S G+ ++E+   R  +D
Sbjct: 171 ---GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYD 214

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGEREFK-NEVFVIGQTHHKNLVRL 583
           +G GSFG V   +++ + S    A+K LD+  V +  + E   NE  ++   +   LV+L
Sbjct: 44  LGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 101
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNL-KPNWNLRTNIAFQIARGLLYLHEDCRA 640
                +  N  +V E++  G + S L   G   +P+       A QI     YLH     
Sbjct: 102 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF---YAAQIVLTFEYLHS---L 155
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            +I+ D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE   +   
Sbjct: 156 DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGY 210
Query: 701 TAKVDVYSFGVLLLEIISCRKSF 723
              VD ++ GVL+ E+ +    F
Sbjct: 211 NKAVDWWALGVLIYEMAAGYPPF 233

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 77/165 (46%), Gaps = 24/165 (14%)
Query: 626 QIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRG 685
           Q  +G+ YLH +   ++IH D+K  N+ L+D    +I DFGLA  +  +  +  K  + G
Sbjct: 150 QTIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KKTLCG 204
Query: 686 TKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIE-MGEEYAILTDWAFDCYRN 744
           T  Y+APE       + +VD++S G +L  ++  +  F+   + E Y  +    +   R+
Sbjct: 205 TPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRH 264
Query: 745 GKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVL 789
             +N +       M                +  DP+LRP++ ++L
Sbjct: 265 --INPVASALIRRM----------------LHADPTLRPSVAELL 291

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 114/274 (41%), Gaps = 45/274 (16%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE----REFKNEVFVIGQTHH--KNL 580
           +G G FG VY G+  +     A+   + DR+   GE         EV ++ +       +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA----FQIARGLLYLHE 636
           +RLL + +   + +L+   L        LF  +     L+  +A    +Q+   + + H 
Sbjct: 72  IRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH- 127
Query: 637 DCRAQIIHCDIKPQNILLD-DYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
           +C   ++H DIK +NIL+D +    ++ DFG   LL      T+ T   GT+ Y  PEW 
Sbjct: 128 NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 181
Query: 696 RNSKITAK-VDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGED 754
           R  +   +   V+S G+LL +++      DI    +  I+    F   R           
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCG----DIPFEHDEEIIRGQVFFRQRVSS-------- 229
Query: 755 KEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKV 788
                  EC   +     WC+   PS RPT +++
Sbjct: 230 -------ECQHLIR----WCLALRPSDRPTFEEI 252

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 114/274 (41%), Gaps = 45/274 (16%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE----REFKNEVFVIGQTHH--KNL 580
           +G G FG VY G+  +     A+   + DR+   GE         EV ++ +       +
Sbjct: 15  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 74
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA----FQIARGLLYLHE 636
           +RLL + +   + +L+   L        LF  +     L+  +A    +Q+   + + H 
Sbjct: 75  IRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH- 130
Query: 637 DCRAQIIHCDIKPQNILLD-DYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
           +C   ++H DIK +NIL+D +    ++ DFG   LL      T+ T   GT+ Y  PEW 
Sbjct: 131 NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 184
Query: 696 RNSKITAK-VDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGED 754
           R  +   +   V+S G+LL +++      DI    +  I+    F   R           
Sbjct: 185 RYHRYHGRSAAVWSLGILLYDMVCG----DIPFEHDEEIIRGQVFFRQRVSS-------- 232
Query: 755 KEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKV 788
                  EC   +     WC+   PS RPT +++
Sbjct: 233 -------ECQHLIR----WCLALRPSDRPTFEEI 255

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 95/203 (46%), Gaps = 19/203 (9%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGEREFK-NEVFVIGQTHHKNLVRL 583
           +G GSFG V   +++   +    A+K LD+  V +  E E   NE  ++   +   LV+L
Sbjct: 49  LGTGSFGRVM--LVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKL 106
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNL-KPNWNLRTNIAFQIARGLLYLHEDCRA 640
                +  N  +V E+   G + S L   G   +P+       A QI     YLH     
Sbjct: 107 EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF---YAAQIVLTFEYLHS---L 160
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            +I+ D+KP+N+++D     +++DFGLAK     + K     + GT  Y+APE   +   
Sbjct: 161 DLIYRDLKPENLMIDQQGYIKVTDFGLAK-----RVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 701 TAKVDVYSFGVLLLEIISCRKSF 723
              VD ++ GVL+ E+ +    F
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 114/274 (41%), Gaps = 45/274 (16%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE----REFKNEVFVIGQTHH--KNL 580
           +G G FG VY G+  +     A+   + DR+   GE         EV ++ +       +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA----FQIARGLLYLHE 636
           +RLL + +   + +L+   L        LF  +     L+  +A    +Q+   + + H 
Sbjct: 72  IRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH- 127
Query: 637 DCRAQIIHCDIKPQNILLD-DYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
           +C   ++H DIK +NIL+D +    ++ DFG   LL      T+ T   GT+ Y  PEW 
Sbjct: 128 NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 181
Query: 696 RNSKITAK-VDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGED 754
           R  +   +   V+S G+LL +++      DI    +  I+    F   R           
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCG----DIPFEHDEEIIGGQVFFRQRVSS-------- 229
Query: 755 KEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKV 788
                  EC   +     WC+   PS RPT +++
Sbjct: 230 -------ECQHLIR----WCLALRPSDRPTFEEI 252

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 77/165 (46%), Gaps = 24/165 (14%)
Query: 626 QIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRG 685
           Q  +G+ YLH +   ++IH D+K  N+ L+D    +I DFGLA  +  +  +  K  + G
Sbjct: 150 QTIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KKXLCG 204
Query: 686 TKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIE-MGEEYAILTDWAFDCYRN 744
           T  Y+APE       + +VD++S G +L  ++  +  F+   + E Y  +    +   R+
Sbjct: 205 TPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRH 264
Query: 745 GKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVL 789
             +N +       M                +  DP+LRP++ ++L
Sbjct: 265 --INPVASALIRRM----------------LHADPTLRPSVAELL 291

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 95/203 (46%), Gaps = 19/203 (9%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGEREFK-NEVFVIGQTHHKNLVRL 583
           +G GSFG V   +++   +    A+K LD+  V +  + E   NE  ++   +   LV+L
Sbjct: 49  IGTGSFGRVM--LVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNL-KPNWNLRTNIAFQIARGLLYLHEDCRA 640
                +  N  +V E++  G + S L   G   +P+       A QI     YLH     
Sbjct: 107 EFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARF---YAAQIVLTFEYLHS---L 160
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            +I+ D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE   +   
Sbjct: 161 DLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 701 TAKVDVYSFGVLLLEIISCRKSF 723
              VD ++ GVL+ E+ +    F
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGEREFK-NEVFVIGQTHHKNLVRL 583
           +G GSFG V   +++ + +    A+K LD+  V +  + E   NE  ++   +   LV+L
Sbjct: 70  LGTGSFGRVM--LVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 127
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNL-KPNWNLRTNIAFQIARGLLYLHEDCRA 640
                +  N  +V E++  G + S L   G   +P+       A QI     YLH     
Sbjct: 128 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF---YAAQIVLTFEYLHS---L 181
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            +I+ D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE   +   
Sbjct: 182 DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGY 236
Query: 701 TAKVDVYSFGVLLLEIISCRKSF 723
              VD ++ GVL+ E+ +    F
Sbjct: 237 NKAVDWWALGVLIYEMAAGYPPF 259

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 95/203 (46%), Gaps = 19/203 (9%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGEREFK-NEVFVIGQTHHKNLVRL 583
           +G GSFG V   +++   +    A+K LD+  V +  + E   NE  ++   +   LV+L
Sbjct: 49  IGTGSFGRVM--LVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNL-KPNWNLRTNIAFQIARGLLYLHEDCRA 640
                +  N  +V E++  G + S L   G   +P+       A QI     YLH     
Sbjct: 107 EFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARF---YAAQIVLTFEYLHS---L 160
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            +I+ D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE   +   
Sbjct: 161 DLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 701 TAKVDVYSFGVLLLEIISCRKSF 723
              VD ++ GVL+ E+ +    F
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGEREFK-NEVFVIGQTHHKNLVRL 583
           +G GSFG V   +++ + +    A+K LD+  V +  + E   NE  ++   +   LV+L
Sbjct: 49  LGTGSFGRVM--LVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNL-KPNWNLRTNIAFQIARGLLYLHEDCRA 640
                +  N  +V E++  G + S L   G   +P+       A QI     YLH     
Sbjct: 107 EYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF---YAAQIVLTFEYLHS---L 160
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            +I+ D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE   +   
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 701 TAKVDVYSFGVLLLEIISCRKSF 723
              VD ++ GVL+ E+ +    F
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 93/201 (46%), Gaps = 12/201 (5%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR---VFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G+G+FG V   +++ + +    A+K L +   + +D       E  V+  T H  L   
Sbjct: 13  LGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT-A 69
Query: 584 LGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQI 642
           L +  +  +RL  V E+ N G L   L                +I   L YLH      +
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS---RDV 126
Query: 643 IHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITA 702
           ++ DIK +N++LD     +I+DFGL K   ++   T+KT   GT  Y+APE   ++    
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFC-GTPEYLAPEVLEDNDYGR 184
Query: 703 KVDVYSFGVLLLEIISCRKSF 723
            VD +  GV++ E++  R  F
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPF 205

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGEREFK-NEVFVIGQTHHKNLVRL 583
           +G GSFG V   +++ + +    A+K LD+  V +  + E   NE  ++   +   LV+L
Sbjct: 49  LGTGSFGRVM--LVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNL-KPNWNLRTNIAFQIARGLLYLHEDCRA 640
                +  N  +V E++  G + S L   G   +P+       A QI     YLH     
Sbjct: 107 EYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF---YAAQIVLTFEYLHS---L 160
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            +I+ D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE   +   
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 701 TAKVDVYSFGVLLLEIISCRKSF 723
              VD ++ GVL+ E+ +    F
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGEREFK-NEVFVIGQTHHKNLVRL 583
           +G GSFG V   +++ + +    A+K LD+  V +  + E   NE  ++   +   LV+L
Sbjct: 49  LGTGSFGRVM--LVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNL-KPNWNLRTNIAFQIARGLLYLHEDCRA 640
                +  N  +V E++  G + S L   G   +P+       A QI     YLH     
Sbjct: 107 EYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF---YAAQIVLTFEYLHS---L 160
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            +I+ D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE   +   
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 701 TAKVDVYSFGVLLLEIISCRKSF 723
              VD ++ GVL+ E+ +    F
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGEREFK-NEVFVIGQTHHKNLVRL 583
           +G GSFG V   +++ + +    A+K LD+  V +  + E   NE  ++   +   LV+L
Sbjct: 42  LGTGSFGRVM--LVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 99
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNL-KPNWNLRTNIAFQIARGLLYLHEDCRA 640
                +  N  +V E++  G + S L   G   +P+       A QI     YLH     
Sbjct: 100 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF---YAAQIVLTFEYLHS---L 153
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            +I+ D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE   +   
Sbjct: 154 DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGY 208
Query: 701 TAKVDVYSFGVLLLEIISCRKSF 723
              VD ++ GVL+ E+ +    F
Sbjct: 209 NKAVDWWALGVLIYEMAAGYPPF 231

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 66/274 (24%), Positives = 112/274 (40%), Gaps = 45/274 (16%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE----REFKNEVFVIGQTHH--KNL 580
           +G G FG VY G+  +     A+   + DR+   GE         EV ++ +       +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA----FQIARGLLYLHE 636
           +RLL + +   + +L+   L        LF  +     L+  +A    +Q+   + + H 
Sbjct: 72  IRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN 128
Query: 637 DCRAQIIHCDIKPQNILLD-DYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
                ++H DIK +NIL+D +    ++ DFG   LL      T+ T   GT+ Y  PEW 
Sbjct: 129 ---XGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 181
Query: 696 RNSKITAK-VDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGED 754
           R  +   +   V+S G+LL +++      DI    +  I+    F   R           
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCG----DIPFEHDEEIIRGQVFFRQRVSX-------- 229
Query: 755 KEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKV 788
                  EC   +     WC+   PS RPT +++
Sbjct: 230 -------ECQHLIR----WCLALRPSDRPTFEEI 252

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 93/201 (46%), Gaps = 12/201 (5%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR---VFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G+G+FG V   +++ + +    A+K L +   + +D       E  V+  T H  L   
Sbjct: 13  LGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT-A 69
Query: 584 LGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQI 642
           L +  +  +RL  V E+ N G L   L                +I   L YLH      +
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS---RDV 126
Query: 643 IHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITA 702
           ++ DIK +N++LD     +I+DFGL K   ++   T+KT   GT  Y+APE   ++    
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFC-GTPEYLAPEVLEDNDYGR 184
Query: 703 KVDVYSFGVLLLEIISCRKSF 723
            VD +  GV++ E++  R  F
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPF 205

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGEREFK-NEVFVIGQTHHKNLVRL 583
           +G GSFG V   +++ + +    A+K LD+  V +  + E   NE  ++   +   LV+L
Sbjct: 50  LGTGSFGRVM--LVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNL-KPNWNLRTNIAFQIARGLLYLHEDCRA 640
                +  N  +V E++  G + S L   G   +P+       A QI     YLH     
Sbjct: 108 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF---YAAQIVLTFEYLHS---L 161
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            +I+ D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE   +   
Sbjct: 162 DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 701 TAKVDVYSFGVLLLEIISCRKSF 723
              VD ++ GVL+ E+ +    F
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 93/201 (46%), Gaps = 12/201 (5%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR---VFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G+G+FG V   +++ + +    A+K L +   + +D       E  V+  T H  L   
Sbjct: 16  LGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT-A 72
Query: 584 LGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQI 642
           L +  +  +RL  V E+ N G L   L                +I   L YLH      +
Sbjct: 73  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS---RDV 129
Query: 643 IHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITA 702
           ++ DIK +N++LD     +I+DFGL K   ++   T+KT   GT  Y+APE   ++    
Sbjct: 130 VYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFC-GTPEYLAPEVLEDNDYGR 187
Query: 703 KVDVYSFGVLLLEIISCRKSF 723
            VD +  GV++ E++  R  F
Sbjct: 188 AVDWWGLGVVMYEMMCGRLPF 208

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGEREFK-NEVFVIGQTHHKNLVRL 583
           +G GSFG V   +++ + +    A+K LD+  V +  + E   NE  ++   +   LV+L
Sbjct: 50  LGTGSFGRVM--LVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNL-KPNWNLRTNIAFQIARGLLYLHEDCRA 640
                +  N  +V E++  G + S L   G   +P+       A QI     YLH     
Sbjct: 108 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF---YAAQIVLTFEYLHS---L 161
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            +I+ D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE   +   
Sbjct: 162 DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 701 TAKVDVYSFGVLLLEIISCRKSF 723
              VD ++ GVL+ E+ +    F
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGEREFK-NEVFVIGQTHHKNLVRL 583
           +G GSFG V   +++ + +    A+K LD+  V +  + E   NE  ++   +   LV+L
Sbjct: 50  LGTGSFGRVM--LVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNL-KPNWNLRTNIAFQIARGLLYLHEDCRA 640
                +  N  +V E++  G + S L   G   +P+       A QI     YLH     
Sbjct: 108 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF---YAAQIVLTFEYLHS---L 161
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            +I+ D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE   +   
Sbjct: 162 DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 701 TAKVDVYSFGVLLLEIISCRKSF 723
              VD ++ GVL+ E+ +    F
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPF 239

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGEREFK-NEVFVIGQTHHKNLVRL 583
           +G GSFG V   +++ + +    A+K LD+  V +  + E   NE  ++   +   LV+L
Sbjct: 42  LGTGSFGRVM--LVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 99
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNL-KPNWNLRTNIAFQIARGLLYLHEDCRA 640
                +  N  +V E++  G + S L   G   +P+       A QI     YLH     
Sbjct: 100 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF---YAAQIVLTFEYLHS---L 153
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            +I+ D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE   +   
Sbjct: 154 DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGY 208
Query: 701 TAKVDVYSFGVLLLEIISCRKSF 723
              VD ++ GVL+ E+ +    F
Sbjct: 209 NKAVDWWALGVLIYEMAAGYPPF 231

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 95/203 (46%), Gaps = 19/203 (9%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGEREFK-NEVFVIGQTHHKNLVRL 583
           +G GSFG V   +++   +    A+K LD+  V +  E E   NE  ++   +   LV+L
Sbjct: 49  LGTGSFGRVM--LVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKL 106
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNL-KPNWNLRTNIAFQIARGLLYLHEDCRA 640
                +  N  +V E+   G + S L   G   +P+       A QI     YLH     
Sbjct: 107 EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF---YAAQIVLTFEYLHS---L 160
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            +I+ D+KP+N+++D     +++DFGLAK     + K     + GT  Y+APE   +   
Sbjct: 161 DLIYRDLKPENLMIDQQGYIQVTDFGLAK-----RVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 701 TAKVDVYSFGVLLLEIISCRKSF 723
              VD ++ GVL+ E+ +    F
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 22/203 (10%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE----REFKNEVFVIGQTHH--KNL 580
           +G G FG VY G+  +     A+   + DR+   GE         EV ++ +       +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA----FQIARGLLYLHE 636
           +RLL + +   + +L+   L        LF  +     L+  +A    +Q+   + + H 
Sbjct: 92  IRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH- 147
Query: 637 DCRAQIIHCDIKPQNILLD-DYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
           +C   ++H DIK +NIL+D +    ++ DFG   LL      T+ T   GT+ Y  PEW 
Sbjct: 148 NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 201
Query: 696 RNSKITAK-VDVYSFGVLLLEII 717
           R  +   +   V+S G+LL +++
Sbjct: 202 RYHRYHGRSAAVWSLGILLYDMV 224

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 96/205 (46%), Gaps = 18/205 (8%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV---FQDGEREFKNEVFVIG--QTHHKNLV 581
           +GRG FG VY G  +  T     A+K LD+     + GE    NE  ++    T     +
Sbjct: 197 IGRGGFGEVY-GCRKADTGKM-YAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254
Query: 582 RLLGFCDEGQNRL-LVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCR 639
             + +     ++L  + + +N G L   L  + +    ++R   A +I  GL ++H    
Sbjct: 255 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA-EIILGLEHMHNRF- 312
Query: 640 AQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNS- 698
             +++ D+KP NILLD++   RISD GLA     + SK    A  GT GY+APE  +   
Sbjct: 313 --VVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPEVLQKGV 366
Query: 699 KITAKVDVYSFGVLLLEIISCRKSF 723
              +  D +S G +L +++     F
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 96/205 (46%), Gaps = 18/205 (8%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV---FQDGEREFKNEVFVIG--QTHHKNLV 581
           +GRG FG VY G  +  T     A+K LD+     + GE    NE  ++    T     +
Sbjct: 197 IGRGGFGEVY-GCRKADTGKM-YAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254
Query: 582 RLLGFCDEGQNRL-LVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCR 639
             + +     ++L  + + +N G L   L  + +    ++R   A +I  GL ++H    
Sbjct: 255 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA-EIILGLEHMHNRF- 312
Query: 640 AQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNS- 698
             +++ D+KP NILLD++   RISD GLA     + SK    A  GT GY+APE  +   
Sbjct: 313 --VVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPEVLQKGV 366
Query: 699 KITAKVDVYSFGVLLLEIISCRKSF 723
              +  D +S G +L +++     F
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 77/165 (46%), Gaps = 24/165 (14%)
Query: 626 QIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRG 685
           Q  +G+ YLH +   ++IH D+K  N+ L+D    +I DFGLA  +  +  +  K  + G
Sbjct: 134 QTIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KKDLCG 188
Query: 686 TKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIE-MGEEYAILTDWAFDCYRN 744
           T  Y+APE       + +VD++S G +L  ++  +  F+   + E Y  +    +   R+
Sbjct: 189 TPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRH 248
Query: 745 GKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVL 789
             +N +       M                +  DP+LRP++ ++L
Sbjct: 249 --INPVASALIRRM----------------LHADPTLRPSVAELL 275

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 96/207 (46%), Gaps = 14/207 (6%)
Query: 527 VGRGSFGIVYKGVIQTRT---STTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G GS+G V K V+ + T       +  KK  R   +GE   K E+ ++ +  HKN+++L
Sbjct: 13  LGEGSYGKV-KEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 584 LG--FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF--QIARGLLYLHEDCR 639
           +   + +E Q   +V E+   G +   L    +  + +     +  Q+  GL YLH    
Sbjct: 72  VDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ-- 128
Query: 640 AQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSK 699
             I+H DIKP N+LL    T +IS  G+A+ L    +       +G+  +  PE      
Sbjct: 129 -GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLD 187
Query: 700 ITA--KVDVYSFGVLLLEIISCRKSFD 724
             +  KVD++S GV L  I +    F+
Sbjct: 188 TFSGFKVDIWSAGVTLYNITTGLYPFE 214

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 96/205 (46%), Gaps = 18/205 (8%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV---FQDGEREFKNEVFVIG--QTHHKNLV 581
           +GRG FG VY G  +  T     A+K LD+     + GE    NE  ++    T     +
Sbjct: 197 IGRGGFGEVY-GCRKADTGKM-YAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254
Query: 582 RLLGFCDEGQNRL-LVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCR 639
             + +     ++L  + + +N G L   L  + +    ++R   A +I  GL ++H    
Sbjct: 255 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA-EIILGLEHMHNRF- 312
Query: 640 AQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNS- 698
             +++ D+KP NILLD++   RISD GLA     + SK    A  GT GY+APE  +   
Sbjct: 313 --VVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPEVLQKGV 366
Query: 699 KITAKVDVYSFGVLLLEIISCRKSF 723
              +  D +S G +L +++     F
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 77/165 (46%), Gaps = 24/165 (14%)
Query: 626 QIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRG 685
           Q  +G+ YLH +   ++IH D+K  N+ L+D    +I DFGLA  +  +  +  K  + G
Sbjct: 150 QTIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KKDLCG 204
Query: 686 TKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIE-MGEEYAILTDWAFDCYRN 744
           T  Y+APE       + +VD++S G +L  ++  +  F+   + E Y  +    +   R+
Sbjct: 205 TPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRH 264
Query: 745 GKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVL 789
             +N +       M                +  DP+LRP++ ++L
Sbjct: 265 --INPVASALIRRM----------------LHADPTLRPSVAELL 291

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGEREFK-NEVFVIGQTHHKNLVRL 583
           +G GSFG V   +++ + S    A+K LD+  V +  + E   NE  ++   +   LV+L
Sbjct: 49  LGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNL-KPNWNLRTNIAFQIARGLLYLHEDCRA 640
                +  N  +V E++  G + S L   G   +P+       A QI     YLH     
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF---YAAQIVLTFEYLHS---L 160
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            +I+ D+KP+N+++D     +++DFG AK     + K     + GT  Y+APE   +   
Sbjct: 161 DLIYRDLKPENLIIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIIISKGY 215
Query: 701 TAKVDVYSFGVLLLEIISCRKSF 723
              VD ++ GVL+ E+ +    F
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 96/205 (46%), Gaps = 18/205 (8%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV---FQDGEREFKNEVFVIG--QTHHKNLV 581
           +GRG FG VY G  +  T     A+K LD+     + GE    NE  ++    T     +
Sbjct: 196 IGRGGFGEVY-GCRKADTGKM-YAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 253
Query: 582 RLLGFCDEGQNRL-LVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCR 639
             + +     ++L  + + +N G L   L  + +    ++R   A +I  GL ++H    
Sbjct: 254 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA-EIILGLEHMHNRF- 311
Query: 640 AQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNS- 698
             +++ D+KP NILLD++   RISD GLA     + SK    A  GT GY+APE  +   
Sbjct: 312 --VVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPEVLQKGV 365
Query: 699 KITAKVDVYSFGVLLLEIISCRKSF 723
              +  D +S G +L +++     F
Sbjct: 366 AYDSSADWFSLGCMLFKLLRGHSPF 390

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 95/203 (46%), Gaps = 19/203 (9%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGEREFK-NEVFVIGQTHHKNLVRL 583
           +G GSFG V   +++   +    A+K LD+  V +  + E   NE  ++   +   LV+L
Sbjct: 49  IGTGSFGRVM--LVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNL-KPNWNLRTNIAFQIARGLLYLHEDCRA 640
                +  N  +V E++  G + S L   G   +P+       A QI     YLH     
Sbjct: 107 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF---YAAQIVLTFEYLHS---L 160
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            +I+ D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE   +   
Sbjct: 161 DLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 701 TAKVDVYSFGVLLLEIISCRKSF 723
              VD ++ GVL+ E+ +    F
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 68/264 (25%), Positives = 114/264 (43%), Gaps = 43/264 (16%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREF--KNEVFVIGQTHHKNLVR 582
           +++G+G +G V+ G  + R    AV V      F   E  +  + E++      H+N++ 
Sbjct: 43  KQIGKGRYGEVWMG--KWRGEKVAVKV-----FFTTEEASWFRETEIYQTVLMRHENILG 95
Query: 583 LLGFCDEGQNR----LLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDC 638
            +    +G        L+ ++  NG+L  +L        ++   +A+    GL +LH + 
Sbjct: 96  FIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSM-LKLAYSSVSGLCHLHTEI 154
Query: 639 -----RAQIIHCDIKPQNILLDDYYTARISDFGLA-KLLTLNQSKTIKTAIR-GTKGYVA 691
                +  I H D+K +NIL+    T  I+D GLA K ++      I    R GTK Y+ 
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214
Query: 692 PEWFRNS------KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 745
           PE    S      +     D+YSFG++L E+   R+     + EEY +            
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEV--ARRCVSGGIVEEYQL------------ 260
Query: 746 KLNVLVGEDK--EAMNDIECLGKL 767
             + LV  D   E M +I C+ KL
Sbjct: 261 PYHDLVPSDPSYEDMREIVCIKKL 284

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR---VFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G+G+FG V   +++ + +    A+K L +   V +D       E  V+  + H  L   
Sbjct: 156 LGKGTFGKVI--LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT-A 212
Query: 584 LGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQI 642
           L +  +  +RL  V E+ N G L   L      + +       +I   L YLH +    +
Sbjct: 213 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE--KNV 270
Query: 643 IHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITA 702
           ++ D+K +N++LD     +I+DFGL K   +    T+KT   GT  Y+APE   ++    
Sbjct: 271 VYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFC-GTPEYLAPEVLEDNDYGR 328
Query: 703 KVDVYSFGVLLLEIISCRKSF 723
            VD +  GV++ E++  R  F
Sbjct: 329 AVDWWGLGVVMYEMMCGRLPF 349

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR---VFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G+G+FG V   +++ + +    A+K L +   V +D       E  V+  + H  L   
Sbjct: 159 LGKGTFGKVI--LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT-A 215
Query: 584 LGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQI 642
           L +  +  +RL  V E+ N G L   L      + +       +I   L YLH +    +
Sbjct: 216 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE--KNV 273
Query: 643 IHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITA 702
           ++ D+K +N++LD     +I+DFGL K   +    T+KT   GT  Y+APE   ++    
Sbjct: 274 VYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFC-GTPEYLAPEVLEDNDYGR 331
Query: 703 KVDVYSFGVLLLEIISCRKSF 723
            VD +  GV++ E++  R  F
Sbjct: 332 AVDWWGLGVVMYEMMCGRLPF 352

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGEREFK-NEVFVIGQTHHKNLVRL 583
           +G GSFG V   +++ + S    A+K LD+  V +  + E   NE  ++   +   LV+L
Sbjct: 49  LGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNL-KPNWNLRTNIAFQIARGLLYLHEDCRA 640
                +  N  +V E++  G + S L   G   +P+       A QI     YLH     
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF---YAAQIVLTFEYLHS---L 160
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            +I+ D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE   +   
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 701 TAKVDVYSFGVLLLEIISCRKSF 723
              VD ++ GVL+ ++ +    F
Sbjct: 216 NKAVDWWALGVLIYQMAAGYPPF 238

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 95/192 (49%), Gaps = 24/192 (12%)
Query: 514 KELEGATNNFK--EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGE----REF 565
           KE+    ++F+  + +GRG+F  V   V++ + +    A+K +++  + + GE    RE 
Sbjct: 54  KEVRLQRDDFEILKVIGRGAFSEV--AVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFRE- 110
Query: 566 KNEVFVIGQTHHKNLVRLLGFCDEGQNRL-LVYEFLNNGTLASFL--FGNLKPNWNLRTN 622
           + +V V G    +  +  L F  + +N L LV E+   G L + L  FG   P    R  
Sbjct: 111 ERDVLVNGD---RRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMAR-- 165
Query: 623 IAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTA 682
             F +A  ++ +    R   +H DIKP NILLD     R++DFG    L L    T+++ 
Sbjct: 166 --FYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFG--SCLKLRADGTVRSL 221
Query: 683 IR-GTKGYVAPE 693
           +  GT  Y++PE
Sbjct: 222 VAVGTPDYLSPE 233

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 93/206 (45%), Gaps = 19/206 (9%)
Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE--FKNEVFVIGQTHHKNLVRL 583
           E+GRG++G V K V   + S   +AVK++     + E++    +   V+  +    +V+ 
Sbjct: 29  EIGRGAYGSVNKMV--HKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQF 86
Query: 584 LGFCDEGQNRLLVYEFLNNG-----TLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDC 638
            G      +  +  E ++            +  ++ P   +   I     + L +L E+ 
Sbjct: 87  YGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPE-EILGKITLATVKALNHLKENL 145
Query: 639 RAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNS 698
           +  IIH DIKP NILLD     ++ DFG++  L  + +KT      G + Y+APE    S
Sbjct: 146 K--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDA---GCRPYMAPERIDPS 200
Query: 699 K----ITAKVDVYSFGVLLLEIISCR 720
                   + DV+S G+ L E+ + R
Sbjct: 201 ASRQGYDVRSDVWSLGITLYELATGR 226

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 95/203 (46%), Gaps = 19/203 (9%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGEREFK-NEVFVIGQTHHKNLVRL 583
           +G GSFG V   +++   +    A+K LD+  V +  + E   NE  ++   +   LV+L
Sbjct: 50  LGTGSFGRVM--LVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNL-KPNWNLRTNIAFQIARGLLYLHEDCRA 640
                +  N  +V E++  G + S L   G   +P+       A QI     YLH     
Sbjct: 108 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF---YAAQIVLTFEYLHS---L 161
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            +I+ D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE   +   
Sbjct: 162 DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEYLAPEIILSKGY 216
Query: 701 TAKVDVYSFGVLLLEIISCRKSF 723
              VD ++ GVL+ E+ +    F
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 95/203 (46%), Gaps = 19/203 (9%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGEREFK-NEVFVIGQTHHKNLVRL 583
           +G GSFG V   +++ + +    A+K LD+  V +  + E   NE  ++   +   LV+L
Sbjct: 50  LGTGSFGRVM--LVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNL-KPNWNLRTNIAFQIARGLLYLHEDCRA 640
                +  N  +V E+   G + S L   G   +P+       A QI     YLH     
Sbjct: 108 EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF---YAAQIVLTFEYLHS---L 161
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            +I+ D+KP+N+++D     +++DFG AK     + K     + GT  Y+APE   +   
Sbjct: 162 DLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 701 TAKVDVYSFGVLLLEIISCRKSF 723
              VD ++ GVL+ E+ +    F
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 95/203 (46%), Gaps = 19/203 (9%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGEREFK-NEVFVIGQTHHKNLVRL 583
           +G GSFG V   +++   +    A+K LD+  V +  + E   NE  ++   +   LV+L
Sbjct: 50  LGTGSFGRVM--LVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNL-KPNWNLRTNIAFQIARGLLYLHEDCRA 640
                +  N  +V E++  G + S L   G   +P+       A QI     YLH     
Sbjct: 108 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF---YAAQIVLTFEYLHS---L 161
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            +I+ D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE   +   
Sbjct: 162 DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 701 TAKVDVYSFGVLLLEIISCRKSF 723
              VD ++ GVL+ E+ +    F
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 95/203 (46%), Gaps = 19/203 (9%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGEREFK-NEVFVIGQTHHKNLVRL 583
           +G GSFG V   +++   +    A+K LD+  V +  + E   NE  ++   +   LV+L
Sbjct: 49  LGTGSFGRVM--LVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNL-KPNWNLRTNIAFQIARGLLYLHEDCRA 640
                +  N  +V E++  G + S L   G   +P+       A QI     YLH     
Sbjct: 107 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF---YAAQIVLTFEYLHS---L 160
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            +I+ D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE   +   
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 701 TAKVDVYSFGVLLLEIISCRKSF 723
              VD ++ GVL+ E+ +    F
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 95/203 (46%), Gaps = 19/203 (9%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGEREFK-NEVFVIGQTHHKNLVRL 583
           +G GSFG V   +++   +    A+K LD+  V +  + E   NE  ++   +   LV+L
Sbjct: 49  LGTGSFGRVM--LVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNL-KPNWNLRTNIAFQIARGLLYLHEDCRA 640
                +  N  +V E++  G + S L   G   +P+       A QI     YLH     
Sbjct: 107 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF---YAAQIVLTFEYLHS---L 160
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            +I+ D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE   +   
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 701 TAKVDVYSFGVLLLEIISCRKSF 723
              VD ++ GVL+ E+ +    F
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 95/203 (46%), Gaps = 19/203 (9%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGEREFK-NEVFVIGQTHHKNLVRL 583
           +G GSFG V   +++   +    A+K LD+  V +  + E   NE  ++   +   LV+L
Sbjct: 50  LGTGSFGRVM--LVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNL-KPNWNLRTNIAFQIARGLLYLHEDCRA 640
                +  N  +V E++  G + S L   G   +P+       A QI     YLH     
Sbjct: 108 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF---YAAQIVLTFEYLHS---L 161
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            +I+ D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE   +   
Sbjct: 162 DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 701 TAKVDVYSFGVLLLEIISCRKSF 723
              VD ++ GVL+ E+ +    F
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 95/203 (46%), Gaps = 19/203 (9%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGEREFK-NEVFVIGQTHHKNLVRL 583
           +G GSFG V   +++   +    A+K LD+  V +  + E   NE  ++   +   LV+L
Sbjct: 49  LGTGSFGRVM--LVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNL-KPNWNLRTNIAFQIARGLLYLHEDCRA 640
                +  N  +V E++  G + S L   G   +P+       A QI     YLH     
Sbjct: 107 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF---YAAQIVLTFEYLHS---L 160
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            +I+ D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE   +   
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 701 TAKVDVYSFGVLLLEIISCRKSF 723
              VD ++ GVL+ E+ +    F
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 92/201 (45%), Gaps = 12/201 (5%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR---VFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G+G+FG V   +++ + +    A+K L +   + +D       E  V+  T H  L   
Sbjct: 18  LGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT-A 74
Query: 584 LGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQI 642
           L +  +  +RL  V E+ N G L   L                +I   L YLH      +
Sbjct: 75  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS---RDV 131
Query: 643 IHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITA 702
           ++ DIK +N++LD     +I+DFGL K   ++   T+K    GT  Y+APE   ++    
Sbjct: 132 VYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFC-GTPEYLAPEVLEDNDYGR 189
Query: 703 KVDVYSFGVLLLEIISCRKSF 723
            VD +  GV++ E++  R  F
Sbjct: 190 AVDWWGLGVVMYEMMCGRLPF 210

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 95/203 (46%), Gaps = 19/203 (9%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGEREFK-NEVFVIGQTHHKNLVRL 583
           +G GSFG V   +++   +    A+K LD+  V +  + E   NE  ++   +   LV+L
Sbjct: 49  LGTGSFGRVM--LVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNL-KPNWNLRTNIAFQIARGLLYLHEDCRA 640
                +  N  +V E++  G + S L   G   +P+       A QI     YLH     
Sbjct: 107 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF---YAAQIVLTFEYLHS---L 160
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            +I+ D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE   +   
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 701 TAKVDVYSFGVLLLEIISCRKSF 723
              VD ++ GVL+ E+ +    F
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 95/203 (46%), Gaps = 19/203 (9%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGEREFK-NEVFVIGQTHHKNLVRL 583
           +G GSFG V   +++   +    A+K LD+  V +  + E   NE  ++   +   LV+L
Sbjct: 49  LGTGSFGRVM--LVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNL-KPNWNLRTNIAFQIARGLLYLHEDCRA 640
                +  N  +V E++  G + S L   G   +P+       A QI     YLH     
Sbjct: 107 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF---YAAQIVLTFEYLHS---L 160
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            +I+ D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE   +   
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 701 TAKVDVYSFGVLLLEIISCRKSF 723
              VD ++ GVL+ E+ +    F
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 95/203 (46%), Gaps = 19/203 (9%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGEREFK-NEVFVIGQTHHKNLVRL 583
           +G GSFG V   +++   +    A+K LD+  V +  + E   NE  ++   +   LV+L
Sbjct: 35  LGTGSFGRVM--LVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 92
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNL-KPNWNLRTNIAFQIARGLLYLHEDCRA 640
                +  N  +V E++  G + S L   G   +P+       A QI     YLH     
Sbjct: 93  EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF---YAAQIVLTFEYLHS---L 146
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            +I+ D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE   +   
Sbjct: 147 DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEYLAPEIILSKGY 201
Query: 701 TAKVDVYSFGVLLLEIISCRKSF 723
              VD ++ GVL+ E+ +    F
Sbjct: 202 NKAVDWWALGVLIYEMAAGYPPF 224

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 95/203 (46%), Gaps = 19/203 (9%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGEREFK-NEVFVIGQTHHKNLVRL 583
           +G GSFG V   +++   +    A+K LD+  V +  + E   NE  ++   +   LV+L
Sbjct: 49  LGTGSFGRVM--LVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNL-KPNWNLRTNIAFQIARGLLYLHEDCRA 640
                +  N  +V E++  G + S L   G   +P+       A QI     YLH     
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF---YAAQIVLTFEYLHS---L 160
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            +I+ D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE   +   
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 701 TAKVDVYSFGVLLLEIISCRKSF 723
              VD ++ GVL+ E+ +    F
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 95/203 (46%), Gaps = 19/203 (9%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGEREFK-NEVFVIGQTHHKNLVRL 583
           +G GSFG V   +++ + S    A+K LD+  V +  + E   NE  ++   +   LV+L
Sbjct: 49  LGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNL-KPNWNLRTNIAFQIARGLLYLHEDCRA 640
                +  N  +V E++  G + S L   G   +P+       A QI     YLH     
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF---YAAQIVLTFEYLHS---L 160
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            +I+ D+KP+N+L+D     +++DFG AK     + K     + GT  Y+AP    +   
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPAIILSKGY 215
Query: 701 TAKVDVYSFGVLLLEIISCRKSF 723
              VD ++ GVL+ E+ +    F
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/217 (22%), Positives = 101/217 (46%), Gaps = 22/217 (10%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD--GEREFKNEVFVIGQTHHKN 579
             K  +G G++G+V       + +   VA+KK++   +     R  + E+ ++    H+N
Sbjct: 14  QLKSLLGEGAYGVVCSAT--HKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKHEN 70
Query: 580 LVRLLGFCD----EGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLH 635
           ++ +         E  N + + + L    L   +   +  + +++  I +Q  R +  LH
Sbjct: 71  IITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFI-YQTLRAVKVLH 129
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIR--GTKGYVAPE 693
               + +IH D+KP N+L++     ++ DFGLA+++  + +   +   +  G   YVA  
Sbjct: 130 G---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATR 186
Query: 694 WFR-------NSKITAKVDVYSFGVLLLEIISCRKSF 723
           W+R       ++K +  +DV+S G +L E+   R  F
Sbjct: 187 WYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIF 223

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 96/201 (47%), Gaps = 20/201 (9%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVK---KLDRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +GRG+FG V   +++ +++    A+K   K + + +     F  E  ++   +   +V+L
Sbjct: 77  IGRGAFGEV--QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 134
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA-FQIARGLLYLHEDCRAQI 642
                + +   +V E++  G L      NL  N+++    A F  A  +L L        
Sbjct: 135 FYAFQDDRYLYMVMEYMPGGDLV-----NLMSNYDVPEKWARFYTAEVVLALDAIHSMGF 189
Query: 643 IHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIK--TAIRGTKGYVAPEWFR---- 696
           IH D+KP N+LLD     +++DFG    + +N+   ++  TA+ GT  Y++PE  +    
Sbjct: 190 IHRDVKPDNMLLDKSGHLKLADFGTC--MKMNKEGMVRCDTAV-GTPDYISPEVLKSQGG 246
Query: 697 NSKITAKVDVYSFGVLLLEII 717
           +     + D +S GV L E++
Sbjct: 247 DGYYGRECDWWSVGVFLYEML 267

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 96/201 (47%), Gaps = 20/201 (9%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVK---KLDRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +GRG+FG V   +++ +++    A+K   K + + +     F  E  ++   +   +V+L
Sbjct: 82  IGRGAFGEV--QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 139
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA-FQIARGLLYLHEDCRAQI 642
                + +   +V E++  G L      NL  N+++    A F  A  +L L        
Sbjct: 140 FYAFQDDRYLYMVMEYMPGGDLV-----NLMSNYDVPEKWARFYTAEVVLALDAIHSMGF 194
Query: 643 IHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIK--TAIRGTKGYVAPEWFR---- 696
           IH D+KP N+LLD     +++DFG    + +N+   ++  TA+ GT  Y++PE  +    
Sbjct: 195 IHRDVKPDNMLLDKSGHLKLADFGTC--MKMNKEGMVRCDTAV-GTPDYISPEVLKSQGG 251
Query: 697 NSKITAKVDVYSFGVLLLEII 717
           +     + D +S GV L E++
Sbjct: 252 DGYYGRECDWWSVGVFLYEML 272

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 92/201 (45%), Gaps = 12/201 (5%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR---VFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G+G+FG V   +++ + +    A+K L +   + +D       E  V+  T H  L   
Sbjct: 13  LGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT-A 69
Query: 584 LGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQI 642
           L +  +  +RL  V E+ N G L   L                +I   L YLH      +
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS---RDV 126
Query: 643 IHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITA 702
           ++ DIK +N++LD     +I+DFGL K   ++   T+K    GT  Y+APE   ++    
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFC-GTPEYLAPEVLEDNDYGR 184
Query: 703 KVDVYSFGVLLLEIISCRKSF 723
            VD +  GV++ E++  R  F
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPF 205

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 96/201 (47%), Gaps = 20/201 (9%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVK---KLDRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +GRG+FG V   +++ +++    A+K   K + + +     F  E  ++   +   +V+L
Sbjct: 82  IGRGAFGEV--QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 139
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA-FQIARGLLYLHEDCRAQI 642
                + +   +V E++  G L      NL  N+++    A F  A  +L L        
Sbjct: 140 FYAFQDDRYLYMVMEYMPGGDLV-----NLMSNYDVPEKWARFYTAEVVLALDAIHSMGF 194
Query: 643 IHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIK--TAIRGTKGYVAPEWFR---- 696
           IH D+KP N+LLD     +++DFG    + +N+   ++  TA+ GT  Y++PE  +    
Sbjct: 195 IHRDVKPDNMLLDKSGHLKLADFGTC--MKMNKEGMVRCDTAV-GTPDYISPEVLKSQGG 251
Query: 697 NSKITAKVDVYSFGVLLLEII 717
           +     + D +S GV L E++
Sbjct: 252 DGYYGRECDWWSVGVFLYEML 272

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 92/201 (45%), Gaps = 12/201 (5%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR---VFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G+G+FG V   +++ + +    A+K L +   + +D       E  V+  T H  L   
Sbjct: 13  LGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT-A 69
Query: 584 LGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQI 642
           L +  +  +RL  V E+ N G L   L                +I   L YLH      +
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS---RDV 126
Query: 643 IHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITA 702
           ++ DIK +N++LD     +I+DFGL K   ++   T+K    GT  Y+APE   ++    
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFC-GTPEYLAPEVLEDNDYGR 184
Query: 703 KVDVYSFGVLLLEIISCRKSF 723
            VD +  GV++ E++  R  F
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPF 205

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 92/201 (45%), Gaps = 12/201 (5%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR---VFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G+G+FG V   +++ + +    A+K L +   + +D       E  V+  T H  L   
Sbjct: 13  LGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT-A 69
Query: 584 LGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQI 642
           L +  +  +RL  V E+ N G L   L                +I   L YLH      +
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS---RDV 126
Query: 643 IHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITA 702
           ++ DIK +N++LD     +I+DFGL K   ++   T+K    GT  Y+APE   ++    
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFC-GTPEYLAPEVLEDNDYGR 184
Query: 703 KVDVYSFGVLLLEIISCRKSF 723
            VD +  GV++ E++  R  F
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPF 205

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 89/195 (45%), Gaps = 18/195 (9%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGER---EFKNEVFVIGQTHHKNLV 581
           +++G G+FG+    +++ + S   VAVK ++R    GE+     K E+       H N+V
Sbjct: 25  KDIGSGNFGVAR--LMRDKQSNELVAVKYIER----GEKIDENVKREIINHRSLRHPNIV 78
Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ 641
           R         +  +V E+ + G L   +    + + +       Q+  G+ Y H     Q
Sbjct: 79  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA---MQ 135
Query: 642 IIHCDIKPQNILLDDYYTAR--ISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSK 699
           + H D+K +N LLD     R  I  FG +K   L+     K+ + GT  Y+APE     +
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQP--KSTV-GTPAYIAPEVLLKKE 192
Query: 700 ITAKV-DVYSFGVLL 713
              KV DV+S GV L
Sbjct: 193 YDGKVADVWSCGVTL 207

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 11/201 (5%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR---VFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G+G+FG V   +++ + +    A+K L +   V +D       E  V+  + H  L   
Sbjct: 18  LGKGTFGKVI--LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT-A 74
Query: 584 LGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQI 642
           L +  +  +RL  V E+ N G L   L      + +       +I   L YLH +    +
Sbjct: 75  LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE--KNV 132
Query: 643 IHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITA 702
           ++ D+K +N++LD     +I+DFGL K   +    T+K    GT  Y+APE   ++    
Sbjct: 133 VYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKXFC-GTPEYLAPEVLEDNDYGR 190
Query: 703 KVDVYSFGVLLLEIISCRKSF 723
            VD +  GV++ E++  R  F
Sbjct: 191 AVDWWGLGVVMYEMMCGRLPF 211

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 92/222 (41%), Gaps = 42/222 (18%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE-----------REFKNEVFVIGQT 575
           +  GS+G V  GV    +    VA+K++     DG            +    E+ ++   
Sbjct: 30  ISSGSYGAVCAGV---DSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF 86
Query: 576 HHKNLVRL----LGFCDEGQNRLLVYEFLNNGTLASFLFGN---LKPNWNLRTNIAFQIA 628
           HH N++ L    + F +   ++L +   L    LA  +      + P         + I 
Sbjct: 87  HHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHI--QYFMYHIL 144
Query: 629 RGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKG 688
            GL  LHE   A ++H D+ P NILL D     I DF LA+  T + +KT          
Sbjct: 145 LGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKT---------H 192
Query: 689 YVAPEWFRNSKI-------TAKVDVYSFGVLLLEIISCRKSF 723
           YV   W+R  ++       T  VD++S G ++ E+ + +  F
Sbjct: 193 YVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALF 234

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 102/203 (50%), Gaps = 19/203 (9%)
Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHH-KNLVRLL 584
           ++GRG +  V++ +    T+   V VK L  V ++   + K E+ ++       N++ L 
Sbjct: 44  KLGRGKYSEVFEAI--NITNNEKVVVKILKPVKKN---KIKREIKILENLRGGPNIITLA 98
Query: 585 GFCDEGQNRL--LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQI 642
               +  +R   LV+E +NN      L+  L  ++++R  + ++I + L Y H      I
Sbjct: 99  DIVKDPVSRTPALVFEHVNNTDFKQ-LYQTLT-DYDIRFYM-YEILKALDYCHS---MGI 152
Query: 643 IHCDIKPQNILLD-DYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI- 700
           +H D+KP N+++D ++   R+ D+GLA+     Q   ++ A R  KG   PE   + ++ 
Sbjct: 153 MHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG---PELLVDYQMY 209
Query: 701 TAKVDVYSFGVLLLEIISCRKSF 723
              +D++S G +L  +I  ++ F
Sbjct: 210 DYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 11/201 (5%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR---VFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G+G+FG V   +++ + +    A+K L +   V +D       E  V+  + H  L   
Sbjct: 17  LGKGTFGKVI--LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT-A 73
Query: 584 LGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQI 642
           L +  +  +RL  V E+ N G L   L      + +       +I   L YLH +    +
Sbjct: 74  LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE--KNV 131
Query: 643 IHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITA 702
           ++ D+K +N++LD     +I+DFGL K   +    T+K    GT  Y+APE   ++    
Sbjct: 132 VYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKXFC-GTPEYLAPEVLEDNDYGR 189
Query: 703 KVDVYSFGVLLLEIISCRKSF 723
            VD +  GV++ E++  R  F
Sbjct: 190 AVDWWGLGVVMYEMMCGRLPF 210

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 11/201 (5%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR---VFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G+G+FG V   +++ + +    A+K L +   V +D       E  V+  + H  L   
Sbjct: 16  LGKGTFGKVI--LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT-A 72
Query: 584 LGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQI 642
           L +  +  +RL  V E+ N G L   L      + +       +I   L YLH +    +
Sbjct: 73  LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE--KNV 130
Query: 643 IHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITA 702
           ++ D+K +N++LD     +I+DFGL K   +    T+K    GT  Y+APE   ++    
Sbjct: 131 VYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKXFC-GTPEYLAPEVLEDNDYGR 188
Query: 703 KVDVYSFGVLLLEIISCRKSF 723
            VD +  GV++ E++  R  F
Sbjct: 189 AVDWWGLGVVMYEMMCGRLPF 209

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 92/222 (41%), Gaps = 42/222 (18%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE-----------REFKNEVFVIGQT 575
           +  GS+G V  GV    +    VA+K++     DG            +    E+ ++   
Sbjct: 30  ISSGSYGAVCAGV---DSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF 86
Query: 576 HHKNLVRL----LGFCDEGQNRLLVYEFLNNGTLASFLFGN---LKPNWNLRTNIAFQIA 628
           HH N++ L    + F +   ++L +   L    LA  +      + P         + I 
Sbjct: 87  HHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHI--QYFMYHIL 144
Query: 629 RGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKG 688
            GL  LHE   A ++H D+ P NILL D     I DF LA+  T + +KT          
Sbjct: 145 LGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKT---------H 192
Query: 689 YVAPEWFRNSKI-------TAKVDVYSFGVLLLEIISCRKSF 723
           YV   W+R  ++       T  VD++S G ++ E+ + +  F
Sbjct: 193 YVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALF 234

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 81/171 (47%), Gaps = 35/171 (20%)
Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE-----FKNEVFVIGQTHHKNL 580
           ++G+G+FG V+K   + R +   VA+KK   V  + E+E        E+ ++    H+N+
Sbjct: 25  KIGQGTFGEVFKA--RHRKTGQKVALKK---VLMENEKEGFPITALREIKILQLLKHENV 79
Query: 581 VRLLGFCDEGQ---NRL-----LVYEF-------LNNGTLASFLFGNLKPNWNLRTNIAF 625
           V L+  C       NR      LV++F       L +  L  F    +K    +  N   
Sbjct: 80  VNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN--- 136
Query: 626 QIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS 676
               GL Y+H   R +I+H D+K  N+L+      +++DFGLA+  +L ++
Sbjct: 137 ----GLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 180

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 81/171 (47%), Gaps = 35/171 (20%)
Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE-----FKNEVFVIGQTHHKNL 580
           ++G+G+FG V+K   + R +   VA+KK   V  + E+E        E+ ++    H+N+
Sbjct: 24  KIGQGTFGEVFKA--RHRKTGQKVALKK---VLMENEKEGFPITALREIKILQLLKHENV 78
Query: 581 VRLLGFCDEGQ---NR-----LLVYEF-------LNNGTLASFLFGNLKPNWNLRTNIAF 625
           V L+  C       NR      LV++F       L +  L  F    +K    +  N   
Sbjct: 79  VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN--- 135
Query: 626 QIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS 676
               GL Y+H   R +I+H D+K  N+L+      +++DFGLA+  +L ++
Sbjct: 136 ----GLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 179

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 81/171 (47%), Gaps = 35/171 (20%)
Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE-----FKNEVFVIGQTHHKNL 580
           ++G+G+FG V+K   + R +   VA+KK   V  + E+E        E+ ++    H+N+
Sbjct: 25  KIGQGTFGEVFKA--RHRKTGQKVALKK---VLMENEKEGFPITALREIKILQLLKHENV 79
Query: 581 VRLLGFCDEGQ---NR-----LLVYEF-------LNNGTLASFLFGNLKPNWNLRTNIAF 625
           V L+  C       NR      LV++F       L +  L  F    +K    +  N   
Sbjct: 80  VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN--- 136
Query: 626 QIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS 676
               GL Y+H   R +I+H D+K  N+L+      +++DFGLA+  +L ++
Sbjct: 137 ----GLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 180

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 94/203 (46%), Gaps = 19/203 (9%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGEREFK-NEVFVIGQTHHKNLVRL 583
           +G GSFG V   +++ + +    A+K LD+  V +  + E   NE  +    +   LV+L
Sbjct: 50  LGTGSFGRVM--LVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNFPFLVKL 107
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNL-KPNWNLRTNIAFQIARGLLYLHEDCRA 640
                +  N  +V E+   G + S L   G   +P+       A QI     YLH     
Sbjct: 108 EFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARF---YAAQIVLTFEYLHS---L 161
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            +I+ D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE   +   
Sbjct: 162 DLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 701 TAKVDVYSFGVLLLEIISCRKSF 723
              VD ++ GVL+ E+ +    F
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPF 239

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 79/168 (47%), Gaps = 35/168 (20%)
Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE-----FKNEVFVIGQTHHKNL 580
           ++G+G+FG V+K   + R +   VA+KK   V  + E+E        E+ ++    H+N+
Sbjct: 25  KIGQGTFGEVFKA--RHRKTGQKVALKK---VLMENEKEGFPITALREIKILQLLKHENV 79
Query: 581 VRLLGFCDEGQ---NR-----LLVYEF-------LNNGTLASFLFGNLKPNWNLRTNIAF 625
           V L+  C       NR      LV++F       L +  L  F    +K    +  N   
Sbjct: 80  VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN--- 136
Query: 626 QIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTL 673
               GL Y+H   R +I+H D+K  N+L+      +++DFGLA+  +L
Sbjct: 137 ----GLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSL 177

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 37/218 (16%)
Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE--FKN-EVFVIGQTHHKN 579
            +E +G+G FG V++G    +     VAVK    +F   E    F+  E++      H+N
Sbjct: 46  LQESIGKGRFGEVWRG----KWRGEEVAVK----IFSSREERSWFREAEIYQTVMLRHEN 97
Query: 580 LVRLLGFC-----DEGQ--NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLL 632
           +   LGF      D G      LV ++  +G+L  +L             +A   A GL 
Sbjct: 98  I---LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLA 153
Query: 633 YLHEDC-----RAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIR--- 684
           +LH +      +  I H D+K +NIL+    T  I+D GLA +   + + TI  A     
Sbjct: 154 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRV 212
Query: 685 GTKGYVAPEWFRNS------KITAKVDVYSFGVLLLEI 716
           GTK Y+APE   +S      +   + D+Y+ G++  EI
Sbjct: 213 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 94/203 (46%), Gaps = 19/203 (9%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGEREFK-NEVFVIGQTHHKNLVRL 583
           +G GSFG V   +++   +    A+K LD+  V +  + E   NE  ++   +   LV+L
Sbjct: 49  LGTGSFGRVM--LVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNL-KPNWNLRTNIAFQIARGLLYLHEDCRA 640
                +  N  +V E+   G + S L   G   +P+       A QI     YLH     
Sbjct: 107 EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF---YAAQIVLTFEYLHS---L 160
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            +I+ D+KP+N+++D     +++DFG AK     + K     + GT  Y+APE   +   
Sbjct: 161 DLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 701 TAKVDVYSFGVLLLEIISCRKSF 723
              VD ++ GVL+ E+ +    F
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 40/137 (29%), Positives = 64/137 (46%), Gaps = 12/137 (8%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVF---VIGQTHHKNLV 581
           E++G G FG V+K V +      A+   K        E+    EV+   V+GQ  H ++V
Sbjct: 15  EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ--HSHVV 72
Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR----TNIAFQIARGLLYLHED 637
           R      E  + L+  E+ N G+LA  +  N +     +     ++  Q+ RGL Y+H  
Sbjct: 73  RYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS- 131
Query: 638 CRAQIIHCDIKPQNILL 654
               ++H DIKP NI +
Sbjct: 132 --MSLVHMDIKPSNIFI 146

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 37/218 (16%)
Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE--FKN-EVFVIGQTHHKN 579
            +E +G+G FG V++G    +     VAVK    +F   E    F+  E++      H+N
Sbjct: 13  LQESIGKGRFGEVWRG----KWRGEEVAVK----IFSSREERSWFREAEIYQTVMLRHEN 64
Query: 580 LVRLLGFC-----DEGQ--NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLL 632
           +   LGF      D G      LV ++  +G+L  +L             +A   A GL 
Sbjct: 65  I---LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLA 120
Query: 633 YLHEDC-----RAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIR--- 684
           +LH +      +  I H D+K +NIL+    T  I+D GLA +   + + TI  A     
Sbjct: 121 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRV 179
Query: 685 GTKGYVAPEWFRNS------KITAKVDVYSFGVLLLEI 716
           GTK Y+APE   +S      +   + D+Y+ G++  EI
Sbjct: 180 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 40/137 (29%), Positives = 64/137 (46%), Gaps = 12/137 (8%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVF---VIGQTHHKNLV 581
           E++G G FG V+K V +      A+   K        E+    EV+   V+GQ  H ++V
Sbjct: 17  EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ--HSHVV 74
Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR----TNIAFQIARGLLYLHED 637
           R      E  + L+  E+ N G+LA  +  N +     +     ++  Q+ RGL Y+H  
Sbjct: 75  RYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS- 133
Query: 638 CRAQIIHCDIKPQNILL 654
               ++H DIKP NI +
Sbjct: 134 --MSLVHMDIKPSNIFI 148

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 95/203 (46%), Gaps = 19/203 (9%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGEREFK-NEVFVIGQTHHKNLVRL 583
           +G GSFG V   +++ + S    A+K LD+  V +  + E   NE  ++   +   LV+L
Sbjct: 49  LGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNL-KPNWNLRTNIAFQIARGLLYLHEDCRA 640
                +  N  +V E++  G + S L   G   +P+       A QI     YLH     
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF---YAAQIVLTFEYLHS---L 160
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            +I+ D+KP+N+L+D     +++DFG AK     + K     + GT   +APE   +   
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEALAPEIILSKGY 215
Query: 701 TAKVDVYSFGVLLLEIISCRKSF 723
              VD ++ GVL+ E+ +    F
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 94/203 (46%), Gaps = 19/203 (9%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGEREFK-NEVFVIGQTHHKNLVRL 583
           +G GSFG V   +++   +    A+K LD+  V +  + E   NE  ++   +   LV+L
Sbjct: 49  LGTGSFGRVM--LVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNL-KPNWNLRTNIAFQIARGLLYLHEDCRA 640
                +  N  +V E+   G + S L   G   +P+       A QI     YLH     
Sbjct: 107 EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARF---YAAQIVLTFEYLHS---L 160
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            +I+ D+KP+N+++D     +++DFG AK     + K     + GT  Y+APE   +   
Sbjct: 161 DLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 701 TAKVDVYSFGVLLLEIISCRKSF 723
              VD ++ GVL+ E+ +    F
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 40/137 (29%), Positives = 64/137 (46%), Gaps = 12/137 (8%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVF---VIGQTHHKNLV 581
           E++G G FG V+K V +      A+   K        E+    EV+   V+GQ  H ++V
Sbjct: 15  EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ--HSHVV 72
Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR----TNIAFQIARGLLYLHED 637
           R      E  + L+  E+ N G+LA  +  N +     +     ++  Q+ RGL Y+H  
Sbjct: 73  RYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS- 131
Query: 638 CRAQIIHCDIKPQNILL 654
               ++H DIKP NI +
Sbjct: 132 --MSLVHMDIKPSNIFI 146

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 94/214 (43%), Gaps = 33/214 (15%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFK-NEVFVIGQTHHKNLVRL 583
           E VG+G +G V++G  Q       VAVK      +D +  F+  E++      H+N+   
Sbjct: 43  ECVGKGRYGEVWRGSWQGEN----VAVKIFSS--RDEKSWFRETELYNTVMLRHENI--- 93
Query: 584 LGFC-------DEGQNRLLVYEFLNNGTLASFL-FGNLKPNWNLRTNIAFQIARGLLYLH 635
           LGF               L+  +   G+L  +L    L     LR  I   IA GL +LH
Sbjct: 94  LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLR--IVLSIASGLAHLH 151
Query: 636 EDC-----RAQIIHCDIKPQNILLDDYYTARISDFGLAKL--LTLNQSKTIKTAIRGTKG 688
            +      +  I H D+K +NIL+       I+D GLA +   + NQ         GTK 
Sbjct: 152 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 211
Query: 689 YVAPEWFRNSKIT------AKVDVYSFGVLLLEI 716
           Y+APE    +          +VD+++FG++L E+
Sbjct: 212 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 37/218 (16%)
Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE--FKN-EVFVIGQTHHKN 579
            +E +G+G FG V++G    +     VAVK    +F   E    F+  E++      H+N
Sbjct: 8   LQESIGKGRFGEVWRG----KWRGEEVAVK----IFSSREERSWFREAEIYQTVMLRHEN 59
Query: 580 LVRLLGFC-----DEGQ--NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLL 632
           +   LGF      D G      LV ++  +G+L  +L             +A   A GL 
Sbjct: 60  I---LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLA 115
Query: 633 YLHEDC-----RAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIR--- 684
           +LH +      +  I H D+K +NIL+    T  I+D GLA +   + + TI  A     
Sbjct: 116 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRV 174
Query: 685 GTKGYVAPEWFRNS------KITAKVDVYSFGVLLLEI 716
           GTK Y+APE   +S      +   + D+Y+ G++  EI
Sbjct: 175 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 37/218 (16%)
Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE--FKN-EVFVIGQTHHKN 579
            +E +G+G FG V++G    +     VAVK    +F   E    F+  E++      H+N
Sbjct: 10  LQESIGKGRFGEVWRG----KWRGEEVAVK----IFSSREERSWFREAEIYQTVMLRHEN 61
Query: 580 LVRLLGFC-----DEGQ--NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLL 632
           +   LGF      D G      LV ++  +G+L  +L             +A   A GL 
Sbjct: 62  I---LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLA 117
Query: 633 YLHEDC-----RAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIR--- 684
           +LH +      +  I H D+K +NIL+    T  I+D GLA +   + + TI  A     
Sbjct: 118 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRV 176
Query: 685 GTKGYVAPEWFRNS------KITAKVDVYSFGVLLLEI 716
           GTK Y+APE   +S      +   + D+Y+ G++  EI
Sbjct: 177 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 54/107 (50%), Gaps = 9/107 (8%)
Query: 622 NIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKT 681
            IA  I + L +LH   +  +IH D+KP N+L++     +  DFG++  L  + +K I  
Sbjct: 140 KIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDA 197
Query: 682 AIRGTKGYVAPEWFR---NSK-ITAKVDVYSFGVLLLEIISCRKSFD 724
              G K Y APE      N K  + K D++S G+  +E+   R  +D
Sbjct: 198 ---GCKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFPYD 241

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 89/195 (45%), Gaps = 18/195 (9%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGER---EFKNEVFVIGQTHHKNLV 581
           +++G G+FG+    +++ + S   VAVK ++R    GE+     K E+       H N+V
Sbjct: 25  KDIGSGNFGVAR--LMRDKQSNELVAVKYIER----GEKIDENVKREIINHRSLRHPNIV 78
Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ 641
           R         +  +V E+ + G L   +    + + +       Q+  G+ Y H     Q
Sbjct: 79  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA---MQ 135
Query: 642 IIHCDIKPQNILLDDYYTAR--ISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSK 699
           + H D+K +N LLD     R  I  FG +K   L+ S+   T   GT  Y+APE     +
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLH-SQPKDTV--GTPAYIAPEVLLKKE 192
Query: 700 ITAKV-DVYSFGVLL 713
              KV DV+S GV L
Sbjct: 193 YDGKVADVWSCGVTL 207

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 19/208 (9%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTH-HKNLVRL 583
           E +G G++  V   V  +  +    AVK +++           EV  + Q   +KN++ L
Sbjct: 19  ELLGEGAYAKVQGAV--SLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILEL 76
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
           + F ++     LV+E L  G++ + +      N    + +   +A  L +LH      I 
Sbjct: 77  IEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLH---TKGIA 133
Query: 644 HCDIKPQNILLDD---YYTARISDFGLAKLLTLNQSKTIKTAIR-----GTKGYVAPEWF 695
           H D+KP+NIL +        +I DF L   + LN S T  T        G+  Y+APE  
Sbjct: 134 HRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVV 193
Query: 696 RNSKITA-----KVDVYSFGVLLLEIIS 718
                 A     + D++S GV+L  ++S
Sbjct: 194 EVFTDQATFYDKRCDLWSLGVVLYIMLS 221

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 37/218 (16%)
Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE--FKN-EVFVIGQTHHKN 579
            +E +G+G FG V++G    +     VAVK    +F   E    F+  E++      H+N
Sbjct: 7   LQESIGKGRFGEVWRG----KWRGEEVAVK----IFSSREERSWFREAEIYQTVMLRHEN 58
Query: 580 LVRLLGFC-----DEGQ--NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLL 632
           +   LGF      D G      LV ++  +G+L  +L             +A   A GL 
Sbjct: 59  I---LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLA 114
Query: 633 YLHEDC-----RAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIR--- 684
           +LH +      +  I H D+K +NIL+    T  I+D GLA +   + + TI  A     
Sbjct: 115 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRV 173
Query: 685 GTKGYVAPEWFRNS------KITAKVDVYSFGVLLLEI 716
           GTK Y+APE   +S      +   + D+Y+ G++  EI
Sbjct: 174 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 37/218 (16%)
Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE--FKN-EVFVIGQTHHKN 579
            +E +G+G FG V++G    +     VAVK    +F   E    F+  E++      H+N
Sbjct: 33  LQESIGKGRFGEVWRG----KWRGEEVAVK----IFSSREERSWFREAEIYQTVMLRHEN 84
Query: 580 LVRLLGFC-----DEGQ--NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLL 632
           +   LGF      D G      LV ++  +G+L  +L             +A   A GL 
Sbjct: 85  I---LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLA 140
Query: 633 YLHEDC-----RAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIR--- 684
           +LH +      +  I H D+K +NIL+    T  I+D GLA +   + + TI  A     
Sbjct: 141 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRV 199
Query: 685 GTKGYVAPEWFRNS------KITAKVDVYSFGVLLLEI 716
           GTK Y+APE   +S      +   + D+Y+ G++  EI
Sbjct: 200 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/137 (29%), Positives = 64/137 (46%), Gaps = 12/137 (8%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVF---VIGQTHHKNLV 581
           E++G G FG V+K V +      A+   K        E+    EV+   V+GQ  H ++V
Sbjct: 13  EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ--HSHVV 70
Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR----TNIAFQIARGLLYLHED 637
           R      E  + L+  E+ N G+LA  +  N +     +     ++  Q+ RGL Y+H  
Sbjct: 71  RYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS- 129
Query: 638 CRAQIIHCDIKPQNILL 654
               ++H DIKP NI +
Sbjct: 130 --MSLVHMDIKPSNIFI 144

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 94/203 (46%), Gaps = 19/203 (9%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGEREFK-NEVFVIGQTHHKNLVRL 583
           +G GSFG V   +++   +    A+K LD+  V +  + E   NE  ++   +   LV+L
Sbjct: 49  LGTGSFGRVM--LVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNL-KPNWNLRTNIAFQIARGLLYLHEDCRA 640
                +  N  +V E+   G + S L   G   +P+       A QI     YLH     
Sbjct: 107 EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF---YAAQIVLTFEYLHS---L 160
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            +I+ D+KP+N+++D     +++DFG AK     + K     + GT  Y+APE   +   
Sbjct: 161 DLIYRDLKPENLMIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 701 TAKVDVYSFGVLLLEIISCRKSF 723
              VD ++ GVL+ E+ +    F
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 94/214 (43%), Gaps = 33/214 (15%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFK-NEVFVIGQTHHKNLVRL 583
           E VG+G +G V++G  Q       VAVK      +D +  F+  E++      H+N+   
Sbjct: 14  ECVGKGRYGEVWRGSWQGEN----VAVKIFSS--RDEKSWFRETELYNTVMLRHENI--- 64
Query: 584 LGFC-------DEGQNRLLVYEFLNNGTLASFL-FGNLKPNWNLRTNIAFQIARGLLYLH 635
           LGF               L+  +   G+L  +L    L     LR  I   IA GL +LH
Sbjct: 65  LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLR--IVLSIASGLAHLH 122
Query: 636 EDC-----RAQIIHCDIKPQNILLDDYYTARISDFGLAKL--LTLNQSKTIKTAIRGTKG 688
            +      +  I H D+K +NIL+       I+D GLA +   + NQ         GTK 
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182
Query: 689 YVAPEWFRNSKIT------AKVDVYSFGVLLLEI 716
           Y+APE    +          +VD+++FG++L E+
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 94/214 (43%), Gaps = 33/214 (15%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFK-NEVFVIGQTHHKNLVRL 583
           E VG+G +G V++G  Q       VAVK      +D +  F+  E++      H+N+   
Sbjct: 14  ECVGKGRYGEVWRGSWQGEN----VAVKIFSS--RDEKSWFRETELYNTVMLRHENI--- 64
Query: 584 LGFC-------DEGQNRLLVYEFLNNGTLASFL-FGNLKPNWNLRTNIAFQIARGLLYLH 635
           LGF               L+  +   G+L  +L    L     LR  I   IA GL +LH
Sbjct: 65  LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLR--IVLSIASGLAHLH 122
Query: 636 EDC-----RAQIIHCDIKPQNILLDDYYTARISDFGLAKL--LTLNQSKTIKTAIRGTKG 688
            +      +  I H D+K +NIL+       I+D GLA +   + NQ         GTK 
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182
Query: 689 YVAPEWFRNSKIT------AKVDVYSFGVLLLEI 716
           Y+APE    +          +VD+++FG++L E+
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 72/303 (23%), Positives = 123/303 (40%), Gaps = 47/303 (15%)
Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVR 582
           F +++G G F   Y  +++        A+K++    Q    E + E  +    +H N++R
Sbjct: 33  FIQKLGEGGFS--YVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILR 90
Query: 583 LLGFC--DEG--QNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN-----IAFQIARGLLY 633
           L+ +C  + G      L+  F   GTL + +   LK   N  T      +   I RGL  
Sbjct: 91  LVAYCLRERGAKHEAWLLLPFFKRGTLWNEI-ERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 634 LHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN-----QSKTIK--TAIRGT 686
           +H    A   H D+KP NILL D     + D G      ++     Q+ T++   A R T
Sbjct: 150 IHAKGYA---HRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 687 KGYVAPEWF---RNSKITAKVDVYSFGVLLLEIISCRKSFDI--EMGEEYAILTDWAFDC 741
             Y APE F    +  I  + DV+S G +L  ++     +D+  + G+  A+        
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSI 266
Query: 742 YRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVP 801
            ++ + +  + +   +M  +                DP  RP +  +L  LE +     P
Sbjct: 267 PQSPRHSSALWQLLNSMMTV----------------DPHQRPHIPLLLSQLEAL----QP 306
Query: 802 PNP 804
           P P
Sbjct: 307 PAP 309

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/217 (22%), Positives = 101/217 (46%), Gaps = 22/217 (10%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD--GEREFKNEVFVIGQTHHKN 579
             K  +G G++G+V       + +   VA+KK++   +     R  + E+ ++    H+N
Sbjct: 14  QLKSLLGEGAYGVVCSAT--HKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKHEN 70
Query: 580 LVRLLGFCD----EGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLH 635
           ++ +         E  N + + + L    L   +   +  + +++  I +Q  R +  LH
Sbjct: 71  IITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFI-YQTLRAVKVLH 129
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIR--GTKGYVAPE 693
               + +IH D+KP N+L++     ++ DFGLA+++  + +   +   +  G   +VA  
Sbjct: 130 G---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATR 186
Query: 694 WFR-------NSKITAKVDVYSFGVLLLEIISCRKSF 723
           W+R       ++K +  +DV+S G +L E+   R  F
Sbjct: 187 WYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIF 223

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 100/222 (45%), Gaps = 49/222 (22%)
Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFK-NEVFVIGQTHHKNLVRL 583
           E VG+G +G V++G+    +    VAVK      +D +  F+  E++      H N+   
Sbjct: 14  ECVGKGRYGEVWRGLWHGES----VAVKIFSS--RDEQSWFRETEIYNTVLLRHDNI--- 64
Query: 584 LGFC-------DEGQNRLLVYEFLNNGTLASFL-FGNLKPNWNLRTNIAFQIARGLLYLH 635
           LGF        +      L+  +  +G+L  FL    L+P+  LR  +A   A GL +LH
Sbjct: 65  LGFIASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLALR--LAVSAACGLAHLH 122
Query: 636 EDC-----RAQIIHCDIKPQNILLDDYYTARISDFGLAKL-------LTLNQSKTIKTAI 683
            +      +  I H D K +N+L+       I+D GLA +       L +  +  +    
Sbjct: 123 VEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRV---- 178
Query: 684 RGTKGYVAPE---------WFRNSKITAKVDVYSFGVLLLEI 716
            GTK Y+APE          F + K T   D+++FG++L EI
Sbjct: 179 -GTKRYMAPEVLDEQIRTDCFESYKWT---DIWAFGLVLWEI 216

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/217 (22%), Positives = 101/217 (46%), Gaps = 22/217 (10%)
Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD--GEREFKNEVFVIGQTHHKN 579
             K  +G G++G+V       + +   VA+KK++   +     R  + E+ ++    H+N
Sbjct: 14  QLKSLLGEGAYGVVCSAT--HKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKHEN 70
Query: 580 LVRLLGFCD----EGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLH 635
           ++ +         E  N + + + L    L   +   +  + +++  I +Q  R +  LH
Sbjct: 71  IITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFI-YQTLRAVKVLH 129
Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS--------KTIKTAIRGTK 687
               + +IH D+KP N+L++     ++ DFGLA+++  + +        ++  T    T+
Sbjct: 130 G---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATR 186
Query: 688 GYVAPE-WFRNSKITAKVDVYSFGVLLLEIISCRKSF 723
            Y APE    ++K +  +DV+S G +L E+   R  F
Sbjct: 187 WYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIF 223

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 19/203 (9%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGEREFK-NEVFVIGQTHHKNLVRL 583
           +G GSFG V   +++   +    A+K LD+  V +  + E   NE  ++   +   L +L
Sbjct: 50  LGTGSFGRVM--LVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKL 107
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNL-KPNWNLRTNIAFQIARGLLYLHEDCRA 640
                +  N  +V E+   G + S L   G   +P+       A QI     YLH     
Sbjct: 108 EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF---YAAQIVLTFEYLHS---L 161
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            +I+ D+KP+N+++D     +++DFG AK     + K     + GT  Y+APE   +   
Sbjct: 162 DLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 701 TAKVDVYSFGVLLLEIISCRKSF 723
              VD ++ GVL+ E+ +    F
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 19/203 (9%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGEREFK-NEVFVIGQTHHKNLVRL 583
           +G GSFG V   +++   +    A+K LD+  V +  + E   NE  ++   +   L +L
Sbjct: 50  LGTGSFGRVM--LVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKL 107
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNL-KPNWNLRTNIAFQIARGLLYLHEDCRA 640
                +  N  +V E+   G + S L   G   +P+       A QI     YLH     
Sbjct: 108 EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARF---YAAQIVLTFEYLHS---L 161
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            +I+ D+KP+N+++D     +++DFG AK     + K     + GT  Y+APE   +   
Sbjct: 162 DLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 701 TAKVDVYSFGVLLLEIISCRKSF 723
              VD ++ GVL+ E+ +    F
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 19/203 (9%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGEREFK-NEVFVIGQTHHKNLVRL 583
           +G GSFG V   +++   +    A+K LD+  V +  + E   NE  ++   +   L +L
Sbjct: 50  LGTGSFGRVM--LVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKL 107
Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNL-KPNWNLRTNIAFQIARGLLYLHEDCRA 640
                +  N  +V E+   G + S L   G   +P+       A QI     YLH     
Sbjct: 108 EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF---YAAQIVLTFEYLHS---L 161
Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            +I+ D+KP+N+++D     +++DFG AK     + K     + GT  Y+APE   +   
Sbjct: 162 DLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 701 TAKVDVYSFGVLLLEIISCRKSF 723
              VD ++ GVL+ E+ +    F
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 100/237 (42%), Gaps = 39/237 (16%)
Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEV-FVIGQTHHKNLVRLLG 585
           +  G F  VY+   Q   S    A+K+L    ++  R    EV F+   + H N+V+   
Sbjct: 36  LAEGGFAFVYEA--QDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQ--- 90
Query: 586 FC----------DEGQNRLLVYEFLNNGTLASFL-----FGNLKPNWNLRTNIAFQIARG 630
           FC          D GQ   L+   L  G L  FL      G L  +  L+  I +Q  R 
Sbjct: 91  FCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLK--IFYQTCRA 148
Query: 631 LLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLL--------TLNQSKTIKTA 682
           + ++H   +  IIH D+K +N+LL +  T ++ DFG A  +        +  +   ++  
Sbjct: 149 VQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207
Query: 683 I--RGTKGYVAPE---WFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL 734
           I    T  Y  PE    + N  I  K D+++ G +L   + C +    E G +  I+
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILY--LLCFRQHPFEDGAKLRIV 262
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	814
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-125
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-114
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-113
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-76
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-64
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	6e-63
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	7e-62
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	7e-60
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-58
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-57
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	4e-56
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-55
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	5e-55
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-54
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	7e-53
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-52
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-51
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-51
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	9e-42
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-41
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-40
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-39
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	4e-39
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-38
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-38
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-38
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-38
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	6e-38
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	8e-38
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-37
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-37
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-37
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-37
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-37
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-37
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-37
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	3e-37
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	5e-37
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	7e-37
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	7e-37
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-36
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-36
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-36
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-36
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-36
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-36
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-36
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-36
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-36
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-36
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-36
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-36
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	4e-36
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	4e-36
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	5e-36
3pls_A	298	Macrophage-stimulating protein receptor; protein k	6e-36
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	8e-36
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-35
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-35
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-35
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-35
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-35
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-35
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	4e-35
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	5e-35
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	5e-35
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	9e-35
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-34
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-34
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-34
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-34
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-34
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-34
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-34
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-34
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	6e-34
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	9e-34
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-33
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-33
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-33
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-33
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	4e-33
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	4e-33
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	5e-33
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	5e-33
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-32
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-32
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	4e-32
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-31
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-31
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	4e-31
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	4e-30
3ork_A	311	Serine/threonine protein kinase; structural genomi	4e-30
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	5e-30
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	7e-30
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	8e-30
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-29
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-29
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	5e-29
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	8e-29
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-28
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-28
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-28
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-28
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	5e-28
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	5e-28
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	6e-28
3bhy_A	283	Death-associated protein kinase 3; death associate	7e-28
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	8e-28
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	9e-28
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-27
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-27
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-27
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-27
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-27
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	5e-27
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	5e-27
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	6e-27
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	8e-27
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-26
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-26
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-26
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-26
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-26
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-26
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-26
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	4e-26
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	5e-26
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	6e-26
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	7e-26
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-25
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-25
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-25
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-25
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-25
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-25
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-25
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-25
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	5e-25
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	5e-25
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	6e-25
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-24
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-24
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-24
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-24
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-24
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	4e-24
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	5e-24
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	6e-24
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-23
3aln_A	327	Dual specificity mitogen-activated protein kinase;	3e-23
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	4e-23
3an0_A	340	Dual specificity mitogen-activated protein kinase;	5e-23
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-22
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-22
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-22
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	4e-22
2dyl_A	318	Dual specificity mitogen-activated protein kinase	8e-22
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-21
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-21
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-21
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-21
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	4e-21
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	4e-21
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	4e-21
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	4e-21
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-20
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	3e-20
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	4e-20
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	5e-20
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	8e-20
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-19
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-19
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	3e-19
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	3e-19
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	4e-19
3rp9_A	458	Mitogen-activated protein kinase; structural genom	5e-19
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	6e-19
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	7e-19
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-18
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-18
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-18
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	3e-18
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-18
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	7e-18
3o0g_A	292	Cell division protein kinase 5; kinase activator c	9e-18
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-17
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-17
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-17
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-17
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-17
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-17
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-17
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	3e-17
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	4e-17
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	6e-17
3niz_A	311	Rhodanese family protein; structural genomics, str	8e-17
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	8e-17
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	9e-17
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	9e-17
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-16
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-16
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-16
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-16
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-16
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-09
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	5e-16
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	7e-16
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	8e-16
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	9e-16
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-15
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-15
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	5e-15
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	5e-15
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-14
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-14
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-14
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-14
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	3e-14
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	3e-14
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-14
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-13
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	7e-13
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	8e-13
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-12
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-11
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	3e-11
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-11
3m7h_A	276	Putidacin L1; monocot mannose-binding lectin, bact	2e-10
3m7h_A	276	Putidacin L1; monocot mannose-binding lectin, bact	2e-04
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-10
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-10
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	3e-10
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-09
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	4e-09
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	8e-09
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-08
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	5e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	7e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-06
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	4e-07
3a0c_A	110	Mannose/sialic acid-binding lectin; beta-prism II,	2e-05
1xd5_A	112	Gastrodianin-1, antifungal protein GAFP-1; monocot	3e-05
1b2p_A	119	Protein (lectin); mannose-binding lectin, monocot,	4e-05
1dlp_A	236	Lectin scafet precursor; two-domain lectin, beta p	6e-05
1kj1_A	109	Lectin I, lecgna 1; BULB lectin, mannose, plant pr	1e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  378 bits (972), Expect = e-125
 Identities = 121/297 (40%), Positives = 177/297 (59%), Gaps = 13/297 (4%)

Query: 507 NLRCFSYKELEGATNNFKEE--VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR-VFQDGER 563
            L+ FS +EL+ A++NF  +  +GRG FG VYKG +      T VAVK+L     Q GE 
Sbjct: 16  QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA---DGTLVAVKRLKEERTQGGEL 72

Query: 564 EFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP----NWNL 619
           +F+ EV +I    H+NL+RL GFC     RLLVY ++ NG++AS L    +     +W  
Sbjct: 73  QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPK 132

Query: 620 RTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI 679
           R  IA   ARGL YLH+ C  +IIH D+K  NILLD+ + A + DFGLAKL+    +  +
Sbjct: 133 RQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-HV 191

Query: 680 KTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDI--EMGEEYAILTDW 737
            TA+RGT G++APE+    K + K DV+ +GV+LLE+I+ +++FD+     ++  +L DW
Sbjct: 192 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251

Query: 738 AFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEG 794
                +  KL  LV  D +     E + +L+ V++ C Q  P  RP M +V++MLEG
Sbjct: 252 VKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  348 bits (894), Expect = e-114
 Identities = 105/307 (34%), Positives = 157/307 (51%), Gaps = 12/307 (3%)

Query: 498 SPDDGTIETNLRCFSYKELEGATNNFKEE--VGRGSFGIVYKGVIQTRTSTTAVAVKKLD 555
                 +          +LE ATNNF  +  +G G FG VYKGV++       VA+K+  
Sbjct: 16  LSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR---DGAKVALKRRT 72

Query: 556 RVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP 615
                G  EF+ E+  +    H +LV L+GFCDE    +L+Y+++ NG L   L+G+  P
Sbjct: 73  PESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLP 132

Query: 616 ----NWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLL 671
               +W  R  I    ARGL YLH      IIH D+K  NILLD+ +  +I+DFG++K  
Sbjct: 133 TMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKG 189

Query: 672 TLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY 731
           T      + T ++GT GY+ PE+F   ++T K DVYSFGV+L E++  R +    +  E 
Sbjct: 190 TELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREM 249

Query: 732 AILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM 791
             L +WA + + NG+L  +V  +       E L K    ++ C+      RP+M  VL  
Sbjct: 250 VNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK 309

Query: 792 LEGVVEV 798
           LE  + +
Sbjct: 310 LEYALRL 316

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  344 bits (886), Expect = e-113
 Identities = 111/309 (35%), Positives = 164/309 (53%), Gaps = 29/309 (9%)

Query: 505 ETNLRCFSYKELEGATNNFKEE--------VGRGSFGIVYKGVIQTRTSTTAVAVKKLDR 556
           +T    FS+ EL+  TNNF E         +G G FG+VYKG +    + T VAVKKL  
Sbjct: 9   DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV----NNTTVAVKKLAA 64

Query: 557 VFQD----GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFG- 611
           +        +++F  E+ V+ +  H+NLV LLGF  +G +  LVY ++ NG+L   L   
Sbjct: 65  MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124

Query: 612 -NLKP-NWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAK 669
               P +W++R  IA   A G+ +LHE+     IH DIK  NILLD+ +TA+ISDFGLA+
Sbjct: 125 DGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLAR 181

Query: 670 LLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGE 729
                    + + I GT  Y+APE  R  +IT K D+YSFGV+LLEII+   + D     
Sbjct: 182 ASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREP 240

Query: 730 EYAILTDWAFDCYRN-GKLNVLVGEDKEAMN-DIECLGKLVMVSIWCIQEDPSLRPTMKK 787
           +   L D   +       +   +  DK+  + D   +  +  V+  C+ E  + RP +KK
Sbjct: 241 QL--LLDIKEEIEDEEKTIEDYI--DKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKK 296

Query: 788 VLQMLEGVV 796
           V Q+L+ + 
Sbjct: 297 VQQLLQEMT 305

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  249 bits (638), Expect = 2e-76
 Identities = 76/307 (24%), Positives = 123/307 (40%), Gaps = 30/307 (9%)

Query: 511 FSYKELEGATNNFK--EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNE 568
              + L   +   +  E   RG FG V+K  +        VAVK      +    + + E
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEY----VAVKIFPIQDKQSW-QNEYE 68

Query: 569 VFVIGQTHHKNLVRLLGFCDEGQN----RLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA 624
           V+ +    H+N+++ +G    G +      L+  F   G+L+ FL  N   +WN   +IA
Sbjct: 69  VYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIA 127

Query: 625 FQIARGLLYLHEDCRAQ-------IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSK 677
             +ARGL YLHED           I H DIK +N+LL +  TA I+DFGLA      +S 
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187

Query: 678 TIKTAIRGTKGYVAPEWFRNS-----KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA 732
                  GT+ Y+APE    +         ++D+Y+ G++L E+ S   + D  + E   
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247

Query: 733 ILTDWAFDCYRNGKLNVLVGEDK------EAMNDIECLGKLVMVSIWCIQEDPSLRPTMK 786
              +          +  +V   K      +       +  L      C   D   R +  
Sbjct: 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAG 307

Query: 787 KVLQMLE 793
            V + + 
Sbjct: 308 CVGERIT 314

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  217 bits (554), Expect = 2e-64
 Identities = 76/297 (25%), Positives = 140/297 (47%), Gaps = 36/297 (12%)

Query: 513 YKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKL--DRVFQDGEREFKNEVF 570
           + +L       KE++G GSFG V++         + VAVK L       +   EF  EV 
Sbjct: 36  WCDLN-----IKEKIGAGSFGTVHRAEWHG----SDVAVKILMEQDFHAERVNEFLREVA 86

Query: 571 VIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN---LKPNWNLRTNIAFQI 627
           ++ +  H N+V  +G   +  N  +V E+L+ G+L   L  +    + +   R ++A+ +
Sbjct: 87  IMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDV 146

Query: 628 ARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK 687
           A+G+ YLH      I+H ++K  N+L+D  YT ++ DFGL++L     +     +  GT 
Sbjct: 147 AKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA--STFLSSKSAAGTP 203

Query: 688 GYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL 747
            ++APE  R+     K DVYSFGV+L E+ + ++ +   +     +              
Sbjct: 204 EWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWG-NLNPAQVV-------------- 248

Query: 748 NVLVGEDKEAMNDI--ECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVPP 802
              VG   + + +I      ++  +   C   +P  RP+   ++ +L  +++ +VPP
Sbjct: 249 -AAVGFKCKRL-EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  212 bits (543), Expect = 6e-63
 Identities = 85/306 (27%), Positives = 146/306 (47%), Gaps = 39/306 (12%)

Query: 513 YKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVI 572
           YKE+E      +E VGRG+FG+V K     +     VA+K+++   +   + F  E+  +
Sbjct: 7   YKEIE-----VEEVVGRGAFGVVCKA----KWRAKDVAIKQIES--ESERKAFIVELRQL 55

Query: 573 GQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP---NWNLRTNIAFQIAR 629
            + +H N+V+L G C       LV E+   G+L + L G             +   Q ++
Sbjct: 56  SRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQ 113

Query: 630 GLLYLHEDCRAQIIHCDIKPQNILLD-DYYTARISDFGLAKLLTLNQSKTIKTAIRGTKG 688
           G+ YLH      +IH D+KP N+LL       +I DFG A  +     +T  T  +G+  
Sbjct: 114 GVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI-----QTHMTNNKGSAA 168

Query: 689 YVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLN 748
           ++APE F  S  + K DV+S+G++L E+I+ RK FD   G  + I     +  +   +  
Sbjct: 169 WMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRI----MWAVHNGTRPP 224

Query: 749 VLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV---SVPPNPY 805
           ++    K        +  L M    C  +DPS RP+M+++++++  ++     +  P  Y
Sbjct: 225 LIKNLPKP-------IESL-MTR--CWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQY 274

Query: 806 PFSSSM 811
           P   S+
Sbjct: 275 PCQHSL 280

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  211 bits (538), Expect = 7e-62
 Identities = 80/338 (23%), Positives = 130/338 (38%), Gaps = 46/338 (13%)

Query: 511 FSYKELEGATNNFK--EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNE 568
            +  E     +N K  E +GRG +G VYKG +  R     VAVK          + F NE
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERP----VAVKVFS---FANRQNFINE 55

Query: 569 --VFVIGQTHHKNLVRLLGFCDEG-----QNRLLVYEFLNNGTLASFLFGNLKPNWNLRT 621
             ++ +    H N+ R +   +          LLV E+  NG+L  +L  +   +W    
Sbjct: 56  KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSC 114

Query: 622 NIAFQIARGLLYLHED------CRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLT--- 672
            +A  + RGL YLH +       +  I H D+  +N+L+ +  T  ISDFGL+  LT   
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174

Query: 673 ---LNQSKTIKTAIRGTKGYVAPEWFRNS-------KITAKVDVYSFGVLLLEIIS-CRK 721
                +      +  GT  Y+APE    +           +VD+Y+ G++  EI   C  
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234

Query: 722 SFDIEMGEEYAI-LTDWAFDCYRNGKLNVLVGEDK-------EAMNDIECLGKLVMVSIW 773
            F  E   EY +       +      + VLV  +K           +   +  L      
Sbjct: 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIED 294

Query: 774 CIQEDPSLRPTMKKVLQMLEGVV-EVSVPPNPYPFSSS 810
           C  +D   R T +   + +  ++       +  P +  
Sbjct: 295 CWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAHH 332

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  203 bits (518), Expect = 7e-60
 Identities = 82/295 (27%), Positives = 118/295 (40%), Gaps = 45/295 (15%)

Query: 513 YKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKL----DRVFQDGEREFKNE 568
           + EL       +E +G G FG VY+           VAVK      D          + E
Sbjct: 6   FAELT-----LEEIIGIGGFGKVYRAFWIG----DEVAVKAARHDPDEDISQTIENVRQE 56

Query: 569 VFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIA 628
             +     H N++ L G C +  N  LV EF   G L   L G  +   ++  N A QIA
Sbjct: 57  AKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIA 115

Query: 629 RGLLYLHEDCRAQIIHCDIKPQNILLDDYY--------TARISDFGLAKLLTLNQSKTIK 680
           RG+ YLH++    IIH D+K  NIL+              +I+DFGLA+       +T K
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE----WHRTTK 171

Query: 681 TAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD 740
            +  G   ++APE  R S  +   DV+S+GVLL E+++    F   +             
Sbjct: 172 MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFR-GIDGLAVA------- 223

Query: 741 CYRNGKLNVLVGEDKEAMNDI--ECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
                     V  +K A+  I   C      +   C   DP  RP+   +L  L 
Sbjct: 224 --------YGVAMNKLAL-PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLT 269

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  201 bits (513), Expect = 1e-58
 Identities = 73/315 (23%), Positives = 125/315 (39%), Gaps = 49/315 (15%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVR 582
             E +G+G FG   K     R +   + +K+L R  ++ +R F  EV V+    H N+++
Sbjct: 14  HGEVLGKGCFGQAIKVTH--RETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLK 71

Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-NWNLRTNIAFQIARGLLYLHEDCRAQ 641
            +G   + +    + E++  GTL   +        W+ R + A  IA G+ YLH      
Sbjct: 72  FIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMN 128

Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS------------KTIKTAIRGTKGY 689
           IIH D+   N L+ +     ++DFGLA+L+   ++            +  +  + G   +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188

Query: 690 VAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNV 749
           +APE         KVDV+SFG++L EII    +             D+           +
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADP-----------DY-------LPRTM 230

Query: 750 LVGEDKEAMNDIEC-------LGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV---VEVS 799
             G +     D  C          + +    C   DP  RP+  K+   LE +   +   
Sbjct: 231 DFGLNVRGFLDRYCPPNCPPSFFPITV---RCCDLDPEKRPSFVKLEHWLETLRMHLAGH 287

Query: 800 VPPNPYPFSSSMGLY 814
           +P  P       G +
Sbjct: 288 LPLGPQLEQLDRGFW 302

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  197 bits (502), Expect = 2e-57
 Identities = 70/296 (23%), Positives = 124/296 (41%), Gaps = 43/296 (14%)

Query: 513 YKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE-------REF 565
             E+E     +++++G+G FG+V+KG +      + VA+K L     +GE       +EF
Sbjct: 18  DNEIE-----YEKQIGKGGFGLVHKGRLVKDK--SVVAIKSLILGDSEGETEMIEKFQEF 70

Query: 566 KNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-NWNLRTNIA 624
           + EVF++   +H N+V+L G         +V EF+  G L   L     P  W+++  + 
Sbjct: 71  QREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLM 128

Query: 625 FQIARGLLYLHEDCRAQIIHCDIKPQNILLDDY-----YTARISDFGLAKLLTLNQSKTI 679
             IA G+ Y+  +    I+H D++  NI L          A+++DFGL++          
Sbjct: 129 LDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV-----HS 182

Query: 680 KTAIRGTKGYVAPEWF--RNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW 737
            + + G   ++APE         T K D YSF ++L  I++    FD     +   +   
Sbjct: 183 VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI 242

Query: 738 AFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
             +  R     +              L  + +    C   DP  RP    +++ L 
Sbjct: 243 REEGLR---PTIPEDCPPR-------LRNV-IEL--CWSGDPKKRPHFSYIVKELS 285

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  193 bits (493), Expect = 4e-56
 Identities = 73/277 (26%), Positives = 119/277 (42%), Gaps = 26/277 (9%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKL--DRVFQDGEREFKNEVFVIGQTHHKNL 580
             + +G GSFG VYKG          VAVK L          + FKNEV V+ +T H N+
Sbjct: 28  VGQRIGSGSFGTVYKGKWHGD-----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 82

Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFL-FGNLKPNWNLRTNIAFQIARGLLYLHEDCR 639
           +  +G+        +V ++    +L   L     K       +IA Q ARG+ YLH    
Sbjct: 83  LLFMGYSTA-PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---A 138

Query: 640 AQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRN-- 697
             IIH D+K  NI L +  T +I DFGLA   +          + G+  ++APE  R   
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198

Query: 698 -SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKE 756
            +  + + DVY+FG++L E+++ +  +   +     I+              V     K 
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIEMVGRGSLSPDLSKVRSNCPKR 257

Query: 757 AMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
                  + +L+     C+++    RP+  ++L  +E
Sbjct: 258 -------MKRLMA---ECLKKKRDERPSFPRILAEIE 284

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  191 bits (487), Expect = 2e-55
 Identities = 62/290 (21%), Positives = 111/290 (38%), Gaps = 41/290 (14%)

Query: 513 YKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKL--DRVFQDGEREFKNEVF 570
           +K+L      F  ++     G ++KG  Q       + VK L          R+F  E  
Sbjct: 9   FKQLN-----FLTKLNENHSGELWKGRWQG----NDIVVKVLKVRDWSTRKSRDFNEECP 59

Query: 571 VIGQTHHKNLVRLLGFCDE--GQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQ 626
            +    H N++ +LG C      +  L+  ++  G+L + L    N   + +     A  
Sbjct: 60  RLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALD 119

Query: 627 IARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGT 686
           +ARG+ +LH      I    +  +++++D+  TARIS   +                   
Sbjct: 120 MARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-------SPGRMYA 171

Query: 687 KGYVAPEWFRNSK---ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR 743
             +VAPE  +           D++SF VLL E+++    F  ++     I    A +  R
Sbjct: 172 PAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFA-DL-SNMEIGMKVALEGLR 229

Query: 744 NGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
                +  G           + KL+     C+ EDP+ RP    ++ +LE
Sbjct: 230 ---PTIPPGISPH-------VSKLMK---ICMNEDPAKRPKFDMIVPILE 266

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  191 bits (487), Expect = 5e-55
 Identities = 72/297 (24%), Positives = 124/297 (41%), Gaps = 46/297 (15%)

Query: 513 YKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKL--DRVFQDGEREFKNEVF 570
           +++LE       E +G+G FG VY G          VA++ +  +R  +D  + FK EV 
Sbjct: 32  FEQLE-----IGELIGKGRFGQVYHGRWHGE-----VAIRLIDIERDNEDQLKAFKREVM 81

Query: 571 VIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIAR 629
              QT H+N+V  +G C    +  ++       TL S +    +  + N    IA +I +
Sbjct: 82  AYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVK 141

Query: 630 GLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS---KTIKTAIRGT 686
           G+ YLH      I+H D+K +N+  D+     I+DFGL  +  + Q+   +       G 
Sbjct: 142 GMGYLH---AKGILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGW 197

Query: 687 KGYVAPEWFRNSKI---------TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW 737
             ++APE  R             +   DV++ G +  E+ +    F      E  I   W
Sbjct: 198 LCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK-TQPAEAII---W 253

Query: 738 AFDCYRNGKLNVLVGED-KEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
                        +G   K  ++ I    ++  + ++C   +   RPT  K++ MLE
Sbjct: 254 Q------------MGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLE 298

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  184 bits (468), Expect = 2e-52
 Identities = 70/297 (23%), Positives = 118/297 (39%), Gaps = 36/297 (12%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNE--VFVIGQTHHKNL 580
             E VG+G +G V++G  Q       VAVK      +D E+ +  E  ++      H+N+
Sbjct: 12  LLECVGKGRYGEVWRGSWQGEN----VAVKIFSS--RD-EKSWFRETELYNTVMLRHENI 64

Query: 581 VRLLGFCDEGQNR----LLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHE 636
           +  +      ++      L+  +   G+L  +L      +      I   IA GL +LH 
Sbjct: 65  LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLHI 123

Query: 637 DCRAQ-----IIHCDIKPQNILLDDYYTARISDFGLAKLL--TLNQSKTIKTAIRGTKGY 689
           +         I H D+K +NIL+       I+D GLA +   + NQ         GTK Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183

Query: 690 VAPEWFRNS------KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI-LTDWAFDCY 742
           +APE    +          +VD+++FG++L E+     S  I   E+Y     D   +  
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV--EDYKPPFYDVVPNDP 241

Query: 743 RNGKLNVLVGEDK------EAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
               +  +V  D+              L  L  +   C  ++PS R T  ++ + L 
Sbjct: 242 SFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  182 bits (464), Expect = 1e-51
 Identities = 66/297 (22%), Positives = 114/297 (38%), Gaps = 36/297 (12%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNE--VFVIGQTHHKNL 580
            +E +G+G FG V++G  +       VAVK         ER +  E  ++      H+N+
Sbjct: 46  LQESIGKGRFGEVWRGKWRGEE----VAVKIFS---SREERSWFREAEIYQTVMLRHENI 98

Query: 581 VRLLGFCDEGQNR----LLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHE 636
           +  +   ++         LV ++  +G+L  +L             +A   A GL +LH 
Sbjct: 99  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHM 157

Query: 637 D-----CRAQIIHCDIKPQNILLDDYYTARISDFGLAKLL--TLNQSKTIKTAIRGTKGY 689
           +      +  I H D+K +NIL+    T  I+D GLA       +          GTK Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217

Query: 690 VAPEWFRNSKITA------KVDVYSFGVLLLEIISCRKSFDIEMGEEYAI-LTDWAFDCY 742
           +APE   +S          + D+Y+ G++  EI        I   E+Y +   D      
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH--EDYQLPYYDLVPSDP 275

Query: 743 RNGKLNVLVGEDK------EAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
              ++  +V E K            E L  +  +   C   + + R T  ++ + L 
Sbjct: 276 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  181 bits (461), Expect = 3e-51
 Identities = 68/297 (22%), Positives = 119/297 (40%), Gaps = 36/297 (12%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNE--VFVIGQTHHKNL 580
             +++G+G +G V+ G  +       VAVK       + E  +  E  ++      H+N+
Sbjct: 41  MVKQIGKGRYGEVWMGKWRGEK----VAVKVFFT--TE-EASWFRETEIYQTVLMRHENI 93

Query: 581 VRLLGFCDEGQNR----LLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHE 636
           +  +    +G        L+ ++  NG+L  +L  +   +      +A+    GL +LH 
Sbjct: 94  LGFIAADIKGTGSWTQLYLITDYHENGSLYDYL-KSTTLDAKSMLKLAYSSVSGLCHLHT 152

Query: 637 D-----CRAQIIHCDIKPQNILLDDYYTARISDFGLAKLL--TLNQSKTIKTAIRGTKGY 689
           +      +  I H D+K +NIL+    T  I+D GLA       N+         GTK Y
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212

Query: 690 VAPE------WFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI-LTDWAFDCY 742
           + PE         + +     D+YSFG++L E+     S  I   EEY +   D      
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGI--VEEYQLPYHDLVPSDP 270

Query: 743 RNGKLNVLVGEDK------EAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
               +  +V   K         +  ECL ++  +   C   +P+ R T  +V + L 
Sbjct: 271 SYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  155 bits (395), Expect = 9e-42
 Identities = 71/294 (24%), Positives = 120/294 (40%), Gaps = 56/294 (19%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQTHHKNLV 581
             E++GRG+FG V+ G +  R   T VAVK   + +  D + +F  E  ++ Q  H N+V
Sbjct: 118 LGEQIGRGNFGEVFSGRL--RADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIV 175

Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           RL+G C + Q   +V E +  G   +FL     +        +    A G+ YL      
Sbjct: 176 RLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES---K 232

Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTA----IRGTKGYVAPEWFR 696
             IH D+  +N L+ +    +ISDFG+++                 ++ T    APE   
Sbjct: 233 CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT----APEALN 288

Query: 697 NSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLNVLVGEDK 755
             + +++ DV+SFG+LL E  S         G   Y  L+                  ++
Sbjct: 289 YGRYSSESDVWSFGILLWETFSL--------GASPYPNLS------------------NQ 322

Query: 756 EAMNDIECLGKL------------VMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 797
           +    +E  G+L            +M   W    +P  RP+   + Q L+ + +
Sbjct: 323 QTREFVEKGGRLPCPELCPDAVFRLMEQCW--AYEPGQRPSFSTIYQELQSIRK 374

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  152 bits (386), Expect = 2e-41
 Identities = 72/279 (25%), Positives = 123/279 (44%), Gaps = 37/279 (13%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVK--KLDRVFQDGEREFKNEVFVIGQTHHKNL 580
           F  E+GRGSF  VYKG+     +T  VA    +  ++ +   + FK E  ++    H N+
Sbjct: 30  FDIEIGRGSFKTVYKGL--DTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 87

Query: 581 VRLLGFC---DEGQNRLLVY-EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHE 636
           VR         +G+  +++  E + +GTL ++L         +  +   QI +GL +LH 
Sbjct: 88  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT 147

Query: 637 DCRAQIIHCDIKPQNILLDDYY-TARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
                IIH D+K  NI +     + +I D GLA L   + +K +     GT  ++APE +
Sbjct: 148 -RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI----GTPEFMAPEMY 202

Query: 696 RNSKITAKVDVYSFGVLLLEIISCRKSF-DIE-MGEEYAILTDWAFDCYRNGKLNVLV-- 751
              K    VDVY+FG+ +LE+ +    + + +   + Y  +T        +G        
Sbjct: 203 EE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT--------SGVKPASFDK 253

Query: 752 GEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
               E    IE           CI+++   R ++K +L 
Sbjct: 254 VAIPEVKEIIE----------GCIRQNKDERYSIKDLLN 282

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  151 bits (384), Expect = 1e-40
 Identities = 71/301 (23%), Positives = 125/301 (41%), Gaps = 58/301 (19%)

Query: 523 FKEEVGRGSFGIVYKGV--IQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNL 580
           +  ++G+G+FG V           +   VAVK+L     D +R+F+ E+ ++   H   +
Sbjct: 27  YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 86

Query: 581 VRLLGFC--DEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHE 636
           V+  G       Q+  LV E+L +G L  FL  + +   +       + QI +G+ YL  
Sbjct: 87  VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRH-RARLDASRLLLYSSQICKGMEYLGS 145

Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTA-----IRGTKGYVA 691
               + +H D+  +NIL++     +I+DFGLAKLL L++   +        I       A
Sbjct: 146 ---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY----A 198

Query: 692 PEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVL 750
           PE   ++  + + DV+SFGV+L E+ + C KS                  C  + +   +
Sbjct: 199 PESLSDNIFSRQSDVWSFGVVLYELFTYCDKS------------------CSPSAEFLRM 240

Query: 751 VGEDKEAMNDIECLGKL------------------VMVSIWCIQEDPSLRPTMKKVLQML 792
           +G +++       L  L                  +M   W     P  RP+   +   L
Sbjct: 241 MGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCW--APSPQDRPSFSALGPQL 298

Query: 793 E 793
           +
Sbjct: 299 D 299

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  146 bits (371), Expect = 3e-39
 Identities = 70/300 (23%), Positives = 121/300 (40%), Gaps = 47/300 (15%)

Query: 523 FKEEVGRGSFGIVYKGV--IQTRTSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQTHHKN 579
              ++G G FG V       +   +   VAVK L      +   + K E+ ++   +H+N
Sbjct: 25  RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 84

Query: 580 LVRLLGFC--DEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLH 635
           +V+  G C  D G    L+ EFL +G+L  +L  N K   NL+     A QI +G+ YL 
Sbjct: 85  IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYLG 143

Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTA-----IRGTKGYV 690
                Q +H D+  +N+L++  +  +I DFGL K +  ++            +       
Sbjct: 144 S---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWY---- 196

Query: 691 APEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNV 749
           APE    SK     DV+SFGV L E+++ C             I                
Sbjct: 197 APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMI------GPTHGQMTV- 249

Query: 750 LVGEDKEAMNDIE----------CLGKL--VMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 797
                   +N ++          C  ++  +M   W  +  PS R + + +++  E +++
Sbjct: 250 -----TRLVNTLKEGKRLPCPPNCPDEVYQLMRKCW--EFQPSNRTSFQNLIEGFEALLK 302

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  146 bits (372), Expect = 4e-39
 Identities = 70/293 (23%), Positives = 122/293 (41%), Gaps = 59/293 (20%)

Query: 523 FKEEVGRGSFGIVYKGV--IQTRTSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQTHHKN 579
             + +G G+FG VYKG+   +       VA+K+L +       +E  +E +V+    + +
Sbjct: 19  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78

Query: 580 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHED 637
           + RLLG C       L+ + +  G L  ++  + K N   +   N   QIA+G+ YL ED
Sbjct: 79  VCRLLGIC-LTSTVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYL-ED 135

Query: 638 CRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI----KTAIRGTKGYVAPE 693
            R  ++H D+  +N+L+      +I+DFGLAKLL   + +      K  I+      A E
Sbjct: 136 RR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM----ALE 189

Query: 694 WFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLNVLVG 752
              +   T + DV+S+GV + E+++         G + Y             G       
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMT--------FGSKPYD------------GIPA---- 225

Query: 753 EDKEAMNDIE----------CLGKL--VMVSIWCIQEDPSLRPTMKKVLQMLE 793
              E  + +E          C   +  +M   W    D   RP  ++++    
Sbjct: 226 --SEISSILEKGERLPQPPICTIDVYMIMRKCW--MIDADSRPKFRELIIEFS 274

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  149 bits (379), Expect = 1e-38
 Identities = 76/286 (26%), Positives = 124/286 (43%), Gaps = 50/286 (17%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVR 582
            K ++G G +G VY+GV   +  +  VAVK L     + E EF  E  V+ +  H NLV+
Sbjct: 224 MKHKLGGGQYGEVYEGVW--KKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQ 280

Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHEDCRA 640
           LLG C       ++ EF+  G L  +L    +   +      +A QI+  + YL +    
Sbjct: 281 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---K 337

Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ---SKTIKTAIRGTKGYVAPEWFRN 697
             IH ++  +N L+ + +  +++DFGL++L+T +        K  I+ T    APE    
Sbjct: 338 NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAY 393

Query: 698 SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEA 757
           +K + K DV++FGVLL EI +   S        Y  +                     + 
Sbjct: 394 NKFSIKSDVWAFGVLLWEIATYGMS-------PYPGID------------------LSQV 428

Query: 758 MNDIE----------CLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
              +E          C  K+  +   C Q +PS RP+  ++ Q  E
Sbjct: 429 YELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 474

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  144 bits (366), Expect = 1e-38
 Identities = 68/286 (23%), Positives = 123/286 (43%), Gaps = 27/286 (9%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRT--STTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNL 580
           F +++G+G+FG V           +   VAVKKL    ++  R+F+ E+ ++    H N+
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73

Query: 581 VRLLGFC--DEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHE 636
           V+  G C     +N  L+ E+L  G+L  +L  + K   +         QI +G+ YL  
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGT 132

Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTA-----IRGTKGYVA 691
               + IH D+  +NIL+++    +I DFGL K+L  ++            I       A
Sbjct: 133 ---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY----A 185

Query: 692 PEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLV 751
           PE    SK +   DV+SFGV+L E+ +  +       E   ++ +          L  L+
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245

Query: 752 --GEDKEAMNDIECLGKL--VMVSIWCIQEDPSLRPTMKKVLQMLE 793
                    +   C  ++  +M   W    + + RP+ + +   ++
Sbjct: 246 KNNGRLPRPDG--CPDEIYMIMTECW--NNNVNQRPSFRDLALRVD 287

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  145 bits (368), Expect = 1e-38
 Identities = 68/286 (23%), Positives = 124/286 (43%), Gaps = 27/286 (9%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRT--STTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNL 580
           F +++G+G+FG V           +   VAVKKL    ++  R+F+ E+ ++    H N+
Sbjct: 45  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104

Query: 581 VRLLGFC--DEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHE 636
           V+  G C     +N  L+ E+L  G+L  +L  + K   +         QI +G+ YL  
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGT 163

Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTA-----IRGTKGYVA 691
               + IH D+  +NIL+++    +I DFGL K+L  ++            I       A
Sbjct: 164 ---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY----A 216

Query: 692 PEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLV 751
           PE    SK +   DV+SFGV+L E+ +  +       E   ++ +          L  L+
Sbjct: 217 PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 276

Query: 752 GEDK--EAMNDIECLGKL--VMVSIWCIQEDPSLRPTMKKVLQMLE 793
             +      +   C  ++  +M   W    + + RP+ + +   ++
Sbjct: 277 KNNGRLPRPDG--CPDEIYMIMTECW--NNNVNQRPSFRDLALRVD 318

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  143 bits (364), Expect = 2e-38
 Identities = 78/286 (27%), Positives = 118/286 (41%), Gaps = 52/286 (18%)

Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVK--KLDRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           E+G G+FG V KG  Q +     VAVK  K +      + E   E  V+ Q  +  +VR+
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
           +G C E ++ +LV E    G L  +L  N          +  Q++ G+ YL E+     +
Sbjct: 84  IGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL-EESN--FV 139

Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYV---APEWFRNSKI 700
           H D+  +N+LL   + A+ISDFGL+K L  +++     A    K  V   APE     K 
Sbjct: 140 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYY--KAQTHGKWPVKWYAPECINYYKF 197

Query: 701 TAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLNVLVGEDKEAMN 759
           ++K DV+SFGVL+ E  S         G++ Y  +                     E   
Sbjct: 198 SSKSDVWSFGVLMWEAFSY--------GQKPYRGMK------------------GSEVTA 231

Query: 760 DIE----------CLGKL--VMVSIWCIQEDPSLRPTMKKVLQMLE 793
            +E          C  ++  +M   W    D   RP    V   L 
Sbjct: 232 MLEKGERMGCPAGCPREMYDLMNLCW--TYDVENRPGFAAVELRLR 275

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  142 bits (360), Expect = 6e-38
 Identities = 66/299 (22%), Positives = 117/299 (39%), Gaps = 67/299 (22%)

Query: 523 FKEEVGRGSFGIVYKGV-----IQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHH 577
           F E +G+G+F  ++KGV        +   T V +K LD+  ++    F     ++ +  H
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71

Query: 578 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN---LKPNWNLRTNIAFQIARGLLYL 634
           K+LV   G C  G   +LV EF+  G+L ++L  N   +   W L   +A Q+A  + +L
Sbjct: 72  KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKL--EVAKQLAAAMHFL 129

Query: 635 HEDCRAQIIHCDIKPQNILLDDYYTAR--------ISDFGLAKLLTLNQSKTIKTAIRGT 686
            E+    +IH ++  +NILL      +        +SD G++  +        +  I   
Sbjct: 130 -EENT--LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDIL--QERIPWV 184

Query: 687 KGYVAPEWFRNSKI-TAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRN 744
                PE   N K      D +SFG  L EI S         G++  + L          
Sbjct: 185 ----PPECIENPKNLNLATDKWSFGTTLWEICS--------GGDKPLSALD--------- 223

Query: 745 GKLNVLVGEDKEAMNDIECLGKL----------VMVSIWCIQEDPSLRPTMKKVLQMLE 793
                     +  +   E   +L          ++ +      +P  RP+ + +++ L 
Sbjct: 224 ---------SQRKLQFYEDRHQLPAPKAAELANLINNCM--DYEPDHRPSFRAIIRDLN 271

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  143 bits (362), Expect = 8e-38
 Identities = 67/291 (23%), Positives = 132/291 (45%), Gaps = 54/291 (18%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTS-TTAVAVKKLDRVFQDGER-EFKNEVFVIGQTHHKNL 580
            ++ +G G  G V  G ++        VA+K L   + + +R +F +E  ++GQ  H N+
Sbjct: 53  IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI 112

Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHEDC 638
           +RL G    G+  ++V E++ NG+L +FL  +    + +     +   +  G+ YL +  
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSD-- 169

Query: 639 RAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYV---APEWF 695
               +H D+  +N+L+D     ++SDFGL+++L  +      T   G K  +   APE  
Sbjct: 170 -LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTT--TGGKIPIRWTAPEAI 226

Query: 696 RNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLNVLVGED 754
                ++  DV+SFGV++ E+++         GE  Y  +T                  +
Sbjct: 227 AFRTFSSASDVWSFGVVMWEVLAY--------GERPYWNMT------------------N 260

Query: 755 KEAMNDIE----------CLGKL--VMVSIWCIQEDPSLRPTMKKVLQMLE 793
           ++ ++ +E          C   L  +M+  W   +D + RP   +++ +L+
Sbjct: 261 RDVISSVEEGYRLPAPMGCPHALHQLMLDCW--HKDRAQRPRFSQIVSVLD 309

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  146 bits (370), Expect = 1e-37
 Identities = 74/289 (25%), Positives = 118/289 (40%), Gaps = 62/289 (21%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG--EREFKNEVFVIGQTHHKNL 580
             + +G+G FG V  G  +       VAVK +    ++    + F  E  V+ Q  H NL
Sbjct: 197 LLQTIGKGEFGDVMLGDYRGNK----VAVKCI----KNDATAQAFLAEASVMTQLRHSNL 248

Query: 581 VRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHED 637
           V+LLG   E +  L +V E++  G+L  +L    +           +  +   + YL   
Sbjct: 249 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG- 307

Query: 638 CRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRN 697
                +H D+  +N+L+ +   A++SDFGL K  +  Q    K  ++ T    APE  R 
Sbjct: 308 --NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG-KLPVKWT----APEALRE 360

Query: 698 SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLNVLVGEDKE 756
            K + K DV+SFG+LL EI S         G   Y  +                    K+
Sbjct: 361 KKFSTKSDVWSFGILLWEIYSF--------GRVPYPRIP------------------LKD 394

Query: 757 AMNDIE----------CLGKL--VMVSIWCIQEDPSLRPTMKKVLQMLE 793
            +  +E          C   +  VM + W    D + RPT  ++ + LE
Sbjct: 395 VVPRVEKGYKMDAPDGCPPAVYDVMKNCW--HLDAATRPTFLQLREQLE 441

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  141 bits (357), Expect = 1e-37
 Identities = 79/289 (27%), Positives = 123/289 (42%), Gaps = 54/289 (18%)

Query: 524 KEEVGRGSFGIVYKGVIQTRTSTTAVAVKKL-DRVFQDGEREFKNEVFVIGQTHHKNLVR 582
             E+G G+FG V +GV + R     VA+K L     +    E   E  ++ Q  +  +VR
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74

Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK--PNWNLRTNIAFQIARGLLYLHEDCRA 640
           L+G C + +  +LV E    G L  FL G  +  P  N+   +  Q++ G+ YL E+   
Sbjct: 75  LIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNV-AELLHQVSMGMKYL-EEKN- 130

Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYV---APEWFRN 697
             +H D+  +N+LL + + A+ISDFGL+K L  + S    TA    K  +   APE    
Sbjct: 131 -FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS--YYTARSAGKWPLKWYAPECINF 187

Query: 698 SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLNVLVGEDKE 756
            K +++ DV+S+GV + E +S         G++ Y  +                     E
Sbjct: 188 RKFSSRSDVWSYGVTMWEALS--------YGQKPYKKMK------------------GPE 221

Query: 757 AMNDIE----------CLGKL--VMVSIWCIQEDPSLRPTMKKVLQMLE 793
            M  IE          C  +L  +M   W        RP    V Q + 
Sbjct: 222 VMAFIEQGKRMECPPECPPELYALMSDCW--IYKWEDRPDFLTVEQRMR 268

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  145 bits (368), Expect = 1e-37
 Identities = 74/286 (25%), Positives = 125/286 (43%), Gaps = 52/286 (18%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVR 582
            + ++G+G FG V+ G     T    VA+K L       E  F  E  V+ +  H+ LV+
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTR---VAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQ 243

Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHEDCRA 640
           L     E +   +V E+++ G+L  FL G       L    ++A QIA G+ Y+      
Sbjct: 244 LYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---M 299

Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ---SKTIKTAIRGTKGYVAPEWFRN 697
             +H D++  NIL+ +    +++DFGLA+L+  N+    +  K  I+ T    APE    
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----APEAALY 355

Query: 698 SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEA 757
            + T K DV+SFG+LL E+ +  +         Y  +                   ++E 
Sbjct: 356 GRFTIKSDVWSFGILLTELTTKGRV-------PYPGMV------------------NREV 390

Query: 758 MNDIE----------CLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
           ++ +E          C   L  +   C +++P  RPT + +   LE
Sbjct: 391 LDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 436

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  141 bits (358), Expect = 2e-37
 Identities = 71/300 (23%), Positives = 127/300 (42%), Gaps = 60/300 (20%)

Query: 522 NFKEEVGRGSFGIVYKGVIQTRT-STTAVAVKKLDRVFQDGER-EFKNEVFVIGQTHHKN 579
           +F E +GRG FG VY G +          AVK L+R+   GE  +F  E  ++    H N
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87

Query: 580 LVRLLGFCDEGQN-RLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHE 636
           ++ LLG C   +   L+V  ++ +G L +F+      N  ++       Q+A+G+ YL  
Sbjct: 88  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLAS 146

Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLL------TLNQSKTIKTAIRGTKGYV 690
               + +H D+  +N +LD+ +T +++DFGLA+ +      +++     K  ++      
Sbjct: 147 ---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM---- 199

Query: 691 APEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLNV 749
           A E  +  K T K DV+SFGVLL E+++         G   Y  +  +            
Sbjct: 200 ALESLQTQKFTTKSDVWSFGVLLWELMT--------RGAPPYPDVNTF------------ 239

Query: 750 LVGEDKEAMNDIE----------CLGKL--VMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 797
                 +    +           C   L  VM+  W       +RP+  +++  +  +  
Sbjct: 240 ------DITVYLLQGRRLLQPEYCPDPLYEVMLKCW--HPKAEMRPSFSELVSRISAIFS 291

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  141 bits (358), Expect = 2e-37
 Identities = 69/300 (23%), Positives = 113/300 (37%), Gaps = 57/300 (19%)

Query: 523 FKEEVGRGSFGIVYKGVIQ--TRTSTTAVAVKKLDRVFQDGER-EFKNEVFVIGQTHHKN 579
              ++G G FG V           +   VAVK L        R  +K E+ ++   +H++
Sbjct: 35  KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEH 94

Query: 580 LVRLLGFC--DEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHED 637
           +++  G C      +  LV E++  G+L  +L  +           A QI  G+ YLH  
Sbjct: 95  IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHA- 152

Query: 638 CRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTA-----IRGTKGYVAP 692
                IH D+  +N+LLD+    +I DFGLAK +                +       AP
Sbjct: 153 --QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY----AP 206

Query: 693 EWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLV 751
           E  +  K     DV+SFGV L E+++ C  S                       K   L+
Sbjct: 207 ECLKEYKFYYASDVWSFGVTLYELLTHCDSS------------------QSPPTKFLELI 248

Query: 752 GEDKEAMNDIECLGKL------------------VMVSIWCIQEDPSLRPTMKKVLQMLE 793
           G  +  M  +     L                  +M + W  + + S RPT + ++ +L+
Sbjct: 249 GIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCW--ETEASFRPTFENLIPILK 306

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  140 bits (356), Expect = 3e-37
 Identities = 75/294 (25%), Positives = 112/294 (38%), Gaps = 58/294 (19%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTS-TTAVAVKKL---DRVFQDGEREFKNEVFVIGQTHHK 578
             E++G GSFG+V +G     +  T +VAVK L        +   +F  EV  +    H+
Sbjct: 22  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 81

Query: 579 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHE 636
           NL+RL G         +V E    G+L   L  + + ++ L T    A Q+A G+ YL E
Sbjct: 82  NLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYL-E 138

Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYV---APE 693
             R   IH D+  +N+LL      +I DFGL + L  N            K      APE
Sbjct: 139 SKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY--VMQEHRKVPFAWCAPE 194

Query: 694 WFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLNVLVG 752
             +    +   D + FGV L E+ +         G+E +  L                  
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFTY--------GQEPWIGLN----------------- 229

Query: 753 EDKEAMNDIECLGK-------------LVMVSIWCIQEDPSLRPTMKKVLQMLE 793
              + ++ I+  G+              VMV  W     P  RPT   +   L 
Sbjct: 230 -GSQILHKIDKEGERLPRPEDCPQDIYNVMVQCW--AHKPEDRPTFVALRDFLL 280

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  142 bits (361), Expect = 3e-37
 Identities = 69/302 (22%), Positives = 126/302 (41%), Gaps = 60/302 (19%)

Query: 522 NFKEEVGRGSFGIVYKGVIQTRT-STTAVAVKKLDRVFQDGER-EFKNEVFVIGQTHHKN 579
           +F E +GRG FG VY G +          AVK L+R+   GE  +F  E  ++    H N
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151

Query: 580 LVRLLGFCDEGQN-RLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHE 636
           ++ LLG C   +   L+V  ++ +G L +F+      N  ++       Q+A+G+ +L  
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLAS 210

Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTA------IRGTKGYV 690
               + +H D+  +N +LD+ +T +++DFGLA+ +   +  ++         ++      
Sbjct: 211 ---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM---- 263

Query: 691 APEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLNV 749
           A E  +  K T K DV+SFGVLL E+++         G   Y  +  +            
Sbjct: 264 ALESLQTQKFTTKSDVWSFGVLLWELMT--------RGAPPYPDVNTF------------ 303

Query: 750 LVGEDKEAMNDIE----------CLGKL--VMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 797
                 +    +           C   L  VM+  W       +RP+  +++  +  +  
Sbjct: 304 ------DITVYLLQGRRLLQPEYCPDPLYEVMLKCW--HPKAEMRPSFSELVSRISAIFS 355

Query: 798 VS 799
             
Sbjct: 356 TF 357

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  141 bits (357), Expect = 3e-37
 Identities = 73/297 (24%), Positives = 123/297 (41%), Gaps = 59/297 (19%)

Query: 523 FKEEVGRGSFGIVYKGV--IQTRTSTTAVAVKKLDRVFQDGER-EFKNEVFVIGQTHHKN 579
             + +G G FG V+KGV   +  +    V +K ++            + +  IG   H +
Sbjct: 17  KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAH 76

Query: 580 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHED 637
           +VRLLG C  G +  LV ++L  G+L   +  + +     +   N   QIA+G+ YL E 
Sbjct: 77  IVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEE- 133

Query: 638 CRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT----IKTAIRGTKGYVAPE 693
               ++H ++  +N+LL      +++DFG+A LL  +  +      KT I+      A E
Sbjct: 134 --HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM----ALE 187

Query: 694 WFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLNVLVG 752
                K T + DV+S+GV + E+++         G E YA L                  
Sbjct: 188 SIHFGKYTHQSDVWSYGVTVWELMTF--------GAEPYAGLR----------------- 222

Query: 753 EDKEAMNDIE----------CLGKL--VMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 797
              E  + +E          C   +  VMV  W    D ++RPT K++      +  
Sbjct: 223 -LAEVPDLLEKGERLAQPQICTIDVYMVMVKCW--MIDENIRPTFKELANEFTRMAR 276

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  145 bits (368), Expect = 5e-37
 Identities = 75/286 (26%), Positives = 126/286 (44%), Gaps = 52/286 (18%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVR 582
            + ++G+G FG V+ G       TT VA+K L       E  F  E  V+ +  H+ LV+
Sbjct: 271 LEVKLGQGCFGEVWMGTWNG---TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQ 326

Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHEDCRA 640
           L     E +   +V E+++ G+L  FL G       L    ++A QIA G+ Y+      
Sbjct: 327 LYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---M 382

Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ---SKTIKTAIRGTKGYVAPEWFRN 697
             +H D++  NIL+ +    +++DFGLA+L+  N+    +  K  I+ T    APE    
Sbjct: 383 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----APEAALY 438

Query: 698 SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEA 757
            + T K DV+SFG+LL E+ +  +         Y  +                   ++E 
Sbjct: 439 GRFTIKSDVWSFGILLTELTTKGRV-------PYPGMV------------------NREV 473

Query: 758 MNDIE----------CLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
           ++ +E          C   L  +   C +++P  RPT + +   LE
Sbjct: 474 LDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 519

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  139 bits (353), Expect = 7e-37
 Identities = 73/304 (24%), Positives = 128/304 (42%), Gaps = 53/304 (17%)

Query: 523 FKEEVGRGSFGIVYKGV---IQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKN 579
            K E+G G+FG V+      +        VAVK L        ++F+ E  ++    H++
Sbjct: 19  LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78

Query: 580 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN----------------I 623
           +V+  G C +G   ++V+E++ +G L  FL  +      L                   I
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138

Query: 624 AFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTA- 682
           A QIA G++YL        +H D+  +N L+      +I DFG+++ +       +    
Sbjct: 139 ASQIASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 195

Query: 683 ---IRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDW- 737
              IR       PE     K T + DV+SFGV+L EI +         G++ +  L++  
Sbjct: 196 MLPIRWM----PPESIMYRKFTTESDVWSFGVILWEIFTY--------GKQPWFQLSNTE 243

Query: 738 AFDCYRNGKLNVLVGEDKEAMNDIECLGKL--VMVSIWCIQEDPSLRPTMKKVLQMLEGV 795
             +C   G   VL     E      C  ++  VM+  W  Q +P  R  +K++ ++L  +
Sbjct: 244 VIECITQG--RVL-----ERPRV--CPKEVYDVMLGCW--QREPQQRLNIKEIYKILHAL 292

Query: 796 VEVS 799
            + +
Sbjct: 293 GKAT 296

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  140 bits (355), Expect = 7e-37
 Identities = 79/309 (25%), Positives = 141/309 (45%), Gaps = 50/309 (16%)

Query: 523 FKEEVGRGSFGIVYKGV---IQTRTSTTAVAVKKLDRVFQDGER-EFKNEVFVIGQTHHK 578
              E+G+GSFG+VY+GV   +      T VA+K ++      ER EF NE  V+ + +  
Sbjct: 29  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88

Query: 579 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPNWNLR----TNIAFQIA 628
           ++VRLLG   +GQ  L++ E +  G L S+L        N              +A +IA
Sbjct: 89  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148

Query: 629 RGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKG 688
            G+ YL+     + +H D+  +N ++ + +T +I DFG+ + +            +G KG
Sbjct: 149 DGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-----YETDYYRKGGKG 200

Query: 689 YV-----APEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDW-AFDC 741
            +     +PE  ++   T   DV+SFGV+L EI +        + E+ Y  L++      
Sbjct: 201 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT--------LAEQPYQGLSNEQVLRF 252

Query: 742 YRNGKLNVLVGEDKEAMNDIECLGKL--VMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 799
              G   +L     +  ++  C   L  +M   W  Q +P +RP+  +++  ++  +E  
Sbjct: 253 VMEG--GLL-----DKPDN--CPDMLFELMRMCW--QYNPKMRPSFLEIISSIKEEMEPG 301

Query: 800 VPPNPYPFS 808
                + +S
Sbjct: 302 FREVSFYYS 310

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  140 bits (354), Expect = 1e-36
 Identities = 74/292 (25%), Positives = 134/292 (45%), Gaps = 55/292 (18%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTST--TAVAVKKLDRVFQDGER-EFKNEVFVIGQTHHKN 579
            ++ +G G FG VYKG+++T +      VA+K L   + + +R +F  E  ++GQ  H N
Sbjct: 48  RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107

Query: 580 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHED 637
           ++RL G   + +  +++ E++ NG L  FL       +++     +   IA G+ YL   
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLAN- 165

Query: 638 CRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYV---APEW 694
                +H D+  +NIL++     ++SDFGL+++L  +   T  T   G K  +   APE 
Sbjct: 166 --MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT--SGGKIPIRWTAPEA 221

Query: 695 FRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLNVLVGE 753
               K T+  DV+SFG+++ E+++         GE  Y  L+                  
Sbjct: 222 ISYRKFTSASDVWSFGIVMWEVMT--------YGERPYWELS------------------ 255

Query: 754 DKEAMNDIE----------CLGKL--VMVSIWCIQEDPSLRPTMKKVLQMLE 793
           + E M  I           C   +  +M+  W  Q++ + RP    ++ +L+
Sbjct: 256 NHEVMKAINDGFRLPTPMDCPSAIYQLMMQCW--QQERARRPKFADIVSILD 305

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  142 bits (360), Expect = 1e-36
 Identities = 79/314 (25%), Positives = 127/314 (40%), Gaps = 48/314 (15%)

Query: 491 KKKWIRNSPDDGTIETNLRCFSYKELEGATNNFKEEVGRGSFG-IVYKGVIQTRTSTTAV 549
                ++  D+ T    +   S+          K+ +G G+ G IVY+G+   R     V
Sbjct: 4   SPSLEQDDGDEETSVVIVGKISF--------CPKDVLGHGAEGTIVYRGMFDNR----DV 51

Query: 550 AVKKLDRVFQDGEREFKNEVFVIGQ-THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASF 608
           AVK++             EV ++ +   H N++R      + Q + +  E L   TL  +
Sbjct: 52  AVKRILPECFSFAD---REVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE-LCAATLQEY 107

Query: 609 LFGNLKPNWNLRT-NIAFQIARGLLYLHEDCRAQIIHCDIKPQNILL-----DDYYTARI 662
           +      +  L    +  Q   GL +LH      I+H D+KP NIL+          A I
Sbjct: 108 VEQKDFAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMI 164

Query: 663 SDFGLAKLLTLNQ-SKTIKTAIRGTKGYVAPEWFR---NSKITAKVDVYSFGVLLLEIIS 718
           SDFGL K L + + S + ++ + GT+G++APE          T  VD++S G +   +IS
Sbjct: 165 SDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224

Query: 719 CRKSF--DIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQ 776
                       +   +L   + DC     L+    ED  A         L+      I 
Sbjct: 225 EGSHPFGKSLQRQANILLGACSLDC-----LHPEKHEDVIARE-------LIE---KMIA 269

Query: 777 EDPSLRPTMKKVLQ 790
            DP  RP+ K VL+
Sbjct: 270 MDPQKRPSAKHVLK 283

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  138 bits (351), Expect = 1e-36
 Identities = 77/286 (26%), Positives = 123/286 (43%), Gaps = 35/286 (12%)

Query: 515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ 574
           + E   N  +  +G+G++GIVY G     ++   +A+K++        +    E+ +   
Sbjct: 18  DYEYDENGDRVVLGKGTYGIVYAGR--DLSNQVRIAIKEIPERDSRYSQPLHEEIALHKH 75

Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL---FGNLKPNWNLRTNIAFQIARGL 631
             HKN+V+ LG   E     +  E +  G+L++ L   +G LK N         QI  GL
Sbjct: 76  LKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGL 135

Query: 632 LYLHEDCRAQIIHCDIKPQNILLDDYY-TARISDFGLAKLLTLNQSKTIKTAIRGTKGYV 690
            YLH++   QI+H DIK  N+L++ Y    +ISDFG +K L      T      GT  Y+
Sbjct: 136 KYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCT--ETFTGTLQYM 190

Query: 691 APEWFRNSKI--TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLN 748
           APE             D++S G  ++E+ + +  F  E+GE  A +       ++ G   
Sbjct: 191 APEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF-YELGEPQAAM-------FKVGMFK 242

Query: 749 VL--VGED--KEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
           V   + E    EA   I            C + DP  R     +L 
Sbjct: 243 VHPEIPESMSAEAKAFILK----------CFEPDPDKRACANDLLV 278

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  139 bits (352), Expect = 2e-36
 Identities = 82/317 (25%), Positives = 126/317 (39%), Gaps = 58/317 (18%)

Query: 523 FKEEVGRGSFGIVYKGV---IQTRTSTTAVAVKKLDRVFQDGER-EFKNEVFVIGQTHHK 578
               +G G+FG VY+G    +    S   VAVK L  V  + +  +F  E  +I + +H+
Sbjct: 34  LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93

Query: 579 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT-------NIAFQIARGL 631
           N+VR +G   +   R ++ E +  G L SFL           +       ++A  IA G 
Sbjct: 94  NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153

Query: 632 LYLHEDCRAQIIHCDIKPQNILLDDY---YTARISDFGLAKLLTLNQSKTIKTAIRGTKG 688
            YL E      IH DI  +N LL        A+I DFG+A+ +            +G   
Sbjct: 154 QYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS-----YYRKGGCA 205

Query: 689 YV-----APEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDW-AFDC 741
            +      PE F     T+K D +SFGVLL EI S        +G   Y   ++    + 
Sbjct: 206 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--------LGYMPYPSKSNQEVLEF 257

Query: 742 YRNGKLNVLVGEDKEAMNDIE-CLGKL--VMVSIWCIQEDPSLRPTMKKVLQMLEG---- 794
             +G            M+  + C G +  +M   W  Q  P  RP    +L+ +E     
Sbjct: 258 VTSGGR----------MDPPKNCPGPVYRIMTQCW--QHQPEDRPNFAIILERIEYCTQD 305

Query: 795 --VVEVSVPPNPYPFSS 809
             V+  ++P    P   
Sbjct: 306 PDVINTALPIEYGPLVE 322

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  137 bits (348), Expect = 2e-36
 Identities = 69/289 (23%), Positives = 122/289 (42%), Gaps = 58/289 (20%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVR 582
             +E+G G FG+V  G  + +     VAVK +       E EF  E   + +  H  LV+
Sbjct: 12  LLKELGSGQFGVVKLGKWKGQYD---VAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVK 67

Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHEDCRA 640
             G C +     +V E+++NG L ++L  +            + + +  G+ +L      
Sbjct: 68  FYGVCSKEYPIYIVTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLES---H 123

Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ---SKTIKTAIRGTKGYVAPEWFRN 697
           Q IH D+  +N L+D     ++SDFG+ + +  +Q   S   K  ++ +    APE F  
Sbjct: 124 QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS----APEVFHY 179

Query: 698 SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLNVLVGEDKE 756
            K ++K DV++FG+L+ E+ S        +G+  Y + T                  + E
Sbjct: 180 FKYSSKSDVWAFGILMWEVFS--------LGKMPYDLYT------------------NSE 213

Query: 757 AMNDIE----------CLGKL--VMVSIWCIQEDPSLRPTMKKVLQMLE 793
            +  +               +  +M S W   E P  RPT +++L  +E
Sbjct: 214 VVLKVSQGHRLYRPHLASDTIYQIMYSCW--HELPEKRPTFQQLLSSIE 260

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  138 bits (351), Expect = 2e-36
 Identities = 58/276 (21%), Positives = 109/276 (39%), Gaps = 31/276 (11%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE---FKNEVFVIGQTHHKNLV 581
           +++GRG F  VY+           VA+KK+        +       E+ ++ Q +H N++
Sbjct: 38  KKIGRGQFSEVYRA--ACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVI 95

Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR----TNIAFQIARGLLYLHED 637
           +      E     +V E  + G L+  +    K    +          Q+   L ++H  
Sbjct: 96  KYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR 155

Query: 638 CRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRN 697
              +++H DIKP N+ +      ++ D GL +  +   +    + + GT  Y++PE    
Sbjct: 156 ---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA-HSLV-GTPYYMSPERIHE 210

Query: 698 SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEA 757
           +    K D++S G LL E+ + +  F  +    Y++               +   +    
Sbjct: 211 NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLC------------KKIEQCDYPPL 258

Query: 758 MNDI--ECLGKLVMVSIWCIQEDPSLRPTMKKVLQM 791
            +D   E L +LV     CI  DP  RP +  V  +
Sbjct: 259 PSDHYSEELRQLVN---MCINPDPEKRPDVTYVYDV 291

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  138 bits (349), Expect = 2e-36
 Identities = 62/292 (21%), Positives = 114/292 (39%), Gaps = 49/292 (16%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE-FKNEVFVIGQTHHKNLVRL 583
           + +GRG FG+V++            A+K++    ++  RE    EV  + +  H  +VR 
Sbjct: 11  QCLGRGGFGVVFE-AKNKVDDCN-YAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRY 68

Query: 584 LG-FCDEG--------QNRLLVY---EFLNNGTLASFLF---GNLKPNWNLRTNIAFQIA 628
              + ++           ++ +Y   +      L  ++       +   ++  +I  QIA
Sbjct: 69  FNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIA 128

Query: 629 RGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLL----------TLNQSKT 678
             + +LH      ++H D+KP NI        ++ DFGL   +          T   +  
Sbjct: 129 EAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185

Query: 679 IKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA 738
             T   GTK Y++PE    +  + KVD++S G++L E++     F  +M E    LTD  
Sbjct: 186 RHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM-ERVRTLTD-- 239

Query: 739 FDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
               RN K   L  +       +        V    +   P  RP    +++
Sbjct: 240 ---VRNLKFPPLFTQKYPCEYVM--------VQ-DMLSPSPMERPEAINIIE 279

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  137 bits (347), Expect = 2e-36
 Identities = 76/293 (25%), Positives = 126/293 (43%), Gaps = 58/293 (19%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVR 582
           F +E+G G FG+V+ G          VA+K + R     E +F  E  V+ +  H  LV+
Sbjct: 12  FVQEIGSGQFGLVHLGYWLN---KDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQ 67

Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHEDCRA 640
           L G C E     LV EF+ +G L+ +L    +  +   T   +   +  G+ YL E   A
Sbjct: 68  LYGVCLEQAPICLVTEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEE---A 123

Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ---SKTIKTAIRGTKGYVAPEWFRN 697
            +IH D+  +N L+ +    ++SDFG+ + +  +Q   S   K  ++      +PE F  
Sbjct: 124 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA----SPEVFSF 179

Query: 698 SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLNVLVGEDKE 756
           S+ ++K DV+SFGVL+ E+ S         G+  Y   +                  + E
Sbjct: 180 SRYSSKSDVWSFGVLMWEVFS--------EGKIPYENRS------------------NSE 213

Query: 757 AMNDIE----------CLGKL--VMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 797
            + DI               +  +M   W  +E P  RP   ++L+ L  + E
Sbjct: 214 VVEDISTGFRLYKPRLASTHVYQIMNHCW--RERPEDRPAFSRLLRQLAEIAE 264

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  139 bits (351), Expect = 2e-36
 Identities = 70/293 (23%), Positives = 121/293 (41%), Gaps = 59/293 (20%)

Query: 523 FKEEVGRGSFGIVYKGV--IQTRTSTTAVAVKKLDRVFQDGER-EFKNEVFVIGQTHHKN 579
             + +G G+FG VYKG+   +       VA+K+L          E  +E +V+    + +
Sbjct: 19  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78

Query: 580 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHED 637
           + RLLG C       L+ + +  G L  ++  + K N   +   N   QIA+G+ YL ED
Sbjct: 79  VCRLLGIC-LTSTVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYL-ED 135

Query: 638 CRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI----KTAIRGTKGYVAPE 693
            R  ++H D+  +N+L+      +I+DFGLAKLL   + +      K  I+      A E
Sbjct: 136 RR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM----ALE 189

Query: 694 WFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLNVLVG 752
              +   T + DV+S+GV + E+++         G + Y  +                  
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMT--------FGSKPYDGIP----------------- 224

Query: 753 EDKEAMNDIE----------CLGKL--VMVSIWCIQEDPSLRPTMKKVLQMLE 793
              E  + +E          C   +  +MV  W    D   RP  ++++    
Sbjct: 225 -ASEISSILEKGERLPQPPICTIDVYMIMVKCW--MIDADSRPKFRELIIEFS 274

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  140 bits (354), Expect = 2e-36
 Identities = 76/300 (25%), Positives = 141/300 (47%), Gaps = 54/300 (18%)

Query: 514 KELEGATNNFKEEVGRGSFGIVYKGVIQTRTS-TTAVAVKKLDRVFQDGER-EFKNEVFV 571
           KEL+    +  + VG G FG V  G ++  +    +VA+K L   + + +R +F  E  +
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99

Query: 572 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIAR 629
           +GQ  H N++RL G   + +  ++V E++ NG+L SFL  +    + +     +   IA 
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIAS 158

Query: 630 GLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGY 689
           G+ YL  D     +H D+  +NIL++     ++SDFGL ++L  +      T  RG K  
Sbjct: 159 GMKYL-SDMG--YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTT--RGGKIP 213

Query: 690 V---APEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNG 745
           +   +PE     K T+  DV+S+G++L E++S         GE  Y  ++          
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS--------YGERPYWEMS---------- 255

Query: 746 KLNVLVGEDKEAMNDIE----------CLGKL--VMVSIWCIQEDPSLRPTMKKVLQMLE 793
                   +++ +  ++          C   L  +M+  W  Q+D + RP  ++++ +L+
Sbjct: 256 --------NQDVIKAVDEGYRLPPPMDCPAALYQLMLDCW--QKDRNNRPKFEQIVSILD 305

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  137 bits (347), Expect = 3e-36
 Identities = 73/289 (25%), Positives = 119/289 (41%), Gaps = 62/289 (21%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG--EREFKNEVFVIGQTHHKNL 580
             + +G+G FG V  G  +       VAVK +    ++    + F  E  V+ Q  H NL
Sbjct: 25  LLQTIGKGEFGDVMLGDYRGNK----VAVKCI----KNDATAQAFLAEASVMTQLRHSNL 76

Query: 581 VRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHED 637
           V+LLG   E +  L +V E++  G+L  +L    +           +  +   + YL   
Sbjct: 77  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG- 135

Query: 638 CRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRN 697
                +H D+  +N+L+ +   A++SDFGL K  +  Q    K  ++ T    APE  R 
Sbjct: 136 --NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG-KLPVKWT----APEALRE 188

Query: 698 SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLNVLVGEDKE 756
            K + K DV+SFG+LL EI S         G   Y  +                    K+
Sbjct: 189 KKFSTKSDVWSFGILLWEIYS--------FGRVPYPRIP------------------LKD 222

Query: 757 AMNDIE----------CLGKL--VMVSIWCIQEDPSLRPTMKKVLQMLE 793
            +  +E          C   +  VM + W    D ++RP+  ++ + LE
Sbjct: 223 VVPRVEKGYKMDAPDGCPPAVYEVMKNCW--HLDAAMRPSFLQLREQLE 269

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  137 bits (347), Expect = 3e-36
 Identities = 72/293 (24%), Positives = 125/293 (42%), Gaps = 58/293 (19%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVR 582
           F +E+G G FG+V  G  + +     VA+K + +     E EF  E  V+    H+ LV+
Sbjct: 28  FLKELGTGQFGVVKYGKWRGQYD---VAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQ 83

Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHEDCRA 640
           L G C + +   ++ E++ NG L ++L    +  +  +    +   +   + YL      
Sbjct: 84  LYGVCTKQRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLES---K 139

Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ---SKTIKTAIRGTKGYVAPEWFRN 697
           Q +H D+  +N L++D    ++SDFGL++ +  ++   S   K  +R +     PE    
Sbjct: 140 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS----PPEVLMY 195

Query: 698 SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLNVLVGEDKE 756
           SK ++K D+++FGVL+ EI S         G+  Y   T                  + E
Sbjct: 196 SKFSSKSDIWAFGVLMWEIYSL--------GKMPYERFT------------------NSE 229

Query: 757 AMNDIE----------CLGKL--VMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 797
               I              K+  +M S W   E    RPT K +L  +  V++
Sbjct: 230 TAEHIAQGLRLYRPHLASEKVYTIMYSCW--HEKADERPTFKILLSNILDVMD 280

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  136 bits (346), Expect = 4e-36
 Identities = 66/291 (22%), Positives = 115/291 (39%), Gaps = 57/291 (19%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTS-TTAVAVKKLDRVFQDGER-EFKNEVFVIGQTHHKNL 580
               +G G FG VY+GV          VAVK   +      + +F +E  ++    H ++
Sbjct: 16  LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75

Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHEDC 638
           V+L+G  +E +   ++ E    G L  +L  N K +  + T    + QI + + YL E  
Sbjct: 76  VKLIGIIEE-EPTWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYL-ESI 132

Query: 639 RAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ---SKTIKTAIRGTKGYVAPEWF 695
               +H DI  +NIL+      ++ DFGL++ +       +   +  I+      +PE  
Sbjct: 133 N--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM----SPESI 186

Query: 696 RNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLNVLVGED 754
              + T   DV+ F V + EI+S         G++ +  L                   +
Sbjct: 187 NFRRFTTASDVWMFAVCMWEILS--------FGKQPFFWLE------------------N 220

Query: 755 KEAMNDIE----------CLGKL--VMVSIWCIQEDPSLRPTMKKVLQMLE 793
           K+ +  +E          C   L  +M   W    DPS RP   +++  L 
Sbjct: 221 KDVIGVLEKGDRLPKPDLCPPVLYTLMTRCW--DYDPSDRPRFTELVCSLS 269

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  136 bits (346), Expect = 4e-36
 Identities = 78/289 (26%), Positives = 126/289 (43%), Gaps = 56/289 (19%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVR 582
            K ++G G +G VY+GV   +  +  VAVK L     + E EF  E  V+ +  H NLV+
Sbjct: 17  MKHKLGGGQYGEVYEGVW--KKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQ 73

Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHEDCRA 640
           LLG C       ++ EF+  G L  +L    +   +      +A QI+  + YL +    
Sbjct: 74  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---K 130

Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ---SKTIKTAIRGTKGYVAPEWFRN 697
             IH D+  +N L+ + +  +++DFGL++L+T +        K  I+ T    APE    
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAY 186

Query: 698 SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLNVLVGEDKE 756
           +K + K DV++FGVLL EI +         G   Y  +                     +
Sbjct: 187 NKFSIKSDVWAFGVLLWEIAT--------YGMSPYPGID------------------LSQ 220

Query: 757 AMNDIE----------CLGKL--VMVSIWCIQEDPSLRPTMKKVLQMLE 793
               +E          C  K+  +M + W  Q +PS RP+  ++ Q  E
Sbjct: 221 VYELLEKDYRMERPEGCPEKVYELMRACW--QWNPSDRPSFAEIHQAFE 267

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  140 bits (356), Expect = 5e-36
 Identities = 71/289 (24%), Positives = 122/289 (42%), Gaps = 58/289 (20%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVR 582
            ++++G G FG V+       T    VAVK + +        F  E  V+    H  LV+
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHTK---VAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVK 247

Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHEDCRA 640
           L     + +   ++ EF+  G+L  FL  +      L    + + QIA G+ ++ +    
Sbjct: 248 LHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---R 303

Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ---SKTIKTAIRGTKGYVAPEWFRN 697
             IH D++  NIL+      +I+DFGLA+++  N+    +  K  I+ T    APE    
Sbjct: 304 NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT----APEAINF 359

Query: 698 SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLNVLVGEDKE 756
              T K DV+SFG+LL+EI++         G   Y  ++                  + E
Sbjct: 360 GSFTIKSDVWSFGILLMEIVTY--------GRIPYPGMS------------------NPE 393

Query: 757 AMNDIE----------CLGKL--VMVSIWCIQEDPSLRPTMKKVLQMLE 793
            +  +E          C  +L  +M+  W  +  P  RPT + +  +L+
Sbjct: 394 VIRALERGYRMPRPENCPEELYNIMMRCW--KNRPEERPTFEYIQSVLD 440

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  137 bits (346), Expect = 6e-36
 Identities = 67/300 (22%), Positives = 128/300 (42%), Gaps = 58/300 (19%)

Query: 523 FKEEVGRGSFGIVYKGV-IQTRTSTTAVAVKKLDRVFQDGER-EFKNEVFVIGQTHHKNL 580
               +G+G FG+VY G  I    +    A+K L R+ +  +   F  E  ++   +H N+
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84

Query: 581 VRLLGFCDEGQNRLL-VYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHED 637
           + L+G     +     +  ++ +G L  F+    + N  ++   +   Q+ARG+ YL E 
Sbjct: 85  LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAE- 142

Query: 638 CRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYV-----AP 692
              + +H D+  +N +LD+ +T +++DFGLA+ +     +   +  +     +     A 
Sbjct: 143 --QKFVHRDLAARNCMLDESFTVKVADFGLARDI---LDREYYSVQQHRHARLPVKWTAL 197

Query: 693 EWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLNVLV 751
           E  +  + T K DV+SFGVLL E+++         G   Y  +  +              
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLT--------RGAPPYRHIDPF-------------- 235

Query: 752 GEDKEAMNDIE----------CLGKL--VMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 799
               +  + +           C   L  VM   W  + DP++RPT + ++  +E +V   
Sbjct: 236 ----DLTHFLAQGRRLPQPEYCPDSLYQVMQQCW--EADPAVRPTFRVLVGEVEQIVSAL 289

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  138 bits (350), Expect = 8e-36
 Identities = 81/315 (25%), Positives = 124/315 (39%), Gaps = 55/315 (17%)

Query: 523 FKEEVGRGSFGIVYKGV---IQTRTSTTAVAVKKLDRVFQDGER-EFKNEVFVIGQTHHK 578
               +G G+FG VY+G    +    S   VAVK L  V  + +  +F  E  +I + +H+
Sbjct: 75  LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 134

Query: 579 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT-------NIAFQIARGL 631
           N+VR +G   +   R ++ E +  G L SFL           +       ++A  IA G 
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194

Query: 632 LYLHEDCRAQIIHCDIKPQNILLDDY---YTARISDFGLAKLLTLNQSKTIKTAIRGTKG 688
            YL E      IH DI  +N LL        A+I DFG+A+ +            +G   
Sbjct: 195 QYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR-----KGGCA 246

Query: 689 YV-----APEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDW-AFDC 741
            +      PE F     T+K D +SFGVLL EI S        +G   Y   ++    + 
Sbjct: 247 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--------LGYMPYPSKSNQEVLEF 298

Query: 742 YRNGKLNVLVGEDKEAMNDIE-CLGKL--VMVSIWCIQEDPSLRPTMKKVLQMLEGVV-- 796
             +G            M+  + C G +  +M   W  Q  P  RP    +L+ +E     
Sbjct: 299 VTSGGR----------MDPPKNCPGPVYRIMTQCW--QHQPEDRPNFAIILERIEYCTQD 346

Query: 797 -EVSVPPNPYPFSSS 810
            +V     P  +   
Sbjct: 347 PDVINTALPIEYGPL 361

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  135 bits (343), Expect = 1e-35
 Identities = 64/293 (21%), Positives = 117/293 (39%), Gaps = 55/293 (18%)

Query: 521 NNFK--EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHK 578
            +FK  E +G G FG V+K         T   +K++         + + EV  + +  H 
Sbjct: 11  MDFKEIELIGSGGFGQVFK-AKHRIDGKT-YVIKRVKY----NNEKAEREVKALAKLDHV 64

Query: 579 NLVRLLG-FCDEGQNRL---------------LVYEFLNNGTLASFL---FGNLKPNWNL 619
           N+V   G +     +                 +  EF + GTL  ++    G        
Sbjct: 65  NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA 124

Query: 620 RTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI 679
              +  QI +G+ Y+H     ++I+ D+KP NI L D    +I DFGL   L    +   
Sbjct: 125 L-ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLK---NDGK 177

Query: 680 KTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF 739
           +T  +GT  Y++PE   +     +VD+Y+ G++L E++    +   E  + +  L     
Sbjct: 178 RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF-ETSKFFTDL----- 231

Query: 740 DCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQML 792
              R+G ++ +  +             L+      + + P  RP   ++L+ L
Sbjct: 232 ---RDGIISDIFDKK---------EKTLLQ---KLLSKKPEDRPNTSEILRTL 269

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  135 bits (342), Expect = 1e-35
 Identities = 68/277 (24%), Positives = 117/277 (42%), Gaps = 30/277 (10%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ-DGEREF-KNEVFVIGQTHHKNLVR 582
             +G GS+G   K  I+ ++    +  K+LD     + E++   +EV ++ +  H N+VR
Sbjct: 12  YTIGTGSYGRCQK--IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVR 69

Query: 583 LLG-FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLR----TNIAFQIARGLLYLHE 636
                 D     L +V E+   G LAS +    K    L       +  Q+   L   H 
Sbjct: 70  YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 129

Query: 637 --DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 694
             D    ++H D+KP N+ LD     ++ DFGLA++L  + S   KT + GT  Y++PE 
Sbjct: 130 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA-KTFV-GTPYYMSPEQ 187

Query: 695 FRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGED 754
                   K D++S G LL E+ +    F          L        R GK   +    
Sbjct: 188 MNRMSYNEKSDIWSLGCLLYELCALMPPFT---AFSQKEL----AGKIREGKFRRIPYRY 240

Query: 755 KEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM 791
            + +N+I        ++   +      RP+++++L+ 
Sbjct: 241 SDELNEI--------IT-RMLNLKDYHRPSVEEILEN 268

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  136 bits (345), Expect = 1e-35
 Identities = 72/312 (23%), Positives = 126/312 (40%), Gaps = 70/312 (22%)

Query: 523 FKEEVGRGSFGIVYKGV---IQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKN 579
            K E+G G+FG V+      +        VAVK L    +   ++F+ E  ++    H++
Sbjct: 45  LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 104

Query: 580 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN---------------IA 624
           +VR  G C EG+  L+V+E++ +G L  FL  +      L                  +A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164

Query: 625 FQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTA-- 682
            Q+A G++YL        +H D+  +N L+      +I DFG+++ +       +     
Sbjct: 165 SQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 221

Query: 683 --IRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAF 739
             IR       PE     K T + DV+SFGV+L EI +         G++ +  L++   
Sbjct: 222 LPIRWM----PPESILYRKFTTESDVWSFGVVLWEIFT--------YGKQPWYQLSNT-- 267

Query: 740 DCYRNGKLNVLVGEDKEAMNDIE----------CLGKL--VMVSIWCIQEDPSLRPTMKK 787
                           EA++ I           C  ++  +M   W  Q +P  R ++K 
Sbjct: 268 ----------------EAIDCITQGRELERPRACPPEVYAIMRGCW--QREPQQRHSIKD 309

Query: 788 VLQMLEGVVEVS 799
           V   L+ + +  
Sbjct: 310 VHARLQALAQAP 321

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  135 bits (341), Expect = 2e-35
 Identities = 78/299 (26%), Positives = 122/299 (40%), Gaps = 54/299 (18%)

Query: 523 FKEEVGRGSFGIVYKGV---IQTRTSTTAVAVKKLDRVFQDGER-EFKNEVFVIGQTHHK 578
           F EE+G   FG VYKG          T AVA+K L    +   R EF++E  +  +  H 
Sbjct: 13  FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72

Query: 579 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN---------------- 622
           N+V LLG   + Q   +++ + ++G L  FL      +    T+                
Sbjct: 73  NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132

Query: 623 IAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTA 682
           +  QIA G+ YL       ++H D+  +N+L+ D    +ISD GL + +       +   
Sbjct: 133 LVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 189

Query: 683 ----IRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDW 737
               IR      APE     K +   D++S+GV+L E+ S         G + Y   ++ 
Sbjct: 190 SLLPIRWM----APEAIMYGKFSIDSDIWSYGVVLWEVFS--------YGLQPYCGYSNQ 237

Query: 738 -AFDCYRNGKLNVLVGEDKEAMNDIECLGKL--VMVSIWCIQEDPSLRPTMKKVLQMLE 793
              +  RN    VL        +D  C   +  +M+  W   E PS RP  K +   L 
Sbjct: 238 DVVEMIRNR--QVL-----PCPDD--CPAWVYALMIECW--NEFPSRRPRFKDIHSRLR 285

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  135 bits (342), Expect = 2e-35
 Identities = 73/296 (24%), Positives = 116/296 (39%), Gaps = 50/296 (16%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVR 582
               +G+G+FG V K        +   A+KK+    ++      +EV ++   +H+ +VR
Sbjct: 10  EIAVLGQGAFGQVVKAR--NALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVR 66

Query: 583 LLGFCDEGQNRL-------------LVYEFLNNGTLASFL-FGNLKPNWNLRTNIAFQIA 628
                 E +N +             +  E+  NGTL   +   NL    +    +  QI 
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL 126

Query: 629 RGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLT-------------LNQ 675
             L Y+H      IIH D+KP NI +D+    +I DFGLAK +                 
Sbjct: 127 EALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183

Query: 676 SKTIKTAIRGTKGYVAPEWFRNSKI-TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL 734
           S  + +AI GT  YVA E    +     K+D+YS G++  E+I    S  +E       L
Sbjct: 184 SDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI-YPFSTGMERVNILKKL 241

Query: 735 TDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
                   R+  +      D   M       K++      I  DP+ RP  + +L 
Sbjct: 242 --------RSVSIEFPPDFDDNKMKV---EKKIIR---LLIDHDPNKRPGARTLLN 283

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  134 bits (339), Expect = 3e-35
 Identities = 68/291 (23%), Positives = 115/291 (39%), Gaps = 57/291 (19%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRT-STTAVAVKKLDRVFQDGER-EFKNEVFVIGQTHHKNL 580
               +G G FG V++G+  +      AVA+K       D  R +F  E   + Q  H ++
Sbjct: 19  LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 78

Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHEDC 638
           V+L+G   E     ++ E    G L SFL    K + +L +    A+Q++  L YL    
Sbjct: 79  VKLIGVITE-NPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLES-- 134

Query: 639 RAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ---SKTIKTAIRGTKGYVAPEWF 695
             + +H DI  +N+L+      ++ DFGL++ +  +    +   K  I+      APE  
Sbjct: 135 -KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM----APESI 189

Query: 696 RNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLNVLVGED 754
              + T+  DV+ FGV + EI+          G + +  +                   +
Sbjct: 190 NFRRFTSASDVWMFGVCMWEILM--------HGVKPFQGVK------------------N 223

Query: 755 KEAMNDIE----------CLGKL--VMVSIWCIQEDPSLRPTMKKVLQMLE 793
            + +  IE          C   L  +M   W    DPS RP   ++   L 
Sbjct: 224 NDVIGRIENGERLPMPPNCPPTLYSLMTKCW--AYDPSRRPRFTELKAQLS 272

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  133 bits (338), Expect = 4e-35
 Identities = 81/289 (28%), Positives = 125/289 (43%), Gaps = 58/289 (20%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVR 582
             E +G G FG V+ G        T VAVK L +        F  E  ++ Q  H+ LVR
Sbjct: 17  LVERLGAGQFGEVWMGYYNG---HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVR 72

Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHEDCRA 640
           L     + +   ++ E++ NG+L  FL         +    ++A QIA G+ ++ E    
Sbjct: 73  LYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---R 128

Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ---SKTIKTAIRGTKGYVAPEWFRN 697
             IH D++  NIL+ D  + +I+DFGLA+L+  N+    +  K  I+ T    APE    
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT----APEAINY 184

Query: 698 SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLNVLVGEDKE 756
              T K DV+SFG+LL EI++         G   Y  +T                  + E
Sbjct: 185 GTFTIKSDVWSFGILLTEIVT--------HGRIPYPGMT------------------NPE 218

Query: 757 AMNDIE----------CLGKL--VMVSIWCIQEDPSLRPTMKKVLQMLE 793
            + ++E          C  +L  +M   W  +E P  RPT   +  +LE
Sbjct: 219 VIQNLERGYRMVRPDNCPEELYQLMRLCW--KERPEDRPTFDYLRSVLE 265

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  134 bits (340), Expect = 5e-35
 Identities = 78/306 (25%), Positives = 125/306 (40%), Gaps = 66/306 (21%)

Query: 523 FKEEVGRGSFGIVYKGV-IQTRTSTTAVAVK--KLDRVFQDGEREFKNEVFVIGQTHHKN 579
             + +G G FG V +G   Q   ++  VAVK  KLD   Q    EF +E   +    H N
Sbjct: 38  LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN 97

Query: 580 LVRLLGFCDEGQNR-----LLVYEFLNNGTLASFL----FGNLKPNWNLRT--NIAFQIA 628
           ++RLLG C E  ++     +++  F+  G L ++L          +  L+T       IA
Sbjct: 98  VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157

Query: 629 RGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN----QSKTIKTAIR 684
            G+ YL        +H D+  +N +L D  T  ++DFGL+K +       Q +  K  ++
Sbjct: 158 LGMEYLSN---RNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 214

Query: 685 GTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYR 743
                 A E   +   T+K DV++FGV + EI +         G   Y  + +       
Sbjct: 215 WI----AIESLADRVYTSKSDVWAFGVTMWEIAT--------RGMTPYPGVQNH------ 256

Query: 744 NGKLNVLVGEDKEAMNDIE----------CLGKL--VMVSIWCIQEDPSLRPTMKKVLQM 791
                       E  + +           CL +L  +M S W  + DP  RPT   +   
Sbjct: 257 ------------EMYDYLLHGHRLKQPEDCLDELYEIMYSCW--RTDPLDRPTFSVLRLQ 302

Query: 792 LEGVVE 797
           LE ++E
Sbjct: 303 LEKLLE 308

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  140 bits (355), Expect = 5e-35
 Identities = 76/289 (26%), Positives = 123/289 (42%), Gaps = 54/289 (18%)

Query: 524 KEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGER-EFKNEVFVIGQTHHKNLVR 582
             E+G G+FG V +GV + R     VA+K L +  +  +  E   E  ++ Q  +  +VR
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400

Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHEDCRA 640
           L+G C + +  +LV E    G L  FL G  +    +     +  Q++ G+ YL E+   
Sbjct: 401 LIGVC-QAEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYL-EEKN- 456

Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYV---APEWFRN 697
             +H ++  +N+LL + + A+ISDFGL+K L  + S    TA    K  +   APE    
Sbjct: 457 -FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS--YYTARSAGKWPLKWYAPECINF 513

Query: 698 SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLNVLVGEDKE 756
            K +++ DV+S+GV + E +S         G++ Y  +                     E
Sbjct: 514 RKFSSRSDVWSYGVTMWEALSY--------GQKPYKKMK------------------GPE 547

Query: 757 AMNDIE----------CLGKL--VMVSIWCIQEDPSLRPTMKKVLQMLE 793
            M  IE          C  +L  +M   W        RP    V Q + 
Sbjct: 548 VMAFIEQGKRMECPPECPPELYALMSDCW--IYKWEDRPDFLTVEQRMR 594

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  135 bits (342), Expect = 9e-35
 Identities = 72/308 (23%), Positives = 124/308 (40%), Gaps = 57/308 (18%)

Query: 523 FKEEVGRGSFGIVYKGVI-----QTRTSTTAVAVKKLDRVFQDGER-EFKNEVFVIGQ-T 575
             + +G G FG V                  VAVK L     + +  +  +E+ ++    
Sbjct: 85  LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 144

Query: 576 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN------------- 622
            HKN++ LLG C +     ++ E+ + G L  +L     P      +             
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204

Query: 623 ---IAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI 679
                +Q+ARG+ YL      + IH D+  +N+L+ +    +I+DFGLA+ +        
Sbjct: 205 LVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 261

Query: 680 KTA----IRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAI 733
            T     ++      APE   +   T + DV+SFGVL+ EI +        +G      I
Sbjct: 262 TTNGRLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIFT--------LGGSPYPGI 309

Query: 734 LTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKL--VMVSIWCIQEDPSLRPTMKKVLQM 791
             +  F   + G        DK A     C  +L  +M   W     PS RPT K++++ 
Sbjct: 310 PVEELFKLLKEGHRM-----DKPA----NCTNELYMMMRDCW--HAVPSQRPTFKQLVED 358

Query: 792 LEGVVEVS 799
           L+ ++ ++
Sbjct: 359 LDRILTLT 366

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  133 bits (338), Expect = 1e-34
 Identities = 80/339 (23%), Positives = 132/339 (38%), Gaps = 75/339 (22%)

Query: 495 IRNSPDDGTIETNLRCFSYKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKL 554
           ++        + N     Y  L+     F++ +G G+FG V K  I+        A+K++
Sbjct: 1   MKKHHHHHHGKNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM 60

Query: 555 DRVFQDGER-EFKNEVFVIGQ-THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN 612
                  +  +F  E+ V+ +  HH N++ LLG C+      L  E+  +G L  FL  +
Sbjct: 61  KEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKS 120

Query: 613 LKPNWNLRTN----------------IAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDD 656
                +                     A  +ARG+ YL +    Q IH D+  +NIL+ +
Sbjct: 121 RVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGE 177

Query: 657 YYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYV-----APEWFRNSKITAKVDVYSFGV 711
            Y A+I+DFGL        S+  +  ++ T G +     A E    S  T   DV+S+GV
Sbjct: 178 NYVAKIADFGL--------SRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGV 229

Query: 712 LLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLNVLVGEDKEAMNDIE-------- 762
           LL EI+S        +G   Y         C              E    +         
Sbjct: 230 LLWEIVS--------LGGTPY-----CGMTC-------------AELYEKLPQGYRLEKP 263

Query: 763 --CLGKL--VMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 797
             C  ++  +M   W  +E P  RP+  ++L  L  ++E
Sbjct: 264 LNCDDEVYDLMRQCW--REKPYERPSFAQILVSLNRMLE 300

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  133 bits (338), Expect = 2e-34
 Identities = 72/312 (23%), Positives = 125/312 (40%), Gaps = 57/312 (18%)

Query: 523 FKEEVGRGSFGIVYKGVI-----QTRTSTTAVAVKKLDRVFQDGER-EFKNEVFVIGQ-T 575
             + +G G+FG V                  VAVK L     + +  +  +E+ ++    
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98

Query: 576 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN------------- 622
            HKN++ LLG C +     ++ E+ + G L  +L     P      +             
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158

Query: 623 ---IAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI 679
                +Q+ARG+ YL      + IH D+  +N+L+ +    +I+DFGLA+ +        
Sbjct: 159 LVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215

Query: 680 KTA----IRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAI 733
            T     ++      APE   +   T + DV+SFGVL+ EI +        +G      I
Sbjct: 216 TTNGRLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIFT--------LGGSPYPGI 263

Query: 734 LTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKL--VMVSIWCIQEDPSLRPTMKKVLQM 791
             +  F   + G        DK A     C  +L  +M   W     PS RPT K++++ 
Sbjct: 264 PVEELFKLLKEGHRM-----DKPA----NCTNELYMMMRDCW--HAVPSQRPTFKQLVED 312

Query: 792 LEGVVEVSVPPN 803
           L+ ++ ++    
Sbjct: 313 LDRILTLTTNEE 324

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  133 bits (337), Expect = 2e-34
 Identities = 59/286 (20%), Positives = 119/286 (41%), Gaps = 47/286 (16%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE--REFKNEVFVIG--QTHHKNL 580
           +++G G    V++            A+K ++    D +    ++NE+  +   Q H   +
Sbjct: 15  KQIGSGGSSKVFQV---LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 71

Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLHEDC 638
           +RL  +    Q   +V E   N  L S+L    ++ P    R +    +   +  +H+  
Sbjct: 72  IRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWE--RKSYWKNMLEAVHTIHQ-- 126

Query: 639 RAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE----- 693
              I+H D+KP N L+ D    ++ DFG+A  +  + +  +K +  GT  Y+ PE     
Sbjct: 127 -HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184

Query: 694 ------WFRNSKITAKVDVYSFGVLLLEIISCRKSFD---IEMGEEYAILTDWAFDCYRN 744
                     SKI+ K DV+S G +L  +   +  F     ++ + +AI+         N
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP-------N 237

Query: 745 GKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
            ++      +K+  + ++           C++ DP  R ++ ++L 
Sbjct: 238 HEIEFPDIPEKDLQDVLK----------CCLKRDPKQRISIPELLA 273

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  135 bits (342), Expect = 2e-34
 Identities = 77/302 (25%), Positives = 117/302 (38%), Gaps = 57/302 (18%)

Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQT-HHKNL 580
             ++ +G GS G V     Q       VAVK++   F D       E+ ++ ++  H N+
Sbjct: 18  VSEKILGYGSSGTVVF---QGSFQGRPVAVKRMLIDFCD---IALMEIKLLTESDDHPNV 71

Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT-------NIAFQIARGLLY 633
           +R        +   +  E L N  L   +      + NL+        ++  QIA G+ +
Sbjct: 72  IRYYCSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130

Query: 634 LHEDCRAQIIHCDIKPQNILLD-------------DYYTARISDFGLAKLLTLNQS---K 677
           LH     +IIH D+KPQNIL+              +     ISDFGL K L   QS    
Sbjct: 131 LHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187

Query: 678 TIKTAIRGTKGYVAPEWFRNS-------KITAKVDVYSFGVLLLEIISCRKS-FDIEMGE 729
            +     GT G+ APE    S       ++T  +D++S G +   I+S  K  F  +   
Sbjct: 188 NLNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246

Query: 730 EYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGK-LVMVSIWCIQEDPSLRPTMKKV 788
           E  I+          G  + L          +      L+      I  DP  RPT  KV
Sbjct: 247 ESNII---------RGIFS-LDEMKCLHDRSLIAEATDLIS---QMIDHDPLKRPTAMKV 293

Query: 789 LQ 790
           L+
Sbjct: 294 LR 295

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  132 bits (335), Expect = 3e-34
 Identities = 75/309 (24%), Positives = 128/309 (41%), Gaps = 58/309 (18%)

Query: 523 FKEEVGRGSFGIVYKGV---IQTRTSTTAVAVKKLDRVFQDGER-EFKNEVFVIGQ-THH 577
           F + +G G+FG V +     +    +   VAVK L       ER    +E+ V+    +H
Sbjct: 27  FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86

Query: 578 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN--------------- 622
            N+V LLG C  G   L++ E+   G L +FL          +T+               
Sbjct: 87  MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146

Query: 623 ---IAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI 679
               ++Q+A+G+ +L        IH D+  +NILL      +I DFGLA+ +  + +  +
Sbjct: 147 LLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203

Query: 680 KTA----IRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAI 733
           K      ++      APE   N   T + DV+S+G+ L E+ S   S    + +  +   
Sbjct: 204 KGNARLPVKWM----APESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--- 256

Query: 734 LTDWAFDCYRNGKLNVLVGEDKEAMNDIE-CLGKL--VMVSIWCIQEDPSLRPTMKKVLQ 790
                +   + G            M   E    ++  +M + W    DP  RPT K+++Q
Sbjct: 257 ----FYKMIKEGFR----------MLSPEHAPAEMYDIMKTCW--DADPLKRPTFKQIVQ 300

Query: 791 MLEGVVEVS 799
           ++E  +  S
Sbjct: 301 LIEKQISES 309

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  132 bits (335), Expect = 3e-34
 Identities = 57/286 (19%), Positives = 117/286 (40%), Gaps = 47/286 (16%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE--REFKNEVFVIGQTHHKNL-- 580
           +++G G    V++            A+K ++    D +    ++NE+  + +    +   
Sbjct: 34  KQIGSGGSSKVFQV---LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 90

Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLHEDC 638
           +RL  +    Q   +V E   N  L S+L    ++ P    R +    +   +  +H+  
Sbjct: 91  IRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWE--RKSYWKNMLEAVHTIHQ-- 145

Query: 639 RAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE----- 693
              I+H D+KP N L+ D    ++ DFG+A  +  + +  +K +  GT  Y+ PE     
Sbjct: 146 -HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 203

Query: 694 ------WFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE---YAILTDWAFDCYRN 744
                     SKI+ K DV+S G +L  +   +  F   + +    +AI+         N
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP-------N 256

Query: 745 GKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
            ++      +K+  + ++           C++ DP  R ++ ++L 
Sbjct: 257 HEIEFPDIPEKDLQDVLK----------CCLKRDPKQRISIPELLA 292

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  132 bits (335), Expect = 3e-34
 Identities = 74/308 (24%), Positives = 126/308 (40%), Gaps = 55/308 (17%)

Query: 523 FKEEVGRGSFGIVYKGV---IQTRTSTTAVAVKKLDRVFQDGER-EFKNEVFVIGQ-THH 577
             + +GRG+FG V +     I    +   VAVK L       E     +E+ ++    HH
Sbjct: 31  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90

Query: 578 KNLVRLLGFC-DEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN-------------- 622
            N+V LLG C   G   +++ EF   G L+++L          +                
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150

Query: 623 --IAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIK 680
              +FQ+A+G+ +L      + IH D+  +NILL +    +I DFGLA+ +  +     K
Sbjct: 151 ICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 207

Query: 681 TA----IRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAIL 734
                 ++      APE   +   T + DV+SFGVLL EI S   S    +++ EE    
Sbjct: 208 GDARLPLKWM----APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---- 259

Query: 735 TDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKL--VMVSIWCIQEDPSLRPTMKKVLQML 792
                   + G    +               ++   M+  W    +PS RPT  ++++ L
Sbjct: 260 ---FCRRLKEG--TRM---RAPD----YTTPEMYQTMLDCW--HGEPSQRPTFSELVEHL 305

Query: 793 EGVVEVSV 800
             +++ + 
Sbjct: 306 GNLLQANA 313

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  132 bits (335), Expect = 3e-34
 Identities = 64/307 (20%), Positives = 116/307 (37%), Gaps = 67/307 (21%)

Query: 523 FKEEVGRGSFGIVYKGVIQTR-TSTTAVAVK--KLDRVFQDGEREFKNEVFVIGQTHHKN 579
               +G+G FG V +  ++    S   VAVK  K D +      EF  E   + +  H +
Sbjct: 27  LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPH 86

Query: 580 LVRLLGFCDEGQNR------LLVYEFLNNGTLASFLFGNLKPNWNLR------TNIAFQI 627
           + +L+G     + +      +++  F+ +G L +FL  +                    I
Sbjct: 87  VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146

Query: 628 ARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN----QSKTIKTAI 683
           A G+ YL        IH D+  +N +L +  T  ++DFGL++ +       Q    K  +
Sbjct: 147 ACGMEYLSS---RNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPV 203

Query: 684 RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCY 742
           +      A E   ++  T   DV++FGV + EI++         G+  YA + +      
Sbjct: 204 KWL----ALESLADNLYTVHSDVWAFGVTMWEIMT--------RGQTPYAGIENA----- 246

Query: 743 RNGKLNVLVGEDKEAMNDIE----------CLGKL--VMVSIWCIQEDPSLRPTMKKVLQ 790
                        E  N +           C+ ++  +M   W    DP  RP+   +  
Sbjct: 247 -------------EIYNYLIGGNRLKQPPECMEEVYDLMYQCW--SADPKQRPSFTCLRM 291

Query: 791 MLEGVVE 797
            LE ++ 
Sbjct: 292 ELENILG 298

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  133 bits (337), Expect = 6e-34
 Identities = 57/286 (19%), Positives = 118/286 (41%), Gaps = 47/286 (16%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE--REFKNEVFVIGQTHHKNL-- 580
           +++G G    V++            A+K ++    D +    ++NE+  + +    +   
Sbjct: 62  KQIGSGGSSKVFQV---LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 118

Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLHEDC 638
           +RL  +    Q   +V E   N  L S+L    ++ P    R +    +   +  +H+  
Sbjct: 119 IRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWE--RKSYWKNMLEAVHTIHQ-- 173

Query: 639 RAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE----- 693
              I+H D+KP N L+ D    ++ DFG+A  +  + +  +K +  G   Y+ PE     
Sbjct: 174 -HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231

Query: 694 ------WFRNSKITAKVDVYSFGVLLLEIISCRKSFD---IEMGEEYAILTDWAFDCYRN 744
                     SKI+ K DV+S G +L  +   +  F     ++ + +AI+         N
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP-------N 284

Query: 745 GKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
            ++      +K+  + ++C          C++ DP  R ++ ++L 
Sbjct: 285 HEIEFPDIPEKDLQDVLKC----------CLKRDPKQRISIPELLA 320

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  132 bits (333), Expect = 9e-34
 Identities = 60/273 (21%), Positives = 113/273 (41%), Gaps = 31/273 (11%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ-DGEREF-KNEVFVIGQTHHKNLVR 582
           +++G GSFG       ++        +K+++       ERE  + EV V+    H N+V+
Sbjct: 30  QKIGEGSFGKAILV--KSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQ 87

Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR----TNIAFQIARGLLYLHEDC 638
                +E  +  +V ++   G L   +  N +     +     +   QI   L ++H+  
Sbjct: 88  YRESFEENGSLYIVMDYCEGGDLFKRI--NAQKGVLFQEDQILDWFVQICLALKHVHDR- 144

Query: 639 RAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNS 698
             +I+H DIK QNI L    T ++ DFG+A++L        +  I GT  Y++PE   N 
Sbjct: 145 --KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA-RACI-GTPYYLSPEICENK 200

Query: 699 KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAM 758
               K D+++ G +L E+ + + +F+         L         +G    +       +
Sbjct: 201 PYNNKSDIWALGCVLYELCTLKHAFE---AGSMKNL----VLKIISGSFPPVSLHYSYDL 253

Query: 759 NDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM 791
                   LV       + +P  RP++  +L+ 
Sbjct: 254 RS------LVS---QLFKRNPRDRPSVNSILEK 277

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  131 bits (332), Expect = 1e-33
 Identities = 71/311 (22%), Positives = 129/311 (41%), Gaps = 62/311 (19%)

Query: 523 FKEEVGRGSFGIVYKGV---IQTRTSTTAVAVKKLDRVFQDGER-EFKNEVFVIGQTHHK 578
           +  ++G G+FG V++     +      T VAVK L        + +F+ E  ++ +  + 
Sbjct: 51  YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110

Query: 579 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN---------------- 622
           N+V+LLG C  G+   L++E++  G L  FL           ++                
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170

Query: 623 --------IAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN 674
                   IA Q+A G+ YL E    + +H D+  +N L+ +    +I+DFGL++ +   
Sbjct: 171 LSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227

Query: 675 QSKTIKTA----IRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 730
                       IR       PE    ++ T + DV+++GV+L EI S         G +
Sbjct: 228 DYYKADGNDAIPIRWM----PPESIFYNRYTTESDVWAYGVVLWEIFS--------YGLQ 275

Query: 731 -YAILTDW-AFDCYRNGKLNVLVGEDKEAMNDIECLGKL--VMVSIWCIQEDPSLRPTMK 786
            Y  +         R+G  N+L         +  C  +L  +M   W   + P+ RP+  
Sbjct: 276 PYYGMAHEEVIYYVRDG--NIL-----ACPEN--CPLELYNLMRLCW--SKLPADRPSFC 324

Query: 787 KVLQMLEGVVE 797
            + ++L+ + E
Sbjct: 325 SIHRILQRMCE 335

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  130 bits (328), Expect = 1e-33
 Identities = 57/293 (19%), Positives = 109/293 (37%), Gaps = 57/293 (19%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD--GEREFKNEVFVIGQ-THHKNLV 581
           E++G G FG V+K V   R      A+K+  +       E+    EV+       H ++V
Sbjct: 17  EKIGSGEFGSVFKCV--KRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVV 74

Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR----TNIAFQIARGLLYLHED 637
           R      E  + L+  E+ N G+LA  +  N +     +     ++  Q+ RGL Y+H  
Sbjct: 75  RYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM 134

Query: 638 CRAQIIHCDIKPQNILLD-------------------DYYTARISDFGLAKLLTLNQSKT 678
               ++H DIKP NI +                    +    +I D G    ++  Q + 
Sbjct: 135 ---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE 191

Query: 679 IKTAIRGTKGYVAPEWFRNSKI-TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW 737
                 G   ++A E  + +     K D+++  + ++             G+++  +   
Sbjct: 192 ------GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR--NGDQWHEI--- 240

Query: 738 AFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
                R G+L  +     +   +      L+      I  DP  RP+   +++
Sbjct: 241 -----RQGRLPRIPQVLSQEFTE------LLK---VMIHPDPERRPSAMALVK 279

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  136 bits (344), Expect = 2e-33
 Identities = 70/291 (24%), Positives = 117/291 (40%), Gaps = 57/291 (19%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRT-STTAVAVKKLDRVFQDGER-EFKNEVFVIGQTHHKNL 580
               +G G FG V++G+  +      AVA+K       D  R +F  E   + Q  H ++
Sbjct: 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 453

Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHEDC 638
           V+L+G   E     ++ E    G L SFL    K + +L +    A+Q++  L YL E  
Sbjct: 454 VKLIGVITE-NPVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYL-ESK 510

Query: 639 RAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN---QSKTIKTAIRGTKGYVAPEWF 695
           R   +H DI  +N+L+      ++ DFGL++ +  +   ++   K  I+      APE  
Sbjct: 511 R--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM----APESI 564

Query: 696 RNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLNVLVGED 754
              + T+  DV+ FGV + EI+          G + +  +                   +
Sbjct: 565 NFRRFTSASDVWMFGVCMWEILMH--------GVKPFQGVK------------------N 598

Query: 755 KEAMNDIE----------CLGKL--VMVSIWCIQEDPSLRPTMKKVLQMLE 793
            + +  IE          C   L  +M   W    DPS RP   ++   L 
Sbjct: 599 NDVIGRIENGERLPMPPNCPPTLYSLMTKCW--AYDPSRRPRFTELKAQLS 647

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  130 bits (329), Expect = 2e-33
 Identities = 70/312 (22%), Positives = 125/312 (40%), Gaps = 72/312 (23%)

Query: 523 FKEEVGRGSFGIVYKGV---IQTRTSTTAVAVKKLDRVFQDGER-EFKNEVFVIGQ-THH 577
           F + +G G+FG V +     +    +   VAVK L       E+    +E+ ++     H
Sbjct: 50  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109

Query: 578 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL----------FGNLKPNWNLRTN----I 623
           +N+V LLG C  G   L++ E+   G L +FL                N    T      
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169

Query: 624 AFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTA- 682
           + Q+A+G+ +L        IH D+  +N+LL + + A+I DFGLA+ +  + +  +K   
Sbjct: 170 SSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 226

Query: 683 ---IRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILTDW 737
              ++      APE   +   T + DV+S+G+LL EI S        +G      IL   
Sbjct: 227 RLPVKWM----APESIFDCVYTVQSDVWSYGILLWEIFS--------LGLNPYPGILV-- 272

Query: 738 AFDCYRNGKLNVLVGEDKEAMNDIE----------CLGKL--VMVSIWCIQEDPSLRPTM 785
                           + +    ++              +  +M + W    +P+ RPT 
Sbjct: 273 ----------------NSKFYKLVKDGYQMAQPAFAPKNIYSIMQACW--ALEPTHRPTF 314

Query: 786 KKVLQMLEGVVE 797
           +++   L+   +
Sbjct: 315 QQICSFLQEQAQ 326

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  129 bits (326), Expect = 4e-33
 Identities = 63/275 (22%), Positives = 99/275 (36%), Gaps = 40/275 (14%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD--GEREFKNEVFVIGQ-THHKNLV 581
             +G GS+G V+K   +++      AVK+    F+          EV    +   H   V
Sbjct: 63  SRLGHGSYGEVFKV--RSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCV 120

Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLHEDCR 639
           RL    +EG    L  E     +L      +G   P   +           L +LH    
Sbjct: 121 RLEQAWEEGGILYLQTELCG-PSLQQHCEAWGASLPEAQVW-GYLRDTLLALAHLHSQ-- 176

Query: 640 AQIIHCDIKPQNILLDDYYTARISDFGLAKLL-TLNQSKTIKTAIRGTKGYVAPEWFRNS 698
             ++H D+KP NI L      ++ DFGL   L T    +  +    G   Y+APE  +  
Sbjct: 177 -GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE----GDPRYMAPELLQG- 230

Query: 699 KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGED--KE 756
                 DV+S G+ +LE+    +      GE +  L        R G L          E
Sbjct: 231 SYGTAADVFSLGLTILEVACNMELPH--GGEGWQQL--------RQGYLPPEFTAGLSSE 280

Query: 757 AMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM 791
             + +             ++ DP LR T + +L +
Sbjct: 281 LRSVLV----------MMLEPDPKLRATAEALLAL 305

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  130 bits (330), Expect = 4e-33
 Identities = 74/309 (23%), Positives = 128/309 (41%), Gaps = 59/309 (19%)

Query: 523 FKEEVGRGSFGIVYKGVI-----QTRTSTTAVAVKKLDRVFQDGER-EFKNEVFVIGQ-T 575
             + +G G+FG V                T VAVK L     + +  +  +E+ ++    
Sbjct: 73  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 132

Query: 576 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL------------FGNLKPNWNLR--- 620
            HKN++ LLG C +     ++ E+ + G L  +L              +  P   L    
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192

Query: 621 -TNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI 679
             + A+Q+ARG+ YL      + IH D+  +N+L+ +    +I+DFGLA+ +        
Sbjct: 193 LVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 249

Query: 680 KTA----IRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAI 733
            T     ++      APE   +   T + DV+SFGVLL EI +        +G      +
Sbjct: 250 TTNGRLPVKWM----APEALFDRIYTHQSDVWSFGVLLWEIFT--------LGGSPYPGV 297

Query: 734 LTDWAFDCYRNGKLNVLVGEDKEAMNDIE-CLGKL--VMVSIWCIQEDPSLRPTMKKVLQ 790
             +  F   + G            M+    C  +L  +M   W     PS RPT K++++
Sbjct: 298 PVEELFKLLKEGHR----------MDKPSNCTNELYMMMRDCW--HAVPSQRPTFKQLVE 345

Query: 791 MLEGVVEVS 799
            L+ +V ++
Sbjct: 346 DLDRIVALT 354

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  129 bits (325), Expect = 5e-33
 Identities = 62/293 (21%), Positives = 107/293 (36%), Gaps = 45/293 (15%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVR 582
           F +++G G F  V    ++        A+K++    Q    E + E  +    +H N++R
Sbjct: 33  FIQKLGEGGFSYVDL--VEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILR 90

Query: 583 LLGFCDEGQNR----LLVYEFLNNGTLASFLFGNLKPNWNLRT----NIAFQIARGLLYL 634
           L+ +C   +       L+  F   GTL + +         L       +   I RGL  +
Sbjct: 91  LVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAI 150

Query: 635 HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAI-------RGTK 687
           H        H D+KP NILL D     + D G      ++   + +          R T 
Sbjct: 151 HA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207

Query: 688 GYVAPEWF---RNSKITAKVDVYSFGVLLLEIISCRKSFD--IEMGEEYAILTDWAFDCY 742
            Y APE F    +  I  + DV+S G +L  ++     +D   + G+  A+         
Sbjct: 208 SYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL--------- 258

Query: 743 RNGKLNVLVGEDKEAMNDI--ECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
                  +  +     +      L +L+      +  DP  RP +  +L  LE
Sbjct: 259 ------AVQNQLSIPQSPRHSSALWQLL---NSMMTVDPHQRPHIPLLLSQLE 302

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  128 bits (325), Expect = 5e-33
 Identities = 73/312 (23%), Positives = 136/312 (43%), Gaps = 64/312 (20%)

Query: 523 FKEEVGRGSFGIVYKGV---IQTRTSTTAVAVKKLDRVFQDGER-EFKNEVFVIGQTHHK 578
             + +G G FG V K     ++ R   T VAVK L       E  +  +E  V+ Q +H 
Sbjct: 27  LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86

Query: 579 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR------------------ 620
           ++++L G C +    LL+ E+   G+L  FL  + K                        
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146

Query: 621 ------TNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN 674
                  + A+QI++G+ YL E    +++H D+  +NIL+ +    +ISDFGL++ +   
Sbjct: 147 LTMGDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDV--- 200

Query: 675 QSKTIKTAIRGTKGYV-----APEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGE 729
                 + ++ ++G +     A E   +   T + DV+SFGVLL EI++        +G 
Sbjct: 201 --YEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT--------LGG 250

Query: 730 E-YAILTDW-AFDCYRNGKLNVLVGEDKEAMNDIECLGKL--VMVSIWCIQEDPSLRPTM 785
             Y  +     F+  + G  + +   ++       C  ++  +M+  W  +++P  RP  
Sbjct: 251 NPYPGIPPERLFNLLKTG--HRM---ERPD----NCSEEMYRLMLQCW--KQEPDKRPVF 299

Query: 786 KKVLQMLEGVVE 797
             + + LE ++ 
Sbjct: 300 ADISKDLEKMMV 311

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  127 bits (321), Expect = 1e-32
 Identities = 60/203 (29%), Positives = 100/203 (49%), Gaps = 9/203 (4%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE---REFKNEVFVIGQTHHKNLV 581
           +++G G    VY     T  +   VA+K +    ++ E   + F+ EV    Q  H+N+V
Sbjct: 17  DKLGGGGMSTVYLAE-DTILNIK-VAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIV 74

Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ 641
            ++   +E     LV E++   TL+ ++  +   + +   N   QI  G+ + H     +
Sbjct: 75  SMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAH---DMR 131

Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKIT 701
           I+H DIKPQNIL+D   T +I DFG+AK L+   S T    + GT  Y +PE  +     
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPEQAKGEATD 190

Query: 702 AKVDVYSFGVLLLEIISCRKSFD 724
              D+YS G++L E++     F+
Sbjct: 191 ECTDIYSIGIVLYEMLVGEPPFN 213

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  127 bits (322), Expect = 2e-32
 Identities = 68/313 (21%), Positives = 119/313 (38%), Gaps = 61/313 (19%)

Query: 523 FKEEVGRGSFGIVYKGV---IQTRTSTTAVAVKKLDRVFQDGER-EFKNEVFVIGQ-THH 577
           F + +G G+FG V       I     +  VAVK L       ER    +E+ ++ Q   H
Sbjct: 49  FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 108

Query: 578 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN--------------- 622
           +N+V LLG C       L++E+   G L ++L    +                       
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168

Query: 623 --------IAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN 674
                    A+Q+A+G+ +L        +H D+  +N+L+      +I DFGLA+ +  +
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225

Query: 675 QSKTIKTA----IRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKS--FDIEMG 728
            +  ++      ++      APE       T K DV+S+G+LL EI S   +    I + 
Sbjct: 226 SNYVVRGNARLPVKWM----APESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 281

Query: 729 EEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKL--VMVSIWCIQEDPSLRPTMK 786
                     +   +NG    +   D+          ++  +M S W    D   RP+  
Sbjct: 282 AN-------FYKLIQNG--FKM---DQPF----YATEEIYIIMQSCW--AFDSRKRPSFP 323

Query: 787 KVLQMLEGVVEVS 799
            +   L   +  +
Sbjct: 324 NLTSFLGCQLADA 336

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  127 bits (320), Expect = 4e-32
 Identities = 59/198 (29%), Positives = 84/198 (42%), Gaps = 18/198 (9%)

Query: 524 KEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +  VGRGSFG V++     +T     AVKK+    +    E   E+          +V L
Sbjct: 63  QPRVGRGSFGEVHRM-KDKQTGFQ-CAVKKVR--LEVFRVE---ELVACAGLSSPRIVPL 115

Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ 641
            G   EG    +  E L  G+L   +   G L  +         Q   GL YLH     +
Sbjct: 116 YGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPED--RALYYLGQALEGLEYLHTR---R 170

Query: 642 IIHCDIKPQNILLDDY-YTARISDFGLAKLLT---LNQSKTIKTAIRGTKGYVAPEWFRN 697
           I+H D+K  N+LL      A + DFG A  L    L +S      I GT+ ++APE    
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230

Query: 698 SKITAKVDVYSFGVLLLE 715
               AKVD++S   ++L 
Sbjct: 231 KPCDAKVDIWSSCCMMLH 248

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  124 bits (314), Expect = 2e-31
 Identities = 69/314 (21%), Positives = 122/314 (38%), Gaps = 50/314 (15%)

Query: 524 KEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ-THHKNLVR 582
           +  +  G F  VY+   Q   S    A+K+L    ++  R    EV  + + + H N+V+
Sbjct: 33  RRVLAEGGFAFVYEA--QDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQ 90

Query: 583 LLGFC-------DEGQNRLLVYEFLNNGTLASFLF-----GNLKPNWNLRTNIAFQIARG 630
                       D GQ   L+   L  G L  FL      G L  +  L+  I +Q  R 
Sbjct: 91  FCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLK--IFYQTCRA 148

Query: 631 LLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIR------ 684
           + ++H   +  IIH D+K +N+LL +  T ++ DFG A  ++     +     R      
Sbjct: 149 VQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207

Query: 685 ----GTKGYVAPE---WFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW 737
                T  Y  PE    + N  I  K D+++ G +L  +   +  F  E G +  I+   
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF--EDGAKLRIV--- 262

Query: 738 AFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 797
                 NGK ++   + +           L+      +Q +P  R ++ +V+  L+ +  
Sbjct: 263 ------NGKYSIPPHDTQY-----TVFHSLI---RAMLQVNPEERLSIAEVVHQLQEIAA 308

Query: 798 VSVPPNPYPFSSSM 811
                   P +  +
Sbjct: 309 ARNVNPKSPITELL 322

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  125 bits (315), Expect = 3e-31
 Identities = 38/230 (16%), Positives = 72/230 (31%), Gaps = 22/230 (9%)

Query: 523 FKEEVGRGSFGIVYKGV-IQTRTSTTA--VAVKKLDRVFQDGEREFKNEVFVIGQTHHKN 579
               +G G+F  VY+        +       +K                +  +  +    
Sbjct: 69  VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHM 128

Query: 580 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNW-----NLRTNIAFQIARGLLYL 634
            ++           +LV E  + GTL + +              L  + A ++   +  +
Sbjct: 129 FMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQV 188

Query: 635 HEDCRAQIIHCDIKPQNILLDDYYTA-----------RISDFGLAKLLTLNQSKTIKTAI 683
           H+    +IIH DIKP N +L + +              + D G +  + L    TI TA 
Sbjct: 189 HD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAK 245

Query: 684 RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI 733
             T G+   E   N     ++D +     +  ++          G E   
Sbjct: 246 CETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKP 295

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  123 bits (311), Expect = 4e-31
 Identities = 49/216 (22%), Positives = 90/216 (41%), Gaps = 28/216 (12%)

Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE-FKNEVFVIGQTHHKNL 580
              + +G+G+   V++G    + +    A+K  + +      +    E  V+ + +HKN+
Sbjct: 12  LLSDILGQGATANVFRGR--HKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNI 69

Query: 581 VRLLGFCDEGQNRL--LVYEFLNNGTLASFLFGNLKPNWNLRTNIA----FQIARGLLYL 634
           V+L    +E   R   L+ EF   G+L + L       + L  +        +  G+ +L
Sbjct: 70  VKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEP-SNAYGLPESEFLIVLRDVVGGMNHL 128

Query: 635 HEDCRAQIIHCDIKPQNILL----DDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYV 690
            E     I+H +IKP NI+     D     +++DFG A+ L     +   +   GT+ Y+
Sbjct: 129 RE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE--DDEQFVSLY-GTEEYL 182

Query: 691 APE--------WFRNSKITAKVDVYSFGVLLLEIIS 718
            P+             K  A VD++S GV      +
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  120 bits (303), Expect = 4e-30
 Identities = 56/197 (28%), Positives = 91/197 (46%), Gaps = 16/197 (8%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLL 584
            ++G GS GIV     +  +    VAVK +D   Q       NEV ++    H N+V + 
Sbjct: 51  VKIGEGSTGIVCLA-REKHSGRQ-VAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMY 108

Query: 585 GFCDEGQNRLLVYEFLNNGTLASFL-FGNLKPNWNLRTNIAF---QIARGLLYLHEDCRA 640
                G+   ++ EFL  G L   +    L         IA     + + L YLH     
Sbjct: 109 KSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQ-----IATVCEAVLQALAYLHAQ--- 160

Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            +IH DIK  +ILL      ++SDFG    ++ +  K  K+ + GT  ++APE    S  
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR-KSLV-GTPYWMAPEVISRSLY 218

Query: 701 TAKVDVYSFGVLLLEII 717
             +VD++S G++++E++
Sbjct: 219 ATEVDIWSLGIMVIEMV 235

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  120 bits (303), Expect = 4e-30
 Identities = 54/213 (25%), Positives = 90/213 (42%), Gaps = 23/213 (10%)

Query: 525 EEVGRGSFGIVYKGV--IQTRTSTTAVAVKKLDRVFQDGE---REFKNEVFVIGQTHHKN 579
           E +G G    V+        R     VAVK L             F+ E       +H  
Sbjct: 18  EILGFGGMSEVHLARDLRDHRD----VAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73

Query: 580 LVRLL--GFCDEGQNRLLVY---EFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLL 632
           +V +   G   E     L Y   E+++  TL   +   G + P   +   +     + L 
Sbjct: 74  IVAVYDTG-EAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIE--VIADACQALN 130

Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKT-AIRGTKGYVA 691
           + H   +  IIH D+KP NI++      ++ DFG+A+ +  + +   +T A+ GT  Y++
Sbjct: 131 FSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187

Query: 692 PEWFRNSKITAKVDVYSFGVLLLEIISCRKSFD 724
           PE  R   + A+ DVYS G +L E+++    F 
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT 220

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  122 bits (307), Expect = 5e-30
 Identities = 49/212 (23%), Positives = 88/212 (41%), Gaps = 30/212 (14%)

Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE-FKNEVFVIGQTHHKNL 580
              + +G+G+   V++G    + +    A+K  + +      +    E  V+ + +HKN+
Sbjct: 12  LLSDILGQGATANVFRGR--HKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNI 69

Query: 581 VRLLGFCDEGQNRL--LVYEFLNNGTLASFLFGNLKPNWNLRT-----NIAFQIARGLLY 633
           V+L    +E   R   L+ EF   G+L + L      N           +   +  G+ +
Sbjct: 70  VKLFAIEEETTTRHKVLIMEFCPCGSLYTVL--EEPSNAYGLPESEFLIVLRDVVGGMNH 127

Query: 634 LHEDCRAQIIHCDIKPQNILL----DDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGY 689
           L E     I+H +IKP NI+     D     +++DFG A+ L     +   +   GT+ Y
Sbjct: 128 LRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE--DDEQFVSLY-GTEEY 181

Query: 690 VAPE--------WFRNSKITAKVDVYSFGVLL 713
           + P+             K  A VD++S GV  
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  125 bits (314), Expect = 7e-30
 Identities = 64/211 (30%), Positives = 92/211 (43%), Gaps = 25/211 (11%)

Query: 523 FKEEVGRGSFGIVYKGV-IQTRTSTTAVAVKKLDRVFQDGERE-FKNEVFVIGQTHHKNL 580
            KE +G G FG V + +   T      VA+K+  +      RE +  E+ ++ + +H N+
Sbjct: 18  MKERLGTGGFGYVLRWIHQDTGEQ---VAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74

Query: 581 VRLLGFCDEGQN------RLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA----FQIARG 630
           V      D  Q        LL  E+   G L  +L    +    L+          I+  
Sbjct: 75  VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQF-ENCCGLKEGPIRTLLSDISSA 133

Query: 631 LLYLHEDCRAQIIHCDIKPQNILLD---DYYTARISDFGLAKLLTLNQSKTIKTAIRGTK 687
           L YLHE    +IIH D+KP+NI+L         +I D G AK L   Q +     + GT 
Sbjct: 134 LRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD--QGELCTEFV-GTL 187

Query: 688 GYVAPEWFRNSKITAKVDVYSFGVLLLEIIS 718
            Y+APE     K T  VD +SFG L  E I+
Sbjct: 188 QYLAPELLEQKKYTVTVDYWSFGTLAFECIT 218

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  119 bits (300), Expect = 8e-30
 Identities = 57/197 (28%), Positives = 97/197 (49%), Gaps = 16/197 (8%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLL 584
           E++G+G+ G VY   +   T    VA+++++   Q  +    NE+ V+ +  + N+V  L
Sbjct: 26  EKIGQGASGTVYTA-MDVATGQE-VAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYL 83

Query: 585 GFCDEGQNRLLVYEFLNNGTLASFL-FGNLKPNWNLRTNIAF---QIARGLLYLHEDCRA 640
                G    +V E+L  G+L   +    +         IA    +  + L +LH +   
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ-----IAAVCRECLQALEFLHSN--- 135

Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
           Q+IH DIK  NILL    + +++DFG    +T  QSK   T + GT  ++APE       
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-STMV-GTPYWMAPEVVTRKAY 193

Query: 701 TAKVDVYSFGVLLLEII 717
             KVD++S G++ +E+I
Sbjct: 194 GPKVDIWSLGIMAIEMI 210

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  118 bits (298), Expect = 2e-29
 Identities = 59/208 (28%), Positives = 88/208 (42%), Gaps = 19/208 (9%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKL------DRVFQDGEREFKNEVFVIGQTHHK 578
             VGRG  G VY+    T      VA+K +      D VF+   R  + E    G+    
Sbjct: 40  RLVGRGGMGDVYEAE-DTVRERI-VALKLMSETLSSDPVFR--TR-MQREARTAGRLQEP 94

Query: 579 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLHE 636
           ++V +  F +      +    +N   LA+ L   G L P   +   I  QI   L   H 
Sbjct: 95  HVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVA--IVRQIGSALDAAH- 151

Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR 696
              A   H D+KP+NIL+     A + DFG+A   T ++  T      GT  Y+APE F 
Sbjct: 152 --AAGATHRDVKPENILVSADDFAYLVDFGIASATT-DEKLTQLGNTVGTLYYMAPERFS 208

Query: 697 NSKITAKVDVYSFGVLLLEIISCRKSFD 724
            S  T + D+Y+   +L E ++    + 
Sbjct: 209 ESHATYRADIYALTCVLYECLTGSPPYQ 236

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  116 bits (294), Expect = 3e-29
 Identities = 54/197 (27%), Positives = 91/197 (46%), Gaps = 20/197 (10%)

Query: 528 GRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDG-EREFKNEVFVIGQTHHKNLVRLL 584
           G+G FG VY  + + + S   +A+K L +  + + G E + + EV +     H N++RL 
Sbjct: 18  GKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75

Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA----FQIARGLLYLHEDCRA 640
           G+  +     L+ E+   GT+    +  L+               ++A  L Y H     
Sbjct: 76  GYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCH---SK 128

Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
           ++IH DIKP+N+LL      +I+DFG +     ++   +     GT  Y+ PE       
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLDYLPPEMIEGRMH 184

Query: 701 TAKVDVYSFGVLLLEII 717
             KVD++S GVL  E +
Sbjct: 185 DEKVDLWSLGVLCYEFL 201

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  117 bits (296), Expect = 5e-29
 Identities = 51/198 (25%), Positives = 92/198 (46%), Gaps = 16/198 (8%)

Query: 524 KEEVGRGSFGIVYKGVIQTRTSTTAVAVK--KLDRVFQDGEREFKNEVFVIGQ-THHKNL 580
            +E+GRG F +V + +  ++++    A K  K  R  QD   E  +E+ V+        +
Sbjct: 34  SKELGRGKFAVVRQCI--SKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91

Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR--TNIAFQIARGLLYLHEDC 638
           + L    +     +L+ E+   G + S     L    +      +  QI  G+ YLH++ 
Sbjct: 92  INLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN- 150

Query: 639 RAQIIHCDIKPQNILL---DDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
              I+H D+KPQNILL         +I DFG+++ +    +  ++  + GT  Y+APE  
Sbjct: 151 --NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI--GHACELREIM-GTPEYLAPEIL 205

Query: 696 RNSKITAKVDVYSFGVLL 713
               IT   D+++ G++ 
Sbjct: 206 NYDPITTATDMWNIGIIA 223

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  116 bits (294), Expect = 8e-29
 Identities = 56/206 (27%), Positives = 90/206 (43%), Gaps = 26/206 (12%)

Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVK-----KLDRVFQDGERE-FKNEVFVIGQT 575
           +  EE+G G F IV K     +++    A K     +     +   RE  + EV ++ Q 
Sbjct: 15  DIGEELGSGQFAIVKKCR--EKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV 72

Query: 576 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR----TNIAFQIARGL 631
            H N++ L    +   + +L+ E ++ G L    F  L    +L     T+   QI  G+
Sbjct: 73  LHHNVITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQILDGV 128

Query: 632 LYLHEDCRAQIIHCDIKPQNILL----DDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK 687
            YLH     +I H D+KP+NI+L          ++ DFGLA  +        K    GT 
Sbjct: 129 NYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIF-GTP 182

Query: 688 GYVAPEWFRNSKITAKVDVYSFGVLL 713
            +VAPE      +  + D++S GV+ 
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVIT 208

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  115 bits (290), Expect = 1e-28
 Identities = 50/195 (25%), Positives = 92/195 (47%), Gaps = 20/195 (10%)

Query: 528 GRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDG-EREFKNEVFVIGQTHHKNLVRLL 584
           G+G FG VY  + + + +   +A+K L +  + ++G E + + E+ +     H N++R+ 
Sbjct: 23  GKGKFGNVY--LAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80

Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA----FQIARGLLYLHEDCRA 640
            +  + +   L+ EF   G L    +  L+ +       +     ++A  L Y H     
Sbjct: 81  NYFHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSATFMEELADALHYCH---ER 133

Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
           ++IH DIKP+N+L+      +I+DFG +      + +T+     GT  Y+ PE       
Sbjct: 134 KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC----GTLDYLPPEMIEGKTH 189

Query: 701 TAKVDVYSFGVLLLE 715
             KVD++  GVL  E
Sbjct: 190 DEKVDLWCAGVLCYE 204

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  115 bits (291), Expect = 3e-28
 Identities = 56/206 (27%), Positives = 90/206 (43%), Gaps = 26/206 (12%)

Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVK-----KLDRVFQDGERE-FKNEVFVIGQT 575
           +  EE+G G F IV K     +++    A K     +     +   RE  + EV ++ Q 
Sbjct: 15  DIGEELGSGQFAIVKKCR--EKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV 72

Query: 576 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR----TNIAFQIARGL 631
            H N++ L    +   + +L+ E ++ G L    F  L    +L     T+   QI  G+
Sbjct: 73  LHPNIITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQILDGV 128

Query: 632 LYLHEDCRAQIIHCDIKPQNILL----DDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK 687
            YLH     +I H D+KP+NI+L          ++ DFGLA  +        K    GT 
Sbjct: 129 NYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIF-GTP 182

Query: 688 GYVAPEWFRNSKITAKVDVYSFGVLL 713
            +VAPE      +  + D++S GV+ 
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVIT 208

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  116 bits (293), Expect = 3e-28
 Identities = 55/199 (27%), Positives = 92/199 (46%), Gaps = 19/199 (9%)

Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLV 581
           +  EE+G G+FG+V++ V   + +      K ++  +   +   KNE+ ++ Q HH  L+
Sbjct: 54  DILEELGSGAFGVVHRCV--EKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLI 111

Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT-----NIAFQIARGLLYLHE 636
            L    ++    +L+ EFL+ G     LF  +       +     N   Q   GL ++HE
Sbjct: 112 NLHDAFEDKYEMVLILEFLSGGE----LFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 167

Query: 637 DCRAQIIHCDIKPQNILLDDYYTAR--ISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 694
                I+H DIKP+NI+ +    +   I DFGLA    LN  + +K     T  + APE 
Sbjct: 168 H---SIVHLDIKPENIMCETKKASSVKIIDFGLATK--LNPDEIVKVTT-ATAEFAAPEI 221

Query: 695 FRNSKITAKVDVYSFGVLL 713
                +    D+++ GVL 
Sbjct: 222 VDREPVGFYTDMWAIGVLG 240

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  115 bits (289), Expect = 3e-28
 Identities = 45/207 (21%), Positives = 79/207 (38%), Gaps = 34/207 (16%)

Query: 598 EFLNNGTLASFL---FGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILL 654
           +      L  ++            +  +I  QIA  + +LH      ++H D+KP NI  
Sbjct: 141 QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFF 197

Query: 655 DDYYTARISDFGLAKLLTLNQSK----------TIKTAIRGTKGYVAPEWFRNSKITAKV 704
                 ++ DFGL   +  ++ +             T   GTK Y++PE    +  + KV
Sbjct: 198 TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKV 257

Query: 705 DVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECL 764
           D++S G++L E++    SF  +M E   I+TD      RN K                  
Sbjct: 258 DIFSLGLILFELLY---SFSTQM-ERVRIITD-----VRNLKF------PLLFTQKYPQE 302

Query: 765 GKLVMVSIWCIQEDPSLRPTMKKVLQM 791
             +V      +   P+ RP    +++ 
Sbjct: 303 HMMVQ---DMLSPSPTERPEATDIIEN 326

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  115 bits (290), Expect = 5e-28
 Identities = 60/299 (20%), Positives = 121/299 (40%), Gaps = 46/299 (15%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREF-KNEVFVIGQTHHKNLVRL 583
            E+G G+ G+V+K V    +    +A K +    +   R     E+ V+ + +   +V  
Sbjct: 39  SELGAGNGGVVFK-VSHKPSGLV-MARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGF 96

Query: 584 LG-FCDEGQNRLLVY---EFLNNGTLASFL-FGNLKPNWNLRTNIAFQIARGLLYLHEDC 638
            G F  +G+    +    E ++ G+L   L      P   L   ++  + +GL YL E  
Sbjct: 97  YGAFYSDGE----ISICMEHMDGGSLDQVLKKAGRIPEQILGK-VSIAVIKGLTYLREKH 151

Query: 639 RAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNS 698
           +  I+H D+KP NIL++     ++ DFG++  L  + + +      GT+ Y++PE  + +
Sbjct: 152 K--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----GTRSYMSPERLQGT 205

Query: 699 KITAKVDVYSFGVLLLEI----------ISCRKSFDIEMGEEYAILTDWAFDCYRNGKLN 748
             + + D++S G+ L+E+           +           E                LN
Sbjct: 206 HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN 265

Query: 749 VLVGEDKEAMNDIECLGKLVM-------VSIW----------CIQEDPSLRPTMKKVLQ 790
               + +  M   E L  +V          ++          C+ ++P+ R  +K+++ 
Sbjct: 266 KFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  119 bits (300), Expect = 5e-28
 Identities = 41/209 (19%), Positives = 77/209 (36%), Gaps = 26/209 (12%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKL----DRVFQDGEREFKNEVFVIGQTHHKNL 580
             +  G  G +Y  +     +   V +K L    D   Q        E   + +  H ++
Sbjct: 86  GCIAHGGLGWIYLAL-DRNVNGRPVVLKGLVHSGDAEAQ--AM-AMAERQFLAEVVHPSI 141

Query: 581 VRLLGFCDEGQNRL-----LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLH 635
           V++  F +           +V E++   +L       L     +      +I   L YLH
Sbjct: 142 VQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIA--YLLEILPALSYLH 199

Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
                 +++ D+KP+NI+L +    ++ D G    +           + GT G+ APE  
Sbjct: 200 ---SIGLVYNDLKPENIMLTE-EQLKLIDLGAVSRIN--SF----GYLYGTPGFQAPEIV 249

Query: 696 RNSKITAKVDVYSFGVLLLEIISCRKSFD 724
           R +  T   D+Y+ G  L  +     + +
Sbjct: 250 R-TGPTVATDIYTVGRTLAALTLDLPTRN 277

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  114 bits (287), Expect = 6e-28
 Identities = 44/198 (22%), Positives = 86/198 (43%), Gaps = 18/198 (9%)

Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLV 581
              E++GRG FGIV++ V    +S      K +     D     K E+ ++    H+N++
Sbjct: 8   MIAEDLGRGEFGIVHRCV--ETSSKKTYMAKFVKVKGTDQV-LVKKEISILNIARHRNIL 64

Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR----TNIAFQIARGLLYLHED 637
            L    +  +  ++++EF++   +   +       + L      +   Q+   L +LH  
Sbjct: 65  HLHESFESMEELVMIFEFISGLDIFERI---NTSAFELNEREIVSYVHQVCEALQFLHSH 121

Query: 638 CRAQIIHCDIKPQNILLDDYYTA--RISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
               I H DI+P+NI+     ++  +I +FG A+   L      +        Y APE  
Sbjct: 122 ---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ--LKPGDNFRLLF-TAPEYYAPEVH 175

Query: 696 RNSKITAKVDVYSFGVLL 713
           ++  ++   D++S G L+
Sbjct: 176 QHDVVSTATDMWSLGTLV 193

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  113 bits (284), Expect = 7e-28
 Identities = 55/206 (26%), Positives = 88/206 (42%), Gaps = 26/206 (12%)

Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVK-----KLDRVFQDGERE-FKNEVFVIGQT 575
              EE+G G F IV K     + +    A K     +L    +   RE  + EV ++ + 
Sbjct: 8   EMGEELGSGQFAIVRKCR--QKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65

Query: 576 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR----TNIAFQIARGL 631
            H N++ L    +   + +L+ E ++ G L    F  L    +L     T    QI  G+
Sbjct: 66  RHPNIITLHDIFENKTDVVLILELVSGGEL----FDFLAEKESLTEDEATQFLKQILDGV 121

Query: 632 LYLHEDCRAQIIHCDIKPQNILL----DDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK 687
            YLH     +I H D+KP+NI+L          ++ DFG+A  +        K    GT 
Sbjct: 122 HYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI--EAGNEFKNIF-GTP 175

Query: 688 GYVAPEWFRNSKITAKVDVYSFGVLL 713
            +VAPE      +  + D++S GV+ 
Sbjct: 176 EFVAPEIVNYEPLGLEADMWSIGVIT 201

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  113 bits (285), Expect = 8e-28
 Identities = 78/275 (28%), Positives = 129/275 (46%), Gaps = 41/275 (14%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLD-RVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           E++G+GSFG V+KG I  RT    VA+K +D    +D   + + E+ V+ Q     + + 
Sbjct: 28  EKIGKGSFGEVFKG-IDNRTQKV-VAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKY 85

Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF---QIARGLLYLHEDCRA 640
            G   +     ++ E+L  G+    L    +P     T IA    +I +GL YLH +   
Sbjct: 86  YGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHSE--- 138

Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
           + IH DIK  N+LL ++   +++DFG+A  LT  Q K   T + GT  ++APE  + S  
Sbjct: 139 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR-NTFV-GTPFWMAPEVIKQSAY 196

Query: 701 TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD----WA-FDCYRNGKLNVLVGEDK 755
            +K D++S G      I+      IE+       ++       F   +N     L G   
Sbjct: 197 DSKADIWSLG------ITA-----IELARGEPPHSELHPMKVLFLIPKNNP-PTLEGNYS 244

Query: 756 EAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
           + + +         V   C+ ++PS RPT K++L+
Sbjct: 245 KPLKE--------FVE-ACLNKEPSFRPTAKELLK 270

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  115 bits (289), Expect = 9e-28
 Identities = 55/197 (27%), Positives = 93/197 (47%), Gaps = 19/197 (9%)

Query: 524 KEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
            E +G G FG V+K       +   +A K +       + E KNE+ V+ Q  H NL++L
Sbjct: 94  TEILGGGRFGQVHKCE--ETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQL 151

Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGN-LKPNWNLR----TNIAFQIARGLLYLHEDC 638
               +   + +LV E+++ G     LF   +  ++NL          QI  G+ ++H+  
Sbjct: 152 YDAFESKNDIVLVMEYVDGGE----LFDRIIDESYNLTELDTILFMKQICEGIRHMHQ-- 205

Query: 639 RAQIIHCDIKPQNILLDDYYTARI--SDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR 696
              I+H D+KP+NIL  +    +I   DFGLA+       + +K    GT  ++APE   
Sbjct: 206 -MYILHLDLKPENILCVNRDAKQIKIIDFGLARR--YKPREKLKVNF-GTPEFLAPEVVN 261

Query: 697 NSKITAKVDVYSFGVLL 713
              ++   D++S GV+ 
Sbjct: 262 YDFVSFPTDMWSVGVIA 278

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  114 bits (286), Expect = 1e-27
 Identities = 52/222 (23%), Positives = 91/222 (40%), Gaps = 39/222 (17%)

Query: 521 NNFK--EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDR-----------------VFQDG 561
           N+++    + +G F  +              A+KK ++                   +  
Sbjct: 31  NDYRIIRTLNQGKFNKIILC----EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSK 86

Query: 562 EREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNL 619
             +FKNE+ +I    ++  +   G         ++YE++ N ++  F   F  L  N+  
Sbjct: 87  YDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTC 146

Query: 620 RT------NIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTL 673
                    I   +     Y+H      I H D+KP NIL+D     ++SDFG ++ +  
Sbjct: 147 FIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYM-- 202

Query: 674 NQSKTIKTAIRGTKGYVAPEWFRNSKIT--AKVDVYSFGVLL 713
              K IK + RGT  ++ PE+F N      AKVD++S G+ L
Sbjct: 203 -VDKKIKGS-RGTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  113 bits (285), Expect = 2e-27
 Identities = 55/211 (26%), Positives = 88/211 (41%), Gaps = 44/211 (20%)

Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ-THHKNL 580
             KE++G GS+ +  + +   + +    AVK +D+  +D       E+ ++ +   H N+
Sbjct: 25  EVKEDIGVGSYSVCKRCI--HKATNMEFAVKIIDKSKRDPTE----EIEILLRYGQHPNI 78

Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTL--------------ASFLFGNLKPNWNLRTNIAFQ 626
           + L    D+G+   +V E +  G L              AS +               F 
Sbjct: 79  ITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVL--------------FT 124

Query: 627 IARGLLYLHEDCRAQIIHCDIKPQNILL----DDYYTARISDFGLAKLLTLNQSKTIKTA 682
           I + + YLH      ++H D+KP NIL      +  + RI DFG AK L       + T 
Sbjct: 125 ITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN-GLLMTP 180

Query: 683 IRGTKGYVAPEWFRNSKITAKVDVYSFGVLL 713
              T  +VAPE        A  D++S GVLL
Sbjct: 181 C-YTANFVAPEVLERQGYDAACDIWSLGVLL 210

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  112 bits (282), Expect = 2e-27
 Identities = 49/221 (22%), Positives = 89/221 (40%), Gaps = 52/221 (23%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDR---------VFQDGEREFKNEVFVIG 573
            KE +GRG   +V + +   + +    AVK +D            Q+       EV ++ 
Sbjct: 21  PKEILGRGVSSVVRRCI--HKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78

Query: 574 Q-THHKNLVRLLGFCDEGQNRLLVYEFLNNGTL--------------ASFLFGNLKPNWN 618
           + + H N+++L    +      LV++ +  G L                 +         
Sbjct: 79  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIM-------- 130

Query: 619 LRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT 678
                   +   +  LH+     I+H D+KP+NILLDD    +++DFG +    L+  + 
Sbjct: 131 ------RALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQ--LDPGEK 179

Query: 679 IKTAIRGTKGYVAPEWFRNSKITA------KVDVYSFGVLL 713
           ++    GT  Y+APE    S          +VD++S GV++
Sbjct: 180 LREVC-GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  116 bits (293), Expect = 2e-27
 Identities = 49/199 (24%), Positives = 90/199 (45%), Gaps = 19/199 (9%)

Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLV 581
           +  EE+G G+FG+V++     R +    A K +    +  +   + E+  +    H  LV
Sbjct: 160 DIHEELGTGAFGVVHRVT--ERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 217

Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT-----NIAFQIARGLLYLHE 636
            L    ++    +++YEF++ G L    F  +    N  +         Q+ +GL ++HE
Sbjct: 218 NLHDAFEDDNEMVMIYEFMSGGEL----FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 273

Query: 637 DCRAQIIHCDIKPQNILLDDYYTARI--SDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 694
           +     +H D+KP+NI+     +  +   DFGL   L  +  +++K    GT  + APE 
Sbjct: 274 N---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL--DPKQSVKVTT-GTAEFAAPEV 327

Query: 695 FRNSKITAKVDVYSFGVLL 713
                +    D++S GVL 
Sbjct: 328 AEGKPVGYYTDMWSVGVLS 346

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  111 bits (280), Expect = 3e-27
 Identities = 50/202 (24%), Positives = 90/202 (44%), Gaps = 19/202 (9%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLL 584
            E+G G+FG VYK      T     A K ++   ++   ++  E+ ++    H  +V+LL
Sbjct: 25  GELGDGAFGKVYKA-KNKETGAL-AAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLL 82

Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR-TNIAF---QIARGLLYLHEDCRA 640
           G         ++ EF   G + + +    +    L    I     Q+   L +LH     
Sbjct: 83  GAYYHDGKLWIMIEFCPGGAVDAIMLELDRG---LTEPQIQVVCRQMLEALNFLHSK--- 136

Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE-----WF 695
           +IIH D+K  N+L+      R++DFG++        K   + I GT  ++APE       
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR-DSFI-GTPYWMAPEVVMCETM 194

Query: 696 RNSKITAKVDVYSFGVLLLEII 717
           +++    K D++S G+ L+E+ 
Sbjct: 195 KDTPYDYKADIWSLGITLIEMA 216

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  111 bits (279), Expect = 5e-27
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 40/209 (19%)

Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLV 581
            F E +G G+F  V+      R +    A+K + +     +   +NE+ V+ +  H+N+V
Sbjct: 12  IFMEVLGSGAFSEVFLVK--QRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIV 69

Query: 582 RLLGFCDEGQNRLLVYEFLNNGTL--------------ASFLFGNLKPNWNLRTNIAFQI 627
            L    +   +  LV + ++ G L              AS +                Q+
Sbjct: 70  TLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVI--------------QQV 115

Query: 628 ARGLLYLHEDCRAQIIHCDIKPQNILL---DDYYTARISDFGLAKLLTLNQSKTIKTAIR 684
              + YLHE     I+H D+KP+N+L    ++     I+DFGL+K+    Q+  + TA  
Sbjct: 116 LSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME---QNGIMSTAC- 168

Query: 685 GTKGYVAPEWFRNSKITAKVDVYSFGVLL 713
           GT GYVAPE       +  VD +S GV+ 
Sbjct: 169 GTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  112 bits (282), Expect = 5e-27
 Identities = 48/203 (23%), Positives = 82/203 (40%), Gaps = 19/203 (9%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVK-----KLDRVFQDGEREFKNEVFVIGQTHH 577
             E +G+G F +V + +   R +    AVK     K          + K E  +     H
Sbjct: 28  LCEVIGKGPFSVVRRCI--NRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85

Query: 578 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR----TNIAFQIARGLLY 633
            ++V LL          +V+EF++   L   +       +       ++   QI   L Y
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145

Query: 634 LHEDCRAQIIHCDIKPQNILL---DDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYV 690
            H++    IIH D+KP  +LL   ++    ++  FG+A  L  +        + GT  ++
Sbjct: 146 CHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG-LVAGGRV-GTPHFM 200

Query: 691 APEWFRNSKITAKVDVYSFGVLL 713
           APE  +       VDV+  GV+L
Sbjct: 201 APEVVKREPYGKPVDVWGCGVIL 223

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  111 bits (280), Expect = 6e-27
 Identities = 56/206 (27%), Positives = 89/206 (43%), Gaps = 26/206 (12%)

Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVK-----KLDRVFQDGERE-FKNEVFVIGQT 575
           +  EE+G G F +V K     +++    A K     +     +   RE  + EV ++ + 
Sbjct: 14  DTGEELGSGQFAVVKKCR--EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71

Query: 576 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR----TNIAFQIARGL 631
            H N++ L    +   + +L+ E +  G L    F  L    +L     T    QI  G+
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGEL----FDFLAEKESLTEEEATEFLKQILNGV 127

Query: 632 LYLHEDCRAQIIHCDIKPQNILL----DDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK 687
            YLH     QI H D+KP+NI+L          +I DFGLA  +  +     K    GT 
Sbjct: 128 YYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIF-GTP 181

Query: 688 GYVAPEWFRNSKITAKVDVYSFGVLL 713
            +VAPE      +  + D++S GV+ 
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVIT 207

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  112 bits (280), Expect = 8e-27
 Identities = 37/308 (12%), Positives = 76/308 (24%), Gaps = 61/308 (19%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKN 579
             E +  G   +V+  V          A+K         +          F   +   ++
Sbjct: 66  LVEPLRVGDRSVVFL-VRDVERLED-FALKVFTMGAENSRSELERLHEATFAAARLLGES 123

Query: 580 LV------RLLGFCDEGQ--------------------NRLLVYEFL--NNGTLASFLFG 611
                   RLL   D                       N LL+      +   L S L  
Sbjct: 124 PEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDF 183

Query: 612 NLKPNWNL----RTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGL 667
                 +        +  Q+ R    L       ++H    P N+ +       + D   
Sbjct: 184 VYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSA 240

Query: 668 AKLLTLNQSKTIKTAIRGTKGYVAPEWF--RNSKITAKVDVYSFGVLLLEIISCRKSFDI 725
              +      T   A      Y   E+     +  T  ++ +  G+ +  +      F +
Sbjct: 241 LWKVG-----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295

Query: 726 EMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDI---ECLGKLVMVSIWCIQEDPSLR 782
                    T      ++   L V   +     +     + +  L+      +  D   R
Sbjct: 296 V--------TPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIG---RFLNFDRRRR 344

Query: 783 PTMKKVLQ 790
               + ++
Sbjct: 345 LLPLEAME 352

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  110 bits (276), Expect = 1e-26
 Identities = 56/197 (28%), Positives = 96/197 (48%), Gaps = 16/197 (8%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLL 584
           E++G GS+G VYK     + +   VA+K++    +   +E   E+ ++ Q    ++V+  
Sbjct: 35  EKLGEGSYGSVYKA--IHKETGQIVAIKQVP--VESDLQEIIKEISIMQQCDSPHVVKYY 90

Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR-TNIAF---QIARGLLYLHEDCRA 640
           G   +  +  +V E+   G+++  +    K    L    IA       +GL YLH     
Sbjct: 91  GSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT---LTEDEIATILQSTLKGLEYLHFM--- 144

Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
           + IH DIK  NILL+    A+++DFG+A  LT   +K   T I GT  ++APE  +    
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKR-NTVI-GTPFWMAPEVIQEIGY 202

Query: 701 TAKVDVYSFGVLLLEII 717
               D++S G+  +E+ 
Sbjct: 203 NCVADIWSLGITAIEMA 219

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  109 bits (274), Expect = 1e-26
 Identities = 53/211 (25%), Positives = 94/211 (44%), Gaps = 41/211 (19%)

Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLD--RVFQDGEREFKNEVFVIGQTHHKN 579
           + KEE+G+G+F +V + V   +T+    A K ++  ++     ++ + E  +  +  H N
Sbjct: 9   DVKEELGKGAFSVVRRCV--HKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPN 66

Query: 580 LVRLLGFCDEGQNRLLVYEFLNNGTL--------------ASFLFGNLKPNWNLRTNIAF 625
           +VRL     E     LV++ +  G L              AS                  
Sbjct: 67  IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCI--------------Q 112

Query: 626 QIARGLLYLHEDCRAQIIHCDIKPQNILL---DDYYTARISDFGLAKLLTLNQSKTIKTA 682
           QI   + Y H +    I+H ++KP+N+LL         +++DFGLA  +  N S+     
Sbjct: 113 QILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDSEAWHGF 167

Query: 683 IRGTKGYVAPEWFRNSKITAKVDVYSFGVLL 713
             GT GY++PE  +    +  VD+++ GV+L
Sbjct: 168 A-GTPGYLSPEVLKKDPYSKPVDIWACGVIL 197

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  111 bits (279), Expect = 2e-26
 Identities = 40/315 (12%), Positives = 91/315 (28%), Gaps = 83/315 (26%)

Query: 525 EEVGRGSFGIVYKGVIQTRTST-TAVAVK---KLDRVFQDGEREFKNEVFVIGQ------ 574
             +G+       +    T   T  +  V      +R   +  ++ K EV  +        
Sbjct: 79  TVLGQEDPYAYLEA---TDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKN 135

Query: 575 -------------------THHKNLVRLLGFCDEGQ--NRLLVYEFLNN------GTLAS 607
                                 K ++R+     +    +R  +Y  + +        L S
Sbjct: 136 QKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLS 195

Query: 608 FLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGL 667
               +     + R  +  Q+ R L  LH      ++H  ++P +I+LD      ++ F  
Sbjct: 196 HSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEH 252

Query: 668 AKLLTLNQSKTIKTAIRGTKGYVAPEWF-----------RNSKITAKVDVYSFGVLLLEI 716
                       +     ++G+  PE             R + +T   D ++ G+++  I
Sbjct: 253 LVRDGA------RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306

Query: 717 ISCRKS-FDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCI 775
             C          +     ++W F        N+     +     +E            +
Sbjct: 307 W-CADLPIT---KDAALGGSEWIF----RSCKNI----PQPVRALLE----------GFL 344

Query: 776 QEDPSLRPTMKKVLQ 790
           +     R    + ++
Sbjct: 345 RYPKEDRLLPLQAME 359

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  112 bits (283), Expect = 2e-26
 Identities = 68/280 (24%), Positives = 110/280 (39%), Gaps = 38/280 (13%)

Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDR---VFQDGEREFKNEVFVIGQTHHK 578
             +  +G+GSFG V       + +    AVK + +     +  +     EV ++ Q  H 
Sbjct: 29  KGQRVLGKGSFGEVILCK--DKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 86

Query: 579 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR----TNIAFQIARGLLYL 634
           N+++L  F ++     LV E    G     LF  +             I  Q+  G+ Y+
Sbjct: 87  NIMKLYEFFEDKGYFYLVGEVYTGGE----LFDEIISRKRFSEVDAARIIRQVLSGITYM 142

Query: 635 HEDCRAQIIHCDIKPQNILL---DDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVA 691
           H+    +I+H D+KP+N+LL         RI DFGL+       SK +K  I GT  Y+A
Sbjct: 143 HK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH--FEASKKMKDKI-GTAYYIA 196

Query: 692 PEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLV 751
           PE         K DV+S GV+L  ++S    F+     +              GK     
Sbjct: 197 PEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD-------ILKKVEKGKYTF-- 246

Query: 752 GEDKEAMNDIECLGK-LVMVSIWCIQEDPSLRPTMKKVLQ 790
             +      +    K L+      +   PS+R + +  L 
Sbjct: 247 --ELPQWKKVSESAKDLIRK---MLTYVPSMRISARDALD 281

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  110 bits (278), Expect = 2e-26
 Identities = 50/220 (22%), Positives = 89/220 (40%), Gaps = 51/220 (23%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--------VFQDGEREFKNEVFVIGQ 574
            K+ +GRG   +V + V   R +    AVK ++           ++     + E  ++ Q
Sbjct: 98  PKDVIGRGVSSVVRRCV--HRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155

Query: 575 -THHKNLVRLLGFCDEGQNRLLVYEFLNNGTL--------------ASFLFGNLKPNWNL 619
              H +++ L+   +      LV++ +  G L                 +          
Sbjct: 156 VAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIM--------- 206

Query: 620 RTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI 679
                  +   + +LH      I+H D+KP+NILLDD    R+SDFG +    L   + +
Sbjct: 207 -----RSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCH--LEPGEKL 256

Query: 680 KTAIRGTKGYVAPEWFRNSKITA------KVDVYSFGVLL 713
           +    GT GY+APE  + S          +VD+++ GV+L
Sbjct: 257 RELC-GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  112 bits (283), Expect = 2e-26
 Identities = 66/282 (23%), Positives = 116/282 (41%), Gaps = 45/282 (15%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLD--RVFQDGEREFKNEVFVIGQTHHKNL 580
             +++G G++G V       + +    A+K +    V      +   EV V+    H N+
Sbjct: 41  RVKKLGSGAYGEVLLCR--DKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNI 98

Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR----TNIAFQIARGLLYLHE 636
           ++L  F ++ +N  LV E    G     LF  +             I  Q+  G+ YLH+
Sbjct: 99  MKLYDFFEDKRNYYLVMECYKGGE----LFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHK 154

Query: 637 DCRAQIIHCDIKPQNILL---DDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE 693
                I+H D+KP+N+LL   +     +I DFGL+ +      K +K  + GT  Y+APE
Sbjct: 155 ---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV--FENQKKMKERL-GTAYYIAPE 208

Query: 694 WFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGE 753
             R  K   K DV+S GV+L  +++    F  +  +E              GK       
Sbjct: 209 VLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE-------ILRKVEKGKYTF---- 256

Query: 754 DKEAMNDI-----ECLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
           D     ++     + + ++       +Q D   R + ++ L+
Sbjct: 257 DSPEWKNVSEGAKDLIKQM-------LQFDSQRRISAQQALE 291

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  108 bits (272), Expect = 2e-26
 Identities = 53/200 (26%), Positives = 90/200 (45%), Gaps = 17/200 (8%)

Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLD-RVFQDGEREFKNEVFVIGQTHHKNL 580
            FK ++G G+FG V+      R+S     +K ++    Q    + + E+ V+    H N+
Sbjct: 25  IFKRKLGSGAFGDVHLVE--ERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNI 82

Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR----TNIAFQIARGLLYLHE 636
           +++    ++  N  +V E    G L   +         L       +  Q+   L Y H 
Sbjct: 83  IKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS 142

Query: 637 DCRAQIIHCDIKPQNILL---DDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE 693
                ++H D+KP+NIL      +   +I DFGLA+L      +    A  GT  Y+APE
Sbjct: 143 ---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK--SDEHSTNAA-GTALYMAPE 196

Query: 694 WFRNSKITAKVDVYSFGVLL 713
            F+   +T K D++S GV++
Sbjct: 197 VFK-RDVTFKCDIWSAGVVM 215

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  110 bits (278), Expect = 4e-26
 Identities = 51/206 (24%), Positives = 96/206 (46%), Gaps = 23/206 (11%)

Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--------VFQDGEREFKNEVFVIG 573
              + +G G+ G V       R +   VA++ + +           D     + E+ ++ 
Sbjct: 138 IMSKTLGSGACGEVKLAF--ERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195

Query: 574 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLY 633
           + +H  ++++  F D  ++  +V E +  G L   + GN +          +Q+   + Y
Sbjct: 196 KLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 254

Query: 634 LHEDCRAQIIHCDIKPQNILL---DDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYV 690
           LHE+    IIH D+KP+N+LL   ++    +I+DFG +K+L   ++  ++T   GT  Y+
Sbjct: 255 LHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLC-GTPTYL 308

Query: 691 APEWFRNSKI---TAKVDVYSFGVLL 713
           APE   +         VD +S GV+L
Sbjct: 309 APEVLVSVGTAGYNRAVDCWSLGVIL 334

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  107 bits (270), Expect = 5e-26
 Identities = 48/209 (22%), Positives = 83/209 (39%), Gaps = 40/209 (19%)

Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLV 581
             +  +GRGS+G V   V   + +    A KK+ + F +    FK E+ ++    H N++
Sbjct: 12  TLENTIGRGSWGEVKIAV--QKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 69

Query: 582 RLLGFCDEGQNRLLVYEFLNNGTL--------------ASFLFGNLKPNWNLRTNIAFQI 627
           RL    ++  +  LV E    G L              A+ +                 +
Sbjct: 70  RLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIM--------------KDV 115

Query: 628 ARGLLYLHEDCRAQIIHCDIKPQNILL---DDYYTARISDFGLAKLLTLNQSKTIKTAIR 684
              + Y H+     + H D+KP+N L          ++ DFGLA        K ++T + 
Sbjct: 116 LSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR--FKPGKMMRTKV- 169

Query: 685 GTKGYVAPEWFRNSKITAKVDVYSFGVLL 713
           GT  YV+P+         + D +S GV++
Sbjct: 170 GTPYYVSPQVLEG-LYGPECDEWSAGVMM 197

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  107 bits (269), Expect = 6e-26
 Identities = 59/193 (30%), Positives = 96/193 (49%), Gaps = 17/193 (8%)

Query: 528 GRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGERE-FKNEVFVIGQTHHKNLVRLL 584
           G+GSF  VY+   ++  +   VA+K +D+  +++ G  +  +NEV +  Q  H +++ L 
Sbjct: 20  GKGSFAGVYRA--ESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77

Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA----FQIARGLLYLHEDCRA 640
            + ++     LV E  +NG +  +L   +KP      N A     QI  G+LYLH     
Sbjct: 78  NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKP---FSENEARHFMHQIITGMLYLH---SH 131

Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            I+H D+   N+LL      +I+DFGLA  L +   K   T + GT  Y++PE    S  
Sbjct: 132 GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK-HYT-LCGTPNYISPEIATRSAH 189

Query: 701 TAKVDVYSFGVLL 713
             + DV+S G + 
Sbjct: 190 GLESDVWSLGCMF 202

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  107 bits (269), Expect = 7e-26
 Identities = 57/211 (27%), Positives = 89/211 (42%), Gaps = 42/211 (19%)

Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLD--RVFQDGEREFKNEVFVIGQTHHKN 579
           N    +G+GSFG V K     R +    AVK ++              EV ++ +  H N
Sbjct: 25  NIVCMLGKGSFGEVLKCK--DRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPN 82

Query: 580 LVRLLGFCDEGQNRLLVYEFLNNGTL--------------ASFLFGNLKPNWNLRTNIAF 625
           +++L    ++  +  +V E    G L              A+ +                
Sbjct: 83  IMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARII--------------K 128

Query: 626 QIARGLLYLHEDCRAQIIHCDIKPQNILL---DDYYTARISDFGLAKLLTLNQSKTIKTA 682
           Q+  G+ Y+H+     I+H D+KP+NILL   +     +I DFGL+      Q+  +K  
Sbjct: 129 QVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC--FQQNTKMKDR 183

Query: 683 IRGTKGYVAPEWFRNSKITAKVDVYSFGVLL 713
           I GT  Y+APE  R      K DV+S GV+L
Sbjct: 184 I-GTAYYIAPEVLRG-TYDEKCDVWSAGVIL 212

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  109 bits (275), Expect = 1e-25
 Identities = 65/215 (30%), Positives = 100/215 (46%), Gaps = 39/215 (18%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKN-EVFVIGQTHHKNLVRL 583
           + +G GSFG+VY+  +    S   VA+KK   V QD  + FKN E+ ++ +  H N+VRL
Sbjct: 60  KVIGNGSFGVVYQAKL--CDSGELVAIKK---VLQD--KRFKNRELQIMRKLDHCNIVRL 112

Query: 584 LG-FCDEGQNRL-----LVYEFLNNGTLASFLFGNLKPNWNLRTN----IAFQIARGLLY 633
              F   G+ +      LV +++   T+        +    L         +Q+ R L Y
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 171

Query: 634 LHEDCRAQIIHCDIKPQNILLD-DYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYV-- 690
           +H      I H DIKPQN+LLD D    ++ DFG AK L   +             Y+  
Sbjct: 172 IH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---------SYICS 219

Query: 691 ----APEW-FRNSKITAKVDVYSFGVLLLEIISCR 720
               APE  F  +  T+ +DV+S G +L E++  +
Sbjct: 220 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  107 bits (269), Expect = 1e-25
 Identities = 82/292 (28%), Positives = 128/292 (43%), Gaps = 61/292 (20%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQT-HHKNLVRL 583
           E VG G++G VYKG    +T     A+K +D V  D E E K E+ ++ +  HH+N+   
Sbjct: 30  ELVGNGTYGQVYKG-RHVKTGQL-AAIKVMD-VTGDEEEEIKQEINMLKKYSHHRNIATY 86

Query: 584 LG-----FCDEGQNRL-LVYEFLNNGTLA----SFLFGNLKPNWNLRTNIAF---QIARG 630
            G           ++L LV EF   G++     +     LK  W     IA+   +I RG
Sbjct: 87  YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW-----IAYICREILRG 141

Query: 631 LLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYV 690
           L +LH+    ++IH DIK QN+LL +    ++ DFG++  L     +   T I GT  ++
Sbjct: 142 LSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR-NTFI-GTPYWM 196

Query: 691 APE-----WFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD----WA-FD 740
           APE        ++    K D++S G      I+      IEM E    L D     A F 
Sbjct: 197 APEVIACDENPDATYDFKSDLWSLG------ITA-----IEMAEGAPPLCDMHPMRALFL 245

Query: 741 CYRNGKLNVLVGED-KEAMND-IECLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
             RN     L  +   +     IE           C+ ++ S RP  +++++
Sbjct: 246 IPRNPA-PRLKSKKWSKKFQSFIES----------CLVKNHSQRPATEQLMK 286

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  107 bits (270), Expect = 1e-25
 Identities = 56/243 (23%), Positives = 86/243 (35%), Gaps = 58/243 (23%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVK-----KLDRVFQDGEREFKNEVFVIGQTHH 577
            K  +G+GS+G+V   +     +    A+K     K+ ++        K EV ++ + HH
Sbjct: 30  LKGAIGQGSYGVVRVAI--ENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH 87

Query: 578 KNLVRLLGFCDEGQNRLLVYEFLNNGTL------------------------------AS 607
            N+ RL    ++ Q   LV E  + G L                                
Sbjct: 88  PNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNE 147

Query: 608 FLFGNLKPNWNLRTNIAF----------QIARGLLYLHEDCRAQIIHCDIKPQNILL--D 655
                    +    +             QI   L YLH      I H DIKP+N L   +
Sbjct: 148 EAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTN 204

Query: 656 DYYTARISDFGLAKLLTLN---QSKTIKTAIRGTKGYVAPEWFRNS--KITAKVDVYSFG 710
             +  ++ DFGL+K        +   + T   GT  +VAPE    +      K D +S G
Sbjct: 205 KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNESYGPKCDAWSAG 263

Query: 711 VLL 713
           VLL
Sbjct: 264 VLL 266

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  107 bits (270), Expect = 2e-25
 Identities = 54/208 (25%), Positives = 90/208 (43%), Gaps = 41/208 (19%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVR 582
            + E+GRG+  IVY+     + +    A+K L +     ++  + E+ V+ +  H N+++
Sbjct: 57  VESELGRGATSIVYRCK--QKGTQKPYALKVLKK--TVDKKIVRTEIGVLLRLSHPNIIK 112

Query: 583 LLGFCDEGQNRLLVYEFLNNGTL--------------ASFLFGNLKPNWNLRTNIAFQIA 628
           L    +      LV E +  G L              A+                  QI 
Sbjct: 113 LKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVK--------------QIL 158

Query: 629 RGLLYLHEDCRAQIIHCDIKPQNILL---DDYYTARISDFGLAKLLTLNQSKTIKTAIRG 685
             + YLHE     I+H D+KP+N+L          +I+DFGL+K++       +KT   G
Sbjct: 159 EAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV--EHQVLMKTVC-G 212

Query: 686 TKGYVAPEWFRNSKITAKVDVYSFGVLL 713
           T GY APE  R      +VD++S G++ 
Sbjct: 213 TPGYCAPEILRGCAYGPEVDMWSVGIIT 240

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  110 bits (276), Expect = 2e-25
 Identities = 58/211 (27%), Positives = 89/211 (42%), Gaps = 42/211 (19%)

Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLD--RVFQDGEREFKNEVFVIGQTHHKN 579
           N    +G+GSFG V K     R +    AVK ++              EV ++ +  H N
Sbjct: 25  NIVCMLGKGSFGEVLKCK--DRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPN 82

Query: 580 LVRLLGFCDEGQNRLLVYEFLNNGTL--------------ASFLFGNLKPNWNLRTNIAF 625
           +++L    ++  +  +V E    G L              A+               I  
Sbjct: 83  IMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA--------------RIIK 128

Query: 626 QIARGLLYLHEDCRAQIIHCDIKPQNILL---DDYYTARISDFGLAKLLTLNQSKTIKTA 682
           Q+  G+ Y+H+     I+H D+KP+NILL   +     +I DFGL+      Q+  +K  
Sbjct: 129 QVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC--FQQNTKMKDR 183

Query: 683 IRGTKGYVAPEWFRNSKITAKVDVYSFGVLL 713
           I GT  Y+APE  R      K DV+S GV+L
Sbjct: 184 I-GTAYYIAPEVLRG-TYDEKCDVWSAGVIL 212

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  108 bits (272), Expect = 2e-25
 Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 40/215 (18%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKN-EVFVIGQTHHKNLVRL 583
           + +G GSFG+V++  +     +  VA+KK   V QD  + FKN E+ ++    H N+V L
Sbjct: 46  KVIGNGSFGVVFQAKLVE---SDEVAIKK---VLQD--KRFKNRELQIMRIVKHPNVVDL 97

Query: 584 LGF-----CDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTN----IAFQIARGLLY 633
             F       + +  L LV E++   T+        K    +         +Q+ R L Y
Sbjct: 98  KAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAY 156

Query: 634 LHEDCRAQIIHCDIKPQNILLD-DYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYV-- 690
           +H      I H DIKPQN+LLD      ++ DFG AK+L   +             Y+  
Sbjct: 157 IH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNV---------SYICS 204

Query: 691 ----APEW-FRNSKITAKVDVYSFGVLLLEIISCR 720
               APE  F  +  T  +D++S G ++ E++  +
Sbjct: 205 RYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  107 bits (270), Expect = 2e-25
 Identities = 53/210 (25%), Positives = 93/210 (44%), Gaps = 41/210 (19%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLD--RVFQDGEREFKNEVFVIGQTHHKNL 580
            KEE+G+G+F +V + V   +T+    A K ++  ++     ++ + E  +  +  H N+
Sbjct: 33  VKEELGKGAFSVVRRCV--HKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 90

Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTL--------------ASFLFGNLKPNWNLRTNIAFQ 626
           VRL     E     LV++ +  G L              AS                  Q
Sbjct: 91  VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCI--------------QQ 136

Query: 627 IARGLLYLHEDCRAQIIHCDIKPQNILL---DDYYTARISDFGLAKLLTLNQSKTIKTAI 683
           I   + Y H +    I+H ++KP+N+LL         +++DFGLA  +  N S+      
Sbjct: 137 ILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDSEAWHGFA 191

Query: 684 RGTKGYVAPEWFRNSKITAKVDVYSFGVLL 713
            GT GY++PE  +    +  VD+++ GV+L
Sbjct: 192 -GTPGYLSPEVLKKDPYSKPVDIWACGVIL 220

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  106 bits (267), Expect = 2e-25
 Identities = 51/220 (23%), Positives = 92/220 (41%), Gaps = 51/220 (23%)

Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDR--------VFQDGEREFKNEVFVIG 573
              + +G G+ G V       R +   VA+K + +           D     + E+ ++ 
Sbjct: 13  IMSKTLGSGACGEVKLAF--ERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70

Query: 574 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTL--------------ASFLFGNLKPNWNL 619
           + +H  ++++  F D  ++  +V E +  G L                  F         
Sbjct: 71  KLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF--------- 120

Query: 620 RTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILL---DDYYTARISDFGLAKLLTLNQS 676
                +Q+   + YLHE     IIH D+KP+N+LL   ++    +I+DFG +K+L   ++
Sbjct: 121 -----YQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ET 170

Query: 677 KTIKTAIRGTKGYVAPEWFRNSKI---TAKVDVYSFGVLL 713
             ++T   GT  Y+APE   +         VD +S GV+L
Sbjct: 171 SLMRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  105 bits (265), Expect = 5e-25
 Identities = 54/208 (25%), Positives = 87/208 (41%), Gaps = 42/208 (20%)

Query: 524 KEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ-THHKNLVR 582
            + +G GSF I  K V   + S  A AVK + +     E   + E+  +     H N+V+
Sbjct: 16  DKPLGEGSFSICRKCV--HKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVK 70

Query: 583 LLGFCDEGQNRLLVYEFLNNGTL--------------ASFLFGNLKPNWNLRTNIAFQIA 628
           L     +  +  LV E LN G L              AS               I  ++ 
Sbjct: 71  LHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEAS--------------YIMRKLV 116

Query: 629 RGLLYLHEDCRAQIIHCDIKPQNILL---DDYYTARISDFGLAKLLTLNQSKTIKTAIRG 685
             + ++H+     ++H D+KP+N+L    +D    +I DFG A+L   +  + +KT    
Sbjct: 117 SAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-QPLKTPC-F 171

Query: 686 TKGYVAPEWFRNSKITAKVDVYSFGVLL 713
           T  Y APE    +      D++S GV+L
Sbjct: 172 TLHYAAPELLNQNGYDESCDLWSLGVIL 199

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  108 bits (272), Expect = 5e-25
 Identities = 55/221 (24%), Positives = 92/221 (41%), Gaps = 53/221 (23%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDR-------------VFQDGEREFKNEV 569
              ++G G++G V       +   +  A+K + +               +    E  NE+
Sbjct: 40  KVRKLGSGAYGEVLLCK--EKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEI 97

Query: 570 FVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTL--------------ASFLFGNLKP 615
            ++    H N+++L    ++ +   LV EF   G L              A+        
Sbjct: 98  SLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAA-------- 149

Query: 616 NWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILL---DDYYTARISDFGLAKLLT 672
                 NI  QI  G+ YLH+     I+H DIKP+NILL   +     +I DFGL+    
Sbjct: 150 ------NIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSF-- 198

Query: 673 LNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLL 713
            ++   ++  + GT  Y+APE  +  K   K DV+S GV++
Sbjct: 199 FSKDYKLRDRL-GTAYYIAPEVLK-KKYNEKCDVWSCGVIM 237

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  107 bits (270), Expect = 6e-25
 Identities = 49/210 (23%), Positives = 87/210 (41%), Gaps = 40/210 (19%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLD-RVFQDGERE-FKNEVFVIGQTHHKNL 580
             EE+G+G+F +V + V     +    A   ++ +     + +  + E  +     H N+
Sbjct: 15  LFEELGKGAFSVVRRCV--KVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNI 72

Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTL--------------ASFLFGNLKPNWNLRTNIAFQ 626
           VRL     E  +  L+++ +  G L              AS                  Q
Sbjct: 73  VRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCI--------------QQ 118

Query: 627 IARGLLYLHEDCRAQIIHCDIKPQNILL---DDYYTARISDFGLAKLLTLNQSKTIKTAI 683
           I   +L+ H+     ++H ++KP+N+LL         +++DFGLA  +   Q      A 
Sbjct: 119 ILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA- 174

Query: 684 RGTKGYVAPEWFRNSKITAKVDVYSFGVLL 713
            GT GY++PE  R       VD+++ GV+L
Sbjct: 175 -GTPGYLSPEVLRKDPYGKPVDLWACGVIL 203

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  106 bits (265), Expect = 1e-24
 Identities = 45/311 (14%), Positives = 87/311 (27%), Gaps = 53/311 (17%)

Query: 525 EEVGRG--SFGIVYKGVIQTRTSTTAVAVKK--LDRVFQDGEREFKNEVFVIGQTHHKNL 580
             +G+G      V        T    V V++  L+    +     + E+ V    +H N+
Sbjct: 31  TVIGKGFEDLMTVNLA-RYKPTGEY-VTVRRINLEACSNEMVTFLQGELHVSKLFNHPNI 88

Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF---QIARGLLYLHED 637
           V             +V  F+  G+    L      +      IA+    + + L Y+H  
Sbjct: 89  VPYRATFIADNELWVVTSFMAYGSAKD-LICTHFMDGMNELAIAYILQGVLKALDYIHHM 147

Query: 638 CRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYV------A 691
                +H  +K  +IL+       +S       +  +  +  +      K  V      +
Sbjct: 148 ---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQ-RVVHDFPKYSVKVLPWLS 203

Query: 692 PEWFRNSKI--TAKVDVYSFGVLLLEII----------------------------SCRK 721
           PE  + +     AK D+YS G+   E+                             +   
Sbjct: 204 PEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTI 263

Query: 722 SFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLV--MVSIWCIQEDP 779
             +         + +                 D  +              V   C+Q +P
Sbjct: 264 PAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQ-CLQRNP 322

Query: 780 SLRPTMKKVLQ 790
             RP+   +L 
Sbjct: 323 DARPSASTLLN 333

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  105 bits (264), Expect = 1e-24
 Identities = 55/219 (25%), Positives = 92/219 (42%), Gaps = 41/219 (18%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKN----EVFVIGQTHHKNL 580
              G+G+FG V  G    +++  +VA+KK   V QD    F+N     +  +   HH N+
Sbjct: 29  RMAGQGTFGTVQLGKE--KSTGMSVAIKK---VIQD--PRFRNRELQIMQDLAVLHHPNI 81

Query: 581 VRLL------GFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTN----IAFQIAR 629
           V+L       G  D     L +V E++ + TL        +              FQ+ R
Sbjct: 82  VQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIR 140

Query: 630 GLLYLHEDCRAQIIHCDIKPQNILLDDY-YTARISDFGLAKLLTLNQSKTIKTAIRGTKG 688
            +  LH      + H DIKP N+L+++   T ++ DFG AK L+ ++             
Sbjct: 141 SIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNV---------A 190

Query: 689 YVAPEWFR-------NSKITAKVDVYSFGVLLLEIISCR 720
           Y+   ++R       N   T  VD++S G +  E++   
Sbjct: 191 YICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  104 bits (261), Expect = 1e-24
 Identities = 68/314 (21%), Positives = 113/314 (35%), Gaps = 67/314 (21%)

Query: 525 EEVGRGSFGIVYKGVIQTRTST-TAVAVKKLDR------VFQDGEREFKNEV----FVIG 573
             +G+G FG V+ G    R +    VA+K + R                 EV     V  
Sbjct: 37  PLLGKGGFGTVFAG---HRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGA 93

Query: 574 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA---F-QIAR 629
              H  ++RLL + +  +  +LV E          LF  +     L    +   F Q+  
Sbjct: 94  GGGHPGVIRLLDWFETQEGFMLVLERPLPAQD---LFDYITEKGPLGEGPSRCFFGQVVA 150

Query: 630 GLLYLHEDCRAQIIHCDIKPQNILLD-DYYTARISDFGLAKLLTLNQSKTIKTAIRGTKG 688
            + + H      ++H DIK +NIL+D     A++ DFG   LL     +       GT+ 
Sbjct: 151 AIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL---HDEPYTDFD-GTRV 203

Query: 689 YVAPEWFRNSKIT-AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA-FDCYR--- 743
           Y  PEW    +       V+S G+LL                 Y ++     F+  +   
Sbjct: 204 YSPPEWISRHQYHALPATVWSLGILL-----------------YDMVCGDIPFERDQEIL 246

Query: 744 NGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ---MLEGVVEVSV 800
             +L+       +    I            C+   PS RP+++++L    M     +V +
Sbjct: 247 EAELHFPAHVSPDCCALIR----------RCLAPKPSSRPSLEEILLDPWMQTPAEDVPL 296

Query: 801 PP---NPYPFSSSM 811
            P    P P + S+
Sbjct: 297 NPSKGGPAPLAWSL 310

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  103 bits (259), Expect = 2e-24
 Identities = 50/194 (25%), Positives = 85/194 (43%), Gaps = 20/194 (10%)

Query: 528 GRGSFGIVYKGV-IQTRTSTTAVAVKKLDR--VFQDGERE-FKNEVFVIGQTHHKNLVRL 583
           G+G F   ++     T+      A K + +  + +  +RE    E+ +     H+++V  
Sbjct: 24  GKGGFAKCFEISDADTKEV---FAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80

Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA----FQIARGLLYLHEDCR 639
            GF ++     +V E     +L        K    L    A     QI  G  YLH   R
Sbjct: 81  HGFFEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARYYLRQIVLGCQYLH---R 133

Query: 640 AQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSK 699
            ++IH D+K  N+ L++    +I DFGLA  +  +  +  K  + GT  Y+APE      
Sbjct: 134 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSKKG 191

Query: 700 ITAKVDVYSFGVLL 713
            + +VDV+S G ++
Sbjct: 192 HSFEVDVWSIGCIM 205

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  103 bits (258), Expect = 2e-24
 Identities = 48/206 (23%), Positives = 90/206 (43%), Gaps = 26/206 (12%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE-FKNEV-FVIGQTHHKNLVR 582
            E+GRG++G+V K +    +    +AVK++       E++    ++   +        V 
Sbjct: 13  MELGRGAYGVVEK-MRHVPSGQI-MAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVT 70

Query: 583 LLG-FCDEGQNRLLVY---EFLNNGTLASFLFGNLKPNWNLRTN----IAFQIARGLLYL 634
             G    EG     V+   E ++  +L  F    +     +  +    IA  I + L +L
Sbjct: 71  FYGALFREGD----VWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL 125

Query: 635 HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE- 693
           H      +IH D+KP N+L++     ++ DFG++  L  + +K       G K Y+APE 
Sbjct: 126 HSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKD--IDA-GCKPYMAPER 180

Query: 694 ---WFRNSKITAKVDVYSFGVLLLEI 716
                     + K D++S G+ ++E+
Sbjct: 181 INPELNQKGYSVKSDIWSLGITMIEL 206

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  102 bits (257), Expect = 4e-24
 Identities = 72/293 (24%), Positives = 120/293 (40%), Gaps = 53/293 (18%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLD-RVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           E +G G+  +V             VA+K+++    Q    E   E+  + Q HH N+V  
Sbjct: 21  EVIGSGATAVVQAA-YCAPKKEK-VAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSY 78

Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN------IAF---QIARGLLYL 634
                      LV + L+ G++   +  ++      ++       IA    ++  GL YL
Sbjct: 79  YTSFVVKDELWLVMKLLSGGSVLD-IIKHIVAKGEHKSGVLDESTIATILREVLEGLEYL 137

Query: 635 HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI----KTAIRGTKGYV 690
           H++     IH D+K  NILL +  + +I+DFG++  L      T     KT + GT  ++
Sbjct: 138 HKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV-GTPCWM 193

Query: 691 APEWFRNSKI-TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA-----FDCYRN 744
           APE     +    K D++SFG      I+      IE+    A    +          +N
Sbjct: 194 APEVMEQVRGYDFKADIWSFG------ITA-----IELATGAAPYHKYPPMKVLMLTLQN 242

Query: 745 G--KLNVLVGEDKEAMNDIECLGKLV-----MVSIWCIQEDPSLRPTMKKVLQ 790
               L       +  + D E L K       M+S  C+Q+DP  RPT  ++L+
Sbjct: 243 DPPSL-------ETGVQDKEMLKKYGKSFRKMIS-LCLQKDPEKRPTAAELLR 287

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  103 bits (258), Expect = 5e-24
 Identities = 49/193 (25%), Positives = 84/193 (43%), Gaps = 18/193 (9%)

Query: 528 GRGSFGIVYKGVIQTRTSTTAVAVKKLDR--VFQDGERE-FKNEVFVIGQTHHKNLVRLL 584
           G+G F   ++       +    A K + +  + +  +RE    E+ +     H+++V   
Sbjct: 50  GKGGFAKCFEI--SDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107

Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA----FQIARGLLYLHEDCRA 640
           GF ++     +V E     +L        K    L    A     QI  G  YLH   R 
Sbjct: 108 GFFEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARYYLRQIVLGCQYLH---RN 160

Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
           ++IH D+K  N+ L++    +I DFGLA  +  +  +  K  + GT  Y+APE       
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSKKGH 218

Query: 701 TAKVDVYSFGVLL 713
           + +VDV+S G ++
Sbjct: 219 SFEVDVWSIGCIM 231

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  104 bits (260), Expect = 6e-24
 Identities = 29/234 (12%), Positives = 66/234 (28%), Gaps = 49/234 (20%)

Query: 525 EEVGRGSFGIVYKGVIQTRTST-TAVAVK---KLDRVFQDGEREFKNEVFVIGQT----- 575
             +G+       +    T   T  +  V      +R   +  ++ K EV  +        
Sbjct: 84  TVLGQEDPYAYLEA---TDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKN 140

Query: 576 -----------------HHKNLVRLLGFCDEGQNRLLVYEFL-------NNGTLASFLFG 611
                                  +++    + ++  ++  F        N  T    L  
Sbjct: 141 QKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLS 200

Query: 612 NLK----PNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGL 667
           +         + R  +  Q+ R L  LH      ++H  ++P +I+LD      ++ F  
Sbjct: 201 HSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEH 257

Query: 668 AKLLTLNQSKTIKTAIRGTKGYVAPEWFR-----NSKITAKVDVYSFGVLLLEI 716
                   + +            A           + +T   D ++ G+ +  I
Sbjct: 258 LVRDG-ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  101 bits (253), Expect = 1e-23
 Identities = 49/218 (22%), Positives = 85/218 (38%), Gaps = 47/218 (21%)

Query: 524 KEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ-THHKNLVR 582
           ++ +G G+   V   +     ++   AVK +++           EV ++ Q   H+N++ 
Sbjct: 18  EDVLGEGAHARVQTCI--NLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLE 75

Query: 583 LLGFCDEGQNRLLVYEFLNNGTL--------------ASFLFGNLKPNWNLRTNIAFQIA 628
           L+ F +E     LV+E +  G++              AS               +   +A
Sbjct: 76  LIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEAS--------------VVVQDVA 121

Query: 629 RGLLYLHEDCRAQIIHCDIKPQNILL---DDYYTARISDFGLAKLLTLNQSKTIKTAIR- 684
             L +LH      I H D+KP+NIL    +     +I DF L   + LN   +  +    
Sbjct: 122 SALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPEL 178

Query: 685 ----GTKGYVAPEWFRNSKITAK-----VDVYSFGVLL 713
               G+  Y+APE        A       D++S GV+L
Sbjct: 179 LTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  100 bits (252), Expect = 3e-23
 Identities = 49/210 (23%), Positives = 93/210 (44%), Gaps = 33/210 (15%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE-FKNEVFVIGQT-HHKNLVR 582
            E+GRG++G V K ++   +    +AVK++     + E++    ++ V+ ++     +V+
Sbjct: 28  GEIGRGAYGSVNK-MVHKPSGQI-MAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQ 85

Query: 583 LLG-FCDEGQNRLLVY---EFLNNGTLASFLFGNLKPNWNLRTN------IAFQIARGLL 632
             G    EG      +   E ++  +   F    +    +          I     + L 
Sbjct: 86  FYGALFREGD----CWICMELMS-TSFDKFY-KYVYSVLDDVIPEEILGKITLATVKALN 139

Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLL--TLNQSKTIKTAIRGTKGYV 690
           +L E+ +  IIH DIKP NILLD     ++ DFG++  L  ++ +++       G + Y+
Sbjct: 140 HLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDA-----GCRPYM 192

Query: 691 APE----WFRNSKITAKVDVYSFGVLLLEI 716
           APE             + DV+S G+ L E+
Sbjct: 193 APERIDPSASRQGYDVRSDVWSLGITLYEL 222

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  100 bits (251), Expect = 4e-23
 Identities = 55/204 (26%), Positives = 84/204 (41%), Gaps = 27/204 (13%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFK---NEVFVIGQTHHKNLV 581
            E+G GSFG VY      R S   VA+KK+    +    +++    EV  + +  H N +
Sbjct: 60  REIGHGSFGAVYFA-RDVRNSEV-VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTI 117

Query: 582 RLLGFCDEGQNRLLVYEFLNNG--TLASFLFGNLKPNWNLRTNIAF---QIARGLLYLHE 636
           +  G         LV E+       L       L+        IA       +GL YLH 
Sbjct: 118 QYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVE-----IAAVTHGALQGLAYLHS 172

Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE--- 693
                +IH D+K  NILL +    ++ DFG A    +  + +      GT  ++APE   
Sbjct: 173 H---NMIHRDVKAGNILLSEPGLVKLGDFGSAS--IMAPANSFV----GTPYWMAPEVIL 223

Query: 694 WFRNSKITAKVDVYSFGVLLLEII 717
                +   KVDV+S G+  +E+ 
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIELA 247

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 97.8 bits (244), Expect = 2e-22
 Identities = 63/281 (22%), Positives = 109/281 (38%), Gaps = 51/281 (18%)

Query: 525 EEVGRGSFGIVYKGVIQTRTST-TAVAVKKLDR------VFQDGEREFKNEVFVIGQTHH 577
             +G G FG VY G    R S    VA+K +++                 EV ++ +   
Sbjct: 49  PLLGSGGFGSVYSG---IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 105

Query: 578 K--NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA---F-QIARGL 631
               ++RLL + +   + +L+ E          LF  +     L+  +A   F Q+   +
Sbjct: 106 GFSGVIRLLDWFERPDSFVLILERPEPV---QDLFDFITERGALQEELARSFFWQVLEAV 162

Query: 632 LYLHEDCRAQIIHCDIKPQNILLD-DYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYV 690
            + H      ++H DIK +NIL+D +    ++ DFG   LL   +         GT+ Y 
Sbjct: 163 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFD-GTRVYS 215

Query: 691 APEWFRNSKITA-KVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNV 749
            PEW R  +       V+S G+LL +++     F+     +  I+          G++  
Sbjct: 216 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE----HDEEII---------RGQVFF 262

Query: 750 LVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
                 E  + I           WC+   PS RPT +++  
Sbjct: 263 RQRVSSECQHLIR----------WCLALRPSDRPTFEEIQN 293

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  101 bits (252), Expect = 2e-22
 Identities = 65/199 (32%), Positives = 98/199 (49%), Gaps = 16/199 (8%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKL--DRVFQDGEREF-KNEVFVIGQTHHKNLVRL 583
           +GRG FG V+    Q + +    A KKL   R+ +    +    E  ++ + H + +V L
Sbjct: 193 LGRGGFGEVF--ACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250

Query: 584 LGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIA-F---QIARGLLYLHEDC 638
             +  E +  L LV   +N G +   ++   + N   +   A F   QI  GL +LH+  
Sbjct: 251 A-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR- 308

Query: 639 RAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNS 698
              II+ D+KP+N+LLDD    RISD GLA  L   Q+KT      GT G++APE     
Sbjct: 309 --NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT--KGYAGTPGFMAPELLLGE 364

Query: 699 KITAKVDVYSFGVLLLEII 717
           +    VD ++ GV L E+I
Sbjct: 365 EYDFSVDYFALGVTLYEMI 383

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 96.9 bits (242), Expect = 3e-22
 Identities = 58/200 (29%), Positives = 94/200 (47%), Gaps = 24/200 (12%)

Query: 528 GRGSFGIVYKGV-IQTRTSTTAVAVKKLDR----VFQDGEREFKNEVFVIGQTHHKNLVR 582
           G GS+G V + +  +T       AVK L +       +GE   K E+ ++ +  HKN+++
Sbjct: 14  GEGSYGKVKEVLDSETLCR---RAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70

Query: 583 LLG-FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIA---F-QIARGLLYLHE 636
           L+    +E + ++ +V E+   G     +  ++ P        A   F Q+  GL YLH 
Sbjct: 71  LVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSV-PEKRFPVCQAHGYFCQLIDGLEYLH- 126

Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLL-TLNQSKTIKTAIRGTKGYVAPEWF 695
                I+H DIKP N+LL    T +IS  G+A+ L       T +T+ +G+  +  PE  
Sbjct: 127 --SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS-QGSPAFQPPEIA 183

Query: 696 RNSKI--TAKVDVYSFGVLL 713
                    KVD++S GV L
Sbjct: 184 NGLDTFSGFKVDIWSAGVTL 203

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 97.4 bits (243), Expect = 4e-22
 Identities = 48/213 (22%), Positives = 78/213 (36%), Gaps = 50/213 (23%)

Query: 524 KEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           K+ +G G  G V +     R +    A+K L        +E  +     G     ++V +
Sbjct: 34  KQVLGLGVNGKVLECF--HRRTGQKCALKLLYDS-PKARQEVDHHWQASG---GPHIVCI 87

Query: 584 LGFCDEGQNR----LLVYEFLNNGTL----------------ASFLFGNLKPNWNLRTNI 623
           L   +   +     L++ E +  G L                A+               I
Sbjct: 88  LDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAA--------------EI 133

Query: 624 AFQIARGLLYLHEDCRAQIIHCDIKPQNILL---DDYYTARISDFGLAKLLTLNQSKTIK 680
              I   + +LH      I H D+KP+N+L    +     +++DFG AK  T N  +T  
Sbjct: 134 MRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPC 190

Query: 681 TAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLL 713
                T  YVAPE     K     D++S GV++
Sbjct: 191 ----YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 96.3 bits (240), Expect = 8e-22
 Identities = 50/203 (24%), Positives = 87/203 (42%), Gaps = 22/203 (10%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE-FKNEVFVIGQTH-HKNLVR 582
            E+G G+ G V+K +   +T    +AVK++ R     E +    ++ V+ ++H    +V+
Sbjct: 31  GEMGSGTCGQVWK-MRFRKTGHV-IAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQ 88

Query: 583 LLG-FCDEGQNRLLVY---EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDC 638
             G F         V+   E +                  +   +   I + L YL E  
Sbjct: 89  CFGTFITNTD----VFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK- 143

Query: 639 RAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE----- 693
              +IH D+KP NILLD+    ++ DFG++  L  +++K       G   Y+APE     
Sbjct: 144 -HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA---GCAAYMAPERIDPP 199

Query: 694 WFRNSKITAKVDVYSFGVLLLEI 716
                    + DV+S G+ L+E+
Sbjct: 200 DPTKPDYDIRADVWSLGISLVEL 222

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 98.7 bits (246), Expect = 1e-21
 Identities = 64/197 (32%), Positives = 101/197 (51%), Gaps = 15/197 (7%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKL--DRVFQDGEREF-KNEVFVIGQTHHKNLVRL 583
           +G+G FG V     Q R +    A KKL   R+ +        NE  ++ + + + +V L
Sbjct: 192 LGKGGFGEVC--ACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249

Query: 584 LGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNI--AFQIARGLLYLHEDCRA 640
             +  E ++ L LV   +N G L   ++   +  +     +  A +I  GL  LH +   
Sbjct: 250 -AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE--- 305

Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
           +I++ D+KP+NILLDD+   RISD GLA  +     +TIK  + GT GY+APE  +N + 
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG--QTIKGRV-GTVGYMAPEVVKNERY 362

Query: 701 TAKVDVYSFGVLLLEII 717
           T   D ++ G LL E+I
Sbjct: 363 TFSPDWWALGCLLYEMI 379

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 97.1 bits (242), Expect = 1e-21
 Identities = 49/215 (22%), Positives = 81/215 (37%), Gaps = 51/215 (23%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ-THHKNLV 581
             + +G G  G V +     + +    A+K L         + + EV +  + +   ++V
Sbjct: 66  TSQVLGLGINGKVLQIF--NKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIV 118

Query: 582 RLLGFCDEGQNR----LLVYEFLNNGTL----------------ASFLFGNLKPNWNLRT 621
           R++   +         L+V E L+ G L                AS              
Sbjct: 119 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS-------------- 164

Query: 622 NIAFQIARGLLYLHEDCRAQIIHCDIKPQNILL---DDYYTARISDFGLAKLLTLNQSKT 678
            I   I   + YLH      I H D+KP+N+L          +++DFG AK  T +   +
Sbjct: 165 EIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN--S 219

Query: 679 IKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLL 713
           + T    T  YVAPE     K     D++S GV++
Sbjct: 220 LTTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 96.3 bits (240), Expect = 2e-21
 Identities = 57/215 (26%), Positives = 91/215 (42%), Gaps = 39/215 (18%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE------REFKNEVFVIGQTHHKNL 580
           +G G+ GIV             VA+KKL R FQ+        RE      ++   +HKN+
Sbjct: 33  IGSGAQGIVCA-AYDAILERN-VAIKKLSRPFQNQTHAKRAYRELV----LMKCVNHKNI 86

Query: 581 VRLL------GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYL 634
           + LL         +E Q+  +V E ++   L   +   L     +   + +Q+  G+ +L
Sbjct: 87  IGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHE-RMSY-LLYQMLCGIKHL 143

Query: 635 HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 694
           H    A IIH D+KP NI++    T +I DFGLA+    +   T          YV   +
Sbjct: 144 HS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT---------PYVVTRY 191

Query: 695 FR------NSKITAKVDVYSFGVLLLEIISCRKSF 723
           +R             VD++S G ++ E+I     F
Sbjct: 192 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 226

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 94.0 bits (234), Expect = 3e-21
 Identities = 39/299 (13%), Positives = 78/299 (26%), Gaps = 75/299 (25%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE---REFKNEVFVIGQTHHKNLV 581
              G       ++ +  T      VA+  +D      +   +E  +    + +     + 
Sbjct: 37  IFHGGVPPLQFWQAL-DTALDRQ-VALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94

Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ 641
           R+L         L+V E++  G+L      +  P   +R      +A      H   RA 
Sbjct: 95  RVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGAIR--AMQSLAAAADAAH---RAG 149

Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKIT 701
           +      P  +         +S  G   L                   +           
Sbjct: 150 VALSIDHPSRVR--------VSIDGDVVL--------------AYPATMPDA-------N 180

Query: 702 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILT-DWAFDCYRNGKLNVLVGEDKEAMND 760
            + D+   G  L                 YA+L   W       G  + L   +++    
Sbjct: 181 PQDDIRGIGASL-----------------YALLVNRWPLP--EAGVRSGLAPAERDTAGQ 221

Query: 761 I-----------ECLGKLVMVSIWCIQEDPSLRP--TMKKVLQMLEGVVEVSVPPNPYP 806
                         +  +       +Q D  +R   T+  ++Q    V + +    P  
Sbjct: 222 PIEPADIDRDIPFQISAVAA---RSVQGDGGIRSASTLLNLMQQATAVADRTEVLGPID 277

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 95.1 bits (237), Expect = 4e-21
 Identities = 54/218 (24%), Positives = 92/218 (42%), Gaps = 42/218 (19%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE------REFKNEVFVIGQTHHK 578
             VG G++G V    I  R+    VA+KKL R FQ         RE      ++    H+
Sbjct: 30  THVGSGAYGSVCS-AIDKRSGEK-VAIKKLSRPFQSEIFAKRAYRELL----LLKHMQHE 83

Query: 579 NLVRLL------GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLL 632
           N++ LL             +  LV  F+    L   +         ++  + +Q+ +GL 
Sbjct: 84  NVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEE-KIQ-YLVYQMLKGLK 140

Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 692
           Y+H    A ++H D+KP N+ +++    +I DFGLA+    +   T         GYV  
Sbjct: 141 YIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLAR--HADAEMT---------GYVVT 186

Query: 693 EWFR-------NSKITAKVDVYSFGVLLLEIISCRKSF 723
            W+R              VD++S G ++ E+++ +  F
Sbjct: 187 RWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF 224

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 93.0 bits (232), Expect = 4e-21
 Identities = 64/194 (32%), Positives = 97/194 (50%), Gaps = 19/194 (9%)

Query: 528 GRGSFGIVYKGV-IQTRTSTTAVAVKKLDRV-FQDGEREFKNEVFVIGQTHHKNLVRLLG 585
           G G++G V   V   T  +   VAVK +D     D     K E+ +    +H+N+V+  G
Sbjct: 16  GEGAYGEVQLAVNRVTEEA---VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72

Query: 586 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA---F-QIARGLLYLHEDCRAQ 641
              EG  + L  E+ + G L    F  ++P+  +    A   F Q+  G++YLH      
Sbjct: 73  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIG 125

Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLN-QSKTIKTAIRGTKGYVAPEWFRNSKI 700
           I H DIKP+N+LLD+    +ISDFGLA +   N + + +     GT  YVAPE  +  + 
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLKRREF 184

Query: 701 T-AKVDVYSFGVLL 713
               VDV+S G++L
Sbjct: 185 HAEPVDVWSCGIVL 198

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 94.4 bits (235), Expect = 4e-21
 Identities = 65/284 (22%), Positives = 113/284 (39%), Gaps = 57/284 (20%)

Query: 525 EEVGRGSFGIVYKGV-IQTRTSTTAVAVKKLDR--VFQDGEREFKN------EVFVIGQT 575
             +G G+FG V+  V  +       V VK + +  V +D   E         E+ ++ + 
Sbjct: 30  SPLGSGAFGFVWTAVDKEKNKE---VVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV 86

Query: 576 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA---F-QIARGL 631
            H N++++L   +      LV E   +G     LF  +  +  L   +A   F Q+   +
Sbjct: 87  EHANIIKVLDIFENQGFFQLVMEKHGSG---LDLFAFIDRHPRLDEPLASYIFRQLVSAV 143

Query: 632 LYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVA 691
            YL       IIH DIK +NI++ + +T ++ DFG A  L   + K   T   GT  Y A
Sbjct: 144 GYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE--RGKLFYTFC-GTIEYCA 197

Query: 692 PEWFRNSK-ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA-FDCYR---NGK 746
           PE    +     +++++S GV L                 Y ++ +   F          
Sbjct: 198 PEVLMGNPYRGPELEMWSLGVTL-----------------YTLVFEENPFCELEETVEAA 240

Query: 747 LNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
           ++      KE M+ +  L          +Q  P  R T++K++ 
Sbjct: 241 IHPPYLVSKELMSLVSGL----------LQPVPERRTTLEKLVT 274

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 94.3 bits (235), Expect = 4e-21
 Identities = 66/286 (23%), Positives = 122/286 (42%), Gaps = 33/286 (11%)

Query: 528 GRGSFGIVYKGV-IQTRTSTTAVAVKKLDR--VFQDGEREFKNEVFVIGQTHHKNLVRLL 584
           G+G+F  V     I T      VA+K +D+  +     ++   EV ++   +H N+V+L 
Sbjct: 24  GKGNFAKVKLARHILTGRE---VAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 80

Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIH 644
              +  +   L+ E+ + G +  +L  + +       +   QI   + Y H+     I+H
Sbjct: 81  EVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR---IVH 137

Query: 645 CDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKIT-AK 703
            D+K +N+LLD     +I+DFG +   T+     +     G   Y APE F+  K    +
Sbjct: 138 RDLKAENLLLDADMNIKIADFGFSNEFTVGG--KLDAFC-GAPPYAAPELFQGKKYDGPE 194

Query: 704 VDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIEC 763
           VDV+S GV+L  ++S    FD   G+    L     +    GK  +      +  N ++ 
Sbjct: 195 VDVWSLGVILYTLVSGSLPFD---GQNLKEL----RERVLRGKYRIPFYMSTDCENLLK- 246

Query: 764 LGKLVMVSIWCIQEDPSLRPTMKKVLQ---MLEGVVEVSVPPNPYP 806
                      +  +P  R T++++++   +  G  E  + P   P
Sbjct: 247 ---------RFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEP 283

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 92.8 bits (231), Expect = 1e-20
 Identities = 64/194 (32%), Positives = 97/194 (50%), Gaps = 19/194 (9%)

Query: 528 GRGSFGIVYKGV-IQTRTSTTAVAVKKLDRV-FQDGEREFKNEVFVIGQTHHKNLVRLLG 585
           G G++G V   V   T  +   VAVK +D     D     K E+ +    +H+N+V+  G
Sbjct: 16  GEGAYGEVQLAVNRVTEEA---VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72

Query: 586 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA---F-QIARGLLYLHEDCRAQ 641
              EG  + L  E+ + G L    F  ++P+  +    A   F Q+  G++YLH      
Sbjct: 73  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIG 125

Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTL-NQSKTIKTAIRGTKGYVAPEWFRNSKI 700
           I H DIKP+N+LLD+    +ISDFGLA +    N+ + +     GT  YVAPE  +  + 
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLKRREF 184

Query: 701 T-AKVDVYSFGVLL 713
               VDV+S G++L
Sbjct: 185 HAEPVDVWSCGIVL 198

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 93.4 bits (232), Expect = 3e-20
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 39/217 (17%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE------REFKNEVFVIGQTHHK 578
           + +G G+ GIV             VA+KKL R FQ+        RE      ++   +HK
Sbjct: 68  KPIGSGAQGIVCA-AYDAVLDRN-VAIKKLSRPFQNQTHAKRAYRELV----LMKCVNHK 121

Query: 579 NLVRLL------GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLL 632
           N++ LL         +E Q+  LV E ++   L   +   L       + + +Q+  G+ 
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHER--MSYLLYQMLCGIK 178

Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 692
           +LH    A IIH D+KP NI++    T +I DFGLA+    +   T          YV  
Sbjct: 179 HLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT---------PYVVT 226

Query: 693 EWFR------NSKITAKVDVYSFGVLLLEIISCRKSF 723
            ++R             VD++S G ++ E++  +  F
Sbjct: 227 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF 263

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 92.5 bits (230), Expect = 4e-20
 Identities = 55/250 (22%), Positives = 99/250 (39%), Gaps = 71/250 (28%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKN-EVFVIGQTHHKNLVRL 583
           + +G GSFGIV +       S    A+KK   V QD    +KN E+ ++    H N+++L
Sbjct: 13  KTLGTGSFGIVCEVFD--IESGKRFALKK---VLQD--PRYKNRELDIMKVLDHVNIIKL 65

Query: 584 L-GFCDEGQNRL-------------------------------------LVYEFLNNGTL 605
           +  F   G                                         ++ E++ + TL
Sbjct: 66  VDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TL 124

Query: 606 ASFLFGNLKPNWNLRTN----IAFQIARGLLYLHEDCRAQIIHCDIKPQNILLD-DYYTA 660
              L   ++   ++  N      +Q+ R + ++H      I H DIKPQN+L++    T 
Sbjct: 125 HKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSKDNTL 181

Query: 661 RISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR-------NSKITAKVDVYSFGVLL 713
           ++ DFG AK L  ++             Y+   ++R        ++ T  +D++S G + 
Sbjct: 182 KLCDFGSAKKLIPSEPSV---------AYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232

Query: 714 LEIISCRKSF 723
            E+I  +  F
Sbjct: 233 GELILGKPLF 242

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 91.6 bits (228), Expect = 5e-20
 Identities = 53/227 (23%), Positives = 84/227 (37%), Gaps = 48/227 (21%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE--REFKNEVF---------VIG 573
             +  GS+G V  GV    +    VA+K++     DG       +            ++ 
Sbjct: 28  RFISSGSYGAVCAGV---DSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLN 84

Query: 574 QTHHKNLVRLL-----GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN-----I 623
             HH N++ L                LV E +      + L   +     + +       
Sbjct: 85  HFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-----TDLAQVIHDQRIVISPQHIQYF 139

Query: 624 AFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAI 683
            + I  GL  LHE   A ++H D+ P NILL D     I DF LA+  T + +KT     
Sbjct: 140 MYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKT----- 191

Query: 684 RGTKGYVAPEWFR-------NSKITAKVDVYSFGVLLLEIISCRKSF 723
                YV   W+R           T  VD++S G ++ E+ + +  F
Sbjct: 192 ----HYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALF 234

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 90.0 bits (224), Expect = 8e-20
 Identities = 51/206 (24%), Positives = 94/206 (45%), Gaps = 20/206 (9%)

Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLD--RVFQDGEREF-KNEVFVIGQTHHK 578
            F + +G GSF  V   + +   ++   A+K L+   + ++ +  +   E  V+ +  H 
Sbjct: 33  KFGKILGEGSFSTVV--LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90

Query: 579 NLVRLLG-FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIA-F---QIARGLL 632
             V+L   F D+   +L     +  NG L       ++   +       F   +I   L 
Sbjct: 91  FFVKLYFTFQDD--EKLYFGLSYAKNGEL----LKYIRKIGSFDETCTRFYTAEIVSALE 144

Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 692
           YLH      IIH D+KP+NILL++    +I+DFG AK+L+    +    +  GT  YV+P
Sbjct: 145 YLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 201

Query: 693 EWFRNSKITAKVDVYSFGVLLLEIIS 718
           E           D+++ G ++ ++++
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVA 227

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 90.5 bits (225), Expect = 2e-19
 Identities = 58/239 (24%), Positives = 104/239 (43%), Gaps = 64/239 (26%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE------REFKNEVFVIGQTH 576
             +++G+G++GIV+K  I  RT    VAVKK+   FQ+        RE      +   + 
Sbjct: 13  LVKKLGKGAYGIVWK-SIDRRTGEV-VAVKKIFDAFQNSTDAQRTFREIM---ILTELSG 67

Query: 577 HKNLVRLLG-FCDEGQNRL-LVYEF----LNNGTLASFLFGNLKPNWNLRTN-------- 622
           H+N+V LL     +    + LV+++    L+                 +R N        
Sbjct: 68  HENIVNLLNVLRADNDRDVYLVFDYMETDLHA---------------VIRANILEPVHKQ 112

Query: 623 -IAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKT 681
            + +Q+ + + YLH      ++H D+KP NILL+     +++DFGL++     +  T   
Sbjct: 113 YVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNI 169

Query: 682 AIRGTK-------------GYVAPEWFR-------NSKITAKVDVYSFGVLLLEIISCR 720
            +   +              YVA  W+R       ++K T  +D++S G +L EI+  +
Sbjct: 170 PLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 90.0 bits (224), Expect = 2e-19
 Identities = 48/234 (20%), Positives = 94/234 (40%), Gaps = 58/234 (24%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE------REFKNEVFVIGQTH 576
            K  +G G++G+V        T    VA+KK+   F          RE K    ++    
Sbjct: 15  LKSLLGEGAYGVVCS-ATHKPTGEI-VAIKKI-EPFDKPLFALRTLREIK----ILKHFK 67

Query: 577 HKNLVRLL-----GFCDEGQNRLLVYEF-------------LNNGTLASFLFGNLKPNWN 618
           H+N++ +         +      ++ E              L++  +  F++        
Sbjct: 68  HENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIY-------- 119

Query: 619 LRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT 678
                  Q  R +  LH    + +IH D+KP N+L++     ++ DFGLA+++  + +  
Sbjct: 120 -------QTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADN 169

Query: 679 IKTAIRGTK--GYVAPEWFR-------NSKITAKVDVYSFGVLLLEIISCRKSF 723
            +   + +    +VA  W+R       ++K +  +DV+S G +L E+   R  F
Sbjct: 170 SEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIF 223

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 90.6 bits (225), Expect = 3e-19
 Identities = 54/235 (22%), Positives = 95/235 (40%), Gaps = 50/235 (21%)

Query: 524 KEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE------REFKNEVFVIGQTHH 577
           K  +GRGS+G VY       T    VA+KK++R+F+D        RE      ++ +   
Sbjct: 31  KHLIGRGSYGYVYL-AYDKNTEKN-VAIKKVNRMFEDLIDCKRILREIT----ILNRLKS 84

Query: 578 KNLVRLLG-FCDEGQNRL----LVYEFLNNGTLASFLFGNLKPNWNLRTN----IAFQIA 628
             ++RL      +   +     +V E  +     S L    K    L       I + + 
Sbjct: 85  DYIIRLYDLIIPDDLLKFDELYIVLEIAD-----SDLKKLFKTPIFLTEEHIKTILYNLL 139

Query: 629 RGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK- 687
            G  ++HE   + IIH D+KP N LL+   + ++ DFGLA+ +   +   I   +   + 
Sbjct: 140 LGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEE 196

Query: 688 -------------GYVAPEWFR-------NSKITAKVDVYSFGVLLLEIISCRKS 722
                         +V   W+R           T  +D++S G +  E+++  +S
Sbjct: 197 PGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 89.3 bits (222), Expect = 3e-19
 Identities = 59/231 (25%), Positives = 95/231 (41%), Gaps = 67/231 (29%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE------REFKNEVFVIGQTHHK 578
           + VG G++G V    +  RT    VA+KKL R FQ         RE +    ++    H+
Sbjct: 31  QPVGSGAYGAVCS-AVDGRTGAK-VAIKKLYRPFQSELFAKRAYRELR----LLKHMRHE 84

Query: 579 NLVRLL------GFCDEGQNRLLVYEF-------------LNNGTLASFLFGNLKPNWNL 619
           N++ LL         D+  +  LV  F             L    +   ++         
Sbjct: 85  NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVY--------- 135

Query: 620 RTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI 679
                 Q+ +GL Y+H    A IIH D+KP N+ +++    +I DFGLA+    +   T 
Sbjct: 136 ------QMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR--QADSEMT- 183

Query: 680 KTAIRGTKGYVAPEWFR-------NSKITAKVDVYSFGVLLLEIISCRKSF 723
                   GYV   W+R         + T  VD++S G ++ E+I+ +  F
Sbjct: 184 --------GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF 226

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 88.5 bits (220), Expect = 4e-19
 Identities = 51/206 (24%), Positives = 97/206 (47%), Gaps = 23/206 (11%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG-EREFKNEVFVIGQ--THHKNLV 581
            ++GRG +  V++ +    T+   V VK L  V +   +RE K     I +      N++
Sbjct: 42  RKLGRGKYSEVFEAI--NITNNEKVVVKILKPVKKKKIKREIK-----ILENLRGGPNII 94

Query: 582 RLLG-FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCR 639
            L     D       LV+E +NN      L+  L    ++R  + ++I + L Y H    
Sbjct: 95  TLADIVKDPVSRTPALVFEHVNNTDFKQ-LYQTLTDY-DIRFYM-YEILKALDYCH---S 148

Query: 640 AQIIHCDIKPQNILLD-DYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNS 698
             I+H D+KP N+++D ++   R+ D+GLA+     Q   ++ A   ++ +  PE   + 
Sbjct: 149 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA---SRYFKGPELLVDY 205

Query: 699 KI-TAKVDVYSFGVLLLEIISCRKSF 723
           ++    +D++S G +L  +I  ++ F
Sbjct: 206 QMYDYSLDMWSLGCMLASMIFRKEPF 231

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 89.9 bits (223), Expect = 5e-19
 Identities = 52/237 (21%), Positives = 101/237 (42%), Gaps = 49/237 (20%)

Query: 524 KEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ---DGEREFKNEVFVIGQTHHKNL 580
           +  +G GS+G V +           VA+KK+ RVF+   D +R  + E+ ++ + +H ++
Sbjct: 58  RHLIGTGSYGHVCE-AYDKLEKRV-VAIKKILRVFEDLIDCKRILR-EIAILNRLNHDHV 114

Query: 581 VRLLGFC----DEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTN----IAFQIARGL 631
           V++L        E  + L +V E  +     S      +    L       + + +  G+
Sbjct: 115 VKVLDIVIPKDVEKFDELYVVLEIAD-----SDFKKLFRTPVYLTELHIKTLLYNLLVGV 169

Query: 632 LYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK---- 687
            Y+H    A I+H D+KP N L++   + ++ DFGLA+ +   ++   +  I   +    
Sbjct: 170 KYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMN 226

Query: 688 ---------------GYVAPEWFR------NSKI-TAKVDVYSFGVLLLEIISCRKS 722
                          G+V   W+R        +  T  +DV+S G +  E+++  K 
Sbjct: 227 LVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 87.6 bits (218), Expect = 6e-19
 Identities = 45/157 (28%), Positives = 79/157 (50%), Gaps = 21/157 (13%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE-------REFKNEVFVIGQTHH 577
            ++G GS+G+V+K   + R +   VA+KK     +D         RE +    ++ Q  H
Sbjct: 9   GKIGEGSYGVVFKC--RNRDTGQIVAIKKF-LESEDDPVIKKIALREIR----MLKQLKH 61

Query: 578 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLH 635
            NLV LL      +   LV+E+ ++ T+   L  +    P   ++ +I +Q  + + + H
Sbjct: 62  PNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVK-SITWQTLQAVNFCH 119

Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLT 672
              +   IH D+KP+NIL+  +   ++ DFG A+LLT
Sbjct: 120 ---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLT 153

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 90.7 bits (225), Expect = 7e-19
 Identities = 52/203 (25%), Positives = 88/203 (43%), Gaps = 26/203 (12%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKL--DRVFQ-DGEREFKNE--VFV-IGQTHHKNL 580
           +GRG FG VY    +   +    A+K L   R+    GE    NE  +   +       +
Sbjct: 197 IGRGGFGEVY--GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254

Query: 581 VRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIA-F---QIARGLLYLH 635
           V +  +     ++L  + + +N G L      +L  +         F   +I  GL ++H
Sbjct: 255 VCM-SYAFHTPDKLSFILDLMNGGDL----HYHLSQHGVFSEADMRFYAAEIILGLEHMH 309

Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE-W 694
                 +++ D+KP NILLD++   RISD GLA   +  +         GT GY+APE  
Sbjct: 310 NR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPEVL 362

Query: 695 FRNSKITAKVDVYSFGVLLLEII 717
            +     +  D +S G +L +++
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLL 385

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 86.2 bits (214), Expect = 1e-18
 Identities = 59/226 (26%), Positives = 99/226 (43%), Gaps = 49/226 (21%)

Query: 524 KEEVGRGSFGIVYKGV-IQTRTSTTAVAVK-----KLDRVFQDGEREF------------ 565
           K+E+G+GS+G+V         T     A+K     KL R      R              
Sbjct: 18  KDEIGKGSYGVVKLAYNENDNTY---YAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74

Query: 566 ---------KNEVFVIGQTHHKNLVRLLG-FCDEGQNRL-LVYEFLNNGTLASFLFGNLK 614
                      E+ ++ +  H N+V+L+    D  ++ L +V+E +N G +       LK
Sbjct: 75  QPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV--MEVPTLK 132

Query: 615 PNWNLRTNIA---F-QIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKL 670
           P   L  + A   F  + +G+ YLH     +IIH DIKP N+L+ +    +I+DFG++  
Sbjct: 133 P---LSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNE 186

Query: 671 LTLNQSKTIKTAIRGTKGYVAPEWFRNSKIT---AKVDVYSFGVLL 713
              + +    T   GT  ++APE    ++       +DV++ GV L
Sbjct: 187 FKGSDALLSNTV--GTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 86.6 bits (215), Expect = 2e-18
 Identities = 60/219 (27%), Positives = 96/219 (43%), Gaps = 43/219 (19%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE------REFKNEVFVIGQTHHK 578
             VG G++G V         +   VAVKKL R FQ         RE +    ++    H+
Sbjct: 35  SPVGSGAYGSVCAAFD--TKTGLRVAVKKLSRPFQSIIHAKRTYRELR----LLKHMKHE 88

Query: 579 NLVRLL------GFCDEGQNRLLVYEFLNNGT-LASFLFGNLKPNWNLRTNIAFQIARGL 631
           N++ LL         +E  +  LV   +  G  L + +      + +++  + +QI RGL
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQ-FLIYQILRGL 145

Query: 632 LYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVA 691
            Y+H    A IIH D+KP N+ +++    +I DFGLA+        T         GYVA
Sbjct: 146 KYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTADEMT---------GYVA 191

Query: 692 PEWFR-------NSKITAKVDVYSFGVLLLEIISCRKSF 723
             W+R              VD++S G ++ E+++ R  F
Sbjct: 192 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 230

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 86.6 bits (215), Expect = 3e-18
 Identities = 55/205 (26%), Positives = 85/205 (41%), Gaps = 22/205 (10%)

Query: 528 GRGSFGIVYKGV-IQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGF 586
           G G+FG+        T+     VAVK ++R     E   + E+       H N+VR    
Sbjct: 29  GSGNFGVARLMRDKLTKEL---VAVKYIERGAAIDEN-VQREIINHRSLRHPNIVRFKEV 84

Query: 587 CDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA---F-QIARGLLYLHEDCRAQI 642
                +  ++ E+ + G L    +  +        + A   F Q+  G+ Y H     QI
Sbjct: 85  ILTPTHLAIIMEYASGGEL----YERICNAGRFSEDEARFFFQQLLSGVSYCH---SMQI 137

Query: 643 IHCDIKPQNILLDDYYTAR--ISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            H D+K +N LLD     R  I DFG +K   L+     K+ + GT  Y+APE     + 
Sbjct: 138 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTV-GTPAYIAPEVLLRQEY 194

Query: 701 T-AKVDVYSFGVLLLEIISCRKSFD 724
                DV+S GV L  ++     F+
Sbjct: 195 DGKIADVWSCGVTLYVMLVGAYPFE 219

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 85.0 bits (211), Expect = 3e-18
 Identities = 56/195 (28%), Positives = 95/195 (48%), Gaps = 22/195 (11%)

Query: 528 GRGSFGIVYKGV-IQTRTSTTAVAVKKLDR---VFQDGEREFKNEVFVIGQTHHKNLVRL 583
           G G+FG V  G    T      VAVK L+R      D   + K E+  +    H ++++L
Sbjct: 20  GVGTFGKVKIGEHQLTGHK---VAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76

Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA---F-QIARGLLYLHEDCR 639
                   +  +V E+++ G L    F  +  +  +    A   F QI   + Y H   R
Sbjct: 77  YQVISTPTDFFMVMEYVSGGEL----FDYICKHGRVEEMEARRLFQQILSAVDYCH---R 129

Query: 640 AQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSK 699
             ++H D+KP+N+LLD +  A+I+DFGL+ +++    + ++T+  G+  Y APE      
Sbjct: 130 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS--DGEFLRTSC-GSPNYAAPEVISGRL 186

Query: 700 IT-AKVDVYSFGVLL 713
               +VD++S GV+L
Sbjct: 187 YAGPEVDIWSCGVIL 201

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 85.7 bits (213), Expect = 3e-18
 Identities = 51/157 (32%), Positives = 77/157 (49%), Gaps = 21/157 (13%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE-------REFKNEVFVIGQTHH 577
             VG GS+G+V K   + + +   VA+KK      D +       RE K    ++ Q  H
Sbjct: 31  GLVGEGSYGMVMKC--RNKDTGRIVAIKKF-LESDDDKMVKKIAMREIK----LLKQLRH 83

Query: 578 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLH 635
           +NLV LL  C + +   LV+EF+++ T+   L  F N      ++    FQI  G+ + H
Sbjct: 84  ENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQ-KYLFQIINGIGFCH 141

Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLT 672
                 IIH DIKP+NIL+      ++ DFG A+ L 
Sbjct: 142 ---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLA 175

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 84.6 bits (210), Expect = 7e-18
 Identities = 42/157 (26%), Positives = 76/157 (48%), Gaps = 23/157 (14%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE-------REFKNEVFVIGQTHH 577
            ++G G++G VYK  I T T+ T VA+K++ R+  + E       RE      ++ +  H
Sbjct: 40  TKLGEGTYGEVYKA-IDTVTNET-VAIKRI-RLEHEEEGVPGTAIREVS----LLKELQH 92

Query: 578 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHED 637
           +N++ L           L++E+  N  L  ++  N   +  +  +  +Q+  G+ + H  
Sbjct: 93  RNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCH-- 149

Query: 638 CRAQIIHCDIKPQNILLDDYYTAR-----ISDFGLAK 669
              + +H D+KPQN+LL     +      I DFGLA+
Sbjct: 150 -SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 83.7 bits (208), Expect = 9e-18
 Identities = 51/206 (24%), Positives = 99/206 (48%), Gaps = 22/206 (10%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE-------REFKNEVFVIGQTHH 577
           E++G G++G V+K      T    VA+K++ R+  D E       RE      ++ +  H
Sbjct: 8   EKIGEGTYGTVFKA-KNRETHEI-VALKRV-RLDDDDEGVPSSALREIC----LLKELKH 60

Query: 578 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-NWNLRTNIAFQIARGLLYLHE 636
           KN+VRL       +   LV+EF +   L  +        +  +  +  FQ+ +GL + H 
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119

Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR 696
                ++H D+KPQN+L++     ++++FGLA+   +   +   +A   T  Y  P+   
Sbjct: 120 R---NVLHRDLKPQNLLINRNGELKLANFGLARAFGI-PVRCY-SAEVVTLWYRPPDVLF 174

Query: 697 NSKI-TAKVDVYSFGVLLLEIISCRK 721
            +K+ +  +D++S G +  E+ +  +
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGR 200

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 85.5 bits (212), Expect = 1e-17
 Identities = 55/202 (27%), Positives = 88/202 (43%), Gaps = 21/202 (10%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKL--DRVFQDGERE-FKNEVFVIGQTHHKNLVRL 583
           +GRG+F  V   V++ + +    A+K +    + + GE   F+ E  V+     + + +L
Sbjct: 69  IGRGAFSEVA--VVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL 126

Query: 584 LGFCDEGQNRL-LVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
             F  + +N L LV E+   G L + L  FG   P    R  +A +I   +  +H     
Sbjct: 127 H-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLA-EIVMAIDSVHR---L 181

Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
             +H DIKP NILLD     R++DFG    L  + +     A+ GT  Y++PE  +    
Sbjct: 182 GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQAVGG 240

Query: 701 TAKVDVY-------SFGVLLLE 715
                 Y       + GV   E
Sbjct: 241 GPGTGSYGPECDWWALGVFAYE 262

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 85.2 bits (211), Expect = 1e-17
 Identities = 55/201 (27%), Positives = 91/201 (45%), Gaps = 21/201 (10%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKL--DRVFQDGERE-FKNEVFVIGQTHHKNLVRL 583
           +GRG+FG V   V++ + +    A+K L    + +  E   F+ E  V+     K +  L
Sbjct: 82  IGRGAFGEVA--VVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL 139

Query: 584 LG-FCDEGQNRL-LVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLHEDCR 639
              F D+  N L LV ++   G L + L  F +  P    R  +A ++   +  +H+   
Sbjct: 140 HYAFQDD--NNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLA-EMVIAIDSVHQ--- 193

Query: 640 AQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSK 699
              +H DIKP NIL+D     R++DFG    L  + +     A+ GT  Y++PE  +  +
Sbjct: 194 LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQAME 252

Query: 700 ITAK-----VDVYSFGVLLLE 715
                     D +S GV + E
Sbjct: 253 GGKGRYGPECDWWSLGVCMYE 273

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 84.3 bits (209), Expect = 2e-17
 Identities = 63/222 (28%), Positives = 101/222 (45%), Gaps = 38/222 (17%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKL--DRVFQDGEREF-KNEVFVIGQTHHKNLVRL 583
           +G+GSFG V   ++Q   +    A+K +   +  +  E      E+ ++    H  LV L
Sbjct: 23  IGKGSFGKVC--IVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80

Query: 584 LG-FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIAF----------QIARGL 631
              F DE    + +V + L  G L           ++L+ N+ F          ++   L
Sbjct: 81  WYSFQDEE--DMFMVVDLLLGGDL----R------YHLQQNVHFKEETVKLFICELVMAL 128

Query: 632 LYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVA 691
            YL      +IIH D+KP NILLD++    I+DF +A +L     +T  T + GTK Y+A
Sbjct: 129 DYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLP---RETQITTMAGTKPYMA 182

Query: 692 PEWFRNSKI---TAKVDVYSFGVLLLEIISCRKSFDIEMGEE 730
           PE F + K    +  VD +S GV   E++  R+ + I     
Sbjct: 183 PEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS 224

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 83.0 bits (206), Expect = 2e-17
 Identities = 46/154 (29%), Positives = 80/154 (51%), Gaps = 20/154 (12%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE-------REFKNEVFVIGQTHH 577
           E++G G++G+VYK      T    VA+KK+ R+  + E       RE      ++ + +H
Sbjct: 9   EKIGEGTYGVVYKA-RNKLTGEV-VALKKI-RLDTETEGVPSTAIREIS----LLKELNH 61

Query: 578 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLH 635
            N+V+LL          LV+EFL+   L  F+  +      L    +  FQ+ +GL + H
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120

Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAK 669
                +++H D+KPQN+L++     +++DFGLA+
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 83.4 bits (207), Expect = 2e-17
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 24/208 (11%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE-------REFKNEVFVIGQTHH 577
            E+G G++G V+K     +     VA+K++ RV    E       RE    +  +    H
Sbjct: 17  AEIGEGAYGKVFKA-RDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVA-VLRHLETFEH 73

Query: 578 KNLVRLL----GFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARG 630
            N+VRL         + + +L LV+E ++   L ++L    +P     T  ++ FQ+ RG
Sbjct: 74  PNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRG 132

Query: 631 LLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYV 690
           L +LH      ++H D+KPQNIL+      +++DFGLA++ +   + T       T  Y 
Sbjct: 133 LDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV---TLWYR 186

Query: 691 APEWFRNSKITAKVDVYSFGVLLLEIIS 718
           APE    S     VD++S G +  E+  
Sbjct: 187 APEVLLQSSYATPVDLWSVGCIFAEMFR 214

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 84.4 bits (209), Expect = 2e-17
 Identities = 50/198 (25%), Positives = 88/198 (44%), Gaps = 18/198 (9%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKL--DRVFQDGERE-FKNEVFVIGQTHHKNLVRL 583
           +GRG+FG V   +++ +++    A+K L    + +  +   F  E  ++   +   +V+L
Sbjct: 77  IGRGAFGEVQ--LVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 134

Query: 584 LG-FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ 641
              F D+    L +V E++  G L + +     P    R   A ++   L  +H      
Sbjct: 135 FYAFQDD--RYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTA-EVVLALDAIHS---MG 188

Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKIT 701
            IH D+KP N+LLD     +++DFG    +         TA+ GT  Y++PE  ++    
Sbjct: 189 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGD 247

Query: 702 AK----VDVYSFGVLLLE 715
                  D +S GV L E
Sbjct: 248 GYYGRECDWWSVGVFLYE 265

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 83.1 bits (206), Expect = 2e-17
 Identities = 52/233 (22%), Positives = 98/233 (42%), Gaps = 58/233 (24%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE------REFKNEVFVIGQTHHK 578
           + +G G  G+V+   +        VA+KK+  V  D +      RE K    +I +  H 
Sbjct: 17  KPLGCGGNGLVFS-AVDNDCDKR-VAIKKI--VLTDPQSVKHALREIK----IIRRLDHD 68

Query: 579 NLVRLL--------------GFCDEGQNRLLVYEFLNNGT-LASFLFGNLKPNWNLRTN- 622
           N+V++               G   E  +  +V E++   T LA+ L         L    
Sbjct: 69  NIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM--ETDLANVLEQG-----PLLEEH 121

Query: 623 ---IAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDY-YTARISDFGLAKLLTLNQSKT 678
                +Q+ RGL Y+H    A ++H D+KP N+ ++      +I DFGLA+++  + S  
Sbjct: 122 ARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHK 178

Query: 679 IK-TAIRGTKGYVAPEWFR-------NSKITAKVDVYSFGVLLLEIISCRKSF 723
              +        +  +W+R        +  T  +D+++ G +  E+++ +  F
Sbjct: 179 GHLS------EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLF 225

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 83.1 bits (206), Expect = 3e-17
 Identities = 56/219 (25%), Positives = 98/219 (44%), Gaps = 39/219 (17%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE------REFKNEVFVIGQTHHK 578
             +G G++G+V             VA+KK+   F+         RE K    ++ +  H+
Sbjct: 33  SYIGEGAYGMVCS-AYDNLNKVR-VAIKKIS-PFEHQTYCQRTLREIK----ILLRFRHE 85

Query: 579 NLVRLL-----GFCDEGQNRLLVYEFLNNGT-LASFLFGNLKPNWNLRTNIAFQIARGLL 632
           N++ +         ++ ++  +V + +   T L   L      N ++     +QI RGL 
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLM--ETDLYKLLKTQHLSNDHICY-FLYQILRGLK 142

Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIK-TAIRGTKGYVA 691
           Y+H    A ++H D+KP N+LL+     +I DFGLA++   +   T   T       YVA
Sbjct: 143 YIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT------EYVA 193

Query: 692 PEWFR-------NSKITAKVDVYSFGVLLLEIISCRKSF 723
             W+R       +   T  +D++S G +L E++S R  F
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 84.1 bits (208), Expect = 4e-17
 Identities = 57/195 (29%), Positives = 96/195 (49%), Gaps = 22/195 (11%)

Query: 528 GRGSFGIVYKGV-IQTRTSTTAVAVKKLDR---VFQDGEREFKNEVFVIGQTHHKNLVRL 583
           G G+FG V  G    T      VAVK L+R      D   + + E+  +    H ++++L
Sbjct: 25  GVGTFGKVKVGKHELTGHK---VAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81

Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA---F-QIARGLLYLHEDCR 639
                   +  +V E+++ G L    F  +  N  L    +   F QI  G+ Y H   R
Sbjct: 82  YQVISTPSDIFMVMEYVSGGEL----FDYICKNGRLDEKESRRLFQQILSGVDYCH---R 134

Query: 640 AQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSK 699
             ++H D+KP+N+LLD +  A+I+DFGL+ +++    + ++T+  G+  Y APE      
Sbjct: 135 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS--DGEFLRTSC-GSPNYAAPEVISGRL 191

Query: 700 IT-AKVDVYSFGVLL 713
               +VD++S GV+L
Sbjct: 192 YAGPEVDIWSSGVIL 206

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 82.4 bits (204), Expect = 6e-17
 Identities = 53/222 (23%), Positives = 94/222 (42%), Gaps = 32/222 (14%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVK---KLDRVFQDGEREFK-----NEVFVIGQTH 576
            ++G G F  V+    +   + T VA+K         +  E E K     N+     +  
Sbjct: 25  RKLGWGHFSTVWLA--KDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDS 82

Query: 577 --HKNLVRLLG-FCDEGQNRL---LVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIA 628
               ++++LL  F  +G N +   +V+E L    L + +         L     I+ Q+ 
Sbjct: 83  MGANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRGIPLIYVKQISKQLL 141

Query: 629 RGLLYLHEDCRAQIIHCDIKPQNILLDD------YYTARISDFGLAKLLTLNQSKTIKTA 682
            GL Y+H  C   IIH DIKP+N+L++           +I+D G A     + + +I+  
Sbjct: 142 LGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ-- 197

Query: 683 IRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFD 724
              T+ Y +PE    +      D++S   L+ E+I+    F+
Sbjct: 198 ---TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 236

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 81.1 bits (201), Expect = 8e-17
 Identities = 45/165 (27%), Positives = 85/165 (51%), Gaps = 26/165 (15%)

Query: 517 EGATNNFK--EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE-------REFKN 567
           +G    ++  E+VG G++G+VYK   +       VA+K++ R+  + E       RE   
Sbjct: 17  QGLMEKYQKLEKVGEGTYGVVYKA--KDSQGRI-VALKRI-RLDAEDEGIPSTAIREIS- 71

Query: 568 EVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL---FGNLKPNWNLRTNIA 624
              ++ + HH N+V L+      +   LV+EF+    L   L      L+ +  ++    
Sbjct: 72  ---LLKELHHPNIVSLIDVIHSERCLTLVFEFMEKD-LKKVLDENKTGLQDS-QIKI-YL 125

Query: 625 FQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAK 669
           +Q+ RG+ + H   + +I+H D+KPQN+L++     +++DFGLA+
Sbjct: 126 YQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLAR 167

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 82.5 bits (204), Expect = 8e-17
 Identities = 47/215 (21%), Positives = 92/215 (42%), Gaps = 25/215 (11%)

Query: 524 KEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG-EREFKNEVFVIGQTHHKNLVR 582
             +VGRG++G VYK   +        A+K+++     G       E+ ++ +  H N++ 
Sbjct: 26  GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEG---TGISMSACREIALLRELKHPNVIS 82

Query: 583 LLG-FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTN---------IAFQIARGL 631
           L   F      ++ L++++  +  L   +  +     N +           + +QI  G+
Sbjct: 83  LQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 141

Query: 632 LYLHEDCRAQIIHCDIKPQNILLDDYYTAR----ISDFGLAKLLTL-NQSKTIKTAIRGT 686
            YLH      ++H D+KP NIL+      R    I+D G A+L     +       +  T
Sbjct: 142 HYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 198

Query: 687 KGYVAPEWFRNSKI-TAKVDVYSFGVLLLEIISCR 720
             Y APE    ++  T  +D+++ G +  E+++  
Sbjct: 199 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 81.1 bits (201), Expect = 9e-17
 Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 30/212 (14%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFV-----------IG 573
            E+G G++G VYK   +   S   VA+K + RV           + +           + 
Sbjct: 15  AEIGVGAYGTVYKA--RDPHSGHFVALKSV-RV--PNGGGGGGGLPISTVREVALLRRLE 69

Query: 574 QTHHKNLVRLL----GFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQ 626
              H N+VRL+        + + ++ LV+E ++   L ++L     P     T  ++  Q
Sbjct: 70  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQ 128

Query: 627 IARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGT 686
             RGL +LH +    I+H D+KP+NIL+    T +++DFGLA++ +   + T       T
Sbjct: 129 FLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVV---T 182

Query: 687 KGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS 718
             Y APE    S     VD++S G +  E+  
Sbjct: 183 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR 214

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 80.6 bits (200), Expect = 9e-17
 Identities = 44/154 (28%), Positives = 78/154 (50%), Gaps = 22/154 (14%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE-------REFKNEVFVIGQTHH 577
           E++G G++G+VYK   Q     T  A+KK+ R+ ++ E       RE      ++ +  H
Sbjct: 8   EKIGEGTYGVVYKA--QNNYGET-FALKKI-RLEKEDEGIPSTTIREIS----ILKELKH 59

Query: 578 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLH 635
            N+V+L       +  +LV+E L+   L   L    +      T  +   Q+  G+ Y H
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQD-LKKLL-DVCEGGLESVTAKSFLLQLLNGIAYCH 117

Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAK 669
           +    +++H D+KPQN+L++     +I+DFGLA+
Sbjct: 118 DR---RVLHRDLKPQNLLINREGELKIADFGLAR 148

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 81.2 bits (201), Expect = 1e-16
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 21/205 (10%)

Query: 528 GRGSFGIVYKGV-IQTRTSTTAVAVKKLDR---VFQDGEREFKNEVFVIGQTHHKNLVRL 583
           G GSFG V      +T+     VA+K + R      D     + E+  +    H ++++L
Sbjct: 18  GEGSFGKVKLATHYKTQQK---VALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74

Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLF--GNLKPNWNLRTNIAF-QIARGLLYLHEDCRA 640
                   + ++V E+   G L  ++     +  +   R    F QI   + Y H   R 
Sbjct: 75  YDVITTPTDIVMVIEYAG-GELFDYIVEKKRMTEDEGRRF---FQQIICAIEYCH---RH 127

Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
           +I+H D+KP+N+LLDD    +I+DFGL+ ++T      +KT+  G+  Y APE       
Sbjct: 128 KIVHRDLKPENLLLDDNLNVKIADFGLSNIMT--DGNFLKTSC-GSPNYAAPEVINGKLY 184

Query: 701 T-AKVDVYSFGVLLLEIISCRKSFD 724
              +VDV+S G++L  ++  R  FD
Sbjct: 185 AGPEVDVWSCGIVLYVMLVGRLPFD 209

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 81.7 bits (202), Expect = 2e-16
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 31/212 (14%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKL--DRVFQDGEREF-KNEVFVIGQTHHKNLVRL 583
           +G+G+FG V   +++ + +    A+K L  + +    E      E  V+  + H  L  L
Sbjct: 156 LGKGTFGKVI--LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 213

Query: 584 LGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIAF----------QIARGLL 632
             +  +  +RL  V E+ N G L    F      ++L     F          +I   L 
Sbjct: 214 K-YSFQTHDRLCFVMEYANGGEL----F------FHLSRERVFSEDRARFYGAEIVSALD 262

Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 692
           YLH +    +++ D+K +N++LD     +I+DFGL K   +    T+KT   GT  Y+AP
Sbjct: 263 YLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKT-FCGTPEYLAP 318

Query: 693 EWFRNSKITAKVDVYSFGVLLLEIISCRKSFD 724
           E   ++     VD +  GV++ E++  R  F 
Sbjct: 319 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 350

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 79.9 bits (198), Expect = 2e-16
 Identities = 45/154 (29%), Positives = 76/154 (49%), Gaps = 19/154 (12%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE-----REFKNEVFVIGQTHHKN 579
           E++G G++  VYKG +   T    VA+K++    ++G      RE      ++ +  H+N
Sbjct: 11  EKLGNGTYATVYKG-LNKTTGVY-VALKEVKLDSEEGTPSTAIREIS----LMKELKHEN 64

Query: 580 LVRLLGFCDEGQNRLLVYEFLNN---GTLASFLFGNLKPNWNLRT--NIAFQIARGLLYL 634
           +VRL           LV+EF++N     + S   GN      L       +Q+ +GL + 
Sbjct: 65  IVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124

Query: 635 HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLA 668
           H     +I+H D+KPQN+L++     ++ DFGLA
Sbjct: 125 H---ENKILHRDLKPQNLLINKRGQLKLGDFGLA 155

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 80.4 bits (198), Expect = 3e-16
 Identities = 47/183 (25%), Positives = 82/183 (44%), Gaps = 25/183 (13%)

Query: 622 NIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKT 681
             +FQ+A+G+ +L      + IH D+  +NILL +    +I DFGLA+ +  +     K 
Sbjct: 197 CYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 253

Query: 682 AIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAF 739
             R    ++APE   +   T + DV+SFGVLL EI S   S    +++ EE         
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCRRLK 310

Query: 740 DCYRNGKLNVLVGEDKEAMNDIECLGKL--VMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 797
           +  R    +                 ++   M+  W    +PS RPT  ++++ L  +++
Sbjct: 311 EGTRMRAPD-------------YTTPEMYQTMLDCW--HGEPSQRPTFSELVEHLGNLLQ 355

Query: 798 VSV 800
            + 
Sbjct: 356 ANA 358

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 58.0 bits (140), Expect = 4e-09
 Identities = 36/153 (23%), Positives = 60/153 (39%), Gaps = 13/153 (8%)

Query: 523 FKEEVGRGSFGIVYKGV---IQTRTSTTAVAVKKLDRVFQDGER-EFKNEVFVIGQ-THH 577
             + +GRG+FG V +     I    +   VAVK L       E     +E+ ++    HH
Sbjct: 26  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 85

Query: 578 KNLVRLLGFC-DEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHE 636
            N+V LLG C   G   +++ EF   G L+++L        + R        +G  +   
Sbjct: 86  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-------RSKRNEFVPYKTKGARFRQG 138

Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAK 669
                 I  D+K +   +    ++  S F   K
Sbjct: 139 KDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 78.8 bits (195), Expect = 5e-16
 Identities = 43/153 (28%), Positives = 83/153 (54%), Gaps = 20/153 (13%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE-----REFKNEVFVIGQTHHKN 579
           +++G G++  VYKG  +++ +   VA+K++    ++G      RE      ++    H N
Sbjct: 8   DKLGEGTYATVYKG--KSKLTDNLVALKEIRLEHEEGAPCTAIREVS----LLKDLKHAN 61

Query: 580 LVRLLGFCDEGQNRLLVYEFLNNGTLASFL---FGNLKPNWNLRTNIAFQIARGLLYLHE 636
           +V L       ++  LV+E+L+   L  +L      +  + N++    FQ+ RGL Y H 
Sbjct: 62  IVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMH-NVKL-FLFQLLRGLAYCH- 117

Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAK 669
             R +++H D+KPQN+L+++    +++DFGLA+
Sbjct: 118 --RQKVLHRDLKPQNLLINERGELKLADFGLAR 148

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 78.8 bits (195), Expect = 7e-16
 Identities = 45/156 (28%), Positives = 76/156 (48%), Gaps = 22/156 (14%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKN--------EVFVIGQTH 576
           + +G G F  VYK      T+   VA+KK+ ++      E K+        E+ ++ +  
Sbjct: 16  DFLGEGQFATVYKA-RDKNTNQI-VAIKKI-KL--GHRSEAKDGINRTALREIKLLQELS 70

Query: 577 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL---FGNLKPNWNLRTNIAFQIARGLLY 633
           H N++ LL       N  LV++F+    L   +      L P+ +++        +GL Y
Sbjct: 71  HPNIIGLLDAFGHKSNISLVFDFMETD-LEVIIKDNSLVLTPS-HIKA-YMLMTLQGLEY 127

Query: 634 LHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAK 669
           LH+     I+H D+KP N+LLD+    +++DFGLAK
Sbjct: 128 LHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 78.4 bits (194), Expect = 8e-16
 Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 30/203 (14%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAV-AVKKL--DRVFQDGEREFKNEVFVIGQTHHKNLVRL 583
           +G+GSFG V+     + +    + A+K L    +        K E  ++ + +H  +V+L
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91

Query: 584 LGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIAF----------QIARGLL 632
             +  + + +L L+ +FL  G L    F        L   + F          ++A  L 
Sbjct: 92  H-YAFQTEGKLYLILDFLRGGDL----F------TRLSKEVMFTEEDVKFYLAELALALD 140

Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 692
           +LH      II+ D+KP+NILLD+    +++DFGL+K  +++  K   +   GT  Y+AP
Sbjct: 141 HLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKKAYS-FCGTVEYMAP 195

Query: 693 EWFRNSKITAKVDVYSFGVLLLE 715
           E       T   D +SFGVL+ E
Sbjct: 196 EVVNRRGHTQSADWWSFGVLMFE 218

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 78.4 bits (194), Expect = 9e-16
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 32/212 (15%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKL--DRVFQDGEREF-KNEVFVIGQTHHKNLVRL 583
           +G+G+FG V   +++ + +    A+K L  + +    E      E  V+  T H  L  L
Sbjct: 13  LGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70

Query: 584 LGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIAF----------QIARGLL 632
             +  +  +RL  V E+ N G L    F      ++L     F          +I   L 
Sbjct: 71  K-YAFQTHDRLCFVMEYANGGEL----F------FHLSRERVFTEERARFYGAEIVSALE 119

Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 692
           YLH      +++ DIK +N++LD     +I+DFGL K   ++   T+KT   GT  Y+AP
Sbjct: 120 YLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKE-GISDGATMKT-FCGTPEYLAP 174

Query: 693 EWFRNSKITAKVDVYSFGVLLLEIISCRKSFD 724
           E   ++     VD +  GV++ E++  R  F 
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 206

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 78.5 bits (194), Expect = 1e-15
 Identities = 56/197 (28%), Positives = 93/197 (47%), Gaps = 23/197 (11%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKL--DRVFQDGERE-FKNEVFVIGQTHHKNLVRL 583
           +G GSFG V   +++ + S    A+K L   +V +  + E   NE  ++   +   LV+L
Sbjct: 49  LGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106

Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFL-----FGNLKPNWNLRTNIAFQIARGLLYLHEDC 638
                +  N  +V E++  G + S L     F       + R   A QI     YLH   
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF----SEPHARFYAA-QIVLTFEYLHS-- 159

Query: 639 RAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNS 698
              +I+ D+KP+N+L+D     +++DFG AK +   + +T  T + GT   +APE   + 
Sbjct: 160 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV---KGRT-WT-LCGTPEALAPEIILSK 213

Query: 699 KITAKVDVYSFGVLLLE 715
                VD ++ GVL+ E
Sbjct: 214 GYNKAVDWWALGVLIYE 230

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 76.4 bits (189), Expect = 3e-15
 Identities = 60/200 (30%), Positives = 96/200 (48%), Gaps = 29/200 (14%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKL--DRVFQDGERE-FKNEVFVIGQTHHKNLVRL 583
           +G GSFG V+  +I++R +    A+K L  + V +  + E   +E  ++    H  ++R+
Sbjct: 14  LGTGSFGRVH--LIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 71

Query: 584 LG-FCDEGQNRL-LVYEFLNNGTLASFL-----FGNLKPNWNLRTNI-AFQIARGLLYLH 635
            G F D    ++ ++ +++  G L S L     F N            A ++   L YLH
Sbjct: 72  WGTFQDA--QQIFMIMDYIEGGELFSLLRKSQRFPNP------VAKFYAAEVCLALEYLH 123

Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
                 II+ D+KP+NILLD     +I+DFG AK        T  T + GT  Y+APE  
Sbjct: 124 S---KDIIYRDLKPENILLDKNGHIKITDFGFAK---YVPDVT-YT-LCGTPDYIAPEVV 175

Query: 696 RNSKITAKVDVYSFGVLLLE 715
                   +D +SFG+L+ E
Sbjct: 176 STKPYNKSIDWWSFGILIYE 195

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 75.8 bits (187), Expect = 5e-15
 Identities = 42/215 (19%), Positives = 72/215 (33%), Gaps = 72/215 (33%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ-THHKNLV 581
             + +G G  G V +     + +    A+K L         + + EV +  + +   ++V
Sbjct: 22  TSQVLGLGINGKVLQIF--NKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIV 74

Query: 582 RLLGFCDEGQNR----LLVYEFLNNGTL----------------ASFLFGNLKPNWNLRT 621
           R++   +         L+V E L+ G L                AS              
Sbjct: 75  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS-------------- 120

Query: 622 NIAFQIARGLLYLHEDCRAQIIHCDIKPQNILL---DDYYTARISDFGLAKLLTLNQSKT 678
            I   I   + YLH      I H D+KP+N+L          +++DFG AK  T      
Sbjct: 121 EIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT------ 171

Query: 679 IKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLL 713
                   + Y               D++S GV++
Sbjct: 172 -------GEKY-----------DKSCDMWSLGVIM 188

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 76.5 bits (189), Expect = 5e-15
 Identities = 52/217 (23%), Positives = 100/217 (46%), Gaps = 38/217 (17%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE-FKN----EVFVIGQTHHKN 579
            ++G+G+FG V+K   + R +   VA+KK+  +  + E+E F      E+ ++    H+N
Sbjct: 23  AKIGQGTFGEVFKA--RHRKTGQKVALKKV-LM--ENEKEGFPITALREIKILQLLKHEN 77

Query: 580 LVRLLGFCDEGQNRL--------LVYEFLNN---GTLAS----FLFGNLKPNWNLRTNIA 624
           +V L+  C    +          LV++F  +   G L++    F    +K        + 
Sbjct: 78  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK-------RVM 130

Query: 625 FQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIK--TA 682
             +  GL Y+H   R +I+H D+K  N+L+      +++DFGLA+  +L ++      T 
Sbjct: 131 QMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 187

Query: 683 IRGTKGYVAPEWFRNSKI-TAKVDVYSFGVLLLEIIS 718
              T  Y  PE     +     +D++  G ++ E+ +
Sbjct: 188 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 224

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 75.3 bits (186), Expect = 1e-14
 Identities = 66/222 (29%), Positives = 105/222 (47%), Gaps = 25/222 (11%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKL--DRVFQDGEREF-KNE--VFVIGQTHHKNLV 581
           +G+GSFG V   + + + +    AVK L  D + QD + E    E  +  +   +H  L 
Sbjct: 31  LGKGSFGKVM--LARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLA-RNHPFLT 87

Query: 582 RLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIA-F---QIARGLLYLHE 636
           +L   C +  +RL  V EF+N G L      +++ +       A F   +I   L++LH+
Sbjct: 88  QLF-CCFQTPDRLFFVMEFVNGGDL----MFHIQKSRRFDEARARFYAAEIISALMFLHD 142

Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR 696
                II+ D+K  N+LLD     +++DFG+ K    N   T      GT  Y+APE  +
Sbjct: 143 K---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTT--ATFCGTPDYIAPEILQ 197

Query: 697 NSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILTD 736
                  VD ++ GVLL E++     F+ E  ++   AIL D
Sbjct: 198 EMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND 239

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 77.0 bits (189), Expect = 1e-14
 Identities = 67/222 (30%), Positives = 105/222 (47%), Gaps = 25/222 (11%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKL--DRVFQDGEREF-KNE--VFVIGQTHHKNLV 581
           +G+GSFG V   + + + +    AVK L  D V QD + E    E  V  +       L 
Sbjct: 349 LGKGSFGKVM--LSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP-GKPPFLT 405

Query: 582 RLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIA-F---QIARGLLYLHE 636
           +L   C +  +RL  V E++N G L      +++     +   A F   +IA GL +L  
Sbjct: 406 QLH-SCFQTMDRLYFVMEYVNGGDL----MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS 460

Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR 696
                II+ D+K  N++LD     +I+DFG+ K    +   T KT   GT  Y+APE   
Sbjct: 461 ---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT-KT-FCGTPDYIAPEIIA 515

Query: 697 NSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILTD 736
                  VD ++FGVLL E+++ +  F+ E  +E   +I+  
Sbjct: 516 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH 557

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 74.6 bits (184), Expect = 2e-14
 Identities = 67/222 (30%), Positives = 105/222 (47%), Gaps = 25/222 (11%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKL--DRVFQDGEREF-KNE--VFVIGQTHHKNLV 581
           +G+GSFG V   + + + +    AVK L  D V QD + E    E  V  +       L 
Sbjct: 28  LGKGSFGKVM--LSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP-GKPPFLT 84

Query: 582 RLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIA-F---QIARGLLYLHE 636
           +L   C +  +RL  V E++N G L      +++     +   A F   +IA GL +L  
Sbjct: 85  QLH-SCFQTMDRLYFVMEYVNGGDL----MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS 139

Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR 696
                II+ D+K  N++LD     +I+DFG+ K    +   T KT   GT  Y+APE   
Sbjct: 140 K---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT-KT-FCGTPDYIAPEIIA 194

Query: 697 NSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILTD 736
                  VD ++FGVLL E+++ +  F+ E  +E   +I+  
Sbjct: 195 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH 236

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 73.8 bits (182), Expect = 3e-14
 Identities = 67/228 (29%), Positives = 103/228 (45%), Gaps = 37/228 (16%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKL--DRVFQDGERE-FKNE--VFVIGQTHHKNLV 581
           +G+GSFG V+  + + + +    A+K L  D V  D + E    E  V  +    H  L 
Sbjct: 25  LGKGSFGKVF--LAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-WEHPFLT 81

Query: 582 RLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIAF----------QIARG 630
            +     + +  L  V E+LN G L           +++++   F          +I  G
Sbjct: 82  HMF-CTFQTKENLFFVMEYLNGGDL----M------YHIQSCHKFDLSRATFYAAEIILG 130

Query: 631 LLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYV 690
           L +LH      I++ D+K  NILLD     +I+DFG+ K   L  +KT      GT  Y+
Sbjct: 131 LQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYI 185

Query: 691 APEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILTD 736
           APE     K    VD +SFGVLL E++  +  F  +  EE  ++I  D
Sbjct: 186 APEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD 233

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 73.8 bits (182), Expect = 3e-14
 Identities = 59/219 (26%), Positives = 103/219 (47%), Gaps = 33/219 (15%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKL--DRVFQDGEREF-KNEVFVIGQ-THHKNLVR 582
           +GRGS+  V   +++ + +    A+K +  + V  D + ++ + E  V  Q ++H  LV 
Sbjct: 17  IGRGSYAKVL--LVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74

Query: 583 LLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIAF----------QIARGL 631
           L   C + ++RL  V E++N G L           ++++               +I+  L
Sbjct: 75  LH-SCFQTESRLFFVIEYVNGGDL----M------FHMQRQRKLPEEHARFYSAEISLAL 123

Query: 632 LYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVA 691
            YLHE     II+ D+K  N+LLD     +++D+G+ K        T  +   GT  Y+A
Sbjct: 124 NYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT--STFCGTPNYIA 178

Query: 692 PEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 730
           PE  R       VD ++ GVL+ E+++ R  FDI    +
Sbjct: 179 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 217

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 74.2 bits (183), Expect = 3e-14
 Identities = 60/213 (28%), Positives = 94/213 (44%), Gaps = 33/213 (15%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKL--DRVFQDGEREF-KNEVFVIGQ-THHKNLVR 582
           +G+GSFG V   + + +      AVK L    + +  E +   +E  V+ +   H  LV 
Sbjct: 46  IGKGSFGKVL--LARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 103

Query: 583 LLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIAF----------QIARGL 631
           L  F  +  ++L  V +++N G L    F      ++L+    F          +IA  L
Sbjct: 104 LH-FSFQTADKLYFVLDYINGGEL----F------YHLQRERCFLEPRARFYAAEIASAL 152

Query: 632 LYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVA 691
            YLH      I++ D+KP+NILLD      ++DFGL K    + S T  +   GT  Y+A
Sbjct: 153 GYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTT--STFCGTPEYLA 207

Query: 692 PEWFRNSKITAKVDVYSFGVLLLEIISCRKSFD 724
           PE          VD +  G +L E++     F 
Sbjct: 208 PEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFY 240

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 74.3 bits (183), Expect = 3e-14
 Identities = 58/219 (26%), Positives = 103/219 (47%), Gaps = 33/219 (15%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAVAVKKL--DRVFQDGEREF-KNEVFVIGQ-THHKNLVR 582
           +GRGS+  V   +++ + +    A++ +  + V  D + ++ + E  V  Q ++H  LV 
Sbjct: 60  IGRGSYAKVL--LVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 117

Query: 583 LLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIAF----------QIARGL 631
           L   C + ++RL  V E++N G L           ++++               +I+  L
Sbjct: 118 LH-SCFQTESRLFFVIEYVNGGDL----M------FHMQRQRKLPEEHARFYSAEISLAL 166

Query: 632 LYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVA 691
            YLHE     II+ D+K  N+LLD     +++D+G+ K        T  +   GT  Y+A
Sbjct: 167 NYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT--STFCGTPNYIA 221

Query: 692 PEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 730
           PE  R       VD ++ GVL+ E+++ R  FDI    +
Sbjct: 222 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 260

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 71.8 bits (177), Expect = 1e-13
 Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 32/205 (15%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAV-AVKKL--DRVFQDG-EREF-KNEVFVIGQTHHKNLV 581
           +G+G +G V++    T  +T  + A+K L    + ++  +    K E  ++ +  H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84

Query: 582 RLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIAF----------QIARG 630
            L+ +  +   +L L+ E+L+ G L    F        L     F          +I+  
Sbjct: 85  DLI-YAFQTGGKLYLILEYLSGGEL----F------MQLEREGIFMEDTACFYLAEISMA 133

Query: 631 LLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYV 690
           L +LH+     II+ D+KP+NI+L+     +++DFGL K    + + T  T   GT  Y+
Sbjct: 134 LGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVT-HT-FCGTIEYM 188

Query: 691 APEWFRNSKITAKVDVYSFGVLLLE 715
           APE    S     VD +S G L+ +
Sbjct: 189 APEILMRSGHNRAVDWWSLGALMYD 213

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 69.6 bits (171), Expect = 7e-13
 Identities = 55/219 (25%), Positives = 96/219 (43%), Gaps = 34/219 (15%)

Query: 527 VGRGSFGIVYKGVIQTRTSTTAV-AVKKL--DRVFQDGEREF--KNEVFVIGQT-HHKNL 580
           +G G++G V+     +   T  + A+K L    + Q  +     + E  V+        L
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121

Query: 581 VRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIAF----------QIAR 629
           V L  +  + + +L L+ +++N G L    F       +L     F          +I  
Sbjct: 122 VTLH-YAFQTETKLHLILDYINGGEL----F------THLSQRERFTEHEVQIYVGEIVL 170

Query: 630 GLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGY 689
            L +LH+     II+ DIK +NILLD      ++DFGL+K    ++++       GT  Y
Sbjct: 171 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-FCGTIEY 226

Query: 690 VAPEWFRNSKI--TAKVDVYSFGVLLLEIISCRKSFDIE 726
           +AP+  R         VD +S GVL+ E+++    F ++
Sbjct: 227 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD 265

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 70.1 bits (172), Expect = 8e-13
 Identities = 49/213 (23%), Positives = 87/213 (40%), Gaps = 44/213 (20%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVK---KLDRVFQDGEREFK-----NEVFVIGQTH 576
           + +G+GSFG V K           VA+K      R  +    E +      +     + +
Sbjct: 103 KVIGKGSFGQVVKA--YDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRK---QDKDN 157

Query: 577 HKNLVRLLGFCD---------E--GQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF 625
             N++ +L             E    N   +YE +       F    ++         A 
Sbjct: 158 TMNVIHMLENFTFRNHICMTFELLSMN---LYELIKKNKFQGFSLPLVRK-------FAH 207

Query: 626 QIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTA--RISDFGLAKLLTLNQSKTIKTAI 683
            I + L  LH   + +IIHCD+KP+NILL     +  ++ DFG +      + + + T I
Sbjct: 208 SILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY----EHQRVYTYI 260

Query: 684 RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEI 716
           + ++ Y APE    ++    +D++S G +L E+
Sbjct: 261 Q-SRFYRAPEVILGARYGMPIDMWSLGCILAEL 292

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 69.0 bits (169), Expect = 2e-12
 Identities = 51/206 (24%), Positives = 84/206 (40%), Gaps = 30/206 (14%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAV-AVKKLDRVFQDGEREFK-----NEVFVIGQTHHK 578
             +G+GSFG V K   +      A+  +K         + E +     N+          
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNK---HDTEMKY 116

Query: 579 NLVRLLGFCDEGQNRLLVYEFLN-NGTLASFLFGNLKPN----WNLRT--NIAFQIARGL 631
            +V L        +  LV+E L+ N      L+  L+       +L      A Q+   L
Sbjct: 117 YIVHLKRHFMFRNHLCLVFEMLSYN------LYDLLRNTNFRGVSLNLTRKFAQQMCTAL 170

Query: 632 LYLHEDCRAQIIHCDIKPQNILLDDYYTA--RISDFGLAKLLTLNQSKTIKTAIRGTKGY 689
           L+L       IIHCD+KP+NILL +   +  +I DFG +        + I   I+ ++ Y
Sbjct: 171 LFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ----LGQRIYQYIQ-SRFY 224

Query: 690 VAPEWFRNSKITAKVDVYSFGVLLLE 715
            +PE          +D++S G +L+E
Sbjct: 225 RSPEVLLGMPYDLAIDMWSLGCILVE 250

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 65.7 bits (159), Expect = 1e-11
 Identities = 34/239 (14%), Positives = 63/239 (26%), Gaps = 68/239 (28%)

Query: 519 ATNNFK--EEVGRGSFGIVYKGVIQTRTSTTAVAVKKL--------DRVFQDGEREFKNE 568
            T   +  E++G G FG V++         T VA+K +        +   Q    E   E
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQT----IADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPE 73

Query: 569 VFV---------IGQTHHKNLVRLLGFC------------------------------DE 589
           + +               +  + L                                   +
Sbjct: 74  IIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFK 133

Query: 590 GQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKP 649
                +V EF   G     +   L  +     +I  Q+   L         +  H D+  
Sbjct: 134 DDQLFIVLEFEFGGIDLEQMRTKL-SSLATAKSILHQLTASLAVAEA--SLRFEHRDLHW 190

Query: 650 QNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGY-VAPEWFRNSKITAKVDVY 707
            N+LL      ++      K  T+            + G  V+   +  S++     V 
Sbjct: 191 GNVLLKKTSLKKLHYTLNGKSSTI-----------PSCGLQVSIIDYTLSRLERDGIVV 238

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 65.3 bits (159), Expect = 3e-11
 Identities = 59/306 (19%), Positives = 102/306 (33%), Gaps = 106/306 (34%)

Query: 577 HKNLVRLLG-FCDEGQN---RLLVYEFLNNGTLASFL---FGNLKPNWNLRTNIAFQIAR 629
            + +V+LL  F   G N     +V+E L +  L  ++        P   ++  I  Q+ +
Sbjct: 100 REMVVQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKK-IIQQVLQ 157

Query: 630 GLLYLHEDCRAQIIHCDIKPQNILL--DDYYT---------------------------- 659
           GL YLH  C  +IIH DIKP+NILL  ++ Y                             
Sbjct: 158 GLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215

Query: 660 -------------------ARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
                               +I+D G A  +  + ++ I+     T+ Y + E    S  
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ-----TRQYRSLEVLIGSGY 270

Query: 701 TAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-----------AIL----TDWA------- 738
               D++S   +  E+ +    F+   GEEY            +L               
Sbjct: 271 NTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSK 330

Query: 739 --FDCYRNGKL------------NVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPT 784
             F   + G L             VLV + + +  +       ++     ++  P  R T
Sbjct: 331 EFFT--KKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLL---PMLELIPEKRAT 385

Query: 785 MKKVLQ 790
             + L+
Sbjct: 386 AAECLR 391

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 64.7 bits (158), Expect = 3e-11
 Identities = 44/224 (19%), Positives = 79/224 (35%), Gaps = 50/224 (22%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVK---KLDRVFQDGEREFK-----NEVFVIGQTH 576
             +G G+FG V +  +      + VA+K    + +  +    E        E     +  
Sbjct: 25  GNLGEGTFGKVVE-CLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFL 83

Query: 577 HKNLVRLLGFCD---------E--GQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF 625
               V +  + +         E  G+N    +EFL       +             ++A+
Sbjct: 84  ---CVLMSDWFNFHGHMCIAFELLGKN---TFEFLKENNFQPY-------PLPHVRHMAY 130

Query: 626 QIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIK----- 680
           Q+   L +LHE    Q+ H D+KP+NIL  +     + +   +      ++ +I+     
Sbjct: 131 QLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG 187

Query: 681 ---------TAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLE 715
                    T I  T+ Y  PE           DV+S G +L E
Sbjct: 188 SATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFE 231

>3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276

 Score = 61.6 bits (148), Expect = 2e-10
 Identities = 44/272 (16%), Positives = 70/272 (25%), Gaps = 40/272 (14%)

Query: 24  AQNNGTVPVGATLTAGTSSSPWLSPSGDFAFGFHQLDEENNTNDLFLLSIFYNKIPEKTV 83
                 +P   TL+AG      LSP+  F           + N    L I  N       
Sbjct: 11  GVGTSVLPAYQTLSAGQY---LLSPNQRFKLLLQ-----GDGN----LVIQDNGATVWVA 58

Query: 84  VWYTDNKDQNPAVPRGSQVKLTADQGLVLNDPQGKQVWSSKIDIGT------VAVGHMND 137
                     P   + + +      G  L+D   ++VW +     T           + D
Sbjct: 59  NEQQPFSSTIPLRNKKAPLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQD 118

Query: 138 TGNFVLASSSSGRLWDSFSNPTDTLLLGQMMETEQGLFSRKSENNFSRGRFQFRLLEDGN 197
            GN VL  S +              +   ++     L           G  +     DGN
Sbjct: 119 DGNIVLVDSLALWNGTPAIPLVPGAIDSLLLAPGSELVQGVVYGA---GASKLVFQGDGN 175

Query: 198 LVLNIANLATGFAYDAYYTSGTYDPANSSNSGYRVMFNESGYMYILRRNGGRFDLTTERV 257
           LV    N        A + +GT           R +F   G + +          +    
Sbjct: 176 LVAYGPN------GAATWNAGT-----QGKGAVRAVFQGDGNLVVYGAGNAVLWHSH--- 221

Query: 258 VPAADFYYRATLNFDGVFAQYFYPKNGNGNWS 289
                      L  +G  A      +    W+
Sbjct: 222 -TGGHASAVLRLQANGSIAIL----DEKPVWA 248

>3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276

 Score = 42.7 bits (99), Expect = 2e-04
 Identities = 27/179 (15%), Positives = 43/179 (24%), Gaps = 10/179 (5%)

Query: 147 SSGRLWDSFSNPTDTLLLGQMMETEQGLFSRKSENNFSRGRFQFRLLEDGNLVLNIANLA 206
           +           T  L   Q +   Q L S     N    RF+  L  DGNLV+      
Sbjct: 2   AGRTRIPFNGVGTSVLPAYQTLSAGQYLLS----PN---QRFKLLLQGDGNLVIQDNGAT 54

Query: 207 TGFAYDAYYTSGTYDPANSSNSGYRVMFNESGYMYILRRNGGRFDLTTERVVPAADFYYR 266
              A +      +  P  +  +          ++    R        +            
Sbjct: 55  VWVA-NEQQPFSSTIPLRNKKAPLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTH 113

Query: 267 ATLNFDGVFAQYFYPK--NGNGNWSVAWSEPENICVDIGGGLGSGACGYNSICTLDSDR 323
             L  DG           NG     +     +++ +  G  L  G         L    
Sbjct: 114 LVLQDDGNIVLVDSLALWNGTPAIPLVPGAIDSLLLAPGSELVQGVVYGAGASKLVFQG 172

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 61.6 bits (150), Expect = 2e-10
 Identities = 34/158 (21%), Positives = 65/158 (41%), Gaps = 17/158 (10%)

Query: 521 NNFK--EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHK 578
            ++K    +G GSFG++++G         A+  +           E++    + G T   
Sbjct: 10  VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTG-- 67

Query: 579 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHE 636
            +  +  F  EG + +LV + L  G     L       ++++T    A Q+   +  +HE
Sbjct: 68  -IPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE 124

Query: 637 DCRAQIIHCDIKPQNILLDDYYTAR-----ISDFGLAK 669
                +++ DIKP N L+    +       + DFG+ K
Sbjct: 125 ---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 61.6 bits (150), Expect = 3e-10
 Identities = 39/161 (24%), Positives = 67/161 (41%), Gaps = 23/161 (14%)

Query: 521 NNFK--EEVGRGSFGIVYKGV-IQTRTSTTAVAVK--KLDRVFQDGEREFKNEVFVIGQT 575
            NF+  +++G G+FG +  G  + T      VA+K   +         E++    +    
Sbjct: 9   PNFRVGKKIGCGNFGELRLGKNLYTNEY---VAIKLEPMKSRAPQLHLEYRFYKQLGSGD 65

Query: 576 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLY 633
               + ++  F   G+   +V E L  G     LF      ++L+T   IA Q+   + Y
Sbjct: 66  G---IPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEY 120

Query: 634 LHEDCRAQIIHCDIKPQNILLDDYYTAR-----ISDFGLAK 669
           +H      +I+ D+KP+N L+            I DF LAK
Sbjct: 121 VH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 61.5 bits (150), Expect = 3e-10
 Identities = 36/175 (20%), Positives = 66/175 (37%), Gaps = 36/175 (20%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVK---KLDRVFQDGEREFK-----NEVFVIGQTH 576
           + +G G+FG V +  I  +     VAVK    +DR  +    E +     N         
Sbjct: 20  DTLGEGAFGKVVE-CIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFR 78

Query: 577 HKNLVRLLGFCD---------E--GQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF 625
               V++L + +         E  G +    Y+F+       F         ++R  +A+
Sbjct: 79  ---CVQMLEWFEHHGHICIVFELLGLS---TYDFIKENGFLPF------RLDHIR-KMAY 125

Query: 626 QIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIK 680
           QI + + +LH     ++ H D+KP+NIL          +  + +      +  IK
Sbjct: 126 QICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIK 177

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 59.3 bits (144), Expect = 2e-09
 Identities = 49/230 (21%), Positives = 84/230 (36%), Gaps = 58/230 (25%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVK---KLDRVFQDGEREFK-----NEVFVIGQTH 576
            ++G G+FG V     Q   +    AVK    + +  +  + E                +
Sbjct: 41  RKMGDGTFGRVLLC--QHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQN----DDIN 94

Query: 577 HKNLVRLLGFCD---------E--GQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF 625
           + N+V+  G            E  G +   +YE +       F         +++     
Sbjct: 95  NNNIVKYHGKFMYYDHMCLIFEPLGPS---LYEIITRNNYNGF------HIEDIK-LYCI 144

Query: 626 QIARGLLYLHEDCRAQIIHCDIKPQNILLDD--YYTARISDFGLAKLLTLNQSKTIKTAI 683
           +I + L YL +     + H D+KP+NILLDD  +  + I+   +     +   +T  T I
Sbjct: 145 EILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGI 201

Query: 684 R----G--------------TKGYVAPEWFRNSKITAKVDVYSFGVLLLE 715
           +    G              T+ Y APE   N       D++SFG +L E
Sbjct: 202 KLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE 251

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 58.2 bits (141), Expect = 4e-09
 Identities = 32/173 (18%), Positives = 65/173 (37%), Gaps = 29/173 (16%)

Query: 521 NNFK--EEVGRGSFGIVYKGV------IQTRTSTTAVAVK------KLDRVFQDGEREFK 566
             +K      R + GI+Y+          +       ++K      +L       +R  K
Sbjct: 42  RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101

Query: 567 NEVFVIGQTHHKNLV----RLLGF-CDEGQNRLLVYEFLNNGT-LASFLFGNLKPNWNLR 620
                  +  +   +      +GF   + + R LV   L  G  L S L  + K   + R
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSER 159

Query: 621 T--NIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARI--SDFGLAK 669
           +   +A ++   L +LHE    + +H ++  +NI +D    +++  + +G A 
Sbjct: 160 SVLQVACRLLDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 57.0 bits (138), Expect = 8e-09
 Identities = 41/158 (25%), Positives = 63/158 (39%), Gaps = 19/158 (12%)

Query: 521 NNFK--EEVGRGSFGIVYKGV-IQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ-TH 576
           N ++   ++G GSFG +Y G  I        VA+K      +    +   E  +      
Sbjct: 9   NRYRLGRKIGSGSFGDIYLGTDIAAGE---EVAIKLECV--KTKHPQLHIESKIYKMMQG 63

Query: 577 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYL 634
              +  +     EG   ++V E L  G     LF      ++L+T   +A Q+   + Y+
Sbjct: 64  GVGIPTIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 121

Query: 635 HEDCRAQIIHCDIKPQNILL---DDYYTARISDFGLAK 669
           H       IH D+KP N L+          I DFGLAK
Sbjct: 122 HS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 56.2 bits (135), Expect = 3e-08
 Identities = 45/158 (28%), Positives = 67/158 (42%), Gaps = 19/158 (12%)

Query: 521 NNFK--EEVGRGSFGIVYKGV-IQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHH 577
           N F+   ++G GSFG +Y G  IQT      VA+K  +   +    +   E  +      
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNE---EVAIKLENV--KTKHPQLLYESKIYRILQG 61

Query: 578 KNLV-RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYL 634
              +  +  F  EG   +LV + L  G     LF       +L+T   +A Q+   + ++
Sbjct: 62  GTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119

Query: 635 HEDCRAQIIHCDIKPQNILLDDYYTAR---ISDFGLAK 669
           H       +H DIKP N L+     A    I DFGLAK
Sbjct: 120 HS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 54.7 bits (132), Expect = 5e-08
 Identities = 32/171 (18%), Positives = 64/171 (37%), Gaps = 28/171 (16%)

Query: 521 NNFK--EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLD-----------RVFQD-GEREFK 566
           N +   +++G G FG++Y      +    A  V K++           + +Q   +++  
Sbjct: 37  NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCI 96

Query: 567 NEVFVIGQTHHKNLVRLLGF----CDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT- 621
            +     Q  +  +    G           R +V E L  G     +       +   T 
Sbjct: 97  KKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKIS-GQNGTFKKSTV 153

Query: 622 -NIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARI--SDFGLAK 669
             +  ++   L Y+HE    + +H DIK  N+LL      ++  +D+GL+ 
Sbjct: 154 LQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 55.2 bits (132), Expect = 7e-08
 Identities = 68/516 (13%), Positives = 148/516 (28%), Gaps = 148/516 (28%)

Query: 346 RPDF--ELSCWGGGQGYNKELFDFHELKNI-NWPQSDYERFKPYNEVQCKNTCLSDCFCA 402
              F     C    Q   K +    E+ +I     +     + +  +  K   +   F  
Sbjct: 26  EDAFVDNFDCKDV-QDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVE 84

Query: 403 AVIFNDGSCWFKKLPLSNGMTDSRIAGKAFIKYKNK--GDDPP----SVPRPPDPEDKKK 456
            V+  +   +    P+        +  + +I+ +++   D+      +V R   P  K +
Sbjct: 85  EVLRINYK-FLMS-PIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRL-QPYLKLR 141

Query: 457 SKMMNA--TGSVLL------GSSVFVNFALVC---AFVLGFSF-IYKKKWI----RNSPD 500
             ++      +VL+      G +       VC          F I+   W+     NSP+
Sbjct: 142 QALLELRPAKNVLIDGVLGSGKTWVA--LDVCLSYKVQCKMDFKIF---WLNLKNCNSPE 196

Query: 501 D---------GTIETNL--RCFSYKELEGATNNFKEEVGR-------------------- 529
                       I+ N   R      ++   ++ + E+ R                    
Sbjct: 197 TVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNA 256

Query: 530 ---GSFGIVYKGVIQTR----------TSTTAVAVKKLDRVFQDGEREFKNEVF--VIGQ 574
               +F +  K ++ TR           +TT +++          E +    +    +  
Sbjct: 257 KAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVK---SLLLKYLDC 313

Query: 575 ----------THHKNLVRLLG-FCDEGQNRLLVYEFLNNGTLASFL---FGNLKPNWNLR 620
                     T +   + ++     +G      ++ +N   L + +      L+P    R
Sbjct: 314 RPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPA-EYR 372

Query: 621 TN-----IAFQ----IARGLL--------------YLHEDCRAQIIHCDIKPQNILLDDY 657
                  + F     I   LL               +++  +  ++    K   I +   
Sbjct: 373 KMFDRLSV-FPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSI 431

Query: 658 YTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITA-KVDVYSFGVL---L 713
           Y        L   + L     +  +I     Y  P+ F +  +    +D Y +  +   L
Sbjct: 432 Y--------LELKVKLENEYALHRSIVDH--YNIPKTFDSDDLIPPYLDQYFYSHIGHHL 481

Query: 714 LEIISCRKSFDIEMGEEYAILTDWAFDCYR--NGKL 747
                     +IE  E   +      D +R    K+
Sbjct: 482 ---------KNIEHPERMTLFRMVFLD-FRFLEQKI 507

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 53.7 bits (128), Expect = 2e-07
 Identities = 41/246 (16%), Positives = 91/246 (36%), Gaps = 44/246 (17%)

Query: 551 VKKLD-RVFQDGERE-FKNEVF--VIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLA 606
           V   D +  QD  +     E    +I      +    L +    +   +V +F+      
Sbjct: 30  VDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEV--- 86

Query: 607 SFLFGNLKPNWN-LRTNIAFQ-IARGLLY-LHEDCRAQIIHCDIKPQNILLDDYYTARIS 663
                 L+ N+  L + I  +     ++  ++ + R + ++ D +        Y  +R+ 
Sbjct: 87  ------LRINYKFLMSPIKTEQRQPSMMTRMYIEQRDR-LYNDNQV----FAKYNVSRLQ 135

Query: 664 DFGLAK--LLTLNQSKTIKTAIRGTKGY----VAPEWFRNSKITAKVDVYSFGVLLLEII 717
            +   +  LL L  +K +   I G  G     VA +   + K+  K+D   F +  L + 
Sbjct: 136 PYLKLRQALLELRPAKNV--LIDGVLGSGKTWVALDVCLSYKVQCKMD---FKIFWLNLK 190

Query: 718 SCRKSFDI-EMGEE--YAILTDWAFDCYRNGKLNVLVGEDKEAMNDI-------ECLGKL 767
           +C     + EM ++  Y I  +W      +  + + +   +  +  +        CL  L
Sbjct: 191 NCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCL--L 248

Query: 768 VMVSIW 773
           V++++ 
Sbjct: 249 VLLNVQ 254

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 51.0 bits (121), Expect = 1e-06
 Identities = 76/578 (13%), Positives = 148/578 (25%), Gaps = 214/578 (37%)

Query: 5   RLYFIFLLFQLPYFSHLAIAQNNGTVP--VGATLTAGTSSSPWL---------SPSGDFA 53
               +F             ++    V   V   L     +  +L          PS    
Sbjct: 63  GTLRLFWTLL---------SKQEEMVQKFVEEVLRI---NYKFLMSPIKTEQRQPSMMTR 110

Query: 54  FGFHQLDEENNTNDLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQV--------KLT 105
               Q D   N N +F     YN                   V R            +L 
Sbjct: 111 MYIEQRDRLYNDNQVF---AKYN-------------------VSRLQPYLKLRQALLELR 148

Query: 106 ADQGLVLNDPQ--GKQVWSSKIDIGTVAVGHMNDTGNFVLASSSSGRLWDSFSNPTDTLL 163
             + ++++     GK           VA+         V         W +  N      
Sbjct: 149 PAKNVLIDGVLGSGKTW---------VALDVCLSYK--VQCKMDFKIFWLNLKNCNSPET 197

Query: 164 LGQMMETEQGLFSRKSENNFSRGRFQFRLLEDGNLVLNIANLATGFAYDAYYTSGTYDPA 223
           + +M+   Q L  +   N  SR                             ++S      
Sbjct: 198 VLEML---QKLLYQIDPNWTSRSD---------------------------HSSNIKLRI 227

Query: 224 NSSNSGYRVMFNESGY---MYILRRNGGRFDLTTERVVPAADFYYRATL-------NFDG 273
           +S  +  R +     Y   + +L       ++   +   A +   +  L         D 
Sbjct: 228 HSIQAELRRLLKSKPYENCLLVLL------NVQNAKAWNAFNLSCK-ILLTTRFKQVTDF 280

Query: 274 VFAQ-YFYPKNGNGNWSVAWSEPENICVDIGGGLGSGACGYNSICTLDSDRRPRCAC--- 329
           + A    +    + + ++   E +++ +     L                  PR      
Sbjct: 281 LSAATTTHISLDHHSMTLTPDEVKSLLLKY---LD-----------CRPQDLPREVLTTN 326

Query: 330 PKGYSLLDENDRYGSCRPDFELSCWGGGQGYNKELFDFHELKNINWPQSDYERFKPYNEV 389
           P+  S++ E+ R G    D     W   +  N +     +L  I   +S     +P  E 
Sbjct: 327 PRRLSIIAESIRDGLATWDN----W---KHVNCD-----KLTTII--ESSLNVLEP-AEY 371

Query: 390 QCKNTCLSDCFCAAVIFNDGS---------CWFKKLP-----LSNGMTDSRIAGK----- 430
           +         F    +F   +          WF  +      + N +    +  K     
Sbjct: 372 R-------KMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKES 424

Query: 431 ------AFIKYKNKGDDPPSV----------PRPPDPEDKKKSK------------MMNA 462
                  +++ K K ++  ++          P+  D +D                 + N 
Sbjct: 425 TISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNI 484

Query: 463 --TGSVLLGSSVFVNFALVCAFVLGFSFIYKKKWIRNS 498
                + L   VF++          F F+ +K  IR+ 
Sbjct: 485 EHPERMTLFRMVFLD----------FRFLEQK--IRHD 510

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 52.1 bits (125), Expect = 4e-07
 Identities = 33/173 (19%), Positives = 65/173 (37%), Gaps = 29/173 (16%)

Query: 521 NNFK--EEVGRGSFGIVYKGVIQTRTSTTA---VAVKKLDRVFQDGEREFK-----NEVF 570
             +K    +G+G FG +Y   + +  S  +     VK           E K      +  
Sbjct: 35  AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94

Query: 571 VIGQTHHKNLVRLLGFC----------DEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR 620
            I +      ++ LG            +    R ++ +    G+    ++      ++ +
Sbjct: 95  QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRK 152

Query: 621 T--NIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARI--SDFGLAK 669
           T   ++ +I   L Y+HE    + +H DIK  N+LL+     ++   D+GLA 
Sbjct: 153 TVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110

 Score = 43.6 bits (103), Expect = 2e-05
 Identities = 20/128 (15%), Positives = 38/128 (29%), Gaps = 25/128 (19%)

Query: 33  GATLTAGTSSSPWLSPSGDFAFGFHQLDEENNTNDLFLLSIFYNKIPEKTVVWYTDNKDQ 92
             +L  G S    L     +              D     + Y+       VW ++    
Sbjct: 7   PNSLFTGHS----LEVGPSYRLIM--------QGDCNF--VLYDS---GKPVWASNTGGL 49

Query: 93  NPAVPRGSQVKLTADQGLVLNDPQGKQVWSSKIDIGTVAVG-HMNDTGNFVLASSSSGRL 151
                 G ++ L  +  LV+ D   + +W +K +         +    N V+       +
Sbjct: 50  GS----GCRLTLHNNGNLVIYDQSNRVIWQTKTNGKEDHYVLVLQQDRNVVIYGPV---V 102

Query: 152 WDSFSNPT 159
           W + S P 
Sbjct: 103 WATGSGPA 110

>1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112

 Score = 43.0 bits (101), Expect = 3e-05
 Identities = 28/135 (20%), Positives = 43/135 (31%), Gaps = 30/135 (22%)

Query: 159 TDTLLLGQMMETEQGLFSRKSENNFSRGRFQFRLLEDGNLVLNIANLATGFAYDAYYTSG 218
           +D L  G  ++T   L           G + F +  D NLVL   N        A + SG
Sbjct: 1   SDRLNSGHQLDTGGSLAE---------GGYLFIIQNDCNLVLYDNN-------RAVWASG 44

Query: 219 TYDPANSSNSGYRVMFNESGYMYILRRNGGRFDLTTERVVPAADFYYRATLNFDGVFAQY 278
           T        SG  +     G + I   +   +   T R     +  Y   L  D     Y
Sbjct: 45  TN----GKASGCVLKMQNDGNLVIYSGSRAIWASNTNR----QNGNYYLILQRDRNVVIY 96

Query: 279 FYPKNGNGNWSVAWS 293
                 + + +  W+
Sbjct: 97  ------DNSNNAIWA 105

>1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119

 Score = 43.0 bits (101), Expect = 4e-05
 Identities = 23/126 (18%), Positives = 38/126 (30%), Gaps = 22/126 (17%)

Query: 33  GATLTAGTSSSPWLSPSGDFAFGFHQLDEENNTNDLFLLSIFYNKIPEKTVVWYTDNKDQ 92
              L A  S       +  + F   Q D      +L L    Y+       +W T+    
Sbjct: 14  PQILHATESLEIL-FGTHVYRFIM-QTD-----CNLVL----YDN---NNPIWATNTGGL 59

Query: 93  NPAVPRGSQVKLTADQGLVLNDPQGKQVWSSKIDIGTVAVG-HMNDTGNFVLASSSSGRL 151
                 G +  L  D  LV+   +   VW S +          +    N V+   +   L
Sbjct: 60  GN----GCRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYGDA---L 112

Query: 152 WDSFSN 157
           W + + 
Sbjct: 113 WATQTV 118

>1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236

 Score = 44.5 bits (104), Expect = 6e-05
 Identities = 27/173 (15%), Positives = 50/173 (28%), Gaps = 20/173 (11%)

Query: 84  VWYTDNK---DQNPAVPRGSQVKLTADQGLVLNDPQGKQVWSSKIDIGTVA-VGHMNDTG 139
           V +  +      N A   G +  L +D  LV+   Q    WSS         V  +    
Sbjct: 39  VLFDSDVRVWASNTAGATGCRAVLQSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDR 98

Query: 140 NFVLASSSSGRLWDSFSN-----PTDTLLLGQMMETEQGLFSRKSENNFSRGRFQFRLLE 194
              +          S             +L      +    +  +  +     ++  +  
Sbjct: 99  TVTIYGPGLWDSGTSNKGSVVVANNGNSILYSTQGNDNHPQTLHATQSLQLSPYRLSMET 158

Query: 195 DGNLVLNIANLATGFAYDAYYTSGTYDPANSSNSGYRVMFNESGYMYILRRNG 247
           D NLVL   +       D  +++ T        +G R +   +G M +L    
Sbjct: 159 DCNLVLFDRD-------DRVWSTNTAGK----GTGCRAVLQPNGRMDVLTNQN 200

>1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109

 Score = 41.0 bits (96), Expect = 1e-04
 Identities = 18/78 (23%), Positives = 34/78 (43%), Gaps = 7/78 (8%)

Query: 81  KTVVWYTDNKDQNPAVPRGSQVKLTADQGLVLNDPQGKQVWSSKIDIGT-VAVGHMNDTG 139
            T VW ++         +G +  L +D   V+ D +G+ +W+S    G    V  + + G
Sbjct: 37  STSVWASN---TGILGKKGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDG 93

Query: 140 NFVLASSSSGRLWDSFSN 157
           N V+  S    +W + + 
Sbjct: 94  NVVIYGSD---IWSTGTY 108

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	814
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3m7h_A	276	Putidacin L1; monocot mannose-binding lectin, bact	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
1dlp_A	236	Lectin scafet precursor; two-domain lectin, beta p	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.97
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.94
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.9
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.83
4h3o_A	105	Lectin; cadmium, plant protein; 2.17A {Allium sati	99.82
1b2p_A	119	Protein (lectin); mannose-binding lectin, monocot,	99.81
3a0c_A	110	Mannose/sialic acid-binding lectin; beta-prism II,	99.81
2dpf_A	115	Curculin; sweet taste, taste modifying, plant prot	99.78
1xd5_A	112	Gastrodianin-1, antifungal protein GAFP-1; monocot	99.77
3dzw_A	109	Agglutinin; lectin, mannobiose, mannose-alpha1, 3-	99.72
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.71
3r0e_B	110	Lectin; carbohydrate binding, carbohydrate, sugar	99.66
3a0c_A	110	Mannose/sialic acid-binding lectin; beta-prism II,	99.65
1xd5_A	112	Gastrodianin-1, antifungal protein GAFP-1; monocot	99.65
3mez_B	113	Mannose-specific lectin 3 chain 2; heterotetramer,	99.63
1b2p_A	119	Protein (lectin); mannose-binding lectin, monocot,	99.63
2dpf_A	115	Curculin; sweet taste, taste modifying, plant prot	99.58
3r0e_A	109	Lectin; carbohydrate binding, carbohydrate, sugar	99.56
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.5
3mez_A	111	Mannose-specific lectin 3 chain 1; heterotetramer,	99.44
3mez_A	111	Mannose-specific lectin 3 chain 1; heterotetramer,	99.35
3mez_B	113	Mannose-specific lectin 3 chain 2; heterotetramer,	99.32
3dzw_A	109	Agglutinin; lectin, mannobiose, mannose-alpha1, 3-	99.26
3m7h_A	276	Putidacin L1; monocot mannose-binding lectin, bact	99.25
3r0e_B	110	Lectin; carbohydrate binding, carbohydrate, sugar	99.2
3r0e_A	109	Lectin; carbohydrate binding, carbohydrate, sugar	99.16
1dlp_A	236	Lectin scafet precursor; two-domain lectin, beta p	99.1
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.09
4h3o_A	105	Lectin; cadmium, plant protein; 2.17A {Allium sati	99.07
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	98.89
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.81
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.63
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.28
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.18
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.05
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	97.98
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	97.92
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.9
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.63
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.38
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.31
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.26
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.19
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.61
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.56
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	96.51
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.41
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.25
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.24
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	95.94
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	95.87
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	95.65
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.33
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	94.16
3mes_A	424	Choline kinase; malaria, structural genomics, stru	93.44
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	85.94
3no2_A	276	Uncharacterized protein; six-bladed beta-propeller	84.18
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	83.5
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	81.99

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.7e-52  Score=444.89  Aligned_cols=270  Identities=26%  Similarity=0.371  Sum_probs=220.8

Q ss_pred             ccCHHHHHHhhhccccceeeeeeeeEEEEEEec---CCCceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccceee
Q 041921          510 CFSYKELEGATNNFKEEVGRGSFGIVYKGVIQT---RTSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRLLG  585 (814)
Q Consensus       510 ~~~~~~l~~~~~~~~~~LG~G~~g~Vy~~~~~~---~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~  585 (814)
                      ..++.|+..++..|.++||+|+||+||+|.+..   ...++.||||+++... ....++|.+|+.++++++|||||+++|
T Consensus        17 ~~~~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g   96 (308)
T 4gt4_A           17 QAKLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLG   96 (308)
T ss_dssp             --CCCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cCCcccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcce
Confidence            344556667788899999999999999999742   2356799999997543 334568999999999999999999999


Q ss_pred             eecccccceEEEecCCCCCHHHHhcCC----------------CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCC
Q 041921          586 FCDEGQNRLLVYEFLNNGTLASFLFGN----------------LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKP  649 (814)
Q Consensus       586 ~~~~~~~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp  649 (814)
                      +|.+++..+||||||++|+|.++|...                ..++|..+.+|+.|||+||+|||+.   +|+||||||
T Consensus        97 ~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~  173 (308)
T 4gt4_A           97 VVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLAT  173 (308)
T ss_dssp             EECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred             EEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccc
Confidence            999999999999999999999999642                3578999999999999999999998   999999999


Q ss_pred             CcEEEcCCCcEEEeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccc
Q 041921          650 QNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMG  728 (814)
Q Consensus       650 ~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~  728 (814)
                      +||||++++.+||+|||+++...........+...||+.|||||++.++.++.++|||||||+||||+| |+.||.....
T Consensus       174 ~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~  253 (308)
T 4gt4_A          174 RNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN  253 (308)
T ss_dssp             GGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH
T ss_pred             cceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999997765443333355679999999999999999999999999999999999 8999975543


Q ss_pred             hhhhhHHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 041921          729 EEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV  798 (814)
Q Consensus       729 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~~  798 (814)
                      .+       +...+.++...         +.+..++..+.+++.+||+.||++||||+||++.|+...++
T Consensus       254 ~~-------~~~~i~~~~~~---------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~nl  307 (308)
T 4gt4_A          254 QD-------VVEMIRNRQVL---------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGNL  307 (308)
T ss_dssp             HH-------HHHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC-
T ss_pred             HH-------HHHHHHcCCCC---------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccCC
Confidence            22       12233333221         11224567789999999999999999999999999976554

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.7e-52  Score=441.48  Aligned_cols=262  Identities=24%  Similarity=0.465  Sum_probs=216.7

Q ss_pred             HHhhhccccceeeeeeeeEEEEEEec---CCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccc
Q 041921          517 EGATNNFKEEVGRGSFGIVYKGVIQT---RTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNR  593 (814)
Q Consensus       517 ~~~~~~~~~~LG~G~~g~Vy~~~~~~---~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  593 (814)
                      ....+.+.++||+|+||+||+|.+..   ..++..||||+++.......++|.+|++++++++|||||+++|+|.+++..
T Consensus        11 ~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~   90 (299)
T 4asz_A           11 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL   90 (299)
T ss_dssp             CGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred             CHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence            34456678999999999999999753   235778999999876666677899999999999999999999999999999


Q ss_pred             eEEEecCCCCCHHHHhcCC-------------CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcE
Q 041921          594 LLVYEFLNNGTLASFLFGN-------------LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTA  660 (814)
Q Consensus       594 ~lv~e~~~~gsL~~~l~~~-------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~  660 (814)
                      +||||||++|+|.++|+..             ..++|..++.|+.|||+||+|||++   +|+||||||+||||++++.+
T Consensus        91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~  167 (299)
T 4asz_A           91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLV  167 (299)
T ss_dssp             EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCE
T ss_pred             EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcE
Confidence            9999999999999999653             4689999999999999999999998   99999999999999999999


Q ss_pred             EEeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHH
Q 041921          661 RISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAF  739 (814)
Q Consensus       661 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~  739 (814)
                      ||+|||+++...............||+.|||||.+.+..++.++|||||||++|||+| |+.||......+       +.
T Consensus       168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~-------~~  240 (299)
T 4asz_A          168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-------VI  240 (299)
T ss_dssp             EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-------HH
T ss_pred             EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HH
Confidence            9999999987655443333344569999999999999999999999999999999999 899997543322       12


Q ss_pred             HHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 041921          740 DCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE  797 (814)
Q Consensus       740 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~  797 (814)
                      ..+..+....         .+..++.++.+++.+||+.||++||||++|+++|+++.+
T Consensus       241 ~~i~~~~~~~---------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~  289 (299)
T 4asz_A          241 ECITQGRVLQ---------RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK  289 (299)
T ss_dssp             HHHHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHcCCCCC---------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            2233332111         122345778999999999999999999999999988654

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=6.2e-52  Score=444.80  Aligned_cols=261  Identities=26%  Similarity=0.445  Sum_probs=208.8

Q ss_pred             hhhccccceeeeeeeeEEEEEEec---CCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceE
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQT---RTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL  595 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~---~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  595 (814)
                      ....+.++||+|+||.||+|.+..   ..++..||||+++.......++|.+|+++|++++|||||+++|+|.+++..+|
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            344667899999999999999753   23578999999987666667789999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhcCC---------------CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcE
Q 041921          596 VYEFLNNGTLASFLFGN---------------LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTA  660 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~~---------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~  660 (814)
                      |||||++|+|.++|+..               ..++|.++++|+.|||+||+|||+.   +|+||||||+||||++++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcE
Confidence            99999999999999753               3589999999999999999999998   99999999999999999999


Q ss_pred             EEeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHH
Q 041921          661 RISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAF  739 (814)
Q Consensus       661 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~  739 (814)
                      ||+|||+++.+.........+...||+.|||||++.+..++.++|||||||+||||+| |+.||......+       +.
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~-------~~  270 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE-------AI  270 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH-------HH
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH-------HH
Confidence            9999999997765443333345679999999999999999999999999999999999 899997543322       12


Q ss_pred             HHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 041921          740 DCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV  798 (814)
Q Consensus       740 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~~  798 (814)
                      ..+..+..       +  +.+..++.++.+|+.+||+.||++||||+||+++|+.+.+.
T Consensus       271 ~~i~~g~~-------~--~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          271 DCITQGRE-------L--ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             HHHHHTCC-------C--CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HHHHcCCC-------C--CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence            22222221       0  11223457789999999999999999999999999987654

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=9.9e-51  Score=429.37  Aligned_cols=261  Identities=28%  Similarity=0.407  Sum_probs=204.0

Q ss_pred             HHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeecccccc
Q 041921          516 LEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNR  593 (814)
Q Consensus       516 l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  593 (814)
                      |......+.++||+|+||+||+|++.     ..||||.++...  .+..++|.+|+.++++++|||||++++++.+ +..
T Consensus        33 i~~~~l~l~~~iG~G~fG~Vy~~~~~-----~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~  106 (307)
T 3omv_A           33 IEASEVMLSTRIGSGSFGTVYKGKWH-----GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNL  106 (307)
T ss_dssp             CCTTSCCEEEECCCCSSSEEEEEESS-----SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred             EcHHHeEEeeEEeeCCCcEEEEEEEC-----CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeE
Confidence            33445567899999999999999864     258999886432  3345679999999999999999999999865 568


Q ss_pred             eEEEecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccc
Q 041921          594 LLVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLT  672 (814)
Q Consensus       594 ~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~  672 (814)
                      +||||||++|+|.++|+.. ..++|..+..|+.|||+||+|||+.   +|+||||||+||||++++.+||+|||+|+...
T Consensus       107 ~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~  183 (307)
T 3omv_A          107 AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKS  183 (307)
T ss_dssp             EEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC--
T ss_pred             EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecc
Confidence            9999999999999999764 6799999999999999999999998   99999999999999999999999999998765


Q ss_pred             cCCcccccccccCCCCccccccccc---CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccce
Q 041921          673 LNQSKTIKTAIRGTKGYVAPEWFRN---SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNV  749 (814)
Q Consensus       673 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  749 (814)
                      ............||+.|||||++..   ..++.++|||||||+||||+||+.||........      +...+..+... 
T Consensus       184 ~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~------~~~~~~~~~~~-  256 (307)
T 3omv_A          184 RWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ------IIFMVGRGYAS-  256 (307)
T ss_dssp             ----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH------HHHHHHTTCCC-
T ss_pred             cCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH------HHHHHhcCCCC-
Confidence            4433333355679999999999964   4689999999999999999999999975433221      11222222111 


Q ss_pred             eecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 041921          750 LVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV  796 (814)
Q Consensus       750 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~  796 (814)
                         +... .....++..+.+++.+||+.||++||||.+|++.|+.+.
T Consensus       257 ---p~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~  299 (307)
T 3omv_A          257 ---PDLS-KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ  299 (307)
T ss_dssp             ---CCST-TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred             ---CCcc-cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence               1110 112235577889999999999999999999999998654

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=6.2e-48  Score=412.93  Aligned_cols=249  Identities=25%  Similarity=0.346  Sum_probs=209.5

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEec
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  599 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  599 (814)
                      .|.+.++||+|+||+||+|....  +++.||||+++.......+.+.+|+.+|++++|||||++++++.+++..+|||||
T Consensus        75 ~y~~~~~iG~G~fG~V~~a~~~~--tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  152 (346)
T 4fih_A           75 YLDNFIKIGEGSTGIVCIATVRS--SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  152 (346)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETT--TCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hcEEeEEeecCcCeEEEEEEECC--CCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence            36677899999999999999753  5789999999766566667799999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcccc
Q 041921          600 LNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI  679 (814)
Q Consensus       600 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  679 (814)
                      +++|+|.+++.. ..+++.....++.||+.||+|||++   +|+||||||+||||+.++.+||+|||+++.+......  
T Consensus       153 ~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~--  226 (346)
T 4fih_A          153 LEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--  226 (346)
T ss_dssp             CTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC--
T ss_pred             CCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCCc--
Confidence            999999999875 4689999999999999999999998   9999999999999999999999999999877543322  


Q ss_pred             cccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccC
Q 041921          680 KTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMN  759 (814)
Q Consensus       680 ~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  759 (814)
                      ....+||+.|||||++.+..++.++|||||||++|||++|+.||......+.       ...+..+...       ....
T Consensus       227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~-------~~~i~~~~~~-------~~~~  292 (346)
T 4fih_A          227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA-------MKMIRDNLPP-------RLKN  292 (346)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-------HHHHHHSSCC-------CCSC
T ss_pred             ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH-------HHHHHcCCCC-------CCCc
Confidence            2456899999999999999999999999999999999999999975433221       1222222111       1111


Q ss_pred             cHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          760 DIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       760 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      ......++.+++.+||+.||++|||++|+++
T Consensus       293 ~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          293 LHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            2234567889999999999999999999986

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=4.1e-49  Score=426.23  Aligned_cols=266  Identities=26%  Similarity=0.361  Sum_probs=216.8

Q ss_pred             HHHHhhhccccceeeeeeeeEEEEEEecCC---CceEEEEEEeccccc-cchHhHHHHHHhhhccCC-CCccceeeeecc
Q 041921          515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRT---STTAVAVKKLDRVFQ-DGEREFKNEVFVIGQTHH-KNLVRLLGFCDE  589 (814)
Q Consensus       515 ~l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~---~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~  589 (814)
                      |+....+.+.++||+|+||.||+|.+...+   ..+.||||++..... ...++|.+|+.+|.+++| ||||+++|+|.+
T Consensus        60 Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~  139 (353)
T 4ase_A           60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK  139 (353)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred             EecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe
Confidence            455677888899999999999999976432   346899999976433 334679999999999965 999999999976


Q ss_pred             c-ccceEEEecCCCCCHHHHhcCC----------------CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcE
Q 041921          590 G-QNRLLVYEFLNNGTLASFLFGN----------------LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNI  652 (814)
Q Consensus       590 ~-~~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NI  652 (814)
                      . +..+||||||++|+|.++|+..                ..+++..+..++.|||+||+|||++   +|+||||||+||
T Consensus       140 ~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NI  216 (353)
T 4ase_A          140 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNI  216 (353)
T ss_dssp             TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred             cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccce
Confidence            4 5689999999999999999642                3478999999999999999999998   999999999999


Q ss_pred             EEcCCCcEEEeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhh
Q 041921          653 LLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEY  731 (814)
Q Consensus       653 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~  731 (814)
                      ||++++.+||+|||+|+.+.............||+.|||||++.+..++.++|||||||+||||+| |+.||......+ 
T Consensus       217 Ll~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~-  295 (353)
T 4ase_A          217 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-  295 (353)
T ss_dssp             EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-
T ss_pred             eeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH-
Confidence            999999999999999998765544433355679999999999999999999999999999999998 899997543322 


Q ss_pred             hhHHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 041921          732 AILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV  798 (814)
Q Consensus       732 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~~  798 (814)
                           .+...+.++....         .+...+.++.+++.+||+.||++||||++|++.|+.+++.
T Consensus       296 -----~~~~~i~~g~~~~---------~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~  348 (353)
T 4ase_A          296 -----EFCRRLKEGTRMR---------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  348 (353)
T ss_dssp             -----HHHHHHHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----HHHHHHHcCCCCC---------CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence                 1222233332111         1122456788999999999999999999999999887543

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=4.9e-48  Score=411.61  Aligned_cols=268  Identities=23%  Similarity=0.293  Sum_probs=202.9

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccc----cceE
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ----NRLL  595 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~l  595 (814)
                      ++.+.++||+|+||+||+|++.    ++.||||+++... .....+..|+..+.+++|||||+++++|.+++    ..+|
T Consensus         4 ~i~L~~~iG~G~fG~Vy~~~~~----g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l   78 (303)
T 3hmm_A            4 TIVLQESIGKGRFGEVWRGKWR----GEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GEEEEEEEEECSSSEEEEEEET----TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEEC----CEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence            4567889999999999999873    6899999996532 12223455777778899999999999998654    5789


Q ss_pred             EEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcC-----CCCeeecCCCCCcEEEcCCCcEEEeecCCccc
Q 041921          596 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDC-----RAQIIHCDIKPQNILLDDYYTARISDFGLAKL  670 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~-----~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~  670 (814)
                      ||||+++|+|.++|+.. .++|..+.+++.|+++||+|||+++     .++|+||||||+||||+.++.+||+|||+++.
T Consensus        79 V~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~  157 (303)
T 3hmm_A           79 VSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  157 (303)
T ss_dssp             EEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             EecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence            99999999999999754 5899999999999999999999762     45899999999999999999999999999987


Q ss_pred             cccCCccc--ccccccCCCCcccccccccC------CCCcchhhHHHHHHHHHHHhCCCCCCcccchhh--h------hH
Q 041921          671 LTLNQSKT--IKTAIRGTKGYVAPEWFRNS------KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY--A------IL  734 (814)
Q Consensus       671 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~--~------~~  734 (814)
                      ........  ......||+.|||||++.+.      .++.++|||||||+||||+||+.|+......+.  .      ..
T Consensus       158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~  237 (303)
T 3hmm_A          158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS  237 (303)
T ss_dssp             EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred             ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence            65433221  11345799999999999754      467899999999999999999887753322110  0      00


Q ss_pred             HHHHHHHhhcCccceeecCcc-cccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 041921          735 TDWAFDCYRNGKLNVLVGEDK-EAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE  797 (814)
Q Consensus       735 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~  797 (814)
                      .+.....+..+.+    .+.. ......+.+..+.+++.+||+.||++||||.+|+++|+++.+
T Consensus       238 ~~~~~~~~~~~~~----rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~  297 (303)
T 3hmm_A          238 VEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             HHHHHHHHTTSCC----CCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHhcccC----CCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence            0111222222221    1111 112234677889999999999999999999999999987653

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=6.4e-48  Score=404.90  Aligned_cols=247  Identities=28%  Similarity=0.425  Sum_probs=198.9

Q ss_pred             ccccceeeeeeeeEEEEEEecCCCceEEEEEEeccc--cccchHhHHHHHHhhhccCCCCccceeeeecc----cccceE
Q 041921          522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV--FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDE----GQNRLL  595 (814)
Q Consensus       522 ~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~l  595 (814)
                      .|.++||+|+||+||+|...  ..+..||||++...  .....+.|.+|+.++++++|||||++++++.+    ++..+|
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~l  106 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDT--ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEET--TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEEC--CCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEE
Confidence            56778999999999999975  36789999999643  22334579999999999999999999999865    345799


Q ss_pred             EEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc-CCCcEEEeecCCccccccC
Q 041921          596 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLD-DYYTARISDFGLAKLLTLN  674 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~-~~~~~kl~DfGla~~~~~~  674 (814)
                      ||||+++|+|.++|.....+++.....++.||+.||+|||++ +++|+||||||+||||+ .++.+||+|||+|+.....
T Consensus       107 vmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~  185 (290)
T 3fpq_A          107 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS  185 (290)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred             EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC
Confidence            999999999999999888899999999999999999999997 11399999999999998 4799999999999864432


Q ss_pred             CcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCc
Q 041921          675 QSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGED  754 (814)
Q Consensus       675 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  754 (814)
                      .    ....+||+.|||||++.+ +++.++|||||||++|||+||+.||.......      .+...+..+.....    
T Consensus       186 ~----~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~------~~~~~i~~~~~~~~----  250 (290)
T 3fpq_A          186 F----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA------QIYRRVTSGVKPAS----  250 (290)
T ss_dssp             S----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH------HHHHHHTTTCCCGG----
T ss_pred             c----cCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH------HHHHHHHcCCCCCC----
Confidence            1    245679999999999875 69999999999999999999999996433221      11222333221110    


Q ss_pred             ccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          755 KEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       755 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      .    +.....++.+++.+||+.||++|||++|+++
T Consensus       251 ~----~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          251 F----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             G----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             C----CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0    1112346789999999999999999999986

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=4.9e-48  Score=407.53  Aligned_cols=247  Identities=21%  Similarity=0.283  Sum_probs=210.2

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccc---cccchHhHHHHHHhhhccCCCCccceeeeecccccceEE
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV---FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV  596 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  596 (814)
                      .|.+.++||+|+||+||+|....  +++.||||.+.+.   .....+.+.+|++++++++|||||++++++.+++..+||
T Consensus        33 dy~i~~~lG~G~fg~V~~a~~~~--~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv  110 (311)
T 4aw0_A           33 DFKFGKILGEGSFSTVVLARELA--TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG  110 (311)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccEEEEEEecccCeEEEEEEECC--CCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            47788999999999999999753  6789999999643   233456799999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCc
Q 041921          597 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS  676 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  676 (814)
                      |||+++|+|.++|.....+++.....++.||+.||+|||++   +|+||||||+||||+.++.+||+|||+|+.+.....
T Consensus       111 mEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~  187 (311)
T 4aw0_A          111 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  187 (311)
T ss_dssp             ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred             EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence            99999999999998888899999999999999999999998   999999999999999999999999999998765444


Q ss_pred             ccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCccc
Q 041921          677 KTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKE  756 (814)
Q Consensus       677 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  756 (814)
                      .......+||+.|||||++.+..++.++||||+||++|||++|+.||......+       +...+..+.+..       
T Consensus       188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-------~~~~i~~~~~~~-------  253 (311)
T 4aw0_A          188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL-------IFAKIIKLEYDF-------  253 (311)
T ss_dssp             CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCCCC-------
T ss_pred             cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCCCCC-------
Confidence            433356789999999999999999999999999999999999999997543322       122233332211       


Q ss_pred             ccCcHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 041921          757 AMNDIECLGKLVMVSIWCIQEDPSLRPTMKKV  788 (814)
Q Consensus       757 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~v  788 (814)
                         +.....++.+++.+||+.||++|||++|+
T Consensus       254 ---p~~~s~~~~dli~~lL~~dp~~R~t~~e~  282 (311)
T 4aw0_A          254 ---PEKFFPKARDLVEKLLVLDATKRLGCEEM  282 (311)
T ss_dssp             ---CTTCCHHHHHHHHHHSCSSGGGSTTSGGG
T ss_pred             ---CcccCHHHHHHHHHHccCCHhHCcChHHH
Confidence               11234568899999999999999999986

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=6.3e-48  Score=413.54  Aligned_cols=248  Identities=22%  Similarity=0.321  Sum_probs=200.5

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccc--cccchHhHHHHHHhhhccCCCCccceeeeecccccceEEE
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV--FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY  597 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  597 (814)
                      .|.+.++||+|+||+||+|....  .++.||||++...  .....+.+.+|+.++++++|||||++++++.+++..+|||
T Consensus        25 ~Y~~~~~lG~G~fg~V~~a~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm  102 (350)
T 4b9d_A           25 KYVRLQKIGEGSFGKAILVKSTE--DGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM  102 (350)
T ss_dssp             CEEEEEEC------CEEEEEETT--TCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ceEEeEEEecCCCeEEEEEEECC--CCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            57788999999999999999753  5789999999643  2233467999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCC
Q 041921          598 EFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ  675 (814)
Q Consensus       598 e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~  675 (814)
                      ||+++|+|.++|...  ..+++...+.|+.||+.||+|||++   +|+||||||+||||+.++.+||+|||+|+.+....
T Consensus       103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  179 (350)
T 4b9d_A          103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV  179 (350)
T ss_dssp             ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred             eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence            999999999999654  4568888999999999999999998   99999999999999999999999999998765322


Q ss_pred             cccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcc
Q 041921          676 SKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDK  755 (814)
Q Consensus       676 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  755 (814)
                      .  .....+||+.|||||++.+..++.++|||||||++|||++|+.||......+       +...+..+....      
T Consensus       180 ~--~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~-------~~~~i~~~~~~~------  244 (350)
T 4b9d_A          180 E--LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN-------LVLKIISGSFPP------  244 (350)
T ss_dssp             H--HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHHTCCCC------
T ss_pred             c--cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-------HHHHHHcCCCCC------
Confidence            1  1244679999999999999999999999999999999999999997543322       112222222211      


Q ss_pred             cccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          756 EAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       756 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                         .....+.++.+|+.+||+.||++|||++|+++
T Consensus       245 ---~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          245 ---VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             ---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               11223467889999999999999999999985

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=9.7e-48  Score=410.28  Aligned_cols=250  Identities=22%  Similarity=0.213  Sum_probs=203.5

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEecC
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL  600 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  600 (814)
                      +.+.++||+|+||.||+|....  .++.||||+++..     ....+|+.++++++|||||++++++.+++..+|||||+
T Consensus        60 ~~~~~~lG~G~fG~Vy~a~~~~--~g~~vAiK~i~~~-----~~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  132 (336)
T 4g3f_A           60 MTHQPRVGRGSFGEVHRMKDKQ--TGFQCAVKKVRLE-----VFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL  132 (336)
T ss_dssp             EEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEETT-----TCCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             eEeCcEeccCCCeEEEEEEECC--CCCEEEEEEECHH-----HhHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence            4566789999999999999753  5789999999642     12357999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC-cEEEeecCCccccccCCcc--
Q 041921          601 NNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYY-TARISDFGLAKLLTLNQSK--  677 (814)
Q Consensus       601 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~-~~kl~DfGla~~~~~~~~~--  677 (814)
                      ++|+|.++|.....+++.....++.||+.||+|||++   +|+||||||+||||+.++ .+||+|||+|+.+......  
T Consensus       133 ~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~  209 (336)
T 4g3f_A          133 EGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKS  209 (336)
T ss_dssp             TTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC--------
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccc
Confidence            9999999998888899999999999999999999998   999999999999999887 6999999999987643221  


Q ss_pred             -cccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCccc
Q 041921          678 -TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKE  756 (814)
Q Consensus       678 -~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  756 (814)
                       ......+||+.|||||++.+..++.++|||||||++|||+||+.||......+..       ..+..+...       .
T Consensus       210 ~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~-------~~i~~~~~~-------~  275 (336)
T 4g3f_A          210 LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC-------LKIASEPPP-------I  275 (336)
T ss_dssp             ----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCH-------HHHHHSCCG-------G
T ss_pred             eecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH-------HHHHcCCCC-------c
Confidence             1123457999999999999999999999999999999999999999755433211       111111110       0


Q ss_pred             ccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 041921          757 AMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEG  794 (814)
Q Consensus       757 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~  794 (814)
                      ...+...+..+.+++.+||+.||.+|||+.|+++.|..
T Consensus       276 ~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~  313 (336)
T 4g3f_A          276 REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK  313 (336)
T ss_dssp             GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence            11122345678899999999999999999999987754

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=9.6e-47  Score=413.65  Aligned_cols=249  Identities=25%  Similarity=0.349  Sum_probs=209.2

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEec
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  599 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  599 (814)
                      .|.+.++||+|+||.||+|....  .++.||||++........+.+.+|+.+|++++|||||++++++.+++..+|||||
T Consensus       152 ~y~~~~~iG~G~fG~V~~a~~~~--tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy  229 (423)
T 4fie_A          152 YLDNFIKIGEGSTGIVCIATVRS--SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  229 (423)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETT--TCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hcEeeeEeccCcCcEEEEEEECC--CCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence            46677899999999999999763  5789999999766566667799999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcccc
Q 041921          600 LNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI  679 (814)
Q Consensus       600 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  679 (814)
                      |++|+|.+++.. ..+++.....|+.||+.||+|||++   +|+||||||+||||+.++.+||+|||+++.+......  
T Consensus       230 ~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~--  303 (423)
T 4fie_A          230 LEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--  303 (423)
T ss_dssp             CTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC--
T ss_pred             CCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCcc--
Confidence            999999999865 4589999999999999999999998   9999999999999999999999999999877543322  


Q ss_pred             cccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccC
Q 041921          680 KTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMN  759 (814)
Q Consensus       680 ~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  759 (814)
                      ....+||+.|||||++.+..++.++|||||||++|||++|+.||......+       +...+..+....       ...
T Consensus       304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-------~~~~i~~~~~~~-------~~~  369 (423)
T 4fie_A          304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-------AMKMIRDNLPPR-------LKN  369 (423)
T ss_dssp             BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHHHHSCCCC-------CSC
T ss_pred             ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-------HHHHHHcCCCCC-------Ccc
Confidence            245679999999999999999999999999999999999999997543322       112222221111       111


Q ss_pred             cHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          760 DIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       760 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      .......+.+|+.+||+.||++|||++|+++
T Consensus       370 ~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          370 LHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            1223467889999999999999999999987

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.2e-46  Score=391.71  Aligned_cols=246  Identities=24%  Similarity=0.355  Sum_probs=193.3

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhccCCCCccceeeeecccccceE
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL  595 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  595 (814)
                      ..|.+.++||+|+||+||+|...  .+++.||||.++...   ....+.+.+|+.++++++|||||++++++.+++..+|
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i   90 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHT--TTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIM   90 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECT--TTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEEC--CCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            35788899999999999999864  367899999996432   2334579999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCC
Q 041921          596 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ  675 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~  675 (814)
                      ||||+ +|+|.+++.....+++.....++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+......
T Consensus        91 vmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~  166 (275)
T 3hyh_A           91 VIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN  166 (275)
T ss_dssp             EEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred             EEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence            99999 689999998888999999999999999999999998   99999999999999999999999999998765432


Q ss_pred             cccccccccCCCCcccccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCc
Q 041921          676 SKTIKTAIRGTKGYVAPEWFRNSKI-TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGED  754 (814)
Q Consensus       676 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  754 (814)
                      .   ....+||+.|||||++.+..+ +.++||||+||++|||+||+.||......+       ..+.+..+....     
T Consensus       167 ~---~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~-------~~~~i~~~~~~~-----  231 (275)
T 3hyh_A          167 F---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV-------LFKNISNGVYTL-----  231 (275)
T ss_dssp             -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCCCC-----
T ss_pred             c---cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHcCCCCC-----
Confidence            2   244679999999999998876 579999999999999999999997543221       122233332211     


Q ss_pred             ccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          755 KEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       755 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                           +.....++.+++.+||+.||++|||++|+++
T Consensus       232 -----p~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          232 -----PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             -----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             -----CCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                 1123456789999999999999999999987

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=8.7e-47  Score=398.16  Aligned_cols=250  Identities=24%  Similarity=0.273  Sum_probs=200.0

Q ss_pred             hhhccccceeeeeeeeEEEEEEec-CCCceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeecccccceE
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQT-RTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL  595 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~-~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  595 (814)
                      ..|.+.++||+|+||+||+|.... ...++.||||.++...  ......+.+|+.++++++|||||++++++.+++..+|
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            357888999999999999998743 3357899999996532  2234468899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCC
Q 041921          596 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ  675 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~  675 (814)
                      ||||+++|+|.++|.....+++.....++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+......
T Consensus       104 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  180 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE  180 (304)
T ss_dssp             EECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred             EEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence            999999999999999888899999999999999999999998   99999999999999999999999999998654332


Q ss_pred             cccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcc
Q 041921          676 SKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDK  755 (814)
Q Consensus       676 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  755 (814)
                      ..  ....+||+.|||||++.+..++.++|||||||++|||+||+.||......+       +...+.++....      
T Consensus       181 ~~--~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~-------~~~~i~~~~~~~------  245 (304)
T 3ubd_A          181 KK--AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE-------TMTMILKAKLGM------  245 (304)
T ss_dssp             CC--CCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCCC------
T ss_pred             cc--ccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH-------HHHHHHcCCCCC------
Confidence            22  245679999999999999999999999999999999999999997554322       112222222211      


Q ss_pred             cccCcHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 041921          756 EAMNDIECLGKLVMVSIWCIQEDPSLRPT-----MKKVLQ  790 (814)
Q Consensus       756 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-----~~~vl~  790 (814)
                          +...+.++.+++.+||+.||++|||     ++|+++
T Consensus       246 ----p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          246 ----PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             ----CTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             ----CCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence                1123467889999999999999998     467764

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.1e-44  Score=383.73  Aligned_cols=258  Identities=22%  Similarity=0.358  Sum_probs=188.7

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc-cchHhHHHHHHhhhccCCCCccceeeeecccc-------
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ-------  591 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------  591 (814)
                      .|.+.+.||+|+||+||+|...  .+++.||||+++.... ...+.+.+|+.++++++|||||++++++.+.+       
T Consensus         6 dy~~~~~lG~G~fg~V~~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            6 DFEPIQCLGRGGFGVVFEAKNK--VDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             HEEEEEEEEECC--EEEEEEET--TTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred             hCEEeeEEecCCCeEEEEEEEC--CCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence            3667789999999999999875  3578999999965332 23457899999999999999999999986544       


Q ss_pred             -----cceEEEecCCCCCHHHHhcCCCCC---ChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEe
Q 041921          592 -----NRLLVYEFLNNGTLASFLFGNLKP---NWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARIS  663 (814)
Q Consensus       592 -----~~~lv~e~~~~gsL~~~l~~~~~l---~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~  663 (814)
                           ..+|||||+++|+|.+++.....+   ++...+.|+.||++||+|||++   +|+||||||+||||+.++.+||+
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~  160 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVG  160 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEc
Confidence                 368999999999999999876443   4556788999999999999998   99999999999999999999999


Q ss_pred             ecCCccccccCCccc----------ccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhh
Q 041921          664 DFGLAKLLTLNQSKT----------IKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI  733 (814)
Q Consensus       664 DfGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~  733 (814)
                      |||+|+.+.......          ..+..+||+.|||||.+.+..++.++|||||||++|||++   ||..... ... 
T Consensus       161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~-~~~-  235 (299)
T 4g31_A          161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME-RVR-  235 (299)
T ss_dssp             CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH-HHH-
T ss_pred             cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH-HHH-
Confidence            999998776432211          1134579999999999999999999999999999999996   7753211 100 


Q ss_pred             HHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhcCcCCCCCCC
Q 041921          734 LTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ--MLEGVVEVSVPPN  803 (814)
Q Consensus       734 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~--~L~~~~~~~~p~~  803 (814)
                          ....+.......         ...+....+.+++.+||+.||.+|||+.|+++  .++   +++.|..
T Consensus       236 ----~~~~~~~~~~p~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~---~~~~p~~  291 (299)
T 4g31_A          236 ----TLTDVRNLKFPP---------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFE---DLDFPGK  291 (299)
T ss_dssp             ----HHHHHHTTCCCH---------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGC---CC-----
T ss_pred             ----HHHHHhcCCCCC---------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhC---CCCCCCc
Confidence                111122222110         11223445678999999999999999999987  444   3455543

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=3.2e-42  Score=371.90  Aligned_cols=274  Identities=36%  Similarity=0.629  Sum_probs=233.8

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEecC
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL  600 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  600 (814)
                      +.+.+.||+|+||.||+|.+.   ++..||||++........+++.+|+.++++++||||+++++++.+.+..++||||+
T Consensus        41 y~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  117 (321)
T 2qkw_B           41 FDHKFLIGHGVFGKVYKGVLR---DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYM  117 (321)
T ss_dssp             CSCCCCSCBCSSSEEEEEECT---TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECC
T ss_pred             cCccceeecCCCeeEEEEEEC---CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcC
Confidence            445678999999999999864   47899999997766666778999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCC----CCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCc
Q 041921          601 NNGTLASFLFGNL----KPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS  676 (814)
Q Consensus       601 ~~gsL~~~l~~~~----~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  676 (814)
                      ++++|.+++....    .+++..++.++.|+++||.|||+.   +|+||||||+||+++.++.+||+|||+++.......
T Consensus       118 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  194 (321)
T 2qkw_B          118 ENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQ  194 (321)
T ss_dssp             TTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSC
T ss_pred             CCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecccccccccccc
Confidence            9999999997643    588999999999999999999998   999999999999999999999999999987554332


Q ss_pred             ccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCccc
Q 041921          677 KTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKE  756 (814)
Q Consensus       677 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  756 (814)
                      ........||+.|+|||.+.+..++.++||||||+++|||++|+.||......+......|.......+.+...+++...
T Consensus       195 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (321)
T 2qkw_B          195 THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLA  274 (321)
T ss_dssp             CCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCT
T ss_pred             cccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhc
Confidence            22224456899999999999899999999999999999999999999866554444445555555666666666666665


Q ss_pred             ccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCCC
Q 041921          757 AMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSV  800 (814)
Q Consensus       757 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~~~~  800 (814)
                      .....+.+..+.+++.+||+.||++|||+.++++.|+.+..+..
T Consensus       275 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~  318 (321)
T 2qkw_B          275 DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE  318 (321)
T ss_dssp             TCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSC
T ss_pred             cccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhccc
Confidence            56677889999999999999999999999999999998766543

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-42  Score=381.19  Aligned_cols=267  Identities=20%  Similarity=0.315  Sum_probs=203.5

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc--cchHhHHHHHHhhhccCCCCccceeeeecc------cc
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ--DGEREFKNEVFVIGQTHHKNLVRLLGFCDE------GQ  591 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~  591 (814)
                      .|.+.++||+|+||+||+|...  ..++.||||+++....  ...+.+.+|+.+|++++|||||++++++..      .+
T Consensus        55 ~Y~~~~~lG~G~fG~V~~a~~~--~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           55 EYEIIETIGNGAYGVVSSARRR--LTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             SEEEEEEEEECSSCEEEEEEET--TTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CeEEEEEEecccCeEEEEEEEC--CCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            4778899999999999999975  3678999999965322  234568899999999999999999998753      36


Q ss_pred             cceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcccc
Q 041921          592 NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLL  671 (814)
Q Consensus       592 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~  671 (814)
                      +.+|||||++ |+|.+++.....+++.....++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.+
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~  208 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGL  208 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred             EEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeeec
Confidence            7899999995 78999999888999999999999999999999998   9999999999999999999999999999876


Q ss_pred             ccCCc--ccccccccCCCCcccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccc
Q 041921          672 TLNQS--KTIKTAIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLN  748 (814)
Q Consensus       672 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  748 (814)
                      .....  .......+||+.|||||++.+. .++.++||||+||++|||++|+.||......+..   ..+..........
T Consensus       209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l---~~I~~~~g~p~~~  285 (398)
T 4b99_A          209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQL---QLIMMVLGTPSPA  285 (398)
T ss_dssp             -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHH---HHHHHHHCCCCGG
T ss_pred             ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHH---HHHHHhcCCCChH
Confidence            53321  2222456899999999998775 5689999999999999999999999765432211   1111111100000


Q ss_pred             -----------eeecC-cccccCcH-----HHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhcC
Q 041921          749 -----------VLVGE-DKEAMNDI-----ECLGKLVMVSIWCIQEDPSLRPTMKKVLQ--MLEGV  795 (814)
Q Consensus       749 -----------~~~~~-~~~~~~~~-----~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~--~L~~~  795 (814)
                                 ..... ......+.     ....++.+|+.+||+.||.+|||++|+++  .|.+.
T Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  351 (398)
T 4b99_A          286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY  351 (398)
T ss_dssp             GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred             HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence                       00000 00000011     12356789999999999999999999986  45443

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.1e-41  Score=370.76  Aligned_cols=201  Identities=21%  Similarity=0.330  Sum_probs=170.7

Q ss_pred             hhhccccceeeeeeeeEEEEEEec-CCCceEEEEEEeccccccchHhHHHHHHhhhcc-CCCCccceeeeecccccceEE
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQT-RTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRLLV  596 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  596 (814)
                      ..|.+.++||+|+||+||+|+.+. ...++.||||++...  .....+.+|++++..+ +||||+++++++.+.++.+||
T Consensus        21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lv   98 (361)
T 4f9c_A           21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIA   98 (361)
T ss_dssp             GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEE
T ss_pred             CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEE
Confidence            457788999999999999998753 245789999998653  3455788999999988 699999999999999999999


Q ss_pred             EecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC-CcEEEeecCCccccccCC
Q 041921          597 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDY-YTARISDFGLAKLLTLNQ  675 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~-~~~kl~DfGla~~~~~~~  675 (814)
                      |||+++|+|.+++.   .+++.+...++.||+.||+|||+.   +|+||||||+|||++.+ +.+||+|||+|+......
T Consensus        99 mE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~  172 (361)
T 4f9c_A           99 MPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK  172 (361)
T ss_dssp             EECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCS
T ss_pred             EeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcc
Confidence            99999999999994   488999999999999999999998   99999999999999876 799999999998654321


Q ss_pred             cc--------------------------cccccccCCCCcccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCccc
Q 041921          676 SK--------------------------TIKTAIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIISCRKSFDIEM  727 (814)
Q Consensus       676 ~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~s~Gvvl~elltg~~p~~~~~  727 (814)
                      ..                          ...+..+||+.|||||++.+. .++.++||||+||++|||++|+.||....
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~  251 (361)
T 4f9c_A          173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS  251 (361)
T ss_dssp             CGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCC
Confidence            10                          111335799999999999775 58999999999999999999999996543

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=9e-42  Score=369.15  Aligned_cols=285  Identities=42%  Similarity=0.723  Sum_probs=237.8

Q ss_pred             cccccCHHHHHHhhhcc--ccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc-cchHhHHHHHHhhhccCCCCccce
Q 041921          507 NLRCFSYKELEGATNNF--KEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ-DGEREFKNEVFVIGQTHHKNLVRL  583 (814)
Q Consensus       507 ~~~~~~~~~l~~~~~~~--~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l  583 (814)
                      ..+.|++.++...+.+|  .+.||+|+||.||+|...   ++..||||++..... .....+.+|+.++++++||||+++
T Consensus        16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~   92 (326)
T 3uim_A           16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA---DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL   92 (326)
T ss_dssp             CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS---SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCC
T ss_pred             ccceecHHHHHHHhhccccceeEecCCCcEEEEEEec---CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccce
Confidence            35678888888877766  478999999999999754   478899999975432 233478999999999999999999


Q ss_pred             eeeecccccceEEEecCCCCCHHHHhcCC----CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCc
Q 041921          584 LGFCDEGQNRLLVYEFLNNGTLASFLFGN----LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYT  659 (814)
Q Consensus       584 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~  659 (814)
                      ++++.+.+..++||||+++++|.+++...    ..+++..+..++.|++.||+|||+.+.++|+||||||+|||++.++.
T Consensus        93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~  172 (326)
T 3uim_A           93 RGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE  172 (326)
T ss_dssp             CEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCC
T ss_pred             EEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCC
Confidence            99999999999999999999999999764    34899999999999999999999987779999999999999999999


Q ss_pred             EEEeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccc--hhhhhHHHH
Q 041921          660 ARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMG--EEYAILTDW  737 (814)
Q Consensus       660 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~--~~~~~~~~~  737 (814)
                      +||+|||+++......... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.....  ........|
T Consensus       173 ~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  251 (326)
T 3uim_A          173 AVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW  251 (326)
T ss_dssp             EEECCCSSCEECCSSSSCE-ECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHH
T ss_pred             EEeccCccccccCcccccc-cccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHH
Confidence            9999999998765443322 2445699999999999988999999999999999999999999963321  222334455


Q ss_pred             HHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 041921          738 AFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV  795 (814)
Q Consensus       738 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~  795 (814)
                      .........+..+.+.........+.+..+.+++.+||+.||.+|||+++|+++|++.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          252 VKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             HTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             HHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence            5555566666666666666667788899999999999999999999999999999874

>3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A*

Probab=100.00  E-value=2e-42  Score=358.38  Aligned_cols=229  Identities=20%  Similarity=0.269  Sum_probs=180.4

Q ss_pred             hhcCCccCCCceeecCCCCCceecCCCcEEEeEeeccCCCCCCCcEEEEEEecccCCCeEEEEecCCCCCCCCCC----C
Q 041921           24 AQNNGTVPVGATLTAGTSSSPWLSPSGDFAFGFHQLDEENNTNDLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPR----G   99 (814)
Q Consensus        24 ~~~~~ti~~g~~l~~~~~~~~lvS~~g~F~lGF~~~~~~~~~~~~~~lgiw~~~~~~~t~vW~Anr~~~~~~~~~----~   99 (814)
                      +++.|+|++|++|++++   +|+|++|.|+||||.++       ++||   |+  +++ |||+|||+.  |....    +
T Consensus        11 ~~~~~~l~~g~~l~~~~---~l~S~~g~F~lgf~~~~-------~~~l---y~--~~~-vvW~Anr~~--p~~~~~~~~~   72 (276)
T 3m7h_A           11 GVGTSVLPAYQTLSAGQ---YLLSPNQRFKLLLQGDG-------NLVI---QD--NGA-TVWVANEQQ--PFSSTIPLRN   72 (276)
T ss_dssp             CTTSSEECTTEEBCTTC---EEECTTSSEEEEECTTS-------CEEE---EE--TTE-EEEECSTTS--TTEEEEECCC
T ss_pred             cccCCEecCCCEecCCC---EEEcCCCcEEEEEECCC-------CeEE---EC--CCC-eEEECCCCC--CcCCcccccc
Confidence            45669999999999987   89999999999999421       3577   76  777 999999992  33332    7


Q ss_pred             ceEEEccCCcEEE--eCCCCceEeeeccCC------CceeEEEEecCcCEEEEeCCCCceeecccCCccccccCCc----
Q 041921          100 SQVKLTADQGLVL--NDPQGKQVWSSKIDI------GTVAVGHMNDTGNFVLASSSSGRLWDSFSNPTDTLLLGQM----  167 (814)
Q Consensus       100 ~~l~~~~~G~Lvl--~~~~g~~vWst~~~~------~~~~~a~LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg~~----  167 (814)
                      ++|+|+.||+|||  .|++|++||||+++.      .++++|+|+|+|||||++  +.+||||  ||||||||||+    
T Consensus        73 ~~l~l~~~G~Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~--~~~lWqS--~ptdtlLpg~~~~~~  148 (276)
T 3m7h_A           73 KKAPLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD--SLALWNG--TPAIPLVPGAIDSLL  148 (276)
T ss_dssp             TTCCSEEEESSSEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE--EEEEEES--CTTSCCCCSCTTCEE
T ss_pred             eEEEEeCCCcEEEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecC--CceeeCc--ccccccccccccccc
Confidence            8899999999999  788899999999875      345789999999999998  7799999  99999999999    


Q ss_pred             cccccceeecccCCCCCCCceeEEEccCCceeEEeeccCCCccccceeeccccCCCCCCCCcceeeecCCccEEEEeeCC
Q 041921          168 METEQGLFSRKSENNFSRGRFQFRLLEDGNLVLNIANLATGFAYDAYYTSGTYDPANSSNSGYRVMFNESGYMYILRRNG  247 (814)
Q Consensus       168 l~~~~~l~S~~s~~d~s~G~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~sg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (814)
                      |..+++|   ++.+||++|.|+++++++|+++++ .+.     ..+||++++|...    . ..+.++.+|.+.++..++
T Consensus       149 l~~g~~L---~S~~dps~G~fsl~l~~dGnlvLy-~~~-----~~~yW~Sgt~~~~----~-~~l~l~~dGnLvl~d~~~  214 (276)
T 3m7h_A          149 LAPGSEL---VQGVVYGAGASKLVFQGDGNLVAY-GPN-----GAATWNAGTQGKG----A-VRAVFQGDGNLVVYGAGN  214 (276)
T ss_dssp             ECSSEEE---CTTCEEEETTEEEEECTTSCEEEE-CTT-----SSEEEECCCTTTT----C-CEEEECTTSCEEEECTTS
T ss_pred             cccCccc---ccCCCCCCceEEEeecCCceEEEE-eCC-----CeEEEECCCCCCc----c-EEEEEcCCCeEEEEeCCC
Confidence            7778888   567899999999999999987664 222     2579999998642    2 466777788777776655


Q ss_pred             ceeeeeeeecccCCceEEEEEEecCccEEEEEecCCCCCCeEEEEeccC
Q 041921          248 GRFDLTTERVVPAADFYYRATLNFDGVFAQYFYPKNGNGNWSVAWSEPE  296 (814)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~r~~L~~dG~l~~y~~~~~~~~~W~~~~~~p~  296 (814)
                      ..+..+...  .  ...+|++|+.||+|++|.|    ...|..++.+|.
T Consensus       215 ~~vWsS~t~--~--~~~~rl~Ld~dGnLvly~~----~~~Wqsf~~~P~  255 (276)
T 3m7h_A          215 AVLWHSHTG--G--HASAVLRLQANGSIAILDE----KPVWARFGFQPT  255 (276)
T ss_dssp             CEEEECSCT--T--CTTCEEEECTTSCEEEEEE----EEEEESSSCCTT
T ss_pred             cEEEEecCC--C--CCCEEEEEcCCccEEEEcC----CCeEEccCccCC
Confidence            444433321  1  1237899999999999987    235666666664

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=3e-41  Score=389.46  Aligned_cols=250  Identities=23%  Similarity=0.333  Sum_probs=208.5

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEec
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  599 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  599 (814)
                      .|.+.++||+|+||.||+|....  .++.||||.+........+.+.+|+.+|+.++|||||++++++.+++..+|||||
T Consensus       158 ~Y~i~~~lG~G~fg~V~~~~~~~--tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          158 HYDIHEELGTGAFGVVHRVTERA--TGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccEEEEEEeeccCeEEEEEEECC--CCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            57788999999999999999763  6789999999765555566789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC--CcEEEeecCCccccccCCc
Q 041921          600 LNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDY--YTARISDFGLAKLLTLNQS  676 (814)
Q Consensus       600 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~--~~~kl~DfGla~~~~~~~~  676 (814)
                      |++|+|.++|... ..+++.....++.||+.||.|||++   +|+||||||+|||++.+  +.+||+|||+++.+.....
T Consensus       236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~  312 (573)
T 3uto_A          236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS  312 (573)
T ss_dssp             CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE
T ss_pred             cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCCCc
Confidence            9999999999654 6789999999999999999999998   99999999999999854  8999999999998764432


Q ss_pred             ccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCccc
Q 041921          677 KTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKE  756 (814)
Q Consensus       677 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  756 (814)
                         ....+||+.|||||++.+..++.++|||||||++|||++|+.||......+       ....+..+.....      
T Consensus       313 ---~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~-------~~~~i~~~~~~~~------  376 (573)
T 3uto_A          313 ---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-------TLRNVKSCDWNMD------  376 (573)
T ss_dssp             ---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-------HHHHHHTTCCCCC------
T ss_pred             ---eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-------HHHHHHhCCCCCC------
Confidence               244679999999999999999999999999999999999999997654322       1122222221110      


Q ss_pred             ccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          757 AMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       757 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      ..........+.+|+.+||+.||.+|||+.|+++
T Consensus       377 ~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          377 DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             cccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0011123456789999999999999999999987

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=5.1e-41  Score=384.12  Aligned_cols=248  Identities=23%  Similarity=0.246  Sum_probs=200.3

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhH---HHHHHhhhccCCCCccceeeeecccccc
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREF---KNEVFVIGQTHHKNLVRLLGFCDEGQNR  593 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~---~~E~~~l~~l~h~niv~l~~~~~~~~~~  593 (814)
                      .+.+.++||+|+||.||+|....  .++.||||.+++..   ......+   ..++.+++.++|||||++++++.+.+..
T Consensus       190 df~i~k~LG~G~fG~V~la~~~~--tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          190 DFSVHRIIGRGGFGEVYGCRKAD--TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HeEEEEEEecccCeEEEEEEECC--CCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            35677899999999999999763  67899999996421   1222233   3446777788999999999999999999


Q ss_pred             eEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcccccc
Q 041921          594 LLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTL  673 (814)
Q Consensus       594 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~  673 (814)
                      +|||||+++|+|.++|.....+++.....++.||+.||.|||+.   +|+||||||+||||+.++.+||+|||+|+.+..
T Consensus       268 ylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~  344 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSK  344 (689)
T ss_dssp             EEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence            99999999999999999888899999999999999999999998   999999999999999999999999999987654


Q ss_pred             CCcccccccccCCCCccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeec
Q 041921          674 NQSKTIKTAIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVG  752 (814)
Q Consensus       674 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  752 (814)
                      ...    ...+||+.|||||++.. ..++.++|+|||||++|||++|+.||..........+    ........+.    
T Consensus       345 ~~~----~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i----~~~i~~~~~~----  412 (689)
T 3v5w_A          345 KKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTLTMAVE----  412 (689)
T ss_dssp             CCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHH----HHHHHHCCCC----
T ss_pred             CCC----CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH----HHhhcCCCCC----
Confidence            322    34679999999999964 5799999999999999999999999975443221111    1222222111    


Q ss_pred             CcccccCcHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 041921          753 EDKEAMNDIECLGKLVMVSIWCIQEDPSLRPT-----MKKVLQ  790 (814)
Q Consensus       753 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-----~~~vl~  790 (814)
                            .+.....++.+|+.+||+.||.+|++     ++||++
T Consensus       413 ------~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          413 ------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             ------CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             ------CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence                  11123467889999999999999998     677763

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2.7e-41  Score=362.24  Aligned_cols=265  Identities=28%  Similarity=0.455  Sum_probs=202.6

Q ss_pred             HHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeecccccce
Q 041921          517 EGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRL  594 (814)
Q Consensus       517 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  594 (814)
                      ....+.+.++||+|+||+||+|..    .+..||||.+....  ....+++.+|+.++++++||||+++++++.+....+
T Consensus        35 ~~~~y~i~~~lG~G~~g~V~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  110 (309)
T 3p86_A           35 PWCDLNIKEKIGAGSFGTVHRAEW----HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS  110 (309)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE----TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCE
T ss_pred             ChhHceeeeEeecCCCeEEEEEEE----CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceE
Confidence            345667788999999999999986    36789999986543  223457899999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHhcCCCC---CChhhHHHHHHHHHHHHHHhhhcCCCC--eeecCCCCCcEEEcCCCcEEEeecCCcc
Q 041921          595 LVYEFLNNGTLASFLFGNLK---PNWNLRTNIAFQIARGLLYLHEDCRAQ--IIHCDIKPQNILLDDYYTARISDFGLAK  669 (814)
Q Consensus       595 lv~e~~~~gsL~~~l~~~~~---l~~~~~~~i~~~ia~~l~yLH~~~~~~--i~H~dlkp~NIll~~~~~~kl~DfGla~  669 (814)
                      +||||+++++|.+++.....   +++..++.++.|++.||+|||+.   +  |+||||||+|||++.++.+||+|||+++
T Consensus       111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~  187 (309)
T 3p86_A          111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR  187 (309)
T ss_dssp             EEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred             EEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence            99999999999999987643   89999999999999999999998   7  9999999999999999999999999998


Q ss_pred             ccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccce
Q 041921          670 LLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNV  749 (814)
Q Consensus       670 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  749 (814)
                      ........  .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+...   .+  .......  
T Consensus       188 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~---~~--~~~~~~~--  258 (309)
T 3p86_A          188 LKASTFLS--SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVA---AV--GFKCKRL--  258 (309)
T ss_dssp             ----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH---HH--HHSCCCC--
T ss_pred             cccccccc--cccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HH--HhcCCCC--
Confidence            65433211  134569999999999999999999999999999999999999997554322111   00  0011110  


Q ss_pred             eecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCCCCCCCC
Q 041921          750 LVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVPPNPY  805 (814)
Q Consensus       750 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~~~~p~~p~  805 (814)
                              ..+......+.+++.+||+.||.+|||++++++.|+.+.+-..||.++
T Consensus       259 --------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~~~  306 (309)
T 3p86_A          259 --------EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNR  306 (309)
T ss_dssp             --------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--------
T ss_pred             --------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCCCc
Confidence                    111223467889999999999999999999999999988776666544

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=3e-40  Score=363.20  Aligned_cols=261  Identities=26%  Similarity=0.411  Sum_probs=212.9

Q ss_pred             HhhhccccceeeeeeeeEEEEEEec-----CCCceEEEEEEecccc-ccchHhHHHHHHhhhcc-CCCCccceeeeeccc
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQT-----RTSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEG  590 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~-----~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  590 (814)
                      ...+.+.+.||+|+||.||+|....     ...+..||||.++... ....+++.+|+.+++++ +||||+++++++.+.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            4566778899999999999998752     1346689999997543 23345799999999999 899999999999999


Q ss_pred             ccceEEEecCCCCCHHHHhcCCC----------------CCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE
Q 041921          591 QNRLLVYEFLNNGTLASFLFGNL----------------KPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILL  654 (814)
Q Consensus       591 ~~~~lv~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll  654 (814)
                      +..++||||+++|+|.+++....                .+++..+..++.||+.||.|||+.   +|+||||||+|||+
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEE
Confidence            99999999999999999997542                478899999999999999999998   99999999999999


Q ss_pred             cCCCcEEEeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhh
Q 041921          655 DDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAI  733 (814)
Q Consensus       655 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~  733 (814)
                      +.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+.  
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~--  314 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL--  314 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH--
Confidence            9999999999999987654433222234457889999999999999999999999999999999 9999975433221  


Q ss_pred             HHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 041921          734 LTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE  797 (814)
Q Consensus       734 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~  797 (814)
                           ...+..+...         ..+......+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       315 -----~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~  364 (370)
T 2psq_A          315 -----FKLLKEGHRM---------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT  364 (370)
T ss_dssp             -----HHHHHTTCCC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----HHHHhcCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                 1122222111         1122345678899999999999999999999999998654

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.5e-40  Score=356.98  Aligned_cols=258  Identities=26%  Similarity=0.421  Sum_probs=211.3

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEe
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE  598 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  598 (814)
                      ..+.+.++||+|+||+||+|....  .+..||+|++........+.+.+|++++++++||||+++++++.+++..++|||
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~--~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   87 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRE--TGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE   87 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETT--TCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hHeeccceecCCCCEEEEEEEECC--CCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence            456778899999999999999753  578999999876656667789999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcc
Q 041921          599 FLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSK  677 (814)
Q Consensus       599 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  677 (814)
                      |+++++|.+++.. ...+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++........
T Consensus        88 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  164 (310)
T 3s95_A           88 YIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ  164 (310)
T ss_dssp             CCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred             ecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence            9999999999987 46789999999999999999999998   9999999999999999999999999999876543221


Q ss_pred             cc------------cccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhh---hHHHHHHHHh
Q 041921          678 TI------------KTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA---ILTDWAFDCY  742 (814)
Q Consensus       678 ~~------------~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~---~~~~~~~~~~  742 (814)
                      ..            .....||+.|+|||.+.+..++.++||||||+++|||++|..|+.........   .......   
T Consensus       165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~---  241 (310)
T 3s95_A          165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD---  241 (310)
T ss_dssp             ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH---
T ss_pred             ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc---
Confidence            10            01456999999999999999999999999999999999999998643321110   0000000   


Q ss_pred             hcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 041921          743 RNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV  798 (814)
Q Consensus       743 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~~  798 (814)
                                    ...+...+..+.+++.+||+.||++|||++++++.|+.+..-
T Consensus       242 --------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~  283 (310)
T 3s95_A          242 --------------RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH  283 (310)
T ss_dssp             --------------HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --------------ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence                          001122345688899999999999999999999999886543

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=2.7e-40  Score=357.13  Aligned_cols=268  Identities=23%  Similarity=0.425  Sum_probs=214.6

Q ss_pred             HHHHhhhccccceeeeeeeeEEEEEEecCC-CceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccceeeeeccccc
Q 041921          515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRT-STTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQN  592 (814)
Q Consensus       515 ~l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  592 (814)
                      ++....+.+.+.||+|+||.||+|.+...+ .+..||||.++... ....+.+.+|+.++++++||||+++++++.+.+.
T Consensus        45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  124 (325)
T 3kul_A           45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL  124 (325)
T ss_dssp             BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGC
T ss_pred             ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCc
Confidence            344566778899999999999999986432 35679999997542 3344679999999999999999999999999999


Q ss_pred             ceEEEecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcccc
Q 041921          593 RLLVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLL  671 (814)
Q Consensus       593 ~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~  671 (814)
                      .++||||+++++|.+++... ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus       125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  201 (325)
T 3kul_A          125 AMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVL  201 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             cEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence            99999999999999999755 6789999999999999999999998   9999999999999999999999999999877


Q ss_pred             ccCCccc-ccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccce
Q 041921          672 TLNQSKT-IKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNV  749 (814)
Q Consensus       672 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  749 (814)
                      ....... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+.       ...+..+.   
T Consensus       202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~-------~~~~~~~~---  271 (325)
T 3kul_A          202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV-------ISSVEEGY---  271 (325)
T ss_dssp             C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH-------HHHHHTTC---
T ss_pred             ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHH-------HHHHHcCC---
Confidence            5433221 1123346788999999998999999999999999999999 9999965433221       11122221   


Q ss_pred             eecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCCCC
Q 041921          750 LVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVP  801 (814)
Q Consensus       750 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~~~~p  801 (814)
                            ....+...+..+.+++.+||+.||.+|||+.+++++|+.+...+..
T Consensus       272 ------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~  317 (325)
T 3kul_A          272 ------RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES  317 (325)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred             ------CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence                  0111223456788999999999999999999999999987665443

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.3e-39  Score=347.17  Aligned_cols=250  Identities=26%  Similarity=0.363  Sum_probs=207.9

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEe
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE  598 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  598 (814)
                      ..|.+.++||+|+||+||+|...  ..++.||||++........+.+.+|+.++++++||||+++++++...+..++|||
T Consensus        20 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   97 (297)
T 3fxz_A           20 KKYTRFEKIGQGASGTVYTAMDV--ATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (297)
T ss_dssp             GTBCCCEEEEEETTEEEEEEEBT--TTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hceeeeeeeccCCCeEEEEEEEC--CCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence            45667789999999999999854  3678999999976656666789999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccc
Q 041921          599 FLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT  678 (814)
Q Consensus       599 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  678 (814)
                      |+++++|.+++... .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++......... 
T Consensus        98 ~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-  172 (297)
T 3fxz_A           98 YLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-  172 (297)
T ss_dssp             CCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC-
T ss_pred             CCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc-
Confidence            99999999999765 588999999999999999999998   9999999999999999999999999999876544322 


Q ss_pred             ccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCccccc
Q 041921          679 IKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAM  758 (814)
Q Consensus       679 ~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  758 (814)
                       .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.........      ......+..        ...
T Consensus       173 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~------~~~~~~~~~--------~~~  237 (297)
T 3fxz_A          173 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL------YLIATNGTP--------ELQ  237 (297)
T ss_dssp             -BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHHHHCSC--------CCS
T ss_pred             -cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHHhCCCC--------CCC
Confidence             24456999999999999999999999999999999999999999754332211      111111111        011


Q ss_pred             CcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          759 NDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       759 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      .+......+.+++.+||+.||.+|||++++++
T Consensus       238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          238 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            12234567889999999999999999999986

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=3.4e-39  Score=345.73  Aligned_cols=278  Identities=38%  Similarity=0.629  Sum_probs=224.1

Q ss_pred             cccccCHHHHHHhhhcccc--------ceeeeeeeeEEEEEEecCCCceEEEEEEecccc----ccchHhHHHHHHhhhc
Q 041921          507 NLRCFSYKELEGATNNFKE--------EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF----QDGEREFKNEVFVIGQ  574 (814)
Q Consensus       507 ~~~~~~~~~l~~~~~~~~~--------~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~  574 (814)
                      ....|++.++..++.+|.+        .||+|+||.||+|..    .+..||||++....    ....+.+.+|+.++++
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~   86 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV----NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAK   86 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES----SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHH
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE----CCceEEEEEEecccCcchHHHHHHHHHHHHHHHh
Confidence            4578999999999999864        599999999999985    36789999986432    2234678999999999


Q ss_pred             cCCCCccceeeeecccccceEEEecCCCCCHHHHhcC---CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCc
Q 041921          575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFG---NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQN  651 (814)
Q Consensus       575 l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~---~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~N  651 (814)
                      ++||||+++++++.+.+..++||||+++++|.+++..   ...+++..+..++.|++.||.|||+.   +|+||||||+|
T Consensus        87 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~N  163 (307)
T 2nru_A           87 CQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSAN  163 (307)
T ss_dssp             CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGG
T ss_pred             cCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHH
Confidence            9999999999999999999999999999999999864   35689999999999999999999998   99999999999


Q ss_pred             EEEcCCCcEEEeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhh
Q 041921          652 ILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY  731 (814)
Q Consensus       652 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~  731 (814)
                      |+++.++.+||+|||++................||+.|+|||.+.+ .++.++||||||+++|||++|+.||........
T Consensus       164 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~  242 (307)
T 2nru_A          164 ILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL  242 (307)
T ss_dssp             EEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB
T ss_pred             EEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH
Confidence            9999999999999999987654333322244568999999998865 578999999999999999999999975443221


Q ss_pred             hhHHHHHHHHhhc--CccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 041921          732 AILTDWAFDCYRN--GKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV  796 (814)
Q Consensus       732 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~  796 (814)
                      .  ..+ ...+..  ..+...++... ..........+.+++.+||+.+|.+|||++++++.|+++.
T Consensus       243 ~--~~~-~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          243 L--LDI-KEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             T--THH-HHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             H--HHH-HHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            1  111 111111  11222222222 2235567889999999999999999999999999998764

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=5e-41  Score=357.89  Aligned_cols=270  Identities=25%  Similarity=0.414  Sum_probs=210.0

Q ss_pred             HHHHhhhccccceeeeeeeeEEEEEEe--cCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeeccc--
Q 041921          515 ELEGATNNFKEEVGRGSFGIVYKGVIQ--TRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEG--  590 (814)
Q Consensus       515 ~l~~~~~~~~~~LG~G~~g~Vy~~~~~--~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--  590 (814)
                      ++....+.+.++||+|+||+||+|.+.  +...+..||||++........+.+.+|+.++++++||||+++++++...  
T Consensus         6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   85 (295)
T 3ugc_A            6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR   85 (295)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH
T ss_pred             cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            344567788899999999999999864  2346789999999876555567899999999999999999999998654  


Q ss_pred             ccceEEEecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcc
Q 041921          591 QNRLLVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAK  669 (814)
Q Consensus       591 ~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~  669 (814)
                      ...++||||+++++|.+++... ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~  162 (295)
T 3ugc_A           86 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTK  162 (295)
T ss_dssp             TSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred             CceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence            4589999999999999999765 4589999999999999999999998   99999999999999999999999999998


Q ss_pred             ccccCCcc-cccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhh---------hhHHHHHH
Q 041921          670 LLTLNQSK-TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY---------AILTDWAF  739 (814)
Q Consensus       670 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~---------~~~~~~~~  739 (814)
                      ........ .......++..|+|||.+.+..++.++||||||+++|||++|..|+.....+..         ........
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (295)
T 3ugc_A          163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI  242 (295)
T ss_dssp             -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred             cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence            76543321 111234477789999999999999999999999999999999999864321100         00001111


Q ss_pred             HHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 041921          740 DCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV  796 (814)
Q Consensus       740 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~  796 (814)
                      ..+..+.         ....+...+.++.+++.+||+.||.+|||+++++++|+.+.
T Consensus       243 ~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~  290 (295)
T 3ugc_A          243 ELLKNNG---------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR  290 (295)
T ss_dssp             HHHHTTC---------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHhccC---------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            1111111         11122344578899999999999999999999999998764

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=7.3e-39  Score=345.33  Aligned_cols=261  Identities=24%  Similarity=0.332  Sum_probs=213.9

Q ss_pred             cccCHHHHHHhhhc------------cccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccC
Q 041921          509 RCFSYKELEGATNN------------FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTH  576 (814)
Q Consensus       509 ~~~~~~~l~~~~~~------------~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~  576 (814)
                      ..++++++..++..            ..++||+|+||.||+|....  +++.||||.+........+.+.+|+.++++++
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~--~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~  100 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKH--SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ  100 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEETTTCCSHHHHHHHHHHHTTCC
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECC--CCcEEEEEEEeccchhHHHHHHHHHHHHHhCC
Confidence            56788888877753            34579999999999999753  57899999997666666778999999999999


Q ss_pred             CCCccceeeeecccccceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC
Q 041921          577 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDD  656 (814)
Q Consensus       577 h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~  656 (814)
                      ||||+++++++...+..++||||+++++|.+++.. ..+++..+..++.|+++||.|||+.   +|+||||||+|||++.
T Consensus       101 h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~  176 (321)
T 2c30_A          101 HFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTL  176 (321)
T ss_dssp             CTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECT
T ss_pred             CCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECC
Confidence            99999999999999999999999999999999865 4689999999999999999999998   9999999999999999


Q ss_pred             CCcEEEeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHH
Q 041921          657 YYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD  736 (814)
Q Consensus       657 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~  736 (814)
                      ++.+||+|||++.........  .....||+.|+|||.+.+..++.++||||||+++|||++|+.||........     
T Consensus       177 ~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~-----  249 (321)
T 2c30_A          177 DGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA-----  249 (321)
T ss_dssp             TCCEEECCCTTCEECCSSSCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----
T ss_pred             CCcEEEeeeeeeeecccCccc--cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----
Confidence            999999999999876543222  1345699999999999999999999999999999999999999975433221     


Q ss_pred             HHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          737 WAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       737 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                        ...+.......       ..........+.+++.+||+.||.+|||++++++.
T Consensus       250 --~~~~~~~~~~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          250 --MKRLRDSPPPK-------LKNSHKVSPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             --HHHHHHSSCCC-------CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             --HHHHhcCCCCC-------cCccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              11111111111       11122334678899999999999999999999873

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2.2e-40  Score=357.55  Aligned_cols=270  Identities=27%  Similarity=0.378  Sum_probs=208.3

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeeccccc----ce
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQN----RL  594 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----~~  594 (814)
                      ..+.+.++||+|+||.||+|...    +..||||++... ......+..|+.++++++||||+++++++.+...    .+
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~----~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   98 (322)
T 3soc_A           24 MPLQLLEVKARGRFGCVWKAQLL----NEYVAVKIFPIQ-DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW   98 (322)
T ss_dssp             EEEEEEEEEECSTTCEEEEEEET----TEEEEEEEECGG-GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             hhchhhheecccCceEEEEEEEC----CCEEEEEEeecC-chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence            45677889999999999999864    689999999653 2333456779999999999999999999987543    69


Q ss_pred             EEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcC-------CCCeeecCCCCCcEEEcCCCcEEEeecCC
Q 041921          595 LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDC-------RAQIIHCDIKPQNILLDDYYTARISDFGL  667 (814)
Q Consensus       595 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~-------~~~i~H~dlkp~NIll~~~~~~kl~DfGl  667 (814)
                      +||||+++|+|.+++... .+++..+..++.|++.||+|||+.+       ..+|+||||||+|||++.++.+||+|||+
T Consensus        99 lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~  177 (322)
T 3soc_A           99 LITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL  177 (322)
T ss_dssp             EEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             EEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCc
Confidence            999999999999999764 4899999999999999999999752       23899999999999999999999999999


Q ss_pred             ccccccCCcccccccccCCCCccccccccc-----CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHH-------
Q 041921          668 AKLLTLNQSKTIKTAIRGTKGYVAPEWFRN-----SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILT-------  735 (814)
Q Consensus       668 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~-------  735 (814)
                      ++...............||+.|+|||.+.+     ..++.++||||||+++|||++|+.||............       
T Consensus       178 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~  257 (322)
T 3soc_A          178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP  257 (322)
T ss_dssp             CEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSC
T ss_pred             ccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCC
Confidence            987765443333344679999999999986     35667899999999999999999999754332111000       


Q ss_pred             --HHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 041921          736 --DWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE  797 (814)
Q Consensus       736 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~  797 (814)
                        .................   ........+.++.+++.+||+.||++|||++++++.|+.+.+
T Consensus       258 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~  318 (322)
T 3soc_A          258 SLEDMQEVVVHKKKRPVLR---DYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR  318 (322)
T ss_dssp             CHHHHHHHHTTSCCCCCCC---GGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             chhhhhhhhhcccCCCCcc---ccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence              00111111111111111   111233566789999999999999999999999999987654

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1e-39  Score=342.68  Aligned_cols=259  Identities=25%  Similarity=0.411  Sum_probs=212.5

Q ss_pred             HHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceE
Q 041921          516 LEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL  595 (814)
Q Consensus       516 l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  595 (814)
                      +....+.+.+.||+|+||.||+|...   ++..||||.+... ....+++.+|+.++.+++||||+++++++.+....++
T Consensus         5 l~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   80 (268)
T 3sxs_A            5 LKREEITLLKELGSGQFGVVKLGKWK---GQYDVAVKMIKEG-SMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYI   80 (268)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEET---TTEEEEEEEECBT-TBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred             echhheeeeeeeccCCCceEEEEEec---CceeEEEEEeccC-CCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEE
Confidence            34566778899999999999999875   4678999999754 3345679999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccC
Q 041921          596 VYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN  674 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~  674 (814)
                      ||||+++++|.+++... ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++......
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  157 (268)
T 3sxs_A           81 VTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD  157 (268)
T ss_dssp             EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred             EEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence            99999999999999765 4589999999999999999999998   9999999999999999999999999999876544


Q ss_pred             CcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeecC
Q 041921          675 QSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGE  753 (814)
Q Consensus       675 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  753 (814)
                      ..... ....+|..|+|||.+.+..++.++||||||++++||++ |+.||......+.       ...+..+....    
T Consensus       158 ~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-------~~~~~~~~~~~----  225 (268)
T 3sxs_A          158 QYVSS-VGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV-------VLKVSQGHRLY----  225 (268)
T ss_dssp             CEEEC-CSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-------HHHHHTTCCCC----
T ss_pred             hhhcc-cCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHH-------HHHHHcCCCCC----
Confidence            32221 33446778999999998899999999999999999999 9999975443221       11111211100    


Q ss_pred             cccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 041921          754 DKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV  798 (814)
Q Consensus       754 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~~  798 (814)
                           .+......+.+++.+||+.+|.+|||+.++++.|+.+.+-
T Consensus       226 -----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          226 -----RPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             -----CCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             -----CCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence                 1112245788999999999999999999999999988654

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2e-39  Score=350.20  Aligned_cols=247  Identities=24%  Similarity=0.369  Sum_probs=206.1

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEE
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY  597 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  597 (814)
                      .|.+.+.||+|+||.||+|....  .++.||||++....  ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        16 ~y~~~~~lG~G~~g~V~~a~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           16 NYRLLKTIGKGNFAKVKLARHIL--TGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CEEEEEEEeeCCCEEEEEEEECC--CCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            46678899999999999999753  57899999996532  233456889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcc
Q 041921          598 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSK  677 (814)
Q Consensus       598 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  677 (814)
                      ||+++++|.+++.....+++.....++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++........ 
T Consensus        94 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-  169 (328)
T 3fe3_A           94 EYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK-  169 (328)
T ss_dssp             CCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG-
T ss_pred             ECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCc-
Confidence            9999999999998888899999999999999999999998   999999999999999999999999999987654322 


Q ss_pred             cccccccCCCCcccccccccCCCC-cchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCccc
Q 041921          678 TIKTAIRGTKGYVAPEWFRNSKIT-AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKE  756 (814)
Q Consensus       678 ~~~~~~~gt~~y~aPE~~~~~~~s-~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  756 (814)
                        .....||+.|+|||.+.+..+. .++|||||||++|||++|+.||......+       ....+..+....       
T Consensus       170 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-------~~~~i~~~~~~~-------  233 (328)
T 3fe3_A          170 --LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE-------LRERVLRGKYRI-------  233 (328)
T ss_dssp             --GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCCC-------
T ss_pred             --cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCCC-------
Confidence              2456799999999999888765 78999999999999999999997554322       112222222211       


Q ss_pred             ccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          757 AMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       757 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                         +......+.+++.+||+.||.+|||++++++.
T Consensus       234 ---p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          234 ---PFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             ---CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             ---CCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence               11234567889999999999999999999863

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=3.6e-40  Score=361.57  Aligned_cols=264  Identities=27%  Similarity=0.383  Sum_probs=211.7

Q ss_pred             HHHhhhccccceeeeeeeeEEEEEEec---CCCceEEEEEEeccccc-cchHhHHHHHHhhhcc-CCCCccceeeeeccc
Q 041921          516 LEGATNNFKEEVGRGSFGIVYKGVIQT---RTSTTAVAVKKLDRVFQ-DGEREFKNEVFVIGQT-HHKNLVRLLGFCDEG  590 (814)
Q Consensus       516 l~~~~~~~~~~LG~G~~g~Vy~~~~~~---~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  590 (814)
                      +....+.+.++||+|+||.||+|.+..   ...++.||||+++.... ...+.+.+|++++.++ +||||+++++++.+.
T Consensus        19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~   98 (359)
T 3vhe_A           19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP   98 (359)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred             ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC
Confidence            345567778999999999999998652   34568999999975432 2345799999999999 899999999999875


Q ss_pred             cc-ceEEEecCCCCCHHHHhcCCCC-------------------------------------------------------
Q 041921          591 QN-RLLVYEFLNNGTLASFLFGNLK-------------------------------------------------------  614 (814)
Q Consensus       591 ~~-~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------  614 (814)
                      +. .++||||+++|+|.+++.....                                                       
T Consensus        99 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  178 (359)
T 3vhe_A           99 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE  178 (359)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------------
T ss_pred             CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhh
Confidence            54 8999999999999999976432                                                       


Q ss_pred             -----------CChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcccccccc
Q 041921          615 -----------PNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAI  683 (814)
Q Consensus       615 -----------l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~  683 (814)
                                 +++..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++..............
T Consensus       179 ~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  255 (359)
T 3vhe_A          179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA  255 (359)
T ss_dssp             -----CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--C
T ss_pred             cccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhcccc
Confidence                       78889999999999999999998   9999999999999999999999999999876544333333455


Q ss_pred             cCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCcHH
Q 041921          684 RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIE  762 (814)
Q Consensus       684 ~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  762 (814)
                      .||..|+|||.+.+..++.++||||||+++|||++ |+.||......+.      ....+..+....         .+..
T Consensus       256 ~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~------~~~~~~~~~~~~---------~~~~  320 (359)
T 3vhe_A          256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRRLKEGTRMR---------APDY  320 (359)
T ss_dssp             EECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH------HHHHHHHTCCCC---------CCTT
T ss_pred             CCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH------HHHHHHcCCCCC---------CCCC
Confidence            68999999999999999999999999999999998 9999975443221      111222221111         1112


Q ss_pred             HHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 041921          763 CLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE  797 (814)
Q Consensus       763 ~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~  797 (814)
                      ...++.+++.+||+.||.+|||++++++.|+.+++
T Consensus       321 ~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  355 (359)
T 3vhe_A          321 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  355 (359)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence            34678899999999999999999999999987653

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2.1e-40  Score=365.66  Aligned_cols=259  Identities=25%  Similarity=0.387  Sum_probs=209.9

Q ss_pred             HHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc-cchHhHHHHHHhhhccCCCCccceeeeecccccceE
Q 041921          517 EGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL  595 (814)
Q Consensus       517 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  595 (814)
                      ....+.+.++||+|+||.||+|....  ++..||||.++.... ...++|.+|+.++++++||||+++++++.+.+..++
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  189 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRA--DNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI  189 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETT--TCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEec--CCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence            34556778999999999999999763  567999999875422 234578999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccC
Q 041921          596 VYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN  674 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~  674 (814)
                      ||||+++|+|.+++... ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus       190 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~  266 (377)
T 3cbl_A          190 VMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADG  266 (377)
T ss_dssp             EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence            99999999999999764 4588999999999999999999998   9999999999999999999999999999865432


Q ss_pred             CcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeecC
Q 041921          675 QSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGE  753 (814)
Q Consensus       675 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  753 (814)
                      ..........++..|+|||.+....++.++||||||+++|||++ |+.||......+       +...+..+..      
T Consensus       267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~~~------  333 (377)
T 3cbl_A          267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ-------TREFVEKGGR------  333 (377)
T ss_dssp             EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH-------HHHHHHTTCC------
T ss_pred             ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCC------
Confidence            22111122235778999999998899999999999999999998 999997543322       1122222211      


Q ss_pred             cccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 041921          754 DKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV  796 (814)
Q Consensus       754 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~  796 (814)
                         .+.+...+..+.+++.+||+.||.+|||++++++.|+.+.
T Consensus       334 ---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~  373 (377)
T 3cbl_A          334 ---LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR  373 (377)
T ss_dssp             ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence               0112224567889999999999999999999999998764

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2.9e-39  Score=344.02  Aligned_cols=267  Identities=24%  Similarity=0.332  Sum_probs=211.6

Q ss_pred             HhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc---cchHhHHHHHHhhhccCCCCccceeeeecccccce
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ---DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRL  594 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  594 (814)
                      ...|.+.+.||+|+||.||+|...  ..+..||||.+.....   ...+.+.+|+.++.+++||||+++++++.+++..+
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~   87 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDT--ILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYY   87 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEET--TTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEEC--CCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEE
Confidence            345778899999999999999865  3578899999854322   23357899999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccC
Q 041921          595 LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN  674 (814)
Q Consensus       595 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~  674 (814)
                      +||||+++++|.+++.....+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        88 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  164 (294)
T 4eqm_A           88 LVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET  164 (294)
T ss_dssp             EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred             EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence            9999999999999998888899999999999999999999998   9999999999999999999999999999876543


Q ss_pred             CcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCc
Q 041921          675 QSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGED  754 (814)
Q Consensus       675 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  754 (814)
                      .... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||........      ....+.... ..     
T Consensus       165 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~~~~~-~~-----  231 (294)
T 4eqm_A          165 SLTQ-TNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI------AIKHIQDSV-PN-----  231 (294)
T ss_dssp             -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH------HHHHHSSCC-CC-----
T ss_pred             cccc-cCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhhccC-CC-----
Confidence            2221 1345699999999999999999999999999999999999999975543221      111111111 10     


Q ss_pred             ccccCcHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHhcCcCCCCCC
Q 041921          755 KEAMNDIECLGKLVMVSIWCIQEDPSLRP-TMKKVLQMLEGVVEVSVPP  802 (814)
Q Consensus       755 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-t~~~vl~~L~~~~~~~~p~  802 (814)
                      .........+..+.+++.+||+.||.+|| +++++.+.|+.+.......
T Consensus       232 ~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~  280 (294)
T 4eqm_A          232 VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRAN  280 (294)
T ss_dssp             HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTT
T ss_pred             cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCC
Confidence            00111123456788999999999999998 9999999999876655444

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=4.9e-40  Score=361.74  Aligned_cols=263  Identities=25%  Similarity=0.459  Sum_probs=201.0

Q ss_pred             HHHhhhccccceeeeeeeeEEEEEEecC-CCceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccceeeeecccccc
Q 041921          516 LEGATNNFKEEVGRGSFGIVYKGVIQTR-TSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNR  593 (814)
Q Consensus       516 l~~~~~~~~~~LG~G~~g~Vy~~~~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  593 (814)
                      +....+.+.+.||+|+||.||+|.+... ..+..||||.++... ....++|.+|+.++++++||||+++++++.+.+..
T Consensus        42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  121 (373)
T 2qol_A           42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV  121 (373)
T ss_dssp             CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce
Confidence            3445667788999999999999987522 246789999997542 33446799999999999999999999999999999


Q ss_pred             eEEEecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccc
Q 041921          594 LLVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLT  672 (814)
Q Consensus       594 ~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~  672 (814)
                      ++||||+++++|.+++... ..+++..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus       122 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          122 MIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLE  198 (373)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence            9999999999999999865 4689999999999999999999998   99999999999999999999999999998765


Q ss_pred             cCCcccc-cccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCcccee
Q 041921          673 LNQSKTI-KTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVL  750 (814)
Q Consensus       673 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  750 (814)
                      ....... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+       +...+..+.    
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~-------~~~~i~~~~----  267 (373)
T 2qol_A          199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD-------VIKAVDEGY----  267 (373)
T ss_dssp             ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH-------HHHHHHTTE----
T ss_pred             cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCC----
Confidence            4332111 122235778999999999999999999999999999998 999996543222       111222221    


Q ss_pred             ecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 041921          751 VGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE  797 (814)
Q Consensus       751 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~  797 (814)
                           ........+..+.+++.+||+.||.+||++++|+++|+.+..
T Consensus       268 -----~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~  309 (373)
T 2qol_A          268 -----RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR  309 (373)
T ss_dssp             -----ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence                 011122345678999999999999999999999999987643

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=9.6e-40  Score=343.04  Aligned_cols=256  Identities=27%  Similarity=0.437  Sum_probs=210.5

Q ss_pred             HhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEE
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY  597 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  597 (814)
                      ...+.+.++||+|+||.||+|...   .+..||||++... ....+++.+|+.++++++||||+++++++.+.+..++||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWL---NKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF   84 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET---TTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             hhhceeeheecCCCccEEEEEEec---CCCeEEEEEeccc-ccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEE
Confidence            345677889999999999999975   4678999999754 334567999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCc
Q 041921          598 EFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS  676 (814)
Q Consensus       598 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  676 (814)
                      ||+++++|.+++... ..+++..+..++.|+++||.|||+.   +|+||||||+||+++.++.+||+|||++........
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  161 (269)
T 4hcu_A           85 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY  161 (269)
T ss_dssp             ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred             EeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccccc
Confidence            999999999999754 5689999999999999999999998   999999999999999999999999999986654322


Q ss_pred             ccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcc
Q 041921          677 KTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDK  755 (814)
Q Consensus       677 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  755 (814)
                      .. .....+|..|+|||.+.+..++.++||||||++++||++ |+.||......+.       ...+..+...       
T Consensus       162 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~-------~~~~~~~~~~-------  226 (269)
T 4hcu_A          162 TS-STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV-------VEDISTGFRL-------  226 (269)
T ss_dssp             HS-TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-------HHHHHTTCCC-------
T ss_pred             cc-ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHH-------HHHHhcCccC-------
Confidence            11 133457788999999998999999999999999999999 9999975433221       1112222100       


Q ss_pred             cccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 041921          756 EAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE  797 (814)
Q Consensus       756 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~  797 (814)
                        ..+......+.+++.+||+.||.+|||++++++.|+++.+
T Consensus       227 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          227 --YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence              0111234678899999999999999999999999988654

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=7.9e-40  Score=354.00  Aligned_cols=261  Identities=24%  Similarity=0.393  Sum_probs=204.7

Q ss_pred             HHhhhccccceeeeeeeeEEEEEEecCCC--ceEEEEEEeccc-cccchHhHHHHHHhhhccCCCCccceeeeecccccc
Q 041921          517 EGATNNFKEEVGRGSFGIVYKGVIQTRTS--TTAVAVKKLDRV-FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNR  593 (814)
Q Consensus       517 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~--~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  593 (814)
                      ....+.+.++||+|+||+||+|.....+.  ...||+|.+... .....+++.+|+.++++++||||+++++++.+. ..
T Consensus        13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~   91 (327)
T 3poz_A           13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV   91 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SE
T ss_pred             CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-Ce
Confidence            34556778899999999999999754322  235789988643 234557899999999999999999999999875 47


Q ss_pred             eEEEecCCCCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccc
Q 041921          594 LLVYEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLT  672 (814)
Q Consensus       594 ~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~  672 (814)
                      ++|+||+++|+|.+++.. ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus        92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  168 (327)
T 3poz_A           92 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred             EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence            899999999999999976 46789999999999999999999998   99999999999999999999999999998776


Q ss_pred             cCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceee
Q 041921          673 LNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLV  751 (814)
Q Consensus       673 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  751 (814)
                      ............+|..|+|||.+.+..++.++||||||+++|||++ |+.||.........       ..+..+..    
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-------~~~~~~~~----  237 (327)
T 3poz_A          169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-------SILEKGER----  237 (327)
T ss_dssp             TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-------HHHHTTCC----
T ss_pred             CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHH-------HHHHcCCC----
Confidence            5443333344557889999999999999999999999999999999 99999765433311       11112110    


Q ss_pred             cCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 041921          752 GEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE  797 (814)
Q Consensus       752 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~  797 (814)
                           ..........+.+++.+||+.+|.+|||+.++++.|+.+..
T Consensus       238 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          238 -----LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             -----CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             -----CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                 11122344678899999999999999999999999977543

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-39  Score=359.30  Aligned_cols=269  Identities=28%  Similarity=0.400  Sum_probs=218.0

Q ss_pred             HHHHhhhccccceeeeeeeeEEEEEEecC-----CCceEEEEEEecccc-ccchHhHHHHHHhhhcc-CCCCccceeeee
Q 041921          515 ELEGATNNFKEEVGRGSFGIVYKGVIQTR-----TSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQT-HHKNLVRLLGFC  587 (814)
Q Consensus       515 ~l~~~~~~~~~~LG~G~~g~Vy~~~~~~~-----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  587 (814)
                      ++....+.+.++||+|+||.||+|.....     ..+..||||++.... ....+++.+|+++++++ +||||+++++++
T Consensus        65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  144 (382)
T 3tt0_A           65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC  144 (382)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence            44556778889999999999999987532     234689999997543 23346789999999999 999999999999


Q ss_pred             cccccceEEEecCCCCCHHHHhcCCC----------------CCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCc
Q 041921          588 DEGQNRLLVYEFLNNGTLASFLFGNL----------------KPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQN  651 (814)
Q Consensus       588 ~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~N  651 (814)
                      .+.+..++||||+++++|.+++....                .+++..++.++.||+.||.|||+.   +|+||||||+|
T Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~N  221 (382)
T 3tt0_A          145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARN  221 (382)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGG
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcce
Confidence            99999999999999999999997543                488999999999999999999998   99999999999


Q ss_pred             EEEcCCCcEEEeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchh
Q 041921          652 ILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEE  730 (814)
Q Consensus       652 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~  730 (814)
                      ||++.++.+||+|||+++...............+|..|+|||.+.+..++.++||||||++++||++ |+.||......+
T Consensus       222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~  301 (382)
T 3tt0_A          222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE  301 (382)
T ss_dssp             EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999987654433222244557889999999999999999999999999999999 999997543322


Q ss_pred             hhhHHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCCCCC
Q 041921          731 YAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVPP  802 (814)
Q Consensus       731 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~~~~p~  802 (814)
                             +...+..+....         .+.....++.+++.+||+.||.+|||++++++.|+.+.......
T Consensus       302 -------~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~  357 (382)
T 3tt0_A          302 -------LFKLLKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ  357 (382)
T ss_dssp             -------HHHHHHTTCCCC---------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSC
T ss_pred             -------HHHHHHcCCCCC---------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcC
Confidence                   122222221111         11223467889999999999999999999999999877654433

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.5e-39  Score=367.82  Aligned_cols=258  Identities=26%  Similarity=0.427  Sum_probs=211.4

Q ss_pred             HHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceE
Q 041921          516 LEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL  595 (814)
Q Consensus       516 l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  595 (814)
                      +....+.+.++||+|+||.||+|.+.   .+..||||+++.. ....++|.+|+.++++++||||+++++++. .+..++
T Consensus       185 i~~~~~~~~~~lG~G~fg~V~~~~~~---~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~l  259 (454)
T 1qcf_A          185 IPRESLKLEKKLGAGQFGEVWMATYN---KHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYI  259 (454)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEET---TTEEEEEEEECTT-SBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             echHHeEEEEEcccCCceEEEEEEEC---CccEEEEEEecCC-CccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEE
Confidence            33456677899999999999999985   4678999999764 345678999999999999999999999986 567899


Q ss_pred             EEecCCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcccccc
Q 041921          596 VYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTL  673 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~  673 (814)
                      ||||+++|+|.+++...  ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus       260 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~  336 (454)
T 1qcf_A          260 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIED  336 (454)
T ss_dssp             EECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred             EEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence            99999999999999764  3678899999999999999999998   999999999999999999999999999987653


Q ss_pred             CCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeec
Q 041921          674 NQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVG  752 (814)
Q Consensus       674 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  752 (814)
                      ..... .....++..|+|||.+....++.++||||||+++|||++ |+.||......+.       ...+..+..     
T Consensus       337 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~-------~~~i~~~~~-----  403 (454)
T 1qcf_A          337 NEYTA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV-------IRALERGYR-----  403 (454)
T ss_dssp             HHHHT-TCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-------HHHHHHTCC-----
T ss_pred             Cceec-cCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHHcCCC-----
Confidence            22111 133446789999999998999999999999999999999 9999975433221       111222210     


Q ss_pred             CcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 041921          753 EDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV  798 (814)
Q Consensus       753 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~~  798 (814)
                          .+.+...+..+.+++.+||+.||.+|||+++|+++|+.+...
T Consensus       404 ----~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~  445 (454)
T 1qcf_A          404 ----MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA  445 (454)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred             ----CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence                011223457788999999999999999999999999997654

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-39  Score=353.41  Aligned_cols=261  Identities=26%  Similarity=0.411  Sum_probs=213.1

Q ss_pred             HhhhccccceeeeeeeeEEEEEEecC---CCceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccceeeeecccccc
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQTR---TSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNR  593 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~~---~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  593 (814)
                      ...+.+.+.||+|+||.||+|.....   ..+..||||.++... ....+.+.+|+.++++++||||+++++++.+.+..
T Consensus        46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  125 (343)
T 1luf_A           46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM  125 (343)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred             HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCce
Confidence            45667788999999999999998632   245899999997543 23346799999999999999999999999999999


Q ss_pred             eEEEecCCCCCHHHHhcCC------------------------CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCC
Q 041921          594 LLVYEFLNNGTLASFLFGN------------------------LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKP  649 (814)
Q Consensus       594 ~lv~e~~~~gsL~~~l~~~------------------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp  649 (814)
                      ++||||+++++|.+++...                        ..+++..++.++.||++||.|||+.   +|+||||||
T Consensus       126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp  202 (343)
T 1luf_A          126 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLAT  202 (343)
T ss_dssp             EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred             EEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCc
Confidence            9999999999999999753                        4688999999999999999999998   999999999


Q ss_pred             CcEEEcCCCcEEEeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccc
Q 041921          650 QNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMG  728 (814)
Q Consensus       650 ~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~  728 (814)
                      +|||++.++.+||+|||+++...............+|..|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus       203 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  282 (343)
T 1luf_A          203 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH  282 (343)
T ss_dssp             GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred             ceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCCh
Confidence            999999999999999999987654332222234568899999999998899999999999999999999 9999975433


Q ss_pred             hhhhhHHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 041921          729 EEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE  797 (814)
Q Consensus       729 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~  797 (814)
                      .+       ....+..+.....         +...+..+.+++.+||+.||.+|||+.++++.|+++.+
T Consensus       283 ~~-------~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~  335 (343)
T 1luf_A          283 EE-------VIYYVRDGNILAC---------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  335 (343)
T ss_dssp             HH-------HHHHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             HH-------HHHHHhCCCcCCC---------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence            22       1122233322111         12234678899999999999999999999999998765

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.7e-39  Score=370.87  Aligned_cols=259  Identities=27%  Similarity=0.413  Sum_probs=214.0

Q ss_pred             HHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEE
Q 041921          517 EGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV  596 (814)
Q Consensus       517 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  596 (814)
                      ....+.+.++||+|+||.||+|.+..  .+..||||.++.. ....++|.+|+.++++++||||+++++++.+....+||
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~--~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  294 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKK--YSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII  294 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGG--GTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcC--CCeEEEEEEecCc-ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEE
Confidence            34556778999999999999999863  4689999999754 33467899999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccC
Q 041921          597 YEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN  674 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~  674 (814)
                      |||+++|+|.+++...  ..+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus       295 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  371 (495)
T 1opk_A          295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD  371 (495)
T ss_dssp             EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred             EEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence            9999999999999753  5688999999999999999999998   9999999999999999999999999999876543


Q ss_pred             CcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeecC
Q 041921          675 QSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGE  753 (814)
Q Consensus       675 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  753 (814)
                      .... .....++..|+|||.+....++.++||||||+++|||++ |+.||......+.       .+.+..+.       
T Consensus       372 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~-------~~~~~~~~-------  436 (495)
T 1opk_A          372 TYTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-------YELLEKDY-------  436 (495)
T ss_dssp             CEEC-CTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH-------HHHHHTTC-------
T ss_pred             ceee-cCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHHcCC-------
Confidence            2211 133446789999999999999999999999999999999 9999975443221       11122211       


Q ss_pred             cccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 041921          754 DKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV  798 (814)
Q Consensus       754 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~~  798 (814)
                        ....+...+..+.+++.+||+.||.+|||+.+|+++|+.+...
T Consensus       437 --~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~  479 (495)
T 1opk_A          437 --RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  479 (495)
T ss_dssp             --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred             --CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence              1111223457788999999999999999999999999987543

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=7.3e-40  Score=359.86  Aligned_cols=264  Identities=29%  Similarity=0.415  Sum_probs=211.1

Q ss_pred             HHHHhhhccccceeeeeeeeEEEEEEec---CCCceEEEEEEeccc-cccchHhHHHHHHhhhccCCCCccceeeeeccc
Q 041921          515 ELEGATNNFKEEVGRGSFGIVYKGVIQT---RTSTTAVAVKKLDRV-FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEG  590 (814)
Q Consensus       515 ~l~~~~~~~~~~LG~G~~g~Vy~~~~~~---~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  590 (814)
                      ++....+.+.++||+|+||.||+|.+..   ...+..||||++... ......++.+|+.++++++||||+++++++.+.
T Consensus        67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  146 (367)
T 3l9p_A           67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS  146 (367)
T ss_dssp             BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            3445667788999999999999999652   235678999999653 233445789999999999999999999999999


Q ss_pred             ccceEEEecCCCCCHHHHhcCC-------CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC---cE
Q 041921          591 QNRLLVYEFLNNGTLASFLFGN-------LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYY---TA  660 (814)
Q Consensus       591 ~~~~lv~e~~~~gsL~~~l~~~-------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~---~~  660 (814)
                      ...++||||+++|+|.+++...       ..+++..++.++.||+.||+|||+.   +|+||||||+|||++.++   .+
T Consensus       147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~  223 (367)
T 3l9p_A          147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVA  223 (367)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCE
T ss_pred             CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceE
Confidence            9999999999999999999753       3578999999999999999999998   999999999999999554   59


Q ss_pred             EEeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHH
Q 041921          661 RISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAF  739 (814)
Q Consensus       661 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~  739 (814)
                      ||+|||+++...............+|+.|+|||.+.+..++.++|||||||++|||++ |+.||......+       ..
T Consensus       224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~-------~~  296 (367)
T 3l9p_A          224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-------VL  296 (367)
T ss_dssp             EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-------HH
T ss_pred             EECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HH
Confidence            9999999986543332222234568999999999999999999999999999999998 999997543322       11


Q ss_pred             HHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 041921          740 DCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE  797 (814)
Q Consensus       740 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~  797 (814)
                      ..+..+...         ......+..+.+++.+||+.||.+|||+.+|++.|+.+..
T Consensus       297 ~~i~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~  345 (367)
T 3l9p_A          297 EFVTSGGRM---------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  345 (367)
T ss_dssp             HHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHcCCCC---------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence            222222111         0112234678899999999999999999999999977543

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=2.4e-39  Score=348.03  Aligned_cols=261  Identities=27%  Similarity=0.414  Sum_probs=213.1

Q ss_pred             HHhhhccccceeeeeeeeEEEEEEec---CCCceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccceeeeeccccc
Q 041921          517 EGATNNFKEEVGRGSFGIVYKGVIQT---RTSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQN  592 (814)
Q Consensus       517 ~~~~~~~~~~LG~G~~g~Vy~~~~~~---~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  592 (814)
                      ....+.+.+.||+|+||.||+|....   ...+..||||.+.... ....+.+.+|+.++++++||||+++++++.+.+.
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  100 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP  100 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence            34567778999999999999998742   2345899999997533 2334678999999999999999999999999999


Q ss_pred             ceEEEecCCCCCHHHHhcCCC------------------------CCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCC
Q 041921          593 RLLVYEFLNNGTLASFLFGNL------------------------KPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIK  648 (814)
Q Consensus       593 ~~lv~e~~~~gsL~~~l~~~~------------------------~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlk  648 (814)
                      .++||||+++++|.+++....                        .+++..++.++.||++||.|||+.   +|+|||||
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dik  177 (314)
T 2ivs_A          101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLA  177 (314)
T ss_dssp             CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCS
T ss_pred             eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccc
Confidence            999999999999999997643                        278889999999999999999998   99999999


Q ss_pred             CCcEEEcCCCcEEEeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCccc
Q 041921          649 PQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEM  727 (814)
Q Consensus       649 p~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~  727 (814)
                      |+||+++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus       178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  257 (314)
T 2ivs_A          178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP  257 (314)
T ss_dssp             GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999987654433322234457889999999998899999999999999999999 999997554


Q ss_pred             chhhhhHHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 041921          728 GEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV  796 (814)
Q Consensus       728 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~  796 (814)
                      ....       ...+..+...         ..+......+.+++.+||+.||.+|||+.++++.|+++.
T Consensus       258 ~~~~-------~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~  310 (314)
T 2ivs_A          258 PERL-------FNLLKTGHRM---------ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM  310 (314)
T ss_dssp             GGGH-------HHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHH-------HHHhhcCCcC---------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            3321       1222222111         111234567889999999999999999999999998764

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-39  Score=352.80  Aligned_cols=266  Identities=24%  Similarity=0.354  Sum_probs=213.0

Q ss_pred             HHHHhhhccccceeeeeeeeEEEEEEec---CCCceEEEEEEecccc-ccchHhHHHHHHhhhcc-CCCCccceeeeecc
Q 041921          515 ELEGATNNFKEEVGRGSFGIVYKGVIQT---RTSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQT-HHKNLVRLLGFCDE  589 (814)
Q Consensus       515 ~l~~~~~~~~~~LG~G~~g~Vy~~~~~~---~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  589 (814)
                      ++....+.+.+.||+|+||.||+|....   ...+..||||.+.... ....+.+.+|+.++.++ +||||+++++++.+
T Consensus        41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  120 (344)
T 1rjb_A           41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL  120 (344)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence            3445677788999999999999999742   2356789999997532 33456799999999999 89999999999999


Q ss_pred             cccceEEEecCCCCCHHHHhcCCC-----------------------CCChhhHHHHHHHHHHHHHHhhhcCCCCeeecC
Q 041921          590 GQNRLLVYEFLNNGTLASFLFGNL-----------------------KPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCD  646 (814)
Q Consensus       590 ~~~~~lv~e~~~~gsL~~~l~~~~-----------------------~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~d  646 (814)
                      .+..++||||+++|+|.+++....                       .+++..++.++.||+.||.|||+.   +|+|||
T Consensus       121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~D  197 (344)
T 1rjb_A          121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRD  197 (344)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETT
T ss_pred             CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCC
Confidence            999999999999999999997642                       268899999999999999999998   999999


Q ss_pred             CCCCcEEEcCCCcEEEeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCc
Q 041921          647 IKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDI  725 (814)
Q Consensus       647 lkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~  725 (814)
                      |||+|||++.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||+| |+.||..
T Consensus       198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  277 (344)
T 1rjb_A          198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG  277 (344)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence            999999999999999999999987765443333344557889999999998999999999999999999998 9999975


Q ss_pred             ccchhhhhHHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 041921          726 EMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV  798 (814)
Q Consensus       726 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~~  798 (814)
                      ......      ....+..+..         ...+......+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus       278 ~~~~~~------~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  335 (344)
T 1rjb_A          278 IPVDAN------FYKLIQNGFK---------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD  335 (344)
T ss_dssp             CCCSHH------HHHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             CCcHHH------HHHHHhcCCC---------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence            543221      1112222211         011122356788999999999999999999999999886543

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.4e-39  Score=342.67  Aligned_cols=258  Identities=25%  Similarity=0.402  Sum_probs=208.9

Q ss_pred             HHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceE
Q 041921          516 LEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL  595 (814)
Q Consensus       516 l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  595 (814)
                      +....+.+.++||+|+||.||++...   .+..||||.+... ....+++.+|+.++.+++||||+++++++.+.+..++
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   96 (283)
T 3gen_A           21 IDPKDLTFLKELGTGQFGVVKYGKWR---GQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI   96 (283)
T ss_dssp             CCGGGEEEEEECC---CEEEEEEEET---TTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             CCHHHHHhHhhcCCCCCceEEEEEEc---CCCeEEEEEecCC-CCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEE
Confidence            34456777899999999999999876   5678999999754 3345679999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccC
Q 041921          596 VYEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN  674 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~  674 (814)
                      ||||+++++|.+++.. ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++......
T Consensus        97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  173 (283)
T 3gen_A           97 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD  173 (283)
T ss_dssp             EECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred             EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence            9999999999999987 46789999999999999999999998   9999999999999999999999999999876543


Q ss_pred             CcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeecC
Q 041921          675 QSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGE  753 (814)
Q Consensus       675 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  753 (814)
                      .... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+.       ...+..+...     
T Consensus       174 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~-------~~~~~~~~~~-----  240 (283)
T 3gen_A          174 EYTS-SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET-------AEHIAQGLRL-----  240 (283)
T ss_dssp             HHHS-TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-------HHHHHTTCCC-----
T ss_pred             cccc-ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHH-------HHHHhcccCC-----
Confidence            2211 133446788999999998899999999999999999998 9999975443221       1112222110     


Q ss_pred             cccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 041921          754 DKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE  797 (814)
Q Consensus       754 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~  797 (814)
                          ..+......+.+++.+||+.+|.+|||++++++.|+++.+
T Consensus       241 ----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~  280 (283)
T 3gen_A          241 ----YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD  280 (283)
T ss_dssp             ----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence                0111224678899999999999999999999999987653

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2.3e-39  Score=343.90  Aligned_cols=260  Identities=24%  Similarity=0.396  Sum_probs=207.4

Q ss_pred             HHHHhhhccccceeeeeeeeEEEEEEecCCC-----ceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecc
Q 041921          515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTS-----TTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDE  589 (814)
Q Consensus       515 ~l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~-----~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  589 (814)
                      ++....+.+.+.||+|+||.||+|.....+.     ...||+|.+........+.+.+|+.++++++||||+++++++.+
T Consensus         4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   83 (289)
T 4fvq_A            4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVC   83 (289)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECC
T ss_pred             EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe
Confidence            3445677888999999999999999875332     26799999977666667789999999999999999999999999


Q ss_pred             cccceEEEecCCCCCHHHHhcCCCC-CChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCc--------E
Q 041921          590 GQNRLLVYEFLNNGTLASFLFGNLK-PNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYT--------A  660 (814)
Q Consensus       590 ~~~~~lv~e~~~~gsL~~~l~~~~~-l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~--------~  660 (814)
                      ++..++||||+++++|.+++..... +++..+..++.||+.||.|||+.   +|+||||||+|||++.++.        +
T Consensus        84 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~  160 (289)
T 4fvq_A           84 GDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFI  160 (289)
T ss_dssp             TTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred             CCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCccccccccee
Confidence            9999999999999999999987644 89999999999999999999998   9999999999999998877        9


Q ss_pred             EEeecCCccccccCCcccccccccCCCCccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHH
Q 041921          661 RISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF  739 (814)
Q Consensus       661 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  739 (814)
                      ||+|||++......      ....+|..|+|||.+.+ ..++.++||||||+++|||++|..|+.........      .
T Consensus       161 kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~------~  228 (289)
T 4fvq_A          161 KLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK------L  228 (289)
T ss_dssp             EECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH------H
T ss_pred             eeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHH------H
Confidence            99999998755322      23457899999999987 67899999999999999999965554332221110      0


Q ss_pred             HHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCCC
Q 041921          740 DCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSV  800 (814)
Q Consensus       740 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~~~~  800 (814)
                      ...... ..      .    +.....++.+++.+||+.||.+|||++++++.|+.+.....
T Consensus       229 ~~~~~~-~~------~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~  278 (289)
T 4fvq_A          229 QFYEDR-HQ------L----PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL  278 (289)
T ss_dssp             HHHHTT-CC------C----CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred             HHhhcc-CC------C----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence            111110 00      0    00113457789999999999999999999999999876433

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2.3e-38  Score=346.08  Aligned_cols=251  Identities=25%  Similarity=0.317  Sum_probs=206.5

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccccc------chHhHHHHHHhhhccCCCCccceeeeeccccc
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD------GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQN  592 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  592 (814)
                      ..|.+.+.||+|+||.||++....  ++..||||.+......      ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus        12 ~~y~~~~~LG~G~fg~V~~~~~~~--~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~   89 (361)
T 2yab_A           12 DFYDIGEELGSGQFAIVKKCREKS--TGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD   89 (361)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             hceEEeeEEeeCcCEEEEEEEECC--CCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence            456788999999999999999753  5789999999753321      24678999999999999999999999999999


Q ss_pred             ceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC----cEEEeecCCc
Q 041921          593 RLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYY----TARISDFGLA  668 (814)
Q Consensus       593 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~----~~kl~DfGla  668 (814)
                      .++||||+++++|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++    .+||+|||++
T Consensus        90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~a  166 (361)
T 2yab_A           90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (361)
T ss_dssp             EEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred             EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence            999999999999999998888899999999999999999999998   999999999999998776    7999999999


Q ss_pred             cccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccc
Q 041921          669 KLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLN  748 (814)
Q Consensus       669 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  748 (814)
                      ........   .....||+.|+|||++....++.++|||||||++|||++|..||......+.       ...+..+...
T Consensus       167 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~-------~~~i~~~~~~  236 (361)
T 2yab_A          167 HEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-------LANITAVSYD  236 (361)
T ss_dssp             EECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-------HHHHHTTCCC
T ss_pred             eEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhcCCC
Confidence            87654322   1345699999999999998999999999999999999999999975433221       1122222111


Q ss_pred             eeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          749 VLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       749 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      .  ...    ........+.+++.+||+.||.+|||+.++++
T Consensus       237 ~--~~~----~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          237 F--DEE----FFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             C--CHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             C--Cch----hccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            0  000    00123456889999999999999999999885

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=5.6e-39  Score=346.45  Aligned_cols=253  Identities=27%  Similarity=0.383  Sum_probs=204.5

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEe
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE  598 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  598 (814)
                      .|.+.+.||+|+||.||+|....  .++.||||.+.... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus         8 ~y~i~~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            8 DWDLVQTLGEGAYGEVQLAVNRV--TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hceeeeEEecCCCEEEEEEEECC--CCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            46778899999999999998753  57799999986432 2234678999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccc
Q 041921          599 FLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT  678 (814)
Q Consensus       599 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  678 (814)
                      |+++++|.+++.....+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++..+.......
T Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  162 (323)
T 3tki_A           86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  162 (323)
T ss_dssp             CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence            999999999999888899999999999999999999998   99999999999999999999999999998765443333


Q ss_pred             ccccccCCCCcccccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccc
Q 041921          679 IKTAIRGTKGYVAPEWFRNSKI-TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEA  757 (814)
Q Consensus       679 ~~~~~~gt~~y~aPE~~~~~~~-s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  757 (814)
                      ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||......... ...     +.....        ..
T Consensus       163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~-----~~~~~~--------~~  228 (323)
T 3tki_A          163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSD-----WKEKKT--------YL  228 (323)
T ss_dssp             CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-HHH-----HHTTCT--------TS
T ss_pred             ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-HHH-----Hhcccc--------cC
Confidence            3345679999999999987765 77899999999999999999999754432211 111     111110        00


Q ss_pred             cCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          758 MNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       758 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                      .........+.+++.+||+.||.+|||++|+++.
T Consensus       229 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          229 NPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            0112234667889999999999999999999864

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.1e-38  Score=343.28  Aligned_cols=248  Identities=23%  Similarity=0.269  Sum_probs=205.6

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccc---cccchHhHHHHHHhhhccCCCCccceeeeecccccceE
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV---FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL  595 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  595 (814)
                      ..+.+.+.||+|+||.||++...  ..++.||||.++..   .......+.+|+.++++++||||+++++++.+.+..++
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l   82 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREK--ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF   82 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEET--TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEC--CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence            34667789999999999999875  35789999999653   23345678999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCC
Q 041921          596 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ  675 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~  675 (814)
                      ||||+++|+|..++.....+++.....++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        83 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  159 (337)
T 1o6l_A           83 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             EEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence            999999999999998878899999999999999999999998   99999999999999999999999999998643322


Q ss_pred             cccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcc
Q 041921          676 SKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDK  755 (814)
Q Consensus       676 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  755 (814)
                      ..  .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.......       ....+..+.+.       
T Consensus       160 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-------~~~~i~~~~~~-------  223 (337)
T 1o6l_A          160 AT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-------LFELILMEEIR-------  223 (337)
T ss_dssp             CC--BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCC-------
T ss_pred             Cc--ccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCCC-------
Confidence            11  244579999999999999999999999999999999999999997543222       11112222111       


Q ss_pred             cccCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 041921          756 EAMNDIECLGKLVMVSIWCIQEDPSLRP-----TMKKVLQ  790 (814)
Q Consensus       756 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~~vl~  790 (814)
                         .+.....++.+++.+||+.||.+||     +++++++
T Consensus       224 ---~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          224 ---FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             ---CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ---CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence               1112346788999999999999999     8999875

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=4e-39  Score=363.91  Aligned_cols=260  Identities=28%  Similarity=0.440  Sum_probs=207.2

Q ss_pred             HHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEE
Q 041921          517 EGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV  596 (814)
Q Consensus       517 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  596 (814)
                      ....+.+.++||+|+||.||+|.+.   ....||||.++... ...++|.+|+.++++++||||+++++++.+ +..++|
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv  256 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWN---GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV  256 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET---TTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             ChhHceeeeeecCCCCeEEEEEEEC---CCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEE
Confidence            3455677889999999999999986   35679999997543 345689999999999999999999999876 778999


Q ss_pred             EecCCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccC
Q 041921          597 YEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN  674 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~  674 (814)
                      |||+++|+|.+++...  ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus       257 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  333 (452)
T 1fmk_A          257 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN  333 (452)
T ss_dssp             ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred             ehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence            9999999999999753  5689999999999999999999998   9999999999999999999999999999876543


Q ss_pred             CcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeecC
Q 041921          675 QSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGE  753 (814)
Q Consensus       675 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  753 (814)
                      .... .....++..|+|||.+....++.++||||||+++|||++ |+.||......+       +...+..+..      
T Consensus       334 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-------~~~~i~~~~~------  399 (452)
T 1fmk_A          334 EYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGYR------  399 (452)
T ss_dssp             ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCC------
T ss_pred             ceec-ccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCC------
Confidence            2211 133457889999999998999999999999999999999 999997543322       1122222210      


Q ss_pred             cccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCCCC
Q 041921          754 DKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVP  801 (814)
Q Consensus       754 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~~~~p  801 (814)
                         .+.+...++.+.+++.+||+.||++|||++++++.|+.+.....|
T Consensus       400 ---~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~  444 (452)
T 1fmk_A          400 ---MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP  444 (452)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred             ---CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence               111223457788999999999999999999999999997665443

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=3.3e-39  Score=346.70  Aligned_cols=264  Identities=26%  Similarity=0.406  Sum_probs=214.6

Q ss_pred             HHHhhhccccceeeeeeeeEEEEEEe---cCCCceEEEEEEeccccc-cchHhHHHHHHhhhcc-CCCCccceeeeeccc
Q 041921          516 LEGATNNFKEEVGRGSFGIVYKGVIQ---TRTSTTAVAVKKLDRVFQ-DGEREFKNEVFVIGQT-HHKNLVRLLGFCDEG  590 (814)
Q Consensus       516 l~~~~~~~~~~LG~G~~g~Vy~~~~~---~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  590 (814)
                      +....+.+.+.||+|+||.||+|...   ....+..||||.+..... ...+.+.+|+.+++++ +||||+++++++.+.
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   99 (313)
T 1t46_A           20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (313)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence            44566778899999999999999863   234578999999975432 2346799999999999 999999999999999


Q ss_pred             ccceEEEecCCCCCHHHHhcCCC------------------CCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcE
Q 041921          591 QNRLLVYEFLNNGTLASFLFGNL------------------KPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNI  652 (814)
Q Consensus       591 ~~~~lv~e~~~~gsL~~~l~~~~------------------~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NI  652 (814)
                      +..++||||+++++|.+++....                  .+++..++.++.|+++||.|||+.   +|+||||||+||
T Consensus       100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Ni  176 (313)
T 1t46_A          100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNI  176 (313)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred             CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceE
Confidence            99999999999999999997543                  488999999999999999999998   999999999999


Q ss_pred             EEcCCCcEEEeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhh
Q 041921          653 LLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEY  731 (814)
Q Consensus       653 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~  731 (814)
                      +++.++.+||+|||++................+|+.|+|||.+.+..++.++||||||++++||++ |+.||........
T Consensus       177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~  256 (313)
T 1t46_A          177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK  256 (313)
T ss_dssp             EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred             EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH
Confidence            999999999999999987765543333334557889999999999999999999999999999999 9999975433221


Q ss_pred             hhHHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 041921          732 AILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE  797 (814)
Q Consensus       732 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~  797 (814)
                            ....+..+..         .......+..+.+++.+||+.||.+|||++++++.|+++..
T Consensus       257 ------~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  307 (313)
T 1t46_A          257 ------FYKMIKEGFR---------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS  307 (313)
T ss_dssp             ------HHHHHHHTCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------HHHHhccCCC---------CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence                  1111111110         01112234678899999999999999999999999987543

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.5e-38  Score=341.93  Aligned_cols=252  Identities=25%  Similarity=0.335  Sum_probs=206.6

Q ss_pred             HhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccccc------chHhHHHHHHhhhccCCCCccceeeeecccc
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD------GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ  591 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  591 (814)
                      ...|.+.+.||+|+||.||++...  ..+..||||.+......      ..+++.+|+.++++++||||+++++++.+..
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   87 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREK--STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT   87 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEET--TTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             ccceEeceEEeeCCCeEEEEEEEC--CCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence            356778899999999999999975  35789999998653221      3467999999999999999999999999999


Q ss_pred             cceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC----cEEEeecCC
Q 041921          592 NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYY----TARISDFGL  667 (814)
Q Consensus       592 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~----~~kl~DfGl  667 (814)
                      ..++||||+++++|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++    .+||+|||+
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~  164 (326)
T 2y0a_A           88 DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGL  164 (326)
T ss_dssp             EEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence            9999999999999999998888899999999999999999999998   999999999999999877    899999999


Q ss_pred             ccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCcc
Q 041921          668 AKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL  747 (814)
Q Consensus       668 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  747 (814)
                      ++........   ....||+.|+|||.+....++.++||||||+++|||++|+.||......+.       ...+.....
T Consensus       165 a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-------~~~~~~~~~  234 (326)
T 2y0a_A          165 AHKIDFGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-------LANVSAVNY  234 (326)
T ss_dssp             CEECCTTSCC---CCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-------HHHHHHTCC
T ss_pred             CeECCCCCcc---ccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH-------HHHHHhcCC
Confidence            9876543221   345699999999999989999999999999999999999999975433221       111111111


Q ss_pred             ceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          748 NVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       748 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      ..      ...........+.+++.+||+.||.+|||++++++
T Consensus       235 ~~------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          235 EF------EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             CC------CHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             Cc------CccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            00      00000123456789999999999999999999986

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=3.3e-39  Score=341.33  Aligned_cols=260  Identities=23%  Similarity=0.365  Sum_probs=199.2

Q ss_pred             HHHhhhccccceeeeeeeeEEEEEEecCC-CceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccceeeeecccccc
Q 041921          516 LEGATNNFKEEVGRGSFGIVYKGVIQTRT-STTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNR  593 (814)
Q Consensus       516 l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  593 (814)
                      +....+.+.+.||+|+||.||+|.....+ .+..||||.+.... ....+.+.+|+.++++++||||+++++++. ++..
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~   90 (281)
T 1mp8_A           12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV   90 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred             EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence            34567788899999999999999976432 35689999987533 233457899999999999999999999984 4678


Q ss_pred             eEEEecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccc
Q 041921          594 LLVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLT  672 (814)
Q Consensus       594 ~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~  672 (814)
                      ++||||+++++|.+++... ..+++..+..++.|+++||.|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  167 (281)
T 1mp8_A           91 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  167 (281)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccC
Confidence            9999999999999999765 4689999999999999999999998   99999999999999999999999999998765


Q ss_pred             cCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceee
Q 041921          673 LNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLV  751 (814)
Q Consensus       673 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  751 (814)
                      ...... .....+++.|+|||.+....++.++||||||+++|||++ |+.||......+.       ...+..+...   
T Consensus       168 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~-------~~~i~~~~~~---  236 (281)
T 1mp8_A          168 DSTYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV-------IGRIENGERL---  236 (281)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-------HHHHHTTCCC---
T ss_pred             cccccc-cccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH-------HHHHHcCCCC---
Confidence            432211 123346789999999998899999999999999999997 9999975543321       1112222111   


Q ss_pred             cCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 041921          752 GEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV  796 (814)
Q Consensus       752 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~  796 (814)
                            ..+...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus       237 ------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  275 (281)
T 1mp8_A          237 ------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  275 (281)
T ss_dssp             ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                  111234567889999999999999999999999998764

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2e-38  Score=338.58  Aligned_cols=262  Identities=23%  Similarity=0.312  Sum_probs=199.9

Q ss_pred             HhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhc--cCCCCccceeeeecc----cc
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ--THHKNLVRLLGFCDE----GQ  591 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~----~~  591 (814)
                      ...+.+.+.||+|+||+||+|..    .+..||||++...   ....+..|.+++..  ++||||+++++++.+    ..
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~----~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~   79 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW----QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSST   79 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE----TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE----CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence            45677889999999999999986    3778999998643   34455666666655  799999999998654    34


Q ss_pred             cceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhh--------hcCCCCeeecCCCCCcEEEcCCCcEEEe
Q 041921          592 NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLH--------EDCRAQIIHCDIKPQNILLDDYYTARIS  663 (814)
Q Consensus       592 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH--------~~~~~~i~H~dlkp~NIll~~~~~~kl~  663 (814)
                      ..++||||+++|+|.+++.. ..+++..+..++.|++.||+|||        +.   +|+||||||+|||++.++.+||+
T Consensus        80 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~  155 (301)
T 3q4u_A           80 QLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIA  155 (301)
T ss_dssp             EEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEEC
T ss_pred             eeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEe
Confidence            57899999999999999954 46899999999999999999999        66   99999999999999999999999


Q ss_pred             ecCCccccccCCccc--ccccccCCCCcccccccccC------CCCcchhhHHHHHHHHHHHhC----------CCCCCc
Q 041921          664 DFGLAKLLTLNQSKT--IKTAIRGTKGYVAPEWFRNS------KITAKVDVYSFGVLLLEIISC----------RKSFDI  725 (814)
Q Consensus       664 DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~s~~~Dv~s~Gvvl~elltg----------~~p~~~  725 (814)
                      |||+++.........  ......||+.|+|||.+.+.      .++.++||||||+++|||++|          +.||..
T Consensus       156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~  235 (301)
T 3q4u_A          156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD  235 (301)
T ss_dssp             CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence            999998665433221  11234699999999999876      455799999999999999999          777754


Q ss_pred             ccchhhhhHHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 041921          726 EMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV  795 (814)
Q Consensus       726 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~  795 (814)
                      ........ .. ............   ..............+.+++.+||+.||.+|||++++++.|+++
T Consensus       236 ~~~~~~~~-~~-~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          236 VVPNDPSF-ED-MRKVVCVDQQRP---NIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             TSCSSCCH-HH-HHHHHTTSCCCC---CCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCCCCcch-hh-hhHHHhccCCCC---CCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            33221110 01 111111111000   0011112335678899999999999999999999999999864

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=7.1e-39  Score=361.60  Aligned_cols=250  Identities=27%  Similarity=0.383  Sum_probs=205.4

Q ss_pred             HhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccc-cceEE
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ-NRLLV  596 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv  596 (814)
                      ...+.+.++||+|+||.||+|...    +..||||.++..  ...++|.+|+.++++++||||+++++++.+.+ ..++|
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~----~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv  265 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR----GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV  265 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET----TEEEEEEEESSC--TTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEE
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec----CCeEEEEEeCCc--hHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEE
Confidence            345667789999999999999874    568999999754  24568999999999999999999999987655 78999


Q ss_pred             EecCCCCCHHHHhcCCC--CCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccC
Q 041921          597 YEFLNNGTLASFLFGNL--KPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN  674 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~  674 (814)
                      |||+++|+|.+++....  .+++..++.++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus       266 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  342 (450)
T 1k9a_A          266 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  342 (450)
T ss_dssp             EECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence            99999999999998643  378999999999999999999998   9999999999999999999999999999854322


Q ss_pred             CcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeecC
Q 041921          675 QSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGE  753 (814)
Q Consensus       675 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  753 (814)
                      .     ....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.       ...+..+..      
T Consensus       343 ~-----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~-------~~~i~~~~~------  404 (450)
T 1k9a_A          343 Q-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-------VPRVEKGYK------  404 (450)
T ss_dssp             ---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH-------HHHHHTTCC------
T ss_pred             c-----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHHcCCC------
Confidence            1     22357889999999999999999999999999999999 9999975443221       112222211      


Q ss_pred             cccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 041921          754 DKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE  797 (814)
Q Consensus       754 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~  797 (814)
                         ...+..++..+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       405 ---~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~  445 (450)
T 1k9a_A          405 ---MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT  445 (450)
T ss_dssp             ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence               11122345788899999999999999999999999987654

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-37  Score=335.94  Aligned_cols=269  Identities=20%  Similarity=0.237  Sum_probs=210.0

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccceeeeecccc--cceE
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ--NRLL  595 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~l  595 (814)
                      ..|.+.++||+|+||.||+|....  .++.||||.+.... ....+.+.+|++++++++||||+++++++....  ..++
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   86 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKK--TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL   86 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECC--CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence            456778999999999999999763  57899999997533 234567889999999999999999999987655  6799


Q ss_pred             EEecCCCCCHHHHhcCCC---CCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE----cCCCcEEEeecCCc
Q 041921          596 VYEFLNNGTLASFLFGNL---KPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILL----DDYYTARISDFGLA  668 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~~~---~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll----~~~~~~kl~DfGla  668 (814)
                      ||||+++++|.+++....   .+++..+..++.||+.||+|||+.   +|+||||||+|||+    +.++.+||+|||++
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a  163 (319)
T 4euu_A           87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (319)
T ss_dssp             EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred             EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence            999999999999998653   389999999999999999999998   99999999999999    78888999999999


Q ss_pred             cccccCCcccccccccCCCCcccccccc--------cCCCCcchhhHHHHHHHHHHHhCCCCCCcccchh-hhhHHHHHH
Q 041921          669 KLLTLNQSKTIKTAIRGTKGYVAPEWFR--------NSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAF  739 (814)
Q Consensus       669 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~-~~~~~~~~~  739 (814)
                      +........   ....||..|+|||.+.        +..++.++||||||+++|||++|+.||....... .......+.
T Consensus       164 ~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  240 (319)
T 4euu_A          164 RELEDDEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII  240 (319)
T ss_dssp             EECCTTCCB---CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHH
T ss_pred             eecCCCCce---eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHh
Confidence            876543322   3456999999999986        5678999999999999999999999996443221 111111111


Q ss_pred             HHhhcCccceee-----------cCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 041921          740 DCYRNGKLNVLV-----------GEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV  795 (814)
Q Consensus       740 ~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~  795 (814)
                      .......+..+.           ...............+.+++.+||+.||++|||++|+++...+.
T Consensus       241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~  307 (319)
T 4euu_A          241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (319)
T ss_dssp             HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence            111111111110           00111123456778899999999999999999999999988654

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=5.4e-39  Score=348.56  Aligned_cols=267  Identities=26%  Similarity=0.412  Sum_probs=214.7

Q ss_pred             HHHHhhhccccceeeeeeeeEEEEEEecC-----CCceEEEEEEecccc-ccchHhHHHHHHhhhcc-CCCCccceeeee
Q 041921          515 ELEGATNNFKEEVGRGSFGIVYKGVIQTR-----TSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQT-HHKNLVRLLGFC  587 (814)
Q Consensus       515 ~l~~~~~~~~~~LG~G~~g~Vy~~~~~~~-----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  587 (814)
                      ++....+.+.+.||+|+||.||+|.....     ..+..||||.+.... ....+.+.+|+.+++++ +||||+++++++
T Consensus        31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  110 (334)
T 2pvf_A           31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC  110 (334)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence            44566788889999999999999987421     246789999997543 23345789999999999 899999999999


Q ss_pred             cccccceEEEecCCCCCHHHHhcCCC----------------CCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCc
Q 041921          588 DEGQNRLLVYEFLNNGTLASFLFGNL----------------KPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQN  651 (814)
Q Consensus       588 ~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~N  651 (814)
                      .+.+..++||||+++++|.+++....                .+++..++.++.||++||.|||+.   +|+||||||+|
T Consensus       111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~N  187 (334)
T 2pvf_A          111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARN  187 (334)
T ss_dssp             CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGG
T ss_pred             ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccce
Confidence            99999999999999999999997643                378899999999999999999998   99999999999


Q ss_pred             EEEcCCCcEEEeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchh
Q 041921          652 ILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEE  730 (814)
Q Consensus       652 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~  730 (814)
                      |+++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+
T Consensus       188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~  267 (334)
T 2pvf_A          188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  267 (334)
T ss_dssp             EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH
Confidence            9999999999999999987654432222234457889999999998889999999999999999999 999997543322


Q ss_pred             hhhHHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCCC
Q 041921          731 YAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSV  800 (814)
Q Consensus       731 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~~~~  800 (814)
                      .       ...+..+....         ........+.+++.+||+.+|.+|||+.++++.|+.+.....
T Consensus       268 ~-------~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~  321 (334)
T 2pvf_A          268 L-------FKLLKEGHRMD---------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  321 (334)
T ss_dssp             H-------HHHHHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             H-------HHHHhcCCCCC---------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence            1       11222221110         112334678899999999999999999999999998766543

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-38  Score=340.72  Aligned_cols=250  Identities=21%  Similarity=0.298  Sum_probs=205.5

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEe
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE  598 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  598 (814)
                      ..|.+.+.||+|+||.||++...  .++..+|+|.+... ......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         5 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   81 (321)
T 1tki_A            5 EKYMIAEDLGRGEFGIVHRCVET--SSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEET--TTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hceEeeeEEecCCCeEEEEEEEC--CCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence            35677889999999999999965  35789999998643 3345568999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC--CCcEEEeecCCccccccCC
Q 041921          599 FLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDD--YYTARISDFGLAKLLTLNQ  675 (814)
Q Consensus       599 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~--~~~~kl~DfGla~~~~~~~  675 (814)
                      |+++++|.+++... ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.  ++.+||+|||+++......
T Consensus        82 ~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~  158 (321)
T 1tki_A           82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD  158 (321)
T ss_dssp             CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred             eCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence            99999999999765 4789999999999999999999998   9999999999999987  7899999999998775432


Q ss_pred             cccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcc
Q 041921          676 SKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDK  755 (814)
Q Consensus       676 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  755 (814)
                      .   .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+       ....+..+.....     
T Consensus       159 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i~~~~~~~~-----  223 (321)
T 1tki_A          159 N---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-------IIENIMNAEYTFD-----  223 (321)
T ss_dssp             E---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHHTCCCCC-----
T ss_pred             c---cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH-------HHHHHHcCCCCCC-----
Confidence            2   134568999999999998889999999999999999999999997544322       1111222211100     


Q ss_pred             cccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          756 EAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       756 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                       .......+.++.+++.+||+.||.+|||+.|+++
T Consensus       224 -~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          224 -EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             -HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence             0000123467889999999999999999999987

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=9.1e-39  Score=335.88  Aligned_cols=254  Identities=31%  Similarity=0.439  Sum_probs=194.9

Q ss_pred             HhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc----cchHhHHHHHHhhhccCCCCccceeeeecccccc
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ----DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNR  593 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  593 (814)
                      ...+.+.+.||+|+||.||+|...    +..||||.+.....    ...+.+.+|+.+++.++||||+++++++.+++..
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI----GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL   81 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET----TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc----CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence            345677889999999999999863    67899999865322    2346789999999999999999999999999999


Q ss_pred             eEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC--------CCcEEEeec
Q 041921          594 LLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDD--------YYTARISDF  665 (814)
Q Consensus       594 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~--------~~~~kl~Df  665 (814)
                      ++||||+++++|.+++.. ..+++..+..++.|+++||.|||+....+|+||||||+||+++.        ++.+||+||
T Consensus        82 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           82 CLVMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             EEEEECCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EEEEEcCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            999999999999999864 46889999999999999999999982223999999999999986        778999999


Q ss_pred             CCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcC
Q 041921          666 GLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG  745 (814)
Q Consensus       666 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  745 (814)
                      |++........    ....||+.|+|||.+.+..++.++||||||++++||++|+.||.........      .. ....
T Consensus       161 g~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~------~~-~~~~  229 (271)
T 3dtc_A          161 GLAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVA------YG-VAMN  229 (271)
T ss_dssp             CC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHH------HH-HHTS
T ss_pred             Ccccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------Hh-hhcC
Confidence            99986553322    2346899999999999999999999999999999999999999754332211      11 1111


Q ss_pred             ccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 041921          746 KLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV  795 (814)
Q Consensus       746 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~  795 (814)
                      ...        ...+...+..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus       230 ~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          230 KLA--------LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             CCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             CCC--------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            111        111223346788999999999999999999999999864

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=5.7e-39  Score=346.70  Aligned_cols=263  Identities=22%  Similarity=0.362  Sum_probs=195.1

Q ss_pred             HHhhhccccceeeeeeeeEEEEEEecCCC-ceEEEEEEeccc--cccchHhHHHHHHhhhccCCCCccceeeeecccccc
Q 041921          517 EGATNNFKEEVGRGSFGIVYKGVIQTRTS-TTAVAVKKLDRV--FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNR  593 (814)
Q Consensus       517 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  593 (814)
                      ....+.+.+.||+|+||.||+|.....+. ...||||.+...  .....+++.+|+.++++++||||+++++++......
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  100 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK  100 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence            34467778999999999999998764221 137999999653  334456799999999999999999999999876655


Q ss_pred             ------eEEEecCCCCCHHHHhcCC------CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEE
Q 041921          594 ------LLVYEFLNNGTLASFLFGN------LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTAR  661 (814)
Q Consensus       594 ------~lv~e~~~~gsL~~~l~~~------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~k  661 (814)
                            ++|+||+++++|.+++...      ..+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+|
T Consensus       101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~k  177 (323)
T 3qup_A          101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVC  177 (323)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEE
T ss_pred             cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEE
Confidence                  9999999999999999643      2588999999999999999999998   999999999999999999999


Q ss_pred             EeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHH
Q 041921          662 ISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFD  740 (814)
Q Consensus       662 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~  740 (814)
                      |+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+..       .
T Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~-------~  250 (323)
T 3qup_A          178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY-------N  250 (323)
T ss_dssp             ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-------H
T ss_pred             EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHH-------H
Confidence            999999987654433222234457889999999999999999999999999999999 99999755433211       1


Q ss_pred             HhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 041921          741 CYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV  798 (814)
Q Consensus       741 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~~  798 (814)
                      .+..+..         .......+..+.+++.+||+.||.+|||+.++++.|+++..-
T Consensus       251 ~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~  299 (323)
T 3qup_A          251 YLIGGNR---------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH  299 (323)
T ss_dssp             HHHTTCC---------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHhcCCC---------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            1111111         011223446788999999999999999999999999886543

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=7.1e-39  Score=346.23  Aligned_cols=259  Identities=25%  Similarity=0.400  Sum_probs=205.8

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCC--ceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccceeeeecccccceE
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTS--TTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL  595 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~--~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  595 (814)
                      ..+.+.+.||+|+||.||+|.....+.  ...|++|.+.... ....+.+.+|+.++++++||||+++++++. ++..++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            346677899999999999999764332  2348888885432 334457889999999999999999999986 567899


Q ss_pred             EEecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccC
Q 041921          596 VYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN  674 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~  674 (814)
                      |+||+++++|.+++... ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  168 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD  168 (325)
T ss_dssp             EEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred             EEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence            99999999999999875 5789999999999999999999998   9999999999999999999999999999987655


Q ss_pred             CcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeecC
Q 041921          675 QSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGE  753 (814)
Q Consensus       675 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  753 (814)
                      ..........+|..|+|||.+.+..++.++||||||+++|||++ |+.||......+.       ...+..+....    
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-------~~~~~~~~~~~----  237 (325)
T 3kex_A          169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV-------PDLLEKGERLA----  237 (325)
T ss_dssp             TTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH-------HHHHHTTCBCC----
T ss_pred             cccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH-------HHHHHcCCCCC----
Confidence            44333345668889999999999999999999999999999999 9999976543321       11122221110    


Q ss_pred             cccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 041921          754 DKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE  797 (814)
Q Consensus       754 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~  797 (814)
                           .+......+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       238 -----~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          238 -----QPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             -----CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             -----CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                 011123457789999999999999999999999987643

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=5.9e-38  Score=351.93  Aligned_cols=254  Identities=21%  Similarity=0.276  Sum_probs=207.1

Q ss_pred             HHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeecccccce
Q 041921          517 EGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRL  594 (814)
Q Consensus       517 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  594 (814)
                      ....|.+.++||+|+||.||++...  ..+..+|+|.+....  ....+.+.+|+.++++++||||+++++++.+++..+
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~--~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   86 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKV--LAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHY   86 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEET--TTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEEC--CCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEE
Confidence            3456788899999999999999865  367899999986432  223456899999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc---CCCcEEEeecCCcccc
Q 041921          595 LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLD---DYYTARISDFGLAKLL  671 (814)
Q Consensus       595 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~---~~~~~kl~DfGla~~~  671 (814)
                      +||||+++|+|.+++.....+++.....++.||+.||.|||+.   +|+||||||+|||++   .++.+||+|||++...
T Consensus        87 lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~  163 (444)
T 3soa_A           87 LIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV  163 (444)
T ss_dssp             EEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred             EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence            9999999999999999888899999999999999999999998   999999999999998   5678999999999876


Q ss_pred             ccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceee
Q 041921          672 TLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLV  751 (814)
Q Consensus       672 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  751 (814)
                      ......  .....||+.|+|||.+.+..++.++|||||||++|||++|+.||......+       ....+..+..... 
T Consensus       164 ~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~-------~~~~i~~~~~~~~-  233 (444)
T 3soa_A          164 EGEQQA--WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR-------LYQQIKAGAYDFP-  233 (444)
T ss_dssp             CTTCCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHHTCCCCC-
T ss_pred             cCCCce--eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH-------HHHHHHhCCCCCC-
Confidence            543222  134579999999999999999999999999999999999999997543322       1222223322111 


Q ss_pred             cCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          752 GEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       752 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                           .+........+.+++.+||+.||.+|||+.++++
T Consensus       234 -----~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          234 -----SPEWDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             -----TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             -----ccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                 0011123467889999999999999999999986

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=5e-38  Score=344.25  Aligned_cols=254  Identities=22%  Similarity=0.318  Sum_probs=207.8

Q ss_pred             HHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeecccccce
Q 041921          517 EGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRL  594 (814)
Q Consensus       517 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  594 (814)
                      ....|.+.+.||+|+||.||+|...  ..+..||||.+....  ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~  104 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHK--TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY  104 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEET--TTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEEC--CCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence            4567888899999999999999875  357899999996432  223456899999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC---CcEEEeecCCcccc
Q 041921          595 LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDY---YTARISDFGLAKLL  671 (814)
Q Consensus       595 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~---~~~kl~DfGla~~~  671 (814)
                      +||||+++++|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+|||++.+   +.+||+|||++...
T Consensus       105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~  181 (362)
T 2bdw_A          105 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  181 (362)
T ss_dssp             EEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred             EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence            9999999999999998888899999999999999999999998   99999999999999865   45999999999876


Q ss_pred             ccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceee
Q 041921          672 TLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLV  751 (814)
Q Consensus       672 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  751 (814)
                      .....   .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+       ....+..+..... 
T Consensus       182 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~-------~~~~i~~~~~~~~-  250 (362)
T 2bdw_A          182 NDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-------LYAQIKAGAYDYP-  250 (362)
T ss_dssp             TTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCCCCC-
T ss_pred             cCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHhCCCCCC-
Confidence            53322   134579999999999999899999999999999999999999997543221       1122222222110 


Q ss_pred             cCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          752 GEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       752 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                           ..........+.+++.+||+.||.+|||+.++++.
T Consensus       251 -----~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          251 -----SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             -----TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             -----cccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                 00111234678899999999999999999998753

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=9.6e-39  Score=337.28  Aligned_cols=257  Identities=30%  Similarity=0.463  Sum_probs=209.0

Q ss_pred             HHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEE
Q 041921          517 EGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV  596 (814)
Q Consensus       517 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  596 (814)
                      ...++.+.+.||+|+||.||+|...   ++..||||.+... ....+.+.+|++++++++||||+++++++.+ +..++|
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v   85 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYN---GHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII   85 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET---TTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEc---CCcEEEEEEecCC-cccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEE
Confidence            3456778899999999999999975   4678999999754 3346789999999999999999999999864 568999


Q ss_pred             EecCCCCCHHHHhcCCC--CCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccC
Q 041921          597 YEFLNNGTLASFLFGNL--KPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN  674 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~  674 (814)
                      |||+++++|.+++....  .+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++......
T Consensus        86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  162 (279)
T 1qpc_A           86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (279)
T ss_dssp             EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             EecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence            99999999999997653  689999999999999999999998   9999999999999999999999999999876543


Q ss_pred             CcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeecC
Q 041921          675 QSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGE  753 (814)
Q Consensus       675 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  753 (814)
                      .... .....++..|+|||.+.+..++.++||||||++++||++ |+.||......+       ....+..+...     
T Consensus       163 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~-----  229 (279)
T 1qpc_A          163 EYTA-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-------VIQNLERGYRM-----  229 (279)
T ss_dssp             CEEC-CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCCC-----
T ss_pred             cccc-ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH-------HHHHHhcccCC-----
Confidence            2221 133457889999999998889999999999999999999 899987543322       11122222110     


Q ss_pred             cccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 041921          754 DKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV  798 (814)
Q Consensus       754 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~~  798 (814)
                          ..+...+..+.+++.+|++.||++|||+.++++.|+++...
T Consensus       230 ----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  270 (279)
T 1qpc_A          230 ----VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (279)
T ss_dssp             ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence                01123346788999999999999999999999999886543

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.1e-38  Score=338.26  Aligned_cols=253  Identities=30%  Similarity=0.496  Sum_probs=197.7

Q ss_pred             HhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEE
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY  597 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  597 (814)
                      ...+.+.+.||+|+||.||+|...    +..||||++..  ....+.|.+|+.++++++||||+++++++.+  ..++||
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~   78 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR----AKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVM   78 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET----TEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEE
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC----CeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEE
Confidence            345677889999999999999874    67899999964  2345679999999999999999999999874  589999


Q ss_pred             ecCCCCCHHHHhcCCC---CCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCc-EEEeecCCcccccc
Q 041921          598 EFLNNGTLASFLFGNL---KPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYT-ARISDFGLAKLLTL  673 (814)
Q Consensus       598 e~~~~gsL~~~l~~~~---~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~-~kl~DfGla~~~~~  673 (814)
                      ||+++++|.+++....   .+++..++.++.|+++||+|||+....+|+||||||+|||++.++. +||+|||++.....
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~  158 (307)
T 2eva_A           79 EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT  158 (307)
T ss_dssp             ECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred             EcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence            9999999999998664   3678889999999999999999943238999999999999998876 79999999976543


Q ss_pred             CCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecC
Q 041921          674 NQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGE  753 (814)
Q Consensus       674 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  753 (814)
                      ..     ....||..|+|||.+.+..++.++||||||++++||++|+.||..........    .+ ....+.....   
T Consensus       159 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~----~~-~~~~~~~~~~---  225 (307)
T 2eva_A          159 HM-----TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRI----MW-AVHNGTRPPL---  225 (307)
T ss_dssp             -----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHH----HH-HHHTTCCCCC---
T ss_pred             cc-----ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHH----HH-HHhcCCCCCc---
Confidence            21     23458999999999999999999999999999999999999997543322111    11 1111111111   


Q ss_pred             cccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 041921          754 DKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE  797 (814)
Q Consensus       754 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~  797 (814)
                            ....+..+.+++.+||+.||.+|||++++++.|+.+.+
T Consensus       226 ------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  263 (307)
T 2eva_A          226 ------IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR  263 (307)
T ss_dssp             ------BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred             ------ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence                  11234578899999999999999999999999987654

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=6e-38  Score=332.63  Aligned_cols=254  Identities=27%  Similarity=0.499  Sum_probs=202.6

Q ss_pred             HHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccc-------hHhHHHHHHhhhccCCCCccceeeeecc
Q 041921          517 EGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG-------EREFKNEVFVIGQTHHKNLVRLLGFCDE  589 (814)
Q Consensus       517 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~  589 (814)
                      ....+.+.+.||+|+||.||+|....  ++..||||.+.......       .+.+.+|+.++++++||||+++++++.+
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   94 (287)
T 4f0f_A           17 ADNEIEYEKQIGKGGFGLVHKGRLVK--DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN   94 (287)
T ss_dssp             CSTTEEEEEECCCCSSSCEEEEEETT--TCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT
T ss_pred             hhccceehhccccCCceeEEEEEEcC--CceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC
Confidence            34567778999999999999999753  57889999986432221       1578999999999999999999999876


Q ss_pred             cccceEEEecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCC--eeecCCCCCcEEEcCCCc-----EE
Q 041921          590 GQNRLLVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQ--IIHCDIKPQNILLDDYYT-----AR  661 (814)
Q Consensus       590 ~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~--i~H~dlkp~NIll~~~~~-----~k  661 (814)
                      ..  ++||||+++++|.+++... ..+++..+..++.|++.||+|||+.   +  |+||||||+|||++.++.     +|
T Consensus        95 ~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~k  169 (287)
T 4f0f_A           95 PP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAK  169 (287)
T ss_dssp             TT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred             CC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEE
Confidence            54  7999999999998888655 5789999999999999999999998   7  999999999999987776     99


Q ss_pred             EeecCCccccccCCcccccccccCCCCccccccc--ccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHH
Q 041921          662 ISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF--RNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF  739 (814)
Q Consensus       662 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  739 (814)
                      |+|||+++.....     .....||+.|+|||.+  ....++.++||||||+++|||++|+.||...........     
T Consensus       170 l~Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~-----  239 (287)
T 4f0f_A          170 VADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI-----  239 (287)
T ss_dssp             ECCCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHH-----
T ss_pred             eCCCCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHH-----
Confidence            9999999754332     1345689999999998  445678999999999999999999999975543322111     


Q ss_pred             HHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 041921          740 DCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV  795 (814)
Q Consensus       740 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~  795 (814)
                      ..........        ......+..+.+++.+||+.||.+|||++++++.|+++
T Consensus       240 ~~~~~~~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          240 NMIREEGLRP--------TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             HHHHHSCCCC--------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             HHHhccCCCC--------CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            1111111111        11223456788999999999999999999999999864

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=5.2e-38  Score=346.43  Aligned_cols=250  Identities=24%  Similarity=0.324  Sum_probs=200.6

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhcc-CCCCccceeeeecccccce
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRL  594 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  594 (814)
                      ..+.+.++||+|+||.||+|....  .++.||||.+++..   ....+.+..|..++.++ +||||+++++++.+.+..+
T Consensus        52 ~~y~~~~~LG~G~fG~V~~~~~~~--~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  129 (396)
T 4dc2_A           52 QDFDLLRVIGRGSYAKVLLVRLKK--TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF  129 (396)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT--TTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             hHcEEEEEEeeCCCeEEEEEEECC--CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence            456778899999999999999763  57899999997542   22334588899999887 8999999999999999999


Q ss_pred             EEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccC
Q 041921          595 LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN  674 (814)
Q Consensus       595 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~  674 (814)
                      |||||+++|+|..++.....+++..+..++.||+.||.|||+.   +|+||||||+||||+.++.+||+|||+++.....
T Consensus       130 lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~  206 (396)
T 4dc2_A          130 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  206 (396)
T ss_dssp             EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence            9999999999999998888899999999999999999999998   9999999999999999999999999999853322


Q ss_pred             CcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchh--hhhHHHHHHHHhhcCccceeec
Q 041921          675 QSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILTDWAFDCYRNGKLNVLVG  752 (814)
Q Consensus       675 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  752 (814)
                      ..  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......+  .........+.+..+.+..   
T Consensus       207 ~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~---  281 (396)
T 4dc2_A          207 GD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI---  281 (396)
T ss_dssp             TC--CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCC---
T ss_pred             CC--ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCC---
Confidence            21  1245679999999999999999999999999999999999999996432211  1111122223332322211   


Q ss_pred             CcccccCcHHHHHHHHHHHHHccccCCCCCCCH
Q 041921          753 EDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTM  785 (814)
Q Consensus       753 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~  785 (814)
                             +.....++.+++.+||+.||.+||++
T Consensus       282 -------p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          282 -------PRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             -------CTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             -------CCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence                   11234678899999999999999985

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.4e-38  Score=344.09  Aligned_cols=261  Identities=24%  Similarity=0.381  Sum_probs=202.4

Q ss_pred             HhhhccccceeeeeeeeEEEEEEecCCCc--eEEEEEEeccc-cccchHhHHHHHHhhhccCCCCccceeeeecccccce
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQTRTST--TAVAVKKLDRV-FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRL  594 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~--~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  594 (814)
                      ...+.+.++||+|+||.||+|.....+..  ..|++|.+... .....+++.+|+.++++++||||+++++++.+.. .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            34567788999999999999997643322  25688888543 3445678999999999999999999999998754 78


Q ss_pred             EEEecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcccccc
Q 041921          595 LVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTL  673 (814)
Q Consensus       595 lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~  673 (814)
                      +|+||+++++|.+++... ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus        93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~  169 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence            999999999999999764 6689999999999999999999998   999999999999999999999999999987754


Q ss_pred             CCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeec
Q 041921          674 NQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVG  752 (814)
Q Consensus       674 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  752 (814)
                      ...........+|..|+|||.+.+..++.++||||||+++|||++ |+.||......+..       ..+..+..     
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~-------~~~~~~~~-----  237 (327)
T 3lzb_A          170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-------SILEKGER-----  237 (327)
T ss_dssp             ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-------HHHHTTCC-----
T ss_pred             ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH-------HHHHcCCC-----
Confidence            433332234457889999999999999999999999999999999 99999765443311       11112110     


Q ss_pred             CcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 041921          753 EDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV  798 (814)
Q Consensus       753 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~~  798 (814)
                          ...+......+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus       238 ----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          238 ----LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             ----CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             ----CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence                111222445788999999999999999999999999887643

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=2.5e-38  Score=336.40  Aligned_cols=258  Identities=29%  Similarity=0.401  Sum_probs=209.0

Q ss_pred             hhhcccc-ceeeeeeeeEEEEEEecCCCceEEEEEEeccccc--cchHhHHHHHHhhhccCCCCccceeeeecccccceE
Q 041921          519 ATNNFKE-EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ--DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL  595 (814)
Q Consensus       519 ~~~~~~~-~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  595 (814)
                      ..+.+.+ .||+|+||.||+|.......+..||||.+.....  ...+++.+|+.++++++||||+++++++ +.+..++
T Consensus        16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l   94 (291)
T 1xbb_A           16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML   94 (291)
T ss_dssp             GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred             hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence            4556666 8999999999999876666788999999975422  2246799999999999999999999999 5677899


Q ss_pred             EEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCC
Q 041921          596 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ  675 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~  675 (814)
                      ||||+++++|.+++.....+++..+..++.|+++||.|||+.   +|+||||||+||+++.++.+||+|||++.......
T Consensus        95 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  171 (291)
T 1xbb_A           95 VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE  171 (291)
T ss_dssp             EEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred             EEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeeccCC
Confidence            999999999999999888899999999999999999999998   99999999999999999999999999998765443


Q ss_pred             ccc-ccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeecC
Q 041921          676 SKT-IKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGE  753 (814)
Q Consensus       676 ~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  753 (814)
                      ... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+       +...+..+....    
T Consensus       172 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~~----  240 (291)
T 1xbb_A          172 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGERMG----  240 (291)
T ss_dssp             SEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCCCC----
T ss_pred             CcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCCCC----
Confidence            221 1122346788999999998889999999999999999999 999997544322       112222222111    


Q ss_pred             cccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 041921          754 DKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV  796 (814)
Q Consensus       754 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~  796 (814)
                           .+...+..+.+++.+||+.||.+|||+.++++.|+++.
T Consensus       241 -----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  278 (291)
T 1xbb_A          241 -----CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  278 (291)
T ss_dssp             -----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             -----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                 11234567889999999999999999999999998754

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=9.1e-39  Score=339.08  Aligned_cols=261  Identities=28%  Similarity=0.405  Sum_probs=214.6

Q ss_pred             HHHHHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeeccccc
Q 041921          513 YKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQN  592 (814)
Q Consensus       513 ~~~l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  592 (814)
                      .-++....+.+.+.||+|+||.||+|....  .+..||||.+... ....+++.+|+.++++++||||+++++++.+.+.
T Consensus         7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   83 (288)
T 3kfa_A            7 KWEMERTDITMKHKLGGGQYGEVYEGVWKK--YSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP   83 (288)
T ss_dssp             TTBCCGGGEEEEEESGGGTTCSEEEEEEGG--GTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             cccccccceeEEeecCCCCceeEEEeEecC--CCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            334556677888999999999999999763  5789999999753 3345679999999999999999999999999999


Q ss_pred             ceEEEecCCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccc
Q 041921          593 RLLVYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKL  670 (814)
Q Consensus       593 ~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~  670 (814)
                      .++||||+++++|.+++...  ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++..
T Consensus        84 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~  160 (288)
T 3kfa_A           84 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL  160 (288)
T ss_dssp             EEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGT
T ss_pred             EEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCcccee
Confidence            99999999999999999763  5589999999999999999999999   999999999999999999999999999987


Q ss_pred             cccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccce
Q 041921          671 LTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNV  749 (814)
Q Consensus       671 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  749 (814)
                      ........ .....+|+.|+|||.+.+..++.++||||||++++||++ |..||.........       ..+....   
T Consensus       161 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~-------~~~~~~~---  229 (288)
T 3kfa_A          161 MTGDTYTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-------ELLEKDY---  229 (288)
T ss_dssp             SCSSSSEE-ETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH-------HHHHTTC---
T ss_pred             ccCCcccc-ccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHhccC---
Confidence            66443222 233457889999999998999999999999999999999 99998754432211       1111111   


Q ss_pred             eecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 041921          750 LVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV  796 (814)
Q Consensus       750 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~  796 (814)
                            ....+...+..+.+++.+||+.||.+|||++++++.|+.+.
T Consensus       230 ------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~  270 (288)
T 3kfa_A          230 ------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  270 (288)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ------CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence                  01112234467889999999999999999999999998754

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.4e-38  Score=347.03  Aligned_cols=251  Identities=24%  Similarity=0.336  Sum_probs=201.8

Q ss_pred             HHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccc---cccchHhHHHHHHhhhcc-CCCCccceeeeecccc
Q 041921          516 LEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV---FQDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQ  591 (814)
Q Consensus       516 l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  591 (814)
                      +....+.+.+.||+|+||.||+|....  .++.||||.++..   .....+.+..|..++..+ +||||+++++++.+.+
T Consensus        20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~--~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~   97 (353)
T 3txo_A           20 LGIDNFEFIRVLGKGSFGKVMLARVKE--TGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD   97 (353)
T ss_dssp             ---CCEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             CchhheEEEEEEeeCCCEEEEEEEEcC--CCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Confidence            445567788999999999999999763  5789999999753   223345688899999988 7999999999999999


Q ss_pred             cceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcccc
Q 041921          592 NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLL  671 (814)
Q Consensus       592 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~  671 (814)
                      ..++||||+++|+|.+++.....+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus        98 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~  174 (353)
T 3txo_A           98 RLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG  174 (353)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeec
Confidence            9999999999999999998888899999999999999999999998   9999999999999999999999999999854


Q ss_pred             ccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceee
Q 041921          672 TLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLV  751 (814)
Q Consensus       672 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  751 (814)
                      .....  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......+       ....+..+....  
T Consensus       175 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-------~~~~i~~~~~~~--  243 (353)
T 3txo_A          175 ICNGV--TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD-------LFEAILNDEVVY--  243 (353)
T ss_dssp             CC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCCC--
T ss_pred             ccCCc--cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCCCCC--
Confidence            32221  1244679999999999999899999999999999999999999997654322       112222222111  


Q ss_pred             cCcccccCcHHHHHHHHHHHHHccccCCCCCCCH------HHHHH
Q 041921          752 GEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTM------KKVLQ  790 (814)
Q Consensus       752 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~------~~vl~  790 (814)
                              +......+.+++.+||+.||.+||++      +++++
T Consensus       244 --------p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          244 --------PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             --------CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             --------CCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence                    11234567889999999999999998      66664

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=6.8e-38  Score=333.98  Aligned_cols=263  Identities=18%  Similarity=0.216  Sum_probs=210.3

Q ss_pred             HhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhcc-CCCCccceeeeecccccceEE
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRLLV  596 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  596 (814)
                      ...+.+.+.||+|+||.||+|...  ..++.||||.+...  ...+++.+|+.++.++ +|+|++++++++.+....++|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   84 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNL--LNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV   84 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEET--TTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEEC--CCCcEEEEEEeccC--CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence            345677899999999999999964  36789999998643  2345789999999999 899999999999999999999


Q ss_pred             EecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCc-----EEEeecCCccc
Q 041921          597 YEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYT-----ARISDFGLAKL  670 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~-----~kl~DfGla~~  670 (814)
                      |||+ +++|.+++... ..+++..+..++.||++||+|||+.   +|+||||||+|||++.++.     +||+|||+++.
T Consensus        85 ~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~  160 (298)
T 1csn_A           85 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  160 (298)
T ss_dssp             EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             EEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence            9999 99999999865 4589999999999999999999998   9999999999999987766     99999999987


Q ss_pred             cccCCcc-----cccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcC
Q 041921          671 LTLNQSK-----TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG  745 (814)
Q Consensus       671 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  745 (814)
                      .......     .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..............+.......
T Consensus       161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (298)
T 1csn_A          161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST  240 (298)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred             cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence            7643321     11234569999999999999999999999999999999999999997644322111111111111101


Q ss_pred             ccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 041921          746 KLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE  797 (814)
Q Consensus       746 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~  797 (814)
                      ....+         ....+..+.+++.+||+.||.+|||+++|++.|+++.+
T Consensus       241 ~~~~~---------~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~  283 (298)
T 1csn_A          241 PLREL---------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE  283 (298)
T ss_dssp             CHHHH---------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             cHHHH---------HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence            10000         11234678899999999999999999999999988654

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=3.4e-38  Score=341.20  Aligned_cols=246  Identities=24%  Similarity=0.344  Sum_probs=202.4

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhccCCCCccceeeeecccccceE
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL  595 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  595 (814)
                      ..|.+.+.||+|+||.||+|...  ..+..||||.+....   ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l   86 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHY--KTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM   86 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEET--TTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEEC--CCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            35677889999999999999975  357899999986431   2234578999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCC
Q 041921          596 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ  675 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~  675 (814)
                      ||||+ +|+|.+++.....+++..+..++.|++.||.|||+.   +|+||||||+|||+++++.+||+|||++.......
T Consensus        87 v~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~  162 (336)
T 3h4j_B           87 VIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN  162 (336)
T ss_dssp             EECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred             EEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence            99999 789999998888899999999999999999999999   99999999999999999999999999998765432


Q ss_pred             cccccccccCCCCcccccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCc
Q 041921          676 SKTIKTAIRGTKGYVAPEWFRNSKI-TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGED  754 (814)
Q Consensus       676 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  754 (814)
                      ..   ....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||........               ...+....
T Consensus       163 ~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~---------------~~~i~~~~  224 (336)
T 3h4j_B          163 FL---KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL---------------FKKVNSCV  224 (336)
T ss_dssp             TT---CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC---------------BCCCCSSC
T ss_pred             cc---ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH---------------HHHHHcCC
Confidence            22   34569999999999988775 7899999999999999999999965432110               00000000


Q ss_pred             ccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          755 KEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       755 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      .  ..+......+.+++.+||+.||.+|||++|+++
T Consensus       225 ~--~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          225 Y--VMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             C--CCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             C--CCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            0  011223467889999999999999999999975

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=4.6e-38  Score=340.67  Aligned_cols=260  Identities=16%  Similarity=0.162  Sum_probs=207.0

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhcc-CCCCccceeeeecccccceEEE
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRLLVY  597 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  597 (814)
                      ..+.+.+.||+|+||.||+|...  ..++.||||.+...  ...+++..|+.+++++ +||||+++++++.+.+..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~   84 (330)
T 2izr_A            9 PNFRVGKKIGCGNFGELRLGKNL--YTNEYVAIKLEPMK--SRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL   84 (330)
T ss_dssp             TTEEEEEECCC-CTTSEEEEEET--TTTEEEEEEEEETT--CSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred             CCeEEEEEeeccCCceEEEEEEC--CCCcEEEEEEeccc--cchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence            34667789999999999999964  36789999998643  2345789999999999 9999999999999999999999


Q ss_pred             ecCCCCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCc-----EEEeecCCcccc
Q 041921          598 EFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYT-----ARISDFGLAKLL  671 (814)
Q Consensus       598 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~-----~kl~DfGla~~~  671 (814)
                      ||+ +++|.+++.. ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.     +||+|||+++.+
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~  160 (330)
T 2izr_A           85 ELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY  160 (330)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred             EeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence            999 9999999986 46789999999999999999999998   9999999999999998887     999999999876


Q ss_pred             ccCCccc-----ccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCc
Q 041921          672 TLNQSKT-----IKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK  746 (814)
Q Consensus       672 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  746 (814)
                      .......     ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..............+.    ...
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~----~~~  236 (330)
T 2izr_A          161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIG----DTK  236 (330)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHH----HHH
T ss_pred             ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHH----hhh
Confidence            5433211     1134579999999999999999999999999999999999999998654332211111111    110


Q ss_pred             cceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 041921          747 LNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV  796 (814)
Q Consensus       747 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~  796 (814)
                      ...... ..    ....+ ++.+++..|++.+|.+||++++|++.|+++.
T Consensus       237 ~~~~~~-~~----~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~  280 (330)
T 2izr_A          237 RATPIE-VL----CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLF  280 (330)
T ss_dssp             HHSCHH-HH----TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             ccCCHH-HH----hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence            000000 00    00123 8899999999999999999999999997643

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.4e-38  Score=333.59  Aligned_cols=255  Identities=27%  Similarity=0.431  Sum_probs=209.7

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEe
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE  598 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  598 (814)
                      ..+.+.+.||+|+||.||+|...   ++..||||.+.... ...+++.+|+.++++++||||+++++++.+.+..++|||
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWL---NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTE   83 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET---TTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEC
T ss_pred             hheeeeeEecCCCceeEEEEEec---CCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEe
Confidence            45677889999999999999975   46789999997643 345689999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcc
Q 041921          599 FLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSK  677 (814)
Q Consensus       599 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  677 (814)
                      |+++++|.+++... ..+++..+..++.|+++||.|||+.   +|+|+||||+||+++.++.+||+|||++.........
T Consensus        84 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~  160 (267)
T 3t9t_A           84 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT  160 (267)
T ss_dssp             CCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred             CCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccccc
Confidence            99999999999765 5689999999999999999999998   9999999999999999999999999999866432211


Q ss_pred             cccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeecCccc
Q 041921          678 TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKE  756 (814)
Q Consensus       678 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  756 (814)
                      . .....++..|+|||.+.+..++.++||||||++++||++ |+.||......+       ....+..+...        
T Consensus       161 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~i~~~~~~--------  224 (267)
T 3t9t_A          161 S-STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-------VVEDISTGFRL--------  224 (267)
T ss_dssp             S-TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHHHTTCCC--------
T ss_pred             c-cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH-------HHHHHhcCCcC--------
Confidence            1 133457788999999998899999999999999999999 899987543222       11122222110        


Q ss_pred             ccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 041921          757 AMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE  797 (814)
Q Consensus       757 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~  797 (814)
                       ..+......+.+++.+||+.||.+|||++++++.|+++.+
T Consensus       225 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          225 -YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             -CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence             0111234678899999999999999999999999987654

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.1e-38  Score=340.33  Aligned_cols=270  Identities=21%  Similarity=0.285  Sum_probs=203.7

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccccc---chHhHHHHHHhhhccCCCCccceeeeecccccc--
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNR--  593 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~--  593 (814)
                      ..|.+.+.||+|+||.||+|...  ..++.||||.+......   ....+.+|+.++++++||||+++++++......  
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~   89 (311)
T 3ork_A           12 DRYELGEILGFGGMSEVHLARDL--RDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   89 (311)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEET--TTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred             CcEEEEEEEccCCCEEEEEEEEC--CCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence            45778899999999999999965  36789999999754322   234689999999999999999999998776654  


Q ss_pred             --eEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcccc
Q 041921          594 --LLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLL  671 (814)
Q Consensus       594 --~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~  671 (814)
                        ++||||+++++|.+++.....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.+
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  166 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI  166 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred             ccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence              99999999999999998878899999999999999999999998   9999999999999999999999999999876


Q ss_pred             ccCCcc-cccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCcccee
Q 041921          672 TLNQSK-TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVL  750 (814)
Q Consensus       672 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  750 (814)
                      ...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||........      ............ 
T Consensus       167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~~~~~~~~-  239 (311)
T 3ork_A          167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVREDPIPP-  239 (311)
T ss_dssp             ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHCCCCCH-
T ss_pred             cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhcCCCCCc-
Confidence            543221 112345689999999999999999999999999999999999999975443221      111111111100 


Q ss_pred             ecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHH-HHHHHhcCcCCCCCCCCCC
Q 041921          751 VGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKK-VLQMLEGVVEVSVPPNPYP  806 (814)
Q Consensus       751 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~-vl~~L~~~~~~~~p~~p~~  806 (814)
                            .......+..+.+++.+||+.||.+||++.+ +.+.|..+.....|+.|..
T Consensus       240 ------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~~~~~~~  290 (311)
T 3ork_A          240 ------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKV  290 (311)
T ss_dssp             ------HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCCCSSCCC
T ss_pred             ------ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCCCCCCcc
Confidence                  0001123467889999999999999996554 5566665555444444433

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=6e-39  Score=347.17  Aligned_cols=269  Identities=24%  Similarity=0.359  Sum_probs=212.3

Q ss_pred             HhhhccccceeeeeeeeEEEEEEe--cCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeec--ccccc
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQ--TRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCD--EGQNR  593 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~--~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~  593 (814)
                      ...+.+.+.||+|+||.||++.+.  +...+..||||++........+.+.+|+.++++++||||+++++++.  +....
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            456778899999999999999864  23467899999998765555677999999999999999999999886  45568


Q ss_pred             eEEEecCCCCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccc
Q 041921          594 LLVYEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLT  672 (814)
Q Consensus       594 ~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~  672 (814)
                      ++||||+++++|.+++.. ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++....
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  178 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLP  178 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred             EEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceecc
Confidence            899999999999999976 35689999999999999999999998   99999999999999999999999999998765


Q ss_pred             cCCccc-ccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhh--------HHHHHHHHhh
Q 041921          673 LNQSKT-IKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI--------LTDWAFDCYR  743 (814)
Q Consensus       673 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~--------~~~~~~~~~~  743 (814)
                      ...... ......+|..|+|||.+.+..++.++||||||++++||++|+.||.....+....        ..........
T Consensus       179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (327)
T 3lxl_A          179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE  258 (327)
T ss_dssp             TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHH
T ss_pred             cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhh
Confidence            433221 1233458888999999998889999999999999999999999986432211000        0001111111


Q ss_pred             cCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 041921          744 NGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV  798 (814)
Q Consensus       744 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~~  798 (814)
                      .+         .....+...+..+.+++.+||+.||.+|||++++++.|+.+...
T Consensus       259 ~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  304 (327)
T 3lxl_A          259 EG---------QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG  304 (327)
T ss_dssp             TT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred             cc---------cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence            11         11112234457789999999999999999999999999886543

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=8.4e-39  Score=341.79  Aligned_cols=273  Identities=26%  Similarity=0.371  Sum_probs=211.9

Q ss_pred             CHHHHHHhhhccccceeeeeeeeEEEEEEe--cCCCceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccceeeeec
Q 041921          512 SYKELEGATNNFKEEVGRGSFGIVYKGVIQ--TRTSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCD  588 (814)
Q Consensus       512 ~~~~l~~~~~~~~~~LG~G~~g~Vy~~~~~--~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  588 (814)
                      ...++....+.+.++||+|+||.||+|.+.  +...+..||||.+.... ....+.+.+|+.++++++||||+++++++.
T Consensus        14 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   93 (302)
T 4e5w_A           14 DPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICT   93 (302)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             ChhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEe
Confidence            344445566788899999999999999863  23367899999997432 334567999999999999999999999998


Q ss_pred             cc--ccceEEEecCCCCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeec
Q 041921          589 EG--QNRLLVYEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDF  665 (814)
Q Consensus       589 ~~--~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~Df  665 (814)
                      +.  ...++||||+++++|.+++.. ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        94 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Df  170 (302)
T 4e5w_A           94 EDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDF  170 (302)
T ss_dssp             C---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCC
T ss_pred             cCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcc
Confidence            76  668999999999999999954 46789999999999999999999998   9999999999999999999999999


Q ss_pred             CCccccccCCcc-cccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchh--------hhhHHH
Q 041921          666 GLAKLLTLNQSK-TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE--------YAILTD  736 (814)
Q Consensus       666 Gla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~--------~~~~~~  736 (814)
                      |++......... .......+|..|+|||.+.+..++.++||||||++++||++|+.|+.......        ......
T Consensus       171 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  250 (302)
T 4e5w_A          171 GLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVT  250 (302)
T ss_dssp             TTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHH
T ss_pred             cccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHH
Confidence            999877644321 12234558888999999999999999999999999999999999864321100        000001


Q ss_pred             HHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 041921          737 WAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV  796 (814)
Q Consensus       737 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~  796 (814)
                      .....+..+.         ....+...+..+.+++.+||+.||.+|||+++++++|+.++
T Consensus       251 ~~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          251 RLVNTLKEGK---------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHHHHHHTTC---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHhccC---------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            1111111111         11112234567889999999999999999999999998764

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-38  Score=343.82  Aligned_cols=262  Identities=24%  Similarity=0.450  Sum_probs=203.8

Q ss_pred             HHHhhhccccceeeeeeeeEEEEEEecCC--CceEEEEEEeccccc-cchHhHHHHHHhhhccCCCCccceeeeeccccc
Q 041921          516 LEGATNNFKEEVGRGSFGIVYKGVIQTRT--STTAVAVKKLDRVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQN  592 (814)
Q Consensus       516 l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~--~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  592 (814)
                      +....+.+.+.||+|+||.||+|.....+  .+..||||.++.... ....++.+|+.++++++||||+++++++.+.+.
T Consensus        41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  120 (333)
T 1mqb_A           41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP  120 (333)
T ss_dssp             CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCC
Confidence            34455667789999999999999876432  245799999975432 334568999999999999999999999999999


Q ss_pred             ceEEEecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcccc
Q 041921          593 RLLVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLL  671 (814)
Q Consensus       593 ~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~  671 (814)
                      .++||||+++++|.+++... ..+++..++.++.||++||.|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus       121 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  197 (333)
T 1mqb_A          121 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL  197 (333)
T ss_dssp             EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             cEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence            99999999999999999764 6789999999999999999999998   9999999999999999999999999999876


Q ss_pred             ccCCccc-ccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccce
Q 041921          672 TLNQSKT-IKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNV  749 (814)
Q Consensus       672 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  749 (814)
                      ....... ......+|..|+|||.+.+..++.++||||||+++|||++ |+.||......+       +...+..+..  
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~-------~~~~~~~~~~--  268 (333)
T 1mqb_A          198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-------VMKAINDGFR--  268 (333)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHHHTTCC--
T ss_pred             ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH-------HHHHHHCCCc--
Confidence            5432211 1122346788999999999999999999999999999999 999996543221       1122222211  


Q ss_pred             eecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 041921          750 LVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV  796 (814)
Q Consensus       750 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~  796 (814)
                             .......+..+.+++.+||+.+|.+||++.++++.|+.+.
T Consensus       269 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~  308 (333)
T 1mqb_A          269 -------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI  308 (333)
T ss_dssp             -------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             -------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                   0112234567889999999999999999999999998754

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=2.2e-38  Score=332.64  Aligned_cols=251  Identities=22%  Similarity=0.322  Sum_probs=203.4

Q ss_pred             HhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeeccc--ccc
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEG--QNR  593 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  593 (814)
                      ...+.+.+.||+|+||.||+|...    +..||||.+....  ....+++.+|+.++++++||||+++++++.+.  ...
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   84 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ----GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP   84 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET----TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSC
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC----CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCe
Confidence            346677899999999999999974    6789999986532  23345799999999999999999999999877  778


Q ss_pred             eEEEecCCCCCHHHHhcCCC--CCChhhHHHHHHHHHHHHHHhhhcCCCC--eeecCCCCCcEEEcCCCcEEEeecCCcc
Q 041921          594 LLVYEFLNNGTLASFLFGNL--KPNWNLRTNIAFQIARGLLYLHEDCRAQ--IIHCDIKPQNILLDDYYTARISDFGLAK  669 (814)
Q Consensus       594 ~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~~l~yLH~~~~~~--i~H~dlkp~NIll~~~~~~kl~DfGla~  669 (814)
                      ++||||+++++|.+++....  .+++..+..++.|+++||+|||+.   +  |+||||||+||+++.++.++|.|||++.
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~  161 (271)
T 3kmu_A           85 TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKF  161 (271)
T ss_dssp             EEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred             EeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEecccee
Confidence            99999999999999998764  489999999999999999999997   7  9999999999999999999999998875


Q ss_pred             ccccCCcccccccccCCCCcccccccccCCCCc---chhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCc
Q 041921          670 LLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITA---KVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK  746 (814)
Q Consensus       670 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~---~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  746 (814)
                      ....       ....||+.|+|||.+.+...+.   ++||||||+++|||++|+.||......+.      .......+.
T Consensus       162 ~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~~~  228 (271)
T 3kmu_A          162 SFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI------GMKVALEGL  228 (271)
T ss_dssp             TTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH------HHHHHHSCC
T ss_pred             eecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH------HHHHHhcCC
Confidence            4322       2345899999999998765544   79999999999999999999975433221      111111111


Q ss_pred             cceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 041921          747 LNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE  797 (814)
Q Consensus       747 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~  797 (814)
                      ..         ..+...+..+.+++..||+.||.+|||++++++.|+.+.+
T Consensus       229 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          229 RP---------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             CC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             CC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            11         1112234678899999999999999999999999987653

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.9e-38  Score=371.56  Aligned_cols=251  Identities=29%  Similarity=0.413  Sum_probs=204.7

Q ss_pred             cceeeeeeeeEEEEEEecCCCceEEEEEEeccccc--cchHhHHHHHHhhhccCCCCccceeeeecccccceEEEecCCC
Q 041921          525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ--DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN  602 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  602 (814)
                      ++||+|+||.||+|.+.....+..||||+++....  ...+++.+|+.++++++||||+++++++.+ +..+|||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            47999999999999887666788999999975432  335689999999999999999999999964 568899999999


Q ss_pred             CCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcc-cccc
Q 041921          603 GTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSK-TIKT  681 (814)
Q Consensus       603 gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~  681 (814)
                      |+|.+++.....+++..+..|+.||+.||+|||+.   +|+||||||+||||+.++.+||+|||+++.+...... ....
T Consensus       454 g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~  530 (635)
T 4fl3_A          454 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT  530 (635)
T ss_dssp             EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---------
T ss_pred             CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccccc
Confidence            99999998888899999999999999999999998   9999999999999999999999999999877543321 1113


Q ss_pred             cccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCc
Q 041921          682 AIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMND  760 (814)
Q Consensus       682 ~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  760 (814)
                      ...+|..|+|||++....++.++|||||||++|||++ |+.||......+       +...+..+...         ..+
T Consensus       531 ~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-------~~~~i~~~~~~---------~~p  594 (635)
T 4fl3_A          531 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGERM---------GCP  594 (635)
T ss_dssp             ----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCCC---------CCC
T ss_pred             CCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCC---------CCC
Confidence            3457889999999999999999999999999999998 999997554322       12222222211         112


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 041921          761 IECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV  795 (814)
Q Consensus       761 ~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~  795 (814)
                      ...+.++.+++..||+.||++|||+++|+++|+.+
T Consensus       595 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  629 (635)
T 4fl3_A          595 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  629 (635)
T ss_dssp             TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            23457889999999999999999999999999864

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.4e-37  Score=328.01  Aligned_cols=251  Identities=22%  Similarity=0.312  Sum_probs=207.6

Q ss_pred             HhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEE
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY  597 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  597 (814)
                      ...|.+.+.||+|+||.||+|...  ..+..||+|++........+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQK--GTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM   85 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEET--TTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeC--CCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence            345778899999999999999875  356789999998766666788999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE---cCCCcEEEeecCCccccccC
Q 041921          598 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILL---DDYYTARISDFGLAKLLTLN  674 (814)
Q Consensus       598 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll---~~~~~~kl~DfGla~~~~~~  674 (814)
                      ||+++++|.+++.....+++..+..++.|++.||.|||+.   +|+||||||+||++   +.++.+||+|||++......
T Consensus        86 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~  162 (277)
T 3f3z_A           86 ELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG  162 (277)
T ss_dssp             ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred             eccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence            9999999999998888899999999999999999999998   99999999999999   78899999999999876543


Q ss_pred             CcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCc
Q 041921          675 QSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGED  754 (814)
Q Consensus       675 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  754 (814)
                      ...   ....||+.|+|||.+.+. ++.++||||||++++||++|+.||......+.       ...+..+......   
T Consensus       163 ~~~---~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-------~~~~~~~~~~~~~---  228 (277)
T 3f3z_A          163 KMM---RTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV-------MLKIREGTFTFPE---  228 (277)
T ss_dssp             SCB---CCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHCCCCCCH---
T ss_pred             cch---hccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHH-------HHHHHhCCCCCCc---
Confidence            322   345689999999998754 89999999999999999999999975443221       1112222111100   


Q ss_pred             ccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          755 KEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       755 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      .   ........+.+++.+||+.||.+|||+.++++
T Consensus       229 ~---~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          229 K---DWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             H---HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             h---hhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0   00123467889999999999999999999985

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.3e-38  Score=366.99  Aligned_cols=261  Identities=28%  Similarity=0.440  Sum_probs=212.8

Q ss_pred             HHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceE
Q 041921          516 LEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL  595 (814)
Q Consensus       516 l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  595 (814)
                      +....+.+.++||+|+||.||+|.+.   ....||||+++... ...++|.+|+.++++++|+||+++++++.+ +..+|
T Consensus       264 i~~~~~~~~~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~l  338 (535)
T 2h8h_A          264 IPRESLRLEVKLGQGCFGEVWMGTWN---GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI  338 (535)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEET---TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             cchhhhhhheecccCCCeEEEEEEEC---CCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceE
Confidence            44556778899999999999999986   35679999997543 345689999999999999999999999876 67899


Q ss_pred             EEecCCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcccccc
Q 041921          596 VYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTL  673 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~  673 (814)
                      ||||+++|+|.++|...  ..+++..+..|+.||++||+|||+.   +|+||||||+||||+.++.+||+|||+++....
T Consensus       339 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  415 (535)
T 2h8h_A          339 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED  415 (535)
T ss_dssp             EECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred             eeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence            99999999999999753  5689999999999999999999998   999999999999999999999999999987653


Q ss_pred             CCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeec
Q 041921          674 NQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVG  752 (814)
Q Consensus       674 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  752 (814)
                      .... ......++..|+|||.+....++.++||||||+++|||++ |+.||......+       +...+..+..     
T Consensus       416 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~-------~~~~i~~~~~-----  482 (535)
T 2h8h_A          416 NEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGYR-----  482 (535)
T ss_dssp             HHHH-TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH-------HHHHHHTTCC-----
T ss_pred             Ccee-cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCC-----
Confidence            2211 1123446789999999998999999999999999999999 999997543322       1122222211     


Q ss_pred             CcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCCCC
Q 041921          753 EDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVP  801 (814)
Q Consensus       753 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~~~~p  801 (814)
                          ...+..+...+.+++.+||+.||++|||+++|+++|+.+.....|
T Consensus       483 ----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~  527 (535)
T 2h8h_A          483 ----MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP  527 (535)
T ss_dssp             ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSC
T ss_pred             ----CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCc
Confidence                011223456788999999999999999999999999987664433

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1e-37  Score=344.05  Aligned_cols=252  Identities=25%  Similarity=0.331  Sum_probs=206.6

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEe
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE  598 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  598 (814)
                      ..|.+.+.||+|+||.||+|....  .+..||+|.+..........+.+|+.++++++||||+++++++.+....++|||
T Consensus        51 ~~y~i~~~LG~G~~g~Vy~~~~~~--~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E  128 (387)
T 1kob_A           51 DYYDILEELGSGAFGVVHRCVEKA--TGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE  128 (387)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred             cceEEEEEEecCCCEEEEEEEECC--CCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence            357788999999999999998753  577899999976544455679999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC--CCcEEEeecCCccccccCC
Q 041921          599 FLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDD--YYTARISDFGLAKLLTLNQ  675 (814)
Q Consensus       599 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~--~~~~kl~DfGla~~~~~~~  675 (814)
                      |+++++|.+++... ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.  ++.+||+|||+++......
T Consensus       129 ~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~  205 (387)
T 1kob_A          129 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE  205 (387)
T ss_dssp             CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred             cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence            99999999999765 4789999999999999999999998   9999999999999974  5789999999998765432


Q ss_pred             cccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcc
Q 041921          676 SKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDK  755 (814)
Q Consensus       676 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  755 (814)
                      ..   ....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.       ...+.......  ..  
T Consensus       206 ~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~-------~~~i~~~~~~~--~~--  271 (387)
T 1kob_A          206 IV---KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET-------LQNVKRCDWEF--DE--  271 (387)
T ss_dssp             CE---EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-------HHHHHHCCCCC--CS--
T ss_pred             ce---eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHH-------HHHHHhCCCCC--Cc--
Confidence            21   334699999999999999999999999999999999999999975433211       11111111110  00  


Q ss_pred             cccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          756 EAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       756 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                        ........++.+++.+||+.||.+|||+.++++.
T Consensus       272 --~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          272 --DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             --STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             --cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence              1111234678899999999999999999999873

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.5e-38  Score=335.59  Aligned_cols=249  Identities=22%  Similarity=0.325  Sum_probs=195.7

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc--------------------------cchHhHHHHHHhh
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ--------------------------DGEREFKNEVFVI  572 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~--------------------------~~~~~~~~E~~~l  572 (814)
                      ..|.+.+.||+|+||.||+|...  ..+..||||.+.....                          ...+++.+|+.++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~a~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   90 (298)
T 2zv2_A           13 NQYTLKDEIGKGSYGVVKLAYNE--NDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL   90 (298)
T ss_dssp             TTEEEEEEEEC--CCEEEEEEET--TTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred             cceEEEeEEeecCCEEEEEEEEC--CCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence            35677889999999999999865  3578999999864321                          1135689999999


Q ss_pred             hccCCCCccceeeeecc--cccceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCC
Q 041921          573 GQTHHKNLVRLLGFCDE--GQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQ  650 (814)
Q Consensus       573 ~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~  650 (814)
                      ++++||||+++++++.+  ....++||||+++++|.+++. ...+++..+..++.||++||+|||+.   +|+||||||+
T Consensus        91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~  166 (298)
T 2zv2_A           91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPS  166 (298)
T ss_dssp             HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGG
T ss_pred             HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHH
Confidence            99999999999999976  567899999999999988654 35689999999999999999999998   9999999999


Q ss_pred             cEEEcCCCcEEEeecCCccccccCCcccccccccCCCCcccccccccCC---CCcchhhHHHHHHHHHHHhCCCCCCccc
Q 041921          651 NILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSK---ITAKVDVYSFGVLLLEIISCRKSFDIEM  727 (814)
Q Consensus       651 NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~~~Dv~s~Gvvl~elltg~~p~~~~~  727 (814)
                      |||++.++.+||+|||+++........  .....||+.|+|||.+.+..   .+.++||||||+++|||++|+.||....
T Consensus       167 Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  244 (298)
T 2zv2_A          167 NLLVGEDGHIKIADFGVSNEFKGSDAL--LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER  244 (298)
T ss_dssp             GEEECTTSCEEECCCTTCEECSSSSCE--ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             HEEECCCCCEEEecCCCcccccccccc--ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence            999999999999999999876543221  13456999999999997665   3788999999999999999999997543


Q ss_pred             chhhhhHHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          728 GEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       728 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      ...       ....+.......        +........+.+++.+||+.||++|||+.|+++
T Consensus       245 ~~~-------~~~~~~~~~~~~--------~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          245 IMC-------LHSKIKSQALEF--------PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             HHH-------HHHHHHHCCCCC--------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HHH-------HHHHHhcccCCC--------CCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            221       111122221111        111123467889999999999999999999874

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-37  Score=334.72  Aligned_cols=245  Identities=24%  Similarity=0.322  Sum_probs=204.7

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhccCCCCccceeeeecccccceE
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL  595 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  595 (814)
                      ..+.+.+.||+|+||.||++...  .+++.||+|.++...   ....+.+.+|..+++.++||||+++++++.+.+..++
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l   83 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSR--HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM   83 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET--TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEEC--CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEE
Confidence            34667889999999999999875  357899999996532   2344568899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCC
Q 041921          596 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ  675 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~  675 (814)
                      ||||+++|+|.+++.....+++.....++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        84 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~  160 (318)
T 1fot_A           84 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT  160 (318)
T ss_dssp             EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB
T ss_pred             EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCCcc
Confidence            999999999999998888899999999999999999999998   99999999999999999999999999998654321


Q ss_pred             cccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcc
Q 041921          676 SKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDK  755 (814)
Q Consensus       676 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  755 (814)
                           ....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+       ....+..+.+.       
T Consensus       161 -----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-------~~~~i~~~~~~-------  221 (318)
T 1fot_A          161 -----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK-------TYEKILNAELR-------  221 (318)
T ss_dssp             -----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHHCCCC-------
T ss_pred             -----ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCC-------
Confidence                 34569999999999999999999999999999999999999997543321       11112222111       


Q ss_pred             cccCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 041921          756 EAMNDIECLGKLVMVSIWCIQEDPSLRP-----TMKKVLQ  790 (814)
Q Consensus       756 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~~vl~  790 (814)
                         .+.....++.+++.+||+.||.+||     +++++++
T Consensus       222 ---~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          222 ---FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             ---CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             ---CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence               0112346788999999999999999     8888873

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=8.7e-38  Score=335.42  Aligned_cols=260  Identities=22%  Similarity=0.291  Sum_probs=199.1

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeecccccceEE
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV  596 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  596 (814)
                      ..|.+.++||+|+||+||+|...   .++.||||++....  ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus        21 ~~y~~~~~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   97 (311)
T 3niz_A           21 EKYQKLEKVGEGTYGVVYKAKDS---QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV   97 (311)
T ss_dssp             CEEEEEEEEEECSSCEEEEEEET---TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred             hhhHhhhhccCCCCeEEEEEEEC---CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence            45677889999999999999874   47899999996432  22245789999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCC
Q 041921          597 YEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ  675 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~  675 (814)
                      |||+++ +|.+++... ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        98 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  173 (311)
T 3niz_A           98 FEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPV  173 (311)
T ss_dssp             EECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred             EcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence            999985 787777654 5589999999999999999999998   99999999999999999999999999998765332


Q ss_pred             cccccccccCCCCccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccce-----
Q 041921          676 SKTIKTAIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNV-----  749 (814)
Q Consensus       676 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  749 (814)
                      ..  .....+|+.|+|||.+.+ ..++.++||||||++++||++|+.||......+...   .+...........     
T Consensus       174 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~---~i~~~~~~~~~~~~~~~~  248 (311)
T 3niz_A          174 RS--YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLP---KIFSILGTPNPREWPQVQ  248 (311)
T ss_dssp             C-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHH---HHHHHHCCCCTTTSGGGT
T ss_pred             cc--ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHHHHCCCChHHhhhhh
Confidence            21  134568999999999876 568999999999999999999999997654432211   1111111100000     


Q ss_pred             -----------eecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          750 -----------LVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       750 -----------~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                                 ................++.+++.+||+.||.+|||++|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                       00000000001123457889999999999999999999987

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=3.1e-38  Score=340.96  Aligned_cols=250  Identities=23%  Similarity=0.284  Sum_probs=183.4

Q ss_pred             cceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccC-CCCccceeeeecccccceEEEecCCCC
Q 041921          525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTH-HKNLVRLLGFCDEGQNRLLVYEFLNNG  603 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g  603 (814)
                      ++||+|+||.||+|....  .++.||||.+...   ....+.+|+.++.+++ ||||+++++++.+....++||||++++
T Consensus        17 ~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~   91 (325)
T 3kn6_A           17 KPLGEGSFSICRKCVHKK--SNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG   91 (325)
T ss_dssp             CCSEEETTEEEEEEEETT--TCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred             CccccCCCeEEEEEEECC--CCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCC
Confidence            679999999999999753  5789999998642   3467889999999997 999999999999999999999999999


Q ss_pred             CHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC---cEEEeecCCccccccCCccccc
Q 041921          604 TLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYY---TARISDFGLAKLLTLNQSKTIK  680 (814)
Q Consensus       604 sL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~---~~kl~DfGla~~~~~~~~~~~~  680 (814)
                      +|.+++.....+++..+..++.||+.||+|||+.   +|+||||||+|||++.++   .+||+|||+++........  .
T Consensus        92 ~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~--~  166 (325)
T 3kn6_A           92 ELFERIKKKKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP--L  166 (325)
T ss_dssp             BHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc--c
Confidence            9999999888899999999999999999999998   999999999999998665   8999999999866543221  1


Q ss_pred             ccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCc
Q 041921          681 TAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMND  760 (814)
Q Consensus       681 ~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  760 (814)
                      ....||+.|+|||.+.+..++.++||||||+++|||++|+.||..................+..+.....      ....
T Consensus       167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~------~~~~  240 (325)
T 3kn6_A          167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFE------GEAW  240 (325)
T ss_dssp             -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCC------SHHH
T ss_pred             cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCC------cccc
Confidence            3456899999999999999999999999999999999999999754332111111112233333322110      0001


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          761 IECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       761 ~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      .....++.+++.+||+.||.+|||++++++
T Consensus       241 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          241 KNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             HTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             cCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence            123567889999999999999999999974

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.2e-37  Score=342.34  Aligned_cols=251  Identities=24%  Similarity=0.344  Sum_probs=205.4

Q ss_pred             HhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccc---cccchHhHHHHHHhhhccCCCCccceeeeecccccce
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV---FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRL  594 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  594 (814)
                      ...+.+.+.||+|+||.||++...  ..+..||||.+...   .....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~--~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   91 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKN--DTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMF   91 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEET--TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEEC--CCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            345677889999999999999875  35788999998643   2334467889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccC
Q 041921          595 LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN  674 (814)
Q Consensus       595 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~  674 (814)
                      +||||+++|+|..++.....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++..+...
T Consensus        92 lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  168 (384)
T 4fr4_A           92 MVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE  168 (384)
T ss_dssp             EEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence            9999999999999999888899999999999999999999998   9999999999999999999999999999876543


Q ss_pred             CcccccccccCCCCccccccccc---CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceee
Q 041921          675 QSKTIKTAIRGTKGYVAPEWFRN---SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLV  751 (814)
Q Consensus       675 ~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  751 (814)
                      ..   .....||+.|+|||++..   ..++.++|||||||++|||++|+.||..........+.    ..+......   
T Consensus       169 ~~---~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~----~~~~~~~~~---  238 (384)
T 4fr4_A          169 TQ---ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV----HTFETTVVT---  238 (384)
T ss_dssp             CC---BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHH----HHHHHCCCC---
T ss_pred             Cc---eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHH----HHHhhcccC---
Confidence            22   245679999999999964   45899999999999999999999999754332221111    111111111   


Q ss_pred             cCcccccCcHHHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 041921          752 GEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPT-MKKVLQ  790 (814)
Q Consensus       752 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-~~~vl~  790 (814)
                             .+......+.+++.+||+.||.+||+ ++++++
T Consensus       239 -------~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          239 -------YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             -------CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             -------CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence                   11223467889999999999999998 677664

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=3.3e-38  Score=340.53  Aligned_cols=263  Identities=27%  Similarity=0.458  Sum_probs=212.3

Q ss_pred             HHHhhhccccceeeeeeeeEEEEEEec---CCCceEEEEEEeccccc-cchHhHHHHHHhhhccCCCCccceeeeecccc
Q 041921          516 LEGATNNFKEEVGRGSFGIVYKGVIQT---RTSTTAVAVKKLDRVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ  591 (814)
Q Consensus       516 l~~~~~~~~~~LG~G~~g~Vy~~~~~~---~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  591 (814)
                      +....+.+.+.||+|+||.||+|....   ...+..||||.+..... ....++.+|+.++++++||||+++++++.+.+
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~  101 (322)
T 1p4o_A           22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ  101 (322)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred             chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCC
Confidence            344567788999999999999998652   12467899999975432 23456899999999999999999999999999


Q ss_pred             cceEEEecCCCCCHHHHhcCC----------CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEE
Q 041921          592 NRLLVYEFLNNGTLASFLFGN----------LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTAR  661 (814)
Q Consensus       592 ~~~lv~e~~~~gsL~~~l~~~----------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~k  661 (814)
                      ..++||||+++++|.+++...          ..+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+|
T Consensus       102 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~k  178 (322)
T 1p4o_A          102 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVK  178 (322)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEE
T ss_pred             ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeEE
Confidence            999999999999999999642          3568899999999999999999998   999999999999999999999


Q ss_pred             EeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHH
Q 041921          662 ISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFD  740 (814)
Q Consensus       662 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~  740 (814)
                      |+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.......       ...
T Consensus       179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------~~~  251 (322)
T 1p4o_A          179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-------VLR  251 (322)
T ss_dssp             ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH-------HHH
T ss_pred             ECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH-------HHH
Confidence            999999987654332222233457889999999999999999999999999999999 889987543222       112


Q ss_pred             HhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 041921          741 CYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE  797 (814)
Q Consensus       741 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~  797 (814)
                      .+..+....         .....+..+.+++.+||+.||.+|||+.++++.|++..+
T Consensus       252 ~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          252 FVMEGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             HHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHHcCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence            222222111         112344678899999999999999999999999988655

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2.8e-38  Score=335.66  Aligned_cols=267  Identities=27%  Similarity=0.428  Sum_probs=199.9

Q ss_pred             cCHHHHHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeec
Q 041921          511 FSYKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCD  588 (814)
Q Consensus       511 ~~~~~l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  588 (814)
                      +...|+....+.+.++||+|+||.||+|...     ..||||.++...  ....+.+.+|+.++++++||||+++++++ 
T Consensus        16 ~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-   89 (289)
T 3og7_A           16 ADDWEIPDGQITVGQRIGSGSFGTVYKGKWH-----GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-   89 (289)
T ss_dssp             --CCBCCTTSCEEEEEEEECSSEEEEEEESS-----SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-
T ss_pred             CCCCccCccceeeeeEecCCCCeEEEEEEEc-----CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-
Confidence            3344666778888999999999999999853     359999886432  23346799999999999999999999976 


Q ss_pred             ccccceEEEecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCC
Q 041921          589 EGQNRLLVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGL  667 (814)
Q Consensus       589 ~~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGl  667 (814)
                      .....++||||+++++|.+++... ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~  166 (289)
T 3og7_A           90 TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGL  166 (289)
T ss_dssp             CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-
T ss_pred             cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEcccee
Confidence            456689999999999999999654 6689999999999999999999998   999999999999999999999999999


Q ss_pred             ccccccCCcccccccccCCCCcccccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhc
Q 041921          668 AKLLTLNQSKTIKTAIRGTKGYVAPEWFR---NSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN  744 (814)
Q Consensus       668 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  744 (814)
                      +................||+.|+|||.+.   ...++.++||||||++++||++|+.||......+.      ....+..
T Consensus       167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~  240 (289)
T 3og7_A          167 ATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ------IIEMVGR  240 (289)
T ss_dssp             -----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH------HHHHHHH
T ss_pred             ccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH------HHHHhcc
Confidence            98665433222224456999999999986   56788899999999999999999999975433221      1122222


Q ss_pred             CccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 041921          745 GKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE  797 (814)
Q Consensus       745 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~  797 (814)
                      +.......     ......+..+.+++.+||+.+|.+|||+.+++++|+++.+
T Consensus       241 ~~~~~~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          241 GSLSPDLS-----KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             TSCCCCTT-----SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             cccCcchh-----hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence            22111100     0112345778999999999999999999999999998754

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.1e-38  Score=346.12  Aligned_cols=259  Identities=26%  Similarity=0.470  Sum_probs=196.9

Q ss_pred             hccccceeeeeeeeEEEEEEecCC-CceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccceeeeecc-cccceEEE
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRT-STTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDE-GQNRLLVY  597 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~  597 (814)
                      +.+.+.||+|+||.||+|.+.... ....||||.++... ....++|.+|+.++++++||||+++++++.+ ++..++||
T Consensus        91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~  170 (373)
T 3c1x_A           91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL  170 (373)
T ss_dssp             EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred             eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence            456788999999999999976432 34679999986533 2345679999999999999999999998754 55789999


Q ss_pred             ecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCc
Q 041921          598 EFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS  676 (814)
Q Consensus       598 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  676 (814)
                      ||+++++|.+++... ..+++..+..++.||++||.|||+.   +|+||||||+|||++.++.+||+|||+++.......
T Consensus       171 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~  247 (373)
T 3c1x_A          171 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  247 (373)
T ss_dssp             ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred             ECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccccccc
Confidence            999999999999765 5588999999999999999999998   999999999999999999999999999986643321


Q ss_pred             cc--ccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeecC
Q 041921          677 KT--IKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGE  753 (814)
Q Consensus       677 ~~--~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  753 (814)
                      ..  ......+|..|+|||.+.+..++.++||||||+++|||++ |..||......+..       ..+..+...     
T Consensus       248 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~-------~~~~~~~~~-----  315 (373)
T 3c1x_A          248 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT-------VYLLQGRRL-----  315 (373)
T ss_dssp             ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHH-------HHHHTTCCC-----
T ss_pred             ccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHH-------HHHHcCCCC-----
Confidence            11  1133457889999999999999999999999999999999 66777644332211       111122110     


Q ss_pred             cccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 041921          754 DKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV  798 (814)
Q Consensus       754 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~~  798 (814)
                          ..+...+..+.+++.+||+.||.+|||++++++.|+.+..-
T Consensus       316 ----~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~  356 (373)
T 3c1x_A          316 ----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  356 (373)
T ss_dssp             ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             ----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence                01122346788999999999999999999999999876543

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=9.4e-38  Score=332.08  Aligned_cols=262  Identities=21%  Similarity=0.264  Sum_probs=199.9

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc--cchHhHHHHHHhhhccCCCCccceeeeecccccceEEE
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ--DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY  597 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  597 (814)
                      .|.+.++||+|+||+||+|....  .++.||||++.....  ...+.+.+|+.++++++||||+++++++.+++..++||
T Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   80 (292)
T 3o0g_A            3 KYEKLEKIGEGTYGTVFKAKNRE--THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_dssp             SEEEEEEEEECSSSEEEEEEETT--TCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CceeeeEecCCCCeEEEEEEECC--CCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence            46678899999999999999753  578899999964322  23367889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcc
Q 041921          598 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSK  677 (814)
Q Consensus       598 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  677 (814)
                      ||++++.+..+......+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++........
T Consensus        81 e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  157 (292)
T 3o0g_A           81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC  157 (292)
T ss_dssp             ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC
T ss_pred             ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCcccc
Confidence            9998754444445567899999999999999999999998   9999999999999999999999999999876533221


Q ss_pred             cccccccCCCCcccccccccCC-CCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccc------ee
Q 041921          678 TIKTAIRGTKGYVAPEWFRNSK-ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLN------VL  750 (814)
Q Consensus       678 ~~~~~~~gt~~y~aPE~~~~~~-~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------~~  750 (814)
                        .....||+.|+|||.+.+.. ++.++||||||++++||++|..|+........ .+ ..+.+........      ..
T Consensus       158 --~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~-~~-~~i~~~~~~~~~~~~~~~~~~  233 (292)
T 3o0g_A          158 --YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QL-KRIFRLLGTPTEEQWPSMTKL  233 (292)
T ss_dssp             --CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH-HH-HHHHHHHCCCCTTTCTTGGGS
T ss_pred             --ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH-HH-HHHHHHhCCCChhhhhhhccc
Confidence              13456899999999997765 79999999999999999999888643332211 11 1111111110000      00


Q ss_pred             ec---------CcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          751 VG---------EDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       751 ~~---------~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      .+         ..............+.+++.+||+.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            00         00000111234567889999999999999999999986

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-37  Score=332.62  Aligned_cols=260  Identities=26%  Similarity=0.436  Sum_probs=204.7

Q ss_pred             hccccceeeeeeeeEEEEEEecCC-CceEEEEEEeccccc-cchHhHHHHHHhhhccCCCCccceeeeecccccc-eEEE
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRT-STTAVAVKKLDRVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNR-LLVY  597 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lv~  597 (814)
                      +...++||+|+||+||+|...... ....||+|.+..... ...+.+.+|+.++++++||||+++++++.+.+.. ++|+
T Consensus        23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~  102 (298)
T 3pls_A           23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL  102 (298)
T ss_dssp             EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred             EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence            344588999999999999876432 345799999975433 3346789999999999999999999999876665 9999


Q ss_pred             ecCCCCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCc
Q 041921          598 EFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS  676 (814)
Q Consensus       598 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  676 (814)
                      ||+.+++|.+++.. ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.......
T Consensus       103 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  179 (298)
T 3pls_A          103 PYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREY  179 (298)
T ss_dssp             CCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred             ecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence            99999999999987 46688999999999999999999998   999999999999999999999999999986643321


Q ss_pred             --ccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCc
Q 041921          677 --KTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGED  754 (814)
Q Consensus       677 --~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  754 (814)
                        ........++..|+|||.+.+..++.++||||||++++||++|..|+.......  .+.    ..+..+..       
T Consensus       180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~--~~~----~~~~~~~~-------  246 (298)
T 3pls_A          180 YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF--DLT----HFLAQGRR-------  246 (298)
T ss_dssp             GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG--GHH----HHHHTTCC-------
T ss_pred             cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH--HHH----HHhhcCCC-------
Confidence              111133557899999999999999999999999999999999666653322211  111    11111111       


Q ss_pred             ccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 041921          755 KEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV  798 (814)
Q Consensus       755 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~~  798 (814)
                        ...+......+.+++.+||+.||.+|||++++++.|+++.+.
T Consensus       247 --~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  288 (298)
T 3pls_A          247 --LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA  288 (298)
T ss_dssp             --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence              011122346788999999999999999999999999886443

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2e-38  Score=348.35  Aligned_cols=272  Identities=15%  Similarity=0.178  Sum_probs=205.9

Q ss_pred             HHHhhhccccceeeeeeeeEEEEEEecCC---CceEEEEEEeccccccc-----------hHhHHHHHHhhhccCCCCcc
Q 041921          516 LEGATNNFKEEVGRGSFGIVYKGVIQTRT---STTAVAVKKLDRVFQDG-----------EREFKNEVFVIGQTHHKNLV  581 (814)
Q Consensus       516 l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~---~~~~vavK~l~~~~~~~-----------~~~~~~E~~~l~~l~h~niv  581 (814)
                      +....|.+.++||+|+||.||+|.+....   .++.||||.+.......           ...+..|+..+..++||||+
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv  111 (364)
T 3op5_A           32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP  111 (364)
T ss_dssp             TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred             cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence            34456778899999999999999886432   35789999986532211           11244566677788999999


Q ss_pred             ceeeeeccc----ccceEEEecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc-
Q 041921          582 RLLGFCDEG----QNRLLVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLD-  655 (814)
Q Consensus       582 ~l~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~-  655 (814)
                      ++++++.+.    ...+|||||+ +++|.+++... ..+++..++.|+.||+.||+|||+.   +|+||||||+|||++ 
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~  187 (364)
T 3op5_A          112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNY  187 (364)
T ss_dssp             CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEES
T ss_pred             eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEec
Confidence            999998765    4579999999 99999999765 6799999999999999999999998   999999999999999 


Q ss_pred             -CCCcEEEeecCCccccccCCccc-----ccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccch
Q 041921          656 -DYYTARISDFGLAKLLTLNQSKT-----IKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGE  729 (814)
Q Consensus       656 -~~~~~kl~DfGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~  729 (814)
                       .++.+||+|||+++.+.......     ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus       188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~  267 (364)
T 3op5_A          188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD  267 (364)
T ss_dssp             SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred             CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence             88999999999998765432211     112345999999999999999999999999999999999999999754332


Q ss_pred             hhhhHHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 041921          730 EYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE  797 (814)
Q Consensus       730 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~  797 (814)
                      ...  .......... .+..+.+....   ....+.++.+++..|++.+|.+||++.+|+++|+++.+
T Consensus       268 ~~~--~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~  329 (364)
T 3op5_A          268 PKY--VRDSKIRYRE-NIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLK  329 (364)
T ss_dssp             HHH--HHHHHHHHHH-CHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred             HHH--HHHHHHHhhh-hHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Confidence            211  1111111111 11111111110   11234678899999999999999999999999987554

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.2e-38  Score=334.84  Aligned_cols=258  Identities=29%  Similarity=0.417  Sum_probs=207.7

Q ss_pred             hhhcccc-ceeeeeeeeEEEEEEecCCCceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccceeeeecccccceEE
Q 041921          519 ATNNFKE-EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV  596 (814)
Q Consensus       519 ~~~~~~~-~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  596 (814)
                      ..+.+.+ .||+|+||.||+|.......+..||||.++... ....+++.+|+.++++++||||+++++++ +.+..++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            3444555 899999999999997655568899999997643 23456799999999999999999999999 55678999


Q ss_pred             EecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCC
Q 041921          597 YEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ  675 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~  675 (814)
                      |||+++++|.+++... ..+++..+..++.|+++||.|||+.   +|+||||||+||+++.++.+||+|||++.......
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~  164 (287)
T 1u59_A           88 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD  164 (287)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred             EEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccCc
Confidence            9999999999999754 5689999999999999999999998   99999999999999999999999999998775433


Q ss_pred             ccc-ccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeecC
Q 041921          676 SKT-IKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGE  753 (814)
Q Consensus       676 ~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  753 (814)
                      ... ......+|+.|+|||.+.+..++.++||||||++++||++ |+.||......+.       ...+..+...     
T Consensus       165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-------~~~i~~~~~~-----  232 (287)
T 1u59_A          165 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV-------MAFIEQGKRM-----  232 (287)
T ss_dssp             CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH-------HHHHHTTCCC-----
T ss_pred             ceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH-------HHHHhcCCcC-----
Confidence            221 1123446889999999998889999999999999999999 9999975443221       1222222111     


Q ss_pred             cccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 041921          754 DKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV  796 (814)
Q Consensus       754 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~  796 (814)
                          ..+...+..+.+++.+||+.+|.+|||+.++++.|+.+.
T Consensus       233 ----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  271 (287)
T 1u59_A          233 ----ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  271 (287)
T ss_dssp             ----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                112234568889999999999999999999999998754

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.1e-38  Score=343.59  Aligned_cols=269  Identities=24%  Similarity=0.355  Sum_probs=208.9

Q ss_pred             ccccceeeeeeeeEEEEEEec--CCCceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccceeeeeccc--ccceEE
Q 041921          522 NFKEEVGRGSFGIVYKGVIQT--RTSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEG--QNRLLV  596 (814)
Q Consensus       522 ~~~~~LG~G~~g~Vy~~~~~~--~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv  596 (814)
                      .+.++||+|+||.||++.+..  ...++.||||++.... ....+.+.+|+.++++++||||+++++++.+.  ...++|
T Consensus        34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv  113 (318)
T 3lxp_A           34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV  113 (318)
T ss_dssp             EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred             hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence            778899999999999987642  2367899999997543 23345799999999999999999999999774  567899


Q ss_pred             EecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCc
Q 041921          597 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS  676 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  676 (814)
                      |||+++++|.+++.... +++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++........
T Consensus       114 ~e~~~~~~L~~~l~~~~-~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  189 (318)
T 3lxp_A          114 MEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE  189 (318)
T ss_dssp             ECCCTTCBHHHHGGGSC-CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCS
T ss_pred             EecccCCcHHHHHhhCC-CCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccccccccccc
Confidence            99999999999997654 88999999999999999999998   999999999999999999999999999987764332


Q ss_pred             c-cccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhh--------hHHHHHHHHhhcCcc
Q 041921          677 K-TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA--------ILTDWAFDCYRNGKL  747 (814)
Q Consensus       677 ~-~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~--------~~~~~~~~~~~~~~~  747 (814)
                      . .......+|..|+|||.+.+..++.++||||||++++||++|+.||.........        .........+..+  
T Consensus       190 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  267 (318)
T 3lxp_A          190 YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG--  267 (318)
T ss_dssp             EEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTT--
T ss_pred             ccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcc--
Confidence            1 1123345788899999999989999999999999999999999998643211000        0000111111111  


Q ss_pred             ceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCCCCCC
Q 041921          748 NVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVPPN  803 (814)
Q Consensus       748 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~~~~p~~  803 (814)
                             .....+...+..+.+++.+||+.||.+|||+.+++++|+.+.+--..+.
T Consensus       268 -------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~  316 (318)
T 3lxp_A          268 -------ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQA  316 (318)
T ss_dssp             -------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC--
T ss_pred             -------cCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccCC
Confidence                   1111223345788999999999999999999999999998765544333

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=3.8e-38  Score=338.60  Aligned_cols=263  Identities=26%  Similarity=0.390  Sum_probs=199.5

Q ss_pred             HHHHhhhccccceeeeeeeeEEEEEEecC-CCceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeecccc
Q 041921          515 ELEGATNNFKEEVGRGSFGIVYKGVIQTR-TSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ  591 (814)
Q Consensus       515 ~l~~~~~~~~~~LG~G~~g~Vy~~~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  591 (814)
                      .+....+.+.+.||+|+||.||+|..... ..+..||||.+....  ....+.+.+|+.++++++||||+++++++.+..
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  109 (313)
T 3brb_A           30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS  109 (313)
T ss_dssp             BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred             ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence            34456677888999999999999987643 245689999986432  233457899999999999999999999997755


Q ss_pred             c-----ceEEEecCCCCCHHHHhc------CCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcE
Q 041921          592 N-----RLLVYEFLNNGTLASFLF------GNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTA  660 (814)
Q Consensus       592 ~-----~~lv~e~~~~gsL~~~l~------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~  660 (814)
                      .     .++|+||+++++|.+++.      ....+++..++.++.||++||.|||+.   +|+||||||+||+++.++.+
T Consensus       110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~  186 (313)
T 3brb_A          110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTV  186 (313)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCE
T ss_pred             ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcE
Confidence            3     499999999999999983      335689999999999999999999998   99999999999999999999


Q ss_pred             EEeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHH
Q 041921          661 RISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAF  739 (814)
Q Consensus       661 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~  739 (814)
                      ||+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |+.||.........       
T Consensus       187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~-------  259 (313)
T 3brb_A          187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY-------  259 (313)
T ss_dssp             EECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH-------
T ss_pred             EEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH-------
Confidence            9999999987654332222234457889999999999999999999999999999999 88898754432211       


Q ss_pred             HHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 041921          740 DCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV  796 (814)
Q Consensus       740 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~  796 (814)
                      ..+..+...         ..+...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus       260 ~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~  307 (313)
T 3brb_A          260 DYLLHGHRL---------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL  307 (313)
T ss_dssp             HHHHTTCCC---------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHcCCCC---------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            111122111         111234467889999999999999999999999998764

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.5e-38  Score=342.01  Aligned_cols=263  Identities=27%  Similarity=0.380  Sum_probs=211.4

Q ss_pred             HHhhhccccceeeeeeeeEEEEEEec---CCCceEEEEEEeccccc-cchHhHHHHHHhhhcc-CCCCccceeeeecccc
Q 041921          517 EGATNNFKEEVGRGSFGIVYKGVIQT---RTSTTAVAVKKLDRVFQ-DGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQ  591 (814)
Q Consensus       517 ~~~~~~~~~~LG~G~~g~Vy~~~~~~---~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  591 (814)
                      ....+.+.+.||+|+||.||+|....   ...++.||||.+..... ...+.+.+|+.++.++ +||||+++++++.+.+
T Consensus        25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  104 (316)
T 2xir_A           25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG  104 (316)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCC
Confidence            34567788999999999999998642   34568999999975432 2345789999999999 7999999999987754


Q ss_pred             -cceEEEecCCCCCHHHHhcCCCC----------------CChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE
Q 041921          592 -NRLLVYEFLNNGTLASFLFGNLK----------------PNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILL  654 (814)
Q Consensus       592 -~~~lv~e~~~~gsL~~~l~~~~~----------------l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll  654 (814)
                       ..++||||+++++|.+++.....                +++..+..++.|+++||.|||+.   +|+||||||+||++
T Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~  181 (316)
T 2xir_A          105 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILL  181 (316)
T ss_dssp             SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred             CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEE
Confidence             58999999999999999986543                78899999999999999999998   99999999999999


Q ss_pred             cCCCcEEEeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhh
Q 041921          655 DDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAI  733 (814)
Q Consensus       655 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~  733 (814)
                      +.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........  
T Consensus       182 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~--  259 (316)
T 2xir_A          182 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--  259 (316)
T ss_dssp             CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH--
T ss_pred             CCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHH--
Confidence            9999999999999987654433333244567889999999999999999999999999999998 9999975433221  


Q ss_pred             HHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 041921          734 LTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE  797 (814)
Q Consensus       734 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~  797 (814)
                          ....+..+....         .+......+.+++.+||+.||.+|||+.++++.|+.+.+
T Consensus       260 ----~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  310 (316)
T 2xir_A          260 ----FCRRLKEGTRMR---------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  310 (316)
T ss_dssp             ----HHHHHHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----HHHHhccCccCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                111122221111         111234678899999999999999999999999987653

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.1e-38  Score=365.91  Aligned_cols=250  Identities=29%  Similarity=0.432  Sum_probs=203.3

Q ss_pred             ceeeeeeeeEEEEEEecCCCceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEecCCCCC
Q 041921          526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGT  604 (814)
Q Consensus       526 ~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  604 (814)
                      +||+|+||.||+|.+.....+..||||.++... ....++|.+|+.++++++||||+++++++.+ +..++||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            799999999999998766667889999997643 3345789999999999999999999999976 56899999999999


Q ss_pred             HHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccc-cccc
Q 041921          605 LASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT-IKTA  682 (814)
Q Consensus       605 L~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~-~~~~  682 (814)
                      |.+++... ..+++..+..++.||+.||+|||+.   +|+||||||+||||+.++.+||+|||+++.+....... ....
T Consensus       422 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~  498 (613)
T 2ozo_A          422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA  498 (613)
T ss_dssp             HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----------
T ss_pred             HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccC
Confidence            99999764 5689999999999999999999998   99999999999999999999999999998765432211 1122


Q ss_pred             ccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCcH
Q 041921          683 IRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDI  761 (814)
Q Consensus       683 ~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  761 (814)
                      ..+++.|+|||++....++.++|||||||++|||++ |+.||......+       +...+..+...         ..+.
T Consensus       499 ~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-------~~~~i~~~~~~---------~~p~  562 (613)
T 2ozo_A          499 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQGKRM---------ECPP  562 (613)
T ss_dssp             ---CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH-------HHHHHHTTCCC---------CCCT
T ss_pred             CCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-------HHHHHHcCCCC---------CCCC
Confidence            346789999999999999999999999999999998 999997654332       11222232211         1122


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 041921          762 ECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV  795 (814)
Q Consensus       762 ~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~  795 (814)
                      .++..+.+++..||+.+|.+|||+++|++.|+.+
T Consensus       563 ~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  596 (613)
T 2ozo_A          563 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  596 (613)
T ss_dssp             TCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            3457889999999999999999999999999874

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.2e-37  Score=338.74  Aligned_cols=250  Identities=24%  Similarity=0.323  Sum_probs=200.7

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc---cchHhHHHHHHhhhcc-CCCCccceeeeecccccce
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ---DGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRL  594 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  594 (814)
                      ..+.+.+.||+|+||.||++....  .++.||||.+.....   ...+.+.+|..++.++ +||||+++++++.+.+..+
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   86 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKK--TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF   86 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT--TTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECC--CCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEE
Confidence            346677899999999999999753  578999999975422   2234588899999887 8999999999999999999


Q ss_pred             EEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccC
Q 041921          595 LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN  674 (814)
Q Consensus       595 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~  674 (814)
                      +||||+++|+|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        87 lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~  163 (345)
T 3a8x_A           87 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  163 (345)
T ss_dssp             EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence            9999999999999998877899999999999999999999998   9999999999999999999999999999864322


Q ss_pred             CcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhh--hhHHHHHHHHhhcCccceeec
Q 041921          675 QSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY--AILTDWAFDCYRNGKLNVLVG  752 (814)
Q Consensus       675 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  752 (814)
                      ..  ......||+.|+|||.+.+..++.++|||||||++|||++|+.||........  ........+.+..+....   
T Consensus       164 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~---  238 (345)
T 3a8x_A          164 GD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI---  238 (345)
T ss_dssp             TC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCC---
T ss_pred             CC--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCC---
Confidence            21  12446799999999999999999999999999999999999999964322110  011112222232222211   


Q ss_pred             CcccccCcHHHHHHHHHHHHHccccCCCCCCCH
Q 041921          753 EDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTM  785 (814)
Q Consensus       753 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~  785 (814)
                             +......+.+++.+||+.||.+||++
T Consensus       239 -------p~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          239 -------PRSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             -------CTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             -------CCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence                   11234678899999999999999995

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.2e-38  Score=345.77  Aligned_cols=264  Identities=25%  Similarity=0.390  Sum_probs=211.5

Q ss_pred             HHHHhhhccccceeeeeeeeEEEEEEecCC---CceEEEEEEeccccc-cchHhHHHHHHhhhcc-CCCCccceeeeecc
Q 041921          515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRT---STTAVAVKKLDRVFQ-DGEREFKNEVFVIGQT-HHKNLVRLLGFCDE  589 (814)
Q Consensus       515 ~l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~---~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  589 (814)
                      ++....+.+.+.||+|+||.||+|.....+   ....||||.+..... ...+.+.+|+.+++++ +||||+++++++.+
T Consensus        42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  121 (333)
T 2i1m_A           42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH  121 (333)
T ss_dssp             BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence            344566777899999999999999975422   235899999975432 3345789999999999 89999999999999


Q ss_pred             cccceEEEecCCCCCHHHHhcCC--------------CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc
Q 041921          590 GQNRLLVYEFLNNGTLASFLFGN--------------LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLD  655 (814)
Q Consensus       590 ~~~~~lv~e~~~~gsL~~~l~~~--------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~  655 (814)
                      .+..++||||+++|+|.+++...              ..+++..++.++.|++.||.|||+.   +|+||||||+|||++
T Consensus       122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~  198 (333)
T 2i1m_A          122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLT  198 (333)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEE
T ss_pred             CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEEC
Confidence            99999999999999999998642              3578999999999999999999998   999999999999999


Q ss_pred             CCCcEEEeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhH
Q 041921          656 DYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAIL  734 (814)
Q Consensus       656 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~  734 (814)
                      .++.+||+|||++................+|..|+|||.+.+..++.++||||||+++|||++ |..||........   
T Consensus       199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~---  275 (333)
T 2i1m_A          199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK---  275 (333)
T ss_dssp             GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH---
T ss_pred             CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH---
Confidence            999999999999987654433322234557889999999998899999999999999999999 9999875433221   


Q ss_pred             HHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 041921          735 TDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV  796 (814)
Q Consensus       735 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~  796 (814)
                         .......+...         ..+...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus       276 ---~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~  325 (333)
T 2i1m_A          276 ---FYKLVKDGYQM---------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA  325 (333)
T ss_dssp             ---HHHHHHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---HHHHHhcCCCC---------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence               11111111100         011123467889999999999999999999999998653

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=7.9e-38  Score=341.55  Aligned_cols=253  Identities=23%  Similarity=0.288  Sum_probs=203.6

Q ss_pred             HHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc-----ccchHhHHHHHHhhhccCCCCccceeeeecccc
Q 041921          517 EGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF-----QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ  591 (814)
Q Consensus       517 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  591 (814)
                      ....|.+.+.||+|+||.||+|....  +++.||||.+....     ....+.+.+|+.++++++||||+++++++.+.+
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~   99 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCINRE--TGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDG   99 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             cccceEEeeEEeeCCCEEEEEEEECC--CCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence            45578889999999999999998753  57899999985321     123567999999999999999999999999999


Q ss_pred             cceEEEecCCCCCHHHHhcCC----CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCc---EEEee
Q 041921          592 NRLLVYEFLNNGTLASFLFGN----LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYT---ARISD  664 (814)
Q Consensus       592 ~~~lv~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~---~kl~D  664 (814)
                      ..++||||+++++|.+++...    ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.   +||+|
T Consensus       100 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~D  176 (351)
T 3c0i_A          100 MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGG  176 (351)
T ss_dssp             EEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECC
T ss_pred             EEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEec
Confidence            999999999999999887542    3578999999999999999999998   9999999999999986554   99999


Q ss_pred             cCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhc
Q 041921          665 FGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN  744 (814)
Q Consensus       665 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  744 (814)
                      ||++.........  .....||+.|+|||.+.+..++.++|||||||++|||++|+.||......        ....+..
T Consensus       177 fg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~i~~  246 (351)
T 3c0i_A          177 FGVAIQLGESGLV--AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER--------LFEGIIK  246 (351)
T ss_dssp             CTTCEECCTTSCB--CCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH--------HHHHHHH
T ss_pred             CcceeEecCCCee--ecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH--------HHHHHHc
Confidence            9999876543221  23456999999999999999999999999999999999999999753211        1111222


Q ss_pred             CccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          745 GKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       745 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      +.....  +.    ........+.+++.+||+.||.+|||+.++++
T Consensus       247 ~~~~~~--~~----~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          247 GKYKMN--PR----QWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             TCCCCC--HH----HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCCCC--cc----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            221110  00    00123467889999999999999999999985

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=9e-38  Score=343.53  Aligned_cols=246  Identities=24%  Similarity=0.298  Sum_probs=197.2

Q ss_pred             ccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEecCCCC
Q 041921          524 KEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNG  603 (814)
Q Consensus       524 ~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  603 (814)
                      .+.||+|+||.||+|....  .+..||||.++.......+++.+|+.++++++||||+++++++.+.+..+|||||++++
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~--~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~  171 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETA--TGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG  171 (373)
T ss_dssp             EEECC-----CEEEEEETT--TCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred             ceEEecCcCEEEEEEEEcC--CCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence            4679999999999998753  57899999997655455678999999999999999999999999999999999999999


Q ss_pred             CHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE--cCCCcEEEeecCCccccccCCccccc
Q 041921          604 TLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILL--DDYYTARISDFGLAKLLTLNQSKTIK  680 (814)
Q Consensus       604 sL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll--~~~~~~kl~DfGla~~~~~~~~~~~~  680 (814)
                      +|.+++... ..+++..+..++.||++||.|||+.   +|+||||||+|||+  +.++.+||+|||+++........   
T Consensus       172 ~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~---  245 (373)
T 2x4f_A          172 ELFDRIIDESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL---  245 (373)
T ss_dssp             EEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC---
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc---
Confidence            999988654 5688999999999999999999998   99999999999999  56789999999999876543322   


Q ss_pred             ccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCc
Q 041921          681 TAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMND  760 (814)
Q Consensus       681 ~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  760 (814)
                      ....||+.|+|||.+....++.++|||||||++|||++|+.||......+.  +     ..+.......      .....
T Consensus       246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--~-----~~i~~~~~~~------~~~~~  312 (373)
T 2x4f_A          246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET--L-----NNILACRWDL------EDEEF  312 (373)
T ss_dssp             CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--H-----HHHHHTCCCS------CSGGG
T ss_pred             ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH--H-----HHHHhccCCC------Chhhh
Confidence            334699999999999988999999999999999999999999975543221  1     1111111110      00001


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          761 IECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       761 ~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      .....++.+++.+||+.||.+|||++++++
T Consensus       313 ~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          313 QDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            123467889999999999999999999986

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=3.8e-38  Score=342.20  Aligned_cols=250  Identities=27%  Similarity=0.342  Sum_probs=204.4

Q ss_pred             HHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhcc-CCCCccceeeeecccc
Q 041921          516 LEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQ  591 (814)
Q Consensus       516 l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  591 (814)
                      +....+.+.+.||+|+||.||+|....  .++.||||.++...   ....+.+..|..++..+ +||||+++++++.+.+
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~   91 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKK--TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE   91 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETT--TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECC--CCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence            334556778899999999999999753  57899999997532   23445678899999877 9999999999999999


Q ss_pred             cceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcccc
Q 041921          592 NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLL  671 (814)
Q Consensus       592 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~  671 (814)
                      ..++||||+++|+|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus        92 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  168 (345)
T 1xjd_A           92 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKEN  168 (345)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence            9999999999999999998877899999999999999999999998   9999999999999999999999999999864


Q ss_pred             ccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceee
Q 041921          672 TLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLV  751 (814)
Q Consensus       672 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  751 (814)
                      ......  .....||+.|+|||.+.+..++.++|||||||++|||++|+.||......+       ....+..+...   
T Consensus       169 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-------~~~~i~~~~~~---  236 (345)
T 1xjd_A          169 MLGDAK--TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-------LFHSIRMDNPF---  236 (345)
T ss_dssp             CCTTCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCC---
T ss_pred             ccCCCc--ccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHhCCCC---
Confidence            332211  245679999999999999999999999999999999999999997543322       11222222111   


Q ss_pred             cCcccccCcHHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 041921          752 GEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMK-KVL  789 (814)
Q Consensus       752 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~-~vl  789 (814)
                             .+......+.+++.+||+.||.+||++. +++
T Consensus       237 -------~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          237 -------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             -------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             -------CCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence                   0112346788999999999999999997 664

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.7e-38  Score=342.01  Aligned_cols=262  Identities=29%  Similarity=0.455  Sum_probs=208.4

Q ss_pred             HHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc-ccchHhHHHHHHhhhcc-CCCCccceeeeecccccc
Q 041921          516 LEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNR  593 (814)
Q Consensus       516 l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  593 (814)
                      +....+.+.+.||+|+||.||+|.....+....|+||.+.... ....+.+.+|+.++.++ +||||+++++++.+.+..
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~  101 (327)
T 1fvr_A           22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL  101 (327)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred             ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCce
Confidence            3345677889999999999999998754434466999986532 33445799999999999 999999999999999999


Q ss_pred             eEEEecCCCCCHHHHhcCCC----------------CCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC
Q 041921          594 LLVYEFLNNGTLASFLFGNL----------------KPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDY  657 (814)
Q Consensus       594 ~lv~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~  657 (814)
                      ++||||+++++|.+++....                .+++..++.++.||++||.|||+.   +|+||||||+|||++.+
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~  178 (327)
T 1fvr_A          102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN  178 (327)
T ss_dssp             EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGG
T ss_pred             EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCC
Confidence            99999999999999997654                689999999999999999999998   99999999999999999


Q ss_pred             CcEEEeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHH
Q 041921          658 YTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTD  736 (814)
Q Consensus       658 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~  736 (814)
                      +.+||+|||+++........   ....++..|+|||.+....++.++||||||+++|||++ |+.||......+      
T Consensus       179 ~~~kL~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~------  249 (327)
T 1fvr_A          179 YVAKIADFGLSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------  249 (327)
T ss_dssp             GCEEECCTTCEESSCEECCC-------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------
T ss_pred             CeEEEcccCcCccccccccc---cCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH------
Confidence            99999999999754322111   23457889999999998889999999999999999998 999997543322      


Q ss_pred             HHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCC
Q 041921          737 WAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS  799 (814)
Q Consensus       737 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~~~  799 (814)
                       ....+..+..         ...+......+.+++.+||+.||.+|||++++++.|+.+.+-.
T Consensus       250 -~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  302 (327)
T 1fvr_A          250 -LYEKLPQGYR---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  302 (327)
T ss_dssp             -HHHHGGGTCC---------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             -HHHHhhcCCC---------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence             1122222211         0111233467889999999999999999999999998765543

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=4.2e-38  Score=332.80  Aligned_cols=259  Identities=24%  Similarity=0.368  Sum_probs=205.4

Q ss_pred             HhhhccccceeeeeeeeEEEEEEecC-CCceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccceeeeecccccceE
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQTR-TSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL  595 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  595 (814)
                      ...+.+.+.||+|+||.||+|..... ..+..||||.+.... ....+.+.+|+.++++++||||+++++++.+ +..++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence            34567788999999999999987643 345679999997542 2345679999999999999999999999865 45789


Q ss_pred             EEecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccC
Q 041921          596 VYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN  674 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~  674 (814)
                      ||||+++++|.+++... ..+++..+..++.|+++||.|||+.   +|+||||||+||+++.++.+||+|||++......
T Consensus        90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  166 (281)
T 3cc6_A           90 IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE  166 (281)
T ss_dssp             EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred             EEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence            99999999999999764 5589999999999999999999998   9999999999999999999999999999876543


Q ss_pred             CcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeecC
Q 041921          675 QSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGE  753 (814)
Q Consensus       675 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  753 (814)
                      .... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+..       ..+..+...     
T Consensus       167 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~-------~~~~~~~~~-----  233 (281)
T 3cc6_A          167 DYYK-ASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI-------GVLEKGDRL-----  233 (281)
T ss_dssp             -------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHH-------HHHHHTCCC-----
T ss_pred             cccc-cccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHH-------HHHhcCCCC-----
Confidence            2211 133457889999999998899999999999999999998 99999754332211       111111110     


Q ss_pred             cccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 041921          754 DKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE  797 (814)
Q Consensus       754 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~  797 (814)
                          ..+......+.+++.+||+.||.+|||+.++++.|+.+.+
T Consensus       234 ----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  273 (281)
T 3cc6_A          234 ----PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ  273 (281)
T ss_dssp             ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence                0111234678899999999999999999999999987643

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.7e-38  Score=341.77  Aligned_cols=276  Identities=23%  Similarity=0.312  Sum_probs=201.2

Q ss_pred             hhccc-cceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhcc-CCCCccceeeeecccccceEEE
Q 041921          520 TNNFK-EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRLLVY  597 (814)
Q Consensus       520 ~~~~~-~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  597 (814)
                      .|.+. +.||+|+||.||+|...  ..+..||||.+........+.+.+|+.++.++ +||||+++++++.+.+..++||
T Consensus        13 ~y~i~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   90 (316)
T 2ac3_A           13 VYQLQEDVLGEGAHARVQTCINL--ITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF   90 (316)
T ss_dssp             SCEECCCCCCCCSSEEEEEEECS--SSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eEEecCceecCCceEEEEEEEEc--CCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            45553 67999999999999854  35789999999766555667899999999885 7999999999999999999999


Q ss_pred             ecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCc---EEEeecCCccccccC
Q 041921          598 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYT---ARISDFGLAKLLTLN  674 (814)
Q Consensus       598 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~---~kl~DfGla~~~~~~  674 (814)
                      ||+++++|.+++.....+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.   +||+|||++......
T Consensus        91 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~  167 (316)
T 2ac3_A           91 EKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN  167 (316)
T ss_dssp             ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred             EcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence            9999999999998878899999999999999999999998   9999999999999997766   999999999865432


Q ss_pred             Cc-----ccccccccCCCCccccccccc-----CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhh--------hhHHH
Q 041921          675 QS-----KTIKTAIRGTKGYVAPEWFRN-----SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY--------AILTD  736 (814)
Q Consensus       675 ~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~--------~~~~~  736 (814)
                      ..     ........||+.|+|||.+..     ..++.++||||||+++|||++|+.||......+.        .....
T Consensus       168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  247 (316)
T 2ac3_A          168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN  247 (316)
T ss_dssp             --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHH
T ss_pred             CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHH
Confidence            11     111123458999999999875     5688999999999999999999999975432110        00011


Q ss_pred             HHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhcCcCCCCCCCCCC
Q 041921          737 WAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ--MLEGVVEVSVPPNPYP  806 (814)
Q Consensus       737 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~--~L~~~~~~~~p~~p~~  806 (814)
                      .....+..+......   .   ........+.+++.+||+.||.+|||++|+++  .+.+.......|.|..
T Consensus       248 ~~~~~i~~~~~~~~~---~---~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~~~~~~~~~  313 (316)
T 2ac3_A          248 MLFESIQEGKYEFPD---K---DWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMV  313 (316)
T ss_dssp             HHHHHHHHCCCCCCH---H---HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC-------------
T ss_pred             HHHHHHhccCcccCc---h---hcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCCcccCCCccc
Confidence            112222222221100   0   00123467889999999999999999999998  4555544444444443

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.4e-37  Score=338.80  Aligned_cols=245  Identities=24%  Similarity=0.243  Sum_probs=205.5

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhccCCCCccceeeeecccccceE
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL  595 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  595 (814)
                      ..+.+.+.||+|+||.||++....  .+..||||.+....   ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l  118 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKE--SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM  118 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT--TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECC--CCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence            356677899999999999999753  57899999996432   2344678899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCC
Q 041921          596 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ  675 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~  675 (814)
                      ||||+++|+|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus       119 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~  195 (350)
T 1rdq_E          119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT  195 (350)
T ss_dssp             EEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB
T ss_pred             EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCCc
Confidence            999999999999998877899999999999999999999998   99999999999999999999999999998764321


Q ss_pred             cccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcc
Q 041921          676 SKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDK  755 (814)
Q Consensus       676 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  755 (814)
                           ....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+       ....+..+.+..      
T Consensus       196 -----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-------~~~~i~~~~~~~------  257 (350)
T 1rdq_E          196 -----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-------IYEKIVSGKVRF------  257 (350)
T ss_dssp             -----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCCC------
T ss_pred             -----ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH-------HHHHHHcCCCCC------
Confidence                 34569999999999999999999999999999999999999997543322       112222232211      


Q ss_pred             cccCcHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 041921          756 EAMNDIECLGKLVMVSIWCIQEDPSLRPT-----MKKVLQ  790 (814)
Q Consensus       756 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-----~~~vl~  790 (814)
                          +......+.+++.+||+.||.+||+     ++++++
T Consensus       258 ----p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          258 ----PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             ----CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ----CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence                1123467889999999999999998     888874

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=4.8e-38  Score=344.43  Aligned_cols=252  Identities=23%  Similarity=0.280  Sum_probs=194.6

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEe
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE  598 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  598 (814)
                      ..|.+.++||+|+||+||++...  ..++.||||.+... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~~--~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e   96 (361)
T 3uc3_A           20 DRYDFVKDIGSGNFGVARLMRDK--LTKELVAVKYIERG-AAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME   96 (361)
T ss_dssp             TTEEEEEEESSSTTSSEEEEEET--TTCCEEEEEEEESS-TTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CcEEEEEEeccCCCEEEEEEEEC--CCCcEEEEEEEecC-ccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence            45778899999999999999975  35789999999753 2334678999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCc--EEEeecCCccccccCCc
Q 041921          599 FLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYT--ARISDFGLAKLLTLNQS  676 (814)
Q Consensus       599 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~--~kl~DfGla~~~~~~~~  676 (814)
                      |+++++|.+++.....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.  +||+|||+++.......
T Consensus        97 ~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~  173 (361)
T 3uc3_A           97 YASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ  173 (361)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred             eCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccccCC
Confidence            999999999998878899999999999999999999998   9999999999999987665  99999999974432211


Q ss_pred             ccccccccCCCCcccccccccCCCCcc-hhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcc
Q 041921          677 KTIKTAIRGTKGYVAPEWFRNSKITAK-VDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDK  755 (814)
Q Consensus       677 ~~~~~~~~gt~~y~aPE~~~~~~~s~~-~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  755 (814)
                         .....||+.|+|||.+.+..++.+ +||||||+++|||++|+.||.........  .... ..+.....        
T Consensus       174 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~--~~~~-~~~~~~~~--------  239 (361)
T 3uc3_A          174 ---PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY--RKTI-QRILSVKY--------  239 (361)
T ss_dssp             ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH--HHHH-HHHHTTCC--------
T ss_pred             ---CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH--HHHH-HHHhcCCC--------
Confidence               134569999999999988887665 89999999999999999999754332111  1111 11111111        


Q ss_pred             cccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          756 EAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       756 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      ..+........+.+++.+||+.||.+|||+.++++
T Consensus       240 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  274 (361)
T 3uc3_A          240 SIPDDIRISPECCHLISRIFVADPATRISIPEIKT  274 (361)
T ss_dssp             CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence            11111123467889999999999999999999986

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.4e-37  Score=338.80  Aligned_cols=251  Identities=24%  Similarity=0.291  Sum_probs=204.4

Q ss_pred             HHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccc---cccchHhHHHHHHhhhcc-CCCCccceeeeecccc
Q 041921          516 LEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV---FQDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQ  591 (814)
Q Consensus       516 l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  591 (814)
                      +....+.+.+.||+|+||.||+|...  ..++.||||.++..   .....+.+..|..++..+ +||||+++++++.+.+
T Consensus        17 ~~~~~y~~~~~lG~G~fg~V~~~~~~--~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~   94 (353)
T 2i0e_A           17 MKLTDFNFLMVLGKGSFGKVMLSERK--GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD   94 (353)
T ss_dssp             --CTTEEEEEEEEEETTEEEEEEEET--TEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSS
T ss_pred             CchHHcEEEEEEeeCCCEEEEEEEEC--CCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCC
Confidence            33455677889999999999999975  35789999999753   223445688999999988 8999999999999999


Q ss_pred             cceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcccc
Q 041921          592 NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLL  671 (814)
Q Consensus       592 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~  671 (814)
                      ..++||||+++|+|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus        95 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~  171 (353)
T 2i0e_A           95 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  171 (353)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence            9999999999999999998877899999999999999999999998   9999999999999999999999999999864


Q ss_pred             ccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceee
Q 041921          672 TLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLV  751 (814)
Q Consensus       672 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  751 (814)
                      .....  .....+||+.|+|||.+.+..++.++|||||||++|||++|+.||......+       ..+.+..+.+..  
T Consensus       172 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-------~~~~i~~~~~~~--  240 (353)
T 2i0e_A          172 IWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-------LFQSIMEHNVAY--  240 (353)
T ss_dssp             CCTTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCCC--
T ss_pred             ccCCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH-------HHHHHHhCCCCC--
Confidence            32221  1244679999999999999999999999999999999999999997543322       112222222111  


Q ss_pred             cCcccccCcHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 041921          752 GEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPT-----MKKVLQ  790 (814)
Q Consensus       752 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-----~~~vl~  790 (814)
                              +.....++.+++.+||+.||.+||+     ++++++
T Consensus       241 --------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          241 --------PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             --------CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             --------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence                    1123467889999999999999995     466653

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.1e-37  Score=340.18  Aligned_cols=250  Identities=26%  Similarity=0.345  Sum_probs=191.1

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEe
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE  598 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  598 (814)
                      ..+.+.++||+|+||.||+|....  .++.||||.++...  ..+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        53 ~~y~~~~~lG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           53 DFFEVESELGRGATSIVYRCKQKG--TQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             CcEEEeeEEeeCCCEEEEEEEECC--CCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            456778899999999999999753  56789999997532  34578899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC---CCcEEEeecCCccccccCC
Q 041921          599 FLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDD---YYTARISDFGLAKLLTLNQ  675 (814)
Q Consensus       599 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~---~~~~kl~DfGla~~~~~~~  675 (814)
                      |+++++|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+|||++.   ++.+||+|||+++......
T Consensus       129 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~  205 (349)
T 2w4o_A          129 LVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV  205 (349)
T ss_dssp             CCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred             eCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCccc
Confidence            999999999999888899999999999999999999998   9999999999999975   8899999999998765322


Q ss_pred             cccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcc
Q 041921          676 SKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDK  755 (814)
Q Consensus       676 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  755 (814)
                      .   .....||+.|+|||.+.+..++.++|||||||++|||++|+.||........      ....+........     
T Consensus       206 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~~~~i~~~~~~~~-----  271 (349)
T 2w4o_A          206 L---MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF------MFRRILNCEYYFI-----  271 (349)
T ss_dssp             ----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH------HHHHHHTTCCCCC-----
T ss_pred             c---cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH------HHHHHHhCCCccC-----
Confidence            1   1345689999999999999999999999999999999999999975443221      1122222221110     


Q ss_pred             cccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          756 EAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       756 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                       .+........+.+++.+||+.||++|||+.++++
T Consensus       272 -~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          272 -SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             -TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             0111234467889999999999999999999987

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=8.3e-38  Score=335.63  Aligned_cols=251  Identities=24%  Similarity=0.249  Sum_probs=197.1

Q ss_pred             CHHHHHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc--cchHhHHHHHHhhhcc-CCCCccceeeeec
Q 041921          512 SYKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ--DGEREFKNEVFVIGQT-HHKNLVRLLGFCD  588 (814)
Q Consensus       512 ~~~~l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  588 (814)
                      ...++....+.+.++||+|+||+||+|....  +++.||||++.....  ....++..|+..+.++ +||||+++++++.
T Consensus        50 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~  127 (311)
T 3p1a_A           50 RPESFFQQSFQRLSRLGHGSYGEVFKVRSKE--DGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE  127 (311)
T ss_dssp             SSSCHHHHHEEEEEEEEEETTEEEEEEEETT--TSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             CccchhhhheeeeheeccCCCeEEEEEEECC--CCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE
Confidence            3446667788889999999999999999753  578999999864322  2233455666666555 8999999999999


Q ss_pred             ccccceEEEecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCC
Q 041921          589 EGQNRLLVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGL  667 (814)
Q Consensus       589 ~~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGl  667 (814)
                      +++..++||||+ +++|.+++... ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus       128 ~~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~  203 (311)
T 3p1a_A          128 EGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGL  203 (311)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTT
T ss_pred             eCCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEcccee
Confidence            999999999999 67898888654 5689999999999999999999998   999999999999999999999999999


Q ss_pred             ccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCcc
Q 041921          668 AKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL  747 (814)
Q Consensus       668 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  747 (814)
                      +........   .....||+.|+|||++.+ .++.++||||||++++||++|..++.....          +..+..+..
T Consensus       204 a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~----------~~~~~~~~~  269 (311)
T 3p1a_A          204 LVELGTAGA---GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG----------WQQLRQGYL  269 (311)
T ss_dssp             CEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH----------HHHHTTTCC
T ss_pred             eeecccCCC---CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH----------HHHHhccCC
Confidence            987654322   134569999999999876 789999999999999999999776643211          111222211


Q ss_pred             ceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          748 NVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       748 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      ...        ........+.+++.+||+.||.+|||++++++
T Consensus       270 ~~~--------~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          270 PPE--------FTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             CHH--------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             Ccc--------cccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            100        01123467889999999999999999999986

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.4e-38  Score=344.02  Aligned_cols=268  Identities=25%  Similarity=0.408  Sum_probs=211.3

Q ss_pred             HHhhhccccceeeeeeeeEEEEEEe--cCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccc--c
Q 041921          517 EGATNNFKEEVGRGSFGIVYKGVIQ--TRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ--N  592 (814)
Q Consensus       517 ~~~~~~~~~~LG~G~~g~Vy~~~~~--~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~  592 (814)
                      ....+.+.+.||+|+||.||++...  ....+..||||++........+.+.+|+.++++++||||+++++++...+  .
T Consensus        39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  118 (326)
T 2w1i_A           39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN  118 (326)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred             CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence            3456778899999999999999863  23467899999998765556678999999999999999999999987654  7


Q ss_pred             ceEEEecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcccc
Q 041921          593 RLLVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLL  671 (814)
Q Consensus       593 ~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~  671 (814)
                      .++|+||+++++|.+++... ..+++..+..++.|+++||.|||+.   +|+||||||+||+++.++.+||+|||++...
T Consensus       119 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~  195 (326)
T 2w1i_A          119 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVL  195 (326)
T ss_dssp             CEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence            89999999999999999765 5689999999999999999999998   9999999999999999999999999999877


Q ss_pred             ccCCccc-ccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhh---------hhHHHHHHHH
Q 041921          672 TLNQSKT-IKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY---------AILTDWAFDC  741 (814)
Q Consensus       672 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~---------~~~~~~~~~~  741 (814)
                      ....... ......++..|+|||.+.+..++.++||||||++++||++|+.|+.....+-.         ..........
T Consensus       196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (326)
T 2w1i_A          196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL  275 (326)
T ss_dssp             CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred             cccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHH
Confidence            6443211 11234577889999999988899999999999999999999998753211000         0000111111


Q ss_pred             hhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 041921          742 YRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV  796 (814)
Q Consensus       742 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~  796 (814)
                      +..+.         ....+...+.++.+++.+||+.||.+|||+.++++.|+.+.
T Consensus       276 ~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~  321 (326)
T 2w1i_A          276 LKNNG---------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR  321 (326)
T ss_dssp             HHTTC---------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hhcCC---------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            11111         11112234577899999999999999999999999998764

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=3.6e-37  Score=347.74  Aligned_cols=251  Identities=24%  Similarity=0.375  Sum_probs=208.0

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhccCCCCccceeeeecccccceE
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL  595 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  595 (814)
                      ..|.+.+.||+|+||.||+|....  .++.||||.+....   ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~--~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l   93 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHEL--TGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM   93 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETT--TCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECC--CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            456778899999999999999753  57899999996432   2234578999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCC
Q 041921          596 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ  675 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~  675 (814)
                      ||||+++++|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++.......
T Consensus        94 v~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~  170 (476)
T 2y94_A           94 VMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  170 (476)
T ss_dssp             EEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence            999999999999999888899999999999999999999998   99999999999999999999999999998765432


Q ss_pred             cccccccccCCCCcccccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCc
Q 041921          676 SKTIKTAIRGTKGYVAPEWFRNSKI-TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGED  754 (814)
Q Consensus       676 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  754 (814)
                      .   .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||.......       ....+..+....     
T Consensus       171 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~-------~~~~i~~~~~~~-----  235 (476)
T 2y94_A          171 F---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT-------LFKKICDGIFYT-----  235 (476)
T ss_dssp             C---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH-------HHHHHHTTCCCC-----
T ss_pred             c---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH-------HHHHHhcCCcCC-----
Confidence            2   134569999999999988765 689999999999999999999997543322       112222322111     


Q ss_pred             ccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhc
Q 041921          755 KEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ--MLEG  794 (814)
Q Consensus       755 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~--~L~~  794 (814)
                           +......+.+++.+||+.||.+|||++++++  .+..
T Consensus       236 -----p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~  272 (476)
T 2y94_A          236 -----PQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ  272 (476)
T ss_dssp             -----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred             -----CccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence                 1122356889999999999999999999986  4544

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.1e-37  Score=335.54  Aligned_cols=262  Identities=23%  Similarity=0.264  Sum_probs=204.9

Q ss_pred             HhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeec----ccccc
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCD----EGQNR  593 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~  593 (814)
                      ...|.+.+.||+|+||.||++...  ..++.||||++........+.+.+|+.++++++||||+++++++.    .....
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  105 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGL--HDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA  105 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEET--TTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEec--CCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence            345777899999999999999964  357899999987655556678999999999999999999999986    34578


Q ss_pred             eEEEecCCCCCHHHHhcC----CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcc
Q 041921          594 LLVYEFLNNGTLASFLFG----NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAK  669 (814)
Q Consensus       594 ~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~  669 (814)
                      ++|+||+++++|.+++..    ...+++..++.++.|+++||.|||+.   +|+||||||+||+++.++.+||+|||++.
T Consensus       106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~  182 (317)
T 2buj_A          106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMN  182 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred             EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence            899999999999999875    46789999999999999999999998   99999999999999999999999999987


Q ss_pred             ccccCCccc-------ccccccCCCCcccccccccCC---CCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHH
Q 041921          670 LLTLNQSKT-------IKTAIRGTKGYVAPEWFRNSK---ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF  739 (814)
Q Consensus       670 ~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  739 (814)
                      .........       ......||+.|+|||.+....   ++.++||||||+++|||++|+.||......... .    .
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~----~  257 (317)
T 2buj_A          183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS-V----A  257 (317)
T ss_dssp             ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC-H----H
T ss_pred             hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch-h----h
Confidence            654221110       012235799999999987553   689999999999999999999998532111100 0    0


Q ss_pred             HHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 041921          740 DCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV  798 (814)
Q Consensus       740 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~~  798 (814)
                      ..... .        ...+........+.+++.+||+.||.+|||++++++.|+.+...
T Consensus       258 ~~~~~-~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  307 (317)
T 2buj_A          258 LAVQN-Q--------LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP  307 (317)
T ss_dssp             HHHHC-C----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred             HHhhc-c--------CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence            01111 0        00111123346788999999999999999999999999987543

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.1e-37  Score=332.44  Aligned_cols=259  Identities=26%  Similarity=0.470  Sum_probs=202.0

Q ss_pred             hhccccceeeeeeeeEEEEEEecC-CCceEEEEEEeccccc-cchHhHHHHHHhhhccCCCCccceeeeec-ccccceEE
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTR-TSTTAVAVKKLDRVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCD-EGQNRLLV  596 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~-~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv  596 (814)
                      ++.+.++||+|+||.||+|..... .....+|||.+..... ...+.+.+|+.++++++||||+++++++. .++..++|
T Consensus        26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  105 (298)
T 3f66_A           26 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  105 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             ehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEE
Confidence            456778999999999999987532 2345789999875432 33467899999999999999999999864 45678999


Q ss_pred             EecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCC
Q 041921          597 YEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ  675 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~  675 (814)
                      |||+++++|.+++... ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++......
T Consensus       106 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~  182 (298)
T 3f66_A          106 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  182 (298)
T ss_dssp             EECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGG
T ss_pred             EeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccccccc
Confidence            9999999999999764 5688999999999999999999998   99999999999999999999999999998765432


Q ss_pred             cc--cccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhC-CCCCCcccchhhhhHHHHHHHHhhcCccceeec
Q 041921          676 SK--TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISC-RKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVG  752 (814)
Q Consensus       676 ~~--~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  752 (814)
                      ..  .......+|+.|+|||.+.+..++.++||||||++++||++| ..||......+..       .....+...    
T Consensus       183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~-------~~~~~~~~~----  251 (298)
T 3f66_A          183 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT-------VYLLQGRRL----  251 (298)
T ss_dssp             GCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHH-------HHHHTTCCC----
T ss_pred             hhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHH-------HHHhcCCCC----
Confidence            21  112344578899999999999999999999999999999994 5555433222211       111111110    


Q ss_pred             CcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 041921          753 EDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE  797 (814)
Q Consensus       753 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~  797 (814)
                           ..+...+..+.+++.+||+.||.+|||+++++++|+.+..
T Consensus       252 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  291 (298)
T 3f66_A          252 -----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  291 (298)
T ss_dssp             -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                 0111234678899999999999999999999999988655

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.7e-37  Score=329.42  Aligned_cols=259  Identities=23%  Similarity=0.284  Sum_probs=197.5

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEE
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY  597 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  597 (814)
                      .|.+.+.||+|+||.||+|...   .++.||||++....  ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (288)
T 1ob3_A            3 KYHGLEKIGEGTYGVVYKAQNN---YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF   79 (288)
T ss_dssp             SEEEEEEEEEETTEEEEEEEET---TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             cchhhhhcccCCCEEEEEEEcC---CCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence            4667889999999999999873   57789999986432  223467889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCc
Q 041921          598 EFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS  676 (814)
Q Consensus       598 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  676 (814)
                      ||+++ +|.+++... ..+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||++........
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (288)
T 1ob3_A           80 EHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (288)
T ss_dssp             ECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             EecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence            99985 999988764 6789999999999999999999998   999999999999999999999999999986643221


Q ss_pred             ccccccccCCCCcccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCcc------ce
Q 041921          677 KTIKTAIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL------NV  749 (814)
Q Consensus       677 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------~~  749 (814)
                      .  .....||+.|+|||.+.+. .++.++||||||+++|||++|+.||......+..   ..+.+.......      ..
T Consensus       156 ~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  230 (288)
T 1ob3_A          156 K--YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQL---MRIFRILGTPNSKNWPNVTE  230 (288)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCCTTTSTTGGG
T ss_pred             c--cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHHCCCChhhchhhhc
Confidence            1  1334689999999998764 5899999999999999999999999754432211   111111111000      00


Q ss_pred             e--ecCcc-------cccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          750 L--VGEDK-------EAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       750 ~--~~~~~-------~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      .  .++..       ...........+.+++.+||+.||++|||++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            0  00000       00001123567889999999999999999999985

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.7e-38  Score=343.27  Aligned_cols=252  Identities=21%  Similarity=0.302  Sum_probs=195.1

Q ss_pred             HhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccCC--CCccceeeeecccccc
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHH--KNLVRLLGFCDEGQNR  593 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~  593 (814)
                      ...|.+.+.||+|+||.||++...   .+..||||++....  ....+.+.+|+.++.+++|  +||+++++++.+++..
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~   84 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNE---KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI   84 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECT---TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeC---CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence            345677899999999999999864   47789999986432  2334678999999999976  9999999999999999


Q ss_pred             eEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcccccc
Q 041921          594 LLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTL  673 (814)
Q Consensus       594 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~  673 (814)
                      ++||| +.+++|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+|||++ ++.+||+|||+++.+..
T Consensus        85 ~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~  159 (343)
T 3dbq_A           85 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  159 (343)
T ss_dssp             EEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred             EEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence            99999 56889999999888899999999999999999999998   999999999999997 57899999999987765


Q ss_pred             CCcccccccccCCCCccccccccc-----------CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHh
Q 041921          674 NQSKTIKTAIRGTKGYVAPEWFRN-----------SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY  742 (814)
Q Consensus       674 ~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  742 (814)
                      ...........||+.|+|||.+.+           ..++.++||||||+++|||++|+.||........ .    .....
T Consensus       160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~----~~~~~  234 (343)
T 3dbq_A          160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-K----LHAII  234 (343)
T ss_dssp             ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-H----HHHHH
T ss_pred             ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHH-H----HHHHh
Confidence            443333345679999999999865           6788999999999999999999999974332111 0    11111


Q ss_pred             hcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          743 RNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       743 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                      ...         .....+......+.+++.+||+.||.+|||+.++++.
T Consensus       235 ~~~---------~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          235 DPN---------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             CTT---------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cCC---------cccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence            111         1111111123567899999999999999999999853

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=4.9e-37  Score=331.22  Aligned_cols=252  Identities=25%  Similarity=0.318  Sum_probs=206.9

Q ss_pred             HhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccccc------chHhHHHHHHhhhccCCCCccceeeeecccc
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD------GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ  591 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  591 (814)
                      ...|.+.+.||+|+||.||+|...  .++..||||.+......      ..+++.+|+.++++++||||+++++++.+.+
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   88 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREK--STGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRT   88 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEET--TTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hccEEEeeEeeecCCEEEEEEEEC--CCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            456788899999999999999975  35789999998653221      3467999999999999999999999999999


Q ss_pred             cceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC----cEEEeecCC
Q 041921          592 NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYY----TARISDFGL  667 (814)
Q Consensus       592 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~----~~kl~DfGl  667 (814)
                      ..++||||+++++|.+++.....+++..+..++.|++.||.|||+.   +|+||||||+||+++.++    .+||+|||+
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~  165 (321)
T 2a2a_A           89 DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (321)
T ss_dssp             EEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence            9999999999999999998888899999999999999999999998   999999999999999887    799999999


Q ss_pred             ccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCcc
Q 041921          668 AKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL  747 (814)
Q Consensus       668 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  747 (814)
                      +.........   ....||+.|+|||.+.+..++.++||||||++++||++|+.||......+.       ...+.....
T Consensus       166 ~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-------~~~i~~~~~  235 (321)
T 2a2a_A          166 AHEIEDGVEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-------LANITSVSY  235 (321)
T ss_dssp             CEECCTTCCC---CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-------HHHHHTTCC
T ss_pred             ceecCccccc---cccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHH-------HHHHHhccc
Confidence            9876543221   345689999999999999999999999999999999999999975433221       111111111


Q ss_pred             ceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          748 NVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       748 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      ..  .+.    ........+.+++.+||+.||.+|||++++++
T Consensus       236 ~~--~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          236 DF--DEE----FFSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             CC--CHH----HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             cc--Chh----hhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            00  000    00123456889999999999999999999986

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2e-37  Score=333.65  Aligned_cols=261  Identities=25%  Similarity=0.384  Sum_probs=189.9

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEE
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY  597 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  597 (814)
                      ..+.+.++||+|+||.||+|...  ..+..||||.+.... ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   82 (317)
T 2pmi_A            5 SQFKQLEKLGNGTYATVYKGLNK--TTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF   82 (317)
T ss_dssp             --------------CEEEEEECS--SSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred             cceeEeeEECCCCCEEEEEEEEC--CCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence            34667789999999999999864  357899999986533 233467899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhcCC------CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcccc
Q 041921          598 EFLNNGTLASFLFGN------LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLL  671 (814)
Q Consensus       598 e~~~~gsL~~~l~~~------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~  671 (814)
                      ||++ ++|.+++...      ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus        83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~  158 (317)
T 2pmi_A           83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF  158 (317)
T ss_dssp             ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred             EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence            9998 5999988643      4578999999999999999999998   9999999999999999999999999999876


Q ss_pred             ccCCcccccccccCCCCccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCc---c
Q 041921          672 TLNQSKTIKTAIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK---L  747 (814)
Q Consensus       672 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~  747 (814)
                      ......  .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+..   ..+.+......   .
T Consensus       159 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~  233 (317)
T 2pmi_A          159 GIPVNT--FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQL---KLIFDIMGTPNESLW  233 (317)
T ss_dssp             TSCCCC--CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCSCCTTTC
T ss_pred             CCCccc--CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCCChhHh
Confidence            533221  134568999999999976 46899999999999999999999999765433211   11111111000   0


Q ss_pred             c---eee--cCcc------------cccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          748 N---VLV--GEDK------------EAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       748 ~---~~~--~~~~------------~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      .   .+.  .+..            ...........+.+++.+||+.||.+|||++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          234 PSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             GGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence            0   000  0000            00001123457889999999999999999999986

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=6e-38  Score=350.53  Aligned_cols=253  Identities=20%  Similarity=0.227  Sum_probs=201.9

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhccCCCCccceeeeecccccceEE
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV  596 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  596 (814)
                      .+.+.++||+|+||+||+|....  .++.||||++++..   ......+.+|..++..++||||+++++++.+.+..+||
T Consensus        75 ~y~~~~~LG~G~fG~V~~~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV  152 (437)
T 4aw2_A           75 DFEILKVIGRGAFGEVAVVKLKN--ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLV  152 (437)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETT--TTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred             heEEEEEEEeCCCEEEEEEEEcC--CCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEE
Confidence            44556889999999999999763  57899999996522   22233589999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCC
Q 041921          597 YEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ  675 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~  675 (814)
                      |||+++|+|.+++.. ...+++.....++.||+.||.|||+.   +|+||||||+||||+.++.+||+|||+++......
T Consensus       153 ~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~  229 (437)
T 4aw2_A          153 MDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG  229 (437)
T ss_dssp             ECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred             EecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC
Confidence            999999999999987 47799999999999999999999998   99999999999999999999999999998765433


Q ss_pred             cccccccccCCCCcccccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCcccee
Q 041921          676 SKTIKTAIRGTKGYVAPEWFR-----NSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVL  750 (814)
Q Consensus       676 ~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  750 (814)
                      ... ....+||+.|+|||++.     ...++.++|||||||++|||++|+.||......+..       ..+...... +
T Consensus       230 ~~~-~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~-------~~i~~~~~~-~  300 (437)
T 4aw2_A          230 TVQ-SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY-------GKIMNHKER-F  300 (437)
T ss_dssp             CEE-CCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-------HHHHTHHHH-C
T ss_pred             Ccc-cccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHH-------Hhhhhcccc-c
Confidence            222 13467999999999987     567899999999999999999999999765432211       111110000 0


Q ss_pred             ecCcccccCcHHHHHHHHHHHHHccccCCCC--CCCHHHHHH
Q 041921          751 VGEDKEAMNDIECLGKLVMVSIWCIQEDPSL--RPTMKKVLQ  790 (814)
Q Consensus       751 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~--RPt~~~vl~  790 (814)
                      ..+..    .......+.+++.+||+.+|++  ||+++|+++
T Consensus       301 ~~p~~----~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          301 QFPTQ----VTDVSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             CCCSS----CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             cCCcc----cccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence            00000    0113456788999999888887  999999986

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.3e-37  Score=337.34  Aligned_cols=243  Identities=23%  Similarity=0.308  Sum_probs=203.2

Q ss_pred             HhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc--------cchHhHHHHHHhhhccCCCCccceeeeecc
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ--------DGEREFKNEVFVIGQTHHKNLVRLLGFCDE  589 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  589 (814)
                      ...|.+.+.||+|+||.||+|...  ..+..||||.+.....        ...+.+.+|+.++++++||||+++++++.+
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~  100 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDK--EKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN  100 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEET--TTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             ccceEEEeEEEecCCEEEEEEEEC--CCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence            456677889999999999999865  3678999999975321        133468889999999999999999999999


Q ss_pred             cccceEEEecCCCC-CHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCc
Q 041921          590 GQNRLLVYEFLNNG-TLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLA  668 (814)
Q Consensus       590 ~~~~~lv~e~~~~g-sL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla  668 (814)
                      .+..++||||+..| +|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus       101 ~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~a  177 (335)
T 3dls_A          101 QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSA  177 (335)
T ss_dssp             SSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecccc
Confidence            99999999999777 9999999888899999999999999999999998   9999999999999999999999999999


Q ss_pred             cccccCCcccccccccCCCCcccccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCcc
Q 041921          669 KLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI-TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL  747 (814)
Q Consensus       669 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  747 (814)
                      .........   ....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||.......             ... 
T Consensus       178 ~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-------------~~~-  240 (335)
T 3dls_A          178 AYLERGKLF---YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV-------------EAA-  240 (335)
T ss_dssp             EECCTTCCB---CEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT-------------TTC-
T ss_pred             eECCCCCce---eccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH-------------hhc-
Confidence            876543322   34569999999999988776 789999999999999999999996421100             000 


Q ss_pred             ceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          748 NVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       748 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                         ..      .+......+.+++.+||+.||.+|||++++++.
T Consensus       241 ---~~------~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          241 ---IH------PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             ---CC------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             ---cC------CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               00      011134578899999999999999999999974

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.6e-37  Score=338.59  Aligned_cols=272  Identities=15%  Similarity=0.182  Sum_probs=203.4

Q ss_pred             HHHHhhhccccceeeeeeeeEEEEEEecC-CCceEEEEEEecccccc-----------chHhHHHHHHhhhccCCCCccc
Q 041921          515 ELEGATNNFKEEVGRGSFGIVYKGVIQTR-TSTTAVAVKKLDRVFQD-----------GEREFKNEVFVIGQTHHKNLVR  582 (814)
Q Consensus       515 ~l~~~~~~~~~~LG~G~~g~Vy~~~~~~~-~~~~~vavK~l~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~  582 (814)
                      ++....|.+.+.||+|+||.||+|..... ..+..+|||.+......           ....+.+|+..+..++||||++
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~  112 (345)
T 2v62_A           33 DMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPL  112 (345)
T ss_dssp             CTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCC
T ss_pred             cccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcce
Confidence            34456678889999999999999997631 24678999998653221           1224677888999999999999


Q ss_pred             eeeeecc----cccceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC
Q 041921          583 LLGFCDE----GQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYY  658 (814)
Q Consensus       583 l~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~  658 (814)
                      +++++.+    ....++||||+ +++|.+++.....+++..++.++.||+.||+|||+.   +|+||||||+|||++.++
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~  188 (345)
T 2v62_A          113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKN  188 (345)
T ss_dssp             EEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSS
T ss_pred             eecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCC
Confidence            9999977    67889999999 999999998877899999999999999999999998   999999999999999877


Q ss_pred             --cEEEeecCCccccccCCcc-----cccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhh
Q 041921          659 --TARISDFGLAKLLTLNQSK-----TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY  731 (814)
Q Consensus       659 --~~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~  731 (814)
                        .+||+|||+++.+......     .......||..|+|||.+.+..++.++||||||+++|||++|+.||........
T Consensus       189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~  268 (345)
T 2v62_A          189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV  268 (345)
T ss_dssp             TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred             CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence              9999999999876543211     111345699999999999999999999999999999999999999964322211


Q ss_pred             hhHHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 041921          732 AILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV  796 (814)
Q Consensus       732 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~  796 (814)
                      ...  .............+..    .......+.++.+++.+||+.||.+|||+++|++.|+.+.
T Consensus       269 ~~~--~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  327 (345)
T 2v62_A          269 AVQ--TAKTNLLDELPQSVLK----WAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG  327 (345)
T ss_dssp             HHH--HHHHHHHHTTTHHHHH----HSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred             HHH--HHHHhhcccccHHHHh----hccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence            111  1111111110000000    0001124467889999999999999999999999998753

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=2.8e-37  Score=342.44  Aligned_cols=272  Identities=15%  Similarity=0.162  Sum_probs=204.0

Q ss_pred             hhhccccceeee--eeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeecccccce
Q 041921          519 ATNNFKEEVGRG--SFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRL  594 (814)
Q Consensus       519 ~~~~~~~~LG~G--~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  594 (814)
                      ..|.+.++||+|  +||.||+|....  ++..||||++....  ....+.+.+|+.++++++||||+++++++.+++..+
T Consensus        25 ~~y~~~~~lG~G~~~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  102 (389)
T 3gni_B           25 GCYELLTVIGKGFEDLMTVNLARYKP--TGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW  102 (389)
T ss_dssp             GGEEEEEEEEEETTTTEEEEEEEETT--TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             CcEEEEecccCCcCCceEEEEEEEcC--CCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence            457788999999  999999999753  57899999996533  223456888999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccc
Q 041921          595 LVYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLT  672 (814)
Q Consensus       595 lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~  672 (814)
                      +||||+++++|.+++...  ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++....
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~  179 (389)
T 3gni_B          103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMI  179 (389)
T ss_dssp             EEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred             EEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence            999999999999999765  6789999999999999999999998   99999999999999999999999999987543


Q ss_pred             cCCc-----ccccccccCCCCccccccccc--CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhH--HHHHHHHhh
Q 041921          673 LNQS-----KTIKTAIRGTKGYVAPEWFRN--SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL--TDWAFDCYR  743 (814)
Q Consensus       673 ~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~--~~~~~~~~~  743 (814)
                      ....     ........||..|+|||.+.+  ..++.++|||||||++|||++|+.||...........  .........
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  259 (389)
T 3gni_B          180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD  259 (389)
T ss_dssp             ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred             cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence            2211     111123468999999999987  5789999999999999999999999975433221100  000000000


Q ss_pred             -----cC-------------ccceeec---------CcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--Hhc
Q 041921          744 -----NG-------------KLNVLVG---------EDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM--LEG  794 (814)
Q Consensus       744 -----~~-------------~~~~~~~---------~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~--L~~  794 (814)
                           ..             .+.....         ..............+.+++.+||+.||.+|||++|+++.  +++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~  339 (389)
T 3gni_B          260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ  339 (389)
T ss_dssp             ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGG
T ss_pred             ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHH
Confidence                 00             0000000         000001122335678899999999999999999999853  444


Q ss_pred             C
Q 041921          795 V  795 (814)
Q Consensus       795 ~  795 (814)
                      +
T Consensus       340 ~  340 (389)
T 3gni_B          340 I  340 (389)
T ss_dssp             C
T ss_pred             H
Confidence            3

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.5e-37  Score=336.04  Aligned_cols=252  Identities=23%  Similarity=0.264  Sum_probs=197.2

Q ss_pred             HHhhhccccceeeeeeeeEEEEEEec-CCCceEEEEEEecccc----ccchHhHHHHHHhhhccCCCCccceeeeecccc
Q 041921          517 EGATNNFKEEVGRGSFGIVYKGVIQT-RTSTTAVAVKKLDRVF----QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ  591 (814)
Q Consensus       517 ~~~~~~~~~~LG~G~~g~Vy~~~~~~-~~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  591 (814)
                      ....+.+.+.||+|+||.||++.... ...++.||||.++...    ......+.+|+.++++++||||+++++++.+.+
T Consensus        15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   94 (327)
T 3a62_A           15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG   94 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC
Confidence            34567788999999999999998742 2367899999997532    223456889999999999999999999999999


Q ss_pred             cceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcccc
Q 041921          592 NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLL  671 (814)
Q Consensus       592 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~  671 (814)
                      ..++||||+++++|.+++.....+++.....++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~  171 (327)
T 3a62_A           95 KLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKES  171 (327)
T ss_dssp             CEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred             EEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence            9999999999999999998877889999999999999999999998   9999999999999999999999999999764


Q ss_pred             ccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceee
Q 041921          672 TLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLV  751 (814)
Q Consensus       672 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  751 (814)
                      .....  ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.       ...+......   
T Consensus       172 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-------~~~i~~~~~~---  239 (327)
T 3a62_A          172 IHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT-------IDKILKCKLN---  239 (327)
T ss_dssp             ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-------HHHHHHTCCC---
T ss_pred             ccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHH-------HHHHHhCCCC---
Confidence            43221  11345699999999999998999999999999999999999999975433221       1111112111   


Q ss_pred             cCcccccCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 041921          752 GEDKEAMNDIECLGKLVMVSIWCIQEDPSLRP-----TMKKVLQ  790 (814)
Q Consensus       752 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~~vl~  790 (814)
                             .+......+.+++.+||+.||.+||     +++++++
T Consensus       240 -------~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          240 -------LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             -------CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             -------CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence                   1112346788999999999999999     7778875

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.2e-37  Score=351.66  Aligned_cols=248  Identities=23%  Similarity=0.264  Sum_probs=196.1

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccc---cccchHhHHHHHHhhhccCCCCccceeeeecccccceE
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV---FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL  595 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  595 (814)
                      ..+.+.+.||+|+||.||+|...  ..+..||||.+...   .......+.+|+.++++++||||+++++++.+.+..+|
T Consensus       148 ~~y~~~~~lG~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l  225 (446)
T 4ejn_A          148 NEFEYLKLLGKGTFGKVILVKEK--ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF  225 (446)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET--TTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred             HHcEEeEEEeeCcCEEEEEEEEc--CCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence            34677889999999999999865  36789999999653   22334568899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccC
Q 041921          596 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHE-DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN  674 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~  674 (814)
                      ||||+++++|.+++.....+++..+..++.||+.||+|||+ .   +|+||||||+||||+.++.+||+|||+++.....
T Consensus       226 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  302 (446)
T 4ejn_A          226 VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD  302 (446)
T ss_dssp             EECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred             EEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence            99999999999999888889999999999999999999998 6   8999999999999999999999999999864332


Q ss_pred             CcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCc
Q 041921          675 QSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGED  754 (814)
Q Consensus       675 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  754 (814)
                      ...  .....||+.|+|||++.+..++.++||||||+++|||++|+.||........       ...+......      
T Consensus       303 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-------~~~i~~~~~~------  367 (446)
T 4ejn_A          303 GAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL-------FELILMEEIR------  367 (446)
T ss_dssp             ------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHCCCC------
T ss_pred             Ccc--cccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH-------HHHHHhCCCC------
Confidence            221  2446799999999999999999999999999999999999999975433221       1111111111      


Q ss_pred             ccccCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 041921          755 KEAMNDIECLGKLVMVSIWCIQEDPSLRP-----TMKKVLQ  790 (814)
Q Consensus       755 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~~vl~  790 (814)
                          .+......+.+++.+||+.||.+||     |++++++
T Consensus       368 ----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          368 ----FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             ----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ----CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence                0112346788999999999999999     9999985

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2.7e-37  Score=331.55  Aligned_cols=264  Identities=21%  Similarity=0.326  Sum_probs=199.7

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhccCCCCccceeeeecccccceE
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL  595 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  595 (814)
                      ..|.+.+.||+|+||.||+|....  ++..||||++....   ....+++.+|+.++++++||||+++++++.+.+..++
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l  109 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLL--DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI  109 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETT--TCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEEEeecCCCCceEEEEEEcC--CCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence            357778999999999999998753  57899999987422   2334568999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhcC----CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcccc
Q 041921          596 VYEFLNNGTLASFLFG----NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLL  671 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~  671 (814)
                      ||||+++++|.+++..    ...+++..+..++.|++.||.|||+.   +|+|+||||+||+++.++.+||+|||++...
T Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~  186 (310)
T 2wqm_A          110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF  186 (310)
T ss_dssp             EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred             EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence            9999999999999864    46688999999999999999999998   9999999999999999999999999999866


Q ss_pred             ccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceee
Q 041921          672 TLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLV  751 (814)
Q Consensus       672 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  751 (814)
                      ......  .....|+..|+|||.+.+..++.++||||||++++||++|+.||.........     ....+.........
T Consensus       187 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-----~~~~~~~~~~~~~~  259 (310)
T 2wqm_A          187 SSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS-----LCKKIEQCDYPPLP  259 (310)
T ss_dssp             --------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHH-----HHHHHHTTCSCCCC
T ss_pred             cCCCcc--ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHH-----HHHHhhcccCCCCc
Confidence            533221  13346899999999999999999999999999999999999999644322111     11222222211111


Q ss_pred             cCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCCCCC
Q 041921          752 GEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVPP  802 (814)
Q Consensus       752 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~~~~p~  802 (814)
                              .......+.+++.+||+.||.+|||+.++++.|+++.+...+|
T Consensus       260 --------~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~  302 (310)
T 2wqm_A          260 --------SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS  302 (310)
T ss_dssp             --------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred             --------ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhh
Confidence                    1123467889999999999999999999999999876554433

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2.5e-37  Score=331.46  Aligned_cols=264  Identities=25%  Similarity=0.290  Sum_probs=199.3

Q ss_pred             HHHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc-----ccchHhHHHHHHhhhccC---CCCccceeee
Q 041921          515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF-----QDGEREFKNEVFVIGQTH---HKNLVRLLGF  586 (814)
Q Consensus       515 ~l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~---h~niv~l~~~  586 (814)
                      ++....|.+.++||+|+||+||+|...  ..++.||||.+....     ......+.+|+.++++++   ||||++++++
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~   82 (308)
T 3g33_A            5 SMATSRYEPVAEIGVGAYGTVYKARDP--HSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDV   82 (308)
T ss_dssp             -----CCEEEEEECCSSSCCEEEEECT--TTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEE
T ss_pred             cccccceEEEEEEecCCCeEEEEEEEC--CCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeee
Confidence            455667888999999999999999854  357899999986432     112346778888777775   9999999999


Q ss_pred             ecccc-----cceEEEecCCCCCHHHHhcCCCC--CChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCc
Q 041921          587 CDEGQ-----NRLLVYEFLNNGTLASFLFGNLK--PNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYT  659 (814)
Q Consensus       587 ~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~--l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~  659 (814)
                      +....     ..++||||+. ++|.+++.....  +++..+..++.||+.||+|||+.   +|+||||||+|||++.++.
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~  158 (308)
T 3g33_A           83 CATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGT  158 (308)
T ss_dssp             EEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSC
T ss_pred             eeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCC
Confidence            97654     4789999997 599999987643  89999999999999999999998   9999999999999999999


Q ss_pred             EEEeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHH
Q 041921          660 ARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF  739 (814)
Q Consensus       660 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  739 (814)
                      +||+|||+++........   ....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+..   ..+.
T Consensus       159 ~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~i~  232 (308)
T 3g33_A          159 VKLADFGLARIYSYQMAL---TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL---GKIF  232 (308)
T ss_dssp             EEECSCSCTTTSTTCCCS---GGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHH---HHHH
T ss_pred             EEEeeCccccccCCCccc---CCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHH
Confidence            999999999876533221   4456899999999999999999999999999999999999999765433211   1111


Q ss_pred             HHhhcCc---cceeec-C--cc--ccc-----CcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          740 DCYRNGK---LNVLVG-E--DK--EAM-----NDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       740 ~~~~~~~---~~~~~~-~--~~--~~~-----~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      .......   ...... +  ..  ...     ...+..+.+.+++.+||+.||.+|||+.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          233 DLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             HHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            1111100   000000 0  00  000     01123467889999999999999999999986

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=2.5e-37  Score=325.75  Aligned_cols=253  Identities=26%  Similarity=0.374  Sum_probs=206.2

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEE
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY  597 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  597 (814)
                      ..+.+.+.||+|+||.||+|...  .++..||||.+.... ....+.+.+|+.++++++||||+++++++.+.+..++|+
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNR--VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEET--TTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEEEEeecCCCcEEEEEEEC--CCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence            45778899999999999999865  357799999986432 234467899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcc
Q 041921          598 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSK  677 (814)
Q Consensus       598 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  677 (814)
                      ||+++++|.+++.....+++..+..++.|++.||.|||+.   +|+|+||||+||+++.++.+||+|||++.........
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~  161 (276)
T 2yex_A           85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (276)
T ss_dssp             ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             EecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence            9999999999998888899999999999999999999998   9999999999999999999999999999876543322


Q ss_pred             cccccccCCCCcccccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCccc
Q 041921          678 TIKTAIRGTKGYVAPEWFRNSKI-TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKE  756 (814)
Q Consensus       678 ~~~~~~~gt~~y~aPE~~~~~~~-s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  756 (814)
                      .......|+..|+|||.+.+..+ +.++||||||++++||++|+.||........ ...     .+......        
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~-----~~~~~~~~--------  227 (276)
T 2yex_A          162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYS-----DWKEKKTY--------  227 (276)
T ss_dssp             CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHH-----HHHTTCTT--------
T ss_pred             hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHH-----Hhhhcccc--------
Confidence            22244568999999999987765 7789999999999999999999975443221 111     11111100        


Q ss_pred             ccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          757 AMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       757 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      ..........+.+++.+||+.||.+|||++++++
T Consensus       228 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          228 LNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence            0011223467789999999999999999999986

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.2e-37  Score=332.30  Aligned_cols=264  Identities=23%  Similarity=0.299  Sum_probs=200.2

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc--cchHhHHHHHHhhhccCCCCccceeeeecccccceEEE
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ--DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY  597 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  597 (814)
                      .|.+.++||+|+||.||+|....  .+..||||++.....  ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (311)
T 4agu_A            4 KYEKIGKIGEGSYGVVFKCRNRD--TGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF   81 (311)
T ss_dssp             CEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEeeEEeecCCeEEEEEEeCC--CCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence            46678899999999999999753  578999999865322  22456889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcc
Q 041921          598 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSK  677 (814)
Q Consensus       598 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  677 (814)
                      ||+++++|.+++.....+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++.........
T Consensus        82 e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  158 (311)
T 4agu_A           82 EYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY  158 (311)
T ss_dssp             ECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             EeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence            9999999999998888899999999999999999999998   9999999999999999999999999999876533221


Q ss_pred             cccccccCCCCccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHH--------HHHhhcCc-c
Q 041921          678 TIKTAIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA--------FDCYRNGK-L  747 (814)
Q Consensus       678 ~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~~~-~  747 (814)
                        .....||..|+|||.+.+ ..++.++||||||++++||++|+.||......+........        ...+.... .
T Consensus       159 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (311)
T 4agu_A          159 --YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF  236 (311)
T ss_dssp             ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred             --cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence              134568999999999876 56899999999999999999999999765443221111000        00000000 0


Q ss_pred             ceeecCcccccC-----cHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          748 NVLVGEDKEAMN-----DIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       748 ~~~~~~~~~~~~-----~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      .....+......     .......+.+++.+||+.||.+|||++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            000000000000     0123456889999999999999999999985

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.6e-37  Score=331.44  Aligned_cols=262  Identities=20%  Similarity=0.213  Sum_probs=201.5

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccc---hHhHHHHHHhhhccCCCCccceeeeecccccceE
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG---EREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL  595 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  595 (814)
                      ..|.+.+.||+|+||.||+|....  .++.||||.+.......   .+.+.+|+.++++++||||+++++++.+++..++
T Consensus        34 ~~y~~~~~lg~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 2h34_A           34 GPYRLRRLVGRGGMGDVYEAEDTV--RERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV  111 (309)
T ss_dssp             CCEEEEEEEEECSSSEEEEEEETT--TTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             ccEEEEEEEcCCCCeeEEEEEEcC--CCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence            457788999999999999998653  57899999997543222   3578999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCC
Q 041921          596 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ  675 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~  675 (814)
                      |+||+++++|.+++.....+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++.......
T Consensus       112 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  188 (309)
T 2h34_A          112 DMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEK  188 (309)
T ss_dssp             EEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred             EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence            999999999999998877899999999999999999999998   99999999999999999999999999998765432


Q ss_pred             cccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcc
Q 041921          676 SKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDK  755 (814)
Q Consensus       676 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  755 (814)
                      ... .....|++.|+|||.+.+..++.++||||||+++|||++|+.||.......       ....+.... ..      
T Consensus       189 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~~~~~~-~~------  253 (309)
T 2h34_A          189 LTQ-LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV-------MGAHINQAI-PR------  253 (309)
T ss_dssp             ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH-------HHHHHHSCC-CC------
T ss_pred             ccc-ccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH-------HHHHhccCC-CC------
Confidence            221 134568999999999999999999999999999999999999997543211       111111111 00      


Q ss_pred             cccCcHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHhcCcCCCC
Q 041921          756 EAMNDIECLGKLVMVSIWCIQEDPSLRP-TMKKVLQMLEGVVEVSV  800 (814)
Q Consensus       756 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-t~~~vl~~L~~~~~~~~  800 (814)
                      ........+..+.+++.+||+.||.+|| |++++++.|+...+...
T Consensus       254 ~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~  299 (309)
T 2h34_A          254 PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD  299 (309)
T ss_dssp             GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred             ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence            0011223345788999999999999999 99999999988655543

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=4.9e-37  Score=325.01  Aligned_cols=251  Identities=22%  Similarity=0.325  Sum_probs=205.2

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeecccccceEE
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV  596 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  596 (814)
                      ..|.+.++||+|+||.||+|....  .+..||+|.+....  ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   83 (284)
T 3kk8_A            6 DNYDVKEELGKGAFSVVRRCVHKT--TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   83 (284)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhhhhhhcCcCCeEEEEEEEcC--CCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence            456778899999999999998753  57789999986432  22345688999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCc---EEEeecCCcccccc
Q 041921          597 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYT---ARISDFGLAKLLTL  673 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~---~kl~DfGla~~~~~  673 (814)
                      |||+++++|.+++.....+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.   +||+|||++.....
T Consensus        84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  160 (284)
T 3kk8_A           84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  160 (284)
T ss_dssp             ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence            99999999999998888899999999999999999999998   9999999999999986655   99999999987654


Q ss_pred             CCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecC
Q 041921          674 NQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGE  753 (814)
Q Consensus       674 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  753 (814)
                      ....   ....||+.|+|||.+.+..++.++||||||++++||++|+.||........       ...+..+.....   
T Consensus       161 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-------~~~~~~~~~~~~---  227 (284)
T 3kk8_A          161 SEAW---HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL-------YAQIKAGAYDYP---  227 (284)
T ss_dssp             SCBC---CCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHTCCCCC---
T ss_pred             Cccc---cCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHH-------HHHHHhccccCC---
Confidence            3221   345689999999999999999999999999999999999999975433221       111222221111   


Q ss_pred             cccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          754 DKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       754 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                         ..........+.+++.+||+.||++|||++++++
T Consensus       228 ---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          228 ---SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             ---TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---chhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence               0011123467889999999999999999999986

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=3.6e-38  Score=341.09  Aligned_cols=265  Identities=29%  Similarity=0.425  Sum_probs=206.4

Q ss_pred             HHHHHhhhccccceeeeeeeeEEEEEEe---cCCCceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccceeeeecc
Q 041921          514 KELEGATNNFKEEVGRGSFGIVYKGVIQ---TRTSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDE  589 (814)
Q Consensus       514 ~~l~~~~~~~~~~LG~G~~g~Vy~~~~~---~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  589 (814)
                      .++....+.+.+.||+|+||.||+|...   +...+..||||.+.... .....++.+|+.++++++||||+++++++.+
T Consensus        25 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  104 (327)
T 2yfx_A           25 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ  104 (327)
T ss_dssp             CBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence            3455677888999999999999999854   22356789999996432 3345578999999999999999999999999


Q ss_pred             cccceEEEecCCCCCHHHHhcCC-------CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC---CCc
Q 041921          590 GQNRLLVYEFLNNGTLASFLFGN-------LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDD---YYT  659 (814)
Q Consensus       590 ~~~~~lv~e~~~~gsL~~~l~~~-------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~---~~~  659 (814)
                      ....++||||+++++|.+++...       ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.   +..
T Consensus       105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~  181 (327)
T 2yfx_A          105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRV  181 (327)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCC
T ss_pred             CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcce
Confidence            99999999999999999999754       3478889999999999999999998   9999999999999984   456


Q ss_pred             EEEeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHH
Q 041921          660 ARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWA  738 (814)
Q Consensus       660 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~  738 (814)
                      +||+|||++................+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+       .
T Consensus       182 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~  254 (327)
T 2yfx_A          182 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-------V  254 (327)
T ss_dssp             EEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-------H
T ss_pred             EEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH-------H
Confidence            99999999986544332222234557899999999998899999999999999999998 999987543222       1


Q ss_pred             HHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 041921          739 FDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE  797 (814)
Q Consensus       739 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~  797 (814)
                      ...+..+....         ........+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       255 ~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  304 (327)
T 2yfx_A          255 LEFVTSGGRMD---------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  304 (327)
T ss_dssp             HHHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHhcCCCCC---------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence            11222221110         112234678899999999999999999999999987543

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.6e-37  Score=344.55  Aligned_cols=253  Identities=19%  Similarity=0.241  Sum_probs=202.2

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccc---cccchHhHHHHHHhhhccCCCCccceeeeecccccceE
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV---FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL  595 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  595 (814)
                      ..+.+.++||+|+||.||+|....  .+..||+|.+.+.   .....+.+.+|+.+++.++||||+++++++.+.+..+|
T Consensus        69 ~~y~~~~~LG~G~fG~V~~~~~~~--~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l  146 (410)
T 3v8s_A           69 EDYEVVKVIGRGAFGEVQLVRHKS--TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM  146 (410)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccEEEEEEEcCCCEEEEEEEECC--CCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence            345567889999999999999763  5789999998652   12234468899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCC
Q 041921          596 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ  675 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~  675 (814)
                      ||||+++|+|.+++... .+++.....++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus       147 V~E~~~gg~L~~~l~~~-~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~  222 (410)
T 3v8s_A          147 VMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG  222 (410)
T ss_dssp             EECCCTTEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred             EEeCCCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEeeccCC
Confidence            99999999999999754 578999999999999999999998   99999999999999999999999999998765433


Q ss_pred             cccccccccCCCCcccccccccCC----CCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceee
Q 041921          676 SKTIKTAIRGTKGYVAPEWFRNSK----ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLV  751 (814)
Q Consensus       676 ~~~~~~~~~gt~~y~aPE~~~~~~----~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  751 (814)
                      ... ....+||+.|+|||++....    ++.++|||||||++|||++|+.||......+.       ...+..+....  
T Consensus       223 ~~~-~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-------~~~i~~~~~~~--  292 (410)
T 3v8s_A          223 MVR-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT-------YSKIMNHKNSL--  292 (410)
T ss_dssp             EEE-CCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHHHHTHHHHC--
T ss_pred             ccc-ccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH-------HHHHHhccccc--
Confidence            211 13567999999999998665    78899999999999999999999975543221       11111111000  


Q ss_pred             cCcccccCcHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 041921          752 GEDKEAMNDIECLGKLVMVSIWCIQEDPSL--RPTMKKVLQM  791 (814)
Q Consensus       752 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~--RPt~~~vl~~  791 (814)
                          ..+........+.+++.+||+.+|.+  ||+++||++.
T Consensus       293 ----~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          293 ----TFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             ----CCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             ----cCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence                00011123467889999999999988  9999999863

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=3.3e-37  Score=325.56  Aligned_cols=247  Identities=26%  Similarity=0.369  Sum_probs=201.6

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhccCCCCccceeeeecccccceE
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL  595 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  595 (814)
                      ..+.+.+.||+|+||.||+|...  ..+..||||.+....   ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            9 EDFEIGRPLGKGKFGNVYLAREK--QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEET--TTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccEEEeeEEecCCCeEEEEEEEc--cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            34667789999999999999875  356789999985432   2234578999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCC
Q 041921          596 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ  675 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~  675 (814)
                      ||||+++++|.+++.....+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++.......
T Consensus        87 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~  163 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR  163 (279)
T ss_dssp             EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred             EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCccc
Confidence            999999999999998878899999999999999999999998   99999999999999999999999999986544322


Q ss_pred             cccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcc
Q 041921          676 SKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDK  755 (814)
Q Consensus       676 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  755 (814)
                      .    ....|+..|+|||.+.+..++.++||||||++++||++|+.||......+.       ...+......       
T Consensus       164 ~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~~~~~-------  225 (279)
T 3fdn_A          164 R----TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET-------YKRISRVEFT-------  225 (279)
T ss_dssp             --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHHHHHTCCC-------
T ss_pred             c----cccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH-------HHHHHhCCCC-------
Confidence            1    345689999999999999999999999999999999999999975433221       1111111111       


Q ss_pred             cccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          756 EAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       756 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                         .+......+.+++.+||+.||.+|||++++++.
T Consensus       226 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          226 ---FPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             ---CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             ---CCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence               111234667899999999999999999999853

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=3.5e-37  Score=326.24  Aligned_cols=252  Identities=23%  Similarity=0.299  Sum_probs=207.8

Q ss_pred             HhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhccCCCCccceeeeecccccce
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRL  594 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  594 (814)
                      ...+.+.+.||+|+||.||+|...  ..+..||||.+....   ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   90 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREK--QNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIY   90 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET--TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEc--CCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEE
Confidence            345777899999999999999875  357899999986432   223467899999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccC
Q 041921          595 LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN  674 (814)
Q Consensus       595 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~  674 (814)
                      +||||+++++|.+++.....+++..+..++.|+++||.|||+.   +|+||||||+||+++.++.+||+|||++......
T Consensus        91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  167 (284)
T 2vgo_A           91 LMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL  167 (284)
T ss_dssp             EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred             EEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence            9999999999999998877899999999999999999999998   9999999999999999999999999998765432


Q ss_pred             CcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCc
Q 041921          675 QSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGED  754 (814)
Q Consensus       675 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  754 (814)
                      ..    ....|+..|+|||.+.+..++.++||||||++++||++|+.||......+.       ...+......      
T Consensus       168 ~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-------~~~~~~~~~~------  230 (284)
T 2vgo_A          168 RR----RTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET-------HRRIVNVDLK------  230 (284)
T ss_dssp             CB----CCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHHHHTTCCC------
T ss_pred             cc----ccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH-------HHHHhccccC------
Confidence            21    335689999999999999999999999999999999999999975433221       1111121111      


Q ss_pred             ccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhcC
Q 041921          755 KEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ--MLEGV  795 (814)
Q Consensus       755 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~--~L~~~  795 (814)
                          .+......+.+++.+||+.||.+|||++++++  .+...
T Consensus       231 ----~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~  269 (284)
T 2vgo_A          231 ----FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN  269 (284)
T ss_dssp             ----CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred             ----CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence                11123467889999999999999999999986  55443

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1e-36  Score=322.88  Aligned_cols=249  Identities=25%  Similarity=0.349  Sum_probs=197.0

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEE
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY  597 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  597 (814)
                      ..+.+.++||+|+||.||++...  ..+..||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   99 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEER--SSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM   99 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEET--TTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheeecceeccCCCeEEEEEEEc--cCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence            46778899999999999999865  357889999986543 334567999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhcC----CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE---cCCCcEEEeecCCccc
Q 041921          598 EFLNNGTLASFLFG----NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILL---DDYYTARISDFGLAKL  670 (814)
Q Consensus       598 e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll---~~~~~~kl~DfGla~~  670 (814)
                      ||+++++|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+||++   +.++.+||+|||++..
T Consensus       100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~  176 (285)
T 3is5_A          100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL  176 (285)
T ss_dssp             CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred             EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence            99999999999854    36789999999999999999999998   99999999999999   4568899999999987


Q ss_pred             cccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCcccee
Q 041921          671 LTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVL  750 (814)
Q Consensus       671 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  750 (814)
                      .......   ....||+.|+|||.+. ..++.++||||||++++||++|+.||......+..       ...........
T Consensus       177 ~~~~~~~---~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~-------~~~~~~~~~~~  245 (285)
T 3is5_A          177 FKSDEHS---TNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQ-------QKATYKEPNYA  245 (285)
T ss_dssp             -------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHCCCCCC
T ss_pred             cCCcccC---cCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHH-------hhhccCCcccc
Confidence            6543221   3456899999999986 56899999999999999999999999754432211       11111111100


Q ss_pred             ecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          751 VGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       751 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      ..       .......+.+++.+||+.||++|||++|+++
T Consensus       246 ~~-------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          246 VE-------CRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             C---------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             cc-------cCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00       0112356789999999999999999999985

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.9e-37  Score=335.74  Aligned_cols=249  Identities=21%  Similarity=0.326  Sum_probs=194.9

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccceeeeecccc------
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ------  591 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  591 (814)
                      ..+.+.+.||+|+||.||+|....  ++..||||+++... ....+.+.+|+.++++++||||+++++++.+..      
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   83 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKV--DDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE   83 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETT--TCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcC--CCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence            456778899999999999999753  57899999996433 334567999999999999999999999885543      


Q ss_pred             ---------------------------------------------------cceEEEecCCCCCHHHHhcCCCC---CCh
Q 041921          592 ---------------------------------------------------NRLLVYEFLNNGTLASFLFGNLK---PNW  617 (814)
Q Consensus       592 ---------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~---l~~  617 (814)
                                                                         ..++||||+++++|.+++.....   ..+
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~  163 (332)
T 3qd2_B           84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH  163 (332)
T ss_dssp             HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred             hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence                                                               27899999999999999987643   355


Q ss_pred             hhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcc----------cccccccCCC
Q 041921          618 NLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSK----------TIKTAIRGTK  687 (814)
Q Consensus       618 ~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~----------~~~~~~~gt~  687 (814)
                      ..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++........          .......||+
T Consensus       164 ~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  240 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK  240 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred             HHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence            56889999999999999998   9999999999999999999999999999877654211          1113356999


Q ss_pred             CcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCcHHHHHHH
Q 041921          688 GYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKL  767 (814)
Q Consensus       688 ~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  767 (814)
                      .|+|||.+.+..++.++||||||+++|||++|..|+..    . ..    ............         ........+
T Consensus       241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~----~-~~----~~~~~~~~~~~~---------~~~~~~~~~  302 (332)
T 3qd2_B          241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME----R-VR----IITDVRNLKFPL---------LFTQKYPQE  302 (332)
T ss_dssp             GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH----H-HH----HHHHHHTTCCCH---------HHHHHCHHH
T ss_pred             CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH----H-HH----HHHHhhccCCCc---------ccccCChhH
Confidence            99999999999999999999999999999998765421    0 00    111111111110         122344667


Q ss_pred             HHHHHHccccCCCCCCCHHHHHH
Q 041921          768 VMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       768 ~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      .+++.+||+.||.+|||++++++
T Consensus       303 ~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          303 HMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHccCCCCcCCCHHHHhh
Confidence            89999999999999999999986

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=3.9e-37  Score=334.36  Aligned_cols=252  Identities=25%  Similarity=0.342  Sum_probs=203.2

Q ss_pred             HhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhcc-CCCCccceeeeecccccceEE
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRLLV  596 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  596 (814)
                      ...|.+.+.||+|+||.||++...  ..++.||||.+....    ....+|++++.++ +||||+++++++.+++..++|
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~~~~avK~~~~~~----~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv   94 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHK--ATNMEFAVKIIDKSK----RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV   94 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEET--TTTEEEEEEEEETTT----CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEEEEEeeCCCEEEEEEEEC--CCCCEEEEEEEEccc----CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence            456778899999999999999975  357899999996532    2456788888888 799999999999999999999


Q ss_pred             EecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC----CcEEEeecCCccccc
Q 041921          597 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDY----YTARISDFGLAKLLT  672 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~----~~~kl~DfGla~~~~  672 (814)
                      |||+++|+|.+++.....+++.....++.||+.||.|||+.   +|+||||||+|||+.+.    +.+||+|||+++...
T Consensus        95 ~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~  171 (342)
T 2qr7_A           95 TELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR  171 (342)
T ss_dssp             ECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred             EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence            99999999999998888899999999999999999999998   99999999999998543    359999999998765


Q ss_pred             cCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeec
Q 041921          673 LNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVG  752 (814)
Q Consensus       673 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  752 (814)
                      .....  .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..........    +...+..+.....  
T Consensus       172 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~----~~~~i~~~~~~~~--  243 (342)
T 2qr7_A          172 AENGL--LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEE----ILARIGSGKFSLS--  243 (342)
T ss_dssp             CTTCC--BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHH----HHHHHHHCCCCCC--
T ss_pred             CCCCc--eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHH----HHHHHccCCcccC--
Confidence            43221  134568999999999988889999999999999999999999997543222111    2223333332211  


Q ss_pred             CcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          753 EDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       753 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                          ..........+.+++.+||+.||.+|||++++++
T Consensus       244 ----~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          244 ----GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             ----STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             ----ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                0111223467889999999999999999999985

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.9e-37  Score=341.81  Aligned_cols=270  Identities=19%  Similarity=0.245  Sum_probs=211.0

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccceeeeecccc--cceE
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ--NRLL  595 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~l  595 (814)
                      ..|.+.++||+|+||.||+|....  .+..||||.+.... ....+.+.+|++++++++||||+++++++.+..  ..++
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l   86 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKK--TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL   86 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECC--CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence            456778999999999999999753  57899999997543 233567889999999999999999999987655  6799


Q ss_pred             EEecCCCCCHHHHhcCCC---CCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE----cCCCcEEEeecCCc
Q 041921          596 VYEFLNNGTLASFLFGNL---KPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILL----DDYYTARISDFGLA  668 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~~~---~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll----~~~~~~kl~DfGla  668 (814)
                      ||||+++++|.+++....   .+++..+..++.||+.||+|||+.   +|+||||||+|||+    +.++.+||+|||++
T Consensus        87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a  163 (396)
T 4eut_A           87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (396)
T ss_dssp             EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred             EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence            999999999999998643   389999999999999999999998   99999999999999    77888999999999


Q ss_pred             cccccCCcccccccccCCCCccccccccc--------CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHH
Q 041921          669 KLLTLNQSKTIKTAIRGTKGYVAPEWFRN--------SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD  740 (814)
Q Consensus       669 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  740 (814)
                      +........   ....||..|+|||.+..        ..++.++||||||+++|||++|+.||.........  .+....
T Consensus       164 ~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~--~~~~~~  238 (396)
T 4eut_A          164 RELEDDEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYK  238 (396)
T ss_dssp             EECCCGGGS---SCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC--HHHHHH
T ss_pred             eEccCCCcc---ccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch--HHHHHH
Confidence            876543221   34569999999999865        56788999999999999999999999644321110  111112


Q ss_pred             HhhcCc---cceee-----------cCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 041921          741 CYRNGK---LNVLV-----------GEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV  798 (814)
Q Consensus       741 ~~~~~~---~~~~~-----------~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~~  798 (814)
                      ......   +....           ...............+.+++.+||+.||++|||+.++++.|+.+++.
T Consensus       239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             HHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             HhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            221111   11100           00111122356778889999999999999999999999999886653

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.7e-37  Score=343.55  Aligned_cols=251  Identities=20%  Similarity=0.290  Sum_probs=195.5

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccc--cccchHhHHHHHHhhhccC--CCCccceeeeecccccce
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV--FQDGEREFKNEVFVIGQTH--HKNLVRLLGFCDEGQNRL  594 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~  594 (814)
                      ..|.+.+.||+|+||.||++...   .+..||||.+...  .....+.+.+|+.++.+++  ||||+++++++...+..+
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~  132 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNE---KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY  132 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECT---TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcC---CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEE
Confidence            34677889999999999999864   3778999998643  2334467999999999996  599999999999999999


Q ss_pred             EEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccC
Q 041921          595 LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN  674 (814)
Q Consensus       595 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~  674 (814)
                      |||| +.+++|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+|||++ ++.+||+|||+++.+...
T Consensus       133 lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~  207 (390)
T 2zmd_A          133 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  207 (390)
T ss_dssp             EEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred             EEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence            9999 57889999998888889999999999999999999998   999999999999996 579999999999877644


Q ss_pred             CcccccccccCCCCccccccccc-----------CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhh
Q 041921          675 QSKTIKTAIRGTKGYVAPEWFRN-----------SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR  743 (814)
Q Consensus       675 ~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  743 (814)
                      ..........||+.|+|||++.+           ..++.++|||||||++|||++|+.||........ .    ..... 
T Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~-~----~~~~~-  281 (390)
T 2zmd_A          208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-K----LHAII-  281 (390)
T ss_dssp             ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-H----HHHHH-
T ss_pred             CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHH-H----HHHHh-
Confidence            33322245679999999999865           3688999999999999999999999975432111 1    11111 


Q ss_pred             cCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          744 NGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       744 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                      ......        ..+......+.+++.+||+.||.+|||+.++++.
T Consensus       282 ~~~~~~--------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          282 DPNHEI--------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             CTTSCC--------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CccccC--------CCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence            111110        0011113568899999999999999999999853

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.7e-37  Score=332.36  Aligned_cols=273  Identities=23%  Similarity=0.325  Sum_probs=203.1

Q ss_pred             HHHHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhc--cCCCCccceeeeeccc-
Q 041921          514 KELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ--THHKNLVRLLGFCDEG-  590 (814)
Q Consensus       514 ~~l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~-  590 (814)
                      .+.....+.+.++||+|+||.||+|...    +..||||.+...   ....+..|.+++..  ++||||+++++++.+. 
T Consensus        32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~  104 (337)
T 3mdy_A           32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR----GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGT  104 (337)
T ss_dssp             HTTHHHHCEEEEEEEEETTEEEEEEEET----TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred             ccccccceEEEeEeecCCCeEEEEEEEC----CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence            3445567888999999999999999864    789999998643   23344455555544  4999999999998776 


Q ss_pred             ---ccceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcC-----CCCeeecCCCCCcEEEcCCCcEEE
Q 041921          591 ---QNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDC-----RAQIIHCDIKPQNILLDDYYTARI  662 (814)
Q Consensus       591 ---~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~-----~~~i~H~dlkp~NIll~~~~~~kl  662 (814)
                         ...++||||+++++|.+++... .+++..+..++.|++.||.|||+..     ..+|+||||||+|||++.++.+||
T Consensus       105 ~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl  183 (337)
T 3mdy_A          105 GSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI  183 (337)
T ss_dssp             GGGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred             CCCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence               6789999999999999999654 6899999999999999999999752     348999999999999999999999


Q ss_pred             eecCCccccccCCcccc--cccccCCCCcccccccccCCCCcc------hhhHHHHHHHHHHHhC----------CCCCC
Q 041921          663 SDFGLAKLLTLNQSKTI--KTAIRGTKGYVAPEWFRNSKITAK------VDVYSFGVLLLEIISC----------RKSFD  724 (814)
Q Consensus       663 ~DfGla~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~~------~Dv~s~Gvvl~elltg----------~~p~~  724 (814)
                      +|||+++.+........  .....||+.|+|||.+.+.....+      +||||||+++|||++|          +.||.
T Consensus       184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~  263 (337)
T 3mdy_A          184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH  263 (337)
T ss_dssp             CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence            99999987654332211  123569999999999987766654      9999999999999999          55554


Q ss_pred             cccchhhhhHHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCC
Q 041921          725 IEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS  799 (814)
Q Consensus       725 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~~~  799 (814)
                      .........  ...............   ..........+.++.+++.+||+.||.+|||+.++++.|+.+.+..
T Consensus       264 ~~~~~~~~~--~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  333 (337)
T 3mdy_A          264 DLVPSDPSY--EDMREIVCIKKLRPS---FPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ  333 (337)
T ss_dssp             TTSCSSCCH--HHHHHHHTTSCCCCC---CCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             hhcCCCCch--hhhHHHHhhhccCcc---ccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence            332211100  001111111111110   1111123367888999999999999999999999999999876543

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.2e-37  Score=336.14  Aligned_cols=255  Identities=26%  Similarity=0.286  Sum_probs=198.0

Q ss_pred             HhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccc-----cccchHhHHHHHHhhhccCCCCccceeeeeccccc
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV-----FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQN  592 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  592 (814)
                      ...|.+.+.||+|+||.||+|...  ..+..||||.+...     .....+.+.+|+.++++++||||+++++++.+.+.
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  102 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIEN--QTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQY  102 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEET--TTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhheeecceeeecCCeEEEEEEEC--CCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCe
Confidence            456778899999999999999865  35788999998643     23445679999999999999999999999999999


Q ss_pred             ceEEEecCCCCCHHHHhcCC----------------------------------------CCCChhhHHHHHHHHHHHHH
Q 041921          593 RLLVYEFLNNGTLASFLFGN----------------------------------------LKPNWNLRTNIAFQIARGLL  632 (814)
Q Consensus       593 ~~lv~e~~~~gsL~~~l~~~----------------------------------------~~l~~~~~~~i~~~ia~~l~  632 (814)
                      .++||||+++++|.+++...                                        ..+++..+..++.||++||+
T Consensus       103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~  182 (345)
T 3hko_A          103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH  182 (345)
T ss_dssp             EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence            99999999999999998521                                        11246677889999999999


Q ss_pred             HhhhcCCCCeeecCCCCCcEEEcCCC--cEEEeecCCccccccCCccc--ccccccCCCCccccccccc--CCCCcchhh
Q 041921          633 YLHEDCRAQIIHCDIKPQNILLDDYY--TARISDFGLAKLLTLNQSKT--IKTAIRGTKGYVAPEWFRN--SKITAKVDV  706 (814)
Q Consensus       633 yLH~~~~~~i~H~dlkp~NIll~~~~--~~kl~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~s~~~Dv  706 (814)
                      |||+.   +|+||||||+|||++.++  .+||+|||+++.+.......  ......||+.|+|||.+.+  ..++.++||
T Consensus       183 ~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di  259 (345)
T 3hko_A          183 YLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA  259 (345)
T ss_dssp             HHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHH
T ss_pred             HHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHH
Confidence            99998   999999999999998766  89999999998764322211  1234569999999999975  678999999


Q ss_pred             HHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHH
Q 041921          707 YSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMK  786 (814)
Q Consensus       707 ~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~  786 (814)
                      ||||+++|||++|+.||......+.      ...... +...      ...+........+.+++.+||+.||.+|||+.
T Consensus       260 wslG~il~el~~g~~pf~~~~~~~~------~~~~~~-~~~~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  326 (345)
T 3hko_A          260 WSAGVLLHLLLMGAVPFPGVNDADT------ISQVLN-KKLC------FENPNYNVLSPLARDLLSNLLNRNVDERFDAM  326 (345)
T ss_dssp             HHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHH-CCCC------TTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHH
T ss_pred             HHHHHHHHHHHHCCCCCCCCChHHH------HHHHHh-cccc------cCCcccccCCHHHHHHHHHHcCCChhHCCCHH
Confidence            9999999999999999975543221      111111 1110      00011112346788999999999999999999


Q ss_pred             HHHH
Q 041921          787 KVLQ  790 (814)
Q Consensus       787 ~vl~  790 (814)
                      ++++
T Consensus       327 ~~l~  330 (345)
T 3hko_A          327 RALQ  330 (345)
T ss_dssp             HHHH
T ss_pred             HHhc
Confidence            9986

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.2e-37  Score=339.68  Aligned_cols=245  Identities=27%  Similarity=0.293  Sum_probs=193.2

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc---cchHhHHHHHHh-hhccCCCCccceeeeecccccce
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ---DGEREFKNEVFV-IGQTHHKNLVRLLGFCDEGQNRL  594 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~  594 (814)
                      ..+.+.+.||+|+||.||+|...  ..+..||||.++....   ...+.+..|..+ ++.++||||+++++++.+.+..+
T Consensus        38 ~~y~~~~~lG~G~fg~V~~~~~~--~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~  115 (373)
T 2r5t_A           38 SDFHFLKVIGKGSFGKVLLARHK--AEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY  115 (373)
T ss_dssp             GGEEEEEEEECCTTCEEEEEEET--TTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEEc--CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence            35677899999999999999975  3578999999965432   223456677766 57789999999999999999999


Q ss_pred             EEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccC
Q 041921          595 LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN  674 (814)
Q Consensus       595 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~  674 (814)
                      +||||+++|+|.+++.....+++.....++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus       116 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~  192 (373)
T 2r5t_A          116 FVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH  192 (373)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence            9999999999999998877889999999999999999999998   9999999999999999999999999999864322


Q ss_pred             CcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCc
Q 041921          675 QSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGED  754 (814)
Q Consensus       675 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  754 (814)
                      ..  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......+       ..+.+..+.+..     
T Consensus       193 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-------~~~~i~~~~~~~-----  258 (373)
T 2r5t_A          193 NS--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-------MYDNILNKPLQL-----  258 (373)
T ss_dssp             CC--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH-------HHHHHHHSCCCC-----
T ss_pred             CC--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH-------HHHHHHhcccCC-----
Confidence            21  1245679999999999999999999999999999999999999997543322       111222221110     


Q ss_pred             ccccCcHHHHHHHHHHHHHccccCCCCCCCHHH
Q 041921          755 KEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKK  787 (814)
Q Consensus       755 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~  787 (814)
                           +......+.+++.+||+.||.+||++.+
T Consensus       259 -----~~~~~~~~~~li~~lL~~dp~~R~~~~~  286 (373)
T 2r5t_A          259 -----KPNITNSARHLLEGLLQKDRTKRLGAKD  286 (373)
T ss_dssp             -----CSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred             -----CCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence                 1123456889999999999999999853

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.7e-37  Score=340.51  Aligned_cols=268  Identities=23%  Similarity=0.278  Sum_probs=204.4

Q ss_pred             cCHHHHHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccC-----CCCccceee
Q 041921          511 FSYKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTH-----HKNLVRLLG  585 (814)
Q Consensus       511 ~~~~~l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~~  585 (814)
                      +...++....|.+.++||+|+||.||+|....  .+..||||.+... ....+.+..|+.++.+++     ||||+++++
T Consensus        27 ~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~  103 (360)
T 3llt_A           27 WKKGMLLNNAFLVIRKMGDGTFGRVLLCQHID--NKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHG  103 (360)
T ss_dssp             CCTTCEETTTEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred             eecceEecCEEEEEEEEcccCCeEEEEEEECC--CCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence            33344556677888999999999999999753  5789999999742 234456788999998886     999999999


Q ss_pred             eecccccceEEEecCCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC-------
Q 041921          586 FCDEGQNRLLVYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDD-------  656 (814)
Q Consensus       586 ~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~-------  656 (814)
                      ++...+..++||||+ +++|.+++...  ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.       
T Consensus       104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~  179 (360)
T 3llt_A          104 KFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSL  179 (360)
T ss_dssp             EEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEE
T ss_pred             eeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccc
Confidence            999999999999999 99999999765  3588999999999999999999998   9999999999999975       


Q ss_pred             ------------------CCcEEEeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh
Q 041921          657 ------------------YYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS  718 (814)
Q Consensus       657 ------------------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt  718 (814)
                                        ++.+||+|||++.......     ....||+.|+|||.+.+..++.++|||||||++|||++
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~  254 (360)
T 3llt_A          180 ITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT  254 (360)
T ss_dssp             EEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHH
T ss_pred             cchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHH
Confidence                              7899999999998654322     34568999999999999999999999999999999999


Q ss_pred             CCCCCCcccchhhhhHHH---------HHHHHhhcCccceeecCcc-----cccCcH---------------HHHHHHHH
Q 041921          719 CRKSFDIEMGEEYAILTD---------WAFDCYRNGKLNVLVGEDK-----EAMNDI---------------ECLGKLVM  769 (814)
Q Consensus       719 g~~p~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~-----~~~~~~---------------~~~~~l~~  769 (814)
                      |+.||......+......         +..................     ......               ...+.+.+
T Consensus       255 g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  334 (360)
T 3llt_A          255 GSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCD  334 (360)
T ss_dssp             SSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHH
T ss_pred             CCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHH
Confidence            999997654322111100         0000000000000000000     000000               01256789


Q ss_pred             HHHHccccCCCCCCCHHHHHH
Q 041921          770 VSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       770 l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      ++.+||+.||.+|||++|+++
T Consensus       335 li~~~L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          335 FLYSILQIDPTLRPSPAELLK  355 (360)
T ss_dssp             HHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHHhcCChhhCCCHHHHhc
Confidence            999999999999999999975

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=6.6e-37  Score=327.51  Aligned_cols=259  Identities=24%  Similarity=0.339  Sum_probs=208.6

Q ss_pred             HhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEE
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY  597 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  597 (814)
                      ...+.+.+.||+|+||.||++....  .++.||||.+........+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRL--TGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM   85 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccceeeeeccCCCCceEEEEEECC--CCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence            4567788999999999999998753  57899999997654445567899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE---cCCCcEEEeecCCccccccC
Q 041921          598 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILL---DDYYTARISDFGLAKLLTLN  674 (814)
Q Consensus       598 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll---~~~~~~kl~DfGla~~~~~~  674 (814)
                      ||+++++|.+++.....+++..+..++.|++.||.|||+.   +|+||||||+||++   +.++.+||+|||++......
T Consensus        86 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  162 (304)
T 2jam_A           86 QLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG  162 (304)
T ss_dssp             CCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred             EcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence            9999999999998777899999999999999999999998   99999999999999   78899999999998765432


Q ss_pred             CcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCc
Q 041921          675 QSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGED  754 (814)
Q Consensus       675 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  754 (814)
                      .    .....||+.|+|||.+.+..++.++||||||++++||++|+.||.......       ....+.++....     
T Consensus       163 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~i~~~~~~~-----  226 (304)
T 2jam_A          163 I----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK-------LFEKIKEGYYEF-----  226 (304)
T ss_dssp             T----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHHHHCCCCC-----
T ss_pred             c----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHcCCCCC-----
Confidence            1    133458999999999999999999999999999999999999997543321       112222222111     


Q ss_pred             ccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhcCcCC
Q 041921          755 KEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ--MLEGVVEV  798 (814)
Q Consensus       755 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~--~L~~~~~~  798 (814)
                       ...........+.+++.+||+.||.+|||++++++  .+++...+
T Consensus       227 -~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~  271 (304)
T 2jam_A          227 -ESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTAL  271 (304)
T ss_dssp             -CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSCSC
T ss_pred             -CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCCcc
Confidence             00111223467889999999999999999999986  55554433

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=9.7e-37  Score=331.88  Aligned_cols=271  Identities=23%  Similarity=0.313  Sum_probs=210.1

Q ss_pred             cCHHHHHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhc--cCCCCccceeeeec
Q 041921          511 FSYKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ--THHKNLVRLLGFCD  588 (814)
Q Consensus       511 ~~~~~l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~  588 (814)
                      +...+.....+.+.+.||+|+||.||+|..    .++.||||.+...   ..+.+..|.+++..  ++||||+++++++.
T Consensus        34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~----~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~  106 (342)
T 1b6c_B           34 LLVQRTIARTIVLQESIGKGRFGEVWRGKW----RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADN  106 (342)
T ss_dssp             HHHHHHHHHHCEEEEEEEEETTEEEEEEEE----TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred             eeecccccccEEEEeeecCCCCcEEEEEEE----cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence            334566677889999999999999999986    3789999998643   34567888888877  79999999999998


Q ss_pred             ccc----cceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhh--------hcCCCCeeecCCCCCcEEEcC
Q 041921          589 EGQ----NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLH--------EDCRAQIIHCDIKPQNILLDD  656 (814)
Q Consensus       589 ~~~----~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH--------~~~~~~i~H~dlkp~NIll~~  656 (814)
                      ...    ..++||||+++++|.+++... .+++..++.++.|++.||.|||        +.   +|+||||||+|||++.
T Consensus       107 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~  182 (342)
T 1b6c_B          107 KDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKK  182 (342)
T ss_dssp             CCCSSCCCEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECT
T ss_pred             ccCCccceeEEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECC
Confidence            776    789999999999999999754 6899999999999999999999        65   9999999999999999


Q ss_pred             CCcEEEeecCCccccccCCccc--ccccccCCCCcccccccccC------CCCcchhhHHHHHHHHHHHhC---------
Q 041921          657 YYTARISDFGLAKLLTLNQSKT--IKTAIRGTKGYVAPEWFRNS------KITAKVDVYSFGVLLLEIISC---------  719 (814)
Q Consensus       657 ~~~~kl~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~s~~~Dv~s~Gvvl~elltg---------  719 (814)
                      ++.+||+|||++..........  ......||+.|+|||.+.+.      .++.++||||||+++|||++|         
T Consensus       183 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~  262 (342)
T 1b6c_B          183 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED  262 (342)
T ss_dssp             TSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred             CCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccc
Confidence            9999999999998765433211  11345699999999999765      334789999999999999999         


Q ss_pred             -CCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 041921          720 -RKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE  797 (814)
Q Consensus       720 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~  797 (814)
                       ..||........ .... ....+........+.   ......+....+.+++.+||+.||++|||++++++.|+.+.+
T Consensus       263 ~~~p~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~  336 (342)
T 1b6c_B          263 YQLPYYDLVPSDP-SVEE-MRKVVCEQKLRPNIP---NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  336 (342)
T ss_dssp             CCCTTTTTSCSSC-CHHH-HHHHHTTSCCCCCCC---GGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cccCccccCcCcc-cHHH-HHHHHHHHHhCCCCc---ccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence             677754332111 0111 112222221111111   111234677889999999999999999999999999988654

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=5.9e-37  Score=323.38  Aligned_cols=247  Identities=26%  Similarity=0.371  Sum_probs=182.2

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhccCCCCccceeeeecccccceEE
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV  596 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  596 (814)
                      .+.+.+.||+|+||.||+|...  ..++.||||.+....   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        12 ~y~~~~~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           12 DFKVGNLLGKGSFAGVYRAESI--HTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GEEEEEEEEECSSEEEEEEEET--TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cceeeeeecCCCceEEEEEEEc--cCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            4667789999999999999864  357899999996432   22346789999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCC
Q 041921          597 YEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ  675 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~  675 (814)
                      +||+++++|.+++... ..+++..+..++.|+++||.|||+.   +|+||||||+||+++.++.+||+|||++.......
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  166 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH  166 (278)
T ss_dssp             EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred             EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence            9999999999999875 6789999999999999999999998   99999999999999999999999999998765332


Q ss_pred             cccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcc
Q 041921          676 SKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDK  755 (814)
Q Consensus       676 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  755 (814)
                      ...  ....||+.|+|||.+.+..++.++||||||++++||++|+.||.........       ..        ......
T Consensus       167 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------~~--------~~~~~~  229 (278)
T 3cok_A          167 EKH--YTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL-------NK--------VVLADY  229 (278)
T ss_dssp             ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CCSSCC
T ss_pred             Ccc--eeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH-------HH--------Hhhccc
Confidence            211  2356899999999999888999999999999999999999999754322110       00        000011


Q ss_pred             cccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          756 EAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       756 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      .  .+......+.+++.+||+.||.+|||++++++
T Consensus       230 ~--~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          230 E--MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             C--CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             C--CccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            1  11223467889999999999999999999986

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=2e-37  Score=327.92  Aligned_cols=256  Identities=25%  Similarity=0.352  Sum_probs=206.7

Q ss_pred             HHHHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecc----
Q 041921          514 KELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDE----  589 (814)
Q Consensus       514 ~~l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----  589 (814)
                      .......+.+.+.||+|+||.||+|....  +++.||||.+...    .+.+.+|++++++++||||+++++++..    
T Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   79 (284)
T 2a19_B            6 DKRFGMDFKEIELIGSGGFGQVFKAKHRI--DGKTYVIKRVKYN----NEKAEREVKALAKLDHVNIVHYNGCWDGFDYD   79 (284)
T ss_dssp             CHHHHHHEEEEEEEECSSSCCEEEEEETT--TCCEEEEEEEECC----SGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC
T ss_pred             cchhccccceeeeeccCCceEEEEEEEcC--CCeEEEEEEeccc----cHHHHHHHHHHHhCCCCCEEEEeeeEeccccC
Confidence            34556678888999999999999999753  5789999998653    2467899999999999999999998854    


Q ss_pred             ------------cccceEEEecCCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc
Q 041921          590 ------------GQNRLLVYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLD  655 (814)
Q Consensus       590 ------------~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~  655 (814)
                                  ....++||||+++++|.+++...  ..+++..+..++.|++.||.|||+.   +|+|+||||+||+++
T Consensus        80 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~  156 (284)
T 2a19_B           80 PETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLV  156 (284)
T ss_dssp             ---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEE
T ss_pred             cccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEc
Confidence                        44578999999999999999653  5789999999999999999999998   999999999999999


Q ss_pred             CCCcEEEeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHH
Q 041921          656 DYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILT  735 (814)
Q Consensus       656 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~  735 (814)
                      .++.+||+|||++.........   ....||+.|+|||.+.+..++.++||||||++++||++|..|+...         
T Consensus       157 ~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---------  224 (284)
T 2a19_B          157 DTKQVKIGDFGLVTSLKNDGKR---TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET---------  224 (284)
T ss_dssp             ETTEEEECCCTTCEESSCCSCC---CCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH---------
T ss_pred             CCCCEEECcchhheeccccccc---cccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH---------
Confidence            9999999999999876543321   3346899999999999999999999999999999999999886311         


Q ss_pred             HHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCCCCC
Q 041921          736 DWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVPP  802 (814)
Q Consensus       736 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~~~~p~  802 (814)
                      ......+..+.+.            ......+.+++.+||+.||.+|||+.++++.|+.+..-+...
T Consensus       225 ~~~~~~~~~~~~~------------~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~  279 (284)
T 2a19_B          225 SKFFTDLRDGIIS------------DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKN  279 (284)
T ss_dssp             HHHHHHHHTTCCC------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-----
T ss_pred             HHHHHHhhccccc------------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCcc
Confidence            0011222222211            112356788999999999999999999999998876554433

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.7e-37  Score=327.57  Aligned_cols=250  Identities=27%  Similarity=0.386  Sum_probs=198.2

Q ss_pred             HhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeeccc-ccceEE
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEG-QNRLLV  596 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv  596 (814)
                      ...+.+.+.||+|+||.||++...    +..||||.++..  ...+.+.+|+.++++++||||+++++++.+. +..++|
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv   93 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR----GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV   93 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET----TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred             hhhceEEeEEecCCCceEEEEEEc----CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEE
Confidence            356677899999999999999863    678999999753  3456799999999999999999999987554 578999


Q ss_pred             EecCCCCCHHHHhcCCC--CCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccC
Q 041921          597 YEFLNNGTLASFLFGNL--KPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN  674 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~  674 (814)
                      |||+++++|.+++....  .+++..+..++.|+++||.|||+.   +|+||||||+||+++.++.+||+|||++......
T Consensus        94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  170 (278)
T 1byg_A           94 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  170 (278)
T ss_dssp             ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             EecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence            99999999999997653  378899999999999999999998   9999999999999999999999999998765432


Q ss_pred             CcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeecC
Q 041921          675 QSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGE  753 (814)
Q Consensus       675 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  753 (814)
                      .     ....++..|+|||.+.+..++.++||||||++++||++ |+.||......+.       ...+..+..      
T Consensus       171 ~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~-------~~~~~~~~~------  232 (278)
T 1byg_A          171 Q-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-------VPRVEKGYK------  232 (278)
T ss_dssp             ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH-------HHHHTTTCC------
T ss_pred             c-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHhcCCC------
Confidence            2     22347889999999998899999999999999999998 9999975433221       111222211      


Q ss_pred             cccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 041921          754 DKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE  797 (814)
Q Consensus       754 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~  797 (814)
                         .......+..+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       233 ---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~  273 (278)
T 1byg_A          233 ---MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  273 (278)
T ss_dssp             ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence               01122345678899999999999999999999999987643

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=8.5e-37  Score=323.00  Aligned_cols=252  Identities=25%  Similarity=0.331  Sum_probs=203.4

Q ss_pred             HhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc------cchHhHHHHHHhhhccCCCCccceeeeecccc
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ------DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ  591 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  591 (814)
                      ...+.+.+.||+|+||.||++....  .+..||||.+.....      ...+++.+|+.++++++||||+++++++.+.+
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   81 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKG--TGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKT   81 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcC--CCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCC
Confidence            4567888999999999999999753  577999999864321      13567999999999999999999999999999


Q ss_pred             cceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC----cEEEeecCC
Q 041921          592 NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYY----TARISDFGL  667 (814)
Q Consensus       592 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~----~~kl~DfGl  667 (814)
                      ..++||||+++++|.+++.....+++..+..++.|++.||.|||+.   +|+||||||+||+++.++    .+||+|||+
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~  158 (283)
T 3bhy_A           82 DVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGI  158 (283)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             eEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence            9999999999999999998777899999999999999999999998   999999999999998776    899999999


Q ss_pred             ccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCcc
Q 041921          668 AKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL  747 (814)
Q Consensus       668 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  747 (814)
                      +.........   ....|++.|+|||.+.+..++.++||||||++++||++|+.||......+.       ...+.....
T Consensus       159 ~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~~~~  228 (283)
T 3bhy_A          159 AHKIEAGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQET-------LTNISAVNY  228 (283)
T ss_dssp             CEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHHHHTTCC
T ss_pred             ceeccCCCcc---cccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHH-------HHHhHhccc
Confidence            9876543221   334689999999999999999999999999999999999999975433221       111111111


Q ss_pred             ceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          748 NVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       748 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      ..      ...........+.+++.+||+.||.+|||+.++++
T Consensus       229 ~~------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          229 DF------DEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             CC------CHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CC------cchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence            10      00001123467889999999999999999999986

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=4e-37  Score=338.13  Aligned_cols=255  Identities=18%  Similarity=0.158  Sum_probs=204.3

Q ss_pred             HHhhhccccceeeeeeeeEEEEEEe---cCCCceEEEEEEeccccccchHhHHHHHHhhhccC---CCCccceeeeeccc
Q 041921          517 EGATNNFKEEVGRGSFGIVYKGVIQ---TRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTH---HKNLVRLLGFCDEG  590 (814)
Q Consensus       517 ~~~~~~~~~~LG~G~~g~Vy~~~~~---~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~  590 (814)
                      ....+.+.++||+|+||.||+|...   ....++.||||.++..   ...++..|+.++.+++   |+||+++++++...
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~  139 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ  139 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence            3456677889999999999999532   1235789999999753   4556778888877776   99999999999999


Q ss_pred             ccceEEEecCCCCCHHHHhcC-----CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC---------
Q 041921          591 QNRLLVYEFLNNGTLASFLFG-----NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDD---------  656 (814)
Q Consensus       591 ~~~~lv~e~~~~gsL~~~l~~-----~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~---------  656 (814)
                      +..+|||||+++|+|.+++..     ...+++..+..|+.||++||+|||+.   +|+||||||+||||+.         
T Consensus       140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~  216 (365)
T 3e7e_A          140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDED  216 (365)
T ss_dssp             SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC----
T ss_pred             CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccccc
Confidence            999999999999999999973     46789999999999999999999998   9999999999999998         


Q ss_pred             --CCcEEEeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhH
Q 041921          657 --YYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL  734 (814)
Q Consensus       657 --~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~  734 (814)
                        ++.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||.......    
T Consensus       217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~----  292 (365)
T 3e7e_A          217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE----  292 (365)
T ss_dssp             --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE----
T ss_pred             cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc----
Confidence              89999999999986653333333355679999999999999999999999999999999999999985332211    


Q ss_pred             HHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCC-CCHHHHHHHHhcCcCC
Q 041921          735 TDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLR-PTMKKVLQMLEGVVEV  798 (814)
Q Consensus       735 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~R-Pt~~~vl~~L~~~~~~  798 (814)
                                    ..........   ...+.+.+++..|++.+|.+| |++.++.+.|+++.+-
T Consensus       293 --------------~~~~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~  340 (365)
T 3e7e_A          293 --------------CKPEGLFRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ  340 (365)
T ss_dssp             --------------EEECSCCTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             --------------eeechhcccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence                          0011111111   124566788889999999998 6888888888775543

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2.4e-37  Score=336.94  Aligned_cols=246  Identities=24%  Similarity=0.315  Sum_probs=198.7

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc---cchHhHHHHHHhhhccCCCCccceeeeecccccceE
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ---DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL  595 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  595 (814)
                      ..+...+.||+|+||.||+|...  .++..||||++.....   ...+++.+|+.++++++||||+++++++.+++..++
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  131 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDV--RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL  131 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEET--TTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEc--cCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEE
Confidence            44666789999999999999864  3678999999964322   223568999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhc-CCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccC
Q 041921          596 VYEFLNNGTLASFLF-GNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN  674 (814)
Q Consensus       596 v~e~~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~  674 (814)
                      ||||+. |+|.+++. ....+++..+..++.|+++||.|||+.   +|+||||||+|||++.++.+||+|||++......
T Consensus       132 v~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~  207 (348)
T 1u5q_A          132 VMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  207 (348)
T ss_dssp             EEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred             EEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence            999997 68888775 356789999999999999999999998   9999999999999999999999999999866432


Q ss_pred             CcccccccccCCCCcccccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceee
Q 041921          675 QSKTIKTAIRGTKGYVAPEWFR---NSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLV  751 (814)
Q Consensus       675 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  751 (814)
                            ....||+.|+|||.+.   ...++.++||||||++++||++|+.||........      ......... ... 
T Consensus       208 ------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~------~~~~~~~~~-~~~-  273 (348)
T 1u5q_A          208 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQNES-PAL-  273 (348)
T ss_dssp             ------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHSCC-CCC-
T ss_pred             ------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHHhcCC-CCC-
Confidence                  2346899999999984   56789999999999999999999999965432211      111111111 110 


Q ss_pred             cCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          752 GEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       752 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                             ........+.+++.+||+.||.+|||++++++.
T Consensus       274 -------~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          274 -------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             -------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             -------CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence                   111234668899999999999999999999853

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=9.9e-37  Score=324.65  Aligned_cols=264  Identities=18%  Similarity=0.202  Sum_probs=205.3

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeee-cccccceEEE
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFC-DEGQNRLLVY  597 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~  597 (814)
                      ..+.+.+.||+|+||.||+|...  ..++.||||.+....  ..+++.+|+.++.+++|++++..+.++ .+.+..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 3uzp_A            9 NRYRLGRKIGSGSFGDIYLGTDI--AAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEET--TTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cEEEEEEEEccCCCeEEEEEEEc--CCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence            35667889999999999999964  367899999986532  345789999999999998877776665 5566779999


Q ss_pred             ecCCCCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE---cCCCcEEEeecCCcccccc
Q 041921          598 EFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILL---DDYYTARISDFGLAKLLTL  673 (814)
Q Consensus       598 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll---~~~~~~kl~DfGla~~~~~  673 (814)
                      ||+ +++|.+++.. ...+++..+..++.|++.||+|||+.   +|+||||||+|||+   +.++.+||+|||++.....
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  160 (296)
T 3uzp_A           85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             Eec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence            999 9999999973 46789999999999999999999998   99999999999999   4888999999999987664


Q ss_pred             CCccc-----ccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccc
Q 041921          674 NQSKT-----IKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLN  748 (814)
Q Consensus       674 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  748 (814)
                      .....     ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..............+..........
T Consensus       161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  240 (296)
T 3uzp_A          161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE  240 (296)
T ss_dssp             TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred             cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchH
Confidence            43211     1134569999999999999999999999999999999999999997543221111111111100000000


Q ss_pred             eeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCC
Q 041921          749 VLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS  799 (814)
Q Consensus       749 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~~~  799 (814)
                      .         .....+..+.+++.+||+.||.+|||++++++.|+.+..-.
T Consensus       241 ~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  282 (296)
T 3uzp_A          241 V---------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  282 (296)
T ss_dssp             H---------HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             H---------HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence            0         01123467889999999999999999999999998865443

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=5.7e-37  Score=336.28  Aligned_cols=267  Identities=20%  Similarity=0.316  Sum_probs=204.9

Q ss_pred             HHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccceeeeecccccce
Q 041921          516 LEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRL  594 (814)
Q Consensus       516 l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  594 (814)
                      +....+.+.++||+|+||.||++...  ..+..||+|.+.... ....+.+.+|+.++++++||||+++++++.+++..+
T Consensus        30 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  107 (360)
T 3eqc_A           30 LKDDDFEKISELGAGNGGVVFKVSHK--PSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS  107 (360)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEET--TTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEE
T ss_pred             cccccceeeeeecCCCCeEEEEEEEC--CCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEE
Confidence            34456777889999999999999975  357899999987542 233467899999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccC
Q 041921          595 LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN  674 (814)
Q Consensus       595 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~  674 (814)
                      +||||+++++|.+++.....+++..+..++.|++.||.|||+.  .+|+||||||+|||++.++.+||+|||++......
T Consensus       108 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  185 (360)
T 3eqc_A          108 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  185 (360)
T ss_dssp             EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred             EEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence            9999999999999998877899999999999999999999983  17999999999999999999999999999765432


Q ss_pred             CcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHH---------HHHhhcC
Q 041921          675 QSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA---------FDCYRNG  745 (814)
Q Consensus       675 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~---------~~~~~~~  745 (814)
                      .    .....||+.|+|||.+.+..++.++||||||++++||++|+.||......+........         ......+
T Consensus       186 ~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (360)
T 3eqc_A          186 M----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  261 (360)
T ss_dssp             C--------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred             c----ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence            1    13456899999999999999999999999999999999999999754432211100000         0000000


Q ss_pred             --------------cc----ceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          746 --------------KL----NVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       746 --------------~~----~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                                    ..    ..+................+.+++.+||+.||.+|||++++++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             ------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                          00    0000000000011123457889999999999999999999985

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=3.2e-37  Score=333.79  Aligned_cols=261  Identities=20%  Similarity=0.300  Sum_probs=194.4

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc--cchHhHHHHHHhhhccCCCCccceeeeecccccceEE
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ--DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV  596 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  596 (814)
                      ..|.+.++||+|+||+||+|...  ..+..||||+++....  ...+.+.+|+.++++++||||+++++++.+++..++|
T Consensus        34 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  111 (329)
T 3gbz_A           34 DRYRRITKLGEGTYGEVYKAIDT--VTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI  111 (329)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEET--TTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhEEEEEEEEecCCeEEEEEEEC--CCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence            45777899999999999999865  3678999999964322  2245688999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc-----CCCcEEEeecCCcccc
Q 041921          597 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLD-----DYYTARISDFGLAKLL  671 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~-----~~~~~kl~DfGla~~~  671 (814)
                      |||++ ++|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+|||++     .++.+||+|||+++..
T Consensus       112 ~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~  187 (329)
T 3gbz_A          112 FEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF  187 (329)
T ss_dssp             EECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred             EecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence            99998 59999998888899999999999999999999998   999999999999994     5556999999999876


Q ss_pred             ccCCcccccccccCCCCcccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCc---c
Q 041921          672 TLNQSKTIKTAIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK---L  747 (814)
Q Consensus       672 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~  747 (814)
                      ......  .....||..|+|||.+.+. .++.++|||||||+++||++|+.||......+..  .. +........   .
T Consensus       188 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--~~-~~~~~~~~~~~~~  262 (329)
T 3gbz_A          188 GIPIRQ--FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQL--FK-IFEVLGLPDDTTW  262 (329)
T ss_dssp             C-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HH-HHHHHCCCCTTTS
T ss_pred             CCcccc--cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHH--HH-HHHHhCCCchhhh
Confidence            533221  1345689999999999875 4899999999999999999999999755432211  11 111110000   0


Q ss_pred             -------------ceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          748 -------------NVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       748 -------------~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                                   ..................++.+++.+||+.||.+|||++|+++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             TTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence                         0000000000001113467889999999999999999999986

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=8.5e-37  Score=324.32  Aligned_cols=246  Identities=28%  Similarity=0.425  Sum_probs=198.0

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeecc----cccce
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDE----GQNRL  594 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~  594 (814)
                      +.+.++||+|+||.||+|...  ..+..||+|.+....  ....+.+.+|+.++++++||||+++++++..    ....+
T Consensus        28 ~~~~~~lg~G~~g~Vy~~~~~--~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           28 LKFDIEIGRGSFKTVYKGLDT--ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEET--TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             EEeeeeccCCCCeEEEEeEec--CCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            556778999999999999865  357789999986432  3334578999999999999999999998865    45689


Q ss_pred             EEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCC--eeecCCCCCcEEEc-CCCcEEEeecCCcccc
Q 041921          595 LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ--IIHCDIKPQNILLD-DYYTARISDFGLAKLL  671 (814)
Q Consensus       595 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~--i~H~dlkp~NIll~-~~~~~kl~DfGla~~~  671 (814)
                      +||||+++++|.+++.....+++..+..++.|++.||.|||+.   +  |+||||||+|||++ .++.+||+|||++...
T Consensus       106 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~  182 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence            9999999999999998878899999999999999999999998   7  99999999999998 7899999999999765


Q ss_pred             ccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceee
Q 041921          672 TLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLV  751 (814)
Q Consensus       672 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  751 (814)
                      .....    ....||+.|+|||.+.+ .++.++||||||++++||++|+.||........      ....+..+..... 
T Consensus       183 ~~~~~----~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~------~~~~~~~~~~~~~-  250 (290)
T 1t4h_A          183 RASFA----KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ------IYRRVTSGVKPAS-  250 (290)
T ss_dssp             CTTSB----EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH------HHHHHTTTCCCGG-
T ss_pred             ccccc----ccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH------HHHHHhccCCccc-
Confidence            43321    34568999999998874 589999999999999999999999975433221      1122222211110 


Q ss_pred             cCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          752 GEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       752 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                             ........+.+++.+||+.||.+|||++++++
T Consensus       251 -------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          251 -------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             -------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -------cCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                   11112356889999999999999999999986

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=7.1e-37  Score=325.71  Aligned_cols=263  Identities=19%  Similarity=0.216  Sum_probs=203.1

Q ss_pred             HhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeee-cccccceEE
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFC-DEGQNRLLV  596 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv  596 (814)
                      ...|.+.+.||+|+||.||+|...  ..+..||||.+...  ...+++..|+.++.+++|++++..+..+ .+.+..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~--~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDI--AAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEET--TTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred             CCceEEeeeecCCCCeEEEEEEEc--CCCceEEEEeeccc--ccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence            356778899999999999999865  36789999987543  2334689999999999988877777766 556677999


Q ss_pred             EecCCCCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE---cCCCcEEEeecCCccccc
Q 041921          597 YEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILL---DDYYTARISDFGLAKLLT  672 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll---~~~~~~kl~DfGla~~~~  672 (814)
                      |||+ +++|.+++.. ...+++..+..++.||+.||.|||+.   +|+||||||+|||+   +.++.+||+|||+++...
T Consensus        84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~  159 (296)
T 4hgt_A           84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             EECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             EEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence            9999 9999999974 46789999999999999999999998   99999999999999   788999999999998765


Q ss_pred             cCCccc-----ccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCcc
Q 041921          673 LNQSKT-----IKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL  747 (814)
Q Consensus       673 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  747 (814)
                      ......     ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..............+.........
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  239 (296)
T 4hgt_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  239 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred             CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh
Confidence            443211     113456899999999999999999999999999999999999999754332211111111110000000


Q ss_pred             ceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 041921          748 NVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE  797 (814)
Q Consensus       748 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~  797 (814)
                      ..         .....+..+.+++.+||+.||++|||++++++.|+++.+
T Consensus       240 ~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~  280 (296)
T 4hgt_A          240 EV---------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  280 (296)
T ss_dssp             HH---------HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred             hh---------hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence            00         001124678899999999999999999999999988654

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=5e-37  Score=333.35  Aligned_cols=270  Identities=25%  Similarity=0.369  Sum_probs=197.2

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHH--HHHhhhccCCCCccceeeeec-----ccc
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKN--EVFVIGQTHHKNLVRLLGFCD-----EGQ  591 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~--E~~~l~~l~h~niv~l~~~~~-----~~~  591 (814)
                      ..+.+.+.||+|+||.||+|..    .+..||||.+...   ....+..  |+..+..++||||+++++.+.     ...
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~----~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~   85 (336)
T 3g2f_A           13 DNLKLLELIGRGRYGAVYKGSL----DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM   85 (336)
T ss_dssp             TSEEEEEEEEECSSEEEEEEEE----TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred             HHhheeeecccCCCeEEEEEEE----CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence            4567788999999999999976    4689999998643   2233444  444455689999999998543     334


Q ss_pred             cceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcC------CCCeeecCCCCCcEEEcCCCcEEEeec
Q 041921          592 NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDC------RAQIIHCDIKPQNILLDDYYTARISDF  665 (814)
Q Consensus       592 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~------~~~i~H~dlkp~NIll~~~~~~kl~Df  665 (814)
                      ..++||||+++|+|.+++.... .++..+..++.||++||.|||+..      ..+|+||||||+|||++.++.+||+||
T Consensus        86 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DF  164 (336)
T 3g2f_A           86 EYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDF  164 (336)
T ss_dssp             EEEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCC
T ss_pred             eEEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeec
Confidence            5689999999999999996553 488999999999999999999862      238999999999999999999999999


Q ss_pred             CCccccccCCc------ccccccccCCCCccccccccc-------CCCCcchhhHHHHHHHHHHHhCCCCCCcccchh-h
Q 041921          666 GLAKLLTLNQS------KTIKTAIRGTKGYVAPEWFRN-------SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-Y  731 (814)
Q Consensus       666 Gla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~-~  731 (814)
                      |+++.+.....      ........||+.|+|||.+.+       ..++.++||||||+++|||++|+.|+....... .
T Consensus       165 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~  244 (336)
T 3g2f_A          165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY  244 (336)
T ss_dssp             TTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCC
T ss_pred             cceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHH
Confidence            99987654321      111134569999999999976       456779999999999999999987764322211 0


Q ss_pred             hh-H---------HHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 041921          732 AI-L---------TDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV  798 (814)
Q Consensus       732 ~~-~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~~  798 (814)
                      .. .         ................+.  ............+.+++.+||+.||++|||++|+++.|+++++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~  319 (336)
T 3g2f_A          245 QMAFQTEVGNHPTFEDMQVLVSREKQRPKFP--EAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI  319 (336)
T ss_dssp             CCTTHHHHCSSCCHHHHHHHHTTSCCCCCCC--TTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHhhhcccCCCchHHHHHhhhcccccCCCCC--cccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence            00 0         000111111111111111  11122345677899999999999999999999999999987654

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.4e-37  Score=338.88  Aligned_cols=253  Identities=20%  Similarity=0.196  Sum_probs=200.3

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhccCCCCccceeeeecccccceE
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL  595 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  595 (814)
                      ..+.+.+.||+|+||.||++....  .++.||||++++..   ....+.+.+|..++.+++||||+++++++.+.+..+|
T Consensus        61 ~~f~~~~~lG~G~fG~V~~~~~~~--~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l  138 (412)
T 2vd5_A           61 DDFEILKVIGRGAFSEVAVVKMKQ--TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYL  138 (412)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT--TCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred             hhEEEEEEEeeCCCeEEEEEEECC--CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence            345566889999999999999753  57899999996532   2233458999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccC
Q 041921          596 VYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN  674 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~  674 (814)
                      ||||+++|+|.+++... ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus       139 VmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~  215 (412)
T 2vd5_A          139 VMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD  215 (412)
T ss_dssp             EECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhheeccCC
Confidence            99999999999999764 4789999999999999999999998   9999999999999999999999999999876543


Q ss_pred             CcccccccccCCCCcccccccc-------cCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCcc
Q 041921          675 QSKTIKTAIRGTKGYVAPEWFR-------NSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL  747 (814)
Q Consensus       675 ~~~~~~~~~~gt~~y~aPE~~~-------~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  747 (814)
                      .... ....+||+.|+|||++.       ...++.++|||||||++|||++|+.||......+..       ..+.....
T Consensus       216 ~~~~-~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~-------~~i~~~~~  287 (412)
T 2vd5_A          216 GTVR-SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETY-------GKIVHYKE  287 (412)
T ss_dssp             SCEE-CSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-------HHHHTHHH
T ss_pred             Cccc-cceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHH-------HHHHhccc
Confidence            3221 13457999999999997       457899999999999999999999999765432211       11111000


Q ss_pred             ceeecCcccccCcHHHHHHHHHHHHHccccCCCCC---CCHHHHHH
Q 041921          748 NVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLR---PTMKKVLQ  790 (814)
Q Consensus       748 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~R---Pt~~~vl~  790 (814)
                      . +..+..    ......++.+++.+||+ +|.+|   |+++|+++
T Consensus       288 ~-~~~p~~----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          288 H-LSLPLV----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             H-CCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             C-cCCCcc----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence            0 000000    11234678899999999 99998   68999875

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=9.1e-37  Score=324.76  Aligned_cols=248  Identities=21%  Similarity=0.323  Sum_probs=205.5

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhccCCCCccceeeeecccccceE
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL  595 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  595 (814)
                      ..|.+.+.||+|+||.||++....  .+..+|+|.+....   ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~--~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   92 (294)
T 2rku_A           15 RRYVRGRFLGKGGFAKCFEISDAD--TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV   92 (294)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECC--CCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence            456678899999999999998753  56789999986532   2234568899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCC
Q 041921          596 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ  675 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~  675 (814)
                      ||||+++++|.+++.....+++..+..++.|+++||.|||+.   +|+||||||+||+++.++.+||+|||++.......
T Consensus        93 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  169 (294)
T 2rku_A           93 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  169 (294)
T ss_dssp             EEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence            999999999999998778899999999999999999999998   99999999999999999999999999998765332


Q ss_pred             cccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcc
Q 041921          676 SKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDK  755 (814)
Q Consensus       676 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  755 (814)
                      ..  .....||+.|+|||.+.+..++.++||||||++++||++|+.||......+.       ...+..+...       
T Consensus       170 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-------~~~~~~~~~~-------  233 (294)
T 2rku_A          170 ER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET-------YLRIKKNEYS-------  233 (294)
T ss_dssp             CC--BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHHHHTTCCC-------
T ss_pred             cc--cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHhhccCC-------
Confidence            21  1345689999999999988899999999999999999999999975433221       1111222111       


Q ss_pred             cccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          756 EAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       756 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                         .+......+.+++.+||+.||++|||++++++
T Consensus       234 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          234 ---IPKHINPVAASLIQKMLQTDPTARPTINELLN  265 (294)
T ss_dssp             ---CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ---CccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence               01123356888999999999999999999986

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.3e-37  Score=337.78  Aligned_cols=257  Identities=22%  Similarity=0.285  Sum_probs=188.5

Q ss_pred             HHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccC-CCCccceeeee--------
Q 041921          517 EGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTH-HKNLVRLLGFC--------  587 (814)
Q Consensus       517 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~--------  587 (814)
                      ....+.+.++||+|+||.||+|....  .+..||||++........+.+.+|+.++.++. ||||+++++++        
T Consensus        26 ~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~  103 (337)
T 3ll6_A           26 GELRLRVRRVLAEGGFAFVYEAQDVG--SGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD  103 (337)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEEETT--TCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred             cCceEEEEEEEccCCceEEEEEEECC--CCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence            34467788999999999999999753  57899999986655555677999999999996 99999999998        


Q ss_pred             cccccceEEEecCCCCCHHHHhcC---CCCCChhhHHHHHHHHHHHHHHhhhcCCCC--eeecCCCCCcEEEcCCCcEEE
Q 041921          588 DEGQNRLLVYEFLNNGTLASFLFG---NLKPNWNLRTNIAFQIARGLLYLHEDCRAQ--IIHCDIKPQNILLDDYYTARI  662 (814)
Q Consensus       588 ~~~~~~~lv~e~~~~gsL~~~l~~---~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~--i~H~dlkp~NIll~~~~~~kl  662 (814)
                      ......++|+||+. |+|.+++..   ...+++..++.++.||+.||.|||+.   +  |+||||||+|||++.++.+||
T Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl  179 (337)
T 3ll6_A          104 TGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKL  179 (337)
T ss_dssp             TSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEB
T ss_pred             cCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEE
Confidence            33445789999996 799998864   46689999999999999999999998   7  999999999999999999999


Q ss_pred             eecCCccccccCCccc----------ccccccCCCCccccccc---ccCCCCcchhhHHHHHHHHHHHhCCCCCCcccch
Q 041921          663 SDFGLAKLLTLNQSKT----------IKTAIRGTKGYVAPEWF---RNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGE  729 (814)
Q Consensus       663 ~DfGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~  729 (814)
                      +|||++..........          ......||+.|+|||.+   .+..++.++||||||+++|||++|+.||......
T Consensus       180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~  259 (337)
T 3ll6_A          180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL  259 (337)
T ss_dssp             CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred             ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence            9999998765432211          01134589999999998   5667899999999999999999999999643211


Q ss_pred             hhhhHHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 041921          730 EYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV  798 (814)
Q Consensus       730 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~~  798 (814)
                      .           +..+...        ..........+.+++.+||+.||.+|||++++++.|+.+...
T Consensus       260 ~-----------~~~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~  309 (337)
T 3ll6_A          260 R-----------IVNGKYS--------IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA  309 (337)
T ss_dssp             -----------------CC--------CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             H-----------hhcCccc--------CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            1           0001110        001111224477899999999999999999999999886554

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.8e-37  Score=336.53  Aligned_cols=266  Identities=16%  Similarity=0.167  Sum_probs=205.5

Q ss_pred             HhhhccccceeeeeeeeEEEEEEecCC------CceEEEEEEeccccccchHhHHHHHHhhhccCCCCccc---------
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQTRT------STTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVR---------  582 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~---------  582 (814)
                      ...|.+.+.||+|+||.||+|......      .+..||||.+...     +.+.+|+.++++++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            356778899999999999999976421      3678999998643     46889999999999999988         


Q ss_pred             ------eeeeecc-cccceEEEecCCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEE
Q 041921          583 ------LLGFCDE-GQNRLLVYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNIL  653 (814)
Q Consensus       583 ------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIl  653 (814)
                            +++++.. +...++||||+ +++|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl  191 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIF  191 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEE
Confidence                  5666655 67789999999 99999999875  7799999999999999999999998   9999999999999


Q ss_pred             EcCCC--cEEEeecCCccccccCCcc-----cccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 041921          654 LDDYY--TARISDFGLAKLLTLNQSK-----TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIE  726 (814)
Q Consensus       654 l~~~~--~~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~  726 (814)
                      ++.++  .+||+|||+++.+......     .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  271 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC  271 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence            99998  9999999999876543221     1113346999999999999999999999999999999999999999765


Q ss_pred             cchhhhhHHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 041921          727 MGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV  798 (814)
Q Consensus       727 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~~  798 (814)
                      ...... +... ...+... ...+......   ....+..+.+++.+||+.||.+|||+++++++|+++.+-
T Consensus       272 ~~~~~~-~~~~-~~~~~~~-~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  337 (352)
T 2jii_A          272 LPNTED-IMKQ-KQKFVDK-PGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQD  337 (352)
T ss_dssp             TTCHHH-HHHH-HHHHHHS-CCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             CcCHHH-HHHH-HHhccCC-hhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHh
Confidence            422211 1111 1111111 1111111110   112246788999999999999999999999999886543

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=8e-37  Score=341.57  Aligned_cols=255  Identities=25%  Similarity=0.354  Sum_probs=195.5

Q ss_pred             HHHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--------ccchHhHHHHHHhhhccCCCCccceeee
Q 041921          515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--------QDGEREFKNEVFVIGQTHHKNLVRLLGF  586 (814)
Q Consensus       515 ~l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~  586 (814)
                      +.....|.+.+.||+|+||.||+|....  .+..||||.+....        ......+.+|+.++++++||||++++++
T Consensus       131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  208 (419)
T 3i6u_A          131 KALRDEYIMSKTLGSGACGEVKLAFERK--TCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF  208 (419)
T ss_dssp             HHHHTTEEEEEEEEECSSSEEEEEEETT--TCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEE
T ss_pred             hhhhccEEEEeEEeeCCCeEEEEEEECC--CCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            3445678888999999999999999753  57899999986431        1122358899999999999999999999


Q ss_pred             ecccccceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC---CcEEEe
Q 041921          587 CDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDY---YTARIS  663 (814)
Q Consensus       587 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~---~~~kl~  663 (814)
                      +.. +..++||||+++++|.+++.....+++..+..++.|++.||+|||+.   +|+||||||+|||++.+   ..+||+
T Consensus       209 ~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~  284 (419)
T 3i6u_A          209 FDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT  284 (419)
T ss_dssp             EES-SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred             Eec-CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEe
Confidence            854 45799999999999999999888899999999999999999999998   99999999999999754   459999


Q ss_pred             ecCCccccccCCcccccccccCCCCccccccccc---CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHH
Q 041921          664 DFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRN---SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD  740 (814)
Q Consensus       664 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  740 (814)
                      |||+++.......   .....||+.|+|||.+..   ..++.++||||||+++|||++|+.||........  +    ..
T Consensus       285 DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~----~~  355 (419)
T 3i6u_A          285 DFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--L----KD  355 (419)
T ss_dssp             CSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--H----HH
T ss_pred             ecccceecCCCcc---ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--H----HH
Confidence            9999987653321   134569999999999853   5678899999999999999999999975433211  1    11


Q ss_pred             HhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          741 CYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       741 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      .+..+.......      ........+.+++.+||+.||.+|||++++++
T Consensus       356 ~i~~~~~~~~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          356 QITSGKYNFIPE------VWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             HHHTTCCCCCHH------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHhcCCCCCCch------hhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            122222111100      00123467889999999999999999999986

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2.4e-37  Score=328.51  Aligned_cols=262  Identities=25%  Similarity=0.340  Sum_probs=199.9

Q ss_pred             HhhhccccceeeeeeeeEEEEEEecC-CCceEEEEEEecccc---ccchHhHHHHHHhhhccCCCCccceeeeecccccc
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQTR-TSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNR  593 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  593 (814)
                      ...+.+.+.||+|+||.||+|.+... +....||||.++...   ....+.+.+|+.++++++||||+++++++.+.. .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            34677889999999999999987533 234579999986532   234567899999999999999999999998754 8


Q ss_pred             eEEEecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccc
Q 041921          594 LLVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLT  672 (814)
Q Consensus       594 ~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~  672 (814)
                      ++|+||+++++|.+++... ..+++..+..++.|+++||.|||+.   +|+|+||||+||+++.++.+||+|||++....
T Consensus        96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  172 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALP  172 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccccccc
Confidence            8999999999999999764 5688999999999999999999998   99999999999999999999999999998765


Q ss_pred             cCCccc-ccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCcccee
Q 041921          673 LNQSKT-IKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVL  750 (814)
Q Consensus       673 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  750 (814)
                      ...... ......+|..|+|||.+.+..++.++||||||++++||++ |+.||......+.      . ..+......  
T Consensus       173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~------~-~~~~~~~~~--  243 (291)
T 1u46_A          173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI------L-HKIDKEGER--  243 (291)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH------H-HHHHTSCCC--
T ss_pred             ccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHH------H-HHHHccCCC--
Confidence            433221 1133457889999999998889999999999999999999 9999975433221      1 111111110  


Q ss_pred             ecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 041921          751 VGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV  798 (814)
Q Consensus       751 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~~  798 (814)
                            .......+..+.+++.+||+.||.+|||+.++++.|+++...
T Consensus       244 ------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  285 (291)
T 1u46_A          244 ------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT  285 (291)
T ss_dssp             ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             ------CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence                  011223456788999999999999999999999999876543

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=8.7e-37  Score=331.27  Aligned_cols=248  Identities=21%  Similarity=0.323  Sum_probs=205.2

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhccCCCCccceeeeecccccceE
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL  595 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  595 (814)
                      ..|.+.+.||+|+||.||++....  .+..+|+|.+....   ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        41 ~~y~~~~~lg~G~~g~Vy~~~~~~--~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  118 (335)
T 2owb_A           41 RRYVRGRFLGKGGFAKCFEISDAD--TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV  118 (335)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEECC--CCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence            456677899999999999998753  56789999986532   2234568999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCC
Q 041921          596 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ  675 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~  675 (814)
                      ||||+++++|.+++.....+++..+..++.||++||.|||+.   +|+||||||+|||++.++.+||+|||++.......
T Consensus       119 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  195 (335)
T 2owb_A          119 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  195 (335)
T ss_dssp             EECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence            999999999999998878899999999999999999999998   99999999999999999999999999998765332


Q ss_pred             cccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcc
Q 041921          676 SKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDK  755 (814)
Q Consensus       676 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  755 (814)
                      ..  .....||..|+|||.+.+..++.++||||||+++|||++|+.||......+.       ...+..+...       
T Consensus       196 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-------~~~~~~~~~~-------  259 (335)
T 2owb_A          196 ER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET-------YLRIKKNEYS-------  259 (335)
T ss_dssp             CC--BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHHHHHTCCC-------
T ss_pred             cc--ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH-------HHHHhcCCCC-------
Confidence            21  1345689999999999998999999999999999999999999975433221       1111111111       


Q ss_pred             cccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          756 EAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       756 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                         .+......+.+++.+||+.||.+|||++++++
T Consensus       260 ---~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          260 ---IPKHINPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             ---CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ---CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               01122356788999999999999999999986

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=3.5e-37  Score=333.85  Aligned_cols=265  Identities=25%  Similarity=0.354  Sum_probs=200.4

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccccc--chHhHHHHHHhhhccCCCCccceeeeecccccceEE
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD--GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV  596 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  596 (814)
                      ..|.+.+.||+|+||.||+|....  .+..||||++......  ..+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  102 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKD--TGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV  102 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETT--TCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECC--CCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence            356677899999999999999753  5789999998643322  234588999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCc
Q 041921          597 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS  676 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  676 (814)
                      |||+++++|.+++.....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.......
T Consensus       103 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  179 (331)
T 4aaa_A          103 FEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE  179 (331)
T ss_dssp             EECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred             EecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence            99999999999988888899999999999999999999998   999999999999999999999999999986654322


Q ss_pred             ccccccccCCCCcccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHH--------HHHHHhhcC--
Q 041921          677 KTIKTAIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD--------WAFDCYRNG--  745 (814)
Q Consensus       677 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~--------~~~~~~~~~--  745 (814)
                      .  .....||..|+|||.+.+. .++.++||||||+++|||++|+.||......+......        .....+...  
T Consensus       180 ~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (331)
T 4aaa_A          180 V--YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV  257 (331)
T ss_dssp             ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred             c--cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence            1  1345689999999999875 78999999999999999999999997654322111000        000000000  


Q ss_pred             ----ccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          746 ----KLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       746 ----~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                          .+..+................+.+++.+||+.||.+|||++|+++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                011111110000011134577899999999999999999998875

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2.5e-37  Score=326.32  Aligned_cols=253  Identities=23%  Similarity=0.315  Sum_probs=202.3

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeec--ccccce
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCD--EGQNRL  594 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~  594 (814)
                      ..|.+.+.||+|+||.||++...  .+++.||+|.+....  ....+.+.+|+.++++++||||+++++++.  .....+
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   83 (279)
T 2w5a_A            6 EDYEVLYTIGTGSYGRCQKIRRK--SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY   83 (279)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEET--TTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred             hheeeehhccCCCCcEEEEEEEC--CCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence            35667889999999999999875  357899999996432  233457899999999999999999999874  456789


Q ss_pred             EEEecCCCCCHHHHhcCC----CCCChhhHHHHHHHHHHHHHHhhhcCCCC-----eeecCCCCCcEEEcCCCcEEEeec
Q 041921          595 LVYEFLNNGTLASFLFGN----LKPNWNLRTNIAFQIARGLLYLHEDCRAQ-----IIHCDIKPQNILLDDYYTARISDF  665 (814)
Q Consensus       595 lv~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~~l~yLH~~~~~~-----i~H~dlkp~NIll~~~~~~kl~Df  665 (814)
                      +||||+++++|.+++...    ..+++..++.++.|++.||.|||+.   +     |+||||||+||+++.++.+||+||
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~df  160 (279)
T 2w5a_A           84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDF  160 (279)
T ss_dssp             EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCC
T ss_pred             EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence            999999999999999753    4589999999999999999999998   6     999999999999999999999999


Q ss_pred             CCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcC
Q 041921          666 GLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG  745 (814)
Q Consensus       666 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  745 (814)
                      |++.........  .....|+..|+|||.+.+..++.++||||||+++|||++|+.||......+       ....+..+
T Consensus       161 g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~i~~~  231 (279)
T 2w5a_A          161 GLARILNHDTSF--AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-------LAGKIREG  231 (279)
T ss_dssp             CHHHHC---CHH--HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHT
T ss_pred             chheeecccccc--ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH-------HHHHHhhc
Confidence            999876543211  123468999999999999899999999999999999999999997543221       11222233


Q ss_pred             ccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 041921          746 KLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEG  794 (814)
Q Consensus       746 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~  794 (814)
                      ....+         +.....++.+++.+||+.||.+|||++++++.+..
T Consensus       232 ~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~  271 (279)
T 2w5a_A          232 KFRRI---------PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  271 (279)
T ss_dssp             CCCCC---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             ccccC---------CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence            22111         11234678899999999999999999999987754

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.3e-36  Score=347.57  Aligned_cols=251  Identities=26%  Similarity=0.297  Sum_probs=204.5

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccc---cccchHhHHHHHHhhhccCCCCccceeeeecccccceE
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV---FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL  595 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  595 (814)
                      ..+.+.+.||+|+||.||+|....  .+..||||.+...   .......+.+|+.++++++||||+++++++.+.+..++
T Consensus       184 ~~f~~~~~LG~G~fG~Vy~a~~~~--tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l  261 (576)
T 2acx_A          184 NTFRQYRVLGKGGFGEVCACQVRA--TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL  261 (576)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cceEEEEEEeeCCCEEEEEEEECC--CCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence            445667899999999999999753  5789999999643   22344568899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhcCCC--CCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcccccc
Q 041921          596 VYEFLNNGTLASFLFGNL--KPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTL  673 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~  673 (814)
                      ||||+++|+|.+++....  .+++..+..++.||+.||.|||+.   +|+||||||+||||+.++.+||+|||+++....
T Consensus       262 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~  338 (576)
T 2acx_A          262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE  338 (576)
T ss_dssp             EECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence            999999999999997653  489999999999999999999998   999999999999999999999999999987654


Q ss_pred             CCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecC
Q 041921          674 NQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGE  753 (814)
Q Consensus       674 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  753 (814)
                      ....   ....||+.|+|||++.+..++.++|||||||++|||++|+.||.........   ..+.+.+......     
T Consensus       339 ~~~~---~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~---~~i~~~i~~~~~~-----  407 (576)
T 2acx_A          339 GQTI---KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR---EEVERLVKEVPEE-----  407 (576)
T ss_dssp             TCCE---ECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH---HHHHHHHHHCCCC-----
T ss_pred             Cccc---cccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH---HHHHHHhhccccc-----
Confidence            3221   3457999999999999989999999999999999999999999764332111   1111122111111     


Q ss_pred             cccccCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 041921          754 DKEAMNDIECLGKLVMVSIWCIQEDPSLRP-----TMKKVLQ  790 (814)
Q Consensus       754 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~~vl~  790 (814)
                           .+......+.+++.+||+.||.+||     +++|+++
T Consensus       408 -----~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          408 -----YSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             -----CCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             -----CCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence                 1122346788999999999999999     7888874

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=2.8e-36  Score=340.98  Aligned_cols=262  Identities=24%  Similarity=0.272  Sum_probs=192.9

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccc--cccchHhHHHHHHhhhccCCCCccceeeeeccc------
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV--FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEG------  590 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  590 (814)
                      ..|.+.++||+|+||.||+|....  .++.||||++...  .....+.+.+|+.+++.++||||+++++++...      
T Consensus        62 ~~y~~~~~lG~G~~g~V~~a~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  139 (464)
T 3ttj_A           62 KRYQNLKPIGSGAQGIVCAAYDAV--LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF  139 (464)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETT--TTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             CCeEEEEEeecCCCeEEEEEEECC--CCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence            346677899999999999998653  5789999999753  223345788999999999999999999999654      


Q ss_pred             ccceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccc
Q 041921          591 QNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKL  670 (814)
Q Consensus       591 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~  670 (814)
                      .+.+|||||++++ |.+.+..  .+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus       140 ~~~~lv~E~~~~~-l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~~  213 (464)
T 3ttj_A          140 QDVYLVMELMDAN-LCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (464)
T ss_dssp             CEEEEEEECCSEE-HHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred             CeEEEEEeCCCCC-HHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence            3569999999764 6666643  488999999999999999999998   999999999999999999999999999987


Q ss_pred             cccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhh-HHH-------------
Q 041921          671 LTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI-LTD-------------  736 (814)
Q Consensus       671 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~-~~~-------------  736 (814)
                      ......   .+...||+.|+|||++.+..++.++|||||||+++||++|+.||......+... +..             
T Consensus       214 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~  290 (464)
T 3ttj_A          214 AGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  290 (464)
T ss_dssp             ---CCC---C----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred             cCCCcc---cCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence            654321   244679999999999999999999999999999999999999997654322110 000             


Q ss_pred             --HHHHHhhcC-ccc-----eeecCcc-c--ccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          737 --WAFDCYRNG-KLN-----VLVGEDK-E--AMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       737 --~~~~~~~~~-~~~-----~~~~~~~-~--~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                        .....+... ...     ....... .  ..........+.+++.+||+.||.+|||++|+++.
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence              000000000 000     0000000 0  00011235678999999999999999999999863

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.5e-36  Score=328.32  Aligned_cols=261  Identities=23%  Similarity=0.316  Sum_probs=206.6

Q ss_pred             ccCHHHHHHhhhccc-cceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhcc-CCCCccceee
Q 041921          510 CFSYKELEGATNNFK-EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQT-HHKNLVRLLG  585 (814)
Q Consensus       510 ~~~~~~l~~~~~~~~-~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~  585 (814)
                      .|...+.....|.+. ++||+|+||.||+|....  .++.||||.+....  .....++.+|+.++.++ +||||+++++
T Consensus        19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~   96 (327)
T 3lm5_A           19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKS--TGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE   96 (327)
T ss_dssp             CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred             HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECC--CCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence            455556666666666 889999999999998753  57899999986532  23356789999999999 5699999999


Q ss_pred             eecccccceEEEecCCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC---CCcE
Q 041921          586 FCDEGQNRLLVYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDD---YYTA  660 (814)
Q Consensus       586 ~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~---~~~~  660 (814)
                      ++.+.+..++||||+++++|.+++...  ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.   ++.+
T Consensus        97 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~  173 (327)
T 3lm5_A           97 VYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDI  173 (327)
T ss_dssp             EEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCE
T ss_pred             EEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcE
Confidence            999999999999999999999999654  6789999999999999999999998   9999999999999997   7899


Q ss_pred             EEeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHH
Q 041921          661 RISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD  740 (814)
Q Consensus       661 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  740 (814)
                      ||+|||+++........   ....||+.|+|||.+....++.++||||||+++|||++|+.||......+..       .
T Consensus       174 kL~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-------~  243 (327)
T 3lm5_A          174 KIVDFGMSRKIGHACEL---REIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETY-------L  243 (327)
T ss_dssp             EECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------H
T ss_pred             EEeeCccccccCCcccc---ccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH-------H
Confidence            99999999876543221   3356999999999999999999999999999999999999999754432211       1


Q ss_pred             HhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          741 CYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       741 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                      .+......      ............+.+++.+||+.||.+|||++++++.
T Consensus       244 ~i~~~~~~------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          244 NISQVNVD------YSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             HHHHTCCC------CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             HHHhcccc------cCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence            11111111      0011112345678899999999999999999999863

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=3.1e-36  Score=344.46  Aligned_cols=251  Identities=25%  Similarity=0.352  Sum_probs=201.2

Q ss_pred             HhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeecccccceE
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL  595 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  595 (814)
                      ...|.+.++||+|+||+||+|...  ..+..||||.+....  ......+.+|+.++++++||||+++++++.+....++
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  113 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDK--VTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYL  113 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEET--TTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEEC--CCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            456788899999999999999975  357789999986532  3345678999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC---CcEEEeecCCccccc
Q 041921          596 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDY---YTARISDFGLAKLLT  672 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~---~~~kl~DfGla~~~~  672 (814)
                      ||||+++|+|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+|||++..   +.+||+|||++....
T Consensus       114 v~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~  190 (494)
T 3lij_A          114 VMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE  190 (494)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred             EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence            999999999999998878899999999999999999999998   99999999999999764   459999999998765


Q ss_pred             cCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeec
Q 041921          673 LNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVG  752 (814)
Q Consensus       673 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  752 (814)
                      ....   .....||+.|+|||++. ..++.++|||||||++|||++|+.||......+       +...+..+..... .
T Consensus       191 ~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i~~~~~~~~-~  258 (494)
T 3lij_A          191 NQKK---MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE-------ILRKVEKGKYTFD-S  258 (494)
T ss_dssp             TTBC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCCCCC-S
T ss_pred             CCcc---ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCCCC-c
Confidence            4322   13456999999999986 568999999999999999999999997654322       1222222222110 0


Q ss_pred             CcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          753 EDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       753 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      +     ........+.+++.+||+.||.+|||+.++++
T Consensus       259 ~-----~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          259 P-----EWKNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             G-----GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             h-----hcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence            0     01123467889999999999999999999884

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.4e-37  Score=343.24  Aligned_cols=238  Identities=14%  Similarity=0.124  Sum_probs=185.0

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccc---cccchHhHHHHH---HhhhccCCCCcccee-------ee
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV---FQDGEREFKNEV---FVIGQTHHKNLVRLL-------GF  586 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~---~~l~~l~h~niv~l~-------~~  586 (814)
                      .+.+.+.||+|+||.||+|...  .+++.||||.+...   .....+.+.+|+   .++++++||||++++       ++
T Consensus        74 ~y~~~~~lG~G~~g~V~~a~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           74 TLVRGTVLGQEDPYAYLEATDQ--ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             EEEEEEEEEEETTEEEEEEEC---CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             eEEEcceeecCCCEEEEEEEEC--CCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            4556789999999999999964  35789999999642   233456789999   566666899999998       55


Q ss_pred             ecccc-----------------cceEEEecCCCCCHHHHhcCCCCCC-------hhhHHHHHHHHHHHHHHhhhcCCCCe
Q 041921          587 CDEGQ-----------------NRLLVYEFLNNGTLASFLFGNLKPN-------WNLRTNIAFQIARGLLYLHEDCRAQI  642 (814)
Q Consensus       587 ~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~l~-------~~~~~~i~~~ia~~l~yLH~~~~~~i  642 (814)
                      +.+.+                 ..+|||||+ +|+|.+++.....++       +..++.|+.||+.||+|||+.   +|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence            44432                 278999999 689999997643333       588889999999999999998   99


Q ss_pred             eecCCCCCcEEEcCCCcEEEeecCCccccccCCcccccccccCCCCcccccccccC-----------CCCcchhhHHHHH
Q 041921          643 IHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNS-----------KITAKVDVYSFGV  711 (814)
Q Consensus       643 ~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~~~Dv~s~Gv  711 (814)
                      +||||||+|||++.++.+||+|||+++....     ......| +.|+|||.+.+.           .++.++|||||||
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~  301 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL  301 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence            9999999999999999999999999985432     1134557 999999999887           8999999999999


Q ss_pred             HHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          712 LLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       712 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      ++|||++|+.||........               ...+...      ....+..+.+++.+||+.||.+|||+.++++
T Consensus       302 il~elltg~~Pf~~~~~~~~---------------~~~~~~~------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          302 VIYWIWCADLPITKDAALGG---------------SEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHHHHHHSSCCC------CC---------------SGGGGSS------CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHHHHHHCCCCCcccccccc---------------hhhhhhh------ccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            99999999999964332110               0000000      0122467889999999999999999999985

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.4e-36  Score=337.27  Aligned_cols=245  Identities=24%  Similarity=0.280  Sum_probs=189.2

Q ss_pred             cceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhc-cCCCCccceeeeecc----cccceEEEec
Q 041921          525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ-THHKNLVRLLGFCDE----GQNRLLVYEF  599 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~~~~~lv~e~  599 (814)
                      +.||+|+||+||++...  ..+..||||.++.     ...+.+|+.++.+ .+||||+++++++..    ....+|||||
T Consensus        68 ~~LG~G~~g~V~~~~~~--~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~  140 (400)
T 1nxk_A           68 QVLGLGINGKVLQIFNK--RTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC  140 (400)
T ss_dssp             EEEEEETTEEEEEEEET--TTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred             ceeeeccCeEEEEEEEC--CCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEe
Confidence            68999999999999975  3578999999863     2457788888744 489999999998865    6678999999


Q ss_pred             CCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC---CCcEEEeecCCccccccC
Q 041921          600 LNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDD---YYTARISDFGLAKLLTLN  674 (814)
Q Consensus       600 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~---~~~~kl~DfGla~~~~~~  674 (814)
                      +++|+|.+++...  ..+++..+..|+.||+.||.|||+.   +|+||||||+|||++.   ++.+||+|||+++.....
T Consensus       141 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~  217 (400)
T 1nxk_A          141 LDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH  217 (400)
T ss_dssp             CCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC--
T ss_pred             CCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccccccCCC
Confidence            9999999999875  3589999999999999999999998   9999999999999997   789999999999865532


Q ss_pred             CcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCc
Q 041921          675 QSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGED  754 (814)
Q Consensus       675 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  754 (814)
                      ..   .....||+.|+|||++.+..++.++|||||||++|||++|+.||..........   .....+..+.....    
T Consensus       218 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~---~~~~~i~~~~~~~~----  287 (400)
T 1nxk_A          218 NS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---GMKTRIRMGQYEFP----  287 (400)
T ss_dssp             ------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCC---SHHHHHHHTCCCCC----
T ss_pred             Cc---cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccH---HHHHHHHcCcccCC----
Confidence            21   134568999999999999999999999999999999999999997544321100   00111222221110    


Q ss_pred             ccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          755 KEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       755 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                        .........++.+++.+||+.||.+|||+.++++.
T Consensus       288 --~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          288 --NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             --TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             --CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence              00112244678899999999999999999999873

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-36  Score=333.37  Aligned_cols=256  Identities=22%  Similarity=0.255  Sum_probs=203.9

Q ss_pred             hhhccccceeeeeeeeEEEEEEec-CCCceEEEEEEecccc----ccchHhHHHHHHhhhcc-CCCCccceeeeeccccc
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQT-RTSTTAVAVKKLDRVF----QDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQN  592 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~-~~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  592 (814)
                      ..+.+.+.||+|+||.||++.... ...+..||||.++...    ....+.+.+|+.++.++ +||||+++++++.+.+.
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            457778999999999999998742 2357899999986532    23345688899999999 69999999999999999


Q ss_pred             ceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccc
Q 041921          593 RLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLT  672 (814)
Q Consensus       593 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~  672 (814)
                      .+|||||+++++|.+++.....+++..+..++.||++||.|||+.   +|+||||||+|||++.++.+||+|||+++.+.
T Consensus       134 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  210 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFV  210 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred             EEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence            999999999999999998877899999999999999999999998   99999999999999999999999999998765


Q ss_pred             cCCcccccccccCCCCccccccccc--CCCCcchhhHHHHHHHHHHHhCCCCCCcccchh-hhhHHHHHHHHhhcCccce
Q 041921          673 LNQSKTIKTAIRGTKGYVAPEWFRN--SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLNV  749 (814)
Q Consensus       673 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~  749 (814)
                      ...... .....||+.|+|||.+.+  ..++.++||||||+++|||++|+.||....... ...+   . +.+.....  
T Consensus       211 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~---~-~~~~~~~~--  283 (355)
T 1vzo_A          211 ADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI---S-RRILKSEP--  283 (355)
T ss_dssp             GGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH---H-HHHHHCCC--
T ss_pred             cCCCCc-ccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHH---H-HHHhccCC--
Confidence            433222 134569999999999985  357899999999999999999999997543221 1111   1 11111110  


Q ss_pred             eecCcccccCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 041921          750 LVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRP-----TMKKVLQML  792 (814)
Q Consensus       750 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~~vl~~L  792 (814)
                              ..+......+.+++.+||+.||.+||     |++++++..
T Consensus       284 --------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          284 --------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             --------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             --------CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence                    01122346778999999999999999     999998654

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.9e-36  Score=318.99  Aligned_cols=248  Identities=25%  Similarity=0.369  Sum_probs=197.0

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhccCCCCccceeeeecccccceE
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL  595 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  595 (814)
                      ..|.+.+.||+|+||.||+|....  .++.||||.+....   ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   88 (276)
T 2h6d_A           11 GHYVLGDTLGVGTFGKVKIGEHQL--TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM   88 (276)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccEEEEeeecCCCCeEEEEEEECC--CCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence            456778899999999999999753  57799999986432   2334578999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCC
Q 041921          596 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ  675 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~  675 (814)
                      ||||+++++|.+++.....+++..+..++.|++.||.|||+.   +|+|+||||+||+++.++.+||+|||++.......
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  165 (276)
T 2h6d_A           89 VMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  165 (276)
T ss_dssp             EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred             EEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence            999999999999998877889999999999999999999998   99999999999999999999999999998765432


Q ss_pred             cccccccccCCCCcccccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCc
Q 041921          676 SKTIKTAIRGTKGYVAPEWFRNSKI-TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGED  754 (814)
Q Consensus       676 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  754 (814)
                      ..   ....+++.|+|||.+.+..+ +.++||||||++++||++|+.||.......       ..+.+..+...      
T Consensus       166 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~------  229 (276)
T 2h6d_A          166 FL---RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT-------LFKKIRGGVFY------  229 (276)
T ss_dssp             --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCC------
T ss_pred             ce---ecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH-------HHHHhhcCccc------
Confidence            21   33458999999999987765 689999999999999999999997543221       11222222111      


Q ss_pred             ccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          755 KEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       755 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                          .+......+.+++.+||+.||.+|||++++++.
T Consensus       230 ----~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          230 ----IPEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             ----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             ----CchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                011224568899999999999999999999873

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8.3e-37  Score=338.46  Aligned_cols=266  Identities=22%  Similarity=0.346  Sum_probs=191.3

Q ss_pred             HHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccC-CCCccceeeeecccc-
Q 041921          516 LEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTH-HKNLVRLLGFCDEGQ-  591 (814)
Q Consensus       516 l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-  591 (814)
                      .....|.+.+.||+|+||.||+|....  .+..||||++....  ....+.+.+|+.++.++. ||||+++++++...+ 
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~--~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~   83 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRR--TGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADND   83 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETT--TCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTS
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECC--CCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCC
Confidence            345567888999999999999998653  57899999986432  233456889999999997 999999999986543 


Q ss_pred             -cceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccc
Q 041921          592 -NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKL  670 (814)
Q Consensus       592 -~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~  670 (814)
                       ..++||||++ ++|..++.. ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus        84 ~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~  158 (388)
T 3oz6_A           84 RDVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRS  158 (388)
T ss_dssp             SCEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             CEEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence             6899999997 689998876 4688899999999999999999998   999999999999999999999999999986


Q ss_pred             cccCC-------------------cccccccccCCCCccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcccchh
Q 041921          671 LTLNQ-------------------SKTIKTAIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE  730 (814)
Q Consensus       671 ~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~  730 (814)
                      +....                   .....+...||+.|+|||++.+ ..++.++|||||||+++||++|+.||.......
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~  238 (388)
T 3oz6_A          159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN  238 (388)
T ss_dssp             SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            54311                   1111234579999999999976 678999999999999999999999997654322


Q ss_pred             hhhHHHHHHHHhhcCccce---ee------------------cCccc------------ccCcHHHHHHHHHHHHHcccc
Q 041921          731 YAILTDWAFDCYRNGKLNV---LV------------------GEDKE------------AMNDIECLGKLVMVSIWCIQE  777 (814)
Q Consensus       731 ~~~~~~~~~~~~~~~~~~~---~~------------------~~~~~------------~~~~~~~~~~l~~l~~~Cl~~  777 (814)
                      ...   .+...+.......   +.                  .....            ..........+.+++.+||+.
T Consensus       239 ~~~---~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~  315 (388)
T 3oz6_A          239 QLE---RIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF  315 (388)
T ss_dssp             HHH---HHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCS
T ss_pred             HHH---HHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhcc
Confidence            111   1111110000000   00                  00000            000002245788999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 041921          778 DPSLRPTMKKVLQM  791 (814)
Q Consensus       778 dp~~RPt~~~vl~~  791 (814)
                      ||.+|||++|+++.
T Consensus       316 dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          316 NPNKRISANDALKH  329 (388)
T ss_dssp             SGGGSCCHHHHTTS
T ss_pred             CcccCCCHHHHhCC
Confidence            99999999999875

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.8e-37  Score=332.53  Aligned_cols=265  Identities=21%  Similarity=0.311  Sum_probs=196.4

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccccc-chHhHHHHHHhhhccCCCCccceeeeecccccceEEEe
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD-GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE  598 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  598 (814)
                      +|.+.++||+|+||+||+|....  .+..||||.+...... ....+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (324)
T 3mtl_A            3 TYIKLDKLGEGTYATVYKGKSKL--TDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   80 (324)
T ss_dssp             SEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             ceEEEEEEcCCCCEEEEEEEECC--CCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence            46677899999999999999753  5789999998643322 22356689999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcc
Q 041921          599 FLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSK  677 (814)
Q Consensus       599 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  677 (814)
                      |++ ++|.+++... ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++........
T Consensus        81 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~  156 (324)
T 3mtl_A           81 YLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT  156 (324)
T ss_dssp             CCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred             ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCccc
Confidence            997 5888888764 5688999999999999999999998   9999999999999999999999999999865432221


Q ss_pred             cccccccCCCCccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCc---cceeec-
Q 041921          678 TIKTAIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK---LNVLVG-  752 (814)
Q Consensus       678 ~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~-  752 (814)
                        .....||+.|+|||.+.+ ..++.++||||||++++||++|+.||......+..   ..+.+......   ...... 
T Consensus       157 --~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~~~~~  231 (324)
T 3mtl_A          157 --YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQL---HFIFRILGTPTEETWPGILSN  231 (324)
T ss_dssp             --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCCTTTSTTGGGC
T ss_pred             --cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCCChHhchhhhcc
Confidence              133468999999999876 56899999999999999999999999765443221   11111111100   000000 


Q ss_pred             --------Ccccc----cCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhcC
Q 041921          753 --------EDKEA----MNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ--MLEGV  795 (814)
Q Consensus       753 --------~~~~~----~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~--~L~~~  795 (814)
                              +....    .........+.+++.+||+.||.+|||++|+++  .+.++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  288 (324)
T 3mtl_A          232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL  288 (324)
T ss_dssp             HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred             hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence                    00000    001123467789999999999999999999987  44443

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=2.2e-36  Score=345.12  Aligned_cols=253  Identities=24%  Similarity=0.313  Sum_probs=208.4

Q ss_pred             HHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhccCCCCccceeeeeccccc
Q 041921          516 LEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQN  592 (814)
Q Consensus       516 l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  592 (814)
                      +....|.+.++||+|+||.||+|...  ..+..||||.+....   ....+.+.+|+.++++++||||+++++++.+...
T Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  100 (484)
T 3nyv_A           23 IFSDRYKGQRVLGKGSFGEVILCKDK--ITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGY  100 (484)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEET--TTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             cccCceEEeeEEecCCCEEEEEEEEC--CCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            34567888899999999999999975  357899999986432   3345679999999999999999999999999999


Q ss_pred             ceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE---cCCCcEEEeecCCcc
Q 041921          593 RLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILL---DDYYTARISDFGLAK  669 (814)
Q Consensus       593 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll---~~~~~~kl~DfGla~  669 (814)
                      .++|+||+.+++|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+|||+   +.++.+||+|||+++
T Consensus       101 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  177 (484)
T 3nyv_A          101 FYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLST  177 (484)
T ss_dssp             EEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred             EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence            999999999999999999888899999999999999999999998   99999999999999   567899999999998


Q ss_pred             ccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccce
Q 041921          670 LLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNV  749 (814)
Q Consensus       670 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  749 (814)
                      ........   ....||+.|+|||.+.+ .++.++|||||||++|||++|+.||......+       ....+..+....
T Consensus       178 ~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i~~~~~~~  246 (484)
T 3nyv_A          178 HFEASKKM---KDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD-------ILKKVEKGKYTF  246 (484)
T ss_dssp             HBCCCCSH---HHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCCC
T ss_pred             Eccccccc---ccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHcCCCCC
Confidence            76543221   34569999999999876 68999999999999999999999997554322       112222332211


Q ss_pred             eecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          750 LVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       750 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      .      .+........+.+++.+||+.||.+|||+.++++
T Consensus       247 ~------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          247 E------LPQWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             C------SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             C------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence            1      0111234567889999999999999999999985

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=4.1e-37  Score=328.72  Aligned_cols=263  Identities=22%  Similarity=0.326  Sum_probs=185.8

Q ss_pred             HHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccceeeeecccccce
Q 041921          516 LEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRL  594 (814)
Q Consensus       516 l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  594 (814)
                      +....+.+.+.||+|+||.||+|...  ..+..||||.+.... ....+++.+|+.++++++||||+++++++...+..+
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   89 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCA--PKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW   89 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC------CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred             cchhhhhhhheeccccceEEEEEEEC--CCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence            33456777899999999999999854  256799999986432 234567899999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHhcC--------CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecC
Q 041921          595 LVYEFLNNGTLASFLFG--------NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFG  666 (814)
Q Consensus       595 lv~e~~~~gsL~~~l~~--------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfG  666 (814)
                      +||||+++++|.+++..        ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg  166 (303)
T 2vwi_A           90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFG  166 (303)
T ss_dssp             EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCH
T ss_pred             EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEecc
Confidence            99999999999999863        35689999999999999999999998   99999999999999999999999999


Q ss_pred             CccccccCCcc---cccccccCCCCccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHh
Q 041921          667 LAKLLTLNQSK---TIKTAIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY  742 (814)
Q Consensus       667 la~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  742 (814)
                      ++.........   .......||+.|+|||.+.. ..++.++||||||++++||++|+.||.........      ....
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~~~~  240 (303)
T 2vwi_A          167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL------MLTL  240 (303)
T ss_dssp             HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH------HHHH
T ss_pred             chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH------HHHh
Confidence            99866533211   11133568999999999876 56899999999999999999999999765432211      1111


Q ss_pred             hcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          743 RNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       743 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      ... ....................+.+++.+||+.||.+|||++++++
T Consensus       241 ~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          241 QND-PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             TSS-CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ccC-CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            111 10000000000011123457889999999999999999999986

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=3.5e-36  Score=320.22  Aligned_cols=245  Identities=26%  Similarity=0.357  Sum_probs=194.9

Q ss_pred             cceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEecCCCCC
Q 041921          525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGT  604 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  604 (814)
                      ..||+|+||.||+|...  .++..||||.+........+.+.+|+.++++++||||+++++++.+.+..++||||+++++
T Consensus        28 ~~lg~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  105 (295)
T 2clq_A           28 VVLGKGTYGIVYAGRDL--SNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGS  105 (295)
T ss_dssp             CEEEECSSSEEEEEEET--TTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEE
T ss_pred             EEEeecCcEEEEEEEEC--CCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCC
Confidence            47999999999999965  3578999999976655566789999999999999999999999999999999999999999


Q ss_pred             HHHHhcCC---CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC-CCcEEEeecCCccccccCCccccc
Q 041921          605 LASFLFGN---LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDD-YYTARISDFGLAKLLTLNQSKTIK  680 (814)
Q Consensus       605 L~~~l~~~---~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~-~~~~kl~DfGla~~~~~~~~~~~~  680 (814)
                      |.+++...   ..+++..+..++.|++.||.|||+.   +|+|+||||+||+++. ++.+||+|||++.........  .
T Consensus       106 L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~--~  180 (295)
T 2clq_A          106 LSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC--T  180 (295)
T ss_dssp             HHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------
T ss_pred             HHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCCc--c
Confidence            99999754   3456888899999999999999998   9999999999999987 899999999999876532211  1


Q ss_pred             ccccCCCCcccccccccCC--CCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCccccc
Q 041921          681 TAIRGTKGYVAPEWFRNSK--ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAM  758 (814)
Q Consensus       681 ~~~~gt~~y~aPE~~~~~~--~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  758 (814)
                      ....|+..|+|||.+.+..  ++.++||||||+++|||++|+.||...........    ..... ..     .+.    
T Consensus       181 ~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~----~~~~~-~~-----~~~----  246 (295)
T 2clq_A          181 ETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF----KVGMF-KV-----HPE----  246 (295)
T ss_dssp             CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHH----HHHHH-CC-----CCC----
T ss_pred             cccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHH----hhccc-cc-----ccc----
Confidence            3456899999999997653  78999999999999999999999964332211110    00000 00     000    


Q ss_pred             CcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          759 NDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       759 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      .+.....++.+++.+||+.||++|||++++++
T Consensus       247 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          247 IPESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             CCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             ccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            11223467889999999999999999999985

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.8e-36  Score=323.87  Aligned_cols=248  Identities=26%  Similarity=0.373  Sum_probs=203.9

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEe
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE  598 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  598 (814)
                      .+.+.+.||+|+||.||+|...  ..+..||||.+.... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus        23 ~y~~~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           23 LFTKLEKIGKGSFGEVFKGIDN--RTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             TEEEEEEEEECSSSEEEEEEET--TTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHhhhhcccCCeEEEEEEEC--CCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            4567789999999999999865  357899999986543 3345679999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccc
Q 041921          599 FLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT  678 (814)
Q Consensus       599 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  678 (814)
                      |+++++|.+++.. ..+++..+..++.|++.||.|||+.   +|+|+||||+||+++.++.+||+|||++......... 
T Consensus       101 ~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-  175 (303)
T 3a7i_A          101 YLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-  175 (303)
T ss_dssp             CCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCC-
T ss_pred             eCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCccccc-
Confidence            9999999999865 4688999999999999999999998   9999999999999999999999999999876543221 


Q ss_pred             ccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCccccc
Q 041921          679 IKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAM  758 (814)
Q Consensus       679 ~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  758 (814)
                       .....||..|+|||.+.+..++.++||||||++++||++|+.||.........       ..+..+....     .   
T Consensus       176 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------~~~~~~~~~~-----~---  239 (303)
T 3a7i_A          176 -RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL-------FLIPKNNPPT-----L---  239 (303)
T ss_dssp             -BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-------HHHHHSCCCC-----C---
T ss_pred             -cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHH-------HHhhcCCCCC-----C---
Confidence             13456899999999999999999999999999999999999999754332211       1111111111     0   


Q ss_pred             CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          759 NDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       759 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                       .......+.+++.+||+.||.+|||+.++++.
T Consensus       240 -~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          240 -EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             -CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             -ccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence             11234568899999999999999999999863

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=3.2e-36  Score=341.27  Aligned_cols=195  Identities=23%  Similarity=0.388  Sum_probs=155.0

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeecc-----cc
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDE-----GQ  591 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~  591 (814)
                      ..|.+.+.||+|+||.||+|....  .+..||||++....  ....+.+.+|+.++++++||||+++++++..     ..
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~--~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  130 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKL--EKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD  130 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC----CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             CCeEEeeEeeecCCeEEEEEEECC--CCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence            357788999999999999998753  57899999996532  2234578999999999999999999999843     35


Q ss_pred             cceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcccc
Q 041921          592 NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLL  671 (814)
Q Consensus       592 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~  671 (814)
                      ..++||||+ +++|.+++.....+++..+..++.||+.||+|||+.   +|+||||||+||||+.++.+||+|||+++..
T Consensus       131 ~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  206 (458)
T 3rp9_A          131 ELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTV  206 (458)
T ss_dssp             CEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred             eEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchhc
Confidence            689999997 579999998888899999999999999999999998   9999999999999999999999999999876


Q ss_pred             ccCCcc-------------------------cccccccCCCCccccccc-ccCCCCcchhhHHHHHHHHHHHhC
Q 041921          672 TLNQSK-------------------------TIKTAIRGTKGYVAPEWF-RNSKITAKVDVYSFGVLLLEIISC  719 (814)
Q Consensus       672 ~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~s~~~Dv~s~Gvvl~elltg  719 (814)
                      ......                         ...+..+||+.|+|||++ ....++.++|||||||++|||++|
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            532211                         112445689999999976 556799999999999999999994

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=3.9e-36  Score=329.86  Aligned_cols=252  Identities=23%  Similarity=0.365  Sum_probs=203.4

Q ss_pred             HhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccccc--------chHhHHHHHHhhhcc-CCCCccceeeeec
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD--------GEREFKNEVFVIGQT-HHKNLVRLLGFCD  588 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~--------~~~~~~~E~~~l~~l-~h~niv~l~~~~~  588 (814)
                      ...|.+.+.||+|+||.||+|.+..  ++..||||.++.....        ..+.+.+|+.++.++ +||||+++++++.
T Consensus        93 ~~~y~~~~~lg~G~~g~Vy~a~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  170 (365)
T 2y7j_A           93 YQKYDPKDVIGRGVSSVVRRCVHRA--TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE  170 (365)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhcccceEEecCCCEEEEEEEECC--CCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence            4556777899999999999999753  5789999998653311        134578999999999 8999999999999


Q ss_pred             ccccceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCc
Q 041921          589 EGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLA  668 (814)
Q Consensus       589 ~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla  668 (814)
                      .....++||||+++++|.+++.....+++..+..++.||+.||.|||+.   +|+|+||||+|||++.++.+||+|||++
T Consensus       171 ~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~DfG~~  247 (365)
T 2y7j_A          171 SSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFS  247 (365)
T ss_dssp             BSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             eCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEecCcc
Confidence            9999999999999999999998877899999999999999999999998   9999999999999999999999999999


Q ss_pred             cccccCCcccccccccCCCCccccccccc------CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHh
Q 041921          669 KLLTLNQSKTIKTAIRGTKGYVAPEWFRN------SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY  742 (814)
Q Consensus       669 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  742 (814)
                      ..+......   ....||+.|+|||++.+      ..++.++||||||+++|||++|+.||.......       ....+
T Consensus       248 ~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~-------~~~~i  317 (365)
T 2y7j_A          248 CHLEPGEKL---RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL-------MLRMI  317 (365)
T ss_dssp             EECCTTCCB---CCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHH
T ss_pred             cccCCCccc---ccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH-------HHHHH
Confidence            876543221   34569999999999863      357889999999999999999999997543221       11112


Q ss_pred             hcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          743 RNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       743 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      ..+...... +.     .......+.+++.+||+.||.+|||++++++
T Consensus       318 ~~~~~~~~~-~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          318 MEGQYQFSS-PE-----WDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             HHTCCCCCH-HH-----HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HhCCCCCCC-cc-----cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            222211100 00     0112456889999999999999999999986

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=3.7e-36  Score=343.30  Aligned_cols=253  Identities=25%  Similarity=0.323  Sum_probs=206.0

Q ss_pred             HHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccc--cccchHhHHHHHHhhhccCCCCccceeeeecccccce
Q 041921          517 EGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV--FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRL  594 (814)
Q Consensus       517 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  594 (814)
                      ....|.+.++||+|+||+||+|...  ..+..||||.+...  .......+.+|+.++++++||||+++++++.+....+
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   97 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDR--ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY   97 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEET--TTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEEC--CCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEE
Confidence            4567888999999999999999975  35789999998643  2334567999999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc---CCCcEEEeecCCcccc
Q 041921          595 LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLD---DYYTARISDFGLAKLL  671 (814)
Q Consensus       595 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~---~~~~~kl~DfGla~~~  671 (814)
                      +|+||+++++|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+|||++   .++.+||+|||+++..
T Consensus        98 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  174 (486)
T 3mwu_A           98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (486)
T ss_dssp             EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence            9999999999999998878899999999999999999999998   999999999999995   4567999999999876


Q ss_pred             ccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceee
Q 041921          672 TLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLV  751 (814)
Q Consensus       672 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  751 (814)
                      .....   .....||+.|+|||++.+ .++.++|||||||++|||++|+.||......+       ....+..+..... 
T Consensus       175 ~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i~~~~~~~~-  242 (486)
T 3mwu_A          175 QQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-------ILKRVETGKYAFD-  242 (486)
T ss_dssp             CCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCCCSC-
T ss_pred             CCCCc---cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCCCC-
Confidence            54322   134569999999999875 58999999999999999999999997543322       1122222222110 


Q ss_pred             cCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          752 GEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       752 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                           .+........+.+++.+||+.||.+|||+.++++.
T Consensus       243 -----~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          243 -----LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             -----SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             -----CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                 01112234678899999999999999999999873

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=6.7e-36  Score=319.74  Aligned_cols=254  Identities=25%  Similarity=0.323  Sum_probs=199.8

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc----ccchHhHHHHHHhhhccCCCCccceeeee--ccccc
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF----QDGEREFKNEVFVIGQTHHKNLVRLLGFC--DEGQN  592 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~--~~~~~  592 (814)
                      ..|.+.+.||+|+||.||++...  ..+..||||.+....    ....+.+.+|+.++++++||||+++++++  .+...
T Consensus         5 ~~y~i~~~lg~G~~g~V~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (305)
T 2wtk_C            5 GKYLMGDLLGEGSYGKVKEVLDS--ETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK   82 (305)
T ss_dssp             CCBCCCCEEEECSSCEEEEEEBT--TTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred             cceeEeeEEecCCCeEEEEEEEC--CCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence            45677899999999999999854  357899999996532    23456799999999999999999999998  44567


Q ss_pred             ceEEEecCCCCCHHHHhcC--CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccc
Q 041921          593 RLLVYEFLNNGTLASFLFG--NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKL  670 (814)
Q Consensus       593 ~~lv~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~  670 (814)
                      .++||||++++ |.+++..  ...+++..+..++.||++||.|||+.   +|+||||||+||+++.++.+||+|||++..
T Consensus        83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEA  158 (305)
T ss_dssp             EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccc
Confidence            89999999877 7777654  35688999999999999999999998   999999999999999999999999999987


Q ss_pred             cccCCcccccccccCCCCcccccccccCC--CCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccc
Q 041921          671 LTLNQSKTIKTAIRGTKGYVAPEWFRNSK--ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLN  748 (814)
Q Consensus       671 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  748 (814)
                      ..............||..|+|||.+.+..  .+.++||||||++++||++|+.||......+       ....+..+...
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~i~~~~~~  231 (305)
T 2wtk_C          159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK-------LFENIGKGSYA  231 (305)
T ss_dssp             CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHHCCCC
T ss_pred             cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH-------HHHHHhcCCCC
Confidence            65433332224456899999999997644  4789999999999999999999997543221       11222222211


Q ss_pred             eeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhcC
Q 041921          749 VLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ--MLEGV  795 (814)
Q Consensus       749 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~--~L~~~  795 (814)
                                .+......+.+++.+||+.||.+|||++++++  .+.+.
T Consensus       232 ----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  270 (305)
T 2wtk_C          232 ----------IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK  270 (305)
T ss_dssp             ----------CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred             ----------CCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence                      01123467789999999999999999999995  45543

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3e-36  Score=330.94  Aligned_cols=264  Identities=25%  Similarity=0.302  Sum_probs=196.1

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeecccc-----
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ-----  591 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  591 (814)
                      ..|.+.+.||+|+||.||+|...  ..+..||||++....  ....+.+.+|+.++++++||||+++++++....     
T Consensus        25 ~~y~~~~~lG~G~~g~V~~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  102 (367)
T 1cm8_A           25 AVYRDLQPVGSGAYGAVCSAVDG--RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF  102 (367)
T ss_dssp             SSEEEEEEC------CEEEEEET--TTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             ceEEEeEEeeecCCeEEEEEEEC--CCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence            34667789999999999999865  357899999996432  223456889999999999999999999997653     


Q ss_pred             -cceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccc
Q 041921          592 -NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKL  670 (814)
Q Consensus       592 -~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~  670 (814)
                       ..++||||+ +++|.+++.. ..+++..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus       103 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  177 (367)
T 1cm8_A          103 TDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQ  177 (367)
T ss_dssp             CCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence             459999999 8899999876 4688999999999999999999998   999999999999999999999999999987


Q ss_pred             cccCCcccccccccCCCCccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhc-----
Q 041921          671 LTLNQSKTIKTAIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN-----  744 (814)
Q Consensus       671 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-----  744 (814)
                      .....     +...+|+.|+|||.+.+ ..++.++|||||||+++||++|+.||......+...   .+......     
T Consensus       178 ~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~---~i~~~~g~~~~~~  249 (367)
T 1cm8_A          178 ADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLK---EIMKVTGTPPAEF  249 (367)
T ss_dssp             CCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHHHHHCCCCHHH
T ss_pred             ccccc-----CcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHhcCCCCHHH
Confidence            54321     34568999999999877 679999999999999999999999997554322110   01110000     


Q ss_pred             ------Cc-------cceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhcCcCC
Q 041921          745 ------GK-------LNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ--MLEGVVEV  798 (814)
Q Consensus       745 ------~~-------~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~--~L~~~~~~  798 (814)
                            ..       +......... .........+.+++.+||+.||.+|||++++++  .++.+.+.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~  317 (367)
T 1cm8_A          250 VQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT  317 (367)
T ss_dssp             HHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred             HHHhhhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCC
Confidence                  00       0000000000 011123467889999999999999999999987  46655443

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2.9e-36  Score=338.51  Aligned_cols=200  Identities=25%  Similarity=0.412  Sum_probs=167.5

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc--cchHhHHHHHHhhhccCCCCccceeeeeccc-----c
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ--DGEREFKNEVFVIGQTHHKNLVRLLGFCDEG-----Q  591 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~  591 (814)
                      ..|.+.+.||+|+||.||+|...  ..+..||||++.....  ...+.+.+|+.++++++||||+++++++...     .
T Consensus        26 ~~y~~~~~lG~G~~g~V~~a~~~--~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  103 (432)
T 3n9x_A           26 DNYIIKHLIGRGSYGYVYLAYDK--NTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD  103 (432)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEET--TTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             CCEEEEEEEeecCCEEEEEEEEC--CCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence            45778899999999999999975  3678999999975322  2345789999999999999999999999766     5


Q ss_pred             cceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcccc
Q 041921          592 NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLL  671 (814)
Q Consensus       592 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~  671 (814)
                      ..++||||+. ++|.+++.....+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus       104 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~~  179 (432)
T 3n9x_A          104 ELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTI  179 (432)
T ss_dssp             CEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             eEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence            6899999986 59999999888899999999999999999999998   9999999999999999999999999999876


Q ss_pred             ccCCcc--------------------cccccccCCCCccccccc-ccCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 041921          672 TLNQSK--------------------TIKTAIRGTKGYVAPEWF-RNSKITAKVDVYSFGVLLLEIISCRKSFD  724 (814)
Q Consensus       672 ~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~s~~~Dv~s~Gvvl~elltg~~p~~  724 (814)
                      ......                    ...+...||+.|+|||.+ ....++.++|||||||+++||++|..|+.
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            543211                    112456799999999986 55679999999999999999998655543

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=5.1e-36  Score=322.12  Aligned_cols=252  Identities=23%  Similarity=0.327  Sum_probs=200.3

Q ss_pred             HHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceE
Q 041921          516 LEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL  595 (814)
Q Consensus       516 l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  595 (814)
                      .....+.+.+.||+|+||.||+|...  ..+..||||.+...  ...+++.+|+.++.+++||||+++++++.+.+..++
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  101 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHK--ETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI  101 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEET--TTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEEC--CCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence            34556777889999999999999875  35789999999753  345679999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhc-CCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccC
Q 041921          596 VYEFLNNGTLASFLF-GNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN  674 (814)
Q Consensus       596 v~e~~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~  674 (814)
                      ||||+++++|.+++. ....+++..+..++.|++.||.|||+.   +|+|+||||+||+++.++.+||+|||++......
T Consensus       102 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (314)
T 3com_A          102 VMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT  178 (314)
T ss_dssp             EEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred             EeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence            999999999999997 356789999999999999999999998   9999999999999999999999999999876543


Q ss_pred             CcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCc
Q 041921          675 QSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGED  754 (814)
Q Consensus       675 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  754 (814)
                      ...  .....|+..|+|||.+.+..++.++||||||++++||++|+.||.........      . .........     
T Consensus       179 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~-~~~~~~~~~-----  244 (314)
T 3com_A          179 MAK--RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI------F-MIPTNPPPT-----  244 (314)
T ss_dssp             BSC--BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------H-HHHHSCCCC-----
T ss_pred             ccc--cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHH------H-HHhcCCCcc-----
Confidence            221  13456899999999999989999999999999999999999999754322111      1 111111000     


Q ss_pred             ccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          755 KEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       755 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                        ..........+.+++.+||+.||.+|||+.++++
T Consensus       245 --~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          245 --FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             --CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             --cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence              0112223467889999999999999999999975

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.4e-36  Score=328.12  Aligned_cols=262  Identities=24%  Similarity=0.282  Sum_probs=197.9

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccccc-----chHhHHHHHHhhhccCCCCccceeeeecccccc
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD-----GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNR  593 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  593 (814)
                      ..|.+.+.||+|+||.||+|...  .+++.||||.+......     ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus        10 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (346)
T 1ua2_A           10 KRYEKLDFLGEGQFATVYKARDK--NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI   87 (346)
T ss_dssp             ---CEEEEEEEETTEEEEEEECS--SCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred             cccEEEeEEeecCCEEEEEEEEC--CCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence            45677889999999999999865  35789999999643211     134688999999999999999999999999999


Q ss_pred             eEEEecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccc
Q 041921          594 LLVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLT  672 (814)
Q Consensus       594 ~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~  672 (814)
                      ++||||+++ +|.+++... ..+++..+..++.|+++||.|||+.   +|+||||||+|||++.++.+||+|||+++.+.
T Consensus        88 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  163 (346)
T 1ua2_A           88 SLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFG  163 (346)
T ss_dssp             EEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred             EEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccceecc
Confidence            999999986 888888765 4688999999999999999999998   99999999999999999999999999998765


Q ss_pred             cCCcccccccccCCCCcccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceee
Q 041921          673 LNQSKTIKTAIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLV  751 (814)
Q Consensus       673 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  751 (814)
                      .....  .....||+.|+|||.+.+. .++.++||||||+++|||++|..||......+.  + ..+.............
T Consensus       164 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~--~-~~i~~~~~~~~~~~~~  238 (346)
T 1ua2_A          164 SPNRA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ--L-TRIFETLGTPTEEQWP  238 (346)
T ss_dssp             SCCCC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--H-HHHHHHHCCCCTTTSS
T ss_pred             CCccc--CCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH--H-HHHHHHcCCCChhhhh
Confidence            33221  1345689999999999754 588999999999999999999999875543221  1 1111111110000000


Q ss_pred             c---------CcccccCc-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          752 G---------EDKEAMND-----IECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       752 ~---------~~~~~~~~-----~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                      +         .......+     ......+.+++.+||+.||.+|||++|+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          239 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            0         00000000     1234678999999999999999999999874

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=5.8e-36  Score=338.51  Aligned_cols=260  Identities=18%  Similarity=0.211  Sum_probs=204.4

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCC-CCccceeeeecccccceEEE
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHH-KNLVRLLGFCDEGQNRLLVY  597 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~  597 (814)
                      ..|.+.++||+|+||.||+|...  ..+..||||.+...  ....++..|++++..++| +++..+..++.+.+..+|||
T Consensus         7 ~~y~i~~~LG~G~fG~Vy~a~~~--~~~~~vAvK~~~~~--~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm   82 (483)
T 3sv0_A            7 NKFRLGRKIGSGSFGEIYLGTNI--QTNEEVAIKLENVK--TKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM   82 (483)
T ss_dssp             TTEECCCCCEECSSCEEEEEEET--TTCCEEEEEEEETT--CSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEeeCCCEEEEEEEEC--CCCcEEEEEEeccc--cccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence            45677899999999999999965  35789999987643  233468999999999987 55556666667778889999


Q ss_pred             ecCCCCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE---cCCCcEEEeecCCcccccc
Q 041921          598 EFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILL---DDYYTARISDFGLAKLLTL  673 (814)
Q Consensus       598 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll---~~~~~~kl~DfGla~~~~~  673 (814)
                      ||+ +++|.+++.. ...+++..++.|+.||+.||.|||+.   +|+||||||+||||   +.++.+||+|||+++.+..
T Consensus        83 e~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~  158 (483)
T 3sv0_A           83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD  158 (483)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             ECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence            999 9999999975 46799999999999999999999998   99999999999999   6889999999999987764


Q ss_pred             CCccc-----ccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccc
Q 041921          674 NQSKT-----IKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLN  748 (814)
Q Consensus       674 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  748 (814)
                      .....     ......||..|+|||.+.+..++.++|||||||+||||++|+.||..............+........+.
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~  238 (483)
T 3sv0_A          159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIE  238 (483)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred             CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHH
Confidence            43211     1124669999999999999999999999999999999999999997654422111111111111111111


Q ss_pred             eeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 041921          749 VLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV  795 (814)
Q Consensus       749 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~  795 (814)
                      .+.         ...+.++.+++..||+.+|.+||++++|+++|+.+
T Consensus       239 ~l~---------~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l  276 (483)
T 3sv0_A          239 ALC---------RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL  276 (483)
T ss_dssp             HHH---------TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             HHh---------cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            100         12246789999999999999999999999999876

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.2e-36  Score=325.20  Aligned_cols=251  Identities=20%  Similarity=0.304  Sum_probs=198.6

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEe
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE  598 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  598 (814)
                      ..+.+.+.||+|+||.||+|....  .+..||+|.+........+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        19 ~~y~i~~~lg~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   96 (302)
T 2j7t_A           19 EVWEIVGELGDGAFGKVYKAKNKE--TGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE   96 (302)
T ss_dssp             GTEEEEEEEECSTTCCEEEEEETT--TCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred             cceeecceeccCCCeEEEEEEEcC--CCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence            456778899999999999999753  577999999976656667789999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcc
Q 041921          599 FLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSK  677 (814)
Q Consensus       599 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  677 (814)
                      |+++++|.+++.. ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++........ 
T Consensus        97 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  172 (302)
T 2j7t_A           97 FCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ-  172 (302)
T ss_dssp             CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH-
T ss_pred             eCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccccc-
Confidence            9999999999875 46689999999999999999999998   999999999999999999999999998764322111 


Q ss_pred             cccccccCCCCccccccc-----ccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeec
Q 041921          678 TIKTAIRGTKGYVAPEWF-----RNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVG  752 (814)
Q Consensus       678 ~~~~~~~gt~~y~aPE~~-----~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  752 (814)
                       ......||..|+|||.+     ....++.++||||||++++||++|+.||........      ..... .+....   
T Consensus       173 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~-~~~~~~---  241 (302)
T 2j7t_A          173 -KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV------LLKIA-KSDPPT---  241 (302)
T ss_dssp             -C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHH-HSCCCC---
T ss_pred             -ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH------HHHHh-ccCCcc---
Confidence             11334689999999998     356789999999999999999999999975433211      11111 111111   


Q ss_pred             CcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          753 EDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       753 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                          ...+......+.+++.+||+.||.+|||++++++
T Consensus       242 ----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          242 ----LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             ----CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             ----cCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                1112233467889999999999999999999875

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=2.1e-36  Score=320.58  Aligned_cols=244  Identities=22%  Similarity=0.326  Sum_probs=198.5

Q ss_pred             HHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhcc-CCCCccceeeeecccccc
Q 041921          517 EGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNR  593 (814)
Q Consensus       517 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  593 (814)
                      ....+.+.+.||+|+||.||+|....  ++..||||.+....  .....++.+|+..+.++ +||||+++++++.+.+..
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~   86 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRL--DGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHM   86 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcC--CCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeE
Confidence            34567788999999999999999753  57899999987532  33456788999999999 999999999999999999


Q ss_pred             eEEEecCCCCCHHHHhcCC----CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC-------------
Q 041921          594 LLVYEFLNNGTLASFLFGN----LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDD-------------  656 (814)
Q Consensus       594 ~lv~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~-------------  656 (814)
                      ++||||+++++|.+++...    ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.             
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~  163 (289)
T 1x8b_A           87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDE  163 (289)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC--------------
T ss_pred             EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccc
Confidence            9999999999999999764    6689999999999999999999998   9999999999999984             


Q ss_pred             ------CCcEEEeecCCccccccCCcccccccccCCCCcccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcccch
Q 041921          657 ------YYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIISCRKSFDIEMGE  729 (814)
Q Consensus       657 ------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~  729 (814)
                            ...+||+|||++......      ....||..|+|||.+.+. .++.++||||||++++||++|..++..... 
T Consensus       164 ~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~-  236 (289)
T 1x8b_A          164 DDWASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ-  236 (289)
T ss_dssp             ------CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH-
T ss_pred             ccccCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH-
Confidence                  447999999999876543      223489999999999766 566899999999999999999877643211 


Q ss_pred             hhhhHHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          730 EYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       730 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                               ...+..+....+         +......+.+++.+||+.||.+|||+.++++
T Consensus       237 ---------~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          237 ---------WHEIRQGRLPRI---------PQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             ---------HHHHHTTCCCCC---------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---------HHHHHcCCCCCC---------CcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence                     112222222111         1123467889999999999999999999976

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.8e-36  Score=355.60  Aligned_cols=251  Identities=24%  Similarity=0.293  Sum_probs=206.2

Q ss_pred             HHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccc---cccchHhHHHHHHhhhcc-CCCCccceeeeecccc
Q 041921          516 LEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV---FQDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQ  591 (814)
Q Consensus       516 l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  591 (814)
                      +....+.+.++||+|+||.||+|....  .++.||||.++..   .....+.+..|..++..+ +||||+++++++.+.+
T Consensus       338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~--~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~  415 (674)
T 3pfq_A          338 MKLTDFNFLMVLGKGSFGKVMLSERKG--TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD  415 (674)
T ss_dssp             --CTTEEEEEESSBTTTBCEEEEEESS--SCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSS
T ss_pred             ccccceEEEEEEccCCCEEEEEEEECC--CCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCC
Confidence            344556778899999999999999763  5778999999743   233445688899999988 7999999999999999


Q ss_pred             cceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcccc
Q 041921          592 NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLL  671 (814)
Q Consensus       592 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~  671 (814)
                      ..+|||||+++|+|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+||||+.++.+||+|||+++..
T Consensus       416 ~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~  492 (674)
T 3pfq_A          416 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  492 (674)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred             EEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeecc
Confidence            9999999999999999998878899999999999999999999998   9999999999999999999999999999864


Q ss_pred             ccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceee
Q 041921          672 TLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLV  751 (814)
Q Consensus       672 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  751 (814)
                      ......  .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+       +.+.+..+.+.   
T Consensus       493 ~~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~-------~~~~i~~~~~~---  560 (674)
T 3pfq_A          493 IWDGVT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-------LFQSIMEHNVA---  560 (674)
T ss_dssp             CCTTCC--BCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHSSCCC---
T ss_pred             ccCCcc--cccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH-------HHHHHHhCCCC---
Confidence            332221  245679999999999999999999999999999999999999997654322       12222222221   


Q ss_pred             cCcccccCcHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 041921          752 GEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTM-----KKVLQ  790 (814)
Q Consensus       752 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~-----~~vl~  790 (814)
                             .+.....++.+++.+||+.||.+||++     +||++
T Consensus       561 -------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          561 -------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             -------CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             -------CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence                   111234678899999999999999997     66653

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=5.4e-36  Score=343.40  Aligned_cols=251  Identities=25%  Similarity=0.351  Sum_probs=202.2

Q ss_pred             HhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc-------------cchHhHHHHHHhhhccCCCCcccee
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ-------------DGEREFKNEVFVIGQTHHKNLVRLL  584 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~  584 (814)
                      ...|.+.++||+|+||+||+|....  .+..||||.+.....             ...+++.+|+.++++++||||++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  112 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKN--GHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF  112 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETT--TCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECC--CCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence            3457778999999999999999753  577899999864321             2346789999999999999999999


Q ss_pred             eeecccccceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC---cEE
Q 041921          585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYY---TAR  661 (814)
Q Consensus       585 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~---~~k  661 (814)
                      +++.+....++||||+++|+|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++   .+|
T Consensus       113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~k  189 (504)
T 3q5i_A          113 DVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIK  189 (504)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSEE
T ss_pred             EEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccEE
Confidence            99999999999999999999999998888899999999999999999999998   999999999999998765   699


Q ss_pred             EeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHH
Q 041921          662 ISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC  741 (814)
Q Consensus       662 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  741 (814)
                      |+|||++.........   ....||+.|+|||.+. ..++.++||||||+++|+|++|+.||......+       +...
T Consensus       190 l~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~  258 (504)
T 3q5i_A          190 IVDFGLSSFFSKDYKL---RDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD-------IIKK  258 (504)
T ss_dssp             ECCCTTCEECCTTSCB---CCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHH
T ss_pred             EEECCCCEEcCCCCcc---ccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHH
Confidence            9999999876543221   3456999999999987 468999999999999999999999997654322       1222


Q ss_pred             hhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          742 YRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       742 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      +..+.......      .......++.+++.+||+.||.+|||++++++
T Consensus       259 i~~~~~~~~~~------~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          259 VEKGKYYFDFN------DWKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             HHHCCCCCCHH------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHcCCCCCCcc------ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            22222111000      00123467889999999999999999999985

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=3.9e-36  Score=328.43  Aligned_cols=264  Identities=20%  Similarity=0.256  Sum_probs=198.7

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeecc-------
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDE-------  589 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------  589 (814)
                      ..|.+.++||+|+||.||+|...  ..++.||||++....  ......+.+|+.++++++||||+++++++..       
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHR--KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR   94 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEET--TTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred             cceeEEEEEecCCCcEEEEEEEC--CCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence            46778899999999999999975  357899999985432  2234578899999999999999999999876       


Q ss_pred             -cccceEEEecCCCCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCC
Q 041921          590 -GQNRLLVYEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGL  667 (814)
Q Consensus       590 -~~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGl  667 (814)
                       .+..++||||+++ +|.+.+.. ...+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus        95 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  170 (351)
T 3mi9_A           95 CKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGL  170 (351)
T ss_dssp             --CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchh
Confidence             3468999999986 66666654 46789999999999999999999998   999999999999999999999999999


Q ss_pred             ccccccCCcc--cccccccCCCCccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhc
Q 041921          668 AKLLTLNQSK--TIKTAIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN  744 (814)
Q Consensus       668 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  744 (814)
                      ++.+......  .......||+.|+|||.+.+ ..++.++||||||++++||++|+.||...........   +......
T Consensus       171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~---i~~~~~~  247 (351)
T 3mi9_A          171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLAL---ISQLCGS  247 (351)
T ss_dssp             CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCC
T ss_pred             cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHhCC
Confidence            9876532211  11234568999999999876 4589999999999999999999999986544322111   1111110


Q ss_pred             Cc---ccee--------ec-CcccccCcHH------HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          745 GK---LNVL--------VG-EDKEAMNDIE------CLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       745 ~~---~~~~--------~~-~~~~~~~~~~------~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                      -.   ....        .. .........+      ....+.+++.+||+.||.+|||++|+++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          248 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             CCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence            00   0000        00 0000000011      13458899999999999999999999873

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=6.5e-36  Score=318.74  Aligned_cols=251  Identities=22%  Similarity=0.307  Sum_probs=203.8

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc---------ccchHhHHHHHHhhhccC-CCCccceeeeec
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---------QDGEREFKNEVFVIGQTH-HKNLVRLLGFCD  588 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~  588 (814)
                      ..|.+.+.||+|+||.||+|...  ..++.||||.+....         ....+.+.+|+.++++++ ||||+++++++.
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           17 ENYEPKEILGRGVSSVVRRCIHK--PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEET--TTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hccceeeeecCCCceEEEEEEEc--CcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            45667789999999999999975  357899999986432         112346889999999995 999999999999


Q ss_pred             ccccceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCc
Q 041921          589 EGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLA  668 (814)
Q Consensus       589 ~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla  668 (814)
                      +.+..++||||+++++|.+++.....+++..+..++.||+.||.|||+.   +|+|+||||+||+++.++.+||+|||++
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~  171 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFS  171 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             cCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecccch
Confidence            9999999999999999999998877899999999999999999999998   9999999999999999999999999999


Q ss_pred             cccccCCcccccccccCCCCcccccccc------cCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHh
Q 041921          669 KLLTLNQSKTIKTAIRGTKGYVAPEWFR------NSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY  742 (814)
Q Consensus       669 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  742 (814)
                      .........   ....|++.|+|||.+.      ...++.++||||||++++||++|+.||.......       ....+
T Consensus       172 ~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~  241 (298)
T 1phk_A          172 CQLDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-------MLRMI  241 (298)
T ss_dssp             EECCTTCCB---CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHH
T ss_pred             hhcCCCccc---ccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH-------HHHHH
Confidence            876543221   3456899999999985      4568899999999999999999999997543221       11122


Q ss_pred             hcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          743 RNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       743 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      ..+.....      .+........+.+++.+||+.||.+|||++++++
T Consensus       242 ~~~~~~~~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          242 MSGNYQFG------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             HHTCCCCC------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             hcCCcccC------cccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            22221110      0111234567889999999999999999999985

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=4.7e-36  Score=323.72  Aligned_cols=254  Identities=25%  Similarity=0.352  Sum_probs=199.4

Q ss_pred             HHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--------ccchHhHHHHHHhhhccCCCCccceeeee
Q 041921          516 LEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--------QDGEREFKNEVFVIGQTHHKNLVRLLGFC  587 (814)
Q Consensus       516 l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~  587 (814)
                      .....|.+.+.||+|+||.||+|...  ..+..||||.+....        ......+.+|+.++++++||||+++++++
T Consensus         7 ~l~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   84 (322)
T 2ycf_A            7 ALRDEYIMSKTLGSGACGEVKLAFER--KTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF   84 (322)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEET--TTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hhhhceeEeeEEecCCCEEEEEEEEc--CCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEE
Confidence            44567888999999999999999875  357899999986432        11234588999999999999999999998


Q ss_pred             cccccceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCc---EEEee
Q 041921          588 DEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYT---ARISD  664 (814)
Q Consensus       588 ~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~---~kl~D  664 (814)
                      ..++ .++||||+++++|.+++.....+++.....++.||+.||.|||+.   +|+||||||+|||++.++.   +||+|
T Consensus        85 ~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~D  160 (322)
T 2ycf_A           85 DAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD  160 (322)
T ss_dssp             ESSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred             cCCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEcc
Confidence            7654 899999999999999999888899999999999999999999998   9999999999999987654   99999


Q ss_pred             cCCccccccCCcccccccccCCCCcccccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHH
Q 041921          665 FGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR---NSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC  741 (814)
Q Consensus       665 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  741 (814)
                      ||++........   .....||+.|+|||.+.   ...++.++||||||+++|||++|+.||........  +    ...
T Consensus       161 fg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~----~~~  231 (322)
T 2ycf_A          161 FGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--L----KDQ  231 (322)
T ss_dssp             CTTCEECCCCHH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--H----HHH
T ss_pred             Cccceecccccc---cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--H----HHH
Confidence            999987653221   13356899999999974   56788999999999999999999999975433211  1    111


Q ss_pred             hhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          742 YRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       742 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      +..+......  .    ........+.+++.+||+.||.+|||++++++
T Consensus       232 ~~~~~~~~~~--~----~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          232 ITSGKYNFIP--E----VWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             HHHTCCCCCH--H----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHhCccccCc--h----hhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            1222211100  0    00123467889999999999999999999874

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2e-35  Score=319.92  Aligned_cols=258  Identities=19%  Similarity=0.272  Sum_probs=199.0

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccC-CCCccceeeeecc--cccceE
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTH-HKNLVRLLGFCDE--GQNRLL  595 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~l  595 (814)
                      ..|.+.++||+|+||.||+|....  .+..||||.++.   ...+.+.+|+.++++++ ||||+++++++.+  ....++
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l  110 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINIT--NNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL  110 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECC--CCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence            456778999999999999998653  578999999864   34567999999999997 9999999999987  567899


Q ss_pred             EEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC-cEEEeecCCccccccC
Q 041921          596 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYY-TARISDFGLAKLLTLN  674 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~-~~kl~DfGla~~~~~~  674 (814)
                      ||||+++++|.+++.   .+++..+..++.||+.||+|||+.   +|+||||||+|||++.++ .+||+|||+++.....
T Consensus       111 v~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~  184 (330)
T 3nsz_A          111 VFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  184 (330)
T ss_dssp             EEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             EEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence            999999999999985   378889999999999999999998   999999999999999766 8999999999876543


Q ss_pred             CcccccccccCCCCccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHH--H-----HHHHHhhcCc
Q 041921          675 QSKTIKTAIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILT--D-----WAFDCYRNGK  746 (814)
Q Consensus       675 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~--~-----~~~~~~~~~~  746 (814)
                      ...   ....++..|+|||.+.+ ..++.++||||||++++||++|+.||............  .     .....+....
T Consensus       185 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  261 (330)
T 3nsz_A          185 QEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN  261 (330)
T ss_dssp             CCC---CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred             Ccc---ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhc
Confidence            322   34568999999999877 67899999999999999999999999543322111000  0     0001111110


Q ss_pred             cce--------------eecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          747 LNV--------------LVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       747 ~~~--------------~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      ...              .................+.+++.+||+.||.+|||++|+++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            000              00000011111224578899999999999999999999987

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.1e-36  Score=335.25  Aligned_cols=252  Identities=11%  Similarity=0.052  Sum_probs=180.0

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc---cchHhHHHHHHhhhcc--CCCCcccee-------eee
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ---DGEREFKNEVFVIGQT--HHKNLVRLL-------GFC  587 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l--~h~niv~l~-------~~~  587 (814)
                      ++.+.++||+|+||.||+|....  +++.||||++.....   ...+.+.+|+.++..+  +||||++++       +++
T Consensus        63 ~y~~~~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           63 KLKLVEPLRVGDRSVVFLVRDVE--RLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETT--TTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             eeeeeeeccCCCCEEEEEEEECC--CCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            35677899999999999999753  578999999976432   2334577885444444  699988755       333


Q ss_pred             ccc-----------------ccceEEEecCCCCCHHHHhcCC-CCCChhhH------HHHHHHHHHHHHHhhhcCCCCee
Q 041921          588 DEG-----------------QNRLLVYEFLNNGTLASFLFGN-LKPNWNLR------TNIAFQIARGLLYLHEDCRAQII  643 (814)
Q Consensus       588 ~~~-----------------~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~------~~i~~~ia~~l~yLH~~~~~~i~  643 (814)
                      ...                 ...+|||||++ ++|.+++... ..+.+..+      ..++.||++||+|||+.   +|+
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~iv  216 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLV  216 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCc
Confidence            221                 34799999999 8999999763 34466666      78889999999999998   999


Q ss_pred             ecCCCCCcEEEcCCCcEEEeecCCccccccCCcccccccccCCCCccccccccc--CCCCcchhhHHHHHHHHHHHhCCC
Q 041921          644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRN--SKITAKVDVYSFGVLLLEIISCRK  721 (814)
Q Consensus       644 H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~Dv~s~Gvvl~elltg~~  721 (814)
                      ||||||+||||+.++.+||+|||+++......     ....+|+.|+|||.+.+  ..++.++|||||||++|||++|+.
T Consensus       217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~  291 (371)
T 3q60_A          217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL  291 (371)
T ss_dssp             ETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred             cCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence            99999999999999999999999998664321     13457799999999987  679999999999999999999999


Q ss_pred             CCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          722 SFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       722 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      ||..........        +........................+.+++.+||+.||++|||+.++++
T Consensus       292 Pf~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          292 PFGLVTPGIKGS--------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             STTBCCTTCTTC--------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCCCcCcccccc--------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            997653321100        0000000000111111111234577889999999999999999999874

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.1e-36  Score=357.98  Aligned_cols=261  Identities=24%  Similarity=0.371  Sum_probs=207.3

Q ss_pred             HHHHhhhccccceeeeeeeeEEEEEEecCC-CceEEEEEEeccccc-cchHhHHHHHHhhhccCCCCccceeeeeccccc
Q 041921          515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRT-STTAVAVKKLDRVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQN  592 (814)
Q Consensus       515 ~l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  592 (814)
                      ++....+.+.+.||+|+||.||+|.+...+ .+..||||++..... ...+.+.+|+.++++++||||+++++++. ++.
T Consensus       386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~  464 (656)
T 2j0j_A          386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP  464 (656)
T ss_dssp             BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred             ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCc
Confidence            344567788899999999999999986432 457899999875332 33467999999999999999999999985 466


Q ss_pred             ceEEEecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcccc
Q 041921          593 RLLVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLL  671 (814)
Q Consensus       593 ~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~  671 (814)
                      .++||||+++|+|.+++... ..+++..+..++.|+++||.|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus       465 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~  541 (656)
T 2j0j_A          465 VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  541 (656)
T ss_dssp             CEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred             eEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeec
Confidence            89999999999999999755 4689999999999999999999998   9999999999999999999999999999876


Q ss_pred             ccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCcccee
Q 041921          672 TLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVL  750 (814)
Q Consensus       672 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  750 (814)
                      ....... .....+|+.|+|||.+....++.++||||||+++|||++ |..||......+.       ...+..+...  
T Consensus       542 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~-------~~~i~~~~~~--  611 (656)
T 2j0j_A          542 EDSTYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV-------IGRIENGERL--  611 (656)
T ss_dssp             CC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-------HHHHHHTCCC--
T ss_pred             CCCccee-ccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHH-------HHHHHcCCCC--
Confidence            5432221 123457789999999998899999999999999999997 9999975433221       1112222111  


Q ss_pred             ecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 041921          751 VGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV  796 (814)
Q Consensus       751 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~  796 (814)
                             ..+...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus       612 -------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il  650 (656)
T 2j0j_A          612 -------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  650 (656)
T ss_dssp             -------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence                   011234567889999999999999999999999998764

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=8.7e-36  Score=340.19  Aligned_cols=250  Identities=26%  Similarity=0.289  Sum_probs=201.8

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHHHHHhhhccCCCCccceeeeecccccceEE
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV  596 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  596 (814)
                      .+.+.+.||+|+||.||++....  .++.||||++....   ....+.+..|+.++++++||||+++++++.+.+..++|
T Consensus       186 ~f~~~~~LG~G~fG~Vy~a~~~~--tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          186 WFLDFRVLGRGGFGEVFACQMKA--TGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETT--TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             heEEEEEEeeCCCeEEEEEEECC--CCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            34556789999999999999753  57899999996432   23345788999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhcCC----CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccc
Q 041921          597 YEFLNNGTLASFLFGN----LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLT  672 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~  672 (814)
                      |||+++|+|.+++...    ..+++.....++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.+.
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            9999999999999753    4688999999999999999999998   99999999999999999999999999998765


Q ss_pred             cCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeec
Q 041921          673 LNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVG  752 (814)
Q Consensus       673 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  752 (814)
                      .....  .....||+.|+|||++.+..++.++|||||||++|||++|+.||.........   ..+.+.+......    
T Consensus       341 ~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~---~~~~~~i~~~~~~----  411 (543)
T 3c4z_A          341 AGQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN---KELKQRVLEQAVT----  411 (543)
T ss_dssp             TTCCC--BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH---HHHHHHHHHCCCC----
T ss_pred             CCCcc--cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhH---HHHHHHHhhcccC----
Confidence            43322  13457999999999999999999999999999999999999999754321110   0111222222111    


Q ss_pred             CcccccCcHHHHHHHHHHHHHccccCCCCCCCH-----HHHH
Q 041921          753 EDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTM-----KKVL  789 (814)
Q Consensus       753 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~-----~~vl  789 (814)
                            .+......+.+++.+||+.||.+||++     ++++
T Consensus       412 ------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~  447 (543)
T 3c4z_A          412 ------YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLR  447 (543)
T ss_dssp             ------CCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHH
T ss_pred             ------CCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHH
Confidence                  112234678899999999999999975     5665

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=2.1e-36  Score=325.81  Aligned_cols=258  Identities=26%  Similarity=0.372  Sum_probs=199.2

Q ss_pred             HhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeecccccceE
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL  595 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  595 (814)
                      ...+.+.+.||+|+||.||+|...     ..+|+|.+....  ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        32 ~~~~~~~~~lg~G~~g~V~~~~~~-----~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i  106 (319)
T 2y4i_B           32 FEQLEIGELIGKGRFGQVYHGRWH-----GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAI  106 (319)
T ss_dssp             CSCEECCCBCCCSSSSEEEEEEES-----SSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEE
T ss_pred             HHHeEEeeEeccCCceEEEEEEEc-----CeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEE
Confidence            445677899999999999999874     248999886432  2334568899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhcCCC-CCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccC
Q 041921          596 VYEFLNNGTLASFLFGNL-KPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN  674 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~  674 (814)
                      |+||+++++|.+++.... .+++..+..++.||++||+|||+.   +|+||||||+||+++ ++.+||+|||++......
T Consensus       107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~  182 (319)
T 2y4i_B          107 ITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL  182 (319)
T ss_dssp             ECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred             EeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence            999999999999998754 689999999999999999999998   999999999999998 679999999998765422


Q ss_pred             Cc---ccccccccCCCCccccccccc---------CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHh
Q 041921          675 QS---KTIKTAIRGTKGYVAPEWFRN---------SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY  742 (814)
Q Consensus       675 ~~---~~~~~~~~gt~~y~aPE~~~~---------~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  742 (814)
                      ..   ........|+..|+|||.+..         ..++.++||||||+++|||++|+.||.....+..       ...+
T Consensus       183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-------~~~~  255 (319)
T 2y4i_B          183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI-------IWQM  255 (319)
T ss_dssp             -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHH-------HHHH
T ss_pred             cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHh
Confidence            11   111133458999999999864         3578899999999999999999999975433221       1112


Q ss_pred             hcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCC
Q 041921          743 RNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS  799 (814)
Q Consensus       743 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~~~  799 (814)
                      ..+.......        ......+.+++.+||+.||.+|||+.+++++|+.+.+..
T Consensus       256 ~~~~~~~~~~--------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~  304 (319)
T 2y4i_B          256 GTGMKPNLSQ--------IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN  304 (319)
T ss_dssp             HTTCCCCCCC--------SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred             ccCCCCCCCc--------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence            2221111111        112356789999999999999999999999999876653

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.9e-36  Score=329.93  Aligned_cols=257  Identities=23%  Similarity=0.298  Sum_probs=193.9

Q ss_pred             HhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecc--------
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDE--------  589 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------  589 (814)
                      ...|.+.+.||+|+||.||+|....  ++..||||++...    .+...+|+.+++.++||||+++++++..        
T Consensus         6 ~~~y~~~~~lG~G~fg~V~~a~~~~--~~~~vAiK~~~~~----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~   79 (383)
T 3eb0_A            6 SKKYSLGKTLGTGSFGIVCEVFDIE--SGKRFALKKVLQD----PRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP   79 (383)
T ss_dssp             CTTEEEEEEEECC-CEEEEEEEETT--TCCEEEEEEEECC----TTSCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred             cceEEEEEEEEeccCEEEEEEEECC--CCCEEEEEEEecC----cchHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence            4467788999999999999998753  5789999998643    2234579999999999999999999843        


Q ss_pred             ------------------------------cccceEEEecCCCCCHHHHhc----CCCCCChhhHHHHHHHHHHHHHHhh
Q 041921          590 ------------------------------GQNRLLVYEFLNNGTLASFLF----GNLKPNWNLRTNIAFQIARGLLYLH  635 (814)
Q Consensus       590 ------------------------------~~~~~lv~e~~~~gsL~~~l~----~~~~l~~~~~~~i~~~ia~~l~yLH  635 (814)
                                                    ....++||||++ ++|.+.+.    ....+++..+..++.||++||+|||
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH  158 (383)
T 3eb0_A           80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH  158 (383)
T ss_dssp             ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence                                          233789999998 47766664    4577899999999999999999999


Q ss_pred             hcCCCCeeecCCCCCcEEEc-CCCcEEEeecCCccccccCCcccccccccCCCCcccccccccC-CCCcchhhHHHHHHH
Q 041921          636 EDCRAQIIHCDIKPQNILLD-DYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLL  713 (814)
Q Consensus       636 ~~~~~~i~H~dlkp~NIll~-~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~s~Gvvl  713 (814)
                      +.   +|+||||||+|||++ .++.+||+|||+++.+......   ....+|+.|+|||.+.+. .++.++|||||||++
T Consensus       159 ~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il  232 (383)
T 3eb0_A          159 SL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS---VAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF  232 (383)
T ss_dssp             TT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC---CCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred             HC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC---cCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence            98   999999999999998 6889999999999876543322   345689999999998765 589999999999999


Q ss_pred             HHHHhCCCCCCcccchhhhhHHHHHHHHhhcC---------------ccceeecCcccccCcHHHHHHHHHHHHHccccC
Q 041921          714 LEIISCRKSFDIEMGEEYAILTDWAFDCYRNG---------------KLNVLVGEDKEAMNDIECLGKLVMVSIWCIQED  778 (814)
Q Consensus       714 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~d  778 (814)
                      +||++|+.||......+..  .. +.......               ..............+...+..+.+++.+||+.|
T Consensus       233 ~ell~g~~pf~~~~~~~~~--~~-i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  309 (383)
T 3eb0_A          233 GELILGKPLFSGETSIDQL--VR-IIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE  309 (383)
T ss_dssp             HHHHHSSCSSCCSSHHHHH--HH-HHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred             HHHHhCCCCCCCCChHHHH--HH-HHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence            9999999999865433211  11 11110000               000000001111112224567889999999999


Q ss_pred             CCCCCCHHHHHH
Q 041921          779 PSLRPTMKKVLQ  790 (814)
Q Consensus       779 p~~RPt~~~vl~  790 (814)
                      |.+|||+.|+++
T Consensus       310 P~~R~t~~e~l~  321 (383)
T 3eb0_A          310 PDLRINPYEAMA  321 (383)
T ss_dssp             GGGSCCHHHHHT
T ss_pred             hhhCCCHHHHhc
Confidence            999999999983

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=8.8e-36  Score=325.19  Aligned_cols=256  Identities=20%  Similarity=0.333  Sum_probs=204.1

Q ss_pred             HhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccc-----------------hHhHHHHHHhhhccCCCCc
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG-----------------EREFKNEVFVIGQTHHKNL  580 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~-----------------~~~~~~E~~~l~~l~h~ni  580 (814)
                      ...|.+.+.||+|+||.||+|..    ++..||||.+.......                 .+.+.+|+.++++++||||
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i  105 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK----DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYC  105 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE----TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTB
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc----CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCc
Confidence            34577789999999999999987    47899999996432211                 1789999999999999999


Q ss_pred             cceeeeecccccceEEEecCCCCCHHHH------hcC--CCCCChhhHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCc
Q 041921          581 VRLLGFCDEGQNRLLVYEFLNNGTLASF------LFG--NLKPNWNLRTNIAFQIARGLLYLHE-DCRAQIIHCDIKPQN  651 (814)
Q Consensus       581 v~l~~~~~~~~~~~lv~e~~~~gsL~~~------l~~--~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~i~H~dlkp~N  651 (814)
                      +++++++.+.+..++||||+++++|.++      +..  ...+++..+..++.|++.||.|||+ .   +|+||||||+|
T Consensus       106 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~N  182 (348)
T 2pml_X          106 LTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSN  182 (348)
T ss_dssp             CCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGG
T ss_pred             ceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHh
Confidence            9999999999999999999999999999      665  5678999999999999999999998 7   99999999999


Q ss_pred             EEEcCCCcEEEeecCCccccccCCcccccccccCCCCcccccccccC-CCCc-chhhHHHHHHHHHHHhCCCCCCcccch
Q 041921          652 ILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNS-KITA-KVDVYSFGVLLLEIISCRKSFDIEMGE  729 (814)
Q Consensus       652 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-~~Dv~s~Gvvl~elltg~~p~~~~~~~  729 (814)
                      |+++.++.+||+|||++......    ......|+..|+|||.+.+. .++. ++||||||++++||++|+.||......
T Consensus       183 il~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  258 (348)
T 2pml_X          183 ILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL  258 (348)
T ss_dssp             EEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS
T ss_pred             EEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH
Confidence            99999999999999999876433    12345689999999999877 5666 999999999999999999999755431


Q ss_pred             hhhhHHHHHHHHhhcCccceeecCcc---------cccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          730 EYAILTDWAFDCYRNGKLNVLVGEDK---------EAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       730 ~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      ..      ....+..+..........         ...........+.+++.+||+.||.+|||++++++
T Consensus       259 ~~------~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          259 VE------LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             HH------HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HH------HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            11      122233332211110000         00001234567889999999999999999999987

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=3.2e-36  Score=319.74  Aligned_cols=251  Identities=22%  Similarity=0.309  Sum_probs=185.8

Q ss_pred             HhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccccc-c-hHhHHHHHHhhhccCCCCccceeeeecccccceE
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD-G-EREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL  595 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~-~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  595 (814)
                      ...+.+.++||+|+||.||+|...  ..++.||||++...... . .+.+.++...++.++||||+++++++.+++..++
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l   83 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHV--PSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI   83 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET--TTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEec--CCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence            456778899999999999999975  35789999999653221 2 2334555566888899999999999999999999


Q ss_pred             EEecCCCCCHHHHhc----CCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcccc
Q 041921          596 VYEFLNNGTLASFLF----GNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLL  671 (814)
Q Consensus       596 v~e~~~~gsL~~~l~----~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~  671 (814)
                      ||||++ ++|.+++.    ....+++..+..++.|++.||.|||+.  .+|+||||||+||+++.++.+||+|||++...
T Consensus        84 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           84 CMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             EEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             EEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            999997 58877765    356789999999999999999999984  38999999999999999999999999999876


Q ss_pred             ccCCcccccccccCCCCccccccc----ccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCcc
Q 041921          672 TLNQSKTIKTAIRGTKGYVAPEWF----RNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL  747 (814)
Q Consensus       672 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  747 (814)
                      ......   ....||+.|+|||.+    .+..++.++||||||++++||++|+.||.........     ..........
T Consensus       161 ~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-----~~~~~~~~~~  232 (290)
T 3fme_A          161 VDDVAK---DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ-----LKQVVEEPSP  232 (290)
T ss_dssp             ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHH-----HHHHHHSCCC
T ss_pred             cccccc---cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHH-----HHHHhccCCC
Confidence            543222   334689999999996    5567899999999999999999999999753322111     1111111111


Q ss_pred             ceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          748 NVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       748 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      .         .........+.+++.+||+.||.+|||++++++
T Consensus       233 ~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          233 Q---------LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             C---------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             C---------cccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence            1         011123467889999999999999999999986

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=4.8e-36  Score=334.24  Aligned_cols=265  Identities=20%  Similarity=0.296  Sum_probs=183.8

Q ss_pred             hcc-ccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeec--ccccceEEE
Q 041921          521 NNF-KEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCD--EGQNRLLVY  597 (814)
Q Consensus       521 ~~~-~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~lv~  597 (814)
                      +.+ +++||+|+||.||+|...+...+..||||++...  .....+.+|+.++++++||||+++++++.  .....+|||
T Consensus        22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~   99 (405)
T 3rgf_A           22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF   99 (405)
T ss_dssp             EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred             hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence            344 4579999999999999876556789999999753  23457889999999999999999999994  467889999


Q ss_pred             ecCCCCCHHHHhcCC---------CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE----cCCCcEEEee
Q 041921          598 EFLNNGTLASFLFGN---------LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILL----DDYYTARISD  664 (814)
Q Consensus       598 e~~~~gsL~~~l~~~---------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll----~~~~~~kl~D  664 (814)
                      ||+. ++|.+++...         ..+++..+..|+.||+.||+|||+.   +|+||||||+||||    +.++.+||+|
T Consensus       100 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~D  175 (405)
T 3rgf_A          100 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIAD  175 (405)
T ss_dssp             ECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred             eCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence            9997 4787777521         2488999999999999999999998   99999999999999    6788999999


Q ss_pred             cCCccccccCCcc-cccccccCCCCcccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcccchh------hhhHHH
Q 041921          665 FGLAKLLTLNQSK-TIKTAIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIISCRKSFDIEMGEE------YAILTD  736 (814)
Q Consensus       665 fGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~------~~~~~~  736 (814)
                      ||+++.+...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.....+.      ......
T Consensus       176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~  255 (405)
T 3rgf_A          176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD  255 (405)
T ss_dssp             TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHH
T ss_pred             CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHH
Confidence            9999876543211 112345689999999999874 58999999999999999999999997543210      000111


Q ss_pred             HHHHHhhcCc---ccee-------------ecCccccc--------CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          737 WAFDCYRNGK---LNVL-------------VGEDKEAM--------NDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       737 ~~~~~~~~~~---~~~~-------------~~~~~~~~--------~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                      .+...+....   ...+             ........        ........+.+|+.+||+.||.+|||++|+++.
T Consensus       256 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h  334 (405)
T 3rgf_A          256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD  334 (405)
T ss_dssp             HHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            1111111000   0000             00000000        000114567899999999999999999999873

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=8.2e-36  Score=323.80  Aligned_cols=265  Identities=22%  Similarity=0.314  Sum_probs=204.1

Q ss_pred             HHHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCC------ccceeeeec
Q 041921          515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKN------LVRLLGFCD  588 (814)
Q Consensus       515 ~l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~  588 (814)
                      ++....|.+.+.||+|+||.||+|... ...+..||||.++.. ....+.+.+|+.+++.++|++      ++++++++.
T Consensus        10 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~   87 (339)
T 1z57_A           10 DVLSARYEIVDTLGEGAFGKVVECIDH-KAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE   87 (339)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEET-TTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE
T ss_pred             CCccCceEEEEEEecCCCeEEEEEEec-CCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc
Confidence            334567888899999999999999863 235789999999753 234467889999999987765      999999999


Q ss_pred             ccccceEEEecCCCCCHHHHhcCCC--CCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC----------
Q 041921          589 EGQNRLLVYEFLNNGTLASFLFGNL--KPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDD----------  656 (814)
Q Consensus       589 ~~~~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~----------  656 (814)
                      +.+..++||||+ +++|.+++....  .+++..+..++.||++||+|||+.   +|+||||||+|||++.          
T Consensus        88 ~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~  163 (339)
T 1z57_A           88 HHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPK  163 (339)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC--
T ss_pred             cCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCc
Confidence            999999999999 889999997654  678999999999999999999998   9999999999999987          


Q ss_pred             ---------CCcEEEeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCccc
Q 041921          657 ---------YYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEM  727 (814)
Q Consensus       657 ---------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~  727 (814)
                               ++.+||+|||++.......     ....||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus       164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  238 (339)
T 1z57_A          164 IKRDERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD  238 (339)
T ss_dssp             --CEEEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred             cccccccccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence                     6789999999998654322     33568999999999999999999999999999999999999997654


Q ss_pred             chhhhhHHHHHH--------HHhhcCccc---ee---------------ecC-cccccCcHHHHHHHHHHHHHccccCCC
Q 041921          728 GEEYAILTDWAF--------DCYRNGKLN---VL---------------VGE-DKEAMNDIECLGKLVMVSIWCIQEDPS  780 (814)
Q Consensus       728 ~~~~~~~~~~~~--------~~~~~~~~~---~~---------------~~~-~~~~~~~~~~~~~l~~l~~~Cl~~dp~  780 (814)
                      ..+.........        .........   ..               ..+ ...........+.+.+++.+||+.||.
T Consensus       239 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~  318 (339)
T 1z57_A          239 SKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPA  318 (339)
T ss_dssp             HHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred             hHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcc
Confidence            332211111000        000000000   00               000 000111234577899999999999999


Q ss_pred             CCCCHHHHHH
Q 041921          781 LRPTMKKVLQ  790 (814)
Q Consensus       781 ~RPt~~~vl~  790 (814)
                      +|||++|+++
T Consensus       319 ~Rpt~~ell~  328 (339)
T 1z57_A          319 KRITLREALK  328 (339)
T ss_dssp             TSCCHHHHTT
T ss_pred             cccCHHHHhc
Confidence            9999999985

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=2.1e-35  Score=313.16  Aligned_cols=255  Identities=25%  Similarity=0.327  Sum_probs=206.3

Q ss_pred             HHHHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeecccc
Q 041921          514 KELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ  591 (814)
Q Consensus       514 ~~l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  591 (814)
                      .+.....|.+.+.||+|+||.||+|....  .++.||||.+....  ....+.+.+|+.++++++||||+++++++.+.+
T Consensus        17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~--~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   94 (287)
T 2wei_A           17 QGTFAERYNIVCMLGKGSFGEVLKCKDRI--TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSS   94 (287)
T ss_dssp             THHHHHHEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             HHHHhhcceeeEEEcCCCCEEEEEEEEcC--CCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCC
Confidence            45556788889999999999999998753  57799999986432  234567999999999999999999999999999


Q ss_pred             cceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC---CcEEEeecCCc
Q 041921          592 NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDY---YTARISDFGLA  668 (814)
Q Consensus       592 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~---~~~kl~DfGla  668 (814)
                      ..++|+||+++++|.+++.....+++..+..++.|++.||.|||+.   +|+|+||||+||+++.+   +.+||+|||++
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~  171 (287)
T 2wei_A           95 SFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS  171 (287)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred             eEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence            9999999999999999998777899999999999999999999998   99999999999999754   47999999999


Q ss_pred             cccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccc
Q 041921          669 KLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLN  748 (814)
Q Consensus       669 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  748 (814)
                      .........   ....++..|+|||.+.+ .++.++||||||++++||++|+.||......+       ....+..+...
T Consensus       172 ~~~~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~  240 (287)
T 2wei_A          172 TCFQQNTKM---KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-------ILKRVETGKYA  240 (287)
T ss_dssp             GTBCCCSSC---SCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCC
T ss_pred             eeecCCCcc---ccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCCCC
Confidence            876543221   23358899999999875 48999999999999999999999997543322       11222222221


Q ss_pred             eeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          749 VLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       749 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      ...      +........+.+++.+||+.||.+|||+.++++
T Consensus       241 ~~~------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          241 FDL------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             CCS------GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCc------hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            100      001123467889999999999999999999987

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=3e-35  Score=329.65  Aligned_cols=198  Identities=24%  Similarity=0.330  Sum_probs=170.1

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhcc------CCCCccceeeeeccccc
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQT------HHKNLVRLLGFCDEGQN  592 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~  592 (814)
                      .+|.+.++||+|+||.||+|...  ..++.||||.+... ....+++.+|+.++..+      +|+||+++++++.....
T Consensus        97 ~ry~~~~~LG~G~fg~V~~a~~~--~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  173 (429)
T 3kvw_A           97 YRYEVLKVIGKGSFGQVVKAYDH--KVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH  173 (429)
T ss_dssp             TTEEEEEEEEESSSEEEEEEEET--TTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred             CcEEEEEEcccCccEEEEEEEEC--CCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence            45777899999999999999865  35789999999753 22345677888887776      57799999999999999


Q ss_pred             ceEEEecCCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCc--EEEeecCCc
Q 041921          593 RLLVYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYT--ARISDFGLA  668 (814)
Q Consensus       593 ~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~--~kl~DfGla  668 (814)
                      .++||||+. ++|.+++...  ..+++..+..++.||+.||+|||+.   +|+||||||+||||+.++.  +||+|||++
T Consensus       174 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a  249 (429)
T 3kvw_A          174 ICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSS  249 (429)
T ss_dssp             EEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             EEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccc
Confidence            999999996 6999988765  4589999999999999999999999   9999999999999998887  999999999


Q ss_pred             cccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccc
Q 041921          669 KLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMG  728 (814)
Q Consensus       669 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~  728 (814)
                      .......     ....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       250 ~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~  304 (429)
T 3kvw_A          250 CYEHQRV-----YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE  304 (429)
T ss_dssp             EETTCCC-----CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             eecCCcc-----cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence            7654321     335689999999999999999999999999999999999999976543

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=2.2e-35  Score=324.82  Aligned_cols=261  Identities=24%  Similarity=0.267  Sum_probs=189.9

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeecccc-----
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ-----  591 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  591 (814)
                      ..|.+.+.||+|+||.||+|...  ..+..||||++....  ....+.+.+|+.+++.++||||+++++++...+     
T Consensus        25 ~~y~~~~~lG~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  102 (371)
T 2xrw_A           25 KRYQNLKPIGSGAQGIVCAAYDA--ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  102 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEET--TTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred             hheeEeeeeEecCCEEEEEEEEC--CCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence            34667789999999999999865  357899999996532  223456889999999999999999999987654     


Q ss_pred             -cceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccc
Q 041921          592 -NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKL  670 (814)
Q Consensus       592 -~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~  670 (814)
                       ..++||||+++ +|.+++..  .+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus       103 ~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~  176 (371)
T 2xrw_A          103 QDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART  176 (371)
T ss_dssp             CEEEEEEECCSE-EHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred             cceEEEEEcCCC-CHHHHHhh--ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence             67999999975 78888853  478899999999999999999998   999999999999999999999999999986


Q ss_pred             cccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhH-H--------------
Q 041921          671 LTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL-T--------------  735 (814)
Q Consensus       671 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~-~--------------  735 (814)
                      ......   .....||+.|+|||.+.+..++.++||||||++++||++|+.||......+.... .              
T Consensus       177 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  253 (371)
T 2xrw_A          177 AGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL  253 (371)
T ss_dssp             ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTS
T ss_pred             cccccc---cCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence            643221   1345689999999999999999999999999999999999999975433211000 0              


Q ss_pred             -HHHHHHhhcC-c-----cceeecCcc---cccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          736 -DWAFDCYRNG-K-----LNVLVGEDK---EAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       736 -~~~~~~~~~~-~-----~~~~~~~~~---~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                       .......... .     +........   ...........+.+++.+||+.||.+|||++++++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence             0000000000 0     000000000   00001233678899999999999999999999986

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=7.2e-36  Score=320.87  Aligned_cols=254  Identities=21%  Similarity=0.308  Sum_probs=195.0

Q ss_pred             HHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccC--CCCccceeeeecccc
Q 041921          516 LEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTH--HKNLVRLLGFCDEGQ  591 (814)
Q Consensus       516 l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~  591 (814)
                      +....|.+.+.||+|+||.||++...   ++..||||.+....  ....+.+.+|+.++.+++  |+||+++++++.+.+
T Consensus        25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~  101 (313)
T 3cek_A           25 VKGRIYSILKQIGSGGSSKVFQVLNE---KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ  101 (313)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEECT---TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS
T ss_pred             eccceEEEEEEecCCCCEEEEEEEcC---CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCC
Confidence            34455777889999999999999864   47789999986432  234467899999999997  599999999999999


Q ss_pred             cceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcccc
Q 041921          592 NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLL  671 (814)
Q Consensus       592 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~  671 (814)
                      ..++||| +.+++|.+++.....+++..+..++.|+++||.|||+.   +|+||||||+|||+++ +.+||+|||++...
T Consensus       102 ~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~  176 (313)
T 3cek_A          102 YIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQM  176 (313)
T ss_dssp             EEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC-
T ss_pred             EEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccc
Confidence            9999999 67889999999888899999999999999999999998   9999999999999975 79999999999876


Q ss_pred             ccCCcccccccccCCCCccccccccc-----------CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHH
Q 041921          672 TLNQSKTIKTAIRGTKGYVAPEWFRN-----------SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD  740 (814)
Q Consensus       672 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  740 (814)
                      .............||+.|+|||.+.+           ..++.++||||||++++||++|+.||........ .    ...
T Consensus       177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~----~~~  251 (313)
T 3cek_A          177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-K----LHA  251 (313)
T ss_dssp             -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-H----HHH
T ss_pred             cCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH-H----HHH
Confidence            54433222234568999999999875           4688899999999999999999999975432211 1    111


Q ss_pred             HhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          741 CYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       741 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                      ...... .        ...+......+.+++.+||+.||.+|||++++++.
T Consensus       252 ~~~~~~-~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          252 IIDPNH-E--------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             HHCTTS-C--------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHhccc-c--------cCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence            111111 0        00111123578899999999999999999999863

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.5e-36  Score=322.61  Aligned_cols=249  Identities=25%  Similarity=0.375  Sum_probs=193.2

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhcc-CCCCccceeeeecc------cc
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQT-HHKNLVRLLGFCDE------GQ  591 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~------~~  591 (814)
                      ..+.+.+.||+|+||.||+|....  .++.||||.+... ....+++.+|+.++.++ +||||+++++++..      ..
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~~--~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~  100 (326)
T 2x7f_A           24 GIFELVELVGNGTYGQVYKGRHVK--TGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD  100 (326)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEECC-SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCC
T ss_pred             CcEEEEEEeccCCCEEEEEEEECC--CCCeEEEEEEecC-cccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccc
Confidence            345667899999999999999753  5779999998653 33456899999999999 89999999999976      45


Q ss_pred             cceEEEecCCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcc
Q 041921          592 NRLLVYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAK  669 (814)
Q Consensus       592 ~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~  669 (814)
                      ..++||||+++++|.+++...  ..+++..+..++.||+.||.|||+.   +|+|+||||+||+++.++.+||+|||++.
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  177 (326)
T 2x7f_A          101 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA  177 (326)
T ss_dssp             EEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTTTC
T ss_pred             eEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcCce
Confidence            789999999999999999764  5688999999999999999999998   99999999999999999999999999998


Q ss_pred             ccccCCcccccccccCCCCcccccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhc
Q 041921          670 LLTLNQSKTIKTAIRGTKGYVAPEWFR-----NSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN  744 (814)
Q Consensus       670 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  744 (814)
                      ........  .....||+.|+|||.+.     ...++.++||||||+++|||++|+.||.........      .. +..
T Consensus       178 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~-~~~  248 (326)
T 2x7f_A          178 QLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL------FL-IPR  248 (326)
T ss_dssp             ---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HH-HHH
T ss_pred             ecCcCccc--cccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHH------HH-hhc
Confidence            66432211  13356899999999986     567889999999999999999999999654322111      11 111


Q ss_pred             CccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          745 GKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       745 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      ......        ........+.+++.+||+.||.+|||++++++
T Consensus       249 ~~~~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          249 NPAPRL--------KSKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             SCCCCC--------SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CccccC--------CccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            111111        11123467889999999999999999999987

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=5.9e-36  Score=328.30  Aligned_cols=257  Identities=24%  Similarity=0.295  Sum_probs=180.9

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeeccc------
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEG------  590 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  590 (814)
                      ..|.+.+.||+|+||.||+|...  ..+..||||++....  ....+.+.+|+.+++.++||||+++++++...      
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  106 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAAFDT--KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF  106 (367)
T ss_dssp             TTEEEEEECC----CCEEEEEET--TTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             CceEEeeEEeecCCeEEEEEEEC--CCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence            45667789999999999999865  367899999996532  22345788999999999999999999998654      


Q ss_pred             ccceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccc
Q 041921          591 QNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKL  670 (814)
Q Consensus       591 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~  670 (814)
                      ...++|+|++ +++|.+++.. ..+++..+..++.||++||.|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus       107 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~~  181 (367)
T 2fst_X          107 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARH  181 (367)
T ss_dssp             CCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC------
T ss_pred             CeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecccccc
Confidence            5679999998 6899988865 5689999999999999999999998   999999999999999999999999999986


Q ss_pred             cccCCcccccccccCCCCccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCc---
Q 041921          671 LTLNQSKTIKTAIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK---  746 (814)
Q Consensus       671 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---  746 (814)
                      ....     .....||..|+|||.+.+ ..++.++|||||||+++||++|+.||.........   ..+.+.+....   
T Consensus       182 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l---~~i~~~~g~p~~~~  253 (367)
T 2fst_X          182 TADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL---KLILRLVGTPGAEL  253 (367)
T ss_dssp             --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCSCCHHH
T ss_pred             cccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCCCHHH
Confidence            5432     134568999999999877 67899999999999999999999999765432211   11111110000   


Q ss_pred             --------cceeecCcccc-cCc-----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          747 --------LNVLVGEDKEA-MND-----IECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       747 --------~~~~~~~~~~~-~~~-----~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                              ....+...... ...     ......+.+++.+||+.||.+|||++++++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             HTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence                    00000000000 000     112456889999999999999999999986

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=9.8e-36  Score=332.84  Aligned_cols=255  Identities=25%  Similarity=0.306  Sum_probs=191.2

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeeccc------ccc
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEG------QNR  593 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~  593 (814)
                      .|.+.+.||+|+||.||+|....  .+..||||++...    .+.+.+|++++++++||||+++++++...      ...
T Consensus        55 ~y~~~~~lG~G~fg~Vy~~~~~~--~~~~vaiK~~~~~----~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~  128 (420)
T 1j1b_A           55 SYTDTKVIGNGSFGVVYQAKLCD--SGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL  128 (420)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEECC----TTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred             eEEeeeEEeeCCCEEEEEEEECC--CCcEEEEEEeccc----chhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence            46677899999999999999753  5789999998643    22345799999999999999999988432      236


Q ss_pred             eEEEecCCCCCHHHHhc----CCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC-CcEEEeecCCc
Q 041921          594 LLVYEFLNNGTLASFLF----GNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDY-YTARISDFGLA  668 (814)
Q Consensus       594 ~lv~e~~~~gsL~~~l~----~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~-~~~kl~DfGla  668 (814)
                      ++||||+++ +|.+++.    ....+++..+..++.||++||+|||+.   +|+||||||+||||+.+ +.+||+|||++
T Consensus       129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a  204 (420)
T 1j1b_A          129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA  204 (420)
T ss_dssp             EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhh
Confidence            799999986 5555543    356789999999999999999999998   99999999999999955 67899999999


Q ss_pred             cccccCCcccccccccCCCCcccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhh----
Q 041921          669 KLLTLNQSKTIKTAIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR----  743 (814)
Q Consensus       669 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~----  743 (814)
                      +.+......   ....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+.  +...+ +.+.    
T Consensus       205 ~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~--l~~i~-~~lg~p~~  278 (420)
T 1j1b_A          205 KQLVRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVEII-KVLGTPTR  278 (420)
T ss_dssp             EECCTTCCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHH-HHHCSCCH
T ss_pred             hhcccCCCc---eeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHH-HHhCCCCH
Confidence            876543221   345689999999998765 789999999999999999999999976543221  11111 1110    


Q ss_pred             ------cCccceeecCcccc-----cCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          744 ------NGKLNVLVGEDKEA-----MNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       744 ------~~~~~~~~~~~~~~-----~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                            .........+....     ........++.+|+.+||+.||.+|||+.|+++
T Consensus       279 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          279 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence                  00001110111000     011123467889999999999999999999985

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.1e-35  Score=328.23  Aligned_cols=270  Identities=23%  Similarity=0.281  Sum_probs=204.8

Q ss_pred             ccCHHHHHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccC--------CCCcc
Q 041921          510 CFSYKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTH--------HKNLV  581 (814)
Q Consensus       510 ~~~~~~l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~--------h~niv  581 (814)
                      .+...++....|.+.++||+|+||.||+|...  ..++.||||.+... ....+.+.+|+.++++++        |+||+
T Consensus        28 ~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv  104 (397)
T 1wak_A           28 LVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDI--QGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVV  104 (397)
T ss_dssp             SSCTTCEETTTEEEEEEEEECSSEEEEEEEET--TTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBC
T ss_pred             EEehhhhcCCeEEEEEEeeecCCeeEEEEEec--CCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceee
Confidence            34445555677888999999999999999865  35789999999743 334567889999999986        78899


Q ss_pred             ceeeeec----ccccceEEEecCCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc
Q 041921          582 RLLGFCD----EGQNRLLVYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLD  655 (814)
Q Consensus       582 ~l~~~~~----~~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~  655 (814)
                      ++++++.    +....++||||+ +++|.+++...  ..+++..+..++.||+.||+|||+++  +|+||||||+|||++
T Consensus       105 ~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~  181 (397)
T 1wak_A          105 QLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLS  181 (397)
T ss_dssp             CEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEEC
T ss_pred             eeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEe
Confidence            9999987    567889999999 55665555433  56899999999999999999999852  799999999999999


Q ss_pred             CCC-------------------------------------------------cEEEeecCCccccccCCcccccccccCC
Q 041921          656 DYY-------------------------------------------------TARISDFGLAKLLTLNQSKTIKTAIRGT  686 (814)
Q Consensus       656 ~~~-------------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~~gt  686 (814)
                      .++                                                 .+||+|||++.......     ....||
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~-----~~~~gt  256 (397)
T 1wak_A          182 VNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-----TEDIQT  256 (397)
T ss_dssp             CCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS-----CSCCSC
T ss_pred             ccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC-----ccCCCC
Confidence            775                                                 79999999998765332     334689


Q ss_pred             CCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhh---hHHHHHHHHhhc--------Cc---------
Q 041921          687 KGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA---ILTDWAFDCYRN--------GK---------  746 (814)
Q Consensus       687 ~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~---~~~~~~~~~~~~--------~~---------  746 (814)
                      ..|+|||.+.+..++.++|||||||++|||++|+.||......+..   .....+.+....        +.         
T Consensus       257 ~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~  336 (397)
T 1wak_A          257 RQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKK  336 (397)
T ss_dssp             GGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTT
T ss_pred             CcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCc
Confidence            9999999999999999999999999999999999999765432211   111111111100        00         


Q ss_pred             --cceeecCc---------ccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          747 --LNVLVGED---------KEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       747 --~~~~~~~~---------~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                        +..+....         .......+....+.+++.+||+.||.+|||++|+++
T Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          337 GDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             SSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             cccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence              00000000         001124566788999999999999999999999985

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2.6e-35  Score=326.63  Aligned_cols=261  Identities=23%  Similarity=0.294  Sum_probs=194.0

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeeccccc------
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQN------  592 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------  592 (814)
                      .+|.+.++||+|+||.||+|...   ....||+|++....    +...+|+.+++.++||||+++++++.....      
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~---~~~~~aikk~~~~~----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~  112 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLV---ESDEVAIKKVLQDK----RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF  112 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEET---TTEEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEEC---CCCeEEEEEEecCc----chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence            35677889999999999999976   34459999885432    223479999999999999999999855433      


Q ss_pred             ceEEEecCCCCCHHHHh---cCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc-CCCcEEEeecCCc
Q 041921          593 RLLVYEFLNNGTLASFL---FGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLD-DYYTARISDFGLA  668 (814)
Q Consensus       593 ~~lv~e~~~~gsL~~~l---~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~-~~~~~kl~DfGla  668 (814)
                      .++||||++++.+....   .....+++..+..++.||++||+|||+.   +|+||||||+|||++ .++.+||+|||++
T Consensus       113 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a  189 (394)
T 4e7w_A          113 LNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSA  189 (394)
T ss_dssp             EEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence            78999999876544333   2356789999999999999999999998   999999999999999 7999999999999


Q ss_pred             cccccCCcccccccccCCCCcccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhh----
Q 041921          669 KLLTLNQSKTIKTAIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR----  743 (814)
Q Consensus       669 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~----  743 (814)
                      +........   ....+|+.|+|||.+.+. .++.++|||||||++|||++|+.||......+..  .. +.+...    
T Consensus       190 ~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l--~~-i~~~~g~p~~  263 (394)
T 4e7w_A          190 KILIAGEPN---VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQL--VE-IIKVLGTPSR  263 (394)
T ss_dssp             EECCTTCCC---CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HH-HHHHHCCCCH
T ss_pred             ccccCCCCC---cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH--HH-HHHHhCCCCH
Confidence            876543322   345689999999998765 5899999999999999999999999765432211  11 111100    


Q ss_pred             -----------cCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HhcC
Q 041921          744 -----------NGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM--LEGV  795 (814)
Q Consensus       744 -----------~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~--L~~~  795 (814)
                                 ......................++.+++.+||+.||.+|||+.|+++.  ++++
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  328 (394)
T 4e7w_A          264 EQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL  328 (394)
T ss_dssp             HHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred             HHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence                       000000000000000111244678999999999999999999999863  5544

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2e-35  Score=324.38  Aligned_cols=262  Identities=22%  Similarity=0.289  Sum_probs=199.1

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc-cchHhHHHHHHhhhccCCCCccceeeeeccc-----cc
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEG-----QN  592 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  592 (814)
                      ..|.+.+.||+|+||.||+|...  ..+..||||++..... ...+.+.+|+.++.+++||||+++++++...     ..
T Consensus        27 ~~y~~~~~lG~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           27 PRYTNLSYIGEGAYGMVCSAYDN--LNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEET--TTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             ccEEEEEEeecCCCeEEEEEEEC--CCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence            35777889999999999999865  3578999999975332 2336789999999999999999999998654     36


Q ss_pred             ceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccc
Q 041921          593 RLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLT  672 (814)
Q Consensus       593 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~  672 (814)
                      .++|+||+. ++|.+++... .+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus       105 ~~iv~e~~~-~~L~~~l~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  179 (364)
T 3qyz_A          105 VYIVQDLME-TDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVAD  179 (364)
T ss_dssp             EEEEEECCS-EEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEEcccC-cCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence            799999997 5999988654 588999999999999999999998   99999999999999999999999999998765


Q ss_pred             cCCccc-ccccccCCCCccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccc--
Q 041921          673 LNQSKT-IKTAIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLN--  748 (814)
Q Consensus       673 ~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--  748 (814)
                      ...... ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+...   .+..........  
T Consensus       180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~---~i~~~~~~~~~~~~  256 (364)
T 3qyz_A          180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN---HILGILGSPSQEDL  256 (364)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHH---HHHHHHCSCCHHHH
T ss_pred             CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHH---HHHHHhCCCCHHHH
Confidence            433221 1234579999999998754 458999999999999999999999997654332111   111110000000  


Q ss_pred             -------------eeecCcc--cccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          749 -------------VLVGEDK--EAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       749 -------------~~~~~~~--~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                                   .......  ...........+.+++.+||+.||.+|||++++++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                         0000000  00000123467889999999999999999999986

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.6e-35  Score=324.79  Aligned_cols=271  Identities=20%  Similarity=0.235  Sum_probs=188.6

Q ss_pred             HHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeeccccc---
Q 041921          516 LEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQN---  592 (814)
Q Consensus       516 l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---  592 (814)
                      .....+.+.+.||+|+||.||+|....  .+..||||++... ......+.+|+..+..++||||+++++++.....   
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~   96 (360)
T 3e3p_A           20 KEMDRFQVERMAGQGTFGTVQLGKEKS--TGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR   96 (360)
T ss_dssp             HHHTTEEEC----------CEEEEETT--TCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred             hhccceEEEEEEecCCCeEEEEEEECC--CCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence            344567778999999999999999753  5789999998653 2334467788888999999999999999865433   


Q ss_pred             ----ceEEEecCCCCCHH---HHhcCCCCCChhhHHHHHHHHHHHHHHhh--hcCCCCeeecCCCCCcEEEcC-CCcEEE
Q 041921          593 ----RLLVYEFLNNGTLA---SFLFGNLKPNWNLRTNIAFQIARGLLYLH--EDCRAQIIHCDIKPQNILLDD-YYTARI  662 (814)
Q Consensus       593 ----~~lv~e~~~~gsL~---~~l~~~~~l~~~~~~~i~~~ia~~l~yLH--~~~~~~i~H~dlkp~NIll~~-~~~~kl  662 (814)
                          .++||||++++.+.   .++.....+++..+..++.|++.||.|||  +.   +|+||||||+|||++. ++.+||
T Consensus        97 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~kl  173 (360)
T 3e3p_A           97 RDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTLKL  173 (360)
T ss_dssp             TCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEEEE
T ss_pred             cceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcEEE
Confidence                78999999874322   33345677889999999999999999999  76   9999999999999996 899999


Q ss_pred             eecCCccccccCCcccccccccCCCCcccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhh-HHH----
Q 041921          663 SDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI-LTD----  736 (814)
Q Consensus       663 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~-~~~----  736 (814)
                      +|||+++........   ....||+.|+|||.+.+. .++.++||||||+++|||++|+.||.......... +..    
T Consensus       174 ~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  250 (360)
T 3e3p_A          174 CDFGSAKKLSPSEPN---VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGC  250 (360)
T ss_dssp             CCCTTCBCCCTTSCC---CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred             eeCCCceecCCCCCc---ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCC
Confidence            999999876543322   345689999999998655 48999999999999999999999997654322111 000    


Q ss_pred             ---HHHHHhhcCc--cceeecCc-----ccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HhcC
Q 041921          737 ---WAFDCYRNGK--LNVLVGED-----KEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM--LEGV  795 (814)
Q Consensus       737 ---~~~~~~~~~~--~~~~~~~~-----~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~--L~~~  795 (814)
                         ..+..+....  ........     ............+.+++.+||+.||.+|||+.|+++.  ++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  321 (360)
T 3e3p_A          251 PSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDEL  321 (360)
T ss_dssp             CCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGG
T ss_pred             CCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcccccc
Confidence               0000110000  00000000     0001112246789999999999999999999999863  4443

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=8.9e-36  Score=320.86  Aligned_cols=262  Identities=21%  Similarity=0.276  Sum_probs=191.9

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeec----------
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCD----------  588 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----------  588 (814)
                      ..|.+.+.||+|+||.||+|...  ..++.||||++........+++.+|+.++++++||||+++++++.          
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   88 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDN--DCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV   88 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEET--TTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred             CceeEEEEeccCCCeEEEEEEEC--CCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence            45667789999999999999975  357899999997655555678999999999999999999999873          


Q ss_pred             ----ccccceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc-CCCcEEEe
Q 041921          589 ----EGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLD-DYYTARIS  663 (814)
Q Consensus       589 ----~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~-~~~~~kl~  663 (814)
                          +....++||||++ ++|.+++.. ..+++..+..++.|+++||+|||+.   +|+||||||+||+++ +++.+||+
T Consensus        89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~  163 (320)
T 2i6l_A           89 GSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIG  163 (320)
T ss_dssp             --CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEEC
T ss_pred             ccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEc
Confidence                3467799999998 699999865 4688999999999999999999998   999999999999997 56799999


Q ss_pred             ecCCccccccCCcc-cccccccCCCCccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHH
Q 041921          664 DFGLAKLLTLNQSK-TIKTAIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC  741 (814)
Q Consensus       664 DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  741 (814)
                      |||+++........ .......+|..|+|||.+.. ..++.++||||||++++||++|+.||......+..   ..+...
T Consensus       164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~---~~~~~~  240 (320)
T 2i6l_A          164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM---QLILES  240 (320)
T ss_dssp             CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHH
T ss_pred             cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHh
Confidence            99999876532211 11133457899999998865 67899999999999999999999999765432211   001000


Q ss_pred             hhc----------CccceeecCccc-c-----cCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          742 YRN----------GKLNVLVGEDKE-A-----MNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       742 ~~~----------~~~~~~~~~~~~-~-----~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      ...          ..+......... .     .........+.+++.+||+.||.+|||++++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            000          000000000000 0     001123567889999999999999999999986

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.2e-35  Score=326.15  Aligned_cols=258  Identities=23%  Similarity=0.277  Sum_probs=189.2

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccc-----------hHhHHHHHHhhhccCCCCccceeeee
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG-----------EREFKNEVFVIGQTHHKNLVRLLGFC  587 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~l~~~~  587 (814)
                      ..|.+.+.||+|+||.||+|...   .+..||||++.......           .+.+.+|+.++++++||||+++++++
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   98 (362)
T 3pg1_A           22 SPYTVQRFISSGSYGAVCAGVDS---EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF   98 (362)
T ss_dssp             CSCEEEEEEEEETTEEEEEEECT---TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred             cceEEeEEeccCCCEEEEEEECC---CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence            45566789999999999999864   47899999986432211           26789999999999999999999998


Q ss_pred             cc-----cccceEEEecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEE
Q 041921          588 DE-----GQNRLLVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTAR  661 (814)
Q Consensus       588 ~~-----~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~k  661 (814)
                      ..     ....++||||++ ++|.+++... ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+|
T Consensus        99 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~k  174 (362)
T 3pg1_A           99 VHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDIT  174 (362)
T ss_dssp             EECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred             EeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcCCCCEE
Confidence            43     345799999998 5888877654 5789999999999999999999998   999999999999999999999


Q ss_pred             EeecCCccccccCCcccccccccCCCCccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHH
Q 041921          662 ISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD  740 (814)
Q Consensus       662 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  740 (814)
                      |+|||+++........   ....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+..   ..+..
T Consensus       175 l~Dfg~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~i~~  248 (362)
T 3pg1_A          175 ICDFNLAREDTADANK---THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQL---NKIVE  248 (362)
T ss_dssp             ECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHH
T ss_pred             EEecCccccccccccc---ceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHH---HHHHH
Confidence            9999999755433221   34568999999999876 67899999999999999999999999765432211   11111


Q ss_pred             HhhcCc-------------------cceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          741 CYRNGK-------------------LNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       741 ~~~~~~-------------------~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      ......                   ........ ...........+.+++.+||+.||.+|||++++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          249 VVGTPKIEDVVMFSSPSARDYLRNSLSNVPARA-WTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             HHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCC-HHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HcCCCChHHhhhccchhhhHHHHhhcccCChhh-HHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence            111000                   00000000 00001123456889999999999999999999986

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=5.5e-35  Score=315.78  Aligned_cols=261  Identities=24%  Similarity=0.319  Sum_probs=199.2

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc--cchHhHHHHHHhhhcc---CCCCccceeeeec-----
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ--DGEREFKNEVFVIGQT---HHKNLVRLLGFCD-----  588 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~-----  588 (814)
                      ..|.+.+.||+|+||.||+|.... .++..||||.+.....  .....+.+|+.+++.+   +||||+++++++.     
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~   89 (326)
T 1blx_A           11 QQYECVAEIGEGAYGKVFKARDLK-NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   89 (326)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETT-TTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             hceeeeeeecccccEEEEEEEecC-CCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence            456778899999999999998742 3578899999864322  2234677888777776   8999999999987     


Q ss_pred             ccccceEEEecCCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecC
Q 041921          589 EGQNRLLVYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFG  666 (814)
Q Consensus       589 ~~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfG  666 (814)
                      .....++||||++ ++|.+++...  ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        90 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Dfg  165 (326)
T 1blx_A           90 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG  165 (326)
T ss_dssp             SEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred             CCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecCc
Confidence            5677899999998 6999999764  3489999999999999999999998   99999999999999999999999999


Q ss_pred             CccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCc
Q 041921          667 LAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK  746 (814)
Q Consensus       667 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  746 (814)
                      +++.......   .....||..|+|||.+.+..++.++||||||+++|||++|+.||........  + ..+........
T Consensus       166 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~-~~i~~~~~~~~  239 (326)
T 1blx_A          166 LARIYSFQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ--L-GKILDVIGLPG  239 (326)
T ss_dssp             SCCCCCGGGG---GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--H-HHHHHHHCCCC
T ss_pred             ccccccCCCC---ccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH--H-HHHHHHcCCCC
Confidence            9987653321   1345689999999999998999999999999999999999999975543221  1 11111111000


Q ss_pred             ccee----------e---cCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          747 LNVL----------V---GEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       747 ~~~~----------~---~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      ....          .   ...............+.+++.+||+.||.+|||+.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            0000          0   000000111234567889999999999999999999994

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-35  Score=318.74  Aligned_cols=244  Identities=25%  Similarity=0.363  Sum_probs=192.6

Q ss_pred             HHHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc------cchHhHHHHHHhhhcc----CCCCcccee
Q 041921          515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ------DGEREFKNEVFVIGQT----HHKNLVRLL  584 (814)
Q Consensus       515 ~l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l----~h~niv~l~  584 (814)
                      +.....|.+.+.||+|+||.||+|...  .+++.||||.+.....      .....+.+|+.++.++    +|+||++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~  104 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRL--TDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL  104 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECT--TTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEc--cCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence            444566888899999999999999854  3578999999965322      1233567899999888    899999999


Q ss_pred             eeecccccceEEEec-CCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc-CCCcEEE
Q 041921          585 GFCDEGQNRLLVYEF-LNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLD-DYYTARI  662 (814)
Q Consensus       585 ~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~-~~~~~kl  662 (814)
                      +++.+.+..++|+|+ +.+++|.+++.....+++..+..++.||++||.|||+.   +|+||||||+||+++ .++.+||
T Consensus       105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl  181 (312)
T 2iwi_A          105 DWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKL  181 (312)
T ss_dssp             EEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEEE
T ss_pred             EEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEEE
Confidence            999999999999999 78999999998877899999999999999999999999   999999999999999 8899999


Q ss_pred             eecCCccccccCCcccccccccCCCCcccccccccCCCC-cchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHH
Q 041921          663 SDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKIT-AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC  741 (814)
Q Consensus       663 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  741 (814)
                      +|||++........    ....|+..|+|||.+.+..+. .++||||||+++|||++|+.||.....             
T Consensus       182 ~dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------------  244 (312)
T 2iwi_A          182 IDFGSGALLHDEPY----TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE-------------  244 (312)
T ss_dssp             CCCSSCEECCSSCB----CCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------------
T ss_pred             EEcchhhhcccCcc----cccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-------------
Confidence            99999987654322    345689999999999877664 589999999999999999999963211             


Q ss_pred             hhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          742 YRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       742 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      .......          ........+.+++.+||+.||++|||++++++
T Consensus       245 ~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          245 ILEAELH----------FPAHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             HHHTCCC----------CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HhhhccC----------CcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0011110          01123457889999999999999999999997

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=6e-35  Score=321.36  Aligned_cols=257  Identities=22%  Similarity=0.282  Sum_probs=194.2

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc--cchHhHHHHHHhhhccCCCCccceeeeecccccc---
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ--DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNR---  593 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---  593 (814)
                      .+|.+.+.||+|+||.||+|...  ..+..||||++.....  ...+.+.+|+.++++++||||+++++++...+..   
T Consensus        42 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  119 (371)
T 4exu_A           42 KTYVSPTHVGSGAYGSVCSAIDK--RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  119 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEET--TTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred             ccEEEEeEEecCCCeEEEEEEEC--CCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence            35667789999999999999865  3678999999975322  2245788999999999999999999999877655   


Q ss_pred             ---eEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccc
Q 041921          594 ---LLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKL  670 (814)
Q Consensus       594 ---~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~  670 (814)
                         ++||||+. ++|.+++..  .+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus       120 ~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  193 (371)
T 4exu_A          120 YDFYLVMPFMQ-TDLQKIMGM--EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARH  193 (371)
T ss_dssp             CCCEEEEECCC-EEHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred             eeEEEEEcccc-ccHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence               99999997 688888743  488999999999999999999998   999999999999999999999999999986


Q ss_pred             cccCCcccccccccCCCCccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCc---
Q 041921          671 LTLNQSKTIKTAIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK---  746 (814)
Q Consensus       671 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---  746 (814)
                      .....     ....||+.|+|||.+.+ ..++.++||||||++++||++|+.||......+..   ..+........   
T Consensus       194 ~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~  265 (371)
T 4exu_A          194 ADAEM-----TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQL---TQILKVTGVPGTEF  265 (371)
T ss_dssp             -----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCCHHH
T ss_pred             cccCc-----CCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCCcHHH
Confidence            54322     34568999999999887 67899999999999999999999999765432211   00111000000   


Q ss_pred             --------c----ceeecCccc--ccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          747 --------L----NVLVGEDKE--AMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       747 --------~----~~~~~~~~~--~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                              .    ..+......  ..........+.+++.+||+.||.+|||++++++.
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          266 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             HTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence                    0    000000000  00011235678899999999999999999999863

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=4.9e-35  Score=319.95  Aligned_cols=267  Identities=20%  Similarity=0.272  Sum_probs=199.4

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc-cchHhHHHHHHhhhccCCCCccceeeeeccc-----cc
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEG-----QN  592 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  592 (814)
                      ..+.+.+.||+|+||.||+|...  ..+..||||.+..... .....+.+|+.++++++||||+++++++...     ..
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   88 (353)
T 2b9h_A           11 SDFQLKSLLGEGAYGVVCSATHK--PTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE   88 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEET--TTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred             cceEEeeEEcCCCCeEEEEEEEC--CCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence            35667789999999999999875  3578999999964322 2345688999999999999999999988654     67


Q ss_pred             ceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccc
Q 041921          593 RLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLT  672 (814)
Q Consensus       593 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~  672 (814)
                      .++|+||+. ++|.+++.. ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus        89 ~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  163 (353)
T 2b9h_A           89 VYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIID  163 (353)
T ss_dssp             EEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence            899999997 699998875 4688999999999999999999998   99999999999999999999999999998765


Q ss_pred             cCCccc--------ccccccCCCCccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhh
Q 041921          673 LNQSKT--------IKTAIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR  743 (814)
Q Consensus       673 ~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  743 (814)
                      ......        ......||+.|+|||.+.. ..++.++||||||++++||++|+.||..........   .+.....
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~  240 (353)
T 2b9h_A          164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLL---LIFGIIG  240 (353)
T ss_dssp             ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHC
T ss_pred             cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH---HHHHHhC
Confidence            332111        1123468999999998764 678999999999999999999999997654322111   1111110


Q ss_pred             cCc----cc--------eeecCccc------ccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhcC
Q 041921          744 NGK----LN--------VLVGEDKE------AMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ--MLEGV  795 (814)
Q Consensus       744 ~~~----~~--------~~~~~~~~------~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~--~L~~~  795 (814)
                      ...    ..        ........      ..........+.+++.+||+.||.+|||++++++  .++..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  312 (353)
T 2b9h_A          241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTY  312 (353)
T ss_dssp             CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence            000    00        00000000      0001123567889999999999999999999987  45544

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=6.5e-35  Score=311.41  Aligned_cols=251  Identities=26%  Similarity=0.380  Sum_probs=191.1

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecc---------
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDE---------  589 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---------  589 (814)
                      ..+.+.+.||+|+||.||+|...  .++..||||.+... ....+.+.+|+.++++++||||+++++++.+         
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARNA--LDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEET--TTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             ccchhhheeccCCcEEEEEEEEc--CCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            45677889999999999999865  35789999999643 3345678999999999999999999998754         


Q ss_pred             ----cccceEEEecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEee
Q 041921          590 ----GQNRLLVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISD  664 (814)
Q Consensus       590 ----~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~D  664 (814)
                          ....++||||+++++|.+++... ..+++..++.++.|+++||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~d  159 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGD  159 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECC
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEee
Confidence                45678999999999999999754 4577888999999999999999998   999999999999999999999999


Q ss_pred             cCCccccccCCc------------ccccccccCCCCcccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcccchhh
Q 041921          665 FGLAKLLTLNQS------------KTIKTAIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY  731 (814)
Q Consensus       665 fGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~  731 (814)
                      ||++........            ........||..|+|||.+.+. .++.++||||||+++|||++   |+......  
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~--  234 (303)
T 1zy4_A          160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER--  234 (303)
T ss_dssp             CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHH--
T ss_pred             CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhH--
Confidence            999987643210            1111345689999999999764 68999999999999999998   54322111  


Q ss_pred             hhHHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          732 AILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       732 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      ..    ....+......      ............+.+++.+||+.||.+|||++++++
T Consensus       235 ~~----~~~~~~~~~~~------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          235 VN----ILKKLRSVSIE------FPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             HH----HHHHHHSTTCC------CCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HH----HHHhccccccc------cCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            11    11222222111      011112234567889999999999999999999987

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=7e-35  Score=318.68  Aligned_cols=263  Identities=23%  Similarity=0.312  Sum_probs=201.1

Q ss_pred             HHHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCC------ccceeeeec
Q 041921          515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKN------LVRLLGFCD  588 (814)
Q Consensus       515 ~l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~  588 (814)
                      +.....|.+.+.||+|+||.||+|..... ++..||||.++.. ....+.+.+|+.++++++|++      ++.+.+++.
T Consensus        15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~   92 (355)
T 2eu9_A           15 DWLQERYEIVGNLGEGTFGKVVECLDHAR-GKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN   92 (355)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTT-TTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE
T ss_pred             ceecccEEEEEEeeccCCeEEEEEEecCC-CceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee
Confidence            33456778889999999999999987532 3478999999753 234567889999999998766      899999999


Q ss_pred             ccccceEEEecCCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE------------
Q 041921          589 EGQNRLLVYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILL------------  654 (814)
Q Consensus       589 ~~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll------------  654 (814)
                      ..+..++||||+ +++|.+++...  ..+++..+..++.||+.||+|||+.   +|+||||||+|||+            
T Consensus        93 ~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~  168 (355)
T 2eu9_A           93 FHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEH  168 (355)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC
T ss_pred             eCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccc
Confidence            999999999999 56676666544  4689999999999999999999998   99999999999999            


Q ss_pred             -------cCCCcEEEeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCccc
Q 041921          655 -------DDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEM  727 (814)
Q Consensus       655 -------~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~  727 (814)
                             +.++.+||+|||+++......     ....||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus       169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  243 (355)
T 2eu9_A          169 KSCEEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE  243 (355)
T ss_dssp             -CCCEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             ccccccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence                   568899999999998644322     34568999999999999999999999999999999999999997654


Q ss_pred             chhhhhHHHHHH--------HHhhcCccceeecCc---------------------ccccCcHHHHHHHHHHHHHccccC
Q 041921          728 GEEYAILTDWAF--------DCYRNGKLNVLVGED---------------------KEAMNDIECLGKLVMVSIWCIQED  778 (814)
Q Consensus       728 ~~~~~~~~~~~~--------~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~l~~l~~~Cl~~d  778 (814)
                      ..+.........        .......  ......                     ............+.+++.+||+.|
T Consensus       244 ~~~~~~~~~~~~~~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d  321 (355)
T 2eu9_A          244 NREHLVMMEKILGPIPSHMIHRTRKQK--YFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFD  321 (355)
T ss_dssp             HHHHHHHHHHHHCCCCHHHHHHCSCGG--GEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred             HHHHHHHHHHHcCCCcHHHhhhccchh--hhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCC
Confidence            332111111000        0000000  000000                     001112344668999999999999


Q ss_pred             CCCCCCHHHHHH
Q 041921          779 PSLRPTMKKVLQ  790 (814)
Q Consensus       779 p~~RPt~~~vl~  790 (814)
                      |++|||++++++
T Consensus       322 P~~Rpt~~e~l~  333 (355)
T 2eu9_A          322 PAQRITLAEALL  333 (355)
T ss_dssp             TTTSCCHHHHTT
T ss_pred             hhhCcCHHHHhc
Confidence            999999999984

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.1e-35  Score=320.56  Aligned_cols=243  Identities=23%  Similarity=0.397  Sum_probs=200.3

Q ss_pred             HHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccccc------chHhHHHHHHhhhccC--CCCccceeeee
Q 041921          516 LEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD------GEREFKNEVFVIGQTH--HKNLVRLLGFC  587 (814)
Q Consensus       516 l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~~~~  587 (814)
                      .....|.+.+.||+|+||.||+|...  .+++.||||.+......      ..+.+..|+.++++++  |+||+++++++
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~  117 (320)
T 3a99_A           40 PLESQYQVGPLLGSGGFGSVYSGIRV--SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF  117 (320)
T ss_dssp             CCTTTEEEEEECSSSSSCEEEEEEET--TTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred             CccCceEEEEEEeeCCCeEEEEEEEC--CCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence            34456778899999999999999865  35789999999654221      2246788999999996  59999999999


Q ss_pred             cccccceEEEecCCC-CCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc-CCCcEEEeec
Q 041921          588 DEGQNRLLVYEFLNN-GTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLD-DYYTARISDF  665 (814)
Q Consensus       588 ~~~~~~~lv~e~~~~-gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~-~~~~~kl~Df  665 (814)
                      .+.+..++|+|++.. ++|.+++.....+++..+..++.||++||+|||+.   +|+||||||+|||++ +++.+||+||
T Consensus       118 ~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Df  194 (320)
T 3a99_A          118 ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDF  194 (320)
T ss_dssp             ECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCC
T ss_pred             ecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeC
Confidence            999999999999976 89999998878899999999999999999999998   999999999999999 7899999999


Q ss_pred             CCccccccCCcccccccccCCCCcccccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhc
Q 041921          666 GLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI-TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN  744 (814)
Q Consensus       666 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  744 (814)
                      |+++.......    ....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||.....             ...
T Consensus       195 g~~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-------------~~~  257 (320)
T 3a99_A          195 GSGALLKDTVY----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------------IIR  257 (320)
T ss_dssp             TTCEECCSSCB----CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------------HHH
T ss_pred             ccccccccccc----cCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-------------hhc
Confidence            99987654321    33568999999999987765 6789999999999999999999964211             001


Q ss_pred             CccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          745 GKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       745 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      +...  .        ......++.+++.+||+.||.+|||++++++
T Consensus       258 ~~~~--~--------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          258 GQVF--F--------RQRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             CCCC--C--------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cccc--c--------cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1100  0        1123467889999999999999999999987

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=6.5e-35  Score=321.47  Aligned_cols=274  Identities=20%  Similarity=0.289  Sum_probs=204.7

Q ss_pred             HHHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccC-----------CCCccce
Q 041921          515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTH-----------HKNLVRL  583 (814)
Q Consensus       515 ~l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l  583 (814)
                      .+....|.+.+.||+|+||.||+|...  ..++.||||.+... ....+.+.+|+.++++++           |+||+++
T Consensus        15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~   91 (373)
T 1q8y_A           15 PYKDARYILVRKLGWGHFSTVWLAKDM--VNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL   91 (373)
T ss_dssp             EETTTTEEEEEEEEECSSEEEEEEEET--TTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred             cccCCeEEEEEeeeecCCeEEEEEEec--CCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence            344567888999999999999999865  36789999999743 234456889999998886           8999999


Q ss_pred             eeeecccc----cceEEEecCCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc--
Q 041921          584 LGFCDEGQ----NRLLVYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLD--  655 (814)
Q Consensus       584 ~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~--  655 (814)
                      ++++....    ..++||||+ +++|.+++...  ..+++..+..++.||+.||+|||+.  .+|+||||||+|||++  
T Consensus        92 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~--~~ivH~Dikp~NIll~~~  168 (373)
T 1q8y_A           92 LDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIV  168 (373)
T ss_dssp             CEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEE
T ss_pred             HHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChHHeEEecc
Confidence            99987654    789999999 89999999753  5588999999999999999999984  2899999999999994  


Q ss_pred             ----CCCcEEEeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhh
Q 041921          656 ----DYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY  731 (814)
Q Consensus       656 ----~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~  731 (814)
                          ..+.+||+|||++.......     ....||+.|+|||.+.+..++.++||||||+++|||++|+.||........
T Consensus       169 ~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  243 (373)
T 1q8y_A          169 DSPENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY  243 (373)
T ss_dssp             ETTTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred             CCCcCcceEEEcccccccccCCCC-----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCccccc
Confidence                44589999999998765322     334689999999999999999999999999999999999999975442211


Q ss_pred             ----hhHHHHHHHHhhc--------Cc-----------cceeecC---------cccccCcHHHHHHHHHHHHHccccCC
Q 041921          732 ----AILTDWAFDCYRN--------GK-----------LNVLVGE---------DKEAMNDIECLGKLVMVSIWCIQEDP  779 (814)
Q Consensus       732 ----~~~~~~~~~~~~~--------~~-----------~~~~~~~---------~~~~~~~~~~~~~l~~l~~~Cl~~dp  779 (814)
                          ..+.. +......        +.           ...+...         .............+.+++.+||+.||
T Consensus       244 ~~~~~~~~~-~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  322 (373)
T 1q8y_A          244 TKDDDHIAQ-IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP  322 (373)
T ss_dssp             -CHHHHHHH-HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred             CChHHHHHH-HHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCc
Confidence                11111 1111100        00           0000000         00111235677889999999999999


Q ss_pred             CCCCCHHHHHH--HHhcCcCCCC
Q 041921          780 SLRPTMKKVLQ--MLEGVVEVSV  800 (814)
Q Consensus       780 ~~RPt~~~vl~--~L~~~~~~~~  800 (814)
                      .+|||++|+++  .+.+......
T Consensus       323 ~~Rpt~~ell~hp~f~~~~~~~~  345 (373)
T 1q8y_A          323 RKRADAGGLVNHPWLKDTLGMEE  345 (373)
T ss_dssp             TTCBCHHHHHTCGGGTTCTTCTT
T ss_pred             cccCCHHHHhhChhhhcccCccc
Confidence            99999999997  5666544433

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2.4e-34  Score=317.86  Aligned_cols=201  Identities=26%  Similarity=0.333  Sum_probs=169.5

Q ss_pred             HhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccC-CC-----Cccceeeeecccc
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTH-HK-----NLVRLLGFCDEGQ  591 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~  591 (814)
                      ...|.+.++||+|+||+||+|...  ..++.||||.++.. ....+++..|+.++..++ |+     +|+++++++...+
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  129 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDR--VEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN  129 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEET--TTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEc--CCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence            356777889999999999999865  35789999999743 233456788888888885 44     4999999999999


Q ss_pred             cceEEEecCCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc--CCCcEEEeecCC
Q 041921          592 NRLLVYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLD--DYYTARISDFGL  667 (814)
Q Consensus       592 ~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~--~~~~~kl~DfGl  667 (814)
                      ..+|||||++ ++|.+++...  ..+++..+..++.|++.||.|||++ ..+|+||||||+|||++  .++.+||+|||+
T Consensus       130 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~  207 (382)
T 2vx3_A          130 HLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGS  207 (382)
T ss_dssp             EEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             ceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence            9999999996 5999999765  4689999999999999999999952 23899999999999995  578899999999


Q ss_pred             ccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccc
Q 041921          668 AKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMG  728 (814)
Q Consensus       668 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~  728 (814)
                      ++......     ....||+.|+|||.+.+..++.++|||||||++|||++|+.||.....
T Consensus       208 a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~  263 (382)
T 2vx3_A          208 SCQLGQRI-----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE  263 (382)
T ss_dssp             CEETTCCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             ceeccccc-----ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            98764322     335689999999999999999999999999999999999999986543

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=5.4e-35  Score=317.16  Aligned_cols=257  Identities=20%  Similarity=0.235  Sum_probs=174.6

Q ss_pred             hhhccc-cceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecc----cccc
Q 041921          519 ATNNFK-EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDE----GQNR  593 (814)
Q Consensus       519 ~~~~~~-~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~  593 (814)
                      ..|.+. +.||+|+||.||+|....  .++.||||.+...    .....+....+..++||||+++++++..    ....
T Consensus        28 ~~y~i~~~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           28 DDYQLSKQVLGLGVNGKVLECFHRR--TGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ceeEecceeeeeCCCeEEEEEEECC--CCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            345564 469999999999999763  5789999998642    1222233344566799999999999876    4458


Q ss_pred             eEEEecCCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC---CCcEEEeecCCc
Q 041921          594 LLVYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDD---YYTARISDFGLA  668 (814)
Q Consensus       594 ~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~---~~~~kl~DfGla  668 (814)
                      ++||||+++|+|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.   ++.+||+|||++
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~  178 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFA  178 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence            9999999999999999865  4689999999999999999999998   9999999999999986   455999999999


Q ss_pred             cccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccc
Q 041921          669 KLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLN  748 (814)
Q Consensus       669 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  748 (814)
                      +.......    ....+|+.|+|||.+....++.++||||||+++|||++|+.||..........   .....+..+.. 
T Consensus       179 ~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~~-  250 (336)
T 3fhr_A          179 KETTQNAL----QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP---GMKRRIRLGQY-  250 (336)
T ss_dssp             EEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred             eecccccc----ccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh---hHHHhhhcccc-
Confidence            86553221    33468999999999988889999999999999999999999996543321100   00011111110 


Q ss_pred             eeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhcCcC
Q 041921          749 VLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ--MLEGVVE  797 (814)
Q Consensus       749 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~--~L~~~~~  797 (814)
                           .............+.+++.+||+.||.+|||++++++  .+.+...
T Consensus       251 -----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  296 (336)
T 3fhr_A          251 -----GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMV  296 (336)
T ss_dssp             -----CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGG
T ss_pred             -----ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccccc
Confidence                 0011111234567889999999999999999999997  5555433

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=7e-35  Score=318.73  Aligned_cols=256  Identities=23%  Similarity=0.286  Sum_probs=193.7

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc--cchHhHHHHHHhhhccCCCCccceeeeeccccc----
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ--DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQN----  592 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  592 (814)
                      .+|.+.+.||+|+||.||+|...  ..+..||||++.....  ...+.+.+|+.++++++||||+++++++.....    
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  101 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDK--RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  101 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEET--TTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             ceEEEeeeEecCCCeEEEEEEEC--CCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence            34667789999999999999875  3678999999965322  224578899999999999999999999987654    


Q ss_pred             --ceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccc
Q 041921          593 --RLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKL  670 (814)
Q Consensus       593 --~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~  670 (814)
                        .++||||+. ++|.+++..  .+++..+..++.||+.||.|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus       102 ~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~  175 (353)
T 3coi_A          102 YDFYLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARH  175 (353)
T ss_dssp             CCCEEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred             eeEEEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccC
Confidence              499999997 688887753  488999999999999999999998   999999999999999999999999999986


Q ss_pred             cccCCcccccccccCCCCccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcC----
Q 041921          671 LTLNQSKTIKTAIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG----  745 (814)
Q Consensus       671 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----  745 (814)
                      .....     ....+|+.|+|||.+.+ ..++.++||||||++++||++|+.||......+..   ..+.......    
T Consensus       176 ~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~  247 (353)
T 3coi_A          176 ADAEM-----TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQL---TQILKVTGVPGTEF  247 (353)
T ss_dssp             -------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHH---HHHHHHHCBCCHHH
T ss_pred             CCCCc-----cccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCCCHHH
Confidence            54321     34568999999999877 67899999999999999999999999754432211   1111100000    


Q ss_pred             -------c----cceeecC-cc-cccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          746 -------K----LNVLVGE-DK-EAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       746 -------~----~~~~~~~-~~-~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                             .    +..+... .. ...........+.+++.+||+.||.+|||++++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          248 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             HTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                   0    0000000 00 00011234577889999999999999999999985

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.2e-34  Score=325.40  Aligned_cols=246  Identities=27%  Similarity=0.317  Sum_probs=185.2

Q ss_pred             cccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhcc-CCCCccceeeeecccccceEEEecCC
Q 041921          523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRLLVYEFLN  601 (814)
Q Consensus       523 ~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  601 (814)
                      ..+.||+|+||+||.+...   .++.||||++...   ..+.+.+|+.++.++ +||||+++++++.+++..+|||||+.
T Consensus        19 ~~~~LG~G~~g~V~~~~~~---~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~   92 (434)
T 2rio_A           19 SEKILGYGSSGTVVFQGSF---QGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN   92 (434)
T ss_dssp             EEEEEEECSTTCEEEEEES---SSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred             ccCeEeeCCCeEEEEEEEE---CCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence            3578999999999865433   5789999998642   345678999999876 89999999999999999999999995


Q ss_pred             CCCHHHHhcCCCCC-------ChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC-------------CcEE
Q 041921          602 NGTLASFLFGNLKP-------NWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDY-------------YTAR  661 (814)
Q Consensus       602 ~gsL~~~l~~~~~l-------~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~-------------~~~k  661 (814)
                       |+|.+++......       ++..+..++.||+.||+|||+.   +|+||||||+|||++.+             +.+|
T Consensus        93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k  168 (434)
T 2rio_A           93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL  168 (434)
T ss_dssp             -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred             -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEE
Confidence             6999999765322       3345678999999999999998   99999999999999754             4899


Q ss_pred             EeecCCccccccCCccc--ccccccCCCCccccccccc-------CCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhh
Q 041921          662 ISDFGLAKLLTLNQSKT--IKTAIRGTKGYVAPEWFRN-------SKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEY  731 (814)
Q Consensus       662 l~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~  731 (814)
                      |+|||+++.........  ......||+.|+|||++.+       ..++.++|||||||++|||++ |+.||........
T Consensus       169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~  248 (434)
T 2rio_A          169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES  248 (434)
T ss_dssp             ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH
T ss_pred             EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH
Confidence            99999998776443211  1134569999999999965       568999999999999999999 9999965433221


Q ss_pred             hhHHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          732 AILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       732 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      .         +..+...   .+............++.+++.+||+.||.+|||+.++++
T Consensus       249 ~---------i~~~~~~---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          249 N---------IIRGIFS---LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             H---------HHHTCCC---CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             H---------HhcCCCC---cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            1         0111110   011112234456788999999999999999999999985

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=5e-35  Score=316.35  Aligned_cols=253  Identities=24%  Similarity=0.323  Sum_probs=176.2

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc-cchHhHHHHHH-hhhccCCCCccceeeeecccccceEE
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ-DGEREFKNEVF-VIGQTHHKNLVRLLGFCDEGQNRLLV  596 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv  596 (814)
                      ..+.+.+.||+|+||.||+|...  .+++.||||.+..... ....++..|+. +++.++||||+++++++.+.+..++|
T Consensus        22 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv   99 (327)
T 3aln_A           22 EDLKDLGEIGRGAYGSVNKMVHK--PSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC   99 (327)
T ss_dssp             CSEEC-CEEEECSSEEEEEEEET--TTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHhhehheeccCCCEEEEEEEEc--CCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence            44566789999999999999975  3578999999975422 23345566665 77788999999999999999999999


Q ss_pred             EecCCCCCHHHHhcC-----CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcccc
Q 041921          597 YEFLNNGTLASFLFG-----NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLL  671 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~-----~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~  671 (814)
                      |||+++ +|.+++..     ...+++..+..++.|++.||.|||+.  .+|+||||||+||+++.++.+||+|||+++..
T Consensus       100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            999985 88887753     56789999999999999999999984  38999999999999999999999999999876


Q ss_pred             ccCCcccccccccCCCCccccccc----ccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCcc
Q 041921          672 TLNQSKTIKTAIRGTKGYVAPEWF----RNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL  747 (814)
Q Consensus       672 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  747 (814)
                      ......   ....||..|+|||.+    .+..++.++||||||+++|||++|+.||........     .. .....+..
T Consensus       177 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~-~~~~~~~~  247 (327)
T 3aln_A          177 VDSIAK---TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----QL-TQVVKGDP  247 (327)
T ss_dssp             --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------CCCCCSCC
T ss_pred             cccccc---ccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----HH-HHHhcCCC
Confidence            543221   234689999999998    456789999999999999999999999964322110     00 00001110


Q ss_pred             ceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          748 NVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       748 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      .     .............+.+++.+||+.||.+|||+.++++
T Consensus       248 ~-----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          248 P-----QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             C-----CCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             C-----CCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            0     1111111234567889999999999999999999864

>1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1

Probab=100.00  E-value=2.4e-34  Score=293.61  Aligned_cols=211  Identities=22%  Similarity=0.251  Sum_probs=158.2

Q ss_pred             hcCCccCCCceeecCCCCCceecCCCcEEEeEeeccCCCCCCCcEEEEEEecccCCCeEEEEecCCCCCCCCCCCceEEE
Q 041921           25 QNNGTVPVGATLTAGTSSSPWLSPSGDFAFGFHQLDEENNTNDLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKL  104 (814)
Q Consensus        25 ~~~~ti~~g~~l~~~~~~~~lvS~~g~F~lGF~~~~~~~~~~~~~~lgiw~~~~~~~t~vW~Anr~~~~~~~~~~~~l~~  104 (814)
                      ++.|+|++|++|++++   +|  ++|.|+|||+.++     +    +.+|. .   +|+||+|||+   .+  ..++|+|
T Consensus         6 ~~~~~i~~g~~L~~g~---~l--~~g~f~l~f~~~g-----n----l~ly~-~---~~~vW~an~~---~~--~~~~l~l   62 (236)
T 1dlp_A            6 GLSHEGSHPQTLHAAQ---SL--ELSSFRFTMQSDC-----N----LVLFD-S---DVRVWASNTA---GA--TGCRAVL   62 (236)
T ss_dssp             CSSSSSCSCSCCCTTC---EE--CSTTEEEEECTTS-----C----EEEEE-S---SSEEECCCCC---SC--SCCBCCB
T ss_pred             eccceeCCCCEECCCC---EE--EcCCEEEEECCCC-----c----EEEEE-C---CEEEEECCCC---CC--CCeEEEE
Confidence            4458999999999998   56  5999999998653     1    33444 2   6999999998   33  5688999


Q ss_pred             ccCCcEEEeCCCCceEeeeccCCC-ceeEEEEecCcCEEEEeCCCCceeecccCCcccc----------ccCCccccc-c
Q 041921          105 TADQGLVLNDPQGKQVWSSKIDIG-TVAVGHMNDTGNFVLASSSSGRLWDSFSNPTDTL----------LLGQMMETE-Q  172 (814)
Q Consensus       105 ~~~G~Lvl~~~~g~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~lWQSFd~PtDtl----------Lpg~~l~~~-~  172 (814)
                      +.||||||+|++|++||+|++... +..+|+|+|+|||||++.   ++||||||||||+          +|||+++.+ +
T Consensus        63 ~~dGnLvl~d~~~~~vW~s~~~~~~~~~~~~l~d~Gnlvl~~~---~~W~S~~~p~~t~~lp~~g~d~L~~gq~~~~~~~  139 (236)
T 1dlp_A           63 QSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYGP---GLWDSGTSNKGSVVVANNGNSILYSTQGNDNHPQ  139 (236)
T ss_dssp             CSSSCBCCBCTTTCCSCCCCCCCCSSCCEEEECSSSCEEEECS---EEEECSCCCSSCCCCSSCCCEECCCC--CCCCCC
T ss_pred             cCCCcEEEEcCCCcEEEeCCccccCCcEEEEEeCCCCEEEecC---CEEECCCCCCcccccCCccceEEecCCcCCCccc
Confidence            999999999999999999998643 335899999999999954   8999999998655          777766653 4


Q ss_pred             ceeecccCCCCCCCceeEEEccCCceeEEeeccCCCccccceeeccccCCCCCCCCcceeeecCCccEEEEeeCCceeee
Q 041921          173 GLFSRKSENNFSRGRFQFRLLEDGNLVLNIANLATGFAYDAYYTSGTYDPANSSNSGYRVMFNESGYMYILRRNGGRFDL  252 (814)
Q Consensus       173 ~l~S~~s~~d~s~G~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~sg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (814)
                      +|+|   .+||++|.|+|+++++|++++  ++..     .+||++++|+..   . .....+..++.++++..++..+..
T Consensus       140 ~L~s---~~d~s~G~~~l~l~~dG~LvL--~~~~-----~~~W~s~~~~~~---~-~~~~~L~~~Gnl~ly~~~~~~vw~  205 (236)
T 1dlp_A          140 TLHA---TQSLQLSPYRLSMETDCNLVL--FDRD-----DRVWSTNTAGKG---T-GCRAVLQPNGRMDVLTNQNIAVWT  205 (236)
T ss_dssp             EECS---SCCCBCSSCEEEEETTTEEEE--EBTT-----BCCSCCCCCSSC---S-SCEEEEETTTEEEEEETTTEEEEE
T ss_pred             eEEc---CcEeecCcEEEEECCCCcEEE--EcCC-----EeEEeCCCcCCC---C-ceEEEECCCCcEEEEeCCCcEEEE
Confidence            6764   789999999999999996555  3333     479999998542   1 223445567766666555555544


Q ss_pred             eeeecccCCceEEEEEEecCccEEEE
Q 041921          253 TTERVVPAADFYYRATLNFDGVFAQY  278 (814)
Q Consensus       253 ~~~~~~~~~~~~~r~~L~~dG~l~~y  278 (814)
                      ++..  ... ..+|++|++||++++|
T Consensus       206 s~~~--~~~-~~~rl~Ld~dG~l~ly  228 (236)
T 1dlp_A          206 SGNS--RSA-GRYVFVLQPDRNLAIY  228 (236)
T ss_dssp             CCCC--CSS-SCCEEEECSSSCEEEE
T ss_pred             eCCC--CCC-CCEEEEEcCCCcEEEe
Confidence            4321  122 3478999999999998

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=7e-34  Score=305.92  Aligned_cols=250  Identities=22%  Similarity=0.332  Sum_probs=177.9

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccccc-c-hHhHHHHHHhhhccCCCCccceeeeecccccceEE
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD-G-EREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV  596 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~-~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  596 (814)
                      ..+.+.+.||+|+||.||+|....  ++..||||.+...... . .+.+.++..+++.++||||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv  102 (318)
T 2dyl_A           25 NDLENLGEMGSGTCGQVWKMRFRK--TGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA  102 (318)
T ss_dssp             GGEEEEEEC------CEEEEEETT--TCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             ccccccceeeecCCeeEEEEEEec--CCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence            345667899999999999999753  5779999999654222 1 23345555678888999999999999999999999


Q ss_pred             EecCCCCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccC
Q 041921          597 YEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHE-DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN  674 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~  674 (814)
                      |||+ ++.+..++.. ...+++..+..++.|+++||.|||+ .   +|+|+||||+||+++.++.+||+|||++......
T Consensus       103 ~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  178 (318)
T 2dyl_A          103 MELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD  178 (318)
T ss_dssp             ECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             Eecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence            9999 5556555543 4678999999999999999999998 5   8999999999999999999999999999766543


Q ss_pred             CcccccccccCCCCcccccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccce
Q 041921          675 QSKTIKTAIRGTKGYVAPEWFR-----NSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNV  749 (814)
Q Consensus       675 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  749 (814)
                      ...   ....||+.|+|||.+.     ...++.++||||||+++|||++|+.||........ .    ...... +....
T Consensus       179 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~----~~~~~~-~~~~~  249 (318)
T 2dyl_A          179 KAK---DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE-V----LTKVLQ-EEPPL  249 (318)
T ss_dssp             -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-H----HHHHHH-SCCCC
T ss_pred             ccc---cccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH-H----HHHHhc-cCCCC
Confidence            221   3346899999999984     45688999999999999999999999975332211 1    111111 11111


Q ss_pred             eecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          750 LVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       750 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      +       +........+.+++.+||+.||.+|||++++++
T Consensus       250 ~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          250 L-------PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             C-------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             C-------CccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            1       111123467889999999999999999999875

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.7e-34  Score=319.76  Aligned_cols=247  Identities=25%  Similarity=0.309  Sum_probs=183.8

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhcc-CCCCccceeeeecccccceEEEe
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRLLVYE  598 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  598 (814)
                      .+...+.||+|+||+|+.....   +++.||||++...   ....+.+|+.+++++ +||||+++++++.+.+..+||||
T Consensus        25 ~y~~~~~LG~G~~G~V~~~~~~---~~~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E   98 (432)
T 3p23_A           25 SFCPKDVLGHGAEGTIVYRGMF---DNRDVAVKRILPE---CFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE   98 (432)
T ss_dssp             EEEEEEEEEECGGGCEEEEEES---SSSEEEEEEECTT---TEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             EEecCCeeecCcCEEEEEEEEe---CCeEEEEEEECHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence            3455678999999996543332   5788999999643   223467899999999 89999999999999999999999


Q ss_pred             cCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc-----CCCcEEEeecCCccccc
Q 041921          599 FLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLD-----DYYTARISDFGLAKLLT  672 (814)
Q Consensus       599 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~-----~~~~~kl~DfGla~~~~  672 (814)
                      |+. |+|.+++... ....+.....++.||+.||.|||+.   +|+||||||+|||++     ....+||+|||+++...
T Consensus        99 ~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~  174 (432)
T 3p23_A           99 LCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA  174 (432)
T ss_dssp             CCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred             CCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence            996 5999999765 3455667789999999999999998   999999999999995     33468899999998765


Q ss_pred             cCCcc-cccccccCCCCcccccccc---cCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCcc
Q 041921          673 LNQSK-TIKTAIRGTKGYVAPEWFR---NSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKL  747 (814)
Q Consensus       673 ~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  747 (814)
                      ..... .......||+.|+|||.+.   ...++.++|||||||+++||++ |..||.........       ........
T Consensus       175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~-------~~~~~~~~  247 (432)
T 3p23_A          175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN-------ILLGACSL  247 (432)
T ss_dssp             -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH-------HHTTCCCC
T ss_pred             CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH-------HHhccCCc
Confidence            43221 1224467999999999997   4567889999999999999999 89998543222111       01111111


Q ss_pred             ceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          748 NVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       748 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      .       ...........+.+++.+||+.||.+|||++++++
T Consensus       248 ~-------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          248 D-------CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             T-------TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             c-------ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            0       01112234566789999999999999999999983

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.6e-34  Score=339.03  Aligned_cols=244  Identities=20%  Similarity=0.281  Sum_probs=194.5

Q ss_pred             HHHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccceeeeeccccc-
Q 041921          515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQN-  592 (814)
Q Consensus       515 ~l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-  592 (814)
                      ++....|.+.+.||+|+||.||+|..... +++.||||.+.... ....+.+.+|+.++.+++||||+++++++.+.+. 
T Consensus        76 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  154 (681)
T 2pzi_A           76 DIVAGQYEVKGCIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH  154 (681)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEEGGG-TTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred             CEeCCceEEEEEEeeCCCeEEEEEEEcCC-CCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence            33446788889999999999999997532 36889999986432 2334568999999999999999999999987665 


Q ss_pred             ----ceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCc
Q 041921          593 ----RLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLA  668 (814)
Q Consensus       593 ----~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla  668 (814)
                          .+|||||+++++|.+++..  .+++..+..|+.||+.||.|||+.   +|+||||||+|||++.+ .+||+|||++
T Consensus       155 ~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a  228 (681)
T 2pzi_A          155 GDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAV  228 (681)
T ss_dssp             SCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred             CCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccc
Confidence                6999999999999988765  689999999999999999999998   99999999999999986 9999999999


Q ss_pred             cccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccc
Q 041921          669 KLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLN  748 (814)
Q Consensus       669 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  748 (814)
                      +.....      ....||+.|+|||.+.+.. +.++||||||++++||++|..|+.......                  
T Consensus       229 ~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~------------------  283 (681)
T 2pzi_A          229 SRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG------------------  283 (681)
T ss_dssp             EETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS------------------
T ss_pred             hhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc------------------
Confidence            876532      3456999999999987654 889999999999999999988875321110                  


Q ss_pred             eeecCcccccCcHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHhcC
Q 041921          749 VLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRP-TMKKVLQMLEGV  795 (814)
Q Consensus       749 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-t~~~vl~~L~~~  795 (814)
                       +    ............+.+++.+||+.||.+|| +++++.+.|.++
T Consensus       284 -~----~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  326 (681)
T 2pzi_A          284 -L----PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV  326 (681)
T ss_dssp             -C----CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             -c----cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence             0    00011123346788999999999999999 566677666554

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.6e-34  Score=333.51  Aligned_cols=261  Identities=26%  Similarity=0.284  Sum_probs=195.8

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccc-cccchHhHHHHHHhhhccCCCCccceeeeecc------cc
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV-FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDE------GQ  591 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~  591 (814)
                      ..|.+.++||+|+||.||+|...  ..+..||||.+... .....+.+.+|+.++++++||||+++++++..      .+
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~--~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~   91 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQ--DTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND   91 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCT--TTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred             CCeEEEEEEeeCCCeEEEEEEEC--CCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence            56788899999999999999864  35788999998653 23334678999999999999999999999865      67


Q ss_pred             cceEEEecCCCCCHHHHhcCCC---CCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCc---EEEeec
Q 041921          592 NRLLVYEFLNNGTLASFLFGNL---KPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYT---ARISDF  665 (814)
Q Consensus       592 ~~~lv~e~~~~gsL~~~l~~~~---~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~---~kl~Df  665 (814)
                      ..++||||+++++|.+++....   .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.   +||+||
T Consensus        92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DF  168 (676)
T 3qa8_A           92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDL  168 (676)
T ss_dssp             SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred             eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccc
Confidence            7899999999999999998653   688999999999999999999998   9999999999999997665   999999


Q ss_pred             CCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhh--hHHHHHHH-Hh
Q 041921          666 GLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA--ILTDWAFD-CY  742 (814)
Q Consensus       666 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~--~~~~~~~~-~~  742 (814)
                      |++.........   ....||..|+|||.+.+..++.++||||||+++|||++|+.||.........  ........ ..
T Consensus       169 G~a~~~~~~~~~---~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~  245 (676)
T 3qa8_A          169 GYAKELDQGELC---TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV  245 (676)
T ss_dssp             CCCCBTTSCCCC---CCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CC
T ss_pred             cccccccccccc---ccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhh
Confidence            999876543321   3456999999999999999999999999999999999999999753221100  00000000 00


Q ss_pred             ----hcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHH
Q 041921          743 ----RNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKK  787 (814)
Q Consensus       743 ----~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~  787 (814)
                          ..+.....................+.+++.+||+.||.+|||+++
T Consensus       246 ~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e  294 (676)
T 3qa8_A          246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ  294 (676)
T ss_dssp             SCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred             hhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence                000000000000011123346788999999999999999999976

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=4.4e-33  Score=294.69  Aligned_cols=234  Identities=12%  Similarity=0.046  Sum_probs=183.8

Q ss_pred             HHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccccc---chHhHHHHHHhhhccCCCCccceeeeeccccc
Q 041921          516 LEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQN  592 (814)
Q Consensus       516 l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  592 (814)
                      +....|.+.+.||+|+||.||+|...  ..++.||||.+......   ..+.+.+|+.++.+++||||+++++++.+.+.
T Consensus        28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~  105 (286)
T 3uqc_A           28 IANGRYRLLIFHGGVPPLQFWQALDT--ALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAG  105 (286)
T ss_dssp             ETTTTEEEEEEEEBSTTCEEEEEEET--TTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             EecCcEEEEEEEcccCCeEEEEEEec--CCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCc
Confidence            33456778899999999999999975  35789999999754322   23678999999999999999999999999999


Q ss_pred             ceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccc
Q 041921          593 RLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLT  672 (814)
Q Consensus       593 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~  672 (814)
                      .++||||+++++|.+++...  .......+|+.|++.||+|||+.   +|+||||||+|||++.++.+||++++      
T Consensus       106 ~~lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~------  174 (286)
T 3uqc_A          106 GLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA------  174 (286)
T ss_dssp             EEEEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred             EEEEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc------
Confidence            99999999999999999653  34556788999999999999998   99999999999999999999997543      


Q ss_pred             cCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeec
Q 041921          673 LNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVG  752 (814)
Q Consensus       673 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  752 (814)
                                      |++|       ++.++||||||+++|||++|+.||...........            ......
T Consensus       175 ----------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~------------~~~~~~  219 (286)
T 3uqc_A          175 ----------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP------------AERDTA  219 (286)
T ss_dssp             ----------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE------------CCBCTT
T ss_pred             ----------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH------------HHHHhc
Confidence                            3332       68899999999999999999999975433210000            000000


Q ss_pred             Cccc--ccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 041921          753 EDKE--AMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV  798 (814)
Q Consensus       753 ~~~~--~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~~  798 (814)
                      ....  .......+..+.+++.+||+.||.+| |+.++++.|+.+...
T Consensus       220 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~  266 (286)
T 3uqc_A          220 GQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV  266 (286)
T ss_dssp             SCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred             cCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence            0000  00112245678899999999999999 999999999886554

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=2.2e-32  Score=291.68  Aligned_cols=235  Identities=22%  Similarity=0.278  Sum_probs=179.7

Q ss_pred             hccc-cceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhh-hccCCCCccceeeeecc----cccce
Q 041921          521 NNFK-EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVI-GQTHHKNLVRLLGFCDE----GQNRL  594 (814)
Q Consensus       521 ~~~~-~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~~  594 (814)
                      +.+. +.||+|+||.||++...  ..+..||||.++.     ...+.+|+.++ +..+||||+++++++..    ....+
T Consensus        19 y~~~~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   91 (299)
T 3m2w_A           19 YKVTSQVLGLGINGKVLQIFNK--RTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   91 (299)
T ss_dssp             EEEEEEEEEEETTEEEEEEEET--TTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             hhhcCcccccCCCeEEEEEEEc--CCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence            3444 67999999999999875  3578999999864     34677888887 55699999999999876    67789


Q ss_pred             EEEecCCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC---CCcEEEeecCCcc
Q 041921          595 LVYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDD---YYTARISDFGLAK  669 (814)
Q Consensus       595 lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~---~~~~kl~DfGla~  669 (814)
                      +||||+++++|.+++...  ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.   ++.+||+|||++.
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~  168 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  168 (299)
T ss_dssp             EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence            999999999999999765  3689999999999999999999998   9999999999999997   7899999999986


Q ss_pred             ccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccce
Q 041921          670 LLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNV  749 (814)
Q Consensus       670 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  749 (814)
                      ...                        +..++.++||||||+++|||++|+.||........           .......
T Consensus       169 ~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-----------~~~~~~~  213 (299)
T 3m2w_A          169 ETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----------SPGMKTR  213 (299)
T ss_dssp             ECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSCCS
T ss_pred             ccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-----------hHHHHHH
Confidence            433                        13457789999999999999999999964432110           0000001


Q ss_pred             eecCccccc--CcHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhcCcCCCC
Q 041921          750 LVGEDKEAM--NDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ--MLEGVVEVSV  800 (814)
Q Consensus       750 ~~~~~~~~~--~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~--~L~~~~~~~~  800 (814)
                      .........  ........+.+++.+||+.||.+|||++|+++  .+.+....+.
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~~  268 (299)
T 3m2w_A          214 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ  268 (299)
T ss_dssp             SCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSCC
T ss_pred             HhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCCC
Confidence            100000000  00124567889999999999999999999987  4554443333

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=5.8e-33  Score=309.66  Aligned_cols=235  Identities=14%  Similarity=0.100  Sum_probs=174.8

Q ss_pred             ccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc---cchHhHHHHHHhhhccCC-CCccceeee-----------
Q 041921          522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ---DGEREFKNEVFVIGQTHH-KNLVRLLGF-----------  586 (814)
Q Consensus       522 ~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h-~niv~l~~~-----------  586 (814)
                      ...+.||+|+||.||+|....  .++.||||.+.....   ...+.+.+|+.++..++| +|...+..+           
T Consensus        81 ~~~~~LG~G~fG~Vy~a~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  158 (413)
T 3dzo_A           81 VRGTVLGQEDPYAYLEATDQE--TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK  158 (413)
T ss_dssp             EEEEEEEEETTEEEEEEEETT--TCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred             EEecccccCCCEEEEEEEecC--CCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence            446789999999999999753  577999999873222   235679999999999987 322111111           


Q ss_pred             ----------ecc-----cccceEEEecCCCCCHHHHhc------C-CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeee
Q 041921          587 ----------CDE-----GQNRLLVYEFLNNGTLASFLF------G-NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIH  644 (814)
Q Consensus       587 ----------~~~-----~~~~~lv~e~~~~gsL~~~l~------~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H  644 (814)
                                ...     ....+++|+++ +++|.+++.      . ...+++..++.|+.||++||+|||+.   +|+|
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiH  234 (413)
T 3dzo_A          159 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVH  234 (413)
T ss_dssp             CCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred             cCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cccc
Confidence                      111     12345666654 689999884      1 23467889999999999999999998   9999


Q ss_pred             cCCCCCcEEEcCCCcEEEeecCCccccccCCcccccccccCCCCccccccc----------ccCCCCcchhhHHHHHHHH
Q 041921          645 CDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF----------RNSKITAKVDVYSFGVLLL  714 (814)
Q Consensus       645 ~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~~~Dv~s~Gvvl~  714 (814)
                      |||||+||||+.++.+||+|||+++.....     .....| +.|+|||.+          ....++.++|||||||++|
T Consensus       235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~  308 (413)
T 3dzo_A          235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY  308 (413)
T ss_dssp             SCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred             CCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence            999999999999999999999998865433     134457 999999999          5556889999999999999


Q ss_pred             HHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 041921          715 EIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVL  789 (814)
Q Consensus       715 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl  789 (814)
                      ||++|+.||......+..               .......      ...++.+.+++.+||+.||.+|||+.+++
T Consensus       309 elltg~~Pf~~~~~~~~~---------------~~~~~~~------~~~~~~~~~li~~~l~~dP~~Rpt~~~~l  362 (413)
T 3dzo_A          309 WIWCADLPNTDDAALGGS---------------EWIFRSC------KNIPQPVRALLEGFLRYPKEDRLLPLQAM  362 (413)
T ss_dssp             HHHHSSCCCCTTGGGSCS---------------GGGGSSC------CCCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred             HHHHCCCCCCCcchhhhH---------------HHHHhhc------ccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            999999999754322110               0001100      11236788999999999999999976654

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.97  E-value=1.2e-32  Score=298.87  Aligned_cols=243  Identities=15%  Similarity=0.129  Sum_probs=182.2

Q ss_pred             HHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--------ccchHhHHHHHHhhhccC---------CC
Q 041921          516 LEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--------QDGEREFKNEVFVIGQTH---------HK  578 (814)
Q Consensus       516 l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~---------h~  578 (814)
                      +....|.+.++||+|+||.||+|+.    .++.||||++....        ....+.+.+|+.++++++         ||
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~   92 (336)
T 2vuw_A           17 LPTEKLQRCEKIGEGVFGEVFQTIA----DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTE   92 (336)
T ss_dssp             SCHHHHHTCEEEEEETTEEEEEEEE----TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCC
T ss_pred             cccccchheeeecccCceEEEEEEe----CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCC
Confidence            3456678889999999999999986    36899999997542        222367889999988886         55


Q ss_pred             Cccceee-----------------eecc-------------cccceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHH
Q 041921          579 NLVRLLG-----------------FCDE-------------GQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIA  628 (814)
Q Consensus       579 niv~l~~-----------------~~~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia  628 (814)
                      ||+++.+                 ++.+             .+..+|||||+++|++.+.+.. ..+++..+..++.||+
T Consensus        93 niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~  171 (336)
T 2vuw_A           93 GFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLT  171 (336)
T ss_dssp             CBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHH
T ss_pred             chhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHH
Confidence            5555555                 4433             6789999999999976666644 5678999999999999


Q ss_pred             HHHHHhh-hcCCCCeeecCCCCCcEEEcCCC--------------------cEEEeecCCccccccCCcccccccccCCC
Q 041921          629 RGLLYLH-EDCRAQIIHCDIKPQNILLDDYY--------------------TARISDFGLAKLLTLNQSKTIKTAIRGTK  687 (814)
Q Consensus       629 ~~l~yLH-~~~~~~i~H~dlkp~NIll~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~~gt~  687 (814)
                      .||.||| +.   +|+||||||+|||++.++                    .+||+|||+++....       ....||+
T Consensus       172 ~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~  241 (336)
T 2vuw_A          172 ASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCD  241 (336)
T ss_dssp             HHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCC
T ss_pred             HHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEee
Confidence            9999999 88   999999999999999887                    899999999987653       2346999


Q ss_pred             CcccccccccCCCCcchhhHHHHHH-HHHHHhCCCCCCcccchhhhhHHHHHHHHhh-cCccceeecCcccccCcHHHHH
Q 041921          688 GYVAPEWFRNSKITAKVDVYSFGVL-LLEIISCRKSFDIEMGEEYAILTDWAFDCYR-NGKLNVLVGEDKEAMNDIECLG  765 (814)
Q Consensus       688 ~y~aPE~~~~~~~s~~~Dv~s~Gvv-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  765 (814)
                      .|+|||.+.+.. +.++||||++++ .+++++|..||....      ........+. .....    .............
T Consensus       242 ~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~------~~~~~~~~~~~~~~~~----~~~~~~~~~~~s~  310 (336)
T 2vuw_A          242 VSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL------WLHYLTDKMLKQMTFK----TKCNTPAMKQIKR  310 (336)
T ss_dssp             CTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH------HHHHHHHHHHHTCCCS----SCCCSHHHHHHHH
T ss_pred             cccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh------hhhHHHHhhhhhhccC----cccchhhhhhcCH
Confidence            999999998766 889999998777 777888998874210      0000111111 11110    1111112335678


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHH
Q 041921          766 KLVMVSIWCIQEDPSLRPTMKKVL  789 (814)
Q Consensus       766 ~l~~l~~~Cl~~dp~~RPt~~~vl  789 (814)
                      ++.+++.+||+.|     |++|++
T Consensus       311 ~~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          311 KIQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHHHHHGGGSS-----SHHHHH
T ss_pred             HHHHHHHHHhccC-----CHHHHH
Confidence            8999999999976     899988

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.94  E-value=1.3e-27  Score=275.73  Aligned_cols=185  Identities=19%  Similarity=0.102  Sum_probs=129.5

Q ss_pred             ceeeeeeeeEEEEEEecCCCceEEEEEEecccc----------ccchHhHHHHHHhhhcc-CCCCccceeeeecccccce
Q 041921          526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF----------QDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRL  594 (814)
Q Consensus       526 ~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~----------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  594 (814)
                      .++.|++|.+.++...-  -+..++||.+....          ....++|.+|+++|+++ +|+||+++++++.+++..|
T Consensus       241 ~~~~~~~~~h~~~rr~~--fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~y  318 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYF--FGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGW  318 (569)
T ss_dssp             C-C--------CCEEEE--ECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEE
T ss_pred             ccccCCccccccccccc--ccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEE
Confidence            45666666555443221  35678889885421          12235699999999999 7999999999999999999


Q ss_pred             EEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccC
Q 041921          595 LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN  674 (814)
Q Consensus       595 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~  674 (814)
                      |||||++|++|.++|.....++..   +|+.||+.||+|||++   +|+||||||+||||++++.+||+|||+++.....
T Consensus       319 LVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~  392 (569)
T 4azs_A          319 LVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD  392 (569)
T ss_dssp             EEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred             EEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence            999999999999999988777654   5899999999999999   9999999999999999999999999999877644


Q ss_pred             CcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCC
Q 041921          675 QSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRK  721 (814)
Q Consensus       675 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~  721 (814)
                      ....  ...+||+.|||||.+.+ .+..++|+|++|++++++.++..
T Consensus       393 ~~~~--~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~  436 (569)
T 4azs_A          393 CSWP--TNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWS  436 (569)
T ss_dssp             -CCS--HHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred             Cccc--cCceechhhccHHHhCC-CCCCcccccccccchhhhccccc
Confidence            3222  44679999999999975 45678999999999888766543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.90  E-value=1.2e-24  Score=249.64  Aligned_cols=183  Identities=18%  Similarity=0.246  Sum_probs=146.0

Q ss_pred             ccceeeeeeeeEEEEEEecCCCceEEEEEEecccccc--------chHhHHHHHHhhhccCCCCccceeeeecccccceE
Q 041921          524 KEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD--------GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL  595 (814)
Q Consensus       524 ~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  595 (814)
                      .++||+|+||.||+|..    .+..+++|+.......        ..+.+.+|++++++++||||+++..++...++.+|
T Consensus       341 ~~~LG~G~fg~Vy~~~~----~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  416 (540)
T 3en9_A          341 EHLIGKGAEADIKRDSY----LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI  416 (540)
T ss_dssp             -------CCEEEEEEEC----SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred             CCEEeeCCCEEEEEEEE----CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence            46899999999999954    3567888876432111        12358999999999999999977777778888899


Q ss_pred             EEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCC
Q 041921          596 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ  675 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~  675 (814)
                      ||||+++++|.+++..        +..++.|+++||.|||++   +|+||||||+|||++.  .+||+|||+++......
T Consensus       417 VmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~  483 (540)
T 3en9_A          417 MMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE  483 (540)
T ss_dssp             EEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred             EEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence            9999999999999976        568999999999999998   9999999999999999  99999999999876432


Q ss_pred             ccc-----ccccccCCCCccccccccc--CCCCcchhhHHHHHHHHHHHhCCCCC
Q 041921          676 SKT-----IKTAIRGTKGYVAPEWFRN--SKITAKVDVYSFGVLLLEIISCRKSF  723 (814)
Q Consensus       676 ~~~-----~~~~~~gt~~y~aPE~~~~--~~~s~~~Dv~s~Gvvl~elltg~~p~  723 (814)
                      ...     ......||+.|||||++..  ..|+...|+|+..+-.++.+.++.+|
T Consensus       484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            211     1134679999999999987  56788899999999888888877665

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.83  E-value=6.3e-21  Score=200.39  Aligned_cols=142  Identities=14%  Similarity=0.088  Sum_probs=115.0

Q ss_pred             ccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc------------------cchHhHHHHHHhhhccCCCCccce
Q 041921          522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ------------------DGEREFKNEVFVIGQTHHKNLVRL  583 (814)
Q Consensus       522 ~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~l  583 (814)
                      .+.+.||+|+||.||+|...   ++..||||.++....                  .....+.+|+.++++++  | +++
T Consensus        93 ~~~~~iG~G~~g~Vy~~~~~---~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v  166 (282)
T 1zar_A           93 AIGKLMGEGKESAVFNCYSE---KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV  166 (282)
T ss_dssp             EEEEEEEECSSEEEEEEEET---TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred             EecCEeccCCCceEEEEEeC---CCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence            35688999999999999973   578999999964221                  12346899999999999  4 666


Q ss_pred             eeeecccccceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEe
Q 041921          584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARIS  663 (814)
Q Consensus       584 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~  663 (814)
                      .+++ +.+..++||||+++++|.+ +.      ......++.|++.||.|||+.   +|+||||||+|||++ ++.+||+
T Consensus       167 ~~~~-~~~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~vkl~  234 (282)
T 1zar_A          167 PKVY-AWEGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWII  234 (282)
T ss_dssp             CCEE-EEETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTEEEEC
T ss_pred             CeEE-eccceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCcEEEE
Confidence            6654 3467799999999999988 42      234557999999999999998   999999999999999 9999999


Q ss_pred             ecCCccccccCCcccccccccCCCCcccccccc
Q 041921          664 DFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR  696 (814)
Q Consensus       664 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~  696 (814)
                      |||+++.               +..++|||++.
T Consensus       235 DFG~a~~---------------~~~~~a~e~l~  252 (282)
T 1zar_A          235 DFPQSVE---------------VGEEGWREILE  252 (282)
T ss_dssp             CCTTCEE---------------TTSTTHHHHHH
T ss_pred             ECCCCeE---------------CCCCCHHHHHH
Confidence            9999863               33578999875

>4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D*

Probab=99.82  E-value=9.7e-20  Score=159.30  Aligned_cols=103  Identities=20%  Similarity=0.379  Sum_probs=87.3

Q ss_pred             CccCCCceeecCCCCCceecCCCcEEEeEeeccCCCCCCCcEEEEEEecccCCCeEEEEecCCCCCCCCCCCceEEEccC
Q 041921           28 GTVPVGATLTAGTSSSPWLSPSGDFAFGFHQLDEENNTNDLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLTAD  107 (814)
Q Consensus        28 ~ti~~g~~l~~~~~~~~lvS~~g~F~lGF~~~~~~~~~~~~~~lgiw~~~~~~~t~vW~Anr~~~~~~~~~~~~l~~~~~  107 (814)
                      ++|.+||.|.+|+   +|+|  |.|.|.|...+         .|.++..    .++||+||++   .|....+.|+|+.|
T Consensus         2 n~L~~g~~L~~g~---~L~s--g~y~l~~q~Dg---------NLvly~~----~~~vW~ant~---~~~~~~~~L~l~~d   60 (105)
T 4h3o_A            2 NILDNNEGLYAGQ---SLDV--EPYHFIMQDDC---------NLVLYDH----STSTWASNTE---IGGKSGCSAVLQSD   60 (105)
T ss_dssp             CEECTTEEECTTC---EEEE--TTEEEEECTTS---------CEEEEET----TEEEEECCCC---CTTCCSCEEEECTT
T ss_pred             CCcCCCCEEcCCC---EEEE--CCEEEEECCCC---------eEEEEEC----CEEEEEecCC---CCCCccEEEEEeCC
Confidence            7899999999998   6887  88999997654         4777653    5899999998   44566789999999


Q ss_pred             CcEEEeCCCCceEeeeccCCC-ceeEEEEecCcCEEEEeCCCCceeec
Q 041921          108 QGLVLNDPQGKQVWSSKIDIG-TVAVGHMNDTGNFVLASSSSGRLWDS  154 (814)
Q Consensus       108 G~Lvl~~~~g~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~lWQS  154 (814)
                      |||||+|++|++||+|+++.. ...+|+|+|+|||||++.   .||||
T Consensus        61 GnLvL~d~~~~~vWss~t~~~~~~~~l~L~ddGNlVly~~---~~W~S  105 (105)
T 4h3o_A           61 GNFVVYDSSGRSLWASHSTRGSGNYILILQDDGNVIIYGS---DIWST  105 (105)
T ss_dssp             SCEEEECTTCCEEEECCCCCCSSCEEEEECTTSCEEEEES---EEEEC
T ss_pred             ccEEEECCCcEEEEEecCCCCCCCEEEEEeCCCeEEEECC---cEecC
Confidence            999999999999999998654 346899999999999964   59998

>1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1

Probab=99.81  E-value=1.2e-19  Score=162.62  Aligned_cols=107  Identities=19%  Similarity=0.244  Sum_probs=90.3

Q ss_pred             cCCccCCCceeecCCCCCcee--cCCCcEEEeEeeccCCCCCCCcEEEEEEecccCCCeEEEEecCCCCCCCCCCCceEE
Q 041921           26 NNGTVPVGATLTAGTSSSPWL--SPSGDFAFGFHQLDEENNTNDLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVK  103 (814)
Q Consensus        26 ~~~ti~~g~~l~~~~~~~~lv--S~~g~F~lGF~~~~~~~~~~~~~~lgiw~~~~~~~t~vW~Anr~~~~~~~~~~~~l~  103 (814)
                      ..++|.+|++|.+|+   +|+  |++|.|+|+|+.+|+         | +||++   .++||+||++.   + +.++.|+
T Consensus         7 ~~~~l~~g~~L~~g~---~l~~~S~~g~~~L~~~~dgn---------l-vly~~---~~~vW~sn~~~---~-~~~~~l~   66 (119)
T 1b2p_A            7 KQPDDNHPQILHATE---SLEILFGTHVYRFIMQTDCN---------L-VLYDN---NNPIWATNTGG---L-GNGCRAV   66 (119)
T ss_dssp             SCSSSCCCCEEETTC---EEEEEETTEEEEEEECTTSC---------E-EEEET---TEEEEECCCTT---S-CSSCEEE
T ss_pred             cCcccCCCCEEcCCC---EEEEeCCCCCEEEEEecCCC---------E-EEEEC---CEEEEeCCCcc---C-CCceEEE
Confidence            458999999999999   799  999999999997641         2 57875   79999999982   2 3457899


Q ss_pred             EccCCcEEEeCCCCceEeeeccCCC-ceeEEEEecCcCEEEEeCCCCceeecc
Q 041921          104 LTADQGLVLNDPQGKQVWSSKIDIG-TVAVGHMNDTGNFVLASSSSGRLWDSF  155 (814)
Q Consensus       104 ~~~~G~Lvl~~~~g~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~lWQSF  155 (814)
                      |..||||||+|.++.+||+|++... +...++|+|+|||||++   .++|||=
T Consensus        67 l~~dGNLVl~d~~~~~lW~S~~~~~~g~~~l~l~~~Gnlvl~~---~~~W~Sg  116 (119)
T 1b2p_A           67 LQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG---DALWATQ  116 (119)
T ss_dssp             ECTTSCEEEECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEE---SEEEECC
T ss_pred             EccCCEEEEEeCCCcEEEcCCCCCCCCCEEEEEECCCcEEEEC---ccEeCCC
Confidence            9999999999999999999997643 45689999999999998   3899983

>3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A*

Probab=99.81  E-value=1.6e-19  Score=159.72  Aligned_cols=109  Identities=17%  Similarity=0.323  Sum_probs=90.9

Q ss_pred             CCccCCCceeecCCCCCceecCCCcEEEeEeeccCCCCCCCcEEEEEEecccCCCeEEEEecCCCCCCCCCCCceEEEcc
Q 041921           27 NGTVPVGATLTAGTSSSPWLSPSGDFAFGFHQLDEENNTNDLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLTA  106 (814)
Q Consensus        27 ~~ti~~g~~l~~~~~~~~lvS~~g~F~lGF~~~~~~~~~~~~~~lgiw~~~~~~~t~vW~Anr~~~~~~~~~~~~l~~~~  106 (814)
                      +|+|.+||.|.+++   +|+ ++|.|+|+|+..|+         | ++|+   ..++||.+|++.   + ..++.|+|..
T Consensus         1 ~d~l~~g~~L~~g~---~l~-~~~~~~l~~~~dGn---------l-vl~~---~~~~vW~sn~~~---~-~~~~~l~l~~   59 (110)
T 3a0c_A            1 VNSLSSPNSLFTGH---SLE-VGPSYRLIMQGDCN---------F-VLYD---SGKPVWASNTGG---L-GSGCRLTLHN   59 (110)
T ss_dssp             CCEEETTCEECTTC---EEE-ETTTEEEEECTTSC---------E-EEEE---TTEEEEECCCTT---S-CSSCEEEECT
T ss_pred             CCEeCCCCEECCCC---EEE-ECCCEEEEEcCCCc---------E-EEEE---CCEEEEECCCCC---C-CCcEEEEEeC
Confidence            37899999999998   799 99999999986541         2 5676   369999999972   2 2457899999


Q ss_pred             CCcEEEeCCCCceEeeeccCCC-ceeEEEEecCcCEEEEeCCCCceeecccCCc
Q 041921          107 DQGLVLNDPQGKQVWSSKIDIG-TVAVGHMNDTGNFVLASSSSGRLWDSFSNPT  159 (814)
Q Consensus       107 ~G~Lvl~~~~g~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~lWQSFd~Pt  159 (814)
                      ||||||+|.+|.+||+|++... +...++|+|+|||||++.   .+||||+||.
T Consensus        60 dGNLVl~~~~~~~~W~S~t~~~~g~~~l~l~~dGnlvl~~~---~~W~S~~~~~  110 (110)
T 3a0c_A           60 NGNLVIYDQSNRVIWQTKTNGKEDHYVLVLQQDRNVVIYGP---VVWATGSGPA  110 (110)
T ss_dssp             TSCEEEECTTCCEEEECCCCCSSSCCEEEECTTSCEEEECS---EEEECSCCC-
T ss_pred             CCCEEEECCCCcEEEecCCCCCCCCEEEEEeCCccEEEECC---CEecCCCcCC
Confidence            9999999999999999998744 344899999999999975   7999999984

>2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A*

Probab=99.78  E-value=7.5e-19  Score=157.06  Aligned_cols=109  Identities=20%  Similarity=0.343  Sum_probs=89.7

Q ss_pred             CCccCCCceeecCCCCCceecCCCcEEEeEeeccCCCCCCCcEEEEEEecccCCCeEEEEecCCCCCCCCCCCceEEEcc
Q 041921           27 NGTVPVGATLTAGTSSSPWLSPSGDFAFGFHQLDEENNTNDLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLTA  106 (814)
Q Consensus        27 ~~ti~~g~~l~~~~~~~~lvS~~g~F~lGF~~~~~~~~~~~~~~lgiw~~~~~~~t~vW~Anr~~~~~~~~~~~~l~~~~  106 (814)
                      .|||.+||+|.+++   +|+  +|.|+|+|+..+       ++.   +|+   ..++||.||++.   + ..+++|+|..
T Consensus         2 ~dtl~~gq~L~~g~---~L~--~g~~~L~~~~dg-------nlv---ly~---~~~~vW~sn~~~---~-~~~~~l~l~~   59 (115)
T 2dpf_A            2 DNVLLSGQTLHADH---SLQ--AGAYTLTIQNKC-------NLV---KYQ---NGRQIWASNTDR---R-GSGCRLTLLS   59 (115)
T ss_dssp             CCEEETTCEEETTE---EEE--ETTEEEEECTTS-------CEE---EEE---TTEEEEECSCTT---S-CSSCEEEECT
T ss_pred             CCEeCCCCEECCCC---EEE--CCCEEEEEcCCC-------cEE---EEe---CCEEEEeCCCCC---C-CCceEEEECC
Confidence            48999999999998   687  899999998654       122   354   379999999983   2 2467899999


Q ss_pred             CCcEEEeCCCCceEeeeccCCC-ceeEEEEecCcCEEEEeCCCCceeecccCCcc
Q 041921          107 DQGLVLNDPQGKQVWSSKIDIG-TVAVGHMNDTGNFVLASSSSGRLWDSFSNPTD  160 (814)
Q Consensus       107 ~G~Lvl~~~~g~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~lWQSFd~PtD  160 (814)
                      ||||||+|.++.+||+|++... +..+++|+|+|||||++.   ++||||.+++.
T Consensus        60 ~GnLvl~d~~~~~vW~S~~~~~~g~~~l~l~~dGnlvl~~~---~~W~S~~~~~~  111 (115)
T 2dpf_A           60 DGNLVIYDHNNNDVWGSACWGDNGKYALVLQKDGRFVIYGP---VLWSLGPNGCR  111 (115)
T ss_dssp             TSCEEEECTTCCEEEECCCCCSSSCCEEEECTTSCEEEECS---EEECSSTTCBC
T ss_pred             CCcEEEECCCceEEEEcCCCCCCCCEEEEEeCCCeEEEECC---CEEECCCCCCc
Confidence            9999999998999999998643 345899999999999964   89999998765

>1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A

Probab=99.77  E-value=1.1e-18  Score=155.25  Aligned_cols=109  Identities=19%  Similarity=0.412  Sum_probs=90.2

Q ss_pred             CCccCCCceeecCCCCCceecCCCcEEEeEeeccCCCCCCCcEEEEEEecccCCCeEEEEecCCCCCCCCCCCceEEEcc
Q 041921           27 NGTVPVGATLTAGTSSSPWLSPSGDFAFGFHQLDEENNTNDLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLTA  106 (814)
Q Consensus        27 ~~ti~~g~~l~~~~~~~~lvS~~g~F~lGF~~~~~~~~~~~~~~lgiw~~~~~~~t~vW~Anr~~~~~~~~~~~~l~~~~  106 (814)
                      +|||.+||+|.+++   +|  ++|.|+|+|+.+|+         | ++|++   .++||.+|++.    ...++.|+|..
T Consensus         1 tdtl~~gq~L~~g~---~L--~~~~~~L~~~~dgn---------l-vl~~~---~~~vW~sn~~~----~~~~~~l~l~~   58 (112)
T 1xd5_A            1 SDRLNSGHQLDTGG---SL--AEGGYLFIIQNDCN---------L-VLYDN---NRAVWASGTNG----KASGCVLKMQN   58 (112)
T ss_dssp             CCEEETTEEECTTC---EE--EETTEEEEECTTSC---------E-EEEET---TEEEEECCCTT----SCSSEEEEECT
T ss_pred             CCCCCCCCEECCCC---EE--eCCCEEEEEcCCCc---------E-EEEEC---CEEEEeCCCcC----CCCCEEEEEeC
Confidence            48999999999998   67  58999999987651         2 35654   68999999872    13467899999


Q ss_pred             CCcEEEeCCCCceEeeeccCCC-ceeEEEEecCcCEEEEeCCCCceeecccCC
Q 041921          107 DQGLVLNDPQGKQVWSSKIDIG-TVAVGHMNDTGNFVLASSSSGRLWDSFSNP  158 (814)
Q Consensus       107 ~G~Lvl~~~~g~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~lWQSFd~P  158 (814)
                      +|||||+| ++.+||+|++... +...++|+++|||||++..+.++||||+|.
T Consensus        59 ~GNLvl~d-~~~~~W~S~~~~~~g~~~l~l~~dGnlvl~~~~~~~~W~S~~~~  110 (112)
T 1xd5_A           59 DGNLVIYS-GSRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNV  110 (112)
T ss_dssp             TSCEEEEE-TTEEEEECCCCCSCCCCEEEECTTSCEEEECTTSCEEEECCCCC
T ss_pred             CCCEEEEc-CCEEEEECCccCCCCCEEEEEeCCCcEEEECCCCceEEECCCcc
Confidence            99999999 8889999987643 345899999999999987788999999984

>3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A*

Probab=99.72  E-value=2.2e-17  Score=145.88  Aligned_cols=104  Identities=20%  Similarity=0.383  Sum_probs=84.7

Q ss_pred             CccCCCceeecCCCCCceecCCCcEEEeEeeccCCCCCCCcEEEEEEecccCCCeEEEEecCCCCCCCCCCCceEEEccC
Q 041921           28 GTVPVGATLTAGTSSSPWLSPSGDFAFGFHQLDEENNTNDLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLTAD  107 (814)
Q Consensus        28 ~ti~~g~~l~~~~~~~~lvS~~g~F~lGF~~~~~~~~~~~~~~lgiw~~~~~~~t~vW~Anr~~~~~~~~~~~~l~~~~~  107 (814)
                      +||.+||.|.+++   .|+  +|.|+|+|+..|       +.+|   |..   .++||.+|++.   + +.++.|+|..|
T Consensus         2 ntL~~gq~L~~g~---~L~--~g~~~L~~q~dG-------nLvl---y~~---~~~vW~snt~~---~-~~~~~l~l~~d   59 (109)
T 3dzw_A            2 NILYSGETLSPGE---FLN--NGRYVFIMQEDC-------NLVL---YDV---DKPIWATNTGG---L-DRRCHLSMQSD   59 (109)
T ss_dssp             CEEETTEEECTTC---EEE--ETTEEEEECTTS-------CEEE---EET---TEEEEECCCTT---S-SSSCEEEECTT
T ss_pred             CCcCCCCEeCCCC---EEE--CCCEEEEEcCCC-------cEEE---EeC---CEEEEECCccc---C-CCCEEEEEeCC
Confidence            6899999999998   675  799999998654       1333   654   58999999873   2 34578999999


Q ss_pred             CcEEEeCCCCceEeeeccCCCc-eeEEEEecCcCEEEEeCCCCceeeccc
Q 041921          108 QGLVLNDPQGKQVWSSKIDIGT-VAVGHMNDTGNFVLASSSSGRLWDSFS  156 (814)
Q Consensus       108 G~Lvl~~~~g~~vWst~~~~~~-~~~a~LldsGNlVl~~~~~~~lWQSFd  156 (814)
                      |||||+|.++.++|+|++.... ..+|+|+|+|||||++.   .+|||=-
T Consensus        60 GNLvl~~~~~~~~W~S~t~~~~~~~~~~L~ddGNlvly~~---~~W~s~t  106 (109)
T 3dzw_A           60 GNLVVYSPRNNPIWASNTGGENGNYVCVLQKDRNVVIYGT---ARWATGT  106 (109)
T ss_dssp             SCEEEECTTSCEEEECCCCCSSSCEEEEECTTSCEEEEES---CCCCCCC
T ss_pred             CCEEEECCCCCEEEECCCCCCCCCEEEEEeCCCEEEEECC---CEEeCCC
Confidence            9999999999999999986544 35899999999999985   7999843

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.71  E-value=3.6e-17  Score=169.61  Aligned_cols=136  Identities=17%  Similarity=0.127  Sum_probs=105.7

Q ss_pred             ccccceeeeeeeeEEEEEEecCCCceE--EEEEEecccccc------------------------chHhHHHHHHhhhcc
Q 041921          522 NFKEEVGRGSFGIVYKGVIQTRTSTTA--VAVKKLDRVFQD------------------------GEREFKNEVFVIGQT  575 (814)
Q Consensus       522 ~~~~~LG~G~~g~Vy~~~~~~~~~~~~--vavK~l~~~~~~------------------------~~~~~~~E~~~l~~l  575 (814)
                      .+.+.||+|+||.||+|....  ++..  ||||.++.....                        ....+.+|+.++.++
T Consensus        50 ~i~~~ig~G~~g~Vy~a~~~~--~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           50 AMGGVISTGKEANVFYADGVF--DGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEECSSEEEEEEEEEE--TTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             hhCCEEeecceEEEEEEEEcC--CCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            466789999999999999732  4667  999986432111                        012578999999999


Q ss_pred             CCCCc--cceeeeecccccceEEEecCCC-C----CHHHHhcCCCCCChhhHHHHHHHHHHHHHHhh-hcCCCCeeecCC
Q 041921          576 HHKNL--VRLLGFCDEGQNRLLVYEFLNN-G----TLASFLFGNLKPNWNLRTNIAFQIARGLLYLH-EDCRAQIIHCDI  647 (814)
Q Consensus       576 ~h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH-~~~~~~i~H~dl  647 (814)
                      +|+++  +.++.+    +..+|||||+.+ |    +|.+++..   .++.....++.|++.+|.||| +.   +|+||||
T Consensus       128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~---givHrDl  197 (258)
T 1zth_A          128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEA---ELVHADL  197 (258)
T ss_dssp             HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTS---CEECSSC
T ss_pred             HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHC---CEEeCCC
Confidence            98864  344432    467899999942 4    77776543   235577899999999999999 87   9999999


Q ss_pred             CCCcEEEcCCCcEEEeecCCcccc
Q 041921          648 KPQNILLDDYYTARISDFGLAKLL  671 (814)
Q Consensus       648 kp~NIll~~~~~~kl~DfGla~~~  671 (814)
                      ||+|||++.  .++|+|||++...
T Consensus       198 kp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          198 SEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             STTSEEESS--SEEECCCTTCEET
T ss_pred             CHHHEEEcC--cEEEEECcccccC
Confidence            999999998  9999999999754

>3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara}

Probab=99.66  E-value=2.6e-16  Score=138.84  Aligned_cols=104  Identities=16%  Similarity=0.211  Sum_probs=82.9

Q ss_pred             hcCCccCCCceeecCCCCCceecCCCcEEEeEeeccCCCCCCCcEEEEEEecccCCCeEEEEecCCCCCCCCCCCceEEE
Q 041921           25 QNNGTVPVGATLTAGTSSSPWLSPSGDFAFGFHQLDEENNTNDLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKL  104 (814)
Q Consensus        25 ~~~~ti~~g~~l~~~~~~~~lvS~~g~F~lGF~~~~~~~~~~~~~~lgiw~~~~~~~t~vW~Anr~~~~~~~~~~~~l~~  104 (814)
                      .+.|||.+||.|.+++   +|+|  |.|.|-|...|         -|.+ |..    ++||.+|++.    .+.++.|+|
T Consensus         4 ~~~dtL~~gq~L~~g~---~L~s--g~~~L~~q~dG---------nLvl-~~~----~~vW~snt~~----~~~~~~l~l   60 (110)
T 3r0e_B            4 FTNNLLFSGQVLYGDG---RLTA--KNHQLVMQGDC---------NLVL-YGG----KYGWQSNTHG----NGEHCFLRL   60 (110)
T ss_dssp             CBTTEEETTCEEETTE---EEEC--SSCEEEECTTS---------CEEE-ECS----SSCEECCCTT----SSSSCEEEE
T ss_pred             cccCEECCCCEecCCC---EEEe--CCEEEEEcCCC---------eEEE-ECC----eEEEECCCcC----CCcCEEEEE
Confidence            4679999999999998   7887  56999664332         2555 654    4799999872    234578999


Q ss_pred             ccCCcEEEeCCCCceEeeeccCCC-ceeEEEEecCcCEEEEeCCCCceeec
Q 041921          105 TADQGLVLNDPQGKQVWSSKIDIG-TVAVGHMNDTGNFVLASSSSGRLWDS  154 (814)
Q Consensus       105 ~~~G~Lvl~~~~g~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~lWQS  154 (814)
                      ..||||||+|.++.++|+|++... +..+|+|+|+|||||++   ..+|+|
T Consensus        61 ~~dGNLvl~d~~~~~iW~S~t~~~~~~~~~~L~~dGNlvly~---~~~W~t  108 (110)
T 3r0e_B           61 NHKGELIIKDDDFKTIWSSRSSSKQGEYVLILQDDGFGVIYG---PAIFET  108 (110)
T ss_dssp             CTTSCEEEECTTCCEEEECCCCCSSSCCEEEECTTSCEEEEC---SEEEES
T ss_pred             eCCCcEEEEeCCCCEEEEcCCcCCCCCEEEEEcCCccEEEec---CCEecC
Confidence            999999999999999999998643 33689999999999998   479997

>3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A*

Probab=99.65  E-value=5.2e-16  Score=137.18  Aligned_cols=88  Identities=23%  Similarity=0.356  Sum_probs=74.6

Q ss_pred             CCceEEEccCCcEEEeCCCCceEeeeccCCCc-eeEEEEecCcCEEEEeCCCCceeecccCCccccccCCccccccceee
Q 041921           98 RGSQVKLTADQGLVLNDPQGKQVWSSKIDIGT-VAVGHMNDTGNFVLASSSSGRLWDSFSNPTDTLLLGQMMETEQGLFS  176 (814)
Q Consensus        98 ~~~~l~~~~~G~Lvl~~~~g~~vWst~~~~~~-~~~a~LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg~~l~~~~~l~S  176 (814)
                      ...+|.|..||||||++ .+++||++++...+ ..+++|+|+|||||++.++.++||||                     
T Consensus        20 ~~~~l~~~~dGnlvl~~-~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~~~~~~~~W~S~---------------------   77 (110)
T 3a0c_A           20 PSYRLIMQGDCNFVLYD-SGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQSNRVIWQTK---------------------   77 (110)
T ss_dssp             TTEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECC---------------------
T ss_pred             CCEEEEEcCCCcEEEEE-CCEEEEECCCCCCCCcEEEEEeCCCCEEEECCCCcEEEecC---------------------
Confidence            35789999999999998 58999999986543 35899999999999999889999999                     


Q ss_pred             cccCCCCCCCceeEEEccCCceeEEeeccCCCccccceeecccc
Q 041921          177 RKSENNFSRGRFQFRLLEDGNLVLNIANLATGFAYDAYYTSGTY  220 (814)
Q Consensus       177 ~~s~~d~s~G~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~sg~~  220 (814)
                          +++++|.|+++|+++|+++++-  .       .||+++++
T Consensus        78 ----t~~~~g~~~l~l~~dGnlvl~~--~-------~~W~S~~~  108 (110)
T 3a0c_A           78 ----TNGKEDHYVLVLQQDRNVVIYG--P-------VVWATGSG  108 (110)
T ss_dssp             ----CCCSSSCCEEEECTTSCEEEEC--S-------EEEECSCC
T ss_pred             ----CCCCCCCEEEEEeCCccEEEEC--C-------CEecCCCc
Confidence                3567899999999999977642  1       59999875

>1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A

Probab=99.65  E-value=5.6e-16  Score=137.71  Aligned_cols=92  Identities=29%  Similarity=0.400  Sum_probs=76.3

Q ss_pred             CCceEEEccCCcEEEeCCCCceEeeeccCCCc-eeEEEEecCcCEEEEeCCCCceeecccCCccccccCCccccccceee
Q 041921           98 RGSQVKLTADQGLVLNDPQGKQVWSSKIDIGT-VAVGHMNDTGNFVLASSSSGRLWDSFSNPTDTLLLGQMMETEQGLFS  176 (814)
Q Consensus        98 ~~~~l~~~~~G~Lvl~~~~g~~vWst~~~~~~-~~~a~LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg~~l~~~~~l~S  176 (814)
                      ...+|.|..||||||++. +++||++++...+ ..+|+|+|+|||||++ ++.++||||+                    
T Consensus        19 ~~~~L~~~~dgnlvl~~~-~~~vW~sn~~~~~~~~~l~l~~~GNLvl~d-~~~~~W~S~~--------------------   76 (112)
T 1xd5_A           19 GGYLFIIQNDCNLVLYDN-NRAVWASGTNGKASGCVLKMQNDGNLVIYS-GSRAIWASNT--------------------   76 (112)
T ss_dssp             TTEEEEECTTSCEEEEET-TEEEEECCCTTSCSSEEEEECTTSCEEEEE-TTEEEEECCC--------------------
T ss_pred             CCEEEEEcCCCcEEEEEC-CEEEEeCCCcCCCCCEEEEEeCCCCEEEEc-CCEEEEECCc--------------------
Confidence            357899999999999987 7899999986433 4689999999999999 7789999994                    


Q ss_pred             cccCCCCCCCceeEEEccCCceeEEeeccCCCccccceeeccccCC
Q 041921          177 RKSENNFSRGRFQFRLLEDGNLVLNIANLATGFAYDAYYTSGTYDP  222 (814)
Q Consensus       177 ~~s~~d~s~G~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~sg~~~~  222 (814)
                           ++++|.|+++|+++|+++++. ...     .+||++++|++
T Consensus        77 -----~~~~g~~~l~l~~dGnlvl~~-~~~-----~~~W~S~~~~g  111 (112)
T 1xd5_A           77 -----NRQNGNYYLILQRDRNVVIYD-NSN-----NAIWATHTNVG  111 (112)
T ss_dssp             -----CCSCCCCEEEECTTSCEEEEC-TTS-----CEEEECCCCCC
T ss_pred             -----cCCCCCEEEEEeCCCcEEEEC-CCC-----ceEEECCCccC
Confidence                 456789999999999977753 111     47999999964

>3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0

Probab=99.63  E-value=2.2e-15  Score=133.66  Aligned_cols=106  Identities=12%  Similarity=0.141  Sum_probs=85.5

Q ss_pred             cCCccCCCceeecCCCCCceecCCCcEEEeEeeccCCCCCCCcEEEEEEecccCCCeEEEEecCCCCCCCCCCCceEEEc
Q 041921           26 NNGTVPVGATLTAGTSSSPWLSPSGDFAFGFHQLDEENNTNDLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLT  105 (814)
Q Consensus        26 ~~~ti~~g~~l~~~~~~~~lvS~~g~F~lGF~~~~~~~~~~~~~~lgiw~~~~~~~t~vW~Anr~~~~~~~~~~~~l~~~  105 (814)
                      ..++|.+||.|.+++   +|.  +|.|.|-|...|         .|.++..+  ..++||.+|+..   + ..++.|.|.
T Consensus         5 ~~~tL~~gq~L~~g~---~L~--~g~~~L~~q~dG---------NLvL~~~~--~~~~vWssnt~~---~-~~~~~l~l~   64 (113)
T 3mez_B            5 VRNVLFSSQVMYDNA---QLA--TRDYSLVMRDDC---------NLVLTKGS--KTNIVWESGTSG---R-GQHCFMRLG   64 (113)
T ss_dssp             CSSEEETTCEEETTC---EEE--ETTEEEEECTTS---------CEEEEETT--TTEEEEECCCTT---S-CSSCEEEEC
T ss_pred             cCCEeCCCCEECCCC---EeE--cCCEEEEEcCCC---------EEEEEECC--CCEEEEECCccc---C-CcCEEEEEe
Confidence            458999999999998   676  488999996543         36665431  368999999872   2 235789999


Q ss_pred             cCCcEEEeCCCCceEeeeccCCC-ceeEEEEecCcCEEEEeCCCCceeec
Q 041921          106 ADQGLVLNDPQGKQVWSSKIDIG-TVAVGHMNDTGNFVLASSSSGRLWDS  154 (814)
Q Consensus       106 ~~G~Lvl~~~~g~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~lWQS  154 (814)
                      .||||||+|.+++++|+|++... +..+|+|+|+|||||++   ..+|+|
T Consensus        65 ~dGNLVl~d~~~~~iW~S~t~~~~~~~~~~L~~dGnlvly~---~~~W~s  111 (113)
T 3mez_B           65 HSGELDITDDRLNTVFVSNTVGQEGDYVLILQINGQAVVYG---PAVWST  111 (113)
T ss_dssp             TTSCEEEECTTSCEEEECSCCCSSSCCEEEECTTSCEEEEC---SEEEES
T ss_pred             CCCcEEEECCCCCEEEECCCcCCCCCEEEEEcCCceEEEec---CCEecC
Confidence            99999999999999999998643 33689999999999997   589997

>1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1

Probab=99.63  E-value=1.2e-15  Score=136.68  Aligned_cols=86  Identities=21%  Similarity=0.300  Sum_probs=73.5

Q ss_pred             CceEEEccCCcEEEeCCCCceEeeeccCCCc-eeEEEEecCcCEEEEeCCCCceeecccCCccccccCCccccccceeec
Q 041921           99 GSQVKLTADQGLVLNDPQGKQVWSSKIDIGT-VAVGHMNDTGNFVLASSSSGRLWDSFSNPTDTLLLGQMMETEQGLFSR  177 (814)
Q Consensus        99 ~~~l~~~~~G~Lvl~~~~g~~vWst~~~~~~-~~~a~LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg~~l~~~~~l~S~  177 (814)
                      ..+|.|..||||||++. +++||++++...+ ..+++|+|+|||||++.++.++||||                      
T Consensus        31 ~~~L~~~~dgnlvly~~-~~~vW~sn~~~~~~~~~l~l~~dGNLVl~d~~~~~lW~S~----------------------   87 (119)
T 1b2p_A           31 VYRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQSP----------------------   87 (119)
T ss_dssp             EEEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECS----------------------
T ss_pred             CEEEEEecCCCEEEEEC-CEEEEeCCCccCCCceEEEEccCCEEEEEeCCCcEEEcCC----------------------
Confidence            36799999999999987 8999999986543 36899999999999998889999999                      


Q ss_pred             ccCCCCCCCceeEEEccCCceeEEeeccCCCccccceeeccc
Q 041921          178 KSENNFSRGRFQFRLLEDGNLVLNIANLATGFAYDAYYTSGT  219 (814)
Q Consensus       178 ~s~~d~s~G~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~sg~  219 (814)
                         ++|++|.|+++|+++|+++++-         ..||++|+
T Consensus        88 ---~~~~~g~~~l~l~~~Gnlvl~~---------~~~W~Sg~  117 (119)
T 1b2p_A           88 ---VAGKAGHYVLVLQPDRNVVIYG---------DALWATQT  117 (119)
T ss_dssp             ---CCCCSSCEEEEECTTSCEEEEE---------SEEEECCC
T ss_pred             ---CCCCCCCEEEEEECCCcEEEEC---------ccEeCCCC
Confidence               4567899999999999977652         25999987

>2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A*

Probab=99.58  E-value=5.8e-15  Score=131.73  Aligned_cols=89  Identities=20%  Similarity=0.367  Sum_probs=75.2

Q ss_pred             CceEEEccCCcEEEeCCCCceEeeeccCCCc-eeEEEEecCcCEEEEeCCCCceeecccCCccccccCCccccccceeec
Q 041921           99 GSQVKLTADQGLVLNDPQGKQVWSSKIDIGT-VAVGHMNDTGNFVLASSSSGRLWDSFSNPTDTLLLGQMMETEQGLFSR  177 (814)
Q Consensus        99 ~~~l~~~~~G~Lvl~~~~g~~vWst~~~~~~-~~~a~LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg~~l~~~~~l~S~  177 (814)
                      ..+|.|..||||||++ .+++||++++.... ...++|+++|||||++.++.++|||||+                    
T Consensus        21 ~~~L~~~~dgnlvly~-~~~~vW~sn~~~~~~~~~l~l~~~GnLvl~d~~~~~vW~S~~~--------------------   79 (115)
T 2dpf_A           21 AYTLTIQNKCNLVKYQ-NGRQIWASNTDRRGSGCRLTLLSDGNLVIYDHNNNDVWGSACW--------------------   79 (115)
T ss_dssp             TEEEEECTTSCEEEEE-TTEEEEECSCTTSCSSCEEEECTTSCEEEECTTCCEEEECCCC--------------------
T ss_pred             CEEEEEcCCCcEEEEe-CCEEEEeCCCCCCCCceEEEECCCCcEEEECCCceEEEEcCCC--------------------
Confidence            4679999999999998 57899999986543 3589999999999999888899999997                    


Q ss_pred             ccCCCCCCCceeEEEccCCceeEEeeccCCCccccceeeccccCC
Q 041921          178 KSENNFSRGRFQFRLLEDGNLVLNIANLATGFAYDAYYTSGTYDP  222 (814)
Q Consensus       178 ~s~~d~s~G~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~sg~~~~  222 (814)
                           +++|.|++.++++|+++++  ..       .||++++|..
T Consensus        80 -----~~~g~~~l~l~~dGnlvl~--~~-------~~W~S~~~~~  110 (115)
T 2dpf_A           80 -----GDNGKYALVLQKDGRFVIY--GP-------VLWSLGPNGC  110 (115)
T ss_dssp             -----CSSSCCEEEECTTSCEEEE--CS-------EEECSSTTCB
T ss_pred             -----CCCCCEEEEEeCCCeEEEE--CC-------CEEECCCCCC
Confidence                 3578899999999997775  21       5999999953

>3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara}

Probab=99.56  E-value=9.8e-15  Score=128.52  Aligned_cols=101  Identities=21%  Similarity=0.340  Sum_probs=81.2

Q ss_pred             cCCccCCCceeecCCCCCceecCCCcEEEeEeeccCCCCCCCcEEEEEEecccCCCeEEEEecCCCCCCCCCCCceEEEc
Q 041921           26 NNGTVPVGATLTAGTSSSPWLSPSGDFAFGFHQLDEENNTNDLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLT  105 (814)
Q Consensus        26 ~~~ti~~g~~l~~~~~~~~lvS~~g~F~lGF~~~~~~~~~~~~~~lgiw~~~~~~~t~vW~Anr~~~~~~~~~~~~l~~~  105 (814)
                      +.|||.+||.|.+++   +|  .+|.|.|.|...|         -|-+ |..      +|.+|+..   . +.+++|+|.
T Consensus         2 ~~dtL~~gq~L~~g~---~L--~~g~~~L~~q~dG---------NLvl-~~~------~Wssnt~~---~-~~~~~l~l~   56 (109)
T 3r0e_A            2 GTNYLLSGQTLDTEG---HL--KNGDFDLVMQDDC---------NLVL-YNG------NWQSNTAN---N-GRDCKLTLT   56 (109)
T ss_dssp             CCSEEETTCEECTTC---EE--EETTEEEEECTTS---------CEEE-ETT------TEECCCTT---S-CSSCEEEEC
T ss_pred             ccCCcCCCCCcCCCC---Ee--ECCCEEEEEecCC---------eEEE-EeC------eEEcCCCC---C-CCcEEEEEc
Confidence            568999999999998   57  5799999996543         1333 432      69998772   1 346889999


Q ss_pred             cCCcEEEeCCCCceEeeeccCCCc-eeEEEEecCcCEEEEeCCCCceeec
Q 041921          106 ADQGLVLNDPQGKQVWSSKIDIGT-VAVGHMNDTGNFVLASSSSGRLWDS  154 (814)
Q Consensus       106 ~~G~Lvl~~~~g~~vWst~~~~~~-~~~a~LldsGNlVl~~~~~~~lWQS  154 (814)
                      .||||||+|.++.++|+|++.... ..+|+|+|+|||||++   ..+|+|
T Consensus        57 ~dGnLvl~d~~~~~vWss~t~~~~~~~~~~L~~dGNlvly~---~~~W~s  103 (109)
T 3r0e_A           57 DYGELVIKNGDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFG---PSVFKI  103 (109)
T ss_dssp             TTSCEEEECTTSCEEEECCCCCSSSCCEEEEETTTEEEEEC---SEEEEE
T ss_pred             CCCeEEEEeCCCCEEEcCCCcCCCcCEEEEEcCCCeEEEEe---cCEECC
Confidence            999999999999999999986433 4589999999999997   679998

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.50  E-value=1.1e-14  Score=156.83  Aligned_cols=136  Identities=12%  Similarity=0.042  Sum_probs=95.5

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEecccccc--------------chHhH--------HHHHHhhhccCCC
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD--------------GEREF--------KNEVFVIGQTHHK  578 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~--------------~~~~~--------~~E~~~l~~l~h~  578 (814)
                      |.+.+.||+|++|.||+|...   +++.||||.++.....              .....        ..|...|.++.+.
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~---~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~  173 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADE---KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE  173 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECT---TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             EEecCEeeeCCceEEEEEECC---CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence            567889999999999999864   5789999987532100              00111        2345555555443


Q ss_pred             CccceeeeecccccceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC
Q 041921          579 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYY  658 (814)
Q Consensus       579 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~  658 (814)
                      ++....-+  .....+|||||+++++|..+..      ......++.|++.+|.+||+.   +|+||||||.|||+++++
T Consensus       174 gv~vp~p~--~~~~~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~dg  242 (397)
T 4gyi_A          174 GFPVPEPI--AQSRHTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREEK  242 (397)
T ss_dssp             TCSCCCEE--EEETTEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEEE
T ss_pred             CCCCCeee--eccCceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCCC
Confidence            33211111  1223479999999988876532      223457889999999999998   999999999999998776


Q ss_pred             ----------cEEEeecCCccc
Q 041921          659 ----------TARISDFGLAKL  670 (814)
Q Consensus       659 ----------~~kl~DfGla~~  670 (814)
                                .+.|+||+-+..
T Consensus       243 d~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          243 DAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             CSSCTTSEEEEEEECCCTTCEE
T ss_pred             CcccccccccceEEEEeCCccc
Confidence                      389999997654

>3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0

Probab=99.44  E-value=3.1e-13  Score=119.30  Aligned_cols=102  Identities=12%  Similarity=0.222  Sum_probs=79.5

Q ss_pred             CCccCCCceeecCCCCCceecCCCcEEEeEeeccCCCCCCCcEEEEEEecccCCCeEEEEecCCCCCCCCCCCceEEEcc
Q 041921           27 NGTVPVGATLTAGTSSSPWLSPSGDFAFGFHQLDEENNTNDLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLTA  106 (814)
Q Consensus        27 ~~ti~~g~~l~~~~~~~~lvS~~g~F~lGF~~~~~~~~~~~~~~lgiw~~~~~~~t~vW~Anr~~~~~~~~~~~~l~~~~  106 (814)
                      +++|.+||.|.+|+   +|  .+|.|.|-|...|         -|.+ |..   .. ||.+|+..  +  ...+.|.|..
T Consensus         2 ~~~l~~gq~L~~g~---~L--~~g~~~L~~q~dG---------nLvl-~~~---~~-vW~snt~~--~--~~~~~l~l~~   58 (111)
T 3mez_A            2 NNVLLTGDVIHTDN---QL--SYESAAFVMQGDC---------NLVL-YNE---AG-GFQSNTHG--R--GVDCTLRLNN   58 (111)
T ss_dssp             TTEEETTCEECTTC---EE--EETTEEEEECTTS---------CEEE-ECS---SC-CEECCCTT--S--CSSCEEEECT
T ss_pred             cCEeCCCCEeCCCC---EE--ecCCEEEEEccCC---------eEEE-ECC---CC-EEECCccc--C--CcCEEEEEcC
Confidence            57899999999998   57  4799999996543         1444 543   23 99999872  2  3357899999


Q ss_pred             CCcEEEeCCCCc-eEeeeccCC---CceeEEEEecCcCEEEEeCCCCceeec
Q 041921          107 DQGLVLNDPQGK-QVWSSKIDI---GTVAVGHMNDTGNFVLASSSSGRLWDS  154 (814)
Q Consensus       107 ~G~Lvl~~~~g~-~vWst~~~~---~~~~~a~LldsGNlVl~~~~~~~lWQS  154 (814)
                      ||||||+|.++. +||+|++..   .+..+++|+|+|||||++   ..+|+|
T Consensus        59 dGNLVl~~~~~~~~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~---~~~W~s  107 (111)
T 3mez_A           59 RGQLEIHSANSNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYG---PAIWST  107 (111)
T ss_dssp             TSCEEEECSSCSSCSEEESSSCCCCSSCCEEEECTTSCEEEEC---SEEEEC
T ss_pred             CCcEEEEeCCCCEEEEEeccccCCCCcCEEEEECCCCeEEEec---cCEEcc
Confidence            999999998876 599999632   234589999999999997   679997

>3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0

Probab=99.35  E-value=4e-12  Score=112.17  Aligned_cols=87  Identities=21%  Similarity=0.288  Sum_probs=70.3

Q ss_pred             CceEEEccCCcEEEeCCCCceEeeeccCCCce-eEEEEecCcCEEEEeCCCC-ceeecccCCccccccCCccccccceee
Q 041921           99 GSQVKLTADQGLVLNDPQGKQVWSSKIDIGTV-AVGHMNDTGNFVLASSSSG-RLWDSFSNPTDTLLLGQMMETEQGLFS  176 (814)
Q Consensus        99 ~~~l~~~~~G~Lvl~~~~g~~vWst~~~~~~~-~~a~LldsGNlVl~~~~~~-~lWQSFd~PtDtlLpg~~l~~~~~l~S  176 (814)
                      ..+|.+..||||||++.++  +|++++...+. ..++|+++|||||++.++. ++|||..+                   
T Consensus        21 ~~~L~~q~dGnLvl~~~~~--vW~snt~~~~~~~~l~l~~dGNLVl~~~~~~~~vW~S~t~-------------------   79 (111)
T 3mez_A           21 SAAFVMQGDCNLVLYNEAG--GFQSNTHGRGVDCTLRLNNRGQLEIHSANSNTPVWVYPRS-------------------   79 (111)
T ss_dssp             TEEEEECTTSCEEEECSSC--CEECCCTTSCSSCEEEECTTSCEEEECSSCSSCSEEESSS-------------------
T ss_pred             CEEEEEccCCeEEEECCCC--EEECCcccCCcCEEEEEcCCCcEEEEeCCCCEEEEEeccc-------------------
Confidence            5689999999999999876  99999875433 6899999999999998776 49999831                   


Q ss_pred             cccCCCCCCCceeEEEccCCceeEEeeccCCCccccceeeccc
Q 041921          177 RKSENNFSRGRFQFRLLEDGNLVLNIANLATGFAYDAYYTSGT  219 (814)
Q Consensus       177 ~~s~~d~s~G~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~sg~  219 (814)
                          .....|.|.+.|+.||+++++-         .++|.+++
T Consensus        80 ----~~~~~~~~~l~Lq~dGNlvly~---------~~~W~s~t  109 (111)
T 3mez_A           80 ----VNTVRGNYAATLGPDQHVTIYG---------PAIWSTPA  109 (111)
T ss_dssp             ----CCCCSSCCEEEECTTSCEEEEC---------SEEEECCC
T ss_pred             ----cCCCCcCEEEEECCCCeEEEec---------cCEEccCC
Confidence                1113578999999999999873         35898876

>3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0

Probab=99.32  E-value=6.9e-12  Score=111.08  Aligned_cols=89  Identities=18%  Similarity=0.279  Sum_probs=71.5

Q ss_pred             CCCceEEEccCCcEEEeCC-CCceEeeeccCCCc-eeEEEEecCcCEEEEeCCCCceeecccCCccccccCCccccccce
Q 041921           97 PRGSQVKLTADQGLVLNDP-QGKQVWSSKIDIGT-VAVGHMNDTGNFVLASSSSGRLWDSFSNPTDTLLLGQMMETEQGL  174 (814)
Q Consensus        97 ~~~~~l~~~~~G~Lvl~~~-~g~~vWst~~~~~~-~~~a~LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg~~l~~~~~l  174 (814)
                      ....+|.+..||||||++. .++++|++++...+ ...++|+++|||||++.++.++|||=.+       +         
T Consensus        23 ~g~~~L~~q~dGNLvL~~~~~~~~vWssnt~~~~~~~~l~l~~dGNLVl~d~~~~~iW~S~t~-------~---------   86 (113)
T 3mez_B           23 TRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDDRLNTVFVSNTV-------G---------   86 (113)
T ss_dssp             ETTEEEEECTTSCEEEEETTTTEEEEECCCTTSCSSCEEEECTTSCEEEECTTSCEEEECSCC-------C---------
T ss_pred             cCCEEEEEcCCCEEEEEECCCCEEEEECCcccCCcCEEEEEeCCCcEEEECCCCCEEEECCCc-------C---------
Confidence            3467899999999999988 48999999987543 3589999999999999888899998431       0         


Q ss_pred             eecccCCCCCCCceeEEEccCCceeEEeeccCCCccccceeeccc
Q 041921          175 FSRKSENNFSRGRFQFRLLEDGNLVLNIANLATGFAYDAYYTSGT  219 (814)
Q Consensus       175 ~S~~s~~d~s~G~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~sg~  219 (814)
                               ..|.|.+.|+.+|+++++-         .+.|.+++
T Consensus        87 ---------~~~~~~~~L~~dGnlvly~---------~~~W~s~~  113 (113)
T 3mez_B           87 ---------QEGDYVLILQINGQAVVYG---------PAVWSTAA  113 (113)
T ss_dssp             ---------SSSCCEEEECTTSCEEEEC---------SEEEESCC
T ss_pred             ---------CCCCEEEEEcCCceEEEec---------CCEecCCC
Confidence                     1356899999999998873         25788874

>3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A*

Probab=99.26  E-value=2e-11  Score=107.47  Aligned_cols=86  Identities=26%  Similarity=0.371  Sum_probs=69.7

Q ss_pred             CceEEEccCCcEEEeCCCCceEeeeccCCCc-eeEEEEecCcCEEEEeCCCCceeecccCCccccccCCccccccceeec
Q 041921           99 GSQVKLTADQGLVLNDPQGKQVWSSKIDIGT-VAVGHMNDTGNFVLASSSSGRLWDSFSNPTDTLLLGQMMETEQGLFSR  177 (814)
Q Consensus        99 ~~~l~~~~~G~Lvl~~~~g~~vWst~~~~~~-~~~a~LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg~~l~~~~~l~S~  177 (814)
                      ..+|.|..||||||++. +++||++++...+ ...++|+++|||||++.++.++|||....                   
T Consensus        20 ~~~L~~q~dGnLvly~~-~~~vW~snt~~~~~~~~l~l~~dGNLvl~~~~~~~~W~S~t~~-------------------   79 (109)
T 3dzw_A           20 RYVFIMQEDCNLVLYDV-DKPIWATNTGGLDRRCHLSMQSDGNLVVYSPRNNPIWASNTGG-------------------   79 (109)
T ss_dssp             TEEEEECTTSCEEEEET-TEEEEECCCTTSSSSCEEEECTTSCEEEECTTSCEEEECCCCC-------------------
T ss_pred             CEEEEEcCCCcEEEEeC-CEEEEECCcccCCCCEEEEEeCCCCEEEECCCCCEEEECCCCC-------------------
Confidence            46799999999999987 6899999986543 35899999999999998888999986421                   


Q ss_pred             ccCCCCCCCceeEEEccCCceeEEeeccCCCccccceeeccc
Q 041921          178 KSENNFSRGRFQFRLLEDGNLVLNIANLATGFAYDAYYTSGT  219 (814)
Q Consensus       178 ~s~~d~s~G~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~sg~  219 (814)
                            ..+.|.+.|+.+|+++++-         .+.|.+++
T Consensus        80 ------~~~~~~~~L~ddGNlvly~---------~~~W~s~t  106 (109)
T 3dzw_A           80 ------ENGNYVCVLQKDRNVVIYG---------TARWATGT  106 (109)
T ss_dssp             ------SSSCEEEEECTTSCEEEEE---------SCCCCCCC
T ss_pred             ------CCCCEEEEEeCCCEEEEEC---------CCEEeCCC
Confidence                  1256889999999998873         14787776

>3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A*

Probab=99.25  E-value=1.6e-11  Score=126.78  Aligned_cols=115  Identities=16%  Similarity=0.284  Sum_probs=86.9

Q ss_pred             hcCCccCCCce----eecCCCCCceecCCCcEEEeEeeccCCCCCCCcEEEEEEecccCCCeEEEEecCCCCCCCCCCCc
Q 041921           25 QNNGTVPVGAT----LTAGTSSSPWLSPSGDFAFGFHQLDEENNTNDLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRGS  100 (814)
Q Consensus        25 ~~~~ti~~g~~----l~~~~~~~~lvS~~g~F~lGF~~~~~~~~~~~~~~lgiw~~~~~~~t~vW~Anr~~~~~~~~~~~  100 (814)
                      -++||+.||+.    |..++   .|+| +..++.|+|...-.. .. .++  + |.+  ..+++|.+++.++   .  ..
T Consensus       134 ~ptdtlLpg~~~~~~l~~g~---~L~S-~~dps~G~fsl~l~~-dG-nlv--L-y~~--~~~~yW~Sgt~~~---~--~~  197 (276)
T 3m7h_A          134 TPAIPLVPGAIDSLLLAPGS---ELVQ-GVVYGAGASKLVFQG-DG-NLV--A-YGP--NGAATWNAGTQGK---G--AV  197 (276)
T ss_dssp             CTTSCCCCSCTTCEEECSSE---EECT-TCEEEETTEEEEECT-TS-CEE--E-ECT--TSSEEEECCCTTT---T--CC
T ss_pred             ccccccccccccccccccCc---cccc-CCCCCCceEEEeecC-Cc-eEE--E-EeC--CCeEEEECCCCCC---c--cE
Confidence            45699999999    87776   5765 457777777653211 12 233  3 332  2589999988732   2  26


Q ss_pred             eEEEccCCcEEEeCCCCceEeeeccCCCceeEEEEecCcCEEEEeCCCCceeecccC
Q 041921          101 QVKLTADQGLVLNDPQGKQVWSSKIDIGTVAVGHMNDTGNFVLASSSSGRLWDSFSN  157 (814)
Q Consensus       101 ~l~~~~~G~Lvl~~~~g~~vWst~~~~~~~~~a~LldsGNlVl~~~~~~~lWQSFd~  157 (814)
                      .|.+..+|+|+++|.++.++|++++......+|+|+++|||||++.  ..+||||||
T Consensus       198 ~l~l~~dGnLvl~d~~~~~vWsS~t~~~~~~rl~Ld~dGnLvly~~--~~~Wqsf~~  252 (276)
T 3m7h_A          198 RAVFQGDGNLVVYGAGNAVLWHSHTGGHASAVLRLQANGSIAILDE--KPVWARFGF  252 (276)
T ss_dssp             EEEECTTSCEEEECTTSCEEEECSCTTCTTCEEEECTTSCEEEEEE--EEEEESSSC
T ss_pred             EEEEcCCCeEEEEeCCCcEEEEecCCCCCCEEEEEcCCccEEEEcC--CCeEEccCc
Confidence            8999999999999998899999998755557899999999999976  689999997

>3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara}

Probab=99.20  E-value=6.7e-11  Score=104.10  Aligned_cols=86  Identities=22%  Similarity=0.370  Sum_probs=68.7

Q ss_pred             CCceEEEccCCcEEEeCCCCceEeeeccCCCce-eEEEEecCcCEEEEeCCCCceeecccCCccccccCCccccccceee
Q 041921           98 RGSQVKLTADQGLVLNDPQGKQVWSSKIDIGTV-AVGHMNDTGNFVLASSSSGRLWDSFSNPTDTLLLGQMMETEQGLFS  176 (814)
Q Consensus        98 ~~~~l~~~~~G~Lvl~~~~g~~vWst~~~~~~~-~~a~LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg~~l~~~~~l~S  176 (814)
                      .+.+|.|..||||||++.  +++|++++...+. ..++|+++|||||++.++.++|||-.+       +           
T Consensus        24 g~~~L~~q~dGnLvl~~~--~~vW~snt~~~~~~~~l~l~~dGNLvl~d~~~~~iW~S~t~-------~-----------   83 (110)
T 3r0e_B           24 KNHQLVMQGDCNLVLYGG--KYGWQSNTHGNGEHCFLRLNHKGELIIKDDDFKTIWSSRSS-------S-----------   83 (110)
T ss_dssp             SSCEEEECTTSCEEEECS--SSCEECCCTTSSSSCEEEECTTSCEEEECTTCCEEEECCCC-------C-----------
T ss_pred             CCEEEEEcCCCeEEEECC--eEEEECCCcCCCcCEEEEEeCCCcEEEEeCCCCEEEEcCCc-------C-----------
Confidence            347899999999999986  5899999875433 589999999999999988899998641       1           


Q ss_pred             cccCCCCCCCceeEEEccCCceeEEeeccCCCccccceeeccc
Q 041921          177 RKSENNFSRGRFQFRLLEDGNLVLNIANLATGFAYDAYYTSGT  219 (814)
Q Consensus       177 ~~s~~d~s~G~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~sg~  219 (814)
                             ..|.|.+.|+.||+++++-         .+.|.+|+
T Consensus        84 -------~~~~~~~~L~~dGNlvly~---------~~~W~t~~  110 (110)
T 3r0e_B           84 -------KQGEYVLILQDDGFGVIYG---------PAIFETSS  110 (110)
T ss_dssp             -------SSSCCEEEECTTSCEEEEC---------SEEEESCC
T ss_pred             -------CCCCEEEEEcCCccEEEec---------CCEecCCC
Confidence                   1345899999999998873         25788764

>3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara}

Probab=99.16  E-value=1.3e-10  Score=102.08  Aligned_cols=86  Identities=19%  Similarity=0.301  Sum_probs=68.9

Q ss_pred             CCceEEEccCCcEEEeCCCCceEeeeccCCCc-eeEEEEecCcCEEEEeCCCCceeecccCCccccccCCccccccceee
Q 041921           98 RGSQVKLTADQGLVLNDPQGKQVWSSKIDIGT-VAVGHMNDTGNFVLASSSSGRLWDSFSNPTDTLLLGQMMETEQGLFS  176 (814)
Q Consensus        98 ~~~~l~~~~~G~Lvl~~~~g~~vWst~~~~~~-~~~a~LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg~~l~~~~~l~S  176 (814)
                      ...+|.+..||||||+++    +|+|++...+ ...++|+++|||||++.++.++|+|-..                   
T Consensus        21 g~~~L~~q~dGNLvl~~~----~Wssnt~~~~~~~~l~l~~dGnLvl~d~~~~~vWss~t~-------------------   77 (109)
T 3r0e_A           21 GDFDLVMQDDCNLVLYNG----NWQSNTANNGRDCKLTLTDYGELVIKNGDGSTVWKSGAQ-------------------   77 (109)
T ss_dssp             TTEEEEECTTSCEEEETT----TEECCCTTSCSSCEEEECTTSCEEEECTTSCEEEECCCC-------------------
T ss_pred             CCEEEEEecCCeEEEEeC----eEEcCCCCCCCcEEEEEcCCCeEEEEeCCCCEEEcCCCc-------------------
Confidence            357899999999999984    8999987543 3589999999999999888899976210                   


Q ss_pred             cccCCCCCCCceeEEEccCCceeEEeeccCCCccccceeeccccC
Q 041921          177 RKSENNFSRGRFQFRLLEDGNLVLNIANLATGFAYDAYYTSGTYD  221 (814)
Q Consensus       177 ~~s~~d~s~G~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~sg~~~  221 (814)
                            ...+.|.+.++++|+++++-         .+.|.+++|-
T Consensus        78 ------~~~~~~~~~L~~dGNlvly~---------~~~W~s~t~~  107 (109)
T 3r0e_A           78 ------SVKGNYAAVVHPDGRLVVFG---------PSVFKIDPWV  107 (109)
T ss_dssp             ------CSSSCCEEEEETTTEEEEEC---------SEEEEECTTS
T ss_pred             ------CCCcCEEEEEcCCCeEEEEe---------cCEECCCCcc
Confidence                  02367899999999998873         3589999873

>1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1

Probab=99.10  E-value=2.5e-10  Score=115.81  Aligned_cols=87  Identities=23%  Similarity=0.316  Sum_probs=70.2

Q ss_pred             CceEEEccCCcEEEeCCCCceEeeeccCCCceeEEEEecCcCEEEEeCCCCceeecccCCccccccCCccccccceeecc
Q 041921           99 GSQVKLTADQGLVLNDPQGKQVWSSKIDIGTVAVGHMNDTGNFVLASSSSGRLWDSFSNPTDTLLLGQMMETEQGLFSRK  178 (814)
Q Consensus        99 ~~~l~~~~~G~Lvl~~~~g~~vWst~~~~~~~~~a~LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg~~l~~~~~l~S~~  178 (814)
                      .-+|.|..||+|+|++. +++||++|+.......++|+++|||||+|.++.+||+|+++                     
T Consensus        27 ~f~l~f~~~gnl~ly~~-~~~vW~an~~~~~~~~l~l~~dGnLvl~d~~~~~vW~s~~~---------------------   84 (236)
T 1dlp_A           27 SFRFTMQSDCNLVLFDS-DVRVWASNTAGATGCRAVLQSDGLLVILTAQNTIRWSSGTK---------------------   84 (236)
T ss_dssp             TEEEEECTTSCEEEEES-SSEEECCCCCSCSCCBCCBCSSSCBCCBCTTTCCSCCCCCC---------------------
T ss_pred             CEEEEECCCCcEEEEEC-CEEEEECCCCCCCCeEEEEcCCCcEEEEcCCCcEEEeCCcc---------------------
Confidence            35688888999999986 78999999865555678999999999999999999999975                     


Q ss_pred             cCCCCCCCceeEEEccCCceeEEeeccCCCccccceeecccc
Q 041921          179 SENNFSRGRFQFRLLEDGNLVLNIANLATGFAYDAYYTSGTY  220 (814)
Q Consensus       179 s~~d~s~G~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~sg~~  220 (814)
                          .++|.|.+.|+.+|+++++-         ..+|.+..+
T Consensus        85 ----~~~~~~~~~l~d~Gnlvl~~---------~~~W~S~~~  113 (236)
T 1dlp_A           85 ----GSIGNYVLVLQPDRTVTIYG---------PGLWDSGTS  113 (236)
T ss_dssp             ----CCSSCCEEEECSSSCEEEEC---------SEEEECSCC
T ss_pred             ----ccCCcEEEEEeCCCCEEEec---------CCEEECCCC
Confidence                13467889999999998861         147877655

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.09  E-value=3.4e-10  Score=117.22  Aligned_cols=140  Identities=15%  Similarity=0.056  Sum_probs=109.8

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccC-CCCccceeeeecccccceEEEec
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTH-HKNLVRLLGFCDEGQNRLLVYEF  599 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  599 (814)
                      +.+...++.|+.+.||+...    .+..+++|............+..|+.+++.+. |.++.++++++.+....++||||
T Consensus        16 ~~~~~~~~g~s~~~v~~~~~----~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~   91 (263)
T 3tm0_A           16 YRCVKDTEGMSPAKVYKLVG----ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE   91 (263)
T ss_dssp             SEEEECCSCCSSSEEEEEEC----SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred             ceeEeeccCCCCCeEEEEEC----CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence            44566788888899999863    25689999986532233456899999999884 67788999999888889999999


Q ss_pred             CCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhc------------------------------------------
Q 041921          600 LNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHED------------------------------------------  637 (814)
Q Consensus       600 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~------------------------------------------  637 (814)
                      +++.+|.+.+.     +......++.+++++|+.||+.                                          
T Consensus        92 i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (263)
T 3tm0_A           92 ADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD  166 (263)
T ss_dssp             CSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSS
T ss_pred             cCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCC
Confidence            99999987642     2234457889999999999981                                          


Q ss_pred             --------------CCCCeeecCCCCCcEEEcCCCcEEEeecCCcc
Q 041921          638 --------------CRAQIIHCDIKPQNILLDDYYTARISDFGLAK  669 (814)
Q Consensus       638 --------------~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~  669 (814)
                                    ....++|+|++|.||+++++..+.|+||+.+.
T Consensus       167 ~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                          01358999999999999876566799998765

>4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D*

Probab=99.07  E-value=6.1e-10  Score=96.95  Aligned_cols=77  Identities=31%  Similarity=0.550  Sum_probs=62.9

Q ss_pred             CceEEEccCCcEEEeCCCCceEeeeccCCC--ceeEEEEecCcCEEEEeCCCCceeecccCCccccccCCccccccceee
Q 041921           99 GSQVKLTADQGLVLNDPQGKQVWSSKIDIG--TVAVGHMNDTGNFVLASSSSGRLWDSFSNPTDTLLLGQMMETEQGLFS  176 (814)
Q Consensus        99 ~~~l~~~~~G~Lvl~~~~g~~vWst~~~~~--~~~~a~LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg~~l~~~~~l~S  176 (814)
                      .-+|.+..||||||++. +++||++++...  ....+.|.++|||||+|.++.++|+|-.                    
T Consensus        20 ~y~l~~q~DgNLvly~~-~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~~~~~vWss~t--------------------   78 (105)
T 4h3o_A           20 PYHFIMQDDCNLVLYDH-STSTWASNTEIGGKSGCSAVLQSDGNFVVYDSSGRSLWASHS--------------------   78 (105)
T ss_dssp             TEEEEECTTSCEEEEET-TEEEEECCCCCTTCCSCEEEECTTSCEEEECTTCCEEEECCC--------------------
T ss_pred             CEEEEECCCCeEEEEEC-CEEEEEecCCCCCCccEEEEEeCCccEEEECCCcEEEEEecC--------------------
Confidence            35799999999999984 589999998643  3357999999999999999999998721                    


Q ss_pred             cccCCCCCCCceeEEEccCCceeEE
Q 041921          177 RKSENNFSRGRFQFRLLEDGNLVLN  201 (814)
Q Consensus       177 ~~s~~d~s~G~~~~~~~~~g~~~~~  201 (814)
                           ....|.|.+.|+++|+++++
T Consensus        79 -----~~~~~~~~l~L~ddGNlVly   98 (105)
T 4h3o_A           79 -----TRGSGNYILILQDDGNVIIY   98 (105)
T ss_dssp             -----CCCSSCEEEEECTTSCEEEE
T ss_pred             -----CCCCCCEEEEEeCCCeEEEE
Confidence                 11356789999999999886

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=98.89  E-value=2.6e-09  Score=110.23  Aligned_cols=129  Identities=16%  Similarity=0.047  Sum_probs=96.2

Q ss_pred             eeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCC--ccceeeeecccccceEEEecCCCCCH
Q 041921          528 GRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKN--LVRLLGFCDEGQNRLLVYEFLNNGTL  605 (814)
Q Consensus       528 G~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL  605 (814)
                      +.|..+.||+....   ++..+++|.....   ....+..|+.+++.+++.+  +.+++++...++..++||||+++.+|
T Consensus        29 ~gg~~~~v~~~~~~---~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l  102 (264)
T 1nd4_A           29 IGCSDAAVFRLSAQ---GRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL  102 (264)
T ss_dssp             CTTSSCEEEEEECT---TSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             cCCCCceEEEEecC---CCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCccc
Confidence            35556999998643   4567899987543   2356889999999886544  55688888877788999999999888


Q ss_pred             HHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcC-----------------------------------------------
Q 041921          606 ASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDC-----------------------------------------------  638 (814)
Q Consensus       606 ~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~-----------------------------------------------  638 (814)
                      .  ...      .....++.++++.|..||+..                                               
T Consensus       103 ~--~~~------~~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  174 (264)
T 1nd4_A          103 L--SSH------LAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARL  174 (264)
T ss_dssp             T--TSC------CCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHH
T ss_pred             C--cCc------CCHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHH
Confidence            4  211      123467788888888888642                                               


Q ss_pred             --------CCCeeecCCCCCcEEEcCCCcEEEeecCCccc
Q 041921          639 --------RAQIIHCDIKPQNILLDDYYTARISDFGLAKL  670 (814)
Q Consensus       639 --------~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~  670 (814)
                              ...++|+|++|.||+++++..+.|+||+.+..
T Consensus       175 ~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          175 KARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             HHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                    12399999999999998876677999998753

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.81  E-value=1.3e-08  Score=110.52  Aligned_cols=141  Identities=16%  Similarity=0.188  Sum_probs=104.8

Q ss_pred             cceeeeeeeeEEEEEEecCCCceEEEEEEec--ccc-ccchHhHHHHHHhhhccC--CCCccceeeeeccc---ccceEE
Q 041921          525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLD--RVF-QDGEREFKNEVFVIGQTH--HKNLVRLLGFCDEG---QNRLLV  596 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lv  596 (814)
                      +.|+.|.++.||+....    +..+++|+..  ... ......+..|+.+++.++  +..+++++.++.+.   ...++|
T Consensus        44 ~~l~~G~sn~~y~v~~~----~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v  119 (359)
T 3dxp_A           44 EQFKGGQSNPTFKLVTP----GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI  119 (359)
T ss_dssp             EECCC-CCSCEEEEECS----SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred             EEcCCcccceEEEEEEC----CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence            46899999999998753    3578888775  321 123457888999999986  45688999988776   347999


Q ss_pred             EecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcC--------------------------------------
Q 041921          597 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDC--------------------------------------  638 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~--------------------------------------  638 (814)
                      |||+++..+.+..  ...++...+..++.++++.|+.||...                                      
T Consensus       120 me~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (359)
T 3dxp_A          120 MEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM  197 (359)
T ss_dssp             EECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred             EEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence            9999998774321  123567788899999999999999721                                      


Q ss_pred             -----------------CCCeeecCCCCCcEEEcCCCc--EEEeecCCcccc
Q 041921          639 -----------------RAQIIHCDIKPQNILLDDYYT--ARISDFGLAKLL  671 (814)
Q Consensus       639 -----------------~~~i~H~dlkp~NIll~~~~~--~kl~DfGla~~~  671 (814)
                                       ...++|+|+++.||+++.++.  +.|+||+.+..-
T Consensus       198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                             257999999999999997653  689999988753

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.63  E-value=2.5e-08  Score=105.48  Aligned_cols=186  Identities=18%  Similarity=0.150  Sum_probs=120.2

Q ss_pred             cceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhcc-CCCC--ccceeeeecccc---cceEEEe
Q 041921          525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQT-HHKN--LVRLLGFCDEGQ---NRLLVYE  598 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~n--iv~l~~~~~~~~---~~~lv~e  598 (814)
                      +.++.|....||+..       ..+++|.....  .....+..|.++++.+ .+..  +.+++.......   ..++|||
T Consensus        26 ~~~~~G~~n~v~~v~-------~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~   96 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN-------RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFT   96 (304)
T ss_dssp             CEEEECSSEEEEEST-------TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEE
T ss_pred             EecCCCCcceEEEEC-------CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEc
Confidence            458899999999742       35788876432  2345788999999887 3333  445555554433   3478999


Q ss_pred             cCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhc-----------------------------------------
Q 041921          599 FLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHED-----------------------------------------  637 (814)
Q Consensus       599 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~-----------------------------------------  637 (814)
                      ++++.+|.....  ..++..++..++.++++.|+.||+.                                         
T Consensus        97 ~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  174 (304)
T 3sg8_A           97 KIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD  174 (304)
T ss_dssp             CCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred             ccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence            999988865332  2356667778888888888888851                                         


Q ss_pred             --------------CCCCeeecCCCCCcEEEcC--CCcEEEeecCCccccccCCccccccc------------ccCCCCc
Q 041921          638 --------------CRAQIIHCDIKPQNILLDD--YYTARISDFGLAKLLTLNQSKTIKTA------------IRGTKGY  689 (814)
Q Consensus       638 --------------~~~~i~H~dlkp~NIll~~--~~~~kl~DfGla~~~~~~~~~~~~~~------------~~gt~~y  689 (814)
                                    ..+.++|+|++|.||++++  ...+.|+||+.+..-.+.........            .....+.
T Consensus       175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~  254 (304)
T 3sg8_A          175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKH  254 (304)
T ss_dssp             HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred             HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCC
Confidence                          1245899999999999998  55678999998865432111000000            0000111


Q ss_pred             cc-ccccccCCCCcchhhHHHHHHHHHHHhCCCCC
Q 041921          690 VA-PEWFRNSKITAKVDVYSFGVLLLEIISCRKSF  723 (814)
Q Consensus       690 ~a-PE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~  723 (814)
                      .. |+....  .....+.|+++.+++++.+|..++
T Consensus       255 ~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          255 KDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             SCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence            12 222211  112368999999999999998765

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.05  E-value=1.9e-05  Score=81.55  Aligned_cols=136  Identities=16%  Similarity=0.118  Sum_probs=96.5

Q ss_pred             ceeeeeee-eEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccC-CCCccceeeeecccccceEEEecCCCC
Q 041921          526 EVGRGSFG-IVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTH-HKNLVRLLGFCDEGQNRLLVYEFLNNG  603 (814)
Q Consensus       526 ~LG~G~~g-~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g  603 (814)
                      .+..|..+ .||+....  .++..+++|+-...   ...++..|...|+.+. +-.+.++++++.+++..++|||++++.
T Consensus        31 ~~~~G~S~~~v~rl~~~--~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~  105 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGK--PNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK  105 (272)
T ss_dssp             EEECSSSSCEEEEEECC--TTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred             EccCCCcCCeEEEEEec--CCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence            45555555 58876543  34567888876532   3456888998888774 445778899998888999999999998


Q ss_pred             CHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcC---------------------------------------------
Q 041921          604 TLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDC---------------------------------------------  638 (814)
Q Consensus       604 sL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~---------------------------------------------  638 (814)
                      ++.+....    .......+..++++.|+-||...                                             
T Consensus       106 ~~~~~~~~----~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (272)
T 4gkh_A          106 TAFQVLEE----YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK  181 (272)
T ss_dssp             EHHHHHHH----CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred             cccccccC----CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence            88765432    12334456666677777776420                                             


Q ss_pred             ----------CCCeeecCCCCCcEEEcCCCcEEEeecCCccc
Q 041921          639 ----------RAQIIHCDIKPQNILLDDYYTARISDFGLAKL  670 (814)
Q Consensus       639 ----------~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~  670 (814)
                                ...++|+|+++.|||+++++.+-|+||+.+..
T Consensus       182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                      11379999999999999887778999998753

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=97.98  E-value=3.6e-05  Score=81.05  Aligned_cols=135  Identities=19%  Similarity=0.189  Sum_probs=91.9

Q ss_pred             cceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCC---Cccceeeeec-ccccceEEEecC
Q 041921          525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHK---NLVRLLGFCD-EGQNRLLVYEFL  600 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~  600 (814)
                      +.++.|....||+.       +..+++|.-..  ......+..|..++..+.+.   .+.+.+.++. ..+..++|||++
T Consensus        25 ~~l~~G~~n~v~~v-------g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i   95 (306)
T 3tdw_A           25 ESLGEGFRNYAILV-------NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKV   95 (306)
T ss_dssp             EEEEECSSEEEEEE-------TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECC
T ss_pred             eecCCCcceeEEEE-------CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEecc
Confidence            45788888889976       23577777432  22345789999999999652   3567777764 445678999999


Q ss_pred             CCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhc-------------------------------------------
Q 041921          601 NNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHED-------------------------------------------  637 (814)
Q Consensus       601 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~-------------------------------------------  637 (814)
                      ++..|.+....  .++...+..++.++++.|+.||+.                                           
T Consensus        96 ~G~~l~~~~~~--~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~  173 (306)
T 3tdw_A           96 QGQILGEDGMA--VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT  173 (306)
T ss_dssp             CSEECHHHHHT--TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred             CCeECchhhhh--hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence            99888763221  223444555555555555555532                                           


Q ss_pred             --------------CCCCeeecCCCCCcEEEcC---CCc-EEEeecCCccc
Q 041921          638 --------------CRAQIIHCDIKPQNILLDD---YYT-ARISDFGLAKL  670 (814)
Q Consensus       638 --------------~~~~i~H~dlkp~NIll~~---~~~-~kl~DfGla~~  670 (814)
                                    ..+.++|+|+++.||++++   ++. +.|+||+.+..
T Consensus       174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                          2335799999999999997   455 48999998764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.90  E-value=2.5e-05  Score=84.26  Aligned_cols=82  Identities=7%  Similarity=-0.029  Sum_probs=55.2

Q ss_pred             cce-eeeeeeeEEEEEEec--CC--CceEEEEEEecccc---ccchHhHHHHHHhhhccC-C--CCccceeeeeccc---
Q 041921          525 EEV-GRGSFGIVYKGVIQT--RT--STTAVAVKKLDRVF---QDGEREFKNEVFVIGQTH-H--KNLVRLLGFCDEG---  590 (814)
Q Consensus       525 ~~L-G~G~~g~Vy~~~~~~--~~--~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~---  590 (814)
                      +.| +.|....+|+.....  .+  .+..+++|......   ......+..|+.+++.+. +  ..+.+++.++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            456 788889999876530  00  14578888765422   112346788999988884 3  3577888887665   


Q ss_pred             ccceEEEecCCCCCHH
Q 041921          591 QNRLLVYEFLNNGTLA  606 (814)
Q Consensus       591 ~~~~lv~e~~~~gsL~  606 (814)
                      ...++||||+++..+.
T Consensus       106 g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             SSCEEEEECCCCBCCC
T ss_pred             CCceEEEEecCCCChh
Confidence            3568999999986654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.63  E-value=0.00019  Score=78.63  Aligned_cols=75  Identities=16%  Similarity=0.118  Sum_probs=48.4

Q ss_pred             cceeeeeeeeEEEEEEecCCCceEEEEEEeccccc-------cchHhHHHHHHhhhccCC--CC-ccceeeeecccccce
Q 041921          525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ-------DGEREFKNEVFVIGQTHH--KN-LVRLLGFCDEGQNRL  594 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~-------~~~~~~~~E~~~l~~l~h--~n-iv~l~~~~~~~~~~~  594 (814)
                      +.||.|..+.||++....  .+..++||.......       .....+..|.++++.+..  +. +.+++.+  +.+..+
T Consensus        36 ~~lg~G~~n~vyrv~~~~--~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~  111 (397)
T 2olc_A           36 QEIGDGNLNYVFHIYDQE--HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV  111 (397)
T ss_dssp             EECCSSSSEEEEEEEC------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred             EECCCCceEEEEEEEECC--CCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence            468999999999997542  356799997643211       123456778888887742  33 4455554  344578


Q ss_pred             EEEecCCCC
Q 041921          595 LVYEFLNNG  603 (814)
Q Consensus       595 lv~e~~~~g  603 (814)
                      +|||++++.
T Consensus       112 lvmE~l~g~  120 (397)
T 2olc_A          112 TVMEDLSHL  120 (397)
T ss_dssp             EEECCCTTS
T ss_pred             EEEEeCCCc
Confidence            999999763

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.38  E-value=0.00096  Score=71.06  Aligned_cols=136  Identities=16%  Similarity=0.187  Sum_probs=77.3

Q ss_pred             ceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCC--CCccceeee------ecccccceEEE
Q 041921          526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHH--KNLVRLLGF------CDEGQNRLLVY  597 (814)
Q Consensus       526 ~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~------~~~~~~~~lv~  597 (814)
                      .|+.|..+.||+....    +..+++|.....    ..++..|..++..+..  -.+++++..      ....+..++|+
T Consensus        39 ~l~gG~~n~~~~v~~~----~~~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~  110 (346)
T 2q83_A           39 VIQGNQMALVWKVHTD----SGAVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVY  110 (346)
T ss_dssp             ECC----CEEEEEEET----TEEEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEE
T ss_pred             eccccccCcEEEEEeC----CCCEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEE
Confidence            4666778899998753    235888888642    2334455555555531  133444431      12345678999


Q ss_pred             ecCCCCCHH-----------H---HhcC----C--C--------CCChhhHH----------------------------
Q 041921          598 EFLNNGTLA-----------S---FLFG----N--L--------KPNWNLRT----------------------------  621 (814)
Q Consensus       598 e~~~~gsL~-----------~---~l~~----~--~--------~l~~~~~~----------------------------  621 (814)
                      ||+++..+.           .   .++.    .  .        ...|....                            
T Consensus       111 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  190 (346)
T 2q83_A          111 DWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQ  190 (346)
T ss_dssp             ECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHH
T ss_pred             EeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHH
Confidence            999986432           0   1111    1  0        01232110                            


Q ss_pred             ---HHHHHHHHHHHHhhh----------cCCCCeeecCCCCCcEEEcCCCcEEEeecCCcc
Q 041921          622 ---NIAFQIARGLLYLHE----------DCRAQIIHCDIKPQNILLDDYYTARISDFGLAK  669 (814)
Q Consensus       622 ---~i~~~ia~~l~yLH~----------~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~  669 (814)
                         .+..++.+++.+|+.          .....++|+|+++.|||++.++.+.|+||+.+.
T Consensus       191 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          191 EIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence               111223445666663          124589999999999999888899999999764

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.31  E-value=0.0015  Score=67.85  Aligned_cols=74  Identities=18%  Similarity=0.206  Sum_probs=53.8

Q ss_pred             ccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccC-C--CCccceeeeecccccceEEEecC
Q 041921          524 KEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTH-H--KNLVRLLGFCDEGQNRLLVYEFL  600 (814)
Q Consensus       524 ~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~lv~e~~  600 (814)
                      .+.+|.|..+.||+..+.   +++.+.||+-..........|..|...|+.+. .  -.+++++++.    ..++||||+
T Consensus        20 v~~~g~G~~~~vyrv~l~---DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l   92 (288)
T 3f7w_A           20 VAERGHSHRWHLYRVELA---DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWV   92 (288)
T ss_dssp             EEEEEEETTEEEEEEEET---TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECC
T ss_pred             EEecCCCCCeEEEEEEEC---CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEee
Confidence            356899999999999886   57789999876544444456888999888884 2  2345556543    457899998


Q ss_pred             CCCC
Q 041921          601 NNGT  604 (814)
Q Consensus       601 ~~gs  604 (814)
                      +.+.
T Consensus        93 ~~~~   96 (288)
T 3f7w_A           93 DERP   96 (288)
T ss_dssp             CCCC
T ss_pred             cccC
Confidence            8654

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.26  E-value=0.00089  Score=70.25  Aligned_cols=134  Identities=18%  Similarity=0.131  Sum_probs=88.4

Q ss_pred             cceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccC---CCCccceeeeecccccceEEEecCC
Q 041921          525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTH---HKNLVRLLGFCDEGQNRLLVYEFLN  601 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~  601 (814)
                      +.|+.|....+|+...    ++..+++|.....   ....+..|...|+.+.   ...+++++.++...+..++||||++
T Consensus        42 ~~l~gG~~n~~y~v~~----~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~  114 (312)
T 3jr1_A           42 EKLYSGEMNEIWLIND----EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN  114 (312)
T ss_dssp             EEECCSSSSEEEEEES----SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred             EEeCCccceeeeEEEE----CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence            4589999999998763    3567888876532   3456888998888884   3568889998887788999999999


Q ss_pred             CCCHH--------HH---hcCC---CC-------------------CChhhHH---HHH----------------HHHHH
Q 041921          602 NGTLA--------SF---LFGN---LK-------------------PNWNLRT---NIA----------------FQIAR  629 (814)
Q Consensus       602 ~gsL~--------~~---l~~~---~~-------------------l~~~~~~---~i~----------------~~ia~  629 (814)
                      +..+.        ..   |+..   ..                   -+|....   ++.                ..+++
T Consensus       115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~  194 (312)
T 3jr1_A          115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ  194 (312)
T ss_dssp             CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred             CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence            87542        11   2211   00                   1343211   111                11111


Q ss_pred             -HHHHhhh-cCCCCeeecCCCCCcEEEcCCCcEEEeecC
Q 041921          630 -GLLYLHE-DCRAQIIHCDIKPQNILLDDYYTARISDFG  666 (814)
Q Consensus       630 -~l~yLH~-~~~~~i~H~dlkp~NIll~~~~~~kl~DfG  666 (814)
                       ....|.. ...+.++|+|+.+.||+++.++ +.|.|+.
T Consensus       195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence             1223321 2356899999999999999887 8899974

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.19  E-value=0.0013  Score=72.42  Aligned_cols=80  Identities=9%  Similarity=0.015  Sum_probs=48.2

Q ss_pred             CCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcccccccccCCCCcccccccccC---CCCcchhhHHHHHHHHH
Q 041921          639 RAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNS---KITAKVDVYSFGVLLLE  715 (814)
Q Consensus       639 ~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~~Dv~s~Gvvl~e  715 (814)
                      ...++|+|+++.|||++.++ ++|+||+.+..-.+...... ....-...|.+|+.....   ......++......+|+
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGA-YLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHH-HHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHH-HHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            35899999999999999876 99999998875432211100 000011345666554311   11223556677777777


Q ss_pred             HHhCC
Q 041921          716 IISCR  720 (814)
Q Consensus       716 lltg~  720 (814)
                      .+++.
T Consensus       309 ~y~~~  313 (420)
T 2pyw_A          309 LFNKR  313 (420)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            76653

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.61  E-value=0.0057  Score=67.32  Aligned_cols=74  Identities=11%  Similarity=0.179  Sum_probs=48.9

Q ss_pred             cceeeeeeeeEEEEEEecC-----CCceEEEEEEeccccccchHhHHHHHHhhhccCCCCc-cceeeeecccccceEEEe
Q 041921          525 EEVGRGSFGIVYKGVIQTR-----TSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNL-VRLLGFCDEGQNRLLVYE  598 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e  598 (814)
                      +.|+.|....+|+......     ..+..+++|.....  .....+..|..++..+...++ +++++.+.+    .+|+|
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e  152 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  152 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence            4577788889999887521     12467888877431  122456689998888854444 567776653    38999


Q ss_pred             cCCCCC
Q 041921          599 FLNNGT  604 (814)
Q Consensus       599 ~~~~gs  604 (814)
                      |+++.+
T Consensus       153 ~l~G~~  158 (429)
T 1nw1_A          153 YIPSRP  158 (429)
T ss_dssp             CCCEEE
T ss_pred             EeCCcc
Confidence            998633

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.56  E-value=0.0068  Score=65.31  Aligned_cols=141  Identities=17%  Similarity=0.230  Sum_probs=81.6

Q ss_pred             cceeeeeeeeEEEEEEec-----CCCceEEEEEEeccccccchHhHHHHHHhhhccCCCC-ccceeeeecccccceEEEe
Q 041921          525 EEVGRGSFGIVYKGVIQT-----RTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKN-LVRLLGFCDEGQNRLLVYE  598 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e  598 (814)
                      +.|..|-...+|+....+     ..++..+++|+.... ......+.+|..+++.+.-.+ ..++++++.++    +|+|
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e  130 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLEQ  130 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEE
Confidence            356668788899987642     112467888875332 233456778999988884323 35677776553    9999


Q ss_pred             cCCCCCHHH--------------H---hcCC-----CCCC--hhhHHHHHHHHH-------------------HHHHHhh
Q 041921          599 FLNNGTLAS--------------F---LFGN-----LKPN--WNLRTNIAFQIA-------------------RGLLYLH  635 (814)
Q Consensus       599 ~~~~gsL~~--------------~---l~~~-----~~l~--~~~~~~i~~~ia-------------------~~l~yLH  635 (814)
                      |+++..|..              .   |+..     ....  |.+..++..++.                   +.+..|.
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            998755421              0   1111     1112  333444443332                   1223332


Q ss_pred             h-----cCCCCeeecCCCCCcEEEcCC----CcEEEeecCCccc
Q 041921          636 E-----DCRAQIIHCDIKPQNILLDDY----YTARISDFGLAKL  670 (814)
Q Consensus       636 ~-----~~~~~i~H~dlkp~NIll~~~----~~~kl~DfGla~~  670 (814)
                      .     .....++|+|+.+.||+++.+    +.+.|+||..+..
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            2     123468999999999999876    7899999988753

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=96.51  E-value=0.0076  Score=62.88  Aligned_cols=135  Identities=15%  Similarity=0.145  Sum_probs=73.7

Q ss_pred             ccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCc-cceeeeecccccceEEEecC-C
Q 041921          524 KEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNL-VRLLGFCDEGQNRLLVYEFL-N  601 (814)
Q Consensus       524 ~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~  601 (814)
                      .+.|+.|....+|+.        ..+++|....... .......|+.+++.+....+ .++++++  .+.-++|+||+ +
T Consensus        23 i~~l~gG~tN~~~~~--------~~~vlR~~~~~~~-~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~   91 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA--------GDLCLRIPGKGTE-EYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAG   91 (301)
T ss_dssp             CEEEESCSSEEEEEE--------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTT
T ss_pred             eeEcCCcccccccee--------eeEEEECCCCCcc-ceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCC
Confidence            356888989999987        2477777654211 11234568877777753333 4566553  33457899999 6


Q ss_pred             CCCHHH------------------HhcCCC-CCC-----hhhHHHHHH--------------HHHHHHH----Hhhh-cC
Q 041921          602 NGTLAS------------------FLFGNL-KPN-----WNLRTNIAF--------------QIARGLL----YLHE-DC  638 (814)
Q Consensus       602 ~gsL~~------------------~l~~~~-~l~-----~~~~~~i~~--------------~ia~~l~----yLH~-~~  638 (814)
                      +.+|..                  -||... ...     +.....+..              .+.+.+.    .+.. ..
T Consensus        92 g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~  171 (301)
T 3dxq_A           92 AQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPL  171 (301)
T ss_dssp             CEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCC
T ss_pred             CccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCC
Confidence            544421                  011111 010     011000000              0111111    1111 12


Q ss_pred             CCCeeecCCCCCcEEEcCCCcEEEeecCCccc
Q 041921          639 RAQIIHCDIKPQNILLDDYYTARISDFGLAKL  670 (814)
Q Consensus       639 ~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~  670 (814)
                      ...++|+|+.+.||+ ..++.+.|+||..+..
T Consensus       172 ~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          172 PLAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             CCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             CceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            345899999999999 5666889999988764

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.41  E-value=0.016  Score=61.29  Aligned_cols=33  Identities=30%  Similarity=0.275  Sum_probs=28.1

Q ss_pred             CCCeeecCCCCCcEEEcCC----CcEEEeecCCcccc
Q 041921          639 RAQIIHCDIKPQNILLDDY----YTARISDFGLAKLL  671 (814)
Q Consensus       639 ~~~i~H~dlkp~NIll~~~----~~~kl~DfGla~~~  671 (814)
                      ...++|+|+.+.||+++.+    ..+.|+||+.+..-
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            3579999999999999874    68999999987653

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.25  E-value=0.023  Score=62.90  Aligned_cols=74  Identities=14%  Similarity=0.080  Sum_probs=45.9

Q ss_pred             cceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCc-cceeeeecccccceEEEecCCCC
Q 041921          525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNL-VRLLGFCDEGQNRLLVYEFLNNG  603 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g  603 (814)
                      +.|+.|-...+|+....+  .+..+++|....... ..-....|..++..+...++ .++++++..    .+|+||+++.
T Consensus       114 ~~lsgG~tN~~y~v~~~~--~~~~~vLRi~g~~~~-~~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~  186 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMS--KQAKYLIRLYGPKTD-EIINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGY  186 (458)
T ss_dssp             EEECC--CEEEEEEEETT--TTEEEEEEEECC-CC-SCSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSE
T ss_pred             EEcCCCeEeEEEEEEECC--CCceEEEEECCCChh-hhcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCc
Confidence            468888889999988642  236777887643211 11122578888888865555 567777642    3599999874


Q ss_pred             CH
Q 041921          604 TL  605 (814)
Q Consensus       604 sL  605 (814)
                      +|
T Consensus       187 ~l  188 (458)
T 2qg7_A          187 AL  188 (458)
T ss_dssp             EC
T ss_pred             cC
Confidence            43

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.24  E-value=0.015  Score=61.06  Aligned_cols=138  Identities=14%  Similarity=0.126  Sum_probs=76.9

Q ss_pred             ceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCC--ccceeeee------cccccceEEE
Q 041921          526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKN--LVRLLGFC------DEGQNRLLVY  597 (814)
Q Consensus       526 ~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~------~~~~~~~lv~  597 (814)
                      .|+.|....+|+....    +..+++|.....  ....++..|+.++..+....  +.+++...      ...+..++++
T Consensus        29 ~i~~G~~n~~~~v~~~----~g~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~  102 (322)
T 2ppq_A           29 GIAEGVENSNFLLHTT----KDPLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALI  102 (322)
T ss_dssp             EECC---EEEEEEEES----SCCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEE
T ss_pred             ccCCCcccceEEEEeC----CccEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEE
Confidence            4677888899988754    225778887642  12345667777777764322  33444321      1234568999


Q ss_pred             ecCCCCCHHH--------------Hhc----CC--CC------CChhhHHH------------HHHHHHHHHHHhhhc--
Q 041921          598 EFLNNGTLAS--------------FLF----GN--LK------PNWNLRTN------------IAFQIARGLLYLHED--  637 (814)
Q Consensus       598 e~~~~gsL~~--------------~l~----~~--~~------l~~~~~~~------------i~~~ia~~l~yLH~~--  637 (814)
                      +|+++..+..              .++    ..  ..      ..|.....            +...+.+.+..++..  
T Consensus       103 ~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~  182 (322)
T 2ppq_A          103 SFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWP  182 (322)
T ss_dssp             ECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCC
T ss_pred             EeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCc
Confidence            9998754311              011    10  10      01222110            111234455555532  


Q ss_pred             --CCCCeeecCCCCCcEEEcCCCcEEEeecCCcc
Q 041921          638 --CRAQIIHCDIKPQNILLDDYYTARISDFGLAK  669 (814)
Q Consensus       638 --~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~  669 (814)
                        ....++|+|+++.|||++++..+.|+||+.+.
T Consensus       183 ~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          183 KDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             CSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence              23479999999999999987656899998765

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=95.94  E-value=0.032  Score=58.74  Aligned_cols=138  Identities=12%  Similarity=0.030  Sum_probs=76.9

Q ss_pred             ceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCC--Cccceeee-----ecccccceEEEe
Q 041921          526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHK--NLVRLLGF-----CDEGQNRLLVYE  598 (814)
Q Consensus       526 ~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~-----~~~~~~~~lv~e  598 (814)
                      .|+ |....||+....   ++..+++|..... .....++..|..++..+...  .+++++..     ....+..++++|
T Consensus        33 ~l~-g~~n~~y~v~~~---~g~~~vlK~~~~~-~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~  107 (328)
T 1zyl_A           33 PLN-SYENRVYQFQDE---DRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP  107 (328)
T ss_dssp             EEC-CSSSEEEEECCT---TCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred             eec-CcccceEEEEcC---CCCEEEEEEcCCC-CCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEE
Confidence            355 777789986543   3457889987632 12345677788888777432  24445543     111334578999


Q ss_pred             cCCCCCHH-----H------H---hc----CC-----CCCChhhH----HH---------------HHHHHHHHHHHhhh
Q 041921          599 FLNNGTLA-----S------F---LF----GN-----LKPNWNLR----TN---------------IAFQIARGLLYLHE  636 (814)
Q Consensus       599 ~~~~gsL~-----~------~---l~----~~-----~~l~~~~~----~~---------------i~~~ia~~l~yLH~  636 (814)
                      ++++..+.     .      .   ++    ..     ...++...    ..               +...+.+.+..+..
T Consensus       108 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~  187 (328)
T 1zyl_A          108 SVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTA  187 (328)
T ss_dssp             CCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHH
T ss_pred             ecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHH
Confidence            99875431     1      1   11    10     01111110    00               11111122333322


Q ss_pred             c----CCCCeeecCCCCCcEEEcCCCcEEEeecCCccc
Q 041921          637 D----CRAQIIHCDIKPQNILLDDYYTARISDFGLAKL  670 (814)
Q Consensus       637 ~----~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~  670 (814)
                      .    ....++|+|+++.||+++ + .+.|+||+.+..
T Consensus       188 ~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          188 HWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             HCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             HhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            1    234689999999999999 4 899999987653

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=95.87  E-value=0.032  Score=54.06  Aligned_cols=102  Identities=15%  Similarity=0.018  Sum_probs=66.8

Q ss_pred             CCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccccc
Q 041921          602 NGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIK  680 (814)
Q Consensus       602 ~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  680 (814)
                      .-+|.++|.. ..++++++.+.++.|.+..|.-+-...  .-..+=+.|..|+|..+|.|.+.+ ..+.           
T Consensus        32 ~vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------   97 (229)
T 2yle_A           32 ALSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------   97 (229)
T ss_dssp             EEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred             cccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc-----------
Confidence            3589999975 478999999999999999987762210  111233456899999999988764 1110           


Q ss_pred             ccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCC
Q 041921          681 TAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRK  721 (814)
Q Consensus       681 ~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~  721 (814)
                         .....+.|||... ...+.+.=|||+|+++|.-+-=..
T Consensus        98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL  134 (229)
T 2yle_A           98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL  134 (229)
T ss_dssp             ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred             ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC
Confidence               1122456888763 355788999999999999886333

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=95.65  E-value=0.032  Score=59.91  Aligned_cols=75  Identities=16%  Similarity=0.100  Sum_probs=42.9

Q ss_pred             cceeeeeeeeEEEEEEecCC------CceEEEEEEeccccccchHhHHHHHHhhhccCCCC-ccceeeeecccccceEEE
Q 041921          525 EEVGRGSFGIVYKGVIQTRT------STTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKN-LVRLLGFCDEGQNRLLVY  597 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~  597 (814)
                      +.|+.|....+|+.......      .+..+++|...... ........|..+++.+...+ ..++++..    .-.+||
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v~  113 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRIE  113 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec----CCcEEE
Confidence            45777888899998764210      12577777764321 11123467888888775434 34666554    237899


Q ss_pred             ecCCCCC
Q 041921          598 EFLNNGT  604 (814)
Q Consensus       598 e~~~~gs  604 (814)
                      ||+++..
T Consensus       114 e~i~G~~  120 (369)
T 3c5i_A          114 EWLYGDP  120 (369)
T ss_dssp             ECCCSEE
T ss_pred             EEecCCc
Confidence            9998754

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=94.16  E-value=0.19  Score=53.10  Aligned_cols=32  Identities=25%  Similarity=0.362  Sum_probs=28.0

Q ss_pred             CCCeeecCCCCCcEEEcCCCcEEEeecCCccc
Q 041921          639 RAQIIHCDIKPQNILLDDYYTARISDFGLAKL  670 (814)
Q Consensus       639 ~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~  670 (814)
                      ...++|+|+.+.||++++++.+.|+||+.+..
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            35799999999999999888899999987764

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=93.44  E-value=0.17  Score=55.06  Aligned_cols=76  Identities=12%  Similarity=0.079  Sum_probs=46.4

Q ss_pred             cceeeeeeeeEEEEEEecCCC-----ceEEEEEEeccccccchHhHHHHHHhhhccCCCC-ccceeeeecccccceEEEe
Q 041921          525 EEVGRGSFGIVYKGVIQTRTS-----TTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKN-LVRLLGFCDEGQNRLLVYE  598 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~~-----~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e  598 (814)
                      +.|..|-...+|+........     +..+++|+..... ...-...+|..+++.+...+ ..++++.+.    -++|+|
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e  150 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE  150 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence            356667788899988752211     4678888754322 22223467888888875333 345665432    378999


Q ss_pred             cCCCCCH
Q 041921          599 FLNNGTL  605 (814)
Q Consensus       599 ~~~~gsL  605 (814)
                      |+++..|
T Consensus       151 fI~G~~l  157 (424)
T 3mes_A          151 FIDGEPL  157 (424)
T ss_dssp             CCCSEEC
T ss_pred             EeCCccC
Confidence            9998653

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=85.94  E-value=3  Score=44.90  Aligned_cols=30  Identities=27%  Similarity=0.354  Sum_probs=25.2

Q ss_pred             CeeecCCCCCcEEE------cCCCcEEEeecCCccc
Q 041921          641 QIIHCDIKPQNILL------DDYYTARISDFGLAKL  670 (814)
Q Consensus       641 ~i~H~dlkp~NIll------~~~~~~kl~DfGla~~  670 (814)
                      .++|+|+.+.|||+      +++..++++||.+|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            36799999999999      4567799999998764

>3no2_A Uncharacterized protein; six-bladed beta-propeller, structural genomics, joint center structural genomics, JCSG, protein structure initiative; HET: MSE CIT PEG; 1.35A {Bacteroides caccae}

Probab=84.18  E-value=36  Score=33.98  Aligned_cols=75  Identities=13%  Similarity=0.278  Sum_probs=45.2

Q ss_pred             EEEEEecccCCCeEEEEecCCCCCCC----CCCCceEEEccCCcEEEeCCCCceEeeeccCC-CceeEEEEecCcCEEEE
Q 041921           70 LLSIFYNKIPEKTVVWYTDNKDQNPA----VPRGSQVKLTADQGLVLNDPQGKQVWSSKIDI-GTVAVGHMNDTGNFVLA  144 (814)
Q Consensus        70 ~lgiw~~~~~~~t~vW~Anr~~~~~~----~~~~~~l~~~~~G~Lvl~~~~g~~vWst~~~~-~~~~~a~LldsGNlVl~  144 (814)
                      .+.||=  ....+++|.........+    ...++.+-++.++.+...|.+|+.+|...... .....++.+.+||+++.
T Consensus        16 ~v~~~d--~~tG~~~w~~~~~~~~~~~~~~~~pdG~ilvs~~~~V~~~d~~G~~~W~~~~~~~~~~~~~~~~~dG~~lv~   93 (276)
T 3no2_A           16 KIAIIN--KDTKEIVWEYPLEKGWECNSVAATKAGEILFSYSKGAKMITRDGRELWNIAAPAGCEMQTARILPDGNALVA   93 (276)
T ss_dssp             EEEEEE--TTTTEEEEEEECCTTCCCCEEEECTTSCEEEECBSEEEEECTTSCEEEEEECCTTCEEEEEEECTTSCEEEE
T ss_pred             EEEEEE--CCCCeEEEEeCCCccCCCcCeEECCCCCEEEeCCCCEEEECCCCCEEEEEcCCCCccccccEECCCCCEEEE
Confidence            455653  224678898876521011    12234455555556667788899999998642 23445677788888776


Q ss_pred             eC
Q 041921          145 SS  146 (814)
Q Consensus       145 ~~  146 (814)
                      +.
T Consensus        94 ~~   95 (276)
T 3no2_A           94 WC   95 (276)
T ss_dssp             EE
T ss_pred             ec
Confidence            43

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=83.50  E-value=1.4  Score=42.62  Aligned_cols=115  Identities=10%  Similarity=0.111  Sum_probs=79.7

Q ss_pred             CCCCccceeeeecccccceEEEecCC-CCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE
Q 041921          576 HHKNLVRLLGFCDEGQNRLLVYEFLN-NGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILL  654 (814)
Q Consensus       576 ~h~niv~l~~~~~~~~~~~lv~e~~~-~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll  654 (814)
                      .||++++. .+-.+++...+.|+.-+ ..++.. +   ...+...+++++.+|++...+++..     +|--|+|+||++
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i---k~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~NL~f  112 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I---KSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDELFF  112 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G---GGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGGEEE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H---HhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecceEEE
Confidence            68888876 45556667777777654 233333 2   3467888999999999988666643     788999999999


Q ss_pred             cCCCcEEEeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 041921          655 DDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFD  724 (814)
Q Consensus       655 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~  724 (814)
                      +.++.+++.-.|+-..+.+.                        ..++..=.-.+=+++..+++++..|.
T Consensus       113 ~~~~~p~i~~RGik~~l~P~------------------------~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          113 TRDGLPIAKTRGLQNVVDPL------------------------PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             CTTSCEEESCCEETTTBSCC------------------------CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             cCCCCEEEEEccCccCCCCC------------------------CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            99999999877764433221                        11222234456778888899888774

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=81.99  E-value=2.7  Score=40.74  Aligned_cols=114  Identities=12%  Similarity=0.096  Sum_probs=77.3

Q ss_pred             CCCCccceeeeecccccceEEEecCCC-CCHHHHhcCCCCCChhhHHHHHHHHHHHHH-HhhhcCCCCeeecCCCCCcEE
Q 041921          576 HHKNLVRLLGFCDEGQNRLLVYEFLNN-GTLASFLFGNLKPNWNLRTNIAFQIARGLL-YLHEDCRAQIIHCDIKPQNIL  653 (814)
Q Consensus       576 ~h~niv~l~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~-yLH~~~~~~i~H~dlkp~NIl  653 (814)
                      .||++  -..+-.+++...+.|+.-++ .++..+    ...+...+++++.+|+.... +++.     -+|--|+|+||+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i----~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL~  116 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI----RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENLM  116 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH----HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGEE
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH----HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceEE
Confidence            67877  44444667777787877533 344433    35678899999999988777 6654     478899999999


Q ss_pred             EcCCCcEEEeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 041921          654 LDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFD  724 (814)
Q Consensus       654 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~  724 (814)
                      ++.++.+++.-.|+-..+.                   |.-     .++.-=.-.+=+++..++.++..|.
T Consensus       117 f~~~~~p~i~hRGi~~~lp-------------------P~e-----~~ee~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          117 FNRALEPFFLHVGVKESLP-------------------PDE-----WDDERLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             ECTTCCEEESCCEETTTBS-------------------SCS-----CCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred             EeCCCcEEEEEcCCcccCC-------------------CCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            9999999998877644332                   221     1111223356667777887777663

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	814
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-67
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	5e-66
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-64
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	5e-63
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-62
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	9e-62
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-61
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-61
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	6e-60
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	8e-60
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-59
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-59
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-58
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-58
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-58
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	4e-58
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	5e-58
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-57
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-57
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	8e-57
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-56
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-56
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-56
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-55
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	7e-55
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-54
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	4e-54
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-53
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-51
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	3e-51
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-50
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	6e-49
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	7e-49
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-46
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	4e-46
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	8e-45
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	5e-44
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	8e-44
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-43
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-42
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	8e-42
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	9e-42
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	6e-41
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	7e-41
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-40
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	4e-40
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	4e-40
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	6e-40
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-38
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-38
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	4e-38
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	5e-37
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-36
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	6e-36
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	7e-36
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	7e-34
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-33
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	3e-32
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-31
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	7e-31
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	8e-30
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	9e-27
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	8e-20
d1dlpa2	120	b.78.1.1 (A:116-235) Fetuin-binding protein Scafet	1e-09
d1dlpa2	120	b.78.1.1 (A:116-235) Fetuin-binding protein Scafet	0.001
d1kj1a_	109	b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium	3e-09
d1dlpa1	115	b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p	3e-07
d1xd5a_	112	b.78.1.1 (A:) Gastrodianin (antifungal protein) {G	9e-06
d1xd5a_	112	b.78.1.1 (A:) Gastrodianin (antifungal protein) {G	2e-05

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  223 bits (569), Expect = 2e-67
 Identities = 71/283 (25%), Positives = 124/283 (43%), Gaps = 23/283 (8%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVR 582
             + +G GSFG VYKG         AV +  +        + FKNEV V+ +T H N++ 
Sbjct: 12  VGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 68

Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCRAQ 641
            +G+    Q   +V ++    +L   L     K       +IA Q A+G+ YLH      
Sbjct: 69  FMGYSTAPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--- 124

Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR---NS 698
           IIH D+K  NI L +  T +I DFGLA + +          + G+  ++APE  R    +
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184

Query: 699 KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAM 758
             + + DVY+FG++L E+++ +  +      +              G L+  + + +   
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRD------QIIFMVGRGYLSPDLSKVRS-- 236

Query: 759 NDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVP 801
               C   +  +   C+++    RP   ++L  +E +   S+P
Sbjct: 237 ---NCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR-SLP 275

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  220 bits (560), Expect = 5e-66
 Identities = 71/304 (23%), Positives = 135/304 (44%), Gaps = 35/304 (11%)

Query: 511 FSYKELEGATNNFKEEV-----------GRGSFGIVYKGVIQ-TRTSTTAVAVKKLDRVF 558
           F++++   A   F +E+           G G FG V  G ++        VA+K L   +
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 559 -QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-N 616
            +   R+F +E  ++GQ  H N++ L G   +    +++ EF+ NG+L SFL  N     
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126

Query: 617 WNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS 676
                 +   IA G+ YL +      +H D+  +NIL++     ++SDFGL++ L  + S
Sbjct: 127 VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183

Query: 677 K---TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI 733
               T     +    + APE  +  K T+  DV+S+G+++ E++S  +            
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP---------- 233

Query: 734 LTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
                +    N  +   + +D      ++C   L  + + C Q+D + RP   +++  L+
Sbjct: 234 -----YWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLD 288

Query: 794 GVVE 797
            ++ 
Sbjct: 289 KMIR 292

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (546), Expect = 3e-64
 Identities = 73/286 (25%), Positives = 127/286 (44%), Gaps = 25/286 (8%)

Query: 514 KELEGATNNFK---EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE-FKNEV 569
           K+L    +N      E+G G+FG V +GV + R     VA+K L +  +  + E    E 
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60

Query: 570 FVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-NWNLRTNIAFQIA 628
            ++ Q  +  +VRL+G C + +  +LV E    G L  FL G  +    +    +  Q++
Sbjct: 61  QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 119

Query: 629 RGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS-KTIKTAIRGTK 687
            G+ YL        +H D+  +N+LL + + A+ISDFGL+K L  + S  T ++A +   
Sbjct: 120 MGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176

Query: 688 GYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL 747
            + APE     K +++ DV+S+GV + E +S  +                 +   +  ++
Sbjct: 177 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ---------------KPYKKMKGPEV 221

Query: 748 NVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
              + + K      EC  +L  +   C       RP    V Q + 
Sbjct: 222 MAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (536), Expect = 5e-63
 Identities = 75/273 (27%), Positives = 120/273 (43%), Gaps = 26/273 (9%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVR 582
             E +G G FG V+ G        T VAVK L +        F  E  ++ Q  H+ LVR
Sbjct: 17  LVERLGAGQFGEVWMGYYNG---HTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVR 72

Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFLF--GNLKPNWNLRTNIAFQIARGLLYLHEDCRA 640
           L     +     ++ E++ NG+L  FL     +K   N   ++A QIA G+ ++ E    
Sbjct: 73  LYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN-- 129

Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
             IH D++  NIL+ D  + +I+DFGLA+L+  N+    +   +    + APE       
Sbjct: 130 -YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA-REGAKFPIKWTAPEAINYGTF 187

Query: 701 TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMND 760
           T K DV+SFG+LL EI++  +                 +    N ++   +      +  
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIP---------------YPGMTNPEVIQNLERGYRMVRP 232

Query: 761 IECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
             C  +L  +   C +E P  RPT   +  +LE
Sbjct: 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (535), Expect = 3e-62
 Identities = 58/305 (19%), Positives = 124/305 (40%), Gaps = 38/305 (12%)

Query: 516 LEGATNNFK--EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE-FKNEVFVI 572
           +E   ++F+   E+G G+ G+V+K     + S   +A K +    +   R     E+ V+
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKV--SHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL 58

Query: 573 GQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLL 632
            + +   +V   G         +  E ++ G+L   L    +    +   ++  + +GL 
Sbjct: 59  HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLT 118

Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 692
           YL E  +  I+H D+KP NIL++     ++ DFG++  L  + + +      GT+ Y++P
Sbjct: 119 YLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----GTRSYMSP 172

Query: 693 EWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL---------TDWAFDCYR 743
           E  + +  + + D++S G+ L+E+   R        +E  ++          +       
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232

Query: 744 NGKLNVLVGEDKEAMNDIECLGKLVMVSIW------------------CIQEDPSLRPTM 785
            G+     G D      I  L   ++                      C+ ++P+ R  +
Sbjct: 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 292

Query: 786 KKVLQ 790
           K+++ 
Sbjct: 293 KQLMV 297

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (526), Expect = 9e-62
 Identities = 63/273 (23%), Positives = 112/273 (41%), Gaps = 24/273 (8%)

Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLV 581
            F +E+G G FG+V  G  +       VA+K +       E EF  E  V+    H+ LV
Sbjct: 7   TFLKELGTGQFGVVKYGKWRG---QYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLV 62

Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-NWNLRTNIAFQIARGLLYLHEDCRA 640
           +L G C + +   ++ E++ NG L ++L              +   +   + YL      
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ-- 120

Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
             +H D+  +N L++D    ++SDFGL++ +  +   T     +    +  PE    SK 
Sbjct: 121 -FLHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKF 178

Query: 701 TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMND 760
           ++K D+++FGVL+ EI S  K                 ++ + N +    + +       
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGK---------------MPYERFTNSETAEHIAQGLRLYRP 223

Query: 761 IECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
                K+  +   C  E    RPT K +L  + 
Sbjct: 224 HLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (526), Expect = 1e-61
 Identities = 70/277 (25%), Positives = 121/277 (43%), Gaps = 24/277 (8%)

Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLV 581
            F +E+G G FG+V+ G      +   VA+K +       E +F  E  V+ +  H  LV
Sbjct: 8   TFVQEIGSGQFGLVHLG---YWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLV 63

Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-NWNLRTNIAFQIARGLLYLHEDCRA 640
           +L G C E     LV+EF+ +G L+ +L              +   +  G+ YL E C  
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC-- 121

Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
            +IH D+  +N L+ +    ++SDFG+ + +  +Q  T  T  +    + +PE F  S+ 
Sbjct: 122 -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRY 179

Query: 701 TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMND 760
           ++K DV+SFGVL+ E+ S  K                 ++   N ++   +         
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIP---------------YENRSNSEVVEDISTGFRLYKP 224

Query: 761 IECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 797
                 +  +   C +E P  RP   ++L+ L  + E
Sbjct: 225 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (530), Expect = 1e-61
 Identities = 68/288 (23%), Positives = 127/288 (44%), Gaps = 24/288 (8%)

Query: 522 NFKEEVGRGSFGIVYKGV-IQTRTSTTAVAVKKLDRVFQDGE-REFKNEVFVIGQTHHKN 579
           +F E +GRG FG VY G  +         AVK L+R+   GE  +F  E  ++    H N
Sbjct: 30  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89

Query: 580 LVRLLGFCDEGQNR-LLVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHED 637
           ++ LLG C   +   L+V  ++ +G L +F+      P          Q+A+G+      
Sbjct: 90  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM---KFL 146

Query: 638 CRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI--KTAIRGTKGYVAPEWF 695
              + +H D+  +N +LD+ +T +++DFGLA+ +   +  ++  KT  +    ++A E  
Sbjct: 147 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 206

Query: 696 RNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDK 755
           +  K T K DV+SFGVLL E+++                    +       + V + + +
Sbjct: 207 QTQKFTTKSDVWSFGVLLWELMTRGAPP---------------YPDVNTFDITVYLLQGR 251

Query: 756 EAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVPPN 803
             +    C   L  V + C      +RP+  +++  +  +    +  +
Sbjct: 252 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 299

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (515), Expect = 6e-60
 Identities = 71/271 (26%), Positives = 117/271 (43%), Gaps = 22/271 (8%)

Query: 526 EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE--REFKNEVFVIGQTHHKNLVRL 583
           E+G G+FG V KG  Q +     VAVK L     D     E   E  V+ Q  +  +VR+
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73

Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQII 643
           +G C E ++ +LV E    G L  +L  N          +  Q++ G+ YL     +  +
Sbjct: 74  IGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE---ESNFV 129

Query: 644 HCDIKPQNILLDDYYTARISDFGLAKLLTLNQS-KTIKTAIRGTKGYVAPEWFRNSKITA 702
           H D+  +N+LL   + A+ISDFGL+K L  +++    +T  +    + APE     K ++
Sbjct: 130 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 189

Query: 703 KVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIE 762
           K DV+SFGVL+ E  S  +                 +   +  ++  ++ + +       
Sbjct: 190 KSDVWSFGVLMWEAFSYGQ---------------KPYRGMKGSEVTAMLEKGERMGCPAG 234

Query: 763 CLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
           C  ++  +   C   D   RP    V   L 
Sbjct: 235 CPREMYDLMNLCWTYDVENRPGFAAVELRLR 265

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (516), Expect = 8e-60
 Identities = 61/297 (20%), Positives = 114/297 (38%), Gaps = 28/297 (9%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVR 582
            +E +G+G FG V++G  +       VAVK      ++     + E++      H+N++ 
Sbjct: 7   LQESIGKGRFGEVWRGKWRGEE----VAVKIFSSR-EERSWFREAEIYQTVMLRHENILG 61

Query: 583 LLGFCDEGQNRL----LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDC 638
            +   ++         LV ++  +G+L  +L             +A   A GL +LH + 
Sbjct: 62  FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEI 120

Query: 639 -----RAQIIHCDIKPQNILLDDYYTARISDFGLAKLL--TLNQSKTIKTAIRGTKGYVA 691
                +  I H D+K +NIL+    T  I+D GLA       +          GTK Y+A
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180

Query: 692 PEWFRNS------KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY----AILTDWAFDC 741
           PE   +S      +   + D+Y+ G++  EI        I    +      + +D + + 
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240

Query: 742 YRNGKL-NVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 797
            R       L           E L  +  +   C   + + R T  ++ + L  + +
Sbjct: 241 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  202 bits (513), Expect = 2e-59
 Identities = 71/316 (22%), Positives = 127/316 (40%), Gaps = 48/316 (15%)

Query: 512 SYKELEGATNNFK--EEVGRGSFGIVYKGV---IQTRTSTTAVAVKKLDR-VFQDGEREF 565
               LE   NN +   ++G G+FG V++     +      T VAVK L      D + +F
Sbjct: 4   KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63

Query: 566 KNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP---------- 615
           + E  ++ +  + N+V+LLG C  G+   L++E++  G L  FL                
Sbjct: 64  QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123

Query: 616 --------------NWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTAR 661
                         +   +  IA Q+A G+ YL E      +H D+  +N L+ +    +
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVK 180

Query: 662 ISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRK 721
           I+DFGL++ +                 ++ PE    ++ T + DV+++GV+L EI S   
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240

Query: 722 SFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSL 781
                M  E            R+G +               C  +L  +   C  + P+ 
Sbjct: 241 QPYYGMAHE------EVIYYVRDGNILAC---------PENCPLELYNLMRLCWSKLPAD 285

Query: 782 RPTMKKVLQMLEGVVE 797
           RP+   + ++L+ + E
Sbjct: 286 RPSFCSIHRILQRMCE 301

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (512), Expect = 3e-59
 Identities = 74/300 (24%), Positives = 126/300 (42%), Gaps = 40/300 (13%)

Query: 523 FKEEVGRGSFGIVYKGV---IQTRTSTTAVAVKKLDRVFQDGERE-FKNEVFVIGQ-THH 577
           F + +G G+FG V +     +    +   VAVK L       ERE   +E+ V+    +H
Sbjct: 27  FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86

Query: 578 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP------------------NWNL 619
            N+V LLG C  G   L++ E+   G L +FL                        +   
Sbjct: 87  MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146

Query: 620 RTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI 679
             + ++Q+A+G+ +L        IH D+  +NILL      +I DFGLA+ +  + +  +
Sbjct: 147 LLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203

Query: 680 KTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF 739
           K   R    ++APE   N   T + DV+S+G+ L E+ S   S                 
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS--------------PYP 249

Query: 740 DCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 799
               + K   ++ E    ++      ++  +   C   DP  RPT K+++Q++E  +  S
Sbjct: 250 GMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (507), Expect = 1e-58
 Identities = 72/282 (25%), Positives = 122/282 (43%), Gaps = 26/282 (9%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVR 582
            + ++G+G FG V+ G   T   TT VA+K L          F  E  V+ +  H+ LV+
Sbjct: 21  LEVKLGQGCFGEVWMG---TWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQ 76

Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP--NWNLRTNIAFQIARGLLYLHEDCRA 640
           L       +   +V E+++ G+L  FL G            ++A QIA G+ Y+      
Sbjct: 77  LYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN-- 133

Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI 700
             +H D++  NIL+ +    +++DFGLA+L+  N+  T +   +    + APE     + 
Sbjct: 134 -YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRF 191

Query: 701 TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMND 760
           T K DV+SFG+LL E+ +  +                 +    N ++   V         
Sbjct: 192 TIKSDVWSFGILLTELTTKGRVP---------------YPGMVNREVLDQVERGYRMPCP 236

Query: 761 IECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVPP 802
            EC   L  +   C +++P  RPT + +   LE     + P 
Sbjct: 237 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (503), Expect = 2e-58
 Identities = 68/276 (24%), Positives = 118/276 (42%), Gaps = 32/276 (11%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVR 582
             + +G+G FG V  G  +       VAVK +        + F  E  V+ Q  H NLV+
Sbjct: 11  LLQTIGKGEFGDVMLGDYRGNK----VAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQ 64

Query: 583 LLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKP--NWNLRTNIAFQIARGLLYLHEDCR 639
           LLG   E +  L +V E++  G+L  +L    +     +     +  +   + YL  +  
Sbjct: 65  LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN- 123

Query: 640 AQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSK 699
              +H D+  +N+L+ +   A++SDFGL K  +     + +   +    + APE  R  K
Sbjct: 124 --FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-----STQDTGKLPVKWTAPEALREKK 176

Query: 700 ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMN 759
            + K DV+SFG+LL EI S  +     +  +  +               V  G   +A +
Sbjct: 177 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-------------PRVEKGYKMDAPD 223

Query: 760 DIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV 795
              C   +  V   C   D ++RP+  ++ + LE +
Sbjct: 224 G--CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (507), Expect = 3e-58
 Identities = 71/339 (20%), Positives = 129/339 (38%), Gaps = 52/339 (15%)

Query: 490 YKKKW----IRNSPDDGTIETNLRCFSY-KELEGATNNFK--EEVGRGSFGIVYKGV--- 539
           Y+ +     +  S D+     + R + Y  + E    N +  + +G G+FG V       
Sbjct: 1   YESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYG 60

Query: 540 IQTRTSTTAVAVKKLDRVFQDGERE-FKNEVFVIGQ-THHKNLVRLLGFCDEGQNRLLVY 597
           I     +  VAVK L       ERE   +E+ ++ Q   H+N+V LLG C       L++
Sbjct: 61  ISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIF 120

Query: 598 EFLNNGTLASFLFGNLKP-----------------------NWNLRTNIAFQIARGLLYL 634
           E+   G L ++L    +                         +      A+Q+A+G+ +L
Sbjct: 121 EYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL 180

Query: 635 HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 694
                   +H D+  +N+L+      +I DFGLA+ +  + +  ++   R    ++APE 
Sbjct: 181 EF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPES 237

Query: 695 FRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGED 754
                 T K DV+S+G+LL EI S   +    +  +                   L+   
Sbjct: 238 LFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYK--------------LIQNG 283

Query: 755 KEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
            +         ++ ++   C   D   RP+   +   L 
Sbjct: 284 FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  198 bits (503), Expect = 4e-58
 Identities = 77/292 (26%), Positives = 133/292 (45%), Gaps = 26/292 (8%)

Query: 512 SYKELEGATNNFK--EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEV 569
           +Y + E    +     ++G G +G VY+GV   +  +  VAVK L     + E EF  E 
Sbjct: 8   NYDKWEMERTDITMKHKLGGGQYGEVYEGVW--KKYSLTVAVKTLKEDTMEVE-EFLKEA 64

Query: 570 FVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF--GNLKPNWNLRTNIAFQI 627
            V+ +  H NLV+LLG C       ++ EF+  G L  +L      + +  +   +A QI
Sbjct: 65  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI 124

Query: 628 ARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTK 687
           +  + YL    +   IH D+  +N L+ + +  +++DFGL++L+T   + T     +   
Sbjct: 125 SSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPI 180

Query: 688 GYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL 747
            + APE    +K + K DV++FGVLL EI +   S                +      ++
Sbjct: 181 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP---------------YPGIDLSQV 225

Query: 748 NVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 799
             L+ +D        C  K+  +   C Q +PS RP+  ++ Q  E + + S
Sbjct: 226 YELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 277

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (501), Expect = 5e-58
 Identities = 68/301 (22%), Positives = 138/301 (45%), Gaps = 33/301 (10%)

Query: 503 TIETNLRCFSYKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTA--VAVKKLDRVFQD 560
           T E +  C + +++          +G G FG VYKG+++T +      VA+K L   + +
Sbjct: 1   TTEIHPSCVTRQKV----------IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE 50

Query: 561 GER-EFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-NWN 618
            +R +F  E  ++GQ  H N++RL G   + +  +++ E++ NG L  FL       +  
Sbjct: 51  KQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVL 110

Query: 619 LRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT 678
               +   IA G+ YL        +H D+  +NIL++     ++SDFGL+++L  +   T
Sbjct: 111 QLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAT 167

Query: 679 IKT-AIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW 737
             T   +    + APE     K T+  DV+SFG+++ E+++  +                
Sbjct: 168 YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP-------------- 213

Query: 738 AFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 797
            +    N ++   + +       ++C   +  + + C Q++ + RP    ++ +L+ ++ 
Sbjct: 214 -YWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272

Query: 798 V 798
            
Sbjct: 273 A 273

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (500), Expect = 2e-57
 Identities = 79/329 (24%), Positives = 138/329 (41%), Gaps = 47/329 (14%)

Query: 506 TNLRCFSYKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF-QDGERE 564
           T      + +++     F++ +G G+FG V K  I+        A+K++     +D  R+
Sbjct: 2   TIYPVLDWNDIK-----FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD 56

Query: 565 FKNEVFVIGQ-THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-------- 615
           F  E+ V+ +  HH N++ LLG C+      L  E+  +G L  FL  +           
Sbjct: 57  FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 116

Query: 616 --------NWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGL 667
                   +     + A  +ARG+ YL +    Q IH D+  +NIL+ + Y A+I+DFGL
Sbjct: 117 ANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGL 173

Query: 668 AKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEM 727
           ++     +    KT  R    ++A E    S  T   DV+S+GVLL EI+S   +     
Sbjct: 174 SR---GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP---- 226

Query: 728 GEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKK 787
                      +      +L   + +       + C  ++  +   C +E P  RP+  +
Sbjct: 227 -----------YCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQ 275

Query: 788 VLQMLEGVVE---VSVPPNPYPFSSSMGL 813
           +L  L  ++E     V    Y   +  G+
Sbjct: 276 ILVSLNRMLEERKTYVNTTLYEKFTYAGI 304

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (496), Expect = 2e-57
 Identities = 68/275 (24%), Positives = 120/275 (43%), Gaps = 29/275 (10%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLD--RVFQDGEREFKNEVFVIGQTHHKNL 580
           F  E+GRGSF  VYKG+     +T  VA  +L   ++ +   + FK E  ++    H N+
Sbjct: 13  FDIEIGRGSFKTVYKGLD--TETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70

Query: 581 VRLLGFC----DEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHE 636
           VR            +  +LV E + +GTL ++L         +  +   QI +GL +LH 
Sbjct: 71  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT 130

Query: 637 DCRAQIIHCDIKPQNILLDD-YYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
                IIH D+K  NI +     + +I D GLA L   + +K     + GT  ++APE +
Sbjct: 131 RTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIGTPEFMAPEMY 185

Query: 696 RNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDK 755
              K    VDVY+FG+ +LE+ +    +          +        +    + +   + 
Sbjct: 186 EE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIYRRVTSGVKPASFDKVAIPE- 241

Query: 756 EAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
                   + +++     CI+++   R ++K +L 
Sbjct: 242 --------VKEIIE---GCIRQNKDERYSIKDLLN 265

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (496), Expect = 8e-57
 Identities = 58/275 (21%), Positives = 112/275 (40%), Gaps = 21/275 (7%)

Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTA--VAVKKLDRVF-QDGEREFKNEVFVIGQTHHK 578
              + +G G+FG VYKG+           VA+K+L         +E  +E +V+    + 
Sbjct: 12  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNP 71

Query: 579 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDC 638
           ++ RLLG C     +L+         L                N   QIA+G+ YL    
Sbjct: 72  HVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL---E 128

Query: 639 RAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNS 698
             +++H D+  +N+L+      +I+DFGLAKLL   + +      +    ++A E   + 
Sbjct: 129 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 188

Query: 699 KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAM 758
             T + DV+S+GV + E+++                    +D     +++ ++ + +   
Sbjct: 189 IYTHQSDVWSYGVTVWELMTFGSKP---------------YDGIPASEISSILEKGERLP 233

Query: 759 NDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
               C   + M+ + C   D   RP  ++++    
Sbjct: 234 QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 268

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (490), Expect = 2e-56
 Identities = 71/270 (26%), Positives = 120/270 (44%), Gaps = 21/270 (7%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLD-RVFQDGEREFKNEVFVIGQTHHKNLV 581
             + +G G++G V       R +  AVAVK +D +   D     K E+ +    +H+N+V
Sbjct: 9   LVQTLGEGAYGEVQLA--VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66

Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ 641
           +  G   EG  + L  E+ + G L   +  ++            Q+  G++YLH      
Sbjct: 67  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IG 123

Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI- 700
           I H DIKP+N+LLD+    +ISDFGLA +   N  + +   + GT  YVAPE  +  +  
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 183

Query: 701 TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMND 760
              VDV+S G++L  +++    +D +  +     +DW         LN     D   +  
Sbjct: 184 AEPVDVWSCGIVLTAMLAGELPWD-QPSDSCQEYSDWKEKKTY---LNPWKKIDSAPLAL 239

Query: 761 IECLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
           +             + E+PS R T+  + +
Sbjct: 240 LH----------KILVENPSARITIPDIKK 259

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (489), Expect = 2e-56
 Identities = 63/279 (22%), Positives = 111/279 (39%), Gaps = 30/279 (10%)

Query: 522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE--REFKNEVFVIGQTHHKN 579
                +G GS+G   K   + ++    +  K+LD         +   +EV ++ +  H N
Sbjct: 7   EVLYTIGTGSYGRCQKI--RRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64

Query: 580 LVRLLGFCDEGQNRLL--VYEFLNNGTLASFLFGNLKP----NWNLRTNIAFQIARGLLY 633
           +VR      +  N  L  V E+   G LAS +    K     +      +  Q+   L  
Sbjct: 65  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124

Query: 634 LHE--DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVA 691
            H   D    ++H D+KP N+ LD     ++ DFGLA++L  + S     A  GT  Y++
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA--KAFVGTPYYMS 182

Query: 692 PEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLV 751
           PE         K D++S G LL E+ +    F     +E            R GK   + 
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-------LAGKIREGKFRRIP 235

Query: 752 GEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
               + +N+      ++      +      RP+++++L+
Sbjct: 236 YRYSDELNE------IIT---RMLNLKDYHRPSVEEILE 265

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 4e-56
 Identities = 65/271 (23%), Positives = 113/271 (41%), Gaps = 29/271 (10%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKN 579
               +G+G FG VY    + + S   +A+K L +        E + + EV +     H N
Sbjct: 10  IGRPLGKGKFGNVYLA--REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67

Query: 580 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCR 639
           ++RL G+  +     L+ E+   GT+   L    K +         ++A  L Y H    
Sbjct: 68  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS--- 124

Query: 640 AQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSK 699
            ++IH DIKP+N+LL      +I+DFG +     ++  T+     GT  Y+ PE      
Sbjct: 125 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIEGRM 180

Query: 700 ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMN 759
              KVD++S GVL  E +  +  F+    +E        +      +        + A +
Sbjct: 181 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-------TYKRISRVEFTFPDFVTEGARD 233

Query: 760 DIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
            I             ++ +PS RP +++VL+
Sbjct: 234 LIS----------RLLKHNPSQRPMLREVLE 254

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 1e-55
 Identities = 63/278 (22%), Positives = 109/278 (39%), Gaps = 23/278 (8%)

Query: 523 FKEEVGRGSFGIVYKGV-IQTRTSTTAVAVKKLDRVFQDGERE-FKNEVFVIGQTHHKNL 580
               +G G FG V++G+ +       AVA+K       D  RE F  E   + Q  H ++
Sbjct: 11  LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 70

Query: 581 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-NWNLRTNIAFQIARGLLYLHEDCR 639
           V+L+G   E     ++ E    G L SFL       +       A+Q++  L YL     
Sbjct: 71  VKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR- 128

Query: 640 AQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSK 699
              +H DI  +N+L+      ++ DFGL++ +  + +    +  +    ++APE     +
Sbjct: 129 --FVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRR 185

Query: 700 ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMN 759
            T+  DV+ FGV + EI+         +                NG+   +       + 
Sbjct: 186 FTSASDVWMFGVCMWEILMHGVKPFQGVKNN------DVIGRIENGERLPMPPNCPPTLY 239

Query: 760 DIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 797
                  L+     C   DPS RP   ++   L  ++E
Sbjct: 240 S------LMT---KCWAYDPSRRPRFTELKAQLSTILE 268

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (481), Expect = 7e-55
 Identities = 64/268 (23%), Positives = 116/268 (43%), Gaps = 26/268 (9%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLL 584
           E++G+G+ G VY        +   VA+++++   Q  +    NE+ V+ +  + N+V  L
Sbjct: 26  EKIGQGASGTVYTA--MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYL 83

Query: 585 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIH 644
                G    +V E+L  G+L   +      +      +  +  + L +LH     Q+IH
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHS---NQVIH 139

Query: 645 CDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKV 704
            DIK  NILL    + +++DFG    +T  QSK   + + GT  ++APE         KV
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKV 197

Query: 705 DVYSFGVLLLEIISCRKSF--DIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIE 762
           D++S G++ +E+I     +  +  +   Y I T+   +     KL           + + 
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKL------SAIFRDFLN 251

Query: 763 CLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
                      C+  D   R + K++LQ
Sbjct: 252 ----------RCLDMDVEKRGSAKELLQ 269

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  188 bits (478), Expect = 2e-54
 Identities = 60/272 (22%), Positives = 100/272 (36%), Gaps = 32/272 (11%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE---REFKNEVFVIGQTHHKNLV 581
            E+G GSFG VY    +   ++  VA+KK+    +      ++   EV  + +  H N +
Sbjct: 21  REIGHGSFGAVYFA--RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTI 78

Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ 641
           +  G         LV E+                       +     +GL YLH      
Sbjct: 79  QYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HN 135

Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR---NS 698
           +IH D+K  NILL +    ++ DFG A ++    S        GT  ++APE        
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS------FVGTPYWMAPEVILAMDEG 189

Query: 699 KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAM 758
           +   KVDV+S G+  +E+   +                  F+      L  +   +  A+
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPL---------------FNMNAMSALYHIAQNESPAL 234

Query: 759 NDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
                          C+Q+ P  RPT + +L+
Sbjct: 235 QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 4e-54
 Identities = 67/277 (24%), Positives = 108/277 (38%), Gaps = 24/277 (8%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTS-TTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHK 578
             E++G GSFG+V +G     +  T +VAVK L        +   +F  EV  +    H+
Sbjct: 12  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 71

Query: 579 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-NWNLRTNIAFQIARGLLYLHED 637
           NL+RL G       + +V E    G+L   L  +         +  A Q+A G+ YL   
Sbjct: 72  NLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK 130

Query: 638 CRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSK-TIKTAIRGTKGYVAPEWFR 696
                IH D+  +N+LL      +I DFGL + L  N     ++   +    + APE  +
Sbjct: 131 R---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187

Query: 697 NSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKE 756
               +   D + FGV L E+ +  +   I +                   L+ +  E + 
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI--------------LHKIDKEGER 233

Query: 757 AMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
                +C   +  V + C    P  RPT   +   L 
Sbjct: 234 LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (472), Expect = 1e-53
 Identities = 59/274 (21%), Positives = 107/274 (39%), Gaps = 27/274 (9%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVR 582
              E+G G+FG VYK   Q + ++   A K +D   ++   ++  E+ ++    H N+V+
Sbjct: 16  IIGELGDGAFGKVYKA--QNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 73

Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-NWNLRTNIAFQIARGLLYLHEDCRAQ 641
           LL       N  ++ EF   G + + +    +P   +    +  Q    L YLH+    +
Sbjct: 74  LLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD---NK 130

Query: 642 IIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF-----R 696
           IIH D+K  NIL       +++DFG++   T    +    +  GT  ++APE       +
Sbjct: 131 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSFIGTPYWMAPEVVMCETSK 188

Query: 697 NSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKE 756
           +     K DV+S G+ L+E+                              L +   E   
Sbjct: 189 DRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL--------------LKIAKSEPPT 234

Query: 757 AMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
                            C++++   R T  ++LQ
Sbjct: 235 LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 3e-51
 Identities = 72/289 (24%), Positives = 131/289 (45%), Gaps = 32/289 (11%)

Query: 523 FKEEVGRGSFGIVYKGV---IQTRTSTTAVAVKKLDRVFQDGER-EFKNEVFVIGQTHHK 578
              E+G+GSFG+VY+GV   +      T VA+K ++      ER EF NE  V+ + +  
Sbjct: 24  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 83

Query: 579 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN----------LKPNWNLRTNIAFQIA 628
           ++VRLLG   +GQ  L++ E +  G L S+L               P+ +    +A +IA
Sbjct: 84  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 143

Query: 629 RGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKG 688
            G+ YL+ +   + +H D+  +N ++ + +T +I DFG+ + +                 
Sbjct: 144 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 200

Query: 689 YVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLN 748
           +++PE  ++   T   DV+SFGV+L EI +  +                 +    N ++ 
Sbjct: 201 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE---------------QPYQGLSNEQVL 245

Query: 749 VLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 797
             V E         C   L  +   C Q +P +RP+  +++  ++  +E
Sbjct: 246 RFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 3e-51
 Identities = 74/300 (24%), Positives = 125/300 (41%), Gaps = 41/300 (13%)

Query: 523 FKEEVGRGSFGIVYKGVI-----QTRTSTTAVAVKKLDR-VFQDGEREFKNEVFVIGQ-T 575
             + +G G+FG V                T VAVK L     +    +  +E+ ++    
Sbjct: 17  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76

Query: 576 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP----------------NWNL 619
            HKN++ LLG C +     ++ E+ + G L  +L     P                +   
Sbjct: 77  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136

Query: 620 RTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI 679
             + A+Q+ARG+ YL      + IH D+  +N+L+ +    +I+DFGLA+ +        
Sbjct: 137 LVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193

Query: 680 KTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF 739
            T  R    ++APE   +   T + DV+SFGVLL EI +   S                +
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP---------------Y 238

Query: 740 DCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 799
                 +L  L+ E         C  +L M+   C    PS RPT K++++ L+ +V ++
Sbjct: 239 PGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 298

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 2e-50
 Identities = 73/299 (24%), Positives = 121/299 (40%), Gaps = 39/299 (13%)

Query: 523 FKEEVGRGSFGIVYKGV---IQTRTSTTAVAVKKLDR-VFQDGEREFKNEVFVIGQT-HH 577
             + +GRG+FG V +     I    +   VAVK L         R   +E+ ++    HH
Sbjct: 17  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 76

Query: 578 KNLVRLLGFC-DEGQNRLLVYEFLNNGTLASFLFGNLKP----------------NWNLR 620
            N+V LLG C   G   +++ EF   G L+++L                           
Sbjct: 77  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136

Query: 621 TNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIK 680
              +FQ+A+G+ +L      + IH D+  +NILL +    +I DFGLA+ +  +     K
Sbjct: 137 ICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193

Query: 681 TAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD 740
              R    ++APE   +   T + DV+SFGVLL EI S   S    +  +     +    
Sbjct: 194 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-----EEFCR 248

Query: 741 CYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 799
             + G            M             + C   +PS RPT  ++++ L  +++ +
Sbjct: 249 RLKEGTRMRAPDYTTPEMYQT---------MLDCWHGEPSQRPTFSELVEHLGNLLQAN 298

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  174 bits (442), Expect = 6e-49
 Identities = 60/271 (22%), Positives = 107/271 (39%), Gaps = 24/271 (8%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVR 582
             EE+G G+FG+V++     R +    A K +    +  +   + E+  +    H  LV 
Sbjct: 30  IHEELGTGAFGVVHRV--TERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 87

Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-NWNLRTNIAFQIARGLLYLHEDCRAQ 641
           L    ++    +++YEF++ G L   +       + +       Q+ +GL ++HE     
Sbjct: 88  LHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NN 144

Query: 642 IIHCDIKPQNILL--DDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSK 699
            +H D+KP+NI+         ++ DFGL   L     K       GT  + APE      
Sbjct: 145 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPEVAEGKP 201

Query: 700 ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMN 759
           +    D++S GVL   ++S    F    GE           C  N   +   G  ++  +
Sbjct: 202 VGYYTDMWSVGVLSYILLSGLSPFG---GENDDETLRNVKSCDWNMDDSAFSGISEDGKD 258

Query: 760 DIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
            I             +  DP+ R T+ + L+
Sbjct: 259 FIR----------KLLLADPNTRMTIHQALE 279

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 7e-49
 Identities = 53/274 (19%), Positives = 104/274 (37%), Gaps = 25/274 (9%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDR---VFQDGEREFKNEVFVIGQTHHKN 579
           F + +G GSF  V     +   ++   A+K L++   + ++       E  V+ +  H  
Sbjct: 12  FGKILGEGSFSTVVLA--RELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69

Query: 580 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCR 639
            V+L     + +       +  NG L  ++      +         +I   L YLH    
Sbjct: 70  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG- 128

Query: 640 AQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSK 699
             IIH D+KP+NILL++    +I+DFG AK+L+    +    +  GT  YV+PE      
Sbjct: 129 --IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 186

Query: 700 ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMN 759
                D+++ G ++ ++++    F               F      + +       +A +
Sbjct: 187 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-------IFQKIIKLEYDFPEKFFPKARD 239

Query: 760 DIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE 793
            +E            +  D + R   +++     
Sbjct: 240 LVE----------KLLVLDATKRLGCEEMEGYGP 263

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  167 bits (425), Expect = 1e-46
 Identities = 66/271 (24%), Positives = 112/271 (41%), Gaps = 24/271 (8%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVR 582
             EE+G G+FG+V++ V   + +      K ++  +   +   KNE+ ++ Q HH  L+ 
Sbjct: 33  ILEELGSGAFGVVHRCV--EKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 90

Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-NWNLRTNIAFQIARGLLYLHEDCRAQ 641
           L    ++    +L+ EFL+ G L   +       +     N   Q   GL ++HE     
Sbjct: 91  LHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HS 147

Query: 642 IIHCDIKPQNILLD--DYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSK 699
           I+H DIKP+NI+ +     + +I DFGLA  L       I      T  + APE      
Sbjct: 148 IVHLDIKPENIMCETKKASSVKIIDFGLATKL---NPDEIVKVTTATAEFAAPEIVDREP 204

Query: 700 ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMN 759
           +    D+++ GVL   ++S    F    GE+          C      +       EA +
Sbjct: 205 VGFYTDMWAIGVLGYVLLSGLSPFA---GEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD 261

Query: 760 DIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
            I+            +Q++P  R T+   L+
Sbjct: 262 FIK----------NLLQKEPRKRLTVHDALE 282

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  165 bits (418), Expect = 4e-46
 Identities = 66/285 (23%), Positives = 124/285 (43%), Gaps = 29/285 (10%)

Query: 513 YKELEGATNNFK--EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE-FKNEV 569
           +K+ E   + +   + +G G+F  V     + + +   VA+K + +   +G+    +NE+
Sbjct: 1   WKQAEDIRDIYDFRDVLGTGAFSEVILA--EDKRTQKLVAIKCIAKKALEGKEGSMENEI 58

Query: 570 FVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIAR 629
            V+ +  H N+V L    + G +  L+ + ++ G L   +           + + FQ+  
Sbjct: 59  AVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLD 118

Query: 630 GLLYLHEDCRAQIIHCDIKPQNILL---DDYYTARISDFGLAKLLTLNQSKTIKTAIRGT 686
            + YLH+     I+H D+KP+N+L    D+     ISDFGL+K+       ++ +   GT
Sbjct: 119 AVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME---DPGSVLSTACGT 172

Query: 687 KGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 746
            GYVAPE       +  VD +S GV+   ++     F  E   +        F+     +
Sbjct: 173 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK-------LFEQILKAE 225

Query: 747 LNVLVGEDKEAMNDI-ECLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
                  D    +DI +     +      +++DP  R T ++ LQ
Sbjct: 226 YEF----DSPYWDDISDSAKDFIR---HLMEKDPEKRFTCEQALQ 263

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 8e-45
 Identities = 58/272 (21%), Positives = 113/272 (41%), Gaps = 27/272 (9%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVR 582
             E++GRG FGIV++ V    +S      K +     D +   K E+ ++    H+N++ 
Sbjct: 9   IAEDLGRGEFGIVHRCV--ETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILH 65

Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-NWNLRTNIAFQIARGLLYLHEDCRAQ 641
           L    +  +  ++++EF++   +   +  +    N     +   Q+   L +LH      
Sbjct: 66  LHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS---HN 122

Query: 642 IIHCDIKPQNILLD--DYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSK 699
           I H DI+P+NI+       T +I +FG A+ L    +  +   +     Y APE  ++  
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEVHQHDV 179

Query: 700 ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMN 759
           ++   D++S G L+  ++S    F  E  ++         +   N +       D+EA  
Sbjct: 180 VSTATDMWSLGTLVYVLLSGINPFLAETNQQ-------IIENIMNAEYTF----DEEAFK 228

Query: 760 DI-ECLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
           +I       V      + ++   R T  + LQ
Sbjct: 229 EISIEAMDFVD---RLLVKERKSRMTASEALQ 257

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  161 bits (407), Expect = 5e-44
 Identities = 62/274 (22%), Positives = 104/274 (37%), Gaps = 32/274 (11%)

Query: 521 NNFK--EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVI--- 572
           N+F     +GRG FG VY    +   +    A+K LD+     + GE    NE  ++   
Sbjct: 4   NDFSVHRIIGRGGFGEVYGC--RKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 61

Query: 573 GQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLL 632
                  +V +            + + +N G L   L  +   +       A +I  GL 
Sbjct: 62  STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 121

Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 692
           ++H      +++ D+KP NILLD++   RISD GLA       SK    A  GT GY+AP
Sbjct: 122 HMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF----SKKKPHASVGTHGYMAP 174

Query: 693 EWFRNSK-ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLV 751
           E  +      +  D +S G +L +++     F     ++   +            + +  
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTLTMAVELPD 230

Query: 752 GEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTM 785
               E  + +E            +Q D + R   
Sbjct: 231 SFSPELRSLLE----------GLLQRDVNRRLGC 254

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  157 bits (398), Expect = 8e-44
 Identities = 58/284 (20%), Positives = 108/284 (38%), Gaps = 37/284 (13%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLD---------RVFQDGEREFKNEVFVIG 573
            KE +GRG   +V +     + +    AVK +D            Q+       EV ++ 
Sbjct: 7   PKEILGRGVSSVVRRC--IHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64

Query: 574 QTH-HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLL 632
           +   H N+++L    +      LV++ +  G L  +L   +  +      I   +   + 
Sbjct: 65  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVIC 124

Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 692
            LH+     I+H D+KP+NILLDD    +++DFG +  L   +       + GT  Y+AP
Sbjct: 125 ALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAP 178

Query: 693 EWFR------NSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 746
           E         +     +VD++S GV++  +++    F                    +G 
Sbjct: 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-------MLRMIMSGN 231

Query: 747 LNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
                 E  +  + ++ L          +   P  R T ++ L 
Sbjct: 232 YQFGSPEWDDYSDTVKDLVS------RFLVVQPQKRYTAEEALA 269

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 4e-43
 Identities = 70/271 (25%), Positives = 108/271 (39%), Gaps = 28/271 (10%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDR---VFQDGEREFKNEVFVIGQT-HHK 578
             + +G+GSFG V+      + +    A+K L +   +  D       E  V+     H 
Sbjct: 6   LHKMLGKGSFGKVFLAEF--KKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63

Query: 579 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDC 638
            L  +       +N   V E+LN G L   +    K + +  T  A +I  GL +LH   
Sbjct: 64  FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS-- 121

Query: 639 RAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNS 698
              I++ D+K  NILLD     +I+DFG+ K   L  +K       GT  Y+APE     
Sbjct: 122 -KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNTFCGTPDYIAPEILLGQ 178

Query: 699 KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAM 758
           K    VD +SFGVLL E++  +  F  +  EE        F   R          +KEA 
Sbjct: 179 KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-------LFHSIRMDNPFYPRWLEKEAK 231

Query: 759 NDIECLGKLVMVSIWCIQEDPSLRPTMKKVL 789
           + +                +P  R  ++  +
Sbjct: 232 DLLV----------KLFVREPEKRLGVRGDI 252

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  152 bits (386), Expect = 3e-42
 Identities = 58/285 (20%), Positives = 103/285 (36%), Gaps = 33/285 (11%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQTHHKN 579
             E +G G    V+      R     VAVK L             F+ E       +H  
Sbjct: 11  LGEILGFGGMSEVHLA-RDLRLHRD-VAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68

Query: 580 LVRLLGFC----DEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLH 635
           +V +          G    +V E+++  TL   +             +     + L +  
Sbjct: 69  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS- 127

Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKT-AIRGTKGYVAPEW 694
              +  IIH D+KP NI++      ++ DFG+A+ +  + +   +T A+ GT  Y++PE 
Sbjct: 128 --HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 185

Query: 695 FRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA---ILTDWAFDCYRNGKLNVLV 751
            R   + A+ DVYS G +L E+++    F  +     A   +  D      R+  L    
Sbjct: 186 ARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL---- 241

Query: 752 GEDKEAMNDIECLGKLVMVSIWCIQEDPSLRP-TMKKVLQMLEGV 795
               +    +             + ++P  R  T  ++   L  V
Sbjct: 242 --SADLDAVVL----------KALAKNPENRYQTAAEMRADLVRV 274

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 8e-42
 Identities = 62/284 (21%), Positives = 106/284 (37%), Gaps = 24/284 (8%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF-----QDGEREFKNEVFVIGQTHHKN 579
           + +G G F  VYK   + + +   VA+KK+             R    E+ ++ +  H N
Sbjct: 4   DFLGEGQFATVYKA--RDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPN 61

Query: 580 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCR 639
           ++ LL       N  LV++F+           +L    +          +GL YLH+   
Sbjct: 62  IIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW- 120

Query: 640 AQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSK 699
             I+H D+KP N+LLD+    +++DFGLAK  +        T    T+ Y APE    ++
Sbjct: 121 --ILHRDLKPNNLLLDENGVLKLADFGLAK--SFGSPNRAYTHQVVTRWYRAPELLFGAR 176

Query: 700 -ITAKVDVYSFGVLLLEIISCRKSFD----------IEMGEEYAILTDWAFDCYRNGKLN 748
                VD+++ G +L E++                 I           W   C     + 
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236

Query: 749 VLVGEDKEAMNDIECLGKLVMVSI-WCIQEDPSLRPTMKKVLQM 791
                     +     G  ++  I      +P  R T  + L+M
Sbjct: 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  152 bits (385), Expect = 9e-42
 Identities = 52/294 (17%), Positives = 91/294 (30%), Gaps = 25/294 (8%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVR 582
              ++G GSFG +Y G          VA+K      +    +   E  +         + 
Sbjct: 11  LGRKIGSGSFGDIYLG-TDIAAGEE-VAIKLECV--KTKHPQLHIESKIYKMMQGGVGIP 66

Query: 583 LLGFC-DEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ 641
            + +C  EG   ++V E L       F F + K +      +A Q+   + Y+H      
Sbjct: 67  TIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KN 123

Query: 642 IIHCDIKPQNIL---LDDYYTARISDFGLAKLLTLNQSKTI-----KTAIRGTKGYVAPE 693
            IH D+KP N L           I DFGLAK     ++           + GT  Y +  
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183

Query: 694 WFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGE 753
                + + + D+ S G +L+        +            +   +   +  + VL   
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKG 243

Query: 754 DKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVPPNPYPF 807
                              +C       +P    + Q+   +         Y F
Sbjct: 244 YPSEFATYLN---------FCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVF 288

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  151 bits (381), Expect = 6e-41
 Identities = 60/269 (22%), Positives = 111/269 (41%), Gaps = 32/269 (11%)

Query: 521 NNFK--EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQT 575
            +F+    +G GSFG V+    ++R +    A+K L +             +E  ++   
Sbjct: 4   QDFQILRTLGTGSFGRVHLI--RSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 61

Query: 576 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLH 635
            H  ++R+ G   + Q   ++ +++  G L S L  + +    +    A ++   L YLH
Sbjct: 62  THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH 121

Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
                 II+ D+KP+NILLD     +I+DFG AK +       +   + GT  Y+APE  
Sbjct: 122 SKD---IIYRDLKPENILLDKNGHIKITDFGFAKYV-----PDVTYTLCGTPDYIAPEVV 173

Query: 696 RNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDK 755
                   +D +SFG+L+ E+++    F      +        ++   N +L      ++
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK-------TYEKILNAELRFPPFFNE 226

Query: 756 EAMNDIECLGKLVMVSIWCIQEDPSLRPT 784
           +  + +             I  D S R  
Sbjct: 227 DVKDLLS----------RLITRDLSQRLG 245

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (381), Expect = 7e-41
 Identities = 61/277 (22%), Positives = 110/277 (39%), Gaps = 32/277 (11%)

Query: 524 KEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ-THHKNLVR 582
            + +G G  G V + +   RT     A+K L         + + EV +  + +   ++VR
Sbjct: 17  SQVLGLGINGKVLQ-IFNKRTQEK-FALKMLQDC-----PKARREVELHWRASQCPHIVR 69

Query: 583 LLGFCD----EGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLHE 636
           ++   +      +  L+V E L+ G L S +   G+        + I   I   + YLH 
Sbjct: 70  IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 129

Query: 637 DCRAQIIHCDIKPQNILLDDYY---TARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE 693
                I H D+KP+N+L          +++DFG AK  T + S T       T  YVAPE
Sbjct: 130 ---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT---PCYTPYYVAPE 183

Query: 694 WFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGE 753
                K     D++S GV++  ++     F          ++       R G+      E
Sbjct: 184 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFY---SNHGLAISPGMKTRIRMGQYEFPNPE 240

Query: 754 DKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
             E   +++ L +        ++ +P+ R T+ + + 
Sbjct: 241 WSEVSEEVKMLIR------NLLKTEPTQRMTITEFMN 271

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 2e-40
 Identities = 66/295 (22%), Positives = 114/295 (38%), Gaps = 30/295 (10%)

Query: 519 ATNNFK--EEVGRGSFGIVYKGVIQTRTSTTAVAVKKL--DRVFQDGEREFKNEVFV--- 571
           A   ++   E+G G++G V+K     +     VA+K++      +        EV V   
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKA-RDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63

Query: 572 IGQTHHKNLVRLLGFC-----DEGQNRLLVYEFLNNGTLASFLFGNLKP-NWNLRTNIAF 625
           +    H N+VRL   C     D      LV+E ++                     ++ F
Sbjct: 64  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123

Query: 626 QIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRG 685
           Q+ RGL +LH      ++H D+KPQNIL+      +++DFGLA++ +    +   T++  
Sbjct: 124 QLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMALTSVVV 177

Query: 686 TKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE------YAILTDWAF 739
           T  Y APE    S     VD++S G +  E+   +  F      +        I      
Sbjct: 178 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237

Query: 740 DCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSI----WCIQEDPSLRPTMKKVLQ 790
           D  R+  L       K A    + +  +  +       C+  +P+ R +    L 
Sbjct: 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 4e-40
 Identities = 65/278 (23%), Positives = 107/278 (38%), Gaps = 31/278 (11%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGER------EFKNEVFVIGQTH 576
             EE+G G F +V K   + +++    A K + +      R      + + EV ++ +  
Sbjct: 14  TGEELGSGQFAVVKKC--REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71

Query: 577 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHE 636
           H N++ L    +   + +L+ E +  G L  FL           T    QI  G   ++ 
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG---VYY 128

Query: 637 DCRAQIIHCDIKPQNILLDDYYTAR----ISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 692
               QI H D+KP+NI+L D    +    I DFGLA  +           I GT  +VAP
Sbjct: 129 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTPEFVAP 185

Query: 693 EWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVG 752
           E      +  + D++S GV+   ++S    F            D   +   N        
Sbjct: 186 EIVNYEPLGLEADMWSIGVITYILLSGASPFL----------GDTKQETLANVSAVNYEF 235

Query: 753 EDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
           ED+   N        +      + +DP  R T++  LQ
Sbjct: 236 EDEYFSNTSALAKDFIR---RLLVKDPKKRMTIQDSLQ 270

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 4e-40
 Identities = 59/279 (21%), Positives = 104/279 (37%), Gaps = 43/279 (15%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKL------DRVFQDGEREFKNEVFVIGQ-- 574
               +G G FG VY G+    +    VA+K +      D            EV ++ +  
Sbjct: 8   VGPLLGSGGFGSVYSGI--RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65

Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-NWNLRTNIAFQIARGLLY 633
           +    ++RLL + +   + +L+ E                     L  +  +Q+   + +
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125

Query: 634 LHEDCRAQIIHCDIKPQNILLD-DYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 692
            H      ++H DIK +NIL+D +    ++ DFG   LL      T+ T   GT+ Y  P
Sbjct: 126 CHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPP 178

Query: 693 EWFRNSK-ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLV 751
           EW R  +       V+S G+LL +++     F+               +    G++    
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE-------------HDEEIIRGQVFFRQ 225

Query: 752 GEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ 790
               E  + I           WC+   PS RPT +++  
Sbjct: 226 RVSSECQHLIR----------WCLALRPSDRPTFEEIQN 254

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  146 bits (370), Expect = 6e-40
 Identities = 55/280 (19%), Positives = 107/280 (38%), Gaps = 21/280 (7%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD--GEREFKNEVFVIGQTHHKNLVR 582
           E++G G++G+VYK            A+KK+    +D         E+ ++ +  H N+V+
Sbjct: 8   EKIGEGTYGVVYKA---QNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVK 64

Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQI 642
           L       +  +LV+E L+                    +   Q+  G+ Y H+     +
Sbjct: 65  LYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---V 121

Query: 643 IHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITA 702
           +H D+KPQN+L++     +I+DFGLA+   +   K     I             + K + 
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEIVTLWYRAPDVLMGSKKYST 180

Query: 703 KVDVYSFGVLLLEIISCRKSFDIEMGEE-----YAILTDWAFDCYRNGKLNVLVGEDKEA 757
            +D++S G +  E+++    F      +     + IL       + N         +   
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240

Query: 758 MNDIECLGKLVMVSI-------WCIQEDPSLRPTMKKVLQ 790
              +     L  +           ++ DP+ R T K+ L+
Sbjct: 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  143 bits (362), Expect = 1e-38
 Identities = 47/296 (15%), Positives = 94/296 (31%), Gaps = 27/296 (9%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ-THHKNLV 581
               +G GSFG++++G      +   VA+K   R  +    + ++E            + 
Sbjct: 9   VGRRIGEGSFGVIFEGT--NLLNNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTGIP 64

Query: 582 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQ 641
            +  F  EG + +LV + L             K +       A Q+   +  +HE     
Sbjct: 65  NVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KS 121

Query: 642 IIHCDIKPQNILLDDYYT-----ARISDFGLAKLLTLNQSKTI-----KTAIRGTKGYVA 691
           +++ DIKP N L+    +       + DFG+ K      +K       K  + GT  Y++
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181

Query: 692 PEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLV 751
                  + + + D+ + G + +  +     +            +   +  ++  L  L 
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC 241

Query: 752 GEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVPPNPYPF 807
               E            M             P    +  +   V+E         F
Sbjct: 242 AGFPEEFYKY-------MHYAR--NLAFDATPDYDYLQGLFSKVLERLNTTEDENF 288

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (360), Expect = 2e-38
 Identities = 65/287 (22%), Positives = 118/287 (41%), Gaps = 25/287 (8%)

Query: 522 NFK--EEVGRGSFGIVYKGVIQTRTSTTAVAVKKL--DRVFQDGEREFKNEVFVIGQTHH 577
           NF+  E++G G++G+VYK   + + +   VA+KK+  D   +        E+ ++ + +H
Sbjct: 3   NFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60

Query: 578 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-NWNLRTNIAFQIARGLLYLHE 636
            N+V+LL          LV+EFL+           L      L  +  FQ+ +GL + H 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120

Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR 696
                ++H D+KPQN+L++     +++DFGLA+           T    T  Y APE   
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLARA--FGVPVRTYTHEVVTLWYRAPEILL 175

Query: 697 NSK-ITAKVDVYSFGVLLLEIISCRKSFD-----------IEMGEEYAILTDWAFDCYRN 744
             K  +  VD++S G +  E+++ R  F                     +         +
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235

Query: 745 GKLNVLVGEDKEAMNDIECLGKLVMVSI-WCIQEDPSLRPTMKKVLQ 790
            K +      ++    +  L +     +   +  DP+ R + K  L 
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (361), Expect = 4e-38
 Identities = 65/310 (20%), Positives = 119/310 (38%), Gaps = 28/310 (9%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE-FKNEVFVIGQTHHKNLVRL 583
             +G G++G+V         +   VA+KK+         +    E+ ++ +  H+N++ +
Sbjct: 14  SYIGEGAYGMVCSA--YDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI 71

Query: 584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPN---WNLRTNIAFQIARGLLYLHEDCRA 640
                      +   +L    + + L+  LK      +      +QI RGL Y+H    A
Sbjct: 72  NDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---A 128

Query: 641 QIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSK-TIKTAIRGTKGYVAPEWFRNS- 698
            ++H D+KP N+LL+     +I DFGLA++   +       T    T+ Y APE   NS 
Sbjct: 129 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 188

Query: 699 KITAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILT--------DWAFDCYRNGKLN 748
             T  +D++S G +L E++S R  F  +   +    IL         D         +  
Sbjct: 189 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 248

Query: 749 VLVGEDKEAMNDIECLGKLVMVSI----WCIQEDPSLRPTMKKVLQ---MLEGVVEVSVP 801
           +L    K  +            ++      +  +P  R  +++ L    + +       P
Sbjct: 249 LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEP 308

Query: 802 PNPYPFSSSM 811
               PF   M
Sbjct: 309 IAEAPFKFDM 318

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 5e-37
 Identities = 54/294 (18%), Positives = 110/294 (37%), Gaps = 33/294 (11%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDG--EREFKNEVFVIGQTHHKNLVR 582
            ++G+G+FG V+K   + R +   VA+KK+    +          E+ ++    H+N+V 
Sbjct: 16  AKIGQGTFGEVFKA--RHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVN 73

Query: 583 LLGFCDEGQNR--------LLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYL 634
           L+  C    +          LV++F  +          +K   +    +   +  G   L
Sbjct: 74  LIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG---L 130

Query: 635 HEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS--KTIKTAIRGTKGYVAP 692
           +   R +I+H D+K  N+L+      +++DFGLA+  +L ++      T    T  Y  P
Sbjct: 131 YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPP 190

Query: 693 EWFRNSK-ITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLNVL 750
           E     +     +D++  G ++ E+ +          +   A+++            NV 
Sbjct: 191 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD 250

Query: 751 VGEDKEAMNDIECLGKLVMVSIW--------------CIQEDPSLRPTMKKVLQ 790
             E  E +  ++   + V   +                +  DP+ R      L 
Sbjct: 251 NYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 2e-36
 Identities = 54/282 (19%), Positives = 118/282 (41%), Gaps = 23/282 (8%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD--GEREFKNEVFVIGQTHHKNLVR 582
           E++G G++G V+K   + R +   VA+K++     D         E+ ++ +  HKN+VR
Sbjct: 8   EKIGEGTYGTVFKA--KNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVR 65

Query: 583 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQI 642
           L       +   LV+EF +      F   N   +  +  +  FQ+ +GL + H      +
Sbjct: 66  LHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---V 122

Query: 643 IHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI-T 701
           +H D+KPQN+L++     ++++FGLA+   +       +A   T  Y  P+    +K+ +
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTLWYRPPDVLFGAKLYS 180

Query: 702 AKVDVYSFGVLLLEIISCRKSFDIEMGEE------YAILTDWAFDCYRNGKLNVLVGEDK 755
             +D++S G +  E+ +  +        +      + +L     + + +           
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240

Query: 756 EAMNDIECLGKLVMVSI-------WCIQEDPSLRPTMKKVLQ 790
                   +  +  ++          ++ +P  R + ++ LQ
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 6e-36
 Identities = 67/304 (22%), Positives = 115/304 (37%), Gaps = 45/304 (14%)

Query: 511 FSYKELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVF 570
            SY + +         +G GSFG+VY+  +    S   VA+KK+ +     +R    E+ 
Sbjct: 20  VSYTDTK--------VIGNGSFGVVYQAKL--CDSGELVAIKKVLQ----DKRFKNRELQ 65

Query: 571 VIGQTHHKNLVRLLGFCDEGQNR------LLVYEFLNNGTLASFLFGNLKP---NWNLRT 621
           ++ +  H N+VRL  F      +       LV +++           +            
Sbjct: 66  IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 125

Query: 622 NIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLD-DYYTARISDFGLAKLLTLNQSKTIK 680
              +Q+ R L Y+H      I H DIKPQN+LLD D    ++ DFG AK L   + +   
Sbjct: 126 LYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNV 180

Query: 681 TAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-----YAILT 735
           + I           F  +  T+ +DV+S G +L E++  +  F  + G +       +L 
Sbjct: 181 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLG 240

Query: 736 DWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSI---------WCIQEDPSLRPTMK 786
               +  R  ++N    E K          K+                ++  P+ R T  
Sbjct: 241 TPTREQIR--EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 298

Query: 787 KVLQ 790
           +   
Sbjct: 299 EACA 302

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 7e-36
 Identities = 57/272 (20%), Positives = 98/272 (36%), Gaps = 29/272 (10%)

Query: 521 NNFK--EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKNEVFVIGQT 575
           N+F   + +G+G+FG V     + + +    A+K L +     +D       E  V+  T
Sbjct: 5   NDFDYLKLLGKGTFGKVILV--REKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62

Query: 576 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLH 635
            H  L  L            V E+ N G L   L                +I   L    
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSAL---E 119

Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
                 +++ DIK +N++LD     +I+DFGL K    + +        GT  Y+APE  
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEVL 177

Query: 696 RNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDK 755
            ++     VD +  GV++ E++  R  F  +  E         F+     ++        
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-------LFELILMEEIRFPRTLSP 230

Query: 756 EAMNDIECLGKLVMVSIWCIQEDPSLRPTMKK 787
           EA + +             +++DP  R     
Sbjct: 231 EAKSLLA----------GLLKKDPKQRLGGGP 252

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  131 bits (329), Expect = 7e-34
 Identities = 59/280 (21%), Positives = 111/280 (39%), Gaps = 37/280 (13%)

Query: 521 NNFK--EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGERE---FKNEVFVIGQT 575
           + F   + +G GSFG V     + + S    A+K LD+      ++     NE  ++   
Sbjct: 41  DQFDRIKTLGTGSFGRVMLV--KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98

Query: 576 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLH 635
           +   LV+L     +  N  +V E++  G + S L    + +       A QI     YLH
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158

Query: 636 EDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWF 695
                 +I+ D+KP+N+L+D     +++DFG AK     + K     + GT   +APE  
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEII 210

Query: 696 RNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDK 755
            +      VD ++ GVL+ E+ +    F  +   +        ++   +GK+        
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-------IYEKIVSGKVRFPSHFSS 263

Query: 756 EAMNDIECLGKLVMVSIWCIQEDP-----SLRPTMKKVLQ 790
           +  + +             +Q D      +L+  +  +  
Sbjct: 264 DLKDLLR----------NLLQVDLTKRFGNLKNGVNDIKN 293

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 2e-33
 Identities = 75/334 (22%), Positives = 128/334 (38%), Gaps = 47/334 (14%)

Query: 511 FSYKELEGATNNFK------EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE-- 562
           F  +E+       +      + VG G++G V   V     +   VA+KKL R FQ     
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAV--DGRTGAKVAIKKLYRPFQSELFA 61

Query: 563 REFKNEVFVIGQTHHKNLVRLLGFCDEGQNR------LLVYEFLNNGTLASFLFGNLKPN 616
           +    E+ ++    H+N++ LL      +         LV  F+  GT    L  + K  
Sbjct: 62  KRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLG 119

Query: 617 WNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS 676
            +    + +Q+ +GL Y+H       IH D+KP N+ +++    +I DFGLA+     Q+
Sbjct: 120 EDRIQFLVYQMLKGLRYIHAAGI---IHRDLKPGNLAVNEDCELKILDFGLAR-----QA 171

Query: 677 KTIKTAIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILT 735
            +  T    T+ Y APE   N  + T  VD++S G ++ E+I+ +  F     +    L 
Sbjct: 172 DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS--DHLDQLK 229

Query: 736 DWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSI----------------WCIQEDP 779
           +            V   +  EA N ++ L +L                       +  D 
Sbjct: 230 EIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDA 289

Query: 780 SLRPTMKKVLQM--LEGVVEVSVPPNPYPFSSSM 811
             R T  + L     E + +    P    +  S 
Sbjct: 290 EQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSF 323

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 3e-32
 Identities = 59/277 (21%), Positives = 101/277 (36%), Gaps = 27/277 (9%)

Query: 521 NNFK--EEVGRGSFGIVYKGV-IQTRTSTTAVAVKKLDRVF----QDGEREFKNEVFVIG 573
            NF+  + +G G++G V+    I    +    A+K L +             + E  V+ 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 574 Q-THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLL 632
                  LV L           L+ +++N G L + L    +   +       +I   L 
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE 143

Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 692
           +LH+     II+ DIK +NILLD      ++DFGL+K               GT  Y+AP
Sbjct: 144 HLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV-ADETERAYDFCGTIEYMAP 199

Query: 693 EWFR--NSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVL 750
           +  R  +S     VD +S GVL+ E+++    F ++  +                +    
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN---SQAEISRRILKSEPPYP 256

Query: 751 VGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKK 787
                 A + I+            + +DP  R     
Sbjct: 257 QEMSALAKDLIQ----------RLLMKDPKKRLGCGP 283

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (313), Expect = 1e-31
 Identities = 69/328 (21%), Positives = 122/328 (37%), Gaps = 56/328 (17%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE--REFKNEVFVIGQTHHKNLVR 582
           + +G G+ GIV             VA+KKL R FQ+    +    E+ ++   +HKN++ 
Sbjct: 23  KPIGSGAQGIVCAA--YDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 80

Query: 583 LLGFC------DEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHE 636
           LL         +E Q+  LV E ++            + +    + + +Q+  G+ +LH 
Sbjct: 81  LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHS 137

Query: 637 DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFR 696
                 IH D+KP NI++    T +I DFGLA+      +  + T    T+ Y APE   
Sbjct: 138 AGI---IHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVIL 191

Query: 697 NSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKE 756
                  VD++S G ++ E++  +  F    G +Y    +   +         +      
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHKILF---PGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248

Query: 757 AMNDIECLGKLVMVSI----------------------------WCIQEDPSLRPTMKKV 788
             N +E   K   ++                               +  DP+ R ++   
Sbjct: 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308

Query: 789 LQ-----MLEGVVEVSVPPNPYPFSSSM 811
           LQ     +     EV  PP P  +   +
Sbjct: 309 LQHPYINVWYDPAEVEAPP-PQIYDKQL 335

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  121 bits (305), Expect = 7e-31
 Identities = 52/298 (17%), Positives = 115/298 (38%), Gaps = 42/298 (14%)

Query: 521 NNFK--EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQ-THH 577
           ++++   ++GRG +  V++ +    T+   V VK L  V    +++ K E+ ++      
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAI--NITNNEKVVVKILKPVK---KKKIKREIKILENLRGG 89

Query: 578 KNLVRLLGFCDEGQNRL--LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLH 635
            N++ L     +  +R   LV+E +NN                      ++I + L Y H
Sbjct: 90  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCH 146

Query: 636 EDCRAQIIHCDIKPQNILLD-DYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE- 693
                 I+H D+KP N+++D ++   R+ D+GLA+     Q   ++     ++ +  PE 
Sbjct: 147 SMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV---ASRYFKGPEL 200

Query: 694 WFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL-------TDWAFDCYRNGK 746
                     +D++S G +L  +I  ++ F         ++       T+  +D      
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260

Query: 747 LNVLVG-EDKEAMNDIECLGKLVMVSIW-------------CIQEDPSLRPTMKKVLQ 790
           + +     D    +  +   + V                   ++ D   R T ++ ++
Sbjct: 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (298), Expect = 8e-30
 Identities = 74/333 (22%), Positives = 123/333 (36%), Gaps = 45/333 (13%)

Query: 511 FSYKELEGA----TNNFK--EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGE-- 562
           F  +EL          ++    VG G++G V      T+T    VAVKKL R FQ     
Sbjct: 4   FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAA-FDTKTGLR-VAVKKLSRPFQSIIHA 61

Query: 563 REFKNEVFVIGQTHHKNLVRLLGFCDEGQ-----NRLLVYEFLNNGTLASFLFGNLKPNW 617
           +    E+ ++    H+N++ LL      +     N + +   L    L + +    K   
Sbjct: 62  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTD 120

Query: 618 NLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSK 677
           +    + +QI RGL Y+H       IH D+KP N+ +++    +I DFGLA       + 
Sbjct: 121 DHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLA-----RHTD 172

Query: 678 TIKTAIRGTKGYVAPEWFRNSK-ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD 736
              T    T+ Y APE   N       VD++S G ++ E+++ R  F     +    L  
Sbjct: 173 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT--DHIDQLKL 230

Query: 737 WAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSI----------------WCIQEDPS 780
                   G   +     + A N I+ L ++  ++                   +  D  
Sbjct: 231 ILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSD 290

Query: 781 LRPTMKKVLQM--LEGVVEVSVPPNPYPFSSSM 811
            R T  + L         +    P   P+  S 
Sbjct: 291 KRITAAQALAHAYFAQYHDPDDEPVADPYDQSF 323

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  110 bits (275), Expect = 9e-27
 Identities = 55/316 (17%), Positives = 104/316 (32%), Gaps = 53/316 (16%)

Query: 523 FKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVR 582
              ++G G F  V+    +   + T VA+K +       E   ++E+ ++ + +  +  +
Sbjct: 17  LVRKLGWGHFSTVWLA--KDMVNNTHVAMKIVRGDKVYTEA-AEDEIKLLQRVNDADNTK 73

Query: 583 LLGFCDEGQNRLLVY----------------EFLNNGTLASFLFGNLKPNWNLRTNIAFQ 626
                     +LL +                    N       + +          I+ Q
Sbjct: 74  EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133

Query: 627 IARGLLYLHEDCRAQIIHCDIKPQNILLD-DYYTARISDFGLAKLLTLNQSKTIKTAIRG 685
           +  GL Y+H   R  IIH DIKP+N+L++       +    +A L          T    
Sbjct: 134 LLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191

Query: 686 TKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-----------AIL 734
           T+ Y +PE    +      D++S   L+ E+I+    F+ + G  Y            +L
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELL 251

Query: 735 TDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSI--------------------WC 774
            +      RNGK        +  + +I  L    +  +                      
Sbjct: 252 GELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPM 311

Query: 775 IQEDPSLRPTMKKVLQ 790
           +Q DP  R     ++ 
Sbjct: 312 LQLDPRKRADAGGLVN 327

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 86.0 bits (212), Expect = 8e-20
 Identities = 28/203 (13%), Positives = 55/203 (27%), Gaps = 29/203 (14%)

Query: 525 EEVGRGSFGIVYKGVIQTRTSTTAVAVK----------KLDRVFQDGEREFKNEVFVIGQ 574
           + +G G    V+              VK          K+      G+  F        +
Sbjct: 6   KLMGEGKESAVFNC---YSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 62

Query: 575 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN--IAFQIARGLL 632
              + L +L G           Y +  N  L   +         +     +   I   + 
Sbjct: 63  NEFRALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVA 117

Query: 633 YLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 692
             +      I+H D+   N+L+ +     I DF  +  +     + I             
Sbjct: 118 KFYHRG---IVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWREILE----RDVRNII 169

Query: 693 EWFRNSKITAKVDVYSFGVLLLE 715
            +F       + D+ S    +L+
Sbjct: 170 TYFSR-TYRTEKDINSAIDRILQ 191

>d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

 Score = 54.2 bits (130), Expect = 1e-09
 Identities = 23/129 (17%), Positives = 41/129 (31%), Gaps = 27/129 (20%)

Query: 72  SIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLTADQGLVLNDPQGKQVWSSKIDIGTVA 131
           SI Y+          T +  Q        ++ +  D  LVL D   +   ++    GT  
Sbjct: 11  SILYSTQGNDNHPQ-TLHATQ-SLQLSPYRLSMETDCNLVLFDRDDRVWSTNTAGKGTGC 68

Query: 132 VGHMNDTGNFVLASSSSGRLWDSFSNPTDTLLLGQMMETEQGLFSRKSENNFSRGRFQFR 191
              +   G   + ++ +  +W S +                         + S GR+ F 
Sbjct: 69  RAVLQPNGRMDVLTNQNIAVWTSGN-------------------------SRSAGRYVFV 103

Query: 192 LLEDGNLVL 200
           L  D NL +
Sbjct: 104 LQPDRNLAI 112

>d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

 Score = 37.2 bits (86), Expect = 0.001
 Identities = 26/145 (17%), Positives = 44/145 (30%), Gaps = 37/145 (25%)

Query: 135 MNDTGNFVLASSSSGRLWDSFSNPTDTLLLGQMMETEQGLFSRKSENNFSRGRFQFRLLE 194
           + + GN +L S+          N   TL   Q               +     ++  +  
Sbjct: 5   VANNGNSILYSTQGND------NHPQTLHATQ---------------SLQLSPYRLSMET 43

Query: 195 DGNLVLNIANLATGFAYDAYYTSGTYDPANSSNSGYRVMFNESGYMYILRRNGGR-FDLT 253
           D NLVL   +       D  +++ T        +G R +   +G M +L       +   
Sbjct: 44  DCNLVLFDRD-------DRVWSTNTA----GKGTGCRAVLQPNGRMDVLTNQNIAVWTSG 92

Query: 254 TERVVPAADFYYRATLNFDGVFAQY 278
             R    +   Y   L  D   A Y
Sbjct: 93  NSR----SAGRYVFVLQPDRNLAIY 113

>d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Garlic (Allium sativum) [TaxId: 4682]

 Score = 53.0 bits (127), Expect = 3e-09
 Identities = 27/126 (21%), Positives = 46/126 (36%), Gaps = 25/126 (19%)

Query: 33  GATLTAGTSSSPWLSPSGDFAFGFHQLDEENNTNDLFLLSIFYNKIPEKTVVWYTDNKDQ 92
           G  L AG S          + F            +L L    Y+     T VW ++    
Sbjct: 7   GEGLYAGQSLD-----VEPYHFIM------QEDCNLVL----YDH---STSVWASNT--- 45

Query: 93  NPAVPRGSQVKLTADQGLVLNDPQGKQVWSSKIDIGT-VAVGHMNDTGNFVLASSSSGRL 151
                +G +  L +D   V+ D +G+ +W+S    G    V  + + GN V+  S    +
Sbjct: 46  GILGKKGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGSD---I 102

Query: 152 WDSFSN 157
           W + + 
Sbjct: 103 WSTGTY 108

>d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

 Score = 47.6 bits (113), Expect = 3e-07
 Identities = 25/151 (16%), Positives = 45/151 (29%), Gaps = 39/151 (25%)

Query: 72  SIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLTADQGLVLNDPQGKQVWSSKIDIGTVA 131
           +I +    E +    T +  Q        +  + +D  LVL D    +VW+S     T  
Sbjct: 2   NILFGLSHEGSHPQ-TLHAAQ-SLELSSFRFTMQSDCNLVLFDS-DVRVWASNTAGATGC 58

Query: 132 VGHMNDTGNFVLASSSSGRLWDSFSNPTDTLLLGQMMETEQGLFSRKSENNFSRGRFQFR 191
              +   G  V+ ++ +   W S +                           S G +   
Sbjct: 59  RAVLQSDGLLVILTAQNTIRWSSGT-------------------------KGSIGNYVLV 93

Query: 192 LLEDGNLVLNIANLATGFAYD-AYYTSGTYD 221
           L  D  + +          Y    + SGT +
Sbjct: 94  LQPDRTVTI----------YGPGLWDSGTSN 114

>d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Gastrodianin (antifungal protein)
species: Gastrodia elata [TaxId: 91201]

 Score = 43.2 bits (101), Expect = 9e-06
 Identities = 21/132 (15%), Positives = 41/132 (31%), Gaps = 22/132 (16%)

Query: 29  TVPVGATLTAGTSSSPWLSPSGDFAFGFHQLDEENNTNDLFLLSIFYNKIPEKTVVWYTD 88
            +  G  L  G S +      G + F       + N        + Y+       VW + 
Sbjct: 3   RLNSGHQLDTGGSLA-----EGGYLFII---QNDCNL-------VLYDN---NRAVWASG 44

Query: 89  NKDQNPAVPRGSQVKLTADQGLVLNDPQGKQVWSSKIDIGTVAVGHMNDTGNFVLASSSS 148
              +      G  +K+  D  LV+         S+           +    N V+  +S+
Sbjct: 45  TNGKA----SGCVLKMQNDGNLVIYSGSRAIWASNTNRQNGNYYLILQRDRNVVIYDNSN 100

Query: 149 GRLWDSFSNPTD 160
             +W + +N  +
Sbjct: 101 NAIWATHTNVGN 112

>d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Gastrodianin (antifungal protein)
species: Gastrodia elata [TaxId: 91201]

 Score = 42.5 bits (99), Expect = 2e-05
 Identities = 26/141 (18%), Positives = 41/141 (29%), Gaps = 30/141 (21%)

Query: 159 TDTLLLGQMMETEQGLFSRKSENNFSRGRFQFRLLEDGNLVLNIANLATGFAYDAYYTSG 218
           +D L  G  ++T   L           G + F +  D NLVL            A + SG
Sbjct: 1   SDRLNSGHQLDTGGSLAE---------GGYLFIIQNDCNLVLY-------DNNRAVWASG 44

Query: 219 TYDPANSSNSGYRVMFNESGYMYILRRNGGRFDLTTERVVPAADFYYRATLNFDGVFAQY 278
           T        SG  +     G + I   +               +  Y   L  D     Y
Sbjct: 45  TNGK----ASGCVLKMQNDGNLVIYSGSRA----IWASNTNRQNGNYYLILQRDRNVVIY 96

Query: 279 FYPKNGNGNWSVAWSEPENIC 299
                 + + +  W+   N+ 
Sbjct: 97  ------DNSNNAIWATHTNVG 111

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	814
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.82
d1xd5a_	112	Gastrodianin (antifungal protein) {Gastrodia elata	99.81
d1kj1a_	109	Lectin (agglutinin) {Garlic (Allium sativum) [TaxI	99.8
d1jpca_	108	Lectin (agglutinin) {Snowdrop (Galanthus nivalis)	99.79
d1dlpa2	120	Fetuin-binding protein Scafet precursor {Bluebell	99.71
d1dlpa1	115	Fetuin-binding protein Scafet precursor {Bluebell	99.63
d1b2pa_	119	Lectin (agglutinin) {Bluebell (Scilla campanulata)	99.54
d1dlpa1	115	Fetuin-binding protein Scafet precursor {Bluebell	99.32
d1b2pa_	119	Lectin (agglutinin) {Bluebell (Scilla campanulata)	99.15
d1jpca_	108	Lectin (agglutinin) {Snowdrop (Galanthus nivalis)	99.12
d1kj1a_	109	Lectin (agglutinin) {Garlic (Allium sativum) [TaxI	99.1
d1dlpa2	120	Fetuin-binding protein Scafet precursor {Bluebell	98.96
d1xd5a_	112	Gastrodianin (antifungal protein) {Gastrodia elata	98.87
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.07
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.38
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.35
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.03
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	95.6
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	91.3
d1emoa2	39	Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	89.62
d2vj3a1	42	Neurogenic locus notch homolog protein 1, Notch1 {	80.49

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.9e-48  Score=411.56  Aligned_cols=269  Identities=25%  Similarity=0.441  Sum_probs=205.7

Q ss_pred             ccCHHHHHHhhhc-----------cccceeeeeeeeEEEEEEecCC-CceEEEEEEecccc-ccchHhHHHHHHhhhccC
Q 041921          510 CFSYKELEGATNN-----------FKEEVGRGSFGIVYKGVIQTRT-STTAVAVKKLDRVF-QDGEREFKNEVFVIGQTH  576 (814)
Q Consensus       510 ~~~~~~l~~~~~~-----------~~~~LG~G~~g~Vy~~~~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~  576 (814)
                      .++|+++..++.+           +.++||+|+||+||+|.+...+ ....||||++.... ....++|.+|+.++++++
T Consensus         6 ~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~   85 (299)
T d1jpaa_           6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD   85 (299)
T ss_dssp             GGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC
T ss_pred             CCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCC
Confidence            3455555555544           4467999999999999986433 34579999986533 334567999999999999


Q ss_pred             CCCccceeeeecccccceEEEecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc
Q 041921          577 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLD  655 (814)
Q Consensus       577 h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~  655 (814)
                      |||||++++++.+++..++||||+++|+|.+++... ..+++..+..++.|||+||+|||+.   +|+||||||+||||+
T Consensus        86 HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~  162 (299)
T d1jpaa_          86 HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVN  162 (299)
T ss_dssp             CTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC
T ss_pred             CCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEEC
Confidence            999999999999999999999999999999988774 5789999999999999999999998   999999999999999


Q ss_pred             CCCcEEEeecCCccccccCCcccc---cccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhh
Q 041921          656 DYYTARISDFGLAKLLTLNQSKTI---KTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEY  731 (814)
Q Consensus       656 ~~~~~kl~DfGla~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~  731 (814)
                      .++.+||+|||+++.+........   .....||+.|||||.+.+..++.++|||||||++|||+| |+.||......+ 
T Consensus       163 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~-  241 (299)
T d1jpaa_         163 SNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD-  241 (299)
T ss_dssp             TTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-
T ss_pred             CCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH-
Confidence            999999999999987765432211   122457899999999999999999999999999999998 899997543322 


Q ss_pred             hhHHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 041921          732 AILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE  797 (814)
Q Consensus       732 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~  797 (814)
                            +...+..+..         .+.+.+.+..+.+++.+||+.||++||||.+|++.|+.++.
T Consensus       242 ------~~~~i~~~~~---------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~  292 (299)
T d1jpaa_         242 ------VINAIEQDYR---------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR  292 (299)
T ss_dssp             ------HHHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ------HHHHHHcCCC---------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence                  1122222211         11123355778899999999999999999999999988654

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-48  Score=404.67  Aligned_cols=254  Identities=28%  Similarity=0.447  Sum_probs=199.2

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEec
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  599 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  599 (814)
                      .+.+.++||+|+||+||+|.+.   ++..||||+++.. ....++|.+|++++++++|||||+++|+|.+++..++||||
T Consensus         6 ~~~~~~~iG~G~fg~Vy~~~~~---~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~   81 (263)
T d1sm2a_           6 ELTFVQEIGSGQFGLVHLGYWL---NKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF   81 (263)
T ss_dssp             CEEEEEEEECCSSCCEEEEEET---TTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HcEEEEEEeeCCCeEEEEEEEC---CCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence            4567889999999999999986   4668999999754 34567899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccc
Q 041921          600 LNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT  678 (814)
Q Consensus       600 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  678 (814)
                      +++|+|.+++... ..+++..+..++.|||+||+|||+.   +|+||||||+||||+.++.+||+|||+++.........
T Consensus        82 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~  158 (263)
T d1sm2a_          82 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS  158 (263)
T ss_dssp             CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred             cCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence            9999999998765 6688999999999999999999998   99999999999999999999999999998765443222


Q ss_pred             ccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCC-CCcccchhhhhHHHHHHHHhhcCccceeecCcccc
Q 041921          679 IKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKS-FDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEA  757 (814)
Q Consensus       679 ~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  757 (814)
                      . ....||..|+|||.+.+..++.++|||||||++|||+|+..| +......+       +.+.+..+..  .       
T Consensus       159 ~-~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~-------~~~~i~~~~~--~-------  221 (263)
T d1sm2a_         159 S-TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-------VVEDISTGFR--L-------  221 (263)
T ss_dssp             -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH-------HHHHHHHTCC--C-------
T ss_pred             e-cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHH-------HHHHHHhcCC--C-------
Confidence            1 345689999999999999999999999999999999995444 44322211       1122222211  0       


Q ss_pred             cCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 041921          758 MNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE  797 (814)
Q Consensus       758 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~  797 (814)
                      ..+...+.++.+++.+||+.||++||||++|++.|+++++
T Consensus       222 ~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         222 YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence            0112234678899999999999999999999999988653

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-48  Score=404.28  Aligned_cols=260  Identities=28%  Similarity=0.410  Sum_probs=203.4

Q ss_pred             HhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccc--cccchHhHHHHHHhhhccCCCCccceeeeecccccceE
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV--FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL  595 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  595 (814)
                      ...+.+.++||+|+||+||+|+++     ..||||+++..  ..+..++|.+|+.++++++|||||++++++.+ ...+|
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~-----~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~l   80 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH-----GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAI   80 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS-----SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC-----CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEE
Confidence            445677899999999999999853     25999998643  33445689999999999999999999999865 56899


Q ss_pred             EEecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccC
Q 041921          596 VYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN  674 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~  674 (814)
                      ||||+++|+|.++|... ..+++..+..|+.||++||+|||+.   +|+||||||+||||+.++.+||+|||+++.....
T Consensus        81 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~  157 (276)
T d1uwha_          81 VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW  157 (276)
T ss_dssp             EEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred             EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence            99999999999999754 6689999999999999999999998   9999999999999999999999999999877654


Q ss_pred             CcccccccccCCCCccccccccc---CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceee
Q 041921          675 QSKTIKTAIRGTKGYVAPEWFRN---SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLV  751 (814)
Q Consensus       675 ~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  751 (814)
                      ..........||+.|||||++..   ..++.++|||||||++|||+||+.||........      +...+..+...   
T Consensus       158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~------~~~~~~~~~~~---  228 (276)
T d1uwha_         158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ------IIFMVGRGYLS---  228 (276)
T ss_dssp             --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH------HHHHHHHTSCC---
T ss_pred             CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH------HHHHHhcCCCC---
Confidence            43333355679999999999864   3578999999999999999999999975433221      11112222111   


Q ss_pred             cCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 041921          752 GEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE  797 (814)
Q Consensus       752 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~  797 (814)
                       +.. .......+.++.+++.+||+.||.+||||++|++.|+.+..
T Consensus       229 -p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~  272 (276)
T d1uwha_         229 -PDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR  272 (276)
T ss_dssp             -CCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -Ccc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence             000 01122345678899999999999999999999999987653

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-48  Score=402.30  Aligned_cols=256  Identities=30%  Similarity=0.457  Sum_probs=208.4

Q ss_pred             HHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceE
Q 041921          516 LEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL  595 (814)
Q Consensus       516 l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  595 (814)
                      +....+.+.++||+|+||.||+|.++   ++..||||+++.. ....++|.+|+.++++++|||||++++++.+ +..+|
T Consensus        10 i~~~~~~~~~~iG~G~fg~Vy~~~~~---~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~i   84 (272)
T d1qpca_          10 VPRETLKLVERLGAGQFGEVWMGYYN---GHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI   84 (272)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEET---TTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             cCHHHeEEeEEEecCCCcEEEEEEEC---CCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEE
Confidence            33456778899999999999999976   4678999999754 3456789999999999999999999998865 56799


Q ss_pred             EEecCCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcccccc
Q 041921          596 VYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTL  673 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~  673 (814)
                      ||||+++|+|.+++...  ..+++..+++|+.||++||.|||+.   +|+||||||+||||++++.+||+|||+++.+..
T Consensus        85 v~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~  161 (272)
T d1qpca_          85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIED  161 (272)
T ss_dssp             EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccC
Confidence            99999999999988654  4689999999999999999999998   999999999999999999999999999998764


Q ss_pred             CCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecC
Q 041921          674 NQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGE  753 (814)
Q Consensus       674 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  753 (814)
                      ..... .....||+.|||||.+.+..++.++|||||||++|||+||..|+........      +.+.+..+...     
T Consensus       162 ~~~~~-~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~------~~~~i~~~~~~-----  229 (272)
T d1qpca_         162 NEYTA-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE------VIQNLERGYRM-----  229 (272)
T ss_dssp             SCEEC-CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------HHHHHHTTCCC-----
T ss_pred             Ccccc-ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH------HHHHHHhcCCC-----
Confidence            43222 2445689999999999999999999999999999999997665543322111      11222222110     


Q ss_pred             cccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 041921          754 DKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV  795 (814)
Q Consensus       754 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~  795 (814)
                          ..+...++++.+++.+||+.||++||||++|+++|+.+
T Consensus       230 ----~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~  267 (272)
T d1qpca_         230 ----VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (272)
T ss_dssp             ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence                11123446788999999999999999999999999864

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.3e-48  Score=406.24  Aligned_cols=261  Identities=28%  Similarity=0.421  Sum_probs=215.6

Q ss_pred             HHHHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccce
Q 041921          515 ELEGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRL  594 (814)
Q Consensus       515 ~l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  594 (814)
                      |+....+.+.++||+|+||+||+|.+..  .++.||||+++.. ....++|.+|+.++++++|||||++++++.+++..+
T Consensus        13 ei~~~~~~~~~~iG~G~fg~Vy~a~~~~--~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (287)
T d1opja_          13 EMERTDITMKHKLGGGQYGEVYEGVWKK--YSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY   89 (287)
T ss_dssp             BCCGGGEEEEEETTTTTTSSEEEEEEGG--GTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             EecHHHeEEeeEEeeCCCeEEEEEEECC--CCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeE
Confidence            4555677888999999999999999863  5789999999754 345678999999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccc
Q 041921          595 LVYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLT  672 (814)
Q Consensus       595 lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~  672 (814)
                      |||||+++|+|.+++...  ..+++..+..|+.||++||+|||++   +|+||||||+||||+.++.+||+|||+++...
T Consensus        90 iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~  166 (287)
T d1opja_          90 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT  166 (287)
T ss_dssp             EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred             EEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecC
Confidence            999999999999999653  6789999999999999999999998   99999999999999999999999999999776


Q ss_pred             cCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeec
Q 041921          673 LNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVG  752 (814)
Q Consensus       673 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  752 (814)
                      ...... .....|++.|+|||++.+..++.++|||||||++|||++|..|+.......  .    +.+.+..+..     
T Consensus       167 ~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~--~----~~~~i~~~~~-----  234 (287)
T d1opja_         167 GDTYTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--Q----VYELLEKDYR-----  234 (287)
T ss_dssp             SSSSEE-ETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--H----HHHHHHTTCC-----
T ss_pred             CCCcee-eccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH--H----HHHHHhcCCC-----
Confidence            543322 234558899999999999999999999999999999999877764332221  1    1222222211     


Q ss_pred             CcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 041921          753 EDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE  797 (814)
Q Consensus       753 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~  797 (814)
                          ...+...+.++.+++.+||+.||.+||||++|++.|+.+.+
T Consensus       235 ----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         235 ----MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             ----CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                11122345678999999999999999999999999988654

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-47  Score=399.58  Aligned_cols=250  Identities=30%  Similarity=0.413  Sum_probs=205.7

Q ss_pred             cceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEecCCC
Q 041921          525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN  602 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  602 (814)
                      ++||+|+||+||+|.++....++.||||+++...  ....++|.+|+.++++++|||||+++++|.+ +..+|||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            4699999999999998766667899999996432  2334679999999999999999999999864 567899999999


Q ss_pred             CCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccc-ccc
Q 041921          603 GTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT-IKT  681 (814)
Q Consensus       603 gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~-~~~  681 (814)
                      |+|.+++.....+++..+..|+.||++||+|||+.   +|+||||||+||||+.++.+||+|||+++.+....... ...
T Consensus        92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~  168 (277)
T d1xbba_          92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT  168 (277)
T ss_dssp             EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred             CcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccccccc
Confidence            99999999888999999999999999999999998   99999999999999999999999999998776443322 223


Q ss_pred             cccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccCc
Q 041921          682 AIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMND  760 (814)
Q Consensus       682 ~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  760 (814)
                      ...||+.|||||.+.+..++.++|||||||++|||+| |+.||......+       +...+..+...         +.+
T Consensus       169 ~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~-------~~~~i~~~~~~---------~~p  232 (277)
T d1xbba_         169 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGERM---------GCP  232 (277)
T ss_dssp             --CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCCC---------CCC
T ss_pred             ccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH-------HHHHHHcCCCC---------CCC
Confidence            4568999999999999999999999999999999998 899997543322       12223333211         112


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 041921          761 IECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEG  794 (814)
Q Consensus       761 ~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~  794 (814)
                      ...+.++.+++.+||+.||++||||++|+++|+.
T Consensus       233 ~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~  266 (277)
T d1xbba_         233 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  266 (277)
T ss_dssp             TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             cccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence            2345678899999999999999999999998875

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-47  Score=397.00  Aligned_cols=252  Identities=27%  Similarity=0.377  Sum_probs=205.2

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEe
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE  598 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  598 (814)
                      .|.+.++||+|+||+||+|+...  +++.||||++.... .+..+++.+|++++++++|||||++++++.+++..+||||
T Consensus         6 dy~~~~~lG~G~fg~V~~~~~~~--~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           6 DWDLVQTLGEGAYGEVQLAVNRV--TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ceEEEEEEecCcCeEEEEEEECC--CCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            46778899999999999999753  57899999986432 2334579999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccc
Q 041921          599 FLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT  678 (814)
Q Consensus       599 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  678 (814)
                      |+++|+|.++|.....+++.....++.||++||+|||+.   +|+||||||+|||+++++.+||+|||+++.+.......
T Consensus        84 y~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~  160 (271)
T d1nvra_          84 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  160 (271)
T ss_dssp             CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             ccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence            999999999999888899999999999999999999998   99999999999999999999999999999876544433


Q ss_pred             ccccccCCCCcccccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccc
Q 041921          679 IKTAIRGTKGYVAPEWFRNSKI-TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEA  757 (814)
Q Consensus       679 ~~~~~~gt~~y~aPE~~~~~~~-s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  757 (814)
                      .....+||+.|||||++.+..+ +.++|||||||++|||++|+.||..........      .........        .
T Consensus       161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~------~~~~~~~~~--------~  226 (271)
T d1nvra_         161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY------SDWKEKKTY--------L  226 (271)
T ss_dssp             CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH------HHHHTTCTT--------S
T ss_pred             cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHH------HHHhcCCCC--------C
Confidence            3355779999999999988876 578999999999999999999997543322111      111111110        0


Q ss_pred             cCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          758 MNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       758 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      ........++.+++.+||+.||++|||++|+++
T Consensus       227 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         227 NPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            011123467788999999999999999999865

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-47  Score=398.25  Aligned_cols=255  Identities=29%  Similarity=0.429  Sum_probs=207.8

Q ss_pred             hcccc-ceeeeeeeeEEEEEEecCCCceEEEEEEeccccc-cchHhHHHHHHhhhccCCCCccceeeeecccccceEEEe
Q 041921          521 NNFKE-EVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE  598 (814)
Q Consensus       521 ~~~~~-~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  598 (814)
                      ..+.+ +||+|+||+||+|.+...+.+..||||.++.... ...++|.+|++++++++|||||++++++.+ +..+||||
T Consensus        10 ~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE   88 (285)
T d1u59a_          10 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVME   88 (285)
T ss_dssp             EEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred             eEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEE
Confidence            34556 5999999999999987666677899999975433 335679999999999999999999999864 56899999


Q ss_pred             cCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcc
Q 041921          599 FLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSK  677 (814)
Q Consensus       599 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  677 (814)
                      |+++|+|.+++... ..+++..+..++.||++||+|||+.   +|+||||||+||||+.++.+||+|||+++.+......
T Consensus        89 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~  165 (285)
T d1u59a_          89 MAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY  165 (285)
T ss_dssp             CCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE
T ss_pred             eCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcccccccc
Confidence            99999999998654 6789999999999999999999998   9999999999999999999999999999987654322


Q ss_pred             -cccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcc
Q 041921          678 -TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDK  755 (814)
Q Consensus       678 -~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  755 (814)
                       .......||+.|+|||.+.+..++.++|||||||++|||+| |+.||......+       +...+.++....      
T Consensus       166 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~-------~~~~i~~~~~~~------  232 (285)
T d1u59a_         166 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQGKRME------  232 (285)
T ss_dssp             ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH-------HHHHHHTTCCCC------
T ss_pred             cccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCCC------
Confidence             22234568999999999999999999999999999999998 899997544322       122333332111      


Q ss_pred             cccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 041921          756 EAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV  795 (814)
Q Consensus       756 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~  795 (814)
                         .+...+.++.+++.+||+.||++||||.+|++.|+.+
T Consensus       233 ---~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~  269 (285)
T d1u59a_         233 ---CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  269 (285)
T ss_dssp             ---CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence               1223456788999999999999999999999998753

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-47  Score=390.39  Aligned_cols=245  Identities=26%  Similarity=0.382  Sum_probs=207.6

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccc---cccchHhHHHHHHhhhccCCCCccceeeeecccccceEE
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV---FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV  596 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  596 (814)
                      .|.+.+.||+|+||+||+|....  +++.||||.+...   .....+.+.+|+.++++++|||||++++++.+++..++|
T Consensus         7 dy~i~~~iG~G~fg~Vy~~~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv   84 (263)
T d2j4za1           7 DFEIGRPLGKGKFGNVYLAREKQ--SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   84 (263)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HeEEEEEEecCCCcEEEEEEECC--CCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence            46788999999999999999753  5789999998642   233456789999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCc
Q 041921          597 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS  676 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  676 (814)
                      |||+++|+|.+++.....+++.....++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++.......
T Consensus        85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~  161 (263)
T d2j4za1          85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR  161 (263)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCC
T ss_pred             EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCCcc
Confidence            99999999999998888899999999999999999999998   999999999999999999999999999986653321


Q ss_pred             ccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCccc
Q 041921          677 KTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKE  756 (814)
Q Consensus       677 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  756 (814)
                          ....||+.|||||++.+..++.++|||||||++|||++|+.||......+       ....+..+....       
T Consensus       162 ----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-------~~~~i~~~~~~~-------  223 (263)
T d2j4za1         162 ----TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-------TYKRISRVEFTF-------  223 (263)
T ss_dssp             ----EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHTTCCCC-------
T ss_pred             ----cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCCCC-------
Confidence                34579999999999999999999999999999999999999997543322       122222322211       


Q ss_pred             ccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          757 AMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       757 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                         +...++++.+++.+||+.||.+|||++|+++
T Consensus       224 ---p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         224 ---PDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             ---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---CccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence               1123467889999999999999999999986

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-47  Score=389.68  Aligned_cols=251  Identities=26%  Similarity=0.411  Sum_probs=211.2

Q ss_pred             hccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEecC
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL  600 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  600 (814)
                      +.+.++||+|+||+||+|+++   ++..||||+++.. ....++|.+|+.++++++||||++++|++.+++..++||||+
T Consensus         6 ~~~~~~iG~G~fg~Vy~~~~~---~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~   81 (258)
T d1k2pa_           6 LTFLKELGTGQFGVVKYGKWR---GQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM   81 (258)
T ss_dssp             CCCCCCCCEETTEEEEEEEET---TTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred             CEEeEEEecCCCeEEEEEEEC---CCCEEEEEEECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence            457889999999999999985   5778999999764 345678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcccc
Q 041921          601 NNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI  679 (814)
Q Consensus       601 ~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  679 (814)
                      ++|+|..++... ..+++..+.+++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++.+....... 
T Consensus        82 ~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~-  157 (258)
T d1k2pa_          82 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS-  157 (258)
T ss_dssp             TTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC-
T ss_pred             CCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCcee-
Confidence            999999997654 6788999999999999999999998   99999999999999999999999999998766543322 


Q ss_pred             cccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeecCccccc
Q 041921          680 KTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAM  758 (814)
Q Consensus       680 ~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  758 (814)
                      .....||+.|+|||.+.+..++.++||||||+++|||+| |+.||......+       +...+.++..  +.       
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~-------~~~~i~~~~~--~~-------  221 (258)
T d1k2pa_         158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-------TAEHIAQGLR--LY-------  221 (258)
T ss_dssp             CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-------HHHHHHTTCC--CC-------
T ss_pred             ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH-------HHHHHHhCCC--CC-------
Confidence            244668999999999999999999999999999999998 899997654332       1222333211  11       


Q ss_pred             CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 041921          759 NDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV  795 (814)
Q Consensus       759 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~  795 (814)
                      .+...++++.+++.+||+.||++|||++++++.|.++
T Consensus       222 ~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             CcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence            1122346788999999999999999999999998654

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-47  Score=396.96  Aligned_cols=263  Identities=27%  Similarity=0.407  Sum_probs=207.8

Q ss_pred             HhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEE
Q 041921          518 GATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY  597 (814)
Q Consensus       518 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  597 (814)
                      ...+.+.+.||+|+||.||+|.+.   ++..||||+++.. ....++|.+|+.++++++|||||++++++.+ +..++||
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~---~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~   90 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWN---GTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT   90 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET---TTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEEC---CCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEE
Confidence            456888999999999999999986   3567999999754 4456789999999999999999999999854 5689999


Q ss_pred             ecCCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCC
Q 041921          598 EFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ  675 (814)
Q Consensus       598 e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~  675 (814)
                      ||+++|+|..++...  ..++|..++.|+.||++||+|||+.   +|+||||||+||||+.++.+||+|||+++......
T Consensus        91 Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~  167 (285)
T d1fmka3          91 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  167 (285)
T ss_dssp             CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred             EecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence            999999999998753  5689999999999999999999998   99999999999999999999999999998775443


Q ss_pred             cccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcc
Q 041921          676 SKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDK  755 (814)
Q Consensus       676 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  755 (814)
                      .... ....||+.|+|||.+..+.++.++||||||+++|||++|..|+........      +...+..+..        
T Consensus       168 ~~~~-~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~------~~~~i~~~~~--------  232 (285)
T d1fmka3         168 YTAR-QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE------VLDQVERGYR--------  232 (285)
T ss_dssp             ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------HHHHHHTTCC--------
T ss_pred             ceee-ccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH------HHHHHHhcCC--------
Confidence            3222 445689999999999999999999999999999999997666543322211      1122222211        


Q ss_pred             cccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCCCCCCC
Q 041921          756 EAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSVPPNP  804 (814)
Q Consensus       756 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~~~~p~~p  804 (814)
                       .+.+...++++.+++.+||+.||++||||++|+++|+.......|+.+
T Consensus       233 -~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~~  280 (285)
T d1fmka3         233 -MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQ  280 (285)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCC
T ss_pred             -CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCCCC
Confidence             011223456788999999999999999999999999987766655543

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-47  Score=398.99  Aligned_cols=262  Identities=24%  Similarity=0.445  Sum_probs=203.8

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCC--CceEEEEEEeccccc-cchHhHHHHHHhhhccCCCCccceeeeecccccceE
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRT--STTAVAVKKLDRVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL  595 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~--~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  595 (814)
                      ..+.+.++||+|+||.||+|.+...+  ....||||+++.... ....+|.+|+.++++++|||||+++|++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            34556788999999999999987533  235799999965433 334579999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccC
Q 041921          596 VYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN  674 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~  674 (814)
                      ||||+.+++|.+++... ..+++..+..++.||+.||+|||+.   +|+||||||+||||+.++.+||+|||+++.+...
T Consensus        87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  163 (283)
T d1mqba_          87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  163 (283)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence            99999999999988654 6799999999999999999999998   9999999999999999999999999999877544


Q ss_pred             Cccc-ccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecC
Q 041921          675 QSKT-IKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGE  753 (814)
Q Consensus       675 ~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  753 (814)
                      .... ......||+.|||||++.+..++.++|||||||++|||+++..|+........      +.+.+.++..      
T Consensus       164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~------~~~~i~~~~~------  231 (283)
T d1mqba_         164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE------VMKAINDGFR------  231 (283)
T ss_dssp             ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHTTCC------
T ss_pred             CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH------HHHHHhccCC------
Confidence            3221 22345689999999999999999999999999999999997666543332211      1222333211      


Q ss_pred             cccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 041921          754 DKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV  798 (814)
Q Consensus       754 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~~  798 (814)
                         .+.+...+.++.+++.+||+.||++||||.+|+++|+.+.+.
T Consensus       232 ---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         232 ---LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             ---CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             ---CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence               111223456789999999999999999999999999887653

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-47  Score=405.92  Aligned_cols=260  Identities=24%  Similarity=0.360  Sum_probs=210.5

Q ss_pred             HHHhhhccccceeeeeeeeEEEEEEecCC---CceEEEEEEeccc-cccchHhHHHHHHhhhcc-CCCCccceeeeeccc
Q 041921          516 LEGATNNFKEEVGRGSFGIVYKGVIQTRT---STTAVAVKKLDRV-FQDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEG  590 (814)
Q Consensus       516 l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~---~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  590 (814)
                      +....+.+.++||+|+||+||+|+.....   ....||||.+... .......+.+|+.++.++ +|||||++++++.+.
T Consensus        34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~  113 (325)
T d1rjba_          34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS  113 (325)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence            44456778899999999999999986422   2357999998643 334456799999999998 899999999999999


Q ss_pred             ccceEEEecCCCCCHHHHhcCC-----------------------CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCC
Q 041921          591 QNRLLVYEFLNNGTLASFLFGN-----------------------LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDI  647 (814)
Q Consensus       591 ~~~~lv~e~~~~gsL~~~l~~~-----------------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dl  647 (814)
                      +..+|||||+++|+|.++|...                       ..+++..++.++.||++||+|||+.   +|+||||
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDl  190 (325)
T d1rjba_         114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDL  190 (325)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTC
T ss_pred             CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccC
Confidence            9999999999999999999754                       2478899999999999999999998   9999999


Q ss_pred             CCCcEEEcCCCcEEEeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 041921          648 KPQNILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIE  726 (814)
Q Consensus       648 kp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~  726 (814)
                      ||+|||++.++.+||+|||+|+...............||+.|||||.+.+..++.++|||||||++|||+| |+.||...
T Consensus       191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~  270 (325)
T d1rjba_         191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI  270 (325)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999987765544433345668999999999999999999999999999999998 89999754


Q ss_pred             cchhhhhHHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 041921          727 MGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLE  793 (814)
Q Consensus       727 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~  793 (814)
                      .....      +.+.+..+..         .+.+...++++.+|+.+||+.||++||||+||+++|.
T Consensus       271 ~~~~~------~~~~~~~~~~---------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         271 PVDAN------FYKLIQNGFK---------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             CCSHH------HHHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CHHHH------HHHHHhcCCC---------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            33221      1122222210         1112234567899999999999999999999999985

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-46  Score=392.49  Aligned_cols=249  Identities=25%  Similarity=0.358  Sum_probs=208.0

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEec
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  599 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  599 (814)
                      .|.+.++||+|+||+||+|...  .+++.||||+++.......+.+.+|+.++++++|||||++++++.+++..+|||||
T Consensus        21 ~Y~~~~~iG~G~fg~Vy~a~~~--~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy   98 (293)
T d1yhwa1          21 KYTRFEKIGQGASGTVYTAMDV--ATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (293)
T ss_dssp             TBCSCEECCCSSSCEEEEEEBT--TTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             ccEEEEEEecCcCcEEEEEEEC--CCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence            4677789999999999999864  35789999999765555667899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcccc
Q 041921          600 LNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI  679 (814)
Q Consensus       600 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  679 (814)
                      +++|+|.+++.. ..+++.....++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.+......  
T Consensus        99 ~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~--  172 (293)
T d1yhwa1          99 LAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--  172 (293)
T ss_dssp             CTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC--
T ss_pred             cCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecccccc--
Confidence            999999998865 4689999999999999999999998   9999999999999999999999999999877543322  


Q ss_pred             cccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcccccC
Q 041921          680 KTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKEAMN  759 (814)
Q Consensus       680 ~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  759 (814)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||........      .......+...        ...
T Consensus       173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~------~~~~~~~~~~~--------~~~  238 (293)
T d1yhwa1         173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATNGTPE--------LQN  238 (293)
T ss_dssp             BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHHCSCC--------CSS
T ss_pred             ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH------HHHHHhCCCCC--------CCC
Confidence            2456799999999999999999999999999999999999999975433221      11111222111        111


Q ss_pred             cHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          760 DIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       760 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      +......+.+++.+||+.||.+|||++|+++
T Consensus       239 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            2234567889999999999999999999975

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-46  Score=387.54  Aligned_cols=247  Identities=28%  Similarity=0.428  Sum_probs=198.4

Q ss_pred             ccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeecc----cccceE
Q 041921          522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDE----GQNRLL  595 (814)
Q Consensus       522 ~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~l  595 (814)
                      .|.++||+|+||+||+|...  .++..||+|++....  ....+.|.+|++++++++|||||++++++.+    ....+|
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~--~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i   89 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDT--ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL   89 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEET--TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEEC--CCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence            56788999999999999975  357799999986532  2334568999999999999999999999864    345789


Q ss_pred             EEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc-CCCcEEEeecCCccccccC
Q 041921          596 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLD-DYYTARISDFGLAKLLTLN  674 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~-~~~~~kl~DfGla~~~~~~  674 (814)
                      ||||+++|+|.+++.....+++..+..++.||++||+|||++ ..+|+||||||+|||++ +++.+||+|||+++.....
T Consensus        90 vmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~  168 (270)
T d1t4ha_          90 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS  168 (270)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred             EEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC
Confidence            999999999999998888899999999999999999999997 12399999999999997 5789999999999865432


Q ss_pred             CcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCc
Q 041921          675 QSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGED  754 (814)
Q Consensus       675 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  754 (814)
                      ..    ....||+.|||||++.+ +++.++|||||||++|||++|+.||........      +.+.+..+.....    
T Consensus       169 ~~----~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~------~~~~i~~~~~~~~----  233 (270)
T d1t4ha_         169 FA----KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ------IYRRVTSGVKPAS----  233 (270)
T ss_dssp             SB----EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH------HHHHHTTTCCCGG----
T ss_pred             cc----CCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH------HHHHHHcCCCCcc----
Confidence            22    34679999999999875 599999999999999999999999964432211      1222322211110    


Q ss_pred             ccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          755 KEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       755 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                          .+.....++.+++.+||+.||++|||++|+++
T Consensus       234 ----~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         234 ----FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             ----GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ----cCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence                11122346789999999999999999999976

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-46  Score=391.87  Aligned_cols=250  Identities=22%  Similarity=0.288  Sum_probs=206.7

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEec
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  599 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  599 (814)
                      .|.+.++||+|+||+||+|....  ++..||||+++.......+.+.+|++++++++|||||++++++.+++..+|||||
T Consensus        13 ~Y~i~~~iG~G~fg~Vy~~~~~~--~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy   90 (288)
T d2jfla1          13 FWEIIGELGDGAFGKVYKAQNKE--TSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   90 (288)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             CeEEeEEEeeCCCcEEEEEEECC--CCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence            36677899999999999999753  5788999999876666677899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCccc
Q 041921          600 LNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKT  678 (814)
Q Consensus       600 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  678 (814)
                      +++|+|.+++.+ ...+++..+..++.||++||.|||++   +|+||||||+|||++.++.+||+|||+++.......  
T Consensus        91 ~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~--  165 (288)
T d2jfla1          91 CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--  165 (288)
T ss_dssp             CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH--
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCcc--
Confidence            999999999765 46689999999999999999999998   999999999999999999999999999976543211  


Q ss_pred             ccccccCCCCcccccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecC
Q 041921          679 IKTAIRGTKGYVAPEWFR-----NSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGE  753 (814)
Q Consensus       679 ~~~~~~gt~~y~aPE~~~-----~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  753 (814)
                      ......||+.|||||++.     ...++.++|||||||++|||++|+.||......+.       ...+..+....    
T Consensus       166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~-------~~~i~~~~~~~----  234 (288)
T d2jfla1         166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV-------LLKIAKSEPPT----  234 (288)
T ss_dssp             HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH-------HHHHHHSCCCC----
T ss_pred             cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH-------HHHHHcCCCCC----
Confidence            113467999999999984     45688999999999999999999999976543321       11111221111    


Q ss_pred             cccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          754 DKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       754 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                         ...+...+.++.+++.+||+.||.+|||++|+++
T Consensus       235 ---~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         235 ---LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             ---CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---CCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               1112234567889999999999999999999976

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-46  Score=388.41  Aligned_cols=251  Identities=24%  Similarity=0.336  Sum_probs=193.3

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeecc--cccceE
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDE--GQNRLL  595 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l  595 (814)
                      .|++.+.||+|+||+||+|....  +++.||||.+....  ....+.+.+|++++++++|||||++++++.+  ++..+|
T Consensus         5 dy~~~~~iG~G~fg~Vy~~~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           5 DYEVLYTIGTGSYGRCQKIRRKS--DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             hCEEeEEEecCCCeEEEEEEECC--CCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            46778999999999999999753  57899999986532  2334568999999999999999999998865  456789


Q ss_pred             EEecCCCCCHHHHhcC----CCCCChhhHHHHHHHHHHHHHHhhhcC--CCCeeecCCCCCcEEEcCCCcEEEeecCCcc
Q 041921          596 VYEFLNNGTLASFLFG----NLKPNWNLRTNIAFQIARGLLYLHEDC--RAQIIHCDIKPQNILLDDYYTARISDFGLAK  669 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~~l~yLH~~~--~~~i~H~dlkp~NIll~~~~~~kl~DfGla~  669 (814)
                      ||||+++|+|.+++..    ...+++..++.++.||+.||.|||+..  ..+|+||||||+|||++.++.+||+|||+++
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence            9999999999999863    467899999999999999999999862  1249999999999999999999999999998


Q ss_pred             ccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccce
Q 041921          670 LLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNV  749 (814)
Q Consensus       670 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  749 (814)
                      .+......  .....||+.|||||++.+..++.++|||||||++|||+||+.||......+       +...+.++....
T Consensus       163 ~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~-------~~~~i~~~~~~~  233 (269)
T d2java1         163 ILNHDTSF--AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-------LAGKIREGKFRR  233 (269)
T ss_dssp             HC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHHTCCCC
T ss_pred             ecccCCCc--cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH-------HHHHHHcCCCCC
Confidence            87543322  244679999999999999999999999999999999999999997543322       122233333221


Q ss_pred             eecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          750 LVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       750 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      +         +...++++.+++.+||+.||.+|||++|+++
T Consensus       234 ~---------~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         234 I---------PYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             C---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             C---------CcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            1         1123467889999999999999999999875

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-46  Score=391.35  Aligned_cols=248  Identities=21%  Similarity=0.277  Sum_probs=205.0

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccc---cccchHhHHHHHHhhhccCCCCccceeeeecccccceEE
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV---FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV  596 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  596 (814)
                      .|.+.+.||+|+||+||+|....  +++.||||.+...   .....+.+.+|++++++++||||+++++++.+++..+||
T Consensus         9 dy~i~~~lG~G~fg~Vy~a~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv   86 (288)
T d1uu3a_           9 DFKFGKILGEGSFSTVVLARELA--TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG   86 (288)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETT--TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred             CCEEEEEEeeCCCeEEEEEEECC--CCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence            47788999999999999999753  5788999998642   233446799999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCc
Q 041921          597 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS  676 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  676 (814)
                      |||+++|+|.+++.....+++.....++.|++.||+|||+.   +|+||||||+|||+++++.+||+|||+++.+.....
T Consensus        87 mEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~  163 (288)
T d1uu3a_          87 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  163 (288)
T ss_dssp             ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             EEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence            99999999999999888899999999999999999999998   999999999999999999999999999998765443


Q ss_pred             ccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCccc
Q 041921          677 KTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKE  756 (814)
Q Consensus       677 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  756 (814)
                      ........||+.|||||++.+..++.++|||||||++|||++|+.||......+       +...+..+....       
T Consensus       164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-------~~~~i~~~~~~~-------  229 (288)
T d1uu3a_         164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-------IFQKIIKLEYDF-------  229 (288)
T ss_dssp             ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHTTCCCC-------
T ss_pred             ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH-------HHHHHHcCCCCC-------
Confidence            333345679999999999999999999999999999999999999997543322       122222332211       


Q ss_pred             ccCcHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 041921          757 AMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVL  789 (814)
Q Consensus       757 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl  789 (814)
                         +.....++.+++.+||+.||++|||++|++
T Consensus       230 ---p~~~s~~~~~li~~~L~~dP~~R~t~~e~~  259 (288)
T d1uu3a_         230 ---PEKFFPKARDLVEKLLVLDATKRLGCEEME  259 (288)
T ss_dssp             ---CTTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred             ---CccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence               112346788999999999999999999863

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-46  Score=399.61  Aligned_cols=265  Identities=20%  Similarity=0.315  Sum_probs=205.8

Q ss_pred             HHhhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccceeeeecccccceE
Q 041921          517 EGATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL  595 (814)
Q Consensus       517 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  595 (814)
                      ....|.+.++||+|+||+||+|...  .++..||||+++... ....+++.+|+.++++++|||||++++++.++++.+|
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~--~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~i   81 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHK--PSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   81 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEET--TTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEEC--CCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            3455677889999999999999975  367899999996532 3334678999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccC
Q 041921          596 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHE-DCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN  674 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~  674 (814)
                      ||||+++|+|.+++.....+++..+..++.|++.||.|||+ +   +|+||||||+|||++.++.+||+|||+|+.....
T Consensus        82 VmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  158 (322)
T d1s9ja_          82 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  158 (322)
T ss_dssp             EEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred             EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence            99999999999999888889999999999999999999997 5   7999999999999999999999999999876432


Q ss_pred             CcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHH-HHHHHhh--------cC
Q 041921          675 QSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD-WAFDCYR--------NG  745 (814)
Q Consensus       675 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~-~~~~~~~--------~~  745 (814)
                      ..    ...+||+.|+|||++.+..++.++||||+||++|||++|+.||......+...... .......        .+
T Consensus       159 ~~----~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (322)
T d1s9ja_         159 MA----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  234 (322)
T ss_dssp             TC-------CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred             cc----ccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence            21    34679999999999999999999999999999999999999997654322111000 0000000        00


Q ss_pred             -cc-----------------ceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          746 -KL-----------------NVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       746 -~~-----------------~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                       ..                 ..................++.+++.+||+.||.+|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence             00                 0000000000001112457889999999999999999999986

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.7e-46  Score=391.93  Aligned_cols=260  Identities=25%  Similarity=0.412  Sum_probs=212.1

Q ss_pred             hhhccccceeeeeeeeEEEEEEec---CCCceEEEEEEecccccc-chHhHHHHHHhhhccCCCCccceeeeecccccce
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQT---RTSTTAVAVKKLDRVFQD-GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRL  594 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~---~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  594 (814)
                      ..+.+.++||+|+||+||+|+...   ..++..||||+++..... ..++|.+|++++++++||||+++++++.+.+..+
T Consensus        13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~   92 (301)
T d1lufa_          13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC   92 (301)
T ss_dssp             GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred             HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceE
Confidence            346678899999999999999863   235678999999754333 3457999999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHhcCC------------------------CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCC
Q 041921          595 LVYEFLNNGTLASFLFGN------------------------LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQ  650 (814)
Q Consensus       595 lv~e~~~~gsL~~~l~~~------------------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~  650 (814)
                      +||||+++|+|.++|...                        ..+++..++.|+.|++.||+|||+.   +|+||||||+
T Consensus        93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp~  169 (301)
T d1lufa_          93 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATR  169 (301)
T ss_dssp             EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred             EEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEccc
Confidence            999999999999999642                        2378889999999999999999998   9999999999


Q ss_pred             cEEEcCCCcEEEeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCC-CCCCcccch
Q 041921          651 NILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCR-KSFDIEMGE  729 (814)
Q Consensus       651 NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~-~p~~~~~~~  729 (814)
                      ||||+.++.+||+|||+++.+.........+...||+.|+|||.+.+..++.++|||||||++|||++|. .||......
T Consensus       170 NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~  249 (301)
T d1lufa_         170 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE  249 (301)
T ss_dssp             GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred             ceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHH
Confidence            9999999999999999998776554443334567899999999999999999999999999999999986 466543322


Q ss_pred             hhhhHHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 041921          730 EYAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE  797 (814)
Q Consensus       730 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~  797 (814)
                      +       +...+.++.....         +...+.++.+|+.+||+.+|++||||.+|+++|+++.+
T Consensus       250 e-------~~~~v~~~~~~~~---------p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~  301 (301)
T d1lufa_         250 E-------VIYYVRDGNILAC---------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  301 (301)
T ss_dssp             H-------HHHHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             H-------HHHHHHcCCCCCC---------CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            2       1223334432211         12234678899999999999999999999999998764

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4e-45  Score=386.83  Aligned_cols=251  Identities=24%  Similarity=0.345  Sum_probs=193.0

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc-ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEE
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY  597 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  597 (814)
                      ..|.+.+.||+|+||+||+|...  .+++.||||.+.... ......+.+|+.++++++|||||++++++.+++..+|||
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~--~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm   86 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDK--RTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM   86 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEET--TTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeeccCeEEEEEEEC--CCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            45788899999999999999865  357889999996432 233456889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc---CCCcEEEeecCCccccccC
Q 041921          598 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLD---DYYTARISDFGLAKLLTLN  674 (814)
Q Consensus       598 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~---~~~~~kl~DfGla~~~~~~  674 (814)
                      ||+++|+|.++|.....+++.....++.||+.||+|||+.   +|+||||||+|||+.   +++.+||+|||+++.....
T Consensus        87 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~  163 (307)
T d1a06a_          87 QLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG  163 (307)
T ss_dssp             CCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred             eccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence            9999999999999888999999999999999999999998   999999999999995   5789999999999876543


Q ss_pred             CcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCc
Q 041921          675 QSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGED  754 (814)
Q Consensus       675 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  754 (814)
                      ...   ....||+.|||||++.+..++.++|||||||++|||++|+.||......+       ....+..+....     
T Consensus       164 ~~~---~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-------~~~~i~~~~~~~-----  228 (307)
T d1a06a_         164 SVL---STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK-------LFEQILKAEYEF-----  228 (307)
T ss_dssp             ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHTTCCCC-----
T ss_pred             Cee---eeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH-------HHHHHhccCCCC-----
Confidence            221   34579999999999999999999999999999999999999997543322       112222222111     


Q ss_pred             ccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          755 KEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       755 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                       ..+.....++++.+++.+||+.||.+|||++|+++
T Consensus       229 -~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         229 -DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             -CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             -CCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence             11111234467889999999999999999999988

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.6e-45  Score=388.30  Aligned_cols=246  Identities=23%  Similarity=0.290  Sum_probs=202.9

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc---cchHhHHHHHHhhhccCCCCccceeeeecccccceE
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ---DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL  595 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  595 (814)
                      ..+...++||+|+||+||+|...  .++..||||+++....   ...+.+.+|+.++++++|||||++++++.+++..+|
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i   92 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDV--RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL   92 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEET--TTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEEC--CCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEE
Confidence            34666789999999999999865  3578999999865432   223468999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCC
Q 041921          596 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ  675 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~  675 (814)
                      ||||+++|+|..++.....+++..+..++.||+.||.|||++   +|+||||||+||||+.++.+||+|||+++..... 
T Consensus        93 v~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~-  168 (309)
T d1u5ra_          93 VMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-  168 (309)
T ss_dssp             EEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred             EEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCCC-
Confidence            999999999988888788899999999999999999999998   9999999999999999999999999999865432 


Q ss_pred             cccccccccCCCCccccccccc---CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeec
Q 041921          676 SKTIKTAIRGTKGYVAPEWFRN---SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVG  752 (814)
Q Consensus       676 ~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  752 (814)
                           ....||+.|||||++.+   ..++.++|||||||++|||++|+.||......+.      ..... .+....+  
T Consensus       169 -----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~------~~~i~-~~~~~~~--  234 (309)
T d1u5ra_         169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIA-QNESPAL--  234 (309)
T ss_dssp             -----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHH-HSCCCCC--
T ss_pred             -----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH------HHHHH-hCCCCCC--
Confidence                 33569999999999864   4689999999999999999999999975433211      11111 1111111  


Q ss_pred             CcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          753 EDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       753 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                            .....++.+.+++.+||+.||.+|||++|+++
T Consensus       235 ------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         235 ------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             ------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ------CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence                  11223467889999999999999999999976

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-45  Score=385.00  Aligned_cols=259  Identities=24%  Similarity=0.368  Sum_probs=200.6

Q ss_pred             HHhhhccccceeeeeeeeEEEEEEecCC-CceEEEEEEecccccc-chHhHHHHHHhhhccCCCCccceeeeecccccce
Q 041921          517 EGATNNFKEEVGRGSFGIVYKGVIQTRT-STTAVAVKKLDRVFQD-GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRL  594 (814)
Q Consensus       517 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~-~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  594 (814)
                      ....+.+.+.||+|+||.||+|.+...+ .+..||||.++..... ..+.|.+|+.++++++|||||++++++. ++..+
T Consensus         5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~   83 (273)
T d1mp8a_           5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW   83 (273)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred             CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEE
Confidence            3456788899999999999999876432 3568999999754333 3456999999999999999999999996 46789


Q ss_pred             EEEecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcccccc
Q 041921          595 LVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTL  673 (814)
Q Consensus       595 lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~  673 (814)
                      +||||+++|+|.+++... ..+++..++.++.||++||.|||+.   +|+||||||+||+++.++.+||+|||+++.+..
T Consensus        84 iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~  160 (273)
T d1mp8a_          84 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  160 (273)
T ss_dssp             EEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             EEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccC
Confidence            999999999999987654 5789999999999999999999998   999999999999999999999999999987654


Q ss_pred             CCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeec
Q 041921          674 NQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVG  752 (814)
Q Consensus       674 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  752 (814)
                      ..... .....||+.|+|||.+.+..++.++|||||||++|||++ |..||......+.       ...+.++....   
T Consensus       161 ~~~~~-~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~-------~~~i~~~~~~~---  229 (273)
T d1mp8a_         161 STYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV-------IGRIENGERLP---  229 (273)
T ss_dssp             -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-------HHHHHTTCCCC---
T ss_pred             Cccee-ccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHH-------HHHHHcCCCCC---
Confidence            33222 244568999999999999999999999999999999998 8888875544321       12223332111   


Q ss_pred             CcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 041921          753 EDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV  796 (814)
Q Consensus       753 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~  796 (814)
                            .+...+.++.+++.+||+.||.+|||+++|++.|+.++
T Consensus       230 ------~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~  267 (273)
T d1mp8a_         230 ------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  267 (273)
T ss_dssp             ------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ------CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence                  12234567889999999999999999999999998764

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-45  Score=381.44  Aligned_cols=248  Identities=27%  Similarity=0.404  Sum_probs=197.4

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecc-cccceEEE
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDE-GQNRLLVY  597 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~  597 (814)
                      ..+.+.+.||+|+||.||+|.+.    +..||||+++.  ....++|.+|++++++++||||++++|+|.+ .+..++||
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~----~~~vAvK~i~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~   80 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR----GNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT   80 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET----TEEEEEEECCC--CC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC----CeEEEEEEECc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEE
Confidence            34567889999999999999974    56899999965  3445789999999999999999999999865 45689999


Q ss_pred             ecCCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCC
Q 041921          598 EFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ  675 (814)
Q Consensus       598 e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~  675 (814)
                      ||+++|+|.++|...  ..+++..+++|+.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        81 ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~  157 (262)
T d1byga_          81 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ  157 (262)
T ss_dssp             CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred             eccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCCC
Confidence            999999999999754  3589999999999999999999998   99999999999999999999999999998654332


Q ss_pred             cccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeecCc
Q 041921          676 SKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGED  754 (814)
Q Consensus       676 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  754 (814)
                           ....+|..|+|||++.+..++.++||||||+++|||+| |+.|+......+   +    ...+.++....     
T Consensus       158 -----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~----~~~i~~~~~~~-----  220 (262)
T d1byga_         158 -----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---V----VPRVEKGYKMD-----  220 (262)
T ss_dssp             ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---H----HHHHTTTCCCC-----
T ss_pred             -----ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---H----HHHHHcCCCCC-----
Confidence                 23458899999999999999999999999999999998 677776543322   1    12222221111     


Q ss_pred             ccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 041921          755 KEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV  796 (814)
Q Consensus       755 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~  796 (814)
                          .+...+.++.+++.+||+.||.+||||.+++++|+.+.
T Consensus       221 ----~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~  258 (262)
T d1byga_         221 ----APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  258 (262)
T ss_dssp             ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----CCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence                12233467889999999999999999999999998764

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.8e-44  Score=388.50  Aligned_cols=251  Identities=23%  Similarity=0.327  Sum_probs=208.5

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEec
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  599 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  599 (814)
                      .|.+.++||+|+||.||+|...  ..+..||||++........+.+.+|+.++++++|||||++++++.+++..+|||||
T Consensus        27 ~Y~i~~~lG~G~fg~Vy~~~~~--~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          27 HYDIHEELGTGAFGVVHRVTER--ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             TEEEEEEEEEETTEEEEEEEET--TTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             CeEEEEEEecCcCeEEEEEEEC--CCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            5788899999999999999975  36789999999765555567799999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc--CCCcEEEeecCCccccccCCc
Q 041921          600 LNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLD--DYYTARISDFGLAKLLTLNQS  676 (814)
Q Consensus       600 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~--~~~~~kl~DfGla~~~~~~~~  676 (814)
                      +++|+|.+++.. ...+++..+..|+.||+.||.|||+.   +|+||||||+|||++  .++.+||+|||+++.+.....
T Consensus       105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~  181 (350)
T d1koaa2         105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS  181 (350)
T ss_dssp             CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC
T ss_pred             CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecccccc
Confidence            999999999964 46799999999999999999999998   999999999999996  467899999999987764432


Q ss_pred             ccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCccc
Q 041921          677 KTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKE  756 (814)
Q Consensus       677 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  756 (814)
                      .   ....||+.|||||++.+..++.++|||||||++|||++|+.||......+.       ...+..+.....      
T Consensus       182 ~---~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-------~~~i~~~~~~~~------  245 (350)
T d1koaa2         182 V---KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET-------LRNVKSCDWNMD------  245 (350)
T ss_dssp             E---EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHTCCCSC------
T ss_pred             c---ceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHH-------HHHHHhCCCCCC------
Confidence            2   446799999999999999999999999999999999999999975533221       122222221110      


Q ss_pred             ccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          757 AMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       757 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                      ........+.+.+++.+||+.||++|||++|+++.
T Consensus       246 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         246 DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00111234678899999999999999999999873

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-45  Score=386.51  Aligned_cols=261  Identities=26%  Similarity=0.452  Sum_probs=207.5

Q ss_pred             hhccccceeeeeeeeEEEEEEecCC-CceEEEEEEeccc-cccchHhHHHHHHhhhccCCCCccceeeeecc-cccceEE
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRT-STTAVAVKKLDRV-FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDE-GQNRLLV  596 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv  596 (814)
                      +.+|.++||+|+||+||+|++...+ ....||||+++.. .....++|.+|++++++++||||++++|++.+ +...++|
T Consensus        28 ~~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv  107 (311)
T d1r0pa_          28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  107 (311)
T ss_dssp             EEEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred             eeccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence            4456789999999999999986533 3457999999753 33344679999999999999999999999875 4578999


Q ss_pred             EecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCC
Q 041921          597 YEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ  675 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~  675 (814)
                      |||+++|+|.+++... ..+++..+++++.|+++||.|||+.   +|+||||||+||||++++.+||+|||+++......
T Consensus       108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~  184 (311)
T d1r0pa_         108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  184 (311)
T ss_dssp             EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred             EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence            9999999999998865 5677889999999999999999998   99999999999999999999999999999776543


Q ss_pred             ccc--ccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecC
Q 041921          676 SKT--IKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGE  753 (814)
Q Consensus       676 ~~~--~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  753 (814)
                      ...  ......||+.|+|||.+.+..++.++||||||+++|||+||+.||.......  .+    ...+..+...  .. 
T Consensus       185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~----~~~i~~g~~~--~~-  255 (311)
T d1r0pa_         185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DI----TVYLLQGRRL--LQ-  255 (311)
T ss_dssp             CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------C----HHHHHTTCCC--CC-
T ss_pred             cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HH----HHHHHcCCCC--CC-
Confidence            221  2234568999999999999999999999999999999999888876433211  11    1122222211  11 


Q ss_pred             cccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 041921          754 DKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV  798 (814)
Q Consensus       754 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~~  798 (814)
                            +...+.++.+++.+||+.||++||||.||++.|+.+..-
T Consensus       256 ------p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         256 ------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             ------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             ------cccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence                  112346788999999999999999999999999887543

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-45  Score=386.28  Aligned_cols=259  Identities=29%  Similarity=0.454  Sum_probs=208.2

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccc-cccchHhHHHHHHhhhcc-CCCCccceeeeecccccceEE
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV-FQDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRLLV  596 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  596 (814)
                      ..+.+.++||+|+||.||+|++...+....||||+++.. .....++|.+|+++++++ +|||||++++++.+++..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            345677899999999999999986555568999998653 333456799999999998 799999999999999999999


Q ss_pred             EecCCCCCHHHHhcCC----------------CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcE
Q 041921          597 YEFLNNGTLASFLFGN----------------LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTA  660 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~  660 (814)
                      |||+++|+|.++|+..                ..+++..+.+++.|||+||.|||+.   +|+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence            9999999999999654                5689999999999999999999998   99999999999999999999


Q ss_pred             EEeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCC-CCCcccchhhhhHHHHHH
Q 041921          661 RISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRK-SFDIEMGEEYAILTDWAF  739 (814)
Q Consensus       661 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~-p~~~~~~~~~~~~~~~~~  739 (814)
                      ||+|||+++........   ....||..|+|||.+....++.++|||||||++|||++|.. ||......+       +.
T Consensus       167 kl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~-------~~  236 (309)
T d1fvra_         167 KIADFGLSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LY  236 (309)
T ss_dssp             EECCTTCEESSCEECCC-------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HH
T ss_pred             EEccccccccccccccc---cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH-------HH
Confidence            99999999865543222   23458999999999999999999999999999999999765 564332221       12


Q ss_pred             HHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCC
Q 041921          740 DCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS  799 (814)
Q Consensus       740 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~~~  799 (814)
                      ..+.++..       +  ..+...++++.+++.+||+.||++||||++|++.|+++.+-.
T Consensus       237 ~~i~~~~~-------~--~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~  287 (309)
T d1fvra_         237 EKLPQGYR-------L--EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  287 (309)
T ss_dssp             HHGGGTCC-------C--CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             HHHHhcCC-------C--CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence            22222211       1  112234568899999999999999999999999998876543

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-45  Score=387.79  Aligned_cols=255  Identities=24%  Similarity=0.395  Sum_probs=202.7

Q ss_pred             hccccceeeeeeeeEEEEEEecCCC--ceEEEEEEeccc-cccchHhHHHHHHhhhccCCCCccceeeeecccccceEEE
Q 041921          521 NNFKEEVGRGSFGIVYKGVIQTRTS--TTAVAVKKLDRV-FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY  597 (814)
Q Consensus       521 ~~~~~~LG~G~~g~Vy~~~~~~~~~--~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  597 (814)
                      +++.++||+|+||+||+|.+...+.  ...||||+++.. ..+..++|.+|+.++++++|||||+++++|.++ ..++++
T Consensus        11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~   89 (317)
T d1xkka_          11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT   89 (317)
T ss_dssp             EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEE
T ss_pred             CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEE
Confidence            6677899999999999999764322  237999998653 344567899999999999999999999999764 567889


Q ss_pred             ecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCc
Q 041921          598 EFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS  676 (814)
Q Consensus       598 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  676 (814)
                      ||+.+++|.+++... ..+++..+++++.|||+||+|||++   +|+||||||+||||+.++.+||+|||+++.+.....
T Consensus        90 e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~  166 (317)
T d1xkka_          90 QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK  166 (317)
T ss_dssp             ECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC
T ss_pred             EeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceecccccc
Confidence            999999999888754 6789999999999999999999998   999999999999999999999999999998765544


Q ss_pred             ccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcc
Q 041921          677 KTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDK  755 (814)
Q Consensus       677 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  755 (814)
                      ........||+.|+|||.+.++.++.++|||||||++|||+| |..||......+.       ...+..+..       +
T Consensus       167 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~-------~~~i~~~~~-------~  232 (317)
T d1xkka_         167 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-------SSILEKGER-------L  232 (317)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGH-------HHHHHHTCC-------C
T ss_pred             cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHH-------HHHHHcCCC-------C
Confidence            433344568999999999999999999999999999999999 7888875443321       112222211       0


Q ss_pred             cccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 041921          756 EAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV  795 (814)
Q Consensus       756 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~  795 (814)
                        +.+...+.++.+++.+||+.||.+|||+.+|++.|+.+
T Consensus       233 --~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~  270 (317)
T d1xkka_         233 --PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  270 (317)
T ss_dssp             --CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence              11223456788999999999999999999999988764

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-45  Score=387.80  Aligned_cols=264  Identities=27%  Similarity=0.371  Sum_probs=202.2

Q ss_pred             HHHhhhccccceeeeeeeeEEEEEEecC---CCceEEEEEEecccc-ccchHhHHHHHHhhhcc-CCCCccceeeeeccc
Q 041921          516 LEGATNNFKEEVGRGSFGIVYKGVIQTR---TSTTAVAVKKLDRVF-QDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEG  590 (814)
Q Consensus       516 l~~~~~~~~~~LG~G~~g~Vy~~~~~~~---~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  590 (814)
                      +....+.+.++||+|+||.||+|.....   ..++.||||+++... ....+++..|...+.++ +|+||+.+++++.+.
T Consensus        10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~   89 (299)
T d1ywna1          10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP   89 (299)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred             ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence            3345678889999999999999997643   245789999997533 23345688888888777 789999999998664


Q ss_pred             -ccceEEEecCCCCCHHHHhcCC----------------CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEE
Q 041921          591 -QNRLLVYEFLNNGTLASFLFGN----------------LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNIL  653 (814)
Q Consensus       591 -~~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIl  653 (814)
                       ...++||||+++|+|.++|...                ..+++..+..++.||++||+|||+.   +|+||||||+|||
T Consensus        90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NIL  166 (299)
T d1ywna1          90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNIL  166 (299)
T ss_dssp             TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEE
T ss_pred             CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCcccee
Confidence             4689999999999999999643                2478999999999999999999998   9999999999999


Q ss_pred             EcCCCcEEEeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCC-CCCCcccchhhh
Q 041921          654 LDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCR-KSFDIEMGEEYA  732 (814)
Q Consensus       654 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~-~p~~~~~~~~~~  732 (814)
                      |+.++.+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||+||. .||......+  
T Consensus       167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~--  244 (299)
T d1ywna1         167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--  244 (299)
T ss_dssp             ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH--
T ss_pred             ECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH--
Confidence            9999999999999998766554443335567999999999999999999999999999999999975 5675433222  


Q ss_pred             hHHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 041921          733 ILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE  797 (814)
Q Consensus       733 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~  797 (814)
                          .+...+.++....         .+...+.++.+++.+||+.||++||||+|+++.|+++++
T Consensus       245 ----~~~~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq  296 (299)
T d1ywna1         245 ----EFCRRLKEGTRMR---------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  296 (299)
T ss_dssp             ----HHHHHHHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----HHHHHHhcCCCCC---------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence                1122223322111         111234678899999999999999999999999987653

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-44  Score=378.42  Aligned_cols=251  Identities=25%  Similarity=0.323  Sum_probs=207.2

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc------cchHhHHHHHHhhhccCCCCccceeeeeccccc
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ------DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQN  592 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  592 (814)
                      ..|.+.++||+|+||+||+|...  .+++.||||.++....      ...+.+.+|+.++++++|||||++++++.+++.
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~--~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   87 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREK--STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   87 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEET--TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cCEEEeEEEecCCCeEEEEEEEC--CCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            45788899999999999999975  3578999999864221      234679999999999999999999999999999


Q ss_pred             ceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC----cEEEeecCCc
Q 041921          593 RLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYY----TARISDFGLA  668 (814)
Q Consensus       593 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~----~~kl~DfGla  668 (814)
                      .+|||||+++|+|.++|.....+++.....++.|++.||+|||+.   +|+||||||+|||++.++    .+||+|||++
T Consensus        88 ~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a  164 (293)
T d1jksa_          88 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  164 (293)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhhh
Confidence            999999999999999998888899999999999999999999998   999999999999998766    5999999999


Q ss_pred             cccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccc
Q 041921          669 KLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLN  748 (814)
Q Consensus       669 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  748 (814)
                      +........   ....||+.|+|||.+.+..++.++|||||||++|||++|+.||......+.       ...+..+...
T Consensus       165 ~~~~~~~~~---~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~-------~~~i~~~~~~  234 (293)
T d1jksa_         165 HKIDFGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-------LANVSAVNYE  234 (293)
T ss_dssp             EECTTSCBC---SCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHTTCCC
T ss_pred             hhcCCCccc---cccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH-------HHHHHhcCCC
Confidence            877543322   345689999999999999999999999999999999999999975543221       1222222211


Q ss_pred             eeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          749 VLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       749 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      ..      .......+..+.+++.+||+.||.+|||++|+++
T Consensus       235 ~~------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         235 FE------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             CC------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CC------chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            10      0001123457889999999999999999999986

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=4.7e-44  Score=385.42  Aligned_cols=250  Identities=25%  Similarity=0.339  Sum_probs=208.3

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEec
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  599 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  599 (814)
                      .|.+.++||+|+||.||+|...  ..++.||||.++.......+.+.+|+.++++++|||||++++++.+++..+|||||
T Consensus        30 ~Y~i~~~lG~G~fg~V~~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          30 YYDILEELGSGAFGVVHRCVEK--ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             TEEEEEEEEEETTEEEEEEEET--TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ceEEEEEEecCCCeEEEEEEEC--CCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            4778899999999999999865  35789999999765445556789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc--CCCcEEEeecCCccccccCCc
Q 041921          600 LNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLD--DYYTARISDFGLAKLLTLNQS  676 (814)
Q Consensus       600 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~--~~~~~kl~DfGla~~~~~~~~  676 (814)
                      +++|+|.+++... ..+++.....|+.||+.||+|||+.   +|+||||||+||||+  .++.+||+|||+++.+.....
T Consensus       108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~  184 (352)
T d1koba_         108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI  184 (352)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred             CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCCCc
Confidence            9999999987665 4689999999999999999999998   999999999999998  678999999999998765432


Q ss_pred             ccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCccc
Q 041921          677 KTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKE  756 (814)
Q Consensus       677 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  756 (814)
                      .   ....||+.|+|||++.+..++.++|||||||++|||+||+.||......+       ....+..+....      .
T Consensus       185 ~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-------~~~~i~~~~~~~------~  248 (352)
T d1koba_         185 V---KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-------TLQNVKRCDWEF------D  248 (352)
T ss_dssp             E---EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-------HHHHHHHCCCCC------C
T ss_pred             e---eeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCCC------C
Confidence            2   44569999999999999999999999999999999999999997543322       112222222111      1


Q ss_pred             ccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          757 AMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       757 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      .......+.++.+++.+||+.||.+|||++|+++
T Consensus       249 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         249 EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             cccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1111234467889999999999999999999987

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-45  Score=383.74  Aligned_cols=264  Identities=28%  Similarity=0.400  Sum_probs=211.0

Q ss_pred             HHHhhhccccceeeeeeeeEEEEEEecCC-----CceEEEEEEeccccc-cchHhHHHHHHhhhcc-CCCCccceeeeec
Q 041921          516 LEGATNNFKEEVGRGSFGIVYKGVIQTRT-----STTAVAVKKLDRVFQ-DGEREFKNEVFVIGQT-HHKNLVRLLGFCD  588 (814)
Q Consensus       516 l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~-----~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  588 (814)
                      |....+.+.++||+|+||.||+|+....+     .+..||||+++.... ....++.+|+..+.++ +|||||+++++|.
T Consensus        10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~   89 (299)
T d1fgka_          10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT   89 (299)
T ss_dssp             CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence            33456778899999999999999875432     245899999975433 3346788999999888 8999999999999


Q ss_pred             ccccceEEEecCCCCCHHHHhcCC----------------CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcE
Q 041921          589 EGQNRLLVYEFLNNGTLASFLFGN----------------LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNI  652 (814)
Q Consensus       589 ~~~~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NI  652 (814)
                      ++...++||||+++|+|.++|...                ..+++..++.++.||+.||+|||+.   +|+||||||+||
T Consensus        90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~Ni  166 (299)
T d1fgka_          90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV  166 (299)
T ss_dssp             SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred             cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccce
Confidence            999999999999999999999654                3478999999999999999999998   999999999999


Q ss_pred             EEcCCCcEEEeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhh
Q 041921          653 LLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEY  731 (814)
Q Consensus       653 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~  731 (814)
                      |++.++.+||+|||+++...............+|+.|+|||.+.++.++.++||||||+++|||++ |..||....... 
T Consensus       167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~-  245 (299)
T d1fgka_         167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-  245 (299)
T ss_dssp             EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-
T ss_pred             eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH-
Confidence            999999999999999998776554444455678999999999999999999999999999999998 688876443322 


Q ss_pred             hhHHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 041921          732 AILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV  798 (814)
Q Consensus       732 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~~  798 (814)
                            +.+.+.++....         .+...+.++.+++.+||+.||++|||+.||++.|+++..+
T Consensus       246 ------~~~~i~~~~~~~---------~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~  297 (299)
T d1fgka_         246 ------LFKLLKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL  297 (299)
T ss_dssp             ------HHHHHHTTCCCC---------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------HHHHHHcCCCCC---------CCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence                  223333332111         1112346788999999999999999999999999987543

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-45  Score=379.02  Aligned_cols=258  Identities=26%  Similarity=0.367  Sum_probs=199.1

Q ss_pred             hhhccccceeeeeeeeEEEEEEecC-CCceEEEEEEeccc---cccchHhHHHHHHhhhccCCCCccceeeeecccccce
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTR-TSTTAVAVKKLDRV---FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRL  594 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  594 (814)
                      ..+.+.++||+|+||.||+|.+... +....||||++...   ..+..++|.+|+.++++++||||++++|++.+ ...+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            3467788999999999999987643 33468999998643   23334679999999999999999999999976 4678


Q ss_pred             EEEecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcccccc
Q 041921          595 LVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTL  673 (814)
Q Consensus       595 lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~  673 (814)
                      +||||+++|+|.+++... ..+++..++.++.|||+||.|||++   +|+||||||+||||+.++.+||+|||+++.+..
T Consensus        87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~  163 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  163 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhccc
Confidence            999999999999887654 5689999999999999999999998   999999999999999999999999999998765


Q ss_pred             CCcccc-cccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCcccchhhhhHHHHHHHHhhcCccceee
Q 041921          674 NQSKTI-KTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLV  751 (814)
Q Consensus       674 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  751 (814)
                      ...... .....|+..|+|||.+.+..++.++||||||+++|||+| |+.||......+.      .....+.+. .   
T Consensus       164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~------~~~i~~~~~-~---  233 (273)
T d1u46a_         164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI------LHKIDKEGE-R---  233 (273)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH------HHHHHTSCC-C---
T ss_pred             CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHH------HHHHHhCCC-C---
Confidence            433222 234558889999999999999999999999999999998 8999975433321      111122221 1   


Q ss_pred             cCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 041921          752 GEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV  795 (814)
Q Consensus       752 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~  795 (814)
                           .+.....+..+.+++.+||+.||++||||++|++.|++.
T Consensus       234 -----~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         234 -----LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                 011223346788999999999999999999999999753

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-44  Score=385.38  Aligned_cols=264  Identities=27%  Similarity=0.414  Sum_probs=214.3

Q ss_pred             HHHHhhhccccceeeeeeeeEEEEEEec---CCCceEEEEEEeccccc-cchHhHHHHHHhhhcc-CCCCccceeeeecc
Q 041921          515 ELEGATNNFKEEVGRGSFGIVYKGVIQT---RTSTTAVAVKKLDRVFQ-DGEREFKNEVFVIGQT-HHKNLVRLLGFCDE  589 (814)
Q Consensus       515 ~l~~~~~~~~~~LG~G~~g~Vy~~~~~~---~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  589 (814)
                      |+....+.+.++||+|+||.||+|++..   ...+..||||+++.... ....+|.+|+.+++++ +|||||++++++.+
T Consensus        19 ~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~   98 (311)
T d1t46a_          19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI   98 (311)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence            3555678889999999999999999753   34577999999975433 3345689999999999 79999999999999


Q ss_pred             cccceEEEecCCCCCHHHHhcCC------------------CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCc
Q 041921          590 GQNRLLVYEFLNNGTLASFLFGN------------------LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQN  651 (814)
Q Consensus       590 ~~~~~lv~e~~~~gsL~~~l~~~------------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~N  651 (814)
                      .+..+|||||+++|+|.++|+..                  ..+++..+..++.||++||+|||++   +|+||||||+|
T Consensus        99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~N  175 (311)
T d1t46a_          99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN  175 (311)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccc
Confidence            99999999999999999999643                  2578999999999999999999998   99999999999


Q ss_pred             EEEcCCCcEEEeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCC-CCCCcccchh
Q 041921          652 ILLDDYYTARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCR-KSFDIEMGEE  730 (814)
Q Consensus       652 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~-~p~~~~~~~~  730 (814)
                      ||++.++.+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||+|+. .|+......+
T Consensus       176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~  255 (311)
T d1t46a_         176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS  255 (311)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred             ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH
Confidence            999999999999999999876554444445567999999999999999999999999999999999954 4454332222


Q ss_pred             hhhHHHHHHHHhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 041921          731 YAILTDWAFDCYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV  796 (814)
Q Consensus       731 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~  796 (814)
                      .      +.+.+..+...         ..+...+.++.+|+.+||+.||++||||++|+++|++.+
T Consensus       256 ~------~~~~i~~~~~~---------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i  306 (311)
T d1t46a_         256 K------FYKMIKEGFRM---------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI  306 (311)
T ss_dssp             H------HHHHHHHTCCC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             H------HHHHHhcCCCC---------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence            1      11222222111         111223467899999999999999999999999998643

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-44  Score=380.56  Aligned_cols=263  Identities=27%  Similarity=0.454  Sum_probs=213.2

Q ss_pred             HHHhhhccccceeeeeeeeEEEEEEec---CCCceEEEEEEeccccc-cchHhHHHHHHhhhccCCCCccceeeeecccc
Q 041921          516 LEGATNNFKEEVGRGSFGIVYKGVIQT---RTSTTAVAVKKLDRVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ  591 (814)
Q Consensus       516 l~~~~~~~~~~LG~G~~g~Vy~~~~~~---~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  591 (814)
                      +....+.+.++||+|+||+||+|.+..   ...+..||||+++.... +....|.+|+.++++++||||+++++++..++
T Consensus        17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~   96 (308)
T d1p4oa_          17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   96 (308)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC
Confidence            344566788999999999999998752   12357899999975432 33346899999999999999999999999999


Q ss_pred             cceEEEecCCCCCHHHHhcCC----------CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEE
Q 041921          592 NRLLVYEFLNNGTLASFLFGN----------LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTAR  661 (814)
Q Consensus       592 ~~~lv~e~~~~gsL~~~l~~~----------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~k  661 (814)
                      ..++||||+++|+|.+++...          ..+++..+.+++.|+|+||.|||+.   +|+||||||+|||+++++++|
T Consensus        97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~K  173 (308)
T d1p4oa_          97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVK  173 (308)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEE
T ss_pred             ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEE
Confidence            999999999999999998632          3468899999999999999999998   999999999999999999999


Q ss_pred             EeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCC-CCCCcccchhhhhHHHHHHH
Q 041921          662 ISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCR-KSFDIEMGEEYAILTDWAFD  740 (814)
Q Consensus       662 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~-~p~~~~~~~~~~~~~~~~~~  740 (814)
                      |+|||+++.+.............||+.|+|||.+.+..++.++||||||+++|||+||+ .||......+       +..
T Consensus       174 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~-------~~~  246 (308)
T d1p4oa_         174 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-------VLR  246 (308)
T ss_dssp             ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH-------HHH
T ss_pred             EeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH-------HHH
Confidence            99999998776554443334456899999999999999999999999999999999985 5665332222       112


Q ss_pred             HhhcCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 041921          741 CYRNGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE  797 (814)
Q Consensus       741 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~~  797 (814)
                      .+.++....         .+...+..+.+++.+||+.+|++||||++|+++|++..+
T Consensus       247 ~i~~~~~~~---------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         247 FVMEGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             HHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHHhCCCCC---------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            222332111         112234679999999999999999999999999988654

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-44  Score=376.20  Aligned_cols=267  Identities=23%  Similarity=0.295  Sum_probs=201.5

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccc----cceE
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ----NRLL  595 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~l  595 (814)
                      ++-+.++||+|+||.||+|++.    +..||||+++... .....+..|+..+.+++|||||++++++.+.+    ..++
T Consensus         4 ~~~l~~~iG~G~fg~Vy~~~~~----g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l   78 (303)
T d1vjya_           4 TIVLQESIGKGRFGEVWRGKWR----GEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GEEEEEEEECCSSSEEEEEEET----TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEEC----CEEEEEEEECccc-hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence            4567789999999999999973    6799999996432 11222345666777889999999999997654    5789


Q ss_pred             EEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcC-----CCCeeecCCCCCcEEEcCCCcEEEeecCCccc
Q 041921          596 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDC-----RAQIIHCDIKPQNILLDDYYTARISDFGLAKL  670 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~-----~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~  670 (814)
                      ||||+++|+|.++|+.. .++|..+++++.|+|.||+|||+..     ..+|+||||||+||||+.++.+||+|||+++.
T Consensus        79 v~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~  157 (303)
T d1vjya_          79 VSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  157 (303)
T ss_dssp             EEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence            99999999999999764 6899999999999999999999731     34899999999999999999999999999987


Q ss_pred             cccCCcc--cccccccCCCCcccccccccC------CCCcchhhHHHHHHHHHHHhCCCCCCcccchhhh--------hH
Q 041921          671 LTLNQSK--TIKTAIRGTKGYVAPEWFRNS------KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA--------IL  734 (814)
Q Consensus       671 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~--------~~  734 (814)
                      .......  .......||+.|+|||++...      .++.++|||||||+||||+||..|+.........        ..
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~  237 (303)
T d1vjya_         158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS  237 (303)
T ss_dssp             EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred             ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence            7543322  122346799999999998754      2577899999999999999999887543221100        00


Q ss_pred             HHHHHHHhhcCccceeecCcc-cccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 041921          735 TDWAFDCYRNGKLNVLVGEDK-EAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV  796 (814)
Q Consensus       735 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~  796 (814)
                      ..........+.+    .+.. ......+.+..+.+++.+||+.||++||||.||++.|+++.
T Consensus       238 ~~~~~~~~~~~~~----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~  296 (303)
T d1vjya_         238 VEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  296 (303)
T ss_dssp             HHHHHHHHTTSCC----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHhcccc----CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            1112222222222    1111 11123456778999999999999999999999999998764

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-43  Score=377.28  Aligned_cols=247  Identities=23%  Similarity=0.274  Sum_probs=207.5

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccc---cccchHhHHHHHHhhhccCCCCccceeeeecccccceEE
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV---FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV  596 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  596 (814)
                      .+.+.+.||+|+||.||+|...  .+++.||||++++.   .....+.+.+|+.+|++++||||+++++++.+++..++|
T Consensus         6 dy~~~~~lG~G~fg~V~~~~~~--~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           6 DFDYLKLLGKGTFGKVILVREK--ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GEEEEEEEEECSSEEEEEEEET--TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hcEEEEEEecCcCeEEEEEEEC--CCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            3677889999999999999865  36789999999643   233456789999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCc
Q 041921          597 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS  676 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  676 (814)
                      |||+++|+|.+++.....+++...+.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......
T Consensus        84 ~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~  160 (337)
T d1o6la_          84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred             eeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence            99999999999999888899999999999999999999998   999999999999999999999999999986653322


Q ss_pred             ccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCccc
Q 041921          677 KTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKE  756 (814)
Q Consensus       677 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  756 (814)
                      .  ....+||+.|+|||++.+..++.++|||||||++|||++|+.||......+       +.+.+..+.+..       
T Consensus       161 ~--~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~-------~~~~i~~~~~~~-------  224 (337)
T d1o6la_         161 T--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-------LFELILMEEIRF-------  224 (337)
T ss_dssp             C--BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCCC-------
T ss_pred             c--cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH-------HHHHHhcCCCCC-------
Confidence            1  245679999999999999999999999999999999999999997654322       112222332211       


Q ss_pred             ccCcHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 041921          757 AMNDIECLGKLVMVSIWCIQEDPSLRPT-----MKKVLQ  790 (814)
Q Consensus       757 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-----~~~vl~  790 (814)
                         +.....++.+++.+||+.||.+||+     ++|+++
T Consensus       225 ---p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         225 ---PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             ---CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ---CccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence               1123456789999999999999995     788875

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.4e-43  Score=374.65  Aligned_cols=244  Identities=24%  Similarity=0.322  Sum_probs=206.3

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccc---cccchHhHHHHHHhhhccCCCCccceeeeecccccceEE
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV---FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV  596 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  596 (814)
                      .|.+.++||+|+||+||+|...  .+++.||||+++..   .....+.+.+|+.++++++|||||++++++.+++..++|
T Consensus         5 dy~i~~~lG~G~fg~Vy~a~~~--~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   82 (316)
T d1fota_           5 DFQILRTLGTGSFGRVHLIRSR--HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   82 (316)
T ss_dssp             GEEEEEEEEECSSCEEEEEEET--TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             HeEEEEEEecCcCcEEEEEEEC--CCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence            3677899999999999999975  35789999999642   233456789999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCc
Q 041921          597 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS  676 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  676 (814)
                      |||+++|+|..++.....+++.....++.||+.||+|||++   +|+||||||+||||+.++.+||+|||+++...... 
T Consensus        83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~-  158 (316)
T d1fota_          83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-  158 (316)
T ss_dssp             ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB-
T ss_pred             eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecccc-
Confidence            99999999999999888899999999999999999999998   99999999999999999999999999998765332 


Q ss_pred             ccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCccc
Q 041921          677 KTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKE  756 (814)
Q Consensus       677 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  756 (814)
                          ....||+.|||||.+.+..++.++|||||||++|||++|+.||......+       ....+..+....       
T Consensus       159 ----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~-------~~~~i~~~~~~~-------  220 (316)
T d1fota_         159 ----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK-------TYEKILNAELRF-------  220 (316)
T ss_dssp             ----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHHCCCCC-------
T ss_pred             ----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH-------HHHHHHcCCCCC-------
Confidence                34679999999999999999999999999999999999999997543322       112222222111       


Q ss_pred             ccCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 041921          757 AMNDIECLGKLVMVSIWCIQEDPSLRP-----TMKKVLQ  790 (814)
Q Consensus       757 ~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~~vl~  790 (814)
                         +.....++.+++.+||+.||.+||     |++++++
T Consensus       221 ---p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         221 ---PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             ---CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             ---CCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence               112345688999999999999996     8999975

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=4e-43  Score=365.75  Aligned_cols=250  Identities=22%  Similarity=0.301  Sum_probs=205.7

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccccc---------chHhHHHHHHhhhccC-CCCccceeeeecc
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD---------GEREFKNEVFVIGQTH-HKNLVRLLGFCDE  589 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~---------~~~~~~~E~~~l~~l~-h~niv~l~~~~~~  589 (814)
                      .|.+.++||+|+||+||+|+..  .+++.||||+++.....         ..+.+.+|+.++++++ ||||+++++++.+
T Consensus         4 ~y~~~~~iG~G~~g~V~~~~~~--~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           4 NYEPKEILGRGVSSVVRRCIHK--PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TEEEEEEEEECSSEEEEEEEET--TTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cCEEceEEecCcCeEEEEEEEC--CCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            4677899999999999999865  36789999998643211         1235889999999997 9999999999999


Q ss_pred             cccceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcc
Q 041921          590 GQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAK  669 (814)
Q Consensus       590 ~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~  669 (814)
                      ++..+|||||+++|+|.++|.....+++...+.++.||++||+|||+.   +|+||||||+||||+.++.+||+|||+++
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~  158 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSC  158 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchhee
Confidence            999999999999999999998888899999999999999999999998   99999999999999999999999999998


Q ss_pred             ccccCCcccccccccCCCCccccccccc------CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhh
Q 041921          670 LLTLNQSKTIKTAIRGTKGYVAPEWFRN------SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR  743 (814)
Q Consensus       670 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  743 (814)
                      .+......   ....||..|+|||.+.+      ..++.++||||+||++|||++|+.||.......       ....+.
T Consensus       159 ~~~~~~~~---~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~-------~~~~i~  228 (277)
T d1phka_         159 QLDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-------MLRMIM  228 (277)
T ss_dssp             ECCTTCCB---CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHH
T ss_pred             EccCCCce---eeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH-------HHHHHH
Confidence            77653322   44679999999999853      346889999999999999999999997654322       112222


Q ss_pred             cCccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          744 NGKLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       744 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      ++....      ........++++.+++.+||+.||.+|||++|+++
T Consensus       229 ~~~~~~------~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         229 SGNYQF------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             HTCCCC------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             hCCCCC------CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            232211      11112234567889999999999999999999875

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=2e-43  Score=369.64  Aligned_cols=259  Identities=22%  Similarity=0.293  Sum_probs=203.3

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc---cchHhHHHHHHhhhccCCCCccceeeeeccccc---
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ---DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQN---  592 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---  592 (814)
                      ..|.+.+.||+|+||+||+|...  ..++.||||.++....   ...+.|.+|+.++++++||||+++++++...+.   
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~   84 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDL--RLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   84 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEET--TTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEEC--CCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence            34778899999999999999965  3578999999975332   223468999999999999999999999876543   


Q ss_pred             -ceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcccc
Q 041921          593 -RLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLL  671 (814)
Q Consensus       593 -~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~  671 (814)
                       .+|||||+++++|.+++.....+++.+...++.||++||+|||+.   +|+||||||+|||++.++..+|+|||.+...
T Consensus        85 ~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~  161 (277)
T d1o6ya_          85 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI  161 (277)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred             eEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhhh
Confidence             789999999999999998888899999999999999999999998   9999999999999999999999999998765


Q ss_pred             ccCCcc-cccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCcccee
Q 041921          672 TLNQSK-TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVL  750 (814)
Q Consensus       672 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  750 (814)
                      ...... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||......+      ...+.+..+...  
T Consensus       162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~~~~~~~~~--  233 (277)
T d1o6ya_         162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQHVREDPIP--  233 (277)
T ss_dssp             C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHCCCCC--
T ss_pred             ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH------HHHHHHhcCCCC--
Confidence            433221 22244679999999999999999999999999999999999999997544322      112222222111  


Q ss_pred             ecCcccccCcHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHhcC
Q 041921          751 VGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRP-TMKKVLQMLEGV  795 (814)
Q Consensus       751 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-t~~~vl~~L~~~  795 (814)
                           ........++++.+++.+||+.||.+|| |++++++.|.++
T Consensus       234 -----~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~  274 (277)
T d1o6ya_         234 -----PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  274 (277)
T ss_dssp             -----GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             -----CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence                 0111122446788999999999999999 899999888765

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-43  Score=369.47  Aligned_cols=260  Identities=22%  Similarity=0.259  Sum_probs=199.7

Q ss_pred             cceeeeeeeeEEEEEEecCCCceEEEEEEecccccc-----chHhHHHHHHhhhccCCCCccceeeeecccccceEEEec
Q 041921          525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD-----GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  599 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  599 (814)
                      ++||+|+||+||+|...  ..++.||||+++.....     ..+.+.+|+.++++++|||||++++++.++++.+|||||
T Consensus         4 ~~lG~G~fg~Vy~~~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           4 DFLGEGQFATVYKARDK--NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEETTEEEEEEECS--SCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             eEeccCcCeEEEEEEEC--CCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            67999999999999965  35789999998643221     134689999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcccc
Q 041921          600 LNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSKTI  679 (814)
Q Consensus       600 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  679 (814)
                      +.++++..++.....+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++......... 
T Consensus        82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~-  157 (299)
T d1ua2a_          82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY-  157 (299)
T ss_dssp             CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCC-
T ss_pred             hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcccc-
Confidence            99998888887778899999999999999999999998   99999999999999999999999999998765433221 


Q ss_pred             cccccCCCCcccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceee-------
Q 041921          680 KTAIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLV-------  751 (814)
Q Consensus       680 ~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------  751 (814)
                       ....||+.|+|||++... .++.++|||||||++|||++|+.||......+..   ..+.+...........       
T Consensus       158 -~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l---~~i~~~~~~~~~~~~~~~~~~~~  233 (299)
T d1ua2a_         158 -THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQL---TRIFETLGTPTEEQWPDMCSLPD  233 (299)
T ss_dssp             -CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHHHCCCCTTTSSSTTSSTT
T ss_pred             -cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHH---HHHHHhcCCCChhhccchhccch
Confidence             345699999999998654 5799999999999999999999999755432211   1111111110000000       


Q ss_pred             --cCcccccCc-----HHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhc
Q 041921          752 --GEDKEAMND-----IECLGKLVMVSIWCIQEDPSLRPTMKKVLQ--MLEG  794 (814)
Q Consensus       752 --~~~~~~~~~-----~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~--~L~~  794 (814)
                        ........+     ....+.+.+++.+||+.||++|||++|+++  .|.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~  285 (299)
T d1ua2a_         234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN  285 (299)
T ss_dssp             CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred             hhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCC
Confidence              000000000     122467889999999999999999999987  4543

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-42  Score=368.72  Aligned_cols=249  Identities=21%  Similarity=0.294  Sum_probs=204.6

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeecccccceEEEec
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  599 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  599 (814)
                      .|.+.++||+|+||+||+|....  +++.||||.++.. ......+.+|+++|++++|||||++++++.+++..+|||||
T Consensus         6 rY~i~~~lG~G~fg~Vy~~~~~~--~~~~~AiK~i~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           6 KYMIAEDLGRGEFGIVHRCVETS--SKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETT--TTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ceEEEEEEecCCCeEEEEEEECC--CCcEEEEEEEcCC-cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            47788999999999999998753  5789999999754 23345688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCCC-CCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC--CCcEEEeecCCccccccCCc
Q 041921          600 LNNGTLASFLFGNL-KPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDD--YYTARISDFGLAKLLTLNQS  676 (814)
Q Consensus       600 ~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~--~~~~kl~DfGla~~~~~~~~  676 (814)
                      +++|+|.++|.... .+++.+...++.||+.||+|||+.   +|+||||||+|||++.  ...+||+|||+++.......
T Consensus        83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~  159 (321)
T d1tkia_          83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN  159 (321)
T ss_dssp             CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccCCc
Confidence            99999999998764 689999999999999999999998   9999999999999984  45899999999987654322


Q ss_pred             ccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCccc
Q 041921          677 KTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKE  756 (814)
Q Consensus       677 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  756 (814)
                      .   ....+|+.|+|||.+.+..++.++|||||||++|||++|+.||......+       +...+..+.....      
T Consensus       160 ~---~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~-------~~~~i~~~~~~~~------  223 (321)
T d1tkia_         160 F---RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-------IIENIMNAEYTFD------  223 (321)
T ss_dssp             E---EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHHTCCCCC------
T ss_pred             c---cccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCCCC------
Confidence            1   34568999999999999999999999999999999999999997654322       1122222221100      


Q ss_pred             ccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          757 AMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       757 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      .........++.+++.+||+.||.+|||++|+++
T Consensus       224 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         224 EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0000113456789999999999999999999987

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-43  Score=372.06  Aligned_cols=247  Identities=28%  Similarity=0.348  Sum_probs=204.1

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccc---cccchHhHHHHHHhhh-ccCCCCccceeeeecccccceE
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV---FQDGEREFKNEVFVIG-QTHHKNLVRLLGFCDEGQNRLL  595 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~l  595 (814)
                      .|.+.++||+|+||+||+|+..  .+++.||||.+++.   .....+.+..|..++. .++|||||++++++.+++..+|
T Consensus         3 dy~i~~~iG~G~fg~Vy~~~~~--~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi   80 (320)
T d1xjda_           3 DFILHKMLGKGSFGKVFLAEFK--KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF   80 (320)
T ss_dssp             TEEEEEEEEECSSSEEEEEEET--TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             CeEEeeEEecCCCcEEEEEEEC--CCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence            4678899999999999999975  36789999999642   1233445677777665 6899999999999999999999


Q ss_pred             EEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCC
Q 041921          596 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQ  675 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~  675 (814)
                      ||||+++|+|.+++.....+++.....++.||+.||+|||+.   +|+||||||+|||++.++++||+|||+++......
T Consensus        81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~  157 (320)
T d1xjda_          81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD  157 (320)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhccccc
Confidence            999999999999999888899999999999999999999998   99999999999999999999999999998665433


Q ss_pred             cccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCcc
Q 041921          676 SKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDK  755 (814)
Q Consensus       676 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  755 (814)
                      ..  .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+       +...+..+....      
T Consensus       158 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~-------~~~~i~~~~~~~------  222 (320)
T d1xjda_         158 AK--TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-------LFHSIRMDNPFY------  222 (320)
T ss_dssp             CC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCCC------
T ss_pred             cc--ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCCCCC------
Confidence            22  244679999999999999999999999999999999999999997654322       122222222111      


Q ss_pred             cccCcHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 041921          756 EAMNDIECLGKLVMVSIWCIQEDPSLRPTMK-KVLQ  790 (814)
Q Consensus       756 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~-~vl~  790 (814)
                          +...+.++.+++.+||+.||.+|||+. ++++
T Consensus       223 ----p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         223 ----PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             ----CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             ----CccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence                112346688999999999999999995 6753

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.7e-42  Score=373.31  Aligned_cols=244  Identities=24%  Similarity=0.244  Sum_probs=205.9

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccc---cccchHhHHHHHHhhhccCCCCccceeeeecccccceEE
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV---FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV  596 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  596 (814)
                      .|.+.++||+|+||.||+|...  .+++.||||.+...   .....+.+.+|+.++++++|||||++++++.+....++|
T Consensus        42 ~y~i~~~lG~G~fg~Vy~a~~~--~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v  119 (350)
T d1rdqe_          42 QFDRIKTLGTGSFGRVMLVKHK--ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GEEEEEEEEECSSCEEEEEEET--TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CeEEEEEeecCcCcEEEEEEEC--CCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence            5677889999999999999975  35789999998642   223445789999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCc
Q 041921          597 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS  676 (814)
Q Consensus       597 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  676 (814)
                      +||+.+|+|..++.....+++.....++.||+.||.|||+.   +|+||||||+||||+.++.+||+|||+++.+.... 
T Consensus       120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~-  195 (350)
T d1rdqe_         120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-  195 (350)
T ss_dssp             EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB-
T ss_pred             cccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccccc-
Confidence            99999999999998888899999999999999999999998   99999999999999999999999999998765322 


Q ss_pred             ccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeecCccc
Q 041921          677 KTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVGEDKE  756 (814)
Q Consensus       677 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  756 (814)
                          ....||+.|||||++.+..++.++|||||||++|||+||+.||.......       ....+..+....       
T Consensus       196 ----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-------~~~~i~~~~~~~-------  257 (350)
T d1rdqe_         196 ----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-------IYEKIVSGKVRF-------  257 (350)
T ss_dssp             ----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCCC-------
T ss_pred             ----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH-------HHHHHhcCCCCC-------
Confidence                34569999999999999999999999999999999999999997543222       112222222111       


Q ss_pred             ccCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 041921          757 AMNDIECLGKLVMVSIWCIQEDPSLRP-----TMKKVLQ  790 (814)
Q Consensus       757 ~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~~vl~  790 (814)
                         +.....++.+++.+||+.||.+|+     |++++++
T Consensus       258 ---p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         258 ---PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             ---CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ---CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence               112346788999999999999994     8999985

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.4e-42  Score=374.10  Aligned_cols=248  Identities=23%  Similarity=0.243  Sum_probs=199.5

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc---ccchHhHHH---HHHhhhccCCCCccceeeeecccccc
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF---QDGEREFKN---EVFVIGQTHHKNLVRLLGFCDEGQNR  593 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~---E~~~l~~l~h~niv~l~~~~~~~~~~  593 (814)
                      .|.+.++||+|+||.||+|+...  +++.||||.+....   ......+.+   |+.+++.++|||||++++++.+.+..
T Consensus         5 dy~i~~~lG~G~fg~Vy~~~~~~--t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           5 DFSVHRIIGRGGFGEVYGCRKAD--TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETT--TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hCeeeeEEecCCCeEEEEEEECC--CCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            36678899999999999999753  57899999986421   122233444   46777888999999999999999999


Q ss_pred             eEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcccccc
Q 041921          594 LLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTL  673 (814)
Q Consensus       594 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~  673 (814)
                      +|||||+++|+|.++|.....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.+..
T Consensus        83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~  159 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSK  159 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred             EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence            99999999999999998888889999999999999999999998   999999999999999999999999999987654


Q ss_pred             CCcccccccccCCCCccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccceeec
Q 041921          674 NQSKTIKTAIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVLVG  752 (814)
Q Consensus       674 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  752 (814)
                      ...    ....||+.|+|||++.. ..++.++|||||||++|||+||+.||..........    +.+........    
T Consensus       160 ~~~----~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~----~~~~~~~~~~~----  227 (364)
T d1omwa3         160 KKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTLTMAVE----  227 (364)
T ss_dssp             SCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH----HHHHSSSCCCC----
T ss_pred             Ccc----cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH----HHHhcccCCCC----
Confidence            322    34579999999999975 568999999999999999999999997654432211    11111111110    


Q ss_pred             CcccccCcHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 041921          753 EDKEAMNDIECLGKLVMVSIWCIQEDPSLRPT-----MKKVLQ  790 (814)
Q Consensus       753 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-----~~~vl~  790 (814)
                            .+.....++.+++.+||+.||.+|||     ++|+++
T Consensus       228 ------~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         228 ------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             ------CCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             ------CCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence                  11123467889999999999999999     688874

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-42  Score=365.70  Aligned_cols=249  Identities=23%  Similarity=0.278  Sum_probs=196.5

Q ss_pred             hhccc-cceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhcc-CCCCccceeeeecc----cccc
Q 041921          520 TNNFK-EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQT-HHKNLVRLLGFCDE----GQNR  593 (814)
Q Consensus       520 ~~~~~-~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~  593 (814)
                      .|.+. +.||+|+||+||+|....  +++.||||+++.     ...+.+|+.++.++ +|||||++++++.+    +...
T Consensus        12 ~y~i~~~~lG~G~fg~Vy~a~~~~--~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          12 DYKVTSQVLGLGINGKVLQIFNKR--TQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             TEEEEEEEEEECSSCEEEEEEETT--TCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             CEEEeeEEeeeccCeEEEEEEECC--CCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            45554 469999999999999753  578999999864     34678899887655 89999999999865    4668


Q ss_pred             eEEEecCCCCCHHHHhcCC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC---CCcEEEeecCCc
Q 041921          594 LLVYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDD---YYTARISDFGLA  668 (814)
Q Consensus       594 ~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~---~~~~kl~DfGla  668 (814)
                      +|||||+++|+|.++|...  ..+++.....|+.||+.||+|||+.   +|+||||||+|||++.   .+.+||+|||++
T Consensus        85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a  161 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA  161 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccccccee
Confidence            9999999999999999764  4689999999999999999999998   9999999999999985   567999999999


Q ss_pred             cccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccc
Q 041921          669 KLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLN  748 (814)
Q Consensus       669 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  748 (814)
                      +........   ....||+.|||||++.+..++.++|||||||++|||+||+.||.........   ......+..+.. 
T Consensus       162 ~~~~~~~~~---~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~---~~~~~~i~~~~~-  234 (335)
T d2ozaa1         162 KETTSHNSL---TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---PGMKTRIRMGQY-  234 (335)
T ss_dssp             EECCCCCCC---CCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCSS-
T ss_pred             eeccCCCcc---ccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH---HHHHHHHhcCCC-
Confidence            876644322   4457999999999999999999999999999999999999999654332210   001111111111 


Q ss_pred             eeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          749 VLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       749 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                           ............++.+++.+||+.||++|||+.|+++
T Consensus       235 -----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         235 -----EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             -----SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             -----CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                 0011111234577899999999999999999999987

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-42  Score=359.64  Aligned_cols=240  Identities=24%  Similarity=0.402  Sum_probs=197.3

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccccc------chHhHHHHHHhhhccC--CCCccceeeeeccc
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD------GEREFKNEVFVIGQTH--HKNLVRLLGFCDEG  590 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~  590 (814)
                      .+|.+.++||+|+||+||+|....  +++.||||+++.....      ...++.+|+.++++++  |||||++++++.+.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~   81 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVS--DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP   81 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECC--CCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence            457788999999999999999753  5789999998643211      1234789999999986  89999999999999


Q ss_pred             ccceEEEecCCC-CCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC-CCcEEEeecCCc
Q 041921          591 QNRLLVYEFLNN-GTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDD-YYTARISDFGLA  668 (814)
Q Consensus       591 ~~~~lv~e~~~~-gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~-~~~~kl~DfGla  668 (814)
                      +..++||||+.+ +++.+++.....+++..+..++.||++||+|||+.   +|+||||||+|||++. ++.+||+|||++
T Consensus        82 ~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a  158 (273)
T d1xwsa_          82 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSG  158 (273)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccccc
Confidence            999999999975 68888888888899999999999999999999998   9999999999999985 579999999999


Q ss_pred             cccccCCcccccccccCCCCcccccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCcc
Q 041921          669 KLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKI-TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL  747 (814)
Q Consensus       669 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  747 (814)
                      +......    .+...||+.|+|||++.+..+ +.++|||||||++|||++|+.||.....             +..+..
T Consensus       159 ~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------------i~~~~~  221 (273)
T d1xwsa_         159 ALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------------IIRGQV  221 (273)
T ss_dssp             EECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------------HHHCCC
T ss_pred             eeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-------------Hhhccc
Confidence            8754332    244679999999999987765 5679999999999999999999964210             011111


Q ss_pred             ceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          748 NVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       748 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      .  .        +...+.++.+++.+||+.||++|||++|+++
T Consensus       222 ~--~--------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         222 F--F--------RQRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             C--C--------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             C--C--------CCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            0  1        1112467889999999999999999999987

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-41  Score=355.38  Aligned_cols=266  Identities=23%  Similarity=0.303  Sum_probs=199.8

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEE
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY  597 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  597 (814)
                      .|.+.++||+|+||+||+|+...  .++.||||+++...  ....+++.+|++++++++|||||++++++.++++.++||
T Consensus         3 ~Y~~~~~lG~G~fg~Vy~~~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~   80 (298)
T d1gz8a_           3 NFQKVEKIGEGTYGVVYKARNKL--TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF   80 (298)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETT--TCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCEeccEEecCcCeEEEEEEECC--CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence            45667899999999999999753  57799999996432  233567999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhcC-CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCc
Q 041921          598 EFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQS  676 (814)
Q Consensus       598 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  676 (814)
                      ||+.++.+...... ...+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......
T Consensus        81 e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~  157 (298)
T d1gz8a_          81 EFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  157 (298)
T ss_dssp             ECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred             eecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCcc
Confidence            99976555444333 46689999999999999999999998   999999999999999999999999999987654332


Q ss_pred             ccccccccCCCCcccccccccCC-CCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcC---c---cce
Q 041921          677 KTIKTAIRGTKGYVAPEWFRNSK-ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG---K---LNV  749 (814)
Q Consensus       677 ~~~~~~~~gt~~y~aPE~~~~~~-~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~---~~~  749 (814)
                      .  .....||+.|+|||.+.... .+.++|||||||++|||++|+.||......+..  .. +.......   .   ...
T Consensus       158 ~--~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~--~~-i~~~~~~~~~~~~~~~~~  232 (298)
T d1gz8a_         158 T--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL--FR-IFRTLGTPDEVVWPGVTS  232 (298)
T ss_dssp             C--TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HH-HHHHHCCCCTTTSTTGGG
T ss_pred             c--ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHH--HH-HHHhcCCCchhhcccccc
Confidence            2  24457999999999877665 578999999999999999999999754332211  00 11111000   0   000


Q ss_pred             eecCcc----cccC-----cHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HhcC
Q 041921          750 LVGEDK----EAMN-----DIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM--LEGV  795 (814)
Q Consensus       750 ~~~~~~----~~~~-----~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~--L~~~  795 (814)
                      ..+...    ....     ......++.+++.+||+.||.+|||++|+++-  |+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~  289 (298)
T d1gz8a_         233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV  289 (298)
T ss_dssp             STTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             ccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence            000000    0000     11234678899999999999999999999874  5544

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=4.6e-41  Score=353.59  Aligned_cols=260  Identities=22%  Similarity=0.276  Sum_probs=200.3

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEE
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY  597 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  597 (814)
                      +|.+.++||+|+||+||+|...   +++.||||+++...  ....+.+.+|+.++++++||||+++++++.+++..++++
T Consensus         3 ~Y~~~~~iG~G~fg~Vy~~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~   79 (286)
T d1ob3a_           3 KYHGLEKIGEGTYGVVYKAQNN---YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF   79 (286)
T ss_dssp             SEEEEEEEEEETTEEEEEEEET---TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             CceeccEEecCCCcEEEEEEeC---CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEE
Confidence            4567789999999999999875   56899999996532  333567999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcc
Q 041921          598 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSK  677 (814)
Q Consensus       598 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  677 (814)
                      ||+.++.+..+......+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++.........
T Consensus        80 e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~  156 (286)
T d1ob3a_          80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK  156 (286)
T ss_dssp             ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             EeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCccc
Confidence            9999988888888788899999999999999999999998   9999999999999999999999999999876543221


Q ss_pred             cccccccCCCCcccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCc------ccee
Q 041921          678 TIKTAIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK------LNVL  750 (814)
Q Consensus       678 ~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~~~  750 (814)
                        .....+++.|+|||.+.+. .++.++|||||||+++||++|+.||......+..  .. +........      ....
T Consensus       157 --~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~--~~-i~~~~~~~~~~~~~~~~~~  231 (286)
T d1ob3a_         157 --YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQL--MR-IFRILGTPNSKNWPNVTEL  231 (286)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HH-HHHHHCCCCTTTSTTGGGS
T ss_pred             --cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHH--HH-HHHhhCCCChhhccchhhh
Confidence              1334689999999998754 5689999999999999999999999754332211  11 111110000      0000


Q ss_pred             ---------ecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          751 ---------VGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       751 ---------~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                               ................+.+++.+||+.||++|||++|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                     0000000111123457889999999999999999999974

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-40  Score=352.61  Aligned_cols=262  Identities=23%  Similarity=0.294  Sum_probs=197.2

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhcc---CCCCccceeeeecc----
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQT---HHKNLVRLLGFCDE----  589 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~----  589 (814)
                      ..|.+.++||+|+||+||+|.... ..++.||||+++...  ......+.+|+.+++.+   +||||+++++++..    
T Consensus         7 ~~Y~i~~~LG~G~fg~V~~a~~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           7 QQYECVAEIGEGAYGKVFKARDLK-NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETT-TTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             CCEEEEEEEecccCeEEEEEEEEC-CCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            457778899999999999998742 236789999986432  22334577788777766   79999999999853    


Q ss_pred             -cccceEEEecCCCCCHHHHhc-CCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCC
Q 041921          590 -GQNRLLVYEFLNNGTLASFLF-GNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGL  667 (814)
Q Consensus       590 -~~~~~lv~e~~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGl  667 (814)
                       ....++++||+.++.+..... ....+++.....++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg~  162 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL  162 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred             cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchhh
Confidence             456789999999888765544 346788999999999999999999998   999999999999999999999999999


Q ss_pred             ccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCcc
Q 041921          668 AKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL  747 (814)
Q Consensus       668 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  747 (814)
                      ++.......   .....||+.|+|||++.+..++.++||||+||++|||++|+.||......+..   ..+.........
T Consensus       163 ~~~~~~~~~---~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~---~~i~~~~~~~~~  236 (305)
T d1blxa_         163 ARIYSFQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL---GKILDVIGLPGE  236 (305)
T ss_dssp             CCCCCGGGG---GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCCG
T ss_pred             hhhhccccc---CCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHH---HHHHHhhCCCch
Confidence            986553322   24567999999999999999999999999999999999999999765433211   111111100000


Q ss_pred             ce-----------e--ecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          748 NV-----------L--VGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       748 ~~-----------~--~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      ..           .  ..............+.+.+|+.+||+.||++|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            00           0  0000000011123456788999999999999999999986

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-39  Score=348.16  Aligned_cols=268  Identities=19%  Similarity=0.219  Sum_probs=198.7

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccc--cccchHhHHHHHHhhhccCCCCccceeeeecc-------
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRV--FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDE-------  589 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------  589 (814)
                      .+|.+.++||+|+||+||+|+..  .+++.||||++...  .....+++.+|+.+|++++||||+++++++..       
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~   87 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHR--KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR   87 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEET--TTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred             CCEEEEEEEecCcCeEEEEEEEC--CCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence            46677899999999999999975  36789999998543  23345678999999999999999999998854       


Q ss_pred             -cccceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCc
Q 041921          590 -GQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLA  668 (814)
Q Consensus       590 -~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla  668 (814)
                       ..+.++||||+.++.+..+......++......++.||++||.|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus        88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~  164 (318)
T d3blha1          88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLA  164 (318)
T ss_dssp             ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeeccee
Confidence             346789999999988887777778889999999999999999999998   9999999999999999999999999999


Q ss_pred             cccccCCcc--cccccccCCCCcccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcC
Q 041921          669 KLLTLNQSK--TIKTAIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG  745 (814)
Q Consensus       669 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  745 (814)
                      +.+......  .......||+.|+|||.+.+. .++.++|||||||+++||++|+.||......................
T Consensus       165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  244 (318)
T d3blha1         165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE  244 (318)
T ss_dssp             EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence            876543221  111335699999999998765 68999999999999999999999997654333221111110000000


Q ss_pred             cc--------ceeecCcccccCc-------HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          746 KL--------NVLVGEDKEAMND-------IECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       746 ~~--------~~~~~~~~~~~~~-------~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                      ..        .............       ......+++++.+||+.||++|||++|+++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence            00        0000000000011       1123466789999999999999999999864

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.9e-39  Score=343.48  Aligned_cols=259  Identities=19%  Similarity=0.201  Sum_probs=195.8

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCcccee-eeecccccceEEEe
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLL-GFCDEGQNRLLVYE  598 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~-~~~~~~~~~~lv~e  598 (814)
                      +|.+.++||+|+||.||+|+...  +++.||||.+...  ....++..|++++++++|+|++..+ .+..+.+..++|||
T Consensus         8 rY~l~~~iG~G~fG~Vy~a~~~~--~~~~vAvK~~~~~--~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           8 RYRLGRKIGSGSFGDIYLGTDIA--AGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETT--TTEEEEEEEEESC--TTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             EEEEeEEEeeCCCcEEEEEEECC--CCCEEEEEEEchh--ccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence            57788999999999999998753  5789999988643  2345689999999999877766555 45566778889999


Q ss_pred             cCCCCCHHHHh-cCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc---CCCcEEEeecCCccccccC
Q 041921          599 FLNNGTLASFL-FGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLD---DYYTARISDFGLAKLLTLN  674 (814)
Q Consensus       599 ~~~~gsL~~~l-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~---~~~~~kl~DfGla~~~~~~  674 (814)
                      |+.+ +|...+ .....+++..+..++.|++.||+|||++   +|+||||||+|||++   .+..+||+|||+++.+...
T Consensus        84 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~  159 (299)
T d1ckia_          84 LLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  159 (299)
T ss_dssp             CCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred             EcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence            9955 555544 4567899999999999999999999998   999999999999986   4567999999999987643


Q ss_pred             Ccc-----cccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccce
Q 041921          675 QSK-----TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNV  749 (814)
Q Consensus       675 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  749 (814)
                      ...     .......||+.|||||.+.+..++.++|||||||++|||++|+.||..........................
T Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (299)
T d1ckia_         160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV  239 (299)
T ss_dssp             TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHH
T ss_pred             ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhH
Confidence            321     112345799999999999999999999999999999999999999976543221111100000000000000


Q ss_pred             eecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 041921          750 LVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV  795 (814)
Q Consensus       750 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~  795 (814)
                               .....+.++.+++..|++.+|++||+++++.+.|+.+
T Consensus       240 ---------~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~  276 (299)
T d1ckia_         240 ---------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  276 (299)
T ss_dssp             ---------HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred             ---------hccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence                     0112346788999999999999999999999888764

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.3e-39  Score=342.88  Aligned_cols=261  Identities=17%  Similarity=0.204  Sum_probs=205.4

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCC-CCccceeeeecccccceEEE
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHH-KNLVRLLGFCDEGQNRLLVY  597 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~  597 (814)
                      ..|.+.++||+|+||+||+|+...  .++.||||.+...  ....++.+|+++++.++| +|++.+++++.++...++||
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~--~~~~vAvK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm   80 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLL--NNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI   80 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETT--TTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEECC--CCCEEEEEEEccc--cCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence            467788999999999999999753  5789999988543  234468889999999965 89999999999999999999


Q ss_pred             ecCCCCCHHHHhcCC-CCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC-----CCcEEEeecCCcccc
Q 041921          598 EFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDD-----YYTARISDFGLAKLL  671 (814)
Q Consensus       598 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~-----~~~~kl~DfGla~~~  671 (814)
                      ||+ +++|.+++... ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.     ++.+||+|||+++.+
T Consensus        81 e~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~  156 (293)
T d1csna_          81 DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  156 (293)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             Eec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence            998 68999988764 5689999999999999999999998   9999999999999974     578999999999987


Q ss_pred             ccCCcc-----cccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCc
Q 041921          672 TLNQSK-----TIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK  746 (814)
Q Consensus       672 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  746 (814)
                      ......     .......||+.|||||.+.+..++.++||||||+++|||+||+.||..............+........
T Consensus       157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (293)
T d1csna_         157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP  236 (293)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred             ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC
Confidence            543221     112345799999999999999999999999999999999999999975544322211111111111111


Q ss_pred             cceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 041921          747 LNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV  796 (814)
Q Consensus       747 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L~~~~  796 (814)
                      ...+         ....++++.+++..|++.+|.+||+++.+.+.|+++.
T Consensus       237 ~~~l---------~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~  277 (293)
T d1csna_         237 LREL---------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL  277 (293)
T ss_dssp             HHHH---------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             hHHh---------cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            1110         0113457888999999999999999999988887643

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-39  Score=349.87  Aligned_cols=264  Identities=23%  Similarity=0.284  Sum_probs=194.8

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCccceeeeeccc------ccc
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEG------QNR  593 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~  593 (814)
                      +|...++||+|+||+||+|+...  .++.||||++....    ..+.+|++++++++||||+++++++...      ...
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~--~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~   94 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCD--SGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL   94 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEECCS----SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECC--CCCEEEEEEECccc----hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence            45667889999999999999763  57899999996532    2345799999999999999999998432      346


Q ss_pred             eEEEecCCCCCHHHHh---cCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC-cEEEeecCCcc
Q 041921          594 LLVYEFLNNGTLASFL---FGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYY-TARISDFGLAK  669 (814)
Q Consensus       594 ~lv~e~~~~gsL~~~l---~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~-~~kl~DfGla~  669 (814)
                      +|||||++++.+..+.   .....+++..+..++.||+.||+|||+.   +|+||||||+|||++.++ .+||+|||+++
T Consensus        95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~  171 (350)
T d1q5ka_          95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK  171 (350)
T ss_dssp             EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred             EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchh
Confidence            8999999876544433   3556789999999999999999999998   999999999999999765 89999999998


Q ss_pred             ccccCCcccccccccCCCCccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhh-HHH-------HHHH
Q 041921          670 LLTLNQSKTIKTAIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI-LTD-------WAFD  740 (814)
Q Consensus       670 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~-~~~-------~~~~  740 (814)
                      .+......   ....||..|+|||.+.+ ..++.++||||+||++|||++|+.||......+... +..       ..+.
T Consensus       172 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~  248 (350)
T d1q5ka_         172 QLVRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR  248 (350)
T ss_dssp             ECCTTSCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             hccCCccc---ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhh
Confidence            76543322   34569999999998765 578999999999999999999999997554322110 000       0000


Q ss_pred             HhhcC----ccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhcC
Q 041921          741 CYRNG----KLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ--MLEGV  795 (814)
Q Consensus       741 ~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~--~L~~~  795 (814)
                      .....    ....................++.+|+.+||+.||.+|||+.|+++  .++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  309 (350)
T d1q5ka_         249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL  309 (350)
T ss_dssp             HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence            00000    111111111111112234567889999999999999999999985  34444

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-39  Score=346.21  Aligned_cols=255  Identities=21%  Similarity=0.234  Sum_probs=204.5

Q ss_pred             hhhccccceeeeeeeeEEEEEEec-CCCceEEEEEEecccc----ccchHhHHHHHHhhhccCC-CCccceeeeeccccc
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQT-RTSTTAVAVKKLDRVF----QDGEREFKNEVFVIGQTHH-KNLVRLLGFCDEGQN  592 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~-~~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~  592 (814)
                      ..|.+.++||+|+||+||+|.... ...++.||||.++...    ....+.+.+|++++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            347888999999999999998743 3457899999986432    2334678999999999976 899999999999999


Q ss_pred             ceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccc
Q 041921          593 RLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLT  672 (814)
Q Consensus       593 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~  672 (814)
                      .++++||+.+|+|.+++.....+.......++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.+.
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~  180 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFV  180 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred             eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence            999999999999999998888888899999999999999999998   99999999999999999999999999998765


Q ss_pred             cCCcccccccccCCCCcccccccccC--CCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCcccee
Q 041921          673 LNQSKTIKTAIRGTKGYVAPEWFRNS--KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLNVL  750 (814)
Q Consensus       673 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  750 (814)
                      ....... ....|++.|+|||.+...  .++.++|||||||+||||++|+.||..........   .+.+.......   
T Consensus       181 ~~~~~~~-~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~---~i~~~~~~~~~---  253 (322)
T d1vzoa_         181 ADETERA-YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA---EISRRILKSEP---  253 (322)
T ss_dssp             GGGGGGG-CGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH---HHHHHHHHCCC---
T ss_pred             ccccccc-cccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHhcccCCC---
Confidence            4433322 445699999999999754  46889999999999999999999997654332111   11111111111   


Q ss_pred             ecCcccccCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 041921          751 VGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRP-----TMKKVLQ  790 (814)
Q Consensus       751 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~~vl~  790 (814)
                             ..+.....++.+++.+||+.||.+||     |++|+++
T Consensus       254 -------~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         254 -------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             -------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             -------CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence                   01123457888999999999999999     4788875

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-39  Score=338.41  Aligned_cols=262  Identities=20%  Similarity=0.269  Sum_probs=204.3

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeecccccceEEE
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY  597 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  597 (814)
                      +|.+.++||+|+||+||+|+..  .+++.||||+++...  ....+++.+|+.+++.++||||+++++++.+....++|+
T Consensus         3 ry~~i~~LG~G~fg~V~~~~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~   80 (292)
T d1unla_           3 KYEKLEKIGEGTYGTVFKAKNR--ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_dssp             SEEEEEEEEECSSSEEEEEEET--TTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEeeeEEecCcCeEEEEEEEC--CCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence            4667789999999999999975  367889999986432  233567899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccCCcc
Q 041921          598 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLNQSK  677 (814)
Q Consensus       598 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  677 (814)
                      |++.+++|..++.....+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||.++........
T Consensus        81 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~  157 (292)
T d1unla_          81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC  157 (292)
T ss_dssp             ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC
T ss_pred             eeccccccccccccccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCcc
Confidence            9999999999998888899999999999999999999998   9999999999999999999999999999877543322


Q ss_pred             cccccccCCCCcccccccccCC-CCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcC---cc------
Q 041921          678 TIKTAIRGTKGYVAPEWFRNSK-ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG---KL------  747 (814)
Q Consensus       678 ~~~~~~~gt~~y~aPE~~~~~~-~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~------  747 (814)
                      .  ....++..|+|||.+.... ++.++|||||||+++||++|+.||......... + ..+.......   ..      
T Consensus       158 ~--~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~  233 (292)
T d1unla_         158 Y--SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ-L-KRIFRLLGTPTEEQWPSMTKL  233 (292)
T ss_dssp             C--CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH-H-HHHHHHHCCCCTTTCTTGGGS
T ss_pred             c--eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHH-H-HHHHhhcCCCChhhhhhhhhc
Confidence            1  3345788999999987665 689999999999999999999997543322211 1 1111111100   00      


Q ss_pred             ------ceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          748 ------NVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       748 ------~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                            ...................+.+++.+||+.||.+|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                  0000000001111233456788999999999999999999986

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-39  Score=346.88  Aligned_cols=263  Identities=21%  Similarity=0.271  Sum_probs=195.1

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc-cchHhHHHHHHhhhccCCCCccceeeeecccc----cce
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ----NRL  594 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~  594 (814)
                      +|.+.++||+|+||+||+|+..  .+++.||||+++.... ...+.+.+|+.+|++++||||+++++++....    ..+
T Consensus         9 rY~~~~~LG~G~fg~Vy~~~~~--~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           9 RYTNLSYIGEGAYGMVCSAYDN--VNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             TEEEEEECC---CCCEEEEEET--TTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CeEEEEEEeeccCeEEEEEEEC--CCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            4667789999999999999864  3678999999975432 23457899999999999999999999986643    235


Q ss_pred             EEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccccC
Q 041921          595 LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLTLN  674 (814)
Q Consensus       595 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~~~  674 (814)
                      ++++|+.+|+|.+++... .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++......
T Consensus        87 ~l~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~  162 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD  162 (345)
T ss_dssp             EEEEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred             EEEEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence            556677899999999654 689999999999999999999998   9999999999999999999999999999876544


Q ss_pred             Ccc-cccccccCCCCccccccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCccc----
Q 041921          675 QSK-TIKTAIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLN----  748 (814)
Q Consensus       675 ~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----  748 (814)
                      ... .......||+.|+|||.+.. ..++.++||||+||+++||++|+.||......+......   .........    
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~~  239 (345)
T d1pmea_         163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL---GILGSPSQEDLNC  239 (345)
T ss_dssp             GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH---HHHCSCCHHHHHT
T ss_pred             CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHh---hhccCCChhhhhh
Confidence            322 12244669999999999854 467889999999999999999999997654322111110   000000000    


Q ss_pred             -------e-eecCcccccCc-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          749 -------V-LVGEDKEAMND-----IECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       749 -------~-~~~~~~~~~~~-----~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                             . ...........     .....++.+++.+||+.||.+|||++|+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                   0 00000000000     1123468899999999999999999999974

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-39  Score=347.22  Aligned_cols=267  Identities=25%  Similarity=0.291  Sum_probs=193.9

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeecccc-----
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ-----  591 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  591 (814)
                      .+|.+.++||+|+||+||+|...  ..++.||||+++...  ....+.+.+|+.+|++++|||||++++++...+     
T Consensus        18 ~~Y~~i~~lG~G~fg~V~~~~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~   95 (346)
T d1cm8a_          18 AVYRDLQPVGSGAYGAVCSAVDG--RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF   95 (346)
T ss_dssp             SSEEEEEEC------CEEEEEET--TTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             CcEEEEEEEecCCCeEEEEEEEC--CCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence            35667789999999999999965  357899999997432  223456899999999999999999999997654     


Q ss_pred             -cceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccc
Q 041921          592 -NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKL  670 (814)
Q Consensus       592 -~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~  670 (814)
                       +.++||||+ +.+|..++. ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus        96 ~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~  170 (346)
T d1cm8a_          96 TDFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQ  170 (346)
T ss_dssp             CCCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             ceEEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccceec
Confidence             469999999 557777664 45689999999999999999999998   999999999999999999999999999987


Q ss_pred             cccCCcccccccccCCCCcccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHH--------HHH
Q 041921          671 LTLNQSKTIKTAIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA--------FDC  741 (814)
Q Consensus       671 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~--------~~~  741 (814)
                      .....     +...||+.|+|||.+.+. .++.++||||+||+++||++|+.||...............        ...
T Consensus       171 ~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (346)
T d1cm8a_         171 ADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR  245 (346)
T ss_dssp             CCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred             cCCcc-----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhh
Confidence            65332     445699999999998764 5789999999999999999999999765432211100000        000


Q ss_pred             hhcC-------ccceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HhcCcCC
Q 041921          742 YRNG-------KLNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM--LEGVVEV  798 (814)
Q Consensus       742 ~~~~-------~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~--L~~~~~~  798 (814)
                      ....       .+......... .........+.+|+.+||+.||.+|||++|+++.  |+++.+.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~  310 (346)
T d1cm8a_         246 LQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT  310 (346)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred             hcchhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCc
Confidence            0000       00000000000 0111223567899999999999999999999974  6665443

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=5.7e-38  Score=336.66  Aligned_cols=258  Identities=20%  Similarity=0.301  Sum_probs=196.4

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccC-CCCccceeeeecc--cccceE
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTH-HKNLVRLLGFCDE--GQNRLL  595 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~l  595 (814)
                      ..|.+.++||+|+||+||+|+..  ..++.||||+++..   ..+++.+|+.+|++++ ||||+++++++..  ....++
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~--~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~  109 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINI--TNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL  109 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEET--TTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEEC--CCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence            35778899999999999999965  36789999998643   3567899999999995 9999999999864  456889


Q ss_pred             EEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC-cEEEeecCCccccccC
Q 041921          596 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYY-TARISDFGLAKLLTLN  674 (814)
Q Consensus       596 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~-~~kl~DfGla~~~~~~  674 (814)
                      ||||+++++|..+.   +.+++..+..++.||+.||.|||+.   +|+||||||+|||++.++ .+||+|||+++.....
T Consensus       110 v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~  183 (328)
T d3bqca1         110 VFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  183 (328)
T ss_dssp             EEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred             EEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCC
Confidence            99999999997764   4688999999999999999999998   999999999999998654 6999999999876644


Q ss_pred             CcccccccccCCCCcccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhh--HHH-----HHHHHhhcCc
Q 041921          675 QSKTIKTAIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI--LTD-----WAFDCYRNGK  746 (814)
Q Consensus       675 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~--~~~-----~~~~~~~~~~  746 (814)
                      ...   ....+|+.|+|||.+.+. .++.++||||+||+++||++|+.||..........  +..     ..........
T Consensus       184 ~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  260 (328)
T d3bqca1         184 QEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN  260 (328)
T ss_dssp             CCC---CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred             Ccc---cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence            322   445689999999998765 47999999999999999999999997554322110  000     0000000000


Q ss_pred             c------ceeec--------CcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 041921          747 L------NVLVG--------EDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ  790 (814)
Q Consensus       747 ~------~~~~~--------~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~  790 (814)
                      .      .....        .............++.+|+.+||+.||.+|||++|+++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0      00000        00011111223467889999999999999999999986

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-37  Score=335.45  Aligned_cols=261  Identities=23%  Similarity=0.269  Sum_probs=187.5

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEecccc--ccchHhHHHHHHhhhccCCCCccceeeeecc------cc
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDE------GQ  591 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~  591 (814)
                      .|.+.++||+|+||+||+|...  .+++.||||++....  ......+.+|+.++++++||||+++++++..      ..
T Consensus        18 ~Y~i~~~LG~G~fg~V~~~~d~--~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~   95 (355)
T d2b1pa1          18 RYQNLKPIGSGAQGIVCAAYDA--VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ   95 (355)
T ss_dssp             TEEEEEECSCC--CEEEEEEET--TTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             CeEEEEEeecCcCeEEEEEEEC--CCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence            3566789999999999999865  367899999996432  2234568999999999999999999999853      46


Q ss_pred             cceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCcccc
Q 041921          592 NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLL  671 (814)
Q Consensus       592 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~  671 (814)
                      +.++||||+.++.+. .+.  ..+++.....++.||+.||.|||+.   +|+||||||+|||++.++.+|++|||+++..
T Consensus        96 ~~~iv~Ey~~~~l~~-~~~--~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~~  169 (355)
T d2b1pa1          96 DVYLVMELMDANLCQ-VIQ--MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA  169 (355)
T ss_dssp             EEEEEEECCSEEHHH-HHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             eeEEEEeccchHHHH-hhh--cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhcc
Confidence            789999999765554 443  4578999999999999999999998   9999999999999999999999999998876


Q ss_pred             ccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhH-H---------------
Q 041921          672 TLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL-T---------------  735 (814)
Q Consensus       672 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~-~---------------  735 (814)
                      ......   +...+|+.|+|||.+.+..+++++||||+||+++||++|+.||........... .               
T Consensus       170 ~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~  246 (355)
T d2b1pa1         170 GTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ  246 (355)
T ss_dssp             --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred             cccccc---ccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence            543322   445689999999999999999999999999999999999999975432211100 0               


Q ss_pred             HHHHHHhhcCc-c-----ceeecCcc---cccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 041921          736 DWAFDCYRNGK-L-----NVLVGEDK---EAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQM  791 (814)
Q Consensus       736 ~~~~~~~~~~~-~-----~~~~~~~~---~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~  791 (814)
                      ........... .     ........   ...........+.+|+.+||+.||++|||++|+++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            00000001000 0     00000000   011123456788999999999999999999999853

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-38  Score=338.05  Aligned_cols=268  Identities=24%  Similarity=0.272  Sum_probs=198.1

Q ss_pred             hhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccc--cchHhHHHHHHhhhccCCCCccceeeeecc-----ccc
Q 041921          520 TNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQ--DGEREFKNEVFVIGQTHHKNLVRLLGFCDE-----GQN  592 (814)
Q Consensus       520 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~  592 (814)
                      +|.+.++||+|+||+||+|...  .+++.||||+++....  ...+++.+|+.++++++|||+|++++++..     ...
T Consensus        19 rY~i~~~LG~G~fg~Vy~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          19 RYQNLSPVGSGAYGSVCAAFDT--KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             TEEEEEECGGGTTSSEEEEEET--TTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CeEEEEEEecCCCeEEEEEEEC--CCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            4677789999999999999865  3688999999975322  234568899999999999999999999854     334


Q ss_pred             ceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEeecCCccccc
Q 041921          593 RLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARISDFGLAKLLT  672 (814)
Q Consensus       593 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~~~  672 (814)
                      .+++++|+.+|+|.+++.. ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+|++|||++....
T Consensus        97 ~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~  172 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTD  172 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred             eEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcccC
Confidence            5777888899999999865 4689999999999999999999998   99999999999999999999999999987654


Q ss_pred             cCCcccccccccCCCCcccccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCcccchhhhhHHHHHHHHhhcCc-----
Q 041921          673 LNQSKTIKTAIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK-----  746 (814)
Q Consensus       673 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-----  746 (814)
                      ...     ....||..|+|||.+.+. .++.++|||||||++|||++|+.||..........   .+........     
T Consensus       173 ~~~-----~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~---~i~~~~~~~~~~~~~  244 (348)
T d2gfsa1         173 DEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK---LILRLVGTPGAELLK  244 (348)
T ss_dssp             GGG-----SSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCCCCHHHHT
T ss_pred             ccc-----ccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHH---HHHHhcCCCChHHhh
Confidence            322     345689999999987665 46889999999999999999999997553322111   1111100000     


Q ss_pred             -------------cceeecCcccccCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhcCcCCCCCC
Q 041921          747 -------------LNVLVGEDKEAMNDIECLGKLVMVSIWCIQEDPSLRPTMKKVLQ--MLEGVVEVSVPP  802 (814)
Q Consensus       747 -------------~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~--~L~~~~~~~~p~  802 (814)
                                   .......... .........+.+|+.+||+.||.+|||++|+++  .+.+..+.+..|
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~~  314 (348)
T d2gfsa1         245 KISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEP  314 (348)
T ss_dssp             TCCCHHHHHHHTTSCCCCCCCHH-HHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSCC
T ss_pred             hccchhhhhhhhhcccCCCcchh-hhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccCC
Confidence                         0000000000 000123456789999999999999999999997  566655444333

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.1e-33  Score=304.12  Aligned_cols=265  Identities=21%  Similarity=0.277  Sum_probs=188.1

Q ss_pred             hhhccccceeeeeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccC-----------CCCccceeeee
Q 041921          519 ATNNFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTH-----------HKNLVRLLGFC  587 (814)
Q Consensus       519 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~  587 (814)
                      .+|.+.++||+|+||+||+|+..  .+++.||||+++.. ....+.+.+|+.++++++           |+||+++++++
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~--~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~   89 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDM--VNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF   89 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEET--TTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEEC--CCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence            45888999999999999999965  36789999999753 223456788888888775           57899999888


Q ss_pred             ccc--ccceEEEecCCCCC-HHHHh--cCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC----
Q 041921          588 DEG--QNRLLVYEFLNNGT-LASFL--FGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYY----  658 (814)
Q Consensus       588 ~~~--~~~~lv~e~~~~gs-L~~~l--~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~----  658 (814)
                      ...  ...+++++++..+. .....  .....+++..+..++.||+.||+|||+.  .+|+||||||+|||++.++    
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~~  167 (362)
T d1q8ya_          90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPEN  167 (362)
T ss_dssp             EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTT
T ss_pred             eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeeeccCcccc
Confidence            653  34556666655443 22222  2346778889999999999999999983  2899999999999998654    


Q ss_pred             --cEEEeecCCccccccCCcccccccccCCCCcccccccccCCCCcchhhHHHHHHHHHHHhCCCCCCcccchhhh----
Q 041921          659 --TARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA----  732 (814)
Q Consensus       659 --~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~s~Gvvl~elltg~~p~~~~~~~~~~----  732 (814)
                        .++++|||.+.......     ....||+.|+|||.+....++.++||||+||+++||++|+.||.........    
T Consensus       168 ~~~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~  242 (362)
T d1q8ya_         168 LIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD  242 (362)
T ss_dssp             EEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred             cceeeEeeccccccccccc-----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence              49999999998654322     3456999999999999999999999999999999999999999754331111    


Q ss_pred             hHHHHHHHHhh--------cC-----------ccceeecCc---------ccccCcHHHHHHHHHHHHHccccCCCCCCC
Q 041921          733 ILTDWAFDCYR--------NG-----------KLNVLVGED---------KEAMNDIECLGKLVMVSIWCIQEDPSLRPT  784 (814)
Q Consensus       733 ~~~~~~~~~~~--------~~-----------~~~~~~~~~---------~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt  784 (814)
                      .+...+ ..+.        .+           ....+....         ...........++.+++.+||+.||.+|||
T Consensus       243 ~~~~~~-~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt  321 (362)
T d1q8ya_         243 HIAQII-ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD  321 (362)
T ss_dssp             HHHHHH-HHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred             HHHHHH-HHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcC
Confidence            111100 0000        00           000000000         011123456788999999999999999999


Q ss_pred             HHHHHHH--Hhc
Q 041921          785 MKKVLQM--LEG  794 (814)
Q Consensus       785 ~~~vl~~--L~~  794 (814)
                      ++|+++.  +++
T Consensus       322 a~e~L~Hp~f~~  333 (362)
T d1q8ya_         322 AGGLVNHPWLKD  333 (362)
T ss_dssp             HHHHHTCGGGTT
T ss_pred             HHHHhcCcccCC
Confidence            9999873  554

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.82  E-value=8.9e-21  Score=184.99  Aligned_cols=161  Identities=14%  Similarity=0.135  Sum_probs=118.8

Q ss_pred             ccccceeeeeeeeEEEEEEecCCCceEEEEEEecccccc------------------chHhHHHHHHhhhccCCCCccce
Q 041921          522 NFKEEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVFQD------------------GEREFKNEVFVIGQTHHKNLVRL  583 (814)
Q Consensus       522 ~~~~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~------------------~~~~~~~E~~~l~~l~h~niv~l  583 (814)
                      .++++||+|+||+||+|...   +++.||||.++.....                  ....+..|...+.++.|.+++..
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~---~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~   79 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSE---KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKV   79 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEET---TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCE
T ss_pred             hhCCEeeeCcceEEEEEECC---CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceE
Confidence            46789999999999999875   5789999987531110                  01234568888999999999988


Q ss_pred             eeeecccccceEEEecCCCCCHHHHhcCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEe
Q 041921          584 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCRAQIIHCDIKPQNILLDDYYTARIS  663 (814)
Q Consensus       584 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i~H~dlkp~NIll~~~~~~kl~  663 (814)
                      +++.    ..+++|||+++..+..       ++......++.|++++|+|||+.   +|+||||||+|||++++ .++|+
T Consensus        80 ~~~~----~~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~li  144 (191)
T d1zara2          80 YAWE----GNAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWII  144 (191)
T ss_dssp             EEEE----TTEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEEC
T ss_pred             EEec----CCEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEE
Confidence            8663    3479999998866543       44556678999999999999998   99999999999999965 58999


Q ss_pred             ecCCccccccCCcccccccccCCCCccc------ccccccCCCCcchhhHHHHH
Q 041921          664 DFGLAKLLTLNQSKTIKTAIRGTKGYVA------PEWFRNSKITAKVDVYSFGV  711 (814)
Q Consensus       664 DfGla~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~s~~~Dv~s~Gv  711 (814)
                      |||+|..........          |..      .|.+ .+.+..++|+||..-
T Consensus       145 DFG~a~~~~~~~~~~----------~l~rd~~~~~~~f-~r~y~~~~d~~s~~~  187 (191)
T d1zara2         145 DFPQSVEVGEEGWRE----------ILERDVRNIITYF-SRTYRTEKDINSAID  187 (191)
T ss_dssp             CCTTCEETTSTTHHH----------HHHHHHHHHHHHH-HHHHCCCCCHHHHHH
T ss_pred             ECCCcccCCCCCcHH----------HHHHHHHHHHHHH-cCCCCCcccHHHHHH
Confidence            999997654222111          111      1111 356788899999654

>d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Gastrodianin (antifungal protein)
species: Gastrodia elata [TaxId: 91201]

Probab=99.81  E-value=4.5e-20  Score=161.89  Aligned_cols=111  Identities=19%  Similarity=0.365  Sum_probs=91.7

Q ss_pred             CCccCCCceeecCCCCCceecCCCcEEEeEeeccCCCCCCCcEEEEEEecccCCCeEEEEecCCCCCCCCCCCceEEEcc
Q 041921           27 NGTVPVGATLTAGTSSSPWLSPSGDFAFGFHQLDEENNTNDLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLTA  106 (814)
Q Consensus        27 ~~ti~~g~~l~~~~~~~~lvS~~g~F~lGF~~~~~~~~~~~~~~lgiw~~~~~~~t~vW~Anr~~~~~~~~~~~~l~~~~  106 (814)
                      +|||.|||.|.+|+   .|+  +|.|+|.|+..|         .|.|+..    .++||.||++   .+ ...+.|.|+.
T Consensus         1 tDtL~~gq~L~~g~---~l~--~g~~~l~~q~DG---------NLvly~~----~~~vW~s~~~---~~-~~~~~l~l~~   58 (112)
T d1xd5a_           1 SDRLNSGHQLDTGG---SLA--EGGYLFIIQNDC---------NLVLYDN----NRAVWASGTN---GK-ASGCVLKMQN   58 (112)
T ss_dssp             CCEEETTEEECTTC---EEE--ETTEEEEECTTS---------CEEEEET----TEEEEECCCT---TS-CSSEEEEECT
T ss_pred             CCEecCCCEecCCC---EEE--ECCEEEEEcCCC---------CEEEEcC----CcEEEEccCc---cC-CCCcEEEEec
Confidence            48999999999999   676  599999998765         3666653    5899999987   22 3457899999


Q ss_pred             CCcEEEeCCCCceEeeeccCCC-ceeEEEEecCcCEEEEeCCCCceeecccCCcc
Q 041921          107 DQGLVLNDPQGKQVWSSKIDIG-TVAVGHMNDTGNFVLASSSSGRLWDSFSNPTD  160 (814)
Q Consensus       107 ~G~Lvl~~~~g~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~lWQSFd~PtD  160 (814)
                      ||+|||+|. +.++|+++++.. +..+|+|+|+|||||++.++.++|||+.+|+|
T Consensus        59 dGnLvl~~~-~~~~w~s~t~~~~~~~~l~L~ddGNlvly~~~~~~~W~S~t~~~n  112 (112)
T d1xd5a_          59 DGNLVIYSG-SRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNVGN  112 (112)
T ss_dssp             TSCEEEEET-TEEEEECCCCCSCCCCEEEECTTSCEEEECTTSCEEEECCCCCCC
T ss_pred             cccEEEEec-CCeEEEEeeccCCCceEEEEcCCCCEEEECCCCcEEecCCCccCC
Confidence            999999996 567888776644 44589999999999999999999999999985

>d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Garlic (Allium sativum) [TaxId: 4682]

Probab=99.80  E-value=1.7e-19  Score=156.53  Aligned_cols=107  Identities=21%  Similarity=0.356  Sum_probs=88.5

Q ss_pred             CCccCCCceeecCCCCCceecCCCcEEEeEeeccCCCCCCCcEEEEEEecccCCCeEEEEecCCCCCCCCCCCceEEEcc
Q 041921           27 NGTVPVGATLTAGTSSSPWLSPSGDFAFGFHQLDEENNTNDLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLTA  106 (814)
Q Consensus        27 ~~ti~~g~~l~~~~~~~~lvS~~g~F~lGF~~~~~~~~~~~~~~lgiw~~~~~~~t~vW~Anr~~~~~~~~~~~~l~~~~  106 (814)
                      .|+|.+||.|.+|+   .|+  +|.|.|+|...+         .|.++..    .++||+||++   .++...++|.|+.
T Consensus         1 ~~~L~~g~~L~~g~---~l~--~g~~~l~~q~dg---------nLvl~~~----~~~vW~ant~---~~~~~~~~l~l~~   59 (109)
T d1kj1a_           1 RNLLTNGEGLYAGQ---SLD--VEPYHFIMQEDC---------NLVLYDH----STSVWASNTG---ILGKKGCKAVLQS   59 (109)
T ss_dssp             CCEEETTCEEETTC---EEE--ETTEEEEECTTS---------CEEEEET----TEEEEECCCC---CTTCCCCEEEECT
T ss_pred             CCCccCCCEEeCCC---EEE--eCCEEEEecCCC---------eEEEEeC----CEEEEEeCCC---CCCceeEEEEEcC
Confidence            37899999999998   565  589999997654         3566543    5899999998   4556678899999


Q ss_pred             CCcEEEeCCCCceEeeeccCC-CceeEEEEecCcCEEEEeCCCCceeecccC
Q 041921          107 DQGLVLNDPQGKQVWSSKIDI-GTVAVGHMNDTGNFVLASSSSGRLWDSFSN  157 (814)
Q Consensus       107 ~G~Lvl~~~~g~~vWst~~~~-~~~~~a~LldsGNlVl~~~~~~~lWQSFd~  157 (814)
                      ||+|||+|++|++||+|+++. .+..+|+|+|+|||||++.   .+|||+-|
T Consensus        60 dGnLvl~~~~g~~vW~s~t~~~~~~~~l~L~ddGNlvly~~---~~W~S~t~  108 (109)
T d1kj1a_          60 DGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGS---DIWSTGTY  108 (109)
T ss_dssp             TSCEEEECSSSCEEEECCCCCCSSCCEEEECTTSCEEEECC---EEEECCCC
T ss_pred             CceEEEEeCCCcEEEEEeeECCCCCEEEEEeCCCcEEEECC---CEecCCCc
Confidence            999999999999999999864 3456899999999999964   59999875

>d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Snowdrop (Galanthus nivalis) [TaxId: 4670]

Probab=99.79  E-value=2.1e-19  Score=155.94  Aligned_cols=106  Identities=21%  Similarity=0.349  Sum_probs=88.0

Q ss_pred             CCccCCCceeecCCCCCceecCCCcEEEeEeeccCCCCCCCcEEEEEEecccCCCeEEEEecCCCCCCCCCCCceEEEcc
Q 041921           27 NGTVPVGATLTAGTSSSPWLSPSGDFAFGFHQLDEENNTNDLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLTA  106 (814)
Q Consensus        27 ~~ti~~g~~l~~~~~~~~lvS~~g~F~lGF~~~~~~~~~~~~~~lgiw~~~~~~~t~vW~Anr~~~~~~~~~~~~l~~~~  106 (814)
                      +|+|.+||.|.+|+   .|.  +|.|.|.|+..|         .|.|+..    .++||.||++   .+ ...+.|.|..
T Consensus         1 ~~~L~~g~~L~~G~---~l~--ng~~~l~~q~DG---------NLvly~~----~~~vW~s~~~---~~-~~~~~l~l~~   58 (108)
T d1jpca_           1 DNILYSGETLSTGE---FLN--YGSFVFIMQEDC---------NLVLYDV----DKPIWATNTG---GL-SRSCFLSMQT   58 (108)
T ss_dssp             CCEEETTEEECTTC---EEE--ETTEEEEECTTS---------CEEEEET----TEEEEECCCT---TS-CSSCEEEECT
T ss_pred             CCCccCCCEecCCC---EEE--cCCEEEEECCCC---------eEEEEeC----CceeeEeCCC---CC-CCccEEEEec
Confidence            47899999999998   564  699999998765         3677663    5789999988   22 3456899999


Q ss_pred             CCcEEEeCCCCceEeeeccCCCce-eEEEEecCcCEEEEeCCCCceeecccC
Q 041921          107 DQGLVLNDPQGKQVWSSKIDIGTV-AVGHMNDTGNFVLASSSSGRLWDSFSN  157 (814)
Q Consensus       107 ~G~Lvl~~~~g~~vWst~~~~~~~-~~a~LldsGNlVl~~~~~~~lWQSFd~  157 (814)
                      +|+|||.|++|.+||||++..... .+|+|+|+|||||++.   .+||||+|
T Consensus        59 ~Gnlvl~~~~g~~vWsS~t~~~~~~~~l~L~ddGNlVly~~---~~W~S~t~  107 (108)
T d1jpca_          59 DGNLVVYNPSNKPIWASNTGGQNGNYVCILQKDRNVVIYGT---DRWATGTH  107 (108)
T ss_dssp             TSCEEEECTTCCEEEECCCCCSCSCEEEEECTTSCEEEEEC---CCCCCCCC
T ss_pred             cceEEEECCCccceEEccccCCCCcEEEEEcCCCCEEEeCC---CcccCCCC
Confidence            999999999999999999765443 5789999999999964   48999987

>d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.71  E-value=9e-18  Score=147.91  Aligned_cols=101  Identities=21%  Similarity=0.278  Sum_probs=85.6

Q ss_pred             EEecccCCCeEEEEecCCCCCCCCCCCceEEEccCCcEEEeCCCCceEeeeccCCCc-eeEEEEecCcCEEEEeCCCCce
Q 041921           73 IFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLTADQGLVLNDPQGKQVWSSKIDIGT-VAVGHMNDTGNFVLASSSSGRL  151 (814)
Q Consensus        73 iw~~~~~~~t~vW~Anr~~~~~~~~~~~~l~~~~~G~Lvl~~~~g~~vWst~~~~~~-~~~a~LldsGNlVl~~~~~~~l  151 (814)
                      |||.++++++.+|++|++  .+.....-+|.|..||||||++. +.++|++++...+ ..+|+|+++|||||++.++.+|
T Consensus        12 il~~~~~~~~~~~~l~~~--q~l~~g~y~L~~q~DGNLvL~~~-~~~vW~s~t~~~~~~~~~~l~~~GnLvl~d~~~~~l   88 (120)
T d1dlpa2          12 ILYSTQGNDNHPQTLHAT--QSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQNIAV   88 (120)
T ss_dssp             ECCCC--CCCCCCEECSS--CCCBCSSCEEEEETTTEEEEEBT-TBCCSCCCCCSSCSSCEEEEETTTEEEEEETTTEEE
T ss_pred             EEEcCCCCCCcccEEcCC--CeeEcCCEEEEEcCCCcEEEecC-CcEEEEEccccCCCcEEEEEeCCeeEEEEcCCCCEE
Confidence            899999999999999999  34445567899999999999985 6789999987654 4689999999999999999999


Q ss_pred             eecccCCccccccCCccccccceeecccCCCCCCCceeEEEccCCceeEE
Q 041921          152 WDSFSNPTDTLLLGQMMETEQGLFSRKSENNFSRGRFQFRLLEDGNLVLN  201 (814)
Q Consensus       152 WQSFd~PtDtlLpg~~l~~~~~l~S~~s~~d~s~G~~~~~~~~~g~~~~~  201 (814)
                      ||||.                         +.++|.|.+.|++||++++|
T Consensus        89 W~S~t-------------------------~~~~~~~~l~Lq~DGnlvlY  113 (120)
T d1dlpa2          89 WTSGN-------------------------SRSAGRYVFVLQPDRNLAIY  113 (120)
T ss_dssp             EECCC-------------------------CCSSSCCEEEECSSSCEEEE
T ss_pred             EEeCC-------------------------CCCCCcEEEEECCCCcEEEe
Confidence            99983                         34678899999999999886

>d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.63  E-value=5.3e-17  Score=141.29  Aligned_cols=111  Identities=20%  Similarity=0.236  Sum_probs=90.8

Q ss_pred             EEecccCCCeEEEEecCCCCCCCCCCCceEEEccCCcEEEeCCCCceEeeeccCCCceeEEEEecCcCEEEEeCCCCcee
Q 041921           73 IFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLTADQGLVLNDPQGKQVWSSKIDIGTVAVGHMNDTGNFVLASSSSGRLW  152 (814)
Q Consensus        73 iw~~~~~~~t~vW~Anr~~~~~~~~~~~~l~~~~~G~Lvl~~~~g~~vWst~~~~~~~~~a~LldsGNlVl~~~~~~~lW  152 (814)
                      |||.-.++.+..|..+.+  .+......+|.|..||||||++ .+.++|++++.+..+..+.|+|+|||||++.++.+||
T Consensus         3 ~~~~~~~~~~~~~tl~~~--~~l~~g~~~l~~q~DGNLvL~~-~~~~vW~s~t~~~~~~~l~l~~dGNLvl~d~~~~~vW   79 (115)
T d1dlpa1           3 ILFGLSHEGSHPQTLHAA--QSLELSSFRFTMQSDCNLVLFD-SDVRVWASNTAGATGCRAVLQSDGLLVILTAQNTIRW   79 (115)
T ss_dssp             CCBCSSSSSCSCSCCCTT--CEECSTTEEEEECTTSCEEEEE-SSSEEECCCCCSCSCCBCCBCSSSCBCCBCTTTCCSC
T ss_pred             EEEecCCCCCCcceecCC--CcEEcCCEEEEECCCCeEEEEc-CCeeEEEcccCCCCceEEEEeccCCEEEEccCCCEEE
Confidence            566655566777888877  3445566789999999999998 5689999998877778899999999999999999999


Q ss_pred             ecccCCccccccCCccccccceeecccCCCCCCCceeEEEccCCceeEEeeccCCCccccceeecccc
Q 041921          153 DSFSNPTDTLLLGQMMETEQGLFSRKSENNFSRGRFQFRLLEDGNLVLNIANLATGFAYDAYYTSGTY  220 (814)
Q Consensus       153 QSFd~PtDtlLpg~~l~~~~~l~S~~s~~d~s~G~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~sg~~  220 (814)
                      ||+.                         +.++|.|.+.|++||+++++   .      .++|.+|+-
T Consensus        80 sS~t-------------------------~~~~g~y~l~Lq~DGNlvlY---~------~~~Wssgt~  113 (115)
T d1dlpa1          80 SSGT-------------------------KGSIGNYVLVLQPDRTVTIY---G------PGLWDSGTS  113 (115)
T ss_dssp             CCCC-------------------------CCCSSCCEEEECSSSCEEEE---C------SEEEECSCC
T ss_pred             EcCC-------------------------CCCCCCEEEEECCCCcEEEe---C------CCeecCCCC
Confidence            9873                         34689999999999998876   1      358998874

>d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.54  E-value=1e-14  Score=127.54  Aligned_cols=102  Identities=20%  Similarity=0.282  Sum_probs=79.3

Q ss_pred             CccCCCceeecCCCCCceecCCCcEEEeEeeccCCCCCCCcEEEEEEecccCCCeEEEEecCCCCCCCCCCCceEEEccC
Q 041921           28 GTVPVGATLTAGTSSSPWLSPSGDFAFGFHQLDEENNTNDLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLTAD  107 (814)
Q Consensus        28 ~ti~~g~~l~~~~~~~~lvS~~g~F~lGF~~~~~~~~~~~~~~lgiw~~~~~~~t~vW~Anr~~~~~~~~~~~~l~~~~~  107 (814)
                      .+|.++|+|       ...+..|.|.|.|...|         -|.+ |.   ..++||.+|+..   + ...+.|.|..|
T Consensus        15 ~~l~~~q~l-------~~~~~~~~y~l~mQ~DG---------NLVL-y~---~~~~vWssnt~~---~-~~~~~l~l~~d   70 (119)
T d1b2pa_          15 QILHATESL-------EILFGTHVYRFIMQTDC---------NLVL-YD---NNNPIWATNTGG---L-GNGCRAVLQPD   70 (119)
T ss_dssp             CEEETTCEE-------EEEETTEEEEEEECTTS---------CEEE-EE---TTEEEEECCCTT---S-CSSCEEEECTT
T ss_pred             CEEeCCCeE-------EEecCCceEEEEECCCC---------cEEE-EE---CCeEEEEecCCC---C-CcceEEEEEeC
Confidence            456666666       35778999999998765         2444 33   258899999872   2 33578999999


Q ss_pred             CcEEEeCCCCceEeeeccCCCc-eeEEEEecCcCEEEEeCCCCceeeccc
Q 041921          108 QGLVLNDPQGKQVWSSKIDIGT-VAVGHMNDTGNFVLASSSSGRLWDSFS  156 (814)
Q Consensus       108 G~Lvl~~~~g~~vWst~~~~~~-~~~a~LldsGNlVl~~~~~~~lWQSFd  156 (814)
                      |+|+|.|++|.+||++++.... ..+++|+|+|||||++   ..+|||-.
T Consensus        71 GnLvL~d~~g~~vWsS~t~~~~~~~~l~Lq~DGNlvlYg---~~~W~S~T  117 (119)
T d1b2pa_          71 GVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG---DALWATQT  117 (119)
T ss_dssp             SCEEEECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEE---SEEEECCC
T ss_pred             CCEEEECCCCcEEEECCCcCCCCceEEEEcCCCCEEEEC---CCEeccCC
Confidence            9999999999999999986543 4579999999999995   36999965

>d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.32  E-value=8.6e-13  Score=114.30  Aligned_cols=88  Identities=23%  Similarity=0.280  Sum_probs=68.7

Q ss_pred             CCCcEEEeEeeccCCCCCCCcEEEEEEecccCCCeEEEEecCCCCCCCCCCCceEEEccCCcEEEeCCCCceEeeeccCC
Q 041921           48 PSGDFAFGFHQLDEENNTNDLFLLSIFYNKIPEKTVVWYTDNKDQNPAVPRGSQVKLTADQGLVLNDPQGKQVWSSKIDI  127 (814)
Q Consensus        48 ~~g~F~lGF~~~~~~~~~~~~~~lgiw~~~~~~~t~vW~Anr~~~~~~~~~~~~l~~~~~G~Lvl~~~~g~~vWst~~~~  127 (814)
                      .+|.|.|.|...|         -|.|+..    .++||.+|..     ....+++.|..||||||.|.++++||++.+..
T Consensus        24 ~~g~~~l~~q~DG---------NLvL~~~----~~~vW~s~t~-----~~~~~~l~l~~dGNLvl~d~~~~~vWsS~t~~   85 (115)
T d1dlpa1          24 ELSSFRFTMQSDC---------NLVLFDS----DVRVWASNTA-----GATGCRAVLQSDGLLVILTAQNTIRWSSGTKG   85 (115)
T ss_dssp             CSTTEEEEECTTS---------CEEEEES----SSEEECCCCC-----SCSCCBCCBCSSSCBCCBCTTTCCSCCCCCCC
T ss_pred             EcCCEEEEECCCC---------eEEEEcC----CeeEEEcccC-----CCCceEEEEeccCCEEEEccCCCEEEEcCCCC
Confidence            3577999998665         2667542    4789988754     23457899999999999999999999999864


Q ss_pred             C-ceeEEEEecCcCEEEEeCCCCceeeccc
Q 041921          128 G-TVAVGHMNDTGNFVLASSSSGRLWDSFS  156 (814)
Q Consensus       128 ~-~~~~a~LldsGNlVl~~~~~~~lWQSFd  156 (814)
                      . +..+++|+++|||||++   ..+|+|-.
T Consensus        86 ~~g~y~l~Lq~DGNlvlY~---~~~Wssgt  112 (115)
T d1dlpa1          86 SIGNYVLVLQPDRTVTIYG---PGLWDSGT  112 (115)
T ss_dssp             CSSCCEEEECSSSCEEEEC---SEEEECSC
T ss_pred             CCCCEEEEECCCCcEEEeC---CCeecCCC
Confidence            3 33479999999999994   46999854

>d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.15  E-value=9.1e-11  Score=102.07  Aligned_cols=85  Identities=21%  Similarity=0.324  Sum_probs=69.1

Q ss_pred             eEEEccCCcEEEeCCCCceEeeeccCCCc-eeEEEEecCcCEEEEeCCCCceeecccCCccccccCCccccccceeeccc
Q 041921          101 QVKLTADQGLVLNDPQGKQVWSSKIDIGT-VAVGHMNDTGNFVLASSSSGRLWDSFSNPTDTLLLGQMMETEQGLFSRKS  179 (814)
Q Consensus       101 ~l~~~~~G~Lvl~~~~g~~vWst~~~~~~-~~~a~LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg~~l~~~~~l~S~~s  179 (814)
                      +|.+..||||||+++ +.+||++++.+.+ ...+.|.++|||||++.++.+||+|.-                       
T Consensus        33 ~l~mQ~DGNLVLy~~-~~~vWssnt~~~~~~~~l~l~~dGnLvL~d~~g~~vWsS~t-----------------------   88 (119)
T d1b2pa_          33 RFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQSPV-----------------------   88 (119)
T ss_dssp             EEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECSC-----------------------
T ss_pred             EEEECCCCcEEEEEC-CeEEEEecCCCCCcceEEEEEeCCCEEEECCCCcEEEECCC-----------------------
Confidence            588899999999975 5789999987554 468999999999999999999998632                       


Q ss_pred             CCCCCCCceeEEEccCCceeEEeeccCCCccccceeecccc
Q 041921          180 ENNFSRGRFQFRLLEDGNLVLNIANLATGFAYDAYYTSGTY  220 (814)
Q Consensus       180 ~~d~s~G~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~sg~~  220 (814)
                        .-+.|.|.+.|++||+++++-         .+.|.|++.
T Consensus        89 --~~~~~~~~l~Lq~DGNlvlYg---------~~~W~S~T~  118 (119)
T d1b2pa_          89 --AGKAGHYVLVLQPDRNVVIYG---------DALWATQTV  118 (119)
T ss_dssp             --CCCSSCEEEEECTTSCEEEEE---------SEEEECCCC
T ss_pred             --cCCCCceEEEEcCCCCEEEEC---------CCEeccCCc
Confidence              124578999999999998862         258988763

>d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Snowdrop (Galanthus nivalis) [TaxId: 4670]

Probab=99.12  E-value=1.3e-10  Score=99.69  Aligned_cols=85  Identities=25%  Similarity=0.373  Sum_probs=68.6

Q ss_pred             ceEEEccCCcEEEeCCCCceEeeeccCCCce-eEEEEecCcCEEEEeCCCCceeecccCCccccccCCccccccceeecc
Q 041921          100 SQVKLTADQGLVLNDPQGKQVWSSKIDIGTV-AVGHMNDTGNFVLASSSSGRLWDSFSNPTDTLLLGQMMETEQGLFSRK  178 (814)
Q Consensus       100 ~~l~~~~~G~Lvl~~~~g~~vWst~~~~~~~-~~a~LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg~~l~~~~~l~S~~  178 (814)
                      -+|.+..||||||++ .+.+||++++...+. ..++|+++|||||++.++.+||+|                        
T Consensus        21 ~~l~~q~DGNLvly~-~~~~vW~s~~~~~~~~~~l~l~~~Gnlvl~~~~g~~vWsS------------------------   75 (108)
T d1jpca_          21 FVFIMQEDCNLVLYD-VDKPIWATNTGGLSRSCFLSMQTDGNLVVYNPSNKPIWAS------------------------   75 (108)
T ss_dssp             EEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEEC------------------------
T ss_pred             EEEEECCCCeEEEEe-CCceeeEeCCCCCCCccEEEEeccceEEEECCCccceEEc------------------------
Confidence            578999999999998 458999999876543 589999999999999999999986                        


Q ss_pred             cCCCCCCCceeEEEccCCceeEEeeccCCCccccceeeccc
Q 041921          179 SENNFSRGRFQFRLLEDGNLVLNIANLATGFAYDAYYTSGT  219 (814)
Q Consensus       179 s~~d~s~G~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~sg~  219 (814)
                       .+..+.+.|.+.|+++|+++++-         .+.|.|++
T Consensus        76 -~t~~~~~~~~l~L~ddGNlVly~---------~~~W~S~t  106 (108)
T d1jpca_          76 -NTGGQNGNYVCILQKDRNVVIYG---------TDRWATGT  106 (108)
T ss_dssp             -CCCCSCSCEEEEECTTSCEEEEE---------CCCCCCCC
T ss_pred             -cccCCCCcEEEEEcCCCCEEEeC---------CCcccCCC
Confidence             12224578899999999998872         23677764

>d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Garlic (Allium sativum) [TaxId: 4682]

Probab=99.10  E-value=1.7e-10  Score=98.92  Aligned_cols=86  Identities=30%  Similarity=0.519  Sum_probs=68.7

Q ss_pred             ceEEEccCCcEEEeCCCCceEeeeccCCC--ceeEEEEecCcCEEEEeCCCCceeecccCCccccccCCccccccceeec
Q 041921          100 SQVKLTADQGLVLNDPQGKQVWSSKIDIG--TVAVGHMNDTGNFVLASSSSGRLWDSFSNPTDTLLLGQMMETEQGLFSR  177 (814)
Q Consensus       100 ~~l~~~~~G~Lvl~~~~g~~vWst~~~~~--~~~~a~LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg~~l~~~~~l~S~  177 (814)
                      -+|.|..||||||.+ .+.+||++++...  ....+.|.++|||||++.++.++|+|                       
T Consensus        21 ~~l~~q~dgnLvl~~-~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~s-----------------------   76 (109)
T d1kj1a_          21 YHFIMQEDCNLVLYD-HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAEGRSLWAS-----------------------   76 (109)
T ss_dssp             EEEEECTTSCEEEEE-TTEEEEECCCCCTTCCCCEEEECTTSCEEEECSSSCEEEEC-----------------------
T ss_pred             EEEEecCCCeEEEEe-CCEEEEEeCCCCCCceeEEEEEcCCceEEEEeCCCcEEEEE-----------------------
Confidence            568889999999987 5689999998643  34579999999999999999999987                       


Q ss_pred             ccCCCCCCCceeEEEccCCceeEEeeccCCCccccceeecccc
Q 041921          178 KSENNFSRGRFQFRLLEDGNLVLNIANLATGFAYDAYYTSGTY  220 (814)
Q Consensus       178 ~s~~d~s~G~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~sg~~  220 (814)
                        .+..+.|.|.+.|+++|+++++-         .+.|.|+++
T Consensus        77 --~t~~~~~~~~l~L~ddGNlvly~---------~~~W~S~t~  108 (109)
T d1kj1a_          77 --HSVRGNGNYVLVLQEDGNVVIYG---------SDIWSTGTY  108 (109)
T ss_dssp             --CCCCCSSCCEEEECTTSCEEEEC---------CEEEECCCC
T ss_pred             --eeECCCCCEEEEEeCCCcEEEEC---------CCEecCCCc
Confidence              11123577899999999998861         247888764

>d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=98.96  E-value=6.7e-10  Score=96.80  Aligned_cols=110  Identities=25%  Similarity=0.287  Sum_probs=72.8

Q ss_pred             EEecCcCEEEEeCCCCceeecccCCccccccCCccccccceeecccCCCCCCCceeEEEccCCceeEEeeccCCCccccc
Q 041921          134 HMNDTGNFVLASSSSGRLWDSFSNPTDTLLLGQMMETEQGLFSRKSENNFSRGRFQFRLLEDGNLVLNIANLATGFAYDA  213 (814)
Q Consensus       134 ~LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg~~l~~~~~l~S~~s~~d~s~G~~~~~~~~~g~~~~~~~~~~~~~~~~~  213 (814)
                      +|+|+||+||++.      +|+|.|+++|.++|.|.               .|.|+|.|+.||+++++-.  .     ..
T Consensus         4 v~~~~~n~il~~~------~~~~~~~~~l~~~q~l~---------------~g~y~L~~q~DGNLvL~~~--~-----~~   55 (120)
T d1dlpa2           4 VVANNGNSILYST------QGNDNHPQTLHATQSLQ---------------LSPYRLSMETDCNLVLFDR--D-----DR   55 (120)
T ss_dssp             CCSSCCCEECCCC--------CCCCCCEECSSCCCB---------------CSSCEEEEETTTEEEEEBT--T-----BC
T ss_pred             EEEeCCCeEEEcC------CCCCCcccEEcCCCeeE---------------cCCEEEEEcCCCcEEEecC--C-----cE
Confidence            4455555555422      67899999999999874               5789999999999987632  2     35


Q ss_pred             eeeccccCCCCCCCCcceeeecCCccEEEEeeCCceeeeeeeecccCCceEEEEEEecCccEEEE
Q 041921          214 YYTSGTYDPANSSNSGYRVMFNESGYMYILRRNGGRFDLTTERVVPAADFYYRATLNFDGVFAQY  278 (814)
Q Consensus       214 ~~~sg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~L~~dG~l~~y  278 (814)
                      +|.+....    ......+.+..+|.+.+...++..+ ........ . ..++++|+.||+|++|
T Consensus        56 vW~s~t~~----~~~~~~~~l~~~GnLvl~d~~~~~l-W~S~t~~~-~-~~~~l~Lq~DGnlvlY  113 (120)
T d1dlpa2          56 VWSTNTAG----KGTGCRAVLQPNGRMDVLTNQNIAV-WTSGNSRS-A-GRYVFVLQPDRNLAIY  113 (120)
T ss_dssp             CSCCCCCS----SCSSCEEEEETTTEEEEEETTTEEE-EECCCCCS-S-SCCEEEECSSSCEEEE
T ss_pred             EEEEcccc----CCCcEEEEEeCCeeEEEEcCCCCEE-EEeCCCCC-C-CcEEEEECCCCcEEEe
Confidence            78776532    1234556777888877766655443 33322111 2 2348999999999999

>d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Gastrodianin (antifungal protein)
species: Gastrodia elata [TaxId: 91201]

Probab=98.87  E-value=5.1e-09  Score=90.35  Aligned_cols=111  Identities=24%  Similarity=0.323  Sum_probs=77.7

Q ss_pred             ccccccCCccccccceeecccCCCCCCCceeEEEccCCceeEEeeccCCCccccceeeccccCCCCCCCCcceeeecCCc
Q 041921          159 TDTLLLGQMMETEQGLFSRKSENNFSRGRFQFRLLEDGNLVLNIANLATGFAYDAYYTSGTYDPANSSNSGYRVMFNESG  238 (814)
Q Consensus       159 tDtlLpg~~l~~~~~l~S~~s~~d~s~G~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~sg~~~~~~~~~~~~~~~~~~~~  238 (814)
                      ||||+|||.|..++.|++         |.|+|.++.||+++++...       .++|.++....    ..+..+.+..+|
T Consensus         1 tDtL~~gq~L~~g~~l~~---------g~~~l~~q~DGNLvly~~~-------~~vW~s~~~~~----~~~~~l~l~~dG   60 (112)
T d1xd5a_           1 SDRLNSGHQLDTGGSLAE---------GGYLFIIQNDCNLVLYDNN-------RAVWASGTNGK----ASGCVLKMQNDG   60 (112)
T ss_dssp             CCEEETTEEECTTCEEEE---------TTEEEEECTTSCEEEEETT-------EEEEECCCTTS----CSSEEEEECTTS
T ss_pred             CCEecCCCEecCCCEEEE---------CCEEEEEcCCCCEEEEcCC-------cEEEEccCccC----CCCcEEEEeccc
Confidence            899999999999999965         9999999999999887421       46898876532    334567788888


Q ss_pred             cEEEEeeCCceeeeeeeecccCCceEEEEEEecCccEEEEEecCCCCCCeEEEEeccCCcc
Q 041921          239 YMYILRRNGGRFDLTTERVVPAADFYYRATLNFDGVFAQYFYPKNGNGNWSVAWSEPENIC  299 (814)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~L~~dG~l~~y~~~~~~~~~W~~~~~~p~~~C  299 (814)
                      .+.+...+ ..+ .....  ......++++|+.||+|++|.-      .....|+...+.|
T Consensus        61 nLvl~~~~-~~~-w~s~t--~~~~~~~~l~L~ddGNlvly~~------~~~~~W~S~t~~~  111 (112)
T d1xd5a_          61 NLVIYSGS-RAI-WASNT--NRQNGNYYLILQRDRNVVIYDN------SNNAIWATHTNVG  111 (112)
T ss_dssp             CEEEEETT-EEE-EECCC--CCSCCCCEEEECTTSCEEEECT------TSCEEEECCCCCC
T ss_pred             cEEEEecC-CeE-EEEee--ccCCCceEEEEcCCCCEEEECC------CCcEEecCCCccC
Confidence            87766543 333 22221  1122345899999999999832      1246787765544

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.07  E-value=9.7e-06  Score=80.83  Aligned_cols=132  Identities=16%  Similarity=0.052  Sum_probs=92.2

Q ss_pred             eeeeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccC-CCCccceeeeecccccceEEEecCCCCCHHHH
Q 041921          530 GSFGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTH-HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASF  608 (814)
Q Consensus       530 G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~  608 (814)
                      +..+.||+...    ++..+.||+...........+..|...+..+. +-.+.+++.+..+++..++||+++++.++.+.
T Consensus        25 ~s~~~v~rv~~----~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~  100 (263)
T d1j7la_          25 MSPAKVYKLVG----ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEE  100 (263)
T ss_dssp             CSSSEEEEEEC----SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHH
T ss_pred             CCCCcEEEEEe----CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccc
Confidence            33467998753    35567888886655545556788888887763 44567888888888888999999999888665


Q ss_pred             hcCCCCCChhhHHHHHHHHHHHHHHhhhcC--------------------------------------------------
Q 041921          609 LFGNLKPNWNLRTNIAFQIARGLLYLHEDC--------------------------------------------------  638 (814)
Q Consensus       609 l~~~~~l~~~~~~~i~~~ia~~l~yLH~~~--------------------------------------------------  638 (814)
                      ...     ......++.++++.++.||+..                                                  
T Consensus       101 ~~~-----~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  175 (263)
T d1j7la_         101 YED-----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLK  175 (263)
T ss_dssp             TTT-----CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHH
T ss_pred             ccc-----cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHH
Confidence            422     1223345555666666666321                                                  


Q ss_pred             ------CCCeeecCCCCCcEEEcCCCcEEEeecCCccc
Q 041921          639 ------RAQIIHCDIKPQNILLDDYYTARISDFGLAKL  670 (814)
Q Consensus       639 ------~~~i~H~dlkp~NIll~~~~~~kl~DfGla~~  670 (814)
                            ...++|+|+.|.|||++++...-|+||+.+..
T Consensus       176 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         176 TEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             HSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             hcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                  12379999999999999876677999987753

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.38  E-value=0.00033  Score=73.81  Aligned_cols=76  Identities=17%  Similarity=0.121  Sum_probs=47.5

Q ss_pred             cceeeeeeeeEEEEEEecCCCceEEEEEEecccc-------ccchHhHHHHHHhhhccC-C--CCccceeeeecccccce
Q 041921          525 EEVGRGSFGIVYKGVIQTRTSTTAVAVKKLDRVF-------QDGEREFKNEVFVIGQTH-H--KNLVRLLGFCDEGQNRL  594 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-------~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~  594 (814)
                      +.||.|....||+.....  +++.++||.-....       .........|.+.|+.+. +  ..+++++.+  +++..+
T Consensus        32 ~eig~G~~N~vfrV~~~~--~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~  107 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQE--HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV  107 (392)
T ss_dssp             EECCSSSSEEEEEEEC------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred             EEeCCCceEeEEEEEeCC--CCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCE
Confidence            568999999999987542  45688899653211       112234556787777662 2  345566655  445678


Q ss_pred             EEEecCCCCC
Q 041921          595 LVYEFLNNGT  604 (814)
Q Consensus       595 lv~e~~~~gs  604 (814)
                      +|||++++..
T Consensus       108 lvmE~L~~~~  117 (392)
T d2pula1         108 TVMEDLSHLK  117 (392)
T ss_dssp             EEECCCTTSE
T ss_pred             EEEeccCCcc
Confidence            9999997643

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.35  E-value=0.00034  Score=68.72  Aligned_cols=129  Identities=16%  Similarity=0.072  Sum_probs=80.4

Q ss_pred             eeeee-eeeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCC--CCccceeeeecccccceEEEecCCCC
Q 041921          527 VGRGS-FGIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHH--KNLVRLLGFCDEGQNRLLVYEFLNNG  603 (814)
Q Consensus       527 LG~G~-~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g  603 (814)
                      +..|. .+.||+....   ++..+.+|.-...   ....+..|...++.+..  -.+.+++.+..+++..++|||++++.
T Consensus        18 ~~~G~s~~~v~r~~~~---~~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~   91 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQ---GRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ   91 (255)
T ss_dssp             CSCTTSSCEEEEEECT---TSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred             cCCcccCCeEEEEEeC---CCCEEEEEeCCcc---CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence            33444 2578987643   4556777865433   23357778888877743  34667888888888889999999876


Q ss_pred             CHHHHhcCCCCCChhhHHHHHHHHHHHHHHhh------------------------------------------------
Q 041921          604 TLASFLFGNLKPNWNLRTNIAFQIARGLLYLH------------------------------------------------  635 (814)
Q Consensus       604 sL~~~l~~~~~l~~~~~~~i~~~ia~~l~yLH------------------------------------------------  635 (814)
                      ++.+..        .....++.++++.|+-||                                                
T Consensus        92 ~~~~~~--------~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (255)
T d1nd4a_          92 DLLSSH--------LAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA  163 (255)
T ss_dssp             ETTTSC--------CCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred             cccccc--------ccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHH
Confidence            543210        000111122222222222                                                


Q ss_pred             ---hc----CCCCeeecCCCCCcEEEcCCCcEEEeecCCcc
Q 041921          636 ---ED----CRAQIIHCDIKPQNILLDDYYTARISDFGLAK  669 (814)
Q Consensus       636 ---~~----~~~~i~H~dlkp~NIll~~~~~~kl~DfGla~  669 (814)
                         ..    ....++|+|+.|.|||++++..+-|+||+.+.
T Consensus       164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         164 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence               21    11248999999999999987667899998765

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.03  E-value=0.011  Score=59.89  Aligned_cols=132  Identities=14%  Similarity=0.051  Sum_probs=74.1

Q ss_pred             eeEEEEEEecCCCceEEEEEEeccccccchHhHHHHHHhhhccCCCCc--cceeee-----ecccccceEEEecCCCCCH
Q 041921          533 GIVYKGVIQTRTSTTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNL--VRLLGF-----CDEGQNRLLVYEFLNNGTL  605 (814)
Q Consensus       533 g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~~-----~~~~~~~~lv~e~~~~gsL  605 (814)
                      -.||++...   ++..+++|..+.. ....+++..|...+..+....+  +..+..     ...+...+.+++++++..+
T Consensus        36 N~vy~v~~~---dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~  111 (325)
T d1zyla1          36 NRVYQFQDE---DRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF  111 (325)
T ss_dssp             SEEEEECCT---TCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred             ceeEEEEcC---CCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence            369988765   5778999987643 2345678888888888753322  222211     1234456788998876322


Q ss_pred             -----HHH-------------hcCC-----CCCCh-------------------hhHHHHHHHHHHHHHHhhh----cCC
Q 041921          606 -----ASF-------------LFGN-----LKPNW-------------------NLRTNIAFQIARGLLYLHE----DCR  639 (814)
Q Consensus       606 -----~~~-------------l~~~-----~~l~~-------------------~~~~~i~~~ia~~l~yLH~----~~~  639 (814)
                           ..+             ....     ...++                   ..+..+...+.+.+..+..    ...
T Consensus       112 ~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p  191 (325)
T d1zyla1         112 EADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT  191 (325)
T ss_dssp             CSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred             CCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCC
Confidence                 111             1110     11111                   1111222222333333332    234


Q ss_pred             CCeeecCCCCCcEEEcCCCcEEEeecCCccc
Q 041921          640 AQIIHCDIKPQNILLDDYYTARISDFGLAKL  670 (814)
Q Consensus       640 ~~i~H~dlkp~NIll~~~~~~kl~DfGla~~  670 (814)
                      .+++|+|+.+.|||++++  ..++||+-+..
T Consensus       192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         192 VLRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             ceeecCCCCcccEEEeCC--ceEEechhccc
Confidence            579999999999999754  45899987763

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=95.60  E-value=0.018  Score=59.89  Aligned_cols=75  Identities=12%  Similarity=0.180  Sum_probs=48.6

Q ss_pred             cceeeeeeeeEEEEEEecCC-----CceEEEEEEeccccccchHhHHHHHHhhhccCCCCc-cceeeeecccccceEEEe
Q 041921          525 EEVGRGSFGIVYKGVIQTRT-----STTAVAVKKLDRVFQDGEREFKNEVFVIGQTHHKNL-VRLLGFCDEGQNRLLVYE  598 (814)
Q Consensus       525 ~~LG~G~~g~Vy~~~~~~~~-----~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e  598 (814)
                      +.|+.|---.+|+....+..     ....|.++..- . ........+|..+++.+.-.++ .++++++.+    .+|+|
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e  121 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  121 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence            46777888899998876421     23345555543 2 2334456788888888853444 477887754    68899


Q ss_pred             cCCCCCH
Q 041921          599 FLNNGTL  605 (814)
Q Consensus       599 ~~~~gsL  605 (814)
                      |+++..|
T Consensus       122 fi~g~~l  128 (395)
T d1nw1a_         122 YIPSRPL  128 (395)
T ss_dssp             CCCEEEC
T ss_pred             EeccccC
Confidence            9987443

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=91.30  E-value=0.47  Score=46.76  Aligned_cols=31  Identities=26%  Similarity=0.320  Sum_probs=27.5

Q ss_pred             CCCeeecCCCCCcEEEcCCCcEEEeecCCcc
Q 041921          639 RAQIIHCDIKPQNILLDDYYTARISDFGLAK  669 (814)
Q Consensus       639 ~~~i~H~dlkp~NIll~~~~~~kl~DfGla~  669 (814)
                      ..+++|+|+.+.||+++.+...-|.||+.+.
T Consensus       182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccccccCCcchhhhhcccccceeEecccccc
Confidence            4579999999999999988777899999875

>d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Fibrillin-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=89.62  E-value=0.066  Score=32.89  Aligned_cols=33  Identities=24%  Similarity=0.558  Sum_probs=24.4

Q ss_pred             CcccccCCCCCCCCCCCCcccccCCCCCCccccCCCCCcCC
Q 041921          297 NICVDIGGGLGSGACGYNSICTLDSDRRPRCACPKGYSLLD  337 (814)
Q Consensus       297 ~~C~~~~~~~~~~~CG~~g~C~~~~~~~~~C~C~~GF~~~~  337 (814)
                      |.|.+      -..|| ||.|+.- ...-.|.|-.||+|..
T Consensus         2 dECsi------gnpCG-nGTCtNv-iGgFec~C~~GFepgp   34 (39)
T d1emoa2           2 DECSV------GNPCG-NGTCKNV-IGGFECTCEEGFEPGP   34 (39)
T ss_dssp             CGGGT------TCSSS-SSCEEEC-SSSEEECCSSSSCCCS
T ss_pred             Ccccc------CCccC-Cceeeec-ccceEEeecCCcCCCc
Confidence            56777      57888 7889742 3345799999999853

>d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Neurogenic locus notch homolog protein 1, Notch1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=80.49  E-value=0.24  Score=32.53  Aligned_cols=26  Identities=23%  Similarity=0.603  Sum_probs=20.9

Q ss_pred             CCCCCCCcccccCCCCCCccccCCCCC
Q 041921          308 SGACGYNSICTLDSDRRPRCACPKGYS  334 (814)
Q Consensus       308 ~~~CG~~g~C~~~~~~~~~C~C~~GF~  334 (814)
                      ...|..+|.|.. ...+-.|.|++||+
T Consensus        10 ~~pC~n~g~C~n-~~g~y~C~C~~G~~   35 (42)
T d2vj3a1          10 ANPCEHAGKCIN-TLGSFECQCLQGYT   35 (42)
T ss_dssp             SCSSSTTCEEEE-CSSSEEEECCTTEE
T ss_pred             CCCCCCCcEeEC-CCCCEEeECCCCCc
Confidence            468999999974 34456899999996